PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hunt, JH; Mutti, NS; Havukainen, H; Henshaw, MT; Amdam, GV				Hunt, James H.; Mutti, Navdeep S.; Havukainen, Heli; Henshaw, Michael T.; Amdam, Gro V.			Development of an RNA Interference Tool, Characterization of Its Target, and an Ecological Test of Caste Differentiation in the Eusocial Wasp Polistes	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PAPER WASP; GENE-EXPRESSION; SOCIAL WASPS; METRICUS HYMENOPTERA; JUVENILE-HORMONE; HEXAMERIN GENES; VESPID WASPS; PROTEIN; PHOSPHORYLATION	Recent advancements in genomics provide new tools for evolutionary ecological research. The paper wasp genus Polistes is a model for social insect evolution and behavioral ecology. We developed RNA interference (RNAi)-mediated gene silencing to explore proposed connections between expression of hexameric storage proteins and worker vs. gyne (potential future foundress) castes in naturally-founded colonies of P. metricus. We extended four fragments of putative hexamerin-encoding P. metricus transcripts acquired from a previous study and fully sequenced a gene that encodes Hexamerin 2, one of two proposed hexameric storage proteins of P. metricus. MALDI-TOF/TOF, LC-MSMS, deglycosylation, and detection of phosphorylation assays showed that the two putative hexamerins diverge in peptide sequence and biochemistry. We targeted the hexamerin 2 gene in 5(th) (last)-instar larvae by feeding RNAi-inducing double-stranded hexamerin 2 RNA directly to larvae in naturally-founded colonies in the field. Larval development and adult traits were not significantly altered in hexamerin 2 knockdowns, but there were suggestive trends toward increased developmental time and less developed ovaries, which are gyne characteristics. By demonstrating how data acquisition from 454/Roche pyrosequencing can be combined with biochemical and proteomics assays and how RNAi can be deployed successfully in field experiments on Polistes, our results pave the way for functional genomic research that can contribute significantly to learning the interactions of environment, development, and the roles they play in paper wasp evolution and behavioral ecology.	[Hunt, James H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Mutti, Navdeep S.; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Havukainen, Heli; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Havukainen, Heli] Univ Bergen, Dept Biomed, Bergen, Norway; [Henshaw, Michael T.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; University of Bergen; Grand Valley State University	Hunt, JH (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	jim_hunt@ncsu.edu		Salmela, Heli/0000-0002-6917-2922	NSF [0819807]; National Program for Research in Functional Genomics; Research Council of Norway (RCN); RCN [180504, 185306, 191699]; PEW Charitable Trust	NSF(National Science Foundation (NSF)); National Program for Research in Functional Genomics; Research Council of Norway (RCN)(Research Council of Norway); RCN; PEW Charitable Trust	Research at NCSU was supported by NSF grant #0819807 to JHH and C. M. Grozinger. PROBE received support from the National Program for Research in Functional Genomics, which is funded by the Research Council of Norway (RCN). GVA was supported by RCN 180504, 185306, and 191699 and the PEW Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Arif A, 2008, INSECT BIOCHEM MOLEC, V38, P307, DOI 10.1016/j.ibmb.2007.11.007; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cristino AS, 2010, INSECT MOL BIOL, V19, P137, DOI 10.1111/j.1365-2583.2009.00970.x; Deleurance E-P, 1955, INSECT SOC, V2, P285; Evans H. E., 1958, Proceedings 10th International Congress of Entomology Montreal 1956, V2, P449; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Nunes FMF, 2009, INSECT BIOCHEM MOLEC, V39, P157, DOI 10.1016/j.ibmb.2008.10.011; GAMBOA GJ, 1979, CAN ENTOMOL, V111, P919, DOI 10.4039/Ent111919-8; Garland Jr. T, EXPT EVOLUTION CONCE; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Henshaw M, 2011, INSECTES SO IN PRESS; Hines HM, 2007, P NATL ACAD SCI USA, V104, P3295, DOI 10.1073/pnas.0610140104; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010674; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; Hunt JH, 2007, EVOLUTION SOCIAL WAS; JONES G, 1990, J BIOL CHEM, V265, P8596; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Korb J, 2009, SCIENCE, V324, P758, DOI 10.1126/science.1170660; Kucharski R, 2005, J MOL NEUROSCI, V27, P269, DOI 10.1385/JMN:27:3:269; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; METCALF RA, 1980, AM NAT, V116, P642, DOI 10.1086/283655; METCALF RA, 1977, BEHAV ECOL SOCIOBIOL, V2, P353, DOI 10.1007/BF00299505; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Mutti NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022195; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Naumann I. D., 1991, INSECTS AUSTR, VII, P916; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RABB R. L., 1960, ANN ENT SOC AMER, V53, P111; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rau P., 1918, WASP STUDIES AFIELD; Reeve HK, 2001, MG BEH ECOL, P57; Resetarits Jr. WJ, EXPT ECOLOGY ISSUES; ROSSI AM, 1988, ECOL ENTOMOL, V13, P437, DOI 10.1111/j.1365-2311.1988.tb00376.x; Ryu KS, 2009, BIOCHEM J, V421, P87, DOI 10.1042/BJ20082170; Starks PT, 1998, P ROY SOC B-BIOL SCI, V265, P1407, DOI 10.1098/rspb.1998.0449; STRASSMANN JE, 1988, ECOLOGY, V69, P1497, DOI 10.2307/1941647; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Toth AL, 2010, P ROY SOC B-BIOL SCI, V277, P2139, DOI 10.1098/rspb.2010.0090; Turillazzi S., 1996, NATURAL HIST EVOLUTI; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wolschin F, 2011, BIOL LETTERS, V7, P112, DOI 10.1098/rsbl.2010.0463; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	57	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26641	10.1371/journal.pone.0026641	http://dx.doi.org/10.1371/journal.pone.0026641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069460	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900022
J	Pollock, DD; de Koning, APJ; Kim, H; Castoe, TA; Churchill, MEA; Kechris, KJ				Pollock, David D.; de Koning, A. P. Jason; Kim, Hyunmin; Castoe, Todd A.; Churchill, Mair E. A.; Kechris, Katerina J.			Bayesian Analysis of High-Throughput Quantitative Measurement of Protein-DNA Interactions	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-BINDING; GENE-REGULATION; CHROMATIN IMMUNOPRECIPITATION; SEQUENCE SPECIFICITIES; SITE DISCOVERY; GENOME; MICROARRAYS; RECOGNITION; MODEL; YEAST	Transcriptional regulation depends upon the binding of transcription factor (TF) proteins to DNA in a sequence-dependent manner. Although many experimental methods address the interaction between DNA and proteins, they generally do not comprehensively and accurately assess the full binding repertoire (the complete set of sequences that might be bound with at least moderate strength). Here, we develop and evaluate through simulation an experimental approach that allows simultaneous high-throughput quantitative analysis of TF binding affinity to thousands of potential DNA ligands. Tens of thousands of putative binding targets can be mixed with a TF, and both the pre-bound and bound target pools sequenced. A hierarchical Bayesian Markov chain Monte Carlo approach determines posterior estimates for the dissociation constants, sequence-specific binding energies, and free TF concentrations. A unique feature of our approach is that dissociation constants are jointly estimated from their inferred degree of binding and from a model of binding energetics, depending on how many sequence reads are available and the explanatory power of the energy model. Careful experimental design is necessary to obtain accurate results over a wide range of dissociation constants. This approach, which we call Simultaneous Ultra high-throughput Ligand Dissociation EXperiment (SULDEX), is theoretically capable of rapid and accurate elucidation of an entire TF-binding repertoire.	[Pollock, David D.; de Koning, A. P. Jason; Kim, Hyunmin; Castoe, Todd A.; Churchill, Mair E. A.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Churchill, Mair E. A.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Kechris, Katerina J.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health	Pollock, DD (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	David.Pollock@UCDenver.edu	Pollock, David D/M-4740-2016; Churchill, Mair E. A./C-5549-2014	Pollock, David D/0000-0002-7627-4214; Churchill, Mair E. A./0000-0003-0862-235X; de Koning, A.P. Jason/0000-0001-5450-5600; Kechris, Katerina/0000-0002-3725-5459	National Institutes of Health [R01, GM083127]; University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059456, R01GM083127, R01GM079154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors acknowledge the support of the National Institutes of Health (R01, GM083127) and University of Colorado setup funds to DDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awadhi F, 2004, STAT PROBABIL LETT, V69, P189, DOI 10.1016/j.spl.2004.06.025; Ananko EA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-56; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Borneman AR, 2007, FUNCT INTEGR GENOMIC, V7, P335, DOI 10.1007/s10142-007-0054-7; Bulyk ML, 2006, METHOD ENZYMOL, V410, P279, DOI 10.1016/S0076-6879(06)10013-0; Bulyk ML, 2007, ADV BIOCHEM ENG BIOT, V104, P65, DOI 10.1007/10_025; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; CAREY M, 1999, TRANSCRIPTIONAL REGU; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; DAI X, 2007, NUCL ACIDS RES; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Friberg Markus T, 2007, J Bioinform Comput Biol, V5, P105, DOI 10.1142/S0219720007002540; FRIDEN P, 1988, MOL CELL BIOL, V8, P2690, DOI 10.1128/MCB.8.7.2690; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gelman A., 2004, BAYESIAN DATA ANAL; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Gustafsdottir SM, 2007, P NATL ACAD SCI USA, V104, P3067, DOI 10.1073/pnas.0611229104; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JOLMA A, GENOME RES, V20, P861; Kinney JB, 2007, P NATL ACAD SCI USA, V104, P501, DOI 10.1073/pnas.0609908104; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Liu X, 2002, J MOL BIOL, V323, P1, DOI 10.1016/S0022-2836(02)00894-X; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Manke T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000039; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Pape Utz J, 2006, Genome Inform, V17, P134; Reddy TE, 2007, PLOS COMPUT BIOL, V3, P844, DOI 10.1371/journal.pcbi.0030090; Roberts GO, 1997, ANN APPL PROBAB, V7, P110, DOI 10.1214/aoap/1034625254; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Stepanova M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S27; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van Oeffelen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn140; Wang JB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-345; Wang XH, 2008, NUCLEIC ACIDS RES, V36, P4863, DOI 10.1093/nar/gkn477; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	58	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26105	10.1371/journal.pone.0026105	http://dx.doi.org/10.1371/journal.pone.0026105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069446	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900007
J	Bihrer, V; Waidmann, O; Friedrich-Rust, M; Forestier, N; Susser, S; Haupenthal, J; Welker, M; Shi, Y; Peveling-Oberhag, J; Polta, A; von Wagner, M; Radeke, HH; Sarrazin, C; Trojan, J; Zeuzem, S; Kronenberger, B; Piiper, A				Bihrer, Verena; Waidmann, Oliver; Friedrich-Rust, Mireen; Forestier, Nicole; Susser, Simone; Haupenthal, Joerg; Welker, Martin; Shi, Ying; Peveling-Oberhag, Jan; Polta, Andreas; von Wagner, Michael; Radeke, Heinfried H.; Sarrazin, Christoph; Trojan, Joerg; Zeuzem, Stefan; Kronenberger, Bernd; Piiper, Albrecht			Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; SUPPRESSOR GENE; EXPRESSION; MIR-21; INFLAMMATION; ACTIVATION; INFECTION; BIOMARKER; MIR-122; TUMORS	Background: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies, rendering it an interesting candidate as serum/plasma marker for malignancies. Here we correlated serum miR-21 levels with clinical parameters in patients with different stages of chronic hepatitis C virus infection (CHC) and CHC-associated HCC. Methodology/Principal Findings: 62 CHC patients, 29 patients with CHC and HCC and 19 healthy controls were prospectively enrolled. RNA was extracted from the sera and miR-21 as well as miR-16 levels were analyzed by quantitative real-time PCR; miR-21 levels (normalized by miR-16) were correlated with standard liver parameters, histological grading and staging of CHC. The data show that serum levels of miR-21 were elevated in patients with CHC compared to healthy controls (P<0.001); there was no difference between serum miR-21 in patients with CHC and CHC-associated HCC. Serum miR-21 levels correlated with histological activity index (HAI) in the liver (r = -0.494, P = 0.00002), alanine aminotransferase (ALT) (r = -0.309, P = 0.007), aspartate aminotransferase (r = -0.495, P = 0.000007), bilirubin (r = -0.362, P = 0.002), international normalized ratio (r = -0.338, P = 0.034) and gamma-glutamyltransferase (r = -0.244, P = 0.034). Multivariate analysis revealed that ALT and miR-21 serum levels were independently associated with HAI. At a cut-off dC(T) of 1.96, miR-21 discriminated between minimal and mild-severe necroinflammation (AUC = 0.758) with a sensitivity of 53.3% and a specificity of 95.2%. Conclusions/Significance: The serum miR-21 level is a marker for necroinflammatory activity, but does not differ between patients with HCV and HCV-induced HCC.	[Bihrer, Verena; Waidmann, Oliver; Friedrich-Rust, Mireen; Forestier, Nicole; Susser, Simone; Haupenthal, Joerg; Welker, Martin; Shi, Ying; Peveling-Oberhag, Jan; Polta, Andreas; von Wagner, Michael; Sarrazin, Christoph; Trojan, Joerg; Zeuzem, Stefan; Kronenberger, Bernd; Piiper, Albrecht] Univ Frankfurt M, Dept Med 1, Frankfurt, Germany; [Radeke, Heinfried H.] Univ Frankfurt M, Inst Pharmacol, ZAFES, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Bihrer, V (corresponding author), Univ Frankfurt M, Dept Med 1, Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Radeke, Heinfried H/E-3772-2013	Radeke, Heinfried H/0000-0002-4499-2510; Haupenthal, Jorg/0000-0003-3991-2800	Else Kroner-Fresenius Foundation; Deutsche Forschungsgemeinschaft [GRK 1172]; Dr. Paul und Ursula Klein foundation; Marie Christine Held und Erika Hecker foundation; Scolari Foundation; Heinrich und Erna Schaufler Foundation	Else Kroner-Fresenius Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Paul und Ursula Klein foundation; Marie Christine Held und Erika Hecker foundation; Scolari Foundation; Heinrich und Erna Schaufler Foundation	This work was supported by grants from the Else Kroner-Fresenius Foundation, the Deutsche Forschungsgemeinschaft (GRK 1172), and the foundations Dr. Paul und Ursula Klein, Marie Christine Held und Erika Hecker, the Scolari Foundation and the Heinrich und Erna Schaufler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Varnholt H, 2008, ANN HEPATOL, V7, P104, DOI 10.1016/S1665-2681(19)31864-2; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Zen K, 2010, MED RES REV; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-0586	33	111	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26971	10.1371/journal.pone.0026971	http://dx.doi.org/10.1371/journal.pone.0026971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066022	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000039
J	Rosner, R; Warzecha, AK				Rosner, Ronny; Warzecha, Anne-Kathrin			Relating Neuronal to Behavioral Performance: Variability of Optomotor Responses in the Blowfly	PLOS ONE			English	Article							FLY CALLIPHORA-ERYTHROCEPHALA; NECK MOTOR-NEURONS; OPTIC-FLOW; LOBULA PLATE; NONLINEAR INTEGRATION; MOTION INFORMATION; HEAD MOVEMENTS; SYSTEM; FLIGHT; CELLS	Behavioral responses of an animal vary even when they are elicited by the same stimulus. This variability is due to stochastic processes within the nervous system and to the changing internal states of the animal. To what extent does the variability of neuronal responses account for the overall variability at the behavioral level? To address this question we evaluate the neuronal variability at the output stage of the blowfly's (Calliphora vicina) visual system by recording from motion-sensitive interneurons mediating head optomotor responses. By means of a simple modelling approach representing the sensory-motor transformation, we predict head movements on the basis of the recorded responses of motion-sensitive neurons and compare the variability of the predicted head movements with that of the observed ones. Large gain changes of optomotor head movements have previously been shown to go along with changes in the animals' activity state. Our modelling approach substantiates that these gain changes are imposed downstream of the motion-sensitive neurons of the visual system. Moreover, since predicted head movements are clearly more reliable than those actually observed, we conclude that substantial variability is introduced downstream of the visual system.	[Rosner, Ronny] Univ Marburg, Dept Biol, Marburg, Germany; [Warzecha, Anne-Kathrin] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany	Philipps University Marburg; University of Bielefeld	Rosner, R (corresponding author), Univ Marburg, Dept Biol, Marburg, Germany.	ronny.rosner@biologie.uni-marburg.de; akwarzecha@uni-bielefeld.de			Volkswagen Stiftung [I/78 316]	Volkswagen Stiftung(Volkswagen)	This project was financed by a grant of the Volkswagen Stiftung to Anne-Kathrin Warzecha (I/78 316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers U, 2007, J NEUROPHYSIOL, V97, P2032, DOI 10.1152/jn.01116.2006; Blaj G, 2004, J COMP PHYSIOL A, V190, P861, DOI 10.1007/s00359-004-0541-4; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Bostrom KJ, 2010, VISION RES, V50, P870, DOI 10.1016/j.visres.2010.02.010; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; EGELHAAF M, 1987, J COMP PHYSIOL A, V161, P777, DOI 10.1007/BF00610219; Egelhaaf Martin, 2005, P185; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Gilbert C, 1998, J EXP BIOL, V201, P2735; GILBERT C, 1995, J COMP NEUROL, V361, P285, DOI 10.1002/cne.903610207; Grewe J, 2003, J NEUROSCI, V23, P10776; Grewe J, 2007, THESIS BIELEFELD U; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; Haag J, 2010, P NATL ACAD SCI USA, V107, P20104, DOI 10.1073/pnas.1009381107; Haag J, 2008, J NEUROSCI, V28, P14435, DOI 10.1523/JNEUROSCI.3603-08.2008; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; Hausen K., 1989, P391; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1977, NATURE, V270, P338, DOI 10.1038/270338a0; Hengstenberg Roland, 1993, Reviews of Oculomotor Research, V5, P285; Hooper SL, 2007, J NEUROPHYSIOL, V98, P1718, DOI 10.1152/jn.01283.2006; Hooper SL, 2006, J NEUROPHYSIOL, V96, P2072, DOI 10.1152/jn.00366.2006; Huston SJ, 2009, J NEUROSCI, V29, P13097, DOI 10.1523/JNEUROSCI.2915-09.2009; Jung SN, 2011, J NEUROSCI, V31, P9231, DOI 10.1523/JNEUROSCI.1138-11.2011; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Kurtz R, 2001, J NEUROSCI, V21, P6957, DOI 10.1523/JNEUROSCI.21-17-06957.2001; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Lindemann JP, 2008, BIOL CYBERN, V98, P213, DOI 10.1007/s00422-007-0205-x; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Longden KD, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00153; Longden KD, 2009, J NEUROPHYSIOL, V102, P3606, DOI 10.1152/jn.00395.2009; Maimon G, 2011, CURR OPIN NEUROBIOL, V21, P559, DOI 10.1016/j.conb.2011.05.001; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; MCCANN GD, 1972, J GEN PHYSIOL, V59, P534, DOI 10.1085/jgp.59.5.534; MILDE JJ, 1987, J COMP PHYSIOL A, V160, P225, DOI 10.1007/BF00609728; NALBACH G, 1994, J COMP PHYSIOL A, V175, P695; Neuhofer D, 2011, J COMP PHYSIOL A, V197, P251, DOI 10.1007/s00359-010-0606-5; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; Rasche C, 2009, VISION RES, V49, P514, DOI 10.1016/j.visres.2008.12.003; Rosner R, 2010, J EXP BIOL, V213, P331, DOI 10.1242/jeb.035386; Rosner R, 2009, J EXP BIOL, V212, P1170, DOI 10.1242/jeb.027060; SANDEMAN DC, 1980, J EXP BIOL, V85, P43; Schilstra C, 1999, J EXP BIOL, V202, P1481; Simmons PJ, 2010, J EXP BIOL, V213, P2629, DOI 10.1242/jeb.043547; Spavieri DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000860; STRAUSFELD NJ, 1985, CELL TISSUE RES, V240, P601, DOI 10.1007/BF00216350; STRAUSFELD NJ, 1987, J COMP PHYSIOL A, V160, P205, DOI 10.1007/BF00609727; STRAUSFELD NJ, 1985, CELL TISSUE RES, V240, P617, DOI 10.1007/BF00216351; TYCHSEN L, 1986, J NEUROPHYSIOL, V56, P953, DOI 10.1152/jn.1986.56.4.953; van Steveninck RD, 2001, MOTION VISION, P279; Vogel A, 2005, J NEUROPHYSIOL; Warzecha AK, 2003, NEUROSCIENCE, V119, P1103, DOI 10.1016/S0306-4522(03)00204-5; Warzecha AK, 2001, MOTION VISION, P239; Warzecha AK, 1996, PHILOS T ROY SOC B, V351, P1579, DOI 10.1098/rstb.1996.0142; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Zhurov Y, 2006, J NEUROSCI, V26, P7056, DOI 10.1523/JNEUROSCI.5277-05.2006; Zoccolan D, 2002, J NEUROSCI, V22, P10790	61	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26886	10.1371/journal.pone.0026886	http://dx.doi.org/10.1371/journal.pone.0026886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066014	Green Published, gold			2022-12-27	WOS:000296916000030
J	Hampton, M; Melvin, RG; Kendall, AH; Kirkpatrick, BR; Peterson, N; Andrews, MT				Hampton, Marshall; Melvin, Richard G.; Kendall, Anne H.; Kirkpatrick, Brian R.; Peterson, Nichole; Andrews, Matthew T.			Deep Sequencing the Transcriptome Reveals Seasonal Adaptive Mechanisms in a Hibernating Mammal	PLOS ONE			English	Article							FATTY-ACID-BINDING; PANCREATIC TRIACYLGLYCEROL LIPASE; GENE-EXPRESSION; RNA; MUSCLE; ACTIVATION; LIPOLYSIS; SELECTION; ACCURATE; ALBUMIN	Mammalian hibernation is a complex phenotype involving metabolic rate reduction, bradycardia, profound hypothermia, and a reliance on stored fat that allows the animal to survive for months without food in a state of suspended animation. To determine the genes responsible for this phenotype in the thirteen-lined ground squirrel (Ictidomys tridecemlineatus) we used the Roche 454 platform to sequence mRNA isolated at six points throughout the year from three key tissues: heart, skeletal muscle, and white adipose tissue (WAT). Deep sequencing generated approximately 3.7 million cDNA reads from 18 samples (6 time points 63 tissues) with a mean read length of 335 bases. Of these, 3,125,337 reads were assembled into 140,703 contigs. Approximately 90% of all sequences were matched to proteins in the human UniProt database. The total number of distinct human proteins matched by ground squirrel transcripts was 13,637 for heart, 12,496 for skeletal muscle, and 14,351 for WAT. Extensive mitochondrial RNA sequences enabled a novel approach of using the transcriptome to construct the complete mitochondrial genome for I. tridecemlineatus. Seasonal and activity-specific changes in mRNA levels that met our stringent false discovery rate cutoff (1.0610 211) were used to identify patterns of gene expression involving various aspects of the hibernation phenotype. Among these patterns are differentially expressed genes encoding heart proteins AT1A1, NAC1 and RYR2 controlling ion transport required for contraction and relaxation at low body temperatures. Abundant RNAs in skeletal muscle coding ubiquitin pathway proteins ASB2, UBC and DDB1 peak in October, suggesting an increase in muscle proteolysis. Finally, genes in WAT that encode proteins involved in lipogenesis (ACOD, FABP4) are highly expressed in August, but gradually decline in expression during the seasonal transition to lipolysis.	[Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA; [Melvin, Richard G.; Kendall, Anne H.; Kirkpatrick, Brian R.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Peterson, Nichole] Univ Minnesota, BioMed Genom Ctr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities	Hampton, M (corresponding author), Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA.	mandrews@d.umn.edu		Melvin, Richard George/0000-0001-6428-6763; Hampton, Marshall/0000-0002-9725-3316	National Institutes of Health [RC2HL101625, 1F32DK084718]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research funded by National Institutes of Health grant RC2HL101625 to MTA. RGM is supported by NIH postdoctoral fellowship 1F32DK084718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 1998, P NATL ACAD SCI USA, V95, P8392, DOI 10.1073/pnas.95.14.8392; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; BAHR R, 1991, ACTA PHYSIOL SCAND, V143, P105, DOI 10.1111/j.1748-1716.1991.tb09205.x; Bauer VW, 2001, AM J PHYSIOL-REG I, V281, pR1186, DOI 10.1152/ajpregu.2001.281.4.R1186; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonstra R, 2011, FUNCT ECOL, V25, P1348, DOI 10.1111/j.1365-2435.2011.01890.x; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; BRODERSEN R, 1990, EUR J BIOCHEM, V189, P343, DOI 10.1111/j.1432-1033.1990.tb15495.x; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Caesar R, 2008, J LIPID RES, V49, P1588, DOI 10.1194/jlr.D800013-JLR200; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng YZ, 2011, MAR GENOM, V4, P17, DOI 10.1016/j.margen.2010.12.001; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cinti S, 2007, ADIPOSE TISSUE ADIPO, P3, DOI [10.1007/978-1-59745-370-7_1, DOI 10.1007/978-1-59745-370-7_1]; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hershey JD, 2008, PHYSIOL BIOCHEM ZOOL, V81, P138, DOI 10.1086/524391; Israel D, 2010, TRENDS ENDOCRIN MET, V21, P10, DOI 10.1016/j.tem.2009.07.004; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; KOFUJI P, 1992, AM J PHYSIOL, V263, pC1241, DOI 10.1152/ajpcell.1992.263.6.C1241; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Melvin RG, 2008, J MOL EVOL, V66, P232, DOI 10.1007/s00239-008-9078-4; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Russell RL, 2010, J COMP PHYSIOL B, V180, P1165, DOI 10.1007/s00360-010-0484-8; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374; Shanmugam M, 2011, CARDIOVASC RES, V89, P353, DOI 10.1093/cvr/cvq294; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shimura M, 2005, BIOCHEM BIOPH RES CO, V334, P861, DOI 10.1016/j.bbrc.2005.06.186; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Songu-Mize E, 2001, AM J PHYSIOL-HEART C, V281, pH2072, DOI 10.1152/ajpheart.2001.281.5.H2072; Spiegelman B M, 1997, Eur J Med Res, V2, P457; Squire TL, 2003, PHYSIOL GENOMICS, V16, P131, DOI 10.1152/physiolgenomics.00168.2002; Squire TL, 2003, PHYSIOL GENOMICS, V16, P119, DOI 10.1152/physiolgenomics.00167.2002; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; STEFFEN JM, 1991, COMP BIOCHEM PHYS B, V99, P815, DOI 10.1016/0305-0491(91)90147-6; Sun ZC, 2011, HISTOCHEM CELL BIOL, V135, P27, DOI 10.1007/s00418-010-0776-9; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Townsend KL, 2008, J COMP PHYSIOL B, V178, P217, DOI 10.1007/s00360-007-0215-y; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	62	72	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27021	10.1371/journal.pone.0027021	http://dx.doi.org/10.1371/journal.pone.0027021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046435	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800059
J	Leimgruber, A; Ferber, M; Irving, M; Hussain-Kahn, H; Wieckowski, S; Derre, L; Rufer, N; Zoete, V; Michielin, O				Leimgruber, Antoine; Ferber, Mathias; Irving, Melita; Hussain-Kahn, Hamid; Wieckowski, Sebastien; Derre, Laurent; Rufer, Nathalie; Zoete, Vincent; Michielin, Olivier			TCRep 3D: An Automated In Silico Approach to Study the Structural Properties of TCR Repertoires	PLOS ONE			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; V-ALPHA DOMAIN; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; CONFORMATIONAL-CHANGES; PROTEIN STRUCTURES; PEPTIDE COMPLEX; 2.5 ANGSTROM; BETA-CHAIN	TCRep 3D is an automated systematic approach for TCR-peptide-MHC class I structure prediction, based on homology and ab initio modeling. It has been considerably generalized from former studies to be applicable to large repertoires of TCR. First, the location of the complementary determining regions of the target sequences are automatically identified by a sequence alignment strategy against a database of TCR V alpha and V beta chains. A structure-based alignment ensures automated identification of CDR3 loops. The CDR are then modeled in the environment of the complex, in an ab initio approach based on a simulated annealing protocol. During this step, dihedral restraints are applied to drive the CDR1 and CDR2 loops towards their canonical conformations, described by Al-Lazikani et. al. We developed a new automated algorithm that determines additional restraints to iteratively converge towards TCR conformations making frequent hydrogen bonds with the pMHC. We demonstrated that our approach outperforms popular scoring methods (Anolea, Dope and Modeller) in predicting relevant CDR conformations. Finally, this modeling approach has been successfully applied to experimentally determined sequences of TCR that recognize the NY-ESO-1 cancer testis antigen. This analysis revealed a mechanism of selection of TCR through the presence of a single conserved amino acid in all CDR3 beta sequences. The important structural modifications predicted in silico and the associated dramatic loss of experimental binding affinity upon mutation of this amino acid show the good correspondence between the predicted structures and their biological activities. To our knowledge, this is the first systematic approach that was developed for large TCR repertoire structural modeling.	[Leimgruber, Antoine; Ferber, Mathias; Michielin, Olivier] Lausanne Univ Hosp CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; [Leimgruber, Antoine; Ferber, Mathias; Irving, Melita; Hussain-Kahn, Hamid; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [Leimgruber, Antoine; Rufer, Nathalie; Michielin, Olivier] Ludwig Inst Canc Res, Lausanne Branch, Lausanne, Switzerland; [Irving, Melita; Rufer, Nathalie; Michielin, Olivier] Natl Ctr Competence Res NCCR, Lausanne, Switzerland; [Wieckowski, Sebastien; Rufer, Nathalie] Univ Hosp Ctr, Dept Res, Lausanne, Switzerland; [Wieckowski, Sebastien; Rufer, Nathalie] Univ Lausanne, Lausanne, Switzerland; [Derre, Laurent] Lausanne Univ Hosp CHUV, Dept Urol, Urol Res Unit, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Leimgruber, A (corresponding author), Lausanne Univ Hosp CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland.	olivier.michielin@unil.ch	Michielin, Olivier/ABE-7924-2020; Wieckowski, Sébastien/AAF-4147-2020; Laurent, Derré/AAE-1010-2020	Wieckowski, Sébastien/0000-0001-8121-4446; Laurent, Derré/0000-0002-3403-161X	Swiss National Science Foundation [SCORE 3232B0-103172, 3200B0-103173]; Multidisciplinary Oncology Center (CePO) of the Lausanne University Hospital (CHUV); National Center of Competence in Research (NCCR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Multidisciplinary Oncology Center (CePO) of the Lausanne University Hospital (CHUV); National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss National Science Foundation (Grant Number: SCORE 3232B0-103172, 3200B0-103173) and was also supported by the Multidisciplinary Oncology Center (CePO) of the Lausanne University Hospital (CHUV), and the National Center of Competence in Research (NCCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Baumgaertner P, 2006, CANCER RES, V66, P1912, DOI 10.1158/0008-5472.CAN-05-3793; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; Huang JC, 2005, EUR J IMMUNOL, V35, P299, DOI 10.1002/eji.200425501; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Machius M, 2001, J MOL BIOL, V310, P689, DOI 10.1006/jmbi.2001.4794; MCCORMACK WT, 1991, P NATL ACAD SCI USA, V88, P7699, DOI 10.1073/pnas.88.17.7699; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Michielin O, 2000, J MOL BIOL, V300, P1205, DOI 10.1006/jmbi.2000.3788; Plaksin D, 1999, J MOL BIOL, V289, P1153, DOI 10.1006/jmbi.1999.2855; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Rudolph MG, 2001, J MOL BIOL, V314, P1, DOI 10.1006/jmbi.2001.5113; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Spang R, 2002, J COMPUT BIOL, V9, P747, DOI 10.1089/106652702761034172; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Valmori D, 2002, J IMMUNOL, V168, P4231, DOI 10.4049/jimmunol.168.8.4231; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005	51	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26301	10.1371/journal.pone.0026301	http://dx.doi.org/10.1371/journal.pone.0026301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053188	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800014
J	Bhadury, P; Bik, H; Lambshead, JD; Austen, MC; Smerdon, GR; Rogers, AD				Bhadury, Punyasloke; Bik, Holly; Lambshead, John D.; Austen, Melanie C.; Smerdon, Gary R.; Rogers, Alex D.			Molecular Diversity of Fungal Phylotypes Co-Amplified Alongside Nematodes from Coastal and Deep-Sea Marine Environments	PLOS ONE			English	Article							IDENTIFICATION; BIODIVERSITY	Nematodes and fungi are both ubiquitous in marine environments, yet few studies have investigated relationships between these two groups. Microbial species share many well-documented interactions with both free-living and parasitic nematode species, and limited data from previous studies have suggested ecological associations between fungi and nematodes in benthic marine habitats. This study aimed to further document the taxonomy and distribution of fungal taxa often co-amplified from nematode specimens. A total of 15 fungal 18S rRNA phylotypes were isolated from nematode specimens representing both deep-sea and shallow water habitats; all fungal isolates displayed high pairwise sequence identities with published data in Genbank (99-100%) and unpublished high-throughput 454 environmental datasets (>95%). BLAST matches indicate marine fungal sequences amplified in this study broadly represent taxa within the phyla Ascomycota and Basidiomycota, and several phylotypes showed robust groupings with known taxa in phylogenetic topologies. In addition, some fungal phylotypes appeared to be present in disparate geographic habitats, suggesting cosmopolitan distributions or closely related species complexes in at least some marine fungi. The present study was only able to isolate fungal DNA from a restricted set of nematode taxa; further work is needed to fully investigate the taxonomic scope and function of nematode-fungal interactions.	[Bhadury, Punyasloke] Indian Inst Sci Educ & Res Kolkata, Integrat Taxon & Microbial Ecol Res Grp, Dept Biol Sci, Kolkata, W Bengal, India; [Bik, Holly] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Bik, Holly; Lambshead, John D.] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Austen, Melanie C.; Smerdon, Gary R.] Plymouth Marine Lab, Plymouth, Devon, England; [Rogers, Alex D.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Indian Institute of Science Education & Research (IISER) - Kolkata; University System Of New Hampshire; University of New Hampshire; NERC National Oceanography Centre; University of Southampton; Plymouth Marine Laboratory; University of Oxford	Bhadury, P (corresponding author), Indian Inst Sci Educ & Res Kolkata, Integrat Taxon & Microbial Ecol Res Grp, Dept Biol Sci, Kolkata, W Bengal, India.	pbhadury@iiserkol.ac.in; h.bik@unh.edu	Austen, Melanie/GLU-1418-2022; Smerdon, Gary/W-2035-2019	Austen, Melanie/0000-0001-8133-0498; Smerdon, Gary/0000-0003-1121-0778; Bik, Holly/0000-0002-4356-3837; Bhadury, Punyasloke/0000-0001-8714-7475	IISERK	IISERK	This work is supported by grants awarded to PB from IISERK. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PRACTICAL GUIDE SYSM, DOI [10.1016/c2013-0-14457-1, DOI 10.1016/C2013-0-14457-1, DOI 10.1016/C2013-0-10998-1]; Austen MC, 2004, NEMATOL MONOGR PERSP, V2, P775; Bakhtiar Y, 2001, APPL SOIL ECOL, V17, P107, DOI 10.1016/S0929-1393(01)00129-9; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Bayer C, 2009, ENV MICROBIOL REP, V1, P136, DOI 10.1111/j.1758-2229.2009.00019.x; Berbee ML, 2001, MYCOTA SYSTEMATIC EV; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bhadury P, 2010, HYDROBIOLOGIA, V641, P245, DOI 10.1007/s10750-009-0088-z; Bhadury P, 2009, AQUAT BIOL, V5, P149, DOI 10.3354/ab00145; Bik HM, METAGENETIC AN UNPUB; Bik HM, 2009, NEMATOLOGY, V11, P827, DOI 10.1163/156854109X422922; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Buchan A, 2003, APPL ENVIRON MICROB, V69, P6676, DOI 10.1128/AEM.69.11.6676-6687.2003; Cook AA, 2005, MAR ECOL PROG SER, V291, P103, DOI 10.3354/meps291103; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; de Hoog GS, 1977, MYCOLOGIA, V69, P1242; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; HYDE KD, 1995, HYDROBIOLOGIA, V295, P107, DOI 10.1007/BF00029117; Hyde KD, 1998, BIODIVERS CONSERV, V7, P1147, DOI 10.1023/A:1008823515157; Hyde KD, 2000, MARINE MYCOLOGY PRAC; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jones EBG, 1993, ASPECTS TROPICAL MYC; Kohlmeyer J, 2001, MYCOL RES, V105, P500, DOI 10.1017/S0953756201003847; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Landry E.T., 2006, MYCOLOGIST, V20, P15, DOI [DOI 10.1016/J.MYC0L.2005.11.010, 10.1016/j.mycol.2005.11.010]; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Polz MF, 1999, APPL ENVIRON MICROB, V65, P4271; Prasannarai K, 2001, CURR SCI INDIA, V81, P304; Riemann F, 2002, MAR ECOL-P S Z N I, V23, P93, DOI 10.1046/j.1439-0485.2002.02765.x; RIEMANN F, 1978, OECOLOGIA, V34, P75, DOI 10.1007/BF00346242; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Somerfield P. J, 2005, METHODS STUDY MARINE; Tamura K, 2011, MOL BIOL EV IN PRESS; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Wu ZH, 2003, APPL ENVIRON MICROB, V69, P5389, DOI 10.1128/AEM.69.9.5389-5397.2003; Zuccaro A, 2005, FUNGAL COMMUNITIES S; Zuccaro A, 2008, APPL ENVIRON MICROB, V74, P931, DOI 10.1128/AEM.01158-07	40	26	26	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26445	10.1371/journal.pone.0026445	http://dx.doi.org/10.1371/journal.pone.0026445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046287	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600018
J	Huang, JQ; Morehouse, C; Streicher, K; Higgs, BW; Gao, J; Czapiga, M; Boutrin, A; Zhu, W; Brohawn, P; Chang, Y; Viner, J; LaVallee, T; Richman, L; Jallal, B; Yao, YH				Huang, Jiaqi; Morehouse, Chris; Streicher, Katie; Higgs, Brandon W.; Gao, Jin; Czapiga, Meggan; Boutrin, Anmarie; Zhu, Wei; Brohawn, Philip; Chang, Yong; Viner, Jaye; LaVallee, Theresa; Richman, Laura; Jallal, Bahija; Yao, Yihong			Altered Expression of Insulin Receptor Isoforms in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; DIABETES-MELLITUS PATIENTS; THYROID-CANCER; HYBRID RECEPTORS; SKELETAL-MUSCLE; GENE; CELLS; PREDICTORS; PROGNOSIS; MECHANISM	Purpose: Insulin-like growth factor (IGF) signaling through human insulin receptor isoform A (IR-A) contributes to tumorigenesis and intrinsic resistance to anti-IGF1R therapy. In the present study, we (a) developed quantitative TaqMan real time-PCR-based assays (qRT-PCR) to measure human insulin receptor isoforms with high specificity, (b) evaluated isoform expression levels in molecularly-defined breast cancer subtypes, and (c) identified the IR-A:IR-B mRNA ratio as a potential biomarker guiding patient stratification for anti-IGF therapies. Experimental Design: mRNA expression levels of IR-A and IR-B were measured in 42 primary breast cancers and 19 matched adjacent normal tissues with TaqMan qRT-PCR assays. The results were further confirmed in 165 breast cancers. The tumor samples were profiled using whole genome microarrays and subsequently subtyped using the PAM50 breast cancer gene signature. The relationship between the IR-A: IR-B ratio and cancer subtype, as well as markers of proliferation were characterized. Results: The mRNA expression levels of IR-A in the breast tumors were similar to those observed in the adjacent normal tissues, while the mRNA levels of IR-B were significantly decreased in tumors. The IR-A: IR-B ratio was significantly higher in luminal B breast cancer than in luminal A. Strong concordance between the IR-A: IR-B ratio and the composite Oncotype DX proliferation score was observed for stratifying the latter two breast cancer subtypes. Conclusions: The reduction in IR-B expression is the key to the altered IR-A: IR-B ratio observed in breast cancer. The IR-A: IR-B ratio may have biomarker utility in guiding a patient stratification strategy for an anti-IGF therapeutic.	[Huang, Jiaqi; Morehouse, Chris; Streicher, Katie; Higgs, Brandon W.; Gao, Jin; Czapiga, Meggan; Boutrin, Anmarie; Zhu, Wei; Brohawn, Philip; Chang, Yong; Viner, Jaye; LaVallee, Theresa; Richman, Laura; Jallal, Bahija; Yao, Yihong] MedImmune LLC, Gaithersburg, MD USA	AstraZeneca; Medimmune	Huang, JQ (corresponding author), MedImmune LLC, Gaithersburg, MD USA.	YaoY@MedImmune.com		Higgs, Brandon/0000-0002-2951-0245	MedImmune	MedImmune(AstraZenecaMedimmune)	All the authors of this manuscript are Medimmune employees and Astrazeneca stock owners. The work presented is entirely funded by MedImmune. MedImmune is developing an anti-IGF monoclonal antibody. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Belfiore A, 1999, BIOCHIMIE, V81, P403, DOI 10.1016/S0300-9084(99)80088-1; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; HARING HU, 1994, DIABETOLOGIA, V37, pS149, DOI 10.1007/BF00400838; Jones HE, 2006, BRIT J CANCER, V95, P172, DOI 10.1038/sj.bjc.6603237; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; Malaguarnera R., 2001, J CLIN ENDOCR METAB, V96, P766; Marcom PK, 2007, BREAST CANCER RES TR, V102, P43, DOI 10.1007/s10549-006-9307-8; MILAZZO G, 1992, CANCER RES, V52, P3924; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; PAPA V, 1990, J CLIN INVEST, V86, P1503, DOI 10.1172/JCI114868; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SESTI G, 1991, BIOCHEM BIOPH RES CO, V181, P1419, DOI 10.1016/0006-291X(91)92097-4; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; SOOS MA, 1993, ADV EXP MED BIOL, V343, P145; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Vella V, 2001, J CLIN PATHOL-MOL PA, V54, P121, DOI 10.1136/mp.54.3.121; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5	33	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26177	10.1371/journal.pone.0026177	http://dx.doi.org/10.1371/journal.pone.0026177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046260	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600011
J	Ohshige, T; Iwata, M; Omori, S; Tanaka, Y; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Kashiwagi, A; Kawamori, R; Tobe, K; Kadowaki, T; Nakamura, Y; Maeda, S				Ohshige, Toshihiko; Iwata, Minoru; Omori, Shintaro; Tanaka, Yasushi; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Kashiwagi, Atsunori; Kawamori, Ryuzo; Tobe, Kazuyuki; Kadowaki, Takashi; Nakamura, Yusuke; Maeda, Shiro			Association of New Loci Identified in European Genome-Wide Association Studies with Susceptibility to Type 2 Diabetes in the Japanese	PLOS ONE			English	Article							PLASMA-GLUCOSE LEVELS; RISK LOCI; REPLICATION; VARIANTS; MTNR1B; KCNQ1	Background: Several novel susceptibility loci for type 2 diabetes have been identified through genome-wide association studies (GWAS) for type 2 diabetes or quantitative traits related to glucose metabolism in European populations. To investigate the association of the 13 new European GWAS-derived susceptibility loci with type 2 diabetes in the Japanese population, we conducted a replication study using 3 independent Japanese case-control studies. Methodology/Principal Findings: We examined the association of single nucleotide polymorphisms (SNPs) within 13 loci (MTNR1B, GCK, IRS1, PROX1, BCL11A, ZBED3, KLF14, TP53INP1, KCNQ1, CENTD2, HMGA2, ZFAND6 and PRC1) with type 2 diabetes using 4,964 participants (2,839 cases and 2,125 controls) from 3 independent Japanese samples. The association of each SNP with type 2 diabetes was analyzed by logistic regression analysis. Further, we performed combined meta-analyses for the 3 studies and previously performed Japanese GWAS data (4,470 cases vs. 3,071 controls). The meta-analysis revealed that rs2943641 in the IRS1 locus was significantly associated with type 2 diabetes, (P = 0.0034, OR = 1.15 95% confidence interval; 1.05-1.26) and 3 SNPs, rs10930963 in the MTNR1B locus, rs972283 in the KLF14 locus, and rs231362 in the KCNQ1 locus, had nominal association with type 2 diabetes in the present Japanese samples (P<0.05). Conclusions: These results indicate that IRS1 locus may be common locus for type 2 diabetes across different ethnicities.	[Ohshige, Toshihiko; Maeda, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Kanagawa, Japan; [Ohshige, Toshihiko; Omori, Shintaro; Tanaka, Yasushi] St Marianna Univ, Sch Med, Div Endocrinol & Metab,Dept Internal Med, Kawasaki Ku, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Div Endocrinol & Metab, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Shiga, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 113, Japan; [Watada, Hirotaka; Kawamori, Ryuzo; Maeda, Shiro] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo 113, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	RIKEN; Saint Marianna University; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University; University of Tokyo; University of Tokyo	Ohshige, T (corresponding author), RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Kanagawa, Japan.	smaeda@src.riken.jp	Hirose, Hiroshi/F-8556-2014; Kashiwagi, Atsunori/H-8712-2019	Watada, Hirotaka/0000-0001-5961-1816; Maegawa, Hiroshi/0000-0002-4611-8149; Omori, Shintaro/0000-0003-3039-7259	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Omori S, 2009, DIABETOLOGIA, V52, P1554, DOI 10.1007/s00125-009-1397-5; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	24	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26911	10.1371/journal.pone.0026911	http://dx.doi.org/10.1371/journal.pone.0026911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046406	Green Submitted, gold, Green Published			2022-12-27	WOS:000296519600077
J	Anderson, CM; Chen, SY; Dimon, MT; Oke, A; DeRisi, JL; Fung, JC				Anderson, Carol M.; Chen, Stacy Y.; Dimon, Michelle T.; Oke, Ashwini; DeRisi, Joseph L.; Fung, Jennifer C.			ReCombine: A Suite of Programs for Detection and Analysis of Meiotic Recombination in Whole-Genome Datasets	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; INTERFERENCE; CROSSOVERS; RESOLUTION; ALIGNMENT; MEIOSIS; MODEL	In meiosis, the exchange of DNA between chromosomes by homologous recombination is a critical step that ensures proper chromosome segregation and increases genetic diversity. Products of recombination include reciprocal exchanges, known as crossovers, and non-reciprocal gene conversions or non-crossovers. The mechanisms underlying meiotic recombination remain elusive, largely because of the difficulty of analyzing large numbers of recombination events by traditional genetic methods. These traditional methods are increasingly being superseded by high-throughput techniques capable of surveying meiotic recombination on a genome-wide basis. Next-generation sequencing or microarray hybridization is used to genotype thousands of polymorphic markers in the progeny of hybrid yeast strains. New computational tools are needed to perform this genotyping and to find and analyze recombination events. We have developed a suite of programs, ReCombine, for using short sequence reads from next-generation sequencing experiments to genotype yeast meiotic progeny. Upon genotyping, the program CrossOver, a component of ReCombine, then detects recombination products and classifies them into categories based on the features found at each location and their distribution among the various chromatids. CrossOver is also capable of analyzing segregation data from microarray experiments or other sources. This package of programs is designed to allow even researchers without computational expertise to use high-throughput, whole-genome methods to study the molecular mechanisms of meiotic recombination.	[Anderson, Carol M.; Chen, Stacy Y.; Oke, Ashwini; Fung, Jennifer C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Anderson, Carol M.; Chen, Stacy Y.; Oke, Ashwini; Fung, Jennifer C.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Dimon, Michelle T.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Dimon, Michelle T.] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Anderson, CM (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	jfung@biochem.ucsf.edu		Anderson, Carol/0000-0002-0308-5447	NIH [R01 GM097213-01]; American Cancer Society [RSG CCG 110688]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH Grant: R01 GM097213-01, American Cancer Society Research Scholar Grant: RSG CCG 110688 (http://www.cancer.org/) and Howard Hughes Medical Institute (http://www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgon R, 2009, BIOINFORMATICS, V25, P1056, DOI 10.1093/bioinformatics/btp104; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cromie GA, 2007, TRENDS CELL BIOL, V17, P448, DOI 10.1016/j.tcb.2007.07.007; de los Santos T, 2003, GENETICS, V164, P81; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; *ILL, 2008, SEQ AN SOFTW US GUID; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mancera E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r36; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MCCUSKER JH, 1994, GENETICS, V136, P1261; MCPEEK MS, 1995, GENETICS, V139, P1031; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1962, GENETICS, V47, P1253; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; STAHL FW, 1995, GENETICS, V139; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; van Oeveren J, 2009, METHODS MOL BIOL, V578, P73, DOI 10.1007/978-1-60327-411-1_4; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; ZHAO HY, 1995, GENETICS, V139, P1045; Zhao QA, 2010, RICE, V3, P98, DOI 10.1007/s12284-010-9051-x	29	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25509	10.1371/journal.pone.0025509	http://dx.doi.org/10.1371/journal.pone.0025509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046241	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000007
J	Dawe, RJ; Bennett, DA; Schneider, JA; Arfanakis, K				Dawe, Robert J.; Bennett, David A.; Schneider, Julie A.; Arfanakis, Konstantinos			Neuropathologic Correlates of Hippocampal Atrophy in the Elderly: A Clinical, Pathologic, Postmortem MRI Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ALZHEIMER-DISEASE; NEUROFIBRILLARY TANGLES; ENTORHINAL CORTEX; SHAPE-ANALYSIS; LEWY BODIES; DEMENTIA; VOLUME; MEMORY	The volume of the hippocampus measured with structural magnetic resonance imaging (MRI) is increasingly used as a biomarker for Alzheimer's disease (AD). However, the neuropathologic basis of structural MRI changes in the hippocampus in the elderly has not been directly assessed. Postmortem MRI of the aging human brain, combined with histopathology, could be an important tool to address this issue. Therefore, this study combined postmortem MRI and histopathology in 100 elderly subjects from the Rush Memory and Aging Project and the Religious Orders Study. First, to validate the information contained in postmortem MRI data, we tested the hypothesis that postmortem hippocampal volume is smaller in subjects with clinically diagnosed Alzheimer's disease compared to subjects with mild or no cognitive impairment, as observed in antemortem imaging studies. Subsequently, the relations of postmortem hippocampal volume to AD pathology, Lewy bodies, amyloid angiopathy, gross infarcts, microscopic infarcts, and hippocampal sclerosis were examined. It was demonstrated that hippocampal volume was smaller in persons with a clinical diagnosis of AD compared to those with no cognitive impairment (P = 2.6x10(-7)) or mild cognitive impairment (P = 9.6x10(-7)). Additionally, hippocampal volume was related to multiple cognitive abilities assessed proximate to death, with its strongest association with episodic memory. Among all pathologies investigated, the most significant factors related to lower hippocampal volume were shown to be AD pathology (P = 0.0018) and hippocampal sclerosis (P = 4.2x10(-7)). Shape analysis allowed for visualization of the hippocampal regions most associated with volume loss for each of these two pathologies. Overall, this investigation confirmed the relation of hippocampal volume measured postmortem to clinical diagnosis of AD and measures of cognition, and concluded that both AD pathology and hippocampal sclerosis affect hippocampal volume in old age, though the impacts of each pathology on the shape of the hippocampus may differ.	[Dawe, Robert J.; Arfanakis, Konstantinos] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Dawe, Robert J.; Bennett, David A.; Schneider, Julie A.; Arfanakis, Konstantinos] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Illinois Institute of Technology; Rush University	Dawe, RJ (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	arfanakis@iit.edu	Arfanakis, Konstantinos/AAN-3148-2021	Arfanakis, Konstantinos/0000-0001-9705-597X	National Institute on Aging [P30AG10161, R01AG15819, R01AG17917]; Illinois Department of Public Health; Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc.; NATIONAL INSTITUTE ON AGING [R01AG017917, P30AG010161, R01AG015819] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported with grants from the National Institute on Aging (P30AG10161, R01AG15819, R01AG17917), the Illinois Department of Public Health, and from the Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala TA, 2000, NEUROLOGY, V54, P843, DOI 10.1212/WNL.54.4.843; Apostolova LG, 2010, NEUROIMAGE, V51, P488, DOI 10.1016/j.neuroimage.2009.12.125; Arfanakis K, 2007, BRAIN IMAGING BEHAV, V1, P11, DOI 10.1007/s11682-007-9001-4; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Arvanitakis Z, 2011, ANN NEUROL, V69, P320, DOI 10.1002/ana.22112; Barber R, 2001, DEMENT GERIATR COGN, V12, P198, DOI 10.1159/000051258; Barkhof F, 2007, NEUROLOGY, V69, P1521, DOI 10.1212/01.wnl.0000277459.83543.99; Behl C, 2000, J NEURAL TRANSM, V107, P1325, DOI 10.1007/s007020070021; BEHL C, 1994, BRAIN RES, V645, P253, DOI 10.1016/0006-8993(94)91659-4; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; BOBINSKI M, 1995, DEMENTIA, V6, P205, DOI 10.1159/000106948; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; CoreyBloom J, 1997, NEUROLOGY, V48, P154, DOI 10.1212/WNL.48.1.154; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Dickerson BC, 2001, NEUROBIOL AGING, V22, P747, DOI 10.1016/S0197-4580(01)00271-8; DICKSON DW, 1994, ACTA NEUROPATHOL, V88, P212; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; HUESGEN CT, 1993, NEUROLOGY, V43, P145, DOI 10.1212/WNL.43.1_Part_1.145; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jack CR, 2002, NEUROLOGY, V58, P750, DOI 10.1212/WNL.58.5.750; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Killiany RJ, 2002, NEUROLOGY, V58, P1188, DOI 10.1212/WNL.58.8.1188; Laakso MP, 1996, NEUROBIOL AGING, V17, P535, DOI 10.1016/0197-4580(96)00036-X; Li S, 2007, AM J NEURORADIOL, V28, P1339, DOI 10.3174/ajnr.A0620; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mortimer JA, 2004, NEUROLOGY, V62, P428, DOI 10.1212/01.WNL.0000106463.66966.65; Paniagua B, 2009, INSIGHT J; Postle BR, 2000, NEUROIMAGE, V11, P409, DOI 10.1006/nimg.2000.0570; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Schneider JA, 2007, ANN NEUROL, V62, P59, DOI 10.1002/ana.21142; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Seewann A, 2009, ACTA NEUROL SCAND, V119, P349, DOI 10.1111/j.1600-0404.2008.01137.x; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Styner M., 2006, INSIGHT J; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; van de Pol LA, 2006, NEUROLOGY, V66, P236, DOI 10.1212/01.wnl.0000194240.47892.4d; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4; Zarow C, 2008, CURR NEUROL NEUROSCI, V8, P363, DOI 10.1007/s11910-008-0057-3	66	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26286	10.1371/journal.pone.0026286	http://dx.doi.org/10.1371/journal.pone.0026286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043314	gold, Green Published, Green Submitted			2022-12-27	WOS:000295984400042
J	Edelson, BT; Bradstreet, TR; Wumesh, KC; Hildner, K; Herzog, JW; Sim, J; Russell, JH; Murphy, TL; Unanue, ER; Murphy, KM				Edelson, Brian T.; Bradstreet, Tara R.; Wumesh, K. C.; Hildner, Kai; Herzog, Jeremy W.; Sim, Julia; Russell, John H.; Murphy, Theresa L.; Unanue, Emil R.; Murphy, Kenneth M.			Batf3-Dependent CD11b(low/-) Peripheral Dendritic Cells Are GM-CSF-Independent and Are Not Required for Th Cell Priming after Subcutaneous Immunization	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LANGERHANS CELLS; MULTIPLE-SCLEROSIS; CROSS-PRESENTATION; EFFECTOR PHASE; T(H)17 CELLS; TGF-BETA; CD8-ALPHA(+); SKIN	Dendritic cells (DCs) subsets differ in precursor cell of origin, functional properties, requirements for growth factors, and dependence on transcription factors. Lymphoid-tissue resident CD8(alpha+) conventional DCs (cDCs) and CD11b(low/-)CD103(+) non-lymphoid DCs are developmentally related, each being dependent on FMS-like tyrosine kinase 3 ligand (Flt3L), and requiring the transcription factors Batf3, Irf8, and Id2 for development. It was recently suggested that granulocyte/macrophage colony stimulating factor (GM-CSF) was required for the development of dermal CD11b(low/-) Langerin(+)CD103(+) DCs, and that this dermal DC subset was required for priming autoreactive T cells in experimental autoimmune encephalitis (EAE). Here, we compared development of peripheral tissue DCs and susceptibility to EAE in GM-CSF receptor deficient (Csf2rb(-/-)) and Batf3(-/-) mice. We find that Batf3-dependent dermal CD11b(low/-)Langerin(+) DCs do develop in Csf2rb(-/-) mice, but that they express reduced, but not absent, levels of CD103. Further, Batf3(-/-) mice lacking all peripheral CD11b(low/-) DCs show robust Th cell priming after subcutaneous immunization and are susceptible to EAE. Our results suggest that defective T effector priming and resistance to EAE exhibited by Csf2rb(-/-) mice does not result from the absence of dermal CD11b(low/-) Langerin(+)CD103(+) DCs.	[Edelson, Brian T.; Bradstreet, Tara R.; Wumesh, K. C.; Hildner, Kai; Herzog, Jeremy W.; Murphy, Theresa L.; Unanue, Emil R.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Hildner, Kai; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Sim, Julia; Russell, John H.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Edelson, BT (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu		Russell, John/0000-0002-3680-9587; Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; Burroughs Wellcome Fund Career Award for Medical Scientists; Washington University School of Medicine; American Society of Hematology; German Research Foundation; National Institutes of Health [AI024742]; National Multiple Sclerosis Society [RG 4352]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024742, R01AI062832, R37AI024742] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Washington University School of Medicine; American Society of Hematology; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KMM was supported by the Howard Hughes Medical Institute (www.hhmi.org), BTE by a Burroughs Wellcome Fund Career Award for Medical Scientists (www.bwfund.org), a Jack H. Ladenson Fellowship in Experimental Clinical Pathology at Washington University School of Medicine, and an American Society of Hematology Scholar Award (www.hematology.org), KH by the Emmy Noether Program of the German Research Foundation (www.dfg.de/index.jsp), ERU by a grant from the National Institutes of Health (www.nih.gov, AI024742), and JHR by a grant from the National Multiple Sclerosis Society (www. nationalmssociety.org, RG 4352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; Lees JR, 2010, J NEUROIMMUNOL, V220, P10, DOI 10.1016/j.jneuroim.2009.11.017; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nicola NA, 1996, BLOOD, V87, P2665, DOI 10.1182/blood.V87.7.2665.bloodjournal8772665; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; ZHAN Y, 2011, EUR J IMMUN IN PRESS	38	90	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25660	10.1371/journal.pone.0025660	http://dx.doi.org/10.1371/journal.pone.0025660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22065991	Green Published, gold			2022-12-27	WOS:000295984400016
J	Nally, JE; Monahan, AM; Miller, IS; Bonilla-Santiago, R; Souda, P; Whitelegge, JP				Nally, Jarlath E.; Monahan, Avril M.; Miller, Ian S.; Bonilla-Santiago, Ruben; Souda, Puneet; Whitelegge, Julian P.			Comparative Proteomic Analysis of Differentially Expressed Proteins in the Urine of Reservoir Hosts of Leptospirosis	PLOS ONE			English	Article							RENAL COLONIZATION; RAT; COMPLEMENT; INFECTION; DISEASE; CARRIER; LIPL32; INJURY; CATTLE; MODEL	Rattus norvegicus is a natural reservoir host for pathogenic species of Leptospira. Experimentally infected rats remain clinically normal, yet persistently excrete large numbers of leptospires from colonized renal tubules via urine, despite a specific host immune response. Whilst persistent renal colonization and shedding is facilitated in part by differential antigen expression by leptospires to evade host immune responses, there is limited understanding of kidney and urinary proteins expressed by the host that facilitates such biological equilibrium. Urine pellets were collected from experimentally infected rats shedding leptospires and compared to urine from non-infected controls spiked with in vitro cultivated leptospires for analysis by 2-D DIGE. Differentially expressed host proteins include membrane metallo endopeptidase, napsin A aspartic peptidase, vacuolar H+ATPase, kidney aminopeptidase and immunoglobulin G and A. Loa22, a virulence factor of Leptospira, as well as the GroEL, were increased in leptospires excreted in urine compared to in vitro cultivated leptospires. Urinary IgG from infected rats was specific for leptospires. Results confirm differential protein expression by both host and pathogen during chronic disease and include markers of kidney function and immunoglobulin which are potential biomarkers of infection.	[Nally, Jarlath E.; Monahan, Avril M.; Miller, Ian S.; Bonilla-Santiago, Ruben] Univ Coll Dublin, UCD Sch Agr Food Sci & Vet Med, Vet Sci Ctr, Dublin 2, Ireland; [Nally, Jarlath E.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Coll Life Sci, Dublin 2, Ireland; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University College Dublin; University College Dublin; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Nally, JE (corresponding author), Univ Coll Dublin, UCD Sch Agr Food Sci & Vet Med, Vet Sci Ctr, Dublin 2, Ireland.	Jarlath.Nally@ucd.ie		Miller, Ian/0000-0003-2118-6345	Science Foundation Ireland [05/YI2/B696]; Department of Agriculture, Fisheries and Food, Ireland [RSF06 363]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture, Fisheries and Food, Ireland	This research is supported by grant number 05/YI2/B696, President of Ireland Young Researcher Award from Science Foundation Ireland, and grant number RSF06 363 from the Research Stimulus Fund, Department of Agriculture, Fisheries and Food, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ER, 2010, VIRCHOWS ARCH, V456, P367, DOI 10.1007/s00428-010-0894-8; Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; ELLIS WA, 1981, VET REC, V108, P555, DOI 10.1136/vr.108.26.555; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Ido Y, 1917, J EXP MED, V26, P341, DOI 10.1084/jem.26.3.341; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; LEONARD FC, 1993, RES VET SCI, V55, P195, DOI 10.1016/0034-5288(93)90081-P; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08; MORRISON WI, 1976, J PATHOL, V120, P83, DOI 10.1002/path.1711200204; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005; Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Nortier JL, 1997, KIDNEY INT, V51, P288, DOI 10.1038/ki.1997.35; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Schauer-Vukasinovic V, 2000, BBA-GENE STRUCT EXPR, V1492, P207, DOI 10.1016/S0167-4781(00)00069-5; Schauer-Vukasinovic V, 2001, Biochim Biophys Acta, V1524, P51; SHANKLAND SJ, 1994, KIDNEY INT, V46, P430, DOI 10.1038/ki.1994.291; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; THIERMANN AB, 1977, AM J TROP MED HYG, V26, P970, DOI 10.4269/ajtmh.1977.26.970; Thongboonkerd V, 2003, NEPHRON EXP NEPHROL, V95, pE69, DOI 10.1159/000073674; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003	30	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26046	10.1371/journal.pone.0026046	http://dx.doi.org/10.1371/journal.pone.0026046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043303	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400031
J	Sharif-Paghaleh, E; Sunassee, K; Tavare, R; Ratnasothy, K; Koers, A; Ali, N; Alhabbab, R; Blower, PJ; Lechler, RI; Smyth, LA; Mullen, GE; Lombardi, G				Sharif-Paghaleh, Ehsan; Sunassee, Kavitha; Tavare, Richard; Ratnasothy, Kulachelvy; Koers, Alexander; Ali, Niwa; Alhabbab, Rowa; Blower, Philip J.; Lechler, Robert I.; Smyth, Lesley A.; Mullen, Gregory E.; Lombardi, Giovanna			In Vivo SPECT Reporter Gene Imaging of Regulatory T Cells	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; TRANSPLANTATION TOLERANCE; SODIUM/IODIDE SYMPORTER; THERAPY; TUMORS	Regulatory T cells (Tregs) were identified several years ago and are key in controlling autoimmune diseases and limiting immune responses to foreign antigens, including alloantigens. In vivo imaging techniques including intravital microscopy as well as whole body imaging using bioluminescence probes have contributed to the understanding of in vivo Treg function, their mechanisms of action and target cells. Imaging of the human sodium/iodide symporter via Single Photon Emission Computed Tomography (SPECT) has been used to image various cell types in vivo. It has several advantages over the aforementioned imaging techniques including high sensitivity, it allows non-invasive whole body studies of viable cell migration and localisation of cells over time and lastly it may offer the possibility to be translated to the clinic. This study addresses whether SPECT/CT imaging can be used to visualise the migratory pattern of Tregs in vivo. Treg lines derived from CD4(+)CD25(+)FoxP3(+) cells were retrovirally transduced with a construct encoding for the human Sodium Iodide Symporter (NIS) and the fluorescent protein mCherry and stimulated with autologous DCs. NIS expressing self-specific Tregs were specifically radiolabelled in vitro with Technetium-99m pertechnetate ((TcO4-)-Tc-99m) and exposure of these cells to radioactivity did not affect cell viability, phenotype or function. In addition adoptively transferred Treg-NIS cells were imaged in vivo in C57BL/6 (BL/6) mice by SPECT/CT using (TcO4-)-Tc-99m. After 24 hours NIS expressing Tregs were observed in the spleen and their localisation was further confirmed by organ biodistribution studies and flow cytometry analysis. The data presented here suggests that SPECT/CT imaging can be utilised in preclinical imaging studies of adoptively transferred Tregs without affecting Treg function and viability thereby allowing longitudinal studies within disease models.	[Sharif-Paghaleh, Ehsan; Ratnasothy, Kulachelvy; Ali, Niwa; Alhabbab, Rowa; Lechler, Robert I.; Smyth, Lesley A.; Mullen, Gregory E.; Lombardi, Giovanna] Kings Coll London, MRC, Ctr Transplantat, Guys Hosp, London WC2R 2LS, England; [Sharif-Paghaleh, Ehsan; Sunassee, Kavitha; Tavare, Richard; Koers, Alexander; Blower, Philip J.; Mullen, Gregory E.] Kings Coll London, Div Imaging Sci, St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Sharif-Paghaleh, E (corresponding author), Kings Coll London, MRC, Ctr Transplantat, Guys Hosp, London WC2R 2LS, England.	greg.mullen@kcl.ac.uk; giovanna.lombardi@kcl.ac.uk	Blower, Phil/GSD-5552-2022; Alhabbab, Rowa/AAY-5063-2020; Alhabbab, Rowa/L-9293-2015	Tavare, Richard/0000-0001-5150-5963; Ali, Niwa/0000-0003-4473-8747; Alhabbab, Rowa/0000-0001-7135-9967; Blower, Philip/0000-0001-6290-1590	King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support from King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences, The Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust and The British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Boland A, 2000, CANCER RES, V60, P3484; Che J, 2003, J NUCL MED, V44, p28P; Cho JY, 2002, GENE THER, V9, P1139, DOI 10.1038/sj.gt.3301787; Feng NH, 2004, CHINESE MED J-PEKING, V117, P1184; Geissler EK, 2009, GUT, V58, P452, DOI 10.1136/gut.2008.163527; Gong N, 2011, J NEUROIMMUNOL, V230, P33, DOI 10.1016/j.jneuroim.2010.08.014; Haberkorn U, 2001, EXP CLIN ENDOCR DIAB, V109, P60, DOI 10.1055/s-2001-11010; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KANWAR B, 2008, METHODS, V329, P21; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; ONISHI Y, 2008, SCIENCES, V105, P10113; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; Ribas A, 2010, FUTURE ONCOL, V6, P1671, DOI 10.2217/FON.10.137; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sagoo P, 2008, CURR OPIN ORGAN TRAN, V13, P645, DOI 10.1097/MOT.0b013e328317a476; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen DHY, 2001, THYROID, V11, P415, DOI 10.1089/105072501300176372; SIGNORE A, 2010, CHEM REV; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang QZ, 2006, CURR OPIN IMMUNOL, V18, P496, DOI 10.1016/j.coi.2006.05.007; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tavare R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019662; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	32	35	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25857	10.1371/journal.pone.0025857	http://dx.doi.org/10.1371/journal.pone.0025857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043296	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400024
J	Le Bras, GF; Allison, GL; Richards, NF; Ansari, SS; Washington, MK; Andl, CD				Le Bras, Gregoire F.; Allison, Gillian L.; Richards, Nicole F.; Ansari, Shazia S.; Washington, M. Kay; Andl, Claudia D.			CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CD44-MEDIATED TUMOR INVASION; ACTIVIN-A; GROWTH-FACTOR; CARCINOMA-CELLS; CATHEPSIN-B; STEM-CELLS; IN-VIVO; RECEPTOR; EXPRESSION	E-cadherin is frequently lost during epithelial-mesenchymal transition and the progression of epithelial tumorigenesis. We found a marker of epithelial-mesenchymal transition, CD44, upregulated in response to functional loss of E-cadherin in esophageal cell lines and cancer. Loss of E-cadherin expression correlates with increased expression of CD44 standard isoform. Using an organotypic reconstruct model, we show increased CD44 expression in areas of cell invasion is associated with MMP-9 at the leading edge. Moreover, Activin A increases cell invasion through CD44 upregulation after E-cadherin loss. Taken together, our results provide functional evidence of CD44 upregulation in esophageal cancer invasion.	[Le Bras, Gregoire F.; Allison, Gillian L.; Richards, Nicole F.; Ansari, Shazia S.; Andl, Claudia D.] Vanderbilt Univ, Dept Surg, Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA; [Washington, M. Kay] Vanderbilt Univ, Dept Pathol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Andl, Claudia D.] Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Le Bras, GF (corresponding author), Vanderbilt Univ, Dept Surg, Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA.	claudia.andl@vanderbilt.edu			American Gastroenterological Association (AGA)/Foundation for Digestive Health and Nutrition (FDHN); National Institutes of Health [DK075379]; Digestive Disease Research Center [P30-DK058404]; Vanderbilt Ingram Cancer Center [P30-CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075379, P30DK058404] Funding Source: NIH RePORTER	American Gastroenterological Association (AGA)/Foundation for Digestive Health and Nutrition (FDHN); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Center; Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CDA is the recipient of a Research Scholar Award from the American Gastroenterological Association (AGA)/Foundation for Digestive Health and Nutrition (FDHN) and supported by the National Institutes of Health (DK075379). We wish to thank the Immunohistology Core and the Translational Core at Vanderbilt University for sectioning and IHC stainings, and other Core facilities supported through the Digestive Disease Research Center (P30-DK058404) and the Vanderbilt Ingram Cancer Center Support grant (P30-CA068485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; Andl CD, 2006, CANCER RES, V66, P9878, DOI 10.1158/0008-5472.CAN-05-4157; Andl CD, 2010, NEOPLASIA, V12, P485, DOI 10.1593/neo.10216; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Fang X, 2011, ONCOGENE; Gotoda T, 2000, GUT, V46, P14, DOI 10.1136/gut.46.1.14; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Harada H, 2003, MOL CANCER RES, V1, P729; Hughes SJ, 1997, CANCER RES, V57, P5571; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Klingbeil P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2915; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kuo YC, 2009, INT J CANCER, V124, P2568, DOI 10.1002/ijc.24263; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Nozoe T, 2004, J CANCER RES CLIN, V130, P334, DOI 10.1007/s00432-004-0542-2; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; Schlemper RJ, 2000, J GASTROEN HEPATOL, V15, pG49, DOI 10.1046/j.1440-1746.2000.02266.x; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu Y, 2003, J BIOL CHEM, V278, P8661, DOI 10.1074/jbc.M208181200; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Yoshinaga K, 2008, INT J ONCOL, V33, P453, DOI 10.3892/ijo_00000027; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Yu J, 1997, CYTOKINES CELL MOL T, V3, P169; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	48	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27063	10.1371/journal.pone.0027063	http://dx.doi.org/10.1371/journal.pone.0027063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069487	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900002
J	Bernard, Y; Ribeiro, N; Thuaud, F; Turkeri, G; Dirr, R; Boulberdaa, M; Nebigil, CG; Desaubry, L				Bernard, Yohann; Ribeiro, Nigel; Thuaud, Frederic; Tuerkeri, Guelen; Dirr, Ronan; Boulberdaa, Mounia; Nebigil, Canan G.; Desaubry, Laurent			Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CARDIAC DYSFUNCTION; SARCOPLASMIC-RETICULUM; CELL-DEATH; IN-VITRO; INDUCED CARDIOMYOPATHY; GROWTH-FACTOR; THERAPY; HEAT-SHOCK-PROTEIN-27; ANTHRACYCLINES	Background: Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natural compounds that display potent neuroprotective effects, may also alleviate doxorubicin-induced cardiotoxicity. Methodology/Principal Findings: Our in vitro data established that a pretreatment with flavaglines significantly increased viability of doxorubicin-injured H9c2 cardiomyocytes as demonstrated by annexin V, TUNEL and active caspase-3 assays. We demonstrated also that phosphorylation of the small heat shock protein Hsp27 is involved in the mechanism by which flavaglines display their cardioprotective effect. Furthermore, knocking-down Hsp27 in H9c2 cardiomyocytes completely reversed this cardioprotection. Administration of our lead compound (FL3) to mice attenuated cardiomyocyte apoptosis and cardiac fibrosis, as reflected by a 50% decrease of mortality. Conclusions/Significance: These results suggest a prophylactic potential of flavaglines to prevent doxorubicin-induced cardiac toxicity.	[Bernard, Yohann; Ribeiro, Nigel; Thuaud, Frederic; Dirr, Ronan; Desaubry, Laurent] Univ Strasbourg, Therapeut Innovat Lab, CNRS, UMR7200, Illkirch Graffenstaden, France; [Bernard, Yohann; Tuerkeri, Guelen; Boulberdaa, Mounia; Nebigil, Canan G.] Univ Strasbourg, Inst Rech, Ecole Biotechnol Strasbourg, CNRS,FRE 3211, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bernard, Y (corresponding author), Univ Strasbourg, Therapeut Innovat Lab, CNRS, UMR7200, Illkirch Graffenstaden, France.	canan.nebigil-desaubry@unistra.fr; desaubry@unistra.fr	Nebigil, Canan/AAK-7162-2021; Türkeri Birant, Gülen/AFV-3015-2022; Desaubry, Laurent G/R-5446-2017	Nebigil, Canan/0000-0002-2035-5795; Türkeri Birant, Gülen/0000-0001-6869-3948; Desaubry, Laurent G/0000-0002-1192-2970	"Association pour la Recherche sur le Cancer" (ARC); Conectus; French Ministry of research	"Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); Conectus; French Ministry of research(Ministry of Research, FranceEuropean Commission)	The authors are grateful for grant support from the "Association pour la Recherche sur le Cancer" (ARC) and Conectus. N.R. was supported by ARC and F.T. and R.D. by the French Ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 1998, J MOL CELL CARDIOL, V30, P243, DOI 10.1006/jmcc.1997.0588; Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Berdichevski A, 2010, J PHARMACOL EXP THER, V332, P413, DOI 10.1124/jpet.109.161158; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bryant J, 2007, BRIT J CANCER, V96, P226, DOI 10.1038/sj.bjc.6603562; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Cortes-Funes H, 2007, CARDIOVASC TOXICOL, V7, P56, DOI 10.1007/s12012-007-0015-3; Esaki M, 2008, AM J PHYSIOL-HEART C, V294, pH1048, DOI 10.1152/ajpheart.01102.2007; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Goubaeva F, 2007, BIOCHEM BIOPH RES CO, V352, P97, DOI 10.1016/j.bbrc.2006.10.177; GRIFFIN MO, AM J PHYSL CELL PHYS, V299, pC539; Iarussi Diana, 2005, Paediatr Drugs, V7, P67, DOI 10.2165/00148581-200507020-00001; Imondi AR, 1998, SEMIN ONCOL, V25, P22; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; Kim Soyoung, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P319, DOI 10.2174/187152006777698123; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Krischer JP, 1997, J CLIN ONCOL, V15, P1544, DOI 10.1200/JCO.1997.15.4.1544; LAI HC, EUR J PHARM, V644, P176; Li K, 2006, CIRCULATION, V113, P2211, DOI 10.1161/CIRCULATIONAHA.105.560250; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Liu L, 2007, EUR J HEART FAIL, V9, P762, DOI 10.1016/j.ejheart.2007.03.007; Mai A, 2009, CURR PHARM DESIGN, V15, P3940, DOI 10.2174/138161209789649349; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nebigil CG, 2003, FASEB J, V17, P1373, DOI 10.1096/fj.02-1122fje; Olson RD, 2005, CARDIOVASC TOXICOL, V5, P269, DOI 10.1385/CT:5:3:269; Proksch P, 2001, CURR ORG CHEM, V5, P923, DOI 10.2174/1385272013375049; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Turakhia S, 2007, AM J PHYSIOL-HEART C, V293, pH3111, DOI 10.1152/ajpheart.00328.2007; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; van Dalen EC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub3; Venkatakrishnan CD, 2008, AM J PHYSIOL-HEART C, V294, pH1736, DOI 10.1152/ajpheart.91507.2007; Venkatakrishnan CD, 2006, AM J PHYSIOL-HEART C, V291, pH2680, DOI 10.1152/ajpheart.00395.2006; Voegeli TS, 2009, INFLAMM RES, V58, P336, DOI 10.1007/s00011-009-8166-2; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	46	42	42	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25302	10.1371/journal.pone.0025302	http://dx.doi.org/10.1371/journal.pone.0025302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065986	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000003
J	Bhardwaj, V; Meier, S; Petersen, LN; Ingle, RA; Roden, LC				Bhardwaj, Vaibhav; Meier, Stuart; Petersen, Lindsay N.; Ingle, Robert A.; Roden, Laura C.			Defence Responses of Arabidopsis thaliana to Infection by Pseudomonas syringae Are Regulated by the Circadian Clock	PLOS ONE			English	Article							PAMP-TRIGGERED IMMUNITY; GENE-EXPRESSION; SALICYLIC-ACID; KEY PATHWAYS; LIGHT; RESISTANCE; TRANSCRIPTION; RHYTHMS; RECOGNITION; SUPPRESSES	The circadian clock allows plants to anticipate predictable daily changes in abiotic stimuli, such as light; however, whether the clock similarly allows plants to anticipate interactions with other organisms is unknown. Here we show that Arabidopsis thaliana (Arabidopsis) has circadian clock-mediated variation in resistance to the virulent bacterial pathogen Pseudomonas syringae pv. tomato DC3000 (Pst DC3000), with plants being least susceptible to infection in the subjective morning. We suggest that the increased resistance to Pst DC3000 observed in the morning in Col-0 plants results from clock-mediated modulation of pathogen associated molecular pattern (PAMP)-triggered immunity. Analysis of publicly available microarray data revealed that a large number of Arabidopsis defence-related genes showed both diurnal-and circadian-regulation, including genes involved in the perception of the PAMP flagellin which exhibit a peak in expression in the morning. Accordingly, we observed that PAMP-triggered callose deposition was significantly higher in wild-type plants inoculated with Pst DC3000 hrpA in the subjective morning than in the evening, while no such temporal difference was evident in arrhythmic plants. Our results suggest that PAMP-triggered immune responses are modulated by the circadian clock and that temporal regulation allows plants to anticipate and respond more effectively to pathogen challenges in the daytime.	[Bhardwaj, Vaibhav; Petersen, Lindsay N.; Ingle, Robert A.; Roden, Laura C.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; [Meier, Stuart] King Abdullah Univ Sci & Technol, Div Chem Life Sci & Engn, Thuwal, Saudi Arabia	University of Cape Town; King Abdullah University of Science & Technology	Bhardwaj, V (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa.	Robert.ingle@uct.ac.za	Roden, Laura/O-4024-2019; Roden, Laura/D-1364-2010; Ingle, Robert A/C-5599-2008	Roden, Laura/0000-0002-1941-898X; Roden, Laura/0000-0002-1941-898X; Ingle, Robert A/0000-0002-8362-3777	National Research Foundation, South Africa; University of Cape Town Research Committee	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Cape Town Research Committee	LCR and RAI received funding from the National Research Foundation (Competitive support for unrated researcher program), South Africa (www.nrf.ac.za) and the University of Cape Town Research Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Chandra-Shekara AC, 2006, PLANT J, V45, P320, DOI 10.1111/j.1365-313X.2005.02618.x; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Griebel T, 2008, PLANT PHYSIOL, V147, P790, DOI 10.1104/pp.108.119503; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; HIRANO SS, MICROBIAL ECOLOGY LE, P271; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Ichimura K, 1998, BIOCHEM BIOPH RES CO, V253, P532, DOI 10.1006/bbrc.1998.9796; Ingle RA, 2006, BIOESSAYS, V28, P880, DOI 10.1002/bies.20457; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim Min Gab, 2008, V415, P443, DOI 10.1007/978-1-59745-570-1_26; KING EO, 1954, J LAB CLIN MED, V44, P301; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; McClung CR, 2011, NATURE, V470, P44, DOI 10.1038/470044a; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauerbrunn N, 2004, PLANTA, V218, P552, DOI 10.1007/s00425-003-1143-z; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Smart M, 2010, S AFR J BOT, V76, P375, DOI 10.1016/j.sajb.2010.01.002; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; Zeier J, 2004, PLANTA, V219, P673, DOI 10.1007/s00425-004-1272-z	47	110	115	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26968	10.1371/journal.pone.0026968	http://dx.doi.org/10.1371/journal.pone.0026968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066021	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000038
J	Kleinau, G; Pratzka, J; Nurnberg, D; Gruters, A; Fuhrer-Sakel, D; Krude, H; Kohrle, J; Schoneberg, T; Biebermann, H				Kleinau, Gunnar; Pratzka, Juliane; Nuernberg, Daniela; Grueters, Annette; Fuehrer-Sakel, Dagmar; Krude, Heiko; Koehrle, Josef; Schoeneberg, Torsten; Biebermann, Heike			Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; OCTOPAMINE RECEPTOR; CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHARACTERIZATION; MONOAMINE TRANSPORTERS; DOPAMINE TRANSPORTER; SELECTIVE ANTAGONIST; OLFACTORY RECEPTORS; ACTIVATION; 3-IODOTHYRONAMINE	Trace amine-associated receptors (TAAR) are rhodopsin-like G-protein-coupled receptors (GPCR). TAAR are involved in modulation of neuronal, cardiac and vascular functions and they are potentially linked with neurological disorders like schizophrenia and Parkinson's disease. Subtype TAAR1, the best characterized TAAR so far, is promiscuous for a wide set of ligands and is activated by trace amines tyramine (TYR), phenylethylamine (PEA), octopamine (OA), but also by thyronamines, dopamine, and psycho-active drugs. Unfortunately, effects of trace amines on signaling of the two homologous beta-adrenergic receptors 1 (ADRB1) and 2 (ADRB2) have not been clarified yet in detail. We, therefore, tested TAAR1 agonists TYR, PEA and OA regarding their effects on ADRB1/2 signaling by co-stimulation studies. Surprisingly, trace amines TYR and PEA are partial allosteric antagonists at ADRB1/2, whereas OA is a partial orthosteric ADRB2-antagonist and ADRB1-agonist. To specify molecular reasons for TAAR1 ligand promiscuity and for observed differences in signaling effects on particular aminergic receptors we compared TAAR, tyramine (TAR) octopamine (OAR), ADRB1/2 and dopamine receptors at the structural level. We found especially for TAAR1 that the remarkable ligand promiscuity is likely based on high amino acid similarity in the ligand-binding region compared with further aminergic receptors. On the other hand few TAAR specific properties in the ligand-binding site might determine differences in ligand-induced effects compared to ADRB1/2. Taken together, this study points to molecular details of TAAR1-ligand promiscuity and identified specific trace amines as allosteric or orthosteric ligands of particular beta-adrenergic receptor subtypes.	[Kleinau, Gunnar; Pratzka, Juliane; Nuernberg, Daniela; Grueters, Annette; Krude, Heiko; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Koehrle, Josef] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Fuehrer-Sakel, Dagmar] Univ Klinikum Essen, Klin Endokrinol, Zentrum Innere Med, Essen, Germany; [Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Leipzig University	Kleinau, G (corresponding author), Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Köhrle, Josef/AAH-6438-2020; Kleinau, Gunnar/GPX-6330-2022	Köhrle, Josef/0000-0002-9187-9078; Biebermann, Heike/0000-0002-2024-7778	Deutsche Forschungsgemeinschaft (DFG): Graduate College [1208, TP1, TP3, KL2334/2-1]	Deutsche Forschungsgemeinschaft (DFG): Graduate College(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG): Graduate College 1208 (Hormonal Regulation of Energy Metabolism, Body Weight and Growth) TP1 and TP3, and grant KL2334/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airriess CN, 1997, BRIT J PHARMACOL, V122, P191, DOI 10.1038/sj.bjp.0701348; ARAKAWA S, 1990, NEURON, V4, P343, DOI 10.1016/0896-6273(90)90047-J; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berry MD, 2004, J NEUROCHEM, V90, P257, DOI 10.1111/j.1471-4159.2004.02501.x; Bly M, 2005, SCHIZOPHR RES, V80, P367, DOI 10.1016/j.schres.2005.06.003; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bradaia A, 2009, P NATL ACAD SCI USA, V106, P20081, DOI 10.1073/pnas.0906522106; Branchek TA, 2003, CURR OPIN PHARMACOL, V3, P90, DOI 10.1016/S1471-4892(02)00028-0; BROWN CM, 1988, BRIT J PHARMACOL, V93, P417, DOI 10.1111/j.1476-5381.1988.tb11449.x; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; Carpene C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V338, P1189, DOI 10.1016/j.bbrc.2005.10.058; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CODY V, 1984, ENDOCR RES, V10, P91, DOI 10.3109/07435808409035410; D'Andrea G, 2010, NEUROSCI LETT, V469, P348, DOI 10.1016/j.neulet.2009.12.025; DAVID JC, 1985, PROG NEUROBIOL, V24, P141, DOI 10.1016/0301-0082(85)90009-7; Duan JB, 2004, AM J HUM GENET, V75, P624, DOI 10.1086/424887; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; Ghelardoni S, 2009, J CELL MOL MED, V13, P3082, DOI 10.1111/j.1582-4934.2009.00728.x; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Gompf HS, 2010, BRAIN RES, V1351, P130, DOI 10.1016/j.brainres.2010.06.067; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; Hu LYA, 2009, BIOCHEM J, V424, P39, DOI 10.1042/BJ20090998; Huang ES, 2003, PROTEIN SCI, V12, P1360, DOI 10.1110/ps.0305603; Huang J, 2008, BIOCHEM BIOPH RES CO, V371, P610, DOI 10.1016/j.bbrc.2008.03.135; Huang J, 2007, BIOCHEMISTRY-US, V46, P5896, DOI 10.1021/bi602593t; Hussain A, 2009, P NATL ACAD SCI USA, V106, P4313, DOI 10.1073/pnas.0803229106; Ianculescu AG, 2010, MOL BIOSYST, V6, P1338, DOI 10.1039/b926583j; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kratochwil NA, 2005, J CHEM INF MODEL, V45, P1324, DOI 10.1021/ci050221u; Krautwurst D, 2008, CHEM BIODIVERS, V5, P842, DOI 10.1002/cbdv.200890099; Lewin AH, 2006, AAPS J, V8, pE138, DOI 10.1208/aapsj080116; Lewin AH, 2009, BIOORG MED CHEM LETT, V19, P5913, DOI 10.1016/j.bmcl.2009.08.058; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu ISC, 1998, MOL BRAIN RES, V53, P98, DOI 10.1016/S0169-328X(97)00283-0; Ma GY, 2010, PLANTA MED, V76, P981, DOI 10.1055/s-0029-1240884; Maguire JJ, 2009, PHARMACOL REV, V61, P1, DOI 10.1124/pr.109.001107; Massarsky A, 2011, J EXP ZOOL PART A, V315A, P251, DOI 10.1002/jez.672; MEYER T, 1983, HORM METAB RES, V15, P602, DOI 10.1055/s-2007-1018803; Miller GM, 2005, J PHARMACOL EXP THER, V313, P983, DOI 10.1124/jpet.105.084459; Pae CU, 2010, PSYCHIAT RES, V180, P20, DOI 10.1016/j.psychres.2009.08.007; Pae CU, 2009, NEUROSCI LETT, V465, P257, DOI 10.1016/j.neulet.2009.09.025; Panas HN, 2010, J NEUROSCI RES, V88, P1962, DOI 10.1002/jnr.22367; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Peeters MC, 2011, FASEB J, V25, P632, DOI 10.1096/fj.10-164319; Piehl S, 2010, ENDOCR REV, P2009; Piehl S, 2008, RAPID COMMUN MASS SP, V22, P3286, DOI 10.1002/rcm.3732; Pietsch CA, 2007, ENDOCRINOLOGY, V148, P1921, DOI 10.1210/en.2006-1172; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Revel FG, 2011, P NATL ACAD SCI USA, V108, P8485, DOI 10.1073/pnas.1103029108; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Snead AN, 2008, BIOORG MED CHEM LETT, V18, P5920, DOI 10.1016/j.bmcl.2008.08.013; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Stalder H, 2011, BIOORGANIC IN PRESS; Stalder H, 2011, BIOORG MED CHEM LETT, V21, P1227, DOI 10.1016/j.bmcl.2010.12.075; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Tan ES, 2008, CHEM BIOL, V15, P343, DOI 10.1016/j.chembiol.2008.03.004; Tan ES, 2007, J MED CHEM, V50, P2787, DOI 10.1021/jm0700417; Tan ES, 2009, ACS CHEM BIOL, V4, P209, DOI 10.1021/cb800304d; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Vanti WB, 2003, BIOCHEM BIOPH RES CO, V305, P67, DOI 10.1016/S0006-291X(03)00709-5; Vilar S, 2011, J MOL GRAPH MODEL, V29, P809, DOI 10.1016/j.jmgm.2011.01.005; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wallach JV, 2009, MED HYPOTHESES, V72, P91, DOI 10.1016/j.mehy.2008.07.052; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wichard JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016811; Wolinsky TD, 2007, GENES BRAIN BEHAV, V6, P628, DOI 10.1111/j.1601-183X.2006.00292.x; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Xie ZH, 2008, J PHARMACOL EXP THER, V325, P629, DOI 10.1124/jpet.107.135079; Xie ZH, 2007, J PHARMACOL EXP THER, V321, P116, DOI 10.1124/jpet.106.116863; Xie ZH, 2007, J PHARMACOL EXP THER, V321, P128, DOI 10.1124/jpet.106.117382; Zeng ZZ, 1998, BIOCHEM BIOPH RES CO, V242, P575, DOI 10.1006/bbrc.1997.7591; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948; Zucchi R, 2010, HEART FAIL REV, V15, P171, DOI 10.1007/s10741-008-9120-z	88	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27073	10.1371/journal.pone.0027073	http://dx.doi.org/10.1371/journal.pone.0027073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073124	Green Submitted, gold, Green Published			2022-12-27	WOS:000296916000051
J	Dang, SY; Hong, T; Wisniewski, T; Zhang, W				Dang, Suying; Hong, Tao; Wisniewski, Thomas; Zhang, Wei			Dissolution of Pre-Existing Platelet Thrombus by Synergistic Administration of Low Concentrations of Bifunctional Antibodies against beta 3 Integrin	PLOS ONE			English	Article							GLYCOPROTEIN-IIB/IIIA ANTAGONISTS; CONFORMATION-SPECIFIC BLOCKADE; ACUTE ISCHEMIC-STROKE; MOLECULAR MIMICRY; GPIIB/IIIA; METAANALYSIS; MORTALITY; REQUIRES; TARGETS; LIGAND	Most antithrombotic approaches target prevention rather than the more clinically relevant issue of resolution of an existing thrombus. In this study, we describe a novel and effective therapeutic strategy for ex vivo clearance of pre-existing platelet thrombus by the combination of two bifunctional platelet GPIIIa49-66 ligands that target different parts of the arterial thrombus. We produced an additional GPIIIa49-66 agent (named APAC), which homes to activated platelets. Like our previously described SLK (which targets newly deposited fibrin strands surrounding the platelet thrombus), APAC destroys platelet aggregates ex vivo in an identical fashion with 85% destruction of platelet aggregates at 2 hours. The combined application of APAC and SLK demonstrated a similar to 2 fold greater platelet thrombus dissolution than either agent alone at a low concentration (0.025 mu M). Platelet-rich clot lysis experiments demonstrated the time required for 50% platelet-rich fibrin clot lysis (T-50%) by APAC (95 +/- 6.1 min) or SLK (145 +/- 7.1 min) was much longer than that by combined APAC+SLK (65 +/- 7.6 min) at the final concentration of 0.025 mM (APAC+SLK vs APAC, p<0.05; APAC+SLK vs SLK, p, 0.01). Thus these low concentrations of a combination of both agents are likely to be more effective and less toxic when used therapeutically in vivo.	[Dang, Suying] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200030, Peoples R China; [Dang, Suying; Hong, Tao; Zhang, Wei] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Wisniewski, Thomas; Zhang, Wei] NYU, Sch Med, Dept Neurol, New York, NY USA; [Wisniewski, Thomas; Zhang, Wei] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wisniewski, Thomas; Zhang, Wei] NYU, Sch Med, Dept Psychiat, New York, NY USA	Shanghai Jiao Tong University; East China Normal University; New York University; New York University; New York University	Dang, SY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200030, Peoples R China.	Thomas.wisniewski@nyumc.org; zygluck@gmail.com	Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966	National Institutes of Health [AG20245, DA004315]; National Natural Science Foundation of China [81170481]; Shanghai Pujiang Talent Program [11PJ1403200]; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG020245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talent Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health grants AG20245, DA004315; National Natural Science Foundation of China (81170481); and Shanghai Pujiang Talent Program (11PJ1403200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Aster RH, 2004, SEMIN THROMB HEMOST, V30, P569, DOI 10.1055/s-2004-835677; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Caro JJ, 2000, STROKE, V31, P582, DOI 10.1161/01.STR.31.3.582; Chew DP, 2001, CIRCULATION, V103, P201; Choi JH, 2006, STROKE, V37, P419, DOI 10.1161/01.STR.0000198808.90579.65; Cox D, 2004, CURR PHARM DESIGN, V10, P1587, DOI 10.2174/1381612043384673; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li ZD, 2005, BLOOD, V106, P572, DOI 10.1182/blood-2005-01-0243; Li Z, 2008, J BIOL CHEM, V283, P3224, DOI 10.1074/jbc.M705902200; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mandava P, 2008, DRUGS, V68, P1019, DOI 10.2165/00003495-200868080-00001; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; Quinn MJ, 2002, CIRCULATION, V106, P379, DOI 10.1161/01.CIR.0000019581.22812.B2; Schwarz M, 2004, FASEB J, V18, P1704, DOI 10.1096/fj.04-1513fje; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Stoll P, 2007, ARTERIOSCL THROM VAS, V27, P1206, DOI 10.1161/ATVBAHA.106.138875; Zhang LL, 2004, MOL GENET METAB, V82, P304, DOI 10.1016/j.ymgme.2004.05.008; Zhang W, 2010, AUTOIMMUNITY, V43, P682, DOI 10.3109/08916934.2010.506207; Zhang W, 2010, BLOOD, V116, P2336, DOI 10.1182/blood-2010-01-264358; Zhang W, 2009, BLOOD, V113, P4086, DOI 10.1182/blood-2008-09-181073	26	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27012	10.1371/journal.pone.0027012	http://dx.doi.org/10.1371/journal.pone.0027012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046432	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800057
J	Koh, CY; Kumar, S; Kazimirova, M; Nuttall, PA; Radhakrishnan, UP; Kim, S; Jagadeeswaran, P; Imamura, T; Mizuguchi, J; Iwanaga, S; Swaminathan, K; Kini, RM				Koh, Cho Yeow; Kumar, Sundramurthy; Kazimirova, Maria; Nuttall, Patricia A.; Radhakrishnan, Uvaraj P.; Kim, Seongcheol; Jagadeeswaran, Pudur; Imamura, Takayuki; Mizuguchi, Jun; Iwanaga, Sadaaki; Swaminathan, Kunchithapadam; Kini, R. Manjunatha			Crystal Structure of Thrombin in Complex with S-Variegin: Insights of a Novel Mechanism of Inhibition and Design of Tunable Thrombin Inhibitors	PLOS ONE			English	Article							HUMAN ALPHA-THROMBIN; RECOMBINANT HUMAN PRETHROMBIN-2; PRO-ARG CHLOROMETHYLKETONE; HEMATOPHAGOUS ANIMALS; DABIGATRAN ETEXILATE; BOVINE THROMBIN; HIRUDIN; SITE; SPECIFICITY; ANTICOAGULANTS	The inhibition of thrombin is one of the important treatments of pathological blood clot formation. Variegin, isolated from the tropical bont tick, is a novel molecule exhibiting a unique 'two-modes' inhibitory property on thrombin active site (competitive before cleavage, noncompetitive after cleavage). For the better understanding of its function, we have determined the crystal structure of the human alpha-thrombin:synthetic-variegin complex at 2.4 angstrom resolution. The structure reveals a new mechanism of thrombin inhibition by disrupting the charge relay system. Based on the structure, we have designed 17 variegin variants, differing in potency, kinetics and mechanism of inhibition. The most active variant is about 70 times more potent than the FDA-approved peptidic thrombin inhibitor, hirulog-1/bivalirudin. In vivo antithrombotic effects of the variegin variants correlate well with their in vitro affinities for thrombin. Our results encourage that variegin and the variants show strong potential for the development of tunable anticoagulants.	[Koh, Cho Yeow; Kumar, Sundramurthy; Swaminathan, Kunchithapadam; Kini, R. Manjunatha] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kazimirova, Maria] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Nuttall, Patricia A.] NERC, Ctr Ecol & Hydrol, Oxford OX1 3SR, England; [Radhakrishnan, Uvaraj P.; Kim, Seongcheol; Jagadeeswaran, Pudur] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Imamura, Takayuki; Mizuguchi, Jun; Iwanaga, Sadaaki] Chemosero Therapeut Res Inst, Kumamoto, Japan; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	National University of Singapore; Slovak Academy of Sciences; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of North Texas System; University of North Texas Denton; Virginia Commonwealth University	Koh, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsks@nus.edu.sg; dbskinim@nus.edu.sg	Koh, Cho Yeow/J-4635-2019; Kini, Manjunatha/H-8029-2012; Nuttall, Pat A/I-6142-2012; Kazimirova, Maria/U-8222-2017	Koh, Cho Yeow/0000-0003-0002-4603; Nuttall, Pat A/0000-0002-0385-8294; Kazimirova, Maria/0000-0001-6904-8342; Kini, Manjunatha/0000-0002-6100-3251	National University of Singapore; Natural Environment Research Council [CEH010021] Funding Source: researchfish	National University of Singapore(National University of Singapore); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work is supported by the Academic Research Grants from National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2006, ATHEROSCLEROSIS, V186, P240, DOI 10.1016/j.atherosclerosis.2005.10.042; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; BRAUN PJ, 1988, BIOCHEMISTRY-US, V27, P6517, DOI 10.1021/bi00417a048; Champagne Donald E., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P375, DOI 10.2174/1568006043335862; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DODT J, 1988, FEBS LETT, V229, P87, DOI 10.1016/0014-5793(88)80803-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson BI, 2008, NAT REV DRUG DISCOV, V7, P557, DOI 10.1038/nrd2622; Fareed J, 2004, BEST PRACT RES CL HA, V17, P127, DOI 10.1016/j.beha.2004.03.008; Fethiere J, 1996, PROTEIN SCI, V5, P1174; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Greinacher A, 2008, THROMB HAEMOSTASIS, V99, P819, DOI 10.1160/TH07-11-0693; Gross PL, 2008, ARTERIOSCL THROM VAS, V28, P380, DOI 10.1161/ATVBAHA.108.162677; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Huntington JA, 2008, BIOL CHEM, V389, P1025, DOI 10.1515/BC.2008.113; Jagadeeswaran Pudur, 2006, V129, P187; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Koh CY, 2008, EXPERT REV HEMATOL, V1, P135, DOI 10.1586/17474086.1.2.135; Koh CY, 2009, CHEMBIOCHEM, V10, P2155, DOI 10.1002/cbic.200900371; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu CC, 2007, J AM CHEM SOC, V129, P10648, DOI 10.1021/ja0735002; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; MARTIN PD, 1992, J BIOL CHEM, V267, P7911; Martin PD, 1996, BIOCHEMISTRY-US, V35, P13030, DOI 10.1021/bi960656y; Matthews JH, 1996, BIOPHYS J, V71, P2830, DOI 10.1016/S0006-3495(96)79479-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sion-Usakiewicz JJ, 2000, BIOCHEMISTRY-US, V39, P2384, DOI 10.1021/bi992419b; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; SlonUsakiewicz JJ, 1997, BIOCHEMISTRY-US, V36, P13494, DOI 10.1021/bi970857h; Soejima K, 2001, J BIOCHEM, V130, P269, DOI 10.1093/oxfordjournals.jbchem.a002982; STONE SR, 1995, J ENZYM INHIB, V9, P3, DOI 10.3109/14756369509040677; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Warkentin TE, 2008, THROMB HAEMOSTASIS, V99, P830, DOI 10.1160/TH07-10-0644; White CM, 2005, AM HEART J, V149, pS54, DOI 10.1016/j.ahj.2004.10.023; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P155, DOI 10.1160/TH07-03-0183; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WITTING JI, 1992, BIOCHEM J, V283, P737, DOI 10.1042/bj2830737; Yeh RW, 2006, AM HEART J, V151, P1131, DOI 10.1016/j.ahj.2005.09.002; Yonemura H, 2004, J BIOCHEM, V135, P577, DOI 10.1093/jb/mvh070	58	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26367	10.1371/journal.pone.0026367	http://dx.doi.org/10.1371/journal.pone.0026367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053189	gold, Green Published			2022-12-27	WOS:000299081800015
J	Xie, Y; Zhang, ZH; Niu, LL; Wang, Q; Wang, CD; Lan, JC; Deng, JB; Fu, Y; Nie, HM; Yan, N; Yang, DY; Hao, GY; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Xie, Yue; Zhang, Zhihe; Niu, Lili; Wang, Qiang; Wang, Chengdong; Lan, Jingchao; Deng, Jiabo; Fu, Yan; Nie, Huaming; Yan, Ning; Yang, Deying; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			The Mitochondrial Genome of Baylisascaris procyonis	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; HUMAN HOOKWORMS; ANIMAL HEALTH; CODON USAGE; DNA; SEQUENCE; PCR; IDENTIFICATION; EVOLUTION	Background: Baylisascaris procyonis (Nematoda: Ascaridida), an intestinal nematode of raccoons, is emerging as an important helminthic zoonosis due to serious or fatal larval migrans in animals and humans. Despite its significant veterinary and public health impact, the epidemiology, molecular ecology and population genetics of this parasite remain largely unexplored. Mitochondrial (mt) genomes can provide a foundation for investigations in these areas and assist in the diagnosis and control of B. procyonis. In this study, the first complete mt genome sequence of B. procyonis was determined using a polymerase chain reaction (PCR)-based primer-walking strategy. Methodology/Principal Findings: The circular mt genome (14781 bp) of B. procyonis contained 12 protein-coding, 22 transfer RNA and 2 ribosomal RNA genes congruent with other chromadorean nematodes. Interestingly, the B. procyonis mtDNA featured an extremely long AT-rich region (1375 bp) and a high number of intergenic spacers (17), making it unique compared with other secernentean nematodes characterized to date. Additionally, the entire genome displayed notable levels of AT skew and GC skew. Based on pairwise comparisons and sliding window analysis of mt genes among the available 11 Ascaridida mtDNAs, new primer pairs were designed to amplify specific short fragments of the genes cytb (548 bp fragment) and rrnL (200 bp fragment) in the B. procyonis mtDNA, and tested as possible alternatives to existing mt molecular beacons for Ascaridida. Finally, phylogenetic analysis of mtDNAs provided novel estimates of the interrelationships of Baylisasaris and Ascaridida. Conclusions/Significance: The complete mt genome sequence of B. procyonis sequenced here should contribute to molecular diagnostic methods, epidemiological investigations and ecological studies of B. procyonis and other related ascaridoids. The information will be important in refining the phylogenetic relationships within the order Ascaridida and enriching the resource of markers for systematic, population genetic and evolutionary biological studies of parasitic nematodes of socio-economic importance.	[Xie, Yue; Fu, Yan; Nie, Huaming; Yan, Ning; Yang, Deying; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Zhang, Zhihe; Wang, Chengdong; Lan, Jingchao] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China; [Niu, Lili; Wang, Qiang; Deng, Jiabo] Chengdu Zool Garden, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Xie, Y (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn	Wang, Qiang/AAV-7131-2021	Hao, Guiying/0000-0003-0233-4947	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0848]; Chengdu Research of Giant Panda Breeding [CPF2010-08]; Ministry of Education, China [20095103110007]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chengdu Research of Giant Panda Breeding; Ministry of Education, China(Ministry of Education, China)	This work was supported by grant from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (grant no. IRT0848), the Research Fund (Project No. CPF2010-08) for the Chengdu Research of Giant Panda Breeding and the Special Funds for the Training of PhD Students from the Ministry of Education, China (grant no. 20095103110007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson TJC, 1998, ADV PARASIT, V41, P219, DOI 10.1016/S0065-308X(08)60425-X; Beaver PC, 1984, CLIN PARASITOLOGY, V9th; Blizzard EL, 2010, J PARASITOL, V96, P1128, DOI 10.1645/GE-2518.1; Blizzard EL, 2010, EMERG INFECT DIS, V16, P1803, DOI 10.3201/eid1611.100549; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Blouin MS, 1998, J HELMINTHOL, V72, P285, DOI 10.1017/S0022149X00016618; BOSCHETTI A, 1995, J FORENSIC SCI, V40, P1097; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CUNNINGHAM CK, 1994, CLIN INFECT DIS, V18, P868, DOI 10.1093/clinids/18.6.868; Dangoudoubiyam S, 2009, J PARASITOL, V95, P571, DOI 10.1645/GE-1905.1; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Gatcombe RR, 2010, PARASITOL RES, V106, P499, DOI 10.1007/s00436-009-1692-6; Gavin PJ, 2005, CLIN MICROBIOL REV, V18, P703, DOI 10.1128/CMR.18.4.703-718.2005; Gavin PJ, 2001, AM SOC MICR C; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartwich G., 1974, CIH Keys Nematode Parasites Vert, VNo. 2,1974, P1; He Guang-zhi, 2008, Zhongguo Shouyi Kexue, V38, P933; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Hu M, 2004, ADV PARASIT, V56, P133, DOI 10.1016/S0065-308X(03)56003-1; Hu M, 2003, PARASITOLOGY, V127, P37, DOI 10.1017/S0031182003003275; Hu M, 2003, INT J PARASITOL, V33, P1393, DOI 10.1016/S0020-7519(03)00130-9; Hu M, 2002, INT J PARASITOL, V32, P145, DOI 10.1016/S0020-7519(01)00316-2; Huff D S, 1984, Pediatr Pathol, V2, P345; Jex AR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000273; Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79; Jex AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-11; Kazacos Kevin R., 2001, P301, DOI 10.1002/9780470377000.ch11; KAZACOS KR, 1989, J AM VET MED ASSOC, V195, P894; Kazacos KR, 2000, CONT PEDIAT S, V17, P1; Keddie EM, 1998, MOL BIOCHEM PARASIT, V95, P111, DOI 10.1016/S0166-6851(98)00102-9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lavrov DV, 2001, GENETICS, V157, P621; Leles D, 2009, VET PARASITOL, V163, P167, DOI 10.1016/j.vetpar.2009.03.050; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1992, GENETICS, V130, P471; Orihel T.C., 1995, PARASITES HUMAN TISS; Park SY, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e56; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saccone C, 2000, GENE, V261, P153, DOI 10.1016/S0378-1119(00)00484-4; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Wickramasinghe S, 2009, MOL BIOCHEM PARASIT, V166, P89, DOI 10.1016/j.molbiopara.2009.02.012; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Yatawara L, 2010, MOL BIOCHEM PARASIT, V173, P32, DOI 10.1016/j.molbiopara.2010.05.004; Zhan B, 2001, J PARASITOL, V87, P1227, DOI 10.1645/0022-3395(2001)087[1227:SSIOHH]2.0.CO;2	54	29	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27066	10.1371/journal.pone.0027066	http://dx.doi.org/10.1371/journal.pone.0027066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046447	Green Submitted, gold, Green Published			2022-12-27	WOS:000299081800068
J	Zhang, G; Lehmann, HC; Bogdanova, N; Gao, T; Zhang, JY; Sheikh, KA				Zhang, Gang; Lehmann, Helmar C.; Bogdanova, Nataliia; Gao, Tong; Zhang, Jiangyang; Sheikh, Kazim A.			Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLAMMATORY DEMYELINATING POLYNEUROPATHY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; IGG ANTI-GM1 ANTIBODY; RHO-GTPASES; NEURONAL MORPHOGENESIS; AXONAL DEGENERATION; CLINICAL RECOVERY; ANIMAL-MODELS; GROWTH CONE	Guillain-Barre syndrome (GBS) is a monophasic immune neuropathic disorder in which a significant proportion of patients have incomplete recovery. The patients with incomplete recovery almost always have some degree of failure of axon regeneration and target reinnervation. Anti-ganglioside antibodies (Abs) are the most commonly recognized autoimmune markers in all forms of GBS and specific Abs are associated with the slow/poor recovery. We recently demonstrated that specific anti-ganglioside Abs inhibit axonal regeneration and nerve repair in preclinical models by activation of small GTPase RhoA and its downstream effectors. The objective of this study was to determine whether erythropoietin (EPO), a pleiotropic cytokine with neuroprotective and neurotrophic properties, enhances nerve regeneration in preclinical cell culture and animal models of autoimmune neuropathy/nerve repair generated with monoclonal and patient derived Abs. Primary neuronal cultures and a standardized sciatic crush nerve model were used to assess the efficacy of EPO in reversing inhibitory effects of anti-ganglioside Abs on nerve repair. We found that EPO completely reversed the inhibitory effects of anti-ganglioside Abs on axon regeneration in cell culture models and significantly improved nerve regeneration/repair in an animal model. Moreover, EPO-induced proregenerative effects in nerve cells are through EPO receptors and Janus kinase 2/Signal transducer and activator of transcription 5 pathway and not via early direct modulation of small GTPase RhoA. These preclinical studies indicate that EPO is a viable candidate drug to develop further for neuroprotection and enhancing nerve repair in patients with GBS.	[Zhang, Gang; Bogdanova, Nataliia; Gao, Tong; Sheikh, Kazim A.] Univ Texas Med Sch, Dept Neurol, Houston, TX 77030 USA; [Lehmann, Helmar C.] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Zhang, Jiangyang] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	University of Texas System; University of Texas Health Science Center Houston; Heinrich Heine University Dusseldorf; Johns Hopkins University	Zhang, G (corresponding author), Univ Texas Med Sch, Dept Neurol, Houston, TX 77030 USA.	kazim.sheikh@uth.tmc.edu	Lehmann, Helmar C/G-4998-2016	Lehmann, Helmar C/0000-0001-6205-2293; Zhang, Jiangyang/0000-0003-0740-2662; Zhang, Jiangyang/0000-0003-4146-8163	GBS/CIDP (Guillain-Barre Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy) Foundation International; NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS42888, NS54962]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054962, R01NS042888] Funding Source: NIH RePORTER	GBS/CIDP (Guillain-Barre Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy) Foundation International; NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by GBS/CIDP (Guillain-Barre Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy) Foundation International (http://www.gbs-cidp.org) and NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke; http://www.ninds.nih.gov) (Grant numbers: NS42888 and NS54962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammarguellat F, 2001, BIOCHEM BIOPH RES CO, V284, P1031, DOI 10.1006/bbrc.2001.5085; Armati PJ, 1996, BAILLIERE CLIN NEUR, V5, P47; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Bianchi R, 2005, J PERIPHER NERV SYST, V10, P7; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BROWN WF, 1984, BRAIN, V107, P219, DOI 10.1093/brain/107.1.219; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Campana WM, 2001, FASEB J, V15, P1804, DOI 10.1096/fj.00-0857fje; Carpo M, 1999, J NEUROL SCI, V168, P78, DOI 10.1016/S0022-510X(99)00173-2; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; GREGSON NA, 1993, Q J MED, V86, P111; Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; ILYAS AA, 1992, J NEUROL SCI, V107, P111, DOI 10.1016/0022-510X(92)90217-9; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Keswani SC, 2004, NEUROSCI LETT, V371, P102, DOI 10.1016/j.neulet.2004.08.080; Keswani SC, 2004, ANN NEUROL, V56, P815, DOI 10.1002/ana.20285; Knabe W, 2005, ANAT EMBRYOL, V210, P209, DOI 10.1007/s00429-005-0019-3; Koga M, 2003, NEUROLOGY, V60, P1514, DOI 10.1212/01.WNL.0000061615.77865.83; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kuwabara S, 1998, NEUROLOGY, V51, P1656, DOI 10.1212/WNL.51.6.1656; Kuwabara S, 1998, ANN NEUROL, V44, P202, DOI 10.1002/ana.410440210; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Maurer M, 2002, NEUROMUSCULAR DISORD, V12, P405, DOI 10.1016/S0960-8966(01)00302-9; Pankratova S, 2010, BRAIN, V133, P2281, DOI 10.1093/brain/awq101; Pollard JD, 2011, J PERIPHER NERV SYST, V16, P15, DOI 10.1111/j.1529-8027.2011.00323.x; Press R, 2001, J NEUROL SCI, V190, P41, DOI 10.1016/S0022-510X(01)00580-9; Rees JH, 1998, J NEUROL NEUROSUR PS, V64, P74, DOI 10.1136/jnnp.64.1.74; Ropper AH., 1991, CONT NEUROLOGY SERIE, P73; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Sheikh KA, 2004, ANN NEUROL, V56, P228, DOI 10.1002/ana.20173; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; SIMONE IL, 1993, J NEUROL SCI, V114, P49, DOI 10.1016/0022-510X(93)90048-4; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sytkowski AJ, 2007, SCI STKE, V2007, ppe38, DOI DOI 10.1126/STKE.3952007PE38; Taylor JM, 2003, MUSCLE NERVE, V28, P344, DOI 10.1002/mus.10432; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001; WAKSMAN BH, 1956, J NEUROPATH EXP NEUR, V15, P293, DOI 10.1097/00005072-195607000-00005; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; YUKI N, 1993, MUSCLE NERVE, V16, P642, DOI 10.1002/mus.880160610; Zhang G, 2004, BRAIN, V127, P1085, DOI 10.1093/brain/awh127; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033	68	18	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27067	10.1371/journal.pone.0027067	http://dx.doi.org/10.1371/journal.pone.0027067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046448	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800069
J	Machado, CJ; Bliss-Moreau, E; Platt, ML; Amaral, DG				Machado, Christopher J.; Bliss-Moreau, Eliza; Platt, Michael L.; Amaral, David G.			Social and Nonsocial Content Differentially Modulates Visual Attention and Autonomic Arousal in Rhesus Macaques	PLOS ONE			English	Article							MONKEYS MACACA-MULATTA; TEMPORAL CORTEX; SELECTIVE RESPONSES; PUPILLARY DILATION; FACIAL-EXPRESSION; AMYGDALA LESIONS; NEURAL BASIS; NEURONS; FACES; CHIMPANZEES	The sophisticated analysis of gestures and vocalizations, including assessment of their emotional valence, helps group-living primates efficiently navigate their social environment. Deficits in social information processing and emotion regulation are important components of many human psychiatric illnesses, such as autism, schizophrenia and social anxiety disorder. Analyzing the neurobiology of social information processing and emotion regulation requires a multidisciplinary approach that benefits from comparative studies of humans and animal models. However, many questions remain regarding the relationship between visual attention and arousal while processing social stimuli. Using noninvasive infrared eye-tracking methods, we measured the visual social attention and physiological arousal (pupil diameter) of adult male rhesus monkeys (Macaca mulatta) as they watched social and nonsocial videos. We found that social videos, as compared to nonsocial videos, captured more visual attention, especially if the social signals depicted in the videos were directed towards the subject. Subject-directed social cues and nonsocial nature documentary footage, compared to videos showing conspecifics engaging in naturalistic social interactions, generated larger pupil diameters (indicating heightened sympathetic arousal). These findings indicate that rhesus monkeys will actively engage in watching videos of various kinds. Moreover, infrared eye tracking technology provides a mechanism for sensitively gauging the social interest of presented stimuli. Adult male rhesus monkeys' visual attention and physiological arousal do not always trend in the same direction, and are likely influenced by the content and novelty of a particular visual stimulus. This experiment creates a strong foundation for future experiments that will examine the neural network responsible for social information processing in nonhuman primates. Such studies may provide valuable information relevant to interpreting the neural deficits underlying human psychiatric illnesses such as autism, schizophrenia and social anxiety disorder.	[Machado, Christopher J.; Bliss-Moreau, Eliza; Amaral, David G.] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Machado, Christopher J.; Bliss-Moreau, Eliza; Amaral, David G.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Ctr Neuroecon Studies, Dept Neurobiol, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	University of California System; University of California Davis; University of California System; University of California Davis; Duke University; Duke University	Machado, CJ (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.	cjmachado@ucdavis.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Institute of Mental Health [K99-MH083883, R37-MH57502]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057502, K99MH083883, R01MH086712] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institute of Mental Health (K99-MH083883) to C.J. Machado and (R37-MH57502) to D. G. Amaral. All work was carried out at the California National Primate Research Center (RR00069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Andreassi, 2000, PSYCHOPHYSIOLOGY HUM, P218; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Bauman MD, 2006, BEHAV NEUROSCI, V120, P749, DOI 10.1037/0735-7044.120.4.749; Bauman MD, 2004, J COGNITIVE NEUROSCI, V16, P1388, DOI 10.1162/0898929042304741; BECHARA A, 2006, SOCIAL NEUROSCIENCE, P13; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; BROTHERS L, 1993, BEHAV BRAIN RES, V57, P53, DOI 10.1016/0166-4328(93)90061-T; BROTHERS L, 2002, SO NEUROSCI SER, P367; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; Capitanio JP, 2002, PRIMATES, V43, P169, DOI 10.1007/BF02629645; Chevalier-Skolnikoff S., 1973, DARWIN FACIAL EXPRES, P11; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3179, DOI 10.1152/jn.01131.2002; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; de Gelder B, 2009, NEUROREPORT, V20, P642, DOI 10.1097/WNR.0b013e32832a1e56; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Ekman P, 1975, UNMAKING FACE, P212; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Fleishman LJ, 1998, ANIM BEHAV, V56, P1035, DOI 10.1006/anbe.1998.0894; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; FRIEDMAN D, 1973, ELECTROEN CLIN NEURO, V34, P475, DOI 10.1016/0013-4694(73)90065-5; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; HOEHNSARIC R, 1988, PSYCHIAT CLIN N AM, V11, P375; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; JOHNSON LN, 1988, OPHTHALMOLOGY, V95, P1649; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Kardon RH, 1995, NEUROOPHTHALMOLOGICA, P421; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; KLING A, 1979, EXP NEUROL, V66, P88, DOI 10.1016/0014-4886(79)90065-7; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Machado CJ, 2008, BEHAV NEUROSCI, V122, P251, DOI 10.1037/0735-7044.122.2.251; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Machado CJ, 2011, AM J PRIMATOL, V73, P562, DOI 10.1002/ajp.20928; Malkova L, 2003, ANN NY ACAD SCI, V985, P540, DOI 10.1111/j.1749-6632.2003.tb07122.x; MD Bauman, 2007, HDB DEV COGNITIVE NE, P161; Mendoza SP, 1997, FOLIA PRIMATOL, V68, P307, DOI 10.1159/000157256; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Nijsen MJMA, 1998, PHYSIOL BEHAV, V63, P233, DOI 10.1016/S0031-9384(97)00431-9; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; PLIMPTON EH, 1981, DEV PSYCHOBIOL, V14, P109, DOI 10.1002/dev.420140204; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Schumann CM, 2006, UNDERSTANDING AUTISM, P227; Siegle GJ, 2004, INT J PSYCHOPHYSIOL, V52, P63, DOI 10.1016/j.ijpsycho.2003.12.010; Siegle GJ, 2001, BIOL PSYCHIAT, V49, P624, DOI 10.1016/S0006-3223(00)01024-6; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; STEINHAUER SR, 1992, ANN NY ACAD SCI, V658, P182, DOI 10.1111/j.1749-6632.1992.tb22845.x; Stern RM, 2001, PSYCHOPHYSIOLOGICAL, P125; THOMPSON HS, 1982, AM J OPHTHALMOL, V93, P681, DOI 10.1016/0002-9394(82)90460-3; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; van den Buuse M, 2001, PSYCHOPHYSIOLOGY, V38, P490, DOI 10.1017/S0048577201990687; VAN HOOF J. A. R. A. M., 1967, P7; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; Weisz J, 2006, PSYCHOPHYSIOLOGY, V43, P261, DOI 10.1111/j.1469-8986.2006.00395.x; WILSON FAW, 1994, BEHAV BRAIN RES, V60, P79, DOI 10.1016/0166-4328(94)90066-3	78	35	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26598	10.1371/journal.pone.0026598	http://dx.doi.org/10.1371/journal.pone.0026598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046313	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600034
J	Servais, EL; Suzuki, K; Colovos, C; Rodriguez, L; Sima, C; Fleisher, M; Rusch, VW; Sadelain, M; Adusumilli, PS				Servais, Elliot L.; Suzuki, Kei; Colovos, Christos; Rodriguez, Luis; Sima, Camelia; Fleisher, Martin; Rusch, Valerie W.; Sadelain, Michel; Adusumilli, Prasad S.			An In Vivo Platform for Tumor Biomarker Assessment	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; RESPONSE EVALUATION; CANCER	Tumor biomarkers provide a quantitative tool for following tumor progression and response to therapy. However, investigations of clinically useful tumor biomarkers are time-consuming, costly, and limited by patient and tumor heterogeneity. In addition, assessment of biomarkers as indicators of therapy response is confounded by the concomitant use of multiple therapeutic interventions. Herein we report our use of a clinically relevant orthotopic animal model of malignant pleural mesothelioma for investigating tumor biomarkers. Utilizing multi-modality imaging with correlative histopathology, we demonstrate the utility and accuracy of the mouse model in investigating tumor biomarkers - serum soluble mesothelin-related peptide (SMRP) and osteopontin (OPN). This model revealed percentage change in SMRP level to be an accurate biomarker of tumor progression and therapeutic response - a finding consistent with recent clinical studies. This in vivo platform demonstrates the advantages of a validated mouse model for the timely and cost-effective acceleration of human biomarker translational research.	[Servais, Elliot L.; Suzuki, Kei; Colovos, Christos; Rodriguez, Luis; Rusch, Valerie W.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Div Thorac Surg, New York, NY 10021 USA; [Servais, Elliot L.; Colovos, Christos; Rodriguez, Luis; Sadelain, Michel; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Sima, Camelia] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Fleisher, Martin] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Servais, EL (corresponding author), Mem Sloan Kettering Canc Ctr, Div Thorac Surg, 1275 York Ave, New York, NY 10021 USA.	adusumip@mskcc.org		Colovos, Christos/0000-0003-1054-5656; Rusch, Valerie/0000-0003-2345-6900	Department of Defense Research Grant, Mesothelioma Applied Research Foundation (MARF) [PR101053]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; American Association for Thoracic Surgery (AATS); IASLC - International Association for the Study of Lung Cancer Young Investigator; National Lung Cancer Partnership/LUNGevity Foundation; Stony Wold-Herbert Fund, New York State Empire Clinical Research Investigator Program (ECRIP); National Cancer Institute [U54CA137788/U54CA132378]; NATIONAL CANCER INSTITUTE [U54CA137788] Funding Source: NIH RePORTER	Department of Defense Research Grant, Mesothelioma Applied Research Foundation (MARF)(United States Department of Defense); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; American Association for Thoracic Surgery (AATS); IASLC - International Association for the Study of Lung Cancer Young Investigator; National Lung Cancer Partnership/LUNGevity Foundation; Stony Wold-Herbert Fund, New York State Empire Clinical Research Investigator Program (ECRIP); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by PR101053 Department of Defense Research Grant, Mesothelioma Applied Research Foundation (MARF) Grant in memory of Lance S. Ruble, William H. Goodwin and Alice Goodwin, the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center, American Association for Thoracic Surgery (AATS)-Third Edward D. Churchill Research Scholarship, IASLC - International Association for the Study of Lung Cancer Young Investigator Award, National Lung Cancer Partnership/LUNGevity Foundation Research Grant, Stony Wold-Herbert Fund, New York State Empire Clinical Research Investigator Program (ECRIP), and U54CA137788/U54CA132378 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2006, J THORAC CARDIOV SUR, V132, P1179, DOI 10.1016/j.jtcvs.2006.07.005; Adusumilli PS, 2006, J GENE MED, V8, P603, DOI 10.1002/jgm.877; Armato SG, 2006, AM J ROENTGENOL, V186, P1000, DOI 10.2214/AJR.05.0076; Bast RC, 2005, CLIN CANCER RES, V11, P6103, DOI 10.1158/1078-0432.CCR-04-2213; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Ceresoli GL, 2006, J CLIN ONCOL, V24, P4587, DOI 10.1200/JCO.2006.06.8999; Cristaudo A, 2007, CLIN CANCER RES, V13, P5076, DOI 10.1158/1078-0432.CCR-07-0629; Francis RJ, 2007, J NUCL MED, V48, P1449, DOI 10.2967/jnumed.107.042333; Garbow JR, 2008, CLIN CANCER RES, V14, P1363, DOI 10.1158/1078-0432.CCR-07-1757; Krug LM, 2009, J CLIN ONCOL, V27, P3007, DOI 10.1200/JCO.2008.20.3943; Makawita S, 2010, CLIN CHEM, V56, P212, DOI 10.1373/clinchem.2009.127019; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Rai AJ, 2010, CLIN CHEM LAB MED, V48, P271, DOI 10.1515/CCLM.2010.066; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Servais EL, 2011, CURR PROTOC PHARM; van Klaveren RJ, 2004, LUNG CANCER, V43, P63, DOI 10.1016/S0169-5002(03)00292-7; WHEATLEYPRICE P, 2010, J CLIN ONCOL	18	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26722	10.1371/journal.pone.0026722	http://dx.doi.org/10.1371/journal.pone.0026722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046338	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600048
J	Grant, BJ; Lukman, S; Hocker, HJ; Sayyah, J; Brown, JH; McCammon, JA; Gorfe, AA				Grant, Barry J.; Lukman, Suryani; Hocker, Harrison J.; Sayyah, Jaqueline; Brown, Joan Heller; McCammon, J. Andrew; Gorfe, Alemayehu A.			Novel Allosteric Sites on Ras for Lead Generation	PLOS ONE			English	Article							AIDED DRUG DESIGN; PROTEIN-LIGAND INTERACTIONS; RELAXED COMPLEX SCHEME; CANCER-THERAPY; K-RAS; DEVELOPMENTAL DISORDERS; RECEPTOR FLEXIBILITY; MEMBRANE ORIENTATION; ACCURATE DOCKING; SCORING FUNCTION	Aberrant Ras activity is a hallmark of diverse cancers and developmental diseases. Unfortunately, conventional efforts to develop effective small molecule Ras inhibitors have met with limited success. We have developed a novel multi-level computational approach to discover potential inhibitors of previously uncharacterized allosteric sites. Our approach couples bioinformatics analysis, advanced molecular simulations, ensemble docking and initial experimental testing of potential inhibitors. Molecular dynamics simulation highlighted conserved allosteric coupling of the nucleotide-binding switch region with distal regions, including loop 7 and helix 5. Bioinformatics methods identified novel transient small molecule binding pockets close to these regions and in the vicinity of the conformationally responsive switch region. Candidate binders for these pockets were selected through ensemble docking of ZINC and NCI compound libraries. Finally, cell-based assays confirmed our hypothesis that the chosen binders can inhibit the downstream signaling activity of Ras. We thus propose that the predicted allosteric sites are viable targets for the development and optimization of new drugs.	[Grant, Barry J.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Lukman, Suryani] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Lukman, Suryani] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Hocker, Harrison J.; Gorfe, Alemayehu A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Sayyah, Jaqueline; Brown, Joan Heller; McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); University of Cambridge; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego	Grant, BJ (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	bjgrant@umich.edu; sl471@cam.ac.uk; Alemayehu.G.Abebe@uth.tmc.edu	McCammon, J. Andrew/AAG-1832-2021	Grant, Barry/0000-0002-2215-4196; Lukman, Suryani/0000-0002-8913-1343	National Institutes of Health; National Science Foundation; Howard Hughes Medical Institute; Center for Theoretical Biological Physics; Agency for Science, Technology and Research, Singapore; University of Texas Medical School in Houston; Gulf Coast Consortia Training in Pharmacological Sciences; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657, R01GM036927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center for Theoretical Biological Physics; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); University of Texas Medical School in Houston; Gulf Coast Consortia Training in Pharmacological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Institutes of Health, National Science Foundation, Howard Hughes Medical Institute and Center for Theoretical Biological Physics. SL thanks the Agency for Science, Technology and Research, Singapore for studentship. AG and HH acknowledge financial support from the University of Texas Medical School in Houston and the Gulf Coast Consortia Training in Pharmacological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2008, CELL CYCLE, V7, P2667, DOI 10.4161/cc.7.17.6596; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2; [Anonymous], 2008, AMBER 10; Aoki K, 2005, METH MOLEC MED, V106, P193; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P593, DOI 10.1007/BF00126217; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Bollag Gideon, 2003, Curr Opin Investig Drugs, V4, P1436; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Carlson HA, 2000, MOL PHARMACOL, V57, P213; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fukunishi Y, 2011, PROTEIN SCI, V20, P95, DOI 10.1002/pro.540; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Futatsugi N, 2001, BIOPHYS J, V81, P3483, DOI 10.1016/S0006-3495(01)75979-6; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Gorfe AA, 2010, CURR MED CHEM, V17, P1, DOI 10.2174/092986710789957832; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; GRANT BJ, 2010, CURR OPIN STRUCT BIO; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Jayakanthan M, 2009, LETT DRUG DES DISCOV, V6, P14, DOI 10.2174/157018009787158526; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lobell RB, 2001, CANCER RES, V61, P8758; Lukman S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000922; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Muegge I, 2006, J MED CHEM, V49, P5895, DOI 10.1021/jm050038s; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pickett SD, 2000, J CHEM INF COMP SCI, V40, P263, DOI 10.1021/ci990261w; Rauen Katherine A, 2010, Am J Med Genet A, V152A, P4, DOI 10.1002/ajmg.a.33183; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebti SM, 2000, EXPERT OPIN INV DRUG, V9, P2767, DOI 10.1517/13543784.9.12.2767; Spoerner M, 2005, BIOCHEM BIOPH RES CO, V334, P709, DOI 10.1016/j.bbrc.2005.06.144; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000820; Wong CF, 2003, ANNU REV PHARMACOL, V43, P31, DOI 10.1146/annurev.pharmtox.43.100901.140216; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	77	116	120	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25711	10.1371/journal.pone.0025711	http://dx.doi.org/10.1371/journal.pone.0025711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046245	Green Published, gold			2022-12-27	WOS:000296517000009
J	Standley, CJ; Wade, CM; Stothard, JR				Standley, Claire J.; Wade, Christopher M.; Stothard, J. Russell			A Fresh Insight into Transmission of Schistosomiasis: A Misleading Tale of Biomphalaria in Lake Victoria	PLOS ONE			English	Article							INTESTINAL SCHISTOSOMIASIS; PHENOTYPIC PLASTICITY; PLANORBIDAE; GASTROPODA; SEQUENCES; MANSONI; BIOGEOGRAPHY; PHYLOGENY; AFRICA; REGION	Lake Victoria is a known hot-spot for Schistosoma mansoni, which utilises freshwater snails of the genus Biomphalaria as intermediate hosts. Different species of Biomphalaria are associated with varying parasite compatibility, affecting local transmission. It is thought that two species, B. choanomphala and B. sudanica, inhabit Lake Victoria; despite their biomedical importance, the taxonomy of these species has not been thoroughly examined. This study combined analysis of morphological and molecular variables; the results demonstrated that molecular groupings were not consistent with morphological divisions. Habitat significantly predicted morphotype, suggesting that the different Lake Victorian forms of Biomphalaria are ecophentoypes of one species. The nomenclature should be revised accordingly; the names B. choanomphala choanomphala and B. c. sudanica are proposed. From a public health perspective, these findings can be utilised by policy-makers for better understanding of exposure risk, resulting in more effective and efficient control initiatives.	[Standley, Claire J.; Wade, Christopher M.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Standley, Claire J.; Stothard, J. Russell] Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Nottingham; Natural History Museum London	Standley, CJ (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	standley@princeton.edu	Stothard, John Russell/AAK-4829-2021	Stothard, John Russell/0000-0002-9370-3420; Wade, Christopher/0000-0002-1269-9694	Natural History Museum; EU [032203]	Natural History Museum; EU(European Commission)	This research was funded by a Natural History Museum student PhD grant and the EU project CONTRAST (FP6 STREP contract no: 032203, http://www.eu-contrast.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNAUD L, 1994, CR ACAD SCI III-VIE, V317, P581; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Brown DS, 1994, FRESHWATER SNAILS AF, DOI 10.1201/9781482295184; DeJong RJ, 2001, MOL BIOL EVOL, V18, P2225, DOI 10.1093/oxfordjournals.molbev.a003769; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DEWITT WB, 1954, J PARASITOL, V40, P453, DOI 10.2307/3273895; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; FILES VS, 1949, J PARASITOL, V35, P555, DOI 10.2307/3273632; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irie T, 2008, BIOL BULL-US, V215, P126, DOI 10.2307/25470693; Jorgensen A, 2007, ZOOL J LINN SOC-LOND, V151, P337, DOI 10.1111/j.1096-3642.2007.00330.x; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; MAGENDANTZ M, 1972, B WORLD HEALTH ORGAN, V47, P331; Malek EA, 1985, SNAIL HOSTS SCHISTOS; Mandahl-Barth G, 1957, B WORLD HEALTH ORGAN, V16, P1103; Plam M, 2008, AFR ZOOL, V43, P34, DOI 10.3377/1562-7020(2008)43[34:SBSGPI]2.0.CO;2; Prentice M. A., 1972, Uganda Medical Journal, V1, P136; Spatz L, 2000, MEM I OSWALDO CRUZ, V95, P807, DOI 10.1590/S0074-02762000000600010; Standley CJ, 2009, GEOSPATIAL HEALTH, V4, P39, DOI 10.4081/gh.2009.209; Steinauer ML, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000222; Stothard JR, 2006, MEM I OSWALDO CRUZ, V101, P119, DOI 10.1590/S0074-02762006000900019; Stothard JR, 2005, AM J TROP MED HYG, V73, P949, DOI 10.4269/ajtmh.2005.73.949; Stothard JR, 1997, J NAT HIST, V31, P727, DOI 10.1080/00222939700770361; Teso V, J MAR BIOL ASS UK 1, P1; Urabe M, 1998, J MOLLUS STUD, V64, P329, DOI 10.1093/mollus/64.3.329; Vidigal THDA, 2004, MEM I OSWALDO CRUZ, V99, P153, DOI 10.1590/S0074-02762004000200007	28	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26563	10.1371/journal.pone.0026563	http://dx.doi.org/10.1371/journal.pone.0026563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22046308	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200025
J	Fujita, T; Fujii, H				Fujita, Toshitsugu; Fujii, Hodaka			Direct Identification of Insulator Components by Insertional Chromatin Immunoprecipitation	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; CTCF; EXPRESSION; PROTEIN; GENES; INTERFERENCE; PURIFICATION; MECHANISMS; BOUNDARIES; BINDING	Comprehensive understanding of mechanisms of epigenetic regulation requires identification of molecules bound to genomic regions of interest in vivo. However, non-biased methods to identify molecules bound to specific genomic loci in vivo are limited. Here, we applied insertional chromatin immunoprecipitation (iChIP) to direct identification of components of insulator complexes, which function as boundaries of chromatin domain. We found that the chicken beta-globin HS4 (cHS4) insulator complex contains an RNA helicase protein, p68/DDX5; an RNA species, steroid receptor RNA activator 1; and a nuclear matrix protein, Matrin-3, in vivo. Binding of p68 and Matrin-3 to the cHS4 insulator core sequence was mediated by CCCTC-binding factor (CTCF). Thus, our results showed that it is feasible to directly identify proteins and RNA bound to a specific genomic region in vivo by using iChIP.	[Fujita, Toshitsugu; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Osaka, Japan	Osaka University	Fujita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Osaka, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/N-9792-2019; Fujii, Hodaka/A-2420-2008; FUJITA, Toshitsugu/ABH-5101-2020; Fujita, Toshitsugu/AAB-4964-2022	Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; 	Tokyo Biochemical Research Foundation [22710185]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118516, 23114707]	Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Tokyo Biochemical Research Foundation (T. F.), http://www.tokyobrf.or.jp/english/; Grant-in-Aid for Young Scientists (B) (#22710185) (T. F.), Grant-in-Aid for Scientific Research on Innovative Areas (#23118516) (T. F.), (#23114707) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.mext.go.jp/english/a06.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BOFFA LC, 1995, P NATL ACAD SCI USA, V92, P1901, DOI 10.1073/pnas.92.6.1901; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Hanawa H, 2009, MOL THER, V17, P667, DOI 10.1038/mt.2009.1; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2007, FEBS LETT, V581, P975, DOI 10.1016/j.febslet.2007.01.083; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jasinskas A, 1999, CHROMOSOME RES, V7, P341, DOI 10.1023/A:1009211929408; Kurokawa R, 2009, RNA BIOL, V6, P233, DOI 10.4161/rna.6.3.8329; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; WORKMAN JL, 1985, BIOCHEMISTRY-US, V24, P7486, DOI 10.1021/bi00346a068; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; ZHANG XY, 1982, NUCLEIC ACIDS RES, V10, P1481, DOI 10.1093/nar/10.5.1481	31	35	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26109	10.1371/journal.pone.0026109	http://dx.doi.org/10.1371/journal.pone.0026109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043306	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400034
J	McElwain, MA; Ko, DC; Gordon, MD; Fyrst, H; Saba, JD; Nusse, R				McElwain, Mark A.; Ko, Dennis C.; Gordon, Michael D.; Fyrst, Henrik; Saba, Julie D.; Nusse, Roel			A Suppressor/Enhancer Screen in Drosophila Reveals a Role for Wnt-Mediated Lipid Metabolism in Primordial Germ Cell Migration	PLOS ONE			English	Article							CERAMIDE 1-PHOSPHATE; GENE FAMILY; IN-VIVO; KINASE; MELANOGASTER; WUNEN; INHIBITOR; REDUCTASE; PROTEINS; RECEPTOR	Wnt proteins comprise a large family of secreted ligands implicated in a wide variety of biological roles. WntD has previously been shown to inhibit the nuclear accumulation of Dorsal/NF-kappa B protein during embryonic dorsal/ventral patterning and the adult innate immune response, independent of the well-studied Armadillo/beta-catenin pathway. In this paper, we present a novel phenotype for WntD mutant embryos, suggesting that this gene is involved in migration of primordial germ cells (PGC) to the embryonic gonad. Additionally, we describe a genetic suppressor/enhancer screen aimed at identifying genes required for WntD signal transduction, based on the previous observation that maternal overexpression of WntD results in lethally dorsalized embryos. Using an algorithm to narrow down our hits from the screen, we found two novel WntD signaling components: Fz4, a member of the Frizzled family, and the Drosophila Ceramide Kinase homolog, Dcerk. We show here that Dcerk and Dmulk (Drosophila Multi-substrate lipid kinase) redundantly mediate PGC migration. Our data are consistent with a model in which the activity of lipid phosphate phosphatases shapes a concentration gradient of ceramide-1-phosphate (C1P), the product of Dcerk, allowing proper PGC migration.	[McElwain, Mark A.; Ko, Dennis C.; Gordon, Michael D.; Nusse, Roel] Stanford Univ, Dept Dev Biol, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Fyrst, Henrik; Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Ctr Canc Res, Oakland, CA 94609 USA	Howard Hughes Medical Institute; Stanford University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	McElwain, MA (corresponding author), Stanford Univ, Dept Dev Biol, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	rnusse@stanford.edu	Gordon, Michael D/H-9586-2012	Gordon, Michael D/0000-0002-5440-986X	Howard Hughes Medical Institute; National Institutes of Health [GM066954]; National Human Genome Research Institute [T32 HG00044]; Stanford Graduate Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066954] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanford Graduate Fellowship(Stanford University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Howard Hughes Medical Institute funds awarded to RN and National Institutes of Health grant GM066954 awarded to JDS. MAM was supported by the Stanford Genome Training Program (Grant Number T32 HG00044 from the National Human Genome Research Institute) and by a Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-15; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; D Renault A, 2006, CURR OPIN GENET DEV, V16, P348, DOI 10.1016/j.gde.2006.06.015; Dasgupta U, 2009, P NATL ACAD SCI USA, V106, P20063, DOI 10.1073/pnas.0911028106; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Fyrst H, 2004, J LIPID RES, V45, P54, DOI 10.1194/jlr.M300005-JLR200; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Granado MH, 2009, CELL SIGNAL, V21, P405, DOI 10.1016/j.cellsig.2008.11.003; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; HAY B, 1990, DEVELOPMENT, V109, P425; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Renault AD, 2002, MECH DEVELOP, V119, pS293, DOI 10.1016/S0925-4773(03)00131-X; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Sullards M C, 2001, Sci STKE, V2001, ppl1; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang N, 1996, GENETICS, V143, P1231	38	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26993	10.1371/journal.pone.0026993	http://dx.doi.org/10.1371/journal.pone.0026993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069480	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900042
J	Park, C; Ahn, J; Yoon, Y; Park, S				Park, Chihyun; Ahn, Jaegyoon; Yoon, Youngmi; Park, Sanghyun			A Multi-Sample Based Method for Identifying Common CNVs in Normal Human Genomic Structure Using High-Resolution aCGH Data	PLOS ONE			English	Article							ARRAY CGH DATA; COPY-NUMBER VARIATION; HIDDEN MARKOV MODEL; GENE-EXPRESSION; SEGMENTATION; ABERRATIONS; SCALE; IDENTIFICATION; ALGORITHMS; DISCOVERY	Background: It is difficult to identify copy number variations (CNV) in normal human genomic data due to noise and nonlinear relationships between different genomic regions and signal intensity. A high-resolution array comparative genomic hybridization (aCGH) containing 42 million probes, which is very large compared to previous arrays, was recently published. Most existing CNV detection algorithms do not work well because of noise associated with the large amount of input data and because most of the current methods were not designed to analyze normal human samples. Normal human genome analysis often requires a joint approach across multiple samples. However, the majority of existing methods can only identify CNVs from a single sample. Methodology and Principal Findings: We developed a multi-sample-based genomic variations detector (MGVD) that uses segmentation to identify common breakpoints across multiple samples and a k-means-based clustering strategy. Unlike previous methods, MGVD simultaneously considers multiple samples with different genomic intensities and identifies CNVs and CNV zones (CNVZs); CNVZ is a more precise measure of the location of a genomic variant than the CNV region (CNVR). Conclusions and Significance: We designed a specialized algorithm to detect common CNVs from extremely high-resolution multi-sample aCGH data. MGVD showed high sensitivity and a low false discovery rate for a simulated data set, and outperformed most current methods when real, high-resolution HapMap datasets were analyzed. MGVD also had the fastest runtime compared to the other algorithms evaluated when actual, high-resolution aCGH data were analyzed. The CNVZs identified by MGVD can be used in association studies for revealing relationships between phenotypes and genomic aberrations. Our algorithm was developed with standard C++ and is available in Linux and MS Windows format in the STL library. It is freely available at: http://embio.yonsei.ac.kr/similar to Park/mgvd.php.	[Park, Chihyun; Ahn, Jaegyoon; Park, Sanghyun] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea; [Yoon, Youngmi] Gachon Univ Med & Sci, Div Informat Engn, Inchon, South Korea	Yonsei University; Gachon University	Park, C (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea.	sanghyun@cs.yonsei.ac.kr			National Research Foundation of Korea; Korea government(MEST) [2011-0005154]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government(MEST) (No. 2011-0005154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ben-Yaacov E, 2008, BIOINFORMATICS, V24, pI139, DOI 10.1093/bioinformatics/btn272; Berger JA, 2006, IEEE ACM T COMPUT BI, V3, P2, DOI 10.1109/TCBB.2006.10; BLEAKLEY K, 2009, JOINT SEGMENTATION M; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Eilers PHC, 2005, BIOINFORMATICS, V21, P1146, DOI 10.1093/bioinformatics/bti148; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Huang J, 2007, BIOINFORMATICS, V23, P2463, DOI 10.1093/bioinformatics/btm359; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, J MOL DIAGN, V6, P411; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; LaFramboise T, 2009, BIOINFORMATICS, V25, P722, DOI 10.1093/bioinformatics/btp063; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Pique-Regi R, 2009, BIOINFORMATICS, V25, P1223, DOI 10.1093/bioinformatics/btp119; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rueda OM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-308; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shah SP, 2008, CYTOGENET GENOME RES, V123, P343, DOI 10.1159/000184726; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yu TW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-145; Zhang NR, 2010, BIOMETRIKA, V97, P631, DOI 10.1093/biomet/asq025; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708	40	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26975	10.1371/journal.pone.0026975	http://dx.doi.org/10.1371/journal.pone.0026975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073121	Green Submitted, gold, Green Published			2022-12-27	WOS:000296916000040
J	Poparic, I; Schreibmayer, W; Schoser, B; Desoye, G; Gorischek, A; Miedl, H; Hochmeister, S; Binder, J; Quasthoff, S; Wagner, K; Windpassinger, C; Malle, E				Poparic, Ivana; Schreibmayer, Wolfgang; Schoser, Benedikt; Desoye, Gernot; Gorischek, Astrid; Miedl, Heidi; Hochmeister, Sonja; Binder, Josepha; Quasthoff, Stefan; Wagner, Klaus; Windpassinger, Christian; Malle, Ernst			Four and a Half LIM Protein 1C (FHL1C): A Binding Partner for Voltage-Gated Potassium Channel K-v1.5	PLOS ONE			English	Article							MUTATIONS; KV1.5; EXPRESSION; MYOPATHY; DOMAIN; CHORIOCARCINOMA; FAMILY; CELLS; GIRK1	Four-and-a-half LIM domain protein 1 isoform A (FHL1A) is predominantly expressed in skeletal and cardiac muscle. Mutations in the FHL1 gene are causative for several types of hereditary myopathies including X-linked myopathy with postural muscle atrophy (XMPMA). We here studied myoblasts from XMPMA patients. We found that functional FHL1A protein is completely absent in patient myoblasts. In parallel, expression of FHL1C is either unaffected or increased. Furthermore, a decreased proliferation rate of XMPMA myoblasts compared to controls was observed but an increased number of XMPMA myoblasts was found in the G(0)/G(1) phase. Furthermore, low expression of K-v1.5, a voltage-gated potassium channel known to alter myoblast proliferation during the G(1) phase and to control repolarization of action potential, was detected. In order to substantiate a possible relation between K-v1.5 and FHL1C, a pull-down assay was performed. A physical and direct interaction of both proteins was observed in vitro. In addition, confocal microscopy revealed substantial colocalization of FHL1C and K-v1.5 within atrial cells, supporting a possible interaction between both proteins in vivo. Two-electrode voltage clamp experiments demonstrated that coexpression of K-v1.5 with FHL1C in Xenopus laevis oocytes markedly reduced K+ currents when compared to oocytes expressing K-v1.5 only. We here present the first evidence on a biological relevance of FHL1C.	[Poparic, Ivana; Wagner, Klaus; Windpassinger, Christian] Med Univ Graz, Inst Mol Biol & Biochem, Inst Human Genet, Graz, Austria; [Schreibmayer, Wolfgang; Gorischek, Astrid] Med Univ Graz, Inst Mol Biol & Biochem, Inst Biophys, Graz, Austria; [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Desoye, Gernot] Med Univ Graz, Inst Mol Biol & Biochem, Dept Obstet & Gynaecol, Graz, Austria; [Hochmeister, Sonja; Quasthoff, Stefan] Med Univ Graz, Inst Mol Biol & Biochem, Dept Neurol, Graz, Austria; [Binder, Josepha] Med Univ Graz, Inst Mol Biol & Biochem, Dept Cardiol, Graz, Austria; [Malle, Ernst] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Munich; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Poparic, I (corresponding author), Med Univ Graz, Inst Mol Biol & Biochem, Inst Human Genet, Graz, Austria.	christian.windpassinger@medunigraz.at	Malle, Ernst/D-3071-2013; Schoser, Benedikt/AAH-6286-2020	Schreibmayer, Wolfgang/0000-0002-4631-7922; Desoye, Gernot/0000-0002-5715-3230; Schoser, Benedikt/0000-0002-2757-8131	Country of Styria [GZ: A3-16.R-10/2009-112]; Medical University of Graz, Austria	Country of Styria; Medical University of Graz, Austria	This work received financial supported by the Country of Styria (GZ: A3-16.R-10/2009-112). The PhD program Molecular Medicine of the Medical University of Graz, Austria funded IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Chen DH, 2010, J NEUROL SCI, V296, P22, DOI 10.1016/j.jns.2010.06.017; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cowling BS, 2011, NEUROMUSCULAR DISORD, V21, P237, DOI 10.1016/j.nmd.2011.01.001; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Goti D, 2000, J NEUROCHEM, V74, P1374, DOI 10.1046/j.1471-4159.2000.0741374.x; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Hofer D, 2006, EUR J PHARMACOL, V538, P5, DOI 10.1016/j.ejphar.2006.03.034; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kitz K, 2011, FREE RADICAL BIO MED, V50, P854, DOI 10.1016/j.freeradbiomed.2010.12.039; Knoblauch H, 2010, ANN NEUROL, V67, P136, DOI 10.1002/ana.21839; Kovacevic A, 2006, FEBS LETT, V580, P161, DOI 10.1016/j.febslet.2005.11.067; Lee SMY, 1999, GENE, V237, P253, DOI 10.1016/S0378-1119(99)00251-6; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Ng EKO, 2001, J CELL BIOCHEM, V82, P1, DOI 10.1002/jcb.1110; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Rauh A, 2008, BRIT J PHARMACOL, V154, P13, DOI 10.1038/bjp.2008.92; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Schoser B, 2009, NEUROLOGY, V73, P543, DOI 10.1212/WNL.0b013e3181b2a4b3; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sharma P, 2011, MOL BIOSYST, V7, P1185, DOI 10.1039/c0mb00235f; Shathasivam T, 2010, J CELL MOL MED, V14, P2702, DOI 10.1111/j.1582-4934.2010.01176.x; Taniguchi A, 1994, MOL CELL BIOL, V18, P644; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Villalonga N, 2008, BBA-MOL CELL RES, V1783, P728, DOI 10.1016/j.bbamcr.2008.01.001; Wagner V, 2010, J CELL BIOCHEM, V110, P598, DOI 10.1002/jcb.22564; Wang JA, 1998, LANCET, V352, P290, DOI 10.1016/S0140-6736(05)60264-4; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Ward TH, 2004, CELL MOL LIFE SCI, V61, P172, DOI 10.1007/s00018-003-3355-6; Weiss U, 2001, DIABETOLOGIA, V44, P209, DOI 10.1007/s001250051601; Weng JF, 2011, ANN VASC SURG, V25, P240, DOI 10.1016/j.avsg.2010.10.001; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Yang Z, 2008, CARDIOVASC RES, V78, P449, DOI 10.1093/cvr/cvn038	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26524	10.1371/journal.pone.0026524	http://dx.doi.org/10.1371/journal.pone.0026524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053194	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800020
J	Resnick, A				Resnick, Andrew			Chronic Fluid Flow Is an Environmental Modifier of Renal Epithelial Function	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIUM; CILIARY MECHANOSENSATION; SOMATOSTATIN RECEPTOR-3; COLLECTING DUCT; KIF3A SUBUNIT; MTOR PATHWAY; MOUSE MODEL; KINESIN-II; CELLS	Although solitary or sensory cilia are present in most cells of the body and their existence has been known since the sixties, very little is been known about their functions. One suspected function is fluid flow sensing-physical bending of cilia produces an influx of Ca++, which can then result in a variety of activated signaling pathways. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive disease, typically appearing in the 5th decade of life and is one of the most common monogenetic inherited human diseases, affecting approximately 600,000 people in the United States. Because ADPKD is a slowly progressing disease, I asked how fluid flow may act, via the primary cilium, to alter epithelial physiology during the course of cell turnover. I performed an experiment to determine under what conditions fluid flow can result in a change of function of renal epithelial tissue. A wildtype epithelial cell line derived the cortical collecting duct of a heterozygous offspring of the Immortomouse (Charles River Laboratory) was selected as our model system. Gentle orbital shaking was used to induce physiologically relevant fluid flow, and periodic measurements of the transepithelial Sodium current were performed. At the conclusion of the experiment, mechanosensitive proteins of interest were visualized by immunostaining. I found that fluid flow, in itself, modifies the transepithelial sodium current, cell proliferation, and the actin cytoskeleton. These results significantly impact the understanding of both the mechanosensation function of primary cilia as well as the understanding of ADPKD disease progression.	Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA	Cleveland State University	Resnick, A (corresponding author), Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA.	a.resnick@csuohio.edu	Resnick, Andrew H/A-6841-2018	Resnick, Andrew H/0000-0002-7526-6394	National Institutes of Health [DK71027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK071027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded under the National Institutes of Health, grant number DK71027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouAlaiwi WA, 2011, HUM MOL GENET, V20, P354, DOI 10.1093/hmg/ddq470; Alberts B, 2008, MOL BIOL CELL; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Becker JU, 2010, KIDNEY BLOOD PRESS R, V33, P129, DOI 10.1159/000314380; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Blom G., 1958, STAT ESTIMATES TRANS; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brown NE, 2003, KIDNEY INT, V63, P1220, DOI 10.1046/j.1523-1755.2003.00863.x; Calvet JP, 2003, P NATL ACAD SCI USA, V100, P5583, DOI 10.1073/pnas.1031799100; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Fischer E, 2009, SEMIN CELL DEV BIOL, V20, P998, DOI 10.1016/j.semcdb.2009.09.016; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P73, DOI 10.2220/biomedres.32.73; Kolb RJ, 2004, HYPERTENSION, V44, P352, DOI 10.1161/01.HYP.0000136645.90116.1a; Lamb H., 1945, HYDRODYNAMICS; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu W, 2005, AM J PHYSIOL-RENAL, V289, pF978, DOI 10.1152/ajprenal.00260.2004; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Meneton P, 2000, AM J PHYSIOL-RENAL, V278, pF339, DOI 10.1152/ajprenal.2000.278.3.F339; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P193, DOI 10.1007/s00232-002-1055-z; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Resnick A, 2008, FRONT BIOSCI-LANDMRK, V13, P1665, DOI 10.2741/2790; Resnick A, 2007, BIOPHYS J, V93, P1380, DOI 10.1529/biophysj.107.105007; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; SATIR P, 1961, SCI AM, V204, P108, DOI 10.1038/scientificamerican0261-108; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Siroky BJ, 2006, AM J PHYSIOL-RENAL, V290, pF1320, DOI 10.1152/ajprenal.00463.2005; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weimbs T, 2006, CELL CYCLE, V5, P2425, DOI 10.4161/cc.5.21.3408; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27058	10.1371/journal.pone.0027058	http://dx.doi.org/10.1371/journal.pone.0027058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046444	Green Published, gold			2022-12-27	WOS:000299081800065
J	Sharifah, EN; Eguchi, M				Sharifah, Emilia Noor; Eguchi, Mitsuru			The Phytoplankton Nannochloropsis oculata Enhances the Ability of Roseobacter Clade Bacteria to Inhibit the Growth of Fish Pathogen Vibrio anguillarum	PLOS ONE			English	Article							ACYL-HOMOSERINE LACTONE; ANTIBACTERIAL ACTIVITY; BIOFILM FORMATION; MARINE; BACTERIOPLANKTON; AQUACULTURE; PHAEOBACTER; STRAIN-27-4; MICROALGAE; EUGLENOZOA	Background: Phytoplankton cultures are widely used in aquaculture for a variety of applications, especially as feed for fish larvae. Phytoplankton cultures are usually grown in outdoor tanks using natural seawater and contain probiotic or potentially pathogenic bacteria. Some Roseobacter clade isolates suppress growth of the fish pathogen Vibrio anguillarum. However, most published information concerns interactions between probiotic and pathogenic bacteria, and little information is available regarding the importance of phytoplankton in these interactions. The objectives of this study, therefore, were to identify probiotic Roseobacter clade members in phytoplankton cultures used for rearing fish larvae and to investigate their inhibitory activity towards bacterial fish pathogens in the presence of the phytoplankton Nannochloropsis oculata. Methodology/Principal Findings: The fish pathogen V. anguillarum, was challenged with 6 Roseobacter clade isolates (Sulfitobacter sp. (2 strains), Thalassobius sp., Stappia sp., Rhodobacter sp., and Antarctobacter sp.) from phytoplankton cultures under 3 different nutritional conditions. In an organic nutrient-rich medium (VNSS), 6 Roseobacter clade isolates, as well as V. anguillarum, grew well (10(9) CFU/ml), even when cocultured. In contrast, in a phytoplankton culture medium (ESM) based on artificial seawater, coculture with the 6 isolates decreased the viability of V. anguillarum by approximately more than 10-fold. Excreted substances in media conditioned by growth of the phytoplankton N. oculata (NCF medium) resulted in the complete eradication of V. anguillarum when cocultured with the roseobacters. Autoclaved NCF had the same inhibitory effect. Furthermore, Sulfitobacter sp. much more efficiently incorporated C-14-photosynthetic metabolites (C-14-EPM) excreted by N. oculata than did V. anguillarum. Conclusion/Significance: Cocultures of a phytoplankton species and Roseobacter clade members exhibited a greater antibacterial effect against an important fish pathogen (V. anguillarum) than roseobacters alone. Thus, cooperation of N. oculata, and perhaps other phytoplankton species, with certain roseobacters might provide a powerful tool for eliminating fish pathogens from fish-rearing tanks.	[Sharifah, Emilia Noor; Eguchi, Mitsuru] Kinki Univ, Grad Sch Agr, Nara, Japan	Kindai University (Kinki University)	Sharifah, EN (corresponding author), Kinki Univ, Grad Sch Agr, Nara, Japan.	eguchi@nara.kindai.ac.jp		, SHARIFAH NOOR EMILIA BINTI SY JAMIL FAD`AAK/0000-0002-9355-5085	Japan Society for the Promotion of Science [21380127]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Grant-in-Aid for Scientific Research (B) (21380127) of the Japan Society for the Promotion of Science and by the Global COE program (International Education and Research Center for Aquaculture Science of Bluefin Tuna and Other Cultured Fish) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2006, ENVIRON MICROBIOL, V8, P2022, DOI 10.1111/j.1462-2920.2006.01082.x; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; BERMAN T, 1975, MAR BIOL, V33, P215, DOI 10.1007/BF00390925; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brinkmeyer R, 2000, EUR J PHYCOL, V35, P315, DOI 10.1080/09670260010001735921; Bruhn JB, 2006, APPL ENVIRON MICROB, V72, P3011, DOI 10.1128/AEM.72.4.3011-3015.2006; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; Garrity G., 2005, BERGEYS MANUAL SYSTE; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Hamana K, 2004, J GEN APPL MICROBIOL, V50, P297, DOI 10.2323/jgam.50.297; Hamana K, 2008, J GEN APPL MICROBIOL, V54, P135, DOI 10.2323/jgam.54.135; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Hjelm M, 2004, APPL ENVIRON MICROB, V70, P7288, DOI 10.1128/AEM.70.12.7288-7294.2004; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Huervana F. H., 2006, Acta Ichthyologica et Piscatoria, V36, P17; Kamjunke N, 2008, J PHYCOL, V44, P616, DOI 10.1111/j.1529-8817.2008.00520.x; Lu KG, 2008, J APPL PHYCOL, V20, P1061, DOI 10.1007/s10811-007-9307-z; Miyamoto N, 1997, FISHERIES SCI, V63, P253, DOI 10.2331/fishsci.63.253; Miyamoto N, 1996, FISHERIES SCI, V62, P710, DOI 10.2331/fishsci.62.710; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Muller-Feuga A, 2000, J APPL PHYCOL, V12, P527, DOI 10.1023/A:1008106304417; Nakase G, 2007, FISHERIES SCI, V73, P784, DOI 10.1111/j.1444-2906.2007.01397.x; Nakase G, 2007, FISHERIES SCI, V73, P543, DOI 10.1111/j.1444-2906.2007.01366.x; Natrah FMI, 2011, AQUACULTURE, V317, P53, DOI 10.1016/j.aquaculture.2011.04.038; Naviner M, 1999, AQUACULTURE, V174, P15, DOI 10.1016/S0044-8486(98)00513-4; Oie G, 1997, AQUACULTURE, V153, P103, DOI 10.1016/S0044-8486(96)01514-1; Palmer PJ, 2007, AQUACULTURE, V272, P1, DOI 10.1016/j.aquaculture.2007.06.018; Planas M, 2006, AQUACULTURE, V255, P323, DOI 10.1016/j.aquaculture.2005.11.039; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; PROVASOLI L, 1957, ARCH MIKROBIOL, V25, P392, DOI 10.1007/BF00446694; Ruiz-Ponte C, 1999, MAR BIOTECHNOL, V1, P52, DOI 10.1007/PL00011751; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salvesen I, 2000, AQUACULT INT, V8, P275, DOI 10.1023/A:1009200926452; TAJIMA K, 1985, FISH PATHOL, V20, P131; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taniguchi A, 2011, AQUA SCI IN PRESS; Tendencia EA, 2004, AQUACULTURE, V232, P145, DOI 10.1016/S0044-8486(03)00531-3; Thorne SH, 1999, J BACTERIOL, V181, P981, DOI 10.1128/JB.181.3.981-990.1999; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x	49	47	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26756	10.1371/journal.pone.0026756	http://dx.doi.org/10.1371/journal.pone.0026756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053210	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800036
J	Wei, Q; Hariharan, V; Huang, H				Wei, Qi; Hariharan, Venkatesh; Huang, Hayden			Cell-Cell Contact Preserves Cell Viability via Plakoglobin	PLOS ONE			English	Article							GAMMA-CATENIN EXPRESSION; BETA-CATENIN; E-CADHERIN; IN-VITRO; ADHESION; DIFFERENTIATION; CARCINOMA; CANCER; GROWTH; PHOSPHORYLATION	Control over cell viability is a fundamental property underlying numerous physiological processes. Cell spreading on a substrate was previously demonstrated to be a major factor in determining the viability of individual cells. In multicellular organisms, cell-cell contact is likely to play a significant role in regulating cell vitality, but its function is easily masked by cell-substrate interactions, thus remains incompletely characterized. In this study, we show that suspended immortalized human keratinocyte sheets with persisting intercellular contacts exhibited significant contraction, junctional actin localization, and reinforcement of cell-cell adhesion strength. Further, cells within these sheets remain viable, in contrast to trypsinized cells suspended without either cell-cell or cell-substrate contact, which underwent apoptosis at high rates. Suppression of plakoglobin weakened cell-cell adhesion in cell sheets and suppressed apoptosis in suspended, trypsinized cells. These results demonstrate that cell-cell contact may be a fundamental control mechanism governing cell viability and that the junctional protein plakoglobin is a key regulator of this process. Given the near-ubiquity of plakoglobin in multicellular organisms, these findings could have significant implications for understanding cell adhesion, modeling disease progression, developing therapeutics and improving the viability of tissue engineering protocols.	[Wei, Qi; Hariharan, Venkatesh; Huang, Hayden] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Wei, Q (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	hayden.huang@columbia.edu			National Institutes of Health [R01HL102361]; National Science Foundation [1130376]; Div Of Civil, Mechanical, & Manufact Inn [1130376] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work received partial support from National Institutes of Health grant no. R01HL102361 and National Science Foundation grant no. 1130376, the latter of which started during the revisions of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Denk C, 1997, CANCER LETT, V120, P185, DOI 10.1016/S0304-3835(97)00308-X; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giroldi LA, 1999, INT J CANCER, V82, P70, DOI 10.1002/(SICI)1097-0215(19990702)82:1<70::AID-IJC13>3.0.CO;2-#; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Huang HD, 2006, J CELL PHYSIOL, V209, P122, DOI 10.1002/jcp.20712; Huang H, 2008, CELL MOTIL CYTOSKEL, V65, P964, DOI 10.1002/cm.20319; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Kanazawa Y, 2008, ANTICANCER RES, V28, P655; Kolligs FT, 2000, GENE DEV, V14, P1319; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Mannix RJ, 2008, NAT NANOTECHNOL, V3, P36, DOI 10.1038/nnano.2007.418; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Narkio-Makela M, 2009, ARCH OTOLARYNGOL, V135, P1035, DOI 10.1001/archoto.2009.132; Pantel K, 1998, J CLIN ONCOL, V16, P1407, DOI 10.1200/JCO.1998.16.4.1407; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; SOMMERS CL, 1994, CANCER RES, V54, P3544; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	36	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27064	10.1371/journal.pone.0027064	http://dx.doi.org/10.1371/journal.pone.0027064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046445	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800066
J	Jones, MS; Hudson, NR; Gibbins, C; Fischer, SL				Jones, Morris S.; Hudson, Nolan Ryan; Gibbins, Carl; Fischer, Stephen L.			Evaluation of Type-Specific Real-Time PCR Assays Using the LightCycler and JBAIDS for Detection of Adenoviruses in Species HAdV-C	PLOS ONE			English	Article							IDENTIFICATION; DISEASE; RECOMBINATION; QUANTITATION; MYOCARDITIS; SEROTYPE; CHILDREN	Sporadically, HAdVs from species HAdV-C are detected in acute respiratory disease outbreaks. To rapidly type these viruses, we designed real-time PCR assays that detect and discriminate between adenovirus types HAdV-C1, -C2, -C5, and -C6. Sixteen clinical isolates from the California Department of Public Health were used to validate the new assays. Type-specific TaqMan real-time PCR assays were designed and used independently to successfully identify 16 representative specimens. The lower limit of detection for our LightCycler singleplex real-time PCR assays were calculated to be 100, 100, 100, and 50 genomic copies per reaction for HAdV-C1, HAdV-C2, HAdV-C5 and HAdV-C6, respectively. The results for the singleplex J.B.A.I.D.S. assays were similar. Our assays did not cross-react with other adenoviruses outside of species HAdV-C, respiratory syncytial virus, influenza, or respiratory disease causing bacteria. These assays have the potential to be useful as diagnostic tools for species HAdV-C infection.	[Jones, Morris S.] Calif Dept Hlth Serv, Viral & Rickettsial Dis Lab, Richmond, CA USA; [Hudson, Nolan Ryan; Gibbins, Carl] David Grant Med Ctr, Clin Invest Facil, Travis AFB, CA USA; [Fischer, Stephen L.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA	California Department of Health Care Services	Jones, MS (corresponding author), Calif Dept Hlth Serv, Viral & Rickettsial Dis Lab, Richmond, CA USA.	morris.jones@cdph.ca.gov			United States Air Force Surgeon General-approved Clinical Investigation [FDG20090046E, FDG20090047E, FDG20090048E, FDG20090049E]	United States Air Force Surgeon General-approved Clinical Investigation	The work reported herein was funded under United States Air Force Surgeon General-approved Clinical Investigation No. FDG20090046E, FDG20090047E, FDG20090048E, and FDG20090049E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; EDWARDS KM, 1985, PEDIATRICS, V76, P420; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; Guarner J, 2003, AM J CLIN PATHOL, V120, P845, DOI 10.1309/LBRNGF9MJW2MHT97; Gustafsson B, 2007, BRIT J CANCER, V97, P992, DOI 10.1038/sj.bjc.6603983; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kaltenboeck B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2; Lukashev AN, 2008, J GEN VIROL, V89, P380, DOI 10.1099/vir.0.83057-0; Malasig MD, 2001, J CLIN MICROBIOL, V39, P2984, DOI 10.1128/JCM.39.8.2984-2986.2001; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Metzgar D, 2010, J CLIN MICROBIOL, V48, P1397, DOI 10.1128/JCM.01600-09; Metzgar D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007081; PORTER HJ, 1993, J CLIN PATHOL, V46, P154, DOI 10.1136/jcp.46.2.154; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Rubin B. A., 1993, Acta Microbiologica Hungarica, V40, P303; Sarantis H, 2004, J CLIN MICROBIOL, V42, P3963, DOI 10.1128/JCM.42.9.3963-3969.2004; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Xu WH, 2001, J MED VIROL, V64, P537, DOI 10.1002/jmv.1083; Xu WH, 2000, J CLIN MICROBIOL, V38, P4114, DOI 10.1128/JCM.38.11.4114-4120.2000	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26862	10.1371/journal.pone.0026862	http://dx.doi.org/10.1371/journal.pone.0026862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046386	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400040
J	Fort, PE; Losiewicz, MK; Reiter, CEN; Singh, RSJ; Nakamura, M; Abcouwer, SF; Barber, AJ; Gardner, TW				Fort, Patrice E.; Losiewicz, Mandy K.; Reiter, Chad E. N.; Singh, Ravi S. J.; Nakamura, Makoto; Abcouwer, Steven F.; Barber, Alistair J.; Gardner, Thomas W.			Differential Roles of Hyperglycemia and Hypoinsulinemia in Diabetes Induced Retinal Cell Death: Evidence for Retinal Insulin Resistance	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; VASCULAR-PERMEABILITY; LOCAL INSULIN; MULLER CELLS; RAT RETINA; APOPTOSIS; EXPRESSION; NEURONS; CHOLESTEROL; PROTEINS	Diabetes pathology derives from the combination of hyperglycemia and hypoinsulinemia or insulin resistance leading to diabetic complications including diabetic neuropathy, nephropathy and retinopathy. Diabetic retinopathy is characterized by numerous retinal defects affecting the vasculature and the neuro-retina, but the relative contributions of the loss of retinal insulin signaling and hyperglycemia have never been directly compared. In this study we tested the hypothesis that increased retinal insulin signaling and glycemic normalization would exert differential effects on retinal cell survival and retinal physiology during diabetes. We have demonstrated in this study that both subconjunctival insulin administration and systemic glycemic reduction using the sodium-glucose linked transporter inhibitor phloridzin affected the regulation of retinal cell survival in diabetic rats. Both treatments partially restored the retinal insulin signaling without increasing plasma insulin levels. Retinal transcriptomic and histological analysis also clearly demonstrated that local administration of insulin and systemic glycemia normalization use different pathways to counteract the effects of diabetes on the retina. While local insulin primarily affected inflammation-associated pathways, systemic glycemic control affected pathways involved in the regulation of cell signaling and metabolism. These results suggest that hyperglycemia induces resistance to growth factor action in the retina and clearly demonstrate that both restoration of glycemic control and retinal insulin signaling can act through different pathways to both normalize diabetes-induced retinal abnormality and prevent vision loss.	[Fort, Patrice E.; Losiewicz, Mandy K.; Abcouwer, Steven F.; Gardner, Thomas W.] Univ Michigan, Kellogg Eye Ctr, Ophthalmol & Visual Sci Dept, Ann Arbor, MI 48109 USA; [Reiter, Chad E. N.; Singh, Ravi S. J.; Nakamura, Makoto; Barber, Alistair J.] Penn State Coll Med, Dept Ophthalmol, Hershey, PA USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Fort, PE (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ophthalmol & Visual Sci Dept, Ann Arbor, MI 48109 USA.	patricef@umich.edu		Gardner, Thomas/0000-0002-5112-5810; Barber, Alistair/0000-0003-4235-2293; Nakamura, Makoto/0000-0002-6464-4302; Abcouwer, Steven F/0000-0003-2580-1288; Fort, Patrice/0000-0003-3956-1908	National Institutes of Health - National Eye Institute [EY20582]; American Diabetes Association [7-08-RA-50]; Penn State University; NATIONAL EYE INSTITUTE [R01EY020582] Funding Source: NIH RePORTER	National Institutes of Health - National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Diabetes Association(American Diabetes Association); Penn State University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health - National Eye Institute grant EY20582, American Diabetes Association grant 7-08-RA-50, and the Jack and Nancy Turner Professorship at Penn State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Wendy Dunton of the JDRF Diabetic Retinopathy Center grant provided expert assistance with animals. Dr. Willard Freeman, Mrs Georgina Bixler and Mr. Robert Brucklacher of the Penn State Hershey genomics core provided assistance with the microarray and qPCR analysis. Penn State University holds intellectual property related to the use of periocular insulin to treat diabetic retinopathy.	Abcouwer SF, 2010, INVEST OPHTH VIS SCI, V51, P5920, DOI 10.1167/iovs.10-5264; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Bixler GV, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-40; Chan O, 2005, AM J PHYSIOL-REG I, V289, pR235, DOI 10.1152/ajpregu.00674.2004; Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; ENNIS SR, 1982, INVEST OPHTH VIS SCI, V23, P447; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Fox TE, 2011, AM J PHYSIOL-ENDOC M, V300, pE600, DOI 10.1152/ajpendo.00641.2010; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Freitas HS, 2008, ENDOCRINOLOGY, V149, P717, DOI 10.1210/en.2007-1088; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; IKEDA T, 1994, BRAIN RES, V649, P260, DOI 10.1016/0006-8993(94)91072-3; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Kim YH, 2008, DIABETES, V57, P2181, DOI 10.2337/db07-1431; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; LISATO G, 1992, DIABETOLOGIA, V35, P310, DOI 10.1007/BF00401197; Liu IM, 2008, INT J EXP PATHOL, V89, P292, DOI 10.1111/j.1365-2613.2008.00595.x; Magen D, 2005, KIDNEY INT, V67, P34, DOI 10.1111/j.1523-1755.2005.00053.x; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Neumiller JJ, 2010, DRUGS, V70, P377, DOI 10.2165/11318680-000000000-00000; PANAYOTOVAHEIERMANN M, 1995, J BIOL CHEM, V270, P27099, DOI 10.1074/jbc.270.45.27099; Pande M, 2011, DIABETES, V60, P1981, DOI 10.2337/db10-1541; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Rajala RVS, 2009, INVEST OPHTH VIS SCI, V50, P1033, DOI 10.1167/iovs.08-2851; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reiter CEN, 2003, AM J PHYSIOL-ENDOC M, V285, pE763, DOI 10.1152/ajpendo.00507.2002; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Ridgway T, 1997, BIOCHEM SOC T, V25, p106S; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; ROBERGE FG, 1988, J IMMUNOL, V140, P2193; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; Sandirasegarane L, 2001, BIOCHEM BIOPH RES CO, V283, P158, DOI 10.1006/bbrc.2001.4739; Singhal A, 1997, BRAIN RES, V763, P209, DOI 10.1016/S0006-8993(97)00412-5; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065	48	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26498	10.1371/journal.pone.0026498	http://dx.doi.org/10.1371/journal.pone.0026498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046295	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600024
J	Kenkel, CD; Aglyamova, G; Alamaru, A; Bhagooli, R; Capper, R; Cunning, R; deVillers, A; Haslun, JA; Hedouin, L; Keshavmurthy, S; Kuehl, KA; Mahmoud, H; McGinty, ES; Montoya-Maya, PH; Palmer, CV; Pantile, R; Sanchez, JA; Schils, T; Silverstein, RN; Squiers, LB; Tang, PC; Goulet, TL; Matz, MV				Kenkel, Carly D.; Aglyamova, Galina; Alamaru, Ada; Bhagooli, Ranjeet; Capper, Roxana; Cunning, Ross; deVillers, Amanda; Haslun, Joshua A.; Hedouin, Laetitia; Keshavmurthy, Shashank; Kuehl, Kristin A.; Mahmoud, Huda; McGinty, Elizabeth S.; Montoya-Maya, Phanor H.; Palmer, Caroline V.; Pantile, Raffaella; Sanchez, Juan A.; Schils, Tom; Silverstein, Rachel N.; Squiers, Logan B.; Tang, Pei-Ciao; Goulet, Tamar L.; Matz, Mikhail V.			Development of Gene Expression Markers of Acute Heat-Light Stress in Reef-Building Corals of the Genus Porites	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; FLUORESCENT PROTEINS; CLIMATE-CHANGE; SCLERACTINIAN CORAL; RELATIVE QUANTIFICATION; MONTASTRAEA-FAVEOLATA; THERMAL-STRESS; PIGMENTS; HOST; DISEASE	Coral reefs are declining worldwide due to increased incidence of climate-induced coral bleaching, which will have widespread biodiversity and economic impacts. A simple method to measure the sub-bleaching level of heat-light stress experienced by corals would greatly inform reef management practices by making it possible to assess the distribution of bleaching risks among individual reef sites. Gene expression analysis based on quantitative PCR (qPCR) can be used as a diagnostic tool to determine coral condition in situ. We evaluated the expression of 13 candidate genes during heat-light stress in a common Caribbean coral Porites astreoides, and observed strong and consistent changes in gene expression in two independent experiments. Furthermore, we found that the apparent return to baseline expression levels during a recovery phase was rapid, despite visible signs of colony bleaching. We show that the response to acute heat-light stress in P. astreoides can be monitored by measuring the difference in expression of only two genes: Hsp16 and actin. We demonstrate that this assay discriminates between corals sampled from two field sites experiencing different temperatures. We also show that the assay is applicable to an Indo-Pacific congener, P. lobata, and therefore could potentially be used to diagnose acute heat-light stress on coral reefs worldwide.	[Kenkel, Carly D.; Aglyamova, Galina; Capper, Roxana; Matz, Mikhail V.] Univ Texas Austin, Austin, TX 78712 USA; [Alamaru, Ada] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Bhagooli, Ranjeet] Univ Mauritius, Reduit, Mauritius; [Bhagooli, Ranjeet] Biodivers & Environm Inst, Reduit, Mauritius; [Cunning, Ross; Silverstein, Rachel N.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [deVillers, Amanda; Schils, Tom] Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA; [Haslun, Joshua A.; Squiers, Logan B.] Texas A&M Univ Corpus Christi, Corpus Christi, TX USA; [Hedouin, Laetitia] Univ Perpignan, F-66025 Perpignan, France; [Keshavmurthy, Shashank] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Kuehl, Kristin A.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Mahmoud, Huda] Kuwait Univ, Dept Biol Sci, Safat, Kuwait; [McGinty, Elizabeth S.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Montoya-Maya, Phanor H.] Oceanog Res Inst, Durban, South Africa; [Palmer, Caroline V.] ARC Ctr Excellence, Townsville, Qld, Australia; [Palmer, Caroline V.] James Cook Univ, Townsville, Qld, Australia; [Palmer, Caroline V.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pantile, Raffaella] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Sanchez, Juan A.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Tang, Pei-Ciao] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Goulet, Tamar L.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Texas System; University of Texas Austin; Tel Aviv University; University of Mauritius; University of Miami; University of Guam; Texas A&M University System; Texas A&M University Corpus Christi; Universite Perpignan Via Domitia; Academia Sinica - Taiwan; State University System of Florida; Florida International University; Kuwait University; University of Texas System; University of Texas Arlington; James Cook University; Newcastle University - UK; Australian Institute of Marine Science; Universidad de los Andes (Colombia); University of Louisiana Lafayette; University of Mississippi	Kenkel, CD (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	carly.kenkel@gmail.com	Matz, Mikhail V/K-4392-2017; Schils, Tom/A-7087-2008; sanchez, juan/GSD-8167-2022; Keshavmurthy, Shashank/C-3672-2013; Palmer, Caroline/B-6498-2011	Matz, Mikhail V/0000-0001-5453-9819; Schils, Tom/0000-0002-1516-9082; Keshavmurthy, Shashank/0000-0002-2235-9132; Palmer, Caroline/0000-0002-5903-995X; Sanchez, Juan Armando/0000-0001-7149-8369; Bhagooli, Ranjeet/0000-0002-5041-4047; Cunning, Ross/0000-0001-7241-1181; Kenkel, Carly/0000-0003-1126-4311; Montoya Maya, Phanor Hernando/0000-0002-6160-6175; Aglyamova, Galina/0000-0001-6105-6399; HEDOUIN, Laetitia/0000-0001-6565-3633	National Science Foundation [DEB-1054766]; Title V-Graduate programs/ELITE Graduate program [MA-91697601]; WIOMSA MARG III; Aharon Katzir-Katchalsky; Anat Krauskopf Fund Travel Award; NSF [IOS-0747205]; University of Mississippi; National Science Council; Academia Sinica, Taiwan; NSF GRF; Natural Environmental Research Council (NERC); Roche; Applied Biosystems/Ambion; Takara Biosciences/Clonetech; Thermo-Fisher/Nanodrop; Rainin	National Science Foundation(National Science Foundation (NSF)); Title V-Graduate programs/ELITE Graduate program; WIOMSA MARG III; Aharon Katzir-Katchalsky; Anat Krauskopf Fund Travel Award; NSF(National Science Foundation (NSF)); University of Mississippi; National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan); NSF GRF(National Science Foundation (NSF)); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Roche(Roche Holding); Applied Biosystems/Ambion; Takara Biosciences/Clonetech; Thermo-Fisher/Nanodrop; Rainin	The authors would like to acknowledge the following funding agencies: National Science Foundation grant DEB-1054766 to MVM; Title V-Graduate programs/ELITE Graduate program: Event Travel Request program to LBS and JAH; Environmental Protection Agency Greater Research Opportunity Graduate Fellowship to KAK (MA-91697601); WIOMSA MARG III to PHM and RB; Aharon Katzir-Katchalsky Student Travel Fellowships and Anat Krauskopf Fund Travel Award to AA; NSF IOS-0747205 and funding from the University of Mississippi ORSP to TLG; Grants from both the National Science Council and Academia Sinica, Taiwan to KS; NSF GRF to RNS; Natural Environmental Research Council (NERC) studentship to CVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A major portion of this work was carried out as part of the "QPCR for coral biologists'' workshops taught by MVM and CDK at Mote Tropical Research Laboratory. The qPCR workshops are sponsored by Roche, Applied Biosystems/Ambion, Takara Biosciences/Clonetech, Thermo-Fisher/Nanodrop, and Rainin. These companies donated equipment and reagents. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Aranda M, 2011, MOL ECOL, V20, P2955, DOI 10.1111/j.1365-294X.2011.05153.x; Bates D, 2005, R NEWS, V5, P4; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Chicharo MA, 2008, INT J MOL SCI, V9, P1453, DOI 10.3390/ijms9081453; Csaszar NBM, 2009, MARINE ECOLOGY PROGR, V392; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Edge SE, 2008, J EXP MAR BIOL ECOL, V355, P114, DOI 10.1016/j.jembe.2007.12.004; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Karp G, 2004, CELL MOL BIOL; Kawaguti S, 1944, PALAO TROPICAL BIOL, V2, P58; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Morgan MB, 2005, MAR POLLUT BULL, V51, P524, DOI 10.1016/j.marpolbul.2005.09.023; Morgan MB, 2002, MAR POLLUT BULL, V44, P1206, DOI 10.1016/S0025-326X(02)00177-7; Morgan MB, 2001, ENVIRON TOXICOL CHEM, V20, P537, DOI 10.1002/etc.5620200312; Muller J, 2007, PROTOPLASMA, V230, P231, DOI 10.1007/s00709-006-0239-2; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberts D, 2008, LABDSV ORDINATION MU; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Team RDC, 2019, R LANG ENV STAT COMP; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yakob L, 2011, P NATL ACAD SCI USA, V108, P1967, DOI 10.1073/pnas.1015443108	66	72	72	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26914	10.1371/journal.pone.0026914	http://dx.doi.org/10.1371/journal.pone.0026914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046408	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000296519600078
J	Manunta, MDI; McAnulty, RJ; Tagalakis, AD; Bottoms, SE; Campbell, F; Hailes, HC; Tabor, AB; Laurent, GJ; O'Callaghan, C; Hart, SL				Manunta, Maria D. I.; McAnulty, Robin J.; Tagalakis, Aristides D.; Bottoms, Stephen E.; Campbell, Frederick; Hailes, Helen C.; Tabor, Alethea B.; Laurent, Geoffrey J.; O'Callaghan, Christopher; Hart, Stephen L.			Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium	PLOS ONE			English	Article							BETA-GALACTOSIDASE ACTIVITY; GENERATION PHARMACEUTICAL IMPACTOR; PLACEBO-CONTROLLED TRIAL; CYSTIC-FIBROSIS GENE; EXPRESSION IN-VIVO; ADENOASSOCIATED VIRUS; PHYSICAL STABILITY; SYNTHETIC VECTOR; DNA COMPLEXES; DOUBLE-BLIND	Background: Gene therapy mediated by synthetic vectors may provide opportunities for new treatments for cystic fibrosis (CF) via aerosolisation. Vectors for CF must transfect the airway epithelium efficiently and not cause inflammation so they are suitable for repeated dosing. The inhaled aerosol should be deposited in the airways since the cystic fibrosis transmembrane conductance regulator gene (CFTR) is expressed predominantly in the epithelium of the submucosal glands and in the surface airway epithelium. The aim of this project was to develop an optimised aerosol delivery approach applicable to treatment of CF lung disease by gene therapy. Methodology: The vector suspension investigated in this study comprises receptor-targeting peptides, cationic liposomes and plasmid DNA that self-assemble by electrostatic interactions to form a receptor-targeted nanocomplex (RTN) of approximately 150 nm with a cationic surface charge of +50 mV. The aerodynamic properties of aerosolised nanocomplexes produced with three different nebulisers were compared by determining aerosol deposition in the different stages of a Next Generation Pharmaceutical Impactor (NGI). We also investigated the yield of intact plasmid DNA by agarose gel electrophoresis and densitometry, and transfection efficacies in vitro and in vivo. Results: RTNs nebulised with the AeroEclipse II BAN were the most effective, compared to other nebulisers tested, for gene delivery both in vitro and in vivo. The biophysical properties of the nanocomplexes were unchanged after nebulisation while the deposition of RTNs suggested a range of aerosol aerodynamic sizes between 5.5 mu m-1.4 mu m cut off (NGI stages 3-6) compatible with deposition in the central and lower airways. Conclusions: RTNs showed their ability at delivering genes via nebulisation, thus suggesting their potential applications for therapeutic interventions of cystic fibrosis and other respiratory disorders.	[Manunta, Maria D. I.; Tagalakis, Aristides D.; Hart, Stephen L.] UCL, Wolfson Ctr Gene Therapy Childhood Dis, UCL Inst Child Hlth, London, England; [McAnulty, Robin J.; Bottoms, Stephen E.; Laurent, Geoffrey J.] UCL, Ctr Resp Res, London, England; [Campbell, Frederick; Hailes, Helen C.; Tabor, Alethea B.] UCL, Dept Chem, London, England; [O'Callaghan, Christopher] Univ Leicester, Leicester Royal Infirm, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Leicester	Manunta, MDI (corresponding author), UCL, Wolfson Ctr Gene Therapy Childhood Dis, UCL Inst Child Hlth, London, England.	s.hart@ich.ucl.ac.uk	McAnulty, Robin J/C-2502-2008; Hart, Stephen L/C-1615-2008; Manunta, Maria Domenica Iole/J-8167-2012	McAnulty, Robin J/0000-0003-1936-4245; Hart, Stephen L/0000-0001-8254-376X; Manunta, Maria Domenica Iole/0000-0002-1875-5335; Hailes, Helen/0000-0001-5574-4742	SPARKS - The children's medical research charity [06ICH10]; Medical Research Council [G1000440] Funding Source: researchfish; Sparks Charity [06ICH10] Funding Source: researchfish; MRC [G1000440] Funding Source: UKRI	SPARKS - The children's medical research charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Sparks Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by a charity: SPARKS - The children's medical research charity. https://www.sparks.org.uk. Sparks Grant 06ICH10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton EWFW, 1999, LANCET, V353, P947, DOI 10.1016/S0140-6736(98)06532-5; ANDERSEN D H, 1958, J Chronic Dis, V7, P58, DOI 10.1016/0021-9681(58)90185-1; Anderson Paula, 2010, Ther Adv Respir Dis, V4, P177, DOI 10.1177/1753465810371107; Bell P, 2005, HISTOCHEM CELL BIOL, V124, P77, DOI 10.1007/s00418-005-0793-2; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Birchall JC, 2000, INT J PHARM, V197, P221, DOI 10.1016/S0378-5173(00)00339-2; BUCHWALD M, 1989, AM J PHYSIOL, V257, pL47, DOI 10.1152/ajplung.1989.257.2.L47; Buller C, 2003, METHOD FIND EXP CLIN, V25, P713, DOI 10.1358/mf.2003.25.9.793338; Celi A, 1999, AM J PHYSIOL-LUNG C, V277, pL465, DOI 10.1152/ajplung.1999.277.3.L465; Chan SCH, 2008, RESP MED, V102, P287, DOI 10.1016/j.rmed.2007.08.013; Chirmule N, 1998, J VIROL, V72, P6138, DOI 10.1128/JVI.72.7.6138-6145.1998; Crook K, 1996, GENE THER, V3, P834; Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001; Cunningham S, 2002, J GENE MED, V4, P438, DOI 10.1002/jgm.270; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Eastman SJ, 1997, HUM GENE THER, V8, P313, DOI 10.1089/hum.1997.8.3-313; Elhissi AMA, 2007, INT J PHARMACEUT, V334, P62, DOI 10.1016/j.ijpharm.2006.10.022; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; Flotte TR, 2001, CHEST, V120, p124S, DOI 10.1378/chest.120.3_suppl.124S; Griesenbach Uta, 2009, Expert Rev Respir Med, V3, P363, DOI 10.1586/ers.09.25; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guillaume C, 2000, J PHARM SCI, V89, P639, DOI 10.1002/(SICI)1520-6017(200005)89:5<639::AID-JPS9>3.0.CO;2-L; Guo ZS, 1996, GENE THER, V3, P802; Hart SL, 1998, HUM GENE THER, V9, P575, DOI 10.1089/hum.1998.9.4-575; Hurley CA, 2004, J ORG CHEM, V69, P980, DOI 10.1021/jo035422g; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Jenkins RG, 2003, GENE THER, V10, P1026, DOI 10.1038/sj.gt.3301963; Jenkins RG, 2000, GENE THER, V7, P393, DOI 10.1038/sj.gt.3301095; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Marple VA, 2004, J AEROSOL MED, V17, P335, DOI 10.1089/jam.2004.17.335; Marple VA, 2003, J AEROSOL MED, V16, P283, DOI 10.1089/089426803769017659; Meng QH, 2004, J GENE MED, V6, P210, DOI 10.1002/jgm.483; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Mueller C, 2008, CLIN REV ALLERG IMMU, V35, P164, DOI 10.1007/s12016-008-8080-3; OCallaghan C, 1997, THORAX, V52, pS31, DOI 10.1136/thx.52.2008.S31; PEARSON B, 1963, LAB INVEST, V12, P1249; Pelisek J, 2000, J VASC RES, V37, P585, DOI 10.1159/000054092; RIORDAN JR, 1989, SCIENCE, V245, P1066; Ruiz FE, 2001, HUM GENE THER, V12, P751, DOI 10.1089/104303401750148667; Tagalakis AD, 2008, MOL THER, V16, P907, DOI 10.1038/mt.2008.38; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Weiss DJ, 1997, HUM GENE THER, V8, P1545, DOI 10.1089/hum.1997.8.13-1545; Weiss DJ, 1999, HISTOCHEM J, V31, P231, DOI 10.1023/A:1003642025421; Wilson JM, 1995, J CLIN INVEST, V96, P2547, DOI 10.1172/JCI118318; Writer M, 2006, J LIPOSOME RES, V16, P373, DOI 10.1080/08982100600992500; Writer MJ, 2004, J DRUG TARGET, V12, P185, DOI 10.1080/10611860410001724459; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155	49	35	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26768	10.1371/journal.pone.0026768	http://dx.doi.org/10.1371/journal.pone.0026768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046351	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600055
J	Wang, B; Chen, J				Wang, Bo; Chen, Jin			Scatter-Hoarding Rodents Prefer Slightly Astringent Food	PLOS ONE			English	Article							OAK-DISPERSAL SYNDROME; CONDENSED TANNINS; SEED; NUTRIENT; ACORNS; DIET; RATS	The mutualistic interaction between scatter-hoarding rodents and their seed plants is highly complex yet poorly understood. Plants may benefit from the seed dispersal behavior of rodents, as long as seed consumption is minimized. In parallel, rodents may maximize foraging efficiency and cache high-quality resources for future consumption. Defensive compounds, such as tannins, are thought to be a major mechanism for plant control over rodent behavior. However, previous studies, using naturally occurring seeds, have not provided conclusive evidence supporting this hypothesis. Here, we test the importance of tannin concentrations on the scatter-hoarding behavior of rodents by using an artificial seed system. We combined feeding trials and field observations to examine the overall impact of seed tannin concentrations on rodent behavior and health. We found that rodents favored seeds with an intermediate amount of tannin (similar to 5%) in the field. Meanwhile, in rodents that were fed a diet with different tannin content, only diets with high tannin content (25%, 15%, and 10%) caused a significant negative influence on rodent survival and health. Significant differences were not found among treatments with tannin levels of 0-5%. In contrast to many existing studies, our results clearly demonstrate that scatter-hoarding rodents prefer slightly 'astringent' food. In the co-evolutionary arms race between plants and animals, our results suggest that while tannins may play a significant role in reducing general predation levels by the faunal community, they have no precise control over the behavior of their mutualistic partner. Instead, the two partners appear to have reached an evolutionary point where both parties receive adequate benefits, with the year-to-year outcome being dependent on a wide range of factors beyond the control of either partner.	[Wang, Bo; Chen, Jin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Beijing 100864, Yunnan, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Sch, Beijing 100864, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, B (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Beijing 100864, Yunnan, Peoples R China.	cj@xtbg.org.cn			National Basic Research Program of China (973 Program) [2007CB411603]; National Natural Science Foundation of China [31100315]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program-2007CB411603) and the National Natural Science Foundation of China (31100315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsana K, 2004, BIOSCI BIOTECH BIOCH, V68, P584, DOI 10.1271/bbb.68.584; BERNAYS EA, 1989, ADV ECOL RES, V19, P263; BLYTT HJ, 1988, J CHEM ECOL, V14, P1455, DOI 10.1007/BF01012417; Chen Z, 2009, ZOO BIOL, V28, P1; ChungMacCoubrey AL, 1997, PHYSIOL ZOOL, V70, P270, DOI 10.1086/639595; Downs CT, 2003, J CHEM ECOL, V29, P845, DOI 10.1023/A:1022975531372; FOWLER ME, 1965, J AM VET MED ASSOC, V147, P1215; LINDROTH RL, 1984, J CHEM ECOL, V10, P229, DOI 10.1007/BF00987851; Shimada T, 2003, POPUL ECOL, V45, P7, DOI 10.1007/s10144-002-0134-4; Shimada T, 2001, ECOL RES, V16, P803, DOI 10.1046/j.1440-1703.2001.00435.x; Smallwood PD, 2001, AM ZOOL, V41, P840, DOI 10.1668/0003-1569(2001)041[0840:TUBOTC]2.0.CO;2; Steele MA, 2001, AM ZOOL, V41, P852, DOI 10.1668/0003-1569(2001)041[0852:TPBOTO]2.0.CO;2; Tebib K, 1997, FOOD CHEM, V59, P135, DOI 10.1016/S0308-8146(96)00253-1; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; Wang B, 2008, ACTA OECOL, V34, P379, DOI 10.1016/j.actao.2008.07.001; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Wood MD, 2005, NORTHEAST NAT, V12, P463, DOI 10.1656/1092-6194(2005)012[0463:TALCOA]2.0.CO;2; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020	19	19	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26424	10.1371/journal.pone.0026424	http://dx.doi.org/10.1371/journal.pone.0026424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046284	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600017
J	Herman, MA; Nahir, B; Jahr, CE				Herman, Melissa A.; Nahir, Ben; Jahr, Craig E.			Distribution of Extracellular Glutamate in the Neuropil of Hippocampus	PLOS ONE			English	Article							SYNAPTICALLY RELEASED GLUTAMATE; NMDA RECEPTORS; DENDRITIC SPINES; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; TRANSPORTERS; PLASTICITY; SYNAPSES; INHIBITION; ACTIVATION	Reported values of extracellular glutamate concentrations in the resting state depend on the method of measurement andvary similar to 1000-fold. As glutamate levels in the micromolar range can cause receptor desensitization and excitotoxicity, and thus affect neuronal excitability, an accurate determination of ambient glutamate is important. Part of the variability of previous measurements may have resulted from the sampling of glutamate in different extracellular compartments, e. g., synaptic versus extrasynaptic volumes. A steep concentration gradient of glutamate between these two compartments could be maintained, for example, by high densities of glutamate transporters arrayed at the edges of synapses. We have used two photon laser scanning microscopy and electrophysiology to investigate whether extracellular glutamate is compartmentalized in acute hippocampal slices. Pharmacological blockade of NMDARs had no effect on Ca(2+) transients generated in dendritic shafts or spines of CA1 pyramidal neurons by depolarization, suggesting that ambient glutamate is too low to activate a significant number of NMDARs. Furthermore, blockade of transporters did not flood the synapse with glutamate, indicating that synaptic NMDARs are not protected from high concentrations of extrasynaptic glutamate. We suggest that, in the CA1 region of hippocampus, glutamate transporters do not create a privileged space within the synapse but rather keep ambient glutamate at very low levels throughout the neuropil.	[Herman, Melissa A.; Nahir, Ben; Jahr, Craig E.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Herman, MA (corresponding author), Charite, Neurosci Res Ctr, D-13353 Berlin, Germany.	jahr@ohsu.edu	Herman, Melissa/AAX-2314-2020	Herman, Melissa/0000-0003-0464-6653	National Institutes of Health (NIH) [NS07381, NS066037, NS040056]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066037, R01NS040056, R56NS040056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) NS07381(BN) and NIH NS066037 and NS040056 (Dr. Jahr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Diamond JS, 1997, J NEUROSCI, V17, P4672; DODT HU, 2002, SCI STKE, pPL2; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Lehre KP, 1997, BRAIN RES, V744, P129, DOI 10.1016/S0006-8993(96)01022-0; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mathew SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017311; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nyitrai G, 2006, CURR TOP MED CHEM, V6, P935, DOI 10.2174/156802606777323674; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pendyam S, 2009, NEUROSCIENCE, V158, P1266, DOI 10.1016/j.neuroscience.2008.11.014; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Yamashita T, 2009, J PHYSIOL-LONDON, V587, P2327, DOI 10.1113/jphysiol.2008.167759; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	41	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26501	10.1371/journal.pone.0026501	http://dx.doi.org/10.1371/journal.pone.0026501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069455	Green Submitted, gold, Green Published			2022-12-27	WOS:000297150900017
J	Renaud, G; Neves, P; Folador, EL; Ferreira, CG; Passetti, F				Renaud, Gabriel; Neves, Pedro; Folador, Edson Luiz; Ferreira, Carlos Gil; Passetti, Fabio			Segtor: Rapid Annotation of Genomic Coordinates and Single Nucleotide Variations Using Segment Trees	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; DATABASE; VARIANTS; FEATURES; RETRIEVAL; SOFTWARE; FORMAT	Various research projects often involve determining the relative position of genomic coordinates, intervals, single nucleotide variations (SNVs), insertions, deletions and translocations with respect to genes and their potential impact on protein translation. Due to the tremendous increase in throughput brought by the use of next-generation sequencing, investigators are routinely faced with the need to annotate very large datasets. We present Segtor, a tool to annotate large sets of genomic coordinates, intervals, SNVs, indels and translocations. Our tool uses segment trees built using the start and end coordinates of the genomic features the user wishes to use instead of storing them in a database management system. The software also produces annotation statistics to allow users to visualize how many coordinates were found within various portions of genes. Our system currently can be made to work with any species available on the UCSC Genome Browser. Segtor is a suitable tool for groups, especially those with limited access to programmers or with interest to analyze large amounts of individual genomes, who wish to determine the relative position of very large sets of mapped reads and subsequently annotate observed mutations between the reads and the reference. Segtor (http://lbbc.inca.gov.br/segtor/) is an open-source tool that can be freely downloaded for non-profit use. We also provide a web interface for testing purposes.	[Renaud, Gabriel; Neves, Pedro; Folador, Edson Luiz; Passetti, Fabio] Inst Nacl Canc INCA, Bioinformat Unit, Rio De Janeiro, Brazil	National Cancer Institute (Inca)	Renaud, G (corresponding author), Inst Nacl Canc INCA, Bioinformat Unit, Rio De Janeiro, Brazil.	passetti@inca.gov.br	Passetti, Fabio/D-2422-2009; Ferreira, Carlos Gil/AAD-4104-2020; Ferreira, Carlos Gil/G-4957-2013	Passetti, Fabio/0000-0001-5672-7848; Ferreira, Carlos Gil/0000-0002-7228-7018; Renaud, Gabriel/0000-0002-0630-027X; Folador, Edson Luiz/0000-0002-6752-9334	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [382791/2009-6, 380934/2009-4, 577593/2008-0, 312733/2009-7]; Ministerio da Ciencia e Tecnologia/Fundo Setorial de Saude (MCT/CT-Saude); Departamento de Ciencia e Tecnologia/Secretaria de Ciencia; Tecnologia e Insumos Estrategicos/Ministerio da Saude (DECIT/SCTIE/MS); Swiss Bridge Foundation; Fundacao do Cancer and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia e Tecnologia/Fundo Setorial de Saude (MCT/CT-Saude); Departamento de Ciencia e Tecnologia/Secretaria de Ciencia; Tecnologia e Insumos Estrategicos/Ministerio da Saude (DECIT/SCTIE/MS); Swiss Bridge Foundation; Fundacao do Cancer and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	GR is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (382791/2009-6). ELF is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (380934/2009-4). FP acknowledges the support of Ministerio da Ciencia e Tecnologia/Fundo Setorial de Saude (MCT/CT-Saude), Departamento de Ciencia e Tecnologia/Secretaria de Ciencia, Tecnologia e Insumos Estrategicos/Ministerio da Saude (DECIT/SCTIE/MS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (577593/2008-0 and 312733/2009-7). FP, CGF and the Bioinformatics Unit acknowledge the support of the Swiss Bridge Foundation, Fundacao do Cancer and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2007, BIOINFORMATICS, V23, P1386, DOI 10.1093/bioinformatics/btl647; [Anonymous], SEQUENCE READ ARQUIV; [Anonymous], GENOME VARIATION SER; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bentley Jon L., 1977, SOLUTIONS KLEE UNPUB; Berg M. D., 2008, COMPUTATIONAL GEOMET, V3rd, DOI DOI 10.1007/978-3-540-77974-2; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krebs A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-533; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pakakasama S, 2008, INT J LAB HEMATOL, V30, P286, DOI 10.1111/j.1751-553X.2007.00954.x; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2020, R LANG ENV STAT COMP; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shetty AC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-471; Varas F, 2009, STEM CELLS, V27, P300, DOI 10.1634/stemcells.2008-0696; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Werner T, 2010, BRIEF BIOINFORM, V11, P499, DOI 10.1093/bib/bbq018; Woolfe A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r20	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26715	10.1371/journal.pone.0026715	http://dx.doi.org/10.1371/journal.pone.0026715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069465	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900027
J	Ribeiro, ALDL; Degiacomi, G; Ewann, F; Buroni, S; Incandela, ML; Chiarelli, LR; Mori, G; Kim, J; Contreras-Dominguez, M; Park, YS; Han, SJ; Brodin, P; Valentini, G; Rizzi, M; Riccardi, G; Pasca, MR				Ribeiro, Ana Luisa de Jesus Lopes; Degiacomi, Giulia; Ewann, Fanny; Buroni, Silvia; Incandela, Maria Loreto; Chiarelli, Laurent R.; Mori, Giorgia; Kim, Jaeseung; Contreras-Dominguez, Monica; Park, Young-Sam; Han, Sung-Jun; Brodin, Priscille; Valentini, Giovanna; Rizzi, Menico; Riccardi, Giovanna; Pasca, Maria Rosalia			Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis	PLOS ONE			English	Article							D-RIBOSE 2'-EPIMERASE; TUBERCULOSIS; ARABINAN	Tuberculosis is still a leading cause of death worldwide. The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Recently, two different classes of chemical series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivatives have been found to be highly active against M. tuberculosis, including XDR-TB strains. The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-beta-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis. Interestingly, it has been shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target. Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by reduction of a critical nitro-group to an amino-group. In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated. Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1. Using fluorescence titration and mass spectrometry it has been possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria. Additionally, M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB. By LC/MS2 analysis it has been demonstrated that NfnB is responsible for DNB inactivation. Taken together, our data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.	[Ribeiro, Ana Luisa de Jesus Lopes; Degiacomi, Giulia; Buroni, Silvia; Incandela, Maria Loreto; Mori, Giorgia; Riccardi, Giovanna; Pasca, Maria Rosalia] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Ribeiro, Ana Luisa de Jesus Lopes; Rizzi, Menico] Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy; [Ewann, Fanny; Kim, Jaeseung; Contreras-Dominguez, Monica; Park, Young-Sam; Han, Sung-Jun; Brodin, Priscille] Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea; [Chiarelli, Laurent R.; Valentini, Giovanna] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy	University of Pavia; University of Eastern Piedmont Amedeo Avogadro; Institut Pasteur Korea; University of Pavia	Ribeiro, ALDL (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	mariarosalia.pasca@unipv.it	Han, Sung-Jun/B-9547-2012; Pasca, Maria Rosalia/J-8752-2016; Brodin, Priscille/N-6979-2019; Buroni, Silvia/AAX-5454-2020; Brodin, Priscille/E-5802-2014; Mori, Giorgia/X-8670-2019; Mori, Giorgia/ABE-2271-2021; Chiarelli, Laurent Roberto/J-8368-2016; Degiacomi, Giulia/ABC-7235-2020; riccardi, gabriele/A-9269-2012	Pasca, Maria Rosalia/0000-0002-8906-4937; Brodin, Priscille/0000-0003-0991-7344; Brodin, Priscille/0000-0003-0991-7344; Mori, Giorgia/0000-0003-3469-5632; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Degiacomi, Giulia/0000-0002-3626-8311; RICCARDI, Giovanna/0000-0003-3295-0070; deboosere, Nathalie/0000-0002-2873-5485; Buroni, Silvia/0000-0002-6979-2275	European Commission [260872]; Korea Research Foundation [K204EA000001-08E0100-00100, K204EA000001-09E0100-00100, K20802001409-09B1300-03700]; National Research foundation of Korea (NRF); Korea government(MEST) [2011-00244]; KISTI	European Commission(European CommissionEuropean Commission Joint Research Centre); Korea Research Foundation(National Research Foundation of Korea); National Research foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KISTI(Korea Institute of Science & Technology Information (KISTI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by the European Commission (contract no 260872 - More Medicines for Tuberculosis, MM4TB), the Korea Research Foundation (Grant K204EA000001-08E0100-00100, K204EA000001-09E0100-00100, K20802001409-09B1300-03700) and INSERM-Avenir. This work was also supported by the National Research foundation of Korea (NRF) grant funded by the Korea government(MEST)(No. 2011-00244), Gyeonggi-do and KISTI.	Brodin P, 2010, WO 2010/003533, Patent No. 2010003533; Crellin PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016869; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Lalloo Umesh G, 2010, Curr HIV/AIDS Rep, V7, P143, DOI 10.1007/s11904-010-0054-4; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Sambrook J., 2001, MOL CLONING LAB MANU; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; Zumla A, 2009, LANCET INFECT DIS, V9, P197, DOI 10.1016/S1473-3099(09)70045-3	16	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26675	10.1371/journal.pone.0026675	http://dx.doi.org/10.1371/journal.pone.0026675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069462	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900024
J	Zhang, YY; Zhen, Y; Dong, YL; Xu, ZP; Yue, Y; Golde, TE; Tanzi, RE; Moir, RD; Xie, ZC				Zhang, Yiying; Zhen, Yu; Dong, Yuanlin; Xu, Zhipeng; Yue, Yun; Golde, Todd E.; Tanzi, Rudolph E.; Moir, Robert D.; Xie, Zhongcong			Anesthetic Propofol Attenuates the Isoflurane-Induced Caspase-3 Activation and A beta Oligomerization	PLOS ONE			English	Article							NITROUS OXIDE ANESTHESIA; ALZHEIMERS-DISEASE; SPATIAL MEMORY; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; DNA-DAMAGE; AGED RATS; IN-VITRO; BRAIN; NEUROPROTECTION	Accumulation and deposition of beta-amyloid protein (A beta) are the hallmark features of Alzheimer's disease. The inhalation anesthetic isoflurane has been shown to induce caspase activation and increase A beta accumulation. In addition, recent studies suggest that isoflurane may directly promote the formation of cytotoxic soluble A beta oligomers, which are thought to be the key pathological species in AD. In contrast, propofol, the most commonly used intravenous anesthetic, has been reported to have neuroprotective effects. We therefore set out to compare the effects of isoflurane and propofol alone and in combination on caspase-3 activation and A beta oligomerization in vitro and in vivo. Naive and stably-transfected H4 human neuroglioma cells that express human amyloid precursor protein, the precursor for A beta; neonatal mice; and conditioned cell culture media containing secreted human A beta 40 or A beta 42 were treated with isoflurane and/or propofol. Here we show for the first time that propofol can attenuate isoflurane-induced caspase-3 activation in cultured cells and in the brain tissues of neonatal mice. Furthermore, propofol-mediated caspase inhibition occurred when there were elevated levels of A beta. Finally, isoflurane alone induces A beta 42, but not A beta 40, oligomerization, and propofol can inhibit the isoflurane-mediated oligomerization of A beta 42. These data suggest that propofol may mitigate the caspase-3 activation by attenuating the isoflurane-induced A beta 42 oligomerization. Our findings provide novel insights into the possible mechanisms of isoflurane-induced neurotoxicity that may aid in the development of strategies to minimize potential adverse effects associated with the administration of anesthetics to patients.	[Zhang, Yiying; Zhen, Yu; Dong, Yuanlin; Xu, Zhipeng; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA USA; [Zhang, Yiying; Zhen, Yu; Dong, Yuanlin; Xu, Zhipeng; Tanzi, Rudolph E.; Moir, Robert D.; Xie, Zhongcong] Harvard Univ, Sch Med, Charlestown, MA USA; [Zhang, Yiying; Zhen, Yu; Dong, Yuanlin; Xu, Zhipeng; Tanzi, Rudolph E.; Moir, Robert D.; Xie, Zhongcong] Massachusetts Gen Hosp, Genet & Aging Res Unit, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA; [Zhen, Yu] Capital Med Univ, Dept Anesthesia, Beijing Friendship Hosp, Beijing, Peoples R China; [Yue, Yun] Capital Med Univ, Dept Anesthesia, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Golde, Todd E.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Capital Medical University; Capital Medical University; State University System of Florida; University of Florida	Zhang, YY (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA USA.	zxie@partners.org	Tanzi, Rudolph/AAE-9622-2019; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; Moir, Robert D./0000-0001-5431-3553; Dong, Yuanlin/0000-0002-4760-0519	National Institutes of Health (Bethesda, Maryland) [K08 NS048140, R21 AG029856, R01 GM088801]; American Geriatrics Society (New York, New York); Alzheimer's Association (Chicago, Illinois); National Natural Science Foundation of China [30928026, 81000474/H0902]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029856] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Geriatrics Society (New York, New York); Alzheimer's Association (Chicago, Illinois)(Alzheimer's Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants (Bethesda, Maryland) (K08 NS048140, R21 AG029856 and R01 GM088801); American Geriatrics Society Jahnigen Award (New York, New York); Investigator-Initiated Research Grant from Alzheimer's Association (Chicago, Illinois) to ZX; National Natural Science Foundation of China (30928026) to ZX and YY, and National Natural Science Foundation of China (81000474/H0902) to Y. Zhen. The Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School provided the cost of anesthetic isoflurane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Barnes NY, 1998, J NEUROSCI, V18, P5869; Bayona NA, 2004, ANESTHESIOLOGY, V100, P1151, DOI 10.1097/00000542-200405000-00017; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Bittner EA, 2011, CAN J ANESTH, V58, P216, DOI 10.1007/s12630-010-9418-x; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cattano D, 2008, ANESTH ANALG, V106, P1712, DOI 10.1213/ane.0b013e318172ba0a; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Engeland CG, 1999, CAN J ANAESTH, V46, P586, DOI 10.1007/BF03013552; Holtzman DM, 1997, NAT MED, V3, P954, DOI 10.1038/nm0997-954; Jevtovic-Todorovic V, 2001, BRAIN RES, V913, P185, DOI 10.1016/S0006-8993(01)02800-1; JevtovicTodorovic V, 1997, J CEREBR BLOOD F MET, V17, P168, DOI 10.1097/00004647-199702000-00006; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kovacs DM, 1999, J NEUROCHEM, V73, P2278, DOI 10.1046/j.1471-4159.1999.0732278.x; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lee IH, 2008, ANESTH ANALG, V107, P1211, DOI 10.1213/ane.0b013e31817ee879; Lewis PA, 2001, BBA-MOL BASIS DIS, V1537, P58, DOI 10.1016/S0925-4439(01)00054-0; Loetscher H, 1997, J BIOL CHEM, V272, P20655, DOI 10.1074/jbc.272.33.20655; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Lunkes A, 1998, ESSAYS BIOCHEM, V33, P149, DOI 10.1042/bse0330149; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; Mattson MP, 2002, INT REV NEUROBIOL, V53, P387; Namura S, 1998, J NEUROSCI, V18, P3659; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raina AK, 2003, PROG NEURO-PSYCHOPH, V27, P251, DOI 10.1016/S0278-5846(03)00020-4; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Su JH, 1997, J NEUROPATH EXP NEUR, V56, P86, DOI 10.1097/00005072-199701000-00009; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Tang JX, 2010, ANESTH ANALG, V110, P421, DOI 10.1213/ANE.0b013e3181b80939; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wu GJ, 2011, BRAIN RES, V1384, P42, DOI 10.1016/j.brainres.2011.02.004; Wu X, 2011, NEUROBIOL AGING; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664	48	50	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27019	10.1371/journal.pone.0027019	http://dx.doi.org/10.1371/journal.pone.0027019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069482	gold, Green Submitted, Green Published			2022-12-27	WOS:000297150900043
J	Boggild, AK; Valencia, BM; Veland, N; Ramos, AP; Calderon, F; Arevalo, J; Low, DE; Llanos-Cuentas, A				Boggild, Andrea K.; Mark Valencia, Braulio; Veland, Nicolas; Pilar Ramos, Ana; Calderon, Flor; Arevalo, Jorge; Low, Donald E.; Llanos-Cuentas, Alejandro			Non-Invasive Cytology Brush PCR Diagnostic Testing in Mucosal Leishmaniasis: Superior Performance to Conventional Biopsy with Histopathology	PLOS ONE			English	Article							AMERICAN TEGUMENTARY LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; CUTANEOUS LEISHMANIASIS; MUCOCUTANEOUS LEISHMANIASIS; MOLECULAR DIAGNOSIS; NEW-WORLD; IDENTIFICATION; COLOMBIA; ASSAY; PERU	Background: Traditional methods of diagnosing mucosal leishmaniasis (ML), such as biopsy with histopathology, are insensitive and require collection of an invasive diagnostic specimen. Methods: We compared standard invasive procedures including biopsy histopathology, biopsy PCR, and leishmanin skin test (LST) to a novel, non-invasive, cytology-brush based PCR for the diagnosis of ML in Lima, Peru. Consensus reference standard was 2/4 tests positive, and outcome measures were sensitivity and specificity. Leishmania species identification was performed by PCR-based assays of positive specimens. Results: Twenty-eight patients were enrolled, 23 of whom fulfilled criteria for a diagnosis of ML. Sensitivity and specificity of biopsy with histopathology were 21.7% [95% CI 4.9-38.5%] and 100%; 69.6% [95% CI 50.8-88.4%] and 100% for LST; 95.7% [95% CI 87.4-100%] and 100% for biopsy PCR; and 95.7% [95% CI 87.4-100%] and 90% [95% CI 71.4-100%] for cytology brush PCR using both Cervisoft (R) and Histobrush (R) cervical cytology brushes. Represented species identified by PCR-RFLP included: L. (V). braziliensis (n = 4), and L. (V). peruviana (n = 3). Conclusions: Use of commercial grade cytology brush PCR for diagnosis of ML is sensitive, rapid, well tolerated, and carries none of the risks of invasive diagnostic procedures such as biopsy. Further optimization is required for adequate species identification. Further evaluation of this method in field and other settings is warranted.	[Boggild, Andrea K.] Univ Toronto, Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON M5G 1L7, Canada; [Mark Valencia, Braulio; Veland, Nicolas; Pilar Ramos, Ana; Calderon, Flor; Arevalo, Jorge; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Arevalo, Jorge] Univ Peruana Cayetano Heredia, Fac Ciencias, Dept Bioquim Biol Mol & Farmacol, Lima, Peru; [Low, Donald E.] Ontario Agcy Hlth Protect & Promot, Labs Branch, Etobicoke, ON, Canada; [Low, Donald E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Llanos-Cuentas, Alejandro] Hosp Nacl Cayetano Heredia, Lima, Peru	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Toronto	Boggild, AK (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON M5G 1L7, Canada.	andrea.boggild@utoronto.ca	Arroyo, Braulio Mark Valencia/AAF-6136-2019; Low, Donald/B-1726-2012	Arroyo, Braulio Mark Valencia/0000-0001-6741-3908; Arevalo, Jorge/0000-0003-3837-2849; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Veland, Nicolas/0000-0002-3096-7867	Royal Society of Tropical Medicine and Hygiene; Royal College of Physicians and Surgeons of Canada	Royal Society of Tropical Medicine and Hygiene; Royal College of Physicians and Surgeons of Canada	This study was funded by the Royal Society of Tropical Medicine and Hygiene through a Garnham Fellowship (www.rstmh.org). AKB was supported by a Detweiler Traveling Fellowship through the Royal College of Physicians and Surgeons of Canada during the study period (www.rcpsc.medical.org). Personnel and facility support for the Arevalo molecular laboratory (NV, JA) were provided by the Institutional Collaboration Framework Agreement 3 from the Belgian Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Boggild AK, 2007, J CLIN MICROBIOL, V45, P3680, DOI 10.1128/JCM.01286-07; Boggild AK, 2010, CLIN INFECT DIS, V50, pE1, DOI 10.1086/648730; David CV, 2009, DERMATOL THER, V22, P491, DOI 10.1111/j.1529-8019.2009.01272.x; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; Figueroa RA, 2009, J INFECT DIS, V200, P638, DOI 10.1086/600109; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348; Lucas CM, 1998, AM J TROP MED HYG, V59, P312, DOI 10.4269/ajtmh.1998.59.312; Mimori T, 2002, ACTA TROP, V81, P197, DOI 10.1016/S0001-706X(01)00215-7; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Oliveira JGS, 2005, ACTA TROP, V94, P55, DOI 10.1016/j.actatropica.2004.12.003; Osorio LE, 1998, AM J TROP MED HYG, V59, P49, DOI 10.4269/ajtmh.1998.59.49; Pirmez C, 1999, J CLIN MICROBIOL, V37, P1819, DOI 10.1128/JCM.37.6.1819-1823.1999; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Rodriguez-Cortes A, 2010, AM J TROP MED HYG, V82, P251, DOI 10.4269/ajtmh.2010.09-0366; SANTRICH C, 1990, AM J TROP MED HYG, V42, P51, DOI 10.4269/ajtmh.1990.42.51; Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657; Victoir K, 2003, T ROY SOC TROP MED H, V97, P80, DOI 10.1016/S0035-9203(03)90031-9; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; World Health Organization, LEISHM BURD DIS; Zhang WW, 2006, CLIN INFECT DIS, V42, P801, DOI 10.1086/500326	27	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26395	10.1371/journal.pone.0026395	http://dx.doi.org/10.1371/journal.pone.0026395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046280	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400018
J	Douaud, M; Feve, K; Pituello, F; Gourichon, D; Boitard, S; Leguern, E; Coquerelle, G; Vieaud, A; Batini, C; Naquet, R; Vignal, A; Tixier-Boichard, M; Pitel, F				Douaud, Marine; Feve, Katia; Pituello, Fabienne; Gourichon, David; Boitard, Simon; Leguern, Eric; Coquerelle, Gerard; Vieaud, Agathe; Batini, Cesira; Naquet, Robert; Vignal, Alain; Tixier-Boichard, Michele; Pitel, Frederique			Epilepsy Caused by an Abnormal Alternative Splicing with Dosage Effect of the SV2A Gene in a Chicken Model	PLOS ONE			English	Article							ANTIEPILEPTIC DRUG LEVETIRACETAM; LIGHT-INDUCED SEIZURES; VESICLE PROTEIN 2A; BRAIN CHIMERAS; EPILEPTIFORM SEIZURES; DIVERGENT SELECTION; REFLEX EPILEPSY; DOMESTIC FOWL; BINDING-SITE; AVIAN MODEL	Photosensitive reflex epilepsy is caused by the combination of an individual's enhanced sensitivity with relevant light stimuli, such as stroboscopic lights or video games. This is the most common reflex epilepsy in humans; it is characterized by the photoparoxysmal response, which is an abnormal electroencephalographic reaction, and seizures triggered by intermittent light stimulation. Here, by using genetic mapping, sequencing and functional analyses, we report that a mutation in the acceptor site of the second intron of SV2A (the gene encoding synaptic vesicle glycoprotein 2A) is causing photosensitive reflex epilepsy in a unique vertebrate model, the Fepi chicken strain, a spontaneous model where the neurological disorder is inherited as an autosomal recessive mutation. This mutation causes an aberrant splicing event and significantly reduces the level of SV2A mRNA in homozygous carriers. Levetiracetam, a second generation antiepileptic drug, is known to bind SV2A, and SV2A knock-out mice develop seizures soon after birth and usually die within three weeks. The Fepi chicken survives to adulthood and responds to levetiracetam, suggesting that the low-level expression of SV2A in these animals is sufficient to allow survival, but does not protect against seizures. Thus, the Fepi chicken model shows that the role of the SV2A pathway in the brain is conserved between birds and mammals, in spite of a large phylogenetic distance. The Fepi model appears particularly useful for further studies of physiopathology of reflex epilepsy, in comparison with induced models of epilepsy in rodents. Consequently, SV2A is a very attractive candidate gene for analysis in the context of both mono- and polygenic generalized epilepsies in humans.	[Douaud, Marine; Feve, Katia; Boitard, Simon; Vignal, Alain; Pitel, Frederique] INRA, ENVT, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; [Pituello, Fabienne] Univ Toulouse 3, CNRS, Ctr Biol Dev, F-31062 Toulouse, France; [Gourichon, David] INRA, PEAT, Pole Expt Avicole Tours, F-37380 Nouzilly, France; [Leguern, Eric] INSERM, Neurogenet Mol & Cellulaire, Paris, France; [Coquerelle, Gerard; Vieaud, Agathe; Tixier-Boichard, Michele] INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Batini, Cesira] CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, Paris, France; [Naquet, Robert] CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Douaud, M (corresponding author), INRA, ENVT, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France.	frederique.pitel@toulouse.inra.fr	Pitel, Frédérique/C-2847-2009; Vignal, Alain/I-6253-2017; Vignal, Alain/AAJ-5697-2021	Pitel, Frédérique/0000-0002-1477-7633; Vignal, Alain/0000-0002-6797-2125; Vignal, Alain/0000-0002-6797-2125	French Research National Agency; French Ministry, MESR - Ministere de l'Enseignement Superieur et de la Recherche; Animal Genetics Division of INRA - Institut National de la Recherche Agronomique	French Research National Agency(French National Research Agency (ANR)); French Ministry, MESR - Ministere de l'Enseignement Superieur et de la Recherche; Animal Genetics Division of INRA - Institut National de la Recherche Agronomique	This work was supported in part by the French Research National Agency through the chick RH project. M. D. is a PhD fellow supported by the French Ministry, MESR - Ministere de l'Enseignement Superieur et de la Recherche and by the Animal Genetics Division of INRA - Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; Batini C, 2004, ARCH ITAL BIOL, V142, P297; Batini C, 1996, TRENDS NEUROSCI, V19, P246, DOI 10.1016/0166-2236(96)10026-6; Boido D, 2010, NEUROSCIENCE, V171, P268, DOI 10.1016/j.neuroscience.2010.08.046; BORDAS A, 1992, BRIT POULTRY SCI, V33, P741, DOI 10.1080/00071669208417515; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crawford R.D, 1990, POULTRY BREEDING GEN; CRAWFORD RD, 1970, J HERED, V61, P185; CRICHLOW EC, 1974, CAN J PHYSIOL PHARM, V52, P424, DOI 10.1139/y74-057; CRITTENDEN LB, 1993, POULTRY SCI, V72, P334, DOI 10.3382/ps.0720334; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Douaud M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-129; Drouilhet L, 2010, BIOL REPROD, V82, P815, DOI 10.1095/biolreprod.109.082065; FADLALLAH N, 1995, BRAIN RES, V675, P55, DOI 10.1016/0006-8993(95)00038-R; Fletcher EV, 2011, J BIOL CHEM; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; GAVORA JS, 1979, POULTRY SCI, V58, P1133, DOI 10.3382/ps.0581133; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Green P, 1990, DOCUMENTATION CRI MA; GUY N, 1992, NEUROSCI LETT, V145, P55, DOI 10.1016/0304-3940(92)90202-I; GUY NTM, 1993, EXP BRAIN RES, V93, P196; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Harding GFA, 1997, EPILEPSIA, V38, P663, DOI 10.1111/j.1528-1157.1997.tb01235.x; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kaminski RM, 2009, EPILEPSIA; Kasteleijn-Nolst Trenite DG, 1996, EPILEPSY RES, V25, P225; KILLAM KF, 1967, ELECTROEN CLIN NEURO, V23, P91; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LECLERCQ B, 1980, BRIT POULTRY SCI, V21, P107, DOI 10.1080/00071668008416644; LEMEUR M, 1981, CELL, V23, P561, DOI 10.1016/0092-8674(81)90152-5; Leroux Sophie, 2010, BMC Res Notes, V3, P214, DOI 10.1186/1756-0500-3-214; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Mignon-Grasteau S, 2001, POULTRY SCI, V80, P849, DOI 10.1093/ps/80.7.849; Morgan CT, 1939, J COMP PSYCHOL, V27, P505, DOI 10.1037/h0058757; Naquet R, 2002, EPILEPSY MOVEMENT DI, P29; Nowack A, 2010, AM J PHYSL CELL PHYS; Pinard-Van der Laan MH, 1998, POULTRY SCI, V77, P185, DOI 10.1093/ps/77.2.185; Pinard-van der Laan MH, 2004, GENET SEL EVOL, V36, P65, DOI 10.1051/gse:2003051; Pinto D, 2005, HUM MOL GENET, V14, P171, DOI 10.1093/hmg/ddi018; Pinto D, 2007, GENET EPIDEMIOL, V31, P42, DOI 10.1002/gepi.20190; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Prasad AN, 2011, BRAIN DEV-JPN, V33, P758, DOI 10.1016/j.braindev.2011.05.014; Shang EY, 2011, J CELL BIOCHEM, V112, P2784, DOI 10.1002/jcb.23192; Sills GJ, 2010, EPILEPSY CURR, V10, P47, DOI 10.1111/j.1535-7511.2009.01351.x; Sterne-Weiler T, 2011, GENOME RES; Striano P, 2009, EPILEPSIA, V50, P933, DOI 10.1111/j.1528-1167.2008.01741.x; Tauer U, 2005, ANN NEUROL, V57, P866, DOI 10.1002/ana.20500; Team RDC, 2006, R LANG ENV STAT COMP; TEILLET MA, 1991, P NATL ACAD SCI USA, V88, P6966, DOI 10.1073/pnas.88.16.6966; van Vliet EA, 2008, EPILEPSIA, V49, P1151, DOI 10.1111/j.1528-1167.2007.01516.x; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Waltz S, 1994, IDIOPATHIC GEN EPILE, P317; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	59	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26932	10.1371/journal.pone.0026932	http://dx.doi.org/10.1371/journal.pone.0026932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046416	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400051
J	Fougeron, AS; Farine, JP; Flaven-Pouchon, J; Everaerts, C; Ferveur, JF				Fougeron, Anne-Sophie; Farine, Jean-Pierre; Flaven-Pouchon, Justin; Everaerts, Claude; Ferveur, Jean-Francois			Fatty-Acid Preference Changes during Development in Drosophila melanogaster	PLOS ONE			English	Article							AGGREGATION PHEROMONE; DIETARY-FAT; RECEPTOR; TASTE; LARVAE; TRP; PALATABILITY; MUTATIONS; CHANNELS; BEHAVIOR	Fatty-acids (FAs) are required in the diet of many animals throughout their life. However, the mechanisms involved in the perception of and preferences for dietary saturated and unsaturated FAs (SFAs and UFAs, respectively) remain poorly explored, especially in insects. Using the model species Drosophila melanogaster, we measured the responses of wild-type larvae and adults to pure SFAs (14, 16, and 18 carbons) and UFAs (C18 with 1, 2, or 3 double-bonds). Individual and group behavioral tests revealed different preferences in larvae and adults. Larvae preferred UFAs whereas SFAs tended to induce both a strong aversion and a persistent aggregation behavior. Adults generally preferred SFAs, and laid more eggs and had a longer life span when ingesting these substances as compared to UFAs. Our data suggest that insects can discriminate long-chain dietary FAs. The developmental change in preference shown by this species might reflect functional variation in use of FAs or stage-specific nutritional requirements, and may be fundamental for insect use of these major dietary components.	[Fougeron, Anne-Sophie; Farine, Jean-Pierre; Flaven-Pouchon, Justin; Everaerts, Claude; Ferveur, Jean-Francois] Univ Bourgogne, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Fougeron, AS (corresponding author), Univ Bourgogne, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, Dijon, France.	jean-francois.ferveur@u-bourgogne.fr			Centre National de la Recherche Scientifique; Burgundy Regional Council; ANR (INSAVEL)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR))	Financial support was provided by the Centre National de la Recherche Scientifique, the Burgundy Regional Council and the ANR (INSAVEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2011, XLSTAT 2011 DAT AN S; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Barrozo RB, 2004, CHEM SENSES, V29, P833, DOI 10.1093/chemse/bjh249; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Bauerfeind SS, 2007, J INSECT PHYSIOL, V53, P964, DOI 10.1016/j.jinsphys.2007.01.013; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bernays EA, 1991, HOST PLANT SELECTION; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; Bray GA, 2004, PHYSIOL BEHAV, V83, P549, DOI 10.1016/j.physbeh.2004.08.039; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Cunnane SC, 2003, PROG LIPID RES, V42, P544, DOI 10.1016/S0163-7827(03)00038-9; DADD RH, 1980, J NUTR, V110, P1152, DOI 10.1093/jn/110.6.1152; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammock JA, 2007, ARTHROPOD-PLANT INTE, V1, P27, DOI 10.1007/s11829-007-9005-4; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Inoshita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019770; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; Jors S, 2006, J BIOL CHEM, V281, P29693, DOI 10.1074/jbc.M602215200; Jumean Z, 2011, J INSECT BEHAV, V24, P249, DOI 10.1007/s10905-010-9251-7; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Labbe D, 2008, CHEMOSENS PERCEPT, V1, P217, DOI 10.1007/s12078-008-9029-x; Lacaille F, 2009, BEHAV GENET, V39, P554, DOI 10.1007/s10519-009-9286-8; Lacey ES, 2009, J CHEM ECOL, V35, P733, DOI 10.1007/s10886-009-9633-5; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Figueiras ANL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-8; MCKECHNIE SW, 1993, J NUTR, V123, P106, DOI 10.1093/jn/123.1.106; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; MIYAKAWA Y, 1980, J INSECT PHYSIOL, V26, P685, DOI 10.1016/0022-1910(80)90041-4; Montmayeur JP, 2010, FAT DETECTION TASTE, P609; Mullens BA, 2009, PEST MANAG SCI, V65, P1360, DOI 10.1002/ps.1823; NARISE S, 1991, JPN J GENET, V66, P411, DOI 10.1266/jjg.66.411; Oike H, 2006, BBA-MOL CELL BIOL L, V1761, P1078, DOI 10.1016/j.bbalip.2006.07.005; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Ravussin E, 1997, J AM DIET ASSOC, V97, pS42, DOI 10.1016/S0002-8223(97)00728-1; Rohlfs M, 2003, P ROY SOC B-BIOL SCI, V270, pS33, DOI 10.1098/rsbl.2003.0002; Saitou K, 2009, PHYSIOL BEHAV, V96, P142, DOI 10.1016/j.physbeh.2008.09.014; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; SKINNER WA, 1970, EXPERIENTIA, V26, P728, DOI 10.1007/BF02232510; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; STANLEYSAMUELSON DW, 1985, COMP BIOCHEM PHYS B, V81, P749, DOI 10.1016/0305-0491(85)90399-2; Stewart JE, 2011, PROG LIPID RES, V50, P225, DOI 10.1016/j.plipres.2011.02.002; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Tsuruta M, 1999, PHYSIOL BEHAV, V66, P285, DOI 10.1016/S0031-9384(98)00299-6; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x; Yoneda T, 2007, PHYSIOL BEHAV, V91, P304, DOI 10.1016/j.physbeh.2007.03.006	62	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26899	10.1371/journal.pone.0026899	http://dx.doi.org/10.1371/journal.pone.0026899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046401	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400044
J	Lavan, D; McDonald, JS; Westbrook, RF; Arabzadeh, E				Lavan, Doron; McDonald, James S.; Westbrook, R. Frederick; Arabzadeh, Ehsan			Behavioural Correlate of Choice Confidence in a Discrete Trial Paradigm	PLOS ONE			English	Article							FORAGING DECISIONS; PARIETAL CORTEX; MATCHING LAW; REINFORCEMENT; PROBABILITY; PIGEON; REPRESENTATION; MONKEYS; SYSTEM	How animals make choices in a changing and often uncertain environment is a central theme in the behavioural sciences. There is a substantial literature on how animals make choices in various experimental paradigms but less is known about the way they assess a choice after it has been made in terms of the expected outcome. Here, we used a discrete trial paradigm to characterise how the reward history shaped the behaviour on a trial by trial basis. Rats initiated each trial which consisted of a choice between two drinking spouts that differed in their probability of delivering a sucrose solution. Critically, sucrose was delivered after a delay from the first lick at the spouts - this allowed us to characterise the behavioural profile during the window between the time of choice and its outcome. Rats' behaviour converged to optimum choice, both during the acquisition phase and after the reversal of contingencies. We monitored the post-choice behaviour at a temporal precision of 1 millisecond; lick-response profiles revealed that rats spent more time at the spout with the higher reward probability and exhibited a sparser lick pattern. This was the case when we exclusively examined the unrewarded trials, where the outcome was identical. The differential licking profiles preceded the differential choice ratios and could thus predict the changes in choice behaviour.	[Lavan, Doron; McDonald, James S.; Westbrook, R. Frederick; Arabzadeh, Ehsan] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Lavan, D (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	ehsan@unsw.edu.au		Arabzadeh, Ehsan/0000-0001-9632-0735; Mcdonald, James/0000-0003-1362-1095; Westbrook, Fred/0000-0002-6880-9274	Australian Research Council [DP0987133]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council Discovery Project Grant DP0987133 to EA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; BITTERMAN ME, 1958, AM J PSYCHOL, V71, P94, DOI 10.2307/1419199; BULLOCK DH, 1962, AM J PSYCHOL, V75, P634, DOI 10.2307/1420288; Davies, 1997, BEHAV ECOLOGY; Davison M., 1988, ERLBAUM; Foster TA, 2004, J EXP ANAL BEHAV, V81, P5, DOI 10.1901/jeab.2004.81-5; GRAF V, 1964, J EXP ANAL BEHAV, V7, P151, DOI 10.1901/jeab.1964.7-151; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Healy SD, 2003, ADV STUD BEHAV, V32, P325, DOI 10.1016/S0065-3454(03)01007-6; Herrnstein R. J., 1997, MATCHING LAW PAPERS; Kacelnik A, 1996, AM ZOOL, V36, P402; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; KREBS JR, 1977, NATURE, V256, P583; LEA SEG, 1979, ANIM BEHAV, V27, P875, DOI 10.1016/0003-3472(79)90025-3; Mazur JE, 2010, J EXP PSYCHOL ANIM B, V36, P321, DOI 10.1037/a0017588; MEYER DR, 1960, J COMP PHYSIOL PSYCH, V53, P173, DOI 10.1037/h0045852; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Sakai Y, 2008, NEURAL COMPUT, V20, P227, DOI 10.1162/neco.2008.20.1.227; SHIMP CP, 1969, PSYCHOL REV, V76, P97, DOI 10.1037/h0027311; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; WILK MB, 1968, BIOMETRIKA, V55, P1; Woolverton WL, 1998, PSYCHOPHARMACOLOGY, V138, P102, DOI 10.1007/s002130050651	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26863	10.1371/journal.pone.0026863	http://dx.doi.org/10.1371/journal.pone.0026863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046387	gold, Green Submitted, Green Published			2022-12-27	WOS:000296521400041
J	Hua, YJ; Duan, SW; Murmann, AE; Larsen, N; Kjems, J; Lund, AH; Peter, ME				Hua, Youjia; Duan, Shiwei; Murmann, Andrea E.; Larsen, Niels; Kjems, Jorgen; Lund, Anders H.; Peter, Marcus E.			miRConnect: Identifying Effector Genes of miRNAs and miRNA Families in Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; ANTICANCER DRUG DISCOVERY; REGULATORY MODULES; MIR-200 FAMILY; MESSENGER-RNAS; EXPRESSION PROFILES; MICRORNA TARGETS; GROWTH; LINES	micro(mi)RNAs are small non-coding RNAs that negatively regulate expression of most mRNAs. They are powerful regulators of various differentiation stages, and the expression of genes that either negatively or positively correlate with expressed miRNAs is expected to hold information on the biological state of the cell and, hence, of the function of the expressed miRNAs. We have compared the large amount of available gene array data on the steady state system of the NCI60 cell lines to two different data sets containing information on the expression of 583 individual miRNAs. In addition, we have generated custom data sets containing expression information of 54 miRNA families sharing the same seed match. We have developed a novel strategy for correlating miRNAs with individual genes based on a summed Pearson Correlation Coefficient (sPCC) that mimics an in silico titration experiment. By focusing on the genes that correlate with the expression of miRNAs without necessarily being direct targets of miRNAs, we have clustered miRNAs into different functional groups. This has resulted in the identification of three novel miRNAs that are linked to the epithelial-to-mesenchymal transition (EMT) in addition to the known EMT regulators of the miR-200 miRNA family. In addition, an analysis of gene signatures associated with EMT, c-MYC activity, and ribosomal protein gene expression allowed us to assign different activities to each of the functional clusters of miRNAs. All correlation data are available via a web interface that allows investigators to identify genes whose expression correlates with the expression of single miRNAs or entire miRNA families. miRConnect.org will aid in identifying pathways regulated by miRNAs without requiring specific knowledge of miRNA targets.	[Hua, Youjia; Murmann, Andrea E.; Peter, Marcus E.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Duan, Shiwei] Ningbo Univ, Dept Med, Ningbo, Zhejiang, Peoples R China; [Larsen, Niels; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol, Aarhus, Denmark; [Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Lund, Anders H.] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark	Northwestern University; Feinberg School of Medicine; Ningbo University; Aarhus University; University of Copenhagen; University of Copenhagen	Hua, YJ (corresponding author), Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	m-peter@northwestern.edu	Lund, Anders H./F-4786-2014; Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012; Kjems, Jorgen/I-3490-2016	Lund, Anders H./0000-0002-7407-3398; Duan, Shiwei/0000-0001-7682-2877; Kjems, Jorgen/0000-0003-4128-9317; Peter, Marcus Ernst/0000-0003-3216-036X	Lundbeck Foundation [R31-2007-1447] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Campanaro S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-383; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chickering D.M., 1996, LEARNING DATA ARTIFI, P121, DOI [DOI 10.1007/978-1-4612-2404-4_12, DOI 10.1007/978-1-4612-2404-412]; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang JC, 2006, LECT NOTES COMPUT SC, V3909, P114; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Liu B, 2009, J BIOMED INFORM, V42, P685, DOI 10.1016/j.jbi.2009.01.005; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Martins PAD, 2010, CARDIOVASC RES, V87, P397, DOI 10.1093/cvr/cvq196; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shi LM, 2000, J CHEM INF COMP SCI, V40, P367, DOI 10.1021/ci990087b; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	64	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26521	10.1371/journal.pone.0026521	http://dx.doi.org/10.1371/journal.pone.0026521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046300	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600027
J	Lapierre, P; Troesch, M; Alvarez, F; Soudeyns, H				Lapierre, Pascal; Troesch, Myriam; Alvarez, Fernando; Soudeyns, Hugo			Structural Basis for Broad Neutralization of Hepatitis C Virus Quasispecies	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; E2 GLYCOPROTEIN; HYPERVARIABLE REGION-1; PROTEIN; ANTIBODIES; RECEPTOR; INFECTION; RESPONSES; BINDING	Monoclonal antibodies directed against hepatitis C virus (HCV) E2 protein can neutralize cell-cultured HCV and pseudoparticles expressing envelopes derived from multiple HCV subtypes. For example, based on antibody blocking experiments and alanine scanning mutagenesis, it was proposed that the AR3B monoclonal antibody recognized a discontinuous conformational epitope comprised of amino acid residues 396-424, 436-447, and 523-540 of HCV E2 envelope protein. Intriguingly, one of these segments (436-447) overlapped with hypervariable region 3 (HVR3), a domain that exhibited significant intrahost and interhost genetic diversity. To reconcile these observations, amino-acid sequence variability was examined and homology-based structural modelling of E2 based on tick-borne encephalitis virus (TBEV) E protein was performed based on 413 HCV sequences derived from 18 subjects with chronic hepatitis C. Here we report that despite a high degree of amino-acid sequence variability, the three-dimensional structure of E2 is remarkably conserved, suggesting broad recognition of structural determinants rather than specific residues. Regions 396-424 and 523-540 were largely exposed and in close spatial proximity at the surface of E2. In contrast, region 436-447, which overlaps with HVR3, was >35 angstrom away, and estimates of buried surface were inconsistent with HVR3 being part of the AR3B binding interface. High-throughput structural analysis of HCV quasispecies could facilitate the development of novel vaccines that target conserved structural features of HCV envelope and elicit neutralizing antibody responses that are less vulnerable to viral escape.	[Lapierre, Pascal; Alvarez, Fernando] Ctr Hosp Univ, Ctr Rech, Serv Gastroenterol Hepatol & Nutr, Montreal, PQ, Canada; [Troesch, Myriam; Soudeyns, Hugo] Ctr Hosp Univ, Ctr Rech, Unite Iimmunopathol Virale, Montreal, PQ, Canada; [Troesch, Myriam; Alvarez, Fernando; Soudeyns, Hugo] Univ Montreal, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Alvarez, Fernando; Soudeyns, Hugo] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lapierre, P (corresponding author), Ctr Hosp Univ, Ctr Rech, Serv Gastroenterol Hepatol & Nutr, Montreal, PQ, Canada.	hugo.soudeyns@recherche-ste-justine.qc.ca	Lapierre, Pascal/ABD-2247-2021	Lapierre, Pascal/0000-0002-2753-3566	Canadian Institutes of Health Research (CIHR)-Health Canada Research Initiative on Hepatitis C [EOP-41537]; CANFAR-Canadian Foundation for AIDS Research [013515]; Elizabeth Glaser Pediatric AIDS Foundation [28-PG-51355]; Reseau SIDA et Maladies Infectieuses (Fonds de la Recherche en Sante du Quebec); CIHR; Fondation de l'Hopital Sainte-Justine	Canadian Institutes of Health Research (CIHR)-Health Canada Research Initiative on Hepatitis C(Canadian Institutes of Health Research (CIHR)); CANFAR-Canadian Foundation for AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; Reseau SIDA et Maladies Infectieuses (Fonds de la Recherche en Sante du Quebec)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); Fondation de l'Hopital Sainte-Justine	This work was supported by grants from the Canadian Institutes of Health Research (CIHR)-Health Canada Research Initiative on Hepatitis C (grant no. EOP-41537), CANFAR-Canadian Foundation for AIDS Research (grant no. 013515), The Elizabeth Glaser Pediatric AIDS Foundation (grant no. 28-PG-51355), and an infrastructure grant from Reseau SIDA et Maladies Infectieuses (Fonds de la Recherche en Sante du Quebec). PL was supported by a CIHR Doctoral Research Award. MT was the recipient of a scholarship from Fondation de l'Hopital Sainte-Justine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G, 1997, PEDIATR INFECT DIS J, V16, P533, DOI 10.1097/00006454-199705000-00021; Albecka A, 2011, J VIROL, V85, P1777, DOI 10.1128/JVI.02170-10; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Beld M, 1999, HEPATOLOGY, V29, P1288, DOI 10.1002/hep.510290442; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cuevas JM, 2008, J VIRAL HEPATITIS, V15, P578, DOI 10.1111/j.1365-2893.2008.00991.x; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gal-Tanamy M, 2008, P NATL ACAD SCI USA, V105, P19450, DOI 10.1073/pnas.0809879105; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; KATO N, 1992, BIOCHEM BIOPH RES CO, V189, P119, DOI 10.1016/0006-291X(92)91533-V; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; KATO N, 1992, VIRUS RES, V22, P107, DOI 10.1016/0168-1702(92)90038-B; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09; Keck ZY, 2011, J VIROL; Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Marceau G, 2005, HEPATOLOGY, V42, P675, DOI 10.1002/hep.20816; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; McCaffrey K, 2007, J VIROL, V81, P9584, DOI 10.1128/JVI.02782-06; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; MURPHY D, 1994, J INFECT DIS, V169, P473, DOI 10.1093/infdis/169.2.473; O'Leary JG, 2008, GASTROENTEROLOGY, V134, P1764, DOI 10.1053/j.gastro.2008.02.028; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Polyak SJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-41; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres-Puente M, 2008, INFECT GENET EVOL, V8, P74, DOI 10.1016/j.meegid.2007.10.005; Troesch M, 2005, AIDS, V19, P775, DOI 10.1097/01.aids.0000168971.57681.6e; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K	58	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26981	10.1371/journal.pone.0026981	http://dx.doi.org/10.1371/journal.pone.0026981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046426	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600084
J	Anderson, TK; Sukhdeo, MVK				Anderson, Tavis K.; Sukhdeo, Michael V. K.			Host Centrality in Food Web Networks Determines Parasite Diversity	PLOS ONE			English	Article							COMPARTMENTALIZATION; STABILITY; EVOLUTION; TOPOLOGY; PREY; PLEA	Background: Parasites significantly alter topological metrics describing food web structure, yet few studies have explored the relationship between food web topology and parasite diversity. Methods/Principal Findings: This study uses quantitative metrics describing network structure to investigate the relationship between the topology of the host food web and parasite diversity. Food webs were constructed for four restored brackish marshes that vary in species diversity, time post restoration and levels of parasitism. Our results show that the topology of the food web in each brackish marsh is highly nested, with clusters of generalists forming a distinct modular structure. The most consistent predictors of parasite diversity within a host were: trophic generality, and eigenvector centrality. These metrics indicate that parasites preferentially colonise host species that are highly connected, and within modules of tightly interacting species in the food web network. Conclusions/Significance: These results suggest that highly connected free-living species within the food web may represent stable trophic relationships that allow for the persistence of complex parasite life cycles. Our data demonstrate that the structure of host food webs can have a significant effect on the establishment of parasites, and on the potential for evolution of complex parasite life cycles.	[Anderson, Tavis K.] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA; [Sukhdeo, Michael V. K.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Anderson, TK (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	tkanderson@wisc.edu		Anderson, Tavis/0000-0002-3138-5535	American Society of Parasitology; Rutgers University Foundation	American Society of Parasitology; Rutgers University Foundation	This research was funded in part by a Willis A. Reid Jr. student research grant (American Society of Parasitology) to TKA, and by the Rutgers University Foundation Parasite Research Fund to TKA and MVKS. There are no current other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allesina S, 2006, ECOL MODEL, V194, P150, DOI 10.1016/j.ecolmodel.2005.10.016; Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; Anderson TK, 2010, PARASITOLOGY, V137, P743, DOI 10.1017/S0031182009991430; [Anonymous], BIRDS N AM ONLINE; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Borgatti SP, 1999, SOC NETWORKS, V21, P375; BRAGIN AB, 2005, FISHERIES RESOURCE I; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Butts CT, 2008, J STAT SOFTW, V24, DOI [10.18637/jss.v024.i02, DOI 10.18637/JSS.V024.I02]; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Chen HW, 2008, OIKOS, V117, P1847, DOI 10.1111/j.1600-0706.2008.16607.x; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Combes Claude., 2001, PARASITISM ECOLOGY E; DAIBER DC, 1982, ANIMALS TIDAL MARSH; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Elton C., 1927, ANIMAL ECOLOGY; FROESE R, 2009, FISHBASE 2000 CONCEP; Graczyk TK, 2003, PARASITOL RES, V89, P107, DOI 10.1007/s00436-002-0729-x; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Harris CE, 2006, COMP PARASITOL, V73, P72, DOI 10.1654/41716.1; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hernandez AD, 2008, OECOLOGIA, V156, P613, DOI 10.1007/s00442-008-0999-9; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; HUXHAM M, 1995, J ANIM ECOL, V64, P168, DOI 10.2307/5752; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Knudsen R, 1996, J FISH BIOL, V48, P1256, DOI 10.1111/j.1095-8649.1996.tb01819.x; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; LAFFERTY KD, 1992, AM NAT, V140, P854, DOI 10.1086/285444; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty Kevin D., 2006, P119; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; LEWIS EE, 2002, BEH ECOLOGY PARASITE; LIAW A, 2010, BREIMAN CUTLERS RAND; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Marcogliese DJ, 1997, TRENDS ECOL EVOL, V12, P320, DOI 10.1016/S0169-5347(97)01080-X; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MAX K, 2011, CARET CLASSIFICATION; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Melian CJ, 2004, ECOLOGY, V85, P352, DOI 10.1890/02-0638; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Newman M.E.J., 2008, NEW PALGRAVE ENCY EC, P312, DOI [DOI 10.1057/978-1-349-95121-5_2565-1, 10.1057/978-1-349-95121-5_2565-1]; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Piechnik DA, 2008, OIKOS, V117, P665, DOI 10.1111/j.0030-1299.2008.15915.x; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; Poulin R, 2004, EVOL ECOL, V18, P231, DOI 10.1023/B:EVEC.0000035029.55952.68; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Poulin R., 2007, EVOL ECOL, V2; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; R Core Team, 2021, R LANGUAGE ENV STAT; SEIGEL A, 2006, AVIAN RESPONSE URBAN; Seigel Alison, 2005, Urban Habitats, V3, P87; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Sukhdeo Michael V. K., 2005, P54; Therneau T.M, 2010, RPART RECURSIVE PART; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson RM, 2005, J ANIM ECOL, V74, P77, DOI 10.1111/j.1365-2656.2004.00899.x; TINER RW, 2002, WETLAND STATUS TREND; Valtonen ET, 2010, OECOLOGIA, V162, P139, DOI 10.1007/s00442-009-1451-5; WARREN PH, 1994, TRENDS ECOL EVOL, V9, P136, DOI 10.1016/0169-5347(94)90178-3; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Weinstein MP, 2007, ESTUAR COAST, V30, P365, DOI 10.1007/BF02700179; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; YUHAS C, 2001, BENTHIC COMMUNITIES; Yuhas Catherine E., 2005, Urban Habitats, V3, P158	88	34	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26798	10.1371/journal.pone.0026798	http://dx.doi.org/10.1371/journal.pone.0026798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046360	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000033
J	Jongen, PJ; Sindic, C; Sanders, E; Hawkins, S; Linssen, W; van Munster, E; Frequin, S; Borm, G				Jongen, Peter Joseph; Sindic, Christian; Sanders, Evert; Hawkins, Stanley; Linssen, Wim; van Munster, Erik; Frequin, Stephan; Borm, George		Functional Composite Quality Life	Adverse Events of Interferon Beta-1a: A Prospective Multi-Centre International ICH-GCP-Based CRO-Supported External Validation Study in Daily Practice	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; QUALITY-OF-LIFE; NATURAL-HISTORY; BENEFITS; TRIAL; PLACEBO; DISEASE; TIME; MS	Background: Due to methodological shortcomings the available post-registration data on the adverse events (AEs) occurring in interferon beta-1a (INFb-1a)-treated patients fail to adequately validate phase III data and only partially inform on safety in daily practice. We assessed AEs in relapsing remitting multiple sclerosis (RRMS) patients treated with intramuscular (IM) INFb-1a in daily practice using data quality assurance measures similar to those in phase III trials. Methods: A prospective, International Conference on Harmonization (ICH) - Good Clinical Practice (GCP)-based, clinical research organization (CRO)-supported study in 36 practices in the Netherlands, Belgium, the United Kingdom and Luxembourg. During 24 months after start of IM INFb-1a treatment 275 RRMS patients were assessed for AEs' severity (mild, moderate, severe) and relationship to treatment (not, unlikely, likely, definite). Data were compared with those reported in the pivotal phase III trial. Findings: 75.3% of the patients experienced one or more AEs that were likely or definitely related to INFb-1a. Of all AEs 40.5% were likely or definitely treatment-related; 68.5% of these were mild, and 3% severe. 6.6% of the patients discontinued treatment because of an AE. Compared to the pivotal phase III trial, we found statistically significantly lower incidences for most of the common AEs: headache, muscle ache, fatigue, fever, chills, nausea. One patient died following two cerebral vascular events in study month 22, both AEs were assessed as not related to INFb-1a. Conclusion: Three out of four RRMS patients treated with IM INFb-1a in daily practice experience treatment-related AEs, most of these being mild. Our data externally validate the favorable phase III safety profile of IM INFb-1a and suggest that the real-life incidence of treatment-related AEs is less than reported in the pivotal phase III trial. Larger studies are needed to detect rare, potentially hazardous AEs of IM INFb-1a.	[Jongen, Peter Joseph] MS4 Res Inst, Nijmegen, Netherlands; [Sindic, Christian] Clin Univ St Luc UCL, Serv Neurol, Brussels, Belgium; [Sanders, Evert] Amphia Hosp, Dept Neurol, Breda, Netherlands; [Hawkins, Stanley] Royal Victoria Hosp, No Ireland Reg Neurol Serv, Belfast BT12 6BA, Antrim, North Ireland; [Linssen, Wim] St Lucas Andreas Ziekenhuis, Dept Neurol, Amsterdam, Netherlands; [van Munster, Erik] Jeroen Bosch Ziekenhuis, Dept Neurol, Shertogenbosch, Netherlands; [Frequin, Stephan] St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands; [Borm, George] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Amphia Hospital; Sint Lucas Andreas Hospital; Jeroen Bosch Ziekenhuis; St. Antonius Hospital Utrecht; Radboud University Nijmegen	Jongen, PJ (corresponding author), MS4 Res Inst, Nijmegen, Netherlands.	ms4ri@kpnmail.nl		D'hooghe, Marie/0000-0002-0917-4176	Biogen-Idec	Biogen-Idec(Biogen)	The study was funded by Biogen-Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Study personnel were reimbursed for study-related data collection activities by Biogen-Idec at reasonable and customary rates according to a predetermined research budget schedule.	Bosche B, 2006, ACTA NEUROL SCAND, V113, P433, DOI 10.1111/j.1600-0404.2006.00638.x; Clanet M, 2002, NEUROLOGY, V59, P1507, DOI 10.1212/01.WNL.0000032256.35561.D6; Coppola G, 2006, EUR J NEUROL, V13, P1014, DOI 10.1111/j.1468-1331.2006.01422.x; Fernandez O, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.2003.01350.x; Gottberg K, 2000, MULT SCLER, V6, P349, DOI 10.1191/135245800678827978; International Conference on Harmonisation, 1997, FED REGISTER, V62, P25691; Ioannidis JPA, 1998, LANCET, V352, P1752, DOI 10.1016/S0140-6736(05)79825-1; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jongen P, 2010, J NEUROL, V257, P584, DOI 10.1007/s00415-009-5378-x; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Leary SM, 2004, J NEUROL NEUROSUR PS, V75, P508, DOI 10.1136/jnnp.2003.018598; Meyer FP, 2000, ARZNEIMITTEL-FORSCH, V50, P768; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; *MIN HLTH WELF SPO, 2000, INT PUBL SER HLTH WE, V2; Munschauer FE, 1997, CLIN THER, V19, P883, DOI 10.1016/S0149-2918(97)80042-2; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Panitch H, 2005, J NEUROL SCI, V239, P67, DOI 10.1016/j.jns.2005.08.003; Patti F, 2006, ACTA NEUROL SCAND, V113, P241, DOI 10.1111/j.1600-0404.2005.00565.x; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Simone IL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-96; Trojano M, 2003, MULT SCLER J, V9, P451, DOI 10.1191/1352458503ms948oa; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Trojano M, 2006, MULT SCLER J, V12, P578, DOI 10.1177/1352458506070620; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Zivadinov R, 2003, J NEUROL SCI, V216, P113, DOI 10.1016/S0022-510X(03)00225-9	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26568	10.1371/journal.pone.0026568	http://dx.doi.org/10.1371/journal.pone.0026568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046309	Green Published, gold			2022-12-27	WOS:000296517000021
J	Miro, JM; Manzardo, C; Mussini, C; Johnson, M; Monforte, AD; Antinori, A; Gill, MJ; Sighinolfi, L; Uberti-Foppa, C; Borghi, V; Sabin, C				Miro, Jose M.; Manzardo, Christian; Mussini, Cristina; Johnson, Margaret; Monforte, Antonella d'Arminio; Antinori, Andrea; Gill, M. John; Sighinolfi, Laura; Uberti-Foppa, Caterina; Borghi, Vanni; Sabin, Caroline		Late Presenters Investigators	Survival Outcomes and Effect of Early vs. Deferred cART Among HIV-Infected Patients Diagnosed at the Time of an AIDS-Defining Event: A Cohort Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TUBERCULOSIS; INDIVIDUALS; INITIATION; ERA	Objectives: We analyzed clinical progression among persons diagnosed with HIV at the time of an AIDS-defining event, and assessed the impact on outcome of timing of combined antiretroviral treatment (cART). Methods: Retrospective, European and Canadian multicohort study.. Patients were diagnosed with HIV from 1997-2004 and had clinical AIDS from 30 days before to 14 days after diagnosis. Clinical progression (new AIDS event, death) was described using Kaplan-Meier analysis stratifying by type of AIDS event. Factors associated with progression were identified with multivariable Cox regression. Progression rates were compared between those starting early (<30 days after AIDS event) or deferred (30-270 days after AIDS event) cART. Results: The median (interquartile range) CD4 count and viral load (VL) at diagnosis of the 584 patients were 42 (16, 119) cells/mu L and 5.2 (4.5, 5.7) log(10) copies/mL. Clinical progression was observed in 165 (28.3%) patients. Older age, a higher VL at diagnosis, and a diagnosis of non-Hodgkin lymphoma (NHL) (vs. other AIDS events) were independently associated with disease progression. Of 366 patients with an opportunistic infection, 178 (48.6%) received early cART. There was no significant difference in clinical progression between those initiating cART early and those deferring treatment (adjusted hazard ratio 1.32 [95% confidence interval 0.87, 2.00], p = 0.20). Conclusions: Older patients and patients with high VL or NHL at diagnosis had a worse outcome. Our data suggest that earlier initiation of cART may be beneficial among HIV-infected patients diagnosed with clinical AIDS in our setting.	[Miro, Jose M.; Manzardo, Christian] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Mussini, Cristina; Borghi, Vanni] Univ Modena & Reggio Emilia, Clin Infect & Trop Dis, Modena, Italy; [Mussini, Cristina; Borghi, Vanni] Azienda Policlin, Modena, Italy; [Johnson, Margaret] Royal Free Hosp, Ian Charleson Ctr, London NW3 2QG, England; [Monforte, Antonella d'Arminio] San Paolo Univ Hosp, Clin Infect Dis, Milan, Italy; [Antinori, Andrea] Natl Inst Infect Dis L Spallanzani, IRCCS, Rome, Italy; [Gill, M. John] So Alberta Clin, Calgary, AB, Canada; [Sighinolfi, Laura] St Anna Hosp, Dept Infect Dis, Ferrara, Italy; [Uberti-Foppa, Caterina] Univ Vita & Salute, Dept Infect Dis, Milan, Italy; [Sabin, Caroline] UCL Med Ctr, London, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universita di Modena e Reggio Emilia; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; IRCCS Lazzaro Spallanzani; University of Ferrara; Arcispedale Sant'Anna; Vita-Salute San Raffaele University; University of London; University College London	Miro, JM (corresponding author), Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain.	jmmiro@ub.edu	Foppa, Caterina Uberti/ABH-3089-2020; manzardo, Christian/G-7971-2011; Mussini, Cristina/K-8672-2016; Sighinolfi, Laura/AAH-1426-2020; , Felipe/F-4242-2014; Sabin, Caroline/C-2464-2008; Antinori, Andrea/K-7125-2016; Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Foppa, Caterina Uberti/0000-0001-5271-9138; Mussini, Cristina/0000-0002-6615-4198; , Felipe/0000-0001-7658-5832; Sabin, Caroline/0000-0001-5173-2760; Antinori, Andrea/0000-0003-2121-4684; Dodsley, Maria/0000-0001-7587-558X; De Lazzari, Elisa/0000-0003-2614-6545; Gill, Michael John/0000-0002-8546-8790	Istituto Superiore di Sanita, Italy [40G.43, 30G.3]; "Fundacion Maximo Soriano Jimenez'' (Barcelona, Spain); Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS); Instituto de Salud Carlos III, Madrid (Spain) [ISCIII-RETIC RD06/006, INT10/219]; Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain)	Istituto Superiore di Sanita, Italy; "Fundacion Maximo Soriano Jimenez'' (Barcelona, Spain); Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Madrid (Spain)(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain)(Generalitat de Catalunya)	This work was partially supported by Istituto Superiore di Sanita, VI Programma Nazionale di ricerca sull'AIDS 2006, Italy, Projects: "Eziopatogenesi, studi immunologici e virologici dell'HIV/AIDS'' - Grant: 40G.43 (Mussini), "Ricerca clinica e terapia della malattia da HIV'' - Grant 30G.3 (Antinori), by the "Fundacion Maximo Soriano Jimenez'' (Barcelona, Spain) and the "Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS),'' and grant ISCIII-RETIC RD06/006 from the Instituto de Salud Carlos III, Madrid (Spain)(Manzardo, Miro). Dr. Miro was a recipient of an INT10/219 Intensification Research Grant (I3SNS & PRICS programs) from the "Instituto de Salud Carlos III, Madrid (Spain)'' and the "Departament de Salut de la Generalitat de Catalunya, Barcelona (Spain)''. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim S, 2011, 18 C RETR OPP INF FE; BLANC FX, 2010, 18 INT AIDS C IAS VI; French Martyn A, 2007, Curr HIV/AIDS Rep, V4, P16, DOI 10.1007/s11904-007-0003-z; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Havlir D, 2011, 18 C RETR OPP INF FE; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Manzardo C, 2007, JAIDS-J ACQ IMM DEF, V46, pS9, DOI 10.1097/01.qai.0000286599.38431.ef; Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Sobrino-Vegas P, 2009, CURR HIV RES, V7, P224, DOI 10.2174/157016209787581535; SORIANO E, 1988, AIDS, V2, P429, DOI 10.1097/00002030-198812000-00003; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	22	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26009	10.1371/journal.pone.0026009	http://dx.doi.org/10.1371/journal.pone.0026009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043301	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400029
J	Dempwolff, F; Reimold, C; Reth, M; Graumann, PL				Dempwolff, Felix; Reimold, Christian; Reth, Michael; Graumann, Peter L.			Bacillus subtilis MreB Orthologs Self-Organize into Filamentous Structures underneath the Cell Membrane in a Heterologous Cell System	PLOS ONE			English	Article							BACTERIAL ACTIN MREB; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; SHAPE; MORPHOGENESIS; PROTEINS; RODZ; CYTOSKELETON; LOCALIZATION; HOMOLOG	Actin-like bacterial cytoskeletal element MreB has been shown to be essential for the maintenance of rod cell shape in many bacteria. MreB forms rapidly remodelling helical filaments underneath the cell membrane in Bacillus subtilis and in other bacterial cells, and co-localizes with its two paralogs, Mbl and MreBH. We show that MreB localizes as dynamic bundles of filaments underneath the cell membrane in Drosophila S2 Schneider cells, which become highly stable when the ATPase motif in MreB is modified. In agreement with ATP-dependent filament formation, the depletion of ATP in the cells lead to rapid dissociation of MreB filaments. Extended induction of MreB resulted in the formation of membrane protrusions, showing that like actin, MreB can exert force against the cell membrane. Mbl also formed membrane associated filaments, while MreBH formed filaments within the cytosol. When co-expressed, MreB, Mbl and MreBH built up mixed filaments underneath the cell membrane. Membrane protein RodZ localized to endosomes in S2 cells, but localized to the cell membrane when co-expressed with Mbl, showing that bacterial MreB/Mbl structures can recruit a protein to the cell membrane. Thus, MreB paralogs form a self-organizing and dynamic filamentous scaffold underneath the membrane that is able to recruit other proteins to the cell surface.	[Dempwolff, Felix; Reimold, Christian; Reth, Michael; Graumann, Peter L.] Univ Freiburg, Fak Biol, Freiburg, Germany	University of Freiburg	Dempwolff, F (corresponding author), Univ Freiburg, Fak Biol, Freiburg, Germany.	peter.graumann@biologie.uni-freibug.de		Dempwolff, Felix/0000-0002-7788-8445; Graumann, Peter/0000-0002-8033-5171	Deutsche Forschungsgemeinschaft [FOR 929, SFB 746, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 929, SFB 746 and IRTG 1478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bhatnagar V, 1998, MOL CELL BIOCHEM, V189, P99, DOI 10.1023/A:1006876411202; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; CORTESE JD, 1989, P NATL ACAD SCI USA, V86, P5773, DOI 10.1073/pnas.86.15.5773; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Gerdes K, 2009, EMBO J, V28, P171, DOI 10.1038/emboj.2008.287; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2010, MOL MICROBIOL, V78, P1145, DOI 10.1111/j.1365-2958.2010.07395.x; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Srinivasan R, 2007, CURR BIOL, V17, P266, DOI 10.1016/j.cub.2006.11.069; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148	28	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27035	10.1371/journal.pone.0027035	http://dx.doi.org/10.1371/journal.pone.0027035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069484	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900045
J	Gerstung, M; Eriksson, N; Lin, J; Vogelstein, B; Beerenwinkel, N				Gerstung, Moritz; Eriksson, Nicholas; Lin, Jimmy; Vogelstein, Bert; Beerenwinkel, Niko			The Temporal Order of Genetic and Pathway Alterations in Tumorigenesis	PLOS ONE			English	Article							WAITING TIME; HUMAN BREAST; TREE MODELS; CANCER; PROGRESSION; MUTATIONS; EVOLUTION; EVENTS; ONCOGENESIS; SEQUENCE	Cancer evolves through the accumulation of mutations, but the order in which mutations occur is poorly understood. Inference of a temporal ordering on the level of genes is challenging because clinically and histologically identical tumors often have few mutated genes in common. This heterogeneity may at least in part be due to mutations in different genes having similar phenotypic effects by acting in the same functional pathway. We estimate the constraints on the order in which alterations accumulate during cancer progression from cross-sectional mutation data using a probabilistic graphical model termed Hidden Conjunctive Bayesian Network (H-CBN). The possible orders are analyzed on the level of genes and, after mapping genes to functional pathways, also on the pathway level. We find stronger evidence for pathway order constraints than for gene order constraints, indicating that temporal ordering results from selective pressure acting at the pathway level. The accumulation of changes in core pathways differs among cancer types, yet a common feature is that progression appears to begin with mutations in genes that regulate apoptosis pathways and to conclude with mutations in genes involved in invasion pathways. H-CBN models provide a quantitative and intuitive model of tumorigenesis showing that the genetic events can be linked to the phenotypic progression on the level of pathways.	[Gerstung, Moritz; Beerenwinkel, Niko] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Gerstung, Moritz; Beerenwinkel, Niko] SIB, Basel, Switzerland; [Eriksson, Nicholas] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Lin, Jimmy; Vogelstein, Bert] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Ludwig Ctr, Baltimore, MD USA; [Lin, Jimmy; Vogelstein, Bert] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Chicago; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Gerstung, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	niko.beerenwinkel@bsse.ethz.ch		Gerstung, Moritz/0000-0001-6709-963X	SystemsX.ch; Swiss initiative in systems biology [2009/024]; Swiss National Science Foundation; NATIONAL CANCER INSTITUTE [R37CA043460] Funding Source: NIH RePORTER	SystemsX.ch; Swiss initiative in systems biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by SystemsX.ch (www.systemsx.ch), the Swiss initiative in systems biology, under grant No. 2009/024, evaluated by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; BAKER SJ, 1990, CANCER RES, V50, P7717; Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2009, BIOMETRIKA, V96, P645, DOI 10.1093/biomet/asp023; Beerenwinkel N, 2007, BERNOULLI, V13, P893, DOI 10.3150/07-BEJ6133; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Beerenwinkel N, 2006, J THEOR BIOL, V242, P409, DOI 10.1016/j.jtbi.2006.03.013; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Desper R, 2000, J COMPUT BIOL, V7, P789, DOI 10.1089/10665270050514936; Durrett R, 2009, ANN APPL PROBAB, V19, P676, DOI 10.1214/08-AAP559; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerstung M, 2010, MATH POPUL STUD, V17, P115, DOI 10.1080/08898480.2010.490994; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Laurent-Puig P, 1999, EUR J CANCER PREV, V8, pS39; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; MOOLGAVKAR SH, 1992, J NATL CANCER I, V84, P610, DOI 10.1093/jnci/84.8.610; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Radmacher MD, 2001, J THEOR BIOL, V212, P535, DOI 10.1006/jtbi.2001.2395; Rahnenfuhrer J, 2005, BIOINFORMATICS, V21, P2438, DOI 10.1093/bioinformatics/bti312; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	37	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27136	10.1371/journal.pone.0027136	http://dx.doi.org/10.1371/journal.pone.0027136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069497	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900057
J	Nasstrom, T; Goncalves, S; Sahlin, C; Nordstrom, E; Sundquist, VS; Lannfelt, L; Bergstrom, J; Outeiro, TF; Ingelsson, M				Nasstrom, Thomas; Goncalves, Susana; Sahlin, Charlotte; Nordstrom, Eva; Sundquist, Valentina Screpanti; Lannfelt, Lars; Bergstrom, Joakim; Outeiro, Tiago F.; Ingelsson, Martin			Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; FIBRIL FORMATION; IN-VITRO; LEWY BODIES; A-BETA; MODEL; COMPLEMENTATION; IMMUNIZATION; INCLUSIONS	Recent research implicates soluble aggregated forms of alpha-synuclein as neurotoxic species with a central role in the pathogenesis of Parkinson's disease and related disorders. The pathway by which alpha-synuclein aggregates is believed to follow a step-wise pattern, in which dimers and smaller oligomers are initially formed. Here, we used H4 neuroglioma cells expressing alpha-synuclein fused to hemi: GFP constructs to study the effects of alpha-synuclein monoclonal antibodies on the early stages of aggregation, as quantified by Bimolecular Fluorescence Complementation assay. Widefield and confocal microscopy revealed that cells treated for 48 h with monoclonal antibodies internalized antibodies to various degrees. C-terminal and oligomer-selective alpha-synuclein antibodies reduced the extent of alpha-synuclein dimerization/oligomerization, as indicated by decreased GFP fluorescence signal. Furthermore, ELISA measurements on lysates and conditioned media from antibody treated cells displayed lower alpha-synuclein levels compared to untreated cells, suggesting increased protein turnover. Taken together, our results propose that extracellular administration of monoclonal antibodies can modify or inhibit early steps in the aggregation process of alpha-synuclein, thus providing further support for passive immunization against diseases with alpha-synuclein pathology.	[Nasstrom, Thomas; Sahlin, Charlotte; Lannfelt, Lars; Bergstrom, Joakim; Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth Geriatr, Rudbeck Lab, Uppsala, Sweden; [Goncalves, Susana; Outeiro, Tiago F.] Inst Med Mol, Cell & Mol Neurosci Unit, Lisbon, Portugal; [Outeiro, Tiago F.] Univ Lisbon, Inst Fisiol, Fac Med, P-1699 Lisbon, Portugal; [Nordstrom, Eva; Sundquist, Valentina Screpanti] BioArctic Neurosci AB, Stockholm, Sweden; [Outeiro, Tiago F.] Univ Med Gottingen, Dept NeuroDegenerat & Restaurat Res, Gottingen, Germany	Uppsala University; Universidade de Lisboa; Universidade de Lisboa; University of Gottingen	Nasstrom, T (corresponding author), Uppsala Univ, Dept Publ Hlth Geriatr, Rudbeck Lab, Uppsala, Sweden.	martin.ingelsson@pubcare.uu.se	Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Goncalves, Susana/B-4663-2015	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; Goncalves, Susana/0000-0002-8025-2624	Swedish Research Council [2006-2822, 2006-6326, 2006-3464]; Uppsala Berzelii Technology Center for Neurodiagnostics; Swedish Brain Foundation; Lundbeck foundation; Swedish Alzheimer Foundation; Swedish Parkinson Foundation; Swedish Society of Medicine; AXA; Fundacao para a Ciencia e Tecnologia (FCT); European Molecular Biology Organization EMBO Installation; Marie Curie International Reintegration	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Center for Neurodiagnostics; Swedish Brain Foundation; Lundbeck foundation(Lundbeckfonden); Swedish Alzheimer Foundation; Swedish Parkinson Foundation; Swedish Society of Medicine; AXA; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization EMBO Installation; Marie Curie International Reintegration(European Commission)	Swedish Research Council (2006-2822(LL); 2006-6326 and 2006-3464(MI)), Uppsala Berzelii Technology Center for Neurodiagnostics, Swedish Brain Foundation, Lundbeck foundation, Swedish Alzheimer Foundation, Swedish Parkinson Foundation, Swedish Society of Medicine, private donations from Hans and Helen Danielsson, private donations from Lennart and Christina Kalen, Stohne's Foundation, Soderstrom-Konigska Foundation, Swedish Dementia Foundation, Bjorklund's Foundation for ALS research, Magn Bergwall Foundation, Thore Nilsson Foundation, Old Servants' Foundation, Ahlen Foundation, Loo and Hans Osterman's Foundation, Jeansson's Foundation, Larsson-Rost's Foundation, Golje's Foundation. SG is supported by a PhD fellowship from AXA Research Fund. TFO is supported by Fundacao para a Ciencia e Tecnologia (FCT), a European Molecular Biology Organization EMBO Installation Grant, and a Marie Curie International Reintegration Grant (Neurofold). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VSS and EN are employed by BioArctic Neuroscience AB, who, in collaboration with the group at Uppsala university were intellectually involved in the execution of the experiments.	Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chadchankar H, 2011, BRAIN RES, V1382, P37, DOI 10.1016/j.brainres.2011.01.064; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Gai WP, 2003, EXP NEUROL, V181, P68, DOI 10.1016/S0014-4886(03)00004-9; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; HAGAN PL, 1986, J NUCL MED, V27, P422; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lord A, 2009, NEUROBIOL DIS, V36, P425, DOI 10.1016/j.nbd.2009.08.007; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	32	56	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27230	10.1371/journal.pone.0027230	http://dx.doi.org/10.1371/journal.pone.0027230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073131	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000059
J	Cheung, SSF; Leung, JWC; Lam, AKM; Lam, KSL; Chung, SSM; Lo, ACY; Chung, SK				Cheung, Simon S. F.; Leung, Justin W. C.; Lam, Amy K. M.; Lam, Karen S. L.; Chung, Stephen S. M.; Lo, Amy C. Y.; Chung, Sookja K.			Selective Over-Expression of Endothelin-1 in Endothelial Cells Exacerbates Inner Retinal Edema and Neuronal Death in Ischemic Retina	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MULLER GLIAL-CELLS; ELEVATED GLUTAMATE; VITREOUS BODY; MODEL; PROTECTS; REPERFUSION; MECHANISMS; PATHOLOGY; DAMAGE	The level of endothelin-1 (ET-1), a potent vasoconstrictor, was associated with retinopathy under ischemia. The effects of endothelial endothelin-1 (ET-1) over-expression in a transgenic mouse model using Tie-1 promoter (TET-1 mice) on pathophysiological changes of retinal ischemia were investigated by intraluminal insertion of a microfilament up to middle cerebral artery (MCA) to transiently block the ophthalmic artery. Two-hour occlusion and twenty-two-hour reperfusion were performed in homozygous (Hm) TET-1 mice and their non-transgenic (NTg) littermates. Presence of pyknotic nuclei in ganglion cell layer (GCL) was investigated in paraffin sections of ipsilateral (ischemic) and contralateral (non-ischemic) retinae, followed by measurement of the thickness of inner retinal layer. Moreover, immunocytochemistry of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS) and aquaporin-4 (AQP4) peptides on retinal sections were performed to study glial cell reactivity, glutamate metabolism and water accumulation, respectively after retinal ischemia. Similar morphology was observed in the contralateral retinae of NTg and Hm TET-1 mice, whereas ipsilateral retina of NTg mice showed slight structural and cellular changes compared with the corresponding contralateral retina. Ipsilateral retinae of Hm TET-1 mice showed more significant changes when compared with ipsilateral retina of NTg mice, including more prominent cell death in GCL characterized by the presence of pyknotic nuclei, elevated GS immunoreactivity in Muller cell bodies and processes, increased AQP-4 immunoreactivity in Muller cell processes, and increased inner retinal thickness. Thus, over-expression of endothelial ET-1 in TET-1 mice may contribute to increased glutamate-induced neurotoxicity on neuronal cells and water accumulation in inner retina leading to edema.	[Cheung, Simon S. F.; Leung, Justin W. C.; Lam, Amy K. M.; Lo, Amy C. Y.; Chung, Sookja K.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chung, Stephen S. M.] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Karen S. L.; Chung, Stephen S. M.; Lo, Amy C. Y.; Chung, Sookja K.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, SSF (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk; skchung@hkucc.hku.hk	Lo, Amy C. Y./C-1195-2009	Lo, Amy C. Y./0000-0003-4239-6851; Leung, Justin Wai Chung/0000-0003-4601-390X	Research Grants Council of Hong Kong (RGC) HKU [7220/02M, 7313/04M]	Research Grants Council of Hong Kong (RGC) HKU	This study was supported by the Research Grants Council of Hong Kong (RGC) HKU 7220/02M and 7313/04M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikian V, 2001, CEREBROVASC DIS, V12, P108, DOI 10.1159/000047689; Block F, 1997, NEUROSCI LETT, V232, P45, DOI 10.1016/S0304-3940(97)00575-2; Bringmann A, 1999, INVEST OPHTH VIS SCI, V40, P3316; Bringmann A, 2005, ACTA OPHTHALMOL SCAN, V83, P528, DOI 10.1111/j.1600-0420.2005.00565.x; Chaudhary G, 2003, FUND CLIN PHARMACOL, V17, P703, DOI 10.1046/j.0767-3981.2003.00209.x; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Cheung AKH, 2007, EXP EYE RES, V85, P608, DOI 10.1016/j.exer.2007.07.013; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Ho MCY, 2001, FASEB J, V15, P618, DOI 10.1096/fj.99-1022com; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Inoue-Matsuhisa E, 2003, EXP EYE RES, V76, P445, DOI 10.1016/S0014-4835(02)00333-0; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kim TW, 2000, ARCH OPHTHALMOL-CHIC, V118, P533; Koon HW, 2002, ROLE ENDOTHELIN 1 NI; Koon MHW, 2001, FASEB J, V15, pA482; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Lau J, 2006, EXP EYE RES, V82, P132, DOI 10.1016/j.exer.2005.06.002; Leung JWC, 2004, J CARDIOVASC PHARM, V44, pS293, DOI 10.1097/01.fjc.0000166277.70538.b0; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Matthews CC, 2000, J NEUROCHEM, V75, P1045, DOI 10.1046/j.1471-4159.2000.0751045.x; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Shihara M, 1998, AM J PHYSIOL-REG I, V275, pR658, DOI 10.1152/ajpregu.1998.275.2.R658; TAKEI K, 1993, GRAEF ARCH CLIN EXP, V231, P476, DOI 10.1007/BF02044235; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019; YANOFF M, 1984, SURV OPHTHALMOL, V28, P505, DOI 10.1016/0039-6257(84)90233-9; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235	33	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26184	10.1371/journal.pone.0026184	http://dx.doi.org/10.1371/journal.pone.0026184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053184	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800010
J	Massa, AN; Childs, KL; Lin, HN; Bryan, GJ; Giuliano, G; Buell, CR				Massa, Alicia N.; Childs, Kevin L.; Lin, Haining; Bryan, Glenn J.; Giuliano, Giovanni; Buell, C. Robin			The Transcriptome of the Reference Potato Genome Solanum tuberosum Group Phureja Clone DM1-3 516R44	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; RNA-SEQ; NETWORK ANALYSIS; ABIOTIC STRESS; IDENTIFICATION; GENERATION; LIBRARIES; DATABASE; GENES	Advances in molecular breeding in potato have been limited by its complex biological system, which includes vegetative propagation, autotetraploidy, and extreme heterozygosity. The availability of the potato genome and accompanying gene complement with corresponding gene structure, location, and functional annotation are powerful resources for understanding this complex plant and advancing molecular breeding efforts. Here, we report a reference for the potato transcriptome using 32 tissues and growth conditions from the doubled monoploid Solanum tuberosum Group Phureja clone DM1-3 516R44 for which a genome sequence is available. Analysis of greater than 550 million RNA-Seq reads permitted the detection and quantification of expression levels of over 22,000 genes. Hierarchical clustering and principal component analyses captured the biological variability that accounts for gene expression differences among tissues suggesting tissue-specific gene expression, and genes with tissue or condition restricted expression. Using gene coexpression network analysis, we identified 18 gene modules that represent tissue-specific transcriptional networks of major potato organs and developmental stages. This information provides a powerful resource for potato research as well as studies on other members of the Solanaceae family.	[Massa, Alicia N.; Childs, Kevin L.; Lin, Haining; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Bryan, Glenn J.] James Hutton Inst, Dundee, Scotland; [Giuliano, Giovanni] Italian Natl Agcy New Technol Energy & Sustainabl, Casaccia Res Ctr, Rome, Italy	Michigan State University; James Hutton Institute; Italian National Agency New Technical Energy & Sustainable Economics Development	Massa, AN (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Giuliano, Giovanni/A-2701-2012; Childs, Kevin/C-9513-2014	Giuliano, Giovanni/0000-0002-2486-0510; Bryan, Glenn/0000-0002-7752-5740; Buell, C Robin/0000-0002-6727-4677; Childs, Kevin/0000-0002-3680-062X	United States National Science Foundation [DBI-0604907/DBI-0834044]; Italian Ministries of Research; Agriculture (ALISAL project); EC	United States National Science Foundation(National Science Foundation (NSF)); Italian Ministries of Research; Agriculture (ALISAL project); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the United States National Science Foundation to Dr. Buell (DBI-0604907/DBI-0834044) and by grants from the Italian Ministries of Research (Special fund for basic research) and of Agriculture (ALISAL project) and the EC (METAPRO project) to Dr. Giuliano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachem C, 2000, POTATO RES, V43, P297, DOI 10.1007/BF02360536; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Crookshanks M, 2001, FEBS LETT, V506, P123, DOI 10.1016/S0014-5793(01)02888-5; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; Ginzberg I, 2009, J EXP BOT, V60, P4411, DOI 10.1093/jxb/erp281; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li XQ, 2007, ACTA HORTIC, V745, P6; MENDIBURU AO, 1977, THEOR APPL GENET, V49, P53, DOI 10.1007/BF00275164; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Papademetriou MK, 2008, RAP PUBLICATION; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Rensink W, 2005, GENOME, V48, P598, DOI 10.1139/G05-034; Rensink Willem Albert, 2005, Functional & Integrative Genomics, V5, P201, DOI 10.1007/s10142-005-0141-6; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Ronning CM, 2003, PLANT PHYSIOL, V131, P419, DOI 10.1104/pp.013581; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	27	87	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26801	10.1371/journal.pone.0026801	http://dx.doi.org/10.1371/journal.pone.0026801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046362	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800042
J	Short, KH; Petren, K				Short, Kristen Harfmann; Petren, Kenneth			Fine-Scale Genetic Structure Arises during Range Expansion of an Invasive Gecko	PLOS ONE			English	Article							POPULATION-STRUCTURE; DISPERSAL STRATEGIES; DIVERSITY; FREQUENCY; COLONIZATION; COMPETITION; BOTTLENECK; MECHANISMS; EVOLUTION; INFERENCE	Processes of range expansion are increasingly important in light of current concerns about invasive species and range shifts due to climate change. Theoretical studies suggest that genetic structuring may occur during range expansion. Ephemeral genetic structure can have important evolutionary implications, such as propagating genetic changes along the wave front of expansion, yet few studies have shown evidence of such structure. We tested the hypothesis that genetic structure arises during range expansion in Hemidactylus mabouia, a nocturnal African gecko recently introduced to Florida, USA. Twelve highly variable microsatellite loci were used to screen 418 individuals collected from 43 locations from four sampling sites across Florida, representing a gradient from earlier (similar to 1990s) to very recent colonization. We found earlier colonized locations had little detectable genetic structure and higher allelic richness than more recently colonized locations. Genetic structuring was pronounced among locations at spatial scales of tens to hundreds of meters near the leading edge of range expansion. Despite the rapid pace of range expansion in this introduced gecko, dispersal is limited among many suitable habitat patches. Fine-scale genetic structure is likely the result of founder effects during colonization of suitable habitat patches. It may be obscured over time and by scale-dependent modes of dispersal. Further studies are needed to determine if such genetic structure affects adaptation and trait evolution in range expansions and range shifts.	[Short, Kristen Harfmann; Petren, Kenneth] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Short, KH (corresponding author), Manchester Coll, N Manchester, IN USA.	khshort@manchester.edu		Petren, Kenneth/0000-0002-7936-6042	University Research Council; University of Cincinnati	University Research Council; University of Cincinnati	Funding was provided by the University Research Council and by the Weiman Wendel Benedict Fund at the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Baker HG, GENETICS COLONIZING; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Burton OJ, 2008, GENETICS, V179, P941, DOI 10.1534/genetics.108.087890; Butterfield Brian P., 1993, Herpetological Review, V24, P111; CASE TJ, 1994, ECOLOGY, V75, P464, DOI 10.2307/1939550; Castric V, 2003, GENETICS, V163, P983; Ciofi C, 1999, P ROY SOC B-BIOL SCI, V266, P2269, DOI 10.1098/rspb.1999.0918; Darling JA, 2004, MOL ECOL, V13, P2969, DOI 10.1111/j.1365-294X.2004.02313.x; Darling JA, 2009, MOL ECOL, V18, P4827, DOI 10.1111/j.1365-294X.2009.04405.x; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; Dytham C, 2009, P ROY SOC B-BIOL SCI, V276, P1407, DOI 10.1098/rspb.2008.1535; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Fleischer RC, 2008, MOL ECOL, V17, P464, DOI 10.1111/j.1365-294X.2007.03532.x; Gibson SY, 2009, CONSERVATION BIOL; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kluge AG, 1969, EVOLUTION GEOGRAPHIC; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Lewis PO, 2001, GENETIC DATA ANAL GD; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; McInerny GJ, 2009, P ROY SOC B-BIOL SCI, V276, P1527, DOI 10.1098/rspb.2008.1567; Meshaka WE, 2000, J HERPETOL, V34, P163, DOI 10.2307/1565258; Parisod C, 2008, HEREDITY, V101, P536, DOI 10.1038/hdy.2008.95; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; PETREN K, 1993, SCIENCE, V259, P354, DOI 10.1126/science.259.5093.354; Petren K, 1998, P NATL ACAD SCI USA, V95, P11739, DOI 10.1073/pnas.95.20.11739; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Short KH, 2011, ECOLOGY EVO IN PRESS; Short KH, 2011, BIOL INVASI IN PRESS; Short KH, 2008, MOL ECOL RESOUR, V8, P1319, DOI 10.1111/j.1755-0998.2008.02270.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson AB, 1999, CAN J FISH AQUAT SCI, V56, P2248, DOI 10.1139/cjfas-56-12-2248; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zenger KR, 2003, MOL ECOL, V12, P789, DOI 10.1046/j.1365-294X.2003.01759.x	53	27	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26258	10.1371/journal.pone.0026258	http://dx.doi.org/10.1371/journal.pone.0026258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053186	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800012
J	Audoly, G; Vincentelli, R; Edouard, S; Georgiades, K; Mediannikov, O; Gimenez, G; Socolovschi, C; Mege, JL; Cambillau, C; Raoult, D				Audoly, Gilles; Vincentelli, Renaud; Edouard, Sophie; Georgiades, Kalliopi; Mediannikov, Oleg; Gimenez, Gregory; Socolovschi, Cristina; Mege, Jean-Louis; Cambillau, Christian; Raoult, Didier			Effect of Rickettsial Toxin VapC on Its Eukaryotic Host	PLOS ONE			English	Article							ANTITOXIN LOCI; SPOTTED-FEVER; CELLS; IDENTIFICATION; EXPRESSION; MORTALITY; EVOLUTION; CONORII; SYSTEM; FELIS	Rickettsia are intracellular bacteria typically associated with arthropods that can be transmitted to humans by infected vectors. Rickettsia spp. can cause mild to severe human disease with a possible protection effect of corticosteroids when antibiotic treatments are initiated. We identified laterally transferred toxin-antitoxin (TA) genetic elements, including vapB/C, in several Rickettsia genomes and showed that they are functional in bacteria and eukaryotic cells. We also generated a plaque assay to monitor the formation of lytic plaques over time and demonstrated that chloramphenicol accelerates host cell lysis of vapB/C-containing Rickettsia. Whole-genome expression, TUNEL and FISH assays on the infected cells following exposure to the antibiotic revealed early apoptosis of host cells, which was linked to over-transcription of bacterial vapB/C operons and subsequent cytoplasmic VapC toxin release. VapC that is expressed in Escherichia coli and Saccharomyces cerevisiae or microinjected into mammalian cells is toxic through RNase activity and is prevented by dexamethasone. This study provides the first biological evidence that toxin-antitoxin elements act as pathogenic factors in bacterial host cells, confirming comparative genomic evidence of their role in bacterial pathogenicity. Our results suggest that early mortality following antibiotic treatment of some bacterial infections can be prevented by administration of dexamethasone.	[Audoly, Gilles; Edouard, Sophie; Georgiades, Kalliopi; Mediannikov, Oleg; Gimenez, Gregory; Socolovschi, Cristina; Mege, Jean-Louis; Raoult, Didier] CNRS, Unite Rickettsies URMITE, IRD 198, UMR 6236, Marseille, France; [Vincentelli, Renaud; Cambillau, Christian] CNRS, AFMB, UMR 6098, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Audoly, G (corresponding author), CNRS, Unite Rickettsies URMITE, IRD 198, UMR 6236, Marseille, France.	didier.raoult@gmail.com	Mediannikov, Oleg/H-4018-2015; MEGE, JEAN-LOUIS/O-6063-2016; RAOULT, Didier/A-8434-2008	Mediannikov, Oleg/0000-0001-6039-2008; RAOULT, Didier/0000-0002-0633-5974; Audoly, Gilles/0000-0001-8242-471X				Botelho-Nevers E, 2008, INT J ANTIMICROB AG, V32, P344, DOI 10.1016/j.ijantimicag.2008.04.027; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eremeeva ME, 2005, ANN NY ACAD SCI, V1063, P47, DOI 10.1196/annals.1355.006; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goulard C, 2010, J BACTERIOL, V192, P3669, DOI 10.1128/JB.00336-10; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kristoffersen P, 2000, APPL ENVIRON MICROB, V66, P5524, DOI 10.1128/AEM.66.12.5524-5526.2000; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Merhej V, 2009, CLIN MICROBIOL INFEC, V15, P336, DOI 10.1111/j.1469-0691.2008.02265.x; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Nieto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011289; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Paddock CD, 1999, J INFECT DIS, V179, P1469, DOI 10.1086/314776; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Picardeau M, 2003, FEMS MICROBIOL LETT, V229, P277, DOI 10.1016/S0378-1097(03)00848-6; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; RAOULT D, 1989, ANTIMICROB AGENTS CH, V33, P621, DOI 10.1128/AAC.33.5.621; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Renvoise A, 2011, TRENDS MOL MED, V17, P573, DOI 10.1016/j.molmed.2011.05.009; Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278; Rovery C, 2008, INFECT DIS CLIN N AM, V22, P515, DOI 10.1016/j.idc.2008.03.003; Saisongkorh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012666; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; WOODWARD TE, 1978, MED TIMES, V106, P90; WORKMAN JB, 1952, NEW ENGL J MED, V246, P962, DOI 10.1056/NEJM195206192462503; Yamamoto TAM, 2002, FEBS LETT, V519, P191, DOI 10.1016/S0014-5793(02)02764-3; ZARDA B, 1991, J GEN MICROBIOL, V137, P2823, DOI 10.1099/00221287-137-12-2823	37	41	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26528	10.1371/journal.pone.0026528	http://dx.doi.org/10.1371/journal.pone.0026528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046301	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400024
J	Lichtnekert, J; Kulkarni, OP; Mulay, SR; Rupanagudi, KV; Ryu, M; Allam, R; Vielhauer, V; Muruve, D; Lindenmeyer, MT; Cohen, CD; Anders, HJ				Lichtnekert, Julia; Kulkarni, Onkar P.; Mulay, Shrikant R.; Rupanagudi, Khader Valli; Ryu, Mi; Allam, Ramanjaneyulu; Vielhauer, Volker; Muruve, Dan; Lindenmeyer, Maja T.; Cohen, Clemens D.; Anders, Hans-Joachim			Anti-GBM Glomerulonephritis Involves IL-1 but Is Independent of NLRP3/ASC Inflammasome-Mediated Activation of Caspase-1	PLOS ONE			English	Article							INTRINSIC RENAL-CELLS; TUMOR-NECROSIS-FACTOR; CRESCENTIC GLOMERULONEPHRITIS; NALP3 INFLAMMASOME; GLOMERULAR INJURY; MESANGIAL CELLS; TOLL-LIKE; MICE; EXPRESSION; IL-1-BETA	IL-1 beta and IL-18 are proinflammatory cytokines that contribute to renal immune complex disease, but whether IL-1 beta and IL-18 are mediators of intrinsic glomerular inflammation is unknown. In contrast to other cytokines the secretion of IL-1 beta and IL-18 requires a second stimulus that activates the inflammasome-ASC-caspase-1 pathway to cleave pro-IL-1 beta and -IL-18 into their mature and secretable forms. As the NLRP3 inflammasome and caspase-1 were shown to contribute to postischemic and postobstructive tubulointerstitial inflammation, we hypothesized a similar role for NLRP3, ASC, and caspase-1 in glomerular immunopathology. This concept was supported by the finding that lack of IL-1R1 reduced antiserum-induced focal segmental necrosis, crescent formation, and tubular atrophy when compared to wildtype mice. Lack of IL-18 reduced tubular atrophy only. However, NLRP3-, ASC- or caspase-1-deficiency had no significant effect on renal histopathology or proteinuria of serum nephritis. In vitro studies with mouse glomeruli or mesangial cells, glomerular endothelial cells, and podocytes did not reveal any pro-IL-1 beta induction upon LPS stimulation and no caspase-1 activation after an additional exposure to the NLRP3 agonist ATP. Only renal dendritic cells, which reside mainly in the tubulointerstitium, expressed pro-IL-1 beta and were able to activate the NLRP3-caspase-1 axis and secrete mature IL-1 beta. Together, the NLRP3-ASC-caspase-1 axis does not contribute to intrinsic glomerular inflammation via glomerular parenchymal cells as these cannot produce IL-1 beta during sterile inflammation.	[Lichtnekert, Julia; Kulkarni, Onkar P.; Mulay, Shrikant R.; Rupanagudi, Khader Valli; Ryu, Mi; Allam, Ramanjaneyulu; Vielhauer, Volker; Anders, Hans-Joachim] Univ Munich, Nephrol Ctr, Med Policlin, Munich, Germany; [Muruve, Dan] Univ Calgary, Dept Med, Div Nephrol & Hypertens, Calgary, AB, Canada; [Muruve, Dan] Univ Calgary, Immunol Res Grp, Inst Infect Immun & Inflammat, Calgary, AB, Canada; [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich, Zurich, Switzerland; [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich Hosp, Inst Physiol, CH-8091 Zurich, Switzerland; [Lindenmeyer, Maja T.; Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland	University of Munich; University of Calgary; University of Calgary; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Lichtnekert, J (corresponding author), Univ Munich, Nephrol Ctr, Med Policlin, Munich, Germany.	hjanders@med.uni-muenchen.de	Allam, Ramanjaneyulu/N-4053-2016; Mulay, Shrikant R./AAZ-2641-2021; Anders, Hans-Joachim/ABD-6247-2021	Allam, Ramanjaneyulu/0000-0002-2789-3596; Mulay, Shrikant R./0000-0003-4261-445X; Anders, Hans-Joachim/0000-0003-2434-2956; Lindenmeyer, Maja/0000-0003-4162-9107	Deutsche Forschungsgemeinschaft [GRK 1202]; Deutsche Nierenstiftung; Else Kroner-Fresenius Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Nierenstiftung; Else Kroner-Fresenius Stiftung	The study was funded by the Deutsche Forschungsgemeinschaft (GRK 1202, H.J.A.), the Deutsche Nierenstiftung (J.L.), and the Else Kroner-Fresenius Stiftung (C.D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2009, J AM SOC NEPHROL, V20, P1986, DOI 10.1681/ASN.2008101067; Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; ANDERS HJ, 2011, J AM SOC NEPHROL, V22; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Brown HJ, 2006, J IMMUNOL, V177, P1925, DOI 10.4049/jimmunol.177.3.1925; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hagele H, 2009, AM J PATHOL, V175, P1896, DOI 10.2353/ajpath.2009.090182; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; KARKAR AM, 1992, CLIN EXP IMMUNOL, V90, P312; Kinoshita K, 2004, J IMMUNOL, V173, P5312, DOI 10.4049/jimmunol.173.8.5312; Kitching AR, 2005, J AM SOC NEPHROL, V16, P2023, DOI 10.1681/ASN.2004121075; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Lichtnekert J, 2009, AM J PHYSIOL-RENAL, V296, pF867, DOI 10.1152/ajprenal.90213.2008; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Ninichuk V, 2007, AM J PATHOL, V170, P1267, DOI 10.2353/ajpath.2007.060937; Reich HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013451; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Timoshanko JR, 2004, AM J PATHOL, V164, P1967, DOI 10.1016/S0002-9440(10)63757-1; Timoshanko JR, 2004, J AM SOC NEPHROL, V15, P910, DOI 10.1097/01.ASN.0000115704.86897.F4; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	43	67	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26778	10.1371/journal.pone.0026778	http://dx.doi.org/10.1371/journal.pone.0026778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046355	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000296521400033
J	Mysara, M; Garibaldi, JM; ElHefnawi, M				Mysara, Mohamed; Garibaldi, Jonathan M.; ElHefnawi, Mahmoud			MysiRNA-Designer: A Workflow for Efficient siRNA Design	PLOS ONE			English	Article							TARGET SITE ACCESSIBILITY; RNA INTERFERENCE; MAMMALIAN-CELLS; HYBRIDIZATION THERMODYNAMICS; SECONDARY STRUCTURE; SELECTION; SPECIFICITY; SEQUENCES; IDENTIFICATION; LIBRARY	The design of small interfering RNA (siRNA) is a multi factorial problem that has gained the attention of many researchers in the area of therapeutic and functional genomics. MysiRNA score was previously introduced that improves the correlation of siRNA activity prediction considering state of the art algorithms. In this paper, a new program, MysiRNA-Designer, is described which integrates several factors in an automated work-flow considering mRNA transcripts variations, siRNA and mRNA target accessibility, and both near-perfect and partial off-target matches. It also features the MysiRNA score, a highly ranked correlated siRNA efficacy prediction score for ranking the designed siRNAs, in addition to top scoring models Biopredsi, DISR, Thermocomposition21 and i-Score, and integrates them in a unique siRNA score-filtration technique. This multi-score filtration layer filters siRNA that passes the 90% thresholds calculated from experimental dataset features. MysiRNA-Designer takes an accession, finds conserved regions among its transcript space, finds accessible regions within the mRNA, designs all possible siRNAs for these regions, filters them based on multi-scores thresholds, and then performs SNP and off-target filtration. These strict selection criteria were tested against human genes in which at least one active siRNA was designed from 95.7% of total genes. In addition, when tested against an experimental dataset, MysiRNA-Designer was found capable of rejecting 98% of the false positive siRNAs, showing superiority over three state of the art siRNA design programs. MysiRNA is a freely accessible (Microsoft Windows based) desktop application that can be used to design siRNA with a high accuracy and specificity. We believe that MysiRNA-Designer has the potential to play an important role in this area.	[Mysara, Mohamed; ElHefnawi, Mahmoud] Natl Res Ctr, Informat & Syst Dept, Cairo, Egypt; [Mysara, Mohamed; ElHefnawi, Mahmoud] Natl Res Ctr, Biomed Informat & Chemoinformat Grp, Div Engn Res, Cairo, Egypt; [Mysara, Mohamed; ElHefnawi, Mahmoud] Natl Res Ctr, Ctr Excellence Adv Sci, Cairo, Egypt; [Mysara, Mohamed; ElHefnawi, Mahmoud] Inst Informat Technol, Div Biomed Informat & Bioinformat, 6th Of October City, Egypt; [Garibaldi, Jonathan M.; ElHefnawi, Mahmoud] E JUST, Comp Sci & Engn Dept, Alexandria, Egypt; [Mysara, Mohamed] Univ Nottingham, Intelligent Modeling & Anal Res Grp, Sch Comp Sci, Nottingham NG7 2RD, England	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Egypt-Japan University of Science & Technology; University of Nottingham	Mysara, M (corresponding author), Natl Res Ctr, Informat & Syst Dept, Cairo, Egypt.	Mohamed.Mysara@nottingham.ac.uk; jmg@Cs.nott.ac.uk; mahef@aucegypt.edu	Mysara, Mohamed/AAH-4242-2019; ElHefnawi, Mahmoud/S-7426-2016	Mysara, Mohamed/0000-0001-5746-4330; Garibaldi, Jonathan/0000-0002-9690-7074; ElHefnawi, Mahmoud/0000-0003-3896-6911	Information Technology Institute (Egypt); National Research Center (Egypt); University of Nottingham (UK)	Information Technology Institute (Egypt); National Research Center (Egypt)(National Research Centre (NRC)); University of Nottingham (UK)	We thank Kinji Ohno, Andreu Alibes, Hakim Tafer and Walaa Adly for helpful discussions comments and technical assistance. We appreciate the kind help and support of Information Technology Institute (Egypt), National Research Center (Egypt) and the University of Nottingham (UK).	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; ELHEFNAWI M, 2011, BIOINFORMAT IN PRESS, V2; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gredell JA, 2008, BIOTECHNOL BIOENG, V100, P744, DOI 10.1002/bit.21798; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 2010, METHODS MOL BIOL, V623, P137, DOI 10.1007/978-1-60761-588-0_9; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; MYSARA M, 2011, J BIOMEDICAL INFORM, P1; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Patzel V, 2007, DRUG DISCOV TODAY, V12, P139, DOI 10.1016/j.drudis.2006.11.015; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takasaki S, 2004, CELL CYCLE, V3, P790; TUSCHL T, 2006, RNA INTERFERENCE SIN; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; ULRIKE M, IMMUNOLOGY; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520	40	24	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e25642	10.1371/journal.pone.0025642	http://dx.doi.org/10.1371/journal.pone.0025642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046244	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600005
J	Wang, XY; Yang, X; Yang, CT; Wu, ZH; Xu, HL; Shen, YQ				Wang, Xiangyu; Yang, Xue; Yang, Chunting; Wu, Zhenhua; Xu, Honglin; Shen, Yuequan			Crystal Structure of Outer Membrane Protein NMB0315 from Neisseria meningitidis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; GLYCYLGLYCINE ENDOPEPTIDASE; STAPHYLOCOCCUS-AUREUS; MENINGOCOCCAL DISEASE; BACILLUS-SUBTILIS; VIRULENCE FACTOR; LASA PROTEASE; LYTM; PURIFICATION; LYSOSTAPHIN	NMB0315 is an outer membrane protein of Neisseria meningitidis serogroup B (NMB) and a potential candidate for a broad-spectrum vaccine against meningococcal disease. The crystal structure of NMB0315 was solved by single-wavelength anomalous dispersion (SAD) at a resolution of 2.4 angstrom and revealed to be a lysostaphin-type peptidase of the M23 metallopeptidase family. The overall structure consists of three well-separated domains and has no similarity to any previously published structure. However, only the topology of the carboxyl-terminal domain is highly conserved among members of this family, and this domain is a zinc-dependent catalytic unit. The amino-terminal domain of the structure blocks the substrate binding pocket in the carboxyl-terminal domain, indicating that the wild-type full-length protein is in an inactive conformational state. Our studies improve the understanding of the catalytic mechanism of M23 metallopeptidases.	[Wang, Xiangyu; Yang, Xue; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Xiangyu; Yang, Xue; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yang, Chunting; Wu, Zhenhua; Xu, Honglin] Natl Vaccine & Serum Inst, Virol Lab, Beijing, Peoples R China	Nankai University; Nankai University	Wang, XY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	xhlyct@yahoo.com; yshen@nankai.edu.cn	Shen, Yuequan/C-8950-2013	Shen, Yuequan/0000-0002-3775-0900	973 Program [2007CB914301, 2009CB825504]; TBR program [08QTPTJC28200, 08SYSYTC00200]; NIDP program [2008ZX10004-015]	973 Program(National Basic Research Program of China); TBR program; NIDP program	This study was supported by the 973 Program (grants 2007CB914301, 2009CB825504), TBR program (08QTPTJC28200, 08SYSYTC00200) to Y. Shen, and NIDP program (2008ZX10004-015) to H. Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AJ, 1998, HDB PROTEOLYTIC ENZY, Vxxix, P1666; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Filippis I, 2009, J MED MICROBIOL, V58, P1127, DOI 10.1099/jmm.0.011189-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Frosch M, 2006, HDB MENINGOCOCCAL DI, P17; Gustin JK, 1996, J BACTERIOL, V178, P6608, DOI 10.1128/jb.178.22.6608-6617.1996; HART CA, 1993, J MED MICROBIOL, V39, P3, DOI 10.1099/00222615-39-1-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Ragurnani S, 2008, PROTEINS, V72, P1096, DOI 10.1002/prot.22095; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schielke S, 2010, MED MICROBIOL IMMUN, V199, P185, DOI 10.1007/s00430-010-0150-5; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26845	10.1371/journal.pone.0026845	http://dx.doi.org/10.1371/journal.pone.0026845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046377	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600064
J	Kumar, S; Gupta, S				Kumar, Sandeep; Gupta, Sudhiranjan			Thymosin Beta 4 Prevents Oxidative Stress by Targeting Antioxidant and Anti-Apoptotic Genes in Cardiac Fibroblasts	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; EPITHELIAL-CELLS; MYOCARDIAL-INFARCTION; MESSENGER-RNA; TGF-BETA; IN-VITRO; MIGRATION; CORNEAL; HEART; DEATH	Rationale: Thymosin beta-4 (T beta 4) is a ubiquitous protein with diverse functions relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory responses. The effecter molecules targeted by T beta 4 for cardiac protection remains unknown. The purpose of this study is to determine the molecules targeted by T beta 4 that mediate cardio-protection under oxidative stress. Methods: Rat neonatal fibroblasts cells were exposed to hydrogen peroxide (H2O2) in presence and absence of T beta 4 and expression of antioxidant, apoptotic and pro-fibrotic genes was evaluated by quantitative real-time PCR and western blotting. Reactive oxygen species (ROS) levels were estimated by DCF-DA using fluorescent microscopy and fluorimetry. Selected antioxidant and antiapoptotic genes were silenced by siRNA transfections in cardiac fibroblasts and the effect of T beta 4 on H2O2-induced profibrotic events was evaluated. Results: Pre-treatment with T beta 4 resulted in reduction of the intracellular ROS levels induced by H2O2 in the cardiac fibroblasts. This was associated with an increased expression of antioxidant enzymes Cu/Zn superoxide dismutase (SOD) and catalase and reduction of Bax/Bcl(2) ratio. T beta 4 treatment reduced the expression of pro-fibrotic genes [connective tissue growth factor (CTGF), collagen type-1 (Col-I) and collagen type-3 (Col-III)] in the cardiac fibroblasts. Silencing of Cu/Zn-SOD and catalase gene triggered apoptotic cell death in the cardiac fibroblasts, which was prevented by treatment with T beta 4. Conclusion: This is the first report that exhibits the targeted molecules modulated by T beta 4 under oxidative stress utilizing the cardiac fibroblasts. T beta 4 treatment prevented the profibrotic gene expression in the in vitro settings. Our findings indicate that T beta 4 selectively targets and upregulates catalase, Cu/Zn-SOD and Bcl(2), thereby, preventing H2O2-induced profibrotic changes in the myocardium. Further studies are warranted to elucidate the signaling pathways involved in the cardio-protection afforded by T beta 4.	[Kumar, Sandeep; Gupta, Sudhiranjan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kumar, S (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA.	sgupta@medicine.tamhsc.edu	Kumar, Sandeep/AAX-4612-2021	Kumar, Sandeep/0000-0003-3440-3628	Texas A&M start-up funds; American Heart Association	Texas A&M start-up funds; American Heart Association(American Heart Association)	This work is partly funded by Texas A&M start-up funds and a Scientist Development Grant from The American Heart Association to S. Gupta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Bubb MR, 2003, VITAM HORM, V66, P297, DOI 10.1016/S0083-6729(03)01008-2; CHEN Y, 1994, FREE RADICAL BIO MED, V17, P529, DOI 10.1016/0891-5849(94)90092-2; COHEN J, 1974, P S HELD OCT 1972 RO; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Crockford D, 2010, ANN NY ACAD SCI, V1194, P179, DOI 10.1111/j.1749-6632.2010.05492.x; Dean RT, 1997, BIOCHEM J, V324, P1; DHALLA AK, 1994, AM J PHYSIOL, V266, pH1280, DOI 10.1152/ajpheart.1994.266.4.H1280; Dimmeler S, 2007, CELL, V130, P401, DOI 10.1016/j.cell.2007.07.028; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; FRANK H, 1989, BIOCHEM J, V260, P873, DOI 10.1042/bj2600873; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GOLDSTEIN AL, 2010, THYM HLTH DIS 2 INT, V11; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Han H, 2004, AM J PHYSIOL-HEART C, V286, pH2169, DOI 10.1152/ajpheart.00199.2003; Ho JHC, 2008, BRIT J OPHTHALMOL, V92, P992, DOI 10.1136/bjo.2007.136747; Ho JHC, 2007, INVEST OPHTH VIS SCI, V48, P27, DOI 10.1167/iovs.06-0826; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Iglesias-de la Cruz MC, 2001, KIDNEY INT, V59, P87, DOI 10.1046/j.1523-1755.2001.00469.x; Jelaska A, 1999, SPRINGER SEMIN IMMUN, V21, P385, DOI 10.1007/BF00870301; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; KUKIN ML, 2003, OXIDATIVE STRESS CAR, V20, P291; Kumar S, 2009, FREE RADICAL BIO MED, V47, P699, DOI 10.1016/j.freeradbiomed.2009.05.028; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; MARON BJ, 2006, HYPERTROPHIC CARDIOM, V11; MATATA BM, 2007, OXIDATIVE STRESS CLI, V6; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Murphy MP, 1998, GEN PHARMACOL, V31, P179, DOI 10.1016/S0306-3623(97)00418-7; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Sadoshima J, 2006, ANTIOXID REDOX SIGN, V8, P1621, DOI 10.1089/ars.2006.8.1621; SCHORB W, 1993, CIRC RES, V72, P1245, DOI 10.1161/01.RES.72.6.1245; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shrivastava S., 2010, ANN NY ACAD SCI, V1194, P87, DOI 10.1111/j.1749-6632.2010.05468.x; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; Suh JH, 2001, FASEB J, V15, P700, DOI 10.1096/fj.00-0176com; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Young JD, 1999, NAT MED, V5, P1424	57	60	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26912	10.1371/journal.pone.0026912	http://dx.doi.org/10.1371/journal.pone.0026912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046407	gold, Green Submitted, Green Published			2022-12-27	WOS:000296517000040
J	Herschhorn, A; Finzi, A; Jones, DM; Courter, JR; Sugawara, A; Smith, AB; Sodroski, JG				Herschhorn, Alon; Finzi, Andres; Jones, David M.; Courter, Joel R.; Sugawara, Akihiro; Smith, Amos B., III; Sodroski, Joseph G.			An Inducible Cell-Cell Fusion System with Integrated Ability to Measure the Efficiency and Specificity of HIV-1 Entry Inhibitors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITOR; CHEMOKINE RECEPTOR CCR5; HTLV-III/LAV ENVELOPE; CONFORMATIONAL-CHANGES; REVERSE-TRANSCRIPTASE; CXCR4 CORECEPTOR; POTENT INHIBITOR; AIDS PATIENTS; ASSAY SYSTEM	HIV-1 envelope glycoproteins (Envs) mediate virus entry by fusing the viral and target cell membranes, a multi-step process that represents an attractive target for inhibition. Entry inhibitors with broad-range activity against diverse isolates of HIV-1 may be extremely useful as lead compounds for the development of therapies or prophylactic microbicides. To facilitate the identification of such inhibitors, we have constructed a cell-cell fusion system capable of simultaneously monitoring inhibition efficiency and specificity. In this system, effector cells stably express a tetracycline-controlled transactivator (tTA) that enables tightly inducible expression of both HIV-1 Env and the Renilla luciferase (R-Luc) reporter protein. Target cells express the HIV-1 receptors, CD4 and CCR5, and carry the firefly luciferase (F-Luc) reporter gene under the control of a tTA-responsive promoter. Thus, Env-mediated fusion of these two cell types allows the tTA to diffuse to the target cell and activate the expression of the F-Luc protein. The efficiency with which an inhibitor blocks cell-cell fusion is measured by a decrease in the F-Luc activity, while the specificity of the inhibitor is evaluated by its effect on the R-Luc activity. The system exhibited a high dynamic range and high Z'-factor values. The assay was validated with a reference panel of inhibitors that target different steps in HIV-1 entry, yielding inhibitory concentrations comparable to published virus inhibition data. Our system is suitable for large-scale screening of chemical libraries and can also be used for detailed characterization of inhibitory and cytotoxic properties of known entry inhibitors.	[Herschhorn, Alon; Finzi, Andres; Sodroski, Joseph G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Immunol Canc & AIDS, Boston, MA 02115 USA; [Herschhorn, Alon; Finzi, Andres; Sodroski, Joseph G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Jones, David M.; Courter, Joel R.; Sugawara, Akihiro; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Sodroski, Joseph G.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; Harvard University; Harvard T.H. Chan School of Public Health	Herschhorn, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Immunol Canc & AIDS, 44 Binney St, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu	Sugawara, Akihiro/G-6120-2017	Sugawara, Akihiro/0000-0003-1266-7497; Finzi, Andres/0000-0002-4992-5288	American Foundation for AIDS Research [107431-45-RFRL]; Japan Society for the Promotion of Science (JSPS); National Institutes of Health [GM56550, AI24755, AI67854, AI60354]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024755, R01AI024755, U19AI067854, U01AI067854, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22890175] Funding Source: KAKEN	American Foundation for AIDS Research; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A.F. was supported by an American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research # 107431-45-RFRL. A.S. was supported by a Japan Society for the Promotion of Science (JSPS) research fellowship. The study was supported by the National Institutes of Health (grants GM56550, AI24755, AI67854 and AI60354), the International AIDS Vaccine Initiative, and the late William F. McCarty-Cooper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Arenas-Pinto A, 2011, ANTIVIR THER, V16, P219, DOI 10.3851/IMP1739; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bradley J, 2004, J BIOMOL SCREEN, V9, P516, DOI 10.1177/1087057104264577; BURKLY L, 1995, J VIROL, V69, P4267, DOI 10.1128/JVI.69.7.4267-4273.1995; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Cheng DC, 2010, BIOCHEM BIOPH RES CO, V391, P1780, DOI 10.1016/j.bbrc.2009.12.155; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Edinger AL, 1999, METH MOLEC MED, V17, P41, DOI 10.1385/0-89603-369-4:41; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Guo Q, 2003, J VIROL, V77, P10528, DOI 10.1128/JVI.77.19.10528-10536.2003; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Herschhorn A, 2008, J MED CHEM, V51, P5702, DOI 10.1021/jm800473d; Herschhorn A, 2010, J IMMUNOL, V185, P7623, DOI 10.4049/jimmunol.1001561; Ho HT, 2006, J VIROL, V80, P4017, DOI 10.1128/JVI.80.8.4017-4025.2006; HOWELL DN, 1985, J IMMUNOL, V134, P971; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Huerta L, 2005, J GEN VIROL, V86, P1961, DOI 10.1099/vir.0.80635-0; Ji CH, 2006, J BIOMOL SCREEN, V11, P65, DOI 10.1177/1087057105282959; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; KRAMER S, 2011, J BIOMOL SCREEN; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; LYERLY HK, 1987, AIDS RES HUM RETROV, V3, P409, DOI 10.1089/aid.1987.3.409; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Markosyan RM, 2002, VIROLOGY, V302, P174, DOI 10.1006/viro.2002.1593; Mavoungou D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-9; Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Murray EJ, 2010, J VIROL, V84, P7288, DOI 10.1128/JVI.00535-10; Peuchant O, 2007, ANTIVIR THER, V12, P559; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Tremblay CL, 2000, J ACQ IMMUN DEF SYND, V25, P99, DOI 10.1097/00126334-200010010-00001; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wang T, 2003, J MED CHEM, V46, P4236, DOI 10.1021/jm034082o; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yuan YZ, 2011, VIROLOGY, V413, P293, DOI 10.1016/j.virol.2011.02.019; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	72	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26731	10.1371/journal.pone.0026731	http://dx.doi.org/10.1371/journal.pone.0026731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069466	Green Submitted, gold, Green Published			2022-12-27	WOS:000297150900028
J	Plazzi, F; Ceregato, A; Taviani, M; Passamonti, M				Plazzi, Federico; Ceregato, Alessandro; Taviani, Marco; Passamonti, Marco			A Molecular Phylogeny of Bivalve Mollusks: Ancient Radiations and Divergences as Revealed by Mitochondrial Genes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CILIARY MECHANISMS; NUCLEOTIDE SUBSTITUTION; ANOMALODESMATA MOLLUSCA; MUSSELS BIVALVIA; TREE; 18S; INTERRELATIONSHIPS; LAMELLIBRANCHS; CHARACTERS	Background: Bivalves are very ancient and successful conchiferan mollusks (both in terms of species number and geographical distribution). Despite their importance in marine biota, their deep phylogenetic relationships were scarcely investigated from a molecular perspective, whereas much valuable work has been done on taxonomy, as well as phylogeny, of lower taxa. Methodology/Principal Findings: Here we present a class-level bivalve phylogeny with a broad sample of 122 ingroup taxa, using four mitochondrial markers (MT-RNR1, MT-RNR2, MT-CO1, MT-CYB). Rigorous techniques have been exploited to set up the dataset, analyze phylogenetic signal, and infer a single final tree. In this study, we show the basal position of Opponobranchia to all Autobranchia, as well as of Palaeoheterodonta to the remaining Autobranchia, which we here propose to call Amarsipobranchia. Anomalodesmata were retrieved as monophyletic and basal to (Heterodonta + Pteriomorphia). Conclusions/Significance: Bivalve morphological characters were traced onto the phylogenetic trees obtained from the molecular analysis; our analysis suggests that eulamellibranch gills and heterodont hinge are ancestral characters for all Autobranchia. This conclusion would entail a re-evaluation of bivalve symplesiomorphies.	[Plazzi, Federico; Passamonti, Marco] Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy; [Ceregato, Alessandro; Taviani, Marco] CNR, Ist Sci Marine, I-40126 Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Plazzi, F (corresponding author), Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy.	federico.plazzi@unibo.it	Taviani, Marco/AAF-2168-2020; Passamonti, Marco/J-7502-2012; Plazzi, Federico/A-3906-2013; Ceregato, Alessandro/J-3977-2015; CNR, Ismar/P-1247-2014	Taviani, Marco/0000-0003-0414-4274; Plazzi, Federico/0000-0001-5920-7557; Ceregato, Alessandro/0000-0002-7133-7183; CNR, Ismar/0000-0001-5351-1486; Passamonti, Marco/0000-0002-6222-8225	University and Research Italian Ministry (MIUR) [2007NSHJL8_002]; University of Bologna [A.31.CANZELSEW]	University and Research Italian Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Bologna	This work was supported by the University and Research Italian Ministry (MIUR PRIN07, grant number 2007NSHJL8_002 to MP) and the the "Canziani Bequest" fund (University of Bologna, grant number A.31.CANZELSEW to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 1963, MARINE MOLLUSCAN GEN; Atkins D, 1938, Q J MICROSC SCI, V80, P345; Atkins D, 1937, Q J MICROSC SCI, V79, P375; Atkins D, 1936, Q J MICROSC SCI, V79, P181; Beckenbach AT, 2005, J MOL EVOL, V60, P141, DOI 10.1007/s00239-004-0178-5; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; BRASIER MD, 1978, GEOL MAG, V115, P21, DOI 10.1017/S0016756800040954; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Calendini F, 2009, PAUPUP; Campbell DC, 2000, GEOL SOC SPEC PUBL, V177, P31, DOI 10.1144/GSL.SP.2000.177.01.03; Canapa A, 1999, J MOL EVOL, V48, P463, DOI 10.1007/PL00006490; Carter JG, 2000, GEOL SOC SPEC PUBL, V177, P47, DOI 10.1144/GSL.SP.2000.177.01.04; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cope JCW, 1997, PALAEONTOLOGY, V40, P713; Cope JCW, 2002, GEOL SOC SPEC PUBL, V194, P35, DOI 10.1144/GSL.SP.2002.194.01.04; Cope JCW, 1999, GEOBIOS-LYON, V32, P175, DOI 10.1016/S0016-6995(99)80029-1; Cope John C.W., 1996, P361; Distel DL, 2000, MOL PHYLOGENET EVOL, V15, P25, DOI 10.1006/mpev.1999.0733; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Dress A, 1996, DISCRETE APPL MATH, V71, P95, DOI 10.1016/S0166-218X(96)00059-5; Dreyer H, 2003, ZOOL J LINN SOC-LOND, V139, P229, DOI 10.1046/j.1096-3642.2003.00065.x; Fang ZJ, 2006, GEOL J, V41, P303, DOI 10.1002/gj.1048; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Giribet G, 2003, SM S COMP E, P45; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Giribet Gonzalo, 2008, P105; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Graf DL, 2000, J MOLLUS STUD, V66, P157, DOI 10.1093/mollus/66.2.157; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper EM, 2006, ZOOL J LINN SOC-LOND, V148, P395, DOI 10.1111/j.1096-3642.2006.00260.x; Harper EM, 2000, GEOL SOC SPEC PUBL, V177, P129, DOI 10.1144/GSL.SP.2000.177.01.07; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; HEALY JM, 1995, ZOOL SCR, V24, P21, DOI 10.1111/j.1463-6409.1995.tb00472.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huff SW, 2004, J MOLLUS STUD, V70, P379, DOI 10.1093/mollus/70.4.379; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KEEN A M, 1971, P1064; Khalloufi N, 2011, J MOLLUS STUD, P1; Kirkendale L, 2009, BIOL J LINN SOC, V97, P448, DOI 10.1111/j.1095-8312.2009.01215.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; La Perna R., 1998, B MALACOLOGICO, V33, P11; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Machordom A, 2003, BIOL J LINN SOC, V78, P235, DOI 10.1046/j.1095-8312.2003.00158.x; Maruyama T, 1998, BIOL BULL, V195, P70, DOI 10.2307/1542777; Matsumoto M, 2003, MOL PHYLOGENET EVOL, V27, P429, DOI 10.1016/S1055-7903(03)00013-7; Millard V, 2001, CLASSIFICATION MOLLU; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Morton Brian, 1996, P337; Morton J. E., 1964, P1; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Newell N. D., 1965, AM MUS NOVIT, V2206, P1, DOI DOI 10.1206/0003-0082(2001)347<0001:SLBPFT>2.0.CO;2; Nieselt-Struwe K, 2001, MOL BIOL EVOL, V18, P1204, DOI 10.1093/oxfordjournals.molbev.a003907; Nuin P., 2007, MRMTGUI CROSS PLATFO; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Park JK, 2000, MOL PHYLOGENET EVOL, V14, P75, DOI 10.1006/mpev.1999.0691; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Pereyra S, 2008, ENVIRON BIOL FISH, V83, P245, DOI 10.1007/s10641-008-9329-7; Plazzi F, 2010, MOL PHYLOGENET EVOL, V57, P641, DOI 10.1016/j.ympev.2010.08.032; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Pojeta J, 2000, AM MALACOL BULL, V15, P157; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PURCHON RD, 1987, PHILOS T ROY SOC B, V316, P277, DOI 10.1098/rstb.1987.0028; Purchon RD, 1958, P CENT BICENT C BIOL, P69; Puslednik L, 2008, MOL PHYLOGENET EVOL, V48, P1178, DOI 10.1016/j.ympev.2008.05.006; Reinhart PW, 1935, B MUSEE ROYAL HIST N, V11, P5; Roe KJ, 2003, SM S COMP E, P91; Rosengarten RD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-33; Rost H, 1955, ALLAN HANCOCK PAC EX, V20, P177; RUNNEGAR B, 1992, AM MALACOL BULL, V9, P117; Salvini-Plawen Luitfried v., 1996, P29; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt HA, 2003, CURRENT PROTOCOLS BI, P661; Schneider JA, 1999, MOL PHYLOGENET EVOL, V13, P59, DOI 10.1006/mpev.1999.0636; Serb JM, 2003, MOL PHYLOGENET EVOL, V28, P1, DOI 10.1016/S1055-7903(03)00026-5; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; STANLEY STEVEN M., 1968, J PALEONTOL, V42, P214; Starobogatov Yaroslav I., 1992, Ruthenica, V2, P1; STASEK CHARLES R., 1963, VELIGER, V6, P91; Steiner G, 1996, J MOL EVOL, V43, P58, DOI 10.1007/BF02352300; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; Taylor JD, 2009, NAUTILUS, V123, P9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsubaki R, 2011, MOL PHYLOGENET EVOL, V58, P97, DOI 10.1016/j.ympev.2010.11.014; Vokes HE, 1980, GENERA BIVALVIA; Wagele JW, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-12; Waller T.R., 1990, P49; Waller Thomas R., 1998, P1; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Williams ST, 2004, J MOLLUS STUD, V70, P187, DOI 10.1093/mollus/70.2.187; YONGE C. M., 1939, PHIL TRANS ROY SOC LONDON SER B, V230, P79, DOI 10.1098/rstb.1939.0005; Yonge C. M., 1969, P MALACOLOGICAL SOC, V38, P493, DOI DOI 10.1093/OXFORDJOURNALS.MOLLUS.A065067; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Zbawicka M, 2007, GENE, V406, P191, DOI 10.1016/j.gene.2007.10.003	113	65	67	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27147	10.1371/journal.pone.0027147	http://dx.doi.org/10.1371/journal.pone.0027147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069499	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900059
J	Rahman, M; Chan, APK; Tai, IT				Rahman, Mahbuba; Chan, Annie P. K.; Tai, Isabella T.			A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; COLORECTAL CANCERS; MELANOMA-CELLS; NULL MICE; PROTEIN; EXPRESSION; APOPTOSIS; RICH	SPARC, a matricellular protein with tumor suppressor properties in certain human cancers, was initially identified in a genome-wide analysis of differentially expressed genes in chemotherapy resistance. Its exciting new role as a potential chemosensitizer arises from its ability to augment the apoptotic cascade, although the exact mechanisms are unclear. This study further examines the mechanism by which SPARC may be promoting apoptosis and identifies a smaller peptide analogue with greater chemosensitizing and tumor-regressing properties than the native protein. We examined the possibility that the apoptosis-enhancing activity of SPARC could reside within one of its three biological domains (N-terminus (NT), the follistatin-like (FS), or extracellular (EC) domains), and identified the N-terminus as the region with its chemosensitizing properties. These results were not only confirmed by studies utilizing stable cell lines overexpressing the different domains of SPARC, but as well, with a synthetic 51-aa peptide spanning the NT-domain. It revealed that the NT-domain induced a significantly greater reduction in cell viability than SPARC, and that it enhanced the apoptotic cascade via its activation of caspase 8. Moreover, in chemotherapy resistant human colon, breast and pancreatic cancer cells, its chemosensitizing properties also depended on its ability to dissociate Bcl2 from caspase 8. These observations translated to clinically significant findings in that, in-vivo, mouse tumor xenografts overexpressing the NT-domain of SPARC had significantly greater sensitivity to chemotherapy and tumor regression, even when compared to the highly-sensitive SPARC-overexpressing tumors. Our results identified an interplay between the NT-domain, Bcl2 and caspase 8 that helps augment apoptosis and as a consequence, a tumor's response to therapy. This NT-domain of SPARC and its 51-aa peptide are highly efficacious in modulating and enhancing apoptosis, thereby conferring greater chemosensitivity to resistant tumors. Our findings provide additional insight into mechanisms involved in chemotherapy resistance and a potential novel therapeutic that specifically targets this devastating phenomenon.	[Rahman, Mahbuba; Chan, Annie P. K.; Tai, Isabella T.] Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada; [Rahman, Mahbuba; Chan, Annie P. K.; Tai, Isabella T.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Rahman, M (corresponding author), Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada.	itai@bcgsc.ca	Rahman, Mahbuba/AAR-2085-2020; Tai, Isabella T/E-8035-2012	Rahman, Mahbuba/0000-0003-4586-4067; 	Canadian Institutes of Health Research (CIHR) [MOP 82881]; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was funded by the Canadian Institutes of Health Research (CIHR, MOP 82881) (www.cihr-irsc.gc.ca), and the Michael Smith Foundation for Health Research (MSFHR) (www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw AD, 2001, WOUND REPAIR REGEN, V9, P522, DOI 10.1046/j.1524-475x.2001.00522.x; Chan JM, 2010, CARCINOGENESIS, V31, P812, DOI 10.1093/carcin/bgq034; CHEETHAM S, 2008, BR J CANC; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; Chlenski A, 2004, CANCER RES, V64, P7420, DOI 10.1158/0008-5472.CAN-04-2141; Chlenski A, 2002, CANCER RES, V62, P7357; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Gilles C, 1998, CANCER RES, V58, P5529; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MODICANAPOLITANO JS, 1989, CANCER RES, V49, P3369; Mohammad R, 2008, RECENT PAT ANTI-CANC, V3, P20, DOI 10.2174/157489208783478676; Motamed K, 1999, INT J BIOCHEM CELL B, V31, P1363, DOI 10.1016/S1357-2725(99)00090-4; Omidvar N, 2007, CANCER RES, V67, P11657, DOI 10.1158/0008-5472.CAN-07-0196; Poulaki V, 2001, CANCER RES, V61, P4864; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schultz C, 2002, CANCER RES, V62, P6270; Taghizadeh F, 2007, MOL CANCER THER, V6, P309, DOI 10.1158/1535-7163.MCT-06-0517; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Wang WJ, 2006, NEPHROL DIAL TRANSPL, V21, P1278, DOI 10.1093/ndt/gfk036; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4	34	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26390	10.1371/journal.pone.0026390	http://dx.doi.org/10.1371/journal.pone.0026390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069448	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900009
J	Yeung, BHY; Wong, CKC				Yeung, Bonnie H. Y.; Wong, Chris K. C.			Stanniocalcin-1 Regulates Re-Epithelialization in Human Keratinocytes	PLOS ONE			English	Article							GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; STAUROSPORINE; INHIBITOR; ACTIVATION; MIGRATION; CANCER; CELLS; GSK-3-BETA; INDUCTION	Stanniocalcin-1 (STC1), a glycoprotein hormone, is believed to be involved in various biological processes such as inflammation, oxidative responses and cell migration. Riding on these emerging evidences, we hypothesized that STC1 may participate in the re-epithelialization during wound healing. Re-epithelialization is a critical step that involves keratinocyte lamellipodia (e-lam) formation, followed by cell migration. In this study, staurosporine (STS) treatment induced human keratinocyte (HaCaT) e-lam formation on fibronectin matrix and migration via the activation of focal adhesion kinase (FAK), the surge of intracellular calcium level [Ca2+](i) and the inactivation of Akt. In accompanied with these migratory features, a time-and dose-dependent increase in STC1 expression was detected. STC1 gene expression was found not the downstream target of FAK-signaling as illustrated by FAK inhibition using PF573228. The reduction of [Ca2+](i) by BAPTA/AM blocked the STS-mediated keratinocyte migration and STC1 gene expression. Alternatively the increase of [Ca2+](i) by ionomycin exerted promotional effect on STS-induced STC1 gene expression. The inhibition of Akt by SH6 and GSK3 beta by lithium chloride (LiCl) could respectively induce and inhibit the STS-mediated e-lam formation, cell migration and STC1 gene expression. The STS-mediated e-lam formation and cell migration were notably hindered or induced respectively by STC1 knockdown or overexpression. This notion was further supported by the scratched wound assay. Collectively the findings provide the first evidence that STC1 promotes re-epithelialization in wound healing.	[Yeung, Bonnie H. Y.; Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Baptist University	Yeung, BHY (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China.	ckcwong@hkbu.edu.hk	wong, chris/GSN-0962-2022		General Research Fund/Research Grant Council Hong Kong [261610]	General Research Fund/Research Grant Council Hong Kong(Hong Kong Research Grants Council)	This work was supported by the General Research Fund/Research Grant Council Hong Kong (261610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBUL A, 1995, OTOLARYNG CLIN N AM, V28, P955; Basini G, 2009, ANN NY ACAD SCI, V1171, P94, DOI 10.1111/j.1749-6632.2009.04680.x; BONGA SEW, 1991, INT REV CYTOL, V128, P139; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Chakraborty A, 2007, AM J PHYSIOL-RENAL, V292, pF895, DOI 10.1152/ajprenal.00219.2006; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; De Niu P, 2000, MOL CELL ENDOCRINOL, V162, P131, DOI 10.1016/S0303-7207(00)00199-4; Diaz-Velasquez CE, 2008, J CELL BIOCHEM, V105, P147, DOI 10.1002/jcb.21810; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Holmes DIR, 2008, CELL SIGNAL, V20, P569, DOI 10.1016/j.cellsig.2007.11.009; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; Jauhiainen S, 2011, ARTERIOSCL THROM VAS, V31, P1617, DOI 10.1161/ATVBAHA.111.225961; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kanellis J, 2004, AM J PHYSIOL-RENAL, V286, pF356, DOI 10.1152/ajprenal.00138.2003; Klein D, 2009, ANGIOGENESIS, V12, P251, DOI 10.1007/s10456-009-9145-5; Koivisto L, 2003, J CELL SCI, V116, P3749, DOI 10.1242/jcs.00693; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Lai KP, 2007, BIOCHEM BIOPH RES CO, V356, P968, DOI 10.1016/j.bbrc.2007.03.074; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Law AYS, 2008, EXP CELL RES, V314, P2975, DOI 10.1016/j.yexcr.2008.07.002; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McCudden CR, 2004, MOL CELL ENDOCRINOL, V213, P167, DOI 10.1016/j.mce.2003.10.042; Nguyen A, 2009, ONCOGENE, V28, P1982, DOI 10.1038/onc.2009.65; Paciga M, 2003, J BIOL CHEM, V278, P49549, DOI 10.1074/jbc.M307302200; RASOULY D, 1994, EUR J PHARM-MOLEC PH, V269, P255, DOI 10.1016/0922-4106(94)90094-9; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; SAKO T, 1988, CANCER RES, V48, P4646; Salabat MR, 2005, GASTROENTEROLOGY, V128, pA532; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Tamura S, 2011, ANTICANCER RES, V31, P325; Tohmiya Y, 2004, TOHOKU J EXP MED, V204, P125, DOI 10.1620/tjem.204.125; Vaidya RJ, 2006, CELL MOL LIFE SCI, V63, P2871, DOI 10.1007/s00018-006-6379-x; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Wascher RA, 2003, CLIN CANCER RES, V9, P1427; Westberg JA, 2007, STROKE, V38, P1025, DOI 10.1161/01.STR.0000258113.67252.fa; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yeung HY, 2003, ENDOCRINOLOGY, V144, P4446, DOI 10.1210/en.2003-0504; YOSHIMURA M, 1995, J BIOL CHEM, V270, P2298, DOI 10.1074/jbc.270.5.2298; Zlot C, 2003, J BIOL CHEM, V278, P47654, DOI 10.1074/jbc.M301353200	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27094	10.1371/journal.pone.0027094	http://dx.doi.org/10.1371/journal.pone.0027094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069492	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900052
J	Epstein, JH; Zambriski, JA; Rostal, MK; Heard, DJ; Daszak, P				Epstein, Jonathan H.; Zambriski, Jennifer A.; Rostal, Melinda K.; Heard, Darryl J.; Daszak, Peter			Comparison of Intravenous Medetomidine and Medetomidine/Ketamine for Immobilization of Free-Ranging Variable Flying Foxes (Pteropus hypomelanus)	PLOS ONE			English	Article							SHORT-TERM IMMOBILIZATION; NIPAH VIRUS; FRUIT BATS; KETAMINE; PARAMYXOVIRUS; COMBINATIONS; MALAYSIA	Medetomidine (0.03 mg/kg) and medetomidine/ketamine (0.05/5.0 and 0.025/2.5 mg/kg), administered by intravenous injection, were evaluated for short-term immobilization of wild-caught variable flying foxes (Pteropus hypomelanus). Medetomidine alone produced incomplete chemical restraint and a stressful, prolonged induction. Both ketamine/medetomidine doses produced a smooth induction and complete immobilization. The combined medetomidine/ketamine dose of 0.025/2.5 mg/kg produced a rapid induction (2326224 sec) with minimal struggling and vocalization, a complete and effective immobilization period, and tended to lead to a faster and better quality recovery than medetomidine alone or a higher dose of medetomidine and ketamine (0.05/5.0 mg/kg), thus reducing holding time and permitting an earlier release of the bat back into the wild.	[Epstein, Jonathan H.; Rostal, Melinda K.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Zambriski, Jennifer A.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Heard, Darryl J.] Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA	EcoHealth Alliance; Cornell University; State University System of Florida; University of Florida	Epstein, JH (corresponding author), EcoHlth Alliance, New York, NY USA.	epstein@ecohealthalliance.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695	National Institute of Allergy and Infectious Disease (NIAID) [1 K08 AI067549, 1 R01 AI079231-01]; Fogarty International Center [2R01-TW005869]; Ecohealth Alliance's Consortium for Conservation Medicine; V. Kann Rasmussen Foundation; Consortium for Conservation Medicine; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079231, K08AI067549] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ecohealth Alliance's Consortium for Conservation Medicine; V. Kann Rasmussen Foundation; Consortium for Conservation Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a National Institute of Allergy and Infectious Disease (NIAID) award (1 K08 AI067549), National Institute of Health (NIH)/National Science Foundation- Ecology and Evolution of Infectious Disease (NSF EEID) award from the Fogarty International Center (2R01-TW005869) and a NIAID Non-Biodefense emerging infectious disease research opportunities award (1 R01 AI079231-01). JAZ was funded by a grant from Ecohealth Alliance's Consortium for Conservation Medicine and the V. Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of the Consortium for Conservation Medicine Program at EcoHealth Alliance. We would like to thank Dr. Gretchen Kaufman and Dr. Louise Maranda for their assistance and review of this paper. We would also like to thank the Veterinary Research Institute in Ipoh, Perak, Malaysia, for their logistical support, as well as Dr. Kevin J. Olival and Dr. Sohayati Abdul Raman for their assistance in the field.	Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Carpenter R.E., 1986, P634; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Heard D. J., 2003, ZOO WILD ANIMAL MED, P315; Heard D, 2006, J WILDLIFE DIS, V42, P437, DOI 10.7589/0090-3558-42.2.437; Heard DJ, 1996, J ZOO WILDLIFE MED, V27, P44; JALANKA HH, 1990, J ZOO WILDLIFE MED, V21, P259; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; McColl KA, 2000, REV SCI TECH OIE, V19, P177, DOI 10.20506/rst.19.1.1221; Plumb D. C, 2005, VET DRUG HDB; Rainey William E., 1998, P326; Sohayati AR, 2008, J ZOO WILDLIFE MED, V39, P674, DOI 10.1638/2006-0061.1; West G, 2007, ZOO ANIMAL WILDLIFE	19	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25361	10.1371/journal.pone.0025361	http://dx.doi.org/10.1371/journal.pone.0025361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065987	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000004
J	Huang, D; Wang, Y; Wang, L; Zhang, FX; Deng, S; Wang, R; Zhang, Y; Huang, K				Huang, Dan; Wang, Yan; Wang, Lin; Zhang, Fengxiao; Deng, Shan; Wang, Rui; Zhang, Yun; Huang, Kai			Poly(ADP-ribose) Polymerase 1 Is Indispensable for Transforming Growth Factor-beta Induced Smad3 Activation in Vascular Smooth Muscle Cell	PLOS ONE			English	Article							TGF-BETA; REACTIVE OXYGEN; CARDIAC FIBROBLASTS; NUCLEAR EXPORT; TRANSCRIPTION; EXPRESSION; DISEASE; TRANSFORMING-GROWTH-FACTOR-BETA-1; ATHEROSCLEROSIS; PROLIFERATION	Background: Transforming growth factor type-beta (TGF-beta)/Smad pathway plays an essential role in vascular fibrosis. Reactive oxygen species (ROS) generation also mediates TGF-beta signaling-induced vascular fibrosis, suggesting that some sort of interaction exists between Smad and redox pathways. However, the underlying molecular mechanism is largely unknown. This study aims to investigate the influence of poly(ADP-ribose) polymerase 1 (PARP1), a downstream effector of ROS, on TGF-beta signaling transduction through Smad3 pathway in rat vascular smooth muscle cells (VSMCs). Methods and Results: TGF-beta 1 treatment promoted PARP1 activation through induction of ROS generation in rat VSMCs. TGF-beta 1-induced phosphorylation and nuclear accumulation of Smad3 was prevented by treatment of cells with PARP inhibitor, 3-aminobenzamide (3AB) or N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-2-(N, N-dimethylamino) acetami (PJ34), or PARP1 siRNA. TGF-beta 1 treatment promoted poly(ADP-ribosy) lation of Smad3 via activation of PARP1 in the nucleus. Poly(ADP-ribosy) lation enhanced Smad-Smad binding element (SBE) complex formation in nuclear extracts and increased DNA binding activity of Smad3. Pretreatment with 3AB, PJ34, or PARP1 siRNA prevented TGF-beta 1-induced Smad3 transactivation and expression of Smad3 target genes, including collagen I alpha 1, collagen III alpha 1 and tissue inhibitor of metalloproteinase 1, in rat VSMCs. Conclusions: PARP1 is indispensable for TGF-beta 1 induced Smad3 activation in rat VSMCs. Targeting PARP1 may be a promising therapeutic approach against vascular diseases induced by dysregulation of TGF-beta/Smad3 pathway.	[Huang, Dan; Wang, Yan; Zhang, Fengxiao; Deng, Shan; Wang, Rui; Huang, Kai] Huazhong Univ Sci & Technol, Dept Cardiovasc Dis, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Lin] Huazhong Univ Sci & Technol, Cent Lab, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Zhang, Yun; Huang, Kai] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shandong University	Huang, D (corresponding author), Huazhong Univ Sci & Technol, Dept Cardiovasc Dis, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	zhangyun@sdu.edu.cn; huangkai1@mail.hust.edu.cn		Zhang, Fengxiao/0000-0002-5109-4196	National Natural Science Foundation of China [30971245, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30971245, 81000112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2007, CARDIOVASC RES, V73, P568, DOI 10.1016/j.cardiores.2006.11.027; Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; August P, 2006, NEW ENGL J MED, V354, P2721, DOI 10.1056/NEJMcibr062143; BATTLE T, 1994, TISSUE CELL, V26, P943, DOI 10.1016/0040-8166(94)90043-4; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chiu J, 2008, J MOL CELL CARDIOL, V45, P385, DOI 10.1016/j.yjmcc.2008.06.009; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hong YH, 1997, J IMMUNOL, V159, P2418; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; Khan R, 2007, CARDIOVASC RES, V74, P223, DOI 10.1016/j.cardiores.2007.02.012; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Liu RM, 2004, AM J PHYSIOL-LUNG C, V286, pL121, DOI 10.1152/ajplung.00231.2003; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Shevalye H, 2010, BBA-MOL BASIS DIS, V1802, P1020, DOI 10.1016/j.bbadis.2010.07.004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sugiura H, 2009, PULM PHARMACOL THER, V22, P487, DOI 10.1016/j.pupt.2009.04.002; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vidakovic M, 2009, J MOL BIOL, V388, P730, DOI 10.1016/j.jmb.2009.03.032; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E	42	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27123	10.1371/journal.pone.0027123	http://dx.doi.org/10.1371/journal.pone.0027123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073128	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000055
J	Narasaki, CT; Mertens, K; Samuel, JE				Narasaki, Craig T.; Mertens, Katja; Samuel, James E.			Characterization of the GDP-D-Mannose Biosynthesis Pathway in Coxiella burnetii: The Initial Steps for GDP-beta-D-Virenose Biosynthesis	PLOS ONE			English	Article							PHASE-I LIPOPOLYSACCHARIDE; ESCHERICHIA-COLI; Q-FEVER; PHOSPHOMANNOSE ISOMERASE; PSEUDOMONAS-AERUGINOSA; POLYACRYLAMIDE GELS; STRAIN PRISCILLA; O-ANTIGENS; 9 MILE; PROTEINS	Coxiella burnetii, the etiologic agent of human Q fever, is a Gram-negative and naturally obligate intracellular bacterium. The O-specific polysaccharide chain (O-PS) of the lipopolysaccharide (LPS) of C. burnetii is considered a heteropolymer of the two unusual sugars beta-D-virenose and dihydrohydroxystreptose and mannose. We hypothesize that GDP-D-mannose is a metabolic intermediate to GDP-beta-D-virenose. GDP-D-mannose is synthesized from fructose-6-phosphate in 3 successive reactions; Isomerization to mannose-6-phosphate catalyzed by a phosphomannose isomerase (PMI), followed by conversion to mannose-1-phosphate mediated by a phosphomannomutase (PMM) and addition of GDP by a GDP-mannose pyrophosphorylase (GMP). GDP-D-mannose is then likely converted to GDP-6-deoxy-D-lyxo-hex-4-ulopyranose (GDP-Sug), a virenose intermediate, by a GDP-mannose-4,6-dehydratase (GMD). To test the validity of this pathway in C. burnetii, three open reading frames (CBU0671, CBU0294 and CBU0689) annotated as bifunctional type II PMI, as PMM or GMD were functionally characterized by complementation of corresponding E. coli mutant strains and in enzymatic assays. CBU0671, failed to complement an Escherichia coli manA (PMM) mutant strain. However, complementation of an E. coli manC (GMP) mutant strain restored capsular polysaccharide biosynthesis. CBU0294 complemented a Pseudomonas aeruginosa algC (GMP) mutant strain and showed phosphoglucomutase activity (PGM) in a pgm E. coli mutant strain. Despite the inability to complement a manA mutant, recombinant C. burnetii PMI protein showed PMM enzymatic activity in biochemical assays. CBU0689 showed dehydratase activity and determined kinetic parameters were consistent with previously reported data from other organisms. These results show the biological function of three C. burnetii LPS biosynthesis enzymes required for the formation of GDP-D-mannose and GDP-Sug. A fundamental understanding of C. burnetii genes that encode PMI, PMM and GMP is critical to fully understand the biosynthesic pathway of GDP-beta-D-virenose and LPS structure in C. burnetii.	[Narasaki, Craig T.; Mertens, Katja; Samuel, James E.] Texas A&M Univ, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Narasaki, CT (corresponding author), Texas A&M Univ, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA.	JSamuel@medicine.tamhsc.edu		Mertens-Scholz, Katja/0000-0001-7421-7577	NIAID/NIH [U54AI057156]; United States Air Force; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Air Force(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/NIH grant number U54AI057156. CT Narasaki was supported by the United States Air Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1971, J BACTERIOL, V108, P621, DOI 10.1128/JB.108.2.621-626.1971; Albermann C, 2001, GLYCOBIOLOGY, V11, P655, DOI 10.1093/glycob/11.8.655; Albermann C, 2000, GLYCOBIOLOGY, V10, P875, DOI 10.1093/glycob/10.9.875; AMANO K, 1987, J BIOL CHEM, V262, P4740; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Denison AM, 2007, FEMS MICROBIOL LETT, V267, P102, DOI 10.1111/j.1574-6968.2006.00544.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Ftacek P, 2000, J ENDOTOXIN RES, V6, P369, DOI 10.1177/09680519000060050701; GRACY RW, 1968, J BIOL CHEM, V243, P3161; HACKSTADT T, 1988, INFECT IMMUN, V56, P802, DOI 10.1128/IAI.56.4.802-807.1988; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hoover TA, 2002, INFECT IMMUN, V70, P6726, DOI 10.1128/IAI.70.12.6726-2733.2002; JAYARATNE P, 1994, J BACTERIOL, V176, P3126, DOI 10.1128/jb.176.11.3126-3139.1994; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; LUKACOVA M, 1994, ACTA VIROL, V38, P263; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; MUNCHPETERSEN A, 1962, METHOD ENZYMOL, V5, P171, DOI 10.1016/S0076-6879(62)05203-9; Ornsland A, 2008, J BACTERIOL, V190, P3203, DOI 10.1128/JB.01911-07; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SACORREIA I, 1987, J BACTERIOL, V169, P3224, DOI 10.1128/jb.169.7.3224-3231.1987; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SAMUEL JE, 1985, INFECT IMMUN, V49, P775, DOI 10.1128/IAI.49.3.775-779.1985; SCHRAMEK S, 1985, EUR J BIOCHEM, V148, P455, DOI 10.1111/j.1432-1033.1985.tb08861.x; SCHRAMEK S, 1982, INFECT IMMUN, V38, P53, DOI 10.1128/IAI.38.1.53-57.1982; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Skultety L, 1998, CARBOHYD POLYM, V35, P189, DOI 10.1016/S0144-8617(97)00246-4; Sousa SA, 2008, APPL MICROBIOL BIOT, V80, P1015, DOI 10.1007/s00253-008-1612-1; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Toman R, 2003, ANN NY ACAD SCI, V990, P563, DOI 10.1111/j.1749-6632.2003.tb07427.x; Toman R, 1996, CARBOHYD RES, V283, P175, DOI 10.1016/0008-6215(96)87610-5; TOMAN R, 1993, ACTA VIROL, V37, P196; TOMAN R, 1991, ACTA VIROL, V35, P531; Toman R, 1998, CARBOHYD RES, V306, P291, DOI 10.1016/S0008-6215(97)10037-4; Toman Rudolf, 2004, BMC Biochemistry, V5, P1, DOI 10.1186/1471-2091-5-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vadovic P, 2005, ANN NY ACAD SCI, V1063, P149, DOI 10.1196/annals.1355.023; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372; Zhang Guoquan, 2004, Expert Rev Vaccines, V3, P577, DOI 10.1586/14760584.3.5.577	48	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25514	10.1371/journal.pone.0025514	http://dx.doi.org/10.1371/journal.pone.0025514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065988	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000005
J	Shah, M; Kasambira, TS; Adrian, PV; Madhi, SA; Martinson, NA; Dorman, SE				Shah, Maunank; Kasambira, Tafadzwa S.; Adrian, Peter V.; Madhi, Shabir A.; Martinson, Neil A.; Dorman, Susan E.			Longitudinal Analysis of QuantiFERON-TB Gold In-Tube in Children with Adult Household Tuberculosis Contact in South Africa: A Prospective Cohort Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CELL RESPONSES; INFECTION; DIAGNOSIS; ASSAY; CONVERSIONS	Background: QuantiFERON-TB Gold In Tube (QFT-GIT) is a tool for detecting M. tuberculosis infection. However, interpretation and utility of serial QFT-GIT testing of pediatric tuberculosis (TB) contacts is not well understood. We compared TB prevalence between baseline and 6 months follow-up using QFT-GIT and tuberculin skin testing (TST) in children who were household contacts of adults with pulmonary TB in South Africa, and explored factors associated with QFT-GIT conversions and reversions. Method: Prospective study with six month longitudinal follow-up. Results: Among 270 enrolled pediatric contacts, 196 (73%) underwent 6-month follow-up testing. The 6-month prevalence estimate of MTB infection in pediatric contacts increased significantly from a baseline of 29% (79/270, 95% CI [24-35]) to 38% (103/270, 95% CI [32-44], p < 0.001) using QFT-GIT; prevalence increased from a baseline of 28% (71/254, 95% CI [23-34]) to 33% (88/263, 95% CI [21-32], p = 0.002) using TST. Prevalence estimates were influenced by thresholds for positivity for TST, but not for QFT-GIT. Among 134 children with a negative or indeterminate baseline QFT-GIT, 24 (18%) converted to positive at follow-up; conversion rates did not differ significantly when using more stringent thresholds to define QFT-GIT conversion. Older age > 10 years (AOR 8.9 95% CI [1.1-72]) and baseline TST positivity >= 5 mm (AOR 5.2 95% CI [1.2-23]) were associated with QFT-GIT conversion. Among 62 children with a positive baseline QFT-GIT, 9 (15%) reverted to negative; female gender (AOR 18.5 95% CI [1.1-321]; p = 0.04] was associated with reversion, while children with baseline positive TST were less likely to have QFT-GIT reversion (AOR 0.01 95% CI [0.001-0.24]). Conclusion: Among pediatric contacts of adult household TB cases in South Africa, prevalence estimates of TB infection increased significantly from baseline to 6 months. Conversions and reversions occurred among pediatric TB contacts using QFT-GIT, but QFT-GIT conversion rates were less influenced by thresholds used for conversions than were TST conversion rates.	[Shah, Maunank; Kasambira, Tafadzwa S.; Martinson, Neil A.; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Adrian, Peter V.; Madhi, Shabir A.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Adrian, Peter V.; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa	Johns Hopkins University; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand	Shah, M (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mshah28@jhmi.edu			United States Agency for International Development; twin Fogarty International Center [5U2RTW007373, 5U2RTW007370]; FOGARTY INTERNATIONAL CENTER [U2RTW007373, U2RTW007370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089259] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); twin Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	QuantiFERON (R)-TB Gold In-Tube kits were generously supplied by the Foundation for Innovative New Diagnostics, Geneva, Switzerland. Financial support for this study was received from the United States Agency for International Development. NAM is partially supported by twin Fogarty International Center Grants 5U2RTW007373 and 5U2RTW007370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir M, 2009, CLIN INFECT DIS, V48, P302, DOI 10.1086/595847; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Cellestis, 2006, QUANT TB GOLD TUB ME; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Department of Health SA, 2004, S AFRICAN NAT TUB CO; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hosmer DW, 2000, APPL LOGISTIC REGRES, P116; Kasambira TS, 2011, INT J TUBERC LUNG D, V15, P628, DOI 10.5588/ijtld.10.0555; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mendez-Echevarria A, 2011, PEDIATR INFECT DIS J, V30, P426, DOI 10.1097/INF.0b013e3182001294; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Starke JR, 1996, PRIMARY CARE, V23, P861, DOI 10.1016/S0095-4543(05)70367-5; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850	20	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26787	10.1371/journal.pone.0026787	http://dx.doi.org/10.1371/journal.pone.0026787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066009	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000025
J	Zhou, GD; Zhu, HP; Phillips, TD; Wang, JB; Wang, SZ; Wang, F; Amendt, BA; Couroucli, XI; Donnelly, KC; Moorthy, B				Zhou, Guo-Dong; Zhu, Huiping; Phillips, Tracie D.; Wang, Jianbo; Wang, Shi-Zhou; Wang, Fen; Amendt, Brad A.; Couroucli, Xanthi I.; Donnelly, Kirby C.; Moorthy, Bhagavatula			Effects of Dietary Fish Oil on the Depletion of Carcinogenic PAH-DNA Adduct Levels in the Liver of B6C3F1 Mouse	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LUNG-CANCER RISK; CELL-GROWTH; DAMAGE; APOPTOSIS; OMEGA-3-FATTY-ACIDS; COLON; N-3; EXPOSURE; MICE	Many carcinogenic polycyclic aromatic hydrocarbons (PAHs) and their metabolites can bind covalently to DNA. Carcinogen-DNA adducts may lead to mutations in critical genes, eventually leading to cancer. In this study we report that fish oil (FO) blocks the formation of DNA adducts by detoxification of PAHs. B6C3F1 male mice were fed a FO or corn oil (CO) diet for 30 days. The animals were then treated with seven carcinogenic PAHs including benzo(a) pyrene (BaP) with one of two doses via a single intraperitoneal injection. Animals were terminated at 1, 3, or 7 d after treatment. The levels of DNA adducts were analyzed by the P-32-postlabeling assay. Our results showed that the levels of total hepatic DNA adducts were significantly decreased in FO groups compared to CO groups with an exception of low PAH dose at 3 d (P = 0.067). Total adduct levels in the high dose PAH groups were 41.36 +/- 6.48 (Mean +/- SEM) and 78.72 +/- 8.03 in 10(9) nucleotides (P = 0.011), respectively, for the FO and CO groups at 7 d. Animals treated with the low dose (2.5 fold lower) PAHs displayed similar trends. Total adduct levels were 12.21 +/- 2.33 in the FO group and 24.07 +/- 1.99 in the CO group, P = 0.008. BPDE-dG adduct values at 7 d after treatment of high dose PAHs were 32.34 +/- 1.94 (CO group) and 21.82 +/- 3.37 (FO group) in 10(9) nucleotides with P value being 0.035. Low dose groups showed similar trends for BPDE-dG adduct in the two diet groups. FO significantly enhanced gene expression of Cyp1a1 in both the high and low dose PAH groups. Gstt1 at low dose of PAHs showed high levels in FO compared to CO groups with P values being 0.014. Histological observations indicated that FO played a hepatoprotective role during the early stages. Our results suggest that FO has a potential to be developed as a cancer chemopreventive agent.	[Zhou, Guo-Dong; Wang, Jianbo; Wang, Fen; Amendt, Brad A.] Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Zhou, Guo-Dong; Phillips, Tracie D.; Wang, Shi-Zhou; Donnelly, Kirby C.] Texas A&M Univ, Syst Hlth Sci Ctr, Sch Rural Publ Hlth, College Stn, TX USA; [Zhu, Huiping] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Couroucli, Xanthi I.; Moorthy, Bhagavatula] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; Baylor College of Medicine	Zhou, GD (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.	gzhou@ibt.tamhsc.edu		Amendt, Brad A./0000-0001-6524-1006	National Institutes of Health [ES04917, ES009132, ES019689, ES09106, HL070921, HL087174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087174, R01HL070921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019689, P30ES009106, P42ES004917, R01ES009132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research work was supported by grants from the National Institutes of Health, numbers ES04917, ES009132, ES019689, ES09106 (National Institute of Environmental Health Sciences), and numbers HL070921 and HL087174 (National Heart, Lung, and Blood Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak H, 2006, INT J CANCER, V118, P1618, DOI 10.1002/ijc.21551; Bancroft LK, 2003, FREE RADICAL BIO MED, V35, P149, DOI 10.1016/S0891-5849(03)00240-5; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Boudreau MD, 2001, CANCER RES, V61, P1386; Chang WCL, 1997, CARCINOGENESIS, V18, P721, DOI 10.1093/carcin/18.4.721; Fan YY, 2011, CANCER PREV RES, V4, P1267, DOI 10.1158/1940-6207.CAPR-10-0368; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Garter S, 2007, INT J CANCER, V120, P2499, DOI 10.1002/ijc.22477; Grant WB, 2009, ANTICANCER RES, V29, P3537; Gunter MJ, 2007, CARCINOGENESIS, V28, P1426, DOI 10.1093/carcin/bgm022; GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hong MY, 2000, CANCER EPIDEM BIOMAR, V9, P819; Hong MY, 2005, NUTR CANCER, V52, P166, DOI 10.1207/s15327914nc5202_7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jude S, 2006, PROG BIOPHYS MOL BIO, V90, P299, DOI 10.1016/j.pbiomolbio.2005.05.006; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Katiyar SK, 2010, CANCER PREV RES, V3, P179, DOI 10.1158/1940-6207.CAPR-09-0044; Lim K, 2009, MOL CANCER THER, V8, P3046, DOI 10.1158/1535-7163.MCT-09-0551; Mabon N, 1996, MUTAT RES-GENET TOX, V371, P87, DOI 10.1016/S0165-1218(96)90098-1; Mahadik SP, 2006, INT REV PSYCHIATR, V18, P119, DOI 10.1080/09540260600581993; Manson MM, 2005, RECENT RESULTS CANC, V166, P257; Mernitz H, 2009, NUTR CANCER, V61, P663, DOI 10.1080/01635580902825589; Pan J, 2009, CHEM RES TOXICOL, V22, P798, DOI 10.1021/tx800355k; Phillips DH, 2002, CARCINOGENESIS, V23, P1979, DOI 10.1093/carcin/23.12.1979; Phillips TD, 2006, THESIS TEXAS A M U; POIRIER MC, 1994, ENVIRON HEALTH PERSP, V102, P161, DOI 10.2307/3432171; Randerath E, 1996, ARCH TOXICOL, V70, P683, DOI 10.1007/s002040050329; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; Randerath K, 1999, ENVIRON MOL MUTAGEN, V33, P303, DOI 10.1002/(SICI)1098-2280(1999)33:4<303::AID-EM7>3.0.CO;2-0; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Strouch MJ, 2009, J SURG RES; Takezaki T, 2003, NUTR CANCER, V45, P160, DOI 10.1207/S15327914NC4502_04; Tang DL, 2001, CANCER RES, V61, P6708; U.S. EPA, EPA INT RISK INF SYS; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; van Beelen VA, 2006, FEBS LETT, V580, P4587, DOI 10.1016/j.febslet.2006.07.028; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; WATTENBERG LW, 1992, CANCER RES, V52, pS2085; Wattenberg LW, 1996, PREV MED, V25, P44, DOI 10.1006/pmed.1996.0015; WATTENBERG LW, 1985, CANCER RES, V45, P1; Wendel M, 2009, ANTI-CANCER AGENT ME, V9, P457, DOI 10.2174/1871520610909040457; Weylandt KH, 2011, CARCINOGENESIS; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; World Health Organization, CANC; Yam D, 2001, CANCER CHEMOTH PHARM, V47, P34, DOI 10.1007/s002800000205; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhou GD, 2005, CANCER EPIDEM BIOMAR, V14, P1230, DOI 10.1158/1055-9965.EPI-04-0759; Zhou GD, 2004, INT J CANCER, V112, P877, DOI 10.1002/ijc.20375; Zhou GD, 1999, NUTR CANCER, V35, P87, DOI 10.1207/S1532791487-95; Zhou GD, 2010, TOXICOL APPL PHARM, V249, P224, DOI 10.1016/j.taap.2010.09.019; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128	55	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26589	10.1371/journal.pone.0026589	http://dx.doi.org/10.1371/journal.pone.0026589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066002	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000018
J	Costa, FF; Bischof, JM; Vanin, EF; Lulla, RR; Wang, M; Sredni, ST; Rajaram, V; Bonaldo, MD; Wang, DL; Goldman, S; Tomita, T; Soares, MB				Costa, Fabricio F.; Bischof, Jared M.; Vanin, Elio F.; Lulla, Rishi R.; Wang, Min; Sredni, Simone T.; Rajaram, Veena; Bonaldo, Maria de Fatima; Wang, Deli; Goldman, Stewart; Tomita, Tadanori; Soares, Marcelo B.			Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma	PLOS ONE			English	Article							INTRACRANIAL EPENDYMOMA; EXPRESSION; GLIOMA; CELLS; LET-7; PCR	Introduction: We have examined expression of microRNAs (miRNAs) in ependymomas to identify molecular markers of value for clinical management. miRNAs are non-coding RNAs that can block mRNA translation and affect mRNA stability. Changes in the expression of miRNAs have been correlated with many human cancers. Materials and Methods: We have utilized TaqMan Low Density Arrays to evaluate the expression of 365 miRNAs in ependymomas and normal brain tissue. We first demonstrated the similarity of expression profiles of paired frozen tissue (FT) and paraffin-embedded specimens (FFPE). We compared the miRNA expression profiles of 34 FFPE ependymoma samples with 8 microdissected normal brain tissue specimens enriched for ependymal cells. miRNA expression profiles were then correlated with tumor location, histology and other clinicopathological features. Results: We have identified miRNAs that are over-expressed in ependymomas, such as miR-135a and miR-17-5p, and down-regulated, such as miR-383 and miR-485-5p. We have also uncovered associations between expression of specific miRNAs which portend a worse prognosis. For example, we have identified a cluster of miRNAs on human chromosome 14q32 that is associated with time to relapse. We also found that miR-203 is an independent marker for relapse compared to the parameters that are currently used. Additionally, we have identified three miRNAs (let-7d, miR-596 and miR-367) that strongly correlate to overall survival. Conclusion: We have identified miRNAs that are differentially expressed in ependymomas compared with normal ependymal tissue. We have also uncovered significant associations of miRNAs with clinical behavior. This is the first report of clinically relevant miRNAs in ependymomas.	[Costa, Fabricio F.; Bischof, Jared M.; Vanin, Elio F.; Lulla, Rishi R.; Wang, Min; Sredni, Simone T.; Bonaldo, Maria de Fatima; Soares, Marcelo B.] Northwestern Univ, Childrens Mem Res Ctr, Canc Biol & Epigenom Program, Feinberg Sch Med, Chicago, IL 60611 USA; [Costa, Fabricio F.; Bischof, Jared M.; Vanin, Elio F.; Lulla, Rishi R.; Wang, Min; Sredni, Simone T.; Bonaldo, Maria de Fatima; Soares, Marcelo B.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Rajaram, Veena] Childrens Mem Hosp, Dept Pathol & Lab Med, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago	Costa, FF (corresponding author), Northwestern Univ, Childrens Mem Res Ctr, Canc Biol & Epigenom Program, Feinberg Sch Med, Chicago, IL 60611 USA.	fcosta@childrensmemorial.org; m-soares@northwestern.edu	Costa, Fabricio/M-5309-2017; Lien, Brian/AAI-7882-2020	Lulla, Rishi/0000-0003-4109-2207; Sredni, Simone/0000-0002-1715-3885	Everett/O'Connor Charitable Trust; Dr. Ralph & Marian C. Falk Medical Research Trust; Gus Foundation; Maeve McNicholas Memorial Foundation; Medical Research Institute Council	Everett/O'Connor Charitable Trust; Dr. Ralph & Marian C. Falk Medical Research Trust; Gus Foundation; Maeve McNicholas Memorial Foundation; Medical Research Institute Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was in part supported by the Everett/O'Connor Charitable Trust, Dr. Ralph & Marian C. Falk Medical Research Trust, Gus Foundation, The Maeve McNicholas Memorial Foundation and the Medical Research Institute Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birks DK, 2011, PEDIATR BLOOD CANCER, V56, P211, DOI 10.1002/pbc.22723; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHIANG Y, 2010, J GASTROINTEST SURG; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; JENNINGS MT, 1994, HUM PATHOL, V25, P464, DOI 10.1016/0046-8177(94)90118-X; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Li SSL, 2009, J CELL BIOCHEM, V106, P1020, DOI 10.1002/jcb.22084; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Massimino M, 2009, FUTURE ONCOL, V5, P207, DOI 10.2217/14796694.5.2.207; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Monoranu CM, 2008, CANCER GENET CYTOGEN, V182, P18, DOI 10.1016/j.cancergencyto.2007.12.008; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Robbins Cotran, 2005, CENTRAL NERVOUS SYST; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Szafranska AE, 2008, J MOL DIAGN, V10, P415, DOI 10.2353/jmoldx.2008.080018; Tabori U, 2008, BRIT J CANCER, V99, P1129, DOI 10.1038/sj.bjc.6604652; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tihan T, 2008, MODERN PATHOL, V21, P165, DOI 10.1038/modpathol.3800999; Williams SV, 2010, GENE CHROMOSOME CANC, V49, P642, DOI 10.1002/gcc.20775; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Xie HH, 2010, P NATL ACAD SCI USA, V107, P6952, DOI 10.1073/pnas.0913836107; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	39	92	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e25114	10.1371/journal.pone.0025114	http://dx.doi.org/10.1371/journal.pone.0025114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053178	Green Submitted, gold, Green Published			2022-12-27	WOS:000299081800004
J	da Costa, G; Gomes, RA; Guerreiro, A; Mateus, E; Monteiro, E; Barroso, E; Coelho, AV; Freire, AP; Cordeiro, C				da Costa, Goncalo; Gomes, Ricardo A.; Guerreiro, Ana; Mateus, Elia; Monteiro, Estela; Barroso, Eduardo; Coelho, Ana V.; Freire, Ana Ponces; Cordeiro, Carlos			Beyond Genetic Factors in Familial Amyloidotic Polyneuropathy: Protein Glycation and the Loss of Fibrinogen's Chaperone Activity	PLOS ONE			English	Article							HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS; TTR MET 30; END-PRODUCTS; LIVER-TRANSPLANTATION; HUMAN TRANSTHYRETIN; MONOZYGOTIC TWINS; ALZHEIMER-DISEASE; FIBRIL FORMATION; 2 PAIRS; METHYLGLYOXAL	Familial amyloidotic polyneuropathy (FAP) is a systemic conformational disease characterized by extracellular amyloid fibril formation from plasma transthyretin (TTR). This is a crippling, fatal disease for which liver transplantation is the only effective therapy. More than 80 TTR point mutations are associated with amyloidotic diseases and the most widely accepted disease model relates TTR tetramer instability with TTR point mutations. However, this model fails to explain two observations. First, native TTR also forms amyloid in systemic senile amyloidosis, a geriatric disease. Second, age at disease onset varies by decades for patients bearing the same mutation and some mutation carrier individuals are asymptomatic throughout their lives. Hence, mutations only accelerate the process and non-genetic factors must play a key role in the molecular mechanisms of disease. One of these factors is protein glycation, previously associated with conformational diseases like Alzheimer's and Parkinson's. The glycation hypothesis in FAP is supported by our previous discovery of methylglyoxal-derived glycation of amyloid fibrils in FAP patients. Here we show that plasma proteins are differentially glycated by methylglyoxal in FAP patients and that fibrinogen is the main glycation target. Moreover, we also found that fibrinogen interacts with TTR in plasma. Fibrinogen has chaperone activity which is compromised upon glycation by methylglyoxal. Hence, we propose that methylglyoxal glycation hampers the chaperone activity of fibrinogen, rendering TTR more prone to aggregation, amyloid formation and ultimately, disease.	[da Costa, Goncalo; Guerreiro, Ana; Freire, Ana Ponces; Cordeiro, Carlos] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal; [Gomes, Ricardo A.; Coelho, Ana V.] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Mateus, Elia; Monteiro, Estela] Hosp Curry Cabral, Unidade Transplantacao Hepat, Lisbon, Portugal; [Coelho, Ana V.] Univ Evora, Dept Quim, Evora, Portugal	Universidade de Lisboa; University of Evora	da Costa, G (corresponding author), Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal.	caac@fc.ul.pt	Coelho, Ana V/H-8885-2012; FT-ICR-MS, Lisboa/T-5273-2018; Coelho, Ana V Varela/O-3977-2014; da Costa, Gonçalo/H-9059-2012; Gomes, Ricardo/E-8379-2012; Costa, Goncalo/G-9100-2014	Coelho, Ana V/0000-0002-6143-4203; Coelho, Ana V Varela/0000-0002-6143-4203; da Costa, Gonçalo/0000-0001-8732-4478; Gomes, Ricardo/0000-0001-7155-0059; Costa, Goncalo/0000-0001-8732-4478; Ponces-Freire, Ana/0000-0003-2280-8193; Leite Guerreiro, Ana Catarina/0000-0001-7733-6336; Mateus, Elia/0000-0001-8632-3983; Barroso, Eduardo/0000-0001-9059-7362; Cordeiro, Carlos/0000-0001-6327-8606	Fundacao para a Ciencia e a Tecnologia do Ministerio da Ciencia Tecnologia e Ensino Superior, Portugal [REDE/1501/REM/2005, PDTC/QUI/70610/2006, SFRH/BPD/41037/2007]; Centro de Quimica e Bioquimica [QUI-LVT-612]	Fundacao para a Ciencia e a Tecnologia do Ministerio da Ciencia Tecnologia e Ensino Superior, Portugal; Centro de Quimica e Bioquimica	We acknowledge the Fundacao para a Ciencia e a Tecnologia do Ministerio da Ciencia Tecnologia e Ensino Superior, Portugal (www.fct.mctes.pt), for the Instrument Network Grant [REDE/1501/REM/2005], for grants [PDTC/QUI/70610/2006] and [SFRH/BPD/41037/2007], and Centro de Quimica e Bioquimica (http://cqb.fc.ul.pt/) pluriannual funding [QUI-LVT-612]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altland K, 2003, ELECTROPHORESIS, V24, P2265, DOI 10.1002/elps.200305464; Ando E, 2001, ANN INTERN MED, V135, P931, DOI 10.7326/0003-4819-135-10-200111200-00026; ANDO Y, 1991, J AUTONOM NERV SYST, V35, P63, DOI 10.1016/0165-1838(91)90039-6; ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; Azoulay D, 1999, J AM COLL SURGEONS, V189, P584, DOI 10.1016/S1072-7515(99)00208-2; Beirao I, 2004, KIDNEY INT, V66, P2004, DOI 10.1111/j.1523-1755.2004.00971.x; Beirao I, 1999, CLIN NEPHROL, V51, P45; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bumagina Z, 2010, INT J MOL SCI, V11, P4556, DOI 10.3390/ijms11114556; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; da Costa G, 2008, J CHEM ECOL, V34, P376, DOI 10.1007/s10886-007-9413-z; Da Costa G, 2009, AMYLOID, V16, P201, DOI 10.3109/13506120903421561; da Costa G, 2010, PROTEOM CLIN APPL, V4, P674, DOI 10.1002/prca.200900118; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Geroldi D, 2006, J AM GERIATR SOC, V54, P1149, DOI 10.1111/j.1532-5415.2006.00776.x; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Gomes RA, 2008, BIOCHEM J, V416, P317, DOI 10.1042/BJ20080632; Gomes RA, 2008, FEMS YEAST RES, V8, P174, DOI 10.1111/j.1567-1364.2007.00337.x; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Holmgren G, 2005, J MED GENET, V42, P953, DOI 10.1136/jmg.2005.033720; Holmgren G, 2004, J INTERN MED, V256, P453, DOI 10.1111/j.1365-2796.2004.01399.x; Holmgren G, 1997, AMYLOID, V4, P178, DOI 10.3109/13506129709014382; Hoshii Y, 1996, PATHOL INT, V46, P738, DOI 10.1111/j.1440-1827.1996.tb03542.x; IKEDA S, 1992, EUR NEUROL, V32, P308, DOI 10.1159/000116850; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Liepnieks JJ, 2010, NEUROLOGY, V75, P324, DOI 10.1212/WNL.0b013e3181ea15d4; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Misciagna G, 2005, J AM COLL NUTR, V24, P22, DOI 10.1080/07315724.2005.10719439; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; MIYATA T, 1994, J CLIN INVEST, V93, P521, DOI 10.1172/JCI117002; Munar-Ques M, 1999, J MED GENET, V36, P629; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; Munch G, 1998, J NEURAL TRANSM, V105, P439, DOI 10.1007/s007020050069; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; Nyhlin N, 2000, J INTERN MED, V247, P485, DOI 10.1046/j.1365-2796.2000.00668.x; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Rudolph T, 2008, CLIN MED RES, V6, P80, DOI 10.3121/cmr.2008.794; Santos R, 2009, MAR BIOTECHNOL, V11, P686, DOI 10.1007/s10126-009-9182-5; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Sasaki N, 2002, NEUROSCI LETT, V326, P117, DOI 10.1016/S0304-3940(02)00310-5; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; SKINNER M, 1994, ANN INTERN MED, V120, P133, DOI 10.7326/0003-4819-120-2-199401150-00006; Suhr OB, 2002, TRANSPLANTATION, V73, P674, DOI 10.1097/00007890-200203150-00016; Takei Y, 1999, ANN INTERN MED, V131, P592, DOI 10.7326/0003-4819-131-8-199910190-00008; Takei Y, 2007, LIVER TRANSPLANT, V13, P215, DOI 10.1002/lt.20954; TANAKA M, 1988, J NEUROL NEUROSUR PS, V51, P576, DOI 10.1136/jnnp.51.4.576; Tang HD, 2009, BIOCHEM BIOPH RES CO, V378, P662, DOI 10.1016/j.bbrc.2008.11.112; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Weiss Walter, 2009, Methods Mol Biol, V564, P13, DOI 10.1007/978-1-60761-157-8_2; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Westwood ME, 1997, BBA-MOL CELL RES, V1356, P84, DOI 10.1016/S0167-4889(96)00154-1; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296	66	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e24850	10.1371/journal.pone.0024850	http://dx.doi.org/10.1371/journal.pone.0024850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053176	Green Submitted, gold, Green Published			2022-12-27	WOS:000299081800002
J	Hazeki, K; Kametani, Y; Murakami, H; Uehara, M; Ishikawa, Y; Nigorikawa, K; Takasuga, S; Sasaki, T; Seya, T; Matsumoto, M; Hazeki, O				Hazeki, Kaoru; Kametani, Yukiko; Murakami, Hiroki; Uehara, Masami; Ishikawa, Yuki; Nigorikawa, Kiyomi; Takasuga, Shunsuke; Sasaki, Takehiko; Seya, Tsukasa; Matsumoto, Misako; Hazeki, Osamu			Phosphoinositide 3-Kinasec Controls the Intracellular Localization of CpG to Limit DNA-PKcs-Dependent IL-10 Production in Macrophages	PLOS ONE			English	Article							PI3K-GAMMA INHIBITION; RHEUMATOID-ARTHRITIS; NEGATIVE REGULATION; REGULATORY SUBUNIT; CELLS REQUIRES; BACTERIAL-DNA; I INTERFERON; ACTIVATION; KINASE; P110-GAMMA	Synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG) stimulate innate immune responses. Phosphoinositide 3-kinase (PI3K) has been implicated in CpG-induced immune activation; however, its precise role has not yet been clarified. CpG-induced production of IL-10 was dramatically increased in macrophages deficient in PI3K gamma (p110 gamma(-/-)). By contrast, LPS-induced production of IL-10 was unchanged in the cells. CpG-induced, but not LPS-induced, IL-10 production was almost completely abolished in SCID mice having mutations in DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Furthermore, wortmannin, an inhibitor of DNA-PKcs, completely inhibited CpG-induced IL-10 production, both in wild type and p110 gamma(-/-) cells. Microscopic analyses revealed that CpG preferentially localized with DNA-PKcs in p110 gamma(-/-) cells than in wild type cells. In addition, CpG was preferentially co-localized with the acidic lysosomal marker, LysoTracker, in p110 gamma(-/-) cells, and with an early endosome marker, EEA1, in wild type cells. Over-expression of p110 gamma in Cos7 cells resulted in decreased acidification of CpG containing endosome. A similar effect was reproduced using kinase-dead mutants, but not with a ras-binding site mutant, of p110 gamma. Thus, it is likely that p110 gamma, in a manner independent of its kinase activity, inhibits the acidification of CpG-containing endosomes. It is considered that increased acidification of CpG-containing endosomes in p110 gamma(-/-) cells enforces endosomal escape of CpG, which results in increased association of CpG with DNA-PKcs to up-regulate IL-10 production in macrophages.	[Hazeki, Kaoru; Kametani, Yukiko; Murakami, Hiroki; Uehara, Masami; Ishikawa, Yuki; Nigorikawa, Kiyomi; Hazeki, Osamu] Hiroshima Univ, Div Mol Med Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Takasuga, Shunsuke; Sasaki, Takehiko] Akita Univ, Sch Med, Dept Pathol & Immunol, Akita 010, Japan; [Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan	Hiroshima University; Akita University; Hokkaido University	Hazeki, K (corresponding author), Hiroshima Univ, Div Mol Med Sci, Grad Sch Biomed Sci, Hiroshima, Japan.	khazeki@hiroshima-u.ac.jp	Seya, Tsukasa/A-4336-2012	Sasaki, Takehiko/0000-0003-1837-3748	 [KAKENHI20590060];  [22590065];  [23590078];  [KAKENHI22114008]; Grants-in-Aid for Scientific Research [24659214, 23590558, 22114008] Funding Source: KAKEN	; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (C), KAKENHI20590060, 22590065 and 23590078, and Grant-in-Aid for Scientific Research on Innovative Areas, KAKENHI22114008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hazeki K, 2006, MOL PHARMACOL, V69, P1717, DOI 10.1124/mol.105.021162; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirsch E, 2009, TRENDS BIOCHEM SCI, V34, P244, DOI 10.1016/j.tibs.2009.02.003; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Ohashi PS, 2005, NAT MED, V11, P924, DOI 10.1038/nm0905-924; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Saegusa K, 2007, MOL IMMUNOL, V44, P1323, DOI 10.1016/j.molimm.2006.05.008; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Wilson HL, 2006, INT REV IMMUNOL, V25, P183, DOI 10.1080/08830180600785868; Yotsumoto S, 2008, J IMMUNOL, V180, P809, DOI 10.4049/jimmunol.180.2.809	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26836	10.1371/journal.pone.0026836	http://dx.doi.org/10.1371/journal.pone.0026836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053215	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800048
J	Celorio-Mancera, MD; Courtiade, J; Muck, A; Heckel, DG; Musser, RO; Vogel, H				Celorio-Mancera, Maria de la Paz; Courtiade, Juliette; Muck, Alexander; Heckel, David G.; Musser, Richard O.; Vogel, Heiko			Sialome of a Generalist Lepidopteran Herbivore: Identification of Transcripts and Proteins from Helicoverpa armigera Labial Salivary Glands	PLOS ONE			English	Article							GALLERIA-MELLONELLA; GLUCOSE-OXIDASE; GMC OXIDOREDUCTASES; MASS-SPECTROMETRY; BOMBYX-MORI; INSECT; LYSOZYME; GENE; ENZYME; INHIBITOR	Although the importance of insect saliva in insect-host plant interactions has been acknowledged, there is very limited information on the nature and complexity of the salivary proteome in lepidopteran herbivores. We inspected the labial salivary transcriptome and proteome of Helicoverpa armigera, an important polyphagous pest species. To identify the majority of the salivary proteins we have randomly sequenced 19,389 expressed sequence tags (ESTs) from a normalized cDNA library of salivary glands. In parallel, a non-cytosolic enriched protein fraction was obtained from labial salivary glands and subjected to two-dimensional gel electrophoresis (2-DE) and de novo peptide sequencing. This procedure allowed comparison of peptides and EST sequences and enabled us to identify 65 protein spots from the secreted labial saliva 2DE proteome. The mass spectrometry analysis revealed ecdysone, glucose oxidase, fructosidase, carboxyl/cholinesterase and an uncharacterized protein previously detected in H. armigera midgut proteome. Consistently, their corresponding transcripts are among the most abundant in our cDNA library. We did find redundancy of sequence identification of saliva-secreted proteins suggesting multiple isoforms. As expected, we found several enzymes responsible for digestion and plant offense. In addition, we identified non-digestive proteins such as an arginine kinase and abundant proteins of unknown function. This identification of secreted salivary gland proteins allows a more comprehensive understanding of insect feeding and poses new challenges for the elucidation of protein function.	[Celorio-Mancera, Maria de la Paz; Courtiade, Juliette; Muck, Alexander; Heckel, David G.; Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Musser, Richard O.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	Max Planck Society; Western Illinois University	Celorio-Mancera, MD (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	hvogel@ice.mpg.de	Heckel, David G/K-2138-2013; de la Paz Celorio-Mancera, Maria/ABG-2046-2020; Celorio Mancera, Maria de la Paz/J-6687-2012	Heckel, David G/0000-0001-8991-2150; de la Paz Celorio-Mancera, Maria/0000-0003-0296-0577; Musser, Richard/0000-0002-9331-4249	Max Planck Society; National Science Foundation Plant Genome Research Initiative [0820367]; Direct For Biological Sciences [0820367] Funding Source: National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation Plant Genome Research Initiative; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Max Planck Society. Partial support for collaborative travel was provided by the National Science Foundation Plant Genome Research Initiative (No. 0820367 to ROM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai Hiromu, 2003, Handbuch der Zoologie (Berlin), V4, P377; Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; Araujo RN, 2007, INT J PARASITOL, V37, P1351, DOI 10.1016/j.ijpara.2007.04.017; ARRESE EL, 1994, J LIPID RES, V35, P1652; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assumpcao TCF, 2011, J PROTEOME RES, V10, P669, DOI 10.1021/pr100866h; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; BURTON RL, 1976, J INSECT PHYSIOL, V22, P1045, DOI 10.1016/0022-1910(76)90110-4; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Calvo E, 2008, INSECT BIOCHEM MOLEC, V38, P499, DOI 10.1016/j.ibmb.2007.12.006; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Celorio-Mancera MP, 2011, BMC GENOMIC IN PRESS; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Cong LN, 2009, J BIOSCI BIOENG, V107, P583, DOI 10.1016/j.jbiosc.2009.01.016; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Huq NL, 2007, INT J PEPT RES THER, V13, P547, DOI 10.1007/s10989-007-9109-9; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Kirsch R, 2011, P NATL ACAD SCI USA, V108, P4897, DOI 10.1073/pnas.1013846108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMOS FJA, 1991, COMP BIOCHEM PHYS B, V100, P265, DOI 10.1016/0305-0491(91)90372-K; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414; Maczkowiak F, 2006, GENETICA, V128, P145, DOI 10.1007/s10709-005-5578-y; Martins RM, 2006, BIOCHEMISTRY-US, V45, P1765, DOI 10.1021/bi0514515; Mathews MC, 1997, ARCH INSECT BIOCHEM, V34, P57, DOI 10.1002/(SICI)1520-6327(1997)34:1<57::AID-ARCH5>3.0.CO;2-T; Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P138, DOI 10.1002/arch.20031; Musser RO, 2002, J CHEM ECOL, V28, P1691, DOI 10.1023/A:1019985417720; Nakagawa H, 2007, GLYCOBIOLOGY, V17, P157, DOI 10.1093/glycob/cwl058; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; POWNING RF, 1973, COMP BIOCHEM PHYSIOL, V45, P669, DOI 10.1016/0305-0491(73)90205-8; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Samaranayake YH, 1997, APMIS, V105, P875, DOI 10.1111/j.1699-0463.1997.tb05097.x; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tunaz H, 2004, COMP BIOCHEM PHYS B, V139, P27, DOI 10.1016/j.cbpc.2004.05.010; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1199, DOI 10.1016/S0965-1748(02)00083-8; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wedde M, 1998, EUR J BIOCHEM, V255, P535, DOI 10.1046/j.1432-1327.1998.2550535.x; Wedde M, 2007, BIOL CHEM, V388, P119, DOI 10.1515/BC.2007.013; Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025; Zong N, 2004, CHINESE SCI BULL, V49, P1596, DOI 10.1360/03wc0185	70	34	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26676	10.1371/journal.pone.0026676	http://dx.doi.org/10.1371/journal.pone.0026676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046331	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400031
J	Xu, QH; Ni, SJ; Wu, F; Liu, F; Ye, X; Mougin, B; Meng, X; Du, X				Xu, Qinghua; Ni, Shujuan; Wu, Fei; Liu, Fang; Ye, Xun; Mougin, Bruno; Meng, Xia; Du, Xiang			Investigation of Variation in Gene Expression Profiling of Human Blood by Extended Principle Component Analysis	PLOS ONE			English	Article							WHOLE-BLOOD; MICROARRAY ANALYSIS; RNA EXTRACTION; BIOINFORMATICS; NORMALIZATION; DECONVOLUTION; AMPLIFICATION; TRANSCRIPTOME; BIOCONDUCTOR; SUMMARIES	Background: Human peripheral blood is a promising material for biomedical research. However, various kinds of biological and technological factors result in a large degree of variation in blood gene expression profiles. Methodology/Principal Findings: Human peripheral blood samples were drawn from healthy volunteers and analysed using the Human Genome U133Plus2 Microarray. We applied a novel approach using the Principle Component Analysis and Eigen-R-2 methods to dissect the overall variation of blood gene expression profiles with respect to the interested biological and technological factors. The results indicated that the predominating sources of the variation could be traced to the individual heterogeneity of the relative proportions of different blood cell types (leukocyte subsets and erythrocytes). The physiological factors like age, gender and BMI were demonstrated to be associated with 5.3% to 9.2% of the total variation in the blood gene expression profiles. We investigated the gene expression profiles of samples from the same donors but with different levels of RNA quality. Although the proportion of variation associated to the RNA Integrity Number was mild (2.1%), the significant impact of RNA quality on the expression of individual genes was observed. Conclusions: By characterizing the major sources of variation in blood gene expression profiles, such variability can be minimized by modifications to study designs. Increasing sample size, balancing confounding factors between study groups, using rigorous selection criteria for sample quality, and well controlled experimental processes will significantly improve the accuracy and reproducibility of blood transcriptome study.	[Xu, Qinghua; Wu, Fei; Liu, Fang; Ye, Xun; Meng, Xia] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China; [Ni, Shujuan; Du, Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Ni, Shujuan; Du, Xiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Mougin, Bruno] Ctr Christophe Merieux, Grenoble, France; [Ni, Shujuan; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Xu, QH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China.	dx2008cn@yahoo.com.cn	XU, Qinghua/AAZ-9641-2021	XU, Qinghua/0000-0002-9380-5566	International Cooperation and Exchanges Foundation of Shanghai [074107060]; bioMerieux company; National Natural Science Foundation of China [81071791]	International Cooperation and Exchanges Foundation of Shanghai; bioMerieux company; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the International Cooperation and Exchanges Foundation of Shanghai (074107060) and from the bioMerieux company. This study was partially supported by grants from National Natural Science Foundation of China (Grant No. 81071791). As QX, FW, FL, XY, BM and XM are the employees of bioMerieux company and have contributed to this work, hence, as one of the funders, bioMerieux company played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen LS, 2008, BIOINFORMATICS, V24, P2260, DOI 10.1093/bioinformatics/btn411; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gnatenko Dmitri V., 2009, V496, P245, DOI 10.1007/978-1-59745-553-4_16; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karlovich C, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-33; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Li L, 2005, J MOL DIAGN, V7, P48, DOI 10.1016/S1525-1578(10)60008-6; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Radich JP, 2004, GENOMICS, V83, P980, DOI 10.1016/j.ygeno.2003.12.013; Rainen L, 2002, CLIN CHEM, V48, P1883; Schoor O, 2003, BIOTECHNIQUES, V35, P1192, DOI 10.2144/03356rr01; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schroeder LD, 1986, UNDERSTANDING REGRES, P96; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Staratschek-Jox A, 2009, EXPERT REV MOL DIAGN, V9, P271, DOI 10.1586/ERM.09.9; Thach DC, 2003, J IMMUNOL METHODS, V283, P269, DOI 10.1016/j.jim.2003.10.004; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wang J, 2004, CLIN BIOCHEM, V37, P741, DOI 10.1016/j.clinbiochem.2004.03.013; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wissler C, 1905, SCIENCE, V22, P309, DOI 10.1126/science.22.558.309; Yang T, 2004, MOL BRAIN RES, V132, P155, DOI 10.1016/j.molbrainres.2003.10.014	44	18	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26905	10.1371/journal.pone.0026905	http://dx.doi.org/10.1371/journal.pone.0026905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046403	Green Published, gold			2022-12-27	WOS:000296521400045
J	Jayakumar, C; Mohamed, R; Ranganathan, PV; Ramesh, G				Jayakumar, Calpurnia; Mohamed, Riyaz; Ranganathan, Punithavathi Vilapakkam; Ramesh, Ganesan			Intracellular Kinases Mediate Increased Translation and Secretion of Netrin-1 from Renal Tubular Epithelial Cells	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PROMOTES ANGIOGENESIS; UNC5B RECEPTOR; KIDNEY; INFLAMMATION; PERVANADATE; MIGRATION; PROTECTS; PATHWAY	Background: Netrin-1 is a laminin-related secreted protein, is highly induced after tissue injury, and may serve as a marker of injury. However, the regulation of netrin-1 production is not unknown. Current study was carried out in mouse and mouse kidney cell line (TKPTS) to determine the signaling pathways that regulate netrin-1 production in response to injury. Methods and Principal Findings: Ischemia reperfusion injury of the kidney was induced in mice by clamping renal pedicle for 30 minutes. Cellular stress was induced in mouse proximal tubular epithelial cell line by treating with pervanadate, cisplatin, lipopolysaccharide, glucose or hypoxia followed by reoxygenation. Netrin-1 expression was quantified by real time RT-PCR and protein production was quantified using an ELISA kit. Cellular stress induced a large increase in netrin-1 production without increase in transcription of netrin-1 gene. Mitogen activated protein kinase, ERK mediates the drug induced netrin-1 mRNA translation increase without altering mRNA stability. Conclusion: Our results suggest that netrin-1 expression is suppressed at the translational level and MAPK activation leads to rapid translation of netrin-1 mRNA in the kidney tubular epithelial cells.	[Jayakumar, Calpurnia; Mohamed, Riyaz; Ranganathan, Punithavathi Vilapakkam; Ramesh, Ganesan] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA	University System of Georgia; Augusta University	Jayakumar, C (corresponding author), Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA.	gramesh@georgiahealth.edu	Ramesh, Ganesan/C-9134-2014	Ramesh, Ganesan/0000-0002-8968-0721; Mohamed, Riyaz/0000-0003-2398-3057	NIH-NIDDK [R01DK083379 - 02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083379] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from NIH-NIDDK (R01DK083379 - 02) to Ganesan Ramesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Daum G, 1998, FEBS LETT, V427, P271, DOI 10.1016/S0014-5793(98)00448-7; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; HIMMELFARB J, 2008, CLIN J AM SOC NEPHRO; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Mirakaj V, 2010, AM J RESP CRIT CARE; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; RAJASUNDARI A, 2011, LAB INVEST; Ramesh G, 2007, AM J PHYSIOL-RENAL, V292, pF812, DOI 10.1152/ajprenal.00277.2006; Ramesh G, 2011, BIOMARKERS, V16, P172, DOI 10.3109/1354750X.2010.541564; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Reeves WB, 2008, AM J PHYSIOL-RENAL, V294, pF731, DOI 10.1152/ajprenal.00507.2007; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PHYSIOL-RENAL, V296, pF723, DOI 10.1152/ajprenal.90686.2008; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251	20	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26776	10.1371/journal.pone.0026776	http://dx.doi.org/10.1371/journal.pone.0026776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046354	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600057
J	Kewalramani, G; Fink, LN; Asadi, F; Klip, A				Kewalramani, Girish; Fink, Lisbeth Nielsen; Asadi, Farzad; Klip, Amira			Palmitate-Activated Macrophages Confer Insulin Resistance to Muscle Cells by a Mechanism Involving Protein Kinase C theta and epsilon	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE MACROPHAGES; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; RECEPTOR SUBSTRATE-1; FATTY-ACIDS; TNF-ALPHA; SERINE PHOSPHORYLATION; IL-2 PROMOTER; PKC-THETA	Background: Macrophage-derived factors contribute to whole-body insulin resistance, partly by impinging on metabolically active tissues. As proof of principle for this interaction, conditioned medium from macrophages treated with palmitate (CMPA) reduces insulin action and glucose uptake in muscle cells. However, the mechanism whereby CM-PA confers this negative response onto muscle cells remains unknown. Methodology/Principal Findings: L6-GLUT4myc myoblasts were exposed for 24 h to palmitate-free conditioned medium from RAW 264.7 macrophages pre-treated with 0.5 mM palmitate for 6 h. This palmitate-free CM-PA, containing selective cytokines and chemokines, inhibited myoblast insulin-stimulated insulin receptor substrate 1 (IRS1) tyrosine phosphorylation, AS160 phosphorylation, GLUT4 translocation and glucose uptake. These effects were accompanied by a rise in c-Jun N-terminal kinase (JNK) activation, degradation of Inhibitor of kappa B alpha (I kappa B alpha), and elevated expression of proinflammatory cytokines in myoblasts. Notably, CM-PA caused IRS1 phosphorylation on Ser1101, and phosphorylation of novel PKC theta and epsilon. Co-incubation of myoblasts with CM-PA and the novel and conventional PKC inhibitor Go6983 (but not with the conventional PKC inhibitor Go6976) prevented PKC theta and epsilon activation, JNK phosphorylation, restored I kappa B alpha mass and reduced proinflammatory cytokine production. Go6983 also restored insulin signalling and glucose uptake in myoblasts. Moreover, co-silencing both novel PKC theta and epsilon isoforms in myoblasts by RNA interference, but not their individual silencing, prevented the inflammatory response and restored insulin sensitivity to CM-PA-treated myoblasts. Conclusions/Clinical Significance: The results suggest that the block in muscle insulin action caused by CM-PA is mediated by novel PKC theta and PKC epsilon. This study re-establishes the participation of macrophages as a relay in the action of fatty acids on muscle cells, and further identifies PKC theta and PKC epsilon as key elements in the inflammatory and insulin resistance responses of muscle cells to macrophage products. Furthermore, it portrays these PKC isoforms as potential targets for the treatment of fatty acid-induced, inflammation-linked insulin resistance.	[Kewalramani, Girish; Fink, Lisbeth Nielsen; Asadi, Farzad; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Fink, Lisbeth Nielsen] Novo Nordisk AS, Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Asadi, Farzad] Univ Tehran, Sch Vet Med, Dept Biochem, Tehran, Iran	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Novo Nordisk; Hagedorn Research Institute; University of Tehran	Kewalramani, G (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca	Fink, Lisbeth/AAN-7830-2020; Fink, Lisbeth N/F-8344-2010	Fink, Lisbeth N/0000-0003-3621-8098	Canadian Institutes of Health Research [MT12601]; Mathematics of Information Technology and Complex Systems (MITACS); Hagedorn Research Institute, Novo Nordisk A/S, Gentofte, Denmark	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Mathematics of Information Technology and Complex Systems (MITACS); Hagedorn Research Institute, Novo Nordisk A/S, Gentofte, Denmark	This work was supported by grant MT12601 to Amira Klip from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). Girish Kewalramani was supported by a Mathematics of Information Technology and Complex Systems (MITACS) post-doctoral fellowship. Hagedorn Research Institute, Novo Nordisk A/S, Gentofte, Denmark supported this study through a postdoctoral international fellowship to and the employment of Lisbeth Nielsen Fink, who helped perform the experiments, analyse the data and write the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; Barma P, 2009, BBA-MOL BASIS DIS, V1792, P190, DOI 10.1016/j.bbadis.2008.11.014; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Chen LY, 2005, J BIOL CHEM, V280, P22497, DOI 10.1074/jbc.M413033200; CHIN JE, 1994, MOL ENDOCRINOL, V8, P51, DOI 10.1210/me.8.1.51; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Dey D, 2006, MOL CELL ENDOCRINOL, V246, P60, DOI 10.1016/j.mce.2005.12.014; Dey D, 2005, CELL PHYSIOL BIOCHEM, V16, P217, DOI 10.1159/000089847; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Ikeda Y, 2001, DIABETES, V50, P584, DOI 10.2337/diabetes.50.3.584; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Ji YY, 2009, BIOCHEM PHARMACOL, V78, P1186, DOI 10.1016/j.bcp.2009.06.095; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kawai Y, 2002, IUBMB LIFE, V54, P365, DOI 10.1080/15216540216031; Kellerer M, 1997, FEBS LETT, V418, P119, DOI 10.1016/S0014-5793(97)01357-4; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Li YP, 1999, ANTIOXID REDOX SIGN, V1, P97, DOI 10.1089/ars.1999.1.1-97; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mack E, 2008, DIABETES-METAB RES, V24, P577, DOI 10.1002/dmrr.881; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Nasser MW, 2005, J IMMUNOL, V174, P6927, DOI 10.4049/jimmunol.174.11.6927; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Samokhvalov V, 2009, AM J PHYSIOL-ENDOC M, V296, pE37, DOI 10.1152/ajpendo.90667.2008; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zick Y, 2003, INT J OBESITY, V27, pS56, DOI 10.1038/sj.ijo.0802503	63	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26947	10.1371/journal.pone.0026947	http://dx.doi.org/10.1371/journal.pone.0026947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046423	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600083
J	Deng, KY; Chu, TG				Deng, Kuiying; Chu, Tianguang			Adaptive Evolution of Cooperation through Darwinian Dynamics in Public Goods Games	PLOS ONE			English	Article							STRATEGIES; DILEMMAS; TRAGEDY; COMMONS	The linear or threshold Public Goods game (PGG) is extensively accepted as a paradigmatic model to approach the evolution of cooperation in social dilemmas. Here we explore the significant effect of nonlinearity of the structures of public goods on the evolution of cooperation within the well-mixed population by adopting Darwinian dynamics, which simultaneously consider the evolution of populations and strategies on a continuous adaptive landscape, and extend the concept of evolutionarily stable strategy (ESS) as a coalition of strategies that is both convergent-stable and resistant to invasion. Results show (i) that in the linear PGG contributing nothing is an ESS, which contradicts experimental data, (ii) that in the threshold PGG contributing the threshold value is a fragile ESS, which cannot resist the invasion of contributing nothing, and (iii) that there exists a robust ESS of contributing more than half in the sigmoid PGG if the return rate is relatively high. This work reveals the significant effect of the nonlinearity of the structures of public goods on the evolution of cooperation, and suggests that, compared with the linear or threshold PGG, the sigmoid PGG might be a more proper model for the evolution of cooperation within the well-mixed population.	[Deng, Kuiying; Chu, Tianguang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Deng, Kuiying] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Chu, Tianguang] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China	Peking University; Uppsala University; Peking University	Deng, KY (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	RossDeng@pku.edu.cn; chutg@pku.edu.cn	Chu, Tianguang/C-3521-2012		National Natural Science Foundation of China [60974064, 60736022]; Erasmus Mundus External Cooperation Window LiSUM project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Erasmus Mundus External Cooperation Window LiSUM project	This work was supported by the National Natural Science Foundation of China under grant Nos. 60974064 and 60736022 (http://www.nsfc.gov.cn/Portal0/default124.htm). K. Deng acknowledges the support from a scholarship within the Erasmus Mundus External Cooperation Window LiSUM project (http://www.lisum.ugent.be/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELE S, 2005, ERIM REPORT SERIES R; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Axelrod R., 2006, EVOLUTION COOPERATIO; Brown JS, 2008, P ROY SOC B-BIOL SCI, V275, P1985, DOI 10.1098/rspb.2007.1685; Cohen Y, 1999, EVOL ECOL RES, V1, P923; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Frank, 1998, FDN SOCIAL EVOLUTION; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; McGill BJ, 2007, ANNU REV ECOL EVOL S, V38, P403, DOI 10.1146/annurev.ecolsys.36.091704.175517; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szathmary E, 1995, MAJOR TRANSITIONS EV; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Vincent TL, 1996, EVOL ECOL, V10, P567, DOI 10.1007/BF01237708; Wu ZX, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.022102	25	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25496	10.1371/journal.pone.0025496	http://dx.doi.org/10.1371/journal.pone.0025496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046240	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000006
J	Li, H; Zhang, XL; Bi, LJ; He, J; Jiang, T				Li, He; Zhang, Xiaoli; Bi, Lijun; He, Jin; Jiang, Tao			Determination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzae	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; ESCHERICHIA-COLI; INHIBITION; TRICLOSAN; MECHANISM; RESISTANCE; NADH	Background: Enoyl-ACP reductase (ENR) catalyses the last reduction reaction in the fatty acid elongation cycle in bacteria and is a good antimicrobial target candidate. FabV is the most recently discovered class of ENR, but we lack information about the atomic structure and the key residues involved in reductase activity except for the known conserved tyrosine and lysine residues in the Y-X-8-K active site motif. Methodology/Principal Findings: Here we report the crystal structure of FabV from Xanthomonas oryzae (xoFabV). The crystal structure of this enzyme has been solved to 1.6A resolution in space group P2(1)2(1)2(1). The model of xoFabV consists of one monomer in the asymmetric unit which is composed of 13 alpha-helices and 11 beta-strands, representing a canonical Rossmann fold architecture. Structural comparison presents that the locations of the conserved tyrosine (Y236) and lysine (K245) residues in the Y-X-8-K active site motif of xoFabV and the Y-X-6-K motif of ecFabI are notably similar. However, the conformations of Y236 in xoFabV and Y156 in ecFabI are distinct. Structure-based site-directed mutagenesis and enzymatic activity assays reveal that in addition to the conserved Y236 and K245 in the Y-X-8-K motif, Y53, D111 and Y226 are key residues implicated in the reductase activity, and F113 and T276 are also important for enzyme function. Moreover, a proposed active lysine located immediately after the Y-X-8-K motif in FabV from Burkholderia mallei (bmFabV) is altered to an inactive V246 in xoFabV. Conclusions/Significance: We determine the first crystal structure of the FabV enzyme and identify several residues important for its enzymatic activity. These findings lay a solid foundation for the development of specific antibacterial inhibitors of the pathogenic bacteria, such as Vibrio cholerae, Burkholderia species and Xanthomonas species.	[Li, He; Zhang, Xiaoli; Bi, Lijun; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhang, Xiaoli; He, Jin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Huazhong Agricultural University	Li, H (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	hejin@mail.hzau.edu.cn; tjiang@sun5.ibp.ac.cn			Chinese National Natural Science Funds [31070065]; Fundamental Research Funds for Central Universities of China [2009PY019]; Hubei Natural Science Fund of China [2010CDB10003]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities of China; Hubei Natural Science Fund of China	This work was supported by the Chinese National Natural Science Funds (Grant No. 31070065), the Fundamental Research Funds for Central Universities of China (2009PY019) and the Hubei Natural Science Fund of China (2010CDB10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baldock C, 1996, SCIENCE, V274, P2107, DOI 10.1126/science.274.5295.2107; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; Min J, 2011, J MOL CATAL B-ENZYM, V68, P174, DOI 10.1016/j.molcatb.2010.10.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saito J, 2008, PROTEIN SCI, V17, P691, DOI 10.1110/ps.073288808; Seefeld MA, 2003, J MED CHEM, V46, P1627, DOI 10.1021/jm0204035; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Yang H, 2010, BIOCONJUGATE CHEM, V21, P1341, DOI 10.1021/bc1001533; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	34	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26743	10.1371/journal.pone.0026743	http://dx.doi.org/10.1371/journal.pone.0026743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039545	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200049
J	Kim, TW; Moon, Y; Kim, K; Lee, JE; Koh, HC; Rhyu, IJ; Kim, H; Sun, W				Kim, Tae Woo; Moon, Younghye; Kim, Kyungjin; Lee, Jeong Eun; Koh, Hyun Chul; Rhyu, Im Joo; Kim, Hyun; Sun, Woong			Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; PROGRAMMED CELL-DEATH; SUBSTANTIA-NIGRA; GENE-TRANSFER; FACTOR AIF; RAT MODEL; POLY(ADP-RIBOSE) POLYMERASE-1; NEUROMUSCULAR DEVELOPMENT; NEUROTROPHIC FACTOR; MOTOR DYSFUNCTION	Parkinson's disease (PD) is a common, late-onset movement disorder with selective degeneration of dopaminergic (DA) neurons in the substantia nigra (SN). Although the neurotoxin 6-hydroxydopamine (6-OHDA) has been used to induce progressive degeneration of DA neurons in various animal models of PD, the precise molecular pathway and the impact of anti-apoptotic treatment on this neurodegeneration are less understood. Following a striatal injection of 6-OHDA, we observed atrophy and progressive death of DA neurons in wild-type mice. These degenerating DA neurons never exhibited signs of apoptosis (i.e., caspase-3 activation and cytoplasmic release of cytochrome C), but rather show nuclear translocation of apoptosis-inducing factor (AIF), a hallmark of regulated necrosis. However, mice with genetic deletion of the proapoptotic gene Bax (Bax-KO) exhibited a complete absence of 6-OHDA-induced DA neuron death and nuclear translocation of AIF, indicating that 6-OHDA-induced DA neuronal death is mediated by Bax-dependent AIF activation. On the other hand, DA neurons that survived in Bax-KO mice exhibited marked neuronal atrophy, without significant improvement of PD-related behavioral deficits. These findings suggest that anti-apoptotic therapy may not be sufficient for PD treatment, and the prevention of Bax-independent neuronal atrophy may be an important therapeutic target.	[Kim, Tae Woo; Moon, Younghye; Rhyu, Im Joo; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Program BK21, Dept Anat, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Lee, Jeong Eun; Koh, Hyun Chul] Hanyang Univ, Dept Pharmacol, Coll Med, Seoul 133791, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Hanyang University	Kim, TW (corresponding author), Korea Univ, Coll Med, Program BK21, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr		sun, woong/0000-0003-1792-4894; Moon, Younghye/0000-0002-3737-0043; Kim, Hyun/0000-0002-7210-5798; Rhyu, Im Joo/0000-0002-5558-6278	Korean Ministry of Education, Science and Technology [2010K000803, 20100020237, 20100000143]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korean Ministry of Education, Science and Technology Grants 2010K000803 (WS), 20100020237 (WS), and 20100000143 (WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Buss RR, 2006, J NEUROSCI, V26, P13413, DOI 10.1523/JNEUROSCI.3528-06.2006; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Crocker SJ, 2001, EUR J NEUROSCI, V14, P391, DOI 10.1046/j.0953-816x.2001.01653.x; Cutillas B, 1999, NEUROREPORT, V10, P2605, DOI 10.1097/00001756-199908200-00030; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Ebert AD, 2008, J NEUROSCI RES, V86, P317, DOI 10.1002/jnr.21480; Fonfria E, 2002, EUR J NEUROSCI, V16, P2013, DOI 10.1046/j.1460-9568.2002.02269.x; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; ICHITANI Y, 1994, EXP NEUROL, V130, P269, DOI 10.1006/exnr.1994.1205; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kramer BC, 2004, J NEUROCYTOL, V33, P213, DOI 10.1023/B:NEUR.0000030696.62829.ec; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Marti MJ, 2002, BRAIN RES, V958, P185, DOI 10.1016/S0006-8993(02)03694-6; Mladenovic A, 2004, BRAIN RES, V996, P237, DOI 10.1016/j.brainres.2003.10.035; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Mori A, 2005, NEUROSCI RES, V51, P265, DOI 10.1016/j.neures.2004.11.008; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Novikova L, 2006, NEUROSCIENCE, V140, P67, DOI 10.1016/j.neuroscience.2006.02.007; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Oiwa Y, 2003, J NEUROSURG, V98, P136, DOI 10.3171/jns.2003.98.1.0136; Park OH, 2007, EUR J NEUROSCI, V26, P1421, DOI 10.1111/j.1460-9568.2007.05787.x; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Reix S, 2007, NEUROBIOL AGING, V28, P351, DOI 10.1016/j.neurobiolaging.2006.01.003; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Spooren WPJM, 1998, NEUROSCIENCE, V85, P649; Sun W, 2003, MOL CELL NEUROSCI, V24, P875, DOI 10.1016/S1044-7431(03)00219-7; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Turmel H, 2001, MOVEMENT DISORD, V16, P185, DOI 10.1002/mds.1037; Vaudano E, 2001, EUR J NEUROSCI, V13, P1, DOI 10.1046/j.1460-9568.2001.01356.x; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Yang LC, 1998, J NEUROSCI, V18, P8145; Yu SW, 2009, ASN NEURO, V1, DOI 10.1042/AN20090046; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zheng JS, 2005, MOL BRAIN RES, V134, P155, DOI 10.1016/j.molbrainres.2004.06.029; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	76	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25346	10.1371/journal.pone.0025346	http://dx.doi.org/10.1371/journal.pone.0025346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043283	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400010
J	Lee, S; Jia, YL; Jia, M; Gealy, DR; Olsen, KM; Caicedo, AL				Lee, Seonghee; Jia, Yulin; Jia, Melissa; Gealy, David R.; Olsen, Kenneth M.; Caicedo, Ana L.			Molecular Evolution of the Rice Blast Resistance Gene Pi-ta in Invasive Weedy Rice in the USA	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; RED RICE; ORYZA-SATIVA; CULTIVATED RICE; FLOW; INFERENCE; INTROGRESSION; REGISTRATION; POLYMORPHISM; MUTATIONS	The Pi-ta gene in rice has been effectively used to control rice blast disease caused by Magnaporthe oryzae worldwide. Despite a number of studies that reported the Pi-ta gene in domesticated rice and wild species, little is known about how the Pi-ta gene has evolved in US weedy rice, a major weed of rice. To investigate the genome organization of the Pi-ta gene in weedy rice and its relationship to gene flow between cultivated and weedy rice in the US, we analyzed nucleotide sequence variation at the Pi-ta gene and its surrounding 2 Mb region in 156 weedy, domesticated and wild rice relatives. We found that the region at and around the Pi-ta gene shows very low genetic diversity in US weedy rice. The patterns of molecular diversity in weeds are more similar to cultivated rice (indica and aus), which have never been cultivated in the US, rather than the wild rice species, Oryza rufipogon. In addition, the resistant Pi-ta allele (Pi-ta) found in the majority of US weedy rice belongs to the weedy group strawhull awnless (SH), suggesting a single source of origin for Pi-ta. Weeds with Pita were resistant to two M. oryzae races, IC17 and IB49, except for three accessions, suggesting that component(s) required for the Pi-ta mediated resistance may be missing in these accessions. Signatures of flanking sequences of the Pi-ta gene and SSR markers on chromosome 12 suggest that the susceptible pi-ta allele (pi-ta), not Pi-ta, has been introgressed from cultivated to weedy rice by out-crossing.	[Lee, Seonghee] Univ Arkansas, Rice Res Extens Ctr, Stuttgart, AR 72160 USA; [Lee, Seonghee] Samuel Roberts Noble Fdn Inc, Ardmore, OK USA; [Jia, Yulin; Jia, Melissa; Gealy, David R.] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Olsen, Kenneth M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Caicedo, Ana L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Arkansas System; University of Arkansas Fayetteville; Noble Research Institute; United States Department of Agriculture (USDA); Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Lee, S (corresponding author), Univ Arkansas, Rice Res Extens Ctr, Stuttgart, AR 72160 USA.	yulin.jia@usda.ars.gov	jia, yu/HHR-9047-2022; Jia, Yulin/T-8235-2019	Jia, Yulin/0000-0002-2132-0498; Olsen, Kenneth/0000-0002-8338-3638	National Science Foundation [DBI-0638820]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [NP301]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by the National Science Foundation Plant Genome Research Program under grant DBI-0638820 to Y. Jia, K. Olsen, and A. Caicedo. Additional funding for this project is from the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program NP301 project titled 'Response of Diverse Rice Germplasm to Biotic and Abiotic Stresses'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gealy DR, 2006, WEED TECHNOL, V20, P839, DOI 10.1614/WT-05-066.1; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Gross BL, 2010, MOL ECOL, V19, P3380, DOI 10.1111/j.1365-294X.2010.04707.x; Gross BL, 2009, NEW PHYTOL, V184, P842, DOI 10.1111/j.1469-8137.2009.02957.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia Y, 2009, HEREDITY, V103, P333, DOI 10.1038/hdy.2009.95; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jia Y, 2008, MOL PLANT MICROBE IN, V21, P396, DOI 10.1094/MPMI-21-4-0396; Jia YL, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P137, DOI 10.1007/978-1-4020-9500-9_14; Lee S, 2009, GENETICS, V183, P1315, DOI 10.1534/genetics.109.108266; LEWONTIN RC, 1964, GENETICS, V49, P49; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Messeguer J, 2004, MOL BREEDING, V13, P103, DOI 10.1023/B:MOLB.0000012285.39859.9d; Moldenhauer KAK, 2007, CROP SCI, V47, P446, DOI 10.2135/cropsci2006.06.0415; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Pritchard JK, 2000, GENETICS, V155, P945; Rajguru SN, 2005, WEED SCI, V53, P567, DOI 10.1614/WS-04-111R1.1; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rybka K, 1997, MOL PLANT MICROBE IN, V10, P517, DOI 10.1094/MPMI.1997.10.4.517; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shivrain VK, 2007, CROP PROT, V26, P349, DOI 10.1016/j.cropro.2005.09.019; Shivrain VK, 2006, WEED TECHNOL, V20, P576, DOI 10.1614/WT-05-067R1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Wang X, 2008, PHYTOPATHOLOGY, V98, P1305, DOI 10.1094/PHYTO-98-12-1305; Webster T.M., 2000, P S WEED SCI SOC, V53, P247	39	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26260	10.1371/journal.pone.0026260	http://dx.doi.org/10.1371/journal.pone.0026260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043312	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400040
J	Cui, J; Yuan, XP; Wang, LN; Jones, G; Zhang, SY				Cui, Jie; Yuan, Xinpu; Wang, Lina; Jones, Gareth; Zhang, Shuyi			Recent Loss of Vitamin C Biosynthesis Ability in Bats	PLOS ONE			English	Article							L-ASCORBIC-ACID; GAMMA-LACTONE OXIDASE; EVOLUTION; PHYLOGENIES; ENZYME; GENE	The traditional assumption that bats cannot synthesize vitamin C (Vc) has been challenged recently. We have previously shown that two Old World bat species (Rousettus leschenaultii and Hipposideros armiger) have functional L-gulonolactone oxidase (GULO), an enzyme that catalyzes the last step of Vc biosynthesis de novo. Given the uncertainties surrounding when and how bats lost GULO function, exploration of gene evolutionary patterns is needed. We therefore sequenced GULO genes from 16 bat species in 5 families, aiming to establish their evolutionary histories. In five cases we identified pseudogenes for the first time, including two cases in the genus Pteropus (P. pumilus and P. conspicillatus) and three in family Hipposideridae (Coelops frithi, Hipposideros speoris, and H. bicolor). Evolutionary analysis shows that the Pteropus clade has the highest v ratio and has been subjected to relaxed selection for less than 3 million years. Purifying selection acting on the pseudogenized GULO genes of roundleaf bats (family Hipposideridae) suggests they have lost the ability to synthesize Vc recently. Limited mutations in the reconstructed GULO sequence of the ancestor of all bats contrasts with the many mutations in the ancestral sequence of recently emerged Pteropus bats. We identified at least five mutational steps that were then related to clade origination times. Together, our results suggest that bats lost the ability to biosynthesize vitamin C recently by exhibiting stepwise mutation patterns during GULO evolution that can ultimately lead to pseudogenization.	[Cui, Jie; Yuan, Xinpu; Wang, Lina; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	East China Normal University; University of Bristol	Cui, J (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn	Cui, Jie/ABB-3831-2020	Cui, Jie/0000-0001-8176-9951; Jones, Gareth/0000-0002-1904-3735	Chinese National Science Foundation [31172077]; East China Normal University [2010044]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); East China Normal University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Chinese National Science Foundation (Grant No. 31172077) to S.Z., the PhD Program Scholarship Fund of East China Normal University (2010044) to J.C., and a Biotechnology and Biological Sciences Research Council China Partnering Award to G.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; BIRNEY EC, 1976, NATURE, V260, P626, DOI 10.1038/260626a0; BURNS JJ, 1957, NATURE, V180, P552, DOI 10.1038/180553a0; Challem JJ, 1997, MED HYPOTHESES, V48, P387, DOI 10.1016/S0306-9877(97)90033-5; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE I, 1961, ANN NY ACAD SCI, V92, P36, DOI 10.1111/j.1749-6632.1961.tb46105.x; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; CHAUDHURI CR, 1969, SCIENCE, V164, P435, DOI 10.1126/science.164.3878.435; Cui J, 2011, MOL BIOL EVOL, V28, P1025, DOI 10.1093/molbev/msq286; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hollar LJ, 1997, P NATL ACAD SCI USA, V94, P5716, DOI 10.1073/pnas.94.11.5716; JENNESS R, 1980, COMP BIOCHEM PHYS B, V67, P195, DOI 10.1016/0305-0491(80)90131-5; JUKES TH, 1975, J HUM EVOL, V4, P85, DOI 10.1016/0047-2484(75)90002-0; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Moreau R, 1998, P NATL ACAD SCI USA, V95, P10279, DOI 10.1073/pnas.95.17.10279; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; NISHIKIMI M, 1992, J BIOL CHEM, V267, P21967; PAULING L, 1970, P NATL ACAD SCI USA, V67, P1643, DOI 10.1073/pnas.67.4.1643; POLLOCK JI, 1987, AM J PHYS ANTHROPOL, V73, P65, DOI 10.1002/ajpa.1330730106; ROY RN, 1958, NATURE, V182, P319, DOI 10.1038/182319a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troadec MB, 2008, CELL, V132, P921, DOI 10.1016/j.cell.2008.03.005; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	29	19	19	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27114	10.1371/journal.pone.0027114	http://dx.doi.org/10.1371/journal.pone.0027114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069493	gold, Green Submitted, Green Published			2022-12-27	WOS:000297150900053
J	Pascopella, L; DeRiemer, K; Watt, JP; Flood, JM				Pascopella, Lisa; DeRiemer, Kathryn; Watt, James P.; Flood, Jennifer M.			When Tuberculosis Comes Back: Who Develops Recurrent Tuberculosis in California?	PLOS ONE			English	Article							UNITED-STATES; MYCOBACTERIUM-BOVIS; TREATMENT OUTCOMES; HIV; RELAPSE; THERAPY; SMOKING; RISK; MORTALITY	Background: Recurrent tuberculosis suggests potentially modifiable gaps in tuberculosis treatment and control activities. The frequency of late recurrences following treatment completion has not been well-studied. We determined the frequency of, and risk factors associated with, tuberculosis that recurs at least one year after completion of anti-tuberculosis therapy in California. Methods: The study population included culture-positive, pulmonary tuberculosis patients reported to the California tuberculosis case registry from 1993 to 2007 who completed anti-tuberculosis therapy. A person with late recurrent tuberculosis was defined as an individual that appeared in the registry more than once, determined by match on name and date-of-birth, with at least one year between treatment completion of the first episode and treatment initiation of the second episode. Results: Among 23,517 tuberculosis patients, 148 (0.63%) had a late recurrence. Independent risk factors for recurrence included: infection with a pyrazinamide mono-resistant isolate (adjusted hazard ratio, 2.93; p = 0.019); initiation of an isoniazid- and rifampin-only treatment regimen (adjusted hazard ratio, 2.55; p = 0.0412); sputum smear-positive disease (adjusted hazard ratio, 1.96; p = 0.0003); human immunodeficiency virus infection (adjusted hazard ratio, 1.81; p = 0.0149); and birth in the United States (adjusted hazard ratio, 1.88; p = 0.0002). Infection with an isoniazid mono-resistant isolate was protective (adjusted hazard ratio, 0.25; p = 0.0171). Conclusions: The low frequency of late recurrent tuberculosis in California suggests that local TB control programs are largely successful at preventing this adverse outcome. Nonetheless, we identified subpopulations at increased risk of late tuberculosis recurrence that may benefit from additional medical or public health interventions.	[Pascopella, Lisa; Flood, Jennifer M.] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA; [DeRiemer, Kathryn] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	California Department of Public Health; University of California System; University of California Davis	Pascopella, L (corresponding author), Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Richmond, CA 94804 USA.	Lisa.Pascopella@cdph.ca.gov		DeRiemer, Kathryn/0000-0002-8375-7505	Centers for Disease Control and Prevention [5 U52 PS900515-28]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U52PS900515] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006452] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Centers for Disease Control and Prevention cooperative agreement # 5 U52 PS900515-28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; Behr MA, 1997, CLIN INFECT DIS, V25, P806, DOI 10.1086/515550; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P47; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V44, P2; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; Francis J, 2008, DRUG RESISTANT TUBER, P284; Geiter L, ENDING NEGLECT ELIMI; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Hsu LC, 2001, J ACQ IMMUN DEF SYND, V28, P345, DOI 10.1097/00126334-200112010-00007; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; LoBue PA, 2005, INT J TUBERC LUNG D, V9, P333; Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; National Cancer Institute, 2010, JOINP REGR PROGR; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Okechukwu CA, 2010, PUBLIC HEALTH REP, V125, P225, DOI 10.1177/003335491012500211; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Rodwell TC, 2008, EMERG INFECT DIS, V14, P909, DOI 10.3201/eid1406.071485; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; SLUTKIN G, 1988, AM REV RESPIR DIS, V138, P1622, DOI 10.1164/ajrccm/138.6.1622; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sterling TR, 1999, AIDS, V13, P1899, DOI 10.1097/00002030-199910010-00012; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8	28	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26541	10.1371/journal.pone.0026541	http://dx.doi.org/10.1371/journal.pone.0026541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069456	Green Published, gold			2022-12-27	WOS:000297150900018
J	Wu, WH; Gersch, E; Kwak, K; Jagu, S; Karanam, B; Huh, WK; Garcea, RL; Roden, RBS				Wu, Wai-Hong; Gersch, Elizabeth; Kwak, Kihyuck; Jagu, Subhashini; Karanam, Balasubramanyam; Huh, Warner K.; Garcea, Robert L.; Roden, Richard B. S.			Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; MINOR CAPSID PROTEIN; BOVINE PAPILLOMAVIRUS; HPV INFECTION; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; CLINICAL-TRIALS; CERVICAL-CANCER; LINEAR EPITOPES	Capsomers were produced in bacteria as glutathione-S-transferase (GST) fusion proteins with human papillomavirus type 16 L1 lacking the first nine and final 29 residues (GST-HPV16L1 Delta) alone or linked with residues 13-47 of HPV18, HPV31 and HPV45 L2 in tandem (GST-HPV16L1 Delta-L2x3). Subcutaneous immunization of mice with GST-HPV16L1 Delta or GST-HPV16L1 Delta-L2x3 in alum and monophosphoryl lipid A induced similarly high titers of HPV16 neutralizing antibodies. GST-HPV16L1 Delta-L2x3 also elicited moderate L2-specific antibody titers. Intravaginal challenge studies showed that immunization of mice with GST-HPV16 L1 Delta or GST-HPV16L1 Delta-L2x3 capsomers, like Cervarix (R), provided complete protection against HPV16. Conversely, vaccination with GST-HPV16 L1 Delta capsomers failed to protect against HPV18 challenge, whereas mice immunized with either GST-HPV16L1 Delta-L2x3 capsomers or Cervarix (R) were each completely protected. Thus, while the L2-specific response was moderate, it did not interfere with immunity to L1 in the context of GST-HPV16L1 Delta-L2x3 and is sufficient to mediate L2-dependent protection against an experimental vaginal challenge with HPV18.	[Wu, Wai-Hong; Kwak, Kihyuck; Jagu, Subhashini; Karanam, Balasubramanyam; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Gersch, Elizabeth; Garcea, Robert L.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Huh, Warner K.] Univ Alabama Birmingham, Dept Gynecol Oncol, Birmingham, AL USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA	Johns Hopkins University; University of Colorado System; University of Colorado Boulder; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins University	Wu, WH (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	Public Health Service [CA133749, CA118790, P50 CA098252, RC2 CA148499]; American Cancer Society [RSG 116279]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA118790, RC2CA148499, R01CA133749] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Public Health Service grants CA133749, CA118790, P50 CA098252, and RC2 CA148499 and by the American Cancer Society RSG 116279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2005, METH MOLEC MED, V119, P445; CAPRON A, 1994, TROP GEOGR MED, V46, P242; Capron A, 2005, TRENDS PARASITOL, V21, P143, DOI 10.1016/j.pt.2005.01.003; Chackerian B, 2002, J IMMUNOL, V169, P6120, DOI 10.4049/jimmunol.169.11.6120; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Combita AL, 2002, J VIROL, V76, P6480, DOI 10.1128/JVI.76.13.6480-6486.2002; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; Fligge C, 2001, VIROLOGY, V283, P353, DOI 10.1006/viro.2000.0875; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Karanam B, 2009, IMMUNOL CELL BIOL, V87, P287, DOI 10.1038/icb.2009.13; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Laniosz V, 2007, J VIROL, V81, P7435, DOI 10.1128/JVI.00571-07; Li ML, 1997, J VIROL, V71, P2988, DOI 10.1128/JVI.71.4.2988-2995.1997; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; RODEN RBS, 1994, J VIROL, V68, P7570, DOI 10.1128/JVI.68.11.7570-7574.1994; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Rose RC, 1998, J VIROL, V72, P6151, DOI 10.1128/JVI.72.7.6151-6154.1998; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; Varsani A, 2003, J VIROL, V77, P8386, DOI 10.1128/JVI.77.15.8386-8393.2003; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	49	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27141	10.1371/journal.pone.0027141	http://dx.doi.org/10.1371/journal.pone.0027141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069498	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900058
J	Yang, YH; Liang, LR; Zhai, ZG; He, HY; Xie, WM; Peng, XX; Wang, C				Yang, Yuanhua; Liang, Lirong; Zhai, Zhenguo; He, Hangyong; Xie, Wanmu; Peng, Xiaoxia; Wang, Chen		Investigators Natl Cooperative Pro	Pulmonary Embolism Incidence and Fatality Trends in Chinese Hospitals from 1997 to 2008: A Multicenter Registration Study	PLOS ONE			English	Article							DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; UNITED-STATES; THROMBOEMBOLISM; EPIDEMIOLOGY; POPULATION; RECURRENT; PREVALENCE; DISEASE; PATTERN	Background: There has not been sufficient evidence to support the Asians being less susceptible to pulmonary embolism (PE) than other ethnicities, because the prevalence of PE/deep venous thrombosis (DVT) in different racial and ethnic groups has not been carefully studied until recently except in Caucasians. To test the hypothesis that the Chinese population has a lower risk for PE, this study comprehensively assessed the hospital-based incidence and case fatality rates for PE during the 1997-2008 in China. Methods: A registration study of patients with suspected PE syndromes admitted to 60 level-3 hospitals involved in the National Cooperative Project for the Prevention and Treatment of Venous Thromboembolism (NCPPT) was conducted from January 1997 to December 2008. The only exclusion criterion was an age of less than 18 years. Helical computed tomography scan, ventilation-perfusion lung scintigraphy or pulmonary angiography was carried out before or after hospitalization. All images were reviewed and evaluated independently by two specialists. Results: A total of 18,206 patients were confirmed with PE from 16,972,182 hospital admissions. The annual incidence was 0.1% (95% CI: 0.1% to 0.2%). The overall incidence of PE in male patients (0.2%, 95% CI: 0.1% to 0.3%) was higher than that in female patients (0.1% and 95% CI: 0.0% to 0.1%). An increasing incidence gradient for PE was noticed from Southern to Northern China. In addition, the case fatality rate was apparently decreasing: 25.1% (95% CI: 16.2% to 36.9%) in 1997 to 8.7% (95% CI: 3.5% to 15.8%) in 2008. Conclusions: Our findings suggest the relatively stable PE incidence and decreasing fatality trends in Chinese hospitals may be partially attributable to the implementation of the NCCPT and suggest the government should reevaluate the severity of PE so that health resources for the prevention, diagnosis and treatment of PE could be used to their fullest.	[Yang, Yuanhua; Liang, Lirong; Zhai, Zhenguo; He, Hangyong; Xie, Wanmu; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China; [Yang, Yuanhua; Liang, Lirong; Zhai, Zhenguo; He, Hangyong; Xie, Wanmu; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Beijing, Peoples R China; [Peng, Xiaoxia] Capital Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Peng, Xiaoxia] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Wang, Chen] Beijing Hosp, Minist Hlth, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Beijing Hospital	Yang, YH (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing, Peoples R China.	niuniu@ccmu.edu.cn; cyh-birm@263.net	Zhai, Zhen/GYA-1598-2022		China Key Research Projects of the 11th National Five-Year Development Plan [2006BAI01A06]	China Key Research Projects of the 11th National Five-Year Development Plan	This study was supported by a grant from the China Key Research Projects of the 11th National Five-Year Development Plan (2006BAI01A06 to Dr. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bick RL, 2006, CLIN APPL THROMB-HEM, V12, P125, DOI 10.1177/107602960601200201; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Chau KY, 1997, PATHOLOGY, V29, P263, DOI 10.1080/00313029700169035; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Dilley A, 1998, AM J EPIDEMIOL, V147, P30; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2005, BLOOD, V106, p267A; Kitamukai O, 2003, INTERNAL MED, V42, P1090, DOI 10.2169/internalmedicine.42.1090; Klatsky AL, 2000, AM J CARDIOL, V85, P1334, DOI 10.1016/S0002-9149(00)00766-9; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Lilienfeld DE, 2000, INT J EPIDEMIOL, V29, P465, DOI 10.1093/ije/29.3.465; Liu H. S. Y., 2002, Hong Kong Medical Journal, V8, P400; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415, DOI 10.2214/ajr.176.6.1761415; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Stein PD, 2005, AM J CARDIOL, V95, P1525, DOI 10.1016/j.amjcard.2005.02.030; Stein PD, 2004, ARCH INTERN MED, V164, P2260, DOI 10.1001/archinte.164.20.2260; Stein PD, 2004, AM J MED, V116, P435, DOI 10.1016/j.amjmed.2003.11.020; Stein PD, 2003, ARCH INTERN MED, V163, P1689, DOI 10.1001/archinte.163.14.1689; Stein PD, 2002, CHEST, V121, P802, DOI 10.1378/chest.121.3.802; Stein PD, 1999, CHEST, V116, P909, DOI 10.1378/chest.116.4.909; STEIN PD, 1991, CHEST, V100, P604, DOI 10.1378/chest.100.3.604; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Wang C, 2010, CHEST, V137, P254, DOI 10.1378/chest.09-0765; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; White RH, 2006, THROMB HAEMOSTASIS, V96, P267, DOI 10.1160/TH06-07-0365; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; WOO KS, 1988, INT J CARDIOL, V20, P373, DOI 10.1016/0167-5273(88)90291-4; Wu Yangfeng, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P11; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc; Zhou B, 1998, CVD PREVENT, V1, P207	35	46	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26861	10.1371/journal.pone.0026861	http://dx.doi.org/10.1371/journal.pone.0026861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069474	gold, Green Submitted, Green Published			2022-12-27	WOS:000297150900036
J	Yu, JN; Won, C; Jun, J; Lim, Y; Kwak, M				Yu, Jeong-Nam; Won, Changman; Jun, Jumin; Lim, YoungWoon; Kwak, Myounghai			Fast and Cost-Effective Mining of Microsatellite Markers Using NGS Technology: An Example of a Korean Water Deer Hydropotes inermis argyropus	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; POPULATION-GENETICS; MOLECULAR MARKERS; GENOME; GENERATION; DIVERSITY; LIBRARIES	Background: Microsatellites, a special class of repetitive DNA sequence, have become one of the most popular genetic markers for population/conservation genetic studies. However, its application to endangered species has been impeded by high development costs, a lack of available sequences, and technical difficulties. The water deer Hydropotes inermis is the sole existing endangered species of the subfamily Capreolinae. Although population genetics studies are urgently required for conservation management, no species-specific microsatellite marker has been reported. Methods: We adopted next-generation sequencing (NGS) to elucidate the microsatellite markers of Korean water deer and overcome these impediments on marker developments. We performed genotyping to determine the efficiency of this method as applied to population genetics. Results: We obtained 98 Mbp of nucleotide information from 260,467 sequence reads. A total of 20,101 di-/tri-nucleotide repeat motifs were identified; di-repeats were 5.9-fold more common than tri-repeats. [CA](n) and [AAC](n)/[AAT](n) repeats were the most frequent di- and tri-repeats, respectively. Of the 17,206 di-repeats, 12,471 microsatellite primer pairs were derived. PCR amplification of 400 primer pairs yielded 106 amplicons and 79 polymorphic markers from 20 individual Korean water deer. Polymorphic rates of the 79 new microsatellites varied from 2 to 11 alleles per locus (H-e: 0.050-0.880; H-o: 0.000-1.000), while those of known microsatellite markers transferred from cattle to Chinese water deer ranged from 4 to 6 alleles per locus (H-e: 0.279-0.714; H-o: 0.300-0.400). Conclusions: Polymorphic microsatellite markers from Korean water deer were successfully identified using NGS without any prior sequence information and deposited into the public database. Thus, the methods described herein represent a rapid and low-cost way to investigate the population genetics of endangered/non-model species.	[Yu, Jeong-Nam; Won, Changman; Jun, Jumin; Lim, YoungWoon; Kwak, Myounghai] Natl Inst Biol Resources, Inchon, South Korea; [Jun, Jumin] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	National Institute of Biological Resources; Ewha Womans University	Yu, JN (corresponding author), Natl Inst Biol Resources, Environm Res Complex, Inchon, South Korea.	mhkwak1@korea.kr			National Institute of Biological Resources of the Korean Government	National Institute of Biological Resources of the Korean Government	This project was supported by a grant entitled "The Genetic Evaluation of Important Biological Resources (2010)" from the National Institute of Biological Resources of the Korean Government (http://www.nibr.go.kr/eng/main/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; CHRISTIANSEN FB, 1988, AM NAT, V131, P149, DOI 10.1086/284782; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; Ellison CK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-428; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Guan Lei, 2004, Zhong Yao Cai, V27, P5; Harris RB, 2008, IUCN 2011 IUCN RED L; Hu J, 2007, SMALL RUMINANT RES, V67, P252, DOI 10.1016/j.smallrumres.2005.10.007; Hu J, 2006, BIOCHEM GENET, V44, P161, DOI 10.1007/s10528-006-9020-7; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jiao Y, 2008, CONSERV GENET, V9, P771, DOI 10.1007/s10592-007-9388-x; Karaiskou N, 2008, J HERED, V99, P688, DOI 10.1093/jhered/esn052; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Koh HS, 2009, BIOCHEM GENET, V47, P860, DOI 10.1007/s10528-009-9285-8; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lian H, 2009, CONSERV GENET, V10, P681, DOI 10.1007/s10592-008-9614-1; Metzgar D, 2000, GENOME RES, V10, P72; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Ouborg NJ, 1999, J ECOL, V87, P551, DOI 10.1046/j.1365-2745.1999.00389.x; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Rozen S, 2000, Methods Mol Biol, V132, P365; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shanker A, 2007, SCI HORTIC-AMSTERDAM, V113, P353, DOI 10.1016/j.scienta.2007.04.011; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; von Stackelberg M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-9; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; Won CM, 1999, MAMMAL REV, V29, P3, DOI 10.1046/j.1365-2907.1999.00034.x; Xu Hongfa, 1998, Acta Theriologica Sinica, V18, P161; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	43	51	60	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26933	10.1371/journal.pone.0026933	http://dx.doi.org/10.1371/journal.pone.0026933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069476	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900038
J	Jansen, R; Timmerman, J; Loos, M; Spijker, S; van Ooyen, A; Brussaard, AB; Mansvelder, HD; Smit, AB; de Gunst, M; Linkenkaer-Hansen, K				Jansen, Rick; Timmerman, Jaap; Loos, Maarten; Spijker, Sabine; van Ooyen, Arjen; Brussaard, Arjen B.; Mansvelder, Huibert D.; Smit, August B.; de Gunst, Mathisca; Linkenkaer-Hansen, Klaus		Neurobsik Mouse Phenomics Consorti	Novel Candidate Genes Associated with Hippocampal Oscillations	PLOS ONE			English	Article							FAST NETWORK OSCILLATIONS; QUANTITATIVE TRAIT LOCI; LONG-TERM-MEMORY; GAMMA-OSCILLATIONS; MOUSE HIPPOCAMPUS; INBRED STRAINS; VOLUME; EXPRESSION; DORSAL; MICE	The hippocampus is critical for a wide range of emotional and cognitive behaviors. Here, we performed the first genome-wide search for genes influencing hippocampal oscillations. We measured local field potentials (LFPs) using 64-channel multi-electrode arrays in acute hippocampal slices of 29 BXD recombinant inbred mouse strains. Spontaneous activity and carbachol-induced fast network oscillations were analyzed with spectral and cross-correlation methods and the resulting traits were used for mapping quantitative trait loci (QTLs), i.e., regions on the genome that may influence hippocampal function. Using genome-wide hippocampal gene expression data, we narrowed the QTLs to eight candidate genes, including Plcb1, a phospholipase that is known to influence hippocampal oscillations. We also identified two genes coding for calcium channels, Cacna1b and Cacna1e, which mediate presynaptic transmitter release and have not been shown to regulate hippocampal network activity previously. Furthermore, we showed that the amplitude of the hippocampal oscillations is genetically correlated with hippocampal volume and several measures of novel environment exploration.	[Jansen, Rick; de Gunst, Mathisca] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Jansen, Rick; Timmerman, Jaap; van Ooyen, Arjen; Brussaard, Arjen B.; Mansvelder, Huibert D.; Linkenkaer-Hansen, Klaus] Vrije Univ Amsterdam, Dept Integrat Neurophys, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Loos, Maarten; Spijker, Sabine; Smit, August B.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Jansen, R (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	klaus.linkenkaer@cncr.vu.nl	Jansen, Ritsert C/C-1160-2013; Loos, Maarten/A-2768-2012; van der Horst, Gijsbertus TJ/E-3661-2015; Elgersma, Ype/F-5164-2013; Spijker, Sabine/F-2300-2011; Linkenkaer-Hansen, Klaus/A-6757-2009; Pennartz, Cyriel/B-7508-2015; Mansvelder, Huib/N-6138-2018	Jansen, Ritsert C/0000-0003-2977-9110; Loos, Maarten/0000-0003-1629-2928; van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Elgersma, Ype/0000-0002-3758-1297; Linkenkaer-Hansen, Klaus/0000-0003-2140-9780; Pennartz, Cyriel/0000-0001-8328-1175; Jansen, Rick/0000-0002-3333-6737; Mansvelder, Huib/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019; verhage, matthijs/0000-0002-6085-7503	Neuro-Bsik Mouse Phenomics consortium; Netherlands Organization for Scientific Research (NWO) [635.100.005]	Neuro-Bsik Mouse Phenomics consortium; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	M.L. and part of this research were supported by a Neuro-Bsik Mouse Phenomics consortium grant to A.B.B & A.B.S. R.J. was supported by a Computational Life Sciences grant (635.100.005) from the Netherlands Organization for Scientific Research (NWO). K.L.-H. received funding from the Innovative Research Incentive Schemes of the NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; AmmassariTeule M, 1995, PSYCHOBIOLOGY, V23, P284; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Bolivar V, 2003, J NEUROSCI, V23, P9435; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Buzsaki G., 2006, RHYTHMS BRAIN; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Ceriani M, 2010, NEUROSCI RES, V66, P290, DOI 10.1016/j.neures.2009.11.013; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; Crusio Wim E., 1999, P13; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dell KR, 2003, J CELL BIOL, V160, P291, DOI 10.1083/jcb.200301040; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Gurevicius K, 2009, HIPPOCAMPUS, V19, P1232, DOI 10.1002/hipo.20585; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Heistek TS, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00018; Hindriks R, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021133; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen R, 2009, EUR J NEUROSCI, V30, P1092, DOI 10.1111/j.1460-9568.2009.06883.x; Jansen R, 2011, DYNAMICS GENETICS HI; Jeewajee A, 2008, HIPPOCAMPUS, V18, P340, DOI 10.1002/hipo.20394; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kafkafi N, 2005, GENES BRAIN BEHAV, V4, P431, DOI 10.1111/j.1601-183X.2005.00126.x; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LANDER ES, 1989, GENETICS, V121, P185; Lapray D, 2009, BEHAV BRAIN RES, V199, P350, DOI 10.1016/j.bbr.2008.12.028; Linkenkaer-Hansen K, 2007, J NEUROSCI, V27, P13882, DOI 10.1523/JNEUROSCI.3083-07.2007; Llinas RR, 2007, P NATL ACAD SCI USA, V104, P17819, DOI 10.1073/pnas.0707945104; Loos M, 2009, GENES BRAIN BEHAV, V8, P817, DOI 10.1111/j.1601-183X.2009.00528.x; Low P, 2000, CELL DEATH DIFFER, V7, P1210, DOI 10.1038/sj.cdd.4400743; Lu CB, 2011, NEUROBIOL LEARN MEM, V95, P221, DOI 10.1016/j.nlm.2010.11.008; Lu CB, 2010, BRAIN RES, V1323, P65, DOI 10.1016/j.brainres.2010.01.090; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Martin MV, 2006, GENES BRAIN BEHAV, V5, P614, DOI 10.1111/j.1601-183X.2006.00215.x; Middei S, 2007, NEUROBIOL LEARN MEM, V87, P174, DOI 10.1016/j.nlm.2006.08.004; MINER LL, 1995, PSYCHOPHARMACOLOGY, V122, P209, DOI 10.1007/BF02246541; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Mozhui K, 2011, TRANSLATIONAL PSYCHI, DOI [10.1038/tp.2011.1024, DOI 10.1038/TP.2011.1024]; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Passino E, 2002, HIPPOCAMPUS, V12, P63, DOI 10.1002/hipo.10007; Pedrosa E, 2010, J NEUROGENET, V24, P182, DOI 10.3109/01677063.2010.495182; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peirce JL, 2003, GENES BRAIN BEHAV, V2, P238, DOI 10.1034/j.1601-183X.2003.00030.x; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Poil SS, 2011, EUR J NEUROSCI, V34, P394, DOI 10.1111/j.1460-9568.2011.07748.x; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; SCHWEGLER H, 1995, BEHAV BRAIN RES, V67, P29, DOI 10.1016/0166-4328(95)91998-3; Schwegler H, 1996, HIPPOCAMPUS, V6, P136; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; van Aerde KI, 2009, J PHYSIOL-LONDON, V587, P5177, DOI 10.1113/jphysiol.2009.178384; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665	80	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26586	10.1371/journal.pone.0026586	http://dx.doi.org/10.1371/journal.pone.0026586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066001	Green Published, gold			2022-12-27	WOS:000296916000017
J	Zhang, CY; Zhang, JL; Xie, GM; Wang, L; Perc, M				Zhang, Chunyan; Zhang, Jianlei; Xie, Guangming; Wang, Long; Perc, Matjaz			Evolution of Interactions and Cooperation in the Spatial Prisoner's Dilemma Game	PLOS ONE			English	Article							SCALE-FREE NETWORKS; COMPLEX NETWORKS; INDIRECT RECIPROCITY; HETEROGENEOUS POPULATIONS; SOCIAL DILEMMAS; SNOWDRIFT GAME; SELECTION; STRATEGIES; DYNAMICS; MOBILITY	We study the evolution of cooperation in the spatial prisoner's dilemma game where players are allowed to establish new interactions with others. By employing a simple coevolutionary rule entailing only two crucial parameters, we find that different selection criteria for the new interaction partners as well as their number vitally affect the outcome of the game. The resolution of the social dilemma is most probable if the selection favors more successful players and if their maximally attainable number is restricted. While the preferential selection of the best players promotes cooperation irrespective of game parametrization, the optimal number of new interactions depends somewhat on the temptation to defect. Our findings reveal that the "making of new friends" may be an important activity for the successful evolution of cooperation, but also that partners must be selected carefully and their number limited.	[Zhang, Chunyan; Zhang, Jianlei; Xie, Guangming; Wang, Long] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Zhang, Chunyan; Zhang, Jianlei] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, Kerklaan, Netherlands; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	Peking University; University of Groningen; University of Maribor	Zhang, CY (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	xiegming@pku.edu.cn	Xie, Guangming/A-5230-2011; Wang, Long/A-7798-2010; Perc, Matjaz/A-5148-2009; Gao, Y./GWZ-3665-2022	Wang, Long/0000-0001-5600-8157; Perc, Matjaz/0000-0002-3087-541X; Zhang, Jianlei/0000-0002-9932-9265	National Nature Science Foundation of China [60736022, 10972002, 60774089, 10972003, 10926195]; Erasmus Mundus Action; Slovenian Research Agency [Z1-2032, J1-4055]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Erasmus Mundus Action; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Nature Science Foundation of China (Grant Nos. 60736022, 10972002, 60774089, 10972003 and 10926195). In addition, CZ and JZ acknowledge support from the Erasmus Mundus Action (EMA2 Lotus Grant), and MP acknowledges support from the Slovenian Research Agency (Grant Nos. Z1-2032 and J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1995, EVOLUTIONARY GAME TH; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Dugatkin LA, 1996, BIOSYSTEMS, V37, P19, DOI 10.1016/0303-2647(95)01542-6; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gintis H., 2000, GAME THEORY EVOLVING; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2004, J THEOR BIOL, V227, P299, DOI 10.1016/j.jtbi.2003.11.008; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2008, J THEOR BIOL, V250, P723, DOI 10.1016/j.jtbi.2007.10.040; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/183; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Schuster S, 2008, J BIOL PHYS, V34, P1, DOI 10.1007/s10867-008-9101-4; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sigmund K, 2010, PRINC SER THEOR COMP; Sigmund K., 1993, GAMES LIFE EXPLORATI; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Van Segbroeck S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-287; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Wardil L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036115; Wardil L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38001; WILSON DS, 1977, AM NAT, V111, P157, DOI 10.1086/283146; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu Z.-X., 2009, PHYS REV E, V80; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Wu ZX, 2006, CHINESE PHYS LETT, V23, P531, DOI 10.1088/0256-307X/23/3/002; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	80	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26724	10.1371/journal.pone.0026724	http://dx.doi.org/10.1371/journal.pone.0026724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066006	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000022
J	Zhao, ZS; Wang, J; Zhao, CY; Bi, WN; Yue, ZY; Ma, ZA				Zhao, Zhengshan; Wang, Jing; Zhao, Chunying; Bi, Weina; Yue, Zhenyu; Ma, Zhongmin Alex			Genetic Ablation of PLA2G6 in Mice Leads to Cerebellar Atrophy Characterized by Purkinje Cell Loss and Glial Cell Activation	PLOS ONE			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; INDEPENDENT PHOSPHOLIPASE A(2); PANCREATIC BETA-CELLS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; APOPTOTIC CELLS; EXPRESS GROUP; MICROGLIA	Infantile neuroaxonal dystrophy (INAD) is a progressive, autosomal recessive neurodegenerative disease characterized by axonal dystrophy, abnormal iron deposition and cerebellar atrophy. This disease was recently mapped to PLA2G6, which encodes group VI Ca(2+) -independent phospholipase A(2) (iPLA(2) or iPLA(2)beta). Here we show that genetic ablation of PLA2G6 in mice (iPLA(2)beta(-/-)) leads to the development of cerebellar atrophy by the age of 13 months. Atrophied cerebella exhibited significant loss of Purkinje cells, as well as reactive astrogliosis, the activation of microglial cells, and the pronounced up-regulation of the pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). Moreover, glial cell activation and the elevation in TNF-alpha and IL-1 beta expression occurred before apparent cerebellar atrophy. Our findings indicate that the absence of PLA2G6 causes neuroinflammation and Purkinje cell loss and ultimately leads to cerebellar atrophy. Our study suggests that iPLA(2)beta(-/-) mice are a valuable model for cerebellar atrophy in INAD and that early antiinflammatory therapy may help slow the progression of cerebellar atrophy in this deadly neurodegenerative disease.	[Zhao, Zhengshan; Zhao, Chunying; Bi, Weina; Ma, Zhongmin Alex] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, New York, NY 10029 USA; [Wang, Jing; Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhao, ZS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, New York, NY 10029 USA.	zhongmin.ma@mssm.edu	Wang, Jing/E-6217-2012		NIH/NINDS [R01 NS063962, R01NS060809]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060809, R01NS063962] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS, R01 NS063962, R01NS060809 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BARLOW JK, 1989, ANN NEUROL, V25, P413, DOI 10.1002/ana.410250416; Biancheri R, 2007, EUR J PAEDIATR NEURO, V11, P175, DOI 10.1016/j.ejpn.2006.11.013; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Carrilho I, 2008, EUR J PAEDIAT NEUROL; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Farina L, 1999, NEURORADIOLOGY, V41, P376, DOI 10.1007/s002340050768; Ge Y, 2004, TOXICOL LETT, V150, P325, DOI 10.1016/j.toxlet.2004.02.003; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lee J, 2002, NEUROMOL MED, V2, P29; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; MacKenzie-Graham A, 2009, NEUROIMAGE, V48, P637, DOI 10.1016/j.neuroimage.2009.06.073; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Michlewska S, 2007, AUTOIMMUNITY, V40, P267, DOI 10.1080/08916930701357208; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nardocci N, 1999, NEUROLOGY, V52, P1472, DOI 10.1212/WNL.52.7.1472; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Subramanian Sharath, 2010, Recent Pat Cardiovasc Drug Discov, V5, P54; TANABE Y, 1993, NEUROLOGY, V43, P110, DOI 10.1212/WNL.43.1_Part_1.110; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tonelli A, 2010, CLIN GENET, V78, P432, DOI 10.1111/j.1399-0004.2010.01417.x; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Wu Y, 2009, EUR J NEUROL, V16, P240, DOI 10.1111/j.1468-1331.2008.02397.x; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	48	29	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26991	10.1371/journal.pone.0026991	http://dx.doi.org/10.1371/journal.pone.0026991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046428	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800055
J	Zhou, M; Bao, YQ; Lu, JX; Zhou, J; Jia, WP				Zhou, Mi; Bao, Yuqian; Lu, Junxi; Zhou, Jian; Jia, Weiping			Serum A-FABP Is Increased and Closely Associated with Elevated NT-proBNP Levels in Type 2 Diabetic Patients Treated with Rosiglitazone	PLOS ONE			English	Article							ACID-BINDING PROTEIN; NATRIURETIC PEPTIDE LEVELS; METABOLIC SYNDROME; APOLIPOPROTEIN-E; HEART-FAILURE; ATHEROSCLEROSIS; EXPRESSION; DISEASE; OBESITY; GAMMA	Background: Adipocyte fatty acid-binding protein (A-FABP) has been shown to play important roles in the development of metabolic syndrome, diabetes, and cardiovascular diseases. In this study we investigated the possible role of A-FABP in the development of cardiac dysfunction related to rosiglitazone treatment. Methodology/Principal Findings: A total of 84 patients with newly diagnosed type 2 diabetes were treated with rosiglitazone for 48 weeks. Circulating A-FABP and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were determined at baseline and repeated at 24 and 48 weeks. After the 48-week rosiglitazone treatment period, serum levels of both A-FABP and NT-proBNP increased progressively and significantly (P<0.01). Serum levels of A-FABP were demonstrated to be positively correlated with gender and waist circumference both at baseline and the end of the study, and with age, body mass index (BMI), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and NT-proBNP at 48 weeks (all P<0.05). In addition, changes in A-FABP were significantly and positively correlated with changes in NTproBNP (r = 0.239, P = 0.039). Furthermore, multiple stepwise regression analysis showed that the changes in A-FABP were independently and positively associated with changes in NT-proBNP after adjusting for confounding factors ( = 0.320, P = 0.007). Conclusions/Significance: Rosiglitazone-mediated increase of A-FABP is closely associated with the elevation of NT-proBNP, a well-establish beta ed marker of cardiac dysfunction. The findings of our study imply that A-FABP may mediate the cross-talk between heart and adipose tissue.	[Zhou, Mi] Shanghai Jiao Tong Univ, Sch Med, Dept Med, Shanghai 200030, Peoples R China; [Zhou, Mi; Bao, Yuqian; Lu, Junxi; Zhou, Jian; Jia, Weiping] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Affiliated Peoples Hosp 6,De, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn			National 973 Program [2011CB504001]; Shanghai Municipality for Basic Research [08dj1400601]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Program for Outstanding Medical Academic Leader in Shanghai [LJ06010]	National 973 Program(National Basic Research Program of China); Shanghai Municipality for Basic Research; Shanghai Key Laboratory of Diabetes Mellitus; Program for Outstanding Medical Academic Leader in Shanghai	This work was funded by the National 973 Program (2011CB504001), Major Program of Shanghai Municipality for Basic Research (08dj1400601), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200), and Program for Outstanding Medical Academic Leader in Shanghai (LJ06010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bao YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019115; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Cabre A, 2007, Atherosclerosis, V195, pe150; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2008, AM J CARDIOL, V101, p16A, DOI [10.1016/j.amjcard.2007.11.014, 10.1016/j.amjcard.2607.11.014]; El Muayed ML, 2004, AM J CARDIOL, V93, P600, DOI 10.1016/j.amjcard.2003.11.025; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Kemal YT, 2007, ACTA DIABETOL, V44, P149, DOI 10.1007/s00592-007-0256-4; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Larsson H, 1998, DIABETOLOGIA, V41, P772, DOI 10.1007/s001250050986; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehra MR, 2004, J AM COLL CARDIOL, V43, P1590, DOI 10.1016/j.jacc.2003.10.066; Miyoshi T, 2010, ATHEROSCLEROSIS, V211, P164, DOI 10.1016/j.atherosclerosis.2010.01.032; Niemeyer NV, 2002, PHARMACOTHERAPY, V22, P924, DOI 10.1592/phco.22.11.924.33626; Ogawa S, 2003, J CLIN ENDOCR METAB, V88, P3993, DOI 10.1210/jc.2002-021765; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665; Sambanis C, 2008, ACTA DIABETOL, V45, P23, DOI 10.1007/s00592-007-0014-7; Schachtrup C, 2004, BIOCHEM J, V382, P239, DOI 10.1042/BJ20031340; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; Wang J, 2008, ACTA PHARMACOL SIN, V29, P252, DOI 10.1111/j.1745-7254.2008.00744.x; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yu W, 2011, CLIN PHARMACOL THER, V89, P437, DOI 10.1038/clpt.2010.351	35	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27032	10.1371/journal.pone.0027032	http://dx.doi.org/10.1371/journal.pone.0027032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046439	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800062
J	Cardenal-Munoz, E; Ramos-Morales, F				Cardenal-Munoz, Elena; Ramos-Morales, Francisco			Analysis of the Expression, Secretion and Translocation of the Salmonella enterica Type III Secretion System Effector SteA	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; PATHOGENICITY ISLAND-2; EPITHELIAL-CELLS; CHROMOSOMAL GENES; VIRULENCE FACTORS; MESSENGER-RNA; N-TERMINUS	Many Gram-negative pathogens possess virulence-related type III secretion systems. Salmonella enterica uses two of these systems, encoded on the pathogenicity islands SPI-1 and SPI-2, respectively, to translocate more than 30 effector proteins into eukaryotic host cells. SteA is one of the few effectors that can be translocated by both systems. We investigated the conditions affecting the synthesis of this effector, its secretion to culture media and its translocation into host cells. Whereas steA was expressed under a wide range of conditions, some factors, including low and high osmolarity, and presence of butyrate, decreased expression. SteA was efficiently secreted to the culture media under both SPI-1 and SPI-2 inducing conditions. The kinetics of translocation into murine macrophages and human epithelial cells was studied using fusions with the 3xFLAG tag, and fusions with CyaA from Bordetella pertussis. Translocation into macrophages under non-invasive conditions was mainly dependent on the SPI-2-encoded type III secretion system but some participation of the SPI-1 system was also detected 6 hours post-infection. Interestingly, both type III secretion systems had a relevant role in the translocation of SteA into epithelial cells. Finally, a deletion approach allowed the identification of the N-terminal signal necessary for translocation of this effector. The amino acid residues 1-10 were sufficient to direct translocation into host cells through both type III secretion systems. Our results provide new examples of functional overlapping between the two type III secretion systems of Salmonella.	[Cardenal-Munoz, Elena; Ramos-Morales, Francisco] Univ Seville, Fac Biol, Dept Genet, Seville, Spain	University of Sevilla	Cardenal-Munoz, E (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	framos@us.es	Cardenal-Munoz, Elena/J-5819-2019; Ramos-Morales, Francisco/C-5734-2008	Cardenal-Munoz, Elena/0000-0003-4757-9323; Ramos-Morales, Francisco/0000-0002-1151-4547	Spanish Ministry of Science and Innovation [SAF2010-15015]; European Regional Development Fund; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain [P08-CVI-03487]; Junta de Andalucia	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); Junta de Andalucia(Junta de Andalucia)	This work was supported by grant SAF2010-15015 from the Spanish Ministry of Science and Innovation and the European Regional Development Fund, and grant P08-CVI-03487 from the Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain. ECM is the recipient of a predoctoral fellowship from the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Baumler AJ, 1997, TRENDS MICROBIOL, V5, P318, DOI 10.1016/S0966-842X(97)01082-2; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crawford JA, 2002, MOL MICROBIOL, V46, P855, DOI 10.1046/j.1365-2958.2002.03214.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Deiwick J, 1998, J BACTERIOL, V180, P4775, DOI 10.1128/JB.180.18.4775-4780.1998; Drecktrah D, 2005, CELL MICROBIOL, V7, P105, DOI 10.1111/j.1462-5822.2004.00436.x; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; GLASER P, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P239; Gong H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-73; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; HEDEGAARD L, 1985, MOL GEN GENET, V201, P38, DOI 10.1007/BF00397984; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones MA, 1998, INFECT IMMUN, V66, P5799, DOI 10.1128/IAI.66.12.5799-5804.1998; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Kim BH, 2007, MICROBIOL-SGM, V153, P2998, DOI 10.1099/mic.0.2007/007872-0; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Malik-Kale P, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00125; Maloy S.R., 1990, EXPT TECHNIQUES BACT; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valinsky L, 2002, MOL PLANT PATHOL, V3, P97, DOI 10.1046/j.1464-6722.2002.00099.x; Van Engelenburg SB, 2010, NAT METHODS, V7, P325, DOI [10.1038/NMETH.1437, 10.1038/nmeth.1437]; Van Immerseel F, 2004, AVIAN DIS, V48, P384, DOI 10.1637/7094; Van Immerseel F, 2004, POULTRY SCI, V83, P69, DOI 10.1093/ps/83.1.69; Walker KA, 2009, J BACTERIOL, V191, P1816, DOI 10.1128/JB.01402-08; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	89	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26930	10.1371/journal.pone.0026930	http://dx.doi.org/10.1371/journal.pone.0026930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046414	gold, Green Submitted, Green Published			2022-12-27	WOS:000296521400049
J	Sarthi, J; Elefant, F				Sarthi, Jessica; Elefant, Felice			dTip60 HAT Activity Controls Synaptic Bouton Expansion at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; HISTONE ACETYLTRANSFERASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; MICROTUBULE STABILITY; TUBULIN ACETYLATION; MEMORY FORMATION; RECEPTOR; TRANSCRIPTION; GENE; PHOSPHORYLATION	Background: Histone acetylation of chromatin plays a key role in promoting the dynamic transcriptional responses in neurons that influence the neuroplasticity linked to cognitive ability, yet the specific histone acetyltransferases (HATs) that create such epigenetic marks remain to be elucidated. Methods and Findings: Here we use the Drosophila neuromuscular junction (NMJ) as a well-characterized synapse model to identify HATs that control synaptic remodeling and structure. We show that the HAT dTip60 is concentrated both pre and post-synaptically within the NMJ. Presynaptic targeted reduction of dTip60 HAT activity causes a significant increase in synaptic bouton number that specifically affects type Is boutons. The excess boutons show a suppression of the active zone synaptic function marker bruchpilot, suggesting defects in neurotransmission function. Analysis of microtubule organization within these excess boutons using immunohistochemical staining to the microtubule associated protein futsch reveals a significant increase in the rearrangement of microtubule loop architecture that is required for bouton division. Moreover, alpha-tubulin acetylation levels of microtubules specifically extending into the terminal synaptic boutons are reduced in response to dTip60 HAT reduction. Conclusions: Our results are the first to demonstrate a causative role for the HAT dTip60 in the control of synaptic plasticity that is achieved, at least in part, via regulation of the synaptic microtubule cytoskeleton. These findings have implications for dTip60 HAT dependant epigenetic mechanisms underlying cognitive function.	[Sarthi, Jessica; Elefant, Felice] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Sarthi, J (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	fe22@drexel.edu			National Institutes of Health (NIH) [R01HD057939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant R01HD057939 to Dr. Elefant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Baas PW, 2010, CELL CYCLE, V9, P2273; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Benfenati Fabio, 2007, Acta Biomed, V78 Suppl 1, P58; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; BROADIE KS, 1993, J NEUROSCI, V13, P144; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Colon-Ramos DA, 2009, CURR TOP DEV BIOL, V87, P53, DOI 10.1016/S0070-2153(09)01202-2; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer M, 2009, DEV NEUROBIOL, V69, P212, DOI 10.1002/dneu.20700; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Johnson EL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000193; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Knapek S, 2011, J NEUROSCI, V31, P3453, DOI 10.1523/JNEUROSCI.2585-10.2011; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Lorbeck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018412; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mattson MP, 2003, AGEING RES REV, V2, P329, DOI 10.1016/S1568-1637(03)00013-8; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Muller U, 2002, ZOOLOGY, V105, P313, DOI 10.1078/0944-2006-00075; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Singh N, 2010, J NEUROCHEM, V115, P493, DOI 10.1111/j.1471-4159.2010.06892.x; SNOW PM, 1987, J NEUROSCI, V7, P4137; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Sweatt JD, 2010, SCIENCE, V328, P701, DOI 10.1126/science.1189968; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Torroja L, 1999, J NEUROSCI, V19, P7793; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Wynshaw-Boris A, 2009, CELL, V136, P393, DOI 10.1016/j.cell.2009.01.024; Zhu XM, 2007, GENETICS, V175, P1229, DOI 10.1534/genetics.106.063685; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	72	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26202	10.1371/journal.pone.0026202	http://dx.doi.org/10.1371/journal.pone.0026202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046262	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400012
J	Arbeille, P; Yuan, M; Bai, YQ; Jiang, SZ; Gauquelin, G; Aubry, P; Wan, YM; Custaud, MA; Li, YH				Arbeille, Philippe; Yuan, Ming; Bai, Yanqiang; Jiang, Shizhong; Gauquelin, Gullemette; Aubry, Patrick; Wan, Yuming; Custaud, Marc Antoine; Li, Yinghui			Temporal Artery Flow Response during the Last Minute of a Head Up Tilt Test, in Relation with Orthostatic Intolerance after a 60 Day Head-Down Bedrest	PLOS ONE			English	Article							BODY NEGATIVE-PRESSURE; CEREBRAL AUTOREGULATION	Objective: Check if the Temporal flow response to Tilt could provide early hemodynamic pattern in the minutes preceding a syncope during the Tilt test performed after a 60-d head down bedrest (HDBR). Method: Twenty-one men divided into 3 groups [Control (Con), Resistive Vibration (RVE) and Chinese Herb (Herb)] underwent a 60 day HDBR. Pre and Post HDBR a 20 min Tilt identified Finishers (F) and Non Finishers (NF). Cerebral (MCA), Temporal (TEMP), Femoral (FEM) flow velocity, were measured by Doppler during the Tilt. Blood pressure (BP) was measured by arm cuff and cardiopress. Results and Discussion: Four of the 21 subjects were NF at the post HDBR Tilt test (Con gr:2, RVE gr: 1, Herb gr: 1). At 1 min and 10 s before end of Tilt in NF gr, FEM flow decreased less and MCA decreased more at post HDBR Tilt compared to pre (p<0.05), while in the F gr they changed similarly as pre. In NF gr: TEMP flow decreased more at post HDBR Tilt compared to pre, but only at 10 s before the end of Tilt (P<0.05). During the last 10 s a negative TEMP diastolic component appeared which induced a drop in mean velocity until Tilt arrest. Conclusion: The sudden drop in TEMP flow with onset of a negative diastolic flow preceding the decrease in MCA flow confirm that the TEMP vascular resistance respond more directly than the cerebral one to the cardiac output redistribution and that this response occur several seconds before syncope.	[Arbeille, Philippe] Univ Hop Trousseau, UMPS CERCOM Med Physiol Spatial, Tours, France; [Yuan, Ming; Bai, Yanqiang; Jiang, Shizhong; Wan, Yuming; Li, Yinghui] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Gauquelin, Gullemette; Aubry, Patrick] Ctr Natl Etud Spatiales, Paris, France; [Custaud, Marc Antoine] Fac Med Angers, UMR CNRS INSERM 6214 771, Angers, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Arbeille, P (corresponding author), Univ Hop Trousseau, UMPS CERCOM Med Physiol Spatial, Tours, France.	arbeille@med.univ-tours.fr; yinghuidd@vip.sina.com	Custaud, Marc-Antoine/K-1376-2015		CNES; State Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center [SMFA09A02]; China Advanced Space Medico-engineering Research Project [SJ200801, 2011SY5406018]; China Manned Space Flight Project Fundation; Major State Basic Research Development Program of China (973 Program) [2011CB707704]	CNES(Centre National D'etudes Spatiales); State Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center; China Advanced Space Medico-engineering Research Project; China Manned Space Flight Project Fundation; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by CNES, the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (grant no. SMFA09A02), China Advanced Space Medico-engineering Research Project (no. SJ200801, 2011SY5406018), China Manned Space Flight Project Fundation and Major State Basic Research Development Program of China (973 Program, no 2011CB707704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Arbeille P, 2012, EUR J APPL PHYSIOL, V112, P277, DOI 10.1007/s00421-011-1935-y; ARBEILLE P, 1995, AVIAT SPACE ENVIR MD, V66, P131; Arbeille P, 1997, ULTRASOUND MED BIOL, V23, P415, DOI 10.1016/S0301-5629(96)00225-6; Arbeille P, 2008, J GRAVIT PHYSL, V15, P49; Brown CM, 2003, J NEUROL SCI, V208, P71, DOI 10.1016/S0022-510X(02)00438-0; Guo H, 2006, J APPL PHYSIOL, V100, P1785, DOI 10.1152/japplphysiol.00690.2005; Herault S, 2000, EUR J APPL PHYSIOL, V81, P384, DOI 10.1007/s004210050058; Kuriyama K, 2000, AVIAT SPACE ENVIR MD, V71, P1033; Traon APL, 1999, CLIN PHYSIOL, V19, P360, DOI 10.1046/j.1365-2281.1999.00189.x	10	2	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e22963	10.1371/journal.pone.0022963	http://dx.doi.org/10.1371/journal.pone.0022963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22073117	Green Published, gold			2022-12-27	WOS:000296519600001
J	Holtzman, T; Jorntell, H				Holtzman, Tahl; Jorntell, Henrik			Sensory Coding by Cerebellar Mossy Fibres through Inhibition-Driven Phase Resetting and Synchronisation	PLOS ONE			English	Article							LATERAL RETICULAR NUCLEUS; RAT SOMATOSENSORY CORTEX; CELLS IN-VIVO; GRANULE CELLS; GOLGI CELLS; INFERIOR OLIVE; VISUAL-CORTEX; NETWORK OSCILLATIONS; PYRAMIDAL NEURONS; CORTICAL NETWORKS	Temporal coding of spike-times using oscillatory mechanisms allied to spike-time dependent plasticity could represent a powerful mechanism for neuronal communication. However, it is unclear how temporal coding is constructed at the single neuronal level. Here we investigate a novel class of highly regular, metronome-like neurones in the rat brainstem which form a major source of cerebellar afferents. Stimulation of sensory inputs evoked brief periods of inhibition that interrupted the regular firing of these cells leading to phase-shifted spike-time advancements and delays. Alongside phase-shifting, metronome cells also behaved as band-pass filters during rhythmic sensory stimulation, with maximal spike-stimulus synchronisation at frequencies close to the idiosyncratic firing frequency of each neurone. Phase-shifting and band-pass filtering serve to temporally align ensembles of metronome cells, leading to sustained volleys of near-coincident spike-times, thereby transmitting synchronised sensory information to downstream targets in the cerebellar cortex.	[Holtzman, Tahl] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Holtzman, Tahl] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Jorntell, Henrik] Sect Neurophysiol, Lund, Sweden; [Jorntell, Henrik] Neuronano Res Ctr, Lund, Sweden	University of Cambridge; University of Cambridge	Holtzman, T (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.	th247@cam.ac.uk			Medical Research Council, United Kingdom; Isaac Newton Trust, Cambridge, United Kingdom	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Isaac Newton Trust, Cambridge, United Kingdom	This work was funded by the Medical Research Council, United Kingdom and the Isaac Newton Trust, Cambridge, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011911; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amzica F, 1997, P NATL ACAD SCI USA, V94, P1985, DOI 10.1073/pnas.94.5.1985; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; BERRIDGE KC, 1987, BEHAV BRAIN RES, V23, P59, DOI 10.1016/0166-4328(87)90242-7; Bevan MD, 2002, J NEUROPHYSIOL, V87, P1348, DOI 10.1152/jn.00582.2001; Botev Z.I., 2006, NOVEL NONPARAMETRIC; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; Bruno RM, 2003, J NEUROSCI, V23, P9565; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Buzsaki G., 2006, RHYTHMS BRAIN; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Courtemanche R, 2002, J NEUROPHYSIOL, V88, P771, DOI 10.1152/jn.2002.88.2.771; D'Angelo E, 2005, PROG BRAIN RES, V148, P71, DOI 10.1016/S0079-6123(04)48007-8; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; EKEROT CF, 1990, EXP BRAIN RES, V79, P109, DOI 10.1007/BF00228879; EKEROT CF, 1990, EXP BRAIN RES, V79, P129, DOI 10.1007/BF00228881; Ezure K, 1997, EXP BRAIN RES, V113, P230, DOI 10.1007/BF02450321; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Gutkin BS, 2005, J NEUROPHYSIOL, V94, P1623, DOI 10.1152/jn.00359.2004; Hajos N, 2009, NEURAL NETWORKS, V22, P1113, DOI 10.1016/j.neunet.2009.07.024; Hartmann MJ, 1998, J NEUROPHYSIOL, V80, P1598, DOI 10.1152/jn.1998.80.3.1598; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Heine SA, 2010, J NEUROSCI, V30, P17004, DOI 10.1523/JNEUROSCI.3513-10.2010; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Holtzman T, 2011, J PHYSL; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kwag J, 2009, NAT NEUROSCI, V12, P1219, DOI 10.1038/nn.2388; Kwag J, 2009, NEUROREPORT, V20, P1209, DOI 10.1097/WNR.0b013e32832f5cc7; Leznik E, 2002, J NEUROSCI, V22, P2804, DOI 10.1523/JNEUROSCI.22-07-02804.2002; Llinas RR, 2009, NEUROSCIENCE, V162, P797, DOI 10.1016/j.neuroscience.2009.04.045; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Makarov Valeri A, 2010, Comput Intell Neurosci, P340541, DOI 10.1155/2010/340541; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Marino J, 1996, NEUROSCI LETT, V219, P107, DOI 10.1016/S0304-3940(96)13184-0; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Phoka E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000768; Prsa M, 2009, J NEUROSCI, V29, P250, DOI 10.1523/JNEUROSCI.4791-08.2009; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rinzel J., 1989, METHODS NEURONAL MOD, P135; Saarinen A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000004; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Samengo I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009669; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.002.2007; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.004.2007; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Stanford IM, 2003, J NEUROPHYSIOL, V89, P1713, DOI 10.1152/jn.00864.2002; Stiefel KM, 2010, EUR J NEUROSCI, V31, P1019, DOI 10.1111/j.1460-9568.2010.07146.x; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vinogradova O S, 1998, Membr Cell Biol, V11, P715; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Xu W, 2008, J PHYSIOL-LONDON, V586, P4951, DOI 10.1113/jphysiol.2008.160879; Xu W, 2010, EUR J NEUROSCI, V32, P591, DOI 10.1111/j.1460-9568.2010.07307.x	84	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26503	10.1371/journal.pone.0026503	http://dx.doi.org/10.1371/journal.pone.0026503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046297	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600025
J	Kimura, Y; Ding, BS; Imai, N; Nolan, DJ; Butler, JM; Rafii, S				Kimura, Yuki; Ding, Bisen; Imai, Norikazu; Nolan, Daniel J.; Butler, Jason M.; Rafii, Shahin			c-Kit-Mediated Functional Positioning of Stem Cells to Their Niches Is Essential for Maintenance and Regeneration of Adult Hematopoiesis	PLOS ONE			English	Article							PROGENITOR CELLS; CRE RECOMBINASE; VASCULAR NICHE; SELF-RENEWAL; RECEPTOR; RECONSTITUTION; ACTIVATION; MUTATIONS; INVERSION; FAMILY	The mechanism by which hematopoietic stem and progenitor cells (HSPCs) through interaction with their niches maintain and reconstitute adult hematopoietic cells is unknown. To functionally and genetically track localization of HSPCs with their niches, we employed novel mutant loxPs, lox66 and lox71 and Cre-recombinase technology to conditionally delete c-Kit in adult mice, while simultaneously enabling GFP expression in the c-Kit-deficient cells. Conditional deletion of c-Kit resulted in hematopoietic failure and splenic atrophy both at steady state and after marrow ablation leading to the demise of the treated adult mice. Within the marrow, the c-Kit-expressing GFP(+) cells were positioned to Kit ligand (KL)-expressing niche cells. This c-Kit-mediated cellular adhesion was essential for long-term maintenance and expansion of HSPCs. These results lay the foundation for delivering KL within specific niches to maintain and restore hematopoiesis.	[Kimura, Yuki; Ding, Bisen; Imai, Norikazu; Nolan, Daniel J.; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Ding, Bisen; Nolan, Daniel J.; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY USA; [Ding, Bisen; Nolan, Daniel J.; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY USA	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute	Kimura, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	kimuray@mskcc.org; srafii@med.cornell.edu			New York Community Trust; Clinical and Translational and Science Center at Weill Cornell Medical College [UL1RR024996]; New York Empire Stem Cell; Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board; New York State Department of Health (NYSTEM) [C024180, C026438, C026878]; National Heart Lung and Blood Institute; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Anbinder and Newmans Own Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	New York Community Trust; Clinical and Translational and Science Center at Weill Cornell Medical College; New York Empire Stem Cell; Ansary Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Empire State Stem Cell Board; New York State Department of Health (NYSTEM); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities Research Foundation; Anbinder and Newmans Own Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds from the New York Community Trust, Pilot Research Award of the Clinical and Translational and Science Center at Weill Cornell Medical College Grant Number UL1RR024996 to Y.K., New York Empire Stem Cell to Y.K. and S.R., Ansary Stem Cell Institute, Howard Hughes Medical Institute, Empire State Stem Cell Board and New York State Department of Health grants (NYSTEM, C024180, C026438, C026878), National Heart Lung and Blood Institute, Qatar National Priorities Research Foundation NPRP08-663-3-140, and Anbinder and Newmans Own Foundation to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI S, 1992, BLOOD, V79, P650; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; KODAMA H, 1994, EXP HEMATOL, V22, P979; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Milde T, 2007, LEUKEMIA, V21, P824, DOI 10.1038/sj.leu.2404525; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oberdoerffer P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng140; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang ZW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf089	30	58	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26918	10.1371/journal.pone.0026918	http://dx.doi.org/10.1371/journal.pone.0026918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046410	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600079
J	Ishikita, H				Ishikita, Hiroshi			Tyrosine Deprotonation and Associated Hydrogen Bond Rearrangements in a Photosynthetic Reaction Center	PLOS ONE			English	Article							INDUCED STRUCTURAL-CHANGES; PANCREATIC RIBONUCLEASE-A; ELECTRON-TRANSFER; PHOTOSYSTEM-II; RHODOPSEUDOMONAS-VIRIDIS; HISTIDINE-RESIDUES; PROTON-TRANSFER; IMIDAZOLE RING; SPECIAL PAIR; PROTEINS	Photosynthetic reaction centers from Blastochloris viridis possess Tyr-L162 located mid-way between the special pair chlorophyll (P) and the heme (heme3). While mutation of the tyrosine does not affect the kinetics of electron transfer from heme3 to P, recent time-resolved Laue diffraction studies reported displacement of Tyr-L162 in response to the formation of the photo-oxidized P+center dot N, implying a possible tyrosine deprotonation event. pK(a) values for Tyr-L162 were calculated using the corresponding crystal structures. Movement of deprotonated Tyr-L162 toward Thr-M185 was observed in P+center dot formation. It was associated with rearrangement of the H-bond network that proceeds to P via Thr-M185 and His-L168.	[Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	hiro@cp.kyoto-u.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150	JST; Ministry of Education, Science, Sport and Culture of Japan [21770163]; MEXT; Takeda Science Foundation	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JST PRESTO program, Grant-in-Aid for Science Research from the Ministry of Education, Science, Sport and Culture of Japan (21770163), Special Coordination Fund for Promoting Science and Technology of MEXT, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARTLING B, 1992, CHEM PHYS LETT, V196, P128, DOI 10.1016/0009-2614(92)85941-3; DOHSE B, 1995, BIOCHEMISTRY-US, V34, P11335, DOI 10.1021/bi00036a006; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Ishikita H, 2005, P NATL ACAD SCI USA, V102, P16215, DOI 10.1073/pnas.0503826102; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P14772, DOI 10.1021/bi051099v; Ishikita H, 2005, J AM CHEM SOC, V127, P14714, DOI 10.1021/ja052567r; Ishikita H, 2005, J BIOL CHEM, V280, P12446, DOI 10.1074/jbc.M413531200; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ishikita H, 2006, BIOPHYS J, V90, P3886, DOI 10.1529/biophysj.105.076984; KNAPP EW, 1987, J CHEM PHYS, V87, P3880, DOI 10.1063/1.452943; LENDZIAN F, 1988, CHEM PHYS LETT, V148, P377, DOI 10.1016/0009-2614(88)87191-4; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; Ortega JM, 1998, BIOPHYS J, V74, P1135, DOI 10.1016/S0006-3495(98)77831-2; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Rabenstein B, 1998, EUR BIOPHYS J BIOPHY, V27, P626, DOI 10.1007/s002490050174; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; SEBBAN P, 1995, BIOCHEMISTRY-US, V34, P8390, DOI 10.1021/bi00026a021; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159	29	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26808	10.1371/journal.pone.0026808	http://dx.doi.org/10.1371/journal.pone.0026808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039551	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200050
J	Andreini, C; Bertini, I; Cavallaro, G				Andreini, Claudia; Bertini, Ivano; Cavallaro, Gabriele			Minimal Functional Sites Allow a Classification of Zinc Sites in Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BINDING SITES; STRUCTURAL CLASSIFICATION; ALCOHOL-DEHYDROGENASE; METAL SITES; DOMAIN; SELECTIVITY; INSIGHTS; DATABASE; FINGERS	Zinc is indispensable to all forms of life as it is an essential component of many different proteins involved in a wide range of biological processes. Not differently from other metals, zinc in proteins can play different roles that depend on the features of the metal-binding site. In this work, we describe zinc sites in proteins with known structure by means of three-dimensional templates that can be automatically extracted from PDB files and consist of the protein structure around the metal, including the zinc ligands and the residues in close spatial proximity to the ligands. This definition is devised to intrinsically capture the features of the local protein environment that can affect metal function, and corresponds to what we call a minimal functional site (MFS). We used MFSs to classify all zinc sites whose structures are available in the PDB and combined this classification with functional annotation as available in the literature. We classified 77% of zinc sites into ten clusters, each grouping zinc sites with structures that are highly similar, and an additional 16% into seven pseudo-clusters, each grouping zinc sites with structures that are only broadly similar. Sites where zinc plays a structural role are predominant in eight clusters and in two pseudo-clusters, while sites where zinc plays a catalytic role are predominant in two clusters and in five pseudo-clusters. We also analyzed the amino acid composition of the coordination sphere of zinc as a function of its role in the protein, highlighting trends and exceptions. In a period when the number of known zinc proteins is expected to grow further with the increasing awareness of the cellular mechanisms of zinc homeostasis, this classification represents a valuable basis for structure-function studies of zinc proteins, with broad applications in biochemistry, molecular pharmacology and de novo protein design.	[Andreini, Claudia; Bertini, Ivano; Cavallaro, Gabriele] Univ Florence, Magnet Resonance Ctr CERM, Sesto Fiorentino, Italy; [Andreini, Claudia; Bertini, Ivano] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Andreini, C (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Sesto Fiorentino, Italy.	bertini@cerm.unifi.it	Cavallaro, Gabriele/C-6991-2008; Andreini, Claudia/AAB-2364-2022; Cavallaro, Gabriele/GRE-9439-2022; Andreini, Claudia/D-5614-2014	Andreini, Claudia/0000-0003-4329-8225; Andreini, Claudia/0000-0003-4329-8225	MIUR (Ministero Italiano dell'Universita e della Ricerca) [RBFR08WGXT]	MIUR (Ministero Italiano dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Ministero Italiano dell'Universita e della Ricerca) through the FIRB (Fondo per gli Investimenti della Ricerca di Base) project RBFR08WGXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Andreini C, 2009, J MOL BIOL, V388, P356, DOI 10.1016/j.jmb.2009.02.052; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertini I., 2001, HDB METALLOPROTEINS; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kumasaka T, 2007, J BIOL CHEM, V282, P37103, DOI 10.1074/jbc.M704476200; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MYERS LC, 1993, BIOCHEMISTRY-US, V32, P14089, DOI 10.1021/bi00214a003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pauly TA, 2003, STRUCTURE, V11, P1071, DOI 10.1016/S0969-2126(03)00167-9; Peroza EA, 2009, J MOL BIOL, V387, P207, DOI 10.1016/j.jmb.2009.01.035; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; PETTERSSON G, 1987, CRIT REV BIOCHEM MOL, V21, P349, DOI 10.3109/10409238609113616; Qian CM, 2003, J BIOL INORG CHEM, V8, P394, DOI 10.1007/s00775-002-0428-1; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sun YN, 2009, J VIROL, V83, P10931, DOI 10.1128/JVI.02579-08; Tanaka Y, 2005, J BIOCHEM, V138, P263, DOI 10.1093/jb/mvi120; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	49	98	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26325	10.1371/journal.pone.0026325	http://dx.doi.org/10.1371/journal.pone.0026325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043316	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400047
J	Hakansson, J; Stahlberg, A; Sand, FW; Gerhardt, H; Semb, H				Hakansson, Joakim; Stahlberg, Anders; Sand, Fredrik Wolfhagen; Gerhardt, Holger; Semb, Henrik			N-CAM Exhibits a Regulatory Function in Pathological Angiogenesis in Oxygen Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; NITRIC-OXIDE SYNTHASE; RETINAL NEOVASCULARIZATION; NEURITE OUTGROWTH; FACTOR VEGF; CELL; PREMATURITY; EXPRESSION; HYPOXIA	Background: Diabetic retinopathy and retinopathy of prematurity are diseases caused by pathological angiogenesis in the retina as a consequence of local hypoxia. The underlying mechanism for epiretinal neovascularization (tuft formation), which contributes to blindness, has yet to be identified. Neural cell adhesion molecule (N-CAM) is expressed by Muller cells and astrocytes, which are in close contact with the retinal vasculature, during normal developmental angiogenesis. Methodology/Principal Findings: Notably, during oxygen induced retinopathy (OIR) N-CAM accumulated on astrocytes surrounding the epiretinal tufts. Here, we show that N-CAM ablation results in reduced vascular tuft formation due to reduced endothelial cell proliferation despite an elevation in VEGFA mRNA expression, whereas retinal developmental angiogenesis was unaffected. Conclusion/Significance: We conclude that N-CAM exhibits a regulatory function in pathological angiogenesis in OIR. This is a novel finding that can be of clinical relevance in diseases associated with proliferative vasculopathy.	[Hakansson, Joakim; Sand, Fredrik Wolfhagen; Gerhardt, Holger; Semb, Henrik] Gothenburg Univ, Dept Med Biochem, Sahlgrenska Acad, Gothenburg, Sweden; [Stahlberg, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Stahlberg, Anders] TATAA Bioctr, Gothenburg, Sweden; [Sand, Fredrik Wolfhagen; Semb, Henrik] Lund Univ, Stem Cell Ctr, Dept Lab Med, Lund, Sweden; [Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London, England	University of Gothenburg; University of Gothenburg; Lund University; University of London; Institute of Cancer Research - UK	Hakansson, J (corresponding author), PharmaSurg Sweden AB, Gothenburg, Sweden.	Fredrik.Wolfhagen_Sand@med.lu.se; Henrik.Semb@med.lu.se	Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Semb, Henrik/0000-0002-6747-787X; Stahlberg, Anders/0000-0003-4243-0191; Gerhardt, Holger/0000-0001-9228-7472	Swedish Cancer Foundation; Swedish Research Council; IngaBritt and Arne Lundberg Foundation; Medical Faculty at Lund University; Goljes Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation; Medical Faculty at Lund University; Goljes Foundation	This work was supported by the Swedish Cancer Foundation: www.cancerfonden.se, the Swedish Research Council: http://www.vr.se/, IngaBritt and Arne Lundberg Foundation: www.lundbergsstiftelsen.se and Goljes Foundation: http://www.lindhes.se. FWS was supported by the Medical Faculty at Lund University. JH is presently employed by PharmaSurgics and AS is a share holder in TATAA Biocenter; during this project JH and AS were employed by academic departments and not by the companies. Neither of the companies did fund any part of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH U, 1990, J NEUROCYTOL, V19, P550, DOI 10.1007/BF01257243; Bohnsack BL, 2004, CELL CYCLE, V3, P1506, DOI 10.4161/cc.3.12.1334; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chiarugi V, 2000, ONCOL RES, V12, P1; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; EDVARDSEN K, 1993, P NATL ACAD SCI USA, V90, P11463, DOI 10.1073/pnas.90.24.11463; FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305; FLOWER RW, 1985, INVEST OPHTH VIS SCI, V26, P957; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GIBSON DL, 1990, PEDIATRICS, V86, P405; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; Hedin Ulf, 1999, Thrombosis and Haemostasis, V82, P23; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; KAHN HA, 1974, AM J OPHTHALMOL, V78, P58, DOI 10.1016/0002-9394(74)90010-5; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; LIEPE BA, 1994, J NEUROSCI, V14, P7641; McColm J, 2004, MOL VIS, V10, P512; MILLER JW, 1994, AM J PATHOL, V145, P574; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; PEER J, 1995, LAB INVEST, V72, P638; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawaguchi A, 1999, J HISTOCHEM CYTOCHEM, V47, P919, DOI 10.1177/002215549904700709; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Smith LEH, 2005, BIOL NEONATE, V88, P237, DOI 10.1159/000087587; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Stupack DG, 2003, ONCOGENE, V22, P9022, DOI 10.1038/sj.onc.1207110; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wojciechowski AB, 2004, GLIA, V47, P58, DOI 10.1002/glia.20033; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	47	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26026	10.1371/journal.pone.0026026	http://dx.doi.org/10.1371/journal.pone.0026026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043302	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295984400030
J	Wu, Y; Szestak, T; Stins, M; Craig, AG				Wu, Yang; Szestak, Tadge; Stins, Monique; Craig, Alister G.			Amplification of P. falciparum Cytoadherence through Induction of a Pro-Adhesive State in Host Endothelium	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; TUMOR-NECROSIS-FACTOR; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; IN-VITRO; GENE-TRANSCRIPTION; PLASMA-LEVELS; TNF-ALPHA; BRAIN	This study examined the ability of P. falciparum-infected erythrocytes (IE) to induce a pro-adhesive environment in the host endothelium during malaria infection, prior to the systemic cytokine activation seen in the later phase of disease. Previous work had shown increases in receptor levels but had not measured to actual impact on IE binding. Using a co-culture system with a range of endothelial cells (EC) and IE with different cytoadherent properties, we have characterised the specific expression of adhesion receptors and subsequent IE binding by FACS and adhesion assays. We have also examined the specific signalling pathways induced during co-culture that are potentially involved in the induction of receptor expression. The results confirmed that ICAM-1 is up-regulated, albeit at much lower levels than seen with TNF activation, in response to co-culture with infected erythrocytes in all three tissue endothelial cell types tested but that up-regulation of VCAM-1 is tissue-dependent. This small increase in the levels of EC receptors correlated with large changes in IE adhesion ability. Co-culture with either RBC or IE increased the potential of subsequent adhesion indicating priming/modulation effects on EC which make them more susceptible to adhesion and thereby the recruitment of IE. Trypsin surface digestion of IE and the use of a Pfsbp1-knockout (ko) parasite line abrogated the up-regulation of ICAM-1 and reduced IE binding to EC suggesting that PfEMP-1 and other molecules exported to the IE surface via the PfSBP1 pathway are major mediators of this phenotype. This was also supported by the higher induction of EC adhesion receptors by adherent IE compared to isogenic, non-adherent lines.	[Wu, Yang; Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Stins, Monique] Johns Hopkins Sch Med, RT Johnson Div NeuroImmunol, Baltimore, MD USA	Liverpool School of Tropical Medicine; University of Liverpool; Johns Hopkins University; Johns Hopkins Medicine	Wu, Y (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	agcraig@liv.ac.uk	Stins, Monique/W-2621-2018	Craig, Alister/0000-0003-0914-6164	Wellcome Trust [085391]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant number 085391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEKHUIZEN H, 1994, J VASC RES, V31, P230, DOI 10.1159/000159048; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Brown H, 1999, J INFECT DIS, V180, P1742, DOI 10.1086/315078; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; CLARK IA, 1992, AM J PATHOL, V140, P325; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Cooke BM, 2000, PARASITOL TODAY, V16, P416, DOI 10.1016/S0169-4758(00)01753-1; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; GRANINGER W, 1994, J CLIN PATHOL, V47, P653, DOI 10.1136/jcp.47.7.653; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Ho M, 2005, INFECT IMMUN, V73, P8179, DOI 10.1128/IAI.73.12.8179-8187.2005; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Jenkins N, 2007, J INFECT DIS, V196, P321, DOI 10.1086/518795; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kawai S, 2003, J VET MED SCI, V65, P629, DOI 10.1292/jvms.65.629; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P665, DOI 10.1016/j.trstmh.2009.03.001; McCormick CJ, 1997, J CLIN INVEST, V100, P2521, DOI 10.1172/JCI119794; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Qureshi MH, 2003, J IMMUNOL, V171, P4700, DOI 10.4049/jimmunol.171.9.4700; Richards AL, 1997, INT J PARASITOL, V27, P1251, DOI 10.1016/S0020-7519(97)00122-7; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; ROTHLEIN R, 1994, J IMMUNOL, V152, P2488; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shin YT, 2000, BLOOD, V95, P3232; Stins MF, 1999, INFECT IMMUN, V67, P5522, DOI 10.1128/IAI.67.10.5522-5525.1999; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; TURNER GDH, 1994, AM J PATHOL, V145, P1057; UDEINYA IJ, 1981, SCIENCE, V213, P555, DOI 10.1126/science.7017935; UDEINYA IJ, 1993, AM J TROP MED HYG, V48, P488, DOI 10.4269/ajtmh.1993.48.488; Viebig NK, 2005, INFECT IMMUN, V73, P3271, DOI 10.1128/IAI.73.6.3271-3277.2005; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; Wu Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-67; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298	64	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24784	10.1371/journal.pone.0024784	http://dx.doi.org/10.1371/journal.pone.0024784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043276	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000295984400003
J	Ellis, JA; Ponsonby, AL; Pezic, A; Williamson, E; Cochrane, JA; Dickinson, JL; Dwyer, T				Ellis, Justine A.; Ponsonby, Anne-Louise; Pezic, Angela; Williamson, Elizabeth; Cochrane, Jennifer A.; Dickinson, Joanne L.; Dwyer, Terence			APOE Genotype and Cardio-Respiratory Fitness Interact to Determine Adiposity in 8-Year-Old Children from the Tasmanian Infant Health Survey	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-E PHENOTYPES; PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK; YOUNG-ADULTS; OBESITY; DISEASE; TRIGLYCERIDES; ASSOCIATION; WEIGHT	APOE plays a well established role in lipid metabolism. Animal model evidence suggests APOE may also be associated with adiposity, but this has not been thoroughly investigated in humans. We measured adiposity (BMI, truncal fat mass, waist circumference), physical activity (PA), cardiorespiratory fitness and APOE genotype (E2, E3, E4) in 292 8-year-old children from the Tasmanian Infant Health Survey (TIHS), an Australian population-based prospective birth cohort. Our aims were to examine the association of APOE with child adiposity, and to examine the interplay between this association and other measured factors. We found that APOE was associated with child lipid profiles. APOE was also associated with child adiposity measures. The association was E4 allele-specific, with adiposity lower in the E4-containing group (BMI: Mean difference -0.90 kg/m(2); 95% confidence intervals (CI) -1.51, -0.28; p = 0.004). The association of APOE4 with lower BMI differed by fitness status (difference in effect p = 0.002), and was more evident among the less fit (mean difference -1.78 kg/m(2); 95% CI -2.74, -0.83; p<0.001). Additionally, associations between BMI and lipids were only apparent in those of lower fitness who did not carry APOE4. Similar overall findings were observed when truncal fat mass and waist circumference were used as alternative adiposity measures. APOE4 and cardiorespitatory fitness could interact to influence child adiposity. In studies addressing the genetic determinants of childhood obesity, the context of child fitness should also be taken into account.	[Ellis, Justine A.; Ponsonby, Anne-Louise; Pezic, Angela; Williamson, Elizabeth; Dwyer, Terence] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ponsonby, Anne-Louise; Cochrane, Jennifer A.; Dickinson, Joanne L.; Dwyer, Terence] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Ellis, Justine A.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Tasmania; Menzies Institute for Medical Research; University of Melbourne	Ellis, JA (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	justine.ellis@mcri.edu.au	Dickinson, Joanne/J-7728-2014; Ponsonby, Anne-Louise/AAE-4351-2019; Ellis, Justine A/G-5006-2011; Williamson, Elizabeth/H-3876-2019	Williamson, Elizabeth/0000-0001-6905-876X; Dickinson, Joanne/0000-0003-4621-1703; Ponsonby, Anne-Louise/0000-0002-6581-3657; Ellis, Justine/0000-0003-4103-4445	Australian National Health and Medical Research Council (NHMRC); United States of America National Institutes of Health [001 HD28979-01A1]; Tasmanian State Government; Australian Rotary Health Research Fund; Sudden Infant Death Syndrome Research Foundation; National Sudden Infant Death Syndrome Council of Australia; Department of Human Services and Health; Zonta International; Wyeth Pharmaceuticals; Tasmanian Sanatoria After-Care Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028979] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); United States of America National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tasmanian State Government; Australian Rotary Health Research Fund; Sudden Infant Death Syndrome Research Foundation; National Sudden Infant Death Syndrome Council of Australia; Department of Human Services and Health; Zonta International; Wyeth Pharmaceuticals(Wyeth); Tasmanian Sanatoria After-Care Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Tasmanian Infant Health Survey was funded by the Australian National Health and Medical Research Council (NHMRC), United States of America National Institutes of Health (grant 001 HD28979-01A1), Tasmanian State Government, Australian Rotary Health Research Fund, Sudden Infant Death Syndrome Research Foundation, National Sudden Infant Death Syndrome Council of Australia, Community Organizations' support program of the Department of Human Services and Health, Zonta International, Wyeth Pharmaceuticals and the Tasmanian Sanatoria After-Care Association. JE was supported by an Australian National Health and Medical Research Council Capacity Building Grant in Population Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; d'Espaignet E T, 1990, Paediatr Perinat Epidemiol, V4, P422, DOI 10.1111/j.1365-3016.1990.tb00670.x; Dwyer T, 2008, ARCH DIS CHILD, V93, P760, DOI 10.1136/adc.2007.129122; Dwyer T, 2002, INT J OBESITY, V26, P1301, DOI 10.1038/sj.ijo.0802111; DWYER T, 1991, LANCET, V337, P1244, DOI 10.1016/0140-6736(91)92917-Q; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huang ZH, 2009, J BIOL CHEM, V284, P31512, DOI 10.1074/jbc.M109.004754; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Jones G, 1998, J CLIN ENDOCR METAB, V83, P4274, DOI 10.1210/jc.83.12.4274; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kristensen PL, 2010, EUR J APPL PHYSL, DOI [10.1007/s00421-00010-01491-x, DOI 10.1007/S00421-00010-01491-X]; Kypreos KE, 2009, FEBS J, V276, P5720, DOI 10.1111/j.1742-4658.2009.07301.x; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LEHTIMAKI T, 1994, PEDIATRICS, V94, P489; LEHTIMAKI T, 1990, J LIPID RES, V31, P487; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Medina-Urrutia AX, 2004, HUM BIOL, V76, P605, DOI 10.1353/hub.2004.0059; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Sabin MA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-100; Sassen B, 2009, EUR J CARDIOV PREV R, V16, P677, DOI 10.1097/HJR.0b013e3283312e94; Taimela S, 1996, METABOLISM, V45, P797, DOI 10.1016/S0026-0495(96)90149-3; VANMECHELEN W, 1986, EUR J APPL PHYSIOL O, V55, P503, DOI 10.1007/BF00421645; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594	35	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26679	10.1371/journal.pone.0026679	http://dx.doi.org/10.1371/journal.pone.0026679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069463	Green Accepted, Green Published, gold			2022-12-27	WOS:000297150900025
J	Graciotti, L; Becker, J; Granata, AL; Procopio, AD; Tessarollo, L; Fulgenzi, G				Graciotti, Laura; Becker, Jodi; Granata, Anna Luisa; Procopio, Antonio Domenico; Tessarollo, Lino; Fulgenzi, Gianluca			Dystrophin Is Required for the Normal Function of the Cardio-Protective K-ATP Channel in Cardiomyocytes	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; DUCHENNE MUSCULAR-DYSTROPHY; MDX MICE; CARDIAC MYOCYTES; CREATINE-KINASE; MOUSE MODEL; CARDIOMYOPATHY; CELL; MUSCLE; STRESS	Duchenne and Becker muscular dystrophy patients often develop a cardiomyopathy for which the pathogenesis is still unknown. We have employed the murine animal model of Duchenne muscular dystrophy (mdx), which develops a cardiomyopathy that includes some characteristics of the human disease, to study the molecular basis of this pathology. Here we show that the mdx mouse heart has defects consistent with alteration in compounds that regulate energy homeostasis including a marked decrease in creatine-phosphate (PC). In addition, the mdx heart is more susceptible to anoxia than controls. Since the cardio-protective ATP sensitive potassium channel (K-ATP) complex and PC have been shown to interact we investigated whether deficits in PC levels correlate with other molecular events including K-ATP ion channel complex presence, its functionality and interaction with dystrophin. We found that this channel complex is present in the dystrophic cardiac cell membrane but its ability to sense a drop in the intracellular ATP concentration and consequently open is compromised by the absence of dystrophin. We further demonstrate that the creatine kinase muscle isoform (CKm) is displaced from the plasma membrane of the mdx cardiac cells. Considering that CKm is a determinant of K-ATP channel complex function we hypothesize that dystrophin acts as a scaffolding protein organizing the K-ATP channel complex and the enzymes necessary for its correct functioning. Therefore, the lack of proper functioning of the cardio-protective K-ATP system in the mdx cardiomyocytes may be part of the mechanism contributing to development of cardiac disease in dystrophic patients.	[Graciotti, Laura; Granata, Anna Luisa; Procopio, Antonio Domenico; Fulgenzi, Gianluca] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy; [Becker, Jodi; Tessarollo, Lino; Fulgenzi, Gianluca] NCI, Neural Dev Grp, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Procopio, Antonio Domenico] INRCA Ancona, Ctr Clin Pathol & Innovat Therapy, Ancona, Italy	Marche Polytechnic University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); IRCCS INRCA	Graciotti, L (corresponding author), Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy.	tessarol@mail.nih.gov; fulgenzig@mail.nih.gov	Fulgenzi, Gianluca/AAL-4552-2020; Procopio, Antonio Domenico/AAB-2451-2021	Procopio, Antonio Domenico/0000-0001-6897-8724; Graciotti, Laura/0000-0002-1874-5217; Fulgenzi, Gianluca/0000-0003-2646-7728	National Institutes of Health (NIH), National Cancer Institute; Polytechnic University of Marche; NATIONAL CANCER INSTITUTE [ZIABC010391] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Polytechnic University of Marche; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute for JB, LT and GF. LG, ADP, and ALG were supported by Polytechnic University of Marche "finanziamento di Ateneo 2005,06,07,08,09''. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Branco DM, 2007, J INTERV CARD ELECTR, V20, P1, DOI 10.1007/s10840-007-9168-z; BRIDGES LR, 1986, J NEUROL SCI, V72, P147, DOI 10.1016/0022-510X(86)90003-1; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Crawford RM, 2002, EMBO J, V21, P3936, DOI 10.1093/emboj/cdf388; Crawford RM, 2001, FASEB J, V15, P102, DOI 10.1096/fj.01-0446fje; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Finsterer J, 2006, LUNG, V184, P205, DOI 10.1007/s00408-005-2584-x; FRANK JS, 1994, AM J PHYSIOL-CELL PH, V267, pC1707, DOI 10.1152/ajpcell.1994.267.6.C1707; Gross GJ, 1999, CIRC RES, V84, P973, DOI 10.1161/01.RES.84.9.973; HESCHELER J, 1987, BIOMED BIOCHIM ACTA, V46, pS677; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; Hu XL, 2008, CIRC RES, V103, P1009, DOI 10.1161/CIRCRESAHA.107.170795; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Jovanovic A, 1998, CIRCULATION, V98, P1548, DOI 10.1161/01.CIR.98.15.1548; Jovanovic S, 2005, EMBO REP, V6, P848, DOI 10.1038/sj.embor.7400489; Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015; MORLEY GE, 1992, CIRC RES, V71, P821, DOI 10.1161/01.RES.71.4.821; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Noma A, 1988, Ion Channels, V1, P183; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; SALA S, 1991, J MEMBRANE BIOL, V122, P177, DOI 10.1007/BF01872640; Sasaki N, 2001, AM J PHYSIOL-HEART C, V280, pH1882, DOI 10.1152/ajpheart.2001.280.4.H1882; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stevenson S, 1997, CIRC RES, V80, P269, DOI 10.1161/01.RES.80.2.269; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tomasetti M, 2001, J CHROMATOGR B, V751, P229, DOI 10.1016/S0378-4347(00)00470-9; Townsend D, 2008, MOL THER, V16, P832, DOI 10.1038/mt.2008.52; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27034	10.1371/journal.pone.0027034	http://dx.doi.org/10.1371/journal.pone.0027034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066028	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000047
J	Ji, YQ; Wu, DD; Wu, GS; Wang, GD; Zhang, YP				Ji, Yin-Qiu; Wu, Dong-Dong; Wu, Gui-Sheng; Wang, Guo-Dong; Zhang, Ya-Ping			Multi-Locus Analysis Reveals A Different Pattern of Genetic Diversity for Mitochondrial and Nuclear DNA between Wild and Domestic Pigs in East Asia	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; CHROMOSOMAL LOCALIZATION; PORCINE; ORIGIN; POLYMORPHISM; SELECTION; MUTATION; HISTORY; NUMBER; MODEL	Background: A major reduction of genetic diversity in mtDNA occurred during the domestication of East Asian pigs. However, the extent to which genetic diversity has been lost in the nuclear genome is uncertain. To reveal levels and patterns of nucleotide diversity and to elucidate the genetic relationships and demographic history of domestic pigs and their ancestors, wild boars, we investigated 14 nuclear markers (including 8 functional genes, 2 pseudogenes and 4 intergenic regions) from 11 different chromosomes in East Asia-wide samples and pooled them with previously obtained mtDNA data for a combined analysis. Principal Findings: The results indicated that domestic pigs and wild boars possess comparable levels of nucleotide diversity across the nuclear genome, which is inconsistent with patterns that have been found in mitochondrial genome. Conclusions: This incongruence between the mtDNA and nuclear genomes is suggestive of a large-scale backcross between male wild boars and female domestic pigs in East Asia. Our data reveal the impacts of founder effects and backcross on the pig genome and help us better understand the complex demographic histories of East Asian pigs, which will be useful for future work on artificial selection.	[Ji, Yin-Qiu; Wu, Dong-Dong; Wu, Gui-Sheng; Wang, Guo-Dong; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Ji, Yin-Qiu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wu, Gui-Sheng; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University	Ji, YQ (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Wu, Dong-Dong/AAR-5615-2020		National Basic Research Program of China (973 Program) [2007CB815704]; Ministry of Agriculture of China; National Natural Science Foundation of China [U0836602, 31061160189]; Chinese Academy of Sciences; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Yunnan Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB815704), National program for transgenic research from Ministry of Agriculture of China, National Natural Science Foundation of China (U0836602, 31061160189), Chinese Academy of Sciences, and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Briley GP, 1996, MAMM GENOME, V7, P226, DOI 10.1007/s003359900062; Budiansky Stephen., 1992, COVENANT WILD WHY AN; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Clutton-Brock J., 1989, WALKING LARDER PATTE; Darwin C, 1968, VARIATION ANIMALS PL; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; FU YX, 1993, GENETICS, V133, P693; Giuffra E, 2000, GENETICS, V154, P1785; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Ingvarsson PK, 2004, GENET RES, V83, P31, DOI 10.1017/S0016672303006529; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Knoll A, 2002, ANIM GENET, V33, P390, DOI 10.1046/j.1365-2052.2002.00896_10.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li J, 2010, HEREDITY; Li N, 2003, GENETICS, V165, P2213; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; Luo YB, 2009, JIANGHAN ARCHAEOLOGY, V3, P58; MAEDA N, 1988, GENE, V70, P213, DOI 10.1016/0378-1119(88)90194-1; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Ojeda A, 2008, ANIM GENET, V39, P468, DOI 10.1111/j.1365-2052.2008.01752.x; Ojeda A, 2008, GENETICS, V178, P1639, DOI 10.1534/genetics.107.084269; Ojeda A, 2006, GENETICS, V174, P2119, DOI 10.1534/genetics.106.063057; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scherf B.D., 1995, WORLD WATCH LIST DOM; Skinner TM, 2000, CYTOGENET CELL GENET, V90, P53, DOI 10.1159/000015659; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1983, GENETICS, V105, P437; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; te Pas MFW, 2003, ANIM GENET, V34, P157, DOI 10.1046/j.1365-2052.2003.00965_9.x; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; VIZE PD, 1987, GENE, V55, P339, DOI 10.1016/0378-1119(87)90294-0; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weaks RL, 1997, ANIM GENET, V28, P354, DOI 10.1111/j.1365-2052.1997.00159.x; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; YU TP, 1994, ANIM GENET, V25, P229, DOI 10.1111/j.1365-2052.1994.tb00198.x; [袁靖 Yuan Jing], 2010, [第四纪研究, Quaternary Sciences], V30, P298; Zeuner F. E, 1963, HIST DOMESTICATED AN	64	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26416	10.1371/journal.pone.0026416	http://dx.doi.org/10.1371/journal.pone.0026416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065995	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000011
J	Sjoberg, C; Edward, C; Fastbom, J; Johnell, K; Landahl, S; Narbro, K; Wallerstedt, SM				Sjoberg, Christina; Edward, Christina; Fastbom, Johan; Johnell, Kristina; Landahl, Sten; Narbro, Kristina; Wallerstedt, Susanna Maria			Association between Multi-Dose Drug Dispensing and Quality of Drug Treatment - A Register-Based Study	PLOS ONE			English	Article								Background: In the elderly in Scandinavia, multi-dose drug dispensing (MDD) is a common alternative to ordinary prescriptions (OP). MDD patients receive their drugs in unit bags, one for each dose occasion. The prescribing procedure differs between MDD and OP. The aim of the present study was to investigate the association between MDD and quality of drug treatment (QDT). Methodology/Principal Findings: A cross-sectional study was performed of all inhabitants in Region Vastra Gotaland alive on December 31st 2007, aged >= 65 years, with >= 1 prescribed drug and >= 2 health care visits for >= 2 diagnoses for obstructive pulmonary disease, diabetes mellitus, and/or cardiovascular disease in 2005-2007 (n = 24,146). For each patient, drug treatment on December 31st 2007 was estimated from drugs registered in the Swedish Prescribed Drug Register. QDT was evaluated according to established quality indicators (>= 10 drugs, Long-acting benzodiazepines, Drugs with anticholinergic action, >= 3 psychotropics, and Drugs combinations that should be avoided). Logistic regression, with adjustments for age, sex, burden of disease, and residence, was performed to investigate the association between MDD and QDT. Mean age was 77 years, 51% were females, and 20% used MDD. For all quality indicators, the proportion of patients with poor QDT was greater in patients with MDD than in patients with OP (all P < 0.0001). Unadjusted and adjusted odds ratios (95% confidence intervals) for poor QDT (MDD patients vs. OP patients) ranged from 1.47 (1.30-1.65) to 7.08 (6.30-7.96) and from 1.36 (1.18-1.57) to 5.48 (4.76-6.30), respectively. Conclusions/Significance: Patients with MDD have poorer QDT than patients with OP. This cannot be explained by differences in age, sex, burden of disease, or residence. These findings must be taken into account when designing alternative prescribing systems. Further research is needed to evaluate causative factors and if the findings also apply to other dose dispensing systems.	[Sjoberg, Christina] Sahlgrenska Univ Hospital Molndal, Dept Geriatr, Molndal, Sweden; [Edward, Christina] Cty Council Kalmar, Pharmaceut Unit, Dept Hlth, Kalmar, Sweden; [Fastbom, Johan; Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden; [Fastbom, Johan; Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Landahl, Sten] Univ Gothenburg, Sahlgrenska Univ Hosp Molndal, Dept Publ Hlth & Community Med, Geriatr Unit, Molndal, Sweden; [Narbro, Kristina] Reg Vastra Gotaland, Dept Hlth Adm, Reg Secretariat, Gothenburg, Sweden; [Wallerstedt, Susanna Maria] Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden	Sahlgrenska University Hospital; Stockholm University; Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Sjoberg, C (corresponding author), Sahlgrenska Univ Hospital Molndal, Dept Geriatr, Molndal, Sweden.	christina.a.sjoberg@vgregion.se	Wallerstedt, Susanna/AAE-5607-2020	Wallerstedt, Susanna/0000-0001-7238-1680; Landahl, Sten/0000-0001-7251-9192	Swedish National Board of Health and Welfare	Swedish National Board of Health and Welfare	The study was supported by the Swedish National Board of Health and Welfare. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Gaist D, 2002, NEUROLOGY, V58, P1333, DOI 10.1212/WNL.58.9.1333; Hidle Unn, 2007, J N Y State Nurses Assoc, V38, P4; Hovstadius Bo, 2010, BMC Clin Pharmacol, V10, P16, DOI 10.1186/1472-6904-10-16; Johnell K, 2008, SCAND J PRIM HEALTH, V26, P86, DOI 10.1080/02813430802022196; Johnell K, 2007, DRUG SAFETY, V30, P911, DOI 10.2165/00002018-200730100-00009; Johnell K, 2007, ANN PHARMACOTHER, V41, P1243, DOI 10.1345/aph.1K154; Johnell K, 2009, ANN PHARMACOTHER, V43, P1233, DOI 10.1345/aph.1M147; Kragh Annika, 2004, Lakartidningen, V101, P994; NORDLING S, 2009, WHAT ARE BENEFITS MU; SJOQVIST F, 2011, PHARM SPECIALITIES S; Socialstyrelsen, 2010, IND GOD LAK HOS ALDR; Statens beredning for medicinsk utvardering (Swedish Council on Technology Assessment in Health Care), 2009, 193 STAT BER MED UTV; *SVER KOMM LANDST, 2010, OPPN JAMF HALS SJUKV; STAT SWEDEN WEBSITE	16	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26574	10.1371/journal.pone.0026574	http://dx.doi.org/10.1371/journal.pone.0026574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066000	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000016
J	Abrantes, MC; Lopes, MD; Kok, J				Abrantes, Marta Coelho; Lopes, Maria de Fatima; Kok, Jan			Impact of Manganese, Copper and Zinc Ions on the Transcriptome of the Nosocomial Pathogen Enterococcus faecalis V583	PLOS ONE			English	Article							TRACE-ELEMENTS; VIRULENCE; HOMEOSTASIS; RESPONSES; ARGININE; SYSTEM; GENES; DEGRADATION; METABOLISM; EXPRESSION	Mechanisms that enable Enterococcus to cope with different environmental stresses and their contribution to the switch from commensalism to pathogenicity of this organism are still poorly understood. Maintenance of intracellular homeostasis of metal ions is crucial for survival of these bacteria. In particular Zn2+, Mn2+ and Cu2+ are very important metal ions as they are co-factors of many enzymes, are involved in oxidative stress defense and have a role in the immune system of the host. Their concentrations inside the human body vary hugely, which makes it imperative for Enterococcus to fine-tune metal ion homeostasis in order to survive inside the host and colonize it. Little is known about metal regulation in Enterococcus faecalis. Here we present the first genome-wide description of gene expression of E. faecalis V583 growing in the presence of high concentrations of zinc, manganese or copper ions. The DNA microarray experiments revealed that mostly transporters are involved in the responses of E. faecalis to prolonged exposure to high metal concentrations although genes involved in cellular processes, in energy and amino acid metabolisms and genes related to the cell envelope also seem to play important roles.	[Abrantes, Marta Coelho; Lopes, Maria de Fatima] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Stress Antibiot & Virulence Enterococci, Oeiras, Portugal; [Abrantes, Marta Coelho; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen, Netherlands; [Lopes, Maria de Fatima] Inst Biol Expt & Tecnol, Oeiras, Portugal	Universidade Nova de Lisboa; University of Groningen	Abrantes, MC (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Stress Antibiot & Virulence Enterococci, Oeiras, Portugal.	flopes@itqb.unl.pt	Lopes, Maria de Fátima/J-7019-2018; Kok, Jan/C-9972-2012	Silva Lopes, Maria de Fatima/0000-0003-1243-8424	Fundacao para a Ciencia e Tecnologia [POCTI/BIA-BCM/60643/2004, PTDC/CVT/67270/2006, PEst-OE/EQB/LA0004/2011, SFRH/BD/30362/2006]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors are grateful to Fundacao para a Ciencia e Tecnologia for the Project grants POCTI/BIA-BCM/60643/2004 and PTDC/CVT/67270/2006 and PEst-OE/EQB/LA0004/2011. MCA is grateful to Fundacao para a Ciencia e Tecnologia for the grant SFRH/BD/30362/2006. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Carvalho AS, 2003, J APPL MICROBIOL, V94, P947, DOI 10.1046/j.1365-2672.2003.01853.x; Chicharro JL, 1999, BRIT J SPORT MED, V33, P204, DOI 10.1136/bjsm.33.3.204; Creti R, 2009, INT J ARTIF ORGANS, V32, P611, DOI 10.1177/039139880903200910; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; FELDBERG R S, 1985, Journal of Free Radicals in Biology and Medicine, V1, P459, DOI 10.1016/0748-5514(85)90161-8; Galkin A, 2004, J BIOL CHEM, V279, P14001, DOI 10.1074/jbc.M313410200; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Grimble R F, 1994, New Horiz, V2, P175; Guedon E, 2003, MOL MICROBIOL, V49, P1477, DOI 10.1046/j.1365-2958.2003.03648.x; Hancock L, 2002, J BACTERIOL, V184, P5819, DOI 10.1128/JB.184.21.5819-5825.2002; Hew CM, 2007, SYST APPL MICROBIOL, V30, P257, DOI 10.1016/j.syapm.2006.08.002; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Jakubovics NS, 2009, MOL MICROBIOL, V72, P1, DOI 10.1111/j.1365-2958.2009.06637.x; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; JARVISALO J, 1992, INT ARCH OCC ENV HEA, V63, P495, DOI 10.1007/BF00572116; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004; Lenz CA, 2010, FOOD MICROBIOL, V27, P317, DOI 10.1016/j.fm.2009.11.008; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; Lubben M, 2009, BIOMETALS, V22, P363, DOI 10.1007/s10534-008-9173-4; Magnani D, 2005, BIOMETALS, V18, P407, DOI 10.1007/s10534-005-3715-9; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; Miller J, EXPT MOL GENETICS, P352; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; POWELL JJ, 1992, GUT, V33, P1617, DOI 10.1136/gut.33.12.1617; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Reyes-Jara A, 2010, BIOMETALS, V23, P1105, DOI 10.1007/s10534-010-9356-7; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Thurnham DI, 2005, P NUTR SOC, V64, P502, DOI 10.1079/PNS2005468; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07	53	34	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26519	10.1371/journal.pone.0026519	http://dx.doi.org/10.1371/journal.pone.0026519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053193	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800019
J	Baek, CH; Kang, HY; Roland, KL; Curtiss, R				Baek, Chang-Ho; Kang, Ho-Young; Roland, Kenneth L.; Curtiss, Roy, III			Lrp Acts as Both a Positive and Negative Regulator for Type 1 Fimbriae Production in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							CONTROLS PHASE VARIATION; INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; DNA INVERSION; COOPERATIVE BINDING; PROMOTER REGION; I FIMBRIAE; FIM SWITCH; DELTA-CRP; H-NS	Leucine-responsive regulatory protein (Lrp) is known to be an indirect activator of type 1 fimbriae synthesis in Salmonella enterica serovar Typhimurium via direct regulation of FimZ, a direct positive regulator for type 1 fimbriae production. Using RT-PCR, we have shown previously that fimA transcription is dramatically impaired in both lrp-deletion (Delta lrp) and constitutive-lrp expression (lrp(C)) mutant strains. In this work, we used chromosomal P-fimA-lacZ fusions and yeast agglutination assays to confirm and extend our previous results. Direct binding of Lrp to P-fimA was shown by an electrophoretic mobility shift assay (EMSA) and DNA footprinting assay. Site-directed mutagenesis revealed that the Lrp-binding motifs in P-fimA play a role in both activation and repression of type 1 fimbriae production. Overproduction of Lrp also abrogates fimZ expression. EMSA data showed that Lrp and FimZ proteins independently bind to P-fimA without competitive exclusion. In addition, both Lrp and FimZ binding to P-fimA caused a hyper retardation (supershift) of the DNA-protein complex compared to the shift when each protein was present alone. Nutrition-dependent cellular Lrp levels closely correlated with the amount of type 1 fimbriae production. These observations suggest that Lrp plays important roles in type 1 fimbriation by acting as both a positive and negative regulator and its effect depends, at least in part, on the cellular concentration of Lrp in response to the nutritional environment.	[Baek, Chang-Ho; Roland, Kenneth L.; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kang, Ho-Young] Pusan Natl Univ, Dept Microbiol, Pusan 609735, South Korea	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pusan National University	Curtiss, R (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu			National Institutes of Health [R01AI060557]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (R01AI060557, Salmonella Vaccines Against Bacterial Enteropathogens) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Baek CH, 2003, J MICROBIOL BIOTECHN, V13, P872; Baek CH, 2009, J BACTERIOL, V191, P1278, DOI 10.1128/JB.01142-08; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BLOMFIELD IC, 1993, J BACTERIOL, V175, P27, DOI 10.1128/JB.175.1.27-36.1993; Blomfield IC, 1997, MOL MICROBIOL, V23, P705, DOI 10.1046/j.1365-2958.1997.2241615.x; Bonci A, 1997, J MOL EVOL, V44, P299, DOI 10.1007/PL00006147; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BUCHANAN K, 1985, J BACTERIOL, V162, P799, DOI 10.1128/JB.162.2.799-803.1985; Chen SL, 2005, J MOL BIOL, V345, P251, DOI 10.1016/j.jmb.2004.10.047; Clegg S, 1996, J BACTERIOL, V178, P542, DOI 10.1128/jb.178.2.542-545.1996; Clegg S., 1994, FIMBRIAE ADHESION GE, P105; CURTISS R, 1991, COLONIZATION CONTROL, P169; DORMAN CJ, 1987, J BACTERIOL, V169, P3840, DOI 10.1128/jb.169.8.3840-3843.1987; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; EISENSTEIN BI, 1987, P NATL ACAD SCI USA, V84, P6506, DOI 10.1073/pnas.84.18.6506; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KAWULA TH, 1991, J BACTERIOL, V173, P4116, DOI 10.1128/jb.173.13.4116-4123.1991; KLEMM P, 1984, EUR J BIOCHEM, V143, P395, DOI 10.1111/j.1432-1033.1984.tb08386.x; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; KUKKONEN M, 1993, MOL MICROBIOL, V7, P229, DOI 10.1111/j.1365-2958.1993.tb01114.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landgraf JR, 1996, J BACTERIOL, V178, P6930, DOI 10.1128/jb.178.23.6930-6936.1996; MCCLAIN MS, 1993, J BACTERIOL, V175, P4335, DOI 10.1128/JB.175.14.4335-4344.1993; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McFarland KA, 2008, J BACTERIOL, V190, P602, DOI 10.1128/JB.01388-07; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; OLD DC, 1970, J BACTERIOL, V103, P447, DOI 10.1128/JB.103.2.447-456.1970; Pul U, 2005, MOL MICROBIOL, V58, P864, DOI 10.1111/j.1365-2958.2005.04873.x; PURCELL BK, 1987, J BACTERIOL, V169, P5831, DOI 10.1128/jb.169.12.5831-5834.1987; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; ROSSOLINI GM, 1993, FEMS MICROBIOL LETT, V114, P259, DOI 10.1016/0378-1097(93)90281-6; Saini S, 2009, J BACTERIOL, V191, P3003, DOI 10.1128/JB.01694-08; Sambrook J., 2001, MOL CLONING LAB MANU; SWENSON DL, 1994, MOL GEN GENET, V244, P216, DOI 10.1007/BF00283525; TAVENDALE A, 1983, J MED MICROBIOL, V16, P371, DOI 10.1099/00222615-16-3-371; Tinker JK, 2000, INFECT IMMUN, V68, P3305, DOI 10.1128/IAI.68.6.3305-3313.2000; Tinker JK, 2001, MOL MICROBIOL, V40, P757, DOI 10.1046/j.1365-2958.2001.02430.x; Tinker JK, 2001, J BACTERIOL, V183, P435, DOI 10.1128/JB.183.2.435-442.2001; VANDERWOUDE MW, 1995, MOL MICROBIOL, V17, P303, DOI 10.1111/j.1365-2958.1995.mmi_17020303.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WILLINS DA, 1991, J BIOL CHEM, V266, P10768; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Yeh KS, 2002, MICROBIOL IMMUNOL, V46, P1, DOI 10.1111/j.1348-0421.2002.tb02670.x; Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997; Zhi JZ, 1999, MOL MICROBIOL, V32, P29, DOI 10.1046/j.1365-2958.1999.01314.x	55	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26896	10.1371/journal.pone.0026896	http://dx.doi.org/10.1371/journal.pone.0026896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V31AH	22046399	Green Submitted, gold, Green Published			2022-12-27	WOS:000208856000001
J	Egeland, T; Salas, A				Egeland, Thore; Salas, Antonio			A Statistical Framework for the Interpretation of mtDNA Mixtures: Forensic and Medical Applications	PLOS ONE			English	Article							MITOCHONDRIAL; MUTATIONS; SEQUENCE; CONTAMINATION; PENETRANCE; RESOLUTION; ERRORS; GENOME	Background: Mitochondrial DNA (mtDNA) variation is commonly analyzed in a wide range of different biomedical applications. Cases where more than one individual contribute to a stain genotyped from some biological material give rise to a mixture. Most forensic mixture cases are analyzed using autosomal markers. In rape cases, Y-chromosome markers typically add useful information. However, there are important cases where autosomal and Y-chromosome markers fail to provide useful profiles. In some instances, usually involving small amounts or degraded DNA, mtDNA may be the only useful genetic evidence available. Mitochondrial DNA mixtures also arise in studies dealing with the role of mtDNA variation in tumorigenesis. Such mixtures may be generated by the tumor, but they could also originate in vitro due to inadvertent contamination or a sample mix-up. Methods/Principal Findings: We present the statistical methods needed for mixture interpretation and emphasize the modifications required for the more well-known methods based on conventional markers to generalize to mtDNA mixtures. Two scenarios are considered. Firstly, only categorical mtDNA data is assumed available, that is, the variants contributing to the mixture. Secondly, quantitative data (peak heights or areas) on the allelic variants are also accessible. In cases where quantitative information is available in addition to allele designation, it is possible to extract more precise information by using regression models. More precisely, using quantitative information may lead to a unique solution in cases where the qualitative approach points to several possibilities. Importantly, these methods also apply to clinical cases where contamination is a potential alternative explanation for the data. Conclusions/Significance: We argue that clinical and forensic scientists should give greater consideration to mtDNA for mixture interpretation. The results and examples show that the analysis of mtDNA mixtures contributes substantially to forensic casework and may also clarify erroneous claims made in clinical genetics regarding tumorigenesis.	[Egeland, Thore] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Oslo, Norway; [Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Med Legal, Fac Med, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Fac Med, Galicia, Spain	Norwegian University of Life Sciences; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Egeland, T (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Oslo, Norway.	thore.egeland@umb.no; antonio.salas@usc.es	Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X	Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]; Ministerio de Ciencia e Innovacion [SAF2008-02971]	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This project was partially supported by grants from Fundacion de Investigacion Medica Mutua Madrilena (2008/CL444) and Ministerio de Ciencia e Innovacion (SAF2008-02971) (AS). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt H-J, 2011, FORENSIC SC IN PRESS; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Buckleton JS, FORENSIC DNA EVIDENC; Chen JJZ, 2002, CANCER RES, V62, P6470; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; Egeland T, 2011, FORENSIC SCI INT-GEN, DOI [10.1016/ j.fsigen.2011.1002.1003, DOI 10.1016/J.FSIGEN.2011.1002.1003]; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Holland MM, 2011, CROAT MED J, V52, P299, DOI 10.3325/cmj.2011.52.299; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Montesino M, 2007, FORENSIC SCI INT, V168, P42, DOI 10.1016/j.forsciint.2006.06.066; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P180, DOI 10.1016/j.fsigen.2007.02.007; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Walker JA, 2004, ANAL BIOCHEM, V325, P171, DOI 10.1016/j.ab.2003.10.003; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Yao YG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000681	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26723	10.1371/journal.pone.0026723	http://dx.doi.org/10.1371/journal.pone.0026723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053205	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800031
J	Kancha, RK; von Bubnoff, N; Bartosch, N; Peschel, C; Engh, RA; Duyster, J				Kancha, Rama Krishna; von Bubnoff, Nikolas; Bartosch, Natalie; Peschel, Christian; Engh, Richard A.; Duyster, Justus			Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER MODELS; INHIBITOR; EGFR; RESISTANCE; ACTIVATION; GEFITINIB; MECHANISM; MUTANTS; TUMORS	Background: Overexpression of the ERBB2 kinase is observed in about one-third of breast cancer patients and the dual ERBB1/ERBB2 kinase inhibitor lapatinib was recently approved for the treatment of advanced ERBB2-positive breast cancer. Mutations in the ERBB2 receptor have recently been reported in breast cancer at diagnosis and also in gastric, colorectal and lung cancer. These mutations may have an impact on the clinical responses achieved with lapatinib in breast cancer and may also have a potential impact on the use of lapatinib in other solid cancers. However, the sensitivity of lapatinib towards clinically observed ERBB2 mutations is not known. Methodology/Principal Findings: We cloned a panel of 8 clinically observed ERBB2 mutations, established stable cell lines and characterized their sensitivity towards lapatinib and alternative ERBB2 inhibitors. Both lapatinib-sensitive and lapatinib-resistant ERBB2 mutations were observed. Interestingly, we were able to generate lapatinib resistance mutations in wt-ERBB2 cells incubated with lapatinib for prolonged periods of time. This indicates that these resistance mutations may also cause secondary resistance in lapatinib-treated patients. Lapatinib-resistant ERBB2 mutations were found to be highly resistant towards AEE788 treatment but remained sensitive towards the dual irreversible inhibitors CL-387785 and WZ-4002. Conclusions/Significance: Patients harbouring certain ERBB2 kinase domain mutations at diagnosis may not benefit from lapatinib treatment. Moreover, secondary lapatinib resistance may develop due to kinase domain mutations. Irreversible ERBB2 inhibitors may offer alternative treatment options for breast cancer and other solid tumor patients harbouring lapatinib resistance mutations. In addition, these inhibitors may be of interest in the scenario of secondary lapatinib resistance.	[Kancha, Rama Krishna; von Bubnoff, Nikolas; Bartosch, Natalie; Peschel, Christian; Duyster, Justus] Tech Univ Munich, Dept Internal Med 3, Munich, Germany; [Engh, Richard A.] Univ Tromso, NORSTRUCT, Dept Chem, Tromso, Norway	Technical University of Munich; University of Munich; UiT The Arctic University of Tromso	Kancha, RK (corresponding author), Tech Univ Munich, Dept Internal Med 3, Munich, Germany.	justus.duyster@lrz.tum.de	Kancha, Rama Krishna/B-5992-2009; von Bubnoff, Nikolas/AAG-1845-2021; von Bubnoff, Nikolas/F-2351-2017	Kancha, Rama Krishna/0000-0001-8146-1551; von Bubnoff, Nikolas/0000-0001-9593-8947; Engh, Richard/0000-0002-6207-0560	Wilhelm Sander Stiftung	Wilhelm Sander Stiftung	This work was supported by a grant from the Wilhelm Sander Stiftung to Justus Duyster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bekaii-Saab T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-278; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Cohen EEW, 2005, CLIN CANCER RES, V11, P8105, DOI 10.1158/1078-0432.CCR-05-0926; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Kancha RK, 2009, CLIN CANCER RES, V15, P460, DOI 10.1158/1078-0432.CCR-08-1757; Kancha RK, J THORACIC ONCOLOGY, V6, P387; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kubo T, 2009, CARCINOGENESIS; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Minami Y, 2007, ONCOGENE, V26, P5023, DOI 10.1038/sj.onc.1210292; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	25	92	94	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26760	10.1371/journal.pone.0026760	http://dx.doi.org/10.1371/journal.pone.0026760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046346	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800038
J	Sangha, JS; Khan, W; Ji, XH; Zhang, JZ; Mills, AAS; Critchley, AT; Prithiviraj, B				Sangha, Jatinder S.; Khan, Wajahatullah; Ji, Xiuhong; Zhang, Junzeng; Mills, Aaron A. S.; Critchley, Alan T.; Prithiviraj, Balakrishnan			Carrageenans, Sulphated Polysaccharides of Red Seaweeds, Differentially Affect Arabidopsis thaliana Resistance to Trichoplusia ni (Cabbage Looper)	PLOS ONE			English	Article							LAMBDA-CARRAGEENAN; INSECT HERBIVORY; PLANT-RESPONSES; DEFENSE; JASMONATE; GENE; HYDROLYSIS; EXPRESSION; INFECTION; SALICYLATE	Carrageenans are a collective family of linear, sulphated galactans found in a number of commercially important species of marine red alga. These polysaccharides are known to elicit defense responses in plant and animals and possess anti-viral properties. We investigated the effect of foliar application of iota-, kappa- and lambda-carrageenans (representing various levels of sulphation) on Arabidopsis thaliana in resistance to the generalist insect Trichoplusia ni (cabbage looper) which is known to cause serious economic losses in crop plants. Plants treated with iota- and kappa-carrageenan showed reduced leaf damage, whereas those treated with lambda-carrageenan were similar to that of the control. In a no-choice test, larval weight was reduced by more than 20% in iota- and kappa-carrageenan treatments, but unaffected by lambda-carrageenan. In multiple choice tests, carrageenan treated plants attracted fewer T. ni larvae by the fourth day following infestation as compared to the control. The application of carrageenans did not affect oviposition behaviour of T. ni. Growth of T. ni feeding on an artificial diet amended with carrageenans was not different from that fed with untreated control diet. iota-carrageenan induced the expression of defense genes; PR1, PDF1.2, and TI1, but kappa- and lambda-carrageenans did not. Besides PR1, PDF1.2, and TI1, the indole glucosinolate biosynthesis genes CYP79B2, CYP83B1 and glucosinolate hydrolysing QTL, ESM1 were up-regulated by i-carrageenan treatment at 48 h post infestation. Gas chromatography-mass spectrometry analysis of carrageenan treated leaves showed increased concentrations of both isothiocyanates and nitriles. Taken together, these results show that carrageenans have differential effects on Arabidopsis resistance to T. ni and that the degree of sulphation of the polysaccharide chain may well mediate this effect.	[Sangha, Jatinder S.; Mills, Aaron A. S.; Prithiviraj, Balakrishnan] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Khan, Wajahatullah] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair Unit, Riyadh 11451, Saudi Arabia; [Ji, Xiuhong; Zhang, Junzeng] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE, Canada; [Critchley, Alan T.] Acadian Seaplants Ltd, Dartmouth, NS, Canada	Dalhousie University; King Saud University; National Research Council Canada; Acadian Seaplants Limited	Sangha, JS (corresponding author), Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	bprithiviraj@nsac.ca	Khan, Wajahatullah/J-9574-2012; Critchley, Alan/AAB-1467-2019; Critchley, Alan/AAL-1706-2020	Critchley, Alan/0000-0003-1704-458X; Critchley, Alan/0000-0003-1704-458X; Prithiviraj, Balakrishnan/0000-0002-9822-5261	Atlantic Canada Opportunities Agency; Natural Sciences and Engineering Council of Canada; Nova Scotia Department of Agriculture and Marketing; Acadian Seaplants Limited	Atlantic Canada Opportunities Agency; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Department of Agriculture and Marketing; Acadian Seaplants Limited	BP's lab is supported by Atlantic Canada Opportunities Agency, Natural Sciences and Engineering Council of Canada and the Nova Scotia Department of Agriculture and Marketing. These funders had no role in study design of this work, data collection and analysis, decision to publish, or preparation of the manuscript. Cargill Texturant Solutions donated the Carrageenans used in this study. Alan T. Critchley is an employee of Acadian Seaplants Limited (who also provided funding) and helped with the design and analysis of the experiment and the writing of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Alborn HT, 2007, P NATL ACAD SCI USA, V104, P12976, DOI 10.1073/pnas.0705947104; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Bostock RM, 2001, EUR J PLANT PATHOL, V107, P103, DOI 10.1023/A:1008703904253; Bowley SR, 2008, HITCHHIKERS GUIDE ST, P141; BROADWAY RM, 1986, ENTOMOL EXP APPL, V41, P33, DOI 10.1007/BF00343486; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Chopin T, 1999, HYDROBIOLOGIA, V399, P417, DOI 10.1023/A:1017011723914; Cluzet S, 2004, PLANT CELL ENVIRON, V27, P917, DOI 10.1111/j.1365-3040.2004.01197.x; Cote F, 1998, Subcell Biochem, V29, P385; Craigie JS, 2011, J APPL PHYCOL, V23, P371, DOI 10.1007/s10811-010-9560-4; de Vos M, 2008, PLANT PHYSIOL, V146, P916, DOI 10.1104/pp.107.112185; Fidantsef AL, 1999, PHYSIOL MOL PLANT P, V54, P97, DOI 10.1006/pmpp.1998.0192; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; GORDON-MILLS E M, 1975, Phycologia, V14, P275, DOI 10.2216/i0031-8884-14-4-275.1; Holopainen J. K., 2009, Open Forest Science Journal, V2, P17, DOI 10.2174/1874398600902010017; Jander G, 2001, PLANT PHYSIOL, V126, P890, DOI 10.1104/pp.126.2.890; Karban R, 1997, INDUCED RESPONSES HE, P47; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Khan W, 2009, J PLANT GROWTH REGUL, V28, P386, DOI 10.1007/s00344-009-9103-x; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MCMORRAN A, 1965, CAN ENTOMOL, V97, P58, DOI 10.4039/Ent9758-1; Mercier L, 2001, NEW PHYTOL, V149, P43, DOI 10.1046/j.1469-8137.2001.00011.x; Nagorskaya VP, 2008, BIOL BULL+, V35, P310, DOI 10.1134/S1062359008030126; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Pangestuti R, 2011, MAR DRUGS, V9, P803, DOI 10.3390/md9050803; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sangha JS, 2010, PHYSIOL MOL PLANT P, V75, P38, DOI 10.1016/j.pmpp.2010.08.003; Sangha Jatinder Singh, 2010, BMC Res Notes, V3, P126, DOI 10.1186/1756-0500-3-126; Stiles J, 2008, INVEST OPHTH VIS SCI, V49, P1496, DOI 10.1167/iovs.07-1245; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; ZABLACKIS E, 1991, J PHYCOL, V27, P241, DOI 10.1111/j.0022-3646.1991.00241.x; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	47	21	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26834	10.1371/journal.pone.0026834	http://dx.doi.org/10.1371/journal.pone.0026834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874WN	22046375	Green Published, gold			2022-12-27	WOS:000298988900001
J	Zhou, H; Shen, DF; Bian, ZY; Zong, J; Deng, W; Zhang, Y; Guo, YY; Li, HL; Tang, QZ				Zhou, Heng; Shen, Di-Fei; Bian, Zhou-Yan; Zong, Jing; Deng, Wei; Zhang, Yan; Guo, Yuan-Yuan; Li, Hongliang; Tang, Qi-Zhu			Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload	PLOS ONE			English	Article							STRESS-INDUCIBLE GENE; ATF3 GENE; ENDOTHELIAL-CELLS; EXPRESSION; KINASE; APOPTOSIS; PATHWAYS; PROTECTS; MYOCYTES; FAMILY	Activating transcription factor 3 (ATF3), which is encoded by an adaptive-response gene induced by various stimuli, plays an important role in the cardiovascular system. However, the effect of ATF3 on cardiac hypertrophy induced by a pathological stimulus has not been determined. Here, we investigated the effects of ATF3 deficiency on cardiac hypertrophy using in vitro and in vivo models. Aortic banding (AB) was performed to induce cardiac hypertrophy in mice. Cardiac hypertrophy was estimated by echocardiographic and hemodynamic measurements and by pathological and molecular analysis. ATF3 deficiency promoted cardiac hypertrophy, dysfunction and fibrosis after 4 weeks of AB compared to the wild type (WT) mice. Furthermore, enhanced activation of the MEK-ERK1/2 and JNK pathways was found in ATF3-knockout (KO) mice compared to WT mice. In vitro studies performed in cultured neonatal mouse cardiomyocytes confirmed that ATF3 deficiency promotes cardiomyocyte hypertrophy induced by angiotensin II, which was associated with the amplification of MEK-ERK1/2 and JNK signaling. Our results suggested that ATF3 plays a crucial role in the development of cardiac hypertrophy via negative regulation of the MEK-ERK1/2 and JNK pathways.	[Zhou, Heng; Shen, Di-Fei; Bian, Zhou-Yan; Zong, Jing; Deng, Wei; Zhang, Yan; Guo, Yuan-Yuan; Li, Hongliang; Tang, Qi-Zhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Zhou, Heng; Shen, Di-Fei; Bian, Zhou-Yan; Zong, Jing; Deng, Wei; Zhang, Yan; Guo, Yuan-Yuan; Li, Hongliang; Tang, Qi-Zhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn			National Natural Science Foundation of China [30901628, 30972954, 81000036, 81000095]; Fundamental Research Funds for the Central Universities of China [20103020101000200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China [30901628, 30972954, 81000036 and 81000095](http://www.nsfc.gov.cn/Portal0/default106.htm); and the Fundamental Research Funds for the Central Universities of China [20103020101000200](http://kfy.whu.edu.cn/kfy/inforead_2017_1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen SC, 2008, ATHEROSCLEROSIS, V201, P281, DOI 10.1016/j.atherosclerosis.2008.02.014; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Gilchrist M, 2010, BLOOD, V115, P4734, DOI 10.1182/blood-2009-03-213512; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Huang H, 2010, HYPERTENSION, V56, P232, DOI 10.1161/HYPERTENSIONAHA.110.149963; Hutchinson KR, 2011, J APPL PHYSL; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Kehat I, 2006, ANN NY ACAD SCI, V1080, P97, DOI 10.1196/annals.1380.009; Kehat I, 2006, CARDIOVASC RES, V70, P543, DOI 10.1016/j.cardiores.2006.02.018; Koitabashi N, 2011, J CLIN INVEST; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Lv D, 2011, IUBMB LIFE, V63, P62, DOI 10.1002/iub.416; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Yan L, 2011, CARDIOVASC RES	37	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26744	10.1371/journal.pone.0026744	http://dx.doi.org/10.1371/journal.pone.0026744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053207	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800033
J	Balicer, RD; Catlett, CL; Barnett, DJ; Thompson, CB; Hsu, EB; Morton, MJ; Semon, NL; Watson, CM; Gwon, HS; Links, JM				Balicer, Ran D.; Catlett, Christina L.; Barnett, Daniel J.; Thompson, Carol B.; Hsu, Edbert B.; Morton, Melinda J.; Semon, Natalie L.; Watson, Christopher M.; Gwon, Howard S.; Links, Jonathan M.			Characterizing Hospital Workers' Willingness to Respond to a Radiological Event	PLOS ONE			English	Article							EFFICACY-BASED ASSESSMENT; RADIATION CASUALTIES; PANDEMIC INFLUENZA; DIRTY BOMBS; EMERGENCY; PREPAREDNESS; TERRORISM; NURSES; PERSPECTIVES; PERCEPTIONS	Introduction: Terrorist use of a radiological dispersal device (RDD, or "dirty bomb"), which combines a conventional explosive device with radiological materials, is among the National Planning Scenarios of the United States government. Understanding employee willingness to respond is critical for planning experts. Previous research has demonstrated that perception of threat and efficacy is key in the assessing willingness to respond to a RDD event. Methods: An anonymous online survey was used to evaluate the willingness of hospital employees to respond to a RDD event. Agreement with a series of belief statements was assessed, following a methodology validated in previous work. The survey was available online to all 18,612 employees of the Johns Hopkins Hospital from January to March 2009. Results: Surveys were completed by 3426 employees (18.4%), whose demographic distribution was similar to overall hospital staff. 39% of hospital workers were not willing to respond to a RDD scenario if asked but not required to do so. Only 11% more were willing if required. Workers who were hesitant to agree to work additional hours when required were 20 times less likely to report during a RDD emergency. Respondents who perceived their peers as likely to report to work in a RDD emergency were 17 times more likely to respond during a RDD event if asked. Only 27.9% of the hospital employees with a perception of low efficacy declared willingness to respond to a severe RDD event. Perception of threat had little impact on willingness to respond among hospital workers. Conclusions: Radiological scenarios such as RDDs are among the most dreaded emergency events yet studied. Several attitudinal indicators can help to identify hospital employees unlikely to respond. These risk-perception modifiers must then be addressed through training to enable effective hospital response to a RDD event.	[Balicer, Ran D.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Balicer, Ran D.] Clalit Res Inst, Clalit Hlth Serv, Tel Aviv, Israel; [Catlett, Christina L.; Hsu, Edbert B.; Morton, Melinda J.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Catlett, Christina L.; Hsu, Edbert B.] Johns Hopkins Off Crit Event Preparedness & Respo, Baltimore, MD USA; [Barnett, Daniel J.; Semon, Natalie L.; Links, Jonathan M.] Johns Hopkins Preparedness & Emergency Response R, Baltimore, MD USA; [Barnett, Daniel J.; Semon, Natalie L.; Links, Jonathan M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Barnett, Daniel J.; Semon, Natalie L.; Links, Jonathan M.] Johns Hopkins Publ Hlth Preparedness Programs, Baltimore, MD USA; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Watson, Christopher M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Watson, Christopher M.] Natl Naval Med Ctr, Dept Pediat, Bethesda, MD USA; [Gwon, Howard S.] Johns Hopkins Univ, Sch Med, Off Emergency Management, Baltimore, MD USA	Ben Gurion University; Clalit Health Services; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Walter Reed National Military Medical Center; Johns Hopkins University	Balicer, RD (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel.	rbalicer@netvision.net.il		Watson, Christopher/0000-0001-9575-8815; Barnett, Daniel/0000-0003-1382-6197; Hamer, Melinda/0000-0002-6736-1738	Centers for Disease Control and Prevention (CDC); Preparedness & Emergency Response Research Center (PERRC)[CDC] [1P01tP00288-01, 104264]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Preparedness & Emergency Response Research Center (PERRC)[CDC](United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (CDC), and Preparedness & Emergency Response Research Center (PERRC)[CDC/Grant 1P01tP00288-01; Grant# 104264]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association, 2004, BAS DIS LIF SUPP PRO; American Medical Association, 2004, ADV DIS LIF SUPP PRO; Balicer RD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-436; Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99; Barnett DJ, 2006, J NUCL MED, V47, P1653; Barnett DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009856; Barnett DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006365; Becker SM, 2008, DISASTER MED PUBLIC, V2, P174, DOI 10.1097/DMP.0b013e31817dcd9a; Bushberg JT, 2007, J EMERG MED, V32, P71, DOI 10.1016/j.jemermed.2006.05.034; Center for American Progress, 2007, INT MAP AL QAED ATT; Centers for Disease Control and Prevention, 2003, MASS CAS PRED; Chin F. K. C., 2007, SMJ Singapore Medical Journal, V48, P950; Cone David C, 2006, Am J Disaster Med, V1, P28; Considine J, 2009, DISASTERS, V33, P482, DOI 10.1111/j.1467-7717.2008.01084.x; Department of Homeland Security, 2007, NAT PREP GUID; Department of Homeland Security, 2003, TOP OFF TOPOFF EX SE; DiMaggio C, 2005, BIOSECUR BIOTERROR, V3, P331, DOI 10.1089/bsp.2005.3.331; Dorr HD, 2006, RADIAT ENVIRON BIOPH, V45, P237, DOI 10.1007/s00411-006-0068-x; Errett NA, 2010, ASSESSMENT MED UNPUB; Federal Emergency Management Agency, 2010, NAT INT CTR TRAIN EX; Hall RCW, 2006, GEN HOSP PSYCHIAT, V28, P242, DOI 10.1016/j.genhosppsych.2006.03.001; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Levy K, 2000, Prehosp Disaster Med, V15, P18; Masterson L, 2009, J EMERG MED, V36, P43, DOI 10.1016/j.jemermed.2007.10.074; Mettler FA, 2006, NEW ENGL J MED, V2346, P1554; National Council on Radiation Protection and Measurements, 2001, 138 NAT RES COUNC PR, P138; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Ring JP, 2004, HEALTH PHYS, V86, pS42, DOI 10.1097/00004032-200402001-00013; Rosoff H, 2007, RISK ANAL, V27, P533, DOI 10.1111/j.1539-6924.2007.00908.x; Runge JW, 2009, PREHOSP EMERG CARE, V13, P407, DOI 10.1080/10903120902935371; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Steinhausler F, 2005, HEALTH PHYS, V89, P566, DOI 10.1097/01.HP.0000178545.02726.21; Veenema TG, 2008, DISASTER MED PUBLIC, V2, P224, DOI 10.1097/DMP.0b013e31818a2b7a; Witte K., 1998, HDB COMMUNICATION EM, P423	35	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e25327	10.1371/journal.pone.0025327	http://dx.doi.org/10.1371/journal.pone.0025327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046238	gold, Green Published			2022-12-27	WOS:000296521400004
J	Hall, A; Oirere, M; Thurstans, S; Ndumi, A; Sibson, V				Hall, Andrew; Oirere, Moragwa; Thurstans, Susan; Ndumi, Assumpta; Sibson, Victoria			The Practical Challenges of Evaluating a Blanket Emergency Feeding Programme in Northern Kenya	PLOS ONE			English	Article							COVERAGE	A blanket supplementary feeding programme for young children was implemented for four months in five northern districts of Kenya from January 2010 because of fears of food insecurity exacerbated by drought. An attempt to evaluate the impact of the food on children's anthropometric status was put in place in three districts. The main aim of the analysis was to assess the quality of the data on the cohort of children studied in the evaluation and to propose methods by which it could be improved to evaluate future blanket feeding programmes. Data on the name, age, sex, weight and height of a systematic sample of children recruited at 61 food distribution sites were collected at the first, second and third rounds and again at an extra, fifth food distribution, offered only to the evaluation subjects. Of the 3,544 children enrolled, 483 (13.63%) did not collect a fifth ration. Of the 2,640 children who were considered by their name to be the same at the first and fifth food distribution (13% were different), data on only 902 children (34.17%) were considered acceptable based on their age (an arbitrary +/- 3 months different) and their length or height (between >-1 or <= 4 cm different) at the two instances they were seen. Data on nearly two thirds of children were of questionable quality. The main reasons for the poor quality data were inconsistencies in estimating age or because caretakers may have brought different children. Recommendations are made about how to improve data quality including ensuring that entry to a blanket feeding programme is clearly based on height, not age, to avoid misreporting age; careful identification of subjects at all contacts; and using well-trained, specialist evaluation staff.	[Hall, Andrew] Univ Westminster, Ctr Publ Hlth Nutr, Sch Life Sci, London W1R 8AL, England; [Oirere, Moragwa; Ndumi, Assumpta] Save Children UK, Nairobi, Kenya; [Thurstans, Susan; Sibson, Victoria] Save Children UK, London, England	University of Westminster; Save the Children; Save the Children	Hall, A (corresponding author), Univ Westminster, Ctr Publ Hlth Nutr, Sch Life Sci, London W1R 8AL, England.	ah2108@gmail.com		Thurstans, Susan/0000-0002-7102-446X	European Commission (ECHO); UNICEF in Kenya	European Commission (ECHO)(European CommissionEuropean Commission Joint Research Centre); UNICEF in Kenya	The blanket supplementary feeding programme was supported by the European Commission (ECHO) through the World Food Programme and UNICEF in Kenya. The funders and the Government of Kenya had an opportunity to comment on and approve the evaluation design as a part of the normal planning process for humanitarian interventions. The evaluation was funded as a part of the intervention. The funders had no role in data collection and analysis, the decision to publish, or in the preparation of the manuscript.	*ACF US, 2009, ANTHR RETR MORT SURV; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; HAYES RJ, 2009, RANDOMISED CLUSTER T; *KEN NAT BUR STAT, 2011, KEN NAT BUR STAT 2 C, V1; *KEN NAT BUR STAT, 2007, STAT ABSTR NAIR; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P20; Nielsen J, 2004, AM J CLIN NUTR, V80, P1036, DOI 10.1093/ajcn/80.4.1036; OCHOLA S, 2010, KNOWLEDGE PRACTICE C; Rossi L, 2008, PUBLIC HEALTH NUTR, V11, P699, DOI 10.1017/S1368980007001413; Sadler K, 2007, PUBLIC HEALTH NUTR, V10, P907, DOI 10.1017/S1368980007711035; *SAV CHILDR, 2009, BLANK SUPPL FEED PRO; StataCorp, 2010, STAT STAT SOFTW REL; *WHO, HEIGHT FOR AG BOYS 2; World Health Organization, 2000, MAN NUTR MAJ EM; *WTO, MACR AN GROWTH DAT A	15	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26854	10.1371/journal.pone.0026854	http://dx.doi.org/10.1371/journal.pone.0026854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22073119	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000296519600069
J	Li, X; Mao, XB; Hei, RY; Zhang, ZB; Wen, LT; Zhang, PZ; Qiu, JH; Qiao, L				Li, Xu; Mao, Xiao-Bo; Hei, Ren-Yi; Zhang, Zhi-Bin; Wen, Li-Ting; Zhang, Peng-Zhi; Qiu, Jian-Hua; Qiao, Li			Protective Role of Hydrogen Sulfide against Noise-Induced Cochlear Damage: A Chronic Intracochlear Infusion Model	PLOS ONE			English	Article							SPIRAL MODIOLAR ARTERY; RECEPTORS MEDIATE VASOCONSTRICTION; INDUCED HEARING-LOSS; BLOOD-FLOW; IN-VITRO; BIOSYNTHESIS; VASORELAXANT; MODULATION; MECHANISMS; MICE	Background: A reduction in cochlear blood flow plays an essential role in noise-induced hearing loss (NIHL). The timely regulation of cochlear perfusion determines the progression and prognosis of NIHL. Hydrogen sulfide (H2S) has attracted increasing interest as a vasodilator in cardiovascular systems. This study identified the role of H2S in cochlear blood flow regulation and noise protection. Methodology/Principal Findings: The gene and protein expression of the H2S synthetase cystathionine-c-lyase (CSE) in the rat cochlea was examined using immunofluorescence and real-time PCR. Cochlear CSE mRNA levels varied according to the duration of noise exposure. A chronic intracochlear infusion model was built and artificial perilymph (AP), NaHS or DL-propargylglycine (PPG) were locally administered. Local sodium hydrosulfide (NaHS) significantly increased cochlear perfusion post-noise exposure. Cochlear morphological damage and hearing loss were alleviated in the NaHS group as measured by conventional auditory brainstem response (ABR), cochlear scanning electron microscope (SEM) and outer hair cell (OHC) count. The highest percentage of OHC loss occurred in the PPG group. Conclusions/Significance: Our results suggest that H2S plays an important role in the regulation of cochlear blood flow and the protection against noise. Further studies may identify a new preventive and therapeutic perspective on NIHL and other blood supply-related inner ear diseases.	[Li, Xu; Mao, Xiao-Bo; Hei, Ren-Yi; Wen, Li-Ting; Zhang, Peng-Zhi; Qiu, Jian-Hua; Qiao, Li] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China; [Zhang, Zhi-Bin] Perimed China Ltd, Beijing, Peoples R China	Air Force Military Medical University	Li, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China.	qiujh@fmmu.edu.cn; qiaoli@fmmu.edu.cn			National Natural Science Foundation of China [30973299, 81070791, 30872857, 30930098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from the National Natural Science Foundation of China (No. 30973299, 81070791, 30872857, and 30930098). Jian-Hua Qiu and Li Qiao were the recipients of the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gratton MA, 2010, HEAR RES IN PRESS; Gruber DD, 1998, HEARING RES, V119, P113, DOI 10.1016/S0378-5955(98)00036-7; Herzog M, 2002, J MEMBRANE BIOL, V189, P225, DOI 10.1007/s00232-002-1017-5; Jiang ZG, 2004, HEARING RES, V189, P92, DOI 10.1016/S0378-5955(03)00398-8; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu XH, 2010, BIOL PHARM BULL, V33, P1550, DOI 10.1248/bpb.33.1550; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Nakashima T, 2003, BRAIN RES REV, V43, P17, DOI 10.1016/S0165-0173(03)00189-9; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Ohinata Y, 2000, HEARING RES, V146, P28, DOI 10.1016/S0378-5955(00)00096-4; Olson KR, 2005, ANTIOXID REDOX SIGN, V7, P804, DOI 10.1089/ars.2005.7.804; Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8; Sadanaga M, 1997, HEARING RES, V112, P106, DOI 10.1016/S0378-5955(97)00121-4; Scherer EQ, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-10; Scherer EQ, 2010, STROKE, V41, P2618, DOI 10.1161/STROKEAHA.110.593327; Scherer EQ, 2006, CARDIOVASC RES, V70, P79, DOI 10.1016/j.cardiores.2006.01.011; UREN JR, 1978, BIOCHEM PHARMACOL, V27, P2807, DOI 10.1016/0006-2952(78)90194-6; Vass Z, 2004, NEUROSCIENCE, V124, P919, DOI 10.1016/j.neuroscience.2003.12.030; Wang MJ, 2010, CLIN EXP PHARMACOL P, V37, P764, DOI 10.1111/j.1440-1681.2010.05371.x; Wang QA, 2010, BIOCHEM BIOPH RES CO, V396, P182, DOI 10.1016/j.bbrc.2010.04.061; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Wangemann P, 2005, HEARING RES, V209, P91, DOI 10.1016/j.heares.2005.06.011; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zuidema MY, 2010, AM J PHYSIOL-HEART C, V299, pH1554, DOI 10.1152/ajpheart.01229.2009	32	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26728	10.1371/journal.pone.0026728	http://dx.doi.org/10.1371/journal.pone.0026728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046339	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600049
J	Yen, CC; Lai, YW; Chen, HL; Lai, CW; Lin, CY; Chen, W; Kuan, YP; Hsu, WH; Chen, CM				Yen, Chih-Ching; Lai, Yi-Wen; Chen, Hsiao-Ling; Lai, Cheng-Wei; Lin, Chien-Yu; Chen, Wei; Kuan, Yu-Ping; Hsu, Wu-Huei; Chen, Chuan-Mu			Aerosolized Human Extracellular Superoxide Dismutase Prevents Hyperoxia-Induced Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY OXYGEN-TOXICITY; OXIDATIVE STRESS; TRANSGENIC MICE; BRONCHOPULMONARY DYSPLASIA; METHYLOTROPHIC YEAST; PICHIA-PASTORIS; EC-SOD; INFLAMMATION; EXPRESSION	An important issue in critical care medicine is the identification of ways to protect the lungs from oxygen toxicity and reduce systemic oxidative stress in conditions requiring mechanical ventilation and high levels of oxygen. One way to prevent oxygen toxicity is to augment antioxidant enzyme activity in the respiratory system. The current study investigated the ability of aerosolized extracellular superoxide dismutase (EC-SOD) to protect the lungs from hyperoxic injury. Recombinant human EC-SOD (rhEC-SOD) was produced from a synthetic cassette constructed in the methylotrophic yeast Pichia pastoris. Female CD-1 mice were exposed in hyperoxia (FiO2>95%) to induce lung injury. The therapeutic effects of EC-SOD and copper-zinc SOD (CuZn-SOD) via an aerosol delivery system for lung injury and systemic oxidative stress at 24, 48, 72 and 96 h of hyperoxia were measured by bronchoalveolar lavage, wet/dry ratio, lung histology, and 8-oxo-2'-deoxyguanosine (8-oxo-dG) in lung and liver tissues. After exposure to hyperoxia, the wet/dry weight ratio remained stable before day 2 but increased significantly after day 3. The levels of oxidative biomarker 8-oxo-dG in the lung and liver were significantly decreased on day 2 (P < 0.01) but the marker in the liver increased abruptly after day 3 of hyperoxia when the mortality increased. Treatment with aerosolized rhEC-SOD increased the survival rate at day 3 under hyperoxia to 95.8%, which was significantly higher than that of the control group (57.1%), albumin treated group (33.3%), and CuZn-SOD treated group (75%). The protective effects of EC-SOD against hyperoxia were further confirmed by reduced lung edema and systemic oxidative stress. Aerosolized EC-SOD protected mice against oxygen toxicity and reduced mortality in a hyperoxic model. The results encourage the use of an aerosol therapy with EC-SOD in intensive care units to reduce oxidative injury in patients with severe hypoxemic respiratory failure, including acute respiratory distress syndrome (ARDS).	[Yen, Chih-Ching; Lai, Yi-Wen; Lai, Cheng-Wei; Lin, Chien-Yu; Chen, Wei; Kuan, Yu-Ping; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yen, Chih-Ching; Lai, Yi-Wen; Lai, Cheng-Wei; Lin, Chien-Yu; Chen, Wei; Kuan, Yu-Ping; Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Yen, Chih-Ching; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources, Changhua, Taiwan; [Chen, Wei] Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Chen, Chuan-Mu] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Yen, Chih-Ching] China Med Univ, Coll Hlth Care, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Coll Med, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Da Yeh University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Yen, CC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013; LAI, ZI-LUN/AAM-7870-2020	Chen, Chuan-Mu/0000-0003-2461-9150; LAI, ZI-LUN/0000-0002-6984-9083	National Science Council [NSC-95-2313-B-005-012]; Council of Agriculture [COA-97-6.2.1-U1(9)]; Ministry of Education, Taiwan, Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); Council of Agriculture; Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This research was supported by grant NSC-95-2313-B-005-012 from the National Science Council, grant COA-97-6.2.1-U1(9) from the Council of Agriculture, and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in this design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264; Chang LYL, 2003, AM J RESP CRIT CARE, V167, P57, DOI 10.1164/rccm.200203-232OC; Chen HL, 2004, J MOL MICROB BIOTECH, V8, P141, DOI 10.1159/000085787; Chen HL, 2006, J AGR FOOD CHEM, V54, P8041, DOI 10.1021/jf061379x; Chen HL, 2010, BIOMETALS, V23, P543, DOI 10.1007/s10534-010-9298-0; Cheng WE, 2007, INTENS CARE MED, V33, P1187, DOI 10.1007/s00134-007-0628-9; DOMAGALAKULAWIK J, 2011, INFLAMMATIO IN PRESS, DOI DOI 10.1007/S10753-011-9378-5; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gao F, 2008, ANTIOXID REDOX SIGN, V10, P343, DOI 10.1089/ars.2007.1908; GILLISSEN A, 1993, CHEST, V104, P811, DOI 10.1378/chest.104.3.811; Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119; Gottschling BC, 2001, TOXICOL SCI, V64, P28, DOI 10.1093/toxsci/64.1.28; He HJ, 2002, PROTEIN EXPRES PURIF, V24, P13, DOI 10.1006/prep.2001.1529; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Hu CW, 2006, CLIN CHEM, V52, P1381, DOI 10.1373/clinchem.2005.063735; Hyun JW, 2003, MOL CANCER RES, V1, P290; Keles MS, 2008, CLIN EXP MED, V8, P193, DOI 10.1007/s10238-008-0005-1; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kliment CR, 2011, FREE RADICAL BIO MED, V50, P1075, DOI 10.1016/j.freeradbiomed.2011.02.014; Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Montuschi P, 1998, AM J RESP CRIT CARE, V158, P1524, DOI 10.1164/ajrccm.158.5.9803102; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Nishina K, 1998, ANESTHESIOLOGY, V88, P1300, DOI 10.1097/00000542-199805000-00022; Nozik-Grayck E, 2005, INT J BIOCHEM CELL B, V37, P2466, DOI 10.1016/j.biocel.2005.06.012; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; QUINLAN T, 1994, ENVIRON HEALTH PERSP, V102, P79, DOI 10.2307/3431823; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Robbins CG, 1997, AM J PHYSIOL-LUNG C, V272, pL903, DOI 10.1152/ajplung.1997.272.5.L903; ROSENFELD W, 1984, J PEDIATR-US, V105, P781, DOI 10.1016/S0022-3476(84)80307-8; Simonson SG, 1997, J APPL PHYSIOL, V83, P550, DOI 10.1152/jappl.1997.83.2.550; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Stromqvist M, 1997, TRANSGENIC RES, V6, P271, DOI 10.1023/A:1018406611380; Tsan MF, 2001, INT J MOL MED, V7, P13; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WHITE CW, 1991, J CLIN INVEST, V87, P2162, DOI 10.1172/JCI115249; Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212	41	35	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26870	10.1371/journal.pone.0026870	http://dx.doi.org/10.1371/journal.pone.0026870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046389	Green Published, gold			2022-12-27	WOS:000296519600071
J	Bortz, PDS; Wamhoff, BR				Bortz, Pamela D. Schoppee; Wamhoff, Brian R.			Chromatin Immunoprecipitation (ChIP): Revisiting the Efficacy of Sample Preparation, Sonication, Quantification of Sheared DNA, and Analysis via PCR	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IN-VIVO; CROSS-LINKING; ALPHA-ACTIN; EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; ACTIVATION; PROTEINS; PROMOTER	The "quantitative" ChIP, a tool commonly used to study protein-DNA interactions in cells and tissue, is a difficult assay often plagued with technical error. We present, herein, the process required to merge multiple protocols into a quick, reliable and easy method and an approach to accurately quantify ChIP DNA prior to performing PCR. We demonstrate that high intensity sonication for at least 30 min is required for full cellular disruption and maximum DNA recovery because ChIP lysis buffers fail to lyse formaldehyde-fixed cells. In addition, extracting ChIP DNA with chelex-100 yields samples that are too dilute for evaluation of shearing efficiency or quantification via nanospectrophotometry. However, DNA extracted from the Mock-ChIP supernatant via the phenol-chloroform-isoamyl alcohol (PCIA) method can be used to evaluate DNA shearing efficiency and used as the standard in a fluorescence-based microplate assay. This enabled accurate quantification of DNA in chelex-extracted ChIP samples and normalization to total DNA concentration prior to performing real-time PCR (rtPCR). Thus, a quick ChIP assay that can be completed in nine bench hours over two days has been validated along with a rapid, accurate and repeatable way to quantify ChIP DNA. The resulting rtPCR data more accurately depicts treatment effects on protein-DNA interactions of interest.	[Bortz, Pamela D. Schoppee; Wamhoff, Brian R.] Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc, Charlottesville, VA 22903 USA; [Wamhoff, Brian R.] Univ Virginia Hlth Syst, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA	University of Virginia; University of Virginia	Bortz, PDS (corresponding author), Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc, Charlottesville, VA 22903 USA.	pamela.schoppee.bortz@virginia.edu; wamhoff@virginia.edu			National Institutes of Health [HL81862]; American Heart Association [0535002N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this research was provided by the National Institutes of Health (R01# HL81862 to BRW; http://projectreporter.nih.gov/reporter_searchresults.cfm?&new=1&new=1&icde=8847588&loc=2&loc=2&CFID=39246976&CFTOKEN=23764433) and by an American Heart Association Scientist Development Grant (#0535002N; https://research.americanheart.org/ris/template.jsp?pid=ris.extlogin&_requestid=19732) to BRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2007, BIOTECHNIQUES, V43, P791, DOI 10.2144/000112625; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; BLANK RS, 1992, J BIOL CHEM, V267, P984; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Gelfand BD, 2011, ARTERIOSCL THROM VAS, V31, P1625, DOI 10.1161/ATVBAHA.111.227827; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee MY, 2010, HUM MOL GENET, V19, P468, DOI 10.1093/hmg/ddp511; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Milne Thomas A., 2009, V538, P409, DOI 10.1007/978-1-59745-418-6_21; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	23	29	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26015	10.1371/journal.pone.0026015	http://dx.doi.org/10.1371/journal.pone.0026015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046253	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000012
J	Zhang, HL; Peng, HB				Zhang, Hailong Luke; Peng, H. Benjamin			Mechanism of Acetylcholine Receptor Cluster Formation Induced by DC Electric Field	PLOS ONE			English	Article							SRC-FAMILY KINASES; GROWTH-FACTOR RECEPTORS; MUSCLE-CELLS; NEUROMUSCULAR-JUNCTION; ACTIN POLYMERIZATION; NEURITE GROWTH; IN-VIVO; AGRIN; PHOSPHORYLATION; INDUCTION	Background: The formation of acetylcholine receptor (AChR) cluster is a key event during the development of the neuromuscular junction. It is induced through the activation of muscle-specific kinase (MuSK) by the heparan-sulfate proteoglycan agrin released from the motor axon. On the other hand, DC electric field, a non-neuronal stimulus, is also highly effective in causing AChRs to cluster along the cathode-facing edge of muscle cells. Methodology/Principal Findings: To understand its molecular mechanism, quantum dots (QDs) were used to follow the movement of AChRs as they became clustered under the influence of electric field. From analyses of trajectories of AChR movement in the membrane, it was concluded that diffuse receptors underwent Brownian motion until they were immobilized at sites of cluster formation. This supports the diffusion-mediated trapping model in explaining AChR clustering under the influence of this stimulus. Disrupting F-actin cytoskeleton assembly and interfering with rapsyn-AChR interaction suppressed this phenomenon, suggesting that these are integral components of the trapping mechanism induced by the electric field. Consistent with the idea that signaling pathways are activated by this stimulus, the localization of tyrosine-phosphorylated forms of AChR beta-subunit and Src was observed at cathodal AChR clusters. Furthermore, disrupting MuSK activity through the expression of a kinase-dead form of this enzyme abolished electric field-induced AChR clustering. Conclusions: These results suggest that DC electric field as a physical stimulus elicits molecular reactions in muscle cells in the form of cathodal MuSK activation in a ligand-free manner to trigger a signaling pathway that leads to cytoskeletal assembly and AChR clustering.	Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Zhang, HL (corresponding author), Peking Univ, Peking Univ Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China.	penghb@ust.hk		Zhang, Hailong/0000-0002-1280-2348	Hong Kong RGC [HKUST6417/06M]; HKUST [RPC11SC10]	Hong Kong RGC(Hong Kong Research Grants Council); HKUST	Funding was provided by Hong Kong RGC grant HKUST6417/06M (http://www.ugc.edu.hk/eng/rgc/index.htm), Hong Kong RGC grant HKUST6417/06M, and HKUST intramural grant RPC11SC10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PS, 1999, J ENG MECH-ASCE, V125, P622, DOI 10.1061/(ASCE)0733-9399(1999)125:6(622); Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4954; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; BEDLACK RS, 1992, NEURON, V9, P393, DOI 10.1016/0896-6273(92)90178-G; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Camilleri AA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-46; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; EDWARDS C, 1979, NEUROSCIENCE, V4, P565, DOI 10.1016/0306-4522(79)90134-9; EDWARDS C, 1976, J NEUROBIOL, V7, P377, DOI 10.1002/neu.480070409; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Geng L, 2008, CHEM-BIOL INTERACT, V175, P108, DOI 10.1016/j.cbi.2008.04.017; Geng L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-80; GIUGNI TD, 1987, J CELL BIOL, V104, P1291, DOI 10.1083/jcb.104.5.1291; HARRIS AK, 1990, J EXP ZOOL, V253, P163, DOI 10.1002/jez.1402530206; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; JAFFE LF, 1977, NATURE, V265, P600, DOI 10.1038/265600a0; KIDOKORO Y, 1985, J PHYSIOLOGY PARIS, V80, P212; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Li J, 2011, LAB CHIP, V11, P1298, DOI 10.1039/c0lc00371a; LUTHER PW, 1985, J CELL BIOL, V100, P235, DOI 10.1083/jcb.100.1.235; LUTHER PW, 1983, NATURE, V303, P61, DOI 10.1038/303061a0; Madhavan R, 2006, J NEUROBIOL, V66, P134, DOI 10.1002/neu.20206; Madhavan R, 2005, IUBMB LIFE, V57, P719, DOI 10.1080/15216540500338739; Madhavan R, 2003, J NEUROCYTOL, V32, P685, DOI 10.1023/B:NEUR.0000020617.05656.68; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Marangi PA, 2001, EMBO J, V20, P7060, DOI 10.1093/emboj/20.24.7060; MCLAUGHLIN S, 1981, BIOPHYS J, V34, P85, DOI 10.1016/S0006-3495(81)84838-2; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Mittaud P, 2001, J BIOL CHEM, V276, P14505, DOI 10.1074/jbc.M007024200; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; NUCCITELLI R, 1983, EXP CELL RES, V147, P195, DOI 10.1016/0014-4827(83)90284-7; NUCCITELLI R, 1993, CELL MOTIL CYTOSKEL, V24, P54, DOI 10.1002/cm.970240107; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; PATEL N, 1982, J NEUROSCI, V2, P483; PATEL NB, 1984, J NEUROSCI, V4, P2939; PENG HB, 1995, J NEUROSCI, V15, P3027; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1993, J CELL BIOL, V120, P197, DOI 10.1083/jcb.120.1.197; PENG HB, 1989, DEV BIOL, V131, P197; PENG HB, 1991, METHOD CELL BIOL, V36, P511; POO MM, 1977, NATURE, V265, P602, DOI 10.1038/265602a0; Pullar CE, 2001, CELL MOTIL CYTOSKEL, V50, P207, DOI 10.1002/cm.10009; Qian YPK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-70; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; ROCHLIN MW, 1989, J CELL SCI, V94, P73; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; STOLLBERG J, 1988, J CELL BIOL, V107, P1397, DOI 10.1083/jcb.107.4.1397; STUMP RF, 1983, J CELL BIOL, V97, P1226, DOI 10.1083/jcb.97.4.1226; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Yan XL, 2009, BIOELECTROMAGNETICS, V30, P29, DOI 10.1002/bem.20436; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhou H, 1997, MOL CELL NEUROSCI, V10, P56, DOI 10.1006/mcne.1997.0638	67	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26805	10.1371/journal.pone.0026805	http://dx.doi.org/10.1371/journal.pone.0026805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046365	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000035
J	Mausberg, AK; Horste, GMZ; Dehmel, T; Stettner, M; Lehmann, HC; Sheikh, KA; Kieseier, BC				Mausberg, Anne K.; Hoerste, Gerd Meyer Zu; Dehmel, Thomas; Stettner, Mark; Lehmann, Helmar C.; Sheikh, Kazim A.; Kieseier, Bernd C.			Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; PERIPHERAL-NERVE; TGF-BETA-1; SYSTEM; ENCEPHALOMYELITIS; INFLAMMATION; PROTECTION; CELLS	Erythropoietin (EPO) is a pleiotropic cytokine originally identified for its role in erythropoiesis. In addition, in various preclinical models EPO exhibited protective activity against tissue injury. There is an urgent need for potent treatments of autoimmune driven disorders of the peripheral nervous system (PNS), such as the Guillain-Barre syndrome (GBS), a disabling autoimmune disease associated with relevant morbidity and mortality. To test the therapeutic potential of EPO in experimental autoimmune neuritis (EAN) - an animal model of human GBS - immunological and clinical effects were investigated in a preventive and a therapeutic paradigm. Treatment with EPO reduced clinical disease severity and if given therapeutically also shortened the recovery phase of EAN. Clinical findings were mirrored by decreased inflammation within the peripheral nerve, and myelin was well maintained in treated animals. In contrast, EPO increased the number of macrophages especially in later stages of the experimental disease phase. Furthermore, the anti-inflammatory cytokine transforming growth factor (TGF)-beta was upregulated in the treated cohorts. In vitro experiments revealed less proliferation of T cells in the presence of EPO and TGF-beta was moderately induced, while the secretion of other cytokines was almost not altered by EPO. Our data suggest that EPO revealed its beneficial properties by the induction of beneficial macrophages and the modulation of the immune system towards anti-inflammatory responses in the PNS. Further studies are warranted to elaborate the clinical usefulness of EPO for treating immune-mediated neuropathies in affected patients.	[Mausberg, Anne K.; Hoerste, Gerd Meyer Zu; Dehmel, Thomas; Stettner, Mark; Lehmann, Helmar C.; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Sheikh, Kazim A.] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX USA	Heinrich Heine University Dusseldorf; University of Texas System; University of Texas Health Science Center Houston	Mausberg, AK (corresponding author), Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany.	mausberg@uni-duesseldorf.de	Lehmann, Helmar C/G-4998-2016; Horste, Gerd Meyer zu/O-9549-2016; Stettner, Mark/GQY-7516-2022	Lehmann, Helmar C/0000-0001-6205-2293; Horste, Gerd Meyer zu/0000-0002-4341-4719; Mausberg, Anne K/0000-0001-9026-1703	GBS/CIDP Foundation International	GBS/CIDP Foundation International	Part of this study was supported by the GBS/CIDP Foundation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Brines M, 2006, ERYTHROPOIETIN AND THE NERVOUS SYSTEM: NOVEL THERAPEUTIC OPTIONS FOR NEUROPROTECTION, P147, DOI 10.1007/978-0-387-30011-5_9; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; FORTIER AH, 2001, CURR PROTOC IMMUNOL; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRIFFIN JW, 2005, PERIPHERAL NEUROPATH, P2197; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; JOHNS LD, 1993, J NEUROIMMUNOL, V47, P1, DOI 10.1016/0165-5728(93)90278-7; Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K; JUNG S, 1993, J NEUROL SCI, V119, P195, DOI 10.1016/0022-510X(93)90134-K; KADLUBOWSKI M, 1980, J NEUROL SCI, V48, P171, DOI 10.1016/0022-510X(80)90198-7; Kiefer R, 1996, AM J PATHOL, V148, P211; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2000, J NEUROIMMUNOL, V110, P121, DOI 10.1016/S0165-5728(00)00323-4; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Shaheen MA, 2009, HEMATOLOGY BASIC PRI, P253; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; 2007, LANCET NEUROL, V6, P589	36	28	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26280	10.1371/journal.pone.0026280	http://dx.doi.org/10.1371/journal.pone.0026280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043313	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400041
J	Feng, ZE; Guo, W; Zhang, CP; Xu, Q; Zhang, P; Sun, J; Zhu, HG; Wang, ZH; Li, J; Wang, LZ; Wang, BS; Ren, GX; Ji, T; Tu, WY; Yang, XH; Qiu, WL; Mao, L; Zhang, ZY; Chen, WT				Feng, Zhien; Guo, Wei; Zhang, Chenping; Xu, Qin; Zhang, Ping; Sun, Jian; Zhu, Hanguang; Wang, Zhonghe; Li, Jiang; Wang, Lizhen; Wang, Bingshun; Ren, Guoxin; Ji, Tong; Tu, Wenyong; Yang, Xihu; Qiu, Weiliu; Mao, Li; Zhang, Zhiyuan; Chen, Wantao			CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							CYCLIN D1 EXPRESSION; INDUCTION CHEMOTHERAPY; RANDOMIZED TRIAL; GENE AMPLIFICATION; INITIAL TREATMENT; PROGNOSTIC VALUE; CANCER; MANAGEMENT; ADJUVANT; SURVIVAL	Background: Cyclin D1 (CCND1) has been associated with chemotherapy resistance and poor prognosis. In this study, we tested the hypothesis that CCND1 expression determines response and clinical outcomes in locally advanced head and neck squamous cell carcinoma (HNSCC) patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy. Methodology and Findings: 224 patients with HNSCC were treated with either cisplatin-based chemotherapy followed by surgery and radiotherapy (neoadjuvant group, n = 100) or surgery and radiotherapy (non-neoadjuvant group, n = 124). CCND1 expression was assessed by immunohistochemistry. CCND1 levels were analyzed with chemotherapy response, disease-free survival (DFS) and overall survival (OS). There was no significant difference between the neoadjuvant group and non-neoadjuvant group in DFS and OS (p = 0.929 and p = 0.760) when patients treated with the indiscriminate administration of cisplatin-based chemotherapy. However, in the neoadjuvant group, patients whose tumors showed a low CCND1 expression more likely respond to chemotherapy (p < 0.001) and had a significantly better OS and DFS than those whose tumors showed a high CCND1 expression (73% vs 8%, p < 0.001; 63% vs 6%, p < 0.001). Importantly, patients with a low CCND1 expression in neoadjuvant group received more survival benefits than those in non-neoadjuvant group (p = 0.016), however patients with a high CCND1 expression and treated with neoadjuvant chemotherapy had a significantly poor OS compared to those treated with surgery and radiotherapy (p = 0.032). A multivariate survival analysis also showed CCND1 expression was an independent predictive factor (p < 0.001). Conclusions: This study suggests that some but not all patients with HNSCC may benefit from neoadjuvant chemotherapy with cisplatin-based regimen and CCND1 expression may serve as a predictive biomarker in selecting patients undergo less than two cycles of neoadjuvant chemotherapy.	[Feng, Zhien; Guo, Wei; Zhang, Chenping; Xu, Qin; Zhang, Ping; Sun, Jian; Zhu, Hanguang; Wang, Zhonghe; Ren, Guoxin; Ji, Tong; Tu, Wenyong; Yang, Xihu; Qiu, Weiliu; Zhang, Zhiyuan; Chen, Wantao] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Feng, Zhien; Zhang, Chenping; Xu, Qin; Zhang, Ping; Li, Jiang; Wang, Lizhen; Yang, Xihu; Qiu, Weiliu; Mao, Li; Zhang, Zhiyuan; Chen, Wantao] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Li, Jiang; Wang, Lizhen] Shanghai Jiao Tong Univ, Dept Oral Pathol, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Wang, Bingshun] Shanghai Jiao Tong Univ, Dept Biostat, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Mao, Li] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore	Feng, ZE (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China.	zhzhy@omschina.org.cn; chenwantao2002@gmail.com	Wang, Bing-shun/B-8698-2013; Feng, Zhien/O-2982-2018; zhang, zhiyuan/GRS-2141-2022; Mao, Li/C-7570-2011	Feng, Zhien/0000-0003-1952-6734; Mao, Li/0000-0001-7263-3358; Wang, Bingshun/0000-0002-0435-2543	Science and Technology Commission of Shanghai Municipality [08JC1414400, 09431902200, 10DZ1951300, 10XD1402500]; National Natural Science Foundation of China [30330580, 30973343]; Shanghai Leading Academic Discipline Project [S30206]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Dr. Chen, Dr. Zhiyuan Zhang, Dr. Mao, Dr. Chenping Zhang, Dr. Ping Zhang, Dr. Xu, Dr. Guo, Dr. Feng, Dr. Zhu, Dr. Sun and Dr. Qiu were supported in part by grants from Science and Technology Commission of Shanghai Municipality (08JC1414400, 09431902200 and 10DZ1951300). Dr. Chen, Dr. Ping Zhang and Dr. Xu were supported in part by grants from the National Natural Science Foundation of China (Grant No. 30330580, 30973343) and from Project of Science and Technology Commission of Shanghai Municipality (10XD1402500). Dr. Chen, Dr. Qiu, Dr. Ping Zhang, Dr. Xu, Dr. Li and Dr. Lizhen Wang were supported in part by funds from the Shanghai Leading Academic Discipline Project (S30206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2006, J CLIN ONCOL, V24, P2624, DOI 10.1200/JCO.2005.05.3629; Akervall JA, 1997, CANCER, V79, P380; Allen PJ, 2003, J GASTROINTEST SURG, V7, P109, DOI 10.1016/S1091-255X(02)00121-X; Ancona E, 1997, ANN SURG, V226, P714, DOI 10.1097/00000658-199712000-00008; Beauvillain C, 1997, LARYNGOSCOPE, V107, P648, DOI 10.1097/00005537-199705000-00017; BROWMAN GP, 1994, CANCER INVEST, V12, P662, DOI 10.3109/07357909409023052; Chen Wantao, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P404; COGNETTI F, 1989, J CLIN ONCOL, V7, P829, DOI 10.1200/JCO.1989.7.7.829; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; ElSayed S, 1996, J CLIN ONCOL, V14, P838, DOI 10.1200/JCO.1996.14.3.838; FERLAY J, 2010, 10 IARC; Glynne-Jones R, 2008, J CLIN ONCOL, V26, P3669, DOI 10.1200/JCO.2008.18.1651; Glynne-Jones R, 2007, J CLIN ONCOL, V25, P5281, DOI 10.1200/JCO.2007.12.3133; Hitt R, 2005, EUR J CANCER, V41, P453, DOI 10.1016/j.ejca.2004.10.014; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; JARES P, 1994, CANCER RES, V54, P4813; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; KIES MS, 1985, OTOLARYNG HEAD NECK, V93, P199, DOI 10.1177/019459988509300213; Law S, 1997, J THORAC CARDIOV SUR, V114, P210, DOI 10.1016/S0022-5223(97)70147-8; Lee DJ, 1997, CLIN CANCER RES, V3, P501; Licitra L, 2003, J CLIN ONCOL, V21, P327, DOI 10.1200/JCO.2003.06.146; MUNRO AJ, 1995, BRIT J CANCER, V71, P83, DOI 10.1038/bjc.1995.17; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Rudas M, 2008, CLIN CANCER RES, V14, P1767, DOI 10.1158/1078-0432.CCR-07-4122; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vokes EE, 1996, ANN ONCOL, V7, P15; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Yu ZW, 2005, CLIN CANCER RES, V11, P1160; Zhang P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-224; Zhou XJ, 2009, INT J CANCER, V124, P483, DOI 10.1002/ijc.23964	33	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26399	10.1371/journal.pone.0026399	http://dx.doi.org/10.1371/journal.pone.0026399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065993	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000009
J	Kindl, J; Kalinova, B; Cervenka, M; Jilek, M; Valterova, I				Kindl, Jiri; Kalinova, Blanka; Cervenka, Milan; Jilek, Milan; Valterova, Irena			Male Moth Songs Tempt Females to Accept Mating: The Role of Acoustic and Pheromonal Communication in the Reproductive Behaviour of Aphomia sociella	PLOS ONE			English	Article							CORCYRA-CEPHALONICA STAINTON; ACHROIA-GRISELLA LEPIDOPTERA; GREATER WAX MOTH; SACCHARINA WALKER LEPIDOPTERA; AFRICAN SUGARCANE BORER; SEX-PHEROMONE; WING GLAND; ULTRASONIC COMMUNICATION; SOUND PRODUCTION; RICE MOTH	Background: Members of the subfamily Galleriinae have adapted to different selective environmental pressures by devising a unique mating process. Galleriinae males initiate mating by attracting females with either chemical or acoustic signals (or a combination of both modalities). Six compounds considered candidates for the sex pheromone have recently been identified in the wing gland extracts of Aphomia sociella males. Prior to the present study, acoustic communication had not been investigated. Signals mediating female attraction were likewise unknown. Methodology/Principal Findings: Observations of A. sociella mating behaviour and recordings of male acoustic signals confirmed that males initiate the mating process. During calling behaviour (stationary wing fanning and pheromone release), males disperse pheromone from their wing glands. When a female approaches, males cease calling and begin to produce ultrasonic songs as part of the courtship behaviour. Replaying of recorded courting songs to virgin females and a comparison of the mating efficiency of intact males with males lacking tegullae proved that male ultrasonic signals stimulate females to accept mating. Greenhouse experiments with isolated pheromone glands confirmed that the male sex pheromone mediates long-range female attraction. Conclusion/Significance: Female attraction in A. sociella is chemically mediated, but ultrasonic communication is also employed during courtship. Male ultrasonic songs stimulate female sexual display and significantly affect mating efficiency. Considerable inter-individual differences in song structure exist. These could play a role in female mate selection provided that the female's ear is able to discern them. The A. sociella mating strategy described above is unique within the subfamily Galleriinae.	[Kindl, Jiri; Kalinova, Blanka; Valterova, Irena] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Cervenka, Milan] Czech Tech Univ, Fac Elect Engn, CR-16635 Prague, Czech Republic; [Jilek, Milan] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Technical University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Kindl, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	blanka@uochb.cas.cz	Valterova, Irena/H-1823-2012; Cervenka, Milan/N-3465-2013	Cervenka, Milan/0000-0001-8635-5731; Valterova, Irena/0000-0001-5723-6143	Ministry of Education, Youth and Sports of the Czech Republic [2B06007]; Academy of Sciences of the Czech Republic [Z4055905]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This research was supported financially by Grant #2B06007 (Ministry of Education, Youth and Sports of the Czech Republic) and by Research Project #Z4055905 (Academy of Sciences of the Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; BENNETT AL, 1989, J ENTOMOL SOC S AFR, V52, P317; BENNETT AL, 1991, J ENTOMOL SOC S AFR, V54, P243; BURGER BV, 1993, J CHEM ECOL, V19, P2255, DOI 10.1007/BF00979662; Conner WE, 1999, J EXP BIOL, V202, P1711; Cremer S, 1998, ETHOLOGY, V104, P1, DOI 10.1111/j.1439-0310.1998.tb00025.x; DAHM KH, 1971, NATURWISSENSCHAFTEN, V58, P265, DOI 10.1007/BF00602990; FINN W E, 1977, Southwestern Entomologist, V2, P62; FLINT HM, 1983, J ECON ENTOMOL, V76, P467, DOI 10.1093/jee/76.3.467; Ford LT, 1936, ENTOMOLOGISTS RECORD, V48, P93; Fullard JH, 1998, SPR HDB AUD, V10, P279; GREENFIELD MD, 1983, BEHAVIOUR, V84, P287, DOI 10.1163/156853983X00534; Greenfield MD, 2002, MECH EVOLUTION ARTHR; HALL DR, 1987, J CHEM ECOL, V13, P1575, DOI 10.1007/BF00980201; Jang Y, 1997, J INSECT BEHAV, V10, P87, DOI 10.1007/BF02765476; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Jia FY, 2001, J INSECT BEHAV, V14, P19, DOI 10.1023/A:1007893411662; Jiros P, 2010, P 26 ISCE M TOURS FR; Jones G, 2002, BEHAV ECOL, V13, P375, DOI 10.1093/beheco/13.3.375; Kalinova B, 2009, J NAT PROD, V72, P8, DOI 10.1021/np800434x; KUNESCH G, 1987, Z NATURFORSCH C, V42, P657; KUWAHARA Y, 1980, APPL ENTOMOL ZOOL, V15, P478, DOI 10.1303/aez.15.478; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; Loudon C, 2000, J EXP BIOL, V203, P2977; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Nakano R, 2009, J EXP BIOL, V212, P4072, DOI 10.1242/jeb.032466; Nakano R, 2006, NATURWISSENSCHAFTEN, V93, P292, DOI 10.1007/s00114-006-0100-7; Nakano R, 2010, BIOL LETTERS, V6, P582, DOI 10.1098/rsbl.2010.0058; NEMOTO T, 1990, APPL ENTOMOL ZOOL, V25, P261, DOI 10.1303/aez.25.261; Reinhold K, 1998, ANIM BEHAV, V55, P905, DOI 10.1006/anbe.1997.0594; Roeder KD, 1975, P CAN SOC ZOOL ANN M, P71; Sasaerila Y, 2003, CHEMOECOLOGY, V13, P89, DOI 10.1007/s00049-003-0233-5; SINGH D, 1976, Journal of Research Punjab Agricultural University, V13, P85; Skals N, 2000, PHYSIOL ENTOMOL, V25, P354, DOI 10.1046/j.1365-3032.2000.00204.x; SNEDDEN WA, 1994, PHYSIOL ENTOMOL, V19, P367, DOI 10.1111/j.1365-3032.1994.tb01065.x; Spangler H. G., 1984, Gleanings in Bee Culture, V112, P467; SPANGLER HG, 1984, J ECON ENTOMOL, V77, P346, DOI 10.1093/jee/77.2.346; SPANGLER HG, 1986, J KANSAS ENTOMOL SOC, V59, P555; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; SPANGLER HG, 1987, J INSECT PHYSIOL, V33, P465, DOI 10.1016/0022-1910(87)90109-0; SPANGLER HG, 1985, ANN ENTOMOL SOC AM, V78, P54, DOI 10.1093/aesa/78.1.54; SPANGLER HG, 1986, J COMP PHYSIOL A, V159, P751, DOI 10.1007/BF00603728; SPANGLER HG, 1987, J STORED PROD RES, V23, P203, DOI 10.1016/0022-474X(87)90004-X; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; Takacs S, 2002, NATURWISSENSCHAFTEN, V89, P57, DOI 10.1007/s00114-001-0282-y; Takanashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013144; TREMATERRA P, 1995, J STORED PROD RES, V31, P43, DOI 10.1016/0022-474X(94)00034-Q; ZAGATTI P, 1981, BEHAVIOUR, V78, P81, DOI 10.1163/156853981X00266; ZAGATTI P, 1987, J CHEM ECOL, V13, P1561, DOI 10.1007/BF00980200; Zagatti P, 1985, THESIS U P M CURIE P	51	11	11	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26476	10.1371/journal.pone.0026476	http://dx.doi.org/10.1371/journal.pone.0026476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065997	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000013
J	Hojilla, CV; Jackson, HW; Khokha, R				Hojilla, Carlo V.; Jackson, Hartland W.; Khokha, Rama			TIMP3 Regulates Mammary Epithelial Apoptosis with Immune Cell Recruitment Through Differential TNF Dependence	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLAND INVOLUTION; E-CADHERIN; BRANCHING MORPHOGENESIS; TISSUE INHIBITOR; BREAST-CANCER; CYTOCHROME-C; EXTRACELLULAR-MATRIX; STROMELYSIN-1; EXPRESSION	Post-lactation mammary involution is a homeostatic process requiring epithelial apoptosis and clearance. Given that the deficiency of the extracellular metalloproteinase inhibitor TIMP3 impacts epithelial apoptosis and heightens inflammatory response, we investigated whether TIMP3 regulates these distinct processes during the phases of mammary gland involution in the mouse. Here we show that TIMP3 deficiency leads to TNF dysregulation, earlier caspase activation and onset of mitochondrial apoptosis. This accelerated first phase of involution includes faster loss of initiating signals (STAT3 activation; TGF beta 3) concurrent with immediate luminal deconstruction through E-cadherin fragmentation. Epithelial apoptosis is followed by accelerated adipogenesis and a greater macrophage and T-cell infiltration in Timp3(-/-) involuting glands. Crossing in Tnf deficiency abrogates caspase 3 activation, but heightens macrophage and T-cell influx into Timp3(-/-) glands. The data indicate that TIMP3 differentially impacts apoptosis and inflammatory cell influx, based on involvement of TNF, during the process of mammary involution. An understanding of the molecular factors and wound healing microenvironment of the postpartum mammary gland may have implications for understanding pregnancy-associated breast cancer risk.	[Hojilla, Carlo V.; Jackson, Hartland W.; Khokha, Rama] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hojilla, CV (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada.	rkhokha@uhnres.utoronto.ca	Jackson, Hartland/AAL-7751-2020	Jackson, Hartland/0000-0001-6423-2415; Khokha, Rama/0000-0002-6028-1524	Natural Sciences and Engineering Research Council; National Cancer Institute of Canada; Canadian Breast Cancer Foundation; Canadian Breast Cancer Research Alliance;  [16411]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Breast Cancer Research Alliance; 	Dr. Hojilla was supported by a Natural Sciences and Engineering Research Council of Canada studentship and a National Cancer Institute of Canada Terry Fox Studentship. Dr. Jackson is supported by a Canadian Breast Cancer Foundation Fellowship. This work has been funded by Canadian Breast Cancer Research Alliance grant #16411 to Dr. Khoka. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Black RA, 2004, NAT GENET, V36, P934, DOI 10.1038/ng0904-934; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Cruz-Munoz W, 2006, ONCOGENE; English JL, 2006, J BIOL CHEM; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Garcia-Suarez O, 2003, MICROSC RES TECHNIQ, V62, P514, DOI 10.1002/jemt.10413; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Howard BA, 2000, J MAMMARY GLAND BIOL, V5, P119, DOI 10.1023/A:1026487120779; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; HURLEY WL, 1986, AM J VET RES, V47, P2418; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Khokha R, 2011, COLD SPRING HARB PER, V3; Kwong J, 1999, CELL TISSUE RES, V298, P123, DOI 10.1007/s004419900057; LEE CS, 1969, RES VET SCI, V10, P34; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lund LR, 1996, DEVELOPMENT, V122, P181; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Mahmoodi M, 2005, AM J PATHOL, V166, P1733, DOI 10.1016/S0002-9440(10)62483-2; Marti A, 2001, MECH DEVELOP, V104, P89, DOI 10.1016/S0925-4773(01)00381-1; Mathelin C, 2008, ANTICANCER RES, V28, P2447; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2002, J MAMMARY GLAND BIOL, V7, P163, DOI 10.1023/A:1020351919634; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Nilsen-Hamilton M, 2003, ANN NY ACAD SCI, V995, P94, DOI 10.1111/j.1749-6632.2003.tb03213.x; Noe V, 2001, J CELL SCI, V114, P111; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Song J, 2000, J CLIN INVEST, V106, P1209, DOI 10.1172/JCI10411; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271; Tatarczuch L, 2000, J ANAT, V196, P313, DOI 10.1046/j.1469-7580.2000.19630313.x; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; Varela LM, 1996, ENDOCRINOLOGY, V137, P4915, DOI 10.1210/en.137.11.4915; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Watson CJ, 2009, J ANIM SCI, V87, P35, DOI 10.2527/jas.2008-1333; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; WILSON RA, 1986, VET IMMUNOL IMMUNOP, V13, P151, DOI 10.1016/0165-2427(86)90056-5; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Woessner JF, 2001, J CLIN INVEST, V108, P799, DOI 10.1172/JCI13709; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhao L, 2002, MOL ENDOCRINOL, V16, P2902, DOI 10.1210/me.2001-0330; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	68	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26718	10.1371/journal.pone.0026718	http://dx.doi.org/10.1371/journal.pone.0026718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053204	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800030
J	Lou, HB; Chen, M; Black, SS; Bushell, SR; Ceccarelli, M; Mach, T; Beis, K; Low, AS; Bamford, VA; Booth, IR; Bayley, H; Naismith, JH				Lou, Hubing; Chen, Min; Black, Susan S.; Bushell, Simon R.; Ceccarelli, Matteo; Mach, Tivadar; Beis, Konstantinos; Low, Alison S.; Bamford, Victoria A.; Booth, Ian R.; Bayley, Hagan; Naismith, James H.			Altered Antibiotic Transport in OmpC Mutants Isolated from a Series of Clinical Strains of Multi-Drug Resistant E. coli	PLOS ONE			English	Article							3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL TETRAZOLIUM BROMIDE; OUTER-MEMBRANE PERMEABILITY; BETA-LACTAM ANTIBIOTICS; GRAM-NEGATIVE BACTERIA; LARGER PORE-SIZE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE	Antibiotic-resistant bacteria, particularly Gram negative species, present significant health care challenges. The permeation of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate). We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins may modulate antibiotic passage through the outer membrane.	[Lou, Hubing; Bushell, Simon R.; Beis, Konstantinos; Bamford, Victoria A.; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, St Andrews, Fife, Scotland; [Chen, Min; Mach, Tivadar; Bayley, Hagan] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Black, Susan S.; Low, Alison S.; Booth, Ian R.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland; [Ceccarelli, Matteo] Univ Cagliari, Dept Phys, Monserrato, Italy; [Ceccarelli, Matteo] Univ Cagliari, IOM CNR UOS SLACS, Monserrato, Italy	University of St Andrews; University of Oxford; University of Aberdeen; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Cagliari	Lou, HB (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews, Fife, Scotland.	naismith@st-andrews.ac.uk	Ceccarelli, Matteo/C-8557-2018; Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012; Low, Alison/AHB-3469-2022	Ceccarelli, Matteo/0000-0003-4272-902X; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Low, Alison/0000-0002-8360-1316; Bayley, Hagan/0000-0003-2499-6116; Beis, Konstantinos/0000-0001-5727-4721; Bushell, Simon/0000-0001-5477-6777	Biotechnology Biological Science Research Council; Wellcome Trust [081862/Z/06/Z]; Scottish Funding Council through SULSA; MRC; EU through AEROPATH; University of Aberdeen; University of St Andrews; University of Oxford; University of Cagliari; Biotechnology and Biological Sciences Research Council [B19490] Funding Source: researchfish; Medical Research Council [G0300122] Funding Source: researchfish; MRC [G0300122] Funding Source: UKRI	Biotechnology Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Scottish Funding Council through SULSA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU through AEROPATH; University of Aberdeen; University of St Andrews; University of Oxford; University of Cagliari; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Biotechnology Biological Science Research Council, Wellcome Trust (grants to IRB and to JHN (ref 081862/Z/06/Z), Scottish Funding Council through SULSA (JHN and IRB), MRC (HB), EU through AEROPATH (JHN) and the Universities of Aberdeen, St Andrews, Oxford and Cagliari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 1998, INT J TUBERC LUNG D, V2, P1011; Acosta F, 2003, FISH SHELLFISH IMMUN, V15, P241, DOI 10.1016/S1050-4648(02)00163-8; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bhupathiraju VK, 1999, J MICROBIOL METH, V37, P231, DOI 10.1016/S0167-7012(99)00069-X; Biro I, 2010, BIOPHYS J, V98, P1830, DOI 10.1016/j.bpj.2010.01.026; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521; Cole SP, 1997, INFECT IMMUN, V65, P843, DOI 10.1128/IAI.65.2.843-846.1997; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; DELCOUR AH, 1991, J MEMBRANE BIOL, V119, P267, DOI 10.1007/BF01868731; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P., 1997, NEWSLETT PROTEIN CRY, V33, P22; Hajjar E, 2010, J MOL MODEL; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; James CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005453; KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, P1; Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797; Lou KL, 1996, J BIOL CHEM, V271, P20669, DOI 10.1074/jbc.271.34.20669; Lovelle M, 2011, PHYS CHEM CHEM PHYS, V13, P1521, DOI 10.1039/c0cp00969e; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Mahendran KR, 2010, J PHYS CHEM B, V114, P5170, DOI 10.1021/jp911485k; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189; Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214, DOI 10.1128/JCM.36.5.1214-1219.1998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Procacci P, 1997, J COMPUT CHEM, V18, P1848, DOI 10.1002/(SICI)1096-987X(19971130)18:15<1848::AID-JCC2>3.0.CO;2-O; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Sanbongi Y, 2009, MICROBIOL IMMUNOL, V53, P361, DOI 10.1111/j.1348-0421.2009.00137.x; Schaller A, 2002, ANTIMICROB AGENTS CH, V46, P2636, DOI 10.1128/AAC.46.8.2636-2639.2002; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Turner AK, 2001, INFECT IMMUN, V69, P4969, DOI 10.1128/IAI.69.8.4969-4979.2001; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanGelder P, 1997, J MOL BIOL, V269, P468, DOI 10.1006/jmbi.1997.1063; Vidal S, 2005, J MED CHEM, V48, P1395, DOI 10.1021/jm049652e; WEST IC, 1984, J THEOR BIOL, V110, P11, DOI 10.1016/S0022-5193(84)80011-9; ZIMMERMANN W, 1977, ANTIMICROB AGENTS CH, V12, P368, DOI 10.1128/AAC.12.3.368	69	75	76	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e25825	10.1371/journal.pone.0025825	http://dx.doi.org/10.1371/journal.pone.0025825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053181	gold, Green Submitted, Green Published			2022-12-27	WOS:000299081800007
J	Khan, J; Ezan, F; Cremet, JY; Fautrel, A; Gilot, D; Lambert, M; Benaud, C; Troadec, MB; Prigent, C				Khan, Jabbar; Ezan, Frederic; Cremet, Jean-Yves; Fautrel, Alain; Gilot, David; Lambert, Marine; Benaud, Christelle; Troadec, Marie-Berengere; Prigent, Claude			Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER PROTEIN; HUMAN COLORECTAL CANCERS; B-KINASE; CENTROSOME AMPLIFICATION; GENETIC INSTABILITY; DROSOPHILA AURORA; HISTONE H3; MITOTIC KINASE; BLADDER-CANCER; MEIOSIS I	Aurora kinases belong to a conserved family of serine/threonine kinases key regulators of cell cycle progression. Aurora-A and Aurora-B are expressed in somatic cells and involved mainly in mitosis while Aurora-C is expressed during spermatogenesis and oogenesis and is involved in meiosis. Aurora-C is hardly detectable in normal somatic cells. However all three kinases are overexpressed in many cancer lines. Aurora-A possesses an oncogenic activity while Aurora-B does not. Here we investigated whether Aurora-C possesses such an oncogenic activity. We report that overexpression of Aurora-C induces abnormal cell division resulting in centrosome amplification and multinucleation in both transiently transfected cells and in stable cell lines. Only stable NIH3T3 cell clones overexpressing active Aurora-C formed foci of colonies when grown on soft agar, indicating that a gain of Aurora-C activity is sufficient to transform cells. Furthermore, we reported that NIH-3T3 stable cell lines overexpressing Aurora-C induced tumour formation when injected into nude mice, demonstrating the oncogenic activity of enzymatically active Aurora kinase C. Interestingly enough tumor aggressiveness was positively correlated with the quantity of active kinase, making Aurora-C a potential anti-cancer therapeutic target.	[Khan, Jabbar; Cremet, Jean-Yves; Gilot, David; Benaud, Christelle; Troadec, Marie-Berengere; Prigent, Claude] Inst Genet & Dev Rennes, CNRS, UMR 6061, Rennes, France; [Khan, Jabbar; Ezan, Frederic; Cremet, Jean-Yves; Gilot, David; Benaud, Christelle; Troadec, Marie-Berengere; Prigent, Claude] Univ Rennes 1, Fac Med, UEB, IFR 140, Rennes, France; [Ezan, Frederic] IRSET, EA SeRAIC 4427, Rennes, France; [Fautrel, Alain] Biogenouest, Histopathol Platform H2H2, IFR140, Rennes, France; [Fautrel, Alain] INSERM, U991, Rennes, France; [Lambert, Marine] MRic Microscopy Facil, IFR140, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Khan, J (corresponding author), Inst Genet & Dev Rennes, CNRS, UMR 6061, Rennes, France.	marie-berengere.troadec@univ-rennes1.fr; claude.prigent@univ-rennes1.fr	Troadec, Marie-Berengere/I-6883-2013; Fautrel, Alain/AAL-7391-2020; Benaud, Christelle/M-1178-2018	FAUTREL, Alain/0000-0002-3449-0779; TROADEC, Marie-Berengere/0000-0003-2668-9670	CNRS; Universite de Rennes 1; Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Higher Education of Pakistan; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Rennes 1; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Higher Education of Pakistan(Higher Education Commission of Pakistan); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS, Universite de Rennes 1, the Association pour la Recherche sur le Cancer (CP), the Ligue Nationale Contre le Cancer (MBT and CP), Higher Education of Pakistan (JK), and the Fondation pour la Recherche Medicale (MBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Chen HL, 2005, J BIOMED SCI, V12, P297, DOI 10.1007/s11373-005-0980-0; Cimini D, 2007, CELL CYCLE, V6, P1558, DOI 10.4161/cc.6.13.4452; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Dieterich K, 2009, HUM MOL GENET, V18, P1301, DOI 10.1093/hmg/ddp029; Dutertre S, 2005, CELL CYCLE, V4, P1783, DOI 10.4161/cc.4.12.2172; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Jiang F, 2003, INT J CANCER, V106, P661, DOI 10.1002/ijc.11251; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kamada K, 2004, ONCOL REP, V12, P593; Katayama H, 2008, CELL CYCLE, V7, P2691, DOI 10.4161/cc.7.17.6460; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Li DH, 2003, CLIN CANCER RES, V9, P991; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Lin YS, 2006, GENE EXPRESSION, V13, P15, DOI 10.3727/000000006783991962; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nishida N, 2007, CANCER BIOL THER, V6, P525, DOI 10.4161/cbt.6.4.3817; Ota T, 2002, CANCER RES, V62, P5168; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; Rannou Y, 2008, CELL CYCLE, V7, P3012, DOI 10.4161/cc.7.19.6718; Sasai K, 2004, CELL MOTIL CYTOSKEL, V59, P249, DOI 10.1002/cm.20039; Sato N, 1999, CLIN CANCER RES, V5, P963; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Slattery SD, 2008, CELL CYCLE, V7, P787, DOI 10.4161/cc.7.6.5563; Slattery SD, 2009, CELL CYCLE, V8, P2984; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Spengler D, 2007, CELL CYCLE, V6, P2579, DOI 10.4161/cc.6.20.4781; Takahashi T, 2000, JPN J CANCER RES, V91, P1007, DOI 10.1111/j.1349-7006.2000.tb00878.x; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tatsuka M, 1998, CANCER RES, V58, P4811; Troadec MB, 2006, J HEPATOL, V44, P391, DOI 10.1016/j.jhep.2005.07.033; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; TSOU JH, 2011, J PATHOL; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yan XM, 2005, BIOCHEM BIOPH RES CO, V328, P353, DOI 10.1016/j.bbrc.2004.12.168; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	55	44	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26512	10.1371/journal.pone.0026512	http://dx.doi.org/10.1371/journal.pone.0026512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046298	Green Published, gold			2022-12-27	WOS:000296521400023
J	Reeves, PR; Liu, B; Zhou, ZM; Li, D; Guo, D; Ren, Y; Clabots, C; Lan, RT; Johnson, JR; Wang, L				Reeves, Peter R.; Liu, Bin; Zhou, Zhemin; Li, Dan; Guo, Dan; Ren, Yan; Clabots, Connie; Lan, Ruiting; Johnson, James R.; Wang, Lei			Rates of Mutation and Host Transmission for an Escherichia coli Clone over 3 Years	PLOS ONE			English	Article							HOUSEHOLD MEMBERS; ENVIRONMENT; ADAPTATION; DIVERSITY; EVOLUTION; ALIGNMENT; PATTERNS; SEQUENCE	Although over 50 complete Escherichia coli/Shigella genome sequences are available, it is only for closely related strains, for example the O55:H7 and O157:H7 clones of E. coli, that we can assign differences to individual evolutionary events along specific lineages. Here we sequence the genomes of 14 isolates of a uropathogenic E. coli clone that persisted for 3 years within a household, including a dog, causing a urinary tract infection (UTI) in the dog after 2 years. The 20 mutations observed fit a single tree that allows us to estimate the mutation rate to be about 1.1 per genome per year, with minimal evidence for adaptive change, including in relation to the UTI episode. The host data also imply at least 6 host transfer events over the 3 years, with 2 lineages present over much of that period. To our knowledge, these are the first direct measurements for a clone in a well-defined host community that includes rates of mutation and host transmission. There is a concentration of non-synonymous mutations associated with 2 transfers to the dog, suggesting some selection pressure from the change of host. However, there are no changes to which we can attribute the UTI event in the dog, which suggests that this occurrence after 2 years of the clone being in the household may have been due to chance, or some unknown change in the host or environment. The ability of a UTI strain to persist for 2 years and also to transfer readily within a household has implications for epidemiology, diagnosis, and clinical intervention.	[Reeves, Peter R.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Liu, Bin; Zhou, Zhemin; Li, Dan; Guo, Dan; Ren, Yan; Wang, Lei] Nankai Univ, Tianjin Econ Technol Dev Area Sch Biol Sci & Biot, Tianjin 300071, Peoples R China; [Liu, Bin; Zhou, Zhemin; Li, Dan; Guo, Dan; Ren, Yan; Wang, Lei] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin, Peoples R China; [Clabots, Connie; Johnson, James R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Clabots, Connie; Johnson, James R.] Univ Minnesota, Vet Affairs Med Ctr, Minneapolis, MN USA; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China	University of Sydney; Nankai University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of New South Wales Sydney	Reeves, PR (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	wanglei@nankai.edu.cn	Zhou, Zhemin/AAX-5539-2020; Reeves, Peter R/A-6064-2008; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Reeves, Peter R/0000-0003-4479-7974; Wang, Lei/0000-0003-4427-0881; Lan, Ruiting/0000-0001-9834-5258	National 973 program of China [2009CB522603, 2011CB504900]; Chinese National Science Fund for Distinguished Young Scholars [30788001]; NSFC [31030002]; National Key Programs for Infectious Diseases of China [2008ZX10004-009, 2009ZX10004-108]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs, USA; Veterans Affairs [I01CX000192] Funding Source: NIH RePORTER	National 973 program of China(National Basic Research Program of China); Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NSFC(National Natural Science Foundation of China (NSFC)); National Key Programs for Infectious Diseases of China; Office of Research and Development, Medical Research Service, Department of Veterans Affairs, USA(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by the National 973 program of China grants 2009CB522603 and 2011CB504900, the Chinese National Science Fund for Distinguished Young Scholars grant 30788001, NSFC Key Program grant 31030002, and the National Key Programs for Infectious Diseases of China 2008ZX10004-009 and 2009ZX10004-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The genome sequencing was supported by Tianjin Biochip Corporation, Tianjin, China. The material used in this study is based in part upon work supported by Office of Research and Development, Medical Research Service, Department of Veterans Affairs, USA.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CAUGANT DA, 1981, GENETICS, V98, P467; Darling Aaron E., 2007, V396, P135; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Ferenci T, 2008, ADV MICROB PHYSIOL, V53, P169, DOI 10.1016/S0065-2911(07)53003-1; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Johnson JR, 2006, CLIN INFECT DIS, V43, pE101, DOI 10.1086/508541; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Klemm P, 2006, INFECT IMMUN, V74, P781, DOI 10.1128/IAI.74.1.781-785.2006; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Weissman SJ, 2007, INFECT IMMUN, V75, P3548, DOI 10.1128/IAI.01963-06; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	23	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26907	10.1371/journal.pone.0026907	http://dx.doi.org/10.1371/journal.pone.0026907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046404	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400046
J	Tran, T; Barlow, B; O'Rear, L; Jarvis, B; Li, ZZ; Dickeson, K; Dupont, W; Zutter, M				Thuy Tran; Barlow, Brittney; O'Rear, Lynda; Jarvis, Brenda; Li, Zhengzhi; Dickeson, Kent; Dupont, William; Zutter, Mary			Loss of the alpha 2 beta 1 Integrin Alters Human Papilloma Virus-Induced Squamous Carcinoma Progression In Vivo and In Vitro	PLOS ONE			English	Article							K14-HPV16 TRANSGENIC MICE; CELL CARCINOMA; EPITHELIAL CARCINOGENESIS; SKIN CARCINOGENESIS; MALIGNANT PHENOTYPE; CANCER DEVELOPMENT; ALPHA(2) INTEGRIN; TUMOR PROGRESSION; GENE-EXPRESSION; MAST-CELLS	Expression of the alpha 2 beta 1 integrin, a receptor for collagens and laminin, is altered during tumor progression. Recent studies have linked polymorphisms in the alpha 2 integrin gene with oral, squamous cell carcinoma (SCC). To determine the alpha 2 beta 1 integrin's role in SCC progression, we crossed alpha 2-null mice with K14-HPV16 transgenic animals. Pathological progression to invasive carcinoma was evaluated in HPV-positive, alpha 2-null (HPV/KO) and HPV-positive, wild-type (HPV/WT) animals. alpha 2 beta 1 integrin expression stimulated progression from hyperplasia and papillomatosis to dysplasia with concomitant dermal mast cell infiltration. Moreover, lymph node metastasis was decreased by 31.3% in HPV/KO, compared to HPV/WT, animals. To evaluate the integrin-specific impact on the malignant epithelium versus the microenvironment, we developed primary tumor cell lines. Although transition from dysplasia to carcinoma was unaltered during spontaneous tumor development, isolated primary HPV/KO SCC cell lines demonstrated decreased migration and invasion, compared to HPV/WT cells. When HPV/WT and HPV/KO SCC cells were orthotopically injected into WT or KO hosts, tumor alpha 2 beta 1 integrin expression resulted in decreased tumor latency, regardless of host integrin status. HPV/WT SCC lines failed to demonstrate a proliferative advantage in vitro, however, the HPV/WT tumors demonstrated increased growth compared to HPV/KO SCC lines in vivo. Although contributions of the integrin to the microenvironment cannot be excluded, our studies indicate that alpha 2 beta 1 integrin expression by HPV-transformed keratinocytes modulates SCC growth and progression.	[Thuy Tran; Barlow, Brittney; O'Rear, Lynda; Jarvis, Brenda; Li, Zhengzhi; Dickeson, Kent; Zutter, Mary] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Zutter, Mary] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Dupont, William] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Tran, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.	mary.zutter@vanderbilt.edu	Dupont, William D./I-4430-2012		National Institutes of Health (NIH) [RO1CA115984-01, 2RO1CA098027-07A1]; National Institute of General Medical Sciences/NIH [T32 GM007347]; NATIONAL CANCER INSTITUTE [R01CA115984, R01CA098027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grants RO1CA115984-01 and 2RO1CA098027-07A1 as well as by the Vanderbilt Medical Scientist Training Program National Institute of General Medical Sciences/NIH T32 GM007347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1993, LAB INVEST, V68, P4; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Arbeit JM, 1996, ONCOGENE, V13, P1847; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 1996, AM J PATHOL, V149, P1899; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Crawford NPS, 2006, TRENDS GENET, V22, P555, DOI 10.1016/j.tig.2006.07.009; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; de Visser KE, 2005, CANCER IMMUNOL IMMUN, V54, P1143, DOI 10.1007/s00262-005-0702-5; de Visser KE, 2004, NEOPLASIA, V6, P768, DOI 10.1593/neo.04250; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Dyce OH, 2002, LARYNGOSCOPE, V112, P2025, DOI 10.1097/00005537-200211000-00021; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Evans RD, 2004, CANCER LETT, V213, P189, DOI 10.1016/j.canlet.2004.05.013; Ferlito A, 2002, ORAL ONCOL, V38, P747, DOI 10.1016/S1368-8375(02)00052-0; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gogali A, 2004, EXP ONCOL, V26, P106; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; KITAMURA Y, 1980, CANCER RES, V40, P3392; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nissinen L, 1998, EXP CELL RES, V243, P1, DOI 10.1006/excr.1998.4128; Owens DM, 2001, CANCER RES, V61, P5248; Ramirez NE, 2010, J CLIN INVEST; Rhee JS, 2004, CANCER RES, V64, P952, DOI 10.1158/0008-5472.CAN-03-2445; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Sasaki K, 2003, INT IMMUNOL, V15, P701, DOI 10.1093/intimm/dxg066; Shaw Leslie M, 2005, Methods Mol Biol, V294, P97; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; van Kempen LCL, 2002, DIFFERENTIATION, V70, P610, DOI 10.1046/j.1432-0436.2002.700914.x; Van Slambrouck S, 2009, INT J ONCOL, V34, P1717, DOI 10.3892/ijo_00000302; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Yang CQ, 2003, CANCER RES, V63, P8312; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zutter MM, 1999, AM J PATHOL, V155, P927, DOI 10.1016/S0002-9440(10)65192-9; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	53	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26858	10.1371/journal.pone.0026858	http://dx.doi.org/10.1371/journal.pone.0026858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046385	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400039
J	Aya, K; Suzuki, G; Suwabe, K; Hobo, T; Takahashi, H; Shiono, K; Yano, K; Tsutsumi, N; Nakazono, M; Nagamura, Y; Matsuoka, M; Watanabe, M				Aya, Koichiro; Suzuki, Go; Suwabe, Keita; Hobo, Tokunori; Takahashi, Hirokazu; Shiono, Katsuhiro; Yano, Kentaro; Tsutsumi, Nobuhiro; Nakazono, Mikio; Nagamura, Yoshiaki; Matsuoka, Makoto; Watanabe, Masao			Comprehensive Network Analysis of Anther-Expressed Genes in Rice by the Combination of 33 Laser Microdissection and 143 Spatiotemporal Microarrays	PLOS ONE			English	Article							ORYZA-SATIVA L.; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; COEXPRESSION NETWORKS; SPOROPOLLENIN BIOSYNTHESIS; TAPETUM DEVELOPMENT; POLLEN DEVELOPMENT; MALE GAMETOPHYTE; LOTUS-JAPONICUS; EXINE FORMATION	Co-expression networks systematically constructed from large-scale transcriptome data reflect the interactions and functions of genes with similar expression patterns and are a powerful tool for the comprehensive understanding of biological events and mining of novel genes. In Arabidopsis (a model dicot plant), high-resolution co-expression networks have been constructed from very large microarray datasets and these are publicly available as online information resources. However, the available transcriptome data of rice (a model monocot plant) have been limited so far, making it difficult for rice researchers to achieve reliable co-expression analysis. In this study, we performed co-expression network analysis by using combined 44 K agilent microarray datasets of rice, which consisted of 33 laser microdissection (LM)-microarray datasets of anthers, and 143 spatiotemporal transcriptome datasets deposited in RicexPro. The entire data of the rice co-expression network, which was generated from the 176 microarray datasets by the Pearson correlation coefficient (PCC) method with the mutual rank (MR)-based cut-off, contained 24,258 genes and 60,441 genes pairs. Using these datasets, we constructed high-resolution co-expression subnetworks of two specific biological events in the anther, "meiosis" and "pollen wall synthesis". The meiosis network contained many known or putative meiotic genes, including genes related to meiosis initiation and recombination. In the pollen wall synthesis network, several candidate genes involved in the sporopollenin biosynthesis pathway were efficiently identified. Hence, these two subnetworks are important demonstrations of the efficiency of co-expression network analysis in rice. Our co-expression analysis included the separated transcriptomes of pollen and tapetum cells in the anther, which are able to provide precise information on transcriptional regulation during male gametophyte development in rice. The co-expression network data presented here is a useful resource for rice researchers to elucidate important and complex biological events.	[Aya, Koichiro; Hobo, Tokunori; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Suzuki, Go] Osaka Kyoiku Univ, Div Nat Sci, Kashiwara, Japan; [Suwabe, Keita; Watanabe, Masao] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Suwabe, Keita] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Takahashi, Hirokazu; Shiono, Katsuhiro; Tsutsumi, Nobuhiro; Nakazono, Mikio] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yano, Kentaro] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan; [Nakazono, Mikio] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Watanabe, Masao] Tohoku Univ, Fac Sci, Sendai, Miyagi 980, Japan	Nagoya University; Osaka University of Education; Tohoku University; Mie University; University of Tokyo; Meiji University; Nagoya University; National Institute of Agrobiological Sciences - Japan; Tohoku University	Aya, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@nuagr1.agr.nagoya-u.ac.jp; nabe@ige.tohoku.ac.jp	Tsutsumi, Nobuhiro/C-6051-2016; Watanabe, Masao/E-6300-2011; Watanabe, Masao/N-1465-2019	Tsutsumi, Nobuhiro/0000-0002-2610-6837; Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149; Shiono, Katsuhiro/0000-0001-7897-978X	Japan Society for the Promotion of Science; MEXT [18075003, 1807512, 18075005, 18075006, 23113006, 23113005, 23113001]; MAFF [IPG-0003, IPG-0012, IPG-0019]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan)	K. Suwabe was partially supported by Young Researchers Fellowships from the Japan Society for the Promotion of Science. This work was funded in part by a MEXT Grant (21-COE, 18075003 and 1807512 to MW, 18075005 to NT, G-COE, 18075006 to MM), by a MAFF Grant (IPG-0003 to MM, IPG-0012 to MN, and IPG-0019 to MW), and by Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 23113006 to GS, 23113005 to MM, and 23113001 to MM, and GS) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Ahlers F, 2003, Z NATURFORSCH C, V58, P807; Amagai M, 2003, SEX PLANT REPROD, V15, P213, DOI 10.1007/s00497-002-0159-z; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bubert H, 2002, Z NATURFORSCH C, V57, P1035; Chang L, 2009, CELL RES, V19, P768, DOI 10.1038/cr.2009.52; Deng ZY, 2007, PLANT MOL BIOL, V65, P31, DOI 10.1007/s11103-007-9195-2; Endo M, 2002, FEBS LETT, V514, P229, DOI 10.1016/S0014-5793(02)02371-2; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gene Ontology C, 2008, NUCL ACIDS RES, V36, pD440; Grienenberger E, 2010, PLANT CELL, V22, P4067, DOI 10.1105/tpc.110.080036; Hamada K, 2011, PLANT CELL PHYSIOL, V52, P220, DOI 10.1093/pcp/pcq195; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Hihara Y, 1996, PLANT MOL BIOL, V30, P1181, DOI 10.1007/BF00019551; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jeon JS, 1999, PLANT MOL BIOL, V39, P35, DOI 10.1023/A:1006157603096; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kaur J, 2006, PLANT CELL, V18, P545, DOI 10.1105/tpc.105.039156; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Masuko H, 2006, GENES GENET SYST, V81, P57, DOI 10.1266/ggs.81.57; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2009, MOL PLANT, V2, P1015, DOI 10.1093/mp/ssp055; Nonomura KI, 2007, PLANT CELL, V19, P2583, DOI 10.1105/tpc.107.053199; Nonomura KI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001265; Nonomura KI, 2006, J CELL SCI, V119, P217, DOI 10.1242/jcs.02736; Nonomura KL, 2004, PLANT CELL, V16, P1008, DOI 10.1105/tpc.020701; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Rozema J, 2001, J PHOTOCH PHOTOBIO B, V62, P108, DOI 10.1016/S1011-1344(01)00155-5; Rubinelli P, 1998, PLANT MOL BIOL, V37, P607, DOI 10.1023/A:1005964431302; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; SCOTT R, 1991, PLANT MOL BIOL, V17, P195, DOI 10.1007/BF00039494; Shinohara M, 2003, GENETICS, V164, P855; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Suwabe K, 2008, PLANT CELL PHYSIOL, V49, P1407, DOI 10.1093/pcp/pcn124; Suzuki G, 2009, PLANT CELL PHYSIOL, V50, P1857, DOI 10.1093/pcp/pcp142; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; TSUCHIYA T, 1994, PLANT MOL BIOL, V26, P1737, DOI 10.1007/BF00019488; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028; Wang M, 2010, PLANT CELL, V22, P417, DOI 10.1105/tpc.109.070789; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Yamada K, 2008, PLANT CELL, V20, P2529, DOI 10.1105/tpc.108.059345; Yuan WY, 2009, PLANT J, V59, P303, DOI 10.1111/j.1365-313X.2009.03870.x; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhang LR, 2006, PLANT MOL BIOL, V60, P533, DOI 10.1007/s11103-005-4922-z; Zhang ZB, 2007, PLANT J, V52, P528, DOI 10.1111/j.1365-313X.2007.03254.x; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x	70	50	53	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26162	10.1371/journal.pone.0026162	http://dx.doi.org/10.1371/journal.pone.0026162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046259	gold, Green Submitted, Green Published			2022-12-27	WOS:000296519600010
J	Verde, Z; Santiago, C; Gonzalez-Moro, JMR; Ramos, PD; Martin, SL; Bandres, F; Lucia, A; Gomez-Gallego, F				Verde, Zoraida; Santiago, Catalina; Rodriguez Gonzalez-Moro, Jose Miguel; de Lucas Ramos, Pilar; Lopez Martin, Soledad; Bandres, Fernando; Lucia, Alejandro; Gomez-Gallego, Felix			'Smoking Genes': A Genetic Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE REPLACEMENT THERAPY; MOLECULAR-GENETICS; CIGARETTE-SMOKING; CESSATION SUCCESS; CYP2A6 GENE; ADULT TWINS; DEPENDENCE; BEHAVIOR; METABOLISM	Some controversy exists on the specific genetic variants that are associated with nicotine dependence and smoking-related phenotypes. The purpose of this study was to analyse the association of smoking status and smoking-related phenotypes (included nicotine dependence) with 17 candidate genetic variants: CYP2A6*1x2, CYP2A6*2 (1799T>A) [rs1801272], CYP2A6*9 (-48T>G) [rs28399433], CYP2A6*12, CYP2A13*2 (3375C>T) [rs8192789], CYP2A13*3 (7520C>G), CYP2A13*4 (579G>A), CYP2A13*7 (578C>T) [rs72552266], CYP2B6*4 (785A>G), CYP2B6*9 (516G>T), CHRNA3 546C>T [rs578776], CHRNA5 1192G>A [rs16969968], CNR1 3764C>G [rs6928499], DRD2-ANKK1 2137G>A (Taq1A) [rs1800497], 5HTT LPR, HTR2A -1438A>G [rs6311] and OPRM1 118A>G [rs1799971]. We studied the genotypes of the aforementioned polymorphisms in a cohort of Spanish smokers (cases, N = 126) and ethnically matched never smokers (controls, N = 80). The results showed significant between-group differences for CYP2A6*2 and CYP2A6*12 (both P<0.001). Compared with carriers of variant alleles, the odds ratio (OR) for being a non-smoker in individuals with the wild-type genotype of CYP2A6*12 and DRD2-ANKK1 2137G>A (Taq1A) polymorphisms was 3.60 (95%CI: 1.75, 7.44) and 2.63 (95%CI: 1.41, 4.89) respectively. Compared with the wild-type genotype, the OR for being a non-smoker in carriers of the minor CYP2A6*2 allele was 1.80 (95%CI: 1.24, 2.65). We found a significant genotype effect (all P <= 0.017) for the following smoking-related phenotypes: (i) cigarettes smoked per day and CYP2A13*3; (ii) pack years smoked and CYP2A6*2, CYP2A6*1x2, CYP2A13*7, CYP2B6*4 and DRD2-ANKK1 2137G>A (Taq1A); (iii) nicotine dependence (assessed with the Fagestrom test) and CYP2A6*9. Overall, our results suggest that genetic variants potentially involved in nicotine metabolization (mainly, CYP2A6 polymorphisms) are those showing the strongest association with smoking-related phenotypes, as opposed to genetic variants influencing the brain effects of nicotine, e.g., through nicotinic acetylcholine (CHRNA5), serotoninergic (HTR2A), opioid (OPRM1) or cannabinoid receptors (CNR1).	[Verde, Zoraida; Santiago, Catalina; Lucia, Alejandro; Gomez-Gallego, Felix] Univ Europea Madrid, Dept Biomed, Villaviciosa De Odon, Comunidad De Ma, Spain; [Rodriguez Gonzalez-Moro, Jose Miguel; de Lucas Ramos, Pilar; Lopez Martin, Soledad] Hosp Gen Gregorio Maranon, Dept Neumol, Madrid, Comunidad De Ma, Spain; [Bandres, Fernando] Fdn Tejerina, Dept Aula de Estudios Avanzados, Madrid, Comunidad De Ma, Spain	European University of Madrid; General University Gregorio Maranon Hospital	Verde, Z (corresponding author), Univ Europea Madrid, Dept Biomed, Villaviciosa De Odon, Comunidad De Ma, Spain.	alejandro.lucia@uem.es	Santiago, Catalina/P-8177-2019; Gomez-Gallego, Felix/AAD-9617-2020; Gomez-Gallego, Felix/H-6925-2013; Lucia, Alejandro/M-2759-2014; Santiago, Catalina/K-6803-2014; VERDE, ZORAIDA/A-9914-2012	Santiago, Catalina/0000-0003-3852-8217; Gomez-Gallego, Felix/0000-0002-1968-1761; Lucia, Alejandro/0000-0002-3025-2060; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; Lucia, Alejandro/0000-0002-5565-0997; Rodriguez Gonzalez-Moro, Jose Miguel/0000-0002-8446-3373; BANDRES MOYA, FERNANDO/0000-0002-4675-8226	European University of Madrid [UEM 03-2006]; Spanish Lung Fundation (SEPAR) [035-2006]	European University of Madrid; Spanish Lung Fundation (SEPAR)	This study was supported by the UEM 03-2006 Internal Project of European University of Madrid and by the 035-2006 Project of The Spanish Lung Fundation (SEPAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; CARMELLI D, 1992, NEW ENGL J MED, V327, P829, DOI 10.1056/NEJM199209173271201; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen XN, 2008, ARCH GEN PSYCHIAT, V65, P816, DOI 10.1001/archpsyc.65.7.816; Drgon T, 2009, MOL MED, V15, P268, DOI 10.2119/molmed.2009.00040; Drgon T, 2009, MOL MED, V15, P21, DOI 10.2119/molmed.2008.00096; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; HUGHES JR, 2007, COCHRANE DATABASE SY, P1; John U, 2004, PREV MED, V38, P350, DOI 10.1016/j.ypmed.2003.11.003; Johnstone E, 2006, CLIN PHARMACOL THER, V80, P319, DOI 10.1016/j.clpt.2006.06.011; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Lerman C, 1998, CANCER EPIDEM BIOMAR, V7, P253; Lerman CE, 2007, AM J PREV MED, V33, pS398, DOI 10.1016/j.amepre.2007.09.006; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; MAES HH, 2011, BEHAV GENET; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; Malaiyandi V, 2006, MOL PSYCHIATR, V11, P400, DOI 10.1038/sj.mp.4001794; Munafo MR, 2009, NICOTINE TOB RES, V11, P404, DOI 10.1093/ntr/ntp007; Murray S, 2006, CAN MED ASSOC J, V174, P309, DOI 10.1503/cmaj.051628; Nilsson KW, 2009, UPSALA J MED SCI, V114, P100, DOI 10.1080/03009730902833406; NOBLE EP, 1994, ALCOHOL ALCOHOLISM, V29, P729; O'Loughlin J, 2004, TOB CONTROL, V13, P422, DOI 10.1136/tc.2003.007070; Oscarson M, 2001, DRUG METAB DISPOS, V29, P91; Perkins KA, 2008, BEHAV PHARMACOL, V19, P641, DOI 10.1097/FBP.0b013e32830c367c; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Polina ER, 2009, DRUG ALCOHOL DEPEN, V101, P128, DOI 10.1016/j.drugalcdep.2008.11.001; POMERLEAU OF, 1995, BEHAV GENET, V25, P161, DOI 10.1007/BF02196925; Quaak M, 2009, EUR RESPIR J, V33, P468, DOI 10.1183/09031936.00056908; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; RIBEIRO EB, 1993, BRAIN RES, V621, P311, DOI 10.1016/0006-8993(93)90121-3; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schoedel KA, 2004, PHARMACOGENETICS, V14, P615, DOI 10.1097/00008571-200409000-00006; SILAGY C, 2002, COCHRANE DB SYST REV, P4; Terayama H, 2004, PSYCHIAT GENET, V14, P195, DOI 10.1097/00041444-200412000-00005; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Wang J, 2010, NEUROPSYCHOPHARMACOL, V35, P702, DOI 10.1038/npp.2009.178; Xian H, 2007, ADDICT BEHAV, V32, P137, DOI 10.1016/j.addbeh.2006.03.031; Zhang Lan, 2006, Behav Brain Funct, V2, P28, DOI 10.1186/1744-9081-2-28	47	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26668	10.1371/journal.pone.0026668	http://dx.doi.org/10.1371/journal.pone.0026668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046326	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600040
J	Frohlich, H				Froehlich, Holger			Network Based Consensus Gene Signatures for Biomarker Discovery in Breast Cancer	PLOS ONE			English	Article							HISTOLOGIC GRADE; EXPRESSION; PATHWAY; METASTASIS; PROGNOSIS; ARCHIVE; KEGG	Diagnostic and prognostic biomarkers for cancer based on gene expression profiles are viewed as a major step towards a better personalized medicine. Many studies using various computational approaches have been published in this direction during the last decade. However, when comparing different gene signatures for related clinical questions often only a small overlap is observed. This can have various reasons, such as technical differences of platforms, differences in biological samples or their treatment in lab, or statistical reasons because of the high dimensionality of the data combined with small sample size, leading to unstable selection of genes. In conclusion retrieved gene signatures are often hard to interpret from a biological point of view. We here demonstrate that it is possible to construct a consensus signature from a set of seemingly different gene signatures by mapping them on a protein interaction network. Common upstream proteins of close gene products, which we identified via our developed algorithm, show a very clear and significant functional interpretation in terms of overrepresented KEGG pathways, disease associated genes and known drug targets. Moreover, we show that such a consensus signature can serve as prior knowledge for predictive biomarker discovery in breast cancer. Evaluation on different datasets shows that signatures derived from the consensus signature reveal a much higher stability than signatures learned from all probesets on a microarray, while at the same time being at least as predictive. Furthermore, they are clearly interpretable in terms of enriched pathways, disease associated genes and known drug targets. In summary we thus believe that network based consensus signatures are not only a way to relate seemingly different gene signatures to each other in a functional manner, but also to establish prior knowledge for highly stable and interpretable predictive biomarkers.	Univ Bonn, Bonn Aachen Int Ctr IT B IT, D-5300 Bonn, Germany	University of Bonn	Frohlich, H (corresponding author), Univ Bonn, Bonn Aachen Int Ctr IT B IT, D-5300 Bonn, Germany.	frohlich@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017	Fröhlich, Holger/0000-0002-5328-1243				Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertucci F, 2002, ANN NY ACAD SCI, V975, P217, DOI 10.1111/j.1749-6632.2002.tb05954.x; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gonen Mithat, 2009, Gastrointest Cancer Res, V3, pS19; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; JAIN A, 1988, PRENTICEHALL; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Li LF, 2009, BREAST CANCER RES TR, V113, P231, DOI 10.1007/s10549-008-9925-4; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Meyer JM, 2002, CURR OPIN CHEM BIOL, V6, P434, DOI 10.1016/S1367-5931(02)00340-X; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sims AH, 2009, J CLIN PATHOL, V62, P879, DOI 10.1136/jcp.2008.060376; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Spang R., 2003, BIOSILICO, V1, P64; TIKHONOV A, 1977, W H WINSTON SONS; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167	37	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25364	10.1371/journal.pone.0025364	http://dx.doi.org/10.1371/journal.pone.0025364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046239	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000004
J	Catalano-Dupuy, DL; Musumeci, MA; Lopez-Rivero, A; Ceccarelli, EA				Catalano-Dupuy, Daniela L.; Musumeci, Matias A.; Lopez-Rivero, Arleth; Ceccarelli, Eduardo A.			A Highly Stable Plastidic-Type Ferredoxin-NADP(H) Reductase in the Pathogenic Bacterium Leptospira interrogans	PLOS ONE			English	Article							CATALYTIC EFFICIENCY; ELECTRON-TRANSFER; HEME OXYGENASE; BINDING-SITE; ISOPRENOID BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; AZOTOBACTER-VINELANDII; PLASMODIUM-FALCIPARUM; 2FE-2S FERREDOXIN; COMPLEX-FORMATION	Leptospira interrogans is a bacterium that is capable of infecting animals and humans, and its infection causes leptospirosis with a range of symptoms from flu-like to severe illness and death. Despite being a bacteria, Leptospira interrogans contains a plastidic class ferredoxin-NADP(H) reductase (FNR) with high catalytic efficiency, at difference from the bacterial class FNRs. These flavoenzymes catalyze the electron transfer between NADP(H) and ferredoxins or flavodoxins. The inclusion of a plastidic FNR in Leptospira metabolism and in its parasitic life cycle is not currently understood. Bioinformatic analyses of the available genomic and proteins sequences showed that the presence of this enzyme in nonphotosynthetic bacteria is restricted to the Leptospira genus and that a [4Fe-4S] ferredoxin (LB107) encoded by the Leptospira genome may be the natural substrate of the enzyme. Leptospira FNR (LepFNR) displayed high diaphorase activity using artificial acceptors and functioned as a ferric reductase. LepFNR displayed cytochrome c reductase activity with the Leptospira LB107 ferredoxin with an optimum at pH 6.5. Structural stability analysis demonstrates that LepFNR is one of the most stable FNRs analyzed to date. The persistence of a native folded LepFNR structure was detected in up to 6 M urea, a condition in which the enzyme retains 38% activity. In silico analysis indicates that the high LepFNR stability might be due to robust interactions between the FAD and the NADP(+) domains of the protein. The limited bacterial distribution of plastidic class FNRs and the biochemical and structural properties of LepFNR emphasize the uniqueness of this enzyme in the Leptospira metabolism. Our studies show that in L. interrogans a plastidic-type FNR exchanges electrons with a bacterial-type ferredoxin, process which has not been previously observed in nature.	[Catalano-Dupuy, Daniela L.; Musumeci, Matias A.; Lopez-Rivero, Arleth; Ceccarelli, Eduardo A.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Catalano-Dupuy, DL (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina.	ceccarelli@ibr.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306; Lopez-Rivero, Arleth S./0000-0002-0859-0418; Musumeci, Matias/0000-0003-2358-1365; Catalano-Dupuy, Daniela L./0000-0003-2864-0133	ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina [PICT-2007 01-00645, 00739]; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 252, 114-200901-00337]; Fundacion Bunge y Born, Argentina [FBBEI2/08]; University of Rosario, Argentina [BIO187]	ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Bunge y Born, Argentina; University of Rosario, Argentina	This work was supported by grants PICT-2007 01-00645 and 00739, ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); PIP 252 and 114-200901-00337 from CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (www.conicet.gov.ar); FBBEI2/08 from Fundacion Bunge y Born, Argentina (http://www.fundacionbyb.org); and BIO187 from the University of Rosario, Argentina (www.unr.edu.ar.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Aliverti A, 2004, BBA-PROTEINS PROTEOM, V1696, P93, DOI 10.1016/j.bbapap.2003.09.011; Aliverti A, 2008, ARCH BIOCHEM BIOPHYS, V474, P283, DOI 10.1016/j.abb.2008.02.014; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catalano-Dupuy DL, 2006, BIOCHEMISTRY-US, V45, P13899, DOI 10.1021/bi061152v; Catalano-Dupuy DL, 2008, FLAVINS FLAVOPROTEIN, P249; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256; Chatelet C, 1999, BIOCHEM BIOPH RES CO, V261, P885, DOI 10.1006/bbrc.1999.1138; Elsen S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-271; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Hermoso JA, 2002, J MOL BIOL, V319, P1133, DOI 10.1016/S0022-2836(02)00388-1; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung YS, 1999, J BIOL CHEM, V274, P2978, DOI 10.1074/jbc.274.5.2978; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kimata-Ariga Y, 2007, J BIOCHEM, V141, P421, DOI 10.1093/jb/mvm046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee YH, 2007, J BIOL CHEM, V282, P5959, DOI 10.1074/jbc.M608417200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Maeda M, 2002, J BIOL CHEM, V277, P17101, DOI 10.1074/jbc.M112002200; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P13604, DOI 10.1021/bi9807411; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Medina M, 2009, FEBS J, V276, P3942, DOI 10.1111/j.1742-4658.2009.07122.x; Miethke M, 2011, J BIOL CHEM, V286, P2245, DOI 10.1074/jbc.M110.192468; Milani M, 2007, J MOL BIOL, V367, P501, DOI 10.1016/j.jmb.2007.01.005; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Musumeci MA, 2011, BIOCHEMISTRY-US, V50, P2111, DOI 10.1021/bi101772a; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nascimento AS, 2006, ACTA CRYSTALLOGR F, V62, P662, DOI 10.1107/S1744309106020136; Nascimento AS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-69; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Okada K, 2005, J BIOL CHEM, V280, P20672, DOI 10.1074/jbc.M500865200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Paladini DH, 2009, BIOCHEMISTRY-US, V48, P5760, DOI 10.1021/bi9004232; Pandini V, 2006, BIOCHEMISTRY-US, V45, P3563, DOI 10.1021/bi052326w; Pandini V, 2002, J BIOL CHEM, V277, P48463, DOI 10.1074/jbc.M209388200; Pereira MM, 2002, BBA-PROTEINS PROTEOM, V1601, P1, DOI 10.1016/S1570-9639(02)00406-5; Privalov Peter L., 1992, P83; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; Peregrina JR, 2010, BBA-BIOENERGETICS, V1797, P1638, DOI 10.1016/j.bbabio.2010.05.006; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Rohrich RC, 2005, FEBS LETT, V579, P6433, DOI 10.1016/j.febslet.2005.10.037; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos J, 2007, BIOPHYS J, V93, P1707, DOI 10.1529/biophysj.106.103804; Seeber F, 2005, CURR PHARM DESIGN, V11, P3159, DOI 10.2174/1381612054864957; Seeber Frank, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P99, DOI 10.2174/1568008033340261; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Shukla N, 2005, FEBS J, V272, P2216, DOI 10.1111/j.1742-4658.2005.2005.04645.x; Singh K, 2008, PROTEINS, V71, P1879, DOI 10.1002/prot.21872; Singh K, 2009, J BIOCHEM, V145, P721, DOI 10.1093/jb/mvp029; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Thomsen-Zieger N, 2004, FEBS LETT, V576, P375, DOI 10.1016/j.febslet.2004.09.042; Trueba G, 2004, INT MICROBIOL, V7, P35; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Yeh AP, 2000, J MOL BIOL, V300, P587, DOI 10.1006/jmbi.2000.3871; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yoneyama H, 2006, BIOSCI BIOTECH BIOCH, V70, P1060, DOI 10.1271/bbb.70.1060; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1	69	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26736	10.1371/journal.pone.0026736	http://dx.doi.org/10.1371/journal.pone.0026736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039544	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200048
J	Krenzer, M; Anaclet, C; Vetrivelan, R; Wang, NS; Vong, L; Lowell, BB; Fuller, PM; Lu, J				Krenzer, Martina; Anaclet, Christelle; Vetrivelan, Ramalingam; Wang, Nishang; Linh Vong; Lowell, Bradford B.; Fuller, Patrick M.; Lu, Jun			Brainstem and Spinal Cord Circuitry Regulating REM Sleep and Muscle Atonia	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; PARADOXICAL SLEEP; GABAERGIC NEURONS; BEHAVIOR DISORDER; LOCALIZATION; TEGMENTUM; NUCLEUS; RAT; CAT; MICROINJECTIONS	Background: Previous work has suggested, but not demonstrated directly, a critical role for both glutamatergic and GABAergic neurons of the pontine tegmentum in the regulation of rapid eye movement (REM) sleep. Methodology/Principal Findings: To determine the in vivo roles of these fast-acting neurotransmitters in putative REM pontine circuits, we injected an adeno-associated viral vector expressing Cre recombinase (AAV-Cre) into mice harboring lox-P modified alleles of either the vesicular glutamate transporter 2 (VGLUT2) or vesicular GABA-glycine transporter (VGAT) genes. Our results show that glutamatergic neurons of the sublaterodorsal nucleus (SLD) and glycinergic/GABAergic interneurons of the spinal ventral horn contribute to REM atonia, whereas a separate population of glutamatergic neurons in the caudal laterodorsal tegmental nucleus (cLDT) and SLD are important for REM sleep generation. Our results further suggest that presynaptic GABA release in the cLDT-SLD, ventrolateral periaqueductal gray matter (vlPAG) and lateral pontine tegmentum (LPT) are not critically involved in REM sleep control. Conclusions/Significance: These findings reveal the critical and divergent in vivo role of pontine glutamate and spinal cord GABA/glycine in the regulation of REM sleep and atonia and suggest a possible etiological basis for REM sleep behavior disorder (RBD).	[Krenzer, Martina; Anaclet, Christelle; Vetrivelan, Ramalingam; Wang, Nishang; Fuller, Patrick M.; Lu, Jun] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA; [Linh Vong; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Krenzer, Martina] Univ Marburg, Dept Neurol, Marburg, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Philipps University Marburg	Krenzer, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu		Anaclet, Christelle/0000-0002-0526-8132	Public Service Grants [NS062727, NS061841, NS051609, AG09975, NS073613, NS072337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073613, R01NS051609, R01NS062727, R01NS061841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	Public Service Grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by Public Service Grants NS062727, NS061841, NS051609, AG09975, NS073613 and NS072337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANACLET C, PLOS ONE, V5, pE8788; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Chou TC, 2003, J NEUROSCI, V23, P10691; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Fuller PM, 2007, J PHYSIOL-LONDON, V584, P735, DOI 10.1113/jphysiol.2007.140160; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; JOUVET M, 1959, CR SOC BIOL, V153, P422; Kaur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006346; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; SAKAI K, 1986, CR ACAD SCI III-VIE, V303, P317; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Scherfler C, 2011, ANN NEUROL, V69, P400, DOI 10.1002/ana.22245; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; SIEGEL JM, 1984, NEUROSCI LETT, V45, P241, DOI 10.1016/0304-3940(84)90233-7; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Vanini G, 2007, NEUROSCIENCE, V145, P1157, DOI 10.1016/j.neuroscience.2006.12.051; VANNIMERCIER G, 1991, NEUROSCI LETT, V130, P41, DOI 10.1016/0304-3940(91)90222-F; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; ZERNICKI B, 1986, ARCH ITAL BIOL, V124, P133; Zhang X, 2009, SLEEP MED, V10, P143, DOI 10.1016/j.sleep.2007.12.002	32	96	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24998	10.1371/journal.pone.0024998	http://dx.doi.org/10.1371/journal.pone.0024998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043278	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400005
J	Strino, F; Parisi, F; Kluger, Y				Strino, Francesco; Parisi, Fabio; Kluger, Yuval			VDA, a Method of Choosing a Better Algorithm with Fewer Validations	PLOS ONE			English	Article							MOLECULAR DOCKING PROGRAMS; SYSTEMS BIOLOGY; BINDING-SITES; CANCER; SEQ; PREDICTION; SEQUENCE; TARGET	The multitude of bioinformatics algorithms designed for performing a particular computational task presents end-users with the problem of selecting the most appropriate computational tool for analyzing their biological data. The choice of the best available method is often based on expensive experimental validation of the results. We propose an approach to design validation sets for method comparison and performance assessment that are effective in terms of cost and discrimination power. Validation Discriminant Analysis (VDA) is a method for designing a minimal validation dataset to allow reliable comparisons between the performances of different algorithms. Implementation of our VDA approach achieves this reduction by selecting predictions that maximize the minimum Hamming distance between algorithmic predictions in the validation set. We show that VDA can be used to correctly rank algorithms according to their performances. These results are further supported by simulations and by realistic algorithmic comparisons in silico. VDA is a novel, cost-efficient method for minimizing the number of validation experiments necessary for reliable performance estimation and fair comparison between algorithms. Our VDA software is available at http://sourceforge.net/projects/klugerlab/files/VDA/.	[Strino, Francesco; Parisi, Fabio; Kluger, Yuval] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kluger, Yuval] NYU, Ctr Hlth Informat & Bioinformat, New York, NY USA	Yale University; New York University	Strino, F (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	yuval.kluger@yale.edu	Strino, Francesco/E-5566-2010	Strino, Francesco/0000-0002-9310-4794	National Cancer Institute [P50 CA121974]; New York State Department of Health [FAU 0812160900]; American-Italian Cancer Foundation; Yale SPORE in Skin Cancer; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York State Department of Health; American-Italian Cancer Foundation; Yale SPORE in Skin Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Yale SPORE in Skin Cancer funded by the National Cancer Institute P50 CA121974 (R. Halaban, PI), the Peter T. Rowley Breast Cancer Research Projects funded by the New York State Department of Health FAU 0812160900 (Y.K.) and by the American-Italian Cancer Foundation [Post-Doctoral Research Fellowship to F. S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2002, NAT BIOTECHNOL, V20, P651, DOI 10.1038/nbt0702-651; Andreopoulos B, 2009, BRIEF BIOINFORM, V10, P297, DOI 10.1093/bib/bbn058; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Berg JM, 2010, CLIN PHARMACOL THER, V88, P17, DOI 10.1038/clpt.2010.69; BISHOP CM, 2006, PATTERN RECOGN, P740; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; FORSYTH D, 2008, LECT NOTES COMPUTER; Geraci F, 2010, BIOINFORMATICS, V26, P2217, DOI 10.1093/bioinformatics/btq411; GLYNN PW, 1989, MANAGE SCI, V35, P1367, DOI 10.1287/mnsc.35.11.1367; Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Kumar S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-129; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Li X, 2010, J COMPUT CHEM, V31, P2109, DOI 10.1002/jcc.21498; MEIR R, 2003, LNAI, V2600; MICHIE D, 1968, NATURE, V218, P19, DOI 10.1038/218019a0; O'Malley MA, 2005, BIOESSAYS, V27, P1270, DOI 10.1002/bies.20323; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; SHALEVSHWARTZ S, 2008, SVM OPTIMIZATION INV, P928; Sirbu A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-59; SZALKOWSKI AM, 2010, BRIEF BIOIN IN PRESS; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Welsh JB, 2001, CANCER RES, V61, P5974; Wiese KC, 2006, BIOINFORMATICS, V22, P934, DOI 10.1093/bioinformatics/btl043; Wolkenhauer Olaf, 2010, Cancer Res, V70, P12, DOI 10.1158/0008-5472.CAN-09-2676; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	29	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26074	10.1371/journal.pone.0026074	http://dx.doi.org/10.1371/journal.pone.0026074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22046256	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000063
J	Hu, TX; Yu, M; Zhao, J				Hu, Tian-Xiang; Yu, Miao; Zhao, Jie			Comparative Transcriptional Analysis Reveals Differential Gene Expression between Asymmetric and Symmetric Zygotic Divisions in Tobacco	PLOS ONE			English	Article							ARABIDOPSIS CELL-CULTURES; GLUCOSYL YARIV REAGENT; BARLEY ALEURONE CELLS; APICAL-BASAL AXIS; ARABINOGALACTAN PROTEINS; STOMATAL DEVELOPMENT; NICOTIANA-TABACUM; PLANT DEVELOPMENT; CORTICAL MICROTUBULES; EMBRYO DEVELOPMENT	Asymmetric cell divisions occur widely during many developmental processes in plants. In most angiosperms, the first zygotic cell division is asymmetric resulting in two daughter cells of unequal size and with distinct fates. However, the critical molecular mechanisms regulating this division remain unknown. Previously we showed that treatment of tobacco zygotes with beta-glucosyl Yariv (beta GlcY) could dramatically alter the first zygotic asymmetric division to produce symmetric two-celled proembryos. In the present study, we isolated zygotes and two-celled asymmetric proembryos in vivo by micromanipulation, and obtained symmetric, two-celled proembryos by in vitro cell cultures. Using suppression-subtractive hybridization (SSH) and macroarray analysis differential gene expression between the zygote and the asymmetric and symmetric two-celled proembryos was investigated. After sequencing of the differentially expressed clones, a total of 1610 EST clones representing 685 non-redundant transcripts were obtained. Gene ontology (GO) term analysis revealed that these transcripts include those involved in physiological processes such as response to stimulus, regulation of gene expression, and localization and formation of anatomical structures. A homology search against known genes from Arabidopsis indicated that some of the above transcripts are involved in asymmetric cell division and embryogenesis. Quantitative real-time PCR confirmed the up-or down-regulation of the selected candidate transcripts during zygotic division. A few of these transcripts were expressed exclusively in the zygote, or in either type of the two-celled proembryos. Expression analyses of select genes in different tissues and organs also revealed potential roles of these transcripts in fertilization, seed maturation and organ development. The putative roles of few of the identified transcripts in the regulation of zygotic division are discussed. Further functional work on these candidate transcripts will provide important information for understanding asymmetric zygotic division, generation of apical-basal polarity and cell fate decisions during early embryogenesis.	[Hu, Tian-Xiang; Yu, Miao; Zhao, Jie] Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Hu, TX (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China.	jzhao@whu.edu.cn	Hu, TianXiang/Q-2099-2019	Hu, TianXiang/0000-0002-5127-9211	Major State Basic Research Program of China [2007CB108704]; National Natural Science Foundation of China [30970277, 30821064]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Program of China (2007CB108704) and the National Natural Science Foundation of China (30970277, 30821064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; AESCHBACHER RA, 1995, GENE DEV, V9, P330, DOI 10.1101/gad.9.3.330; Anzi C, 2008, PLANT BIOLOGY, V10, P237, DOI 10.1111/j.1438-8677.2007.00022.x; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; Chen D, 2010, J EXP BOT, V61, P1853, DOI 10.1093/jxb/erq056; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; De Smet I, 2006, PLANT MOL BIOL, V60, P871, DOI 10.1007/s11103-005-4547-2; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; FROISSARD D, 1994, PLANT MOL BIOL, V26, P515, DOI 10.1007/BF00039563; Fukaki H, 2005, PLANT J, V44, P382, DOI 10.1111/j.1365-313X.2005.02537.x; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hall Q, 2002, PLANT CELL, V14, P1161, DOI 10.1105/tpc.010477; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Heidstra Renze, 2007, V45, P1; Hu TX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-167; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; ISHIDA S, 1993, P NATL ACAD SCI USA, V90, P11152, DOI 10.1073/pnas.90.23.11152; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Laux T, 2004, PLANT CELL, V16, pS190, DOI 10.1105/tpc.016014; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Ma LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015971; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Mashiguchi K, 2008, PLANT CELL PHYSIOL, V49, P178, DOI 10.1093/pcp/pcm175; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Menke FLH, 2009, CELL, V137, P1189, DOI 10.1016/j.cell.2009.06.007; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nguema-Ona E, 2007, PLANT J, V52, P240, DOI 10.1111/j.1365-313X.2007.03224.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Procissi A, 2003, PLANT J, V36, P894, DOI 10.1046/j.1365-313X.2003.01933.x; Qin Y, 2006, J EXP BOT, V57, P2061, DOI 10.1093/jxb/erj159; Sardar HS, 2006, PLANT PHYSIOL, V142, P1469, DOI 10.1104/pp.106.088716; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Shibaya T, 2009, PLANTA, V230, P581, DOI 10.1007/s00425-009-0954-y; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Suzuki Y, 2002, PLANT J, V29, P733, DOI 10.1046/j.1365-313X.2002.01259.x; TAKAHASHI Y, 1989, P NATL ACAD SCI USA, V86, P9279, DOI 10.1073/pnas.86.23.9279; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang SF, 2009, BIOL REPROD, V80, P555, DOI 10.1095/biolreprod.108.073197; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu X, 2007, DEV BIOL, V309, P306, DOI 10.1016/j.ydbio.2007.07.019; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu ZN, 2006, GENETICS, V172, P1251, DOI 10.1534/genetics.105.050237; Zhao J, 2011, PLANT J, V65, P131, DOI 10.1111/j.1365-313X.2010.04403.x	76	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27120	10.1371/journal.pone.0027120	http://dx.doi.org/10.1371/journal.pone.0027120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069495	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900055
J	Husain, FT; Pajor, NM; Smith, JF; Kim, HJ; Rudy, S; Zalewski, C; Brewer, C; Horwitz, B				Husain, Fatima T.; Pajor, Nathan M.; Smith, Jason F.; Kim, H. Jeff; Rudy, Susan; Zalewski, Christopher; Brewer, Carmen; Horwitz, Barry			Discrimination Task Reveals Differences in Neural Bases of Tinnitus and Hearing Impairment	PLOS ONE			English	Article							OLDER-ADULTS; AUDITORY ATTENTION; PERCEPTION; DEPRESSION; SPEECH; SYSTEM; AGE	We investigated auditory perception and cognitive processing in individuals with chronic tinnitus or hearing loss using functional magnetic resonance imaging (fMRI). Our participants belonged to one of three groups: bilateral hearing loss and tinnitus (TIN), bilateral hearing loss without tinnitus (HL), and normal hearing without tinnitus (NH). We employed pure tones and frequency-modulated sweeps as stimuli in two tasks: passive listening and active discrimination. All subjects had normal hearing through 2 kHz and all stimuli were low-pass filtered at 2 kHz so that all participants could hear them equally well. Performance was similar among all three groups for the discrimination task. In all participants, a distributed set of brain regions including the primary and non-primary auditory cortices showed greater response for both tasks compared to rest. Comparing the groups directly, we found decreased activation in the parietal and frontal lobes in the participants with tinnitus compared to the HL group and decreased response in the frontal lobes relative to the NH group. Additionally, the HL subjects exhibited increased response in the anterior cingulate relative to the NH group. Our results suggest that a differential engagement of a putative auditory attention and short-term memory network, comprising regions in the frontal, parietal and temporal cortices and the anterior cingulate, may represent a key difference in the neural bases of chronic tinnitus accompanied by hearing loss relative to hearing loss alone.	[Husain, Fatima T.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Husain, Fatima T.; Pajor, Nathan M.; Smith, Jason F.; Horwitz, Barry] Natl Inst Deafness & Other Commun Disorders, Brain Imaging & Modeling Sect, NIH, Bethesda, MD USA; [Kim, H. Jeff; Rudy, Susan; Zalewski, Christopher; Brewer, Carmen] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Bethesda, MD USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Husain, FT (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA.	husainf@illinois.edu			National Institutes of Health-National Institute on Deafness and Other Communication Disorders; Tinnitus Research Consortium; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIDDC000075, ZIADC000064, ZIADC000057] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Tinnitus Research Consortium; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by the National Institutes of Health-National Institute on Deafness and Other Communication Disorders Intramural Research Program and a grant from the Tinnitus Research Consortium to FTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bauer Carol A, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P413, DOI 10.1097/01.moo.0000134443.29853.09; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Brown SC, 1990, GRI MONOGRAPH SERI A, V2; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Clark J G, 1981, ASHA, V23, P493; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik FIM, 2007, J AM ACAD AUDIOL, V18, P539, DOI 10.3766/jaaa.18.7.2; Davis A., 2000, TINNITUS HDB; Deco G, 2011, NEUROSCIENT IN PRESS; Delb W, 2008, APPL PSYCHOPHYS BIOF, V33, P211, DOI 10.1007/s10484-008-9065-y; Dornhoffer John, 2006, Int Tinnitus J, V12, P9; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gao XF, 2011, PSYCHON B REV, V18, P83, DOI 10.3758/s13423-010-0014-4; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Husain FT, 2006, HUM BRAIN MAPP, V27, P636, DOI 10.1002/hbm.20207; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Jacobson Gary P, 2003, J Am Acad Audiol, V14, P393; Jacobson GP, 1996, HEARING RES, V97, P66, DOI 10.1016/0378-5955(96)00055-X; Janata P, 2005, ANN NY ACAD SCI, V1060, P111, DOI 10.1196/annals.1360.008; Kaltenbach JA, 2006, HEARING RES, V216, P224, DOI 10.1016/j.heares.2006.01.002; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; McCoy SL, 2005, Q J EXP PSYCHOL-A, V58, P22, DOI 10.1080/02724980443000151; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Palmer AR, 2007, HEARING RES, V229, P148, DOI 10.1016/j.heares.2006.12.007; Parbery-Clark A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018082; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Steer RA, 1999, BEHAV RES THER, V37, P183, DOI 10.1016/S0005-7967(98)00087-4; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Stewart R, 2009, J AM ACAD AUDIOL, V20, P147, DOI 10.3766/jaaa.20.2.7; Sussman ES, 2005, COGN AFFECT BEHAV NE, V5, P93, DOI 10.3758/CABN.5.1.93; Syka J, 2002, PHYSIOL REV, V82, P601, DOI 10.1152/physrev.00002.2002; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1964, BRIT MED BULL, V20, P12, DOI 10.1093/oxfordjournals.bmb.a070274; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Vernon JA, 1997, TINNITUS TREATMENT R; Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Wunderlich AP, 2010, AUDIOL NEURO-OTOL, V15, P137, DOI 10.1159/000241094	61	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26639	10.1371/journal.pone.0026639	http://dx.doi.org/10.1371/journal.pone.0026639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	846PP	22066003	gold, Green Submitted, Green Published			2022-12-27	WOS:000296916000019
J	Unckless, RL				Unckless, Robert L.			A DNA Virus of Drosophila	PLOS ONE			English	Article							RECENT SPREAD; PARASITE; WOLBACHIA; HOST; POPULATIONS; AMPLIFICATION; CONSEQUENCES; ASSEMBLAGES; NUDIVIRUSES; INFECTION	Little is known about the viruses infecting most species. Even in groups as well-studied as Drosophila, only a handful of viruses have been well-characterized. A viral metagenomic approach was used to explore viral diversity in 83 wild-caught Drosophila innubila, a mushroom feeding member of the quinaria group. A single fly that was injected with, and died from, Drosophila C Virus (DCV) was added to the sample as a control. Two-thirds of reads in the infected sample had DCV as the best BLAST hit, suggesting that the protocol developed is highly sensitive. In addition to the DCV hits, several sequences had Oryctes rhinoceros Nudivirus, a double-stranded DNA virus, as a best BLAST hit. The virus associated with these sequences was termed Drosophila innubila Nudivirus (DiNV). PCR screens of natural populations showed that DiNV was both common and widespread taxonomically and geographically. Electron microscopy confirms the presence of virions in fly fecal material similar in structure to other described Nudiviruses. In 2 species, D. innubila and D. falleni, the virus is associated with a severe (similar to 80-90%) loss of fecundity and significantly decreased lifespan.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Unckless, RL (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	runckles@mail.rochester.edu			Robert L. and Mary L. Sproull University; NSF [DEB-0909932, DEB-0542094, DEB-098872]; Theodore Roosevelt Memorial Grant	Robert L. and Mary L. Sproull University; NSF(National Science Foundation (NSF)); Theodore Roosevelt Memorial Grant	This work was supported by a Robert L. and Mary L. Sproull University Fellowship to Robert L. Unckless, an NSF Doctoral Dissertation Improvement Grant (DEB-0909932) to John Jaenike and RLU, a Theodore Roosevelt Memorial Grant to RLU, and NSF grants (DEB-0542094 and DEB-098872) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Best A, 2009, AM NAT, V173, P779, DOI 10.1086/598494; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; BRUN G, 1980, GENET BIOL DROSOPHIL, P625; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; de Mesy Jensen KL, 1987, POP OFF TECHNIQUE FN; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Fenton A, 2008, PARASITOLOGY, V135, P1545, DOI 10.1017/S003118200700025X; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jaenike J, 2010, MOL ECOL, V19, P414, DOI 10.1111/j.1365-294X.2009.04448.x; Jones EO, 2007, J THEOR BIOL, V246, P10, DOI 10.1016/j.jtbi.2006.12.007; Kapun M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012421; Longdon B, 2011, GENETICS, V188, P141, DOI 10.1534/genetics.111.127696; Miller LK, 1998, VIRUSES, P91; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; PLUS N, 1978, J INVERTEBR PATHOL, V31, P296, DOI 10.1016/0022-2011(78)90219-7; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Unckless RL, 2011, EVOLUTION IN PRESS; Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287; Wang Yong-jie, 2007, Virologica Sinica, V22, P128; Wang YJ, 2008, J VIROL METHODS, V152, P106, DOI 10.1016/j.jviromet.2008.06.003; Wang YJ, 2007, J VIROL, V81, P5395, DOI 10.1128/JVI.02781-06; Wang YJ, 2009, J INVERTEBR PATHOL, V101, P187, DOI 10.1016/j.jip.2009.03.013; Wayne ML, 2011, EVOL ECOL R IN PRESS, V13; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149	47	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26564	10.1371/journal.pone.0026564	http://dx.doi.org/10.1371/journal.pone.0026564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053195	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800021
J	Erblich, B; Zhu, LY; Etgen, AM; Dobrenis, K; Pollard, JW				Erblich, Bryna; Zhu, Liyin; Etgen, Anne M.; Dobrenis, Kostantin; Pollard, Jeffrey W.			Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; C-FMS PROTOONCOGENE; OP/OP MOUSE; IMMUNOHISTOCHEMICAL LOCALIZATION; TARGETED DISRUPTION; SUBVENTRICULAR ZONE; WILD-TYPE; MACROPHAGES; CELLS; EXPRESSION	The brain contains numerous mononuclear phagocytes called microglia. These cells express the transmembrane tyrosine kinase receptor for the macrophage growth factor colony stimulating factor-1 (CSF-1R). Using a CSF-1R-GFP reporter mouse strain combined with lineage defining antibody staining we show in the postnatal mouse brain that CSF-1R is expressed only in microglia and not neurons, astrocytes or glial cells. To study CSF-1R function we used mice homozygous for a null mutation in the Csflr gene. In these mice microglia are >99% depleted at embryonic day 16 and day 1 post-partum brain. At three weeks of age this microglial depletion continues in most regions of the brain although some contain clusters of rounded microglia. Despite the loss of microglia, embryonic brain development appears normal but during the post-natal period the brain architecture becomes perturbed with enlarged ventricles and regionally compressed parenchyma, phenotypes most prominent in the olfactory bulb and cortex. In the cortex there is increased neuronal density, elevated numbers of astrocytes but reduced numbers of oligodendrocytes. Csf1r nulls rarely survive to adulthood and therefore to study the role of CSF-1R in olfaction we used the viable null mutants in the Csf1 (Csf1(op)) gene that encodes one of the two known CSF-1R ligands. Food-finding experiments indicate that olfactory capacity is significantly impaired in the absence of CSF-1. CSF-1R is therefore required for the development of microglia, for a fully functional olfactory system and the maintenance of normal brain structure.	[Erblich, Bryna; Zhu, Liyin; Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY 10461 USA; [Etgen, Anne M.; Dobrenis, Kostantin] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, New York, NY USA; [Etgen, Anne M.; Pollard, Jeffrey W.] Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University	Erblich, B (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY 10461 USA.	jeffrey.pollard@einstein.yu.edu			National Institutes of Health (NIH) [HD 30280, GM T32 07491]; Medical Research Council [G1002033] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; MRC [G1002033] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These studies were supported by a National Institutes of Health (NIH) grant HD 30280. BE was supported by a NIH training grant GM T32 07491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian R, 2010, NEUROENDOCRINOLOGY, V92, P81, DOI 10.1159/000314193; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Baum MJ, 2002, HORM BEHAV, V41, P213, DOI 10.1006/hbeh.2001.1749; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; BERBEL P, 1988, J COMP NEUROL, V276, P132, DOI 10.1002/cne.902760109; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHANG Y, 1994, J NEUROIMMUNOL, V52, P9; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cohen PE, 1997, MOL ENDOCRINOL, V11, P1636, DOI 10.1210/me.11.11.1636; Cohen PE, 2002, ENDOCRINOLOGY, V143, P1413, DOI 10.1210/en.143.4.1413; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Doty RL, 2003, CHEM SENSES, V28, P761, DOI 10.1093/chemse/bjg067; Fedoroff S, 1997, NEUROSCI BIOBEHAV R, V21, P187, DOI 10.1016/S0149-7634(96)00009-7; FELIX R, 1994, J CELL BIOCHEM, V55, P340, DOI 10.1002/jcb.240550311; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Guleria I, 2001, INFECT IMMUN, V69, P1795, DOI 10.1128/IAI.69.3.1795-1807.2001; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Hume David A, 2007, Novartis Found Symp, V281, P2; Kondo Y, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-31; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Lee MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007868; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; MARTIN C, 2010, ENDOCR REV; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Murase S, 2002, HISTOCHEM J, V34, P85, DOI 10.1023/A:1021308328278; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; Pollard JW., 1996, ADV D BIOCH, V4, P153; POW DV, 1989, NEUROSCIENCE, V33, P567, DOI 10.1016/0306-4522(89)90409-0; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; Sasaki A, 2000, NEUROPATHOLOGY, V20, P134, DOI 10.1046/j.1440-1789.2000.00286.x; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999; Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1991, EXP HEMATOL, V19, P1049; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Xiang ZH, 2005, GLIA, V52, P119, DOI 10.1002/glia.20227; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zenker D, 2003, J PHYSIOL-LONDON, V551, P1023, DOI 10.1113/jphysiol.2003.045880; ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233, DOI 10.1007/BF00296784	75	359	365	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26317	10.1371/journal.pone.0026317	http://dx.doi.org/10.1371/journal.pone.0026317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046273	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400016
J	Masala, S; Paccagnini, D; Cossu, D; Brezar, V; Pacifico, A; Ahmed, N; Mallone, R; Sechi, LA				Masala, Speranza; Paccagnini, Daniela; Cossu, Davide; Brezar, Vedran; Pacifico, Adolfo; Ahmed, Niyaz; Mallone, Roberto; Sechi, Leonardo A.			Antibodies Recognizing Mycobacterium avium paratuberculosis Epitopes Cross-React with the Beta-Cell Antigen ZnT8 in Sardinian Type 1 Diabetic Patients	PLOS ONE			English	Article							SUBSPECIES PARATUBERCULOSIS; T-CELLS; ISLET AUTOIMMUNITY; CROHNS-DISEASE; LYMPH-NODES; INFECTION; TRANSPORTER; MELLITUS; NRAMP1; MILK	The environmental factors at play in the pathogenesis of type 1 diabetes (T1D) remain enigmatic. Mycobacterium avium subspecies paratuberculosis (MAP) is transmitted from dairy herds to humans through food contamination. MAP causes an asymptomatic infection that is highly prevalent in Sardinian T1D patients compared with type 2 diabetes (T2D) and healthy controls. Moreover, MAP elicits humoral responses against several mycobacterial proteins. We asked whether antibodies (Abs) against one of these proteins, namely MAP3865c, which displays a sequence homology with the beta-cell protein zinc transporter 8 (ZnT8) could be cross-reactive with ZnT8 epitopes. To this end, Ab responses against MAP3865c were analyzed in Sardinian T1D, T2D and healthy subjects using an enzymatic immunoassay. Abs against MAP3865c recognized two immunodominant transmembrane epitopes in 52-65% of T1D patients, but only in 5-7% of T2D and 3-5% of healthy controls. There was a linear correlation between titers of anti-MAP3865c and anti-ZnT8 Abs targeting these two homologous epitopes, and pre-incubation of sera with ZnT8 epitope peptides blocked binding to the corresponding MAP3865c peptides. These results demonstrate that Abs recognizing MAP3865c epitopes cross-react with ZnT8, possibly underlying a molecular mimicry mechanism, which may precipitate T1D in MAP-infected individuals.	[Masala, Speranza; Paccagnini, Daniela; Cossu, Davide; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Brezar, Vedran; Mallone, Roberto] Cochin St Vincent de Paul Hosp, INSERM, U986, DeAR Lab Avenir, Paris, France; [Brezar, Vedran; Mallone, Roberto] Univ Paris 05, Paris, France; [Pacifico, Adolfo] Univ Sassari, Ist Clin Med, Serv Diabetol, I-07100 Sassari, Italy; [Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Mallone, Roberto] Hop Hotel Dieu, AP HP, Dept Diabetol, Paris, France	University of Sassari; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Sassari; University of Hyderabad; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Masala, S (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	roberto.mallone@inserm.fr; sechila@uniss.it	Cossu, Davide/C-4452-2013; Mallone, Roberto/H-4430-2013; Sechi, Leonardo Antonio/Y-3109-2018; Cossu, Davide/AAD-7958-2019; Ahmed, Niyaz/D-2589-2010	Mallone, Roberto/0000-0002-9846-8861; Cossu, Davide/0000-0002-0557-9467; Ahmed, Niyaz/0000-0001-6425-7583; sechi, leonardo antonio/0000-0003-0566-2049; Masala, Speranza/0000-0003-4943-9164	Sardinian Region L.R.; MIUR; Juvenile Diabetes Research Foundation (JDRF) [1-2008-106]; European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk); Ile-de-France CODDIM; Interface Assistance Publique - Hopitaux de Paris INSERM	Sardinian Region L.R.; MIUR(Ministry of Education, Universities and Research (MIUR)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk)(Novo NordiskJuvenile Diabetes Research Foundation); Ile-de-France CODDIM; Interface Assistance Publique - Hopitaux de Paris INSERM	This research was supported by the Sardinian Region L.R. 7 and the PRIN MIUR (to L.A.S.) and by the Juvenile Diabetes Research Foundation (JDRF grant 1-2008-106), the European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research 2007) and the Ile-de-France CODDIM (grant Soutien aux Jeunes Equipes) (to R.M.). R.M. is an INSERM Avenir Investigator and an Interface Assistance Publique - Hopitaux de Paris INSERM awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; BODANSKY HJ, 1992, BRIT MED J, V304, P1020, DOI 10.1136/bmj.304.6833.1020; Brezar V, 2011, ENDOCR REV, V32, P623, DOI 10.1210/er.2011-0010; Bruno G, 1996, LANCET, V347, P193, DOI 10.1016/S0140-6736(96)90378-5; Calo C., 2008, INT J MODERN ANTHR, V1, P39; Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20; Cossu A, 2011, CLIN IMMUNOL, V141, P49, DOI 10.1016/j.clim.2011.05.002; Cossu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018482; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Donaghy JA, 2004, APPL ENVIRON MICROB, V70, P4899, DOI 10.1128/AEM.70.8.4899-4905.2004; Eltholth MM, 2009, J APPL MICROBIOL, V107, P1061, DOI 10.1111/j.1365-2672.2009.04286.x; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Frongia O, 2001, DIABETES CARE, V24, P1846, DOI 10.2337/diacare.24.10.1846; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Honeyman MC, 2010, J IMMUNOL, V184, P2204, DOI 10.4049/jimmunol.0900709; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Kobayashi Y, 1997, J NEUROIMMUNOL, V73, P169, DOI 10.1016/S0165-5728(96)00187-7; Kondrashova A, 2007, DIABETES CARE, V30, P95, DOI 10.2337/dc06-0711; Mallone R, 2001, DIABETES, V50, P752, DOI 10.2337/diabetes.50.4.752; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Mallone R, 2011, DIABETES, V60, P2020, DOI 10.2337/db11-0700; Muntoni S, 1997, LANCET, V349, P160, DOI 10.1016/S0140-6736(96)04241-9; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; Paccagnini D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007109; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Riccardi G, 2008, FEMS MICROBIOL LETT, V287, P1, DOI 10.1111/j.1574-6968.2008.01320.x; Rosu V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004386; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Takahashi K, 2004, TISSUE ANTIGENS, V63, P231, DOI 10.1111/j.1399-0039.2004.000172.x; Tiwari A, 2006, CAN VET J, V47, P874; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9	47	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26931	10.1371/journal.pone.0026931	http://dx.doi.org/10.1371/journal.pone.0026931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046415	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400050
J	Nettle, D; Colleony, A; Cockerill, M				Nettle, Daniel; Colleony, Agathe; Cockerill, Maria			Variation in Cooperative Behaviour within a Single City	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; SOCIAL-CLASS; PERSPECTIVE; PUNISHMENT; SOCIETIES; NEIGHBORHOODS; EVOLUTION; FAIRNESS; BRITAIN; SCALE	Human cooperative behaviour, as assayed by decisions in experimental economic dilemmas such as the Dictator Game, is variable across human populations. Within-population variation has been less well studied, especially within industrial societies. Moreover, little is known about the extent to which community-level variation in Dictator Game behaviour relates to community-level variation in real-world social behaviour. We chose two neighbourhoods of the city of Newcastle upon Tyne that were similar in most regards, but at opposite ends of the spectrum in terms of level of socioeconomic deprivation. We administered Dictator Games to randomly-selected residents, and also gathered a large number of more naturalistic measures of cooperativeness. There were dramatic differences in Dictator Game behaviour between the two neighbourhoods, with the mean allocation to the other player close to half the stake in the affluent neighbourhood, and close to one tenth of the stake in the deprived neighbourhood. Moreover, the deprived neighbourhood was also characterised by lower self-reported social capital, higher frequencies of crime and antisocial behaviour, a higher frequency of littering, and less willingness to take part in a survey or return a lost letter. On the other hand, there were no differences between the neighbourhoods in terms of the probability of helping a person who dropped an object, needed directions to a hospital, or needed to make change for a coin, and people on the streets were less likely to be alone in the deprived neighbourhood than the affluent one. We conclude that there can be dramatic local differences in cooperative behaviour within the same city, and that these need further theoretical explanation.	[Nettle, Daniel; Colleony, Agathe] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nettle, Daniel; Colleony, Agathe] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Colleony, Agathe] Univ Rennes 1, Rennes, France; [Cockerill, Maria] N Tyneside Council, Sch Improvement Serv, Wallsend, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Universite de Rennes	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Colleony, Agathe/AAT-2364-2020; Nettle, Daniel/B-2259-2008; Cockerill, Maria/HCH-1489-2022	Colleony, Agathe/0000-0001-6096-7254; Nettle, Daniel/0000-0001-9089-2599; Cockerill, Maria/0000-0002-9780-3859				Aktipis CA, 2011, EVOL HUM BEHAV, V32, P263, DOI 10.1016/j.evolhumbehav.2011.01.002; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; [Anonymous], 1932, STAT METHODS RES WOR; Bajekal Madhavi, 2005, Health Stat Q, P18; Bardsley N, 2008, EXP ECON, V11, P122, DOI 10.1007/s10683-007-9172-2; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; DURDAN CA, 1985, ENVIRON BEHAV, V17, P387, DOI 10.1177/0013916585173007; Ermisch J, 2009, J R STAT SOC A STAT, V172, P749, DOI 10.1111/j.1467-985X.2009.00591.x; Falk A, 2007, DISCRIMINATION GROUP; Fessler DMT., 2009, J ECON BEHAV ORGAN, V71, P575, DOI [10.1016/j.jebo.2009.03.007., DOI 10.1016/J.JEBO.2009.03.007]; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gurven M, 2008, J ECON BEHAV ORGAN, V67, P587, DOI 10.1016/j.jebo.2007.09.005; Gurven M, 2008, AM ANTHROPOL, V110, P179, DOI 10.1111/j.1548-1433.2008.00024.x; Halpern D., 2004, SOCIAL CAPITAL; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; LEVINE RV, 1994, J PERS SOC PSYCHOL, V67, P69, DOI 10.1037/0022-3514.67.1.69; Levitt SD, 2007, CAN J ECON, V40, P347, DOI 10.1111/j.1365-2966.2007.00412.x; Li YJ, 2005, EUR SOCIOL REV, V21, P109, DOI 10.1093/esr/jci007; Marlowe FW, 2011, P ROY SOC B-BIOL SCI, V278, P2159, DOI 10.1098/rspb.2010.2342; MERRITT CB, 1948, J ABNORM SOC PSYCH, V43, P90, DOI 10.1037/h0061846; MILGRAM S, 1965, PUBLIC OPIN QUART, V29, P437, DOI 10.1086/267344; Nettle D, 2011, J ETHOLOGY IN PRESS; Nettle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021051; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; PEARCE PL, 1980, SOC PSYCHOL QUART, V43, P363, DOI 10.2307/3033956; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Peterson RA, 2001, J CONSUM RES, V28, P450, DOI 10.1086/323732; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Robinson F., 2005, NO EC REV, V36, P15; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Shaw M, 2005, HEALTH PLACE, V11, P45, DOI 10.1016/j.healthplace.2004.01.003; Wiessner P, 2009, CURR ANTHROPOL, V50, P133, DOI 10.1086/595622; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Wintre MG, 2001, CAN PSYCHOL, V42, P216	42	71	75	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26922	10.1371/journal.pone.0026922	http://dx.doi.org/10.1371/journal.pone.0026922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046411	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400047
J	Berentzen, TL; Jakobsen, MU; Stegger, JG; Halkjaer, J; Tjonneland, A; Sorensen, TIA; Overvad, K				Berentzen, Tina Landsvig; Jakobsen, Marianne Uhre; Stegger, Jakob Gerhard; Halkjaer, Jytte; Tjonneland, Anne; Sorensen, Thorkild I. A.; Overvad, Kim			Changes in Waist Circumference and the Incidence of Acute Myocardial Infarction in Middle-Aged Men and Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; BODY-MASS INDEX; FAT DISTRIBUTION; BLOOD-LIPIDS; WEIGHT-LOSS; MORTALITY; RISK; POPULATION; PREDICTORS	Background: Waist circumference (WC) measured at one point in time is positively associated with the risk of acute myocardial infarction (MI), but the association with changes in WC (DWC) is not clear. We investigated the association between DWC and the risk of MI in middle-aged men and women, and evaluated the influence from concurrent changes in BMI (DBMI). Methodology/Principal Findings: Data on 38,593 participants from the Danish Diet, Cancer and Health study was analysed. Anthropometry was assessed in 1993-97 and 1999-02. Information on fatal and non-fatal MI was obtained from National Registers. Cases were validated by review of the medical records. Hazard ratios (HR) were calculated from Cox proportional hazard models with individuals considered at risk from 1999-02 until December 30 2009. During 8.4 years of follow-up, 1,041 incident cases of MI occurred. WC was positively associated with the risk of MI, but weakly after adjustment for BMI. DWC was not associated with the risk of MI (HR per 5 cm change = 1.01 (0.95, 1.09) with adjustment for covariates, baseline WC, BMI and DBMI). Associations with DWC were not notably different in sub-groups stratified according to baseline WC or DBMI, or when individuals with MI occurring within the first years of follow-up were excluded. Conclusions/Significance: WC was positively associated with the risk of MI in middle-aged men and women, but changes in WC were not. These findings suggest that a reduction in WC may be an insufficient target for prevention of MI in middle-	[Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Stegger, Jakob Gerhard; Overvad, Kim] Aarhus Univ Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg Hosp, Aalborg, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark	University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society	Berentzen, TL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	tb@ipm.regionh.dk	Jakobsen, Marianne Uhre/I-8550-2018	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921	European Commission [LSHM-CT-2005-018734]; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]; The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP)	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen; Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP)	This work was supported by and a part of the project Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP; www.hepadip.org), which is supported by the European Commission as an Integrated Project under the 6th Framework Program (contract LSHM-CT-2005-018734), and part of the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). Funding was also obtained from The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Anderson JW, 2001, OBES RES, V9, p326S, DOI 10.1038/oby.2001.138; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Bigaard J, 2005, J NUTR, V135, P2263; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Dey DK, 2003, OBES RES, V11, P817, DOI 10.1038/oby.2003.113; Eilat-Adar S, 2005, CURR OPIN LIPIDOL, V16, P5, DOI 10.1097/00041433-200502000-00003; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Harrel jF, 2002, APPL LINEAR MODELS L; Heitmann BL, 2011, OBES REV, V12, P478, DOI 10.1111/j.1467-789X.2010.00794.x; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Juel K, 1999, DAN MED BULL, V46, P354; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kristensen JK, 2001, DAN MED BULL, V48, P33; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; McGill H C Jr, 2002, Minerva Pediatr, V54, P437; McGill HC, 2002, CIRCULATION, V105, P2712, DOI 10.1161/01.CIR.0000018121.67607.CE; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Sierra-Johnson J, 2008, EUR J CARDIOV PREV R, V15, P336, DOI 10.1097/HJR.0b013e3282f48348; Stegger JG, 2011, INT J OBES LOND; STEVENS J, 1992, AM J EPIDEMIOL, V135, P1137, DOI 10.1093/oxfordjournals.aje.a116214; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A M, 2000, Ugeskr Laeger, V162, P350; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; WALKER M, 1995, INT J EPIDEMIOL, V24, P694, DOI 10.1093/ije/24.4.694; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zhang X, 2004, INT J OBESITY, V28, P734, DOI 10.1038/sj.ijo.0802634	43	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26849	10.1371/journal.pone.0026849	http://dx.doi.org/10.1371/journal.pone.0026849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046380	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600067
J	Demougeot, L; Toupet, M; Van Nechel, C; Papaxanthis, C				Demougeot, Laurent; Toupet, Michel; Van Nechel, Christian; Papaxanthis, Charalambos			Action Representation in Patients with Bilateral Vestibular Impairments	PLOS ONE			English	Article							MOTOR IMAGERY; TEMPORAL FEATURES; SIMULATED MOVEMENTS; MENTAL PRACTICE; BODY; GAIT; PERFORMANCE; LOCOMOTION; EXECUTION; DOMINANT	During mental actions subjects feel themselves performing a movement without any corresponding motor output. Although broad information is available regarding the influence of central lesions on action representation, little is known about how peripheral damages affect mental events. In the current study, we investigated whether lack of vestibular information influences action representation. Twelve healthy adults and twelve patients with bilateral vestibular damage actually performed and mentally simulated walking and drawing. The locomotor paths implied one (first walking task) and four (second walking task) changes in the walking direction. In the drawing task, participants drew on a sheet of paper a path that was similar to that of the second walking task. We recorded and compared between the two groups the timing of actual and mental movements. We found significant temporal discrepancies between actual and mental walking movements in the group of patients. Conversely, drawing actual and drawing mental durations were similar. For the control group, an isochrony between mental and actual movements was observed for the three tasks. This result denotes an inconsistency between action representation and action execution following vestibular damage, which is specific to walking movements, and emphasizes the role of the vestibular system upon mental states of actions. This observation may have important clinical implications. During action planning vestibular patients may overestimate the capacity of their motor system (imaging faster, executing slower) with harmful consequences for their health.	[Demougeot, Laurent; Papaxanthis, Charalambos] Univ Bourgogne, UFR STAPS, Dijon, France; [Demougeot, Laurent; Papaxanthis, Charalambos] Motricite & Plasticite, Unite 887, Inst Natl Sante & Rech Med, Dijon, France; [Toupet, Michel] Ctr Explorat Fonct Oto Neurol, Paris, France; [Toupet, Michel; Van Nechel, Christian] Inst Rech Oto Neurol, IRON, Paris, France; [Van Nechel, Christian] CHU Brugmann, Unite Troubles Equilibre & Vertiges, Brussels, Belgium; [Van Nechel, Christian] CHU Erasme, Unite Neuro Ophtalmol, Brussels, Belgium	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Libre de Bruxelles	Demougeot, L (corresponding author), Univ Bourgogne, UFR STAPS, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr			INSERM (Institut National de la Sante et de la Recherche Medicale); Conseil Regional de Bourgogne	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale) and by the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Allum J H, 1994, J Vestib Res, V4, P49; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; BLACK FO, 1984, ACTA OTO-LARYNGOL, P110; Borel L, 2004, BEHAV BRAIN RES, V150, P191, DOI 10.1016/S0166-4328(03)00257-2; Cerritelli B, 2000, BEHAV BRAIN RES, V108, P91, DOI 10.1016/S0166-4328(99)00138-2; Collet C, 2011, EXERC SPORT SCI REV, V39, P85, DOI 10.1097/JES.0b013e31820ac5e0; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Demougeot L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006769; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fox C R, 1990, J Vestib Res, V1, P153; Frak V, 2004, NEUROREPORT, V15, P1489, DOI 10.1097/01.wnr.0000132429.68206.48; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; GENTILI RJ, 2010, J NEUROPHYSIOL; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Grabherr L, 2007, J VESTIBUL RES-EQUIL, V17, P279; Grabherr L, 2011, EXP BRAIN RES, V209, P205, DOI 10.1007/s00221-011-2535-0; GROSSMAN GE, 1990, ANN NEUROL, V27, P528, DOI 10.1002/ana.410270512; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; Gueugneau N, 2010, CHRONOBIOL INT, V27, P620, DOI 10.3109/07420521003664205; Gueugneau N, 2009, NEUROREHAB NEURAL RE, V23, P237, DOI 10.1177/1545968308321775; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kagerer FA, 1998, EXP BRAIN RES, V121, P125, DOI 10.1007/s002210050444; Lenggenhager B, 2008, EXP BRAIN RES, V184, P211, DOI 10.1007/s00221-007-1095-9; Lopez C, 2011, MED HYPOTHESES, V76, P816, DOI 10.1016/j.mehy.2011.02.026; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Malouin F, 2004, NEUROREPORT, V15, P1349, DOI 10.1097/01.wnr.0000127465.94899.72; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Maruff P, 2003, SCHIZOPHR RES, V60, P229, DOI 10.1016/S0920-9964(02)00214-1; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; Mast FW, 2006, NEUROPSYCHOLOGIA, V44, P101, DOI 10.1016/j.neuropsychologia.2005.04.005; METCALFE T, 1992, ANN NY ACAD SCI, V656, P695; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Peruch P, 2005, COGNITIVE BRAIN RES, V25, P862, DOI 10.1016/j.cogbrainres.2005.09.012; POZZO T, 1991, ACTA OTO-LARYNGOL, P322; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Rodrigues EC, 2010, NEUROSCIENCE, V169, P743, DOI 10.1016/j.neuroscience.2010.04.081; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; vonBrevern M, 1997, AM J OTOL, V18, P484; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Yaguez L, 1998, BEHAV BRAIN RES, V90, P95, DOI 10.1016/S0166-4328(97)00087-9	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26764	10.1371/journal.pone.0026764	http://dx.doi.org/10.1371/journal.pone.0026764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039548	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200049
J	de Fockert, JW; Caparos, S; Linnell, KJ; Davidoff, J				de Fockert, Jan W.; Caparos, Serge; Linnell, Karina J.; Davidoff, Jules			Reduced Distractibility in a Remote Culture	PLOS ONE			English	Article							ATTENTIONAL CONTROL SETTINGS; AUTISM SPECTRUM DISORDERS; SELECTIVE ATTENTION; PERCEPTUAL LOAD; CAPTURE; GAME; INTERFERENCE; COGNITION; MOTION; ONSET	Background: In visual processing, there are marked cultural differences in the tendency to adopt either a global or local processing style. A remote culture (the Himba) has recently been reported to have a greater local bias in visual processing than Westerners. Here we give the first evidence that a greater, and remarkable, attentional selectivity provides the basis for this local bias. Methodology/Principal Findings: In Experiment 1, Eriksen-type flanker interference was measured in the Himba and in Western controls. In both groups, responses to the direction of a task-relevant target arrow were affected by the compatibility of task-irrelevant distractor arrows. However, the Himba showed a marked reduction in overall flanker interference compared to Westerners. The smaller interference effect in the Himba occurred despite their overall slower performance than Westerners, and was evident even at a low level of perceptual load of the displays. In Experiment 2, the attentional selectivity of the Himba was further demonstrated by showing that their attention was not even captured by a moving singleton distractor. Conclusions/Significance: We argue that the reduced distractibility in the Himba is clearly consistent with their tendency to prioritize the analysis of local details in visual processing.	[de Fockert, Jan W.; Caparos, Serge; Linnell, Karina J.; Davidoff, Jules] Univ London, Dept Psychol, London, England	University of London	de Fockert, JW (corresponding author), Univ London, Dept Psychol, London, England.	j.de-fockert@gold.ac.uk			Economic and Social Research Council [2558227]; Economic and Social Research Council [ES/G022224/1] Funding Source: researchfish; ESRC [ES/G022224/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by Economic and Social Research Council grant 2558227 (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Davidoff J, 2008, COGNITION, V108, P702, DOI 10.1016/j.cognition.2008.06.004; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; de Fockert JW, 2009, BRAIN RES, V1282, P67, DOI 10.1016/j.brainres.2009.05.060; Dichter GS, 2007, NEUROIMAGE, V35, P1219, DOI 10.1016/j.neuroimage.2006.12.038; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; FOSTER S, 2007, PSYCHOL SCI, V18, P377; Franconeri SL, 2005, PERCEPT PSYCHOPHYS, V67, P962, DOI 10.3758/BF03193623; Geurts HM, 2008, J CHILD PSYCHOL PSYC, V49, P848, DOI 10.1111/j.1469-7610.2008.01916.x; Gooding DC, 2006, SCHIZOPHR RES, V88, P169, DOI 10.1016/j.schres.2006.07.009; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HILLSTROM AP, 1994, PERCEPT PSYCHOPHYS, V55, P399, DOI 10.3758/BF03205298; Irons JL, 2011, AUST J PSYCHOL, V63, P224, DOI 10.1111/j.1742-9536.2011.00001.x; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Jung C., 1933, MODERN MAN SEARCH SO; Kaldy Z, 2003, PERCEPTION, V32, P657, DOI 10.1068/p3473; Kelley TA, 2009, J VISION, V9, DOI 10.1167/9.7.16; Kimchi R, 2009, ACTA PSYCHOL, V130, P64, DOI 10.1016/j.actpsy.2008.10.002; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lescroart MD, 2010, VIS COGN, V18, P50, DOI 10.1080/13506280802507806; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Maylor EA, 1998, PSYCHOL AGING, V13, P563, DOI 10.1037/0882-7974.13.4.563; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Mullane JC, 2009, CHILD NEUROPSYCHOL, V15, P321, DOI 10.1080/09297040802348028; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Phillips WA, 2004, PERCEPTION, V33, P79, DOI 10.1068/p5110; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schneider W., 2002, E PRIME VERSION 20 C; Sobe NW, 2010, PAEDAGOG HIST, V46, P149, DOI 10.1080/00309230903528520; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TIPPER SP, 1987, PERS INDIV DIFFER, V8, P667, DOI 10.1016/0191-8869(87)90064-X; Townsend JT, 1983, STOCHASTIC MODELLING; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301; Wilson DE, 2008, PERCEPT PSYCHOPHYS, V70, P1130, DOI 10.3758/PP.70.6.1130; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676	40	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26337	10.1371/journal.pone.0026337	http://dx.doi.org/10.1371/journal.pone.0026337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22046275	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000296507500051
J	Tingley, R; Shine, R				Tingley, Reid; Shine, Richard			Desiccation Risk Drives the Spatial Ecology of an Invasive Anuran (Rhinella marina) in the Australian Semi-Desert	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; ESTABLISHMENT SUCCESS; BUFO-MARINUS; CANE TOADS; RAPID EVOLUTION; CLIMATE; TEMPERATURE; AMPHIBIANS; MOVEMENT; RANGE	Some invasive species flourish in places that impose challenges very different from those faced in their native geographic ranges. Cane toads (Rhinella marina) are native to tropical and subtropical habitats of South and Central America, but have colonised extremely arid regions over the course of their Australian invasion. We radio-tracked 44 adult cane toads at a semi-arid invasion front to investigate how this invasive anuran has managed to expand its geographic range into arid areas that lie outside of its native climatic niche. As predicted from their low physiological control over rates of evaporative water loss, toads selected diurnal shelter sites that were consistently cooler and damper (and thus, conferred lower water loss rates) than nearby random sites. Desiccation risk also had a profound influence on rates of daily movement. Under wet conditions, toads that were far from water moved further between shelter sites than did conspecifics that remained close to water, presumably in an attempt to reach permanent water sources. However, this relationship was reversed under dry conditions, such that only toads that were close to permanent water bodies made substantial daily movements. Toads that were far from water bodies also travelled along straighter paths than did conspecifics that generally remained close to water. Thus, behavioural flexibility-in particular, an ability to exploit spatial and temporal heterogeneity in the availability of moist conditions-has allowed this invasive anuran to successfully colonize arid habitats in Australia. This finding illustrates that risk assessment protocols need to recognise that under some circumstances an introduced species may be able to thrive in conditions far removed from any that it experiences in its native range.	[Tingley, Reid; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Tingley, R (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	reid.tingley@gmail.com	Tingley, Reid/D-7388-2011	Tingley, Reid/0000-0002-7630-7434	Natural Sciences and Engineering Research Council of Canada; University of Sydney; Caring for Our Country; Australian Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Sydney(University of Sydney); Caring for Our Country; Australian Research Council(Australian Research Council)	RT was funded by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship, an Endeavour International Postgraduate Research Scholarship, and a University of Sydney International Postgraduate Award. Additional funding was provided by Caring for Our Country and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cassey P, 2002, BIOL J LINN SOC, V76, P465, DOI 10.1046/j.1095-8312.2002.00086.x; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Darwin C, 2009, ON THE ORIGIN OF SPECIES, P1, DOI 10.1017/CBO9780511694295.004; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Florance D, 2011, P R SOC B IN PRESS; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Jeschke JM, 2008, DIVERS DISTRIB, V14, P913, DOI 10.1111/j.1472-4642.2008.00488.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2010, ECOL APPL, V20, P2273, DOI 10.1890/09-1973.1; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2003, CONSERV BIOL, V17, P1738, DOI 10.1111/j.1523-1739.2003.00353.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Cabal MA, 2009, DIVERS DISTRIB, V15, P911, DOI 10.1111/j.1472-4642.2009.00583.x; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Schwarzkopf L, 2002, OIKOS, V96, P492, DOI 10.1034/j.1600-0706.2002.960311.x; Seebacher F, 1999, J HERPETOL, V33, P208, DOI 10.2307/1565716; Seebacher F, 2002, J HERPETOL, V36, P69, DOI 10.1670/0022-1511(2002)036[0069:SMDBTA]2.0.CO;2; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Smith James G., 2006, Pacific Conservation Biology, V12, P40; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Tingley R, 2010, GLOBAL ECOL BIOGEOGR, V19, P496, DOI 10.1111/j.1466-8238.2010.00530.x; Tracy CR, 2007, J HERPETOL, V41, P597, DOI 10.1670/07-006.1; Ujvari B, 2009, HERPETOL CONSERV BIO, V4, P248; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; WYGODA ML, 1984, PHYSIOL ZOOL, V57, P329, DOI 10.1086/physzool.57.3.30163722; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	40	56	56	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25979	10.1371/journal.pone.0025979	http://dx.doi.org/10.1371/journal.pone.0025979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043300	Green Published, gold			2022-12-27	WOS:000295984400028
J	Chen, JHK; Wong, KH; Chan, KCW; To, SWC; Chen, ZW; Yam, WC				Chen, Jonathan Hon-Kwan; Wong, Ka-Hing; Chan, Kenny Chi-Wai; To, Sabrina Wai-Chi; Chen, Zhiwei; Yam, Wing-Cheong			Phylodynamics of HIV-1 Subtype B among the Men-Having-Sex-with-Men (MSM) Population in Hong Kong	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; PHYLOGENETIC ANALYSIS; DRUG-RESISTANCE; TRANSMISSION; INFECTION; PREVALENCE; TIME	The men-having-sex-with-men (MSM) population has become one of the major risk groups for HIV-1 infection in the Asia Pacific countries. Hong Kong is located in the centre of Asia and the transmission history of HIV-1 subtype B transmission among MSM remained unclear. The aim of this study was to investigate the transmission dynamics of HIV-1 subtype B virus in the Hong Kong MSM population. Samples of 125 HIV-1 subtype B infected MSM patients were recruited in this study. Through this study, the subtype B epidemic in the Hong Kong MSM population was identified spreading mainly among local Chinese who caught infection locally. On the other hand, HIV-1 subtype B infected Caucasian MSM caught infection mainly outside Hong Kong. The Bayesian phylogenetic analysis also indicated that 3 separate subtype B epidemics with divergence dates in the 1990s had occurred. The first and latest epidemics were comparatively small-scaled; spreading among the local Chinese MSM while sauna-visiting was found to be the major sex partner sourcing reservoir for the first subtype B epidemic. However, the second epidemic was spread in a large-scale among local Chinese MSM with a number of them having sourced their sex partners through the internet. The epidemic virus was estimated to have a divergence date in 1987 and the infected population in Hong Kong had a logistic growth throughout the past 20 years. Our study elucidated the evolutionary and demographic history of HIV-1 subtype B virus in Hong Kong MSM population. The understanding of transmission and growth model of the subtype B epidemic provides more information on the HIV-1 transmission among MSM population in other Asia Pacific high-income countries.	[Chen, Jonathan Hon-Kwan; To, Sabrina Wai-Chi; Yam, Wing-Cheong] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Wong, Ka-Hing; Chan, Kenny Chi-Wai] Ctr Hlth Protect, Dept Hlth, Special Prevent Programme, Integrated Treatment Ctr, Hong Kong, Hong Kong, Peoples R China; [Chen, Jonathan Hon-Kwan; Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chen, JHK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	wcyam@hku.hk	Chen, Zhiwei/B-7793-2019; Chen, Jun/K-2085-2012	Chen, Zhiwei/0000-0002-4511-2888; Chen, Jun/0000-0002-3850-4875	AIDS Trust of Hong Kong Special Administrative Region Government [MSS-155R, MSS-164R]	AIDS Trust of Hong Kong Special Administrative Region Government	This study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (MSS-155R and MSS-164R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Chan WK, 2007, AIDS CARE, V19, P289, DOI 10.1080/09540120600872083; Chen JHK, 2008, AIDS RES HUM RETROV, V24, P537, DOI 10.1089/aid.2007.0231; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Chen JHK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012198; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dwyer D. E., 1996, Annals Academy of Medicine Singapore, V25, P188; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Leung TWC, 2008, AIDS RES HUM RETROV, V24, P903, DOI 10.1089/aid.2007.0272; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Park CS, 2006, J MICROBIOL, V44, P655; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; UNAIDS W, 2010, AIDS GLOB REP 2010; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Wong K. H., 2006, Hong Kong Medical Journal, V12, P133; Wong KH, 2010, AIDS RES HUM RETROV, V26, P1079, DOI 10.1089/aid.2009.0272; Yam WC, 2006, J CLIN VIROL, V35, P454, DOI 10.1016/j.jcv.2005.10.012	26	52	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2011	6	9							e25286	10.1371/journal.pone.0025286	http://dx.doi.org/10.1371/journal.pone.0025286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825IJ	22069472	Green Published, gold			2022-12-27	WOS:000295265100081
J	Alonso, MM; Diez-Valle, R; Manterola, L; Rubio, A; Liu, D; Cortes-Santiago, N; Urquiza, L; Jauregi, P; de Munain, AL; Sampron, N; Aramburu, A; Tejada-Solis, S; Vicente, C; Odero, MD; Bandres, E; Garcia-Foncillas, J; Idoate, MA; Lang, FF; Fueyo, J; Gomez-Manzano, C				Alonso, Marta M.; Diez-Valle, Ricardo; Manterola, Lorea; Rubio, Angel; Liu, Dan; Cortes-Santiago, Nahir; Urquiza, Leire; Jauregi, Patricia; Lopez de Munain, Adolfo; Sampron, Nicolas; Aramburu, Ander; Tejada-Solis, Sonia; Vicente, Carmen; Odero, Maria D.; Bandres, Eva; Garcia-Foncillas, Jesus; Idoate, Miguel A.; Lang, Frederick F.; Fueyo, Juan; Gomez-Manzano, Candelaria			Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TUMOR-INITIATING CELLS; HUMAN GLIOBLASTOMA; PLURIPOTENT; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; NEUROGENESIS; BRAIN; STATE	We undertook this study to understand how the transcription factor Sox2 contributes to the malignant phenotype of glioblastoma multiforme (GBM), the most aggressive primary brain tumor. We initially looked for unbalanced genomic rearrangements in the Sox2 locus in 42 GBM samples and found that Sox2 was amplified in 11.5% and overexpressed in all the samples. These results prompted us to further investigate the mechanisms involved in Sox2 overexpression in GBM. We analyzed the methylation status of the Sox2 promoter because high CpG density promoters are associated with key developmental genes. The Sox2 promoter presented a CpG island that was hypomethylated in all the patient samples when compared to normal cell lines. Treatment of Sox2-negative glioma cell lines with 5-azacitidine resulted in the re-expression of Sox2 and in a change in the methylation status of the Sox2 promoter. We further confirmed these results by analyzing data from GBM cases generated by The Cancer Genome Atlas project. We observed Sox2 overexpression (86%; N = 414), Sox2 gene amplification (8.5%; N = 492), and Sox 2 promoter hypomethylation (100%; N = 258), suggesting the relevance of this factor in the malignant phenotype of GBMs. To further explore the role of Sox2, we performed in vitro analysis with brain tumor stem cells (BTSCs) and established glioma cell lines. Downmodulation of Sox2 in BTSCs resulted in the loss of their self-renewal properties. Surprisingly, ectopic expression of Sox2 in established glioma cells was not sufficient to support self-renewal, suggesting that additional factors are required. Furthermore, we observed that ectopic Sox2 expression was sufficient to induce invasion and migration of glioma cells, and knockdown experiments demonstrated that Sox2 was essential for maintaining these properties. Altogether, our data underscore the importance of a pleiotropic role of Sox2 and suggest that it could be used as a therapeutic target in GBM.	[Alonso, Marta M.; Cortes-Santiago, Nahir; Fueyo, Juan; Gomez-Manzano, Candelaria] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Alonso, Marta M.; Liu, Dan; Jauregi, Patricia; Bandres, Eva; Garcia-Foncillas, Jesus] Univ Hosp Navarra, Dept Oncol, Pamplona, Spain; [Diez-Valle, Ricardo; Tejada-Solis, Sonia] Univ Hosp Navarra, Dept Neurosurg, Pamplona, Spain; [Manterola, Lorea; Lopez de Munain, Adolfo; Sampron, Nicolas] BioDonostia Inst, Div Oncol, San Sebastian, Spain; [Rubio, Angel; Aramburu, Ander] Ctr Estudios & Invest Tecn Guipuzcoa CEIT, Dept Biostat, San Sebastian, Spain; [Urquiza, Leire; Vicente, Carmen; Odero, Maria D.] Univ Navarra, Ctr Appl Med Res, Div Oncol, E-31080 Pamplona, Spain; [Idoate, Miguel A.] Univ Hosp Navarra, Dept Pathol, Pamplona, Spain; [Lang, Frederick F.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Instituto de Investigacion Sanitaria Biodonostia; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; University of Texas System; UTMD Anderson Cancer Center	Alonso, MM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	mmalonso@unav.es; cmanzano@mdanderson.org	Rubio, Angel/O-6348-2014; Vicente, Carmen/AAA-7098-2021; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Odero/ABG-9860-2020; Alonso, Marta M/AAI-9457-2020; Cortes-Santiago, Nahir/AHA-0192-2022; Rubio, Angel/Y-8610-2019; Rubio, Angel/M-7387-2019; Idoate, Miguel-Ángel/D-8502-2019	Rubio, Angel/0000-0002-3274-2450; Vicente, Carmen/0000-0002-3363-3459; Odero/0000-0002-8858-2054; Alonso, Marta M/0000-0002-7520-7351; Cortes-Santiago, Nahir/0000-0003-1704-9284; Rubio, Angel/0000-0002-3274-2450; Idoate, Miguel-Ángel/0000-0002-1596-1192; /0000-0002-9509-4032; J, Garcia-Foncillas/0000-0002-7591-8006; Sampron, Nicolas/0000-0002-7841-6837; Gomez-Manzano, Candelaria/0000-0002-1259-2133; Manterola, Lorea/0000-0003-0660-916X; BANDRES, EVA/0000-0002-9497-5356; Fueyo, Juan/0000-0001-6941-2335	The University of Texas MD Anderson Cancer Center; Alex Lemonade Stand Foundation; Spanish Ministry of Education and Science; National Cancer Institute Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	The University of Texas MD Anderson Cancer Center; Alex Lemonade Stand Foundation; Spanish Ministry of Education and Science(Spanish Government); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an institutional grant from The University of Texas MD Anderson Cancer Center (to C.G.M.), a grant from the Alex Lemonade Stand Foundation, and Ramon y Cajal Contract from the Spanish Ministry of Education and Science (to M.M.A.), and a National Cancer Institute Cancer Center Support Grant (CA16672; to The University of Texas MD Anderson Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annovazzi L, CANC GENOMICS PROTEO, V8, P139; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hussenet T, PLOS ONE, V5, P8960; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002	30	153	158	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26740	10.1371/journal.pone.0026740	http://dx.doi.org/10.1371/journal.pone.0026740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069467	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900029
J	Huang, LF; Yao, YM; Li, JF; Dong, N; Liu, C; Yu, Y; He, LX; Sheng, ZY				Huang, Li-feng; Yao, Yong-ming; Li, Jin-feng; Dong, Ning; Liu, Chen; Yu, Yan; He, Li-xin; Sheng, Zhi-yong			Reduction of Plasma Gelsolin Levels Correlates with Development of Multiple Organ Dysfunction Syndrome and Fatal Outcome in Burn Patients	PLOS ONE			English	Article							ILL SURGICAL-PATIENTS; BOX 1 PROTEIN; THERMAL-INJURY; LYSOPHOSPHATIDIC ACID; SCAVENGER SYSTEM; SEPTIC SHOCK; LUNG INJURY; ACTIN; SEPSIS; ASSOCIATION	Background: Depletion of the circulating actin-binding protein, plasma gelsolin (pGSN) has been described in critically ill surgical patients. We hypothesized that the extent of pGSN reduction might correlate with different outcome of burn patients. The study was performed to evaluate the prognostic implications of pGSN levels on the development of multiple organ dysfunction syndrome (MODS) and fatal outcome in a group of severely burn patients. Methods and Findings: 95 patients were included, and they were divided into three groups with different burn area: group I (n = 33), group II (n = 32) and group III (n = 30). According to whether there was development of MODS or not, patients were divided into MODS group (n = 28) and none-MODS group (n = 67); then the patients with MODS were further divided into non-survivor group (n = 17) and survivor group (n = 11). The peripheral blood samples were collected on postburn days (PBD) 1, 3, 7, 14, and 21. The levels of pGSN were determined and T cells were procured from the blood. The contents of cytokines (IL-2, IL-4 and IFN-gamma) released by T cells were also measured. The related factors of prognosis were analyzed by using multivariate logistic regression analysis. The results showed that pGSN concentrations, as well as the levels of IL-2 and IFN-gamma, decreased markedly on PBD 1-21, whereas, the levels of IL-4 increased markedly in all burn groups as compared with normal controls (P<0.05 or P<0.01), and there were obviously differences between group I and group III (P<0.05 or P<0.01). The similar results were found in MODS patients and the non-survivor group as compared with those without MODS and the survival group on days 3-21 postburn (P<0.05 or P<0.01). Moreover, as the pGSN levels decreased, the incidence of septic complication as well as MODS remarkably increased. Conclusions: pGSN levels appear to be an early prognostic marker in patients suffering from major burns.	[Huang, Li-feng; Yao, Yong-ming; Dong, Ning; Yu, Yan; He, Li-xin; Sheng, Zhi-yong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China; [Li, Jin-feng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Liu, Chen] Fourth Mil Univ, Undergrad Med Sch, Student Team 11, Xian, Shanxi, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University; Air Force Military Medical University	Huang, LF (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China.	c_ff@sina.com	li, jinfeng/GVS-5425-2022		National Natural Science Foundation [30901561, 81130035]; National Basic Research Program of China [2012CB518102]; China Postdoctoral Science Foundation [20100480347, 201104125]; National Natural Science Outstanding Youth Foundation of China [30125020]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Outstanding Youth Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported, in part, by grants from the National Natural Science Foundation (No. 30901561, 81130035), the National Basic Research Program of China (No. 2012CB518102), the China Postdoctoral Science Foundation (No. 20100480347, 201104125) and the National Natural Science Outstanding Youth Foundation of China (No. 30125020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Accardo-Palumbo A, 2010, BURNS, V36, P811, DOI 10.1016/j.burns.2009.11.009; Becker PM, 2003, AM J RESP CELL MOL, V28, P478, DOI 10.1165/rcmb.2002-0024OC; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Bucki R, 2008, CURR PROTEIN PEPT SC, V9, P541, DOI 10.2174/138920308786733912; Christofidou-Solomidou M, 2002, LUNG, V180, P91, DOI 10.1007/s004080000084; Davis TA, 2009, INT WOUND J, V6, P11, DOI 10.1111/j.1742-481X.2008.00540.x; DEMLING RH, 1984, SURGERY, V95, P136; DiNubile MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2547; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Erukhimov JA, 2000, AM J RESP CRIT CARE, V162, P288, DOI 10.1164/ajrccm.162.1.9806088; FANG CH, 1995, J AM COLL SURGEONS, V180, P33; Ferjani I, 2010, BIOCHEM BIOPH RES CO, V392, P118, DOI 10.1016/j.bbrc.2009.12.103; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; HEMRIC ME, 1994, J BIOL CHEM, V269, P4125; Huang LF, 2010, CRIT CARE, V14, DOI 10.1186/cc8232; Huang LF, 2009, SHOCK, V31, P322, DOI 10.1097/SHK.0b013e3181834070; Huang S, 1997, CLIN INFECT DIS, V24, P951, DOI 10.1093/clinids/24.5.951; Lavrentieva A, 2008, INTENS CARE MED, V34, P700, DOI 10.1007/s00134-007-0976-5; Lee PS, 2010, BLOOD PURIFICAT, V29, P99, DOI 10.1159/000245632; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003712; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Nguyen LN, 2009, BURNS, V35, P937, DOI 10.1016/j.burns.2009.04.015; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Park JO, 2009, BURNS, V35, P482, DOI 10.1016/j.burns.2008.10.007; Pottiez G, 2010, RAPID COMMUN MASS SP, V24, P2620, DOI 10.1002/rcm.4681; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Schwacha MG, 2002, CYTOKINE, V17, P266, DOI 10.1006/cyto.2001.1003; Spinardi L., 2007, V45, P55; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Yao YM, 2009, CHIN J INTEGR MED, V15, P13, DOI 10.1007/s11655-009-0013-0; Zhang LT, 2010, J INTERF CYTOK RES, V30, P487, DOI 10.1089/jir.2009.0055	45	26	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e25748	10.1371/journal.pone.0025748	http://dx.doi.org/10.1371/journal.pone.0025748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069445	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900006
J	Ferrer, J; Prats, C; Lopez, D; Vidal-Mas, J; Gargallo-Viola, D; Guglietta, A; Giro, A				Ferrer, Jordi; Prats, Clara; Lopez, Daniel; Vidal-Mas, Jaume; Gargallo-Viola, Domingo; Guglietta, Antonio; Giro, Antoni			Thermodynamic Concepts in the Study of Microbial Populations: Age Structure in Plasmodium falciparum Infected Red Blood Cells	PLOS ONE			English	Article							INDIVIDUAL-BASED MODEL; MALARIA; STABILITY; BIOTHERMODYNAMICS; CULTIVATION; ADAPTATION; SIMULATION; INVASION; TOOL	Variability is a hallmark of microbial systems. On the one hand, microbes are subject to environmental heterogeneity and undergo changeable conditions in their immediate surroundings. On the other hand, microbial populations exhibit high cellular diversity. The relation between microbial diversity and variability of population dynamics is difficult to assess. This connection can be quantitatively studied from a perspective that combines in silico models and thermodynamic methods and interpretations. The infection process of Plasmodium falciparum parasitizing human red blood cells under laboratory cultivation conditions is used to illustrate the potential of Individual-based models in the context of predictive microbiology and parasitology. Experimental data from several in vitro cultures are compared to the outcome of an individual-based model and analysed from a thermodynamic perspective. This approach allows distinguishing between intrinsic and external constraints that give rise to the diversity in the infection forms, and it provides a criterion to quantitatively define transient and stationary regimes in the culture. Increasing the ability of models to discriminate between different states of microbial populations enhances their predictive capability which finally leads to a better the control over culture systems. The strategy here presented is of general application and it can substantially improve modelling of other types of microbial communities.	[Ferrer, Jordi; Prats, Clara; Giro, Antoni] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Escola Super Agr Barcelona, Castelldefels, Spain; [Lopez, Daniel] GlaxoSmithKline, Tres Cantos, Spain; [Gargallo-Viola, Domingo; Guglietta, Antonio] Ferrer Grp Res Ctr, Pharmacol & Safety Dept, Barcelona, Spain	Universitat Politecnica de Catalunya; GlaxoSmithKline	Ferrer, J (corresponding author), Univ Politecn Cataluna, Dept Fis & Engn Nucl, Escola Super Agr Barcelona, Castelldefels, Spain.	jordi.ferrer-savall@upc.edu	Ferrer Savall, Jordi/I-5969-2015; Codina, Daniel Lopez/L-5309-2014; Codina, Daniel Lopez/Q-5959-2019; Prats, Clara/L-4797-2014; Giró, Antoni/L-7201-2014	Ferrer Savall, Jordi/0000-0002-5537-6860; Codina, Daniel Lopez/0000-0002-0408-4526; Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Giró, Antoni/0000-0003-1402-1577	Ministerio de Ciencia e Innovacion de Espana [CGL 2007-65142, CGL 2010-20160]; Ipsen Pharma S.A.; Ipsen Pharma	Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ipsen Pharma S.A.(Ipsen); Ipsen Pharma(Ipsen)	This research was supported by the Ministerio de Ciencia e Innovacion de Espana (Spanish National Grants for Basic non-specific Research Projects reference numbers: CGL 2007-65142 and CGL 2010-20160) and by Ipsen Pharma S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: JVM is an employee of GlaxoSmithKline. DGV is a former employee of GlaxoSmithKline and current employee of FerrerGrupo. AGuglietta is an employee of FerrerGrupo. The research group received funding from a commercial source (Ipsen Pharma). These competing interests do not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Crooks L, 2008, PARASITOLOGY, V135, P881, DOI 10.1017/S0031182008004502; Ferrer J, 2008, J BIOL PHYS, V34, P19, DOI 10.1007/s10867-008-9082-3; Ferrer J, 2007, J THEOR BIOL, V248, P448, DOI 10.1016/j.jtbi.2007.05.030; Ferrer J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-203; Ginovart M, 2002, J THEOR BIOL, V214, P305, DOI 10.1006/jtbi.2001.2466; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hanel R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036110; Hartmann D, 2010, BIOMECH MODEL MECHAN, V9, P1, DOI 10.1007/s10237-009-0154-5; Haynie T, 2001, BIOL THERMODYNAMICS; Hellweger FL, 2009, ECOL MODEL, V220, P8, DOI 10.1016/j.ecolmodel.2008.09.004; JENSEN JB, 1979, EXP PARASITOL, V48, P36, DOI 10.1016/0014-4894(79)90052-3; Jou D, 2010, EXTENDED IRREVERSIBLE THERMODYNAMICS, FOURTH EDITION, P1, DOI 10.1007/978-90-481-3074-0; Keller JU, 2008, J NON-EQUIL THERMODY, V33, P321, DOI 10.1515/JNETDY.2008.015; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Li T, 2003, J INFECT DIS, V187, P159, DOI 10.1086/345876; Llopis I, 2008, EUR PHYS J E, V26, P103, DOI 10.1140/epje/i2007-10295-y; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; Mauritz JMA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000339; Morales SE, 2011, FEMS MICROBIOL ECOL, V75, P2, DOI 10.1111/j.1574-6941.2010.00938.x; Neu TR, 2010, FEMS MICROBIOL ECOL, V72, P1, DOI 10.1111/j.1574-6941.2010.00837.x; PASVOL G, 1980, BRIT J HAEMATOL, V45, P285, DOI 10.1111/j.1365-2141.1980.tb07148.x; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Prats C, 2010, AFR J MICROBIOL RES, V4, P400; Preechapornkul P, 2010, SE A J TROP MED PUB, V41, P4; Prigogine I., 1955, INTRO THERMODYNAMICS; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Rupp SP, 2010, ECOL MODEL, V221, P1605, DOI 10.1016/j.ecolmodel.2010.03.014; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Steuer R, 2009, ADV CHEM PHYS, V142, P105, DOI 10.1002/9780470475935.ch3; Straskraba M, 1999, ECOL MODEL, V117, P3, DOI 10.1016/S0304-3800(98)00194-X; Svirezhev YM, 2000, ECOL MODEL, V132, P11, DOI 10.1016/S0304-3800(00)00301-X; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; Tong JC, 2011, DRUG DISCOV TODAY, V16, P42, DOI 10.1016/j.drudis.2010.10.007; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1994, METHOD CELL BIOL, V45, P7; von Stockar U, 2010, J NON-EQUIL THERMODY, V35, P415, DOI 10.1515/JNETDY.2010.024; WAGENSBERG J, 1988, B MATH BIOL, V50, P445, DOI 10.1016/S0092-8240(88)80002-8; WAGENSBERG J, 1988, J PHYS CHEM SOLIDS, V49, P695, DOI 10.1016/0022-3697(88)90202-8; ZOLG JW, 1982, J PARASITOL, V68, P1072, DOI 10.2307/3281094	46	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26690	10.1371/journal.pone.0026690	http://dx.doi.org/10.1371/journal.pone.0026690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066004	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000020
J	Kayali, G; Barbour, E; Dbaibo, G; Tabet, C; Saade, M; Shaib, HA; Debeauchamp, J; Webby, RJ				Kayali, Ghazi; Barbour, Elie; Dbaibo, Ghassan; Tabet, Carelle; Saade, Maya; Shaib, Houssam A.; Debeauchamp, Jennifer; Webby, Richard J.			Evidence of Infection with H4 and H11 Avian Influenza Viruses among Lebanese Chicken Growers	PLOS ONE			English	Article							A H5N1 VIRUS; POULTRY WORKERS; UNITED-STATES; RISK-FACTORS; HONG-KONG; TRANSMISSION; HUMANS; IMMUNOGENICITY; ANTIBODIES; VACCINE	Human infections with H5, H7, and H9 avian influenza viruses are well documented. Exposure to poultry is the most important risk factor for humans becoming infected with these viruses. Data on human infection with other low pathogenicity avian influenza viruses is sparse but suggests that such infections may occur. Lebanon is a Mediterranean country lying under two major migratory birds flyways and is home to many wild and domestic bird species. Previous reports from this country demonstrated that low pathogenicity avian influenza viruses are in circulation but highly pathogenic H5N1 viruses were not reported. In order to study the extent of human infection with avian influenza viruses in Lebanon, we carried out a seroprevalence cross-sectional study into which 200 poultry-exposed individuals and 50 non-exposed controls were enrolled. We obtained their sera and tested it for the presence of antibodies against avian influenza viruses types H4 through H16 and used a questionnaire to collect exposure data. Our microneutralization assay results suggested that backyard poultry growers may have been previously infected with H4 and H11 avian influenza viruses. We confirmed these results by using a horse red blood cells hemagglutination inhibition assay. Our data also showed that farmers with antibodies against each virus type clustered in a small geographic area suggesting that unrecognized outbreaks among birds may have led to these human infections. In conclusion, this study suggests that occupational exposure to chicken is a risk factor for infection with avian influenza especially among backyard growers and that H4 and H11 influenza viruses may possess the ability to cross the species barrier to infect humans.	[Kayali, Ghazi; Debeauchamp, Jennifer; Webby, Richard J.] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA; [Barbour, Elie; Saade, Maya; Shaib, Houssam A.] Amer Univ Beirut, Fac Agr & Food Sci, Beirut, Lebanon; [Dbaibo, Ghassan; Tabet, Carelle] Amer Univ Beirut, Fac Med, Beirut, Lebanon	St Jude Children's Research Hospital; American University of Beirut; American University of Beirut	Kayali, G (corresponding author), St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	ghazi-kayali@uiowa.edu	Dbaibo, Ghassan S./X-2978-2019; barbour, elie k/P-6166-2014; Webby, Richard J/N-5657-2018		National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services, USA [HHSN266200700005C]; American Lebanese Syrian Associated Charities, USA; Office of Grants and Contracts of the American University of Beirut, Lebanon	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, USA; American Lebanese Syrian Associated Charities, USA; Office of Grants and Contracts of the American University of Beirut, Lebanon	This work was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA, under contract number HHSN266200700005C, and by the American Lebanese Syrian Associated Charities, USA. The implementation of the project was through an agreement with the Office of Grants and Contracts of the American University of Beirut, Lebanon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour E K, 2006, Vet Ital, V42, P77; Barbour Elie K, 2007, Vet Ital, V43, P33; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Du Ry van Beest Holle M, 2005, Euro Surveill, V10, P264; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2008, INFLUENZA OTHER RESP, V2, P61, DOI 10.1111/j.1750-2659.2008.00041.x; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kayali G, 2010, ZOONOSES PUBLIC HLTH, V57, P265, DOI 10.1111/j.1863-2378.2009.01231.x; Kayali G, 2009, EVIDENCE PREVIOUS AV; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Myers KP, 2007, CLIN INFECT DIS, V45, P4, DOI 10.1086/518579; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Ortiz EJ, 2007, INFLUENZA OTHER RESP, V1, P65, DOI 10.1111/j.1750-2659.2007.00009.x; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Puzelli S, 2005, J INFECT DIS, V192, P1318, DOI 10.1086/444390; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Thorson A, 2006, ARCH INTERN MED, V166, P119, DOI 10.1001/archinte.166.1.119; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; World Health Organization, 2011, H5N1 AV INFL TIM MAJ; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537	31	44	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26818	10.1371/journal.pone.0026818	http://dx.doi.org/10.1371/journal.pone.0026818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046370	gold, Green Submitted, Green Published			2022-12-27	WOS:000299081800044
J	MacPherson, P; Webb, EL; Choko, AT; Desmond, N; Chavula, K; Mavedzenge, SN; Makombe, SD; Chunda, T; Squire, SB; Corbett, EL				MacPherson, Peter; Webb, Emily L.; Choko, Augustine T.; Desmond, Nicola; Chavula, Kondwani; Mavedzenge, Sue Napierala; Makombe, Simon D.; Chunda, Treza; Squire, S. Bertel; Corbett, Elizabeth L.			Stigmatising Attitudes among People Offered Home-Based HIV Testing and Counselling in Blantyre, Malawi: Construction and Analysis of a Stigma Scale	PLOS ONE			English	Article							AIDS-RELATED STIGMA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; HIV/AIDS; CARE; DURBAN; SITES	Background: HIV/AIDS related stigma is a major barrier to uptake of HIV testing and counselling (HTC). We assessed the extent of stigmatising attitudes expressed by participants offered community-based HTC, and their anticipated stigma from others to assess relationship with HIV test uptake. From these data, we constructed a brief stigma scale for use around the time of HIV testing. Methods and Findings: Adult members of 60 households in urban Blantyre, Malawi, were selected using population-weighted random cluster sampling and offered HTC with the option to self-test before confirmatory HTC. Prior to HTC a 15-item HIV stigma questionnaire was administered. We used association testing and principal components analysis (PCA) to construct a scale measure of stigma. Of 226 adults invited to participate, 216 (95.6%) completed questionnaires and 198/216 (91.7%) opted to undergo HTC (all self-tested). Stigmatising attitudes were uncommon, but anticipated stigma was common, especially fearing verbal abuse (22%) or being abandoned by their partner (11%). Three questions showed little association or consistency with the remaining 12 stigma questions and were not included in the final scale. For the 12-question final scale, Cronbach's alpha was 0.75. Level of stigma was not associated with previously having tested for HIV (p = 0.318) or agreeing to HTC (p = 0.379), but was associated with expressed worry about being or becoming HIV infected (p = 0.003). Conclusions: Anticipated stigma prior to HTC was common among both men and women. However, the high uptake of HTC suggests that this did not translate into reluctance to accept community-based testing. We constructed a brief scale to measure stigma at the time of HIV testing that could rapidly identify individuals requiring additional support following diagnosis and monitor the impact of increasing availability of community-based HTC on prevalence of stigma.	[MacPherson, Peter; Desmond, Nicola; Squire, S. Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter; Choko, Augustine T.; Desmond, Nicola; Chavula, Kondwani; Chunda, Treza; Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Webb, Emily L.; Mavedzenge, Sue Napierala] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Makombe, Simon D.] Minist Hlth, HIV Unit, Lilongwe, Malawi; [Corbett, Elizabeth L.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	MacPherson, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	p.macpherson@liverpool.ac.uk	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022; MacPherson, Peter/AHD-2477-2022	Desmond, Nicola/0000-0002-2874-8569; MacPherson, Peter/0000-0002-0329-9613; Squire, Stephen/0000-0001-7173-9038; Napierala, Sue/0000-0003-1146-8154; Webb, Emily/0000-0002-4019-7456; Corbett, Elizabeth/0000-0002-3552-3181	Wellcome Trust, UK; Wellcome Trust at Liverpool School of Tropical Medicine; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust at Liverpool School of Tropical Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust, UK. PM is funded by the Wellcome Trust Clinical PhD Programme at Liverpool School of Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton P, 2005, HIV RELATED STIGMA D; Aggleton P, 2002, CONCEPTUAL FRAMEWORK; [Anonymous], 2008, EP FACT SHEET HIV AI; Bagchi A.D., 2018, FINDINGS PEOPLE LIVI; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Castro A, 2005, AM J PUBLIC HEALTH, V95, P53, DOI 10.2105/AJPH.2003.028563; Choko A, 2011, 18 C RETR OPP INF; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Galletly CL, 2008, AIDS PATIENT CARE ST, V22, P189, DOI 10.1089/apc.2007.0104; Genberg BL, 2008, JAIDS-J ACQ IMM DEF, V49, P309, DOI 10.1097/QAI.0b013e3181893ed0; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hamra M, 2006, TROP MED INT HEALTH, V11, P513, DOI 10.1111/j.1365-3156.2006.01583.x; Holzemer WL, 2009, SAHARA J-J SOC ASP H, V6, P76, DOI 10.1080/17290376.2009.9724933; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maman S, 2009, SOC SCI MED, V68, P2271, DOI 10.1016/j.socscimed.2009.04.002; Mavedzenge S, 2011, HIV SELF TESTING HLT; Medley AM, 2009, QUAL HEALTH RES, V19, P1744, DOI 10.1177/1049732309353417; Ministry of Health of Malawi, 2010, Q HIV PROGR REP Q2 2; National Statistics Office, 2010, MAL DEM HLTH SURV PR; Ndlovu V, 2009, SAHARA J-J SOC ASP H, V6, P58, DOI 10.1080/17290376.2009.9724931; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nyblade L, 2005, WORKING REPORT MEASU; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Turan JM, 2010, AIDS BEHAV; UNAIDS, 2010, REP GLOB AIDS EP; Visser MJ, 2008, AIDS BEHAV, V12, P759, DOI 10.1007/s10461-008-9363-7; Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044; World Health Organization, 2010, UN ACC SCAL PRIOR HI	39	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26814	10.1371/journal.pone.0026814	http://dx.doi.org/10.1371/journal.pone.0026814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046367	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600060
J	Obermeyer, B; Manes, R; Kiesecker, J; Fargione, J; Sochi, K				Obermeyer, Brian; Manes, Robert; Kiesecker, Joseph; Fargione, Joseph; Sochi, Kei			Development by Design: Mitigating Wind Development's Impacts on Wildlife in Kansas	PLOS ONE			English	Article							BAT FATALITIES; HABITAT FRAGMENTATION; BIODIVERSITY OFFSETS; ENERGY DEVELOPMENT; UNITED-STATES; PRAIRIE; RESPONSES; TURBINES; CONSEQUENCES; DISTURBANCE	Wind energy, if improperly sited, can impact wildlife through direct mortality and habitat loss and fragmentation, in contrast to its environmental benefits in the areas of greenhouse gas, air quality, and water quality. Fortunately, risks to wildlife from wind energy may be alleviated through proper siting and mitigation offsets. Here we identify areas in Kansas where wind development is incompatible with conservation, areas where wind development may proceed but with compensatory mitigation for impacts, and areas where development could proceed without the need for compensatory mitigation. We demonstrate that approximately 10.3 million ha in Kansas (48 percent of the state) has the potential to provide 478 GW of installed capacity while still meeting conservation goals. Of this total, approximately 2.7 million ha would require no compensatory mitigation and could produce up to 125 GW of installed capacity. This is 1,648 percent higher than the level of wind development needed in Kansas by 2030 if the United States is to get 20 percent of its electricity from wind. Projects that avoid and offset impacts consistent with this analysis could be awarded "Green Certification." Certification may help to expand and sustain the wind industry by facilitating the completion of individual projects sited to avoid sensitive areas and protecting the industry's reputation as an ecologically friendly source of electricity.	[Obermeyer, Brian] Nature Conservancy, Cottonwood Falls, KS USA; [Manes, Robert] Nature Conservancy, Topeka, KS USA; [Kiesecker, Joseph] Nature Conservancy, Ft Collins, CO USA; [Fargione, Joseph] Nature Conservancy, Minneapolis, MN USA; [Sochi, Kei] Nature Conservancy, Boulder, CO USA	Nature Conservancy; Nature Conservancy; Nature Conservancy	Obermeyer, B (corresponding author), Nature Conservancy, Cottonwood Falls, KS USA.	jfargione@tnc.org			U.S. Department of Energy; Robertson Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Robertson Foundation	Partial funding was provided by the U.S. Department of Energy and the Robertson Foundation. No additional external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SPAT BAS PLANN TOOL; [Anonymous], 1996, PRAIRIE CONSERVATION; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2008, CURR BIOL, V18, pR695, DOI 10.1016/j.cub.2008.06.029; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Braun CE, 2002, TRANS N AM WILDL NAT, V67, P337; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Conservation Biology Institute, 2010, PAD US 1 1 CBI ED DA; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Department of Energy, 2008, 20 PERC WIND EN 2030; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fry J.A., 2008, US GEOLOGICAL SURVEY, V1379, P18; Glick D, 2005, SMITHSONIAN, V36, P54; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hansen MJ, 2005, BIOL CONSERV, V125, P249, DOI 10.1016/j.biocon.2005.03.024; Hayward B. J., 1970, W NEW MEXICO U RES S, V1, P1; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Horn JW, 2008, J WILDLIFE MANAGE, V72, P123, DOI 10.2193/2006-465; K Doherty, 2011, STUDIES AVIAN BIOL, V38; Kansas Applied Remote Sensing, 2009, 2005 KANS LAND COV P; Kansas Biological Survey, 2011, KANS NAT RES PLANN M; Kiesecker JM, PLOS ONE IN PRESS; Kiesecker Joseph M., 2011, P159; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Knick ST, 2011, STUD AVIAN BIOL, P1; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lockwood JL, 2007, INVASION ECOLOGY; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKee GW, 1998, J WILDLIFE MANAGE, V62, P314, DOI 10.2307/3802294; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; McNew LB, 2010, ANAL GREATER PRAIRIE; Multi-Resolution Land Characteristics Consortium, 2010, NAT LAND COV DAT; National Agricultural Statistics Service, 2010, USDA NASS RDD SPAT A; National Renewable Energy Lab, 2008, WIND POW AM KANS 50; National Research Council, 2007, ENV IM WIND EN PROJ; Natural Resources Conservation Service, 2010, KANS GRASSL RES PROG; Natural Resources Conservation Service, 2010, KANS WILDL HAB INC P; Natural Resources Conservation Service, 2010, NAT SOIL SURV HDB; NOSS RF, 1995, ENDANGERED ECOSYSTEM, P1; PEDERSEN MB, 1991, IMPACT 90 M 2MW WIND; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Playa Lakes Joint Venture, 2011, OUR BIRDS; Pocewicz A, 2008, LANDSCAPE ECOL, V23, P195, DOI 10.1007/s10980-007-9159-6; Powell AFLA, 2008, J FIELD ORNITHOL, V79, P41, DOI 10.1111/j.1557-9263.2008.00144.x; Prendergast JA, 2010, SOUTHWEST NAT, V55, P331, DOI 10.1894/MRD-10.1; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Ramsar Convention on Wetlands, 2011, RAMS CONV ANN RAMS L; Robbins M.B., 2002, N AM BIRDS, V56, P239; Robel R, 2002, EXPECTED IMPACTS GRE; Robel RJ, 2004, TRANS N AM WILDL NAT, V69, P251; Robel RJ, 2011, COMMENTS US FISH WIL; Rocky Mountain Bird Observatory, 2008, ASS CONS PLAYAS E CO; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SKAGEN SK, 1994, CONDOR, V96, P949, DOI 10.2307/1369104; Skagen SK, 2008, WETLANDS, V28, P594, DOI 10.1672/07-84.1; Steinauer EM., 1996, PRAIRIE CONSERVATION, P39; Steuter A., 2003, CONSERVING BIOL DIVE; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; U.S. Fish and Wildlife Service, 2011, SPEC PROF WHOOP CRAN; US Fish and Wildlife Service, 2009, WHOOP CRAN WIND DEV; Ventyx Corporation, 2010, VEL SUIT NEW ENTR; Western Hemisphere Shorebird Reserve Network, 2009, CHEY BOTT; WINKELMAN JE, 1995, P NAT AV WIND POW PL; Zeiler HP, 2009, FOLIA ZOOL, V58, P173	71	26	28	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26698	10.1371/journal.pone.0026698	http://dx.doi.org/10.1371/journal.pone.0026698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046333	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600044
J	Wang, LZ; Cheung, JTM; Pu, F; Li, DY; Zhang, M; Fan, YB				Wang, Lizhen; Cheung, Jason Tak-Man; Pu, Fang; Li, Deyu; Zhang, Ming; Fan, Yubo			Why Do Woodpeckers Resist Head Impact Injury: A Biomechanical Investigation	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CANCELLOUS BONE; ARCHITECTURE; DENSITY; BEHAVIOR; HISTORY; TISSUE; SPORT; SKULL; MASS	Head injury is a leading cause of morbidity and death in both industrialized and developing countries. It is estimated that brain injuries account for 15% of the burden of fatalities and disabilities, and represent the leading cause of death in young adults. Brain injury may be caused by an impact or a sudden change in the linear and/or angular velocity of the head. However, the woodpecker does not experience any head injury at the high speed of 6-7 m/s with a deceleration of 1000 g when it drums a tree trunk. It is still not known how woodpeckers protect their brain from impact injury. In order to investigate this, two synchronous high-speed video systems were used to observe the pecking process, and the force sensor was used to measure the peck force. The mechanical properties and macro/micro morphological structure in woodpecker's head were investigated using a mechanical testing system and micro-CT scanning. Finite element (FE) models of the woodpecker's head were established to study the dynamic intracranial responses. The result showed that macro/micro morphology of cranial bone and beak can be recognized as a major contributor to non-impact-injuries. This biomechanical analysis makes it possible to visualize events during woodpecker pecking and may inspire new approaches to prevention and treatment of human head injury.	[Wang, Lizhen; Pu, Fang; Li, Deyu; Fan, Yubo] Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Wang, Lizhen; Zhang, Ming] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Cheung, Jason Tak-Man] Li Ning Sports Sci Res Ctr, Beijing, Peoples R China	Beihang University; Hong Kong Polytechnic University	Wang, LZ (corresponding author), Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Beijing, Peoples R China.	ming.zhang@polyu.edu.hk; yubofan@buaa.edu.cn	Zhang, Ming/F-8331-2011	Zhang, Ming/0000-0002-6027-4594	National Natural Science Foundation of China [10925208, 11120101001]; Hong Kong Polytechnic University [G-U624]; National Key Lab of Virtual Reality Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Key Lab of Virtual Reality Technology	This project was funded by National Natural Science Foundation of China under the Grant 10925208, 11120101001 (http://www.nsfc.gov.cn/Portal0/default124.htm) and by the Hong Kong Polytechnic University under the grant G-U624 (http://www.polyu.edu.hk/cpa/polyu/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support from the National Key Lab of Virtual Reality Technology.	BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bock WJ, 1999, OSTRICH, V70, P23, DOI 10.1080/00306525.1999.9639746; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3; Corporation LST, 2006, LS DYNA KEYW US MAN; COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584; Cowin SC, 1998, J BIOMECH, V31, P759, DOI 10.1016/S0021-9290(98)00078-5; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6; Holbourn AHS, 1943, LANCET, V2, P438; HOSEY RR, 1982, HOMEOMORPHIC FINITE, P379; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Kabel J, 1999, BONE, V25, P481, DOI 10.1016/S8756-3282(99)00190-8; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lanyon LE, 1996, BONE, V18, pS37, DOI 10.1016/8756-3282(95)00378-9; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Linde F, 1988, Eng Med, V17, P23, DOI 10.1243/EMED_JOUR_1988_017_008_02; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; MAY PRA, 1976, LANCET, V1, P454; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; MLIKOVSKY J, 1989, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V53, P252; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; ROESLER H, 1987, J BIOMECH, V20, P1025, DOI 10.1016/0021-9290(87)90020-0; Ruan J. S., 1994, IMPACT BIOMECHANICS; Ruimerman R, 2001, COMPUT METHOD BIOMEC, V4, P433; Schwab IR, 2002, BRIT J OPHTHALMOL, V86, P843, DOI 10.1136/bjo.86.8.843; SPRING LOWELL W., 1965, CONDOR, V67, P457, DOI 10.2307/1365612; Stalnaker R.L., 1969, MECH PROPERTIES HEAD; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024	39	72	92	10	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26490	10.1371/journal.pone.0026490	http://dx.doi.org/10.1371/journal.pone.0026490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046293	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600022
J	Zhang, ZH; Gao, YX; Gordon, A; Wang, ZZ; Qian, ZJ; Wu, WS				Zhang, Zhonghui; Gao, Yongxing; Gordon, Albert; Wang, Zack Z.; Qian, Zhijian; Wu, Wen-Shu			Efficient Generation of Fully Reprogrammed Human iPS Cells via Polycistronic Retroviral Vector and a New Cocktail of Chemical Compounds	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; INDUCTION; EXPRESSION; ADULT; DERIVATION; INHIBITOR; OCT4	Direct reprogramming of human somatic cells into induced pluripotent stem (iPS) cells by defined transcription factors (TFs) provides great potential for regenerative medicine and biomedical research. This procedure has many challenges, including low reprogramming efficiency, many partially reprogrammed colonies, somatic coding mutations in the genome, etc. Here, we describe a simple approach for generating fully reprogrammed human iPS cells by using a single polycistronic retroviral vector expressing four human TFs in a single open reading frame (ORF), combined with a cocktail containing three small molecules (Sodium butyrate, SB431542, and PD0325901). Our results demonstrate that human iPS cells generated by this approach express human ES cells markers and exhibit pluripotency demonstrated by their abilities to differentiate into the three germ layers in vitro and in vivo. Notably, this approach not only provides a much faster reprogramming process but also significantly diminishes partially reprogrammed iPS cell colonies, thus facilitating efficient isolation of desired fully reprogrammed iPS cell colonies.	[Zhang, Zhonghui; Gao, Yongxing; Gordon, Albert; Wang, Zack Z.; Wu, Wen-Shu] Maine Med Ctr, Maine Med Ctr Res Inst, Ctr Mol Med, Stem & Progenitor Cell Biol Program, Scarborough, ME USA; [Qian, Zhijian] Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL USA; [Zhang, Zhonghui; Wu, Wen-Shu] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Maine Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Zhang, ZH (corresponding author), Maine Med Ctr, Maine Med Ctr Res Inst, Ctr Mol Med, Stem & Progenitor Cell Biol Program, Scarborough, ME USA.	wuw@mmc.org	Wu, Wen-Shu/I-1258-2014	Wu, Wen-Shu/0000-0002-0225-2522	NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [1R21HD061777]; National Institute of Diabetes and Digestive and Kidney Diseases [K01DK078180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061777] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078180] Funding Source: NIH RePORTER	NIH from the Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a NIH grant 1R21HD061777 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. W.S.W. was supported by a K01 award from the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK078180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Callaway Ewen, 2010, Nature, V468, P746, DOI 10.1038/468746a; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	38	34	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26592	10.1371/journal.pone.0026592	http://dx.doi.org/10.1371/journal.pone.0026592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046312	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600033
J	Hult, LTO; Kleiveland, CR; Fosnes, K; Jacobsen, M; Lea, T				Hult, Lene Th Olsen; Kleiveland, Charlotte R.; Fosnes, Kjetil; Jacobsen, Morten; Lea, Tor			EP Receptor Expression in Human Intestinal Epithelium and Localization Relative to the Stem Cell Zone of the Crypts	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; HEMATOPOIETIC STEM; CYCLOOXYGENASE-2 EXPRESSION; PROSTAGLANDINS; PROLIFERATION; CANCER; MARKER; ANTIBODIES; PROTEIN; GROWTH	There is substantial evidence for PGE2 affecting intestinal epithelial proliferation. PGE2 is also reported to be involved in the regulation of growth and differentiation in adult stem cells, both effects mediated by binding to EP-receptors. We have used the Lgr5 as a marker to scrutinize EP-receptor and COX expression in human intestinal epithelial cells with focus on the stem cell area of the crypts. Normal tissue from ileum and colon, but also duodenal biopsies from patients with untreated celiac disease, were investigated by immunohistochemistry and RT-PCR. The combination of fresh flash-frozen tissue and laser microdissection made it possible to isolate RNA from the epithelial cell layer, only. In the small intestine, Lgr5 labels cells are in the +4 position, while in the colon, Lgr5 positive cells are localized to the crypt bottoms. Epithelial crypt cells of normal small intestine expressed neither EP-receptor mRNA nor COX1/2. However, crypt cells in tissue from patients with untreated celiac disease expressed EP2/4 receptor and COX1 mRNA. In the colon, the situation was different. Epithelial crypt cells from normal colon were found to express EP2/4 receptor and COX1/2 transcripts. Thus, there are distinct differences between normal human small intestine and colon with regard to expression of EP2/4 receptors and COX1/2. In normal colon tissue, PGE2-mediated signaling through EP-receptors 2/4 could be involved in regulation of growth and differentiation of the epithelium, while the lack of EP-receptor expression in the small intestinal tissue exclude the possibility of a direct effect of PGE2 on the crypt epithelial cells.	[Hult, Lene Th Olsen; Kleiveland, Charlotte R.; Fosnes, Kjetil; Jacobsen, Morten; Lea, Tor] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Mol Cell Biol Grp, As, Norway; [Jacobsen, Morten] Ostfold Hosp, Fredrikstad, Norway	Norwegian University of Life Sciences	Hult, LTO (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, Mol Cell Biol Grp, As, Norway.	charlotte.kleiveland@umb.no			Norwegian Research Council [185160]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This project has been supported by Norwegian Research Council grant 185160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BJERKNES M, 1989, BIOPHYS J, V55, P1011, DOI 10.1016/S0006-3495(89)82899-1; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Cosme R, 2000, HUM IMMUNOL, V61, P684, DOI 10.1016/S0198-8859(00)00131-2; DuBois RN, 1996, GASTROENTEROLOGY, V110, P1259, DOI 10.1053/gast.1996.v110.pm8613017; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; HALSTENSEN TS, 1990, EUR J IMMUNOL, V20, P1825, DOI 10.1002/eji.1830200829; HERSCHMAN HR, 1994, CANCER METAST REV, V13, P241, DOI 10.1007/BF00666095; HONDA A, 1993, J BIOL CHEM, V268, P7759; IRWIN IS, 1998, GASTROENTEROLOGY, V115, P297; Kase M, 2007, HISTOCHEM CELL BIOL, V127, P215, DOI 10.1007/s00418-006-0241-y; Kleiveland CR, 2008, EXP CELL RES, V314, P1831, DOI 10.1016/j.yexcr.2008.02.004; Kobari L, 2001, J HEMATOTH STEM CELL, V10, P273, DOI 10.1089/15258160151134980; KURTIN PJ, 1985, HUM PATHOL, V16, P353, DOI 10.1016/S0046-8177(85)80229-X; MICHIE SA, 1987, AM J CLIN PATHOL, V88, P457, DOI 10.1093/ajcp/88.4.457; Montgomery RK, 2009, GASTROENTEROLOGY, V136, P2051, DOI 10.1053/j.gastro.2009.04.021; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Potten CS, 2002, J CELL SCI, V115, P2381; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shirahama T, 2000, CLIN CANCER RES, V6, P2424; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Sonoshita M, 2002, CANCER RES, V62, P6846; Stenson WF, 2007, CURR OPIN GASTROEN, V23, P107, DOI 10.1097/MOG.0b013e3280143cb6; TAKEUCHI K, CLIN CHIM ACTA, V411, P459; Tanaka K, 2009, EUR J PHARMACOL, V603, P120, DOI 10.1016/j.ejphar.2008.11.058; Tessner TG, 1998, GASTROENTEROLOGY, V115, P874, DOI 10.1016/S0016-5085(98)70259-8; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Torp SH, 1997, J CLIN PATHOL-MOL PA, V50, P198, DOI 10.1136/mp.50.4.198; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	44	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26816	10.1371/journal.pone.0026816	http://dx.doi.org/10.1371/journal.pone.0026816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046368	gold, Green Submitted, Green Published			2022-12-27	WOS:000296517000037
J	Hogerkorp, CM; Nishimura, Y; Song, KM; Martin, MA; Roederer, M				Hogerkorp, Carl-Magnus; Nishimura, Yoshiaki; Song, Kaimei; Martin, Malcolm A.; Roederer, Mario			The Simian Immunodeficiency Virus Targets Central Cell Cycle Functions through Transcriptional Repression In vivo	PLOS ONE			English	Article							CD4(+) T-CELLS; GENE-EXPRESSION PROFILES; BLOOD MONONUCLEAR-CELLS; HUMAN PERIPHERAL-BLOOD; TOLL-LIKE RECEPTOR; IMMUNE ACTIVATION; TYPE-1 INFECTION; HIV-1 INFECTION; DENDRITIC CELLS; INDUCIBLE GENES	A massive and selective loss of CD4+ memory T cells occurs during the acute phase of immunodeficiency virus infections. The mechanism of this depletion is poorly understood but constitutes a key event with implications for progression. We assessed gene expression of purified T cells in Rhesus Macaques during acute SIVmac239 infection in order to define mechanisms of pathogenesis. We observe a general transcriptional program of over 1,600 interferon- stimulated genes induced in all T cells by the infection. Furthermore, we identify 113 transcriptional changes that are specific to virally infected cells. A striking downregulation of several key cell cycle regulator genes was observed and shared promotor-region E2F binding sites in downregulated genes suggested a targeted transcriptional control of an E2F regulated cell cycle program. In addition, the upregulation of the gene for the fundamental regulator of RNA polymerase II, TAF7, demonstrates that viral interference with the cell cycle and transcriptional regulation programs may be critical components during the establishment of a pathogenic infection in vivo.	[Hogerkorp, Carl-Magnus; Song, Kaimei; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nishimura, Yoshiaki; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hogerkorp, CM (corresponding author), Novo Nordisk AS, Dept Mol Genet, Malov, Denmark.	CMGH@novonordisk.com; Roederer@nih.gov	Roederer, Mario/G-1887-2011		National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005019, ZIAAI000998] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKEL H, 1994, VIROLOGY, V205, P34, DOI 10.1006/viro.1994.1617; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Battistini A, 2002, J INTERF CYTOK RES, V22, P27, DOI 10.1089/107999002753452638; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Brother MB, 1996, VIROLOGY, V222, P252, DOI 10.1006/viro.1996.0416; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; CAPOBIANCHI MR, 1992, AIDS RES HUM RETROV, V8, P575, DOI 10.1089/aid.1992.8.575; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chan Gordon K, 2003, Prog Cell Cycle Res, V5, P431; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; *COMM CAR US LAB A, 1985, GUID CAR US LAB AN; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Devaiah BN, 2010, J BIOL CHEM, V285, P38772, DOI 10.1074/jbc.M110.173864; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2001, P NATL ACAD SCI USA, V98, P12432, DOI 10.1073/pnas.211444798; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Gibellini D, 2002, VIRUS RES, V90, P337, DOI 10.1016/S0168-1702(02)00253-8; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Igarashi T, 2002, J VIROL, V76, P379, DOI 10.1128/JVI.76.1.379-391.2002; Imbeault M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-5; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kashanchi F, 2000, J VIROL, V74, P652, DOI 10.1128/JVI.74.2.652-660.2000; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Ketloy C, 2008, VET IMMUNOL IMMUNOP, V125, P18, DOI 10.1016/j.vetimm.2008.05.001; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lace MJ, 2010, VIROLOGY, V399, P270, DOI 10.1016/j.virol.2009.12.025; Lace MJ, 2009, CARCINOGENESIS, V30, P1336, DOI 10.1093/carcin/bgp150; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Motomura K, 2004, INT IMMUNOPHARMACOL, V4, P1829, DOI 10.1016/j.intimp.2004.07.031; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Nekhai S, 2000, VIROLOGY, V266, P246, DOI 10.1006/viro.1999.0035; Nilsson J, 2004, BIOINFORMATICS, V20, P874, DOI 10.1093/bioinformatics/btg496; Nishimura Y, 2009, P NATL ACAD SCI USA, V106, P8015, DOI 10.1073/pnas.0903022106; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Pijnappel WWMP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-46; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schaefer TM, 2006, MICROBES INFECT, V8, P1839, DOI 10.1016/j.micinf.2006.02.022; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shaheduzzaman S, 2002, J BIOMED SCI, V9, P82, DOI 10.1007/BF02256581; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang Y, 2010, NEUROSCI LETT, V479, P97, DOI 10.1016/j.neulet.2010.05.032; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994	75	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25684	10.1371/journal.pone.0025684	http://dx.doi.org/10.1371/journal.pone.0025684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043290	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400018
J	Leventis, PA; Da Sylva, TR; Rajwans, N; Wasiak, S; McPherson, PS; Boulianne, GL				Leventis, Peter A.; Da Sylva, Tanya R.; Rajwans, Nimerta; Wasiak, Sylwia; McPherson, Peter S.; Boulianne, Gabrielle L.			Liquid facets-Related (lqfR) Is Required for Egg Chamber Morphogenesis during Drosophila Oogenesis	PLOS ONE			English	Article							ENTH-DOMAIN; COOPERATIVE BINDING; CELL-SIZE; PROTEIN; CLATHRIN; GENE; EPSIN; AMPLIFICATION; SYNTAXIN-16; TRAFFICKING	Clathrin interactor 1 [CLINT1] (also called enthoprotin/EpsinR) is an Epsin N-terminal homology (ENTH) domain-containing adaptor protein that functions in anterograde and retrograde clathrin-mediated trafficking between the trans-Golgi network and the endosome. Removal of both Saccharomyces cerevisiae homologs, Ent3p and Ent5p, result in yeast that are viable, but that display a cold-sensitive growth phenotype and mistrafficking of various vacuolar proteins. Similarly, either knockdown or overexpression of vertebrate CLINT1 in cell culture causes mistrafficking of proteins. Here, we have characterized Drosophila CLINT1, liquid-facets Related (lqfR). LqfR is ubiquitously expressed throughout development and is localized to the Golgi and endosome. Strong hypomorphic mutants generated by imprecise P-element excision exhibit extra macrochaetae, rough eyes and are female sterile. Although essentially no eggs are laid, the ovaries do contain late-stage egg chambers that exhibit abnormal morphology. Germline clones reveal that LqfR expression in the somatic follicle cells is sufficient to rescue the oogenesis defects. Clones of mutant lqfR follicle cells have a decreased cell size consistent with a downregulation of Akt1. We find that while total Akt1 levels are increased there is also a significant decrease in activated phosphorylated Akt1. Taken together, these results show that LqfR function is required to regulate follicle cell size and signaling during Drosophila oogenesis.	[Leventis, Peter A.; Da Sylva, Tanya R.; Rajwans, Nimerta; Boulianne, Gabrielle L.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Leventis, Peter A.; Boulianne, Gabrielle L.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Wasiak, Sylwia; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Toronto	Leventis, PA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	gboul@sickkids.ca			Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research [MOP14143, MOP 62684]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research to GLB (MOP14143) and to PSM (MOP 62684). PAL and SW were supported by CIHR Doctoral Research Awards and GLB is the recipient of a Tier I Canada Research Chair in Molecular and Developmental Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Bandura JL, 2005, CURR BIOL, V15, P755, DOI 10.1016/j.cub.2005.02.063; Benard C, 2001, DEVELOPMENT, V128, P4045; Cavaliere V, 2005, DEV DYNAM, V232, P845, DOI 10.1002/dvdy.20333; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chou TB, 1996, GENETICS, V144, P1673; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hussain NK, 2003, J BIOL CHEM, V278, P28823, DOI 10.1074/jbc.M300995200; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; Kalthoff C, 2003, J CHROMATOGR B, V786, P247, DOI 10.1016/S1570-0232(02)00908-X; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kim SY, 2006, GENE EXPR PATTERNS, V6, P504, DOI 10.1016/j.modgep.2005.10.009; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Morgan JR, 2000, J NEUROSCI, V20, P8667; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Robinson DN, 1997, GENETICS, V145, P1063; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; SNYDER PB, 1986, P NATL ACAD SCI USA, V83, P3341, DOI 10.1073/pnas.83.10.3341; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Spradling AC, 1999, GENETICS, V153, P135; Spradling Allan C., 1993, P1; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; STAPLETON M, 2002, GENOME BIOL, V0003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25466	10.1371/journal.pone.0025466	http://dx.doi.org/10.1371/journal.pone.0025466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043285	gold, Green Published, Green Submitted			2022-12-27	WOS:000295984400012
J	Nasi, T; Virtanen, J; Noponen, T; Toppila, J; Salmi, T; Ilmoniemi, RJ				Nasi, Tiina; Virtanen, Jaakko; Noponen, Tommi; Toppila, Jussi; Salmi, Tapani; Ilmoniemi, Risto J.			Spontaneous Hemodynamic Oscillations during Human Sleep and Sleep Stage Transitions Characterized with Near-Infrared Spectroscopy	PLOS ONE			English	Article							LOW-FREQUENCY OSCILLATIONS; RAPID EYE-MOVEMENTS; CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; NEUROIMAGING INSIGHTS; NEURAL ACTIVITY; FLUCTUATIONS; VARIABILITY; OXYGENATION; MECHANISMS	Understanding the interaction between the nervous system and cerebral vasculature is fundamental to forming a complete picture of the neurophysiology of sleep and its role in maintaining physiological homeostasis. However, the intrinsic hemodynamics of slow-wave sleep (SWS) are still poorly known. We carried out 30 all-night sleep measurements with combined near-infrared spectroscopy (NIRS) and polysomnography to investigate spontaneous hemodynamic behavior in SWS compared to light (LS) and rapid-eye-movement sleep (REM). In particular, we concentrated on slow oscillations (3-150 mHz) in oxy- and deoxyhemoglobin concentrations, heart rate, arterial oxygen saturation, and the pulsation amplitude of the photoplethysmographic signal. We also analyzed the behavior of these variables during sleep stage transitions. The results indicate that slow spontaneous cortical and systemic hemodynamic activity is reduced in SWS compared to LS, REM, and wakefulness. This behavior may be explained by neuronal synchronization observed in electrophysiological studies of SWS and a reduction in autonomic nervous system activity. Also, sleep stage transitions are asymmetric, so that the SWS-to-LS and LS-to-REM transitions, which are associated with an increase in the complexity of cortical electrophysiological activity, are characterized by more dramatic hemodynamic changes than the opposite transitions. Thus, it appears that while the onset of SWS and termination of REM occur only as gradual processes over time, the termination of SWS and onset of REM may be triggered more abruptly by a particular physiological event or condition. The results suggest that scalp hemodynamic changes should be considered alongside cortical hemodynamic changes in NIRS sleep studies to assess the interaction between the autonomic and central nervous systems.	[Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Aalto Univ, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland; [Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Univ Helsinki, Cent Hosp, BioMag Lab, HUSLAB, Helsinki, Finland; [Noponen, Tommi] Turku Univ Hosp, Dept Nucl Med, FIN-20520 Turku, Finland; [Noponen, Tommi] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland; [Toppila, Jussi; Salmi, Tapani] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, Helsinki, Finland	Aalto University; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Nasi, T (corresponding author), Aalto Univ, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	jaakko.virtanen@aalto.fi	Näsi, Tiina/E-7314-2012; Ilmoniemi, Risto/E-9704-2012	Näsi, Tiina/0000-0002-5311-3530; Ilmoniemi, Risto/0000-0002-3340-2618	Finnish Cultural Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was primarily funded by personal research grants to Nasi and Virtanen from the Finnish Cultural Foundation (http://www.skr.fi/, grant numbers not given). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Ayalon L, 2007, CURR OPIN PULM MED, V13, P479, DOI 10.1097/MCP.0b013e3282f0e9fb; Bangash MF, 2008, SLEEP, V31, P321, DOI 10.1093/sleep/31.3.321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brassard P, 2010, J APPL PHYSIOL, V108, P1472, DOI 10.1152/japplphysiol.01206.2009; Busek P, 2005, PHYSIOL RES, V54, P369, DOI 10.33549/physiolres.930645; Camm AJ, 1996, EUR HEART J, V17, P354; Chua ECP, 2010, ANN BIOMED ENG, V38, P945, DOI 10.1007/s10439-009-9882-z; Cope M, 1991, THESIS U COLL LONDON; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Desseilles M, 2008, SLEEP, V31, P777, DOI 10.1093/sleep/31.6.777; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Germon TJ, 1998, J CLIN MONITOR COMP, V14, P353, DOI 10.1023/A:1009957032554; Haddock RE, 2005, J PHYSIOL-LONDON, V566, P645, DOI 10.1113/jphysiol.2005.086405; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hong CCH, 2009, HUM BRAIN MAPP, V30, P1705, DOI 10.1002/hbm.20635; HOSHI Y, 1994, BRAIN RES, V652, P257, DOI 10.1016/0006-8993(94)90235-6; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Iber C., 2007, AASM MANUAL SCORING; Igawa M, 2001, PSYCHIAT CLIN NEUROS, V55, P187, DOI 10.1046/j.1440-1819.2001.00819.x; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kubota Y, 2011, BRAIN RES, V1389, P83, DOI 10.1016/j.brainres.2011.02.061; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2009, EUR J NEUROSCI, V29, P1761, DOI 10.1111/j.1460-9568.2009.06720.x; Meadows GE, 2004, J APPL PHYSIOL, V97, P1343, DOI 10.1152/japplphysiol.01101.2003; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Muller T, 2003, MED BIOL ENG COMPUT, V41, P69, DOI 10.1007/BF02343541; Nissila I, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884193; Nissila I, 2005, ADV ELECTROMAG FIELD, V4, P77, DOI 10.1007/0-387-24024-1_3; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Olopade CO, 2007, SLEEP, V30, P1747, DOI 10.1093/sleep/30.12.1747; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Peigneux P, 2004, PSYCHOL BELG, V44, P121; Pizza F, 2010, SLEEP, V33, P205, DOI 10.1093/sleep/33.2.205; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Shelley KH, 2007, ANESTH ANALG, V105, pS31, DOI 10.1213/01.ane.0000269512.82836.c9; Shiotsuka S, 1998, PSYCHIAT CLIN NEUROS, V52, P172, DOI 10.1111/j.1440-1819.1998.tb01012.x; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Spielman AJ, 2000, BRAIN RES, V866, P313, DOI 10.1016/S0006-8993(00)02320-9; Tachtsidis I, 2004, PHYSIOL MEAS, V25, P437, DOI 10.1088/0967-3334/25/2/003; Uchida-Ota M, 2008, NEUROIMAGE, V42, P357, DOI 10.1016/j.neuroimage.2008.03.055; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Zoccoli G, 2002, SLEEP MED REV, V6, P443, DOI 10.1053/smrv.2001.0194	59	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25415	10.1371/journal.pone.0025415	http://dx.doi.org/10.1371/journal.pone.0025415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043284	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400011
J	Chang, XL; Heene, E; Qiao, F; Nick, P				Chang, Xiaoli; Heene, Ernst; Qiao, Fei; Nick, Peter			The Phytoalexin Resveratrol Regulates the Initiation of Hypersensitive Cell Death in Vitis Cell	PLOS ONE			English	Article							STILBENE SYNTHASE GENE; LIFE-SPAN; DISEASE RESISTANCE; BOTRYTIS-CINEREA; AUXIN TRANSPORT; VINIFERA L.; GRAPEVINE; EXPRESSION; ACTIN; PATHOGEN	Resveratrol is a major phytoalexin produced by plants in response to various stresses and promotes disease resistance. The resistance of North American grapevine Vitis rupestris is correlated with a hypersensitive reaction (HR), while susceptible European Vitis vinifera cv. 'Pinot Noir' does not exhibit HR, but expresses basal defence. We have shown previously that in cell lines derived from the two Vitis species, the bacterial effector Harpin induced a rapid and sensitive accumulation of stilbene synthase (StSy) transcripts, followed by massive cell death in V. rupestris. In the present work, we analysed the function of the phytoalexin resveratrol, the product of StSy. We found that cv. 'Pinot Noir' accumulated low resveratrol and its glycoside trans-piceid, whereas V. rupestris produced massive trans-resveratrol and the toxic oxidative delta-viniferin, indicating that the preferred metabolitism of resveratrol plays role in Vitis resistance. Cellular responses to resveratrol included rapid alkalinisation, accumulation of pathogenesis-related protein 5 (PR5) transcripts, oxidative burst, actin bundling, and cell death. Microtubule disruption and induction of StSy were triggered by Harpin, but not by resveratrol. Whereas most responses proceeded with different amplitude for the two cell lines, the accumulation of resveratrol, and the competence for resveratrol-induced oxidative burst differed in quality. The data lead to a model, where resveratrol, in addition to its classical role as antimicrobial phytoalexin, represents an important regulator for initiation of HR-related cell death.	[Chang, Xiaoli; Heene, Ernst; Nick, Peter] Karlsruhe Inst Technol, Bot Inst 1, Dept Mol Cell Biol, Karlsruhe, Germany; [Qiao, Fei] Chinese Acad Trop Agr Sci, Inst Trop Crops Genet Resources, Danzhou, Peoples R China	Helmholtz Association; Karlsruhe Institute of Technology; Chinese Academy of Tropical Agricultural Sciences	Chang, XL (corresponding author), Karlsruhe Inst Technol, Bot Inst 1, Dept Mol Cell Biol, Karlsruhe, Germany.	chang.xiaoli@bio.uni-karlsruhe.de			Chinese Scholarship Council	Chinese Scholarship Council(China Scholarship Council)	This work was supported by fellowships of the Chinese Scholarship Council to Xiaoli Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Aumont V, 2004, J BIOTECHNOL, V109, P287, DOI 10.1016/j.jbiotec.2004.01.004; Barcelo AR, 2003, FUNCT PLANT BIOL, V30, P577, DOI 10.1071/FP02096; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Berghofer T, 2009, BIOCHEM BIOPH RES CO, V387, P590, DOI 10.1016/j.bbrc.2009.07.072; Blagosklonny MV, 2009, AGING-US, V1, P511, DOI 10.18632/aging.100059; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; CALDERON AA, 1992, PLANT CELL TISS ORG, V29, P63, DOI 10.1007/BF00033609; CALDERON AA, 1990, ELECTROPHORESIS, V11, P507, DOI 10.1002/elps.1150110614; Celimene CC, 2001, PHYTOCHEMISTRY, V56, P161, DOI 10.1016/S0031-9422(00)00384-8; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; DING JP, 1993, PLANT J, V3, P83, DOI 10.1111/j.1365-313X.1993.tb00013.x; Donnez D, 2011, PROCESS BIOCHEM, V46, P1056, DOI 10.1016/j.procbio.2011.01.019; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fornara V, 2008, PROTOPLASMA, V233, P83, DOI 10.1007/s00709-008-0309-8; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gonzalez-Barrio R, 2006, J AGR FOOD CHEM, V54, P4222, DOI 10.1021/jf060160f; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; Hofseth LJ, 2010, AGING-US, V2, P183, DOI 10.18632/aging.100143; Hohenberger P, 2011, BBA-BIOMEMBRANES, V1808, P2304, DOI 10.1016/j.bbamem.2011.05.019; HOOS G, 1990, J PHYTOPATHOL, V129, P102, DOI 10.1111/j.1439-0434.1990.tb04293.x; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jovanovic AM, 2010, J EXP BOT, V61, P901, DOI 10.1093/jxb/erp369; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Kushiro T, 2003, NATURE, V422, P122, DOI 10.1038/422122a; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Langcake P, 1997, J CHEM SOC CHEM COMM, V7, P208; Leckband G, 1998, THEOR APPL GENET, V96, P1004, DOI 10.1007/s001220050832; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Maisch J, 2009, J EXP BOT, V60, P603, DOI 10.1093/jxb/ern307; Mazars C, 1997, CELL CALCIUM, V22, P413, DOI 10.1016/S0143-4160(97)90025-7; Morales M, 1997, AM J ENOL VITICULT, V48, P33; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Nick P, 2010, PLANT SIGNAL BEHAV, V5, P94, DOI 10.4161/psb.5.2.10337; Nick Peter, 2008, V11, P175, DOI 10.1007/7089_2007_145; Osmond RIW, 2001, EUR J BIOCHEM, V268, P4190, DOI 10.1046/j.1432-1327.2001.02331.x; Pedreno M.A., 1996, PLANT PEROXIDASES BI, P338; Pezet R, 2004, PHYSIOL MOL PLANT P, V65, P297, DOI 10.1016/j.pmpp.2005.03.002; Pezet R, 2004, VITIS, V43, P145; Qiao F, 2001, THESIS KARLSRUHE I T, P58; Qiao F, 2010, J EXP BOT, V61, P4021, DOI 10.1093/jxb/erq221; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Sano T, 2005, PLANT J, V44, P595, DOI 10.1111/j.1365-313X.2005.02558.x; StarkLorenzen P, 1997, PLANT CELL REP, V16, P668, DOI 10.1007/s002990050299; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Tassoni A, 2005, NEW PHYTOL, V166, P895, DOI 10.1111/j.1469-8137.2005.01383.x; Thomzik JE, 1997, PHYSIOL MOL PLANT P, V51, P265, DOI 10.1006/pmpp.1997.0123; Unger S, 2007, PHYTOPATHOLOGY, V97, P780, DOI 10.1094/PHYTO-97-7-0780; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Xu WR, 2011, J EXP BOT, V62, P2745, DOI 10.1093/jxb/erq447; Zimmermann S, 1997, P NATL ACAD SCI USA, V94, P2751, DOI 10.1073/pnas.94.6.2751	66	94	104	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26405	10.1371/journal.pone.0026405	http://dx.doi.org/10.1371/journal.pone.0026405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053190	Green Published, gold			2022-12-27	WOS:000299081800016
J	Polonelli, L; Giovati, L; Magliani, W; Conti, S; Sforza, S; Calabretta, A; Casoli, C; Ronzi, P; Grilli, E; Gallo, A; Masoero, F; Piva, G				Polonelli, Luciano; Giovati, Laura; Magliani, Walter; Conti, Stefania; Sforza, Stefano; Calabretta, Alessandro; Casoli, Claudio; Ronzi, Paola; Grilli, Ester; Gallo, Antonio; Masoero, Francesco; Piva, Gianfranco			Vaccination of Lactating Dairy Cows for the Prevention of Aflatoxin B-1 Carry Over in Milk	PLOS ONE			English	Article							MUTAGENICITY; METABOLISM; RESPONSES; HEALTH; ASSAY	The potential of anaflatoxin B-1 (AnAFB(1)) conjugated to keyhole limpet hemocyanin (KLH) as a vaccine (AnAFB(1)-KLH) in controlling the carry over of the aflatoxin B-1 (AFB(1)) metabolite aflatoxin M-1 (AFM(1)) in cow milk is reported. AFB(1) is the most carcinogenic compound in food and foodstuffs amongst aflatoxins (AFs). AnAFB(1) is AFB(1) chemically modified as AFB(1)-1(O-carboxymethyl) oxime. In comparison to AFB(1), AnAFB(1) has proven to be non-toxic in vitro to human hepatocarcinoma cells and non mutagenic to Salmonella typhimurium strains. AnAFB(1)-KLH was used for immunization of cows proving to induce a long lasting titer of anti-AFB(1) IgG antibodies (Abs) which were cross reactive with AFB(1), AFG(1), and AFG(2). The elicited anti-AFB(1) Abs were able to hinder the secretion of AFM(1) into the milk of cows continuously fed with AFB(1). Vaccination of lactating animals with conjugated AnAFB(1) may represent a solution to the public hazard constituted by milk and cheese contaminated with AFs.	[Polonelli, Luciano; Giovati, Laura; Magliani, Walter; Conti, Stefania] Univ Parma, Sez Microbiol, Dipartimento Patol & Med Lab, I-43100 Parma, Italy; [Sforza, Stefano; Calabretta, Alessandro] Univ Parma, Dipartimento Chim Organ & Ind, I-43100 Parma, Italy; [Casoli, Claudio; Ronzi, Paola] Univ Milan, Dipartimento Sci Clin L Sacco, Sez Malattie Infett & Immunopatol, Milan, Italy; [Grilli, Ester] Univ Bologna, Dipartimento Sci Med Vet, Bologna, Italy; [Gallo, Antonio; Masoero, Francesco; Piva, Gianfranco] Univ Cattolica Sacro Cuore, Ist Sci Alimenti & Nutr, Fac Agr, Piacenza, Italy	University of Parma; University of Parma; University of Milan; University of Bologna; Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Polonelli, L (corresponding author), Univ Parma, Sez Microbiol, Dipartimento Patol & Med Lab, I-43100 Parma, Italy.	luciano.polonelli@unipr.it	Conti, Stefania/N-3558-2015; Gallo, Antonio/B-1382-2010; Giovati, Laura/ABH-7376-2020; Sforza, Stefano/AAE-9579-2019	Conti, Stefania/0000-0001-9973-8352; Gallo, Antonio/0000-0002-4700-4450; Grilli, Ester/0000-0001-8351-9542; GIOVATI, LAURA/0000-0001-7514-1789; Sforza, Stefano/0000-0001-5559-3411; MASOERO, Francesco/0000-0002-0373-6051	Fondazione Cassa di Risparmio di Parma e Piacenza	Fondazione Cassa di Risparmio di Parma e Piacenza	This work was supported by funds from "Fondazione Cassa di Risparmio di Parma e Piacenza" http://www.fondazionecrp.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, IARC Monogr Eval Carcinog Risks Hum, V56, P445; [Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; Boutrif Ezzeddine, 1995, Natural Toxins, V3, P322, DOI 10.1002/nt.2620030430; CHU FS, 1977, J ASSOC OFF ANA CHEM, V60, P791; Diaz DE, 2004, MYCOPATHOLOGIA, V157, P233, DOI 10.1023/B:MYCO.0000020587.93872.59; Diaz DE, 2003, MYCOPATHOLOGIA, V156, P223, DOI 10.1023/A:1023388321713; Eaton DL, 1994, BIOTRANSFORMATION AF, P45; European Commission, 2002, OFF J EURO COMMUN L, V179, P13; European Communities,, 2001, OFFICIAL J EUROPEAN; FAO, 2004, 81 FAO; Gallo A, 2008, ITAL J ANIM SCI, V7, P53; Helrich KC, 1995, OFF METH AN AOAC; Henry SH, 1999, SCIENCE, V286, P2453, DOI 10.1126/science.286.5449.2453; Hernandez A, 2003, GENET SEL EVOL, V35, pS67, DOI 10.1051/gse:2003017; Herzallah SM, 2009, FOOD CHEM, V114, P1141, DOI 10.1016/j.foodchem.2008.10.077; Kutz RE, 2009, J DAIRY SCI, V92, P3959, DOI 10.3168/jds.2009-2031; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LEE NJ, 1995, J AGR FOOD CHEM, V43, P1730, DOI 10.1021/jf00054a060; Littell RC, 1998, J ANIM SCI, V76, P1216; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Masoero F, 2007, ANIMAL, V1, P1344, DOI 10.1017/S1751731107000663; MCLEAN M, 1995, PHARMACOL THERAPEUT, V65, P163, DOI 10.1016/0163-7258(94)00054-7; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Newman MJ, 1996, VET IMMUNOL IMMUNOP, V50, P43, DOI 10.1016/0165-2427(95)05483-9; Nino-Soto MI, 2008, DEV BIOLOGICALS, V132, P315, DOI 10.1159/000317277; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Odunola O A, 2000, Afr J Med Med Sci, V29, P105; Odunola O A, 1998, Afr J Med Med Sci, V27, P1; Piva G, 1995, NUTR RES, V5, P689; Richard J., 2003, 139 CAST; U. S. Department of Health and Human Services PHS National Toxicology Program, 2005, REP CARC; UENO I, 1978, EXPERIENTIA, V34, P85, DOI 10.1007/BF01921918; Wagter LC, 2000, J DAIRY SCI, V83, P488, DOI 10.3168/jds.S0022-0302(00)74908-3; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; WONG JJ, 1976, P NATL ACAD SCI USA, V73, P2241, DOI 10.1073/pnas.73.7.2241; Xu QH, 2006, BIOCONJUGATE CHEM, V17, P1508, DOI 10.1021/bc060083u; Yousef A. E., 1989, Mycotoxins in dairy products., P127	38	17	18	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26777	10.1371/journal.pone.0026777	http://dx.doi.org/10.1371/journal.pone.0026777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053212	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800040
J	Vanderplanck, C; Ansseau, E; Charron, S; Stricwant, N; Tassin, A; Laoudj-Chenivesse, D; Wilton, SD; Coppee, F; Belayew, A				Vanderplanck, Celine; Ansseau, Eugenie; Charron, Sebastien; Stricwant, Nadia; Tassin, Alexandra; Laoudj-Chenivesse, Dalila; Wilton, Steve D.; Coppee, Frederique; Belayew, Alexandra			The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; THYROID-HORMONE; MU-CRYSTALLIN; MESSENGER-RNA; GENE; MUSCLE; D4Z4; PROTEIN; LOCUS; INHIBITION	Background: Facioscapulohumeral muscular dystrophy (FSHD) is linked to deletions in 4q35 within the D4Z4 repeat array in which we identified the double homeobox 4 (DUX4) gene. We found stable DUX4 mRNAs only derived from the most distal D4Z4 unit and unexpectedly extended to the flanking pLAM region that provided an intron and a polyadenylation signal. DUX4 encodes a transcription factor expressed in FSHD but not control primary myoblasts or muscle biopsies. The DUX4 protein initiates a large transcription deregulation cascade leading to muscle atrophy and oxidative stress, which are FSHD key features. Methodology/Principal Findings: We now show that transfection of myoblasts with a DUX4 expression vector leads to atrophic myotube formation associated with the induction of E3 ubiquitin ligases (MuRF1 and Atrogin1/MAFbx) typical of muscle atrophy. DUX4 induces expression of downstream targets deregulated in FSHD such as mu-crystallin and TP53. We developed specific siRNAs and antisense oligonucleotides (AOs) targeting the DUX4 mRNA. Addition of these antisense agents to primary FSHD myoblast cultures suppressed DUX4 protein expression and affected expression of the above-mentioned markers. Conclusions/Significance: These results constitute a proof of concept for the development of therapeutic approaches for FSHD targeting DUX4 expression.	[Vanderplanck, Celine; Ansseau, Eugenie; Charron, Sebastien; Stricwant, Nadia; Tassin, Alexandra; Coppee, Frederique; Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium; [Laoudj-Chenivesse, Dalila] Ctr Hosp Univ Arnaud de Villeneuve, INSERM U1046, Montpellier, France; [Wilton, Steve D.] Univ Western Australia, Mol Genet Therapy Grp, Nedlands, WA 6009, Australia	University of Mons; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; University of Western Australia	Vanderplanck, C (corresponding author), Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium.	alexandra.belayew@umons.ac.be	BELAYEW, Alexandra/D-5205-2013; Laoudj-Chenivesse, dalila/N-7097-2018	BELAYEW, Alexandra/0000-0001-5115-2424; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Wilton, Steve/0000-0002-9400-893X	Association Belge contre les Maladies Neuro-Musculaires; Association Francaise contre les Myopathies [14078]; FSHD Stichting; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture	Association Belge contre les Maladies Neuro-Musculaires; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); FSHD Stichting; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This study was funded by grants from the Association Belge contre les Maladies Neuro-Musculaires (www.abmm.be), the Association Francaise contre les Myopathies (14078, www.afm-telethon.fr), FSHD Stichting (www.fshd.nl) and Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (www.fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantana A, 2005, CURR OPIN PHARMACOL, V5, P550, DOI 10.1016/j.coph.2005.07.001; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; de Palma L, 2008, JOINT BONE SPINE, V75, P53, DOI 10.1016/j.jbspin.2007.04.019; Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Dixit M, 2007, FASEB J, V21, P870; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Errington SJ, 2003, J GENE MED, V5, P518, DOI 10.1002/jgm.361; Fletcher S, 2010, MOL THER, V18, P1218, DOI 10.1038/mt.2010.45; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; KIM RY, 1992, P NATL ACAD SCI USA, V89, P9292, DOI 10.1073/pnas.89.19.9292; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Masny PS, 2010, EUR J HUM GENET, V18, P448, DOI 10.1038/ejhg.2009.183; MUSCAT GEO, 1995, BIOESSAYS, V17, P211, DOI 10.1002/bies.950170307; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; PADBERG GW, 1995, MUSCLE NERVE, pS73; Reed PW, 2007, EXP NEUROL, V205, P583, DOI 10.1016/j.expneurol.2007.03.009; Richards M, 2011, HUMAN GENET IN PRESS; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; Vickers TA, 2001, NUCLEIC ACIDS RES, V29, P1293, DOI 10.1093/nar/29.6.1293; Vie MP, 1997, MOL ENDOCRINOL, P11; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	49	124	134	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26820	10.1371/journal.pone.0026820	http://dx.doi.org/10.1371/journal.pone.0026820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053214	Green Published, gold			2022-12-27	WOS:000299081800045
J	Ehsani, S; Tao, RZ; Pocanschi, CL; Ren, HZ; Harrison, PM; Schmitt-Ulms, G				Ehsani, Sepehr; Tao, Renzhu; Pocanschi, Cosmin L.; Ren, Hezhen; Harrison, Paul M.; Schmitt-Ulms, Gerold			Evidence for Retrogene Origins of the Prion Gene Family	PLOS ONE			English	Article							GDNF FAMILY; MOLECULAR CHARACTERIZATION; INTRON LOSS; PROTEIN; EXPRESSION; EVOLUTION; PSEUDOGENES; IDENTIFICATION; CONSERVATION; SEQUENCE	The evolutionary origin of prion genes, only known to exist in the vertebrate lineage, had remained elusive until recently. Following a lead from interactome investigations of the murine prion protein, our previous bioinformatic analyses revealed the evolutionary descent of prion genes from an ancestral ZIP metal ion transporter. However, the molecular mechanism of evolution remained unexplored. Here we present a computational investigation of this question based on sequence, intron-exon, synteny and pseudogene analyses. Our data suggest that during the emergence of metazoa, a cysteine-flanked core domain was modularly inserted, or arose de novo, in a preexisting ZIP ancestor gene to generate a prion-like ectodomain in a subbranch of ZIP genes. Approximately a half-billion years later, a genomic insertion of a spliced transcript coding for such a prion-like ZIP ectodomain may have created the prion founder gene. We document that similar genomic insertions involving ZIP transcripts, and probably relying on retropositional elements, have indeed occurred more than once throughout evolution.	[Ehsani, Sepehr; Tao, Renzhu; Pocanschi, Cosmin L.; Ren, Hezhen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ehsani, Sepehr; Tao, Renzhu; Ren, Hezhen; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Toronto; University of Toronto; McGill University	Ehsani, S (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	sepehr.ehsani@utoronto.ca; g.schmittulms@utoronto.ca	Ehsani, Sepehr/E-9257-2010	Ehsani, Sepehr/0000-0002-9613-6898	Garfield Weston Foundation; Canadian Institutes of Health Research [MOP-74734]; PrioNet Canada; Ontario Graduate Scholarship; University of Toronto; MRC [MC_G1000734] Funding Source: UKRI; Medical Research Council [MC_G1000734] Funding Source: researchfish	Garfield Weston Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PrioNet Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship); University of Toronto(University of Toronto); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work on this project was funded through generous support from the Garfield Weston Foundation, the Canadian Institutes of Health Research (MOP-74734) and PrioNet Canada. SE was supported through an Ontario Graduate Scholarship and a University of Toronto Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BELL LM, 1994, J BIOL CHEM, V269, P22758; Brosius J, 2005, CYTOGENET GENOME RES, V110, P8, DOI 10.1159/000084934; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; Cereseto A, 2004, AIDS REV, V6, P13; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; Fablet M, 2009, MOL BIOL EVOL, V26, P2147, DOI 10.1093/molbev/msp125; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Ortutay C, 2007, IMMUNOGENETICS, V59, P333, DOI 10.1007/s00251-007-0191-0; Ortutay C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-299; Premzl M, 2004, MOL BIOL EVOL, V21, P2210, DOI 10.1093/molbev/msh245; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V117, P421; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, TRENDS GENET, V22, P468, DOI 10.1016/j.tig.2006.07.002; Roy SW, 2006, GENOME RES, V16, P1270, DOI 10.1101/gr.5410606; Saeki K, 1996, VIRUS GENES, V12, P15, DOI 10.1007/BF00369996; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Schueler-Furman O, 2006, TRENDS PHARMACOL SCI, V27, P72, DOI 10.1016/j.tips.2005.12.004; Seilacher A, 1998, SCIENCE, V282, P80, DOI 10.1126/science.282.5386.80; Simonic T, 2000, FEBS LETT, V469, P33, DOI 10.1016/S0014-5793(00)01232-1; Sorek R, 2009, HEREDITY, V103, P279, DOI 10.1038/hdy.2009.62; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Terai G, 2010, NUCLEIC ACIDS RES, V38, P1163, DOI 10.1093/nar/gkp1098; VANIN EF, 1984, BIOCHIM BIOPHYS ACTA, V782, P231, DOI 10.1016/0167-4781(84)90057-5; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608	45	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26800	10.1371/journal.pone.0026800	http://dx.doi.org/10.1371/journal.pone.0026800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046361	gold, Green Submitted, Green Published			2022-12-27	WOS:000296521400034
J	Haming, D; Simoes-Costa, M; Uy, B; Valencia, J; Sauka-Spengler, T; Bronner-Fraser, M				Haeming, Daniela; Simoes-Costa, Marcos; Uy, Benjamin; Valencia, Jonathan; Sauka-Spengler, Tatjana; Bronner-Fraser, Marianne			Expression of Sympathetic Nervous System Genes in Lamprey Suggests Their Recruitment for Specification of a New Vertebrate Feature	PLOS ONE			English	Article							ACHAETE-SCUTE HOMOLOG-1; NEURAL CREST CELLS; REGULATORY NETWORK; EVOLUTION; ORIGIN; HEART	The sea lamprey is a basal, jawless vertebrate that possesses many neural crest derivatives, but lacks jaws and sympathetic ganglia. This raises the possibility that the factors involved in sympathetic neuron differentiation were either a gnathostome innovation or already present in lamprey, but serving different purposes. To distinguish between these possibilities, we isolated lamprey homologues of transcription factors associated with peripheral ganglion formation and examined their deployment in lamprey embryos. We further performed Dil labeling of the neural tube combined with neuronal markers to test if neural crest-derived cells migrate to and differentiate in sites colonized by sympathetic ganglia in jawed vertebrates. Consistent with previous anatomical data in adults, our results in lamprey embryos reveal that neural crest cells fail to migrate ventrally to form sympathetic ganglia, though they do form dorsal root ganglia adjacent to the neural tube. Interestingly, however, paralogs of the battery of transcription factors that mediate sympathetic neuron differentiation (dHand, Ascl1 and Phox2b) are present in the lamprey genome and expressed in various sites in the embryo, but fail to overlap in any ganglionic structures. This raises the intriguing possibility that they may have been recruited during gnathostome evolution to a new function in a neural crest derivative.	[Haeming, Daniela; Simoes-Costa, Marcos; Uy, Benjamin; Valencia, Jonathan; Sauka-Spengler, Tatjana; Bronner-Fraser, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Haming, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Simoes-Costa, Marcos/AAX-4780-2020	Bronner, Marianne/0000-0003-4274-1862; Sauka-Spengler, Tatjana/0000-0001-9289-0263	National Institutes of Health [R01 DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institutes of Health (Grant #R01 DE017911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Braun CB, 1996, BRAIN BEHAV EVOLUT, V48, P262, DOI 10.1159/000113205; BURNSTOCK G, 1969, PHARMACOL REV, V21, P247; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gibbins I, 1994, COMP PHYSL EVOLUTION, P1; GOBYRIN VA, 1965, B EXP BIOL MED-USSR, V59, P92; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; JOHNELS A. G., 1956, ACTA ZOOL [STOCKHOLM], V37, P251; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Le Douarin N.M., 1982, NEURAL CREST; LIGNON JM, 1979, J MOL CELL CARDIOL, V11, P447, DOI 10.1016/0022-2828(79)90469-3; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; NICOL JAC, 1952, BIOL REV, V27, P1; Nikitina N., 2009, COLD SPRING HARBOR P; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Northcutt RG, 1996, BRAIN BEHAV EVOLUT, V48, P237, DOI 10.1159/000113203; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; OWSIANNIKOF T, 1883, B ACAD SCI ST PETERS, V28, P440; Pattyn A, 1997, DEVELOPMENT, V124, P4065; ROVAINEN CM, 1979, PHYSIOL REV, V59, P1007, DOI 10.1152/physrev.1979.59.4.1007; Rychlik JL, 2005, J MOL NEUROSCI, V27, P281, DOI 10.1385/JMN:27:3:281; Sauka-Spengler T, 2008, BIOL BULL-US, V214, P303, DOI 10.2307/25470671; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Sauka-Spengler T, 2008, GENESIS, V46, P673, DOI 10.1002/dvg.20436; Schmidt M, 2009, DEV BIOL, V329, P191, DOI 10.1016/j.ydbio.2009.02.020; Scofield MA, 2002, MOL BIOTECHNOL, V21, P171, DOI 10.1385/MB:21:2:171	30	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26543	10.1371/journal.pone.0026543	http://dx.doi.org/10.1371/journal.pone.0026543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046306	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000296521400026
J	Keller, S; Macheleidt, J; Scherlach, K; Schmaler-Ripcke, J; Jacobsen, ID; Heinekamp, T; Brakhage, AA				Keller, Sophia; Macheleidt, Juliane; Scherlach, Kirstin; Schmaler-Ripcke, Jeannette; Jacobsen, Ilse D.; Heinekamp, Thorsten; Brakhage, Axel A.			Pyomelanin Formation in Aspergillus fumigatus Requires HmgX and the Transcriptional Activator HmgR but Is Dispensable for Virulence	PLOS ONE			English	Article							LYSINE BIOSYNTHESIS; HOMOGENTISIC ACID; CONIDIAL PIGMENT; GENE CLUSTERS; MELANIN; IDENTIFICATION; NIDULANS; SYNTHASE; PKSP; HOMOACONITASE	The opportunistic human pathogenic fungus Aspergillus fumigatus is able to produce the dark brown pigment pyomelanin by degradation of L-tyrosine. Pyomelanin was shown to protect the fungus against reactive oxygen intermediates as well as cell wall disturbing compounds and is therefore assumed to protect against immune effector cells during the infection process. Several genes for tyrosine degradation and pyomelanin formation are organized in a cluster in the genome of A. fumigatus. Here, we aimed at further analyzing tyrosine degradation and a possible role of pyomelanin in virulence. For this purpose, the function of two not yet characterized genes of the cluster, i.e., hmgX and hmgR, was analyzed. Generation of corresponding gene deletion mutants and reconstituted strains revealed that hmgX and hmgR are essential for tyrosine degradation. Both mutants, Delta hmgX and Delta hmgR, were not able to use tyrosine as sole carbon or nitrogen source and revealed impaired pyomelanin production. HmgR harbors a Zn(II)2Cys6-DNA binding domain. Analyses of the steady state mRNA levels revealed that HmgR acts as a transcriptional activator for the genes of the tyrosine degradation cluster. Consistently, an HmgR-eGFP fusion protein was localized in the nucleus of A. fumigatus cells. By contrast, HmgX was found to be localized in the cytoplasm and does not contribute to regulation of gene transcription. HPLC analyses showed that HmgX is crucial for the conversion of p-hydroxyphenylpyruvate to homogentisic acid, the main intermediate in pyomelanin formation. Thus, HmgX is supposed to function as an accessory factor to mediate specific activity of HppD. Remarkably, the ability to degrade tyrosine and to form pyomelanin is dispensable for virulence of A. fumigatus in a murine infection model.	[Keller, Sophia; Macheleidt, Juliane; Schmaler-Ripcke, Jeannette; Heinekamp, Thorsten; Brakhage, Axel A.] Hans Knoll Inst HKI, Dept Mol & Appl Microbiol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Scherlach, Kirstin] Hans Knoll Inst HKI, Dept Biomol Chem, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Jacobsen, Ilse D.] Hans Knoll Inst HKI, Dept Microbial Pathogen Mech, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Keller, Sophia; Macheleidt, Juliane; Heinekamp, Thorsten; Brakhage, Axel A.] Univ Jena, Dept Microbiol & Mol Biol, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Keller, S (corresponding author), Hans Knoll Inst HKI, Dept Mol & Appl Microbiol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	thorsten.heinekamp@hki-jena.de; axel.brakhage@hki-jena.de	Jacobsen, Ilse/B-3155-2011	Jacobsen, Ilse/0000-0002-6033-9984; Heinekamp, Thorsten/0000-0001-9503-9634; Scherlach, Kirstin/0000-0002-1326-3761	excellence graduate school, Jena School for Microbial Communication (JSMC)	excellence graduate school, Jena School for Microbial Communication (JSMC)	The work was in part funded by the excellence graduate school, Jena School for Microbial Communication (JSMC; www.jsmc.uni-jena.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brakhage Axel A., 2008, V66; Carreira A, 2001, APPL ENVIRON MICROB, V67, P3463, DOI 10.1128/AEM.67.8.3463-3468.2001; COLLIER RH, 1972, J BACTERIOL, V112, P365, DOI 10.1128/JB.112.1.365-371.1972; COON SL, 1994, APPL ENVIRON MICROB, V60, P3006, DOI 10.1128/AEM.60.8.3006-3010.1994; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FERNANDEZCANON JM, 1995, P NATL ACAD SCI USA, V92, P9132, DOI 10.1073/pnas.92.20.9132; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Grosse C, 2008, APPL ENVIRON MICROB, V74, P4923, DOI 10.1128/AEM.00470-08; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hospenthal DR, 1998, MED MYCOL, V36, P165, DOI 10.1046/j.1365-280X.1998.00147.x; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Iraqui I, 1998, MOL GEN GENET, V257, P238, DOI 10.1007/s004380050644; Iraqui I, 1999, MOL CELL BIOL, V19, P3360; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Krappmann S, 2006, MOL MICROBIOL, V61, P76, DOI 10.1111/j.1365-2958.2006.05215.x; Kupfahl C, 2006, MOL MICROBIOL, V62, P292, DOI 10.1111/j.1365-2958.2006.05373.x; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Langfelder K, 2001, INFECT IMMUN, V69, P6411, DOI 10.1128/IAI.69.10.6411-6418.2001; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Liebmann B, 2004, ARCH MICROBIOL, V181, P378, DOI 10.1007/s00203-004-0667-3; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; MANN S, 1969, ARCH MIKROBIOL, V65, P359, DOI 10.1007/BF00412214; Milcamps A, 1999, MICROBIOL-UK, V145, P935, DOI 10.1099/13500872-145-4-935; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Penalva MA, 2001, FUNGAL GENET BIOL, V34, P1, DOI 10.1006/fgbi.2001.1284; Sambrook J., 2001, MOL CLONING LAB MANU; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; Thywi en A, 2011, FRONT MICROBIO, DOI 103389/fmicb201100096; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Wartenberg D, 2011, INT J MED MICROBIOL, DOI 101016/jijmm201104016; Weidner G, 1997, MOL GEN GENET, V255, P237, DOI 10.1007/s004380050494	53	33	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26604	10.1371/journal.pone.0026604	http://dx.doi.org/10.1371/journal.pone.0026604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046314	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400028
J	Bijtenhoorn, P; Mayerhofer, H; Muller-Dieckmann, J; Utpatel, C; Schipper, C; Hornung, C; Szesny, M; Grond, S; Thurmer, A; Brzuszkiewicz, E; Daniel, R; Dierking, K; Schulenburg, H; Streit, WR				Bijtenhoorn, Patrick; Mayerhofer, Hubert; Mueller-Dieckmann, Jochen; Utpatel, Christian; Schipper, Christina; Hornung, Claudia; Szesny, Matthias; Grond, Stephanie; Thuermer, Andrea; Brzuszkiewicz, Elzbieta; Daniel, Rolf; Dierking, Katja; Schulenburg, Hinrich; Streit, Wolfgang R.			A Novel Metagenomic Short-Chain Dehydrogenase/Reductase Attenuates Pseudomonas aeruginosa Biofilm Formation and Virulence on Caenorhabditis elegans	PLOS ONE			English	Article							ACYL-HOMOSERINE LACTONE; SP STRAIN; CONJUGAL TRANSFER; TI PLASMID; IDENTIFICATION; DEHYDROGENASES/REDUCTASES; EXPRESSION; MODEL; SDR; TRANSFORMATION	In Pseudomonas aeruginosa, the expression of a number of virulence factors, as well as biofilm formation, are controlled by quorum sensing (QS). N-Acylhomoserine lactones (AHLs) are an important class of signaling molecules involved in bacterial QS and in many pathogenic bacteria infection and host colonization are AHL-dependent. The AHL signaling molecules are subject to inactivation mainly by hydrolases (Enzyme Commission class number EC 3) (i.e. N-acyl-homoserine lactonases and N-acyl-homoserine-lactone acylases). Only little is known on quorum quenching mechanisms of oxidoreductases (EC 1). Here we report on the identification and structural characterization of the first NADP-dependent short-chain dehydrogenase/reductase (SDR) involved in inactivation of N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-C-12-HSL) and derived from a metagenome library. The corresponding gene was isolated from a soil metagenome and designated bpiB09. Heterologous expression and crystallographic studies established BpiB09 as an NADP-dependent reductase. Although AHLs are probably not the native substrate of this metagenome-derived enzyme, its expression in P. aeruginosa PAO1 resulted in significantly reduced pyocyanin production, decreased motility, poor biofilm formation and absent paralysis of Caenorhabditis elegans. Furthermore, a genome-wide transcriptome study suggested that the level of lasI and rhlI transcription together with 36 well known QS regulated genes was significantly (>= 10-fold) affected in P. aeruginosa strains expressing the bpiB09 gene in pBBR1MCS-5. Thus AHL oxidoreductases could be considered as potent tools for the development of quorum quenching strategies.	[Bijtenhoorn, Patrick; Utpatel, Christian; Schipper, Christina; Hornung, Claudia; Streit, Wolfgang R.] Univ Hamburg, Abt Mikrobiol & Biotechnol, Biozentrum Klein Flottbek, Hamburg, Germany; [Mayerhofer, Hubert; Mueller-Dieckmann, Jochen] EMBL Hamburg Outstat, Hamburg, Germany; [Szesny, Matthias; Grond, Stephanie] Univ Tubingen, Inst Organ Chem, D-7400 Tubingen, Germany; [Thuermer, Andrea; Brzuszkiewicz, Elzbieta; Daniel, Rolf] Univ Gottingen, Lab Genomanal, Inst Mikrobiol & Genet, Gottingen, Germany; [Dierking, Katja; Schulenburg, Hinrich] Univ Kiel, Dept Evolutionary Ecol & Genet, Kiel, Germany	University of Hamburg; European Molecular Biology Laboratory (EMBL); Eberhard Karls University of Tubingen; University of Gottingen; University of Kiel	Bijtenhoorn, P (corresponding author), Univ Hamburg, Abt Mikrobiol & Biotechnol, Biozentrum Klein Flottbek, Hamburg, Germany.	wolfgang.streit@uni-hamburg.de	Ziegler, Katja/GPT-0482-2022; Schulenburg, Hinrich/A-3886-2009; Dierking, Katja/E-1050-2011; Daniel, Rolf/AAQ-5933-2021; Streit, Wolfgang R/K-1366-2012; Streit, Wolfgang/S-3049-2019	Dierking, Katja/0000-0002-5129-346X; Daniel, Rolf/0000-0002-8646-7925; Streit, Wolfgang/0000-0001-7617-7396; Grond, Stephanie/0000-0002-7549-4936; Mayerhofer, Hubert/0000-0002-3291-2376	Bundesministerium fur Bildung und Forschung-Kompetenznetzwerk GenoMik-Transfer	Bundesministerium fur Bildung und Forschung-Kompetenznetzwerk GenoMik-Transfer(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung-Kompetenznetzwerk GenoMik-Transfer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bijtenhoorn P, 2011, J BIOTECHNOL, V155, P86, DOI 10.1016/j.jbiotec.2010.12.016; Chen RD, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-39; Chowdhary PK, 2008, J BIOTECHNOL, V135, P374, DOI 10.1016/j.jbiotec.2008.05.005; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Czajkowski R, 2011, ENV MICROBIOL REP, V3, P59, DOI 10.1111/j.1758-2229.2010.00188.x; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fuqua C, 1996, J BACTERIOL, V178, P435, DOI 10.1128/jb.178.2.435-440.1996; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2006, FEBS J, V273, P1177, DOI 10.1111/j.1742-4658.2006.05153.x; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luo ZQ, 2001, MOL PLANT MICROBE IN, V14, P98, DOI 10.1094/MPMI.2001.14.1.98; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Morohoshi T, 2008, BIOSCI BIOTECH BIOCH, V72, P1887, DOI 10.1271/bbb.80139; Mueller-Dieckmann J, 2006, ACTA CRYSTALLOGR D, V62, P1446, DOI 10.1107/S0907444906038121; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Papaioannou E, 2009, ANTIMICROB AGENTS CH, V53, P4891, DOI 10.1128/AAC.00380-09; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Popov AN, 2003, ACTA CRYSTALLOGR D, V59, P1145, DOI 10.1107/S0907444903008163; Sambrook J., 2001, MOL CLONING LAB MANU; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schipper C, 2009, APPL ENVIRON MICROB, V75, P224, DOI 10.1128/AEM.01389-08; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Shepherd RW, 2009, APPL ENVIRON MICROB, V75, P45, DOI 10.1128/AEM.01723-08; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Stiernagle Theresa, 2006, WormBook, P1; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Uroz S, 2007, ARCH MICROBIOL, V187, P249, DOI 10.1007/s00203-006-0186-5; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wagner VE, 2007, ANAL BIOANAL CHEM, V387, P469, DOI 10.1007/s00216-006-0964-6; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Zhu CG, 2006, BIOTECHNOL BIOENG, V95, P526, DOI 10.1002/bit.21032	63	74	80	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26278	10.1371/journal.pone.0026278	http://dx.doi.org/10.1371/journal.pone.0026278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046268	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600013
J	Peacock, JD; Huk, DJ; Ediriweera, HN; Lincoln, J				Peacock, Jacqueline D.; Huk, Danielle J.; Ediriweera, Hasini N.; Lincoln, Joy			Sox9 Transcriptionally Represses Spp1 to Prevent Matrix Mineralization in Maturing Heart Valves and Chondrocytes	PLOS ONE			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; EXTRACELLULAR-MATRIX; BONE SIALOPROTEIN; OSTEOBLAST DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; CAMPOMELIC DYSPLASIA; DEFICIENT MICE; AORTIC VALVES; IN-VITRO	Sox9 is an SRY-related transcription factor required for expression of cartilaginous genes in the developing skeletal system and heart valve structures. In contrast to positively regulating cartilaginous matrix, Sox9 also negatively regulates matrix mineralization associated with bone formation. While the transcriptional activation of Sox9 target genes during chondrogenesis has been characterized, the mechanisms by which Sox9 represses osteogenic processes are not so clear. Using ChIP-on-chip and luciferase assays we show that Sox9 binds and represses transactivation of the osteogenic glycoprotein Spp1. In addition, Sox9 knockdown in post natal mouse heart valve explants and rib chondrocyte cultures promotes Spp1 expression and matrix mineralization, while attenuating expression of cartilage genes Type II Collagen and Cartilage Link Protein. Further, we show that Spp1 is required for matrix mineralization induced by Sox9 knockdown. These studies provide insights into the molecular mechanisms by which Sox9 prevents pathologic matrix mineralization in tissues that must remain cartilaginous.	[Peacock, Jacqueline D.; Huk, Danielle J.] Univ Miami, Mol & Cellular Pharmacol Grad Program, Leonard M Miller Sch Med, Miami, FL USA; [Huk, Danielle J.; Lincoln, Joy] Ohio State Univ, Dept Pediat, Ctr Cardiovasc & Pulm Res, Res Inst,Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Lincoln, Joy] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL USA; [Lincoln, Joy] Univ Miami, Dept Med, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Miami; University of Miami	Peacock, JD (corresponding author), Univ Miami, Mol & Cellular Pharmacol Grad Program, Leonard M Miller Sch Med, Miami, FL USA.	joy.lincoln@nationwidechildrens.org		Lincoln, Joy/0000-0003-1517-6888	The American Heart Association [09PRE2050088]; The Florida Biomedical Research Program; The James and Esther King Award [07KN-07]; National Institutes of Health/National Heart, Lung and Blood Institute [R01HL091878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091878] Funding Source: NIH RePORTER	The American Heart Association(American Heart Association); The Florida Biomedical Research Program; The James and Esther King Award; National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The American Heart Association (09PRE2050088) (http://www.heart.org/HEARTORG), The Florida Biomedical Research Program, The James and Esther King Award (07KN-07) (http://www.floridabiomed.com), and the National Institutes of Health/National Heart, Lung and Blood Institute (R01HL091878) (http://www.nhlbi.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Alexopoulos A, 2010, INT J CARDIOL, V139, P142, DOI 10.1016/j.ijcard.2008.10.014; ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Inman CK, 2003, J BIOL CHEM, V278, P48684, DOI 10.1074/jbc.M308001200; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kojima H, 2004, J BIOCHEM, V136, P377, DOI 10.1093/jb/mvh136; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lehmann S, 2009, ANN THORAC SURG, V88, P1476, DOI 10.1016/j.athoracsur.2009.07.025; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; NG LJ, 1997, DEV BIOL, V183; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Ohri R, 2005, CALCIFIED TISSUE INT, V76, P307, DOI 10.1007/s00223-004-0071-7; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pan QH, 2009, BIOCHEM BIOPH RES CO, V379, P356, DOI 10.1016/j.bbrc.2008.12.062; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rennenberg RJMW, 2010, J CELL MOL MED, V14, P2203, DOI 10.1111/j.1582-4934.2010.01139.x; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shibata S, 2002, J ANAT, V200, P309, DOI 10.1046/j.1469-7580.2002.00033.x; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Thirion S, 2004, METH MOLEC MED, V100, P1; Thurner PJ, 2010, BONE, V46, P1564, DOI 10.1016/j.bone.2010.02.014; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	50	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26769	10.1371/journal.pone.0026769	http://dx.doi.org/10.1371/journal.pone.0026769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046352	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600056
J	Katzmarzyk, PT; Champagne, CM; Tudor-Locke, C; Broyles, ST; Harsha, D; Kennedy, BM; Johnson, WD				Katzmarzyk, Peter T.; Champagne, Catherine M.; Tudor-Locke, Catrine; Broyles, Stephanie T.; Harsha, David; Kennedy, Betty M.; Johnson, William D.			A Short-Term Physical Activity Randomized Trial in the Lower Mississippi Delta	PLOS ONE			English	Article							ACTIVITY INTERVENTION; UNITED-STATES; INDIVIDUALS; WALKING; HEALTH; PEDOMETERS; BEHAVIORS; STEPS/DAY; PROGRAM	Background: The purpose of this study was to determine if a short-term pedometer-based intervention results in immediate increases in time spent in moderate-to-vigorous physical activity (MVPA) compared to a minimal educational intervention. Methods: A sample of 43 overweight adults 35 to 64 years of age participated in a one week pedometer-based feasibility trial monitored by accelerometry. Participants were randomized into a one-week education-only group or a group that also wore a pedometer. Accelerometer-measured MVPA was measured over 7 days at baseline and again for 7 days immediately post-intervention. Results: Minutes of MVPA increased significantly in the overall sample (p = 0.02); however, the effect of adding the pedometer to the education program was not significant (p = 0.89). Mean (+/-SE) MVPA increased from 12.7+/-2.4 min/day to 16.2+/-3.6 min/day in the education-only group and from 13.2+/-3.3 min/day to 16.3+/-3.9 min/day in the education+pedometer group. The correlation between change in steps/day and change in MVPA was 0.69 (p<0.0001). Conclusions: The results of this study suggest that the addition of a pedometer to a short-term education program does not produce added benefits with respect to increasing physical activity in the Lower Mississippi Delta.	[Katzmarzyk, Peter T.; Champagne, Catherine M.; Tudor-Locke, Catrine; Broyles, Stephanie T.; Harsha, David; Kennedy, Betty M.; Johnson, William D.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Katzmarzyk, PT (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	Peter.Katzmarzyk@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017; Broyles, Stephanie/C-8647-2011; Champagne, Catherine/N-1956-2017; Tudor-Locke, Catrine/AAC-2829-2021; Johnson, William/N-1972-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Broyles, Stephanie/0000-0003-3168-0056; Champagne, Catherine/0000-0001-6127-1072; Johnson, William/0000-0002-3823-4094	ARS/USDA [58-6251-8-038]; Louisiana Public Facilities Authority Endowed Chair in Nutrition	ARS/USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Louisiana Public Facilities Authority Endowed Chair in Nutrition	This research was supported by ARS/USDA cooperative agreement no. 58-6251-8-038. PTK is partially supported by the Louisiana Public Facilities Authority Endowed Chair in Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe M, 2010, J CARDIOPULM REHABIL, V30, P111, DOI 10.1097/HCR.0b013e3181be7c80; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Camhi SM, 2011, J PHYS ACT HEALTH, V8, P382, DOI 10.1123/jpah.8.3.382; Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S; De Greef K, 2010, HEALTH EDUC RES, V25, P724, DOI 10.1093/her/cyq017; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; McMurdo MET, 2010, J AM GERIATR SOC, V58, P2099, DOI 10.1111/j.1532-5415.2010.03127.x; Napolitano MA, 2010, CONTEMP CLIN TRIALS, V31, P514, DOI 10.1016/j.cct.2010.08.004; Opdenacker J, 2008, PREV MED, V46, P518, DOI 10.1016/j.ypmed.2008.02.017; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Ricbardson CR, 2008, ANN FAM MED, V6, P69, DOI 10.1370/afm.761; Talbot LA, 2003, J AM GERIATR SOC, V51, P387, DOI 10.1046/j.1532-5415.2003.51113.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trust for America's Health, 2010, F FAT OB THREAT AM F; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2004, MED SCI SPORT EXER, V36, P1567, DOI 10.1249/01.MSS.0000139806.53824.2E; Tudor-Locke C, 2008, J PHYS ACT HEALTH, V5, P633, DOI 10.1123/jpah.5.5.633; Tudor-Locke CE, 2002, PATIENT EDUC COUNS, V47, P23, DOI 10.1016/S0738-3991(01)00169-0; Tudor-Locke CE, 2001, DIABETES EDUCATOR, V27, P85, DOI 10.1177/014572170102700110; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Wewel AR, 2008, RESP MED, V102, P20, DOI 10.1016/j.rmed.2007.08.011; Whaley DE, 2008, RES Q EXERCISE SPORT, V79, P245; Wyatt HR, 2005, MED SCI SPORT EXER, V37, P724, DOI 10.1249/01.MSS.0000161750.84096.D4; Zoellner J, 2010, J PHYS ACT HEALTH, V7, P224, DOI 10.1123/jpah.7.2.224	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26667	10.1371/journal.pone.0026667	http://dx.doi.org/10.1371/journal.pone.0026667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841MS	22046325	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000025
J	Saavedra, S; Duch, J; Uzzi, B				Saavedra, Serguei; Duch, Jordi; Uzzi, Brian			Tracking Traders' Understanding of the Market Using e-Communication Data	PLOS ONE			English	Article							BEHAVIOR	Tracking the volume of keywords in Internet searches, message boards, or Tweets has provided an alternative for following or predicting associations between popular interest or disease incidences. Here, we extend that research by examining the role of e-communications among day traders and their collective understanding of the market. Our study introduces a general method that focuses on bundles of words that behave differently from daily communication routines, and uses original data covering the content of instant messages among all day traders at a trading firm over a 40-month period. Analyses show that two word bundles convey traders' understanding of same day market events and potential next day market events. We find that when market volatility is high, traders' communications are dominated by same day events, and when volatility is low, communications are dominated by next day events. We show that the stronger the traders' attention to either same day or next day events, the higher their collective trading performance. We conclude that e-communication among traders is a product of mass collaboration over diverse viewpoints that embodies unique information about their weak or strong understanding of the market.	[Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA; [Saavedra, Serguei] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Duch, Jordi] Univ Rovira & Virgili, Dept Comp Sci & Math, Tarragona, Spain	Northwestern University; Northwestern University; Northwestern University; Universitat Rovira i Virgili	Saavedra, S (corresponding author), Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA.	uzzi@northwestern.edu	Duch, Jordi/A-7000-2008	Duch, Jordi/0000-0003-2639-6333	Kellogg School of Management, Northwestern University; Northwestern Institute on Complex Systems (NICO); Army Research Laboratory [W911NF-09-2-0053]; NUCATS [UL1RR025741]; Spanish Ministry of Science and Technology [FIS2009-13730-C02-02]; Generalitat de Catalunya [SGR-00838-2009]; Office of Advanced Cyberinfrastructure (OAC) [0838564] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Kellogg School of Management, Northwestern University; Northwestern Institute on Complex Systems (NICO); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NUCATS; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SS and BU thank the Kellogg School of Management, Northwestern University, the Northwestern Institute on Complex Systems (NICO), and the Army Research Laboratory under Cooperative Agreement W911NF-09-2-0053 for financial support. SS also thanks NUCATS grant UL1RR025741. JD thanks the Spanish Ministry of Science and Technology (FIS2009-13730-C02-02) and the Generalitat de Catalunya (SGR-00838-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; BAK P, 1993, PHYS REV LETT, V71, P4083, DOI 10.1103/PhysRevLett.71.4083; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; Diermeier D, 2000, J ECON THEORY, V94, P46, DOI 10.1006/jeth.2000.2682; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HARRIS M, 1993, REV FINANC STUD, V6, P473, DOI 10.1093/rfs/6.3.473; Hong H, 2005, J FINANC, V60, P2801, DOI 10.1111/j.1540-6261.2005.00817.x; Kirman A., 2011, COMPLEX EC INDIVIDUA; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LUHN HP, 1960, AM DOC, V11, P288, DOI 10.1002/asi.5090110403; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Newman M.E.J., 2010, NETWORKS INTRO; Page Scott., 2007, DIFFERENCE; PINKER S, 2008, STUFF THOUGHT LANGUA; Poon SH, 2003, J ECON LIT, V41, P478, DOI 10.1257/002205103765762743; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Saavedra S, 2011, P NATL ACAD SCI USA, V108, P5296, DOI 10.1073/pnas.1018462108; Saavedra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013475; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Smith, 2010, P INT AAAI C WEBL SO; Sole RV, 2010, COMPLEXITY, V15, P20, DOI 10.1002/cplx.20305; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Whaley RE, 2000, J PORTFOLIO MANAGE, V26, P12, DOI 10.3905/jpm.2000.319728; Zhao ZY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056107; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; ZOLTAN E, 2008, ADV PHYS, V57, P89	36	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26705	10.1371/journal.pone.0026705	http://dx.doi.org/10.1371/journal.pone.0026705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841MS	22046335	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000027
J	Ahn, JH; Kim, Y; Kim, HS; Greengard, P; Nairn, AC				Ahn, Jung-Hyuck; Kim, Yong; Kim, Hee-Sun; Greengard, Paul; Nairn, Angus C.			Protein Kinase C-Dependent Dephosphorylation of Tyrosine Hydroxylase Requires the B56 delta Heterotrimeric Form of Protein Phosphatase 2A	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; REGULATORY SUBUNIT; PC12 CELLS; PHOSPHORYLATION; EXPRESSION; ALPHA; HOLOENZYME; SERINE-40; RECEPTOR; CASCADE	Tyrosine hydroxylase, which plays a critical role in regulation of dopamine synthesis, is known to be controlled by phosphorylation at several critical sites. One of these sites, Ser40, is phosphorylated by a number of protein kinases, including protein kinase A. The major protein phosphatase that dephosphorylates Ser40 is protein phosphatase-2A (PP2A). A recent study has also linked protein kinase C to the dephosphorylation of Ser40 [1], but the mechanism is unclear. PP2A isoforms are comprised of catalytic, scaffold, and regulatory subunits, the regulatory B subunits being able to influence cellular localization and substrate selection. In the current study, we find that protein kinase C is able to phosphorylate a key regulatory site in the B56 delta subunit leading to activation of PP2A. In turn, activation of the B56 delta-containing heterotrimeric form of PP2A is responsible for enhanced dephosphorylation of Ser40 of tyrosine hydroylase in response to stimulation of PKC. In support of this mechanism, down-regulation of B56 delta expression in N27 cells using RNAi was found to increase dopamine synthesis. Together these studies reveal molecular details of how protein kinase C is linked to reduced tyrosine hydroxylase activity via control of PP2A, and also add to the complexity of protein kinase/protein phosphatase interactions.	[Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Kim, Yong; Greengard, Paul; Nairn, Angus C.] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Kim, Hee-Sun] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Kim, Hee-Sun] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Seoul, South Korea; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Ewha Womans University; Rockefeller University; Ewha Womans University; Ewha Womans University; Yale University	Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	ahnj@ewha.ac.kr; angus.nairn@yale.edu		Nairn, Angus/0000-0002-7075-0195; Ahn, Jung-Hyuck/0000-0001-9589-3881; Greengard, Paul/0000-0002-4437-0893; Kim, Yong/0000-0002-1387-2962	National Institutes of Health [DA10044, MH74866, MH090963]; National Research Foundation of Korea (NRF); Korea government (MEST) [2010-0029354]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was supported by grants from the National Institutes of Health (Grant DA10044, MH74866, and MH090963 to PG and ACN) and National Research Foundation of Korea (NRF) grant funded by Korea government (MEST) (2010-0029354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; Bobrovskaya L, 1998, J NEUROCHEM, V70, P2565; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; CAHILL AL, 1989, NEUROSCIENCE, V30, P811, DOI 10.1016/0306-4522(89)90172-3; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; FUNAKOSHI H, 1991, J BIOL CHEM, V266, P15614; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Huang W, 2005, J CELL PHYSIOL, V205, P37, DOI 10.1002/jcp.20372; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kumer SC, 1996, J NEUROCHEM, V67, P443; Leal RB, 2002, NEUROCHEM RES, V27, P207, DOI 10.1023/A:1014880403970; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Nagase T, 1997, J BIOCHEM, V122, P178; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Saraf A, 2010, BIOCHEMISTRY-US, V49, P986, DOI 10.1021/bi902160t; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26292	10.1371/journal.pone.0026292	http://dx.doi.org/10.1371/journal.pone.0026292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22046270	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200015
J	Pandya, AD; Al-Jaderi, Z; Hoglund, RA; Holmoy, T; Harbo, HF; Norgauer, J; Maghazachi, AA				Pandya, Abhilash D.; Al-Jaderi, Zaidoon; Hoglund, Rune A.; Holmoy, Trygve; Harbo, Hanne F.; Norgauer, Johannes; Maghazachi, Azzam A.			Identification of Human NK17/NK1 Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HETEROTRIMERIC G-PROTEINS; HUMAN NK CELLS; ROR-GAMMA-T; CHEMOKINE RECEPTORS; DIFFERENTIATION; SUBSETS; MOBILIZATION; PRECURSORS; EXPRESSION	Background: Natural killer (NK) cells have both cytolytic and immunoregulatory functions. We recently described that these cells release the inflammatory cytokines IL-17 and IFN-gamma. However, the precise identity of the NK cell subset(s) that secrete these cytokines is not known. Methodology/Principal Findings: To isolate the cells secreting IL-17 and IFN-gamma, we took advantage of the findings that Th17/Th1 cells express chemokine receptors. Therefore, CD56(+) NK cells were stained with antibodies against various chemokine receptors and intracellularly with antibodies toward IL-17 and IFN-gamma. Consequently, we identified previously unrecognized subset of NK cells generated from normal human peripheral blood after activation with IL-2 but not PMA plus ionomycin. The cells are characterized by the expression of CD56(+) and CCR4(+), produce IL-17 and IFN-gamma and are consequently named NK17/NK1 cells. They also express CD161, NKp30, NKp44, NKp46, NKG2D, CD158, CCL22, IL-2R beta and the common gamma chain but not CD127 or IL-23R. Further, they possess T-bet and ROR gamma t transcription factors. Antibodies to IL-1 beta, IL-6, IL-21, or TGF-beta 1 do not inhibit IL-2-induced generation of NK17/NK1 cells, suggesting that IL-2 has the capacity to polarize these cells. Notably, NK17/NK1 cells are abundant in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) without activation, and are generated from the peripheral blood of these patients after activation with IL-2. Conclusions/Significance: NK17/NK1 cells identified here have not been previously described in healthy or MS patients.	[Pandya, Abhilash D.; Al-Jaderi, Zaidoon; Hoglund, Rune A.; Maghazachi, Azzam A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Physiol, Oslo, Norway; [Holmoy, Trygve] Oslo Univ Hosp, Inst Immunol, Oslo, Norway; [Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Norgauer, Johannes] Jena Univ Hosp, Dept Dermatol, Jena, Germany	University of Oslo; University of Oslo; University of Oslo; Friedrich Schiller University of Jena	Pandya, AD (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Physiol, Oslo, Norway.	azzam.maghazachi@medisin.uio.no	Salim, Zaidon/E-7928-2017	Salim, Zaidon/0000-0002-8445-1161; Pandya, Abhilash D./0000-0002-7713-3050; Maghazachi, Azzam/0000-0002-3310-678X; Hoglund, Rune Alexander/0000-0002-5801-3360	University of Oslo; Halvor Hoies Fond; Norwegian Cancer Society; Forskerlinjen fellowship	University of Oslo; Halvor Hoies Fond; Norwegian Cancer Society(Norwegian Cancer Society); Forskerlinjen fellowship	This work was supported by grants from the University of Oslo, Halvor Hoies Fond, and the Norwegian Cancer Society. AP is supported by a student fellowship from the University of Oslo, and RH is supported by Forskerlinjen fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aoukaty A, 1998, IMMUNOLOGY, V95, P618; Al-Falahi Y, 2009, J CELL MOL MED, V13, P2693, DOI 10.1111/j.1582-4934.2008.00640.x; Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Peritt D, 1998, J IMMUNOL, V161, P5821; Robertson MJ, 2000, CELL IMMUNOL, V199, P8, DOI 10.1006/cimm.1999.1601; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Rolin J, 2010, CANCER IMMUNOL IMMUN, V59, P575, DOI 10.1007/s00262-009-0775-7; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Shi FD, 2011, AUTOIMMUNITY, V44, P3, DOI 10.3109/08916931003782122; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3	27	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26780	10.1371/journal.pone.0026780	http://dx.doi.org/10.1371/journal.pone.0026780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039549	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200052
J	Abul-Husn, NS; Annangudi, SP; Ma'ayan, A; Ramos-Ortolaza, DL; Stockton, SD; Gomes, I; Sweedler, JV; Devi, LA				Abul-Husn, Noura S.; Annangudi, Suresh P.; Ma'ayan, Avi; Ramos-Ortolaza, Dinah L.; Stockton, Steven D., Jr.; Gomes, Ivone; Sweedler, Jonathan V.; Devi, Lakshmi A.			Chronic Morphine Alters the Presynaptic Protein Profile: Identification of Novel Molecular Targets Using Proteomics and Network Analysis	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; DORSAL STRIATUM; CEREBRAL-CORTEX; DATABASE; EXPRESSION; COMPONENTS; INHIBITION; EXPOSURE; COCAINE	Opiates produce significant and persistent changes in synaptic transmission; knowledge of the proteins involved in these changes may help to understand the molecular mechanisms underlying opiate dependence. Using an integrated quantitative proteomics and systems biology approach, we explored changes in the presynaptic protein profile following a paradigm of chronic morphine administration that leads to the development of dependence. For this, we isolated presynaptic fractions from the striata of rats treated with saline or escalating doses of morphine, and analyzed the proteins in these fractions using differential isotopic labeling. We identified 30 proteins that were significantly altered by morphine and integrated them into a protein-protein interaction (PPI) network representing potential morphine-regulated protein complexes. Graph theory-based analysis of this network revealed clusters of densely connected and functionally related morphine-regulated clusters of proteins. One of the clusters contained molecular chaperones thought to be involved in regulation of neurotransmission. Within this cluster, cysteine-string protein (CSP) and the heat shock protein Hsc70 were downregulated by morphine. Interestingly, Hsp90, a heat shock protein that normally interacts with CSP and Hsc70, was upregulated by morphine. Moreover, treatment with the selective Hsp90 inhibitor, geldanamycin, decreased the somatic signs of naloxone-precipitated morphine withdrawal, suggesting that Hsp90 upregulation at the presynapse plays a role in the expression of morphine dependence. Thus, integration of proteomics, network analysis, and behavioral studies has provided a greater understanding of morphine-induced alterations in synaptic composition, and identified a potential novel therapeutic target for opiate dependence.	[Abul-Husn, Noura S.; Ma'ayan, Avi; Ramos-Ortolaza, Dinah L.; Stockton, Steven D., Jr.; Gomes, Ivone; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Annangudi, Suresh P.; Sweedler, Jonathan V.] Univ Illinois Urban Champaign, Dept Chem, Beckman Inst, Urbana, IL USA	Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign	Abul-Husn, NS (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Sweedler, Jonathan V/A-9405-2009; Devi P, Lakshmi/GXM-5982-2022; Ma'ayan, Avi/AAG-3131-2019; Annangudi, Suresh/AAD-6408-2020	Sweedler, Jonathan V/0000-0003-3107-9922; Devi P, Lakshmi/0000-0001-9274-4776; Ma'ayan, Avi/0000-0002-6904-1017; Abul-Husn, Noura/0000-0002-5179-1944	National Institutes of Health [DA08863, DA019521, DA017940, 2P30DA018310, 1P50GM071558-01A27398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, K05DA019521, R01DA008863, R56DA008863, R01DA017940, R37DA008863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health DA08863 and DA019521 to L. A. D., DA017940 and 2P30DA018310 to J.V.S., and 1P50GM071558-01A27398 to L. A. D., A. M. and D. L. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Abul-Husn NS, 2006, J PHARMACOL EXP THER, V318, P3303; Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bierczynska-Krzysik A, 2006, INT J MOL MED, V18, P775; Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P401, DOI 10.1016/j.neuint.2006.01.024; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Fadda P, 2005, SYNAPSE, V56, P29, DOI 10.1002/syn.20122; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koshimizu T, 2010, BIOCHEM BIOPH RES CO, V392, P603, DOI 10.1016/j.bbrc.2010.01.089; Li HH, 2006, NEUROREPORT, V17, P71, DOI 10.1097/01.wnr.0000192731.62417.be; Li KW, 2006, PROTEOMICS, V6, P2003, DOI 10.1002/pmic.200500045; Li Q, 2009, EUR J PHARMACOL, V612, P21, DOI 10.1016/j.ejphar.2009.03.049; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-10; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Prokai L, 2005, J MASS SPECTROM, V40, P169, DOI 10.1002/jms.736; Ramos-Ortolaza DL, 2010, METHODS MOL BIOL, V615, P227, DOI 10.1007/978-1-60761-535-4_18; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; SCHRATER PR, 1993, LIFE SCI, V52, P1535, DOI 10.1016/0024-3205(93)90054-7; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SHOAIB M, 1995, PSYCHOPHARMACOLOGY, V117, P240, DOI 10.1007/BF02245193; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Trang T, 2003, BRIT J PHARMACOL, V140, P295, DOI 10.1038/sj.bjp.0705440; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; WISE RA, 1987, PHARMACOL THERAPEUT, V35, P227, DOI 10.1016/0163-7258(87)90108-2; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Xu NJ, 2004, J BIOL CHEM, V279, P40601, DOI 10.1074/jbc.M406896200; Yang L, 2007, J PROTEOME RES, V6, P2239, DOI 10.1021/pr060649o; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	53	41	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25535	10.1371/journal.pone.0025535	http://dx.doi.org/10.1371/journal.pone.0025535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043286	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400013
J	Carr, CA; Stuckey, DJ; Tan, JJ; Tan, SC; Gomes, RSM; Camelliti, P; Messina, E; Giacomello, A; Ellison, GM; Clarke, K				Carr, Carolyn A.; Stuckey, Daniel J.; Tan, Jun Jie; Tan, Suat Cheng; Gomes, Renata S. M.; Camelliti, Patrizia; Messina, Elisa; Giacomello, Alessandro; Ellison, Georgina M.; Clarke, Kieran			Cardiosphere-Derived Cells Improve Function in the Infarcted Rat Heart for at Least 16 Weeks - an MRI Study	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; LEFT-VENTRICULAR FUNCTION; STEM-CELLS; IN-VIVO; MYOCARDIAL-ISCHEMIA; REGENERATION; VALIDATION; EXPANSION; SURVIVAL	Aims: Endogenous cardiac progenitor cells, expanded from explants via cardiosphere formation, present a promising cell source to prevent heart failure following myocardial infarction. Here we used cine-magnetic resonance imaging (MRI) to track administered cardiosphere-derived cells (CDCs) and to measure changes in cardiac function over four months in the infarcted rat heart. Methods and Results: CDCs, cultured from neonatal rat heart, comprised a heterogeneous population including cells expressing the mesenchymal markers CD90 and CD105, the stem cell marker c-kit and the pluripotency markers Sox2, Oct3/4 and Klf-4. CDCs (2 x 10(6)) expressing green fluorescent protein (GFP+) were labelled with fluorescent micron-sized particles of iron oxide (MPIO). Labelled cells were administered to the infarcted rat hearts (n = 7) by intramyocardial injection immediately following reperfusion, then by systemic infusion (4 x 10(6)) 2 days later. A control group (n = 7) was administered cell medium. MR hypointensities caused by the MPIOs were detected at all times and GFP+ cells containing MPIO particles were identified in tissue slices at 16 weeks. At two days after infarction, cardiac function was similar between groups. By 6 weeks, ejection fractions in control hearts had significantly decreased (47+/-2%), but this was not evident in CDC-treated hearts (56+/-3%). The significantly higher ejection fractions in the CDC-treated group were maintained for a further 10 weeks. In addition, CDC-treated rat hearts had significantly increased capillary density in the peri-infarct region and lower infarct sizes. MPIO-labelled cells also expressed cardiac troponin I, von Willebrand factor and smooth muscle actin, suggesting their differentiation along the cardiomyocyte lineage and the formation of new blood vessels. Conclusions: CDCs were retained in the infarcted rat heart for 16 weeks and improved cardiac function.	[Carr, Carolyn A.; Stuckey, Daniel J.; Tan, Jun Jie; Tan, Suat Cheng; Gomes, Renata S. M.; Camelliti, Patrizia; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Stuckey, Daniel J.; Camelliti, Patrizia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tan, Jun Jie] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia; [Messina, Elisa; Giacomello, Alessandro] Univ Roma La Sapienza, Dept Expt Med, Cenci Bolognetti Fdn, Inst Pasteur, Rome, Italy; [Ellison, Georgina M.] Liverpool JM Univ, Stem Cell & Mol Physiol Lab, Liverpool, Merseyside, England	University of Oxford; Imperial College London; Universiti Sains Malaysia; Fondazione Cenci Bolognetti; Sapienza University Rome; Liverpool John Moores University	Carr, CA (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	Carolyn.Carr@dpag.ox.ac.uk	Tan, Jun Jie/D-9864-2012; Camelliti, Patrizia/F-8012-2018; Camelliti, Patrizia/AAA-4489-2020; Ellison-Hughes, Georgina M./B-4597-2016; Messina, Elisa/I-5401-2018; Tan, Suat Cheng/C-8835-2016	Tan, Jun Jie/0000-0002-7027-6657; Camelliti, Patrizia/0000-0002-1346-8089; Camelliti, Patrizia/0000-0002-1346-8089; Ellison-Hughes, Georgina M./0000-0002-2733-3361; Messina, Elisa/0000-0002-1654-9001; Tan, Suat Cheng/0000-0001-5869-6096; Gomes, Renata/0000-0002-9197-8279; stuckey, daniel/0000-0001-8888-627X	British Heart Foundation [PG/07/059/23259]; Malaysian Ministry of Higher Education; EU [PIRG02-GA-2007-224853]; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Malaysian Ministry of Higher Education; EU(European Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (grant number PG/07/059/23259). Dr. Jun Tan and Dr. Suat Tan thank the Malaysian Ministry of Higher Education for studentships. Dr. Ellison is a recipient of a Marie Curie International Re-integration grant from the FP7 EU Marie Curie Actions (PIRG02-GA-2007-224853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; De Celle T, 2004, EXP PHYSIOL, V89, P605, DOI 10.1113/expphysiol.2004.027649; DEBOER MJ, 1994, CIRCULATION, V90, P753, DOI 10.1161/01.CIR.90.2.753; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Miyamoto S, 2009, STEM CELLS DEV; Neuzil J, 2005, REDOX REP, V10, P187, DOI 10.1179/135100005X57391; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Shenje LT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001929; Shintani Y, 2009, J MOL CELL CARDIOL, V47, P288, DOI 10.1016/j.yjmcc.2009.05.009; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stuckey DJ, 2008, NMR BIOMED, V21, P765, DOI 10.1002/nbm.1268; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Tyler DJ, 2006, J CARDIOVASC MAGN R, V8, P327, DOI 10.1080/10976640500451903; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	33	51	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25669	10.1371/journal.pone.0025669	http://dx.doi.org/10.1371/journal.pone.0025669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043289	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000295984400017
J	Nepliouev, I; Zhang, ZS; Stiber, JA				Nepliouev, Igor; Zhang, Zhu-Shan; Stiber, Jonathan A.			Effect of Oxidative Stress on Homer Scaffolding Proteins	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROLINE-RICH MOTIF; MUSCULAR-DYSTROPHY; SYNAPTIC PROTEINS; IP3 RECEPTORS; BINDS; SKELETAL; CHANNELS; DISEASE; KINASE	Homer proteins are a family of multifaceted scaffolding proteins that participate in the organization of signaling complexes at the post-synaptic density and in a variety of tissues including striated muscle. Homer isoforms form multimers via their C-terminal coiled coil domains, which allows for the formation of a polymeric network in combination with other scaffolding proteins. We hypothesized that the ability of Homer isoforms to serve as scaffolds would be influenced by oxidative stress. We have found by standard SDS-PAGE of lysates from adult mouse skeletal muscle exposed to air oxidation that Homer migrates as both a dimer and monomer in the absence of reducing agents and solely as a monomer in the presence of a reducing agent, suggesting that Homer dimers exposed to oxidation could be modified by the presence of an intermolecular disulfide bond. Analysis of the peptide sequence of Homer 1b revealed the presence of only two cysteine residues located adjacent to the C-terminal coiled-coil domain. HEK 293 cells were transfected with wild-type and cysteine mutant forms of Homer 1b and exposed to oxidative stress by addition of menadione, which resulted in the formation of disulfide bonds except in the double mutant (C246G, C365G). Exposure of myofibers from adult mice to oxidative stress resulted in decreased solubility of endogenous Homer isoforms. This change in solubility was dependent on disulfide bond formation. In vitro binding assays revealed that cross-linking of Homer dimers enhanced the ability of Homer 1b to bind Drebrin, a known interacting partner. Our results show that oxidative stress results in disulfide cross-linking of Homer isoforms and loss of solubility of Homer scaffolds. This suggests that disulfide cross-linking of a Homer polymeric network may contribute to the pathophysiology seen in neurodegenerative diseases and myopathies characterized by oxidative stress.	[Nepliouev, Igor] Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Nepliouev, I (corresponding author), Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC 27708 USA.	stibe001@mc.duke.edu			National Institutes of Health/National Heart Lung and Blood Institute [K08 HL077520]; Muscular Dystrophy Association; Howard Hughes Medical Institute; Robert J. Lefkowitz Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077520] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert J. Lefkowitz Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by the following: National Institutes of Health/National Heart Lung and Blood Institute (K08 HL077520), Muscular Dystrophy Association Research Grant, Howard Hughes Medical Institute Physician-Scientist Early Career Award, and Robert J. Lefkowitz Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brodsky JL, 2010, METHOD ENZYMOL, V470, P661, DOI 10.1016/S0076-6879(10)70027-6; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Rabinovic AD, 2000, NEUROSCIENCE, V101, P67, DOI 10.1016/S0306-4522(00)00293-1; Sandona D, 2000, BIOCHEM BIOPH RES CO, V279, P348, DOI 10.1006/bbrc.2000.3948; SETH M, 2009, CIRC RES; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; THOR H, 1982, J BIOL CHEM, V257, P2419; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26128	10.1371/journal.pone.0026128	http://dx.doi.org/10.1371/journal.pone.0026128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043307	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400035
J	Casulli, S; Topcu, S; Fattoum, L; von Gunten, S; Simon, HU; Teillaud, JL; Bayry, J; Kaveri, SV; Elbim, C				Casulli, Sarah; Topcu, Selma; Fattoum, Lakhdar; von Gunten, Stephan; Simon, Hans-Uwe; Teillaud, Jean-Luc; Bayry, Jagadeesh; Kaveri, Srini V.; Elbim, Carole			A Differential Concentration-Dependent Effect of IVIg on Neutrophil Functions: Relevance for Anti-Microbial and Anti-Inflammatory Mechanisms	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS; WHOLE-BLOOD; CELL-DEATH; IN-VITRO; POLYMORPHONUCLEAR LEUKOCYTES; INFECTIOUS-DISEASES; DENDRITIC CELLS; IG PREPARATIONS; APOPTOSIS; AUTOANTIBODIES	Background: Polymorphonuclear neutrophils (PMN) play a key role in host defences against invading microorganisms but can also potentiate detrimental inflammatory reactions in case of excessive or misdirected responses. Intravenous immunoglobulins (IVIg) are used to treat patients with immune deficiencies and, at higher doses, in autoimmune, allergic and systemic inflammatory disorders. Methodology/Principal Findings: We used flow cytometry to examine the effects of IVIg on PMN functions and survival, using whole-blood conditions in order to avoid artifacts due to isolation procedures. IVIg at low concentrations induced PMN activation, as reflected by decreased L-selectin and increased CD11b expression at the PMN surface, oxidative burst enhancement, and prolonged cell survival. In contrast, IVIg at higher concentrations inhibited LPS-induced CD11b degranulation and oxidative burst priming, and counteracted LPS-induced PMN lifespan prolongation. Conclusions/Significance: IVIg appears to have differential, concentration-dependent effects on PMN, possibly supporting the use of IVIg as either an anti-microbial or an anti-inflammatory agent.	[Casulli, Sarah; Topcu, Selma; Fattoum, Lakhdar; Teillaud, Jean-Luc; Bayry, Jagadeesh; Kaveri, Srini V.; Elbim, Carole] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France; [Casulli, Sarah; Topcu, Selma; Fattoum, Lakhdar; Teillaud, Jean-Luc; Bayry, Jagadeesh; Kaveri, Srini V.; Elbim, Carole] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Casulli, Sarah; Topcu, Selma; Fattoum, Lakhdar; Teillaud, Jean-Luc; Bayry, Jagadeesh; Kaveri, Srini V.; Elbim, Carole] INSERM, U872, F-75006 Paris, France; [von Gunten, Stephan; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bern	Casulli, S (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France.	srini.kaveri@crc.jussieu.fr; carole.elbim@upmc.fr	Simon, Hans-Uwe/AAU-7410-2020; Bayry, Jagadeesh/A-6589-2011	Simon, Hans-Uwe/0000-0002-9404-7736; Bayry, Jagadeesh/0000-0003-0498-9808; von Gunten, Stephan/0000-0002-2753-8738; Kaveri, Srini/0000-0002-0837-4053; Teillaud, Jean-Luc/0000-0003-4442-9565	Universite Pierre et Marie Curie, Paris, France	Universite Pierre et Marie Curie, Paris, France	This work has been supported by Universite Pierre et Marie Curie, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altznauer F, 2003, J ALLERGY CLIN IMMUN, V112, P1185, DOI 10.1016/j.jaci.2003.09.045; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Bayry J, 2004, P NATL ACAD SCI USA, V101, P14210, DOI 10.1073/pnas.0402183101; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Cham B, 2002, SEMIN HEMATOL, V39, P107, DOI 10.1053/shem.2002.31916; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; ELBIM C, 1994, INFECT IMMUN, V62, P2195, DOI 10.1128/IAI.62.6.2195-2201.1994; Elbim C, 2008, J IMMUNOL, V181, P8613, DOI 10.4049/jimmunol.181.12.8613; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Gold R, 2007, NAT CLIN PRACT NEURO, V3, P36, DOI 10.1038/ncpneuro0376; Gurcan HM, 2010, AUTOIMMUN REV, V9, P553, DOI 10.1016/j.autrev.2010.03.003; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Hodge G, 2000, CYTOKINE, V12, P1763, DOI 10.1006/cyto.2000.0790; Jarius S, 2007, BLOOD, V109, P4376, DOI 10.1182/blood-2005-12-019604; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kivity S, 2010, CLIN REV ALLERG IMMU, V38, P201, DOI 10.1007/s12016-009-8155-9; Kobayashi SD, 2003, J IMMUNOL, V170, P3357, DOI 10.4049/jimmunol.170.6.3357; Krause I, 2002, TRANSFUSION MED, V12, P133, DOI 10.1046/j.1365-3148.2002.00360.x; Maddur MS, 2011, AUTOIMMUN REV, V10, P809, DOI 10.1016/j.autrev.2011.02.007; Norrby-Teglund A, 2000, J MED MICROBIOL, V49, P849, DOI 10.1099/0022-1317-49-10-849; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Pallister I, 2006, J TRAUMA, V60, P844, DOI 10.1097/01.ta.0000215583.08765.ce; Rebecchi IMM, 2000, CELL BIOCHEM FUNCT, V18, P127, DOI 10.1002/(SICI)1099-0844(200006)18:2<127::AID-CBF865>3.3.CO;2-M; Reipert BM, 2008, VOX SANG, V94, P334, DOI 10.1111/j.1423-0410.2008.001036.x; Ricevuti G, 1997, ANN NY ACAD SCI, V832, P426, DOI 10.1111/j.1749-6632.1997.tb46269.x; Roifman CM, 2003, INT IMMUNOPHARMACOL, V3, P1325, DOI 10.1016/S1567-5769(03)00134-6; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Schaub A, 2011, ALLERGY, V66, P1030, DOI 10.1111/j.1398-9995.2011.02579.x; Seite JF, 2008, AUTOIMMUN REV, V7, P435, DOI 10.1016/j.autrev.2008.04.012; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Simon HU, 2003, ALLERGY, V58, P543, DOI 10.1034/j.1398-9995.2003.00239.x; Takeshita S, 2005, APMIS, V113, P269, DOI 10.1111/j.1600-0463.2005.apm_05.x; Taneja R, 2004, CRIT CARE MED, V32, P1460, DOI 10.1097/01.CCM.0000129975.26905.77; Teeling JL, 1998, CLIN EXP IMMUNOL, V114, P264; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; Udi N, 2008, AUTOIMMUN REV, V7, P445, DOI 10.1016/j.autrev.2008.04.001; van Mirre E, 2004, J IMMUNOL, V173, P332, DOI 10.4049/jimmunol.173.1.332; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; von Gunten S, 2008, AUTOIMMUN REV, V7, P453, DOI 10.1016/j.autrev.2008.03.015; von Gunten S, 2007, AUTOPHAGY, V3, P67, DOI 10.4161/auto.3436; von Gunten S, 2006, BLOOD, V108, P4255, DOI 10.1182/blood-2006-05-021568; von Gunten S, 2010, J CLIN IMMUNOL, V30, pS24, DOI 10.1007/s10875-010-9411-8; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weinmann P, 2007, CLIN EXP RHEUMATOL, V25, P885; Wong SH, 2009, RHEUMATOLOGY, V48, P39, DOI 10.1093/rheumatology/ken412	54	29	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26469	10.1371/journal.pone.0026469	http://dx.doi.org/10.1371/journal.pone.0026469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065996	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000012
J	Lee, VJ; Tan, CH; Yap, J; Cook, AR; Ting, PJ; Loh, JP; Gao, QH; Chen, MI; Kang, WL; Tan, BH; Tambyah, PA				Lee, Vernon J.; Tan, Chi Hsien; Yap, Jonathan; Cook, Alex R.; Ting, Pei-Jun; Loh, Jin-Phang; Gao, Qiuhan; Chen, Mark I.; Kang, Wee Lee; Tan, Boon Huan; Tambyah, Paul A.			Effectiveness of Pandemic H1N1-2009 Vaccination in Reducing Laboratory Confirmed Influenza Infections among Military Recruits in Tropical Singapore	PLOS ONE			English	Article							OUTBREAK	Background: Limited information is available about pandemic H1N1-2009 influenza vaccine effectiveness in tropical communities. We studied the effectiveness of a pandemic H1N1 vaccination program in reducing influenza cases in Singapore. Methods: A surveillance study was conducted among military personnel presenting with febrile respiratory illness from mid-2009 to mid-2010. Consenting individuals underwent nasal washes, which were tested with RT-PCR and subtyped. A vaccination program (inactivated monovalent Panvax H1N1-2009 vaccine) was carried out among recruits. A Bayesian hierarchical model was used to quantify relative risks in the pre- and post-vaccination periods. An autoregressive generalised linear model (GLM) was developed to minimise confounding. Results: Of 2858 participants, 437(15.3%), 60(2.1%), and 273(9.6%) had pandemic H1N1, H3N2, and influenza B. The ratio of relative risks for pandemic H1N1 infection before and after vaccination for the recruit camp relative to other camps was 0.14(0.016,0.49); for H3N2, 0.44(0.035,1.8); and for influenza B, 18(0.77,89). Using the GLM for the recruit camp, post-vaccination weekly cases decreased by 54%(37%, 67%, p<0.001) from that expected without vaccination; influenza B increased by 66 times(9-479 times, p<0.001); with no statistical difference for H3N2 (p = 0.54). Conclusions: Pandemic vaccination reduced H1N1-2009 disease burden among military recruits. Routine seasonal influenza vaccination should be considered.	[Lee, Vernon J.; Tan, Chi Hsien; Yap, Jonathan; Gao, Qiuhan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Ting, Pei-Jun; Loh, Jin-Phang; Tan, Boon Huan] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Kang, Wee Lee] Headquarters Med Corps, Singapore Armed Forces, Singapore, Singapore; [Tambyah, Paul A.] Natl Univ Hlth Syst, Dept Infect Dis, Singapore, Singapore	National University of Singapore; National University of Singapore; Australian National University; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Lee, VJ (corresponding author), Minist Def, Biodef Ctr, Singapore, Singapore.	vernonljm@hotmail.com	Chen, Mark/CAG-2949-2022; Cook, Alex/S-3576-2019; Chen, Mark/AGC-5338-2022; Cook, Alex/B-5941-2011; Yap, Jonathan/AAJ-7266-2020; Tan, Boon Huan/ABB-8381-2021	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Yap, Jonathan/0000-0002-5227-8536; Tan, Boon Huan/0000-0002-4976-7988	Singapore Ministry of Defense; GSK; Baxter; Adamas; Merlion Pharma; Novartis; National University of Singapore	Singapore Ministry of Defense; GSK(GlaxoSmithKline); Baxter; Adamas; Merlion Pharma; Novartis(Novartis); National University of Singapore(National University of Singapore)	This work was supported by a Singapore Ministry of Defense funded operational research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: VJL has received unrelated research support from GSK. PAT has received research support and honoraria from Baxter, Adamas, Merlion Pharma, and Novartis as well as travel support from Pfizer and Wyeth and sits on the boards of the Asia Pacific Advisory Committee on Influenza and the Asian Hygiene Council. ARC has received unrelated research funding from the National University of Singapore. The rest of the authors declare that we do not have any conflict of interests, financial or otherwise, in this study. VJL and ARC are academic editors of PLoS One. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], CLIN APPL IMMUNOL RE, DOI DOI 10.1016/S1529-1049(03)00064-3; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Carrillo-Santisteve P, 2010, EUROSURVEILLANCE, V15, P20; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Eggenberger F, 1923, Z ANGEW MATH MECH, V3, P279, DOI 10.1002/zamm.19230030407; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Lee VJ, 2010, NEW ENGL J MED, V362, P2166, DOI 10.1056/NEJMoa0908482; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Leo YS, 2009, LANCET INFECT DIS, V9, P457, DOI 10.1016/S1473-3099(09)70182-3; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Liu PY, 2009, J MICROBIOL IMMUNOL, V42, P114; Ministry of Health Singapore, 11 CONF NEW CAS INFL; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Plummer M, 2017, JAGS PROGRAM ANAL BA; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Russell KL, 2006, RECRUIT MED, P227; SARTWELL PE, 1951, AM J HYG, V53, P224, DOI 10.1093/oxfordjournals.aje.a119449; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; SEAL J R, 1955, Mil Med, V116, P265; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; World Health Organization, 2009, CDC PROT REALT RTPCR	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26572	10.1371/journal.pone.0026572	http://dx.doi.org/10.1371/journal.pone.0026572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053196	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800022
J	Cirilli, L; de Timary, P; Lefevre, P; Missal, M				Cirilli, Laetitia; de Timary, Philippe; Lefevre, Phillipe; Missal, Marcus			Individual Differences in Impulsivity Predict Anticipatory Eye Movements	PLOS ONE			English	Article							SLOW OCULOMOTOR CONTROL; BASAL GANGLIA CIRCUITS; SMOOTH-PURSUIT; NEURONAL-ACTIVITY; FRONTAL-CORTEX; NUCLEUS-ACCUMBENS; SPATIAL ATTENTION; DECISION-MAKING; REWARD SIGNAL; DOPAMINE	Impulsivity is the tendency to act without forethought. It is a personality trait commonly used in the diagnosis of many psychiatric diseases. In clinical practice, impulsivity is estimated using written questionnaires. However, answers to questions might be subject to personal biases and misinterpretations. In order to alleviate this problem, eye movements could be used to study differences in decision processes related to impulsivity. Therefore, we investigated correlations between impulsivity scores obtained with a questionnaire in healthy subjects and characteristics of their anticipatory eye movements in a simple smooth pursuit task. Healthy subjects were asked to answer the UPPS questionnaire (Urgency Premeditation Perseverance and Sensation seeking Impulsive Behavior scale), which distinguishes four independent dimensions of impulsivity: Urgency, lack of Premeditation, lack of Perseverance, and Sensation seeking. The same subjects took part in an oculomotor task that consisted of pursuing a target that moved in a predictable direction. This task reliably evoked anticipatory saccades and smooth eye movements. We found that eye movement characteristics such as latency and velocity were significantly correlated with UPPS scores. The specific correlations between distinct UPPS factors and oculomotor anticipation parameters support the validity of the UPPS construct and corroborate neurobiological explanations for impulsivity. We suggest that the oculomotor approach of impulsivity put forth in the present study could help bridge the gap between psychiatry and physiology.	[Cirilli, Laetitia; de Timary, Philippe; Lefevre, Phillipe; Missal, Marcus] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [de Timary, Philippe] St Luc Acad Hosp, Dept Adult Psychiat, B-1200 Brussels, Belgium; [Lefevre, Phillipe] Catholic Univ Louvain, Inst Informat & Commun Technol Elect & Appl Math, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Cirilli, L (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	laetitia.cirilli@uclouvain.be			Belgian Fonds National de la Recherche Scientifique; Fondation pour la Recherche Scientifique Medicale; Belgian Program on Interuniversity Attraction Poles; Universite catholique de Louvain	Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche Scientifique Medicale(Fondation pour la Recherche Medicale); Belgian Program on Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Universite catholique de Louvain	This work was supported by the Belgian Fonds National de la Recherche Scientifique, the Fondation pour la Recherche Scientifique Medicale, the Belgian Program on Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy Office, and internal research grants from the Universite catholique de Louvain (Fonds Speciaux de Recherche, Action de Recherche Concertee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU; Badler JB, 2006, J NEUROSCI, V26, P4519, DOI 10.1523/JNEUROSCI.3739-05.2006; Badler J, 2010, J NEUROSCI, V30, P10517, DOI 10.1523/JNEUROSCI.1733-10.2010; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; Barnes GR, 2002, EXP BRAIN RES, V144, P322, DOI 10.1007/s00221-002-1050-8; Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Basso MA, 2005, EUR J NEUROSCI, V22, P448, DOI 10.1111/j.1460-9568.2005.04215.x; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BOMAN DK, 1988, VISION RES, V28, P1157, DOI 10.1016/0042-6989(88)90142-3; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; Boussaoud D, 1997, EUR J NEUROSCI, V9, P2152, DOI 10.1111/j.1460-9568.1997.tb01382.x; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Brovelli A, 2007, J PHYSIOLOGY-PARIS, V101, P110, DOI 10.1016/j.jphysparis.2007.10.002; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; de Brouwer S, 2001, J NEUROPHYSIOL, V86, P550, DOI 10.1152/jn.2001.86.2.550; de Hemptinne C, 2006, J NEUROPHYSIOL, V95, P3770, DOI 10.1152/jn.00007.2006; de Hemptinne C, 2008, J NEUROSCI, V28, P4298, DOI 10.1523/JNEUROSCI.5678-07.2008; de Hemptinne C, 2007, J NEUROSCI, V27, P4334, DOI 10.1523/JNEUROSCI.0388-07.2007; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Dobrossy MD, 2009, FRONT NEUROSCI, P215; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Hadj-Bouziane F, 2003, J PHYSIOL-PARIS, V97, P567, DOI 10.1016/j.jphysparis.2004.01.014; Hadj-Bouziane F, 2003, EXP BRAIN RES, V153, P190, DOI 10.1007/s00221-003-1592-4; Heinen SJ, 2005, J VISION, V5, P493, DOI 10.1167/5.6.1; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ilg UJ, 2008, BRAIN COGNITION, V68, P229, DOI 10.1016/j.bandc.2008.08.014; Jarrett CB, 2002, COGNITIVE BRAIN RES, V14, P383, DOI 10.1016/S0926-6410(02)00140-4; Joiner WM, 2006, EXP BRAIN RES, V175, P305, DOI 10.1007/s00221-006-0554-z; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Klein C, 2008, BRAIN COGNITION, V68, P215, DOI 10.1016/j.bandc.2008.08.012; KOWLER E, 1981, VISION RES, V21, P191, DOI 10.1016/0042-6989(81)90113-9; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; KOWLER E, 1979, VISION RES, V19, P619, DOI 10.1016/0042-6989(79)90238-4; KOWLER E, 1979, VISION RES, V19, P633, DOI 10.1016/0042-6989(79)90239-6; KOWLER E, 1984, VISION RES, V24, P197, DOI 10.1016/0042-6989(84)90122-6; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; LISBERGER SG, 1981, J NEUROPHYSIOL, V46, P229, DOI 10.1152/jn.1981.46.2.229; Lynch JC, 2009, NEUROREPORT, V20, P103, DOI 10.1097/WNR.0b013e32831f1cd2; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Missal M, 2001, J NEUROPHYSIOL, V86, P2413, DOI 10.1152/jn.2001.86.5.2413; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Schultz W, 1998, Adv Pharmacol, V42, P686; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Sharpe JA, 2008, BRAIN COGNITION, V68, P241, DOI 10.1016/j.bandc.2008.08.015; Shichinohe N, 2009, NEURON, V62, P717, DOI 10.1016/j.neuron.2009.05.010; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spengler D, 2006, PSYCHIAT RES, V143, P77, DOI 10.1016/j.psychres.2005.08.020; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Watanabe M, 2011, J COGNITIVE NEUROSCI, V23, P1794, DOI 10.1162/jocn.2010.21554; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Winkel JIR, 2010, FRONT NEUR C; WURTZ RH, 1986, PROG BRAIN RES, V64, P175; Yang SN, 2008, J NEUROPHYSIOL, V99, P1857, DOI 10.1152/jn.00119.2007; Yoshida A, 2009, NEUROREPORT, V20, P121, DOI 10.1097/WNR.0b013e32831af055; Yoshida A, 2009, CEREB CORTEX, V19, P206, DOI 10.1093/cercor/bhn069; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65	86	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26699	10.1371/journal.pone.0026699	http://dx.doi.org/10.1371/journal.pone.0026699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046334	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600045
J	Cote, AL; Byrne, KT; Steinberg, SM; Zhang, PS; Turk, MJ				Cote, Anik L.; Byrne, Katelyn T.; Steinberg, Shannon M.; Zhang, Peisheng; Turk, Mary Jo			Protective CD8 Memory T Cell Responses to Mouse Melanoma Are Generated in the Absence of CD4 T Cell Help	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY GK1.5; TUMOR-IMMUNITY; PROSTATIC TUMORS; MICE; DEPLETION; INDUCTION; ANTI-CD4; INFECTION; EXPANSION; ANTIGEN	Background: We have previously demonstrated that temporary depletion of CD4 T cells in mice with progressive B16 melanoma, followed by surgical tumor excision, induces protective memory CD8 T cell responses to melanoma/melanocyte antigens. We also showed that persistence of these CD8 T cells is supported, in an antigen-dependent fashion, by concurrent autoimmune melanocyte destruction. Herein we explore the requirement of CD4 T cell help in priming and maintaining this protective CD8 T cell response to melanoma. Methodology and Principal Findings: To induce melanoma/melanocyte antigen-specific CD8 T cells, B16 tumor bearing mice were depleted of regulatory T cells (T-reg) by either temporary, or long-term continuous treatment with anti-CD4 (mAb clone GK1.5). Total depletion of CD4 T cells led to significant priming of IFN-gamma-producing CD8 T cell responses to TRP-2 and gp100. Surprisingly, treatment with anti-CD25 (mAb clone PC61), to specifically deplete T-reg cells while leaving help intact, was ineffective at priming CD8 T cells. Thirty to sixty days after primary tumors were surgically excised, mice completely lacking CD4 T cell help developed autoimmune vitiligo, and maintained antigen-specific memory CD8 T cell responses that were highly effective at producing cytokines (IFN-gamma, TNF-alpha, and IL-2). Mice lacking total CD4 T cell help also mounted protection against re-challenge with B16 melanoma sixty days after primary tumor excision. Conclusions and Significance: This work establishes that CD4 T cell help is dispensable for the generation of protective memory T cell responses to melanoma. Our findings support further use of CD4 T cell depletion therapy for inducing long-lived immunity to cancer.	[Cote, Anik L.] Dartmouth Med Sch, Lebanon, NH USA; Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center	Cote, AL (corresponding author), Dartmouth Med Sch, Lebanon, NH USA.	mary.jo.turk@dartmouth.edu		Steinberg, Shannon/0000-0003-1711-2423; Byrne, Katelyn/0000-0002-2459-9041	National Instititutes of Health (NIH) [R01 CA120777, P20 RR 16437, T32 A107363]; Melanoma Research Foundation; American Cancer Society; Dartmouth Medical School; Dartmouth Immunology Program; Joanna M. Nicolay Melanoma Foundation; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA120777] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER	National Instititutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; American Cancer Society(American Cancer Society); Dartmouth Medical School; Dartmouth Immunology Program; Joanna M. Nicolay Melanoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the National Instititutes of Health (NIH)(grants R01 CA120777 and P20 RR 16437 COBRE to MJT), the Melanoma Research Foundation (New Investigator Award to MJT), and the American Cancer Society (Institutional Award to MJT). ALC was supported by a Rosaline Borison Fellowship (Dartmouth Medical School). KTB was supported by NIH T32 A107363, the Dartmouth Immunology Program, and the Joanna M. Nicolay Melanoma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; BUSHELL A, 1995, EUR J IMMUNOL, V25, P2643, DOI 10.1002/eji.1830250936; Byrne KT, 2011, J CLIN INVE IN PRESS; CHACE JH, 1994, J IMMUNOL, V152, P405; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cote AL, 2008, CANCER RES, V68, P1614, DOI 10.1158/0008-5472.CAN-07-6012; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Croce M, 2010, INT J CANCER, V127, P1141, DOI 10.1002/ijc.25140; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hwang ML, 2007, J IMMUNOL, V179, P5829, DOI 10.4049/jimmunol.179.9.5829; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jones Emma, 2002, Cancer Immun, V2, P1; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Kemball CC, 2007, J IMMUNOL, V179, P1113, DOI 10.4049/jimmunol.179.2.1113; Khanolkar A, 2007, IMMUNOL RES, V39, P94, DOI 10.1007/s12026-007-0081-4; Kim YH, 2007, BLOOD, V109, P4655, DOI 10.1182/blood-2006-12-062877; Kline J, 2008, CLIN CANCER RES, V14, P3156, DOI 10.1158/1078-0432.CCR-07-4696; Kmieciak M, 2011, BREAST CANCER RES TR, V126, P385, DOI 10.1007/s10549-010-0942-8; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Nevala WK, 2009, CLIN CANCER RES, V15, P1931, DOI 10.1158/1078-0432.CCR-08-1980; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; RICE JC, 1995, J IMMUNOL, V154, P6644; Sabarth N, 2010, J IMMUNOL, V185, P4590, DOI 10.4049/jimmunol.0803994; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scheibenbogen C, 1997, INT J CANCER, V71, P932, DOI 10.1002/(SICI)1097-0215(19970611)71:6<932::AID-IJC3>3.0.CO;2-Z; Shafer-Weaver KA, 2009, J IMMUNOL, V183, P4848, DOI 10.4049/jimmunol.0900848; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shimizu J, 1999, J IMMUNOL, V163, P5211; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Webster WS, 2007, J IMMUNOL, V179, P2860, DOI 10.4049/jimmunol.179.5.2860; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Xiao HY, 2011, J IMMUNOL, V187, P1788, DOI 10.4049/jimmunol.1101138; Yi HF, 2008, TRANSPLANTATION, V85, P1167, DOI 10.1097/TP.0b013e31816a1242; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264	49	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26491	10.1371/journal.pone.0026491	http://dx.doi.org/10.1371/journal.pone.0026491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046294	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600023
J	Fritz, M; El Rawas, R; Klement, S; Kummer, K; Mayr, MJ; Eggart, V; Salti, A; Bardo, MT; Saria, A; Zernig, G				Fritz, Michael; El Rawas, Rana; Klement, Sabine; Kummer, Kai; Mayr, Michael J.; Eggart, Vincent; Salti, Ahmad; Bardo, Michael T.; Saria, Alois; Zernig, Gerald			Differential Effects of Accumbens Core vs. Shell Lesions in a Rat Concurrent Conditioned Place Preference Paradigm for Cocaine vs. Social Interaction	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; BASOLATERAL AMYGDALA; SEEKING BEHAVIOR; ACTIVATION; REVERSAL	Background: A main challenge in the therapy of drug dependent individuals is to help them reactivate interest in non-drug-associated activities. Among these activities, social interaction is doubly important because treatment adherence itself depends on it. We previously developed a rat experimental model based on the conditioned place preference (CPP) paradigm in which only four 15-min episodes of social interaction with a gender-and weight-matched male conspecific (i) reversed CPP from cocaine to social interaction despite continuing cocaine training and (ii) prevented the reinstatement of cocaine CPP. In the present study, we investigated if the two subregions of the nucleus accumbens (Acb), i. e., the core (AcbC) and the shell (AcbSh), would differentially affect CPP for cocaine vs social interaction. Methodology/Principal Findings: Animals were concurrently trained for CPP pairing cocaine with one compartment and social interaction with the other (i. e., mutually exclusive stimulus presentation during training). Excitotoxic lesioning of the AcbC or the BLA shifted CPP toward social interaction, whereas AcbSh inactivation shifted CPP toward cocaine. Conclusions: Overall, our findings suggest that inactivation of the AcbC or the BLA is sufficient to shift CPP away from a drug of abuse toward social interaction. Lesioning the AcbSh produced the opposite effect.	[Fritz, Michael; El Rawas, Rana; Klement, Sabine; Kummer, Kai; Mayr, Michael J.; Eggart, Vincent; Saria, Alois; Zernig, Gerald] Med Univ Innsbruck, Expt Psychiat Unit, Dept Gen Psychiat & Social Psychiat, Ctr Psychiat & Psychotherapy, Innsbruck, Austria; [Salti, Ahmad] Med Univ Innsbruck, Inst Neurosci, Innsbruck, Austria; [Bardo, Michael T.] Univ Kentucky, Ctr Drug Abuse Res Translat, Lexington, KY USA	Medical University of Innsbruck; Medical University of Innsbruck; University of Kentucky	Fritz, M (corresponding author), Med Univ Innsbruck, Expt Psychiat Unit, Dept Gen Psychiat & Social Psychiat, Ctr Psychiat & Psychotherapy, Innsbruck, Austria.	gerald.zernig@i-med.ac.at	Salti, Ahmad/AFR-7386-2022; Rawas, Rana El/AAR-7062-2020; Kummer, Kai K./G-3294-2014; Fritz, Michael/AGE-9635-2022	Salti, Ahmad/0000-0002-7678-0125; Kummer, Kai K./0000-0002-5854-6503; El Rawas, Rana/0000-0002-8068-4507	Austrian Science Fund [P18787-B05]; Lise-Meitner Fellowhip [M1119-B18]; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	Austrian Science Fund(Austrian Science Fund (FWF)); Lise-Meitner Fellowhip; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	This work was supported by the Austrian Science Fund (P18787-B05) awarded to GZ, by a Lise-Meitner Fellowhip (M1119-B18) awarded to RE and by the Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 2003, AMYGDALA FUNCTIONAL; Berns U, 2004, FORUM PSYCHOANAL, V20, P284, DOI 10.1007/s00451-004-0208-3; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; Fritz M, 2011, ADDICT BIOL, V16, P273, DOI 10.1111/j.1369-1600.2010.00285.x; Fritz M, 2011, PHARMACOLOGY, V87, P45, DOI 10.1159/000322534; Fuchs RA, 2002, BRAIN RES, V929, P15, DOI 10.1016/S0006-8993(01)03366-2; Grawe K, 1997, PSYCHOTHER RES, V7, P1, DOI 10.1080/10503309712331331843; Mashhoon Y, 2009, EUR J NEUROSCI, V29, P1641, DOI 10.1111/j.1460-9568.2009.06705.x; Murphy ER, 2008, EUR J NEUROSCI, V28, P353, DOI 10.1111/j.1460-9568.2008.06309.x; Parkinson JA, 2000, EUR J NEUROSCI, V12, P405, DOI 10.1046/j.1460-9568.2000.00960.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peters J, 2008, J NEUROSCI, V28, P6064; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Sellings LHL, 2003, J NEUROSCI, V23, P6295; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Wright CI, 1996, J NEUROSCI, V16, P1877; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zernig G, 2011, DRUG ALCOHOL DEPEN, V16, P273; Zernig G, 2000, HDB ALCOHOLISM; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923	20	37	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26761	10.1371/journal.pone.0026761	http://dx.doi.org/10.1371/journal.pone.0026761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046347	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600053
J	Martin-Jaular, L; Nakayasu, ES; Ferrer, M; Almeida, IC; del Portillo, HA				Martin-Jaular, Lorena; Nakayasu, Ernesto S.; Ferrer, Mireia; Almeida, Igor C.; del Portillo, Hernando A.			Exosomes from Plasmodium yoelii-Infected Reticulocytes Protect Mice from Lethal Infections	PLOS ONE			English	Article							IN-VITRO; TRANSFERRIN RECEPTOR; MALARIA; VESICLES; MATURATION; MICROPARTICLES; PLASMA; BLOOD; IMMUNIZATION; FALCIPARUM	Exosomes are 30-100-nm membrane vesicles of endocytic origin that are released after the fusion of multivesicular bodies (MVBs) with the plasma membrane. While initial studies suggested that the role of exosomes was limited to the removal of proteins during the maturation of reticulocytes to erythrocytes, recent studies indicate that they are produced by different types of cells and are involved in promoting inter-cellular communication and antigen presentation. Here, we describe the isolation and characterization of exosomes from peripheral blood of BALB/c mice infected with the reticulocyte-prone non-lethal Plasmodium yoelii 17X strain. Importantly, proteomic analysis revealed the presence of parasite proteins in these vesicles. Moreover, immunization of mice with purified exosomes elicited IgG antibodies capable of recognizing P. yoelii-infected red blood cells. Furthermore, lethal challenge of immunized mice with the normocyte-prone lethal P. yoelii 17XL strain caused a significant attenuation in the course of parasitaemia, increased survival time, and altered the cell tropism to reticulocytes. These results were obtained also when the exosomes were isolated from a P. yoelii-infected reticulocyte culture indicating that reticulocyte-derived exosomes carry antigens and are involved in immune modulation. Moreover, inclusion of CpG ODN 1826 in exosome immunizations elicited IgG2a and IgG2b antibodies and promoted survival, clearance of parasites and subsequent sterile protection of 83% of the animals challenged with P. yoelli 17XL. To our knowledge, this is the first report of immune responses elicited by exosomes derived from reticulocytes opening new avenues for the modulation of anti-malaria responses.	[Martin-Jaular, Lorena; Ferrer, Mireia; del Portillo, Hernando A.] Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Nakayasu, Ernesto S.; Almeida, Igor C.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [del Portillo, Hernando A.] ICREA, Barcelona, Spain	ISGlobal; CRESIB; University of Texas System; University of Texas El Paso; ICREA	Martin-Jaular, L (corresponding author), Barcelona Ctr Int Hlth Res, Barcelona, Spain.	hernandoa.delportillo@cresib.cat	del Portillo, Hernando A/L-2131-2014; Nakayasu, Ernesto S./AAJ-8374-2020; Martin Jaular, Lorena/ABI-7121-2020; Almeida, Igor C./AAF-9409-2019	del Portillo, Hernando A/0000-0002-5278-3452; Nakayasu, Ernesto S./0000-0002-4056-2695; Martin Jaular, Lorena/0000-0002-1511-8576; Almeida, Igor C./0000-0002-2443-8213	Generalitat de Catalonia; National Institutes of Health (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1]; European Community [242095]; Private Foundation CELLEX (Catalonia, Spain); Spanish Ministry of Science and Innovation [SAF2009-07760]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Generalitat de Catalonia; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Private Foundation CELLEX (Catalonia, Spain); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ICREA(ICREA)	MF is a recipient of a graduate fellowship from the Generalitat de Catalonia. ICA was partially supported by National Institutes of Health (NIH) grants Nos 5G12RR008124-16A1 and 5G12RR008124-16A1S1. The biomedical Analysis Care Facility/BBRC/UTEP is funded by NIH grants 5G12RR008124-16A1 and 5G12RR008124-16A1S1. HAP is an ICREA Research Professor. Work in the laboratory of HAP is funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement Nu 242095, by the Private Foundation CELLEX (Catalonia, Spain), and by the Spanish Ministry of Science and Innovation (SAF2009-07760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Blanc L, 2010, CURR OPIN HEMATOL, V17, P177, DOI 10.1097/MOH.0b013e328337b4e3; Blanc L, 2009, BLOOD, V114, P3928, DOI 10.1182/blood-2009-06-230086; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Coltel N, 2006, MICROBES INFECT, V8, P2305, DOI 10.1016/j.micinf.2006.04.006; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Hensmann M, 2001, INFECT IMMUN, V69, P2364, DOI 10.1128/IAI.69.4.2364-2371.2001; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; KITCHEN S. F., 1938, AMER JOUR TROP MED, V18, P347; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; NOBLE NA, 1989, BLOOD, V74, P475; Pal-Bhowmick I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-45; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pattaradilokrat S, 2008, MOL BIOCHEM PARASIT, V157, P244, DOI 10.1016/j.molbiopara.2007.10.011; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rieu S, 2000, EUR J BIOCHEM, V267, P583, DOI 10.1046/j.1432-1327.2000.01036.x; Shi QF, 2005, INFECT IMMUN, V73, P6363, DOI 10.1128/IAI.73.10.6363-6371.2005; TAYLORROBINSON AW, 1994, PARASITOL RES, V80, P614, DOI 10.1007/BF00933011; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vidal M, 2010, TRANSFUS CLIN BIOL, V17, P131, DOI 10.1016/j.tracli.2010.05.004; WEISS L, 1989, AM J TROP MED HYG, V41, P144, DOI 10.4269/ajtmh.1989.41.144; WHITE WI, 1991, INFECT IMMUN, V59, P3547, DOI 10.1128/IAI.59.10.3547-3554.1991	43	127	130	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26588	10.1371/journal.pone.0026588	http://dx.doi.org/10.1371/journal.pone.0026588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046311	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600032
J	Haschemi, A; Chin, BY; Jeitler, M; Esterbauer, H; Wagner, O; Bilban, M; Otterbein, LE				Haschemi, Arvand; Chin, Beek Yoke; Jeitler, Markus; Esterbauer, Harald; Wagner, Oswald; Bilban, Martin; Otterbein, Leo E.			Carbon Monoxide Induced PPAR gamma SUMOylation and UCP2 Block Inflammatory Gene Expression in Macrophages	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEINS; OXIDATIVE STRESS; NITRIC-OXIDE; LUNG INJURY; INHIBITION; PATHWAY; HEME; ROS; TRANSREPRESSION; OXYGENASE-1	Carbon monoxide (CO) dampens pro-inflammatory responses in a peroxisome proliferator-activated receptor-gamma (PPAR gamma) and p38 mitogen-activated protein kinase (MAPK) dependent manner. Previously, we demonstrated that CO inhibits lipopolysaccharide (LPS)-induced expression of the proinflammatory early growth response-1 (Egr-1) transcription factor in macrophages via activation of PPAR gamma. Here, we further characterize the molecular mechanisms by which CO modulates the activity of PPAR gamma and Egr-1 repression. We demonstrate that CO enhances SUMOylation of PPAR gamma which we find was attributed to mitochondrial ROS generation. Ectopic expression of a SUMOylation-defective PPAR gamma-K365R mutant partially abolished CO-mediated suppression of LPS-induced Egr-1 promoter activity. Expression of a PPAR gamma-K77R mutant did not impair the effect of CO. In addition to PPAR gamma SUMOylation, CO-activated p38 MAPK was responsible for Egr-1 repression. Blocking both CO-induced PPAR gamma SUMOylation and p38 activation, completely reversed the effects of CO on inflammatory gene expression. In primary macrophages isolated form C57/BL6 male mice, we identify mitochondrial ROS formation by CO as the upstream trigger for the observed effects on Egr-1 in part through uncoupling protein 2 (UCP2). Macrophages derived from bone marrow isolated from Ucp2 gene Knock-Out C57/BL6 mice (Ucp2 2/2), produced significantly less ROS with CO exposure versus wild-type macrophages. Moreover, absence of UCP2 resulted in a complete loss of CO mediated Egr-1 repression. Collectively, these results indentify p38 activation, PPAR gamma-SUMOylation and ROS formation via UCP2 as a cooperative system by which CO impacts the inflammatory response.	[Haschemi, Arvand; Jeitler, Markus; Esterbauer, Harald; Wagner, Oswald; Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Chin, Beek Yoke; Otterbein, Leo E.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Medical University of Vienna; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Haschemi, A (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.	martin.bilban@meduniwien.ac.at		Esterbauer, Harald/0000-0001-7343-7455; Haschemi, Arvand/0000-0001-9532-3205; Bilban, Martin/0000-0001-7043-7142	Vienna Science and Technology Fund; Austrian Science Fund [W1205]; National Institutes of Health [5R01GM088666]; Department of Defense (Center for Integration of Medicine and Innovative Technology);  [LS07-031]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088666] Funding Source: NIH RePORTER	Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (Center for Integration of Medicine and Innovative Technology)(United States Department of Defense); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant LS07-031, Vienna Science and Technology Fund and Austrian Science Fund (W1205, CCHD Ph.D. program), as well as grants 5R01GM088666 (National Institutes of Health) and Department of Defense (Center for Integration of Medicine and Innovative Technology) to LEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Haschemi A, 2007, J IMMUNOL, V178, P5921, DOI 10.4049/jimmunol.178.9.5921; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Nizamutdinova IT, 2009, ATHEROSCLEROSIS, V207, P405, DOI 10.1016/j.atherosclerosis.2009.05.008; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	37	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26376	10.1371/journal.pone.0026376	http://dx.doi.org/10.1371/journal.pone.0026376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046279	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000016
J	Stam, J; Abdulahad, W; Huitema, MG; Roozendaal, C; Limburg, PC; van Stuijvenberg, M; Scholvinck, EH				Stam, Jose; Abdulahad, Wayel; Huitema, Minke G.; Roozendaal, Caroline; Limburg, Pieter C.; van Stuijvenberg, Margriet; Scholvinck, Elisabeth H.			Fluorescent Cell Barcoding as a Tool to Assess the Age-Related Development of Intracellular Cytokine Production in Small Amounts of Blood from Infants	PLOS ONE			English	Article							GAMMA-INTERFERON; FLOW-CYTOMETRY; IFN-GAMMA; PHYTOHEMAGGLUTININ; RESPONSES; CHILDREN; ONTOGENY; TYPE-1	Fluorescent Cell Barcoding (FCB) is a flow cytometric technique which has been used for assessing signaling proteins. This FCB technique has the potential to be applied in other multiparameter analyses. Since data on antigen (Ag)-specific T-cell immune responses, like intracellular cytokine production, are still lacking in infants because limited blood volumes can be obtained for analysis, the FCB technique could be very useful for this purpose. The objectives of this study were to modify the FCB method to be able to measure multiple Ag-specific cytokine reponses in T-cells upon simultaneous stimulation by various antigens and mitogens in small amounts of blood and to investigate the cytokine pattern of T-cell subsets in healthy infants aged six and twelve months. Blood samples, collected from 20 healthy infants aged six and twelve months, were stimulated in vitro with the antigens: phorbol-myristate-acetate (PMA), purified-protein-derivative (PPD), Tetanus-toxoid (TT), Staphylococcal-enterotoxin-B (SEB), and phytohemagglutinin (PHA). Each stimulus was barcoded by labelling with different intensities of fluorescent cell barcoding (FCB) markers. Intracellular production of interleukin-2, interferon-gamma, and tumor necrosis factor-alpha was measured simultaneously in just one blood sample of 600 ml whole blood. Significant age-related differences in cytokine production were shown for PMA, PHA, and TT in CD4(+) T-cells, and for PMA, PHA, SEB, and TT in CD8(+) T-cells. The intracellular cytokine production by CD4(+) and CD8+ T-cells was higher at twelve months compared to six months of age for all antigens, except for PMA, which was lower at the age of twelve months. Based on the consistency in both T-cell subsets, we conclude that the new FCB method is a promising tool to investigate the age-related development of intracellular cytokine production in infants.	[Stam, Jose; van Stuijvenberg, Margriet; Scholvinck, Elisabeth H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands; [Abdulahad, Wayel; Huitema, Minke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Roozendaal, Caroline; Limburg, Pieter C.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Stam, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands.	j.stam@umcg.nl		/0000-0003-3109-4487	Danone Research	Danone Research(Danone Nutricia)	This study was funded by Danone Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Berdat PA, 2003, CLIN CHEM LAB MED, V41, P1335, DOI 10.1515/CCLM.2003.204; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Corbett NP, 2011, PLOS ONE, V5; ELGHAZALI GEB, 1993, EUR J IMMUNOL, V23, P2740, DOI 10.1002/eji.1830231103; FRENKEL L, 1987, J PEDIATR-US, V111, P97, DOI 10.1016/S0022-3476(87)80353-0; Garcia M, 2002, TUBERCULOSIS, V82, P37, DOI 10.1054/tube.2001.0321; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; Hoffmann F, 2005, EUR CYTOKINE NETW, V16, P283; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Krampera M, 1999, CLIN EXP IMMUNOL, V117, P291; Krouwels FH, 1997, J IMMUNOL METHODS, V203, P89, DOI 10.1016/S0022-1759(97)00016-1; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lappalainen M, 2009, PEDIAT ALLERG IMM-UK, V20, P714, DOI 10.1111/j.1399-3038.2009.00865.x; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; MIYAWAKI T, 1985, CLIN EXP IMMUNOL, V59, P505; Morosini M, 2003, INT J TUBERC LUNG D, V7, P994; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000; Smart JM, 2001, PEDIATR ALLERGY IMMU, V12, P181, DOI 10.1034/j.1399-3038.2001.012004181.x; Talreja J, 2003, CLIN EXP IMMUNOL, V131, P292, DOI 10.1046/j.1365-2249.2003.02072.x; van Stuijvenberg M, 2011, BR J NUTR IN PRESS; Vigano A, 1999, BIOL NEONATE, V75, P1, DOI 10.1159/000014071	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25690	10.1371/journal.pone.0025690	http://dx.doi.org/10.1371/journal.pone.0025690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043291	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400019
J	Sun, L; Li, DL; Zhao, M; He, X; Yu, XJ; Miao, Y; Wang, H; Ren, J; Zang, WJ				Sun, Lei; Li, Dong-Ling; Zhao, Mei; He, Xi; Yu, Xiao-Jiang; Miao, Yi; Wang, Hao; Ren, Jun; Zang, Wei-Jin			The Role of Muscarinic Receptors in the Beneficial Effects of Adenosine against Myocardial Reperfusion Injury in Rats	PLOS ONE			English	Article							REDUCES INFARCT SIZE; NERVOUS-SYSTEM; HEART-FAILURE; NITRIC-OXIDE; A(1); ACTIVATION; ACETYLCHOLINE; ISCHEMIA	Adenosine, a catabolite of ATP, displays a wide variety of effects in the heart including regulation of cardiac response to myocardial ischemia and reperfusion injury. Nonetheless, the precise mechanism of adenosine-induced cardioprotection is still elusive. Isolated Sprague-Dawley rat hearts underwent 30 min global ischemia and 120 min reperfusion using a Langendorff apparatus. Both adenosine and acetylcholine treatment recovered the post-reperfusion cardiac function associated with adenosine and muscarinic receptors activation. Simultaneous administration of adenosine and acetylcholine failed to exert any additive protective effect, suggesting a shared mechanism between the two. Our data further revealed a cross-talk between the adenosine and acetylcholine receptor signaling in reperfused rat hearts. Interestingly, the selective M-2 muscarinic acetylcholine receptor antagonist methoctramine significantly attenuated the cardioprotective effect of adenosine. In addition, treatment with adenosine upregulated the expression and the maximal binding capacity of muscarinic acetylcholine receptor, which were inhibited by the selective A(1) adenosine receptor antagonist 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) and the nitric oxide synthase inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME). These data suggested a possible functional coupling between the adenosine and muscarinic receptors behind the observed cardioprotection. Furthermore, nitric oxide was found involved in triggering the response to each of the two receptor agonist. In summary, there may be a cross-talk between the adenosine and muscarinic receptors in ischemic/reperfused myocardium with nitric oxide synthase might serve as the distal converging point. In addition, adenosine contributes to the invigorating effect of adenosine on muscarinic receptor thereby prompting to regulation of cardiac function. These findings argue for a potentially novel mechanism behind the adenosine-mediated cardioprotection.	[Sun, Lei; Li, Dong-Ling; Zhao, Mei; He, Xi; Yu, Xiao-Jiang; Miao, Yi; Wang, Hao; Zang, Wei-Jin] Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China; [Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA	Xi'an Jiaotong University; University of Wyoming	Sun, L (corresponding author), Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China.	zwj@mail.xjtu.edu.cn	Ren, Jun/ACG-5366-2022; lei, sun/HGE-2755-2022; He, Xijing/AAE-7424-2021	Ren, Jun/0000-0002-0275-0783; He, Xijing/0000-0002-0465-5376	National Natural Science Foundation of China [30930105, 30873058, 30910238]; National Basic Research Program of China (973 Program) [2007CB512005]; CMB [F510000/G16916404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); CMB	This work was supported by the National Natural Science Foundation of China (No. 30930105; No. 30873058; No. 30910238), the National Basic Research Program of China (973 Program, No. 2007CB512005) and CMB Distinguished Professorships Award (No. F510000/G16916404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINKLEY PF, 1993, J AM COLL CARDIOL, V21, P655, DOI 10.1016/0735-1097(93)90098-L; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; Donato M, 2007, J CARDIOVASC PHARM, V49, P287, DOI 10.1097/FJC.0b013e31803c55fe; Fenton RA, 2007, J CELL PHYSIOL, V213, P785, DOI 10.1002/jcp.21149; Headrick JP, 2011, BBA-BIOMEMBRANES, V1808, P1413, DOI 10.1016/j.bbamem.2010.11.016; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kin H, 2005, CARDIOVASC RES, V67, P124, DOI 10.1016/j.cardiores.2005.02.015; McIntosh VJ, 2011, J CARDIOVAS IN PRESS; Mustafa S Jamal, 2009, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-540-89615-9_6; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Peart J, 2000, AM J PHYSIOL-HEART C, V279, pH2166, DOI 10.1152/ajpheart.2000.279.5.H2166; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; Sroka K, 2004, Z KARDIOL, V93, P768, DOI 10.1007/s00392-004-0137-6; Sun L, 2011, J PHARMACOL SCI, V115, P205, DOI 10.1254/jphs.10231FP; Tsuboi M, 2003, HEART VESSELS, V18, P26, DOI 10.1007/s003800300004; Xi L, 2008, CIRCULATION, V118, pS32, DOI 10.1161/CIRCULATIONAHA.107.752865; Xu J, 1999, J CARDIOVASC PHARM, V34, P904, DOI 10.1097/00005344-199912000-00020; Xu ZL, 2005, CARDIOVASC RES, V65, P803, DOI 10.1016/j.cardiores.2004.12.004; YAO ZH, 1993, CIRC RES, V73, P1193, DOI 10.1161/01.RES.73.6.1193	20	13	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25618	10.1371/journal.pone.0025618	http://dx.doi.org/10.1371/journal.pone.0025618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073139	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200001
J	Roux, C; Castric, V; Pauwels, M; Wright, SI; Saumitou-Laprade, P; Vekemans, X				Roux, Camille; Castric, Vincent; Pauwels, Maxime; Wright, Stephen I.; Saumitou-Laprade, Pierre; Vekemans, Xavier			Does Speciation between Arabidopsis halleri and Arabidopsis lyrata Coincide with Major Changes in a Molecular Target of Adaptation?	PLOS ONE			English	Article							ZINC TOLERANCE; METAL HYPERACCUMULATION; NATURAL-POPULATIONS; GENETIC-BASIS; EVOLUTION; THALIANA; BRASSICACEAE; HISTORY; MODELS; ORIGIN	Ever since Darwin proposed natural selection as the driving force for the origin of species, the role of adaptive processes in speciation has remained controversial. In particular, a largely unsolved issue is whether key divergent ecological adaptations are associated with speciation events or evolve secondarily within sister species after the split. The plant Arabidopsis halleri is one of the few species able to colonize soils highly enriched in zinc and cadmium. Recent advances in the molecular genetics of adaptation show that the physiology of this derived ecological trait involves copy number expansions of the AhHMA4 gene, for which orthologs are found in single copy in the closely related A. lyrata and the outgroup A. thaliana. To gain insight into the speciation process, we ask whether adaptive molecular changes at this candidate gene were contemporary with important stages of the speciation process. We first inferred the scenario and timescale of speciation by comparing patterns of variation across the genomic backgrounds of A. halleri and A. lyrata. Then, we estimated the timing of the first duplication of AhHMA4 in A. halleri. Our analysis suggests that the historical split between the two species closely coincides with major changes in this molecular target of adaptation in the A. halleri lineage. These results clearly indicate that these changes evolved in A. halleri well before industrial activities fostered the spread of Zn- and Cd-polluted areas, and suggest that adaptive processes related to heavy-metal homeostasis played a major role in the speciation process.	[Roux, Camille; Castric, Vincent; Pauwels, Maxime; Saumitou-Laprade, Pierre; Vekemans, Xavier] Univ Lille Nord France, Lille, France; [Roux, Camille; Castric, Vincent; Pauwels, Maxime; Saumitou-Laprade, Pierre; Vekemans, Xavier] Univ Lille 1, FRE 3268 CNRS, F-59655 Villeneuve Dascq, France; [Wright, Stephen I.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Toronto	Roux, C (corresponding author), Univ Lille Nord France, Lille, France.	xavier.vekemans@univ-lille1.fr	Castric, Vincent/A-2514-2009; Pauwels, Maxime/AAQ-7425-2020; Wright, Stephen I/C-3113-2008; Vekemans, xavier/A-1721-2009	Castric, Vincent/0000-0002-4461-4915; Pauwels, Maxime/0000-0002-0691-7317; Wright, Stephen I/0000-0001-9973-9697; Vekemans, xavier/0000-0002-4836-4394; Saumitou-Laprade, Pierre/0000-0001-7413-3090; roux, camille/0000-0001-9497-1446	French National Research Agency [ANR-06-BIOD]; Region Nord-Pas de Calais [PLANTEQ-6]	French National Research Agency(French National Research Agency (ANR)); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission)	This work was supported by the French National Research Agency (ANR-06-BIOD grant), and by the Region Nord-Pas de Calais (PLANTEQ-6 grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; Alloway BJ, 1995, HEAVY METALS SOILS; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Bert V, 2003, PLANT SOIL, V249, P9, DOI 10.1023/A:1022580325301; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Charlesworth D, 2005, BIOESSAYS, V27, P472, DOI 10.1002/bies.20231; Clauss MJ, 2006, MOL ECOL, V15, P2753, DOI 10.1111/j.1365-294X.2006.02973.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Darwin C., 1859, ORIGINS SPECIES MEAN; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fones H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001093; Foxe JP, 2009, P NATL ACAD SCI USA, V106, P5241, DOI 10.1073/pnas.0807679106; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Freeman JL, 2006, CURR BIOL, V16, P2181, DOI 10.1016/j.cub.2006.09.015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Gustin JL, 2009, PLANT J, V57, P1116, DOI 10.1111/j.1365-313X.2008.03754.x; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hansson B, 2006, GENET RES, V87, P75, DOI 10.1017/S0016672306008020; Heidel AJ, 2010, MOL ECOL, V19, P3364, DOI 10.1111/j.1365-294X.2010.04761.x; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kashem MA, 2010, ENVIRON SCI POLLUT R, V17, P1174, DOI 10.1007/s11356-009-0193-6; Kawabe A, 2006, GENET RES, V88, P45, DOI 10.1017/S0016672306008287; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kubota H, 2003, INT J PHYTOREMEDIAT, V5, P197, DOI 10.1080/713779219; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Lochlainn SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017814; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Pauwels M, 2005, MOL ECOL, V14, P4403, DOI 10.1111/j.1365-294X.2005.02739.x; Pauwels M, 2006, J EVOLUTION BIOL, V19, P1838, DOI 10.1111/j.1420-9101.2006.01178.x; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2004, GENETICS, V166, P373, DOI 10.1534/genetics.166.1.373; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Ruggiero MV, 2008, GENET RES, V90, P37, DOI 10.1017/S0016672307008932; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Shahzad Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000911; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Team RDC, 2009, R LANG ENV STAT COMP; Ting CT, 2000, P NATL ACAD SCI USA, V97, P5313, DOI 10.1073/pnas.090541597; Tsuchimatsu T, 2010, NATURE, V464, P1342, DOI 10.1038/nature08927; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Willems G, 2007, GENETICS, V176, P659, DOI 10.1534/genetics.106.064485; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Wright SI, 2006, GENETICS, V174, P1421, DOI 10.1534/genetics.106.062588	70	67	68	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26872	10.1371/journal.pone.0026872	http://dx.doi.org/10.1371/journal.pone.0026872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069475	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900037
J	Anand, P; Sankaran, S; Mukherjee, S; Yeturu, K; Laskowski, R; Bhardwaj, A; Bhagavat, R; Brahmachari, SK; Chandra, N				Anand, Praveen; Sankaran, Sandhya; Mukherjee, Sumanta; Yeturu, Kalidas; Laskowski, Roman; Bhardwaj, Anshu; Bhagavat, Raghu; Brahmachari, Samir K.; Chandra, Nagasuma		OSDD Consortium	Structural Annotation of Mycobacterium tuberculosis Proteome	PLOS ONE			English	Article							LIGAND-BINDING SITES; FOLD RECOGNITION; STRUCTURE MODELS; GENOME SEQUENCE; PROTEINS; DATABASE; PREDICTION; ALGORITHM; SEARCH; SERVER	Of the similar to 4000 ORFs identified through the genome sequence of Mycobacterium tuberculosis (TB) H37Rv, experimentally determined structures are available for 312. Since knowledge of protein structures is essential to obtain a high-resolution understanding of the underlying biology, we seek to obtain a structural annotation for the genome, using computational methods. Structural models were obtained and validated for similar to 2877 ORFs, covering similar to 70% of the genome. Functional annotation of each protein was based on fold-based functional assignments and a novel binding site based ligand association. New algorithms for binding site detection and genome scale binding site comparison at the structural level, recently reported from the laboratory, were utilized. Besides these, the annotation covers detection of various sequence and sub-structural motifs and quaternary structure predictions based on the corresponding templates. The study provides an opportunity to obtain a global perspective of the fold distribution in the genome. The annotation indicates that cellular metabolism can be achieved with only 219 folds. New insights about the folds that predominate in the genome, as well as the fold-combinations that make up multi-domain proteins are also obtained. 1728 binding pockets have been associated with ligands through binding site identification and sub-structure similarity analyses. The resource (http://proline.physics.iisc.ernet.in/Tbstructuralannotation), being one of the first to be based on structure-derived functional annotations at a genome scale, is expected to be useful for better understanding of TB and for application in drug discovery. The reported annotation pipeline is fairly generic and can be applied to other genomes as well.	[Anand, Praveen; Sankaran, Sandhya; Mukherjee, Sumanta; Yeturu, Kalidas; Bhagavat, Raghu; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Anand, Praveen; Sankaran, Sandhya; Mukherjee, Sumanta; Yeturu, Kalidas; Bhagavat, Raghu; Chandra, Nagasuma] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Laskowski, Roman] Wellcome Trust Genome Campus, European Bioinformat Inst, Cambridge, England; [Brahmachari, Samir K.] Inst Genom & Integrat Biol CSIR, New Delhi, India; [Bhardwaj, Anshu; Brahmachari, Samir K.] Council Ind & Sci Res, New Delhi, India; [OSDD Consortium] CSIR, Open Source Drug Discovery OSDD Consortium, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; Council of Scientific & Industrial Research (CSIR) - India	Anand, P (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nchandra@biochem.iisc.ernet.in		Anand, Praveen/0000-0002-2478-7042; Laskowski, Roman/0000-0001-5528-0087; bhardwaj, anshu/0000-0001-5830-2616; Sandhya, Sankaran/0000-0003-0055-302X; Chandra, Nagasuma/0000-0002-9939-8439				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Carbone V, 2008, ACTA CRYSTALLOGR D, V64, P532, DOI 10.1107/S0907444908004538; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kalidas Y, 2008, J STRUCT BIOL, V161, P31, DOI 10.1016/j.jsb.2007.09.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUMAGAI I, 1992, P NATL ACAD SCI USA, V89, P5887, DOI 10.1073/pnas.89.13.5887; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Loerger TR, 2009, CURR OPIN MICROBIOL, V12, P318, DOI 10.1016/j.mib.2009.04.006; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mereghetti P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-66; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Vogel C, 2004, J MOL BIOL, V336, P809, DOI 10.1016/j.jmb.2003.12.026; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; *WHO, 2009, GLOB TUB CONTR SHORT; Wolf YI, 1999, GENOME RES, V9, P17; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543	56	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27044	10.1371/journal.pone.0027044	http://dx.doi.org/10.1371/journal.pone.0027044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073123	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000050
J	Vandeputte, P; Ischer, F; Sanglard, D; Coste, AT				Vandeputte, Patrick; Ischer, Francoise; Sanglard, Dominique; Coste, Alix T.			In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization	PLOS ONE			English	Article							PLEIOTROPIC DRUG-RESISTANCE; ANTIFUNGAL AGENTS; GENE DISRUPTION; BIOFILM FORMATION; VIRULENCE; EXPRESSION; MECHANISMS; PATHOGEN; CALCINEURIN; METABOLISM	The incidence of fungal infections in immuno-compromised patients increased considerably over the last 30 years. New treatments are therefore needed against pathogenic fungi. With Candida albicans as a model, study of host-fungal pathogen interactions might reveal new sources of therapies. Transcription factors (TF) are of interest since they integrate signals from the host environment and participate in an adapted microbial response. TFs of the Zn2-Cys6 class are specific to fungi and are important regulators of fungal metabolism. This work analyzed the importance of the C. albicans Zn2-Cys6 TF for mice kidney colonization. For this purpose, 77 Zn2-Cys6 TF mutants were screened in a systemic mice model of infection by pools of 10 mutants. We developed a simple barcoding strategy to specifically detect each mutant DNA from mice kidney by quantitative PCR. Among the 77 TF mutant strains tested, eight showed a decreased colonization including mutants for orf19.3405, orf19.255, orf19.5133, RGT1, UGA3, orf19.6182, SEF1 and orf19.2646, and four an increased colonization including mutants for orf19.4166, ZFU2, orf19.1685 and UPC2 as compared to the isogenic wild type strain. Our approach was validated by comparable results obtained with the same animal model using a single mutant and the revertant for an ORF (orf19.2646) with still unknown functions. In an attempt to identify putative involvement of such TFs in already known C. albicans virulence mechanisms, we determined their in vitro susceptibility to pH, heat and oxidative stresses, as well as ability to produce hyphae and invade agar. A poor correlation was found between in vitro and in vivo assays, thus suggesting that TFs needed for mice kidney colonization may involve still unknown mechanisms. This large-scale analysis of mice organ colonization by C. albicans can now be extended to other mutant libraries since our in vivo screening strategy can be adapted to any preexisting mutants.	[Vandeputte, Patrick] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; Univ Hosp Ctr, Lausanne, Switzerland	University of Lausanne	Vandeputte, P (corresponding author), Univ Lausanne, Inst Microbiol, Lausanne, Switzerland.	alix.coste@chuv.ch	Sanglard, Dominique/K-6032-2017; Coste, Alix T./H-3026-2019	Sanglard, Dominique/0000-0002-5244-4178; Coste, Alix T./0000-0001-9481-9778; Vandeputte, Patrick/0000-0002-9425-9253	FBM (Faculte de Biologie et Medecine) of the Lausanne University, Switzerland; Indo-Swiss Research Joint Program (ISRJP) [122917]	FBM (Faculte de Biologie et Medecine) of the Lausanne University, Switzerland; Indo-Swiss Research Joint Program (ISRJP)	Alix Coste was supported by the Bourse Profemme from the FBM (Faculte de Biologie et Medecine) of the Lausanne University, Switzerland. Patrick Vandeputte was supported by the Indo-Swiss Research Joint Program (ISRJP N<SUP>o</SUP>122917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Boon JM, 2003, J AM CHEM SOC, V125, P8195, DOI 10.1021/ja029670q; Bourgeois C, 2010, CURR OPIN MICROBIOL, V13, P401, DOI 10.1016/j.mib.2010.05.004; Brown AJP, 2007, CURR OPIN MICROBIOL, V10, P307, DOI 10.1016/j.mib.2007.04.001; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Brun S, 2005, J ANTIMICROB CHEMOTH, V56, P307, DOI 10.1093/jac/dki200; Brun S, 2003, ANTIMICROB AGENTS CH, V47, P847, DOI 10.1128/AAC.47.3.847-853.2003; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Chamilos G, 2009, J INFECT DIS, V200, P152, DOI 10.1086/599363; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Coste AT, 2008, MICROBIOL-SGM, V154, P1491, DOI 10.1099/mic.0.2007/016063-0; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; de Veerdonk FLV, 2010, FEMS MICROBIOL REV, V34, P1063, DOI 10.1111/j.1574-6976.2010.00232.x; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; FONZI WA, 1993, GENETICS, V134, P717; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Heilmann CJ, 2010, ANTIMICROB AGENTS CH, V54, P353, DOI 10.1128/AAC.01102-09; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hoot SJ, 2008, MICROBIOL-SGM, V154, P2748, DOI 10.1099/mic.0.2008/017475-0; Hoot SJ, 2010, EUKARYOT CELL, V9, P1354, DOI 10.1128/EC.00130-10; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Hube B, 2006, FUTURE MICROBIOL, V1, P209, DOI 10.2217/17460913.1.2.209; Ikeda F, 2000, ANTIMICROB AGENTS CH, V44, P614, DOI 10.1128/AAC.44.3.614-618.2000; Johnston DA, 2009, INFECT IMMUN, V77, P2343, DOI 10.1128/IAI.01458-08; KIESEWETTER DO, 1990, APPL RADIAT ISOTOPES, V41, P139; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Lachke SA, 2003, MOL MICROBIOL, V48, P523, DOI 10.1046/j.1365-2958.2003.t01-1-03448.x; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Lupetti A, 2003, ANTIMICROB AGENTS CH, V47, P262, DOI 10.1128/AAC.47.1.262-267.2003; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacPherson S, 2005, ANTIMICROB AGENTS CH, V49, P1745, DOI 10.1128/AAC.49.5.1745-1752.2005; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Moye-Rowley WS, 2002, ANTIOXID REDOX SIGN, V4, P123, DOI 10.1089/152308602753625915; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Moyrand F, 2008, EUKARYOT CELL, V7, P2069, DOI 10.1128/EC.00189-08; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; NOBLE SM, 2010, NAT GENET, P1; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Ondeyka J, 2009, J NAT PROD, V72, P136, DOI 10.1021/np800511r; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Romani L, 2003, CURR OPIN MICROBIOL, V6, P338, DOI 10.1016/S1369-5274(03)00081-X; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004; Staib P, 2002, INFECT IMMUN, V70, P921, DOI 10.1128/IAI.70.2.921-927.2002; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Talibi D, 1999, J BACTERIOL, V181, P231, DOI 10.1128/JB.181.1.231-240.1999; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Uppuluri P, 2007, MOL MICROBIOL, V64, P1572, DOI 10.1111/j.1365-2958.2007.05760.x; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x	71	37	103	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26962	10.1371/journal.pone.0026962	http://dx.doi.org/10.1371/journal.pone.0026962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073120	Green Published, gold			2022-12-27	WOS:000296916000037
J	Gorlich, A; Wolf, M; Zimmermann, AM; Gurniak, CB; Al Banchaabouchi, M; Sassoe-Pognetto, M; Witke, W; Friauf, E; Rust, MB				Goerlich, Andreas; Wolf, Michael; Zimmermann, Anika-Maria; Gurniak, Christine B.; Al Banchaabouchi, Mumna; Sassoe-Pognetto, Marco; Witke, Walter; Friauf, Eckhard; Rust, Marco B.			N-Cofilin Can Compensate for the Loss of ADF in Excitatory Synapses	PLOS ONE			English	Article							ACTIN-DEPOLYMERIZING FACTOR; SYNAPTIC PLASTICITY; DENDRITIC SPINES; ADF/COFILIN; MICE; ORGANIZATION; CYTOSKELETON; MECHANISMS; DYNAMICS; LTP	Actin plays important roles in a number of synaptic processes, including synaptic vesicle organization and exocytosis, mobility of postsynaptic receptors, and synaptic plasticity. However, little is known about the mechanisms that control actin at synapses. Actin dynamics crucially depend on LIM kinase 1 (LIMK1) that controls the activity of the actin depolymerizing proteins of the ADF/cofilin family. While analyses of mouse mutants revealed the importance of LIMK1 for both pre- and postsynaptic mechanisms, the ADF/cofilin family member n-cofilin appears to be relevant merely for postsynaptic plasticity, and not for presynaptic physiology. By means of immunogold electron microscopy and immunocytochemistry, we here demonstrate the presence of ADF (actin depolymerizing factor), a close homolog of n-cofilin, in excitatory synapses, where it is particularly enriched in presynaptic terminals. Surprisingly, genetic ablation of ADF in mice had no adverse effects on synapse structure or density as assessed by electron microscopy and by the morphological analysis of Golgi-stained hippocampal pyramidal cells. Moreover, a series of electrophysiological recordings in acute hippocampal slices revealed that presynaptic recruitment and exocytosis of synaptic vesicles as well as postsynaptic plasticity were unchanged in ADF mutant mice. The lack of synaptic defects may be explained by the elevated n-cofilin levels observed in synaptic structures of ADF mutants. Indeed, synaptic actin regulation was impaired in compound mutants lacking both ADF and n-cofilin, but not in ADF single mutants. From our results we conclude that n-cofilin can compensate for the loss of ADF in excitatory synapses. Further, our data suggest that ADF and n-cofilin cooperate in controlling synaptic actin content.	[Goerlich, Andreas; Wolf, Michael; Zimmermann, Anika-Maria; Rust, Marco B.] Univ Kaiserslautern, Neurobiol Neurophysiol Grp, Kaiserslautern, Germany; [Gurniak, Christine B.; Witke, Walter] Univ Bonn, Inst Genet, Bonn, Germany; [Al Banchaabouchi, Mumna] European Mouse Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Sassoe-Pognetto, Marco] Univ Turin, Natl Inst Neurosci Italy, Turin, Italy; [Friauf, Eckhard] Univ Kaiserslautern, Anim Physiol Grp, Kaiserslautern, Germany	University of Kaiserslautern; University of Bonn; University of Turin; University of Turin; University of Kaiserslautern	Gorlich, A (corresponding author), Univ Kaiserslautern, Neurobiol Neurophysiol Grp, Kaiserslautern, Germany.	marco.rust@biologie.uni-kl.de	Sassoe-Pognetto, Marco/AAE-3536-2022; Friauf, Eckhard/D-7529-2012	Friauf, Eckhard/0000-0002-1833-1698; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Research Initiative Membrane Transport (RIMB) of the University of Kaiserslautern; Deutsche Forschungsgemeinschaft [RU-1232/1-1]; Stiftung Rheinland-Pfalz [961-386261/877]; Compagnia di San Paolo	Research Initiative Membrane Transport (RIMB) of the University of Kaiserslautern; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung Rheinland-Pfalz; Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by the Research Initiative Membrane Transport (RIMB) of the University of Kaiserslautern. MBR was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (RU-1232/1-1) and by the Stiftung Rheinland-Pfalz (961-386261/877). MSP was supported by a grant from Compagnia di San Paolo (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Herde MK, 2010, J COMP NEUROL, V518, P1724, DOI 10.1002/cne.22298; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lee B, 2002, BRAIN RES, V948, P1, DOI 10.1016/S0006-8993(02)02942-6; LENA JY, 1991, J NEUROSCI RES, V30, P18, DOI 10.1002/jnr.490300104; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; SHOLL DA, 1953, J ANAT, V87, P387; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	25	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26789	10.1371/journal.pone.0026789	http://dx.doi.org/10.1371/journal.pone.0026789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046357	gold, Green Published			2022-12-27	WOS:000299081800041
J	Zorovic, M				Zorovic, Maja			Temporal Processing of Vibratory Communication Signals at the Level of Ascending Interneurons in Nezara viridula (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							SUBSTRATE-BORNE SIGNALS; GREEN STINK BUG; L HETEROPTERA; VIBRATIONAL COMMUNICATION; AUDITORY INTERNEURONS; PROTHORACIC GANGLION; SPECIES RECOGNITION; ACOUSTIC-SIGNALS; HOST PLANTS; CRICKET	During mating, males and females of N. viridula (Heteroptera: Pentatomidae) produce sex-and species-specific calling and courtship substrate-borne vibratory signals, grouped into songs. Recognition and localization of these signals are fundamental for successful mating. The recognition is mainly based on the temporal pattern, i.e. the amplitude modulation, while the frequency spectrum of the signals usually only plays a minor role. We examined the temporal selectivity for vibratory signals in four types of ascending vibratory interneurons in N. viridula. Using intracellular recording and labelling technique, we analyzed the neurons' responses to 30 pulse duration/interval duration (PD/ID) combinations. Two response arrays were created for each neuron type, showing the intensity of the responses either as time-averaged spike counts or as peak instantaneous spike rates. The mean spike rate response arrays showed preference of the neurons for short PDs (below 600 ms) and no selectivity towards interval duration; while the peak spike rate response arrays exhibited either short PD/long ID selectivity or no selectivity at all. The long PD/short ID combinations elicited the weakest responses in all neurons tested. No response arrays showed the receiver preference for either constant period or duty cycle. The vibratory song pattern selectivity matched the PD of N. viridula male vibratory signals, thus pointing to temporal filtering for the conspecific vibratory signals already at level of the ascending interneurons. In some neurons the responses elicited by the vibratory stimuli were followed by distinct, regular oscillations of the membrane potential. The distance between the oscillation peaks matched the temporal structure of the male calling song, indicating a possible resonance based mechanism for signal recognition.	Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Zorovic, M (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	maja.zorovic@nib.si	Zorović, Maja/GON-4796-2022		Slovenian National Research Agency [P1-0255]	Slovenian National Research Agency(Slovenian Research Agency - Slovenia)	The work was funded by the Slovenian National Research Agency (Research Program P1-0255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICHER B, 1990, J COMP PHYSIOL A, V166, P345; BAUER M, 1987, J COMP PHYSIOL A, V161, P95, DOI 10.1007/BF00609458; BROWNELL PH, 1984, SCI AM, V251, P86, DOI 10.1038/scientificamerican1284-86; Bush SL, 2006, J COMP PHYSIOL A, V192, P113, DOI 10.1007/s00359-005-0053-x; CLARIDGE MF, 1993, BIOL J LINN SOC, V48, P267, DOI 10.1111/j.1095-8312.1993.tb00891.x; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; COKL A, 1983, J COMP PHYSIOL, V150, P261; COKL A, 1982, Bioloski Vestnik, V30, P1; Cokl A, 1999, ANIM BEHAV, V58, P1277, DOI 10.1006/anbe.1999.1272; Cokl A, 2000, PHYSIOL ENTOMOL, V25, P196, DOI 10.1046/j.1365-3032.2000.00187.x; Cokl A, 2008, J INSECT PHYSIOL, V54, P1113, DOI 10.1016/j.jinsphys.2008.06.004; Cokl A, 2006, CONT T ENT, P71; de Groot M, 2010, J EXP BIOL, V213, P3213, DOI 10.1242/jeb.044024; DEVRIJER PWF, 1984, NETH J ZOOL, V34, P388, DOI 10.1163/002829684X00218; Hedwig B., 1985, P61; HEDWIG B, 1986, J COMP PHYSIOL A, V158, P413, DOI 10.1007/BF00603625; HENNIG RM, 1988, J COMP PHYSIOL A, V163, P135, DOI 10.1007/BF00612003; Hennig RM, 2004, MICROSC RES TECHNIQ, V63, P351, DOI 10.1002/jemt.20052; Hill PSM, 2009, NATURWISSENSCHAFTEN, V96, P1355, DOI 10.1007/s00114-009-0588-8; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Hrabar Nika, 2004, Acta Zoologica Sinica, V50, P566; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; Miklas N, 2003, J CHEM ECOL, V29, P561, DOI 10.1023/A:1022898620429; Nabatiyan A, 2003, J NEUROPHYSIOL, V90, P2484, DOI 10.1152/jn.00259.2003; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; RONACHER B, 1988, J COMP PHYSIOL A, V163, P517, DOI 10.1007/BF00604905; Ryan MA, 1996, BEHAV PROCESS, V36, P183, DOI 10.1016/0376-6357(95)00026-7; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Stritih N, 2009, J COMP NEUROL, V516, P519, DOI 10.1002/cne.22138; Stritih N, 2009, ZOOLOGY, V112, P48, DOI 10.1016/j.zool.2008.04.005; Stumpner A, 1997, J EXP BIOL, V200, P1089; STUMPNER A, 1991, J EXP BIOL, V158, P411; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; Triblehorn JD, 2009, J NEUROPHYSIOL, V102, P1348, DOI 10.1152/jn.91276.2008; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; WOHLERS DW, 1985, CELL TISSUE RES, V239, P555; WOHLERS DW, 1982, J COMP PHYSIOL, V146, P161, DOI 10.1007/BF00610234; Zorovic M, 2011, J NEUROPHYSIOL, V105, P2181, DOI 10.1152/jn.00416.2010; Zorovic M, 2005, THESIS U LJUBLJANA S; Zorovic M, 2008, J COMP NEUROL, V508, P365, DOI 10.1002/cne.21656; Zunic A, 2011, J INSECT BEHAV, V24, P468, DOI 10.1007/s10905-011-9272-x	45	11	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26843	10.1371/journal.pone.0026843	http://dx.doi.org/10.1371/journal.pone.0026843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053216	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800049
J	Bliziotis, IA; Petrosillo, N; Michalopoulos, A; Samonis, G; Falagas, ME				Bliziotis, Ioannis A.; Petrosillo, Nicola; Michalopoulos, Argyris; Samonis, George; Falagas, Matthew E.			Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; RISK-FACTORS; MORTALITY; METAANALYSIS; EPIDEMIOLOGY; VALIDATION; RESISTANCE	Background: Bacteremia by Pseudomonas aeruginosa represents one severe infection. It is not clear whether beta-lactam monotherapy leads to similar rates of treatment success compared to combinations of beta-lactams with aminoglycosides or quinolones. Methods: Retrospective cohort study from 3 tertiary hospitals (2 in Greece and 1 in Italy). Pseudomonas aeruginosa isolates were susceptible to a beta-lactam and an aminoglycoside or a quinolone. Patients received appropriate therapy for at least 48 hours. Primary outcome of interest was treatment success in patients with definitive beta-lactam combination therapy compared to monotherapy. Secondary outcomes were treatment success keeping the same empirical and definitive regimen, mortality, and toxicity. Results: Out of 92 bacteremias there were 54 evaluable episodes for the primary outcome (20 received monotherapy). Treatment success was higher with combination therapy (85%) compared to beta-lactam monotherapy (65%), however not statistically significantly [Odds ratio (OR) 3.1; 95% Confidence Interval (CI) 0.69-14.7, p = 0.1]. Very long (>2 months) hospitalisation before bacteremia was the only factor independently associated with treatment success (OR 0.73; 95% CI 0.01-0.95, p = 0.046), however this result entailed few episodes. All-cause mortality did not differ significantly between combination therapy [6/31 (19%)] and monotherapy [8/19 (42%)], p = 0.11. Only Charlson comorbidity index was associated with excess mortality (p = 0.03). Conclusion: Our study, in accordance with previous ones, indicates that the choice between monotherapy and combination therapy may not affect treatment success significantly. However, our study does not have statistical power to identify small or moderate differences. A large randomized controlled trial evaluating this issue is justified.	[Bliziotis, Ioannis A.; Michalopoulos, Argyris; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Petrosillo, Nicola] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Michalopoulos, Argyris] Henry Dunant Hosp, Intens Care Unit, Athens, Greece; [Samonis, George] Univ Hosp Herakl, Dept Internal Med, Iraklion, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ Sch Med, Dept Med, Boston, MA USA	Alfa Institute Of Biomedical Sciences; IRCCS Lazzaro Spallanzani; Henry Dunant Hospital; University Hospital of Heraklion; Henry Dunant Hospital; Tufts University	Bliziotis, IA (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Petrosillo, Nicola/AAZ-2095-2021	petrosillo, nicola/0000-0002-2585-7567; Michalopoulos, Argyris/0000-0002-6904-164X	Amphiarion Foundation of Chemotherapeutic Studies, Athens, Greece	Amphiarion Foundation of Chemotherapeutic Studies, Athens, Greece	IAB has been supported by a grant from Amphiarion Foundation of Chemotherapeutic Studies, Athens, Greece for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Bliziotis IA, 2005, CLIN INFECT DIS, V41, P149, DOI 10.1086/430912; Blot S, 2003, J HOSP INFECT, V53, P18, DOI 10.1053/jhin.2002.1329; BODEY GP, 1985, ARCH INTERN MED, V145, P1621, DOI 10.1001/archinte.145.9.1621; Chamot E, 2003, ANTIMICROB AGENTS CH, V47, P2756, DOI 10.1128/AAC.47.9.2756-2764.2003; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatzinikolaou I, 2000, ARCH INTERN MED, V160, P501, DOI 10.1001/archinte.160.4.501; Cheong HS, 2008, EUR J CLIN MICROBIOL, V27, P1219, DOI 10.1007/s10096-008-0568-5; Clark Nina M, 2003, Curr Opin Crit Care, V9, P413, DOI 10.1097/00075198-200310000-00012; Davies CWH, 2003, THORAX, V58, pII18, DOI 10.1136/thorax.58.suppl_2.ii18; Falagas ME, 2010, CLIN INFECT DIS, V50, P468, DOI 10.1086/649929; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V57, P639, DOI 10.1093/jac/dkl044; FLICK MR, 1976, AM J MED, V60, P501, DOI 10.1016/0002-9343(76)90716-6; Harbarth S, 2007, CLIN INFECT DIS, V44, P87, DOI 10.1086/510075; Institute CaLS, 2005, M100S15 CLSINCCLS; Kang CI, 2005, CLIN MICROBIOL INFEC, V11, P415, DOI 10.1111/j.1469-0691.2005.01102.x; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Koprnova J, 2005, J CHEMOTHERAPY, V17, P470, DOI 10.1179/joc.2005.17.5.470; Kvitko CH, 2011, J ANTIMICROB CHEMOTH, V66, P175, DOI 10.1093/jac/dkq390; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Lopez-Dupla M, 2009, AM J INFECT CONTROL, V37, P753, DOI 10.1016/j.ajic.2009.02.003; Martinez JA, 2010, ANTIMICROB AGENTS CH, V54, P3590, DOI 10.1128/AAC.00115-10; Mazuski John E, 2002, Surg Infect (Larchmt), V3, P161, DOI 10.1089/109629602761624171; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Mutlu GM, 2006, CURR OPIN CRIT CARE, V12, P458, DOI 10.1097/01.ccx.0000244127.92612.b4; NCCLS, 2003, M7A6 NCCLS; Niederman MS, 2001, CRIT CARE MED, V29, pN114, DOI 10.1097/00003246-200104001-00011; Osmon S, 2004, CHEST, V125, P607, DOI 10.1378/chest.125.2.607; Parkins MD, 2010, INFECTION, V38, P25, DOI 10.1007/s15010-009-9145-9; Paul M, 2005, LANCET INFECT DIS, V5, P192, DOI 10.1016/S1473-3099(05)70030-X; Paul M, 2004, BMJ-BRIT MED J, V328, P668, DOI 10.1136/bmj.38028.520995.63; Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Siegman-Igra Y, 1998, Int J Infect Dis, V2, P211, DOI 10.1016/S1201-9712(98)90055-8; Sprung CL, 2001, INTENS CARE MED, V27, pS1; Tam VH, 2010, ANTIMICROB AGENTS CH, V54, P3717, DOI 10.1128/AAC.00207-10; Todeschini G, 1998, Int J Infect Dis, V3, P99; Vidal F, 1999, EUR J CLIN MICROBIOL, V18, P473, DOI 10.1007/s100960050326; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121; Vitkauskiene A, 2010, MEDICINA-LITHUANIA, V46, P490, DOI 10.3390/medicina46070071; Waterer GW, 2001, CRIT CARE MED, V29, pN75, DOI 10.1097/00003246-200104001-00004	43	29	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26470	10.1371/journal.pone.0026470	http://dx.doi.org/10.1371/journal.pone.0026470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046290	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600020
J	Cowan, GJM; Creasey, AM; Dhanasarnsombut, K; Thomas, AW; Remarque, EJ; Cavanagh, DR				Cowan, Graeme J. M.; Creasey, Alison M.; Dhanasarnsombut, Kelwalin; Thomas, Alan W.; Remarque, Edmond J.; Cavanagh, David R.			A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; INTRINSICALLY UNSTRUCTURED PROTEINS; PLASMODIUM-FALCIPARUM MALARIA; MEMBRANE ANTIGEN-1 AMA1; GLUTAMATE-RICH PROTEIN; ANTIBODY-RESPONSES; CLINICAL MALARIA; CELLULAR-INHIBITION; SEQUENCE DIVERSITY; SINGLE PROTEIN	Polymorphic parasite antigens are known targets of protective immunity to malaria, but this antigenic variation poses challenges to vaccine development. A synthetic MSP-1 Block 2 construct, based on all polymorphic variants found in natural Plasmodium falciparum isolates has been designed, combined with the relatively conserved Block 1 sequence of MSP-1 and expressed in E. coli. The MSP-1 Hybrid antigen has been produced with high yield by fed-batch fermentation and purified without the aid of affinity tags resulting in a pure and extremely thermostable antigen preparation. MSP-1 hybrid is immunogenic in experimental animals using adjuvants suitable for human use, eliciting antibodies against epitopes from all three Block 2 serotypes. Human serum antibodies from Africans naturally exposed to malaria reacted to the MSP-1 hybrid as strongly as, or better than the same serum reactivities to individual MSP-1 Block 2 antigens, and these antibody responses showed clear associations with reduced incidence of malaria episodes. The MSP-1 hybrid is designed to induce a protective antibody response to the highly polymorphic Block 2 region of MSP-1, enhancing the repertoire of MSP-1 Block 2 antibody responses found among immune and semi-immune individuals in malaria endemic areas. The target population for such a vaccine is young children and vulnerable adults, to accelerate the acquisition of a full range of malaria protective antibodies against this polymorphic parasite antigen.	[Cowan, Graeme J. M.; Creasey, Alison M.; Dhanasarnsombut, Kelwalin; Cavanagh, David R.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Thomas, Alan W.; Remarque, Edmond J.] Biomed Primate Res Ctr, Rijswijk, Netherlands	University of Edinburgh	Cowan, GJM (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	david.cavanagh@ed.ac.uk	Cowan, Graeme/F-2842-2011; Remarque, Ed/AAE-8643-2020; Cavanagh, David R/A-1828-2008	Cowan, Graeme/0000-0002-1949-4253; Cavanagh, David/0000-0003-4360-2637	European Malaria Vaccine Development Association (EMVDA), EU [LSHP-CT-2007-037506]; EMVDA	European Malaria Vaccine Development Association (EMVDA), EU; EMVDA	This work was funded by the European Malaria Vaccine Development Association (EMVDA), EU Framework 6 programme grant number LSHP-CT-2007-037506. KD is in receipt of an EMVDA PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Cavanagh DR, 1998, J IMMUNOL, V161, P347; CAVANAGH DR, 1997, MOL BIOCH PARASITOLO, V85; COHEN S, 1961, NATURE; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Dobano C, 2008, J INFECT DIS, V197, P766, DOI 10.1086/527490; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; Dodoo D, 1999, INFECT IMMUN, V67, P2131, DOI 10.1128/IAI.67.5.2131-2137.1999; Faber BW, 2007, INFECT IMMUN, V75, P5947, DOI 10.1128/IAI.01804-06; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; KRZYCH U, 1995, J IMMUNOL, V155, P4072; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; OEUVRAY C, 1994, BLOOD, V84, P1594; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Parra M, 2000, INFECT IMMUN, V68, P2685, DOI 10.1128/IAI.68.5.2685-2691.2000; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; QUAKYI IA, 1994, J IMMUNOL, V153, P2082; Ramasamy R, 1999, PARASITE IMMUNOL, V21, P397, DOI 10.1046/j.1365-3024.1999.00239.x; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sarthou JL, 1997, INFECT IMMUN, V65, P3271, DOI 10.1128/IAI.65.8.3271-3276.1997; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stubbs J, 2011, INFECT IMMUN, V79, P1143, DOI 10.1128/IAI.01034-10; SZARFMAN A, 1988, J EXP MED, V167, P231, DOI 10.1084/jem.167.1.231; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Tetteh KKA, 2005, INFECT IMMUN, V73, P5928, DOI 10.1128/IAI.73.9.5928-5935.2005; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912	54	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26616	10.1371/journal.pone.0026616	http://dx.doi.org/10.1371/journal.pone.0026616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22073118	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600035
J	Majumder, P; Dasgupta, D				Majumder, Parijat; Dasgupta, Dipak			Effect of DNA Groove Binder Distamycin A upon Chromatin Structure	PLOS ONE			English	Article							SCANNING FORCE MICROSCOPY; BINDING-AFFINITY; HISTONE H3; NUCLEOSOME; NETROPSIN; DRUG; INHIBITION; COMPACTION; ASSOCIATION; MITHRAMYCIN	Background: Distamycin A is a prototype minor groove binder, which binds to B-form DNA, preferentially at A/T rich sites. Extensive work in the past few decades has characterized the binding at the level of double stranded DNA. However, effect of the same on physiological DNA, i.e. DNA complexed in chromatin, has not been well studied. Here we elucidate from a structural perspective, the interaction of distamycin with soluble chromatin, isolated from Sprague-Dawley rat. Methodology/Principal Findings: Chromatin is a hierarchical assemblage of DNA and protein. Therefore, in order to characterize the interaction of the same with distamycin, we have classified the system into various levels, according to the requirements of the method adopted, and the information to be obtained. Isothermal titration calorimetry has been employed to characterize the binding at the levels of chromatin, chromatosome and chromosomal DNA. Thermodynamic parameters obtained thereof, identify enthalpy as the driving force for the association, with comparable binding affinity and free energy for chromatin and chromosomal DNA. Reaction enthalpies at different temperatures were utilized to evaluate the change in specific heat capacity (Delta Cp), which, in turn, indicated a possible binding associated structural change. Ligand induced structural alterations have been monitored by two complementary methods - dynamic light scattering, and transmission electron microscopy. They indicate compaction of chromatin. Using transmission electron microscopy, we have visualized the effect of distamycin upon chromatin architecture at di- and trinucleosome levels. Our results elucidate the simultaneous involvement of linker bending and internucleosomal angle contraction in compaction process induced by distamycin. Conclusions/Significance: We summarize here, for the first time, the thermodynamic parameters for the interaction of distamycin with soluble chromatin, and elucidate its effect on chromatin architecture. The study provides insight into a ligand induced compaction phenomenon, and suggests new mechanisms of chromatin architectural alteration.	[Majumder, Parijat; Dasgupta, Dipak] Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics	Majumder, P (corresponding author), Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India.	dipak.dasgupta@saha.ac.in			Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	This work was funded by the Intramural Grant MMDDA from Department of Atomic Energy, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUDAYA A, 1995, NUCLEIC ACIDS RES, V23, P3385, DOI 10.1093/nar/23.17.3385; Asagi M, 2010, BIOPHYS CHEM, V149, P34, DOI 10.1016/j.bpc.2010.03.014; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; BALDWIN RL, 1992, P NATL ACAD SCI USA, V89, P7110, DOI 10.1073/pnas.89.15.7110; Baron RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010656; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; BELLORINI M, 1995, NUCLEIC ACIDS RES, V23, P1657, DOI 10.1093/nar/23.10.1657; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Brown PM, 1996, J MOL BIOL, V262, P671, DOI 10.1006/jmbi.1996.0544; Broyles SS, 2004, J VIROL, V78, P2137, DOI 10.1128/JVI.78.4.2137-2141.2004; BRUZIK JP, 1987, BIOCHEMISTRY-US, V26, P950, DOI 10.1021/bi00377a040; Bussiek M, 2006, BIOCHEMISTRY-US, V45, P10838, DOI 10.1021/bi060807p; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; Butler PJG, 1998, J MOL BIOL, V281, P401, DOI 10.1006/jmbi.1998.1954; CHURCHILL MEA, 1990, BIOCHEMISTRY-US, V29, P6043, DOI 10.1021/bi00477a023; d'Erme M, 2001, BIOCHEMISTRY-US, V40, P10947, DOI 10.1021/bi002742a; DASGUPTA D, 1987, BIOCHEMISTRY-US, V26, P6381, DOI 10.1021/bi00394a011; DATTAGUPTA N, 1980, BIOCHEMISTRY-US, V19, P5998, DOI 10.1021/bi00567a009; DORN A, 1992, EMBO J, V11, P279, DOI 10.1002/j.1460-2075.1992.tb05050.x; FISH EL, 1988, BIOCHEMISTRY-US, V27, P6026, DOI 10.1021/bi00416a030; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Haq I, 2000, METHOD ENZYMOL, V323, P373; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Lah J, 2000, BIOCHEMISTRY-US, V39, P9317, DOI 10.1021/bi000748u; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; Leuba SH, 1998, BIOPHYS J, V74, P2823, DOI 10.1016/S0006-3495(98)77989-5; LOW CML, 1986, NUCLEIC ACIDS RES, V14, P6785, DOI 10.1093/nar/14.17.6785; LUCK G, 1977, NUCLEIC ACIDS RES, V4, P2655, DOI 10.1093/nar/4.8.2655; MARION C, 1981, EUR J BIOCHEM, V120, P169, DOI 10.1111/j.1432-1033.1981.tb05685.x; Mir MA, 2003, BIOORGAN MED CHEM, V11, P2791, DOI 10.1016/S0968-0896(03)00211-6; Mir MA, 2003, J INORG BIOCHEM, V94, P72, DOI 10.1016/S0162-0134(02)00576-7; Mir MA, 2001, BIOCHEM BIOPH RES CO, V280, P68, DOI 10.1006/bbrc.2000.4075; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Nelson SM, 2007, MUTAT RES-FUND MOL M, V623, P24, DOI 10.1016/j.mrfmmm.2007.03.012; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; RENTZEPERIS D, 1995, BIOCHEMISTRY-US, V34, P2937, DOI 10.1021/bi00009a025; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roca J, 2011, TRANSCR-AUSTIN, V2, P82, DOI 10.4161/trns.2.2.14807; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Sprigg L, 2010, J MED CHEM, V53, P6457, DOI 10.1021/jm1007853; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Taquet A, 1998, BIOCHEMISTRY-US, V37, P9119, DOI 10.1021/bi972735v; Taylor A, 1997, MOL CELL BIOCHEM, V169, P61, DOI 10.1023/A:1006898812618; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; YAO J, 1991, BIOCHEMISTRY-US, V30, P8408, DOI 10.1021/bi00098a019; Zimmer C, 1975, Prog Nucleic Acid Res Mol Biol, V15, P285, DOI 10.1016/S0079-6603(08)60122-1	58	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26486	10.1371/journal.pone.0026486	http://dx.doi.org/10.1371/journal.pone.0026486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046291	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600021
J	Silver, MK; O'Neill, MS; Sowers, MR; Park, SK				Silver, Monica K.; O'Neill, Marie S.; Sowers, MaryFran R.; Park, Sung Kyun			Urinary Bisphenol A and Type-2 Diabetes in US Adults: Data from NHANES 2003-2008	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; GLUCOSE-HOMEOSTASIS; HEMOGLOBIN A(1C); CHRONIC DISEASE; ADIPOSE-TISSUE; HUMAN EXPOSURE; ASSOCIATION; ADIPONECTIN; ALPHA	Objective: Bisphenol A (BPA) is found in plastics and other consumer products; exposure may lead to insulin resistance and development of type-2 diabetes mellitus (T2DM) through over-activation of pancreatic beta-cells. Previous studies using data from the National Health and Nutrition Examination Survey (NHANES) showed an inconsistent association between prevalence of self-reported T2DM and urinary BPA. We used a different diagnosis method of T2DM (hemoglobin A1c (HbA1c)) with a larger subset of NHANES. Methods and Findings: We analyzed data from 4,389 adult participants who were part of a sub-study of environmental phenol measurements in urine from three NHANES cycles from 2003 to 2008. T2DM was defined as having a HbA1c >= 6.5% or use of diabetes medication. The weighted prevalence of T2DM was 9.2%. Analysis of the total sample revealed that a twofold increase in urinary BPA was associated with an odds ratio (OR) of 1.08 of T2DM (95% confidence interval (CI), 1.02 to 1.16), after controlling for potential confounders. However, when we examined each NHANES cycle individually, we only found a statistically significant association in the 2003/04 cycle (n = 1,364, OR = 1.23 (95% CI, 1.07 to 1.42) for each doubling in urinary BPA). We found no association in either the NHANES cycle from 2005/06 (n = 1,363, OR = 1.05 (95% CI, 0.94 to 1.18)); or 2007/08 (n = 1,662, OR = 1.06 (95% CI, 0.91 to 1.23)). Similar patterns of associations between BPA and continuous HbA1c were also observed. Conclusions: Although higher urinary BPA was associated with elevated HbA1c and T2DM in the pooled analysis, it was driven by data from only one NHANES cycle. Additional studies, especially of a longitudinal design with repeated BPA measurements, are needed to further elucidate the association between BPA and T2DM.	[Silver, Monica K.; O'Neill, Marie S.; Park, Sung Kyun] Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [O'Neill, Marie S.; Sowers, MaryFran R.; Park, Sung Kyun] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Silver, MK (corresponding author), Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	sungkyun@umich.edu		Park, Sung Kyun/0000-0001-9981-6250; Silver, Monica K./0000-0002-5920-6906	National Institute of Diabetes and Digestive and Kidney Diseases (through Michigan Diabetes Research and Training Center) [DK020572]; National Institute of Environmental Health Sciences [K01-ES016587]; National Institutes of Health, Department of Health and Human Services, through National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR051384]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, K01ES016587] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (through Michigan Diabetes Research and Training Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health, Department of Health and Human Services, through National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was partly supported by DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases (pilot project through the Michigan Diabetes Research and Training Center). SKP was supported by grant K01-ES016587 from the National Institute of Environmental Health Sciences. The Michigan Bone Health and Metabolism Study has grant support from the National Institutes of Health, Department of Health and Human Services, through the National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR051384]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Alonso-Magdalena P, 2010, HORM-INT J ENDOCRINO, V9, P118, DOI 10.1007/BF03401277; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET; Espelt A, 2011, J EPIDEMIOLOGY COMMU; Gallagher CJ, 2007, DIABETES, V56, P2135, DOI 10.2337/db06-1017; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Herman WH, 2010, POL ARCH MED WEWN, V120, P37, DOI 10.20452/pamw.877; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Kilpatrick ES, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4432; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Livingstone C, 2002, CLIN SCI, V102, P151, DOI 10.1042/cs1020151; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Mazurek JA, 2010, J CLIN ENDOCRINOL ME; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Molenaar EA, 2007, EUR J PUBLIC HEALTH, V17, P199, DOI 10.1093/eurpub/ckl113; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; *NAT CTR ENV HLTH, 2005, NHANES 2003 2004 LAB; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Center for Environmental Health, 2009, NHANES 2005 2006 LAB; National Center for Health Statistics, 2006, NHANES AN REP GUIDL; National Center for Health Statistics, 2010, 2005 2006 DAT DOC CO; National Center for Health Statistics Centers for Disease Control and Prevention, 2009, 2007 2008 DAT DOC CO; National Center for Health Statistics. Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Steenland K, 2011, ENVIRON HEALTH PERSP, V119, P831, DOI 10.1289/ehp.1002521; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zirilli L, 2008, J STEROID BIOCHEM, V109, P212, DOI 10.1016/j.jsbmb.2008.03.026	45	129	134	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26868	10.1371/journal.pone.0026868	http://dx.doi.org/10.1371/journal.pone.0026868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046388	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600070
J	Nakajima, H; Nakajima-Takagi, Y; Tsujita, T; Akiyama, SI; Wakasa, T; Mukaigasa, K; Kaneko, H; Tamaru, Y; Yamamoto, M; Kobayashi, M				Nakajima, Hitomi; Nakajima-Takagi, Yaeko; Tsujita, Tadayuki; Akiyama, Shin-Ichi; Wakasa, Takeshi; Mukaigasa, Katsuki; Kaneko, Hiroshi; Tamaru, Yutaka; Yamamoto, Masayuki; Kobayashi, Makoto			Tissue-Restricted Expression of Nrf2 and Its Target Genes in Zebrafish with Gene-Specific Variations in the Induction Profiles	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CANCER CHEMOPREVENTIVE DITHIOLETHIONES; NAD(P)H-QUINONE OXIDOREDUCTASE1 GENE; ELEMENT-MEDIATED EXPRESSION; DETOXIFYING ENZYME GENES; HEME OXYGENASE-1 GENE; ANTIOXIDANT INDUCTION; KEAP1-NRF2 PATHWAY; OXIDATIVE STRESS; DRUG TOXICITY	The Keap1-Nrf2 system serves as a defense mechanism against oxidative stress and electrophilic toxicants by inducing more than one hundred cytoprotective proteins, including antioxidants and phase 2 detoxifying enzymes. Since induction profiles of Nrf2 target genes have been studied exclusively in cultured cells, and not in animal models, their tissue-specificity has not been well characterized. In this paper, we examined and compared the tissue-specific expression of several Nrf2 target genes in zebrafish larvae by whole-mount in situ hybridization (WISH). Seven zebrafish genes (gstp1, mgst3b, prdx1, frrs1c, fthl, gclc and hmox1a) suitable for WISH analysis were selected from candidates for Nrf2 targets identified by microarray analysis. Tissue-restricted induction was observed in the nose, gill, and/or liver for all seven genes in response to Nrf2-activating compounds, diethylmaleate (DEM) and sulforaphane. The Nrf2 gene itself was dominantly expressed in these three tissues, implying that tissue-restricted induction of Nrf2 target genes is defined by tissue-specific expression of Nrf2. Interestingly, the induction of frrs1c and gclc in liver and nose, respectively, was quite low and that of hmox1a was restricted in the liver. These results indicate the existence of gene-specific variations in the tissue specificity, which can be controlled by factors other than Nrf2.	[Nakajima, Hitomi; Nakajima-Takagi, Yaeko; Tsujita, Tadayuki; Mukaigasa, Katsuki; Kaneko, Hiroshi; Kobayashi, Makoto] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Tsujita, Tadayuki; Yamamoto, Masayuki; Kobayashi, Makoto] Univ Tsukuba, Japan Sci & Technol Agcy, Environm Response Project, Tsukuba, Ibaraki, Japan; [Akiyama, Shin-Ichi; Wakasa, Takeshi; Tamaru, Yutaka] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Kaneko, Hiroshi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; Mie University; Tohoku University	Nakajima, H (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan.	makobayash@md.tsukuba.ac.jp	Tsujita, Tadayuki/AAH-2347-2019; Yamamoto, Masayuki/A-4873-2010; Kobayashi, Makoto/B-2537-2008	Tsujita, Tadayuki/0000-0002-7189-0376; Yamamoto, Masayuki/0000-0002-9073-9436; Kobayashi, Makoto/0000-0001-6660-450X	Ministry of Education, Science, Sports and Culture of Japan; Japan Science and Technology Corporation (ERATO); Ministry of Economy, Trade and Industry of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (ERATO)(Japan Science & Technology Agency (JST)); Ministry of Economy, Trade and Industry of Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (MK, MY) and the Japan Science and Technology Corporation (ERATO) (MY). Zebrafish microarrays were supported by Consortium R&D Project for Regional Revitalization from the Ministry of Economy, Trade and Industry of Japan (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Kelly VP, 2005, MOL CELL BIOL, V25, P3658, DOI 10.1128/MCB.25.9.3658-3669.2005; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kobayashi M, 2010, CHEM BIOL, V17, P419, DOI 10.1016/j.chembiol.2010.05.003; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Marvin M, 2008, DEV DYNAM, V237, P454, DOI 10.1002/dvdy.21414; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Sharma MK, 2006, FEBS J, V273, P3216, DOI 10.1111/j.1742-4658.2006.05330.x; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Vargas JD, 2003, BBA-PROTEINS PROTEOM, V1651, P116, DOI 10.1016/S1570-9639(03)00242-5; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Whanger PD, 2009, BBA-GEN SUBJECTS, V1790, P1448, DOI 10.1016/j.bbagen.2009.05.010; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	49	51	53	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26884	10.1371/journal.pone.0026884	http://dx.doi.org/10.1371/journal.pone.0026884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046393	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000038
J	Mao, L				Mao, Liang			Evaluating the Combined Effectiveness of Influenza Control Strategies and Human Preventive Behavior	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SPREAD; MODEL; SIMULATION; DIFFUSION; AWARENESS	Control strategies enforced by health agencies are a major type of practice to contain influenza outbreaks. Another type of practice is the voluntary preventive behavior of individuals, such as receiving vaccination, taking antiviral drugs, and wearing face masks. These two types of practices take effects concurrently in influenza containment, but little attention has been paid to their combined effectiveness. This article estimates this combined effectiveness using established simulation models in the urbanized area of Buffalo, NY, USA. Three control strategies are investigated, including: Targeted Antiviral Prophylaxis (TAP), workplace/school closure, community travel restriction, as well as the combination of the three. All control strategies are simulated with and without regard to individual preventive behavior, and the resulting effectiveness are compared. The simulation outcomes suggest that weaker control strategies could suffice to contain influenza epidemics, because individuals voluntarily adopt preventive behavior, rendering these weaker strategies more effective than would otherwise have been expected. The preventive behavior of individuals could save medical resources for control strategies and avoid unnecessary socio-economic interruptions. This research adds a human behavioral dimension into the simulation of control strategies and offers new insights into disease containment. Health policy makers are recommended to review current control strategies and comprehend preventive behavior patterns of local populations before making decisions on influenza containment.	Univ Florida, Dept Geog, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Mao, L (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	liangmao@ufl.edu		Mao, Liang/0000-0002-7363-0308	University at Buffalo, State University of New York; University of Florida	University at Buffalo, State University of New York; University of Florida(University of Florida)	This research was supported in part by the Mark Diamond Research Fund and the Hugh Calkins Applied GIS Award, both from the University at Buffalo, State University of New York. Publication of this article was funded by the University of Florida Open-Access publishing fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER M, 1976, HLTH BELIEF MODEL PE; Bian L, 2004, ENVIRON PLANN B, V31, P381, DOI 10.1068/b2833; Brooks RJ, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/0895-7177(96)00103-3; Burke DS, 2006, ACAD EMERG MED, V13, P1142, DOI 10.1111/j.1553-2712.2006.tb01638.x; Camitz M, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-32; CDC, 2008, KEY FACTS SEAS INFL; CDC, 2009, UPD CDC EST 2009 H1N; CDC, 2008, PREV SEAS FLU; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dutta A, 2008, 4524 WORLD BANK SOC; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hatzopoulos V, 2011, MATH BIOSCIENCES; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mao L, 2011, INT J GEOGR INF SCI, V25, P1371, DOI 10.1080/13658816.2011.556121; Mao L, 2010, COMPUT ENVIRON URBAN, V34, P204, DOI 10.1016/j.compenvurbsys.2010.03.004; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; ReferenceUSA, 2009, US BUS DAT; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; USCensus, 2000, US CENS 2000 DAT REL; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; WEINSTEIN ND, 1992, HEALTH PSYCHOL, V11, P170, DOI 10.1037/0278-6133.11.3.170	38	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24706	10.1371/journal.pone.0024706	http://dx.doi.org/10.1371/journal.pone.0024706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834SM	22043275	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400002
J	Willmann, G; Fischer, MD; Schatz, A; Schommer, K; Messias, A; Zrenner, E; Bartz-Schmidt, KU; Gekeler, F				Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Schommer, Kai; Messias, Andre; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian			Quantification of Optic Disc Edema during Exposure to High Altitude Shows No Correlation to Acute Mountain Sickness	PLOS ONE			English	Article							NERVE SHEATH DIAMETER; CEREBRAL EDEMA; INTRACRANIAL-PRESSURE; RETINOPATHY; ILLNESS; PATHOPHYSIOLOGY; CLIMBERS; INSIGHTS; ASCENT; HEAD	Background: The study aimed to quantify changes of the optic nerve head (ONH) during exposure to high altitude and to assess a correlation with acute mountain sickness (AMS). This work is related to the Tuebingen High Altitude Ophthalmology (THAO) study. Methodology/Principal Findings: A confocal scanning laser ophthalmoscope (cSLO, Heidelberg Retina Tomograph, HRT3 (R)) was used to quantify changes at the ONH in 18 healthy participants before, during and after rapid ascent to high altitude (4559 m). Slitlamp biomicroscopy was used for clinical optic disc evaluation; AMS was assessed with Lake Louise (LL) and AMS-cerebral (AMS-c) scores; oxygen saturation (SpO(2)) and heart rate (HR) were monitored. These parameters were used to correlate with changes at the ONH. After the first night spent at high altitude, incidence of AMS was 55% and presence of clinical optic disc edema (ODE) 79%. Key stereometric parameters of the HRT3 (R) used to describe ODE (mean retinal nerve fiber layer [ RNFL] thickness, RNFL cross sectional area, optic disc rim volume and maximum contour elevation) changed significantly at high altitude compared to baseline (p<0.05) and were consistent with clinically described ODE. All changes were reversible in all participants after descent. There was no significant correlation between parameters of ODE and AMS, SpO(2) or HR. Conclusions/Significance: Exposure to high altitude leads to reversible ODE in the majority of healthy subjects. However, these changes did not correlate with AMS or basic physiologic parameters such as SpO(2) and HR. For the first time, a quantitative approach has been used to assess these changes during acute, non-acclimatized high altitude exposure. In conclusion, ODE presents a reaction of the body to high altitude exposure unrelated to AMS.	[Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian] Univ Tubingen, Ctr Ophthalmol, Tubingen, Baden Wurttembe, Germany; [Schommer, Kai] Univ Heidelberg Hosp, Dept Sports Med, Heidelberg, Germany; [Messias, Andre] Univ Sao Paulo, Sch Med Ribeira Preto, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Sao Paulo, Brazil	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Universidade de Sao Paulo	Willmann, G (corresponding author), Univ Tubingen, Ctr Ophthalmol, Tubingen, Baden Wurttembe, Germany.	Dominik.Fischer@med.uni-tuebingen.de	Messias, Andre/H-5801-2012; Messias, Andre MV/C-1560-2012	Messias, Andre/0000-0002-5328-9608; Messias, Andre MV/0000-0002-5328-9608	Wilderness Medical Society (WMS); Novartis; Bausch Lomb; Alcon; Allergan; Ursapharm; OptimaPharma	Wilderness Medical Society (WMS); Novartis(Novartis); Bausch Lomb; Alcon(Novartis); Allergan(AbbVieAllergan); Ursapharm; OptimaPharma	The funders (Wilderness Medical Association, Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, OptimaPharma, Heidelberg Engineering) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our work was directly funded by the Wilderness Medical Society (WMS) with the Charles Houston Award. Additional unconditional grants were provided by Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, and OptimaPharma as well as private donations. The funds were used for logistics such as helicopter transport of all research equipment during the expedition, payment for mountain guides for the participants and the stay at the Capanna Margherita. For the time of the study the Heidelberg Retina Tomograph 3 (HRT3 (R)) was provided by Heidelberg Engineering.	Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; BONIUK M, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P1519; Bosch MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P644, DOI 10.1001/archopht.126.5.644; Bosch MM, 2009, J APPL PHYSIOL, V106, P454, DOI 10.1152/japplphysiol.90904.2008; Bosch MM, 2010, ARCH OPHTHALMOL-CHIC, V128, P184, DOI 10.1001/archophthalmol.2009.385; Bosch MM, 2009, INVEST OPHTH VIS SCI, V51, P1609; BRIGATTI L, 1995, AM J OPHTHALMOL, V120, P433, DOI 10.1016/S0002-9394(14)72656-X; Danesh-Meyer H, 2005, OPHTHALMOLOGY, V112, P1104, DOI 10.1016/j.ophtha.2004.12.041; DICKINSON J, 1983, THORAX, V38, P646, DOI 10.1136/thx.38.9.646; Fagenholz PJ, 2009, J APPL PHYSIOL, V106, P1207, DOI 10.1152/japplphysiol.01188.2007; Fischer R, 2004, CEPHALALGIA, V24, P66, DOI 10.1111/j.1468-2982.2004.00619.x; FRAYSER R, 1970, NEW ENGL J MED, V282, P1183, DOI 10.1056/NEJM197005212822106; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hackett PH, 1999, ADV EXP MED BIOL, V474, P23; HOUSTON CS, 1975, LANCET, V2, P758; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; KELLER HR, 1995, BMJ-BRIT MED J, V310, P1232, DOI 10.1136/bmj.310.6989.1232; Levin LA, 2003, ADLERS PHYSL EYE, P603; Lichter P R, 1976, Trans Am Ophthalmol Soc, V74, P532; Lusky M, 1993, J Glaucoma, V2, P104; MacLaren R E, 1995, J R Army Med Corps, V141, P25; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; Mikelberg F S, 1993, J Glaucoma, V2, P101; Modesti PA, 2011, MED SCI SPORTS EXERC; Morocz IA, 2001, EXP NEUROL, V168, P96, DOI 10.1006/exnr.2000.7596; Naumann GOHA D.J., 1997, PATHOLOGIE AUGES, P1179; O'Connor T, 2004, HIGH ALT MED BIOL, V5, P341, DOI 10.1089/ham.2004.5.341; Pro MJ, 2006, J NEUROL SCI, V250, P114, DOI 10.1016/j.jns.2006.08.012; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Roach R.C., 1993, LAKE LOUISE AMS SCOR; Roach RC, 2001, J EXP BIOL, V204, P3161; ROHRSCHNEIDER K, 1994, OPHTHALMOLOGY, V101, P1044; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; SHULTS WT, 1975, ARCH OPHTHALMOL-CHIC, V93, P404; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Spencer AF, 1996, EYE, V10, P371, DOI 10.1038/eye.1996.76; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Tamburrelli C, 2000, INVEST OPHTH VIS SCI, V41, P2960; Wagner DR, 2006, WILD ENVIRON MED, V17, P221, DOI 10.1580/PR43-05.1; Walsh FB, 1969, CLIN NEUROOPTHALMOLO; WEINREB RN, 1993, ARCH OPHTHALMOL-CHIC, V111, P636, DOI 10.1001/archopht.1993.01090050070031; Wiedman M, 1999, OPHTHALMOLOGY, V106, P1924, DOI 10.1016/S0161-6420(99)90402-5; Wilson MH, 2008, HIGH ALT MED BIOL, V9, P319, DOI 10.1089/ham.2008.1026; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6	47	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27022	10.1371/journal.pone.0027022	http://dx.doi.org/10.1371/journal.pone.0027022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069483	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900044
J	Yap, DB; Walker, DC; Prentice, LM; McKinney, S; Turashvili, G; Mooslehner-Allen, K; de Algara, TR; Fee, J; de Tassigny, XD; Colledge, WH; Aparicio, S				Yap, Damian B.; Walker, David C.; Prentice, Leah M.; McKinney, Steven; Turashvili, Gulisa; Mooslehner-Allen, Katrin; de Algara, Teresa Ruiz; Fee, John; de Tassigny, Xavier d'Anglemont; Colledge, William H.; Aparicio, Samuel			MII5 Is Required for Normal Spermatogenesis	PLOS ONE			English	Article							MICE; CELLS; METHYLTRANSFERASE; MLL5; GENE; DEMETHYLATION; METHYLATION; EXPRESSION; LYSINE-4; LEUKEMIA	Background: MII5 is currently a member of the MII family of SET domain histone methyltransferase proteins but studies have also showed that it could be part of the SET3 branch of proteins. Recently, constitutive knock out animal studies have shown that MII5 is required for proper haematopoietic stem cell differentiation, and loss of MII5 results in synthetic lethality for genome de-methylation. MII5 deficient male mice are infertile and here we analyse the consequences of MII5 deficiency for spermatogenesis. Methodology/Principal Findings: MII5 deficient male mice, but not female mice, are infertile. Here we show using RNA in-situ hybridization that MII5 is expressed in the germ cells of the testes of wild type mice. Consistent with the expression of MII5, we demonstrate by electron microscopy, video microscopy and in vitro fertilisation techniques that MII5 deficient mice have defects in terminal maturation and packaging of sperm. The defects seen include detachment of the acrosomal cap and impaired excess cytoplasm removal. Functional tests of sperm motility show a lack of progressive motility of spermatozoa from MII5 deficient animals. None of these defects could be rescued by in vitro fertilization. Using microarray analysis we show that transcripts implicated in spermatogenesis are dysregulated. Conclusions/Significance: Our data demonstrate a clear role of MII5 in mammalian spermatogenesis at the level of terminal differentiation providing further support for its classification in the SET3 branch of proteins. Moreover, this study identifies Tlk2, Utx, Gpr64, Sult4a1, Rap2ip, Vstm2 and HoxA10 as possible MII5 targets that together may account for the observed spermatozoa maturation defects.	[Yap, Damian B.; Prentice, Leah M.; McKinney, Steven; Turashvili, Gulisa; de Algara, Teresa Ruiz; Fee, John; Aparicio, Samuel] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Yap, Damian B.; Walker, David C.; Prentice, Leah M.; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Mooslehner-Allen, Katrin] Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England; [de Tassigny, Xavier d'Anglemont; Colledge, William H.] Univ Cambridge, Physiol Lab, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	British Columbia Cancer Agency; University of British Columbia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Yap, DB (corresponding author), British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada.	saparicio@bccrc.ca	Colledge, William/X-4976-2019; Mooslehner, Katrin/C-5495-2014	Colledge, William/0000-0002-9603-4429; Mooslehner, Katrin/0000-0001-9070-9205; Aparicio, Samuel/0000-0002-0487-9599; Yap, Damian/0000-0002-5370-4592; Turashvili, Gulisa/0000-0001-6125-5865	British Columbia Cancer Foundation; Canadian Institutes for Health Research; Canada Research Chair in Molecular Oncology	British Columbia Cancer Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Molecular Oncology(Canada Research Chairs)	This study was supported by grants from the British Columbia Cancer Foundation and the Canadian Institutes for Health Research. LP is a Michael Smith Foundation for Health Research Senior Trainee and a Canadian Institute for Health Research Canadian Graduate Scholar. SA is supported by a Canada Research Chair in Molecular Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivatiadou E, 2007, MOL BIOL CELL, V18, P1530, DOI 10.1091/mbc.E06-10-0902; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Alnouti Y, 2006, TOXICOL SCI, V93, P242, DOI 10.1093/toxsci/kfl050; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; IGDOURA SA, 1995, MOL REPROD DEV, V40, P91, DOI 10.1002/mrd.1080400112; Johnston DS, 2007, ANN NY ACAD SCI, V1120, P36, DOI 10.1196/annals.1411.014; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Minchin RF, 2007, INT J BIOCHEM CELL B, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Mood A., 1973, INTRO THEORY STAT; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Podlasek CA, 1999, DEV DYNAM, V214, P1, DOI 10.1002/(SICI)1097-0177(199901)214:1<1::AID-DVDY1>3.0.CO;2-2; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Prentice LM, BMC GENOMICS, V12, P209; Ribas RC, 2006, BIOL REPROD, V74, P307, DOI 10.1095/biolreprod.105.046284; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Russell L. D., 1990, MAMMALIAN SPERMATOGE, P1; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; Shalom S, 1999, MOL REPROD DEV, V52, P392, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;392::AID-MRD8&gt;3.0.CO;2-Y; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Toshimori K, 2003, MICROSC RES TECHNIQ, V61, P1, DOI 10.1002/jemt.10311; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191	41	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27127	10.1371/journal.pone.0027127	http://dx.doi.org/10.1371/journal.pone.0027127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069496	Green Submitted, gold, Green Published			2022-12-27	WOS:000297150900056
J	Eichner, H; Borst, A				Eichner, Hubert; Borst, Alexander			Hands-On Parameter Search for Neural Simulations by a MIDI-Controller	PLOS ONE			English	Article								Computational neuroscientists frequently encounter the challenge of parameter fitting - exploring a usually high dimensional variable space to find a parameter set that reproduces an experimental data set. One common approach is using automated search algorithms such as gradient descent or genetic algorithms. However, these approaches suffer several shortcomings related to their lack of understanding the underlying question, such as defining a suitable error function or getting stuck in local minima. Another widespread approach is manual parameter fitting using a keyboard or a mouse, evaluating different parameter sets following the users intuition. However, this process is often cumbersome and time-intensive. Here, we present a new method for manual parameter fitting. A MIDI controller provides input to the simulation software, where model parameters are then tuned according to the knob and slider positions on the device. The model is immediately updated on every parameter change, continuously plotting the latest results. Given reasonably short simulation times of less than one second, we find this method to be highly efficient in quickly determining good parameter sets. Our approach bears a close resemblance to tuning the sound of an analog synthesizer, giving the user a very good intuition of the problem at hand, such as immediate feedback if and how results are affected by specific parameter changes. In addition to be used in research, our approach should be an ideal teaching tool, allowing students to interactively explore complex models such as Hodgkin-Huxley or dynamical systems.	[Eichner, Hubert; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany	Max Planck Society	Eichner, H (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	eichner@neuro.mpg.de			Max-Planck-Society	Max-Planck-Society(Max Planck Society)	This work was supported by the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnans J.F., 2006, UNIVERSITEXT, Vsecond, DOI [10.1007/978-3-540-35447-5, DOI 10.1007/978-3-540-35447-5]; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holland J. H., 1992, ADAPTATION NATURAL A; Snyman J., 2005, PRACTICAL MATH OPTIM; Spavieri DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000860; Van Geit W, 2008, BIOL CYBERN, V99, P241, DOI 10.1007/s00422-008-0257-6; Wicher D, 2006, J NEUROPHYSIOL, V95, P311, DOI 10.1152/jn.00904.2005	9	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27013	10.1371/journal.pone.0027013	http://dx.doi.org/10.1371/journal.pone.0027013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066027	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000046
J	Haridas, D; Chakraborty, S; Ponnusamy, MP; Lakshmanan, I; Rachagani, S; Cruz, E; Kumar, S; Das, S; Lele, SM; Anderson, JM; Wittel, UA; Hollingsworth, MA; Batra, SK				Haridas, Dhanya; Chakraborty, Subhankar; Ponnusamy, Moorthy P.; Lakshmanan, Imayavaramban; Rachagani, Satyanarayana; Cruz, Eric; Kumar, Sushil; Das, Srustidhar; Lele, Subodh M.; Anderson, Judy M.; Wittel, Uwe A.; Hollingsworth, Michael A.; Batra, Surinder K.			Pathobiological Implications of MUC16 Expression in Pancreatic Cancer	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; MUCIN EXPRESSION; POTENTIAL ROLE; CA-125 GENE; DIAGNOSIS; ADENOCARCINOMA; PROGNOSIS; THERAPY; GROWTH; CELLS	MUC16 (CA125) belongs to a family of high-molecular weight O-glycosylated proteins known as mucins. While MUC16 is well known as a biomarker in ovarian cancer, its expression pattern in pancreatic cancer (PC), the fourth leading cause of cancer related deaths in the United States, remains unknown. The aim of our study was to analyze the expression of MUC16 during the initiation, progression and metastasis of PC for possible implication in PC diagnosis, prognosis and therapy. In this study, a microarray containing tissues from healthy and PC patients was used to investigate the differential protein expression of MUC16 in PC. MUC16 mRNA levels were also measured by RT-PCR in the normal human pancreatic, pancreatitis, and PC tissues. To investigate its expression pattern during PC metastasis, tissue samples from the primary pancreatic tumor and metastases (from the same patient) in the lymph nodes, liver, lung and omentum from Stage IV PC patients were analyzed. To determine its association in the initiation of PC, tissues from PC patients containing pre-neoplastic lesions of varying grades were stained for MUC16. Finally, MUC16 expression was analyzed in 18 human PC cell lines. MUC16 is not expressed in the normal pancreatic ducts and is strongly upregulated in PC and detected in pancreatitis tissue. It is first detected in the high-grade pre-neoplastic lesions preceding invasive adenocarcinoma, suggesting that its upregulation is a late event during the initiation of this disease. MUC16 expression appears to be stronger in metastatic lesions when compared to the primary tumor, suggesting a role in PC metastasis. We have also identified PC cell lines that express MUC16, which can be used in future studies to elucidate its functional role in PC. Altogether, our results reveal that MUC16 expression is significantly increased in PC and could play a potential role in the progression of this disease.	[Haridas, Dhanya; Chakraborty, Subhankar; Ponnusamy, Moorthy P.; Lakshmanan, Imayavaramban; Rachagani, Satyanarayana; Cruz, Eric; Kumar, Sushil; Das, Srustidhar; Hollingsworth, Michael A.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Anderson, Judy M.; Hollingsworth, Michael A.; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Wittel, Uwe A.] Univ Klin Freiburg, Dept Gen & Visceral Surg, Freiburg, Germany; [Lele, Subodh M.; Hollingsworth, Michael A.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Freiburg; University of Nebraska System; University of Nebraska Medical Center	Haridas, D (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	sbatra@unmc.edu	Das, Srustidhar/GVU-1044-2022	lakshmanan, Imayavaramban/0000-0003-1733-2223; Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X	National Institutes of Health [RO1 CA78590, RO1 CA131944, UO1 EDRN CA111294, P50 SPORE CA127297]; Department of Defense [BC101014]; Susan G. Komen Foundation [KG070826]; NCI [5 P30 CA036727-2452]; Nebraska Department of Health [LB595]; NATIONAL CANCER INSTITUTE [R01CA078590, P50CA127297, R01CA131944, P30CA036727, U01CA111294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (RO1 CA78590, RO1 CA131944, UO1 EDRN CA111294 and P50 SPORE CA127297), Department of Defense (BC101014), the Susan G. Komen Foundation (KG070826), NCI Cancer Center Support Grant 5 P30 CA036727-2452 and Nebraska Department of Health Institutional LB595 Grant for Cancer and Smoking Disease Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Chakraborty S, 2011, BBA-REV CANCER, V1815, P44, DOI 10.1016/j.bbcan.2010.09.002; Chakraborty S, 2010, J CLIN PATHOL, V63, P579, DOI 10.1136/jcp.2010.076125; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; DEKKER J, 1991, BIOCHEM J, V277, P423, DOI 10.1042/bj2770423; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Gold DV, 2006, J CLIN ONCOL, V24, P252, DOI 10.1200/JCO.2005.02.8282; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson MD, 2010, APPL IMMUNOHISTO M M, V18, P250, DOI 10.1097/PAI.0b013e3181c925aa; KAMISAWA T, 1995, PANCREAS, V11, P345, DOI 10.1097/00006676-199511000-00005; KLOPPEL G, 1985, HISTOPATHOLOGY, V9, P841, DOI 10.1111/j.1365-2559.1985.tb02870.x; Koliopanos A, 2001, CANCER RES, V61, P4655; MAO CY, 1995, ARCH SURG-CHICAGO, V130, P125; Mckay CJ, 2008, BEST PRACT RES CL GA, V22, P65, DOI 10.1016/j.bpg.2007.11.007; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R; O'Brien TJ, 1998, INT J BIOL MARKER, V13, P188, DOI 10.1177/172460089801300403; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Park HU, 2003, PANCREAS, V26, pe48; Rachagani S, 2009, BIOFACTORS, V35, P509, DOI 10.1002/biof.64; RALL CJN, 1995, CANCER RES, V55, P1831; Senapati S, 2008, HISTOL HISTOPATHOL, V23, P1541, DOI 10.14670/HH-23.1541; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Sheng Xiu-gui, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P460; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takaori K, 2004, PANCREAS, V28, P257, DOI 10.1097/00006676-200404000-00008; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Vincent A, 2008, FASEB J, V22, P3035, DOI 10.1096/fj.07-103390; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yonezawa S, 2008, GUT LIVER, V2, P137, DOI 10.5009/gnl.2008.2.3.137	43	92	98	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26839	10.1371/journal.pone.0026839	http://dx.doi.org/10.1371/journal.pone.0026839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066010	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000026
J	Hayward, DC; Hetherington, S; Behm, CA; Grasso, LC; Foret, S; Miller, DJ; Ball, EE				Hayward, David C.; Hetherington, Suzannah; Behm, Carolyn A.; Grasso, Lauretta C.; Foret, Sylvain; Miller, David J.; Ball, Eldon E.			Differential Gene Expression at Coral Settlement and Metamorphosis - A Subtractive Hybridization Study	PLOS ONE			English	Article							CNIDARIAN ACROPORA-MILLEPORA; REEF-BUILDING CORAL; FLUORESCENT PROTEINS; SCLERACTINIAN CORAL; ANCESTRAL COMPLEXITY; RECOGNITION; DIVERSITY; EVOLUTION; DOMAIN; IDENTIFICATION	Background: A successful metamorphosis from a planktonic larva to a settled polyp, which under favorable conditions will establish a future colony, is critical for the survival of corals. However, in contrast to the situation in other animals, e. g., frogs and insects, little is known about the molecular basis of coral metamorphosis. We have begun to redress this situation with previous microarray studies, but there is still a great deal to learn. In the present paper we have utilized a different technology, subtractive hybridization, to characterize genes differentially expressed across this developmental transition and to compare the success of this method to microarray. Methodology/Principal Findings: Suppressive subtractive hybridization (SSH) was used to identify two pools of transcripts from the coral, Acropora millepora. One is enriched for transcripts expressed at higher levels at the pre-settlement stage, and the other for transcripts expressed at higher levels at the post-settlement stage. Virtual northern blots were used to demonstrate the efficacy of the subtractive hybridization technique. Both pools contain transcripts coding for proteins in various functional classes but transcriptional regulatory proteins were represented more frequently in the post-settlement pool. Approximately 18% of the transcripts showed no significant similarity to any other sequence on the public databases. Transcripts of particular interest were further characterized by in situ hybridization, which showed that many are regulated spatially as well as temporally. Notably, many transcripts exhibit axially restricted expression patterns that correlate with the pool from which they were isolated. Several transcripts are expressed in patterns consistent with a role in calcification. Conclusions: We have characterized over 200 transcripts that are differentially expressed between the planula larva and post-settlement polyp of the coral, Acropora millepora. Sequence, putative function, and in some cases temporal and spatial expression are reported.	[Hayward, David C.; Hetherington, Suzannah; Behm, Carolyn A.; Grasso, Lauretta C.; Ball, Eldon E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Grasso, Lauretta C.; Foret, Sylvain; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Grasso, Lauretta C.; Foret, Sylvain; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld, Australia	Australian National University; James Cook University; James Cook University	Hayward, DC (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	eldon.ball@anu.edu.au	Ball, Eldon E/C-9261-2009; Behm, Carolyn A/A-2102-2008; FORET, Sylvain/B-9207-2012	Ball, Eldon E/0000-0002-6052-1495; Behm, Carolyn A/0000-0002-0603-221X; Hayward, David/0000-0003-2937-2425; Grasso, Lauretta/0000-0001-8897-8289	Australian Research Council [DP0344483]; ARC Centre for the Molecular Genetics of Development; ARC Centre of Excellence for Coral Reef Studies	Australian Research Council(Australian Research Council); ARC Centre for the Molecular Genetics of Development(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	The study was supported by the Australian Research Council through Discovery grant DP0344483 to EEB and DJM and through the ARC Centre for the Molecular Genetics of Development and the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P524, DOI 10.1016/S0968-0004(01)01924-7; Beltran VH, 2010, THESIS J COOK U TOWN; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Davidson B, 2002, DEVELOPMENT, V129, P4739; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Endege WO, 1999, BIOTECHNIQUES, V26, P542, DOI 10.2144/99263cr04; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harrison P.L., 1990, CORAL REEFS, V25, P133; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kenkel CD, 2011, P BIOL SCI, V26, P26; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Knack BA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-136; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; Kurokawa D, 1999, MECH DEVELOP, V80, P41, DOI 10.1016/S0925-4773(98)00192-0; Marlow HQ, 2007, EVOL DEV, V9, P355, DOI 10.1111/j.1525-142X.2007.00173.x; Meyer E, 2011, MOL ECOL; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, 2000, P NATL ACAD SCI USA, V97, P4475, DOI 10.1073/pnas.97.9.4475; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Okubo N, 2007, ZOOL SCI, V24, P1169, DOI 10.2108/zsj.24.1169; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sambrook J., 2001, MOL CLONING LAB MANU; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Starcevic A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013975; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; van Oppen M, 2001, CORAL REEFS, V20, P200, DOI 10.1007/s003380100167; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Yao B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-99; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174	52	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26411	10.1371/journal.pone.0026411	http://dx.doi.org/10.1371/journal.pone.0026411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065994	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000296916000010
J	Hsu, CH; Li, YS; Long, Q; Zhao, QH; Lance, P				Hsu, Chiu-Hsieh; Li, Yisheng; Long, Qi; Zhao, Qiuhong; Lance, Peter			Estimation of Recurrence of Colorectal Adenomas with Dependent Censoring Using Weighted Logistic Regression	PLOS ONE			English	Article							MODEL	In colorectal polyp prevention trials, estimation of the rate of recurrence of adenomas at the end of the trial may be complicated by dependent censoring, that is, time to follow-up colonoscopy and dropout may be dependent on time to recurrence. Assuming that the auxiliary variables capture the dependence between recurrence and censoring times, we propose to fit two working models with the auxiliary variables as covariates to define risk groups and then extend an existing weighted logistic regression method for independent censoring to each risk group to accommodate potential dependent censoring. In a simulation study, we show that the proposed method results in both a gain in efficiency and reduction in bias for estimating the recurrence rate. We illustrate the methodology by analyzing a recurrent adenoma dataset from a colorectal polyp prevention trial.	[Hsu, Chiu-Hsieh; Zhao, Qiuhong] Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ 85721 USA; [Hsu, Chiu-Hsieh; Lance, Peter] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Li, Yisheng] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Long, Qi] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	University of Arizona; University of Arizona; University of Texas System; UTMD Anderson Cancer Center; Emory University	Hsu, CH (corresponding author), Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ 85721 USA.	phsu@azcc.arizona.edu		LI, Yisheng/0000-0001-9847-8544; Long, Qi/0000-0003-0660-5230	National Institutes of Health [CA23704, CA41108, CA130089-01A1]; NATIONAL CANCER INSTITUTE [R03CA130089, R01CA023704, P01CA041108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA23704, CA41108, CA130089-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2005, J NATL CANCER I, V97, P846, DOI 10.1093/jnci/dji144; Betensky RA, 2001, BIOMETRIKA, V88, P703, DOI 10.1093/biomet/88.3.703; Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; FINKELSTEIN DM, 1986, BIOMETRICS, V42, P845, DOI 10.2307/2530698; Groeneboom P., 1992, INFORM BOUNDS NONPAR; Hsu CH, 2007, STAT MED, V26, P1567, DOI 10.1002/sim.2648; Lam KF, 2005, BIOMETRIKA, V92, P573, DOI 10.1093/biomet/92.3.573; LAW CG, 1992, STAT MED, V11, P1569, DOI 10.1002/sim.4780111204; Liu H, 2009, J AM STAT ASSOC, V104, P1168, DOI 10.1198/jasa.2009.tm07494; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Van der Laan M J, 1997, Lifetime Data Anal, V3, P77; van der Laan M.J., 2003, SPR S STAT; van der Laan MJ, 1998, J AM STAT ASSOC, V93, P693, DOI 10.2307/2670119; VAN DER VAART A., 2006, INT J BIOSTAT, V2; Zeng DL, 2004, ANN STAT, V32, P1533, DOI 10.1214/009053604000000508	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25141	10.1371/journal.pone.0025141	http://dx.doi.org/10.1371/journal.pone.0025141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065985	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000002
J	Li, XF; Coyle, D; Maguire, L; McGinnity, TM; Hess, RF				Li, Xingfeng; Coyle, Damien; Maguire, Liam; McGinnity, Thomas M.; Hess, Robert F.			Long Timescale fMRI Neuronal Adaptation Effects in Human Amblyopic Cortex	PLOS ONE			English	Article							RETINOTOPIC ORGANIZATION; VISUAL-CORTEX; DEFICIT; MECHANISMS; REPETITION; BRAIN; MAP	An investigation of long timescale (5 minutes) fMRI neuronal adaptation effects, based on retinotopic mapping and spatial frequency stimuli, is presented in this paper. A hierarchical linear model was developed to quantify the adaptation effects in the visual cortex. The analysis of data involved studying the retinotopic mapping and spatial frequency adaptation effects in the amblyopic cortex. Our results suggest that, firstly, there are many cortical regions, including V1, where neuronal adaptation effects are reduced in the cortex in response to amblyopic eye stimulation. Secondly, our results show the regional contribution is different, and it seems to start from V1 and spread to the extracortex regions. Thirdly, our results show that there is greater adaptation to broadband retinotopic mapping as opposed to narrowband spatial frequency stimulation of the amblyopic eye, and we find significant correlation between fMRI response and the magnitude of the adaptation effect, suggesting that the reduced adaptation may be a consequence of the reduced response to different stimuli reported for amblyopic eyes.	[Li, Xingfeng; Coyle, Damien; Maguire, Liam; McGinnity, Thomas M.] Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland; [Hess, Robert F.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	Ulster University; McGill University	Li, XF (corresponding author), Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland.	x.li@ulster.ac.uk	Hess, Robert F/A-5624-2008; Coyle, Damien H/D-1161-2013; Coyle, Damien/S-5332-2019	Coyle, Damien H/0000-0002-4739-1040; Coyle, Damien/0000-0002-4739-1040; Maguire, Liam/0000-0001-6153-3298; McGinnity, Thomas Martin/0000-0002-9897-4748; Li, Xingfeng/0000-0002-6640-1048	Centre of Excellence in Intelligent Systems (CoEIS); InvestNI; Integrated Development Fund, through ILEX; CIHR [MOP53346]	Centre of Excellence in Intelligent Systems (CoEIS); InvestNI; Integrated Development Fund, through ILEX; CIHR(Canadian Institutes of Health Research (CIHR))	This study is supported under the Centre of Excellence in Intelligent Systems (CoEIS) project, funded by InvestNI and the Integrated Development Fund, through ILEX, and RFH is supported by a CIHR grant (#MOP53346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Barnes GR, 2010, INVEST OPHTHALMOL, V51, P1432; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boynton GM, 2003, J NEUROSCI, V23, P8781; Bryk A. S., 1992, HIERARCHICAL LINEAR; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Conner IP, 2007, J PHYSIOL-LONDON, V583, P159, DOI 10.1113/jphysiol.2007.136242; Conner IP, 2007, J AAPOS, V11, P341, DOI 10.1016/j.jaapos.2007.01.119; Conner IP, 2004, J VISION, V4, P509, DOI 10.1167/4.6.10; Diggle P. J., 2003, ANAL LONGITUDINAL DA; Dumoulin SO, 2003, NEUROIMAGE, V18, P576, DOI 10.1016/S1053-8119(02)00058-7; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hess RF, 2010, HUM BRAIN MAPP, V31, P1233, DOI 10.1002/hbm.20931; Hess RF, 2010, J NEUROPHYSIOL, V104, P475, DOI 10.1152/jn.01060.2009; Hess RF, 2009, HUM BRAIN MAPP, V30, P4054, DOI 10.1002/hbm.20829; Jurcoane A, 2009, VISION RES, V49, P1681, DOI 10.1016/j.visres.2009.04.009; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Li XF, 2007, INVEST OPHTH VIS SCI, V48, P1575, DOI 10.1167/iovs.06-1021; Li XF, 2007, EUR J NEUROSCI, V25, P1265, DOI 10.1111/J.1460-9568.2007.05356.x; Li XF, 2011, NEUROIMAGE, V54, P505, DOI 10.1016/j.neuroimage.2010.07.053; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Muckli L, 2006, VISION RES, V46, P506, DOI 10.1016/j.visres.2005.10.014; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Schacter DL, 2007, CURR OPIN NEUROBIOL, V17, P171, DOI 10.1016/j.conb.2007.02.001; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sireteanu R, 2008, INVEST OPHTH VIS SCI, V49, P3940, DOI 10.1167/iovs.07-0351; Talairach J., 1998, COPLANAR STEREOTAXIC; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Verhoef BE, 2008, J NEUROSCI, V28, P10631, DOI 10.1523/JNEUROSCI.3333-08.2008; Warnking J, 2002, NEUROIMAGE, V17, P1665, DOI 10.1006/nimg.2002.1304	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26562	10.1371/journal.pone.0026562	http://dx.doi.org/10.1371/journal.pone.0026562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065999	gold, Green Submitted, Green Published			2022-12-27	WOS:000296916000015
J	Thakkar, KN; Nichols, HS; McIntosh, LG; Park, S				Thakkar, Katharine N.; Nichols, Heathman S.; McIntosh, Lindsey G.; Park, Sohee			Disturbances in Body Ownership in Schizophrenia: Evidence from the Rubber Hand Illusion and Case Study of a Spontaneous Out-of-Body Experience	PLOS ONE			English	Article							INFERIOR PARIETAL LOBULE; SELF-CONSCIOUSNESS; KETAMINE; PERFORMANCE; INTEGRATION; ACTIVATION; CLOZAPINE; ORIGIN; SCALE; TOUCH	Background: A weakened sense of self may contribute to psychotic experiences. Body ownership, one component of self-awareness, can be studied with the rubber hand illusion (RHI). Watching a rubber hand being stroked while one's unseen hand is stroked synchronously can lead to a sense of ownership over the rubber hand, a shift in perceived position of the real hand, and a limb-specific drop in stimulated hand temperature. We aimed to assess the RHI in schizophrenia using quantifiable measures: proprioceptive drift and stimulation-dependent changes in hand temperature. Methods: The RHI was elicited in 24 schizophrenia patients and 21 matched controls by placing their unseen hand adjacent to a visible rubber hand and brushing real and rubber hands synchronously or asynchronously. Perceived finger location was measured before and after stimulation. Hand temperature was taken before and during stimulation. Subjective strength of the illusion was assessed by a questionnaire. Results: Across groups, the RHI was stronger during synchronous stimulation, indicated by self-report and proprioceptive drift. Patients reported a stronger RHI than controls. Self-reported strength of RHI was associated with schizotypy in controls Proprioceptive drift was larger in patients, but only following synchronous stimulation. Further, we observed stimulation-dependent changes in skin temperature. During right hand stimulation, temperature dropped in the stimulated hand and rose in the unstimulated hand. Interestingly, induction of RHI led to an out-of-body experience in one patient, linking body disownership and psychotic experiences. Conclusions: The RHI is quantitatively and qualitatively stronger in schizophrenia. These findings suggest that patients have a more flexible body representation and weakened sense of self, and potentially indicate abnormalities in temporo-parietal networks implicated in body ownership. Further, results suggest that these body ownership disturbances might be at the heart of a subset of the pathognomonic delusions of passivity.	[Thakkar, Katharine N.; Nichols, Heathman S.; McIntosh, Lindsey G.; Park, Sohee] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Park, Sohee] Vanderbilt Univ, Dept Psychiat, Coll Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Thakkar, KN (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	sohee.park@vanderbilt.edu	Gilling McIntosh, Lindsey/Q-8243-2016	Gilling McIntosh, Lindsey/0000-0001-8562-4098; Park, Sohee/0000-0003-3797-4776; Thakkar, Katharine/0000-0002-0026-2030	National Institute of Mental Health [F31-MH085405-01, R01-MH073028]; National Alliance for Research on Schizophrenia and Depression; National Institute of Child Health and Human Development [P30 HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085405, R01MH073028] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institute of Mental Health Grants F31-MH085405-01 (KNT), R01-MH073028 (SP), National Alliance for Research on Schizophrenia and Depression (SP), and National Institute of Child Health and Human Development P30 HD15052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Arzy S, 2007, NEUROIMAGE, V35, P326, DOI 10.1016/j.neuroimage.2006.11.027; Behere RV, 2010, ACTA PSYCHIAT SCAND; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Chang BP, 2005, J ABNORM PSYCHOL, V114, P85, DOI 10.1037/0021-843X.114.1.85; de Gelder B, 2003, SCHIZOPHR RES, V59, P211, DOI 10.1016/S0920-9964(01)00344-9; Duncan GE, 1998, BRAIN RES, V812, P65, DOI 10.1016/S0006-8993(98)00926-3; Duraiswamy G, 2007, ACTA PSYCHIAT SCAND, V116, P226, DOI 10.1111/j.1600-0447.2007.01032.x; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Foucher JR, 2007, SCHIZOPHR RES, V97, P118, DOI 10.1016/j.schres.2007.08.013; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Kammers MPM, 2009, J COGNITIVE NEUROSCI, V21, P1311, DOI 10.1162/jocn.2009.21095; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, ACTA PSYCHOL, V132, P166, DOI 10.1016/j.actpsy.2009.02.003; Malhotra AK, 1997, BIOL PSYCHIAT, V42, P664, DOI 10.1016/S0006-3223(96)00546-X; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Nelson HE., 1982, NATL ADULT READING T; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Peled A, 2003, SCHIZOPHR RES, V64, P157, DOI 10.1016/S0920-9964(03)00057-4; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; POLLACK WS, 1989, SCHIZOPHRENIA BULL, V15, P311, DOI 10.1093/schbul/15.2.311; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A., 1995, SCHIZOTYPAL PERSONAL; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Wilkins LK, 2011, CONSCIOUS COGN, V20, P943, DOI 10.1016/j.concog.2011.01.005; Williams LE, 2010, SCHIZOPHR RES, V121, P101, DOI 10.1016/j.schres.2009.10.021	43	160	161	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27089	10.1371/journal.pone.0027089	http://dx.doi.org/10.1371/journal.pone.0027089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	846PP	22073126	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000053
J	Gazquez, I; Soto-Varela, A; Aran, I; Santos, S; Batuecas, A; Trinidad, G; Perez-Garrigues, H; Gonzalez-Oller, C; Acosta, L; Lopez-Escamez, JA				Gazquez, Irene; Soto-Varela, Andres; Aran, Ismael; Santos, Sofia; Batuecas, Angel; Trinidad, Gabriel; Perez-Garrigues, Herminio; Gonzalez-Oller, Carlos; Acosta, Lourdes; Lopez-Escamez, Jose A.			High Prevalence of Systemic Autoimmune Diseases in Patients with Meniere's Disease	PLOS ONE			English	Article							ANTIBODIES; PROTEIN; SERA	Background: Autoimmunity appears to be associated with the pathophysiology of Meniere's disease (MD), an inner ear disorder characterized by episodes of vertigo associated with hearing loss and tinnitus. However, the prevalence of autoimmune diseases (AD) in patients with MD has not been studied in individuals with uni or bilateral sensorineural hearing loss (SNHL). Methods and Findings: We estimated the prevalence of AD in 690 outpatients with MD with uni or bilateral SNHL from otoneurology clinics at six tertiary referral hospitals by using clinica criteria and an immune panel (lymphocyte populations, antinuclear antibodies, C3, C4 and proinflammatory cytokines TNF alpha, INF gamma). The observed prevalence of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and ankylosing spondylitis (AS) was higher than expected for the general population (1.39 for RA, 0.87 for SLE and 0.70 for AS, respectively). Systemic AD were more frequently observed in patients with MD and diagnostic criteria for migraine than cases with MD and tension-type headache (p = 0.007). There were clinical differences between patients with uni or bilateral SNHL, but no differences were found in the immune profile. Multiple linear regression showed that changes in lymphocytes subpopulations were associated with hearing loss and persistence of vertigo, suggesting a role for the immune response in MD. Conclusions: Despite some limitations, MD displays an elevated prevalence of systemic AD such as RA, SLE and AS. This finding, which suggests an autoimmune background in a subset of patients with MD, has important implications for the treatment of MD.	[Gazquez, Irene; Lopez-Escamez, Jose A.] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol, Granada, Spain; [Soto-Varela, Andres; Santos, Sofia] Complejo Hosp Univ Santiago de Compostela, Div Otoneurol, Dept Otorhinolaryngol, Santiago De Compostela, Spain; [Aran, Ismael] Complejo Hosp Pontevedra, Dept Otolaryngol, Pontevedra, Spain; [Batuecas, Angel] Hosp Univ Salamanca, Dept Otolaryngol, Salamanaca, Spain; [Trinidad, Gabriel] Hosp Univ Badajoz, Dept Otolaryngol, Badajoz, Spain; [Perez-Garrigues, Herminio] Hosp La Fe, Div Otoneurol, Dept Otorhinolaryngol, E-46009 Valencia, Spain; [Gonzalez-Oller, Carlos; Acosta, Lourdes] Hosp Poniente, Otol & Neurotol Grp, CTS495, Dept Biotechnol, El Ejido, Almeria, Spain; [Lopez-Escamez, Jose A.] Hosp Poniente, Otol & Neurotol Grp, CTS495, Dept Otolaryngol, El Ejido, Almeria, Spain	Pfizer; University of Granada; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Pontevedra; Hospital Universitari i Politecnic La Fe	Gazquez, I (corresponding author), Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol, Granada, Spain.	antonio.lopezescamez@genyo.es	TRINIDAD-RUIZ, GABRIEL/X-8071-2019; Soto-Varela, Andrés/H-6489-2019; Caletrio, Angel Batuecas/AAC-3333-2019; Lopez-Escamez, Jose Antonio/D-6642-2018; RUIZ, GABRIEL GTR TRINIDAD/H-6501-2017	TRINIDAD-RUIZ, GABRIEL/0000-0002-6917-4928; Soto-Varela, Andrés/0000-0001-6763-329X; Caletrio, Angel Batuecas/0000-0003-2613-670X; Lopez-Escamez, Jose Antonio/0000-0002-8583-1430; RUIZ, GABRIEL GTR TRINIDAD/0000-0002-6917-4928	Instituto de Salud Carlos III (ISCIII) [PI10/00920]; Consejeria de Sanidad de la Junta de Castilla y Leon [BIO103-SA-51-11]; EU	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Sanidad de la Junta de Castilla y Leon; EU(European Commission)	This study was funded by a PI10/00920 Research Project from Instituto de Salud Carlos III (ISCIII), Grant BIO103-SA-51-11 from Consejeria de Sanidad de la Junta de Castilla y Leon and EU Regional Development Funds (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JALE had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; ALTERMATT HJ, 1990, ORL J OTO-RHINO-LARY, V52, P143, DOI 10.1159/000276124; Amor-Dorado JC, 2011, MEDICINE, V90, P99, DOI 10.1097/MD.0b013e3182079866; Belinchon A, 2011, LARYNGOSCOPE, V121, P622, DOI 10.1002/lary.21335; Bovo R, 2006, ACTA OTO-LARYNGOL, V126, P1012, DOI 10.1080/00016480600606723; Broughton SS, 2004, SEMIN ARTHRITIS RHEU, V34, P544, DOI 10.1016/j.semarthrit.2004.07.001; DEREBERY MJ, 1991, LARYNGOSCOPE, V101, P225; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gopen Q, 2009, ENT-EAR NOSE THROAT, V88, P1200, DOI 10.1177/014556130908801105; GREEN JD, 1991, OTOLARYNG HEAD NECK, V104, P783, DOI 10.1177/019459989110400603; House JW, 2006, OTOL NEUROTOL, V27, P355, DOI 10.1097/00129492-200604000-00011; Lopez-Escamez JA, 2007, OTOL NEUROTOL, V28, P891; Lopez-Escamez JA, 2010, LARYNGOSCOPE, V120, P103, DOI 10.1002/lary.20650; Lopez-Escamez JA, 2009, ANN OTO RHINOL LARYN, V118, P409, DOI 10.1177/000348940911800603; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Nacci A, 2010, AUDIOL NEURO-OTOL, V15, P1, DOI 10.1159/000218357; Perez Garrigues H, 1995, Ann Otolaryngol Chir Cervicofac, V112, P225; Perez-Garrigues H, 2008, ARCH OTOLARYNGOL, V134, P1149, DOI 10.1001/archotol.134.11.1149; RAUCH SD, 1995, AM J OTOL, V16, P648; Riente L, 2004, CLIN EXP IMMUNOL, V135, P159, DOI 10.1111/j.1365-2249.2004.02317.x; Ruckenstein MJ, 2002, OTOL NEUROTOL, V23, P517, DOI 10.1097/00129492-200207000-00021; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Savastano M, 2007, EUR ARCH OTO-RHINO-L, V264, P15, DOI 10.1007/s00405-006-0147-2; Shin SO, 1997, LARYNGOSCOPE, V107, P222, DOI 10.1097/00005537-199702000-00015; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; STAHLE J, 1989, AM J OTOL, V10, P170; Suslu N, 2009, ACTA OTO-LARYNGOL, V129, P1160, DOI 10.3109/00016480802631966; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; Yeo SW, 2002, ACTA OTO-LARYNGOL, V122, P851, DOI 10.1080/003655402/000028046; YOO TJ, 1983, SCIENCE, V222, P65, DOI 10.1126/science.6623056; Yoo TJ, 2001, ANN OTO RHINOL LARYN, V110, P425, DOI 10.1177/000348940111000506	32	92	99	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26759	10.1371/journal.pone.0026759	http://dx.doi.org/10.1371/journal.pone.0026759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053211	Green Published, gold			2022-12-27	WOS:000299081800037
J	Jones, HFE; Pilditch, CA; Bruesewitz, DA; Lohrer, AM				Jones, Hannah F. E.; Pilditch, Conrad A.; Bruesewitz, Denise A.; Lohrer, Andrew M.			Sedimentary Environment Influences the Effect of an Infaunal Suspension Feeding Bivalve on Estuarine Ecosystem Function	PLOS ONE			English	Article							INLET MASS-SPECTROMETRY; NEW-ZEALAND; AUSTROVENUS-STUTCHBURYI; NUTRIENT FLUXES; IN-SITU; BENTHIC PHOTOSYNTHESIS; TRANSFORMATION RATES; DREISSENA-POLYMORPHA; SUSPENDED SEDIMENT; CERASTODERMA-EDULE	The suspension feeding bivalve Austrovenus stutchburyi is a key species on intertidal sandflats in New Zealand, affecting the appearance and functioning of these systems, but is susceptible to several environmental stressors including sedimentation. Previous studies into the effect of this species on ecosystem function have been restricted in space and time, limiting our ability to infer the effect of habitat change on functioning. We examined the effect of Austrovenus on benthic primary production and nutrient dynamics at two sites, one sandy, the other composed of muddy-sand to determine whether sedimentary environment alters this key species' role. At each site we established large (16 m 2) plots of two types, Austrovenus addition and removal. In winter and summer we deployed light and dark benthic chambers to quantify oxygen and nutrient fluxes and measured sediment denitrification enzyme activity to assess denitrification potential. Rates of gross primary production (GPP) and ammonium uptake were significantly increased when Austrovenus was added, relative to removed, at the sandy site (GPP, 1.5 times greater in winter and summer; ammonium uptake, 8 times greater in summer; 3-factor analysis of variance (ANOVA), p<0.05). Denitrification potential was also elevated in Austrovenus addition plots at the sandy site in summer (by 1.6 times, p<0.1). In contrast, there was no effect of Austrovenus treatment on any of these variables at the muddy-sand site, and overall rates tended to be lower at the muddy-sand site, relative to the sandy site (e.g. GPP was 2.1 to 3.4 times lower in winter and summer, respectively, p<0.001). Our results suggest that the positive effects of Austrovenus on system productivity and denitrification potential is limited at a muddy-sand site compared to a sandy site, and reveal the importance of considering sedimentary environment when examining the effect of key species on ecosystem function.	[Jones, Hannah F. E.; Pilditch, Conrad A.; Bruesewitz, Denise A.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Lohrer, Andrew M.] Natl Inst Water & Atmospher Res NIWA, Hamilton, New Zealand	University of Waikato; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Jones, HFE (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	hfej1@waikato.ac.nz	Jones, Hannah/M-5193-2019	Jones, Hannah/0000-0002-3231-4376; Lohrer, Andrew Martin/0000-0002-3893-6539	University of Waikato; New Zealand Foundation for Research, Science and Technology (FRST) [UOWX0505, C01X0501]	University of Waikato; New Zealand Foundation for Research, Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology)	This research was supported by a University of Waikato Doctoral Scholarship to HJ. DB was supported by the New Zealand Foundation for Research, Science and Technology (FRST Contract No. UOWX0505). AL was supported by the New Zealand Foundation for Research Science & Technology (FRST Contract No. C01X0501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; An S, 2001, LIMNOL OCEANOGR, V46, P62, DOI 10.4319/lo.2001.46.1.0062; An SM, 2001, APPL ENVIRON MICROB, V67, P1171, DOI 10.1128/AEM.67.3.1171-1178.2001; Arar E.J., 1997, IN VITRO DETERMINATI; Barbiero RP, 2006, CAN J FISH AQUAT SCI, V63, P1549, DOI 10.1139/F06-059; BEENTJES MP, 1986, MAR BEHAV PHYSIOL, V12, P171, DOI 10.1080/10236248609378644; Bernot MJ, 2003, APPL ENVIRON MICROB, V69, P5950, DOI 10.1128/AEM.69.10.5950-5956.2003; Billerbeck M, 2007, ESTUAR COAST SHELF S, V71, P704, DOI 10.1016/j.ecss.2006.09.019; Blanchard GF, 2001, J EXP MAR BIOL ECOL, V264, P85, DOI 10.1016/S0022-0981(01)00312-4; Bruesewitz DA, 2008, J N AM BENTHOL SOC, V27, P236, DOI 10.1899/07-031.1; Bruesewitz DA, 2006, CAN J FISH AQUAT SCI, V63, P957, DOI 10.1139/F06-002; Bruesewitz DA, 2011, ECOSYSTEMS, V14, P341, DOI 10.1007/s10021-011-9413-2; Bruesewitz DA, 2009, FRESHWATER BIOL, V54, P1427, DOI 10.1111/j.1365-2427.2009.02195.x; Ciutat A, 2007, J EXP MAR BIOL ECOL, V346, P114, DOI 10.1016/j.jembe.2007.03.005; Coco G, 2006, ECOLOGY, V87, P2862, DOI 10.1890/0012-9658(2006)87[2862:FBBDFA]2.0.CO;2; Cummings V, 2007, J SHELLFISH RES, V26, P89, DOI 10.2983/0730-8000(2007)26[89:OTSOAS]2.0.CO;2; DAVIS WR, 1993, J EXP MAR BIOL ECOL, V171, P187, DOI 10.1016/0022-0981(93)90003-7; De Luca-Abbott S, 2001, MAR POLLUT BULL, V42, P817; Ellis J, 2002, J EXP MAR BIOL ECOL, V267, P147, DOI 10.1016/S0022-0981(01)00355-0; Englund G, 2003, ADV ECOL RES, V33, P161, DOI 10.1016/S0065-2504(03)33011-9; Friedrichs M, 2000, MAR ECOL PROG SER, V192, P219, DOI 10.3354/meps192219; Gardner WS, 2001, J GREAT LAKES RES, V27, P84, DOI 10.1016/S0380-1330(01)70624-7; Giles H, 2006, MAR BIOL, V150, P261, DOI 10.1007/s00227-006-0348-7; Giles H, 2006, AQUACULTURE, V261, P125, DOI 10.1016/j.aquaculture.2006.06.048; Glud RN, 1996, MAR ECOL PROG SER, V141, P303, DOI 10.3354/meps141303; Grant J, 1997, J EXP MAR BIOL ECOL, V216, P33, DOI 10.1016/S0022-0981(97)00089-0; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; GREIG MJ, 1988, NEW ZEAL J MAR FRESH, V22, P391, DOI 10.1080/00288330.1988.9516310; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; HALL SJ, 1990, AM NAT, V136, P657, DOI 10.1086/285121; Hewitt JE, 1996, MAR ECOL PROG SER, V135, P57, DOI 10.3354/meps135057; Hewitt JE, 1997, LIMNOL OCEANOGR, V42, P282, DOI 10.4319/lo.1997.42.2.0282; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HULBERG LW, 1980, CAN J FISH AQUAT SCI, V37, P1130, DOI 10.1139/f80-145; Inwood SE, 2005, J N AM BENTHOL SOC, V24, P227, DOI 10.1899/04-032.1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kana TM, 1998, LIMNOL OCEANOGR, V43, P334, DOI 10.4319/lo.1998.43.2.0334; Kang CK, 2006, MAR ECOL PROG SER, V315, P113, DOI 10.3354/meps315113; Kang CK, 1999, MAR ECOL PROG SER, V187, P147, DOI 10.3354/meps187147; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; KNOWLES R, 1990, FEMS SYMP, P151; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; Morar SR, 2011, J EXP MAR BIOL ECOL, V399, P110, DOI 10.1016/j.jembe.2011.02.034; Mouritsen KN, 2003, OECOLOGIA, V135, P131, DOI 10.1007/s00442-003-1183-x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Needham HR, 2010, MAR ECOL PROG SER, V414, P179, DOI 10.3354/meps08726; Needham HR, 2011, ECOSYSTEMS IN PRESS, DOI [10.1007/s10021-10011-19468-10020, DOI 10.1007/S10021-10011-19468-10020]; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Norkko A, 2002, MAR ECOL PROG SER, V234, P23, DOI 10.3354/meps234023; Norkko J, 2006, MAR ECOL PROG SER, V326, P175, DOI 10.3354/meps326175; Norkko J, 2006, J EXP MAR BIOL ECOL, V333, P12, DOI 10.1016/j.jembe.2005.11.015; Risgaard-Petersen N, 2003, OCEANOGRAPHY, V48, P93; Ryba SA, 2002, CHEMOSPHERE, V48, P139, DOI 10.1016/S0045-6535(02)00027-9; Safi KA, 2003, MAR ECOL PROG SER, V259, P67, DOI 10.3354/meps259067; Sandwell DR, 2009, J EXP MAR BIOL ECOL, V373, P16, DOI 10.1016/j.jembe.2009.02.015; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SINGER JK, 1988, J SEDIMENT PETROL, V58, P534; Stenton-Dozey J, 2001, CAN J FISH AQUAT SCI, V58, P1021, DOI 10.1139/cjfas-58-5-1021; Sundback K, 2000, MAR ECOL PROG SER, V200, P59, DOI 10.3354/meps200059; Tank JL, 2003, FRESHWATER BIOL, V48, P1031, DOI 10.1046/j.1365-2427.2003.01067.x; Tengberg A, 2004, PROG OCEANOGR, V60, P1, DOI 10.1016/j.pocean.2003.12.001; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2003, MAR ECOL PROG SER, V263, P101, DOI 10.3354/meps263101; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Whitlatch RB, 1997, J EXP MAR BIOL ECOL, V216, P171, DOI 10.1016/S0022-0981(97)00095-6; Widdicombe S, 1998, J EXP MAR BIOL ECOL, V228, P241, DOI 10.1016/S0022-0981(98)00032-X	75	54	54	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27065	10.1371/journal.pone.0027065	http://dx.doi.org/10.1371/journal.pone.0027065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046446	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800067
J	Iguchi-Hashimoto, M; Usui, T; Yoshifuji, H; Shimizu, M; Kobayashi, S; Ito, Y; Murakami, K; Shiomi, A; Yukawa, N; Kawabata, D; Nojima, T; Ohmura, K; Fujii, T; Mimori, T				Iguchi-Hashimoto, Mikiko; Usui, Takashi; Yoshifuji, Hajime; Shimizu, Masakazu; Kobayashi, Shio; Ito, Yoshinaga; Murakami, Kosaku; Shiomi, Aoi; Yukawa, Naoichiro; Kawabata, Daisuke; Nojima, Takaki; Ohmura, Koichiro; Fujii, Takao; Mimori, Tsuneyo			Overexpression of a Minimal Domain of Calpastatin Suppresses IL-6 Production and Th17 Development via Reduced NF-kappa B and Increased STAT5 Signals	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; T-HELPER-CELLS; RHEUMATOID-ARTHRITIS; CARTILAGE DESTRUCTION; ENDOGENOUS INHIBITOR; IL-12R-BETA-2 CHAIN; MONOCLONAL-ANTIBODY; ALPHA DEGRADATION; SYNOVIAL-FLUID	Calpain, a calcium-dependent cysteine protease, is reportedly involved in the pathophysiology of autoimmune diseases such as rheumatoid arthritis (RA). In addition, autoantibodies against calpastatin, a natural and specific inhibitor of calpain, are widely observed in RA. We previously reported that E-64-d, a membrane-permeable cysteine protease inhibitor, is effective in treating experimental arthritis. However, the exact role of the calpastatin-calpain balance in primary inflammatory cells remains unclear. Here we investigated the effect of calpain-specific inhibition by overexpressing a minimal functional domain of calpastatin in primary helper T (Th) cells, primary fibroblasts from RA patients, and fibroblast cell lines. We found that the calpastatin-calpain balance varied during Th1, Th2, and Th17 development, and that overexpression of a minimal domain of calpastatin (by retroviral gene transduction) or the inhibition of calpain by E-64-d suppressed the production of IL-6 and IL-17 by Th cells and the production of IL-6 by fibroblasts. These suppressions were associated with reductions in ROR gamma t expression and STAT3 phosphorylation. Furthermore, inhibiting calpain by silencing its small regulatory subunit (CPNS) suppressed Th17 development. We also confirmed that overexpressing a minimal domain of calpastatin suppressed IL-6 by reducing NF-kappa B signaling via the stabilization of I kappa B alpha, without affecting the upstream signal. Moreover, our findings indicated that calpastatin overexpression suppressed IL-17 production by Th cells by up-regulating the STAT5 signal. Finally, overexpression of a minimal domain of calpastatin suppressed IL-6 production efficiently in primary fibroblasts derived from the RA synovium. These findings suggest that inhibiting calpain by overexpressing a minimal domain of calpastatin could coordinately suppress proinflammatory activities, not only those of Th cells but also of synovial fibroblasts. Thus, this strategy may prove viable as a candidate treatment for inflammatory diseases such as RA.	[Iguchi-Hashimoto, Mikiko; Usui, Takashi; Yoshifuji, Hajime; Shimizu, Masakazu; Kobayashi, Shio; Ito, Yoshinaga; Murakami, Kosaku; Shiomi, Aoi; Yukawa, Naoichiro; Kawabata, Daisuke; Nojima, Takaki; Ohmura, Koichiro; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto, Japan; [Usui, Takashi; Kobayashi, Shio] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kyoto University; Kyoto University	Iguchi-Hashimoto, M (corresponding author), Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto, Japan.	takausui@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020; Kosaku, Murakami/T-8806-2019	Ito, Yoshinaga/0000-0002-5567-7014	Japan Society for the Promotion of Science [20591168, 22390201]; Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research [23791112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (TU: 20591168 and TM: 22390201) from the Japan Society for the Promotion of Science, and a grant for intractable diseases from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Benito MJ, 2004, ARTHRITIS RHEUM-US, V50, P1781, DOI 10.1002/art.20260; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BROZIK M, 1992, J RHEUMATOL, V19, P63; Chen F, 2000, AM J PHYSIOL-CELL PH, V279, pC709, DOI 10.1152/ajpcell.2000.279.3.C709; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; DESPRES N, 1995, J CLIN INVEST, V95, P1891, DOI 10.1172/JCI117870; EMORI Y, 1988, J BIOL CHEM, V263, P2364; FUKUI I, 1989, BIOCHEM BIOPH RES CO, V162, P559, DOI 10.1016/0006-291X(89)92347-4; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Hayashi M, 2005, J BIOCHEM, V137, P331, DOI 10.1093/jb/mvi036; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwaki-Egawa S, 2004, J RHEUMATOL, V31, P17; Kanazawa Y, 2000, Mod Rheumatol, V10, P38, DOI 10.3109/s101650070037; Lackner KJ, 1998, BRIT J RHEUMATOL, V37, P1164; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee FYI, 2005, J BIOL CHEM, V280, P29929, DOI 10.1074/jbc.M414600200; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Letavernier E, 2011, EUR J IMMUNOL, V41, P473, DOI 10.1002/eji.201040437; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Liu ZQ, 1996, FEBS LETT, V385, P109, DOI 10.1016/0014-5793(96)00360-2; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matsushita Y, 2005, CLIN EXP IMMUNOL, V139, P355, DOI 10.1111/j.1365-2249.2005.02701.x; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; MIMORI T, 1995, P NATL ACAD SCI USA, V92, P7267, DOI 10.1073/pnas.92.16.7267; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Schaecher K, 2004, NEUROCHEM RES, V29, P1443, DOI 10.1023/B:NERE.0000026410.56000.dd; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Selliah N, 1996, J IMMUNOL, V156, P3215; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; SUZUKI K, 1992, BIOCHEM J, V285, P857, DOI 10.1042/bj2850857; SUZUKI K, 1990, ARTHRITIS RHEUM, V33, P728, DOI 10.1002/art.1780330516; SZOMOR Z, 1995, ANN RHEUM DIS, V54, P477, DOI 10.1136/ard.54.6.477; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Usui T, 1997, J IMMUNOL, V158, P3197; Usui Takashi, 2007, Nihon Rinsho Meneki Gakkai Kaishi, V30, P419; Vittecoq O, 2001, RHEUMATOLOGY, V40, P1126, DOI 10.1093/rheumatology/40.10.1126; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; YAMAMOTO S, 1992, ARTHRITIS RHEUM-US, V35, P1309, DOI 10.1002/art.1780351111; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yoshifuji H, 2005, INT IMMUNOL, V17, P1327, DOI 10.1093/intimm/dxh311	62	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e27020	10.1371/journal.pone.0027020	http://dx.doi.org/10.1371/journal.pone.0027020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046434	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400055
J	Avila-Martin, G; Galan-Arriero, I; Gomez-Soriano, J; Taylor, J				Avila-Martin, Gerardo; Galan-Arriero, Iriana; Gomez-Soriano, Julio; Taylor, Julian			Treatment of Rat Spinal Cord Injury with the Neurotrophic Factor Albumin-Oleic Acid: Translational Application for Paralysis, Spasticity and Pain	PLOS ONE			English	Article							C-FIBER REFLEX; D-ASPARTATE RECEPTOR; HUMAN SERUM-ALBUMIN; CHAIN FATTY-ACIDS; ADULT-RAT; TEMPORAL SUMMATION; NR1 SUBUNIT; DECEREBRATED RABBIT; NEUROPATHIC PAIN; AFFERENT INPUTS	Sensorimotor dysfunction following incomplete spinal cord injury (iSCI) is often characterized by the debilitating symptoms of paralysis, spasticity and pain, which require treatment with novel pleiotropic pharmacological agents. Previous in vitro studies suggest that Albumin (Alb) and Oleic Acid (OA) may play a role together as an endogenous neurotrophic factor. Although Alb can promote basic recovery of motor function after iSCI, the therapeutic effect of OA or Alb-OA on a known translational measure of SCI associated with symptoms of spasticity and change in nociception has not been studied. Following T9 spinal contusion injury in Wistar rats, intrathecal treatment with: i) Saline, ii) Alb (0.4 nanomoles), iii) OA (80 nanomoles), iv) Alb-Elaidic acid (0.4/80 nanomoles), or v) Alb-OA (0.4/80 nanomoles) were evaluated on basic motor function, temporal summation of noxious reflex activity, and with a new test of descending modulation of spinal activity below the SCI up to one month after injury. Albumin, OA and Alb-OA treatment inhibited nociceptive Tibialis Anterior (TA) reflex activity. Moreover Alb-OA synergistically promoted early recovery of locomotor activity to 50 +/- 10% of control and promoted de novo phasic descending inhibition of TA noxious reflex activity to 47 +/- 5% following non-invasive electrical conditioning stimulation applied above the iSCI. Spinal L4-L5 immunohistochemistry demonstrated a unique increase in serotonin fibre innervation up to 4.2 +/- 1.1 and 2.3 +/- 0.3 fold within the dorsal and ventral horn respectively with Alb-OA treatment when compared to uninjured tissue, in addition to a reduction in NR1 NMDA receptor phosphorylation and microglia reactivity. Early recovery of voluntary motor function accompanied with tonic and de novo phasic descending inhibition of nociceptive TA flexor reflex activity following Alb-OA treatment, mediated via known endogenous spinal mechanisms of action, suggests a clinical application of this novel neurotrophic factor for the treatment of paralysis, spasticity and pain.	[Avila-Martin, Gerardo; Galan-Arriero, Iriana; Gomez-Soriano, Julio; Taylor, Julian] Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Castilla La Man, Spain; [Gomez-Soriano, Julio] Univ Castilla La Mancha, Escuela Enfermeri & Fisioterapia Toledo, Toledo, Castilla La Man, Spain	Hospital Nacional de Paraplejicos; Universidad de Castilla-La Mancha	Avila-Martin, G (corresponding author), Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Castilla La Man, Spain.	jscott@sescam.org	Gómez-Soriano, Julio/AAE-2990-2019; Taylor, Julian/AAC-2802-2021; Arriero, Iriana Galan/S-2050-2019	Gómez-Soriano, Julio/0000-0002-5542-4105; Taylor, Julian/0000-0003-2553-2348; Arriero, Iriana Galan/0000-0002-3291-1963; Avila Martin, Gerardo/0000-0001-8982-7634	ISCIII [FIS-07/0806]; INNPACTO Ministerio de Ciencia e Innovacion IPT [01000-2010-016]; Fundacion Mutua Madrilena; Ministerio Ciencia e Innovacion [2007/33]	ISCIII(Instituto de Salud Carlos III); INNPACTO Ministerio de Ciencia e Innovacion IPT; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the following research projects: ISCIII FIS-07/0806, INNPACTO Ministerio de Ciencia e Innovacion IPT 01000-2010-016, Fundacion Mutua Madrilena 2007 and 2010, FISCAM 2007/33, "Consolider-Ingenio 2010" from the "Ministerio Ciencia e Innovacion" [CSDOOC-09-61313]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2001, BRIT J PHARMACOL, V133, P1013, DOI 10.1038/sj.bjp.0704148; Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Alberts GL, 2001, MOL PHARMACOL, V60, P1349, DOI 10.1124/mol.60.6.1349; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; BANKS WA, 1994, J NEUROCHEM, V62, P2404; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; CADDEN SW, 1983, BRAIN RES, V275, P1, DOI 10.1016/0006-8993(83)90412-2; Cain LD, 2007, J NEUROSCI RES, V85, P1558, DOI 10.1002/jnr.21265; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Clarke RW, 2002, NEUROSCIENCE, V112, P555, DOI 10.1016/S0306-4522(02)00093-3; CLARKE RW, 1989, Q J EXP PHYSIOL CMS, V74, P681, DOI 10.1113/expphysiol.1989.sp003320; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Cruz-Almeida Y, 2009, PAIN MED, V10, P1246, DOI 10.1111/j.1526-4637.2009.00713.x; Curatolo M, 1997, BRIT J ANAESTH, V78, P88, DOI 10.1093/bja/78.1.88; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; DEWILLE JW, 1992, DEV NEUROSCI-BASEL, V14, P61, DOI 10.1159/000111648; Dietz V, 2009, BRAIN, V132, P2196, DOI 10.1093/brain/awp124; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; Doly S, 2005, J COMP NEUROL, V490, P256, DOI 10.1002/cne.20667; Elliot KAC, 1969, HANDBOOK NEUROCHEMIS, V2, P103; FALINOWER S, 1994, J NEUROPHYSIOL, V72, P194, DOI 10.1152/jn.1994.72.1.194; Feng XM, 2009, EUR J PHARMACOL, V614, P38, DOI 10.1016/j.ejphar.2009.04.044; Finnerup NB, 2007, EXP NEUROL, V207, P139, DOI 10.1016/j.expneurol.2007.06.001; Finnerup NB, 2004, EUR J NEUROL, V11, P73, DOI 10.1046/j.1351-5101.2003.00725.x; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Gomez-Soriano J, 2010, EXP NEUROL, V224, P507, DOI 10.1016/j.expneurol.2010.05.014; Gomez-Soriano J, 2010, BRIT J PHARMACOL, V161, P972, DOI 10.1111/j.1476-5381.2010.00964.x; Gozariu M, 1997, J NEUROPHYSIOL, V78, P3165, DOI 10.1152/jn.1997.78.6.3165; Granda B, 2003, BRAIN RES, V988, P1, DOI 10.1016/S0006-8993(03)03253-0; Graven-Nielsen T, 2000, PAIN, V85, P483, DOI 10.1016/S0304-3959(99)00308-5; Grossman SD, 2000, J NEUROCHEM, V75, P174, DOI 10.1046/j.1471-4159.2000.0750174.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hains BC, 2002, EXP NEUROL, V175, P347, DOI 10.1006/exnr.2002.7892; HAMILTON JA, 1991, P NATL ACAD SCI USA, V88, P2051, DOI 10.1073/pnas.88.6.2051; Hamon M, 2008, B ACAD NAT MED PARIS, V192, P921, DOI 10.1016/S0001-4079(19)32754-2; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; Holmoy T, 2009, CLIN NEUROL NEUROSUR, V111, P708, DOI 10.1016/j.clineuro.2009.06.005; Hornby TG, 2003, J NEUROPHYSIOL, V89, P416, DOI 10.1152/jn.00979.2001; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Jasmin L, 2001, J NEUROSCI METH, V110, P81, DOI 10.1016/S0165-0270(01)00420-4; JONES CA, 1994, EXP NEUROL, V128, P239, DOI 10.1006/exnr.1994.1133; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; Kwon BK, 2011, J NEUROTRAUM, V28, P1525, DOI 10.1089/neu.2010.1296; Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; Liu XG, 1998, EUR J NEUROSCI, V10, P3069, DOI 10.1046/j.1460-9568.1998.00310.x; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Mullner A, 2008, EUR J NEUROSCI, V27, P326, DOI 10.1111/j.1460-9568.2007.06006.x; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; Oh YT, 2009, NEUROSCI LETT, V464, P93, DOI 10.1016/j.neulet.2009.08.040; Prybylowski KL, 2001, J NEUROCHEM, V76, P797, DOI 10.1046/j.1471-4159.2001.00069.x; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; ROBYBRAMI A, 1987, BRAIN, V110, P1497, DOI 10.1093/brain/110.6.1497; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; Roh DH, 2010, ANESTH ANALG, V110, P622, DOI 10.1213/ANE.0b013e3181c8afc1; Schmitt AB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-8; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Taricco M, 2006, Eura Medicophys, V42, P5; Taylor J, 1999, EUR J NEUROSCI, V11, P363, DOI 10.1046/j.1460-9568.1999.00468.x; Taylor J, 2009, PCTES2009070252; TAYLOR JS, 1991, J PHYSIOL-LONDON, V437, P71, DOI 10.1113/jphysiol.1991.sp018584; Taylor JS, 1997, J NEUROSCI, V17, P5004; Temkin R, 1997, MOL BRAIN RES, V52, P38, DOI 10.1016/S0169-328X(97)00249-0; Tullis JL, 1977, JAMA-J AM MED ASSOC, V237, P460; Vahedi K, 2005, BRIT J NUTR, V94, P909, DOI 10.1079/BJN20051550; Vahidy WH, 2006, EXP BRAIN RES, V174, P781, DOI 10.1007/s00221-006-0672-7; Wang Yanming F, 2005, Cerebrospinal Fluid Res, V2, P7, DOI 10.1186/1743-8454-2-7; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; XU XJ, 1992, NEUROSCIENCE, V51, P641, DOI 10.1016/0306-4522(92)90303-J; Yezierski RP, 2009, J REHABIL RES DEV, V46, P95, DOI 10.1682/JRRD.2008.06.0074; Young W, 2002, PROG BRAIN RES, V137, P231	92	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26107	10.1371/journal.pone.0026107	http://dx.doi.org/10.1371/journal.pone.0026107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046257	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600009
J	Fang, Q; Wang, F; Gatehouse, JA; Gatehouse, AMR; Chen, XX; Hu, C; Ye, GY				Fang, Qi; Wang, Fei; Gatehouse, John A.; Gatehouse, Angharad M. R.; Chen, Xue-xin; Hu, Cui; Ye, Gong-yin			Venom of Parasitoid, Pteromalus puparum, Suppresses Host, Pieris rapae, Immune Promotion by Decreasing Host C-Type Lectin Gene Expression	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; WASP LEPTOPILINA-BOULARDI; MANDUCA-SEXTA; DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; TOBACCO HORNWORM; PERIPLANETA-AMERICANA; LEPIDOPTERAN HOST; HYPHANTRIA-CUNEA; BOMBYX-MORI	Background: Insect hosts have evolved immunity against invasion by parasitoids, and in co-evolutionary response parasitoids have also developed strategies to overcome host immune systems. The mechanisms through which parasitoid venoms disrupt the promotion of host immunity are still unclear. We report here a new mechanism evolved by parasitoid Pteromalus puparum, whose venom inhibited the promotion of immunity in its host Pieris rapae (cabbage white butterfly). Methodology/Principal Findings: A full-length cDNA encoding a C-type lectin (Pr-CTL) was isolated from P. rapae. Quantitative PCR and immunoblotting showed that injection of bacterial and inert beads induced expression of Pr-CTL, with peaks of mRNA and Pr-CTL protein levels at 4 and 8 h post beads challenge, respectively. In contrast, parasitoid venom suppressed Pr-CTL expression when co-injected with beads, in a time and dose-dependent manner. Immunolocalization and immunoblotting results showed that Pr-CTL was first detectable in vesicles present in cytoplasm of granulocytes in host hemolymph, and was then secreted from cells into circulatory fluid. Finally, the secreted Pr-CTL bound to cellular membranes of both granulocytes and plasmatocytes. Injection of double-stranded RNA specific for target gene decreased expression of Pr-CTL, and a few other host immune-related genes. Suppression of Pr-CTL expression also down-regulated antimicrobial and phenoloxidase activities, and reducing phagocytotic and encapsulation rates in host. The inhibitory effect of parasitoid venom on host encapsulation is consistent with its effect in suppressing Pr-CTL expression. Binding assay results showed that recombinant Pr-CTL directly attached to the surface of P. puparum egges. We infer that Pr-CTL may serve as an immune signalling co-effector, first binding to parasitoid eggs, regulating expression of a set of immune-related genes and promoting host immunity. Conclusions/Significance: P. puparum venom inhibits promotion of host immune responses by silencing expression of host C-type lectin gene Pr-CTL, whose expression affected transcription of other host immune-related genes.	[Fang, Qi; Wang, Fei; Chen, Xue-xin; Hu, Cui; Ye, Gong-yin] Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Qi; Wang, Fei; Chen, Xue-xin; Hu, Cui; Ye, Gong-yin] Zhejiang Univ, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Gatehouse, John A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Gatehouse, Angharad M. R.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England	Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Durham University; Newcastle University - UK	Fang, Q (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chu@zju.edu.cn	Chen, Xue-xin/D-1592-2010	Chen, Xue-xin/0000-0002-9109-8853; Gatehouse, John/0000-0002-7192-568X; Gatehouse, Angharad/0000-0002-6406-2927	China National Science Fund for Distinguished Young Scholars [31025021]; China National Science Fund for Innovative Research Groups of Biological Control [31021003]; National Nature Science Foundation of China [30971959, 31101488]; Zhejiang Provincial Natural Science Foundation of China [Z3090191]; China Postdoctoral Science Foundation [20110490184]; BBSRC [BB/G530409/1, BB/E006671/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006671/1, BB/G530409/1] Funding Source: researchfish	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China National Science Fund for Innovative Research Groups of Biological Control(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China National Science Fund for Distinguished Young Scholars (Grant no. 31025021, http://www.nsfc.gov.cn), the China National Science Fund for Innovative Research Groups of Biological Control (Grant no. 31021003, http://www.nsfc.gov.cn), the National Nature Science Foundation of China (Grant no. 30971959, 31101488, http://www.nsfc.gov.cn), the Zhejiang Provincial Natural Science Foundation of China (Grant no. Z3090191, http://www.zjnsf.gov.cn) and the China Postdoctoral Science Foundation (Grant no. 20110490184, http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J, 2004, J INSECT PHYSIOL, V50, P315, DOI 10.1016/j.jinsphys.2004.01.007; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chai LQ, 2008, DEV COMP IMMUNOL, V32, P71, DOI 10.1016/j.dci.2007.04.006; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Dong SZ, 2007, J INSECT PHYSIOL, V53, P468, DOI 10.1016/j.jinsphys.2007.01.008; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Fang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-484; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; JOMORI T, 1991, J BIOL CHEM, V266, P13318; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Nalini M, 2008, J INSECT PHYSIOL, V54, P1125, DOI 10.1016/j.jinsphys.2008.04.023; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Sricharoen S, 2005, DEV COMP IMMUNOL, V29, P1017, DOI 10.1016/j.dci.2005.03.010; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Strand MR, 2006, ARCH INSECT BIOCHEM, V61, P134, DOI 10.1002/arch.20107; Takase H, 2009, DEV COMP IMMUNOL, V33, P789, DOI 10.1016/j.dci.2009.01.005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q., 2007, DPS DATA PROCESSING; Tunaz H, 2009, NATURWISSENSCHAFTEN, V96, P1115, DOI 10.1007/s00114-009-0572-3; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WIESNER A, 1993, J INSECT PHYSIOL, V39, P865, DOI 10.1016/0022-1910(93)90119-C; Wu ML, 2008, J INVERTEBR PATHOL, V99, P186, DOI 10.1016/j.jip.2008.07.005; Ye Gong-yin, 2007, P115; Yoe SM, 2006, COMP BIOCHEM PHYS B, V144, P199, DOI 10.1016/j.cbpb.2006.02.010; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu XQ, 2006, INSECT MOL BIOL, V13, P407; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhang GM, 2006, DEV COMP IMMUNOL, V30, P756, DOI 10.1016/j.dci.2005.11.001; Zhang Z, 2005, TOXICON, V46, P337, DOI 10.1016/j.toxicon.2005.05.005; Zhu JY, 2008, TOXICON, V51, P1391, DOI 10.1016/j.toxicon.2008.03.008	66	38	47	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26888	10.1371/journal.pone.0026888	http://dx.doi.org/10.1371/journal.pone.0026888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046395	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000296519600074
J	Galli, LM; Burrus, LW				Galli, Lisa M.; Burrus, Laura W.			Differential Palmit(e)oylation of Wnt1 on C93 and S224 Residues Has Overlapping and Distinct Consequences	PLOS ONE			English	Article							FOCAL DERMAL HYPOPLASIA; PROTEIN PALMITOYLATION; TRANSMEMBRANE PROTEIN; EXPRESSION PATTERNS; MEMBRANE-PROTEIN; SIGNAL PEPTIDES; NERVOUS-SYSTEM; SONIC-HEDGEHOG; SECRETION; PORCUPINE	Though the mechanisms by which cytosolic/intracellular proteins are regulated by the post-translational addition of palmitate adducts is well understood, little is known about how this lipid modification affects secreted ligands, such as Wnts. Here we use mutational analysis to show that differential modification of the two known palmit(e)oylated residues of Wnt1, C93 and S224, has both overlapping and distinct consequences. Though the relative roles of each residue are similar with respect to stability and secretion, two distinct biological assays in L cells show that modification of C93 primarily modulates signaling via a beta-catenin independent pathway while S224 is crucial for beta-catenin dependent signaling. In addition, pharmacological inhibition of Porcupine (Porcn), an upstream regulator of Wnt, by IWP1, specifically inhibited beta-catenin dependent signaling. Consistent with these observations, mapping of amino acids in peptide domains containing C93 and S224 demonstrate that acylation of C93 is likely to be Porcn-independent while that of S224 is Porcn-dependent. Cumulatively, our data strongly suggest that C93 and S224 are modified by distinct enzymes and that the differential modification of these sites has the potential to influence Wnt signaling pathway choice.	[Galli, Lisa M.; Burrus, Laura W.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Galli, LM (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	LBurrus@sfsu.edu			NIH [5S06GM052588-15, P20MD000544]; NSF [IOS-0950892]; CSUPERB; Division Of Integrative Organismal Systems [0950892] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM052588] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CSUPERB; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	LWB was funded by NIH (5S06GM052588-15), NSF (IOS-0950892), and CSUPERB. The SFSU CMIC was supported NIH P20MD000544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biechele S., 2011, DEV BIOL; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; FUNG YKT, 1985, MOL CELL BIOL, V5, P3337, DOI 10.1128/MCB.5.12.3337; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2004, DEV BIOL, V269, P489, DOI 10.1016/j.ydbio.2004.01.041; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LORENOWICZ MJ, 2009, EXP CELL RES; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mikic I, 2006, METHOD ENZYMOL, V414, P150, DOI 10.1016/S0076-6879(06)14010-0; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Shibamoto S, 1998, GENES CELLS, V3, P659; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	64	32	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26636	10.1371/journal.pone.0026636	http://dx.doi.org/10.1371/journal.pone.0026636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046319	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600038
J	Sueur, C; Briard, L; Petit, O				Sueur, Cedric; Briard, Lea; Petit, Odile			Individual Analyses of Levy Walk in Semi-Free Ranging Tonkean Macaques (Macaca tonkeana)	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; ACTIVITY BUDGETS; MOVEMENT PATTERNS; ALOUATTA-CARAYA; AGE; BEHAVIOR; SEX; DIET; SEGREGATION; STRATEGIES	Animals adapt their movement patterns to their environment in order to maximize their efficiency when searching for food. The Levy walk and the Brownian walk are two types of random movement found in different species. Studies have shown that these random movements can switch from a Brownian to a Levy walk according to the size distribution of food patches. However no study to date has analysed how characteristics such as sex, age, dominance or body mass affect the movement patterns of an individual. In this study we used the maximum likelihood method to examine the nature of the distribution of step lengths and waiting times and assessed how these distributions are influenced by the age and the sex of group members in a semi free-ranging group of ten Tonkean macaques. Individuals highly differed in their activity budget and in their movement patterns. We found an effect of age and sex of individuals on the power distribution of their step lengths and of their waiting times. The males and old individuals displayed a higher proportion of longer trajectories than females and young ones. As regards waiting times, females and old individuals displayed higher rates of long stationary periods than males and young individuals. These movement patterns resembling random walks can probably be explained by the animals moving from one location to other known locations. The power distribution of step lengths might be due to a power distribution of food patches in the enclosure while the power distribution of waiting times might be due to the power distribution of the patch sizes.	[Sueur, Cedric; Briard, Lea; Petit, Odile] Free Univ Brussels, Unit Social Ecol, Brussels, Belgium; [Sueur, Cedric; Briard, Lea; Petit, Odile] Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France; [Sueur, Cedric; Briard, Lea; Petit, Odile] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sueur, C (corresponding author), Free Univ Brussels, Unit Social Ecol, Brussels, Belgium.	cedric.sueur@iphc.cnrs.fr	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Japan Society for the Promotion of Science [PE10062]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	CS was funded by the Japan Society for the Promotion of Science (PE10062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Atkinson RPD, 2002, OIKOS, V98, P134, DOI 10.1034/j.1600-0706.2002.980114.x; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P216, DOI 10.1159/000156823; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Boyer D, 2004, PHYSICA A, V342, P329, DOI 10.1016/j.physa.2004.04.091; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Einstein A, 1956, INVESTIGATIONS THEOR; Fragaszy DM, 1990, BEHAV ECOL, V1, P81, DOI 10.1093/beheco/1.1.81; HARRISON MJS, 1983, ANIM BEHAV, V31, P969, DOI 10.1016/S0003-3472(83)80001-3; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; ISBELL LA, 1993, BEHAV ECOL SOCIOBIOL, V32, P377, DOI 10.1007/BF00168821; Jaman MF, 2008, AM J PRIMATOL, V70, P1133, DOI 10.1002/ajp.20612; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Neuhaus P, 2002, CAN J ZOOL, V80, P1437, DOI 10.1139/Z02-126; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Pombo AR, 2004, LAND USE NATURE CONS, P313; Prates HM, 2008, INT J PRIMATOL, V29, P703, DOI 10.1007/s10764-008-9257-6; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Riley EP, 2008, AM J PRIMATOL, V70, P670, DOI 10.1002/ajp.20543; Riley Erin P., 2005, Tropical Biodiversity, V8, P199; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; Schreier AL, 2010, ANIM BEHAV, V80, P75, DOI 10.1016/j.anbehav.2010.04.002; Shi JB, 2003, CAN J ZOOL, V81, P803, DOI 10.1139/Z03-055; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2011, CURR ZOOL, V57, P8, DOI 10.1093/czoolo/57.1.8; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016131; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Todd PA, 2008, J ETHOL, V26, P273, DOI 10.1007/s10164-007-0059-7; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	44	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26788	10.1371/journal.pone.0026788	http://dx.doi.org/10.1371/journal.pone.0026788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046356	gold, Green Published			2022-12-27	WOS:000296519600058
J	Wen, XS; Yang, JQ; Kim, PJ; Singh, RR				Wen, Xiangshu; Yang, Jun-Qi; Kim, Peter J.; Singh, Ram Raj			Homeostatic Regulation of Marginal Zone B Cells by Invariant Natural Killer T Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; NKT CELLS; CUTTING EDGE; AUTOANTIBODY PRODUCTION; IMMUNOREGULATORY ROLE; IMMUNE-RESPONSES; DENDRITIC CELLS; ACTIVATION; LUPUS; ANTIGEN	Marginal zone B cells (MZB) mount a rapid antibody response, potently activate naive T cells, and are enriched in autoreactive B cells. MZBs express high levels of CD1d, the restriction element for invariant natural killer T cells (iNKT). Here, we examined the effect of iNKT cells on MZB cell activation and numbers in vitro and in vivo in normal and autoimmune mice. Results show that iNKT cells activate MZBs, but restrict their numbers in vitro and in vivo in normal BALB/c and C57/BL6 mice. iNKT cells do so by increasing the activation-induced cell death and curtailing proliferation of MZB cells, whereas they promote the proliferation of follicular B cells. Sorted iNKT cells can directly execute this function, without help from other immune cells. Such MZB regulation by iNKTs is mediated, at least in part, via CD1d on B cells in a contact-dependent manner, whereas iNKT-induced proliferation of follicular B cells occurs in a contact-and CD1d-independent manner. Finally, we show that iNKT cells reduce 'autoreactive' MZB cells in an anti-DNA transgenic model, and limit MZB cell numbers in autoimmune-prone (NZBxNZW)F1 and non-obese diabetic mice, suggesting a potentially new mechanism whereby iNKT cells might regulate pathologic autoimmunity. Differential regulation of follicular B cells versus potentially autoreactive MZBs by iNKT cells has important implications for autoimmune diseases as well as for conditions that require a rapid innate B cell response.	[Wen, Xiangshu; Kim, Peter J.; Singh, Ram Raj] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Autoimmun & Tolerance Lab,Div Rheumatol, Los Angeles, CA 90095 USA; [Yang, Jun-Qi] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yang, Jun-Qi] Jiangsu Inst Parasit Dis, Wuxi, Jiangsu, Peoples R China; [Singh, Ram Raj] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Singh, Ram Raj] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Wen, XS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Autoimmun & Tolerance Lab,Div Rheumatol, Los Angeles, CA 90095 USA.	RRSingh@mednet.ucla.edu	Singh, Ram/AFQ-2369-2022		NIH [AR56465, AI80778]; Arthritis Foundation Southern California Chapter; American Heart Association; NIH-NCRR [CJX1-443835-WS-29646]; NSF [CHE-0722519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Southern California Chapter; American Heart Association(American Heart Association); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by NIH grants AR56465, and AI80778. XW is recipient of the Meyer Investigator Award from the Arthritis Foundation Southern California Chapter. PJK is recipient of American Heart Association Beginning-Grant-in-Aid. The CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, where confocal laser scanning microscopy was performed, is supported with funding from NIH-NCRR shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bialecki E, 2009, J IMMUNOL, V182, P6105, DOI 10.4049/jimmunol.0802273; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Campos-Martin Y, 2006, J IMMUNOL, V176, P6172, DOI 10.4049/jimmunol.176.10.6172; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chung Y, 2006, CANCER RES, V66, P6843, DOI 10.1158/0008-5472.CAN-06-0889; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Fan GC, 2002, J EXP MED, V196, P731, DOI 10.1084/jem.20020223; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; Galli G, 2003, VACCINE, V21, pS48, DOI 10.1016/S0264-410X(03)00200-7; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; Grimaldi CM, 2001, J IMMUNOL, V167, P1886, DOI 10.4049/jimmunol.167.4.1886; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 2000, CELL IMMUNOL, V199, P37, DOI 10.1006/cimm.1999.1602; Lang GA, 2006, IMMUNOLOGY, V119, P116, DOI 10.1111/j.1365-2567.2006.02413.x; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Marino E, 2008, DIABETES, V57, P395, DOI 10.2337/db07-0589; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Mizuno T, 2003, APOPTOSIS, V8, P451, DOI 10.1023/A:1025534223168; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Roark JH, 1998, J IMMUNOL, V160, P3121; Rolf J, 2005, J IMMUNOL, V174, P4821, DOI 10.4049/jimmunol.174.8.4821; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sindhava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011445; Singh N, 1999, J IMMUNOL, V163, P2373; Singh RR, 2002, J IMMUNOL, V169, P587, DOI 10.4049/jimmunol.169.1.587; Sireci G, 2007, EUR J IMMUNOL, V37, P425, DOI 10.1002/eji.200636695; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Wei B, 2005, P NATL ACAD SCI USA, V102, P2010, DOI 10.1073/pnas.0409449102; Wermeling F, 2010, J EXP MED, V207, P943, DOI 10.1084/jem.20091314; Wither JE, 2005, J IMMUNOL, V175, P4309, DOI 10.4049/jimmunol.175.7.4309; Wither JE, 2000, CLIN IMMUNOL, V94, P51, DOI 10.1006/clim.1999.4806; Wither J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2505; Yang JQ, 2003, J IMMUNOL, V171, P4439, DOI 10.4049/jimmunol.171.8.4439; Yang JQ, 2003, J IMMUNOL, V171, P2142, DOI 10.4049/jimmunol.171.4.2142; Yang JQ, 2007, ARTHRITIS RHEUM, V56, P1219, DOI 10.1002/art.22490; Yang JQ, 2011, J IMMUNOL, V186, P1512, DOI 10.4049/jimmunol.1002373	56	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26536	10.1371/journal.pone.0026536	http://dx.doi.org/10.1371/journal.pone.0026536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046304	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600029
J	Bakir-Gungor, B; Sezerman, OU				Bakir-Gungor, Burcu; Sezerman, Osman Ugur			A New Methodology to Associate SNPs with Human Diseases According to Their Pathway Related Context	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARTHRITIS SUSCEPTIBILITY LOCUS; ACTIVATED PROTEIN-KINASE; SCALE-FREE NETWORKS; RHEUMATOID-ARTHRITIS; GENE ONTOLOGY; TRANSCRIPTION FACTORS; CYTOSCAPE PLUGIN; RISK LOCUS; TNF-ALPHA	Genome-wide association studies (GWAS) with hundreds of zthousands of single nucleotide polymorphisms (SNPs) are popular strategies to reveal the genetic basis of human complex diseases. Despite many successes of GWAS, it is well recognized that new analytical approaches have to be integrated to achieve their full potential. Starting with a list of SNPs, found to be associated with disease in GWAS, here we propose a novel methodology to devise functionally important KEGG pathways through the identification of genes within these pathways, where these genes are obtained from SNP analysis. Our methodology is based on functionalization of important SNPs to identify effected genes and disease related pathways. We have tested our methodology on WTCCC Rheumatoid Arthritis (RA) dataset and identified: i) previously known RA related KEGG pathways (e. g., Toll-like receptor signaling, Jak-STAT signaling, Antigen processing, Leukocyte transendothelial migration and MAPK signaling pathways); ii) additional KEGG pathways (e. g., Pathways in cancer, Neurotrophin signaling, Chemokine signaling pathways) as associated with RA. Furthermore, these newly found pathways included genes which are targets of RA-specific drugs. Even though GWAS analysis identifies 14 out of 83 of those drug target genes; newly found functionally important KEGG pathways led to the discovery of 25 out of 83 genes, known to be used as drug targets for the treatment of RA. Among the previously known pathways, we identified additional genes associated with RA (e. g. Antigen processing and presentation, Tight junction). Importantly, within these pathways, the associations between some of these additionally found genes, such as HLA-C, HLA-G, PRKCQ, PRKCZ, TAP1, TAP2 and RA were verified by either OMIM database or by literature retrieved from the NCBI PubMed module. With the whole-genome sequencing on the horizon, we show that the full potential of GWAS can be achieved by integrating pathway and network-oriented analysis and prior knowledge from functional properties of a SNP.	[Bakir-Gungor, Burcu; Sezerman, Osman Ugur] Sabanci Univ, Fac Engn, Istanbul, Turkey; [Bakir-Gungor, Burcu] Bahcesehir Univ, Fac Engn, Dept Comp Engn, Dept Genet Bioinformat, Istanbul, Turkey	Sabanci University; Bahcesehir University	Bakir-Gungor, B (corresponding author), Sabanci Univ, Fac Engn, Istanbul, Turkey.	burcu.gungor@bahcesehir.edu.tr	SEZERMAN, OSMAN U/X-6441-2018; wang, edwin/G-5372-2010	Sezerman, Osman Ugur/0000-0003-0905-6783; Bakir-Gungor, Burcu/0000-0002-2272-6270	TUBITAK [109S218]; MRC [G1001799] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant #109S218 of TUBITAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Bali D, 1999, GENES IMMUN, V1, P28, DOI 10.1038/sj.gene.6363635; Bandyopadhyay Sourav, 2006, Pac Symp Biocomput, P354; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Karchin R, 2009, BRIEF BIOINFORM, V10, P35, DOI 10.1093/bib/bbn047; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martin JE, 2010, ARTHRITIS RHEUM-US, V62, P3183, DOI 10.1002/art.27648; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Saccone SF, 2010, NUCLEIC ACIDS RES, V38, pW201, DOI 10.1093/nar/gkq513; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shriner D, 2007, SCIENCE, V316, P1840; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Tu ZD, 2006, BIOINFORMATICS, V22, pE489, DOI 10.1093/bioinformatics/btl234; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; WANG K, 2007, AM J HUMAN GENETICS, V81; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang LC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-38; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037; Zinovyev A, 2008, BIOINFORMATICS, V24, P876, DOI 10.1093/bioinformatics/btm553	70	42	42	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26277	10.1371/journal.pone.0026277	http://dx.doi.org/10.1371/journal.pone.0026277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046267	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000013
J	Kanaya, N; Kubo, M; Liu, Z; Chu, PG; Wang, C; Yuan, YC; Chen, SA				Kanaya, Noriko; Kubo, Makoto; Liu, Zheng; Chu, Peiguo; Wang, Charles; Yuan, Yate-Ching; Chen, Shiuan			Protective Effects of White Button Mushroom (Agaricus bisporus) against Hepatic Steatosis in Ovariectomized Mice as a Model of Postmenopausal Women	PLOS ONE			English	Article							HYPERCHOLESTEROLEMIC RATS; PLEUROTUS-OSTREATUS; CHOLESTEROL; METABOLISM; EXPRESSION; ERGOSTEROL; MEDICINE; GENE; DIET	Nonalcoholic fatty liver disease (NAFLD) includes various hepatic pathologies ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Estrogen provides a protective effect on the development of NAFLD in women. Therefore, postmenopausal women have a higher risk of developing NAFLD. Hepatic steatosis is an early stage of fatty liver disease. Steatosis can develop to the aggressive stages (nonalcoholic steatohepatitis, fibrosis and cirrhosis). Currently, there is no specific drug to prevent/treat these liver diseases. In this study, we found that white button mushroom (WBM), Agaricus Bisporus, has protective effects against liver steatosis in ovariectomized (OVX) mice (a model of postmenopausal women). OVX mice were fed a high fat diet supplemented with WBM powder. We found that dietary WBM intake significantly lowered liver weight and hepatic injury markers in OVX mice. Pathological examination of liver tissue showed less fat accumulation in the livers of mice on WBM diet; moreover, these animals had improved glucose clearance ability. Microarray analysis revealed that genes related to the fatty acid biosynthesis pathway, particularly the genes for fatty acid synthetase (Fas) and fatty acid elongase 6 (Elovl6), were down-regulated in the liver of mushroom-fed mice. In vitro mechanistic studies using the HepG2 cell line showed that down-regulation of the expression of FAS and ELOVL6 by WBM extract was through inhibition of Liver X receptor (LXR) signaling and its downstream transcriptional factor SREBP1c. These results	[Kanaya, Noriko; Kubo, Makoto; Chen, Shiuan] Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA; [Liu, Zheng; Yuan, Yate-Ching] Beckman Res Inst City Hope, Div Bioinformat, Duarte, CA USA; [Chu, Peiguo] Res Inst City Hope, Dept Pathol, Duarte, CA USA; [Wang, Charles] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Kanaya, N (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA.	schen@coh.org		Liu, Zheng/0000-0002-1635-1556	National Institute of Health [ES08258]; US Mushroom Council; Australian Mushroom Growers Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008258] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Mushroom Council; Australian Mushroom Growers Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants obtained by SC from the National Institute of Health (ES08258) and from the US Mushroom Council and the Australian Mushroom Growers Association (SC). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Andersson T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008475; Bobek P, 1996, NAHRUNG, V40, P222, DOI 10.1002/food.19960400413; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Chen S, 2006, CANCER RES, V66, P12026, DOI 10.1158/0008-5472.CAN-06-2206; Cheng HH, 2002, J AGR FOOD CHEM, V50, P7438, DOI 10.1021/jf020648q; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fukushima M, 2001, EXP BIOL MED, V226, P758, DOI 10.1177/153537020222600808; Gibbons Geoffrey F., 1994, Current Opinion in Lipidology, V5, P191, DOI 10.1097/00041433-199405030-00006; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Grobe YG, 2010, ANN HEPATOL, V9, P402, DOI 10.1016/S1665-2681(19)31616-3; Hoegh-Andersen P, 2004, ARTHRITIS RES THER, V6, pR169, DOI 10.1186/ar1152; Hossain S, 2003, CLIN EXP PHARMACOL P, V30, P470, DOI 10.1046/j.1440-1681.2003.03857.x; Jeong SC, 2010, NUTR RES, V30, P49, DOI 10.1016/j.nutres.2009.12.003; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Kanaya N, 2010, NUTR RES, V30, P714, DOI 10.1016/j.nutres.2010.09.001; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Nagao K, 2010, J NUTR BIOCHEM, V21, P418, DOI 10.1016/j.jnutbio.2009.01.021; Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575; PALOMARES M, 2011, AM SOC CLIN ONC ASCO; Pasumarthy L, 2010, SOUTH MED J, V103, P547, DOI 10.1097/SMJ.0b013e3181de0ce0; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Sgarbi DBD, 1997, MYCOPATHOLOGIA, V139, P9, DOI 10.1023/A:1006803832164; Shao SQ, 2010, J AGR FOOD CHEM, V58, P11616, DOI 10.1021/jf102285b; Shimamura K, 2010, EUR J PHARMACOL, V630, P34, DOI 10.1016/j.ejphar.2009.12.033; Sullivan R, 2006, PERSPECT BIOL MED, V49, P159, DOI 10.1353/pbm.2006.0034; Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Xu J, 2008, STEM CELLS DEV, V17, P143, DOI 10.1089/scd.2007.0094	32	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26654	10.1371/journal.pone.0026654	http://dx.doi.org/10.1371/journal.pone.0026654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046322	gold, Green Submitted, Green Published			2022-12-27	WOS:000296517000024
J	de Diego, ACP; Athmaram, TN; Stewart, M; Rodriguez-Sanchez, B; Sanchez-Vizcaino, JM; Noad, R; Roy, P				Cristina Perez de Diego, Ana; Athmaram, Thimmasandra N.; Stewart, Meredith; Rodriguez-Sanchez, Belen; Manuel Sanchez-Vizcaino, Jose; Noad, Robert; Roy, Polly			Characterization of Protection Afforded by a Bivalent Virus-Like Particle Vaccine against Bluetongue Virus Serotypes 1 and 4 in Sheep	PLOS ONE			English	Article							MEDITERRANEAN BASIN; EXPRESSION; CHALLENGE; EFFICACY; ORBIVIRUS; EUROPE	Background: Bluetongue virus (BTV) is an economically important, arthropod borne, emerging pathogen in Europe, causing disease mainly in sheep and cattle. Routine vaccination for bluetongue would require the ability to distinguish between vaccinated and infected individuals (DIVA). Current vaccines are effective but are not DIVA. Virus-like particles (VLPs) are highly immunogenic structural mimics of virus particles, that only contain a subset of the proteins present in a natural infection. VLPs therefore offer the potential for the development of DIVA compatible bluetongue vaccines. Methodology/Principal Findings: Merino sheep were vaccinated with either monovalent BTV-1 VLPs or a bivalent mixture of BTV-1 VLPs and BTV-4 VLPs, and challenged with virulent BTV-1 or BTV-4. Animals were monitored for clinical signs, antibody responses, and viral RNA. 19/20 animals vaccinated with BTV-1 VLPs either alone or in combination with BTV-4 VLPs developed neutralizing antibodies to BTV-1, and group specific antibodies to BTV VP7. The one animal that showed no detectable neutralizing antibodies, or group specific antibodies, had detectable viral RNA following challenge but did not display any clinical signs on challenge with virulent BTV-1. In contrast, all control animals' demonstrated classical clinical signs for bluetongue on challenge with the same virus. Six animals were vaccinated with bivalent vaccine and challenged with virulent BTV-4, two of these animals had detectable viral levels of viral RNA, and one of these showed clinical signs consistent with BTV infection and died. Conclusions: There is good evidence that BTV-1 VLPs delivered as monovalent or bivalent immunogen protect from bluetongue disease on challenge with virulent BTV-1. However, it is possible that there is some interference in protective response for BTV-4 in the bivalent BTV-1 and BTV-4 VLP vaccine. This raises the question of whether all combinations of bivalent BTV vaccines are possible, or if immunodominance of particular serotypes could interfere with vaccine efficacy.	[Cristina Perez de Diego, Ana; Rodriguez-Sanchez, Belen; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Ctr Anim Hlth Surveillance, Madrid, Spain; [Athmaram, Thimmasandra N.; Stewart, Meredith; Noad, Robert; Roy, Polly] London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England	Complutense University of Madrid; University of London; London School of Hygiene & Tropical Medicine	de Diego, ACP (corresponding author), Univ Complutense Madrid, Ctr Anim Hlth Surveillance, Madrid, Spain.	polly.roy@lshtm.ac.uk	Sánchez-Vizcaíno, José Manuel/G-6299-2015; Rodríguez-Sánchez, Belén/AAF-4046-2021; Rodriguez-Sanchez, Belen/AAQ-8542-2021	Sánchez-Vizcaíno, José Manuel/0000-0002-1502-8968; Rodriguez-Sanchez, Belen/0000-0002-9625-427X; Noad, Rob/0000-0002-0279-8461; Roy, Polly/0000-0001-6535-6911; Stewart, Meredith/0000-0001-6275-2740	European Commission [FP6-2005-SSP-5A]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by funding from European Commission FP6 (FP6-2005-SSP-5A)(http://ec.europa.eu/research/fp6/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Erasmus BJ, 1990, VIRUS INFECT RUMINAN; Eschbaumer M, 2011, VACCINE, V29, P4299, DOI 10.1016/j.vaccine.2011.04.049; FRENCH TJ, 1990, J VIROL, V64, P5695, DOI 10.1128/JVI.64.12.5695-5700.1990; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; MacLachlan NJ, 2008, VET PATHOL, V45, P310, DOI 10.1354/vp.45-3-310; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; MARSHALL JJA, 1990, VIRUS RES, V15, P189, DOI 10.1016/0168-1702(90)90027-9; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Noad R, 2009, VACCINE, V27, pD86, DOI 10.1016/j.vaccine.2009.08.037; Noad RJ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-87; Oura CAL, 2009, VACCINE, V27, P7326, DOI 10.1016/j.vaccine.2009.09.070; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; Roy P, 2006, CURR TOP MICROBIOL, V309, P87; ROY P, 1994, VACCINE, V12, P805, DOI 10.1016/0264-410X(94)90289-5; Roy P, 2009, NAT REV MICROBIOL, V7, P120, DOI 10.1038/nrmicro2052; Roy P, 2009, ADV EXP MED BIOL, V655, P145, DOI 10.1007/978-1-4419-1132-2_11; Savini G, 2009, VET MICROBIOL, V133, P1, DOI 10.1016/j.vetmic.2008.05.032; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Stewart M, 2010, VACCINE, V28, P3047, DOI 10.1016/j.vaccine.2009.10.072; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2011, VET IMMUNOL IMMUNOP, V141, P230, DOI 10.1016/j.vetimm.2011.03.005; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; VANDERWALT NT, 1980, ONDERSTEPOORT J VET, V47, P113; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055	32	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26666	10.1371/journal.pone.0026666	http://dx.doi.org/10.1371/journal.pone.0026666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22046324	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000296513200038
J	Sanad, YM; Kassem, II; Abley, M; Gebreyes, W; LeJeune, JT; Rajashekara, G				Sanad, Yasser M.; Kassem, Issmat I.; Abley, Melanie; Gebreyes, Wondwossen; LeJeune, Jeffrey T.; Rajashekara, Gireesh			Genotypic and Phenotypic Properties of Cattle-Associated Campylobacter and Their Implications to Public Health in the USA	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; THERMOPHILIC CAMPYLOBACTERS; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; BROILER-CHICKENS; FEEDLOT CATTLE; JEJUNI 81-176; DAIRY-CATTLE; PREVALENCE	Since cattle are a major source of food and the cattle industry engages people from farms to processing plants and meat markets, it is conceivable that beef-products contaminated with Campylobacter spp. would pose a significant public health concern. To better understand the epidemiology of cattle-associated Campylobacter spp. in the USA, we characterized the prevalence, genotypic and phenotypic properties of these pathogens. Campylobacter were detected in 181 (19.2%) out of 944 fecal samples. Specifically, 71 C. jejuni, 132 C. coli, and 10 other Campylobacter spp. were identified. The prevalence of Campylobacter varied regionally and was significantly (P<0.05) higher in fecal samples collected from the South (32.8%) as compared to those from the North (14.8%), Midwest (15.83%), and East (12%). Pulsed Field Gel Electrophoresis (PFGE) analysis showed that C. jejuni and C. coli isolates were genotypically diverse and certain genotypes were shared across two or more of the geographic locations. In addition, 13 new C. jejuni and two C. coli sequence types (STs) were detected by Multi Locus Sequence Typing (MLST). C. jejuni associated with clinically human health important sequence type, ST-61 which was not previously reported in the USA, was identified in the present study. Most frequently observed clonal complexes (CC) were CC ST-21, CC ST-42, and CC ST-61, which are also common in humans. Further, the cattle associated C. jejuni strains showed varying invasion and intracellular survival capacity; however, C. coli strains showed a lower invasion and intracellular survival potential compared to C. jejuni strains. Furthermore, many cattle associated Campylobacter isolates showed resistance to several antimicrobials including ciprofloxacin, erythromycin, and gentamicin. Taken together, our results highlight the importance of cattle as a potential reservoir for clinically important Campylobacter.	[Sanad, Yasser M.; Kassem, Issmat I.; LeJeune, Jeffrey T.; Rajashekara, Gireesh] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Sanad, Yasser M.; Abley, Melanie; Gebreyes, Wondwossen; LeJeune, Jeffrey T.; Rajashekara, Gireesh] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sanad, YM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	rajashekara.2@osu.edu	Rajashekara, Gireesh/E-3913-2011; LeJeune, Jeffrey/B-3961-2012	KASSEM, ISSMAT/0000-0002-2978-9573; Sanad, Yasser/0000-0001-6008-5630	National Cattlemen Beef Association; Ohio Agricultural Research and Development Center; Ohio State University; Egyptian Ministry of Higher Education	National Cattlemen Beef Association; Ohio Agricultural Research and Development Center; Ohio State University(Ohio State University); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This research was supported by funds appropriated to GR from National Cattlemen Beef Association, and by the Ohio Agricultural Research and Development Center, The Ohio State University and a scholarship to YMS from the Egyptian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acik MN, 2006, VET MICROBIOL, V115, P370, DOI 10.1016/j.vetmic.2006.02.014; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Bae W, 2005, APPL ENVIRON MICROB, V71, P169, DOI 10.1128/AEM.71.1.169-174.2005; Besser TE, 2005, APPL ENVIRON MICROB, V71, P5752, DOI 10.1128/AEM.71.10.5752-5758.2005; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Clinical and Laboratory Standards Institute, 2006, M2A9 CLIN LAB STAND; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Denis M, 2008, POULTRY SCI, V87, P1662, DOI 10.3382/ps.2008-00010; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Englen MD, 2007, J APPL MICROBIOL, V102, P1570, DOI 10.1111/j.1365-2672.2006.03189.x; Englen MD, 2005, J APPL MICROBIOL, V99, P285, DOI 10.1111/j.1365-2672.2005.02609.x; Gharst G, 2006, J FOOD PROTECT, V69, P1024, DOI 10.4315/0362-028X-69.5.1024; Grove-White DH, 2010, EPIDEMIOL INFECT, V7, P1; Hoar BR, 2001, EPIDEMIOL INFECT, V127, P147, DOI 10.1017/S0950268801005726; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Inglis GD, 2006, APPL ENVIRON MICROB, V72, P4464, DOI 10.1128/AEM.02843-05; KONKEL ME, 1992, INFECT IMMUN, V60, P4945, DOI 10.1128/IAI.60.11.4945-4949.1992; Krause M, 2006, APPL ENVIRON MICROB, V72, P5463, DOI 10.1128/AEM.00291-06; Kwan PSL, 2008, APPL ENVIRON MICROB, V74, P3626, DOI 10.1128/AEM.01669-07; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Litrup E, 2007, J APPL MICROBIOL, V103, P210, DOI 10.1111/j.1365-2672.2006.03214.x; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Meinersmann RJ, 2002, INT J SYST EVOL MICR, V52, P1789, DOI [10.1099/ijs.0.02071-0, 10.1099/00207713-52-5-1789]; Miller WG, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P101; MILNES AS, 2007, EPIDEMIOL INFECT, P1; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Oporto B, 2006, ANN NY ACAD SCI, V1078, P498, DOI 10.1196/annals.1374.095; Patrick ME, 2004, APPL ENVIRON MICROB, V70, P7474, DOI 10.1128/AEM.70.12.7474-7480.2004; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V46, P303, DOI 10.1093/jac/46.2.303; Prasad KN, 1996, J DIARRHOEAL DIS RES, V14, P255; Ragimbeau C, 2008, APPL ENVIRON MICROB, V74, P7715, DOI 10.1128/AEM.00865-08; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Saenz Y, 2000, ANTIMICROB AGENTS CH, V44, P267, DOI 10.1128/AAC.44.2.267-271.2000; SATO K, 2004, APPL ENVIRON MICROB, P1442; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Stanley KN, 1998, J APPL MICROBIOL, V84, P1111; Thakur S, 2005, J FOOD PROTECT, V68, P2402, DOI 10.4315/0362-028X-68.11.2402; Vandeplas S, 2008, BIOTECHNOL AGRON SOC, V12, P317; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0	48	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25778	10.1371/journal.pone.0025778	http://dx.doi.org/10.1371/journal.pone.0025778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22046247	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500020
J	Smith, IM; Hoshi, N				Smith, Ida M.; Hoshi, Naoto			ATP Competitive Protein Kinase C Inhibitors Demonstrate Distinct State-Dependent Inhibition	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PHOSPHORYLATION; BINDING; SUPPRESSION; SUBSTRATE; REPORTER; CHANNELS; PEPTIDE; COMPLEX	We previously reported that some ATP competitive protein kinase C (PKC) inhibitors are either competitive or uncompetitive inhibitors with respect to substrate peptides. In this report, we demonstrate how the interactions between PKC and inhibitors change PKC activation kinetics. A substrate competitive inhibitor, bisindolylmaleimide I, targets activated PKC and stabilizes PKC in the activated conformation. This leads to transient activation and prolonged deactivation of PKC in the presence of bisindolylmaleimide I. In contrast, an uncompetitive substrate inhibitor, bisindolylmaleimide IV, targets quiescent PKC and stabilizes PKC in the quiescent conformation, which generates slower activation and suppressed translocation upon activation of PKC.	[Smith, Ida M.; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Smith, IM (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	nhoshi@uci.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS067288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (grant NS067288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; LEONARD TA, CELL, V144, P55; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; Zhu GZ, 2005, J BIOL CHEM, V280, P36372, DOI 10.1074/jbc.M505031200; Zimmermann B, 2008, BIOCHEM J, V413, P93, DOI 10.1042/BJ20071665	29	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26338	10.1371/journal.pone.0026338	http://dx.doi.org/10.1371/journal.pone.0026338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043317	Green Published, gold			2022-12-27	WOS:000295984400049
J	Zhang, W; Tian, QB; Li, QK; Wang, JM; Wang, CN; Liu, T; Liu, DW; Wang, MW				Zhang, Wei; Tian, Qing-Bao; Li, Qing-Kai; Wang, Jian-Min; Wang, Chao-Nan; Liu, Tian; Liu, Dian-Wu; Wang, Ming-Wei			Lysine 92 Amino Acid Residue of USP46, a Gene Associated with 'Behavioral Despair' in Mice, Influences the Deubiquitinating Enzyme Activity	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASES; DISEASE; ONCOGENE; PATHWAY; DOMAIN; MOUSE	Deubiquitinating enzymes (DUBs) regulate diverse cellular functions by their activity of cleaving ubiquitin from specific protein substrates. Ubiquitin-Specific Protease 46 (USP46) has recently been identified as a quantitative trait gene responsible for immobility in the tail suspension test and forced swimming test in mice. Mice with a lysine codon (Lys 92) deletion in USP46 exhibited loss of 'behavioral despair' under inescapable stresses in addition to abnormalities in circadian behavioral rhythms and the GABAergic system. However, whether this deletion affects enzyme activity is unknown. Here we show that USP46 has deubiquitinating enzyme activity detected by USP cleavage assay using GST-Ub52 as a model substrate. Interestingly, compared to wild type, the Lys 92 deletion mutant resulted in a decreased deubiquitinating enzyme activity of 27.04%. We also determined the relative expression levels of Usp46 in rat tissues using real-time RT-PCR. Usp46 mRNA was expressed in various tissues examined including brain, with the highest expression in spleen. In addition, like rat USP46, both human and mouse USP46 are active toward to the model substrate, indicating the USP cleavage assay is a simple method for testing the deubiquitinating enzyme activity of USP46. These results suggest that the Lys 92 deletion of USP46 could influence enzyme activity and thereby provide a molecular clue how the enzyme regulating the pathogenesis of mental illnesses.	[Zhang, Wei; Tian, Qing-Bao; Li, Qing-Kai; Wang, Jian-Min; Wang, Chao-Nan; Liu, Tian; Liu, Dian-Wu] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Peoples R China; [Wang, Ming-Wei] Hebei Med Univ, Hosp 1, Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, W (corresponding author), Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Peoples R China.	tianqingbao1980@yahoo.com.cn	Wang, Chao/GXF-8353-2022; wang, jian/GVS-0711-2022	Liu, Dian-Wu/0000-0003-2087-6299; Zhang, Wei/0000-0001-7284-530X; Liu, Dian-wu/0000-0001-8037-4448	National Natural Science Foundation of China [30840035, 30970915]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30840035 and 30970915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Kilroy GE, 2009, OBESITY, V17, P665, DOI 10.1038/oby.2008.616; Kushima I, 2010, J HUM GENET, V55, P133, DOI 10.1038/jhg.2009.139; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; ONNO M, 1993, DNA CELL BIOL, V12, P107, DOI 10.1089/dna.1993.12.107; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Shanmugham A, 2008, CURR OPIN DRUG DISC, V11, P688; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Takayama Y, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-18; Tian QB, 2003, J NEUROCHEM, V87, P665, DOI 10.1046/j.1471-4159.2003.02024.x; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200	23	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26297	10.1371/journal.pone.0026297	http://dx.doi.org/10.1371/journal.pone.0026297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043315	gold, Green Submitted, Green Published			2022-12-27	WOS:000295984400044
J	Truong, HHM; Kellogg, TA; McFarland, W; Louie, B; Klausner, JD; Philip, SS; Grant, RM				Truong, Hong-Ha M.; Kellogg, Timothy A.; McFarland, Willi; Louie, Brian; Klausner, Jeffrey D.; Philip, Susan S.; Grant, Robert M.			Sentinel Surveillance of HIV-1 Transmitted Drug Resistance, Acute Infection and Recent Infection	PLOS ONE			English	Article							SEXUAL TRANSMISSION	Background: HIV-1 acute infection, recent infection and transmitted drug resistance screening was integrated into voluntary HIV counseling and testing (VCT) services to enhance the existing surveillance program in San Francisco. This study describes newly-diagnosed HIV cases and characterizes correlates associated with infection. Methodology/Principal Findings: A consecutive sample of persons presenting for HIV VCT at the municipal sexually transmitted infections (STI) clinic from 2004 to 2006 (N = 9,868) were evaluated by standard enzyme-linked immunoassays (EIA). HIV antibody-positive specimens were characterized as recent infections using a less-sensitive EIA. HIV-RNA pooled testing was performed on HIV antibody-negative specimens to identify acute infections. HIV antibody-positive and acute infection specimens were evaluated for drug resistance by sequence analysis. Multivariable logistic regression was performed to evaluate associations. The 380 newly-diagnosed HIV cases included 29 acute infections, 128 recent infections, and 47 drug-resistant cases, with no significant increases or decreases in prevalence over the three years studied. HIV-1 transmitted drug resistance prevalence was 11.0% in 2004, 13.4% in 2005 and 14.9% in 2006 (p = 0.36). Resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI) was the most common pattern detected, present in 28 cases of resistance (59.6%). Among MSM, recent infection was associated with amphetamine use (AOR = 2.67; p<0.001), unprotected anal intercourse (AOR = 2.27; p<0.001), sex with a known HIV-infected partner (AOR = 1.64; p = 0.02), and history of gonorrhea (AOR = 1.62; p = 0.03). Conclusions: New HIV diagnoses, recent infections, acute infections and transmitted drug resistance prevalence remained stable between 2004 and 2006. Resistance to NNRTI comprised more than half of the drug-resistant cases, a worrisome finding given its role as the backbone of first-line antiretroviral therapy in San Francisco as well as worldwide. The integration of HIV-1 drug resistance, recent infection, and acute infection testing should be considered for existing HIV/STI surveillance and prevention activities, particularly in an era of enhanced efforts for early diagnosis and treatment.	[Truong, Hong-Ha M.; Grant, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Truong, Hong-Ha M.; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Kellogg, Timothy A.; McFarland, Willi; Louie, Brian; Klausner, Jeffrey D.; Philip, Susan S.] Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Truong, HHM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Hong-Ha.Truong@ucsf.edu		Grant, Robert/0000-0002-0851-7085	San Francisco Department of Public Health; Gladstone Institute of Virology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	San Francisco Department of Public Health; Gladstone Institute of Virology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support for the HIV infection and drug resistance surveillance program was provided by the San Francisco Department of Public Health and the Gladstone Institute of Virology and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; *CDCP, 2010, MMWR-MORBID MORTAL W, V58, P1296; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rapatski BL, 2005, JAIDS-J ACQ IMM DEF, V38, P241; Temkin E, 2011, SEX TRANSM DIS, V38, P374, DOI 10.1097/OLQ.0b013e31820279bd; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; *UNAIDS WHO, 2 GEN SURV HIV; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; HIV 1 DRUG RESISTANC	20	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25281	10.1371/journal.pone.0025281	http://dx.doi.org/10.1371/journal.pone.0025281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	22046237	Green Submitted, Green Published, gold			2022-12-27	WOS:000295968700009
J	Satyanarayana, A; Balakrishna, N; Pitla, S; Reddy, PY; Mudili, S; Lopamudra, P; Suryanarayana, P; Viswanath, K; Ayyagari, R; Reddy, GB				Satyanarayana, Alleboena; Balakrishna, Nagalla; Pitla, Sujatha; Reddy, Paduru Yadagiri; Mudili, Sivaprasad; Lopamudra, Pratti; Suryanarayana, Palla; Viswanath, Kalluru; Ayyagari, Radha; Reddy, Geereddy Bhanuprakash			Status of B-Vitamins and Homocysteine in Diabetic Retinopathy: Association with Vitamin-B12 Deficiency and Hyperhomocysteinemia	PLOS ONE			English	Article							FOLIC-ACID; RISK-FACTOR; PREVALENCE; MELLITUS; COMPLICATIONS; POPULATION; RESISTANCE; INDIA; EYE	Diabetic retinopathy (DR) is a common cause of blindness. Although many studies have indicated an association between homocysteine and DR, the results so far have been equivocal. Amongst the many determinants of homocysteine, B-vitamin status was shown to be a major confounding factor, yet very little is known about its relationship to DR. In the present study, we, therefore, investigated the status of B-vitamins and homocysteine in DR. A cross-sectional case-control study was conducted with 100 normal control (CN) subjects and 300 subjects with type-2 diabetes (T2D). Of the 300 subjects with T2D, 200 had retinopathy (DR) and 100 did not (DNR). After a complete ophthalmic examination including fundus fluorescein angiography, the clinical profile and the blood levels of all B-vitamins and homocysteine were analyzed. While mean plasma homocysteine levels were found to be higher in T2D patients compared with CN subjects, homocysteine levels were particularly high in the DR group. There were no group differences in the blood levels of vitamins B1 and B2. Although the plasma vitamin-B6 and folic acid levels were significantly lower in the DNR and DR groups compared with the CN group, there were no significant differences between the diabetes groups. Interestingly, plasma vitamin-B12 levels were found to be significantly lower in the diabetes groups compared with the CN group; further, the levels were significantly lower in the DR group compared with the DNR group. Higher homocysteine levels were significantly associated with lower vitamin-B12 and folic acid but not with other B-vitamins. Additionally, hyperhomocysteinemia and vitamin-B12 deficiency did not seem to be related to subjects' age, body mass index, or duration of diabetes. These results thus suggest a possible association between vitamin-B12 deficiency and hyperhomocysteinemia in DR. Further, the data indicate that vitamin-B12 deficiency could be an independent risk factor for DR.	[Satyanarayana, Alleboena; Balakrishna, Nagalla; Pitla, Sujatha; Reddy, Paduru Yadagiri; Mudili, Sivaprasad; Lopamudra, Pratti; Suryanarayana, Palla; Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Viswanath, Kalluru] Pushpagiri Vitreo Retina Inst, Hyderabad, Andhra Pradesh, India; [Ayyagari, Radha] Univ Calif San Diego, San Diego, CA 92103 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of California System; University of California San Diego	Satyanarayana, A (corresponding author), Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India.	geereddy@yahoo.com	Reddy, G Bhanuprakash/AAJ-3494-2020; ALLEBOINA, SATYANARAYANA/ABB-5983-2021; Nagalla, Balakrishna/GRR-4393-2022	Reddy, G Bhanuprakash/0000-0003-4787-3944; ALLEBOINA, SATYANARAYANA/0000-0002-0171-1440; Nagalla, Balakrishna/0000-0002-5613-0942	Department of Science and Technology, Government of India [SR/SO/HS/0055/2008]; Indian Council of Medical Research, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	GBR received grants from the Department of Science and Technology (SR/SO/HS/0055/2008), Government of India; AS received a research fellowship from the Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; BOTTICHER B, 1987, INT J VITAM NUTR RES, V57, P273; Brazionis L, 2008, DIABETES CARE, V31, P50, DOI 10.2337/dc07-0632; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chiu CJ, 2007, AM J CLIN NUTR, V86, P180, DOI 10.1093/ajcn/86.1.180; Coral K, 2009, INVEST OPHTH VIS SCI, V50, P3607, DOI 10.1167/iovs.08-2667; Dandona L, 1999, BRIT J OPHTHALMOL, V83, P937, DOI 10.1136/bjo.83.8.937; FAILLA ML, 1981, J NUTR, V111, P1900, DOI 10.1093/jn/111.11.1900; Fu YP, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/861291; Goldstein M, 2004, EYE, V18, P460, DOI 10.1038/sj.eye.6700702; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hoogeveen EK, 2000, ARCH INTERN MED, V160, P2984, DOI 10.1001/archinte.160.19.2984; International Diabetes Federation, 2009, DIAB ATL; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kowluru RA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1266, DOI 10.1001/archopht.126.9.1266; Lee CTC, 2010, OPHTHALMOLOGY, V117, P71, DOI 10.1016/j.ophtha.2009.06.040; Looker HC, 2003, DIABETOLOGIA, V46, P766, DOI 10.1007/s00125-003-1104-x; Martini LA, 2010, NUTR REV, V68, P341, DOI 10.1111/j.1753-4887.2010.00296.x; Mayer-Davis EJ, 1998, OPHTHALMOLOGY, V105, P2264, DOI 10.1016/S0161-6420(98)91227-1; Misra A, 2002, EUR J NUTR, V41, P68, DOI 10.1007/s003940200010; MOORADIAN AD, 1987, AM J CLIN NUTR, V45, P877, DOI 10.1093/ajcn/45.5.877; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Neugebauer S, 1997, LANCET, V349, P473, DOI 10.1016/S0140-6736(05)61185-3; Ng DPK, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/172593; Nirmalan PK, 2004, ARCH OPHTHALMOL-CHIC, V122, P581, DOI 10.1001/archopht.122.4.581; Pitla S, 2009, ANN NUTR METAB, V54, P1, DOI 10.1159/000199452; Reddy GB, 2008, MOL VIS, V14, P593; Rema M, 1996, DIABETES RES CLIN PR, V34, P29, DOI 10.1016/S0168-8227(96)01327-7; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Rema M, 2002, DIABETIC MED, V19, P910, DOI 10.1046/j.1464-5491.2002.00820.x; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stanger O, 2003, CLIN CHEM LAB MED, V41, P1392, DOI 10.1515/CCLM.2003.214; Thornalley PJ, 2007, DIABETOLOGIA, V50, P2164, DOI 10.1007/s00125-007-0771-4; Thornalley PJ, 2005, CURR DIABETES REV, V1, P287, DOI 10.2174/157339905774574383; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Vermeulen EGJ, 2000, LANCET, V355, P517, DOI 10.1016/S0140-6736(99)07391-2; Viswanath K, 2003, Community Eye Health, V16, P21; Wijekoon EP, 2007, BIOCHEM SOC T, V35; Wright AD, 2008, EYE, V22, P989, DOI 10.1038/sj.eye.6703061; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik C S, 2006, J Assoc Physicians India, V54, P775; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	49	67	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26747	10.1371/journal.pone.0026747	http://dx.doi.org/10.1371/journal.pone.0026747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069468	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900030
J	Fink, M; Thompson, JS; Thoma, F				Fink, Michel; Thompson, Jeffrey S.; Thoma, Fritz			Contributions of Histone H3 Nucleosome Core Surface Mutations to Chromatin Structures, Silencing and DNA Repair	PLOS ONE			English	Article							NUCLEASE-SENSITIVE REGIONS; SACCHAROMYCES-CEREVISIAE; YEAST CHROMATIN; AMINO-TERMINUS; UV LESIONS; METHYLATION; RESOLUTION; COMPACTION; TELOMERES; PROTEIN	Histone H3 mutations in residues that cluster in a discrete region on the nucleosome surface around lysine 79 of H3 affect H3-K79 methylation, impair transcriptional silencing in subtelomeric chromatin, and reveal distinct contributions of histone H3 to various DNA-damage response and repair pathways. These residues might act by recruitment of silencing and DNA-damage response factors. Alternatively, their location on the nucleosome surface suggests a possible involvement in nucleosome positioning, stability and nucleosome interactions. Here, we show that the yeast H3 mutants hht2-T80A, hht2-K79E, hht2-L70S, and hht2-E73D show normal nucleosome positioning and stability in minichromosomes. However, loss of silencing in a subtelomeric URA3 gene correlates with a shift of the promoter nucleosome, while nucleosome positions and stability in the coding region are maintained. Moreover, the H3 mutants show normal repair of UV lesions by photolyase and nucleotide excision repair in minichromosomes and slightly enhanced repair in the subtelomeric region. Thus, these results support a role of those residues in the recruitment of silencing proteins and argue against a general role in nucleosome organization.	[Fink, Michel; Thoma, Fritz] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Thompson, Jeffrey S.] Denison Univ, Dept Biol, Granville, OH 43023 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Denison University	Fink, M (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	fritz.thoma@cell.biol.ethz.ch	Thompson, Jeff/HGB-3965-2022	Thompson, Jeff/0000-0002-9281-2596	Swiss National Science Foundation [3100AO-102152, 100AO-122033]; ETH Zurich [TH41/02-3]; National Institutes of Health [1R15GM093849-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM093849] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Swiss National Science Foundation (www.snf.ch) (grants 3100AO-102152, 100AO-122033 to FT); ETH Zurich (www.ethz.ch) (Research Grant TH41/02-3 to FT); and the National Institutes of Health (1R15GM093849-01 to JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfinsen C.B., 1971, ENZYMES, V4; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bassett A, 2009, CURR OPIN GENET DEV, V19, P159, DOI 10.1016/j.gde.2009.02.010; BERNARDI F, 1992, EMBO J, V11, P1177, DOI 10.1002/j.1460-2075.1992.tb05158.x; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Buchberger JR, 2008, MOL CELL BIOL, V28, P6903, DOI 10.1128/MCB.01210-08; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Chaudhuri S, 2009, NUCL ACIDS RES; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Conde F, 2008, GENETICS, V179, P1197, DOI 10.1534/genetics.108.089003; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Evans ML, 2008, CURR GENET, V53, P259, DOI 10.1007/s00294-008-0182-1; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fink M, 2007, MOL CELL BIOL, V27, P3589, DOI 10.1128/MCB.02077-06; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fry CJ, 2006, MOL CELL BIOL, V26, P9045, DOI 10.1128/MCB.00248-06; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li G, 2011, CURR OPIN GENET DEV; Livingstone-Zatchej M, 2003, J BIOL CHEM, V278, P37471, DOI 10.1074/jbc.M306335200; Livingstone-Zatchej M, 1999, METH MOL B, V119, P245; Livingstone-Zatchej M, 1999, METH MOL B, V119, P363; LOSA R, 1990, NUCLEIC ACIDS RES, V18, P3495, DOI 10.1093/nar/18.12.3495; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Norris A, 2010, GENE DEV, V24, P115, DOI 10.1101/gad.1865510; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; RATTNER JB, 1982, J CELL BIOL, V93, P217, DOI 10.1083/jcb.93.1.217; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; Sancar GB, 2000, MUTAT RES-FUND MOL M, V451, P25, DOI 10.1016/S0027-5107(00)00038-5; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Suter B, 1999, METHOD ENZYMOL, V304, P447; Tanaka S, 1996, J MOL BIOL, V257, P919, DOI 10.1006/jmbi.1996.0212; THOMA F, 1985, NATURE, V315, P250, DOI 10.1038/315250a0; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; THOMA F, 1986, J MOL BIOL, V190, P177, DOI 10.1016/0022-2836(86)90291-3; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; THOMA F, 1988, CELL, V55, P945, DOI 10.1016/0092-8674(88)90240-1; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; THOMAS JO, 1976, FEBS LETT, V66, P274, DOI 10.1016/0014-5793(76)80521-2; Thompson JS, 2003, GENETICS, V163, P447; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Welsem T, 2008, MOL CELL BIOL, V28, P3861, DOI 10.1128/MCB.02050-07; Wu L, 1997, NUCLEIC ACIDS RES, V25, P4230, DOI 10.1093/nar/25.21.4230; Yu Q, 2011, GENETICS; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	68	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26210	10.1371/journal.pone.0026210	http://dx.doi.org/10.1371/journal.pone.0026210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053185	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800011
J	Karbowski, J				Karbowski, Jan			7 Scaling of Brain Metabolism and Blood Flow in Relation to Capillary and Neural Scaling	PLOS ONE			English	Article							OXIDATIVE-METABOLISM; GLUCOSE-METABOLISM; CEREBRAL-CORTEX; VISUAL-CORTEX; STIMULATION; HYPOTHESIS; MAMMALS; LAWS; MICROCIRCULATION; CONNECTIVITY	Brain is one of the most energy demanding organs in mammals, and its total metabolic rate scales with brain volume raised to a power of around 5/6. This value is significantly higher than the more common exponent 3/4 relating whole body resting metabolism with body mass and several other physiological variables in animals and plants. This article investigates the reasons for brain allometric distinction on a level of its microvessels. Based on collected empirical data it is found that regional cerebral blood flow CBF across gray matter scales with cortical volume V as CBF similar to V-1/6, brain capillary diameter increases as V-1/12, and density of capillary length decreases as V-1/6. It is predicted that velocity of capillary blood is almost invariant (similar to V-e), capillary transit time scales as V-1/6, capillary length increases as V1/6+e, and capillary number as V2/3-e, where E is typically a small correction for medium and large brains, due to blood viscosity dependence on capillary radius. It is shown that the amount of capillary length and blood flow per cortical neuron are essentially conserved across mammals. These results indicate that geometry and dynamics of global neuro-vascular coupling have a proportionate character. Moreover, cerebral metabolic, hemodynamic, and microvascular variables scale with allometric exponents that are simple multiples of 1/6, rather than 1/4, which suggests that brain metabolism is more similar to the metabolism of aerobic than resting body. Relation of these findings to brain functional imaging studies involving the link between cerebral metabolism and blood flow is also discussed.	Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Karbowski, J (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland.	jkarbowski@duch.mimuw.edu.pl		Karbowski, Jan/0000-0001-5560-4723	Polish Ministry of Science and Education [NN 518 409238]; Marie Curie Actions EU [FP7-PEOPLE-2007-IRG-210538]	Polish Ministry of Science and Education(Ministry of Science and Higher Education, Poland); Marie Curie Actions EU	The work was supported by the grant from the Polish Ministry of Science and Education (NN 518 409238), and by the Marie Curie Actions EU grant FP7-PEOPLE-2007-IRG-210538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; AMIN TM, 1985, Q J EXP PHYSIOL CMS, V70, P37, DOI 10.1113/expphysiol.1985.sp002895; Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Bar TH, 1980, ADV ANAT EMBRYOL CEL, V59, P71, DOI DOI 10.1007/978-3-642-67432-7; Bentourkia M, 2000, J NEUROL SCI, V181, P19, DOI 10.1016/S0022-510X(00)00396-8; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; BOROWSKY IW, 1989, J COMP NEUROL, V288, P401, DOI 10.1002/cne.902880304; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Calder WA., 1984, SIZE FUNCTION LIFE H; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dawson TH, 2003, P ROY SOC B-BIOL SCI, V270, P755, DOI 10.1098/rspb.2002.2304; Dawson TH, 2008, VASCULAR HEMODYNAMIC; Delp MD, 2001, J PHYSIOL-LONDON, V533, P849, DOI 10.1111/j.1469-7793.2001.t01-1-00849.x; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2000, SCALING BIOL, P113; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Frietsch T, 2000, ANESTHESIOLOGY, V92, P754, DOI 10.1097/00000542-200003000-00019; Frietsch T, 2007, J CEREBR BLOOD F MET, V27, P469, DOI 10.1038/sj.jcbfm.9600360; Gregg DE, 1937, AM J PHYSIOL, V118, P399, DOI 10.1152/ajplegacy.1937.118.2.399; Hakeem AY, 2005, ANAT REC PART A, V287A, P1117, DOI 10.1002/ar.a.20255; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; Ito H, 2003, J CEREBR BLOOD F MET, V23, P665, DOI 10.1097/01.WCB.0000067721.64998.F5; Karbowski J, 2003, J COMPUT NEUROSCI, V15, P347, DOI 10.1023/A:1027467911225; Karbowski J, 2001, PHYS REV LETT, V86, P3674, DOI 10.1103/PhysRevLett.86.3674; Karbowski J, 2009, J COMPUT NEUROSCI, V27, P415, DOI 10.1007/s10827-009-0153-7; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; KAYAR SR, 1994, J EXP BIOL, V194, P69; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Krogh A, 1929, ANATOMY PHYSL CAPILL; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; LENIGERFOLLERT E, 1976, PFLUG ARCH EUR J PHY, V366, P39, DOI 10.1007/BF02486558; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Li JKJ, 2000, SFI S SCI C, P113; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luciano MG, 2001, J CEREBR BLOOD F MET, V21, P285, DOI 10.1097/00004647-200103000-00012; Mayhew TM, 1996, J ANAT, V189, P177; MEIERRUGE W, 1980, MECH AGEING DEV, V14, P233, DOI 10.1016/0047-6374(80)90123-2; Michaloudi H, 2006, BRAIN RES, V1103, P1, DOI 10.1016/j.brainres.2006.05.069; Mitchison G, 1992, P ROY SOC LOND B BIO, V245, P151; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; NILSSON L, 1975, Acta Anaesthesiologica Scandinavica Supplementum, V57, P18; Noda A, 2002, BRAIN RES, V936, P76, DOI 10.1016/S0006-8993(02)02558-1; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; ORLANDI C, 1990, STROKE, V21, P1059, DOI 10.1161/01.STR.21.7.1059; PAWLIK G, 1981, BRAIN RES, V208, P35, DOI 10.1016/0006-8993(81)90619-3; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; ROLAND PE, 1987, J NEUROSCI, V7, P2373; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Schlageter KE, 1999, MICROVASC RES, V58, P312, DOI 10.1006/mvre.1999.2188; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEITZ RJ, 1992, ACTA NEUROL SCAND, V86, P60, DOI 10.1111/j.1600-0404.1992.tb08055.x; SMITH AL, 1972, ANESTHESIOLOGY, V36, P378, DOI 10.1097/00000542-197204000-00015; Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040; Sugihara-Seki M, 2005, FLUID DYN RES, V37, P82, DOI 10.1016/j.fluiddyn.2004.03.006; Tieman SB, 2004, BRAIN RES, V998, P100, DOI 10.1016/j.brainres.2003.11.023; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; TUOR UI, 1991, PEDIATR RES, V29, P517, DOI 10.1203/00006450-199105010-00020; Unekawa M, 2010, BRAIN RES, V1320, P69, DOI 10.1016/j.brainres.2010.01.032; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2000, SFI S SCI C, P87; Woodbury RA, 1937, AM J PHYSIOL, V119, P663, DOI 10.1152/ajplegacy.1937.119.4.663	82	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26709	10.1371/journal.pone.0026709	http://dx.doi.org/10.1371/journal.pone.0026709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053202	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800028
J	Lauritano, C; Borra, M; Carotenuto, Y; Biffali, E; Miralto, A; Procaccini, G; Ianora, A				Lauritano, Chiara; Borra, Marco; Carotenuto, Ylenia; Biffali, Elio; Miralto, Antonio; Procaccini, Gabriele; Ianora, Adrianna			Molecular Evidence of the Toxic Effects of Diatom Diets on Gene Expression Patterns in Copepods	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; APOPTOSIS-REGULATORY PROTEIN-1; CALANUS-FINMARCHICUS CRUSTACEA; FRESH-WATER DIATOMS; TIGRIOPUS-JAPONICUS; CYTOCHROME-P450 ENZYMES; BIOACTIVE ALDEHYDES; LIPID-PEROXIDATION; HATCHING SUCCESS; MARINE DIATOMS	Background: Diatoms are dominant photosynthetic organisms in the world's oceans and are considered essential in the transfer of energy through marine food chains. However, these unicellular plants at times produce secondary metabolites such as polyunsaturated aldehydes and other products deriving from the oxidation of fatty acids that are collectively termed oxylipins. These cytotoxic compounds are responsible for growth inhibition and teratogenic activity, potentially sabotaging future generations of grazers by inducing poor recruitment in marine organisms such as crustacean copepods. Principal Findings: Here we show that two days of feeding on a strong oxylipin-producing diatom (Skeletonema marinoi) is sufficient to inhibit a series of genes involved in aldehyde detoxification, apoptosis, cytoskeleton structure and stress response in the copepod Calanus helgolandicus. Of the 18 transcripts analyzed by RT-qPCR at least 50% were strongly down-regulated (aldehyde dehydrogenase 9, 8 and 6, cellular apoptosis susceptibility and inhibitor of apoptosis IAP proteins, heat shock protein 40, alpha-and beta-tubulins) compared to animals fed on a weak oxylipin-producing diet (Chaetoceros socialis) which showed no changes in gene expression profiles. Conclusions: Our results provide molecular evidence of the toxic effects of strong oxylipin-producing diatoms on grazers, showing that primary defense systems that should be activated to protect copepods against toxic algae can be inhibited. On the other hand other classical detoxification genes (glutathione S-transferase, superoxide dismutase, catalase, cytochrome P450) were not affected possibly due to short exposure times. Given the importance of diatom blooms in nutrient-rich aquatic environments these results offer a plausible explanation for the inefficient use of a potentially valuable food resource, the spring diatom bloom, by some copepod species.	[Lauritano, Chiara; Borra, Marco; Carotenuto, Ylenia; Biffali, Elio; Miralto, Antonio; Procaccini, Gabriele; Ianora, Adrianna] Stn Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Lauritano, C (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	chiara.lauritano@szn.it	Procaccini, Gabriele/A-6618-2010; Carotenuto, Ylenia/ABG-4872-2021; Carotenuto, Ylenia/B-5708-2013; Procaccini, Gabriele/AAA-7040-2019; Borra, Marco/M-9467-2014; Ianora, Adrianna/O-3408-2019; Lauritano, Chiara/Q-4166-2018	Procaccini, Gabriele/0000-0002-6179-468X; Carotenuto, Ylenia/0000-0002-7188-9279; Carotenuto, Ylenia/0000-0002-7188-9279; Procaccini, Gabriele/0000-0002-6179-468X; Lauritano, Chiara/0000-0003-4580-9594; Borra, Marco/0000-0002-6267-2545	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	The work was financed by Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Ann IW, 2004, NATURE REV; Bierkens JGEA, 2000, TOXICOLOGY, V153, P61, DOI 10.1016/S0300-483X(00)00304-8; Bigot A, 2010, ECOTOXICOLOGY, V19, P369, DOI 10.1007/s10646-009-0419-x; Bouraoui Z, 2009, ECOTOX ENVIRON SAFE, V72, P1893, DOI 10.1016/j.ecoenv.2009.05.011; Brinkmann U, 1998, AM J HUM GENET, V62, P509, DOI 10.1086/301773; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Buttino I, 2011, AQUACULTURE IN PRESS; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; CANUTO RA, 1994, CARCINOGENESIS, V15, P1359, DOI 10.1093/carcin/15.7.1359; Carotenuto Y, 2005, LIMNOL OCEANOGR, V50, P449, DOI 10.4319/lo.2005.50.2.0449; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Einsporn S, 2009, ENVIRON TOXICOL CHEM, V28, P402, DOI 10.1897/08-174.1; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fink P, 2006, ARCH HYDROBIOL, V167, P561, DOI 10.1127/0003-9136/2006/0167-0561; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Gerecht A, 2011, J PHYCOLOGY IN PRESS; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Green BT, 2010, NEUROTOXICOL TERATOL, V32, P383, DOI 10.1016/j.ntt.2010.01.011; Guenther J, 2009, MAR ECOL PROG SER, V385, P137, DOI 10.3354/meps08034; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Hansen BH, 2008, AQUAT TOXICOL, V86, P157, DOI 10.1016/j.aquatox.2007.10.009; Hansen BH, 2007, COMP BIOCHEM PHYS D, V2, P250, DOI 10.1016/j.cbd.2007.04.006; Hansen BH, 2010, AQUAT TOXICOL, V99, P212, DOI 10.1016/j.aquatox.2010.04.018; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hasselberg L, 2004, AQUAT TOXICOL, V67, P303, DOI 10.1016/j.aquatox.2003.12.007; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Ianora A, 2004, MAR ECOL PROG SER, V280, P199, DOI 10.3354/meps280199; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Kim BM, 2011, CHEMOSPHERE, V84, P1467, DOI 10.1016/j.chemosphere.2011.04.043; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Koski M, 2007, MAR BIOL, V151, P1785, DOI 10.1007/s00227-007-0615-2; Lauritano C, 2011, MARINE ENV IN PRESS; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Lederman M, 2008, CURR EYE RES, V33, P876, DOI 10.1080/02713680802382989; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lee YM, 2006, MAR ENVIRON RES, V62, pS219, DOI 10.1016/j.marenvres.2006.04.050; Majumdar APN, 2007, AM J PHYSIOL-GASTR L, V293, pG1215, DOI 10.1152/ajpgi.00324.2007; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Olsvik PA, 2009, CHEMOSPHERE, V75, P360, DOI 10.1016/j.chemosphere.2008.12.039; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Rhee JS, 2009, COMP BIOCHEM PHYS C, V149, P104, DOI 10.1016/j.cbpc.2008.07.009; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Romano G, 2011, PLOS ONE IN PRESS; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Salazar-Medina AJ, 2010, J BIOCHEM MOL TOXIC, V24, P218, DOI 10.1002/jbt.20326; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Simon CA, 2010, AQUACULTURE, V310, P52, DOI 10.1016/j.aquaculture.2010.10.031; Snyder MJ, 2000, AQUAT TOXICOL, V48, P529, DOI 10.1016/S0166-445X(00)00085-0; Tai CJ, 2010, EXP CELL RES, V316, P2969, DOI 10.1016/j.yexcr.2010.07.019; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Wan Q, 2011, COMP BIOCHEM PHYS C, V153, P259, DOI 10.1016/j.cbpc.2010.11.009; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	65	44	44	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26850	10.1371/journal.pone.0026850	http://dx.doi.org/10.1371/journal.pone.0026850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046381	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800050
J	Salcedo, E; Tran, T; Ly, X; Lopez, R; Barbica, C; Restrepo, D; Vijayaraghavan, S				Salcedo, Ernesto; Tuan Tran; Ly, Xuan; Lopez, Robert; Barbica, Cortney; Restrepo, Diego; Vijayaraghavan, Sukumar			Activity-Dependent Changes in Cholinergic Innervation of the Mouse Olfactory Bulb	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE; ALZHEIMERS-DISEASE; GLOMERULAR LAYER; RETINAL WAVES; RAT; MAIN; NEURONS; ACETYLCHOLINESTERASE; EXPRESSION; MARKERS	The interplay between olfactory activity and cholinergic modulation remains to be fully understood. This report examines the pattern of cholinergic innervation throughout the murine main olfactory bulb across different developmental stages and in naris-occluded animals. To visualize the pattern of cholinergic innervation, we used a transgenic mouse model, which expresses a fusion of the microtubule-associated protein, tau, with green fluorescence protein (GFP) under the control of the choline acetyltransferase (ChAT) promoter. This tau-GFP fusion product allows for a remarkably vivid and clear visualization of cholinergic innervation in the main olfactory bulb (MOB). Interestingly, we find an uneven distribution of GFP label in the adult glomerular layer (GL), where anterior, medial, and lateral glomerular regions of the bulb receive relatively heavier cholinergic innervation than other regions. In contrast to previous reports, we find a marked change in the pattern of cholinergic innervation to the GL following unilateral naris occlusion between the ipsilateral and contralateral bulbs in adult animals.	[Salcedo, Ernesto; Tuan Tran; Ly, Xuan; Lopez, Robert; Barbica, Cortney; Restrepo, Diego] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA; [Vijayaraghavan, Sukumar] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO USA; [Restrepo, Diego; Vijayaraghavan, Sukumar] Univ Colorado, Sch Med, Neurosci Program, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Salcedo, E (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA.	sukumar.v@ucdenver.edu			National Institutes of Health [RO1DC008855, P30 DC04657]; Colorado Clinical Translational Sciences Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008855, P30DC004657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical Translational Sciences Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work presented in this manuscript was funded by National Institutes of Health grants RO1DC008855 (to SV) and P30 DC04657 (to DR and Thomas E. Finger), and from the Colorado Clinical Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Bansal A, 2000, J NEUROSCI, V20, P7672; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Cherry JA, 1999, J COMP NEUROL, V407, P287; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; COPPOLA DM, 1994, PHYSIOL BEHAV, V56, P729, DOI 10.1016/0031-9384(94)90234-8; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Crespo C, 1999, J COMP NEUROL, V403, P53, DOI 10.1002/(SICI)1096-9861(19990105)403:1<53::AID-CNE5>3.0.CO;2-O; Durand M, 1998, INT J DEV NEUROSCI, V16, P777, DOI 10.1016/S0736-5748(98)00087-2; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Gomez C, 2007, J NEUROCHEM, V100, P924, DOI 10.1111/j.1471-4159.2006.04229.x; Gomez C, 2006, NEUROSCIENCE, V141, P2117, DOI 10.1016/j.neuroscience.2006.05.046; Gomez C, 2005, J CHEM NEUROANAT, V29, P238, DOI 10.1016/j.jchemneu.2005.01.005; Grybko MJ, 2011, EUR J NEUROSCI, V33, P1786, DOI 10.1111/j.1460-9568.2011.07671.x; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hellier JL, 2010, BRAIN RES, V1358, P140, DOI 10.1016/j.brainres.2010.08.027; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KASA P, 1986, PROG NEUROBIOL, V26, P211, DOI 10.1016/0301-0082(86)90016-X; LeJeune H, 1996, J COMP NEUROL, V373, P433, DOI 10.1002/(SICI)1096-9861(19960923)373:3<433::AID-CNE8>3.0.CO;2-3; LEJEUNE H, 1991, J COMP NEUROL, V314, P383, DOI 10.1002/cne.903140212; MACRIDES F, 1981, J COMP NEUROL, V203, P495, DOI 10.1002/cne.902030311; Mandairon N, 2006, EUR J NEUROSCI, V24, P3234, DOI 10.1111/j.1460-9568.2006.05212.x; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; Porteros A, 2007, J COMP NEUROL, V501, P854, DOI 10.1002/cne.21280; RAVEL N, 1994, BEHAV NEUROSCI, V108, P317, DOI 10.1037/0735-7044.108.2.317; ROYET JP, 1989, J COMP NEUROL, V289, P594, DOI 10.1002/cne.902890406; Rushforth SL, 2010, NEUROSCI LETT, V471, P114, DOI 10.1016/j.neulet.2010.01.022; Salcedo E, 2005, CHEM SENSES, V30, P615, DOI 10.1093/chemse/bji055; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; Smith RS, 2010, J NEUROPHYSIOL, V104, P2963, DOI 10.1152/jn.00446.2010; STONE DM, 1990, MOL BRAIN RES, V8, P291, DOI 10.1016/0169-328X(90)90042-C; WEISER M, 1994, SYNAPSE, V16, P81, DOI 10.1002/syn.890160202; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; ZABORSZKY L, 1986, J COMP NEUROL, V250, P282; Zhang M, 2005, J COMP NEUROL, V484, P331, DOI 10.1002/cne.20470; ZHENG LM, 1987, NEUROSCIENCE, V23, P1083, DOI 10.1016/0306-4522(87)90183-7	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e25441	10.1371/journal.pone.0025441	http://dx.doi.org/10.1371/journal.pone.0025441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053179	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800005
J	Bigand, E; Delbe, C; Gerard, Y; Tillmann, B				Bigand, Emmanuel; Delbe, Charles; Gerard, Yannick; Tillmann, Barbara			Categorization of Extremely Brief Auditory Stimuli: Domain-Specific or Domain-General Processes?	PLOS ONE			English	Article							HUMAN VOICE; HUMAN BRAIN; DISCRIMINATION; FAMILIARITY; RECORDINGS; SPEECH; SOUNDS; CORTEX	The present study investigated the minimum amount of auditory stimulation that allows differentiation of spoken voices, instrumental music, and environmental sounds. Three new findings were reported. 1) All stimuli were categorized above chance level with 50 ms-segments. 2) When a peak-level normalization was applied, music and voices started to be accurately categorized with 20 ms-segments. When the root-mean-square (RMS) energy of the stimuli was equalized, voice stimuli were better recognized than music and environmental sounds. 3) Further psychoacoustical analyses suggest that the categorization of extremely brief auditory stimuli depends on the variability of their spectral envelope in the used set. These last two findings challenge the interpretation of the voice superiority effect reported in previously published studies and propose a more parsimonious interpretation in terms of an emerging property of auditory categorization processes.	[Bigand, Emmanuel; Delbe, Charles; Gerard, Yannick] Univ Bourgogne, Ctr Natl Rech Sci, UMR5022, Lab Etud Apprentissage & Dev, Dijon, France; [Delbe, Charles; Tillmann, Barbara] Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team,UMR5292,U1028, Lyon, France; [Delbe, Charles; Tillmann, Barbara] Univ Lyon, Lyon, France; [Delbe, Charles; Tillmann, Barbara] Univ Lyon, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bigand, E (corresponding author), Univ Bourgogne, Ctr Natl Rech Sci, UMR5022, Lab Etud Apprentissage & Dev, Dijon, France.	emmanuel.bigand@u-bourgogne.fr			French Agence Nationale de la Recherce (ANR) [ANR-09-BLAN-O310-01]	French Agence Nationale de la Recherce (ANR)(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherce (ANR) Grant ANR-09-BLAN-O310-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus TR, 2010, IEEE INT SYMP CIRC S, P509, DOI 10.1109/ISCAS.2010.5537589; BALLAS JA, 1993, J EXP PSYCHOL HUMAN, V19, P250, DOI 10.1037/0096-1523.19.2.250; Beauchemin M, 2006, EUR J NEUROSCI, V23, P3081, DOI 10.1111/j.1460-9568.2006.04856.x; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Bigand E, 2009, ANN NY ACAD SCI, V1169, P234, DOI 10.1111/j.1749-6632.2009.04552.x; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Charest I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-127; Delbe C, 2006, 28 ANN C COGN SOC VA; Delbe C, 2008, ANN PSYCHOL, V108, P589; Demonet JF, 2001, J CLIN EXP NEUROPSYC, V23, P49, DOI 10.1076/jcen.23.1.49.1218; EIMAS PD, 1994, J EXP CHILD PSYCHOL, V58, P418, DOI 10.1006/jecp.1994.1043; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Filipic S, 2010, PSYCHON B REV, V17, P335, DOI 10.3758/PBR.17.3.335; Fodor J, MODULARITY MIND ESSA; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Krumhansl CL, 2010, MUSIC PERCEPT, V27, P337, DOI 10.1525/mp.2010.27.5.337; Lattner S, 2003, HUM BRAIN MAPP, V20, P13, DOI 10.1002/hbm.10118; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Macmillan NA, 2005, DETECTION THEORY USE; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Patterson R.D., 1986, FREQUENCY SELECTIVIT, P123; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 1989, CONTEMP MUSIC REV, V4, P227; QUINN PC, 1993, PERCEPTION, V22, P463, DOI 10.1068/p220463; Rapoport E., 1997, Music, Gestalt, and Computing. Studies in Cognitive and Systematic Musicology, P451, DOI 10.1007/BFb0034133; Schellenberg EG, 1999, PSYCHON B REV, V6, P641, DOI 10.3758/BF03212973; Schweinberger SR, 2001, NEUROPSYCHOLOGIA, V39, P921, DOI 10.1016/S0028-3932(01)00023-9; Tiitinen H, 1999, COGNITIVE BRAIN RES, V8, P355, DOI 10.1016/S0926-6410(99)00028-2; Titova N, 2001, NEUROSCI LETT, V308, P63, DOI 10.1016/S0304-3940(01)01970-X; von Kriegstein K, 2007, CURR BIOL, V17, P1123, DOI 10.1016/j.cub.2007.05.061; Wambacq IJA, 2004, NEUROREPORT, V15, P555, DOI 10.1097/00001756-200403010-00034; Zaske R, 2009, EAR BEHOLDER NEURAL, P30	36	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e27024	10.1371/journal.pone.0027024	http://dx.doi.org/10.1371/journal.pone.0027024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046436	Green Published, gold			2022-12-27	WOS:000296521400056
J	Blagrove, M; Fouquet, NC; Henley-Einion, JA; Pace-Schott, EF; Davies, AC; Neuschaffer, JL; Turnbull, OH				Blagrove, Mark; Fouquet, Nathalie C.; Henley-Einion, Josephine A.; Pace-Schott, Edward F.; Davies, Anna C.; Neuschaffer, Jennifer L.; Turnbull, Oliver H.			Assessing the Dream-Lag Effect for REM and NREM Stage 2 Dreams	PLOS ONE			English	Article							MEMORY CONSOLIDATION; SLEEP; EVENTS; REPLICATION; MENTATION; STATES	This study investigates evidence, from dream reports, for memory consolidation during sleep. It is well-known that events and memories from waking life can be incorporated into dreams. These incorporations can be a literal replication of what occurred in waking life, or, more often, they can be partial or indirect. Two types of temporal relationship have been found to characterize the time of occurrence of a daytime event and the reappearance or incorporation of its features in a dream. These temporal relationships are referred to as the day-residue or immediate incorporation effect, where there is the reappearance of features from events occurring on the immediately preceding day, and the dream-lag effect, where there is the reappearance of features from events occurring 5-7 days prior to the dream. Previous work on the dream-lag effect has used spontaneous home recalled dream reports, which can be from Rapid Eye Movement Sleep (REM) and from non-Rapid Eye Movement Sleep (NREM). This study addresses whether the dream-lag effect occurs only for REM sleep dreams, or for both REM and NREM stage 2 (N2) dreams. 20 participants kept a daily diary for over a week before sleeping in the sleep laboratory for 2 nights. REM and N2 dreams collected in the laboratory were transcribed and each participant rated the level of correspondence between every dream report and every diary record. The dream-lag effect was found for REM but not N2 dreams. Further analysis indicated that this result was not due to N2 dream reports being shorter, in terms of number of words, than the REM dream reports. These results provide evidence for a 7-day sleep-dependent non-linear memory consolidation process that is specific to REM sleep, and accord with proposals for the importance of REM sleep to emotional memory consolidation.	[Blagrove, Mark; Fouquet, Nathalie C.; Henley-Einion, Josephine A.; Davies, Anna C.; Neuschaffer, Jennifer L.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Pace-Schott, Edward F.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Pace-Schott, Edward F.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Turnbull, Oliver H.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Swansea University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Amherst; Bangor University	Blagrove, M (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	m.t.blagrove@swansea.ac.uk	Henley, Josie/AFM-0306-2022; Henley, Josie/AAH-2642-2022	Henley, Josie/0000-0002-2709-900X; Henley, Josie/0000-0002-2709-900X; Blagrove, Mark/0000-0002-9854-1854	Wales Institute of Cognitive Neuroscience [WBS066]	Wales Institute of Cognitive Neuroscience	This study was funded by the Wales Institute of Cognitive Neuroscience, grant WBS066 (http://www.wicn.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTROBUS J, 1983, PSYCHOPHYSIOLOGY, V20, P562, DOI 10.1111/j.1469-8986.1983.tb03015.x; Blagrove M, 2011, CONSCIOUS COGN, V20, P384, DOI 10.1016/j.concog.2010.07.006; DEMENT WC, 1965, J NERV MENT DIS, V140, P119, DOI 10.1097/00005053-196502000-00002; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; FOULKES D, 1983, SLEEP, V6, P265, DOI 10.1093/sleep/6.3.265; Iber C., 2007, AASM MANUAL SCORING; Kookoolis A, 2010, DREAMING, V20, P211, DOI 10.1037/a0020640; Kramer M., 2007, DREAM EXPERIENCE SYS; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; Nielsen T. A., 1988, SLEEP RES, V17, P112; Nielsen T.A., 1992, DREAMING, V2, P67, DOI [10.1037/h0094348, DOI 10.1037/H0094348]; NIELSEN TA, 1989, PSYCHIAT J U OTTAWA, V14, P561; Nielsen TA, 2004, J SLEEP RES, V13, P327, DOI 10.1111/j.1365-2869.2004.00421.x; Nielsen TA, 2005, NATURE, V437, P1286, DOI 10.1038/nature04288; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Nikles CD, 1998, J PERS SOC PSYCHOL, V75, P242, DOI 10.1037/0022-3514.75.1.242; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Payne JD, 2010, INT REV NEUROBIOL, V92, P101, DOI 10.1016/S0074-7742(10)92006-0; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; POWELL RA, 1995, PERCEPT MOTOR SKILL, V81, P95, DOI 10.2466/pms.1995.81.1.95; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Saredi R, 1997, DREAMING, V7, P195, DOI 10.1037/h0094474; Schredl M., 2008, INT J DREAM RES, V1, P3, DOI DOI 10.11588/IJ0DR.2008.1.19; Schwartz S, 2003, TRENDS COGN SCI, V7, P325, DOI 10.1016/S1364-6613(03)00162-1; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Smith C, 2010, SLEEP MED CLIN, V5, P217, DOI 10.1016/j.jsmc.2010.01.002; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Stickgold R, 2001, SLEEP, V24, P171, DOI 10.1093/sleep/24.2.171; Stickgold Robert, 2003, SLEEP BRAIN PLASTICI, P17; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wamsley EJ, 2011, SLEEP MED CLIN, V6, P97, DOI 10.1016/j.jsmc.2010.12.008; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wamsley EJ, 2010, SLEEP, V33, P59, DOI 10.1093/sleep/33.1.59; WOOD PB, 1979, DIMENSIONS DREAMS	43	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26708	10.1371/journal.pone.0026708	http://dx.doi.org/10.1371/journal.pone.0026708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046336	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000296519600046
J	Hennig, H; Fleischmann, R; Fredebohm, A; Hagmayer, Y; Nagler, J; Witt, A; Theis, FJ; Geisel, T				Hennig, Holger; Fleischmann, Ragnar; Fredebohm, Anneke; Hagmayer, York; Nagler, Jan; Witt, Annette; Theis, Fabian J.; Geisel, Theo			The Nature and Perception of Fluctuations in Human Musical Rhythms	PLOS ONE			English	Article							RANGE TEMPORAL CORRELATIONS; 1/F NOISE; CARDIAC DYNAMICS; TIME-SERIES; HUMAN BRAIN; HUMAN GAIT; SYSTEMS; EXPONENTS; INTERVAL; COMPLEX	Although human musical performances represent one of the most valuable achievements of mankind, the best musicians perform imperfectly. Musical rhythms are not entirely accurate and thus inevitably deviate from the ideal beat pattern. Nevertheless, computer generated perfect beat patterns are frequently devalued by listeners due to a perceived lack of human touch. Professional audio editing software therefore offers a humanizing feature which artificially generates rhythmic fluctuations. However, the built-in humanizing units are essentially random number generators producing only simple uncorrelated fluctuations. Here, for the first time, we establish long-range fluctuations as an inevitable natural companion of both simple and complex human rhythmic performances. Moreover, we demonstrate that listeners strongly prefer long-range correlated fluctuations in musical rhythms. Thus, the favorable fluctuation type for humanizing interbeat intervals coincides with the one generically inherent in human musical performances.	[Hennig, Holger; Fleischmann, Ragnar; Nagler, Jan; Witt, Annette; Theis, Fabian J.; Geisel, Theo] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Hennig, Holger; Nagler, Jan; Geisel, Theo] Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany; [Hennig, Holger] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Fredebohm, Anneke] Univ Gottingen, Inst Psychol, Gottingen, Germany; [Hagmayer, York] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Witt, Annette; Theis, Fabian J.; Geisel, Theo] BCCN, Gottingen, Germany; [Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany	Max Planck Society; University of Gottingen; Harvard University; University of Gottingen; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hennig, H (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	holgerh@nld.ds.mpg.de	Fleischmann, Ragnar/H-4441-2013; Theis, Fabian J/ABD-5212-2021	Fleischmann, Ragnar/0000-0001-6843-8146; Theis, Fabian J/0000-0002-2419-1943	BMBF, Germany, through the Bernstein Center for Computational Neuroscience [01GQ0430]	BMBF, Germany, through the Bernstein Center for Computational Neuroscience(Federal Ministry of Education & Research (BMBF))	The authors acknowledge financial support by the BMBF, Germany, through the Bernstein Center for Computational Neuroscience, grant no. 01GQ0430 (AW and TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900; Bello JP, 2005, IEEE T SPEECH AUDI P, V13, P1035, DOI 10.1109/TSA.2005.851998; Beran J., 1994, STAT LONG MEMORY PRO; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Buchanan JJ, 1997, HUM MOVEMENT SCI, V16, P1, DOI 10.1016/S0167-9457(96)00040-1; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; GEISEL T, 1987, PHYS REV LETT, V59, P2503, DOI 10.1103/PhysRevLett.59.2503; GEISEL T, 1985, PHYS REV LETT, V54, P616, DOI 10.1103/PhysRevLett.54.616; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; HENNIG H, 2010, Patent No. 7777123; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Jennings HD, 2004, PHYSICA A, V336, P585, DOI 10.1016/j.physa.2003.12.049; Jensen H.J., 1998, SELF ORG CRITICALITY; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; KOGAN S, 2008, ELECT NOISE UCTUATIO; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Lowen SB, 1996, J ACOUST SOC AM, V99, P3585, DOI 10.1121/1.414979; Mantegna R. N., 2000, INTRO ECONOPHYSICS; MEMMESHEIMER RM, 2009, HDB BIOL NETWORKS WO; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PROCACCIA I, 1983, PHYS REV A, V28, P1210, DOI 10.1103/PhysRevA.28.1210; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Roberts S, 2000, PHYS REV E, V62, P2597, DOI 10.1103/PhysRevE.62.2597; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; SHLESINGER MF, 1987, ANN NY ACAD SCI, V504, P214, DOI 10.1111/j.1749-6632.1987.tb48734.x; Smith J.O., 2007, MATH DISCRETE FOURIE; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0	40	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26457	10.1371/journal.pone.0026457	http://dx.doi.org/10.1371/journal.pone.0026457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046289	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600019
J	Laeyendecker, O; Latimore, A; Eshleman, SH; Summerton, J; Oliver, AE; Gamiel, J; Dobbs, T; Mei, J; Murphy, G; Parry, JV; Owen, SM; Quinn, TC				Laeyendecker, Oliver; Latimore, Amanda; Eshleman, Susan H.; Summerton, Jean; Oliver, Amy E.; Gamiel, Jordyn; Dobbs, Trudy; Mei, Joanne; Murphy, Gary; Parry, John V.; Owen, S. Michele; Quinn, Thomas C.			The Effect of Sample Handling on Cross Sectional HIV Incidence Testing Results	PLOS ONE			English	Article							PERFORMANCE-CHARACTERISTICS; ENZYME-IMMUNOASSAY; INFECTION	Objective(s): To determine if mishandling prior to testing would make a sample from a chronically infected subject appear recently infected when tested by cross-sectional HIV incidence assays. Methods: Serum samples from 31 subjects with chronic HIV infection were tested. Samples were subjected to different handling conditions, including incubation at 4 degrees C, 25 degrees C and 37 degrees C, for 1, 3, 7 or 15 days prior to testing. Samples were also subjected to 1,3, 7 and 15 freeze-thaw cycles prior to testing. Samples were tested using the BED capture enzyme immuno assay (BED-CEIA), Vironostika-less sensitive (V-LS), and an avidity assay using the Genetic Systems HIV-1/HIV-2 plus O EIA (avidity assay). Results: Compared to the sample that was not subjected to any mishandling conditions, for the BED-CEIA, V-LS and avidity assay, there was no significant change in test results for samples incubated at 4 degrees C or 25 degrees C prior to testing. No impact on test results occurred after 15 freeze-thaw cycles. A decrease in assay results was observed when samples were held for 3 days or longer at 37 degrees C prior to testing. Conclusions: Samples can be subjected up to 15 freeze-thaw cycles without affecting the results the BED-CEIA, Vironostika-LS, or avidity assays. Storing samples at 4 degrees C or 25 degrees C for up to fifteen days prior to testing had no impact on test results. However, storing samples at 37 degrees C for three or more days did affect results obtained with these assays.	[Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA; [Laeyendecker, Oliver; Summerton, Jean; Oliver, Amy E.; Gamiel, Jordyn; Quinn, Thomas C.] Johns Hopkins Univ Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Latimore, Amanda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Eshleman, Susan H.] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA; [Dobbs, Trudy] Ctr Dis Control & Prevent, Global AIDS Program, Int Lab Branch, Atlanta, GA USA; [Mei, Joanne] Ctr Dis Control & Prevent, Newborn Screening Qual Assurance Program, Atlanta, GA USA; [Murphy, Gary; Parry, John V.] Hlth Protect Agcy, Microbiol Serv, London, England; [Owen, S. Michele] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Health Protection Agency; Centers for Disease Control & Prevention - USA	Laeyendecker, O (corresponding author), NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA.	olaeyen1@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760	U.S. National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [R01-DA11602]; Department of Health and Human Services (DHHS) [N01-AI-35173]; Family Health International [contract N01-AI-45200]; Fred Hutchinson Cancer Research Center; Makerere University [NOI-AI-35173-417]; NIAID; National Institutes of Child Health and Human Development (NICH/HD); National Institute on Drug Abuse; National Institute of Mental Health; Office of AIDS Research, of the NIH, DHHS [1UM1AI068613]; Division of Intramural Research, NIAID, NIH; HIV Network for Prevention Trials (HIVNET); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, N01AI045200, N01AI035173, UM1AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services (DHHS); Family Health International; Fred Hutchinson Cancer Research Center; Makerere University; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development (NICH/HD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Network for Prevention Trials (HIVNET); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), through contract N01-AI-35173 with Family Health International, contract N01-AI-45200 with Fred Hutchinson Cancer Research Center, and subcontracts with Makerere University (NOI-AI-35173-417), (2) the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS (1UM1AI068613). Additional support was provided in part by the Division of Intramural Research, NIAID, NIH. Samples and data from Baltimore were supplied by Jeanne Keruly and Dr. Richard Moore, supported by NIH grant R01-DA11602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; FIPPS DR, 1988, J VIROL METHODS, V20, P127, DOI 10.1016/0166-0934(88)90146-2; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; LAEYENDECKER O, 2009, DECREASING HIV INCID; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; MASCIOTRA TDS, 2010, EIA 17 C RETR OPP IN; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Murphy G, 2008, EURO SURVEILL, V13; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759	12	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e25899	10.1371/journal.pone.0025899	http://dx.doi.org/10.1371/journal.pone.0025899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046249	gold, Green Submitted, Green Published			2022-12-27	WOS:000296519600007
J	Royds, JA; Al Nadaf, S; Wiles, AK; Chen, YJ; Ahn, A; Shaw, A; Bowie, S; Lam, F; Baguley, BC; Braithwaite, AW; MacFarlane, MR; Hung, NA; Slatter, TL				Royds, Janice A.; Al Nadaf, Shafagh; Wiles, Anna K.; Chen, Yu-Jen; Ahn, Antonio; Shaw, Alisha; Bowie, Sara; Lam, Frederic; Baguley, Bruce C.; Braithwaite, Antony W.; MacFarlane, Martin R.; Hung, Noelyn A.; Slatter, Tania L.			The CDKN2A G500 Allele Is More Frequent in GBM Patients with No Defined Telomere Maintenance Mechanism Tumors and Is Associated with Poorer Survival	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; GLIOBLASTOMA-MULTIFORME; FAMILIAL MELANOMA; WIDE ASSOCIATION; IDH1 MUTATIONS; GRADE GLIOMAS; CANCER; SUSCEPTIBILITY; ASTROCYTOMAS; LOCI	Prognostic markers for glioblastoma multiforme (GBM) are important for patient management. Recent advances have identified prognostic markers for GBMs that use telomerase or the alternative lengthening of telomeres (ALT) mechanism for telomere maintenance. Approximately 40% of GBMs have no defined telomere maintenance mechanism (NDTMM), with a mixed survival for affected individuals. This study examined genetic variants in the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene that encodes the p16(INK4a) and p14(ARF) tumor suppressors, and the isocitrate dehydrogenase 1 (IDH1) gene as potential markers of survival for 40 individuals with NDTMM GBMs (telomerase negative and ALT negative by standard assays), 50 individuals with telomerase, and 17 individuals with ALT positive tumors. The analysis of CDKN2A showed NDTMM GBMs had an increased minor allele frequency for the C500G (rs11515) polymorphism compared to those with telomerase and ALT positive GBMs (p = 0.002). Patients with the G500 allele had reduced survival that was independent of age, extent of surgery, and treatment. In the NDTMM group G500 allele carriers had increased loss of CDKN2A gene dosage compared to C500 homozygotes. An analysis of IDH1 mutations showed the R132H mutation was associated with ALT positive tumors, and was largely absent in NDTMM and telomerase positive tumors. In the ALT positive tumors cohort, IDH1 mutations were associated with a younger age for the affected individual. In conclusion, the G500 CDKN2A allele was associated with NDTMM GBMs from older individuals with poorer survival. Mutations in IDH1 were not associated with NDTMM GBMs, and instead were a marker for ALT positive tumors in younger individuals.	[Royds, Janice A.; Al Nadaf, Shafagh; Chen, Yu-Jen; Ahn, Antonio; Shaw, Alisha; Bowie, Sara; Braithwaite, Antony W.; Hung, Noelyn A.; Slatter, Tania L.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Wiles, Anna K.] Univ Otago, Dept Med, Dunedin Sch Med, Dunedin, New Zealand; [Lam, Frederic] Zenith Technol, Dunedin, New Zealand; [Baguley, Bruce C.] Univ Auckland, Auckland Canc Soc Res Ctr, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Braithwaite, Antony W.] Univ Sydney, Childrens Res Inst, Westmead, NSW 2145, Australia; [MacFarlane, Martin R.] Christchurch Hosp, Christchurch, New Zealand	University of Otago; University of Otago; University of Auckland; University of Sydney; Christchurch Hospital New Zealand	Royds, JA (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	tania.slatter@otago.ac.nz		Waters, Shafagh/0000-0003-1144-5411	The Cancer Society of New Zealand; Dunedin School of Medicine, University of Otago	The Cancer Society of New Zealand; Dunedin School of Medicine, University of Otago	The Cancer Society of New Zealand, and the Dunedin School of Medicine, University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; AMARY MF, 2011, J PATHOLOGY; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Brousset P, 1997, BLOOD, V89, P26, DOI 10.1182/blood.V89.1.26.26_26_31; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; BURGER PC, 1987, CANCER, V59, P1617, DOI 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X; Chang SM, 2005, JAMA-J AM MED ASSOC, V293, P557, DOI 10.1001/jama.293.5.557; Chen YJ, 2006, CANCER RES, V66, P6473, DOI 10.1158/0008-5472.CAN-06-0910; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Fargnoli MC, 1998, J INVEST DERMATOL, V111, P1202, DOI 10.1046/j.1523-1747.1998.00412.x; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; GOMI A, 1995, JPN J CANCER RES, V86, P342, DOI 10.1111/j.1349-7006.1995.tb03062.x; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Henson JD, 2005, CLIN CANCER RES, V11, P217; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kreimer-Erlacher H, 2003, J INVEST DERMATOL, V120, P676, DOI 10.1046/j.1523-1747.2003.12085.x; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; LINSKENS MHK, 1995, SCIENCE, V267, P17, DOI 10.1126/science.7848496; MacKie RM, 1998, J INVEST DERMATOL, V111, P269, DOI 10.1046/j.1523-1747.1998.00267.x; McCloud JM, 2004, INT J ONCOL, V25, P1447; McDonald KL, 2010, J NEUROPATH EXP NEUR, V69, P729, DOI 10.1097/NEN.0b013e3181e576cf; Newcomb EW, 2000, HUM PATHOL, V31, P115, DOI 10.1016/S0046-8177(00)80207-5; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sakano S, 2003, INT J CANCER, V104, P98, DOI 10.1002/ijc.10919; Sauroja I, 2000, GENE CHROMOSOME CANC, V28, P404, DOI 10.1002/1098-2264(200008)28:4<404::AID-GCC6>3.0.CO;2-P; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Slatter T, 2010, AM J PATHOL, V177, P2694, DOI 10.2353/ajpath.2010.100468; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tabori U, 2006, NEOPLASIA, V8, P136, DOI 10.1593/neo.05715; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zuchner S, 2008, ANN HUM GENET, V72, P725, DOI 10.1111/j.1469-1809.2008.00474.x	51	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26737	10.1371/journal.pone.0026737	http://dx.doi.org/10.1371/journal.pone.0026737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046342	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600051
J	Westmark, CJ; Westmark, PR; O'Riordan, KJ; Ray, BC; Hervey, CM; Salamat, MS; Abozeid, SH; Stein, KM; Stodola, LA; Tranfaglia, M; Burger, C; Berry-Kravis, EM; Malter, JS				Westmark, Cara J.; Westmark, Pamela R.; O'Riordan, Kenneth J.; Ray, Brian C.; Hervey, Crystal M.; Salamat, M. Shahriar; Abozeid, Sara H.; Stein, Kelsey M.; Stodola, Levi A.; Tranfaglia, Michael; Burger, Corinna; Berry-Kravis, Elizabeth M.; Malter, James S.			Reversal of Fragile X Phenotypes by Manipulation of A beta PP/A beta Levels in Fmr1(KO) Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MENTAL-RETARDATION PROTEIN; MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; MESSENGER-RNA; DOWN-SYNDROME; SYNAPTIC PLASTICITY; MOUSE MODEL; SOLUBLE OLIGOMERS	Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading known genetic cause of autism. Fragile X mental retardation protein (FMRP), which is absent or expressed at substantially reduced levels in FXS, binds to and controls the postsynaptic translation of amyloid beta-protein precursor (A beta PP) mRNA. Cleavage of A beta PP can produce beta-amyloid (A beta), a 39-43 amino acid peptide mis-expressed in Alzheimer's disease (AD) and Down syndrome (DS). A beta is over-expressed in the brain of Fmr1(KO) mice, suggesting a pathogenic role in FXS. To determine if genetic reduction of A beta PP/A beta rescues characteristic FXS phenotypes, we assessed audiogenic seizures (AGS), anxiety, the ratio of mature versus immature dendritic spines and metabotropic glutamate receptor (mGluR)-mediated long-term depression (LTD) in Fmr1(KO) mice after removal of one App allele. All of these phenotypes were partially or completely reverted to normal. Plasma A beta(1-42) was significantly reduced in full-mutation FXS males compared to age-matched controls while cortical and hippocampal levels were somewhat increased, suggesting that A beta is sequestered in the brain. Evolving therapies directed at reducing A beta in AD may be applicable to FXS and A beta may serve as a plasma-based biomarker to facilitate disease diagnosis or assess therapeutic efficacy.	[Westmark, Cara J.; Westmark, Pamela R.; Ray, Brian C.; Abozeid, Sara H.; Stein, Kelsey M.; Stodola, Levi A.; Malter, James S.] Univ Wisconsin, Waisman Ctr Dev Disabil, Madison, WI 53706 USA; [O'Riordan, Kenneth J.; Burger, Corinna] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Salamat, M. Shahriar; Malter, James S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Hervey, Crystal M.; Berry-Kravis, Elizabeth M.] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth M.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth M.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Tranfaglia, Michael] FRAXA Res Fdn, Newburyport, MA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rush University; Rush University; Rush University	Westmark, CJ (corresponding author), Univ Wisconsin, Waisman Ctr Dev Disabil, Madison, WI 53706 USA.	westmark@wisc.edu	Westmark, Cara/AAX-4408-2020; O'Riordan, Kenneth J./H-6467-2019; Westmark, Cara J/L-4647-2019	O'Riordan, Kenneth J./0000-0003-0081-6010; Burger, Corinna/0000-0002-9432-0114	FRAXA Research Foundation; Illinois-Eastern Iowa Kiwanis Spastic Paralysis and Related Disorders Foundation; National Institutes of Health [P30 HD03352, R01DA026067]; University of WI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026067] Funding Source: NIH RePORTER	FRAXA Research Foundation; Illinois-Eastern Iowa Kiwanis Spastic Paralysis and Related Disorders Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of WI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by FRAXA Research Foundation (http://www.FRAXA.org) (C.J.W. and J.S.M.), the Illinois-Eastern Iowa Kiwanis Spastic Paralysis and Related Disorders Foundation (E. B. K.), National Institutes of Health Grants P30 HD03352 (Waisman Center) and R01DA026067 (J.S.M.) and University of WI start-up funds (C.B.). The funders had no role in data collection and analyses or decision to publish. Mike Tranfaglia from FRAXA Research Foundation assisted with study design and critical review of the manuscript.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; [Anonymous], 1994, CELL, V78, P23; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Assini A, 2004, NEUROLOGY, V63, P828, DOI 10.1212/01.WNL.0000137040.64252.ED; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Blanchard BJ, 2002, BIOCHEM BIOPH RES CO, V293, P1197, DOI 10.1016/S0006-291X(02)00346-7; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Clifford S, 2007, J AUTISM DEV DISORD, V37, P738, DOI 10.1007/s10803-006-0205-z; D'Agata V, 2002, NEUROBIOL DIS, V10, P211, DOI 10.1006/nbdi.2002.0506; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Hagerman R. J., 2002, PHYS BEHAV PHENOTYPE, P3; Hagerman RJ, 1999, AM J MED GENET, V83, P313, DOI 10.1002/(SICI)1096-8628(19990402)83:4<313::AID-AJMG15>3.0.CO;2-F; HANSSON O, 2008, NEUROBIOL AGING; Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kent L, 1999, DEV MED CHILD NEUROL, V41, P153, DOI 10.1017/S001216229900033X; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LE WD, 1995, J NEUROCHEM, V65, P2373; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Mehta PD, 2007, J NEUROL SCI, V254, P22, DOI 10.1016/j.jns.2006.12.010; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Merenstein SA, 1996, AM J MED GENET, V64, P388, DOI 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.3.CO;2-S; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Musumeci SA, 1999, EPILEPSIA, V40, P1092, DOI 10.1111/j.1528-1157.1999.tb00824.x; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Qin M, 2005, NEUROSCIENCE, V135, P999, DOI 10.1016/j.neuroscience.2005.06.081; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Schupf N, 2007, ARCH NEUROL-CHICAGO, V64, P1007, DOI 10.1001/archneur.64.7.1007; Serrano F, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-31; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sobow T, 2005, ACTA NEUROBIOL EXP, V65, P117; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Torroja L, 1999, J NEUROSCI, V19, P7793; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wallberg A, 2006, BIOORG MED CHEM LETT, V16, P1142, DOI 10.1016/j.bmcl.2005.11.092; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Weng N, 2008, AM J MED GENET B, V147B, P1253, DOI 10.1002/ajmg.b.30765; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark CJ, 2010, J ALZHEIMERS DIS, V20, P1009, DOI 10.3233/JAD-2010-100087; Westmark CJ, 2001, MOL BRAIN RES, V90, P193, DOI 10.1016/S0169-328X(01)00112-7; WESTMARK CJ, 2009, TRANSLATING MEMORIES; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	91	80	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26549	10.1371/journal.pone.0026549	http://dx.doi.org/10.1371/journal.pone.0026549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046307	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600031
J	Anton, R; Chatterjee, SS; Simundza, J; Cowin, P; DasGupta, R				Anton, Roman; Chatterjee, Sujash S.; Simundza, Julia; Cowin, Pamela; DasGupta, Ramanuj			A Systematic Screen for Micro-RNAs Regulating the Canonical Wnt Pathway	PLOS ONE			English	Article							COLORECTAL-CARCINOMA CELLS; BETA-CATENIN; NEGATIVE REGULATOR; HUMAN CANCER; C-MET; TARGET; GROWTH; INHIBITION; EXPRESSION; APOPTOSIS	MicroRNAs (miRs) and the canonical Wnt pathway are known to be dysregulated in human cancers and play key roles during cancer initiation and progression. To identify miRs that can modulate the activity of the Wnt pathway we performed a cell-based overexpression screen of 470 miRs in human HEK293 cells. We identified 38 candidate miRs that either activate or repress the canonical Wnt pathway. A literature survey of all verified candidate miRs revealed that the Wnt-repressing miRs tend to be anti-oncomiRs and down-regulated in cancers while Wnt-activating miRs tend to be oncomiRs and upregulated during tumorigenesis. Epistasis-based functional validation of three candidate miRs, miR-1, miR-25 and miR-613, confirmed their inhibitory role in repressing the Wnt pathway and suggest that while miR-25 may function at the level of (a) over cap -catenin (beta-cat), miR-1 and miR-613 act upstream of beta-cat. Both miR-25 and miR-1 inhibit cell proliferation and viability during selection of human colon cancer cell lines that exhibit dysregulated Wnt signaling. Finally, transduction of miR-1 expressing lentiviruses into primary mammary organoids derived from Conductin-lacZ mice significantly reduced the expression of the Wnt-sensitive beta-gal reporter. In summary, these findings suggest the potential use of Wnt-modulating miRs as diagnostic and therapeutic tools in Wnt-dependent diseases, such as cancer.	[Anton, Roman; Chatterjee, Sujash S.; DasGupta, Ramanuj] NYU, Dept Pharmacol, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Simundza, Julia; Cowin, Pamela] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Simundza, Julia; Cowin, Pamela] NYU, Langone Med Ctr, Dept Dermatol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Anton, R (corresponding author), NYU, Dept Pharmacol, Langone Med Ctr, Inst Canc, 550 1St Ave, New York, NY 10016 USA.	ramanuj.dasgupta@nyumc.org	Xie, Huangming/B-2260-2012	Dasgupta, Ramanuj/0000-0001-9015-3729; Anton, Roman/0000-0002-9036-0012; Cowin, Pamela/0000-0002-1827-1154	Department of Defense [W81XWH-07-1-0541]; NYSTEM [N09S-012]; Kimmel Stem Cell Biology training program fellowship;  [DOD-BC093088]; NATIONAL CANCER INSTITUTE [R01CA155125] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NYSTEM; Kimmel Stem Cell Biology training program fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by Department of Defense/Breast Cancer Research Program concept award (W81XWH-07-1-0541) and NYSTEM grant (N09S-012) to RD, DOD-BC093088 to PC, and Kimmel Stem Cell Biology training program fellowship to SSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2008, SEMIN REPROD MED, V26, P522, DOI 10.1055/s-0028-1096132; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Chen JS, 2009, PHARMAZIE, V64, P126, DOI 10.1691/ph.2009.8678; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Herynk MH, 2003, CLIN EXP METASTAS, V20, P291, DOI 10.1023/A:1024024218529; Hsi LC, 1999, CARCINOGENESIS, V20, P2045, DOI 10.1093/carcin/20.11.2045; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; KUMAR M, 2010, NEGATIVE REGULATION; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; LIU Q, 2010, ANN REV BIOCH; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Lu WY, 2009, EUR J PHARMACOL, V602, P8, DOI 10.1016/j.ejphar.2008.10.053; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Quaiser T, 2006, BIOESSAYS, V28, P339, DOI 10.1002/bies.20386; Ryu MJ, 2008, BIOCHEM BIOPH RES CO, V377, P1304, DOI 10.1016/j.bbrc.2008.10.171; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; THATCHER EJ, 2008, P NATL ACAD SCI USA; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; WANG T, 2010, BIOCH BIOPHYS RES CO; Wieczorek M, 2008, CANCER BIOL THER, V7, P268, DOI 10.4161/cbt.7.2.5300; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Xu WL, 2010, CANCER BIOTHER RADIO, V25, P529, DOI 10.1089/cbr.2010.0768; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	55	62	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26257	10.1371/journal.pone.0026257	http://dx.doi.org/10.1371/journal.pone.0026257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043311	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400039
J	Rudyk, O; Makra, P; Jansen, E; Shattock, MJ; Poston, L; Taylor, PD				Rudyk, Olena; Makra, Peter; Jansen, Eugene; Shattock, Michael J.; Poston, Lucilla; Taylor, Paul D.			Increased Cardiovascular Reactivity to Acute Stress and Salt-Loading in Adult Male Offspring of Fat Fed Non-Obese Rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; BLOOD-PRESSURE; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; PRENATAL STRESS; NERVOUS-SYSTEM; SENSITIVE HYPERTENSION; ARTERIAL-PRESSURE; RESTRAINT STRESS; SEX-DIFFERENCES	Diet-induced obesity in rat pregnancy has been shown previously to be associated with consistently raised blood pressure in the offspring, attributed to sympathetic over-activation, but the relative contributions to this phenotype of maternal obesity versus raised dietary fat is unknown. Sprague-Dawley female rats were fed either a control (4.3% fat, n = 11) or lard-enriched (23.6% fat, n = 16) chow 10 days prior to mating, throughout pregnancy and lactation. In conscious adult (9-month-old) offspring cardiovascular parameters were measured (radiotelemetry). The short period of fat-feeding did not increase maternal weight versus controls and the baseline blood pressure was similar in offspring of fat fed dams (OF) and controls (OC). However, adult male OF showed heightened cardiovascular reactivity to acute restraint stress (p<0.01; Delta systolic blood pressure (SBP) and Delta heart rate (HR)) with a prolonged recovery time compared to male OC. alpha 1/beta-adrenergic receptor blockade normalised the response. Also, after dietary salt-loading (8%-NaCl ad libitum for 1 week) male OF demonstrated higher SBP (p<0.05) in the awake phase (night-time) and increased low/high frequency ratio of power spectral density of HR variability versus OC. Baroreflex gain and basal power spectral density components of the heart rate or blood pressure were similar in male OF and OC. Minor abnormalities were evident in female OF. Fat feeding in the absence of maternal obesity in pregnant rats leads to altered sympathetic control of cardiovascular function in adult male offspring, and hypertension in response to stressor stimuli.	[Rudyk, Olena; Poston, Lucilla; Taylor, Paul D.] Kings Coll London, Div Womens Hlth, Sch Med, London WC2R 2LS, England; [Rudyk, Olena; Shattock, Michael J.] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Makra, Peter] Univ Szeged, Dept Expt Phys, Szeged, Hungary; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands	University of London; King's College London; University of London; King's College London; Szeged University; Netherlands National Institute for Public Health & the Environment	Rudyk, O (corresponding author), Kings Coll London, Div Womens Hlth, Sch Med, London WC2R 2LS, England.	paul.taylor@kcl.ac.uk	Makra, Péter/GOH-1065-2022; Rudyk, Olena/AAY-3789-2020	Rudyk, Olena/0000-0001-9422-9233; Taylor, Paul David/0000-0002-4740-4307; Shattock, Michael/0000-0001-6242-7585; Poston, Lucilla/0000-0003-1100-2821	British Heart Foundation [PG/06/081/21195]; OTKA, Hungary [404 K69018]; Tommy's Charity (UK)	British Heart Foundation(British Heart Foundation); OTKA, Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Tommy's Charity (UK)	This work was supported by the British Heart Foundation (PG/06/081/21195). P. Makra is funded by OTKA, Hungary (grant 404 K69018). L. Poston is supported by Tommy's Charity (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Cammisotto PG, 2003, AM J PHYSIOL-ENDOC M, V285, pE521, DOI 10.1152/ajpendo.00052.2003; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Cerf ME, 2010, HORM METAB RES, V42, P307, DOI 10.1055/s-0030-1248303; Correia MLG, 2001, HYPERTENSION, V37, P936, DOI 10.1161/01.HYP.37.3.936; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Ely D, 2010, STEROIDS, V75, P747, DOI 10.1016/j.steroids.2009.10.015; Ely DL, 1997, AM J CLIN NUTR, V65, P594; FOLKOW B, 1989, AM J HYPERTENS, V2, pS103, DOI 10.1093/ajh/2.3.103S; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Galipeau D, 2002, AM J PHYSIOL-HEART C, V283, pH2478, DOI 10.1152/ajpheart.00243.2002; Gomez-Merino D, 2002, MED SCI SPORT EXER, V34, P1594, DOI 10.1097/00005768-200210000-00010; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Huang BS, 2006, CURR OPIN CARDIOL, V21, P295, DOI 10.1097/01.hco.0000231398.64362.94; Igosheva N, 2004, J PHYSIOL-LONDON, V557, P273, DOI 10.1113/jphysiol.2003.056911; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; LIMAS C, 1981, HYPERTENSION, V3, P219, DOI 10.1161/01.HYP.3.2.219; Lombardi Federico, 2002, Card Electrophysiol Rev, V6, P245, DOI 10.1023/A:1016329008921; Maccari S, 2003, NEUROSCI BIOBEHAV R, V27, P119, DOI 10.1016/S0149-7634(03)00014-9; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Maris ME, 2005, CLIN EXP PHARMACOL P, V32, P35, DOI 10.1111/j.1440-1681.2005.04156.x; Matthews SG, 2011, EXP NEUROL IN PRESS; Mitra A, 2009, AM J PHYSIOL-REG I, V296, pR20, DOI 10.1152/ajpregu.90553.2008; Muntzel MS, 2007, METABOLISM, V56, P373, DOI 10.1016/j.metabol.2006.10.020; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Ngampramuan S, 2008, AM J PHYSIOL-REG I, V294, pR132, DOI 10.1152/ajpregu.00464.2007; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Nuyt AM, 2009, CURR OPIN NEPHROL HY, V18, P144, DOI 10.1097/MNH.0b013e328326092c; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Pechere-Bertschi A, 2004, AM J HYPERTENS, V17, P994, DOI 10.1016/j.amjhyper.2004.08.009; Peyronnet J, 2002, PFLUG ARCH EUR J PHY, V443, P858, DOI 10.1007/s00424-001-0766-9; Pierce JP, 2009, NEUROSCIENCE, V163, P329, DOI 10.1016/j.neuroscience.2009.06.006; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Porter JP, 2009, AUTON NEUROSCI-BASIC, V150, P140, DOI 10.1016/j.autneu.2009.04.006; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198; Ricci MR, 1999, OBES RES, V7, P233, DOI 10.1002/j.1550-8528.1999.tb00401.x; Rocchini AP, 2000, NUTR METAB CARDIOVAS, V10, P287; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Schreuder MF, 2007, HYPERTENSION, V50, pE158, DOI 10.1161/HYPERTENSIONAHA.107.099994; Song L, 2009, NEUROCHEM RES, V34, P739, DOI 10.1007/s11064-008-9838-y; Souza HCD, 2001, AM J PHYSIOL-HEART C, V280, pH844, DOI 10.1152/ajpheart.2001.280.2.H844; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Taylor PD, 2003, EXP PHYSIOL, V88, P389, DOI 10.1113/eph8802495; Taylor PD, J PHYSL, V558, P943; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Vieau D, 2007, PSYCHONEUROENDOCRINO, V32, pS16, DOI 10.1016/j.psyneuen.2007.03.014; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x	63	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25250	10.1371/journal.pone.0025250	http://dx.doi.org/10.1371/journal.pone.0025250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043281	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400008
J	Mankoo, PK; Shen, RL; Schultz, N; Levine, DA; Sander, C				Mankoo, Parminder K.; Shen, Ronglai; Schultz, Nikolaus; Levine, Douglas A.; Sander, Chris			Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles	PLOS ONE			English	Article							PROPORTIONAL HAZARDS; VARIABLE SELECTION; CANCER; CHEMOTHERAPY; CELLS; DIFFERENTIATION; PROLIFERATION; RESISTANCE; REGRESSION; CARCINOMA	Background: Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas (TCGA) has provided rich molecular and genetic profiles from hundreds of primary surgical samples. These profiles confirm mutations of TP53 in similar to 100% of patients and an extraordinarily complex profile of DNA copy number changes with considerable patient-to-patient diversity. This raises the joint challenge of exploiting all new available datasets and reducing their confounding complexity for the purpose of predicting clinical outcomes and identifying disease relevant pathway alterations. We therefore set out to use multi-data type genomic profiles (mRNA, DNA methylation, DNA copy-number alteration and microRNA) available from TCGA to identify prognostic signatures for the prediction of progression-free survival (PFS) and overall survival (OS). Methodology/Principal Findings: We implemented a multivariate Cox Lasso model and median time-to-event prediction algorithm and applied it to two datasets integrated from the four genomic data types. We (1) selected features through cross-validation; (2) generated a prognostic index for patient risk stratification; and (3) directly predicted continuous clinical outcome measures, that is, the time to recurrence and survival time. We used Kaplan-Meier p-values, hazard ratios (HR), and concordance probability estimates (CPE) to assess prediction performance, comparing separate and integrated datasets. Data integration resulted in the best PFS signature (withheld data: p-value = 0.008; HR = 2.83; CPE = 0.72). Conclusions/Significance: We provide a prediction tool that inputs genomic profiles of primary surgical samples and generates patient-specific predictions for the time to recurrence and survival, along with outcome risk predictions. Using integrated genomic profiles resulted in information gain for prediction of outcomes. Pathway analysis provided potential insights into functional changes affecting disease progression. The prognostic signatures, if prospectively validated, may be useful for interpreting therapeutic outcomes for clinical trials that aim to improve the therapy for SeOvCa patients.	[Mankoo, Parminder K.; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Mankoo, PK (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	cancer-prognosis@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020	Levine, Douglas/0000-0003-1038-8232; Schultz, Nikolaus/0000-0002-0131-4904	National Institutes of Health [U24 CA143840]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health grant U24 CA143840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Causey MW, 2011, J SURG RES, V171, P615, DOI 10.1016/j.jss.2010.04.034; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Daemen A, 2009, GENOME MED, V1, DOI 10.1186/gm39; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; HELLER G, 1992, BIOMETRICS, V48, P101, DOI 10.2307/2532742; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Noetzel E, 2008, Pathologe, V29 Suppl 2, P319, DOI 10.1007/s00292-008-1038-7; Ota T, 2007, REPROD SCI, V14, P605, DOI 10.1177/1933719107307781; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Peluso JJ, 2009, ENDOCRINOLOGY, V150, P4846, DOI 10.1210/en.2009-0730; Poroyo V, 2007, ATLAS GENET CYTOGENE, V11, P58; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Slovin SF, 2005, CLIN CANCER RES, V11, P8669, DOI 10.1158/1078-0432.CCR-05-1668; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Subramanian J, 2011, STAT MED, V30, P642, DOI 10.1002/sim.4106; Tai YT, 2009, BLOOD, V113, P4309, DOI 10.1182/blood-2008-10-183772; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Yu SYM, 2009, TUMOR BIOL, V30, P80, DOI 10.1159/000216843; Zangenberg M, 2009, EUR J HAEMATOL, V83, P439, DOI 10.1111/j.1600-0609.2009.01309.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	70	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e24709	10.1371/journal.pone.0024709	http://dx.doi.org/10.1371/journal.pone.0024709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073136	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000004
J	Vallianou, I; Peroulis, N; Pantazis, P; Hadzopoulou-Cladaras, M				Vallianou, Ioanna; Peroulis, Nikolaos; Pantazis, Panayotis; Hadzopoulou-Cladaras, Margarita			Camphene, a Plant-Derived Monoterpene, Reduces Plasma Cholesterol and Triglycerides in Hyperlipidemic Rats Independently of HMG-CoA Reductase Activity	PLOS ONE			English	Article							CHIOS-MASTIC GUM; LENTISCUS VAR. CHIA; PROSTATE-CANCER CELLS; PISTACIA-LENTISCUS; HELICOBACTER-PYLORI; ESSENTIAL OIL; IN-VITRO; CHEMICAL-COMPOSITION; TRITON WR-1339; ANTIINFLAMMATORY ACTIVITY	Background: Central to the pathology of coronary heart disease is the accumulation of lipids, cholesterol and triglycerides, within the intima of arterial blood vessels. The search for drugs to treat dislipidemia, remains a major pharmaceutical focus. In this study, we evaluated the hypolipidemic properties of the essential oil from Chios mastic gum (MGO). Methodology/Principal Findings: The hypolipidemic effect of MGO was investigated in naive as well as in rats susceptible to detergent-induced hyperlipidemia. Serum cholesterol and triglycerides were determined using commercial kits. HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase activity was measured in HepG2 cell extracts using a radioactive assay; cellular cholesterol and cholesterol esters were assessed using gas chromatography. MGO administration into naive rats resulted in a dose-dependent reduction in the constitutive synthesis of serum cholesterol and triglycerides. In hyperlipidemic rats, MGO treatment had also a strong hypolipidemic effect. By testing various components of MGO, we show for the first time that the hypolipidemic action is associated with camphene. Administration of camphene at a dose of 30 mu g/gr of body weight in hyperlipidemic rats resulted in a 54.5% reduction of total cholesterol (p<0.001), 54% of Low Density Lipoprotein (LDL)-cholesterol (p<0.001) and 34.5% of triglycerides (p<0.001). Treatment of HepG2 cells with camphene led to a decrease in cellular cholesterol content to the same extend as mevinolin, a known HMG-CoA reductase inhibitor. The hypolipidemic action of camphene is independent of HMG-CoA reductase activity, suggesting that its hypocholesterolemic and hypotriglyceridemic effects are associated with a mechanism of action different than that of statins. Conclusions: Given the critical role that the control of hyperlipidemia plays in cardiovascular disease, the results of our study provide insights into the use of camphene as an alternative lipid lowering agent and merits further evaluation.	[Vallianou, Ioanna; Peroulis, Nikolaos; Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Pantazis, Panayotis] ADNA Inc, Oklahoma City, OK USA	Aristotle University of Thessaloniki	Vallianou, I (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece.	cladaras@bio.auth.gr			Core Institutional Funds	Core Institutional Funds	The study was supported by Core Institutional Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aksoy A, 2007, ANGLE ORTHOD, V77, P124, DOI 10.2319/122205-455R.1; ALHABBAL MJ, 1984, CLIN EXP PHARMACOL P, V11, P541, DOI 10.1111/j.1440-1681.1984.tb00864.x; ALSAID MS, 1986, J ETHNOPHARMACOL, V15, P271, DOI 10.1016/0378-8741(86)90165-0; ANDERSON KM, 1987, ATHEROSCLEROSIS, V68, P59, DOI 10.1016/0021-9150(87)90094-3; Andrikopoulos NK, 2003, PHYTOTHER RES, V17, P501, DOI 10.1002/ptr.1185; Balan KV, 2007, PHYTOMEDICINE, V14, P263, DOI 10.1016/j.phymed.2006.03.009; Balan KV, 2005, IN VIVO, V19, P93; Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/14656566.4.11.1901; BLANKENHORN DH, 1987, CONTROL CLIN TRIALS, V8, P354, DOI 10.1016/0197-2456(87)90156-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braca A, 2011, CURR DRUG TARGETS, V12, P302, DOI 10.2174/138945011794815284; BROWN MS, 1974, J BIOL CHEM, V249, P7306; BUSCH SJ, 1990, J BIOL CHEM, V265, P22474; CLEGG RJ, 1980, BIOCHEM PHARMACOL, V29, P2125, DOI 10.1016/0006-2952(80)90183-5; Costet P, 2010, PHARMACOL THERAPEUT, V126, P263, DOI 10.1016/j.pharmthera.2010.02.006; Dabos KJ, 2010, PHYTOMEDICINE, V17, P296, DOI 10.1016/j.phymed.2009.09.010; Dabos KJ, 2010, J ETHNOPHARMACOL, V127, P205, DOI 10.1016/j.jep.2009.11.021; Dedoussis GVZ, 2004, ATHEROSCLEROSIS, V174, P293, DOI 10.1016/j.atherosclerosis.2004.02.011; Dimas K, 2009, IN VIVO, V23, P63; Duru ME, 2003, FITOTERAPIA, V74, P170, DOI 10.1016/S0367-326X(02)00318-0; ENDO A, 1989, ADV ENZYME REGUL, V28, P53, DOI 10.1016/0065-2571(89)90063-0; ENDO A, 1992, J LIPID RES, V33, P1569; FISER RH, 1974, J NUTR, V104, P223, DOI 10.1093/jn/104.2.223; Garcia-Pelayo MC, 2000, ANALYST, V125, P1583, DOI 10.1039/b004481o; Gordon, 1972, PRED ATH HEAD HEART; Grundy SM, 2005, AM J CARDIOL, V96, p47D, DOI 10.1016/j.amjcard.2005.03.020; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNDY SM, 1977, AM J CLIN NUTR, V30, P985, DOI 10.1093/ajcn/30.6.985; GRUNDY SM, 1978, WESTERN J MED, V128, P13; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; He ML, 2007, ACTA PHARMACOL SIN, V28, P567, DOI 10.1111/j.1745-7254.2007.00535.x; He ML, 2007, ACTA PHARMACOL SIN, V28, P446, DOI 10.1111/j.1745-7254.2007.00536.x; He ML, 2006, CANCER-AM CANCER SOC, V106, P2547, DOI 10.1002/cncr.21935; Ho SS, 2005, ATHEROSCLEROSIS, V182, P29, DOI 10.1016/j.atherosclerosis.2005.01.031; Huwez FU, 1998, NEW ENGL J MED, V339, P1946, DOI 10.1056/NEJM199812243392618; ILLINGWORTH DR, 1987, AM J CARDIOL, V60, pG33, DOI 10.1016/0002-9149(87)90589-3; Janakat S, 2002, J ETHNOPHARMACOL, V83, P135, DOI 10.1016/S0378-8741(02)00241-6; Kaliora AC, 2007, WORLD J GASTROENTERO, V13, P6031, DOI 10.3748/wjg.13.6031; Kaliora AC, 2007, WORLD J GASTROENTERO, V13, P748, DOI 10.3748/wjg.13.6031; KALOPISSIS AD, 1980, BIOCHIM BIOPHYS ACTA, V620, P111, DOI 10.1016/0005-2760(80)90190-3; Kang JS, 2007, FOOD CHEM TOXICOL, V45, P494, DOI 10.1016/j.fct.2006.09.013; KELLNER A, 1951, J EXP MED, V93, P373, DOI 10.1084/jem.93.4.373; KORNBRUST DJ, 1989, J PHARMACOL EXP THER, V248, P498; Kourounakis AP, 2002, EXP MOL PATHOL, V73, P135, DOI 10.1006/exmp.2002.2449; Koutsoudaki C, 2005, J AGR FOOD CHEM, V53, P7681, DOI 10.1021/jf050639s; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Loizou S, 2009, EXP BIOL MED, V234, P553, DOI 10.3181/0811-RM-338; Lomnicky Y, 1998, J PHARM PHARMACOL, V50, P1233, DOI 10.1111/j.2042-7158.1998.tb03339.x; Loutrari H, 2006, NUTR CANCER, V55, P86, DOI 10.1207/s15327914nc5501_11; Magiatis P, 1999, PLANTA MED, V65, P749, DOI 10.1055/s-2006-960856; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Mahmoudi M, 2010, EUR REV MED PHARMACO, V14, P765; MARNER FJ, 1991, PHYTOCHEMISTRY, V30, P3709, DOI 10.1016/0031-9422(91)80095-I; Marone P, 2001, J CHEMOTHERAPY, V13, P611, DOI 10.1179/joc.2001.13.6.611; MASTERS BA, 1995, TOXICOL APPL PHARM, V131, P163, DOI 10.1006/taap.1995.1058; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moulos P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-68; Padalia RC, 2010, NAT PROD COMMUN, V5, P279; Pal S, 2002, J NUTR BIOCHEM, V13, P55, DOI 10.1016/S0955-2863(01)00195-4; Papageorgiou V. P., 1991, Journal of Essential Oil Research, V3, P107; Papageorgiou VP, 1997, J CHROMATOGR A, V769, P263, DOI 10.1016/S0021-9673(96)01032-1; Paraschos S, 2007, ANTIMICROB AGENTS CH, V51, P551, DOI 10.1128/AAC.00642-06; Pintore G, 2009, NAT PROD COMMUN, V4, P1685; Plat J, 2005, AM J CARDIOL, V96, p15D, DOI 10.1016/j.amjcard.2005.03.015; Qiao J, 2010, AM J RESP CELL MOL B; Sakagami H, 2009, IN VIVO, V23, P215; Satou T, 2009, NAT PROD COMMUN, V4, P845; SCHURR PE, 1972, LIPIDS, V7, P68, DOI 10.1007/BF02531272; Seok SH, 2004, J ETHNOPHARMACOL, V91, P231, DOI 10.1016/j.jep.2003.12.032; SHEORAIN VS, 1980, ENZYME, V25, P81, DOI 10.1159/000459223; SIRTORI CR, 1978, ATHEROSCLEROSIS, V30, P45, DOI 10.1016/0021-9150(78)90151-X; Sterer N, 2008, J DENT, V36, P535, DOI 10.1016/j.jdent.2008.04.001; Tabanca N, 2010, NAT PROD COMMUN, V5, P1421; Takahashi K, 2003, J PERIODONTOL, V74, P501, DOI 10.1902/jop.2003.74.4.501; Thompson GR, 2005, AM J CARDIOL, V96, p3D, DOI 10.1016/j.amjcard.2005.03.013; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Triantafyllou A, 2007, J ETHNOPHARMACOL, V111, P43, DOI 10.1016/j.jep.2006.10.031; Tschiggerl Christine, 2010, Sci Pharm, V78, P483, DOI 10.3797/scipharm.1004-23; Tsutsumi K., 2003, Current Vascular Pharmacology, V1, P11, DOI 10.2174/1570161033386673; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Verschueren K, 2001, HDB ENV DATA ORGANIC, V1-2, P419; Zhou L, 2009, IN VIVO, V23, P583	83	66	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e20516	10.1371/journal.pone.0020516	http://dx.doi.org/10.1371/journal.pone.0020516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073134	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000003
J	Musthaq, SS; Kwang, J				Musthaq, Syed S.; Kwang, Jimmy			Oral Vaccination of Baculovirus-Expressed VP28 Displays Enhanced Protection against White Spot Syndrome Virus in Penaeus monodon	PLOS ONE			English	Article							ENVELOPE PROTEIN VP28; STRUCTURAL PROTEINS; FUSION PROTEIN; DNA VACCINE; SHRIMP; WSSV; INFECTION; JAPONICUS; STAT; ANTIBODIES	White Spot Syndrome Virus (WSSV) is an infectious pathogen of shrimp and other crustaceans, and neither effective vaccines nor adequate treatments are currently available. WSSV is an enveloped dsDNA virus, and one of its major envelope proteins, VP28, plays a pivotal role in WSSV infection. In an attempt to develop a vaccine against WSSV, we inserted the VP28 gene into a baculovirus vector tailored to express VP28 on the baculovirus surface under the WSSV ie1 promoter (Bac-VP28). The Bac-VP28 incorporated abundant quantity (65.3 mu g/ml) of VP28. Shrimp were treated by oral and immersion vaccination with either Bac-VP28 or wild-type baculovirus (Bac-wt). The treatment was followed by challenge with WSSV after 3 and 15 days. Bac-VP28 vaccinated shrimp showed significantly higher survival rates (oral: 81.7% and 76.7%; immersion: 75% and 68.4%) than Bac-wt or non-treated shrimp (100% mortality). To verify the protective effects of Bac-VP28, we examined in vivo expression of VP28 by immunohistochemistry and quantified the WSSV copy number by qPCR. In addition to that, we quantified the expression levels shrimp genes LGBP and STAT by real-time RT-PCR from the samples obtained from Bac-VP28 vaccinated shrimp at different duration of vaccine regime. Our findings indicate that oral vaccination of shrimp with Bac-VP28 is an attractive preventative measure against WSSV infection that can be used in the field.	[Musthaq, Syed S.; Kwang, Jimmy] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Musthaq, SS (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg						Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Corbeil S, 2000, FISH SHELLFISH IMMUN, V10, P711, DOI 10.1006/fsim.2000.0286; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Durand SV, 2002, J FISH DIS, V25, P381, DOI 10.1046/j.1365-2761.2002.00367.x; FAO, 2008, FAO YB 2008; Fernandez-Alonso M, 2001, VACCINE, V19, P3067, DOI 10.1016/S0264-410X(01)00046-9; Flegel TW, 2007, DEV COMP IMMUNOL, V31, P217, DOI 10.1016/j.dci.2006.06.009; Gao H, 2007, J BIOTECHNOL, V131, P138, DOI 10.1016/j.jbiotec.2007.06.002; Hameed ASS, 2003, DIS AQUAT ORGAN, V57, P157, DOI 10.3354/dao057157; Hameed ASS, 2002, AQUACULTURE, V204, P1, DOI 10.1016/S0044-8486(01)00655-X; Hameed ASS, 2001, AQUACULTURE, V201, P179, DOI 10.1016/S0044-8486(01)00525-7; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Huang R, 2005, J GEN VIROL, V86, P1357, DOI 10.1099/vir.0.80923-0; Jha RK, 2006, IMMUNOL LETT, V105, P68, DOI 10.1016/j.imlet.2006.01.004; Kim CS, 2007, FISH SHELLFISH IMMUN, V23, P242, DOI 10.1016/j.fsi.2006.10.012; Kim DK, 2004, AQUACULTURE, V237, P21, DOI 10.1016/j.aquaculture.2004.03.015; Kwon FJ, 2000, J BIOL CHEM, V275, P19824, DOI 10.1074/jbc.M001114200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HX, 2005, J FISH DIS, V28, P285, DOI 10.1111/j.1365-2761.2005.00630.x; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Musthaq SS, 2006, J INVERTEBR PATHOL, V93, P75, DOI 10.1016/j.jip.2006.06.006; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; Musthaq SS, 2006, AQUACULTURE, V253, P98, DOI 10.1016/j.aquaculture.2005.07.032; Namikoshi A, 2004, AQUACULTURE, V229, P25, DOI 10.1016/S0044-8486(03)00363-6; Ning JF, 2009, VACCINE, V27, P1127, DOI 10.1016/j.vaccine.2008.11.075; Rajeshkumar S, 2009, FISH SHELLFISH IMMUN, V26, P429, DOI 10.1016/j.fsi.2009.01.003; Rout N, 2007, VACCINE, V25, P2778, DOI 10.1016/j.vaccine.2006.12.056; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sarathi M, 2008, MAR BIOTECHNOL, V10, P242, DOI 10.1007/s10126-007-9057-6; Soderhall Kenneth, 1996, P229; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Takahashi Y, 1996, J FISH DIS, V19, P399, DOI 10.1111/j.1365-2761.1996.tb00379.x; TALBOT PJ, 1984, J IMMUNOL METHODS, V73, P177, DOI 10.1016/0022-1759(84)90043-7; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; van Hulten MCW, 2001, VIROLOGY, V285, P228, DOI 10.1006/viro.2001.0928; Venegas CA, 2000, DIS AQUAT ORGAN, V42, P83, DOI 10.3354/dao042083; Wei Ke Qiang, 2005, Shi Yan Sheng Wu Xue Bao, V38, P190; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu JL, 2002, FISH SHELLFISH IMMUN, V13, P391, DOI 10.1006/fsim.2002.0414; Xu H, 2009, FISH SHELLFISH IMMUN, V26, P414, DOI 10.1016/j.fsi.2009.01.001; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131	46	64	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26428	10.1371/journal.pone.0026428	http://dx.doi.org/10.1371/journal.pone.0026428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069450	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900011
J	Yeh, MT; Wang, SW; Yu, CK; Lin, KH; Lei, HY; Su, IJ; Wang, JR				Yeh, Ming-Te; Wang, Shainn-Wei; Yu, Chun-Keung; Lin, Kuei-Hsiang; Lei, Huan-Yao; Su, Ih-Jen; Wang, Jen-Ren			A Single Nucleotide in Stem Loop II of 5 '-Untranslated Region Contributes to Virulence of Enterovirus 71 in Mice	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; RNA SECONDARY STRUCTURE; COXSACKIEVIRUS B3; TRANSLATION INITIATION; UNTRANSLATED REGION; HUMANIZED MICE; MESSENGER-RNA; MOUTH-DISEASE; POLIOVIRUS; REPLICATION	Background: Enterovirus 71 (EV71) has emerged as a neuroinvasive virus responsible for several large outbreaks in the Asia-Pacific region while virulence determinant remains unexplored. Principal Findings: In this report, we investigated increased virulence of unadapted EV71 clinical isolate 237 as compared with isolate 4643 in mice. A fragment 12 nucleotides in length in stem loop (SL) II of 237 5'-untranslated region (UTR) visibly reduced survival time and rate in mice was identified by constructing a series of infectious clones harboring chimeric 5'-UTR. In cells transfected with bicistronic plasmids, and replicon RNAs, the 12-nt fragment of isolate 237 enhanced translational activities and accelerated replication of subgenomic EV71. Finally, single nucleotide change from cytosine to uridine at base 158 in this short fragment of 5'-UTR was proven to reduce viral translation and EV71 virulence in mice. Results collectively indicated a pivotal role of novel virulence determinant C158 on virus translation in vitro and EV71 virulence in vivo. Conclusions: These results presented the first reported virulence determinant in EV71 5'-UTR and first position discovered from unadapted isolates.	[Yeh, Ming-Te; Wang, Shainn-Wei; Yu, Chun-Keung; Lei, Huan-Yao; Wang, Jen-Ren] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yeh, Ming-Te; Wang, Shainn-Wei; Yu, Chun-Keung; Lei, Huan-Yao; Wang, Jen-Ren] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Wang, Shainn-Wei] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan; [Yu, Chun-Keung; Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Lin, Kuei-Hsiang] Kaohsiung Med Univ, Dept Lab Med, Kaohsiung, Taiwan; [Su, Ih-Jen; Wang, Jen-Ren] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Yeh, MT (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	jrwang@mail.ncku.edu.tw	Wang, Shainn-Wei/B-9644-2009; Wang, Jen-Ren/F-5254-2011; Yeh, Ming Te/AAC-6175-2021; Su, Ih-Jen/B-2655-2010	Yeh, Ming Te/0000-0001-8736-180X; Wang, Jen-Ren/0000-0002-4127-4046	National Health Research Institute; National Science Council, Taiwan [NSC 100-2320-B-006-018]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes grants and National Science Council, Taiwan [NSC 100-2320-B-006-018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; Bedard KM, 2004, MICROBES INFECT, V6, P702, DOI 10.1016/j.micinf.2004.03.001; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; BLOMBERG J, 1974, LANCET, V2, P112; Bradrick SS, 2001, J VIROL, V75, P6472, DOI 10.1128/JVI.75.14.6472-6481.2001; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; De Jesus N, 2005, J VIROL, V79, P14235, DOI 10.1128/JVI.79.22.14235-14243.2005; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Dunn JJ, 2000, J VIROL, V74, P4787, DOI 10.1128/JVI.74.10.4787-4794.2000; Dunn JJ, 2003, J INFECT DIS, V187, P1552, DOI 10.1086/374877; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; GUILLOT S, 1994, VACCINE, V12, P503, DOI 10.1016/0264-410X(94)90307-7; Gutierrez AL, 1997, J VIROL, V71, P3826; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Ishii T, 1999, J GEN VIROL, V80, P917, DOI 10.1099/0022-1317-80-4-917; Ishii T, 1998, J VIROL, V72, P2398, DOI 10.1128/JVI.72.3.2398-2405.1998; Kauder SE, 2004, J CLIN INVEST, V113, P1743, DOI 10.1172/JCI200421323; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kung YH, 2010, VIROLOGY, V396, P1, DOI 10.1016/j.virol.2009.10.017; Lee CK, 2005, J GEN VIROL, V86, P197, DOI 10.1099/vir.0.80424-0; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Malnou CE, 2002, J VIROL, V76, P10617, DOI 10.1128/JVI.76.21.10617-10626.2002; Mota J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020762; Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; OMATA T, 1986, J VIROL, V58, P348, DOI 10.1128/JVI.58.2.348-358.1986; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pilipenko EV, 2001, EMBO J, V20, P6899, DOI 10.1093/emboj/20.23.6899; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rezapkin GV, 1999, VIROLOGY, V258, P152, DOI 10.1006/viro.1999.9718; Rinehart JE, 1997, J VIROL, V71, P3986, DOI 10.1128/JVI.71.5.3986-3991.1997; Sambrook J., 2001, MOL CLONING LAB MANU; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SHIROKI K, 1995, J VIROL, V69, P6825, DOI 10.1128/JVI.69.11.6825-6832.1995; SKINNER MA, 1989, J MOL BIOL, V207, P379, DOI 10.1016/0022-2836(89)90261-1; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025530; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; TU ZG, 1995, J VIROL, V69, P4607, DOI 10.1128/JVI.69.8.4607-4618.1995; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; XIANG WK, 1995, J VIROL, V69, P3658, DOI 10.1128/JVI.69.6.3658-3667.1995; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	52	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27082	10.1371/journal.pone.0027082	http://dx.doi.org/10.1371/journal.pone.0027082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069490	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900050
J	Tait, LW; Schiel, DR				Tait, Leigh W.; Schiel, David R.			Legacy Effects of Canopy Disturbance on Ecosystem Functioning in Macroalgal Assemblages	PLOS ONE			English	Article							ALGA HORMOSIRA-BANKSII; HABITAT-FORMING ALGA; KELP FORESTS; PRIMARY PRODUCTIVITY; SEVERE STORM; COMMUNITY; RECOVERY; TEMPERATURE; GROWTH; RECRUITMENT	Macroalgal assemblages are some of the most productive systems on earth and they contribute significantly to nearshore ecosystems. Globally, macroalgal assemblages are increasingly threatened by anthropogenic activities such as sedimentation, eutrophication and climate change. Despite this, very little research has considered the potential effects of canopy loss on primary productivity, although the literature is rich with evidence showing the ecological effects of canopy disturbance. In this study we used experimental removal plots of habitat-dominating algae (Order Fucales) that had been initiated several years previously to construct a chronosequence of disturbed macroalgal communities and to test if there were legacy effects of canopy loss on primary productivity. We used in situ photo-respirometry to test the primary productivity of algal assemblages in control and removal plots at two intertidal elevations. In the mid tidal zone assemblage, the removal plots at two sites had average primary productivity values of only 40% and 60% that of control areas after 90 months. Differences in productivity were associated with lower biomass and density of the fucoid algal canopy and lower taxa richness in the removal plots after 90 months. Low-shore plots, established three years earlier, showed that the loss of the large, dominant fucoid resulted in at least 50% less primary productivity of the algal assemblage than controls, which lasted for 90 months; other smaller fucoid species had recruited but they were far less productive. The long term reduction in primary productivity following a single episode of canopy loss of a dominant species in two tidal zones suggests that these assemblages are not very resilient to large perturbations. Decreased production output may have severe and long-lasting consequences on the surrounding communities and has the potential to alter nutrient cycling in the wider nearshore environment.	[Tait, Leigh W.; Schiel, David R.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand	University of Canterbury	Tait, LW (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	taitl@science.oregonstate.edu		Tait, Leigh/0000-0001-9153-139X	University of Canterbury; Andrew W Mellon Foundation of New York; New Zealand Foundation for Research, Science and Technology [C01X0307, C01X0501]	University of Canterbury; Andrew W Mellon Foundation of New York; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This work was funded by a University of Canterbury scholarship, the Andrew W Mellon Foundation of New York, and the New Zealand Foundation for Research, Science and Technology (Coasts and Oceans OBI, grants C01X0307 and C01X0501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bellgrove A, 2010, MAR ECOL PROG SER, V419, P47, DOI 10.3354/meps08843; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Cervin G, 2005, MAR ECOL PROG SER, V305, P31, DOI 10.3354/meps305031; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FISCHER G, 1992, POLAR BIOL, V12, P341; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; Ingolfsson A, 2008, J MAR BIOL ASSOC UK, V88, P689, DOI 10.1017/S0025315408001161; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Jenkins SR, 2005, MAR ECOL PROG SER, V287, P77, DOI 10.3354/meps287077; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; LITTLER MM, 1982, J PHYCOL, V18, P307, DOI 10.1111/j.0022-3646.1982.00307.x; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Mann KH, 2000, ECOLOGY COASTAL WATE; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Peterson BJ, 2002, OIKOS, V97, P361, DOI 10.1034/j.1600-0706.2002.970306.x; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; SANTELICES B, 1984, MAR ECOL PROG SER, V19, P73, DOI 10.3354/meps019073; Schiel DR, 2007, MAR ECOL PROG SER, V339, P1, DOI 10.3354/meps339001; Schiel DR, 2006, J EXP MAR BIOL ECOL, V338, P233, DOI 10.1016/j.jembe.2006.06.023; Schiel DR, 2011, J EXP MAR BIOL ECOL, V407, P108, DOI 10.1016/j.jembe.2011.07.004; Schiel DR, 2011, J EXP MAR BIOL ECOL, V400, P33, DOI 10.1016/j.jembe.2011.02.026; Schiel DR, 2009, ECOL STUD-ANAL SYNTH, V206, P281, DOI 10.1007/978-3-540-92704-4_20; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Shepherd SA, 2009, BOT MAR, V52, P195, DOI 10.1515/BOT.2009.036; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tait LW, 2010, MAR ECOL PROG SER, V416, P115, DOI 10.3354/meps08781; TAIT LW, 2010, THESIS U CANTERBURY; Underwood AJ, 1999, J EXP MAR BIOL ECOL, V232, P125, DOI 10.1016/S0022-0981(98)00105-1; Underwood AJ, 1998, J EXP MAR BIOL ECOL, V231, P291, DOI 10.1016/S0022-0981(98)00091-4; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x	41	44	44	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26986	10.1371/journal.pone.0026986	http://dx.doi.org/10.1371/journal.pone.0026986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066024	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000042
J	Ocampo, B; Kritikos, A; Cunnington, R				Ocampo, Brenda; Kritikos, Ada; Cunnington, Ross			How Frontoparietal Brain Regions Mediate Imitative and Complementary Actions: An fMRI Study	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; MECHANISMS; CORTEX; MOTOR	The 'mirror neuron system' (MNS), located within inferior parietal lobe (IPL) and inferior frontal gyrus (IFG), creates an internal motor representation of the actions we see and has been implicated in imitation. Recently, the MNS has been implicated in non-identical responses: when the actions we must execute do not match those that we observe. However, in such conflicting situations non action-specific cognitive control networks also located in frontoparietal regions may be involved. In the present functional magnetic resonance imaging (fMRI) study participants made both similar and dissimilar actions within two action contexts: imitative and complementary. We aimed to determine whether activity within IPL/IFG depends on (i) responding under an imitative versus complementary context (ii) responding with similar versus dissimilar responses, and (iii) observing hand actions versus symbolic arrow cue stimuli. Activity within rIPL/rIFG regions was largest during observation of hand actions compared with arrow cues. Specifically, rIPL/rIFG were recruited only during the imitative context, when participants responded with similar actions. When responding to symbolic arrow cues, rIPL/rIFG activity increased during dissimilar responses, reflecting increased demands placed on general cognitive control mechanisms. These results suggest a specific role of rIPL/rIFG during imitation of hand actions, and also a general role of frontoparietal areas in mediating dissimilar responses to both hand actions and symbolic stimuli. We discuss our findings in relation to recent work that has examined the role of frontoparietal brain structures in joint-actions and inter-actor cooperation. We conclude that the specific brain regions identified here to show increased activation during action observation conditions are likely to form part of a mechanism specifically involved in matching observed actions directly with internal motor plans. Conversely, observation of arrow cues recruited part of a wider cognitive control network involved in the rapid remapping of stimulus-response associations.	[Ocampo, Brenda; Kritikos, Ada; Cunnington, Ross] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Ocampo, B (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	b.ocampo@uq.edu.au		Cunnington, Ross/0000-0002-7423-4809	National Health and Medical Research Council of Australia (NHMRC)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by funding of the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brett M, 2002, NEUROIMAGE, V16; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Eriksen CW, 1995, FLANKERS TASK RESPON; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Imamizu H, 2004, J NEUROSCI, V24, P1173, DOI 10.1523/JNEUROSCI.4011-03.2004; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	28	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26945	10.1371/journal.pone.0026945	http://dx.doi.org/10.1371/journal.pone.0026945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046422	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800052
J	Polito, MJ; Trivelpiece, WZ; Karnovsky, NJ; Ng, E; Patterson, WP; Emslie, SD				Polito, Michael J.; Trivelpiece, Wayne Z.; Karnovsky, Nina J.; Ng, Elizabeth; Patterson, William P.; Emslie, Steven D.			Integrating Stomach Content and Stable Isotope Analyses to Quantify the Diets of Pygoscelid Penguins	PLOS ONE			English	Article							CHINSTRAP PENGUINS; ADELIE PENGUINS; TEMPORAL VARIATION; SEASONAL-CHANGES; FORAGING-NICHE; SEABIRDS; POPULATION; DIGESTION; ECOLOGY; ISLAND	Stomach content analysis (SCA) and more recently stable isotope analysis (SIA) integrated with isotopic mixing models have become common methods for dietary studies and provide insight into the foraging ecology of seabirds. However, both methods have drawbacks and biases that may result in difficulties in quantifying inter-annual and species-specific differences in diets. We used these two methods to simultaneously quantify the chick-rearing diet of Chinstrap (Pygoscelis antarctica) and Gentoo (P. papua) penguins and highlight methods of integrating SCA data to increase accuracy of diet composition estimates using SIA. SCA biomass estimates were highly variable and underestimated the importance of soft-bodied prey such as fish. Two-source, isotopic mixing model predictions were less variable and identified inter-annual and species-specific differences in the relative amounts of fish and krill in penguin diets not readily apparent using SCA. In contrast, multi-source isotopic mixing models had difficulty estimating the dietary contribution of fish species occupying similar trophic levels without refinement using SCA-derived otolith data. Overall, our ability to track inter-annual and species-specific differences in penguin diets using SIA was enhanced by integrating SCA data to isotopic mixing modes in three ways: 1) selecting appropriate prey sources, 2) weighting combinations of isotopically similar prey in two-source mixing models and 3) refining predicted contributions of isotopically similar prey in multi-source models.	[Polito, Michael J.; Emslie, Steven D.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Trivelpiece, Wayne Z.] Natl Marine Fisheries Serv, Antarctic Ecosyst Res Div, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA; [Karnovsky, Nina J.; Ng, Elizabeth] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Patterson, William P.] Univ Saskatchewan, Dept Geol Sci, Isotope Lab, Saskatoon, SK S7N 0W0, Canada	University of North Carolina; University of North Carolina Wilmington; National Oceanic Atmospheric Admin (NOAA) - USA; Claremont Colleges; Pomona College; University of Saskatchewan	Polito, MJ (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	mjp7454@uncw.edu	Polito, Michael/G-9118-2012; , Bill/GSD-6628-2022; Patterson, William P/J-6473-2012	Polito, Michael/0000-0001-8639-4431; Patterson, William/0000-0003-3387-708X; Chiaradia, Andre/0000-0002-6178-4211	U.S. AMLR; U.S. National Science Foundation Office of Polar Programs	U.S. AMLR; U.S. National Science Foundation Office of Polar Programs(National Science Foundation (NSF))	This research was funded by U.S. AMLR Program (http://swfsc.noaa.gov) and U.S. National Science Foundation Office of Polar Programs (www.nsf.gov) grants to S. Emslie and W. Trivelpiece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Bond Alexander L., 2009, Marine Ornithology, V37, P183; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Casaux Ricardo J., 1995, Marine Ornithology, V23, P101; CCAMLR, 1997, CCAMLR EC MON PROGR; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2011, POLAR SCI, V5, P286, DOI 10.1016/j.polar.2010.12.004; Chiaradia A, 2010, ICES J MAR SCI, V67, P1710, DOI 10.1093/icesjms/fsq067; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; GALES RP, 1987, IBIS, V129, P335, DOI 10.1111/j.1474-919X.1987.tb03177.x; Hecht T., 1987, South African Journal of Antarctic Research, V17, P2; Hedd A, 2010, AQUAT BIOL, V9, P13, DOI 10.3354/ab00225; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2009, WATERBIRDS, V32, P481, DOI 10.1675/063.032.0401; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jackson S, 1987, FUNCT ECOL, V1, P287, DOI 10.2307/2389433; JACKSON S, 1986, AUK, V103, P617; Jaeger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016484; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Jansen JK, 1998, MAR ECOL PROG SER, V165, P161, DOI 10.3354/meps165161; Karnovsky NJ, 2008, MAR ECOL PROG SER, V357, P291, DOI 10.3354/meps07295; KARNOVSKY NJ, 1997, THESIS MONTANA STATE; Knoff AJ, 2002, WATERBIRDS, V25, P142, DOI 10.1675/1524-4695(2002)025[0142:SIAOTV]2.0.CO;2; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Miller AK, 2008, MAR BIOL, V154, P201, DOI 10.1007/s00227-008-0909-z; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Miller AK, 2009, MAR BIOL, V156, P2527, DOI 10.1007/s00227-009-1277-z; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Nyssen F, 2005, THESIS U LIEGE; Olsson O, 1997, IBIS, V139, P504, DOI 10.1111/j.1474-919X.1997.tb04666.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Polito M, 2002, ANTARCT SCI, V14, P327, DOI 10.1017/S0954102002000184; Polito MJ, 2011, POLAR BIOL, V34, P1057, DOI 10.1007/s00300-011-0966-5; Polito MJ, 2011, MAR ECOL PROG SER, V421, P265, DOI 10.3354/meps08863; Ronconi RA, 2010, MAR ECOL PROG SER, V419, P267, DOI 10.3354/meps08860; RYAN PG, 1986, AUK, V103, P427; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Tierney M, 2009, THESIS U TASMANIA; Tierney M, 2008, MAR ECOL PROG SER, V355, P297, DOI 10.3354/meps07235; VOLKMAN NJ, 1980, CONDOR, V82, P373, DOI 10.2307/1367558; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Williams R., 1990, ANARE RES NOTES, V75, P1; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109	50	102	104	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26642	10.1371/journal.pone.0026642	http://dx.doi.org/10.1371/journal.pone.0026642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053199	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800025
J	Lee, MY; Racine, V; Jagadpramana, P; Sun, L; Yu, WM; Du, TH; Spencer-Dene, B; Rubin, N; Le, L; Ndiaye, D; Bellusci, S; Kratochwil, K; Veltmaat, JM				Lee, May Yin; Racine, Victor; Jagadpramana, Peter; Sun, Li; Yu, Weimiao; Du, Tiehua; Spencer-Dene, Bradley; Rubin, Nicole; Le, Lendy; Ndiaye, Delphine; Bellusci, Saverio; Kratochwil, Klaus; Veltmaat, Jacqueline M.			Ectodermal Influx and Cell Hypertrophy Provide Early Growth for All Murine Mammary Rudiments, and Are Differentially Regulated among Them by Gli3	PLOS ONE			English	Article							GLAND DEVELOPMENT; SIGNALING PATHWAYS; EPITHELIAL-CELLS; HAIR FOLLICLE; MOUSE; IDENTIFICATION; EXPRESSION; PROMOTES; GENE; TBX3	Mammary gland development starts in utero with one or several pairs of mammary rudiments (MRs) budding from the surface ectodermal component of the mammalian embryonic skin. Mice develop five pairs, numbered MR1 to MR5 from pectoral to inguinal position. We have previously shown that Gli3(Xt-J/Xt-J) mutant embryos, which lack the transcription factor Gli3, do not form MR3 and MR5. We show here that two days after the MRs emerge, Gli3(Xt-J/Xt-J) MR1 is 20% smaller, and Gli3(Xt-J/Xt-J) MR2 and MR4 are 50% smaller than their wild type (wt) counterparts. Moreover, while wt MRs sink into the underlying dermis, Gli3(Xt-J/Xt-J) MR4 and MR2 protrude outwardly, to different extents. To understand why each of these five pairs of functionally identical organs has its own, distinct response to the absence of Gli3, we determined which cellular mechanisms regulate growth of the individual MRs, and whether and how Gli3 regulates these mechanisms. We found a 5.5 to 10.7-fold lower cell proliferation rate in wt MRs compared to their adjacent surface ectoderm, indicating that MRs do not emerge or grow via locally enhanced cell proliferation. Cell-tracing experiments showed that surface ectodermal cells are recruited toward the positions where MRs emerge, and contribute to MR growth during at least two days. During the second day of MR development, peripheral cells within the MRs undergo hypertrophy, which also contributes to MR growth. Limited apoptotic cell death counterbalances MR growth. The relative contribution of each of these processes varies among the five MRs. Furthermore, each of these processes is impaired in the absence of Gli3, but to different extents in each MR. This differential involvement of Gli3 explains the variation in phenotype among Gli3(Xt-J/Xt-J) MRs, and may help to understand the variation in numbers and positions of mammary glands among mammals.	[Lee, May Yin; Racine, Victor; Jagadpramana, Peter; Sun, Li; Yu, Weimiao; Veltmaat, Jacqueline M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Lee, May Yin] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Ctr Life Sci CeLS, Singapore 117548, Singapore; [Du, Tiehua] ASTAR, Bioinformat Inst, Singapore, Singapore; [Spencer-Dene, Bradley] Canc Res UK London Res Inst, Expt Histopathol Lab, London, England; [Rubin, Nicole; Le, Lendy; Bellusci, Saverio] Childrens Hosp Los Angeles, Dev Biol Program, Saban Res Inst, Los Angeles, CA 90027 USA; [Ndiaye, Delphine] Inst Curie, CNRS, UMR144, Equipe Morphogenese Cellulaire & Progress Tumor, F-75231 Paris, France; [Kratochwil, Klaus] Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; [Veltmaat, Jacqueline M.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Cancer Research UK; Children's Hospital Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Austrian Academy of Sciences; National University of Singapore	Lee, MY (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.	jmveltmaat@imcb.a-star.edu.sg	Veltmaat, Jacqueline/G-9648-2011; Lee, May Yin/AAB-3450-2021; Yu, Weimiao/AAN-4790-2020; Racine, Victor/I-4576-2014	Lee, May Yin/0000-0003-2366-9463; Racine, Victor/0000-0002-1486-8973	European Commission [QLGA-CT-2000-52130]; California Breast Cancer Research Program [10-FB-0116]; Children's Hospital Los Angeles; Ellis Fund; Graduate Academy and Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR) Singapore	European Commission(European CommissionEuropean Commission Joint Research Centre); California Breast Cancer Research Program; Children's Hospital Los Angeles; Ellis Fund; Graduate Academy and Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR))	This study was financially supported by the European Commission Fifth Framework (QLGA-CT-2000-52130 to JMV), California Breast Cancer Research Program (10-FB-0116 to JMV) and Children's Hospital Los Angeles (to JMV), the Ellis Fund (to KK), and the Graduate Academy and Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; BALINSKY B. I., 1949, TRANS ROY SOC EDINBURGH, V62, P1; BALINSKY BI, 1950, J ANAT, V84, P227; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cho KW, 2006, P NATL ACAD SCI USA, V103, P16788, DOI 10.1073/pnas.0604645103; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; CUNHA GR, 1995, ACTA ANAT, V152, P195; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Gallego MI, 2002, DEV BIOL, V249, P131, DOI 10.1006/dbio.2002.0761; Gonzalez RC, 1992, DIGITAL IMAGE PROCES, Vxvi, P716; GOSHTASBY A, 1986, PATTERN RECOGN, V19, P459, DOI 10.1016/0031-3203(86)90044-0; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Heckman BM, 2007, DEV BIOL, V309, P137, DOI 10.1016/j.ydbio.2007.07.002; HEUBERGER B, 1982, P NATL ACAD SCI-BIOL, V79, P2957, DOI 10.1073/pnas.79.9.2957; Howard B, 2005, GENE DEV, V19, P2078, DOI 10.1101/gad.338505; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; JOHNSON DR, 1969, GENET RES, V13, P275, DOI 10.1017/S0016672300002962; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; KRISS JP, 1961, CANCER RES, V21, P1141; Lankton S, 2008, ACTIVE CONTOUR SEGME; Lewis MT, 2004, J MAMMARY GLAND BIOL, V9, P165, DOI 10.1023/B:JOMG.0000037160.24731.35; Lourakis MIA, 2004, LEVMAR LEVENBERGMARQ; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Mosca E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S8; Mustonen T, 2004, DEVELOPMENT, V131, P4907, DOI 10.1242/dev.01377; PROPPER AY, 1978, DEV BIOL, V67, P225, DOI 10.1016/0012-1606(78)90311-1; Propper AY, 1973, DEV EMBRYONNAIRE GLA, P189; Renault MA, 2009, CIRC RES, V105, P818, DOI 10.1161/CIRCRESAHA.109.206706; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Robinson GW, 1999, J MAMMARY GLAND BIOL, V4, P9, DOI 10.1023/A:1018748418447; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Veltmaat JM, 2004, DEV DYNAM, V229, P349, DOI 10.1002/dvdy.10441; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Yu WM, 2010, CYTOM PART A, V77A, P379, DOI 10.1002/cyto.a.20876	43	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26242	10.1371/journal.pone.0026242	http://dx.doi.org/10.1371/journal.pone.0026242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046263	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400013
J	van de Crommenacker, J; Komdeur, J; Richardson, DS				van de Crommenacker, Janske; Komdeur, Jan; Richardson, David S.			Assessing the Cost of Helping: The Roles of Body Condition and Oxidative Balance in Seychelles Warbler (Acrocephalus sechellensis)	PLOS ONE			English	Article							COOPERATIVELY BREEDING BIRDS; GALLUS-GALLUS-DOMESTICUS; FITNESS BENEFITS; REPRODUCTIVE SUCCESS; ANTIOXIDANT CAPACITY; OXYGEN-CONSUMPTION; ENERGY-EXPENDITURE; TERRITORY QUALITY; SOCIAL-DOMINANCE; PIED FLYCATCHER	In cooperatively breeding species, helping close relatives may provide important fitness benefits. However, helping can be energetically expensive and may result in increased generation of reactive oxygen species. Consequently, an oxidant/antioxidant imbalance can lead to higher oxidative stress susceptibility. Given the potential costs of helping, it may be that only individuals with a sufficiently good body condition and/or stable oxidative balance can afford to help. Knowledge about relationships between social status and oxidative balance in cooperatively breeding systems is still limited. Studying these relationships is important for understanding the costs of helping and physiological pressures of reproduction. Here we evaluate the relationship between helping behaviour, body condition and oxidative balance in a wild population of the cooperatively breeding Seychelles warbler (Acrocephalus sechellensis). In this species, some subordinate individuals help dominant birds with the rearing of young, while others refrain from any assistance. We assessed body condition and oxidative parameters of birds of different social status caught during different breeding stages. We found that, prior to breeding, female subordinates that did not subsequently help (non-helpers) had significantly lower body condition and higher ROMs (reactive oxygen metabolites) than helpers and dominants. During the later stages of breeding, body condition was low in dominants and helpers, but high in non-helpers. Differences in oxidative balance between individuals of different social status were found only during nest care: Dominant males occupied with guarding behaviours tended to have relatively high oxidative stress susceptibility. Furthermore, dominant and helper females showed elevated antioxidant capacity (measured as OXY) in the weeks just prior to egg-laying, possibly representing a change in their reproductive physiology. The results imply that an individuals' oxidative balance may be influenced by factors related to reproduction, which can differ with sex and-within cooperative breeding systems-social status.	[van de Crommenacker, Janske; Komdeur, Jan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Behav Ecol & Self Org, Groningen, Netherlands; [van de Crommenacker, Janske] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Richardson, David S.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Richardson, David S.] Nat Seychelles, Mahe, Seychelles	University of Groningen; University of Groningen; University of East Anglia	van de Crommenacker, J (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Behav Ecol & Self Org, Groningen, Netherlands.	j.van.de.crommenacker@rug.nl	Richardson, David S/A-5082-2010; Komdeur, Jan/X-1261-2019	Richardson, David S/0000-0001-7226-9074; Komdeur, Jan/0000-0002-9241-0124	Dr. J.L. Dobberke Foundation; WOTRO (Wetenschappelijk Onderzoek in de Tropen, Science for Global Development) [W82-289]	Dr. J.L. Dobberke Foundation; WOTRO (Wetenschappelijk Onderzoek in de Tropen, Science for Global Development)	JvdC was supported by a grant from the Dr. J.L. Dobberke Foundation and a WOTRO grant (Wetenschappelijk Onderzoek in de Tropen, Science for Global Development, grant number W82-289; provided by the Netherlands Organisation for Scientific Research) allocated to JK and DSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2000, RES CHEM INTERMEDIAT, V26, P253, DOI 10.1163/156856700X00769; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Alonso-Alvarez C, 2010, PHYSIOL BIOCHEM ZOOL, V83, P110, DOI 10.1086/605395; AMES BN, 1991, OXIDATIVE DAMAGE & REPAIR, P181; Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; AUSTAD SN, 1985, BEHAV ECOL SOCIOBIOL, V17, P19, DOI 10.1007/BF00299423; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2002, FUNCT ECOL, V16, P445, DOI 10.1046/j.1365-2435.2002.00648.x; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Brouwer L, 2009, ETHOLOGY, V115, P576, DOI 10.1111/j.1439-0310.2009.01643.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Brown J.L., 1987, HELPING COMMUNAL BRE; BROWN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P281, DOI 10.1007/BF00302818; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; CHASE ID, 1980, AM NAT, V115, P827, DOI 10.1086/283603; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cockburn A, 2008, J ANIM ECOL, V77, P430, DOI 10.1111/j.1365-2656.2007.01351.x; Conway CJ, 2000, EVOLUTION, V54, P670; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2008, BIOL LETTERS, V4, P119, DOI 10.1098/rsbl.2007.0513; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2010, J COMP PHYSIOL B, V180, P731, DOI 10.1007/s00360-010-0456-z; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; CREEL SR, 1991, BEHAV ECOL SOCIOBIOL, V28, P263; CRICK HQP, 1992, IBIS, V134, P56, DOI 10.1111/j.1474-919X.1992.tb07230.x; Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439; Cullen NJ, 1996, J AVIAN BIOL, V27, P92, DOI 10.2307/3676966; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DEERENBERG C, 1995, ZOOL-ANAL COMPLEX SY, V99, P39; EDEN SF, 1987, BEHAV ECOL SOCIOBIOL, V21, P191, DOI 10.1007/BF00303210; Emlen S.T., 1991, P301; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; Emlen T., 1990, P487; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FREED LA, 1981, ECOLOGY, V62, P1179, DOI 10.2307/1937282; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heinsohn R, 1999, TRENDS ECOL EVOL, V14, P53, DOI 10.1016/S0169-5347(98)01545-6; HEINSOHN R, 1994, P ROY SOC B-BIOL SCI, V256, P293, DOI 10.1098/rspb.1994.0083; HEINSOHN RG, 1992, EVOL ECOL, V6, P97, DOI 10.1007/BF02270705; Houston DC, 1997, P NUTR SOC, V56, P1057, DOI 10.1079/PNS19970110; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Iamele L, 2002, CLIN CHEM LAB MED, V40, P673, DOI 10.1515/CCLM.2002.115; JENNIONS MD, 1994, TRENDS ECOL EVOL, V9, P89, DOI 10.1016/0169-5347(94)90202-X; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; Komdeur J, 1999, BEHAV ECOL, V10, P648, DOI 10.1093/beheco/10.6.648; Komdeur J, 1998, ECOL LETT, V1, P56, DOI 10.1046/j.1461-0248.1998.00009.x; Komdeur J., 1991, COOPERATIVE BREEDING; Komdeur J, 2007, ADV STUD BEHAV, V37, P147, DOI 10.1016/S0065-3454(07)37004-6; Komdeur Jan, 1997, Bird Conservation International, V7, P7; Krinsky NI, 2003, BIOCHEM BIOPH RES CO, V305, P754, DOI 10.1016/S0006-291X(03)00816-7; Lack D., 1968, pvii; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P745, DOI 10.1016/j.cbpc.2004.09.014; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; LOFT S, 1994, FASEB J, V8, P534, DOI 10.1096/fasebj.8.8.8181672; Lusk C, 2003, NATURE, V422, P580, DOI 10.1038/422580b; Meade J, 2010, BEHAV ECOL, V21, P1186, DOI 10.1093/beheco/arq137; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008; MORENO J, 1989, BIOL J LINN SOC, V37, P297, DOI 10.1111/j.1095-8312.1989.tb01907.x; MORENO J, 1995, J ANIM ECOL, V64, P721, DOI 10.2307/5851; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Navara KJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1098, DOI 10.1086/507661; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Ozawa T., 1999, UNDERSTANDING PROCES; PIPER WH, 1990, BEHAV ECOL SOCIOBIOL, V26, P201; Rabenold K.N., 1990, P157, DOI 10.1017/CBO9780511752452.007; Rasbash J., 2004, USERS GUIDE MLWIN VE; REYER HU, 1984, ANIM BEHAV, V32, P1163, DOI 10.1016/S0003-3472(84)80233-X; REYER HU, 1980, BEHAV ECOL SOCIOBIOL, V6, P219, DOI 10.1007/BF00569203; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2003, J EVOLUTION BIOL, V16, P854, DOI 10.1046/j.1420-9101.2003.00592.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Robinson MK, 1997, J SURG RES, V69, P325, DOI 10.1006/jsre.1997.5062; Rubolini D, 2006, J EVOLUTION BIOL, V19, P1571, DOI 10.1111/j.1420-9101.2006.01121.x; Russell AF, 2003, P NATL ACAD SCI USA, V100, P3333, DOI 10.1073/pnas.0636503100; Russell AF, 2003, BEHAV ECOL, V14, P486, DOI 10.1093/beheco/arg022; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; Sapolsky RM, 2004, ANNU REV ANTHROPOL, V33, P393, DOI 10.1146/annurev.anthro.33.070203.144000; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SCHOECH SJ, 1991, CONDOR, V93, P354, DOI 10.2307/1368951; Selman C, 2002, ARCH BIOCHEM BIOPHYS, V401, P255, DOI 10.1016/S0003-9861(02)00050-4; Senar JC, 2000, ANIM BEHAV, V59, P103, DOI 10.1006/anbe.1999.1281; SILVERIN B, 1980, J ZOOL, V190, P241; SOHAL RS, 1987, NATURE, V327, P725; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Stearns S.C., 1992, pi; Surai P. F., 2001, Japanese Poultry Science, V38, P117; Surai P. F., 2002, NATURAL ANTIOXIDANTS; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 1998, ANIM BEHAV, V56, P1375, DOI 10.1006/anbe.1998.0918; Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348; van de Crommenacker J, 2004, P ROY SOC B-BIOL SCI, V271, P1023, DOI 10.1098/rspb.2004.2697; van de Crommenacker J, 2011, J ANIM ECOL, V80, P668, DOI 10.1111/j.1365-2656.2010.01792.x; Vehrencamp Sandra L., 2004, P177, DOI 10.1017/CBO9780511606816.012; Verhulst S, 1997, ARDEA, V85, P111; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walling CA, 2007, BIOL LETTERS, V3, P144, DOI 10.1098/rsbl.2006.0608; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wingfield J., 1987, PSYCHOBIOLOGY REPROD, P149; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	135	42	43	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26423	10.1371/journal.pone.0026423	http://dx.doi.org/10.1371/journal.pone.0026423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046283	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400020
J	Benhamou, S; Sudre, J; Bourjea, J; Ciccione, S; De Santis, A; Luschi, P				Benhamou, Simon; Sudre, Joel; Bourjea, Jerome; Ciccione, Stephane; De Santis, Angelo; Luschi, Paolo			The Role of Geomagnetic Cues in Green Turtle Open Sea Navigation	PLOS ONE			English	Article							MARINE TURTLES; CHELONIA-MYDAS; ISLAND; ORIENTATION; MIGRATION; ANIMALS; OCEAN; MAGNETORECEPTION; MECHANISMS; CURRENTS	Background: Laboratory and field experiments have provided evidence that sea turtles use geomagnetic cues to navigate in the open sea. For instance, green turtles (Chelonia mydas) displaced 100 km away from their nesting site were impaired in returning home when carrying a strong magnet glued on the head. However, the actual role of geomagnetic cues remains unclear, since magnetically treated green turtles can perform large scale (> 2000 km) post-nesting migrations no differently from controls. Methodology/Principal Findings: In the present homing experiment, 24 green turtles were displaced 200 km away from their nesting site on an oceanic island, and tracked, for the first time in this type of experiment, with Global Positioning System (GPS), which is able to provide much more frequent and accurate locations than previously used tracking methods. Eight turtles were magnetically treated for 24-48 h on the nesting beach prior to displacement, and another eight turtles had a magnet glued on the head at the release site. The last eight turtles were used as controls. Detailed analyses of water masses-related (i.e., current-corrected) homing paths showed that magnetically treated turtles were able to navigate toward their nesting site as efficiently as controls, but those carrying magnets were significantly impaired once they arrived within 50 km of home. Conclusions/Significance: While green turtles do not seem to need geomagnetic cues to navigate far from the goal, these cues become necessary when turtles get closer to home. As the very last part of the homing trip (within a few kilometers of home) likely depends on non-magnetic cues, our results suggest that magnetic cues play a key role in sea turtle navigation at an intermediate scale by bridging the gap between large and small scale navigational processes, which both appear to depend on non-magnetic cues.	[Benhamou, Simon] CNRS, CEFE, Montpellier, France; [Sudre, Joel] CNRS, LEGOS, Toulouse, France; IFREMER, La Reunion, France; Kelonia, La Reunion, France; [De Santis, Angelo] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Luschi, Paolo] Univ Pisa, Dipartimento Biol, I-56100 Pisa, Italy	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Ifremer; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Pisa	Benhamou, S (corresponding author), CNRS, CEFE, Montpellier, France.	simon.benhamou@cefe.cnrs.fr	De Santis, Angelo/AAG-2895-2021; Sudre, Joël/G-9220-2018	Sudre, Joël/0000-0001-8876-5179; Luschi, Paolo/0000-0001-7081-3507; Bourjea, Jerome/0000-0001-7149-3648	Agence nationale de la Recherche [ANR-07-BLAN-0220-01]	Agence nationale de la Recherche(French National Research Agency (ANR))	The work was funded by Agence nationale de la Recherche http://www.agence-nationale-recherche.fr/, Programme ESTVOI (ANR-07-BLAN-0220-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENHAMOU S, 1992, ANIM BEHAV, V43, P371, DOI 10.1016/S0003-3472(05)80097-1; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benhamou S, 2003, BEHAV PROCESS, V61, P95, DOI 10.1016/S0376-6357(02)00168-7; Benhamou S, 1996, ANIM BEHAV, V52, P201, DOI 10.1006/anbe.1996.0165; Benhamou S, 2003, J THEOR BIOL, V225, P235, DOI 10.1016/S0022-5193(03)00242-X; Benhamou S, 2003, ANIM BEHAV, V65, P729, DOI 10.1006/anbe.2003.2092; Benhamou S, 2010, ENCY BEHAV NEUROCIEN, V2, P497, DOI DOI 10.1016/B978-0-08-045396-5.00106-8; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; Bonadonna F, 2005, P ROY SOC B-BIOL SCI, V272, P489, DOI 10.1098/rspb.2004.2984; Bourjea Jerome, 2007, Endangered Species Research, V3, P273, DOI 10.3354/esr00053; Bowen Brian W., 1996, P190; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Flemming JEM, 2006, ENVIRONMETRICS, V17, P351, DOI 10.1002/env.774; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Hays GC, 2001, J EXP BIOL, V204, P4093; Hays GC, 2003, P ROY SOC B-BIOL SCI, V270, pS5, DOI 10.1098/rsbl.2003.0022; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Johnsen S, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2897947; KENDALL DG, 1974, J R STAT SOC B, V36, P365; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Luschi P, 2001, BEHAV ECOL SOCIOBIOL, V50, P528, DOI 10.1007/s002650100396; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; Mancho AM, 2006, COMPUT FLUIDS, V35, P416, DOI 10.1016/j.compfluid.2005.02.003; Maus S, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001643; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Papi F, 2000, J EXP BIOL, V203, P3435; Rio MH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006505; Sudre J, 2008, OCEAN DYNAM, V58, P101, DOI 10.1007/s10236-008-0134-9; Thebault E, 2010, SPACE SCI REV, V155, P95, DOI 10.1007/s11214-010-9667-6; Thomas L.N., 2008, OCEAN MODEL EDDY REG, P177, DOI [DOI 10.1029/177GM04, 10.1029/177gm04]; Turiel A, 1998, PHYS REV LETT, V80, P1098, DOI 10.1103/PhysRevLett.80.1098; Turiel A, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/1/015501; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Wiltschko R, 2006, BIOESSAYS, V28, P157, DOI 10.1002/bies.20363; Wyneken J., 2001, ANATOMY SEA TURTLES; Yahia H, 2010, PATTERN RECOGN, V43, P3591, DOI 10.1016/j.patcog.2010.04.011	40	21	22	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26672	10.1371/journal.pone.0026672	http://dx.doi.org/10.1371/journal.pone.0026672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046329	Green Published, gold			2022-12-27	WOS:000296519600042
J	Debarnot, U; Clerget, E; Olivier, E				Debarnot, Ursula; Clerget, Emeline; Olivier, Etienne			Role of the Primary Motor Cortex in the Early Boost in Performance Following Mental Imagery Training	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; MEMORY CONSOLIDATION; TIME-COURSE; SLEEP; PLASTICITY; INTERFERENCE; IMAGINATION; MECHANISMS; EXECUTION	Recently, it has been suggested that the primary motor cortex (M1) plays a critical role in implementing the fast and transient post-training phase of motor skill consolidation, known to yield an early boost in performance. Whether a comparable early boost in performance occurs following motor imagery (MIM) training is still unknown. To address this issue, two groups of subjects learned a finger tapping sequence either by MIM or physical practice (PP). In both groups, performance increased significantly in the post-training phase when compared with the pre-training phase and further increased after a 30 min resting period, indicating that both MIM and PP trainings were equally efficient and induced an early boost in motor performance. This conclusion was corroborated by the results of an additional control group. In a second experiment, we then investigated the causal role of M1 in implementing the early boost process resulting from MIM training. To do so, we inhibited M1 by applying a continuous theta-burst stimulation (cTBS) in healthy volunteers just after they learnt, by MIM, the same finger-tapping task as in Experiment #1. As a control, cTBS was applied over the vertex of subjects who underwent the same experiment. We found that cTBS applied over M1 selectively abolished the early boost process subsequent to MIM training. Altogether, the present study provides evidence that MIM practice induces an early boost in performance and demonstrates that M1 is causally involved in this process. These findings further divulge some degree of behavioral and neuronal similitude between MIM and PP.	[Debarnot, Ursula; Clerget, Emeline; Olivier, Etienne] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Universite Catholique Louvain	Debarnot, U (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	etienne.olivier@uclouvain.be			ARC from the Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain [07/12-007]	ARC from the Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain	This work was supported by grants from the ARC (grant 07/12-007, Communaute Francaise de Belgique, Actions de Recherche Concertees), from the Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain. This work was performed at the Institute of Neuroscience of the Universite Catholique de Louvain (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Carrillo-de-la-Pena MT, 2008, BRAIN RES, V1226, P134, DOI 10.1016/j.brainres.2008.05.089; Cash CD, 2009, J RES MUSIC EDUC, V57, P252, DOI 10.1177/0022429409343470; Censor N, 2011, J PHYSIOL-LONDON, V589, P21, DOI 10.1113/jphysiol.2010.198077; Censor N, 2010, CURR BIOL, V20, P1545, DOI 10.1016/j.cub.2010.07.047; Clerget E, J COGN NEUR IN PRESS; Clerget E, 2009, NEUROREPORT, V20, P1496, DOI 10.1097/WNR.0b013e3283329be8; Debarnot U, 2010, BRAIN COGNITION, V74, P52, DOI 10.1016/j.bandc.2010.06.004; Debarnot U, 2009, SLEEP, V32, P1559, DOI 10.1093/sleep/32.12.1559; Debarnot U, 2009, BRAIN COGNITION, V69, P398, DOI 10.1016/j.bandc.2008.08.029; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Guillot A., 2008, INT REV SPORT EXER P, V1, P31, DOI [10.1080/17509840701823139, DOI 10.1080/17509840701823139]; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; Hotermans C, 2008, EUR J NEUROSCI, V28, P1216, DOI 10.1111/j.1460-9568.2008.06421.x; Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iezzi E, 2010, EUR J NEUROSCI, V31, P585, DOI 10.1111/j.1460-9568.2010.07090.x; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; KARNI A, 1995, NATURE, V377, P155; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Pelgrims B, 2011, HUM BRAIN MAPP, V32, P1471, DOI 10.1002/hbm.21121; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Schmitz Remy, 2009, BMC Res Notes, V2, P170, DOI 10.1186/1756-0500-2-170; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Wohldmann EL, 2008, J EXP PSYCHOL LEARN, V34, P823, DOI 10.1037/0278-7393.34.4.823; Wohldmann EL, 2007, J EXP PSYCHOL LEARN, V33, P254, DOI 10.1037/0278-7393.33.1.254; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233; Zhang X, 2011, J NEUROSCI, V31, P11515, DOI 10.1523/JNEUROSCI.6759-10.2011	59	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26717	10.1371/journal.pone.0026717	http://dx.doi.org/10.1371/journal.pone.0026717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046337	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600047
J	Yang, ML; Dong, J; Liu, H; Li, L; Yang, GY				Yang, Mengliu; Dong, Jing; Liu, Hua; Li, Ling; Yang, Gangyi			Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; PPAR-ALPHA; GLYCEMIC CONTROL; FIBROBLAST-GROWTH-FACTOR-21; GLUCOSE; OBESITY; EXPRESSION; SECRETION; FGF-21; KLOTHO	Background: To investigate the effects of short-term continuous subcutaneous insulin infusion (CSII) on plasma fibroblast growth factor-21 (FGF-21) levels in patients with newly diagnosed type 2 diabetes mellitus (nT2DM). Method: Sixty-eight patients with nT2DM (nT2DM group), and 52 gender-, age- and body mass index (BMI) -matched normal glucose tolerance (NGT group) controls participated in the study. 30 nT2DM patients with FBG >= 14.0 mmol/L were treated with CSII for 2 weeks, and were underwent a euglycemic-hyperinsulinemic clamp pre- and post-treatment. Plasma FGF-21 concentrations were measured with a commercial ELISA kit. The relationship between plasma FGF-21 levels and metabolic parameters was also analyzed. Results: Fasting plasma FGF-21 levels were higher in the nT2DM group than in NGT groups (1.60 +/- 0.08 vs. 1.13 +/- 0.26 mu g/L, P<0.01). In nT2DM patients, fasting plasma FGF-21 concentrations were significantly decreased after CSII treatment for 2 weeks (1.60 +/- 0.08 vs. 1.30 +/- 0.05 mu g/L, P<0.05), accompanied by a significant increase in the whole body glucose uptake (M value) and blood glucose control. The changes in plasma FGF-21 levels (Delta FGF-21) were positively associated with the amelioration of insulin resistance shown by the changes in M value. Conclusion: Plasma FGF-21 level is associated with whole body insulin sensitivity and significantly reduced following short-term CSII treatment.	[Yang, Mengliu; Dong, Jing; Li, Ling; Yang, Gangyi] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Liu, Hua] Univ Mississippi Med Ctr, Dept Pediat, Jackson, MS USA	Chongqing Medical University; University of Mississippi; University of Mississippi Medical Center	Yang, ML (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China.	lingli31@yahoo.com.cn; gangyiyang@yahoo.com.cn		Yang, Gangyi/0000-0002-6458-6747	National Natural Science Foundation of China [30871199, 30771037, 30971388, 81070640]; Ministry of Education of China [20105503110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (30871199, 30771037, 30971388, and 81070640) and the Doctoral Fund of the Ministry of Education of China (20105503110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alvarsson M, 2003, DIABETES CARE, V26, P2231, DOI 10.2337/diacare.26.8.2231; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen WW, 2007, EXP CLIN ENDOCRINOL, V115, P1; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Lormeau B, 1997, METABOLISM, V46, P1074, DOI 10.1016/S0026-0495(97)90281-X; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	27	25	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26359	10.1371/journal.pone.0026359	http://dx.doi.org/10.1371/journal.pone.0026359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046277	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600016
J	Zhang, L; Wu, DX; Shi, HQ; Zhang, CJ; Zhan, XY; Zhou, SX				Zhang, Lin; Wu, Dongxiu; Shi, Huiqiu; Zhang, Canjuan; Zhan, Xiaoyun; Zhou, Shuangxi			Effects of Elevated CO2 and N Addition on Growth and N-2 Fixation of a Legume Subshrub (Caragana microphylla Lam.) in Temperate Grassland in China	PLOS ONE			English	Article							SYMBIOTIC NITROGEN-FIXATION; WOODY-PLANT ENCROACHMENT; LEAF GAS-EXCHANGE; ENVIRONMENTAL-CHANGES; ECOSYSTEM RESPONSES; COMMUNITY STRUCTURE; ATMOSPHERIC CO2; INNER-MONGOLIA; AVAILABILITY; ENRICHMENT	It is well demonstrated that the responses of plants to elevated atmospheric CO2 concentration are species-specific and dependent on environmental conditions. We investigated the responses of a subshrub legume species, Caragana microphylla Lam., to elevated CO2 and nitrogen (N) addition using open-top chambers in a semiarid temperate grassland in northern China for three years. Measured variables include leaf photosynthetic rate, shoot biomass, root biomass, symbiotic nitrogenase activity, and leaf N content. Symbiotic nitrogenase activity was determined by the C2H2 reduction method. Elevated CO2 enhanced photosynthesis and shoot biomass by 83% and 25%, respectively, and the enhancement of shoot biomass was significant only at a high N concentration. In addition, the photosynthetic capacity of C. microphylla did not show down-regulation under elevated CO2. Elevated CO2 had no significant effect on root biomass, symbiotic nitrogenase activity and leaf N content. Under elevated CO2, N addition stimulated photosynthesis and shoot biomass. By contrast, N addition strongly inhibited symbiotic nitrogenase activity and slightly increased leaf N content of C. microphylla under both CO2 levels, and had no significant effect on root biomass. The effect of elevated CO2 and N addition on C. microphylla did not show interannual variation, except for the effect of N addition on leaf N content. These results indicate that shoot growth of C. microphylla is more sensitive to elevated CO2 than is root growth. The stimulation of shoot growth of C. microphylla under elevated CO2 or N addition is not associated with changes in N-2-fixation. Additionally, elevated CO2 and N addition interacted to affect shoot growth of C. microphylla with a stimulatory effect occurring only under combination of these two factors.	[Zhang, Lin; Wu, Dongxiu; Shi, Huiqiu; Zhang, Canjuan; Zhan, Xiaoyun; Zhou, Shuangxi] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Shi, Huiqiu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, L (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	wudx@ibcas.ac.cn		Zhou, Shuangxi/0000-0003-2930-2910	Natural Science Foundation of China [30270945]; Station Foundation of the Chinese Academy of Sciences, State Key Lab of Vegetation and Environmental Change	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Station Foundation of the Chinese Academy of Sciences, State Key Lab of Vegetation and Environmental Change	This work was supported by a grant from the Natural Science Foundation of China (30270945), and Station Foundation of the Chinese Academy of Sciences, State Key Lab of Vegetation and Environmental Change (VEWALNE-project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Arnone JA, 2000, NEW PHYTOL, V147, P73, DOI 10.1046/j.1469-8137.2000.00685.x; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Curtis PS, 1996, PLANT CELL ENVIRON, V19, P127, DOI 10.1111/j.1365-3040.1996.tb00234.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Edwards EJ, 2006, NEW PHYTOL, V169, P157, DOI 10.1111/j.1469-8137.2005.01568.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fischinger SA, 2010, J EXP BOT, V61, P121, DOI 10.1093/jxb/erp287; Hartwig UA, 2000, PLANT SOIL, V224, P43, DOI 10.1023/A:1004601915836; Hungate BA, 2004, SCIENCE, V304, P1291, DOI 10.1126/science.1095549; Hungate BA, 1999, GLOBAL CHANGE BIOL, V5, P781, DOI 10.1046/j.1365-2486.1999.00275.x; Jin VL, 2010, OECOLOGIA, V163, P257, DOI 10.1007/s00442-010-1562-z; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LEE KK, 1977, PLANT SOIL, V47, P519, DOI 10.1007/BF00011022; Lee TD, 2003, PLANT SOIL, V255, P475, DOI 10.1023/A:1026072130269; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Lu XT, 2010, PLANT SOIL, V327, P481, DOI 10.1007/s11104-009-0078-y; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luscher A, 2000, GLOB CHANGE BIOL, V6, P655, DOI 10.1046/j.1365-2486.2000.00345.x; MCCONNAUGHAY KDM, 1993, OECOLOGIA, V94, P550, DOI 10.1007/BF00566971; McKinley DC, 2009, GLOBAL CHANGE BIOL, V15, P2035, DOI 10.1111/j.1365-2486.2008.01836.x; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Pan Q, 2005, J PLANT ECOLOGY, V29, P7; Pearson HL, 2002, ECOSYSTEMS, V5, P587, DOI 10.1007/s10021-002-0172-y; Polley HW, 2003, PLANT ECOL, V164, P85, DOI 10.1023/A:1021271226866; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Rogers A, 2006, PLANT CELL ENVIRON, V29, P1651, DOI 10.1111/j.1365-3040.2006.01549.x; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Scott RL, 2006, GLOBAL CHANGE BIOL, V12, P311, DOI 10.1111/j.1365-2486.2005.01093.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Suter D, 2002, NEW PHYTOL, V154, P65, DOI 10.1046/j.1469-8137.2002.00368.x; THIES JE, 1995, SOIL BIOL BIOCHEM, V27, P575, DOI 10.1016/0038-0717(95)98634-Z; Thomas RB, 2000, NEW PHYTOL, V145, P233, DOI 10.1046/j.1469-8137.2000.00577.x; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wang XZ, 2010, OECOLOGIA, V163, P1, DOI 10.1007/s00442-010-1572-x; West JB, 2005, NEW PHYTOL, V167, P523, DOI 10.1111/j.1469-8137.2005.01444.x; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xiong XiaoGang, 2003, Acta Prataculturae Sinica, V12, P57; [熊小刚 Xiong Xiaogang], 2005, [生态学报, Acta Ecologica Sinica], V25, P1678; Zavaleta ES, 2006, PLANT ECOL, V184, P53, DOI 10.1007/s11258-005-9051-x; Zhang Can-Juan, 2009, Chinese Journal of Plant Ecology, V33, P1165, DOI 10.3773/j.issn.1005-264x.2009.06.017; Zhang L, 2010, J ENVIRON QUAL, V39, P251, DOI 10.2134/jeq2009.0109	49	6	12	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26842	10.1371/journal.pone.0026842	http://dx.doi.org/10.1371/journal.pone.0026842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046376	Green Submitted, gold, Green Published			2022-12-27	WOS:000296519600063
J	Sugiyama, M; Tanaka, Y; Wakita, T; Nakanishi, M; Mizokami, M				Sugiyama, Masaya; Tanaka, Yasuhito; Wakita, Takaji; Nakanishi, Makoto; Mizokami, Masashi			Genetic Variation of the IL-28B Promoter Affecting Gene Expression	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TUMOR MICROSATELLITE-INSTABILITY; POTENT ANTIVIRAL ACTIVITY; GILBERTS-SYNDROME; COLORECTAL-CANCER; UGT1A1 GENE; ADJUVANT CHEMOTHERAPY; BILIRUBIN METABOLISM; INTERFERON-ALPHA; IFN-LAMBDA	The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-alpha (PEG-IFN-alpha) and ribavirin (RBV). The treatment achieves a sustained viral clearance in only approximately 50% of patients. Recent whole genome association studies revealed that single nucleotide polymorphisms (SNPs) around IL-28B have been associated with response to the standard therapy and could predict treatment responses at approximately 80%. However, it is not clear which SNP is most informative because the genomic region containing significant SNPs shows strong linkage disequilibrium. We focused on SNPs in close proximity to the IL-28B gene to evaluate the function of each and identify the SNP affecting the IL-28B expression level most. The structures of IL-28A/B from 5' to 3'-UTR were determined by complete cDNA cloning. Both IL-28A and 28B genes consisted of 6 exons, differing from the CCDS data of NCBI. Two intron SNPs and a nonsynonymous SNP did not affect IL-28B gene function and expression levels but a SNP located in the proximal promoter region influenced gene expression. A (TA) dinucleotide repeat, rs72258881, located in the promoter region was discovered by our functional studies of the proximal SNPs upstream of IL-28B; the transcriptional activity of the promoter increased gradually in a (TA)(n) length-dependent manner following IFN-alpha and lipopolysaccharide stimulation. Healthy Japanese donors exhibited a broad range of (TA) dinucleotide repeat numbers from 10 to 18 and the most prevalent genotype was 12/12 (75%), differing from the database (13/13). However, genetic variation of IL-28A corresponding to that of IL-28B was not detected in these Japanese donors. These findings suggest that the dinucleotide repeat could be associated with the transcriptional activity of IL-28B as well as being a marker to improve the prediction of the response to interferon-based hepatitis C virus treatment.	[Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Sugiyama, Masaya; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem & Cell Biol, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol & Liver Unit, Nagoya, Aichi, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Sugiyama, Masaya] Japan Soc Promot Sci, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Nagoya City University; Nagoya City University; National Institute of Infectious Diseases (NIID); Japan Society for the Promotion of Science	Sugiyama, M (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan.	mmizokami@hospk.ncgm.go.jp		Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]; National Center for Global Health and Medicine [22-302]	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by a Grant-in-Aid from the Ministry of Health Labor and Welfare of Japan and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000) and The Grant of National Center for Global Health and Medicine (22-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Bartlett NW, 2005, J GEN VIROL, V86, P1589, DOI 10.1099/vir.0.80904-0; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; FUKUHARA T, 2010, GASTROENTEROLOGY; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Gupta E, 1997, J CLIN ONCOL, V15, P1502, DOI 10.1200/JCO.1997.15.4.1502; GUPTA E, 1994, CANCER RES, V54, P3723; Iyanagi T, 1998, BBA-MOL BASIS DIS, V1407, P173, DOI 10.1016/S0925-4439(98)00044-1; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Kim GP, 2007, J CLIN ONCOL, V25, P4857, DOI 10.1200/JCO.2007.13.2019; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; MONAGHAN G, 1996, LANCET, V347, P578, DOI DOI 10.1016/S0140-6736(96)91273-8; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Raijmakers MTM, 2000, J HEPATOL, V33, P348, DOI 10.1016/S0168-8278(00)80268-8; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; ROWINSKY EK, 1994, CANCER RES, V54, P427; Sadee W, 2005, HUM MOL GENET, V14, pR207, DOI 10.1093/hmg/ddi261; Sato H, 1996, LANCET, V347, P557, DOI 10.1016/S0140-6736(96)91266-0; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2010, HEPATOL RES, V40, P449, DOI 10.1111/j.1872-034X.2010.00671.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wasserman E, 1997, ANN ONCOL, V8, P1049, DOI 10.1023/A:1008261821434; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80	46	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26620	10.1371/journal.pone.0026620	http://dx.doi.org/10.1371/journal.pone.0026620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046316	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000022
J	Guillemot, N; Kulbicki, M; Chabanet, P; Vigliola, L				Guillemot, Nicolas; Kulbicki, Michel; Chabanet, Pascale; Vigliola, Laurent			Functional Redundancy Patterns Reveal Non-Random Assembly Rules in a Species-Rich Marine Assemblage	PLOS ONE			English	Article							FISH ASSEMBLAGES; ECOSYSTEM FUNCTION; HABITAT STRUCTURE; CORAL-REEFS; DIVERSITY; BIODIVERSITY; RESILIENCE; SEAGRASS; COMMUNITIES; STABILITY	The relationship between species and the functional diversity of assemblages is fundamental in ecology because it contains key information on functional redundancy, and functionally redundant ecosystems are thought to be more resilient, resistant and stable. However, this relationship is poorly understood and undocumented for species-rich coastal marine ecosystems. Here, we used underwater visual censuses to examine the patterns of functional redundancy for one of the most diverse vertebrate assemblages, the coral reef fishes of New Caledonia, South Pacific. First, we found that the relationship between functional and species diversity displayed a non-asymptotic power-shaped curve, implying that rare functions and species mainly occur in highly diverse assemblages. Second, we showed that the distribution of species amongst possible functions was significantly different from a random distribution up to a threshold of similar to 90 species/transect. Redundancy patterns for each function further revealed that some functions displayed fast rates of increase in redundancy at low species diversity, whereas others were only becoming redundant past a certain threshold. This suggested non-random assembly rules and the existence of some primordial functions that would need to be fulfilled in priority so that coral reef fish assemblages can gain a basic ecological structure. Last, we found little effect of habitat on the shape of the functional-species diversity relationship and on the redundancy of functions, although habitat is known to largely determine assemblage characteristics such as species composition, biomass, and abundance. Our study shows that low functional redundancy is characteristic of this highly diverse fish assemblage, and, therefore, that even species-rich ecosystems such as coral reefs may be vulnerable to the removal of a few keystone species.	[Guillemot, Nicolas; Vigliola, Laurent] IRD, UR CoReUs, Noumea, New Caledonia; [Guillemot, Nicolas] Univ Europeenne Bretagne, INRA Ecol & Sante Ecosyst, UMR 985, Rennes, France; [Guillemot, Nicolas] Koniambo Nickel SAS, Noumea, New Caledonia; [Kulbicki, Michel] IRD, UR CoReUs, Banyuls Sur Mer, France; [Chabanet, Pascale] IRD, UR CoReUs, Ste Clotilde, Reunion, France	Institut de Recherche pour le Developpement (IRD); INRAE; Universite de Bretagne Occidentale; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Guillemot, N (corresponding author), IRD, UR CoReUs, Noumea, New Caledonia.	nicolas.guillemot@gmail.com	Vigliola, Laurent/J-7107-2016; Chabanet, Pascale/L-9470-2017	Vigliola, Laurent/0000-0003-4715-7470; Kulbicki, Michel/0000-0003-1258-5061; Chabanet, Pascale/0000-0001-7600-943X	Institute of Research for the Development, Koniambo Nickel SAS; South Pacific Community; Aquaculture and Fisheries Department of the Northern Province of New Caledonia; French Agence Nationale pour la Recherche et la Technologie; FRB (Fondation de la Recherche sur la Biodiversite); Institute of Research for the Development, Koniambo Nickel SAS; South Pacific Community; Aquaculture and Fisheries Department of the Northern Province of New Caledonia; French Agence Nationale pour la Recherche et la Technologie; FRB (Fondation de la Recherche sur la Biodiversite)	Institute of Research for the Development, Koniambo Nickel SAS; South Pacific Community; Aquaculture and Fisheries Department of the Northern Province of New Caledonia; French Agence Nationale pour la Recherche et la Technologie(French National Research Agency (ANR)); FRB (Fondation de la Recherche sur la Biodiversite); Institute of Research for the Development, Koniambo Nickel SAS; South Pacific Community; Aquaculture and Fisheries Department of the Northern Province of New Caledonia; French Agence Nationale pour la Recherche et la Technologie(French National Research Agency (ANR)); FRB (Fondation de la Recherche sur la Biodiversite)	This work was supported by the Institute of Research for the Development, Koniambo Nickel SAS, the South Pacific Community, the Aquaculture and Fisheries Department of the Northern Province of New Caledonia and the French Agence Nationale pour la Recherche et la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors thank the Aquaculture and Fisheries Department of the Northern Province of New Caledonia, the South Pacific Community and Koniambo Nickel SAS which constituted, along with the Institute of Research for the Development, the partnership that allowed the collection of the data used in this paper. In particular, we thank Sebastien Sarramegna, Pierre Labrosse, Gerard Mou-Tham, Pierre Boblin, Nicolas Maihota, Samasoni Sauni, Nathalie Baillon, Nathaniel Cornuet, Denis Poignonec and Sylvain Capo for their precious help in the field. The authors also acknowledge the RESICOD program, financed by FRB (Fondation de la Recherche sur la Biodiversite), for providing a general framework.	Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Bell JJ, 2007, MAR ECOL PROG SER, V339, P73, DOI 10.3354/meps339073; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Buckland S.T., 2001, pi; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chabanet P, 2010, MAR POLLUT BULL, V61, P598, DOI 10.1016/j.marpolbul.2010.06.032; Chen LS, 2002, ZOOL STUD, V41, P47; Clua E, 2006, J EXP MAR BIOL ECOL, V333, P219, DOI 10.1016/j.jembe.2005.12.010; Crowe TP, 2009, ECOL STUD-ANAL SYNTH, V206, P375, DOI 10.1007/978-3-540-92704-4_27; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2001, ECOLOGY, V82, P2417; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; FRICKE R, 2006, COMPENDIUM MARINE SP; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; FROESE R, 1997, FISHBASE 97 CONCEPTS; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Guillemot N, 2010, CORAL REEFS, V29, P445, DOI 10.1007/s00338-010-0587-4; Guillemot N, 2009, FISH RES, V98, P51, DOI 10.1016/j.fishres.2009.03.013; HALPERN BS, 2008, MARINE ECOLOGY PROGR, V264, P147; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Jenkins GP, 1998, J EXP MAR BIOL ECOL, V221, P147, DOI 10.1016/S0022-0981(97)00121-4; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Kulbicki M, 2005, AQUAT LIVING RESOUR, V18, P231, DOI 10.1051/alr:2005029; Labrosse P, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P657; LABROSSE P, 2001, UNDERWATER VISUAL FI; Legendre P., 2012, NUMERICAL ECOLOGY; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Mayfield MM, 2005, ECOLOGY, V86, P2365, DOI 10.1890/05-0141; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2000, MAR ECOL PROG SER, V206, P273, DOI 10.3354/meps206273; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Mouillot D, 2006, AQUAT CONSERV, V16, P469, DOI 10.1002/aqc.769; Mouillot D, 2007, ESTUAR COAST SHELF S, V71, P443, DOI 10.1016/j.ecss.2006.08.022; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Naeem S, 2002, ECOLOGY, V83, P2925; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Ohman MC, 1998, ENVIRON BIOL FISH, V53, P19, DOI 10.1023/A:1007445226928; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Rossier O, 2000, CYBIUM, V24, P3; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sasaki T, 2009, ECOLOGY, V90, P2598, DOI 10.1890/08-1850.1; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; STEELE JH, 1991, BIOSCIENCE, V41, P470, DOI 10.2307/1311804; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Taylor BW, 2006, SCIENCE, V313, P833, DOI 10.1126/science.1128223; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wellnitz T, 2001, ECOL LETT, V4, P177, DOI 10.1046/j.1461-0248.2001.00221.x; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x	84	79	79	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26735	10.1371/journal.pone.0026735	http://dx.doi.org/10.1371/journal.pone.0026735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039543	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200048
J	Park, EJ; Roh, J; Kang, MS; Kim, SN; Kim, Y; Choi, S				Park, Eun-Jung; Roh, Jinkyu; Kang, Min-Sung; Kim, Soo Nam; Kim, Younghun; Choi, Sangdun			Biological Responses to Diesel Exhaust Particles (DEPs) Depend on the Physicochemical Properties of the DEPs	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; P53; HYDROCARBONS; INFLAMMATION; PARTICULATE; EXPRESSION; INDUCTION; DAMAGE; COX-2; DNA	Diesel exhaust particles (DEPs) are the main components of ambient particulate materials, including polyaromatic hydrocarbons (PAHs), n-PAHs, heavy metals, and gaseous materials. Many epidemiological, clinical, and toxicological studies have shown that ambient particles, including DEPs, are associated with respiratory disorders, such as asthma, allergic rhinitis, and lung cancer. However, the relationship between the biological response to DEPs and their chemical composition remains unclear. In this study, we investigated the physicochemical properties of DEPs before toxicological studies, and then administered a single intratracheal instillation of DEPs to mice. The mice were then killed 1, 7, 14 and 28 days after DEP exposure to observe the biological responses induced by DEPs over time. Our findings suggest that DEPs engulfed into cells induced a Th2-type inflammatory response followed by DNA damage, whereas DEPs not engulfed into cells induced a Th1-type inflammatory response. Further, the physicochemical properties, including surface charge, particle size, and chemical composition, of DEPs play a crucial role in determining the biological responses to DEPs. Consequently, we suggest that the biological response to DEPs depend on cell-particle interaction and the physicochemical properties of the particles.	[Park, Eun-Jung; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Roh, Jinkyu; Kim, Younghun] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kang, Min-Sung; Kim, Soo Nam] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup, South Korea	Ajou University; Kwangwoon University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Park, Eun-Jung/Y-4427-2019		National Research Foundation of Korea (NRF) [2010-0028294]; Ministry of Education, Science and Technology [2010-0015356]; Korea Food & Drug Administration [10182KFDA992-2302]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0015356). This work was also partly supported by a grant from the Korea Food & Drug Administration (10182KFDA992-2302) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LZ, 2007, TOXICOLOGY, V229, P91, DOI 10.1016/j.tox.2006.10.007; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Braun A, 2010, TOXICOL SCI, V113, P85, DOI 10.1093/toxsci/kfp239; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chiarugi V, 1998, INT J MOL MED, V2, P715; DiazSanchez D, 1997, ALLERGY, V52, P52; Dupont J, 2004, GYNECOL ONCOL, V94, P449, DOI 10.1016/j.ygyno.2004.05.014; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Inoue K, 2009, EXP BIOL MED, V234, P200, DOI 10.3181/0809-RM-285; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Jardim MJ, 2009, ENVIRON HEALTH PERSP, V117, P1745, DOI 10.1289/ehp.0900756; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lehninger A., 2005, LEHNINGER PRINCIPLES; Li N, 2006, EUR RESPIR J, V27, P667, DOI 10.1183/09031936.06.00025006; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Moller P, 2008, CANCER LETT, V266, P84, DOI 10.1016/j.canlet.2008.02.030; Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001; Nikasinovic L, 2004, J TOXICOL ENV HEAL B, V7, P81, DOI 10.1080/10937400490241952; Ohtani T, 2005, J IMMUNOL, V174, P2412, DOI 10.4049/jimmunol.174.4.2412; Park EJ, 2010, TOXICOL APPL PHARM, V244, P226, DOI 10.1016/j.taap.2009.12.036; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Ris C, 2007, INHAL TOXICOL, V19, P229, DOI 10.1080/08958370701497960; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Schins RPF, 2007, INHAL TOXICOL, V19, P189, DOI 10.1080/08958370701496202; Schober W, 2007, INHAL TOXICOL, V19, P151, DOI 10.1080/08958370701496046; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Xu XH, 2009, TOXICOL LETT, V191, P57, DOI 10.1016/j.toxlet.2009.08.006; Yun YP, 2009, TOXICOL IN VITRO, V23, P21, DOI 10.1016/j.tiv.2008.09.018	33	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26749	10.1371/journal.pone.0026749	http://dx.doi.org/10.1371/journal.pone.0026749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039547	gold, Green Submitted, Green Published			2022-12-27	WOS:000296513200051
J	Lam, SM; Tong, L; Yong, SS; Li, BW; Chaurasia, SS; Shui, GH; Wenk, MR				Lam, Sin Man; Tong, Louis; Yong, Siew Sian; Li, Bowen; Chaurasia, Shyam S.; Shui, Guanghou; Wenk, Markus R.			Meibum Lipid Composition in Asians with Dry Eye Disease	PLOS ONE			English	Article							MEIBOMIAN GLAND SECRETIONS; MASS-SPECTROMETRIC ANALYSIS; OCULAR SURFACE DISEASE; CHAIN FATTY-ACIDS; INTERNATIONAL WORKSHOP; OXIDIZED PHOSPHOLIPIDS; DYSFUNCTION REPORT; SUBCOMMITTEE; IDENTIFICATION; PREVALENCE	Background: Previous lipidomic analyses of the human meibum had largely focused on individuals from non-Asian populations, despite the higher prevalence of dysfunctional tear syndrome (DTS) observed across Asia. Information pertaining to the alterations in lipid profiles in relation to DTS onset and progression is also lacking and warrants comprehensive experimental analysis. Methodologies/Principal Findings: We examined the meibum lipidome of 27 DTS patients and 10 control subjects for a total of 256 lipid species from 12 major lipid classes, including cholesteryl ester (CE), wax ester (WE), triacylglyceride (TAG), (O-acyl)-omega-hydroxy fatty acid (OAHFA), glycerophospholipids (phosphatidylcholine, PC; phosphatidylethanolamine, PE; phosphatidylinositol, PI; phosphatidylglycerol, PG) and sphingolipids (sphingomyelin, SM; ceramide, Cer; glucosylceramide, GluCer; dihexosylceramide, DihexCer). Neutral lipids were analysed using high-performance liquid-chromatography coupled with mass spectrometry (HPLC/MS) and tandem mass spectrometry (MS/MS) was used for the qualitative and quantitative analysis of polar lipid species. DTS patients were classified into three severity groups (i.e. mild, moderate and severe) based on the ocular surface disease index (OSDI). A significantly lower level of TAG (p<0.05) was observed in patients under the moderate category compared to the mild category. Notably, a number of OAHFA species displayed consistently decreasing levels that correlate with increasing disease severity. An attempt was also made to investigate the changes in meibum lipid profiles of DTS patients compared to normal individuals classified based on OSDI score. Several unsaturated TAG and PC species were found at significantly higher levels (p<0.05) in patients than controls. Conclusion: The current study presents, for the first time, a comprehensive lipidome of meibum from individuals of an Asian ethnicity, which can potentially offer new insights into the higher prevalence of DTS observed amongst Asian populations. This study also represents an attempt towards identification of lipid species in meibum which could serve as marker for DTS.	[Lam, Sin Man; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Tong, Louis; Yong, Siew Sian; Chaurasia, Shyam S.] Singapore Eye Res Inst, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore; [Li, Bowen; Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Lam, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	guanghou_shui@nuhs.edu.sg; bchmrw@nus.edu.sg	Chaurasia, Shyam/AAB-4709-2019; Wenk, Markus Rene/D-1441-2014	Chaurasia, Shyam/0000-0001-8725-676X; Shui, Guanghou/0000-0002-1621-9643; Lam, Sin Man/0000-0001-9037-904X; Tong, Louis/0000-0002-3986-6552	National Medical Research Council [NMRC/1206/2009, NMRC/CSA/013/2009]; Singapore National Research Foundation [2007-04]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported by National Medical Research Council grants (NMRC/1206/2009, NMRC/CSA/013/2009) and a grant from the Singapore National Research Foundation under CRP Award No. 2007-04. The authors wish to express their sincere gratitude to Dr. Martin Lear's laboratory for the synthesis of OAHFA 18:1/16:0. They would also like to thank Mr. Andri Riau for his help with meibum sample collection and transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OCUL SURF, V5, P75; ARCINIEGA J, 2010, 6284D912 ARVO; Ashraf MZ, 2009, INT J BIOCHEM CELL B, V41, P1241, DOI 10.1016/j.biocel.2008.11.002; Barr JT, 1999, CORNEA, V18, P34, DOI 10.1097/00003226-199901000-00007; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2007, LIPIDS, V42, P765, DOI 10.1007/s11745-007-3080-2; Butovich IA, 2011, PROG LIPID RES, V50, P278, DOI 10.1016/j.plipres.2011.03.003; Butovich IA, 2009, PROG RETIN EYE RES, V28, P483, DOI 10.1016/j.preteyeres.2009.07.002; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Chen JZ, 2010, INVEST OPHTH VIS SCI, V51, P6220, DOI 10.1167/iovs.10-5687; Dogru M, 2005, AM J OPHTHALMOL, V140, P507, DOI 10.1016/j.ajo.2005.04.034; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HARVEY DJ, 1987, J CHROMATOGR-BIOMED, V414, P253, DOI 10.1016/0378-4347(87)80051-8; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Joffre C, 2008, BRIT J OPHTHALMOL, V92, P116, DOI 10.1136/bjo.2007.126144; Landreville S, 2004, INVEST OPHTH VIS SCI, V45, P3997, DOI 10.1167/iovs.04-0084; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Liu SH, 2011, INVEST OPHTH VIS SCI, V52, P2727, DOI 10.1167/iovs.10-6482; Mathers WD, 1998, ADV EXP MED BIOL, V438, P349; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; McCulley JP, 2004, EXP EYE RES, V78, P361, DOI 10.1016/S0014-4835(03)00203-3; Nichols KK, 2007, INVEST OPHTH VIS SCI, V48, P34, DOI 10.1167/iovs.06-0753; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Ousler GW, 2005, OCUL SURF, V3, P143, DOI 10.1016/S1542-0124(12)70196-9; Rantamaki AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019553; Saville JT, 2011, EXP EYE RES, V92, P238, DOI 10.1016/j.exer.2010.12.012; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shine WE, 2003, CURR EYE RES, V26, P89, DOI 10.1076/ceyr.26.2.89.14515; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Song CH, 1999, INVEST OPHTH VIS SCI, V40, P2744; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Sullivan BD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1286, DOI 10.1001/archopht.124.9.1286; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; TIFFANY JM, 1978, EXP EYE RES, V27, P289, DOI 10.1016/0014-4835(78)90164-1; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Tong L, 2011, BRIT J OPHTHALMOL, V95, P848, DOI 10.1136/bjo.2010.185256; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Wang JM, 2010, BIOCHIMIE, V92, P611, DOI 10.1016/j.biochi.2010.04.007; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wojtowicz JC, 2009, OCUL SURF, V7, P145, DOI 10.1016/S1542-0124(12)70309-9; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s; 2007, OCUL SURF, V5, P93	50	154	163	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24339	10.1371/journal.pone.0024339	http://dx.doi.org/10.1371/journal.pone.0024339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043274	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400001
J	Losse, A; Ullrich, S; Katzmann, E; Borg, S; Wanner, G; Richter, M; Voigt, B; Schweder, T; Schuler, D				Losse, Anna; Ullrich, Susanne; Katzmann, Emanuel; Borg, Sarah; Wanner, Gerd; Richter, Michael; Voigt, Birgit; Schweder, Thomas; Schueler, Dirk			Functional Analysis of the Magnetosome Island in Magnetospirillum gryphiswaldense: The mamAB Operon Is Sufficient for Magnetite Biomineralization	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MAGNETOTACTIC BACTERIA; GENE CLUSTERS; PROTEIN; MEMBRANE; DELETION; REVEALS; IDENTIFICATION; SYSTEM; MUTANT	Bacterial magnetosomes are membrane-enveloped, nanometer-sized crystals of magnetite, which serve for magnetotactic navigation. All genes implicated in the synthesis of these organelles are located in a conserved genomic magnetosome island (MAI). We performed a comprehensive bioinformatic, proteomic and genetic analysis of the MAI in Magnetospirillum gryphiswaldense. By the construction of large deletion mutants we demonstrate that the entire region is dispensable for growth, and the majority of MAI genes have no detectable function in magnetosome formation and could be eliminated without any effect. Only <25% of the region comprising four major operons could be associated with magnetite biomineralization, which correlated with high expression of these genes and their conservation among magnetotactic bacteria. Whereas only deletion of the mamAB operon resulted in the complete loss of magnetic particles, deletion of the conserved mms6, mamGFDC, and mamXY operons led to severe defects in morphology, size and organization of magnetite crystals. However, strains in which these operons were eliminated together retained the ability to synthesize small irregular crystallites, and weakly aligned in magnetic fields. This demonstrates that whereas the mamGFDC, mms6 and mamXY operons have crucial and partially overlapping functions for the formation of functional magnetosomes, the mamAB operon is the only region of the MAI, which is necessary and sufficient for magnetite biomineralization. Our data further reduce the known minimal gene set required for magnetosome formation and will be useful for future genome engineering approaches.	[Losse, Anna; Ullrich, Susanne; Katzmann, Emanuel; Borg, Sarah; Wanner, Gerd; Schueler, Dirk] Univ Munich, Dept Biol 1, Bereich Mikrobiol, LMU Biozentrum, Planegg Martinsried, Germany; [Richter, Michael] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, Bremen, Germany; [Voigt, Birgit] Ernst Moritz Arndt Univ Greifswald, Dept Microbial Physiol, Inst Microbiol, Greifswald, Germany; [Schweder, Thomas] Ernst Moritz Arndt Univ Greifswald, Pharmaceut Biotechnol Res Grp, Inst Pharm, Greifswald, Germany	University of Munich; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Losse, A (corresponding author), Univ Munich, Dept Biol 1, Bereich Mikrobiol, LMU Biozentrum, Planegg Martinsried, Germany.	dirk.schueler@lmu.de		Schweder, Thomas/0000-0002-7213-3596; Schuler, Dirk/0000-0002-2327-0762	Deutsche Forschungsgemeinschaft [DFG Schu1080/13-1]; Konrad-Adenauer-Stiftung e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Konrad-Adenauer-Stiftung e.V.	This work was funded by the Deutsche Forschungsgemeinschaft (DFG Schu1080/13-1; www.dfg.de/index.jsp). A. L. was supported by the Konrad-Adenauer-Stiftung e.V. (www.kas.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu F, 2011, ISME J, P1; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Ding Y, 2010, J BACTERIOL, V192, P1097, DOI 10.1128/JB.01292-09; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Frankel RB, 2006, TRENDS MICROBIOL, V14, P329, DOI 10.1016/j.tim.2006.06.004; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Kolinko I, 2011, J BACTERIOL IN PRESS; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Lang C, 2006, J PHYS-CONDENS MAT, V18, pS2815, DOI 10.1088/0953-8984/18/38/S19; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Murat D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000422; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Scheffel A, 2007, J BACTERIOL, V189, P6437, DOI 10.1128/JB.00421-07; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; Schultheiss D, 2004, APPL ENVIRON MICROB, V70, P3624, DOI 10.1128/aem.70.6.3624-3631.2004; Schultheiss D, 2003, ARCH MICROBIOL, V179, P89, DOI 10.1007/s00203-002-0498-z; Stevenson SE, 2009, J PROTEOMICS, V72, P555, DOI 10.1016/j.jprot.2008.11.005; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P8472, DOI 10.1128/AEM.71.12.8472-8480.2005; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P3369, DOI 10.1128/AEM.71.6.3369-3372.2005; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; Tanaka M, 2010, MOL MICROBIOL, V76, P480, DOI 10.1111/j.1365-2958.2010.07117.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; Ullrich S, 2010, APPL ENVIRON MICROB, V76, P2439, DOI 10.1128/AEM.02805-09; Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091; Wolff S, 2008, MOL CELL PROTEOMICS, V7, P1460, DOI 10.1074/mcp.M700554-MCP200; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740	53	48	52	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25561	10.1371/journal.pone.0025561	http://dx.doi.org/10.1371/journal.pone.0025561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043287	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400014
J	Tse, YC; Bagot, RC; Hutter, JA; Wong, AS; Wong, TP				Tse, Yiu Chung; Bagot, Rosemary C.; Hutter, Juliana A.; Wong, Alice S.; Wong, Tak Pan			Modulation of Synaptic Plasticity by Stress Hormone Associates with Plastic Alteration of Synaptic NMDA Receptor in the Adult Hippocampus	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; MESSENGER-RNA LEVELS; MEDIATED CA2+ ELEVATION; GLUTAMATERGIC TRANSMISSION; GLUCOCORTICOID-RECEPTOR; CALCIUM CURRENTS; NR2B SUBUNITS; RAT-BRAIN; CORTICOSTERONE	Stress exerts a profound impact on learning and memory, in part, through the actions of adrenal corticosterone (CORT) on synaptic plasticity, a cellular model of learning and memory. Increasing findings suggest that CORT exerts its impact on synaptic plasticity by altering the functional properties of glutamate receptors, which include changes in the motility and function of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptor (AMPAR) that are responsible for the expression of synaptic plasticity. Here we provide evidence that CORT could also regulate synaptic plasticity by modulating the function of synaptic N-methyl-D-aspartate receptors (NMDARs), which mediate the induction of synaptic plasticity. We found that stress level CORT applied to adult rat hippocampal slices potentiated evoked NMDAR-mediated synaptic responses within 30 min. Surprisingly, following this fast-onset change, we observed a slow-onset (>1 hour after termination of CORT exposure) increase in synaptic expression of GluN2A-containing NMDARs. To investigate the consequences of the distinct fast-and slow-onset modulation of NMDARs for synaptic plasticity, we examined the formation of long-term potentiation (LTP) and long-term depression (LTD) within relevant time windows. Paralleling the increased NMDAR function, both LTP and LTD were facilitated during CORT treatment. However, 1-2 hours after CORT treatment when synaptic expression of GluN2A-containing NMDARs is increased, bidirectional plasticity was no longer facilitated. Our findings reveal the remarkable plasticity of NMDARs in the adult hippocampus in response to CORT. CORT-mediated slow-onset increase in GluN2A in hippocampal synapses could be a homeostatic mechanism to normalize synaptic plasticity following fast-onset stress-induced facilitation.	[Tse, Yiu Chung; Bagot, Rosemary C.; Hutter, Juliana A.; Wong, Alice S.; Wong, Tak Pan] McGill Univ, Douglas Mental Hlth Univ Inst, Div Neurosci, Montreal, PQ, Canada; [Wong, Tak Pan] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Wong, Tak Pan] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Tse, YC (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Div Neurosci, Montreal, PQ, Canada.	tak.wong@mcgill.ca	Bagot, Rosemary/V-4325-2019	Wong, Tak Pan/0000-0001-8611-4911	National Alliance for Research on Schizophrenia and Depression (NARSAD); Natural Sciences and Engineering Research Council of Canada (NSERC) [214991]; Canadian Institute of Health Research [MOP-106649]	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Young Investigator Award from National Alliance for Research on Schizophrenia and Depression (NARSAD), a discovery grant (214991) from Natural Sciences and Engineering Research Council of Canada (NSERC), and a Canadian Institute of Health Research grant (MOP-106649) to T.P.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2006, J NEUROSCI, V26, P3951, DOI 10.1523/JNEUROSCI.4901-05.2006; BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Droste SK, 2009, J NEUROENDOCRINOL, V21, P132, DOI 10.1111/j.1365-2826.2008.01811.x; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; Fetterolf F, 2011, MOL NEUROBIOL, V44, P71, DOI 10.1007/s12035-011-8190-4; FFRENCHMULLEN JMH, 1995, J NEUROSCI, V15, P903; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Harney SC, 2008, J NEUROSCI, V28, P11685, DOI 10.1523/JNEUROSCI.3035-08.2008; Kamphuis PJGH, 2003, FASEB J, V17, P911, DOI 10.1096/fj.02-0333fje; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; KARST H, 1994, BRAIN RES, V649, P234, DOI 10.1016/0006-8993(94)91069-3; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; KERR DS, 1994, PSYCHOBIOLOGY, V22, P123; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Kohr G, 2003, J NEUROSCI, V23, P10791; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Krugers HJ, 2005, HIPPOCAMPUS, V15, P697, DOI 10.1002/hipo.20092; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu L, 2007, NEUROSCI LETT, V420, P245, DOI 10.1016/j.neulet.2007.05.003; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Longordo F, 2009, J NEUROSCI, V29, P9026, DOI 10.1523/JNEUROSCI.1215-09.2009; Lourenco J, 2010, NAT NEUROSCI, V13, P197, DOI 10.1038/nn.2481; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nair SM, 1998, J NEUROSCI, V18, P2685; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pavlides C, 1996, BRAIN RES, V738, P229, DOI 10.1016/S0006-8993(96)00776-7; Paykel ES, 2003, ACTA PSYCHIAT SCAND, V108, P61, DOI 10.1034/j.1600-0447.108.s418.13.x; Pittenger Christopher, 2007, CNS & Neurological Disorders-Drug Targets, V6, P101, DOI 10.2174/187152707780363267; Qin YJ, 2004, J NEUROCHEM, V89, P364, DOI 10.1111/j.1471-4159.2003.02332.x; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; REY M, 1994, NEUROENDOCRINOLOGY, V60, P36, DOI 10.1159/000126717; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sato S, 2004, BIOCHEM BIOPH RES CO, V321, P510, DOI 10.1016/j.bbrc.2004.06.168; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taniguchi S, 2009, EMBO J, V28, P3717, DOI 10.1038/emboj.2009.300; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Weiland NG, 1997, NEUROSCIENCE, V78, P653, DOI 10.1016/S0306-4522(96)00619-7; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; WONG M, 1994, J NEUROENDOCRINOL, V6, P347, DOI 10.1111/j.1365-2826.1994.tb00592.x; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	85	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27215	10.1371/journal.pone.0027215	http://dx.doi.org/10.1371/journal.pone.0027215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069501	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900061
J	Mukhopadhya, I; Hansen, R; Nicholl, CE; Alhaidan, YA; Thomson, JM; Berry, SH; Pattinson, C; Stead, DA; Russell, RK; El-Omar, EM; Hold, GL				Mukhopadhya, Indrani; Hansen, Richard; Nicholl, Charlotte E.; Alhaidan, Yazeid A.; Thomson, John M.; Berry, Susan H.; Pattinson, Craig; Stead, David A.; Russell, Richard K.; El-Omar, Emad M.; Hold, Georgina L.			A Comprehensive Evaluation of Colonic Mucosal Isolates of Sutterella wadsworthensis from Inflammatory Bowel Disease	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; CAMPYLOBACTER GRACILIS; SP NOV.; IDENTIFICATION; HELICOBACTER; ARCOBACTER; GENETICS; SAMPLES; COLI; BILE	Inflammatory bowel disease (IBD) arises in genetically susceptible individuals as a result of an unidentified environmental trigger, possibly a hitherto unknown bacterial pathogen. Twenty-six clinical isolates of Sutterella wadsworthensis were obtained from 134 adults and 61 pediatric patients undergoing colonoscopy, of whom 69 and 29 respectively had IBD. S. wadsworthensis was initially more frequently isolated from IBD subjects, hence this comprehensive study was undertaken to elucidate its role in IBD. Utilizing these samples, a newly designed PCR was developed, to study the prevalence of this bacterium in adult patients with ulcerative colitis (UC). Sutterella wadsworthensis was detected in 83.8% of adult patients with UC as opposed to 86.1% of control subjects (p = 0.64). Selected strains from IBD cases and controls were studied to elicit morphological, proteomic, genotypic and pathogenic differences. This study reports Scanning Electron Microscopy (SEM) appearances and characteristic MALDI-TOF MS protein profiles of S. wadsworthensis for the very first time. SEM showed that the bacterium is pleomorphic, existing in predominantly two morphological forms, long rods and coccobacilli. No differences were noted in the MALDI-TOF mass spectrometry proteomic analysis. There was no distinct clustering of strains identified from cases and controls on sequence analysis. Cytokine response after monocyte challenge with strains from patients with IBD and controls did not yield any significant differences. Our studies indicate that S. wadsworthensis is unlikely to play a role in the pathogenesis of IBD. Strains from cases of IBD could not be distinguished from those identified from controls.	[Mukhopadhya, Indrani; Hansen, Richard; Nicholl, Charlotte E.; Alhaidan, Yazeid A.; Thomson, John M.; Berry, Susan H.; El-Omar, Emad M.; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Aberdeen, Scotland; [Hansen, Richard] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Pattinson, Craig; Stead, David A.] Univ Aberdeen, Inst Med Sci, Aberdeen Prote Grp, Aberdeen, Scotland; [Russell, Richard K.] Royal Hosp Sick Children, Dept Paediat Gastroenterol, Glasgow G3 8SJ, Lanark, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Glasgow	Mukhopadhya, I (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Foresterhill, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mukhopadhya, Indrani/K-1113-2019; El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020	Mukhopadhya, Indrani/0000-0003-2577-518X; Hold, Georgina Louise/0000-0001-7573-3397; Alhaidan, Yazeid/0000-0002-0569-2988; Stead, David/0000-0001-9268-5868; El-Omar, Emad/0000-0002-0011-3924; Hansen, Richard/0000-0002-3944-6646	Chief Scientist Office in Scotland [CAF/08/01, IBD-0178]; GI Research Unit, Aberdeen Royal Infirmary; Medical Research Council patient research cohorts initiative [G0800675]; Medical Research Council [G0800675] Funding Source: researchfish; Chief Scientist Office [CAF/08/01] Funding Source: researchfish; MRC [G0800675] Funding Source: UKRI	Chief Scientist Office in Scotland; GI Research Unit, Aberdeen Royal Infirmary; Medical Research Council patient research cohorts initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Clinical Academic Training Fellowship from the Chief Scientist Office in Scotland (CAF/08/01), which also funded the salary of RH and the Broad Medical Research Program (Grant number IBD-0178). JMT was supported by grants from the GI Research Unit, Aberdeen Royal Infirmary. The Royal Hospital for Sick Children, Glasgow IBD team is generously supported by the Catherine McEwan Foundation. RKR has received support from a Medical Research Council patient research cohorts initiative grant (G0800675) for Paediatric Inflammatory Bowel Disease Cohort and Treatment Study (PICTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alispahic M, 2010, J MED MICROBIOL, V59, P295, DOI 10.1099/jmm.0.016576-0; Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Greetham HL, 2004, INT J SYST EVOL MICR, V54, P1581, DOI 10.1099/ijs.0.63098-0; Haag AF, 2011, J BIOL CHEM, V286, P17455, DOI 10.1074/jbc.M111.236356; Hansen R, 2011, GUT, V60, pA147, DOI 10.1136/gut.2011.239301.311; Hansen R, 2010, J GASTROENTEROL, V45, P266, DOI 10.1007/s00535-009-0191-y; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Ilina EN, 2009, J MOL DIAGN, V11, P75, DOI 10.2353/jmoldx.2009.080079; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kolinska R, 2008, FOLIA MICROBIOL, V53, P403, DOI 10.1007/s12223-008-0061-7; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Marteau P, 2009, DIGEST DIS, V27, P99, DOI 10.1159/000268128; Molitoris E, 1997, CLIN INFECT DIS, V25, pS264, DOI 10.1086/516234; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Reller LB, 1983, 83 ANN M AM SOC MI C, VC274, P357; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakon H, 2008, INT J SYST EVOL MICR, V58, P970, DOI 10.1099/ijs.0.65456-0; Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Wexler HM, 1996, INT J SYST BACTERIOL, V46, P252, DOI 10.1099/00207713-46-1-252; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	30	53	56	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27076	10.1371/journal.pone.0027076	http://dx.doi.org/10.1371/journal.pone.0027076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073125	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000296916000052
J	Danilov, AV; Neupane, D; Nagaraja, AS; Feofanova, EV; Humphries, LA; DiRenzo, J; Korc, M				Danilov, Alexey V.; Neupane, Divas; Nagaraja, Archana Sidalaghatta; Feofanova, Elena V.; Humphries, Leigh Ann; DiRenzo, James; Korc, Murray			DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance	PLOS ONE			English	Article							P53 TARGET GENES; FACTOR-KAPPA-B; DUCTAL ADENOCARCINOMA; EPITHELIAL-CELLS; CARCINOMA CELLS; CYCLE ARREST; LUNG-CANCER; PHASE-III; IN-VIVO; P63	Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to current chemotherapy regimens, in part due to alterations in the p53 tumor suppressor pathway. p53 homolog p63 is a transcription factor essential for the development and differentiation of epithelial surfaces. However its function in cancer is controversial and its role in PDAC is not known. We discovered that Delta Np63 alpha was the predominantly expressed p63 variant in pancreatic cancer cell lines. Delta Np63 alpha protein and mRNA levels were high in T3M4, BxPC3 and COLO-357 pancreatic cancer cells and low in ASPC-1 and PANC-1 cells. Overexpression of Delta Np63 alpha in PANC-1 cells and shRNA-mediated knockdown in T3M4 cells indicated that Delta Np63 alpha promoted anchorage-dependent and -independent growth, motility and invasion, and enhanced resistance to cisplatin-induced apoptosis. Epidermal growth factor receptor (EGFR) signaling pathways contribute to the biological aggressiveness of PDAC, and we found that the motogenic effects of Delta Np63 alpha were augmented in presence of EGF. Ectopic expression of Delta Np63 alpha resulted in upregulation of EGFR and beta 1-integrin in PANC-1 cells. Conversely, Delta Np63 alpha knockdown had an opposite effect in T3M4 cells. Delta Np63 alpha potentiated EGF-mediated activation of ERK, Akt and JNK signaling. Chromatin immunoprecipitation and functional reporter assays demonstrated that Delta Np63 alpha activated EGFR transcription. 14-3-3 sigma transcription was also positively regulated by Delta Np63 alpha and we have previously shown that 14-3-3 sigma contributes to chemoresistance in pancreatic cancer cell lines. Conversely, shRNA-mediated knockdown of 14-3-3 sigma led to abrogation of the Delta Np63 alpha effects on cell proliferation and invasion. Thus, p53 homolog Delta Np63 sigma enhances the oncogenic potential of pancreatic cancer cells through trans-activation of EGFR and 14-3-3 sigma.	[Danilov, Alexey V.; Feofanova, Elena V.; Humphries, Leigh Ann; Korc, Murray] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Danilov, Alexey V.; Nagaraja, Archana Sidalaghatta; Korc, Murray] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Neupane, Divas; DiRenzo, James; Korc, Murray] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Danilov, AV (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA.	Murray.Korc@dartmouth.edu	Nagaraja, Archana Sidalaghatta/AAE-2205-2021; Nagaraja, Archana/AAE-8529-2021	Nagaraja, Archana/0000-0002-2851-9272	Department of Medicine Junior Faculty Award; Norris Cotton Cancer Center; Hitchcock Foundation; National Cancer Institute [CA-R37-075059]; NATIONAL CANCER INSTITUTE [R37CA075059, P30CA023108, R01CA075059] Funding Source: NIH RePORTER	Department of Medicine Junior Faculty Award; Norris Cotton Cancer Center; Hitchcock Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Department of Medicine Junior Faculty Award (Dr. Danilov), a Norris Cotton Cancer Center Prouty Pilot Project Award (Dr. Danilov), a Hitchcock Foundation Award (Dr. Danilov), and by the National Cancer Institute Grant CA-R37-075059 (Dr. Korc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; BALDWIN RL, 1993, GROWTH FACTORS, V8, P23, DOI 10.3109/08977199309029131; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bheda A, 2008, ONCOGENE, V27, P4315, DOI 10.1038/onc.2008.65; Biliran H, 2005, CLIN CANCER RES, V11, P6075, DOI 10.1158/1078-0432.CCR-04-2419; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Boldrup L, 2009, J PATHOL, V218, P428, DOI 10.1002/path.2560; Bost F, 1999, MOL CELL BIOL, V19, P1938; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Flaman JM, 1998, ONCOGENE, V16, P1369, DOI 10.1038/sj.onc.1201889; Fujita H, 2011, INT J ONCOL, V38, P629, DOI 10.3892/ijo.2011.908; Fukushima H, 2009, CANCER RES, V69, P9263, DOI 10.1158/0008-5472.CAN-09-1188; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kopp R, 2002, ANTICANCER RES, V22, P1161; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Matsuda K, 2002, CANCER RES, V62, P5611; McDade SS, 2011, J CELL SCI, V124, P1635, DOI 10.1242/jcs.084723; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Noma B, 2008, INT J ONCOL, V33, P1187, DOI 10.3892/ijo_00000108; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Preis M, 2010, CANC BIOL THER, P9; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Uramoto H, 2006, ANTICANCER RES, V26, P1785; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	55	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26815	10.1371/journal.pone.0026815	http://dx.doi.org/10.1371/journal.pone.0026815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053213	Green Submitted, gold, Green Published			2022-12-27	WOS:000299081800043
J	Van Nieuwerburgh, F; Soetaert, S; Podshivalova, K; Wang, EAL; Schaffer, L; Deforce, D; Salomon, DR; Head, SR; Ordoukhanian, P				Van Nieuwerburgh, Filip; Soetaert, Sandra; Podshivalova, Katie; Wang, Eileen Ay-Lin; Schaffer, Lana; Deforce, Dieter; Salomon, Daniel R.; Head, Steven R.; Ordoukhanian, Phillip			Quantitative Bias in Illumina TruSeq and a Novel Post Amplification Barcoding Strategy for Multiplexed DNA and Small RNA Deep Sequencing	PLOS ONE			English	Article								Here we demonstrate a method for unbiased multiplexed deep sequencing of RNA and DNA libraries using a novel, efficient and adaptable barcoding strategy called Post Amplification Ligation-Mediated ( PALM). PALM barcoding is performed as the very last step of library preparation, eliminating a potential barcode-induced bias and allowing the flexibility to synthesize as many barcodes as needed. We sequenced PALM barcoded micro RNA (miRNA) and DNA reference samples and evaluated the quantitative barcode-induced bias in comparison to the same reference samples prepared using the Illumina TruSeq barcoding strategy. The Illumina TruSeq small RNA strategy introduces the barcode during the PCR step using differentially barcoded primers, while the TruSeq DNA strategy introduces the barcode before the PCR step by ligation of differentially barcoded adaptors. Results show virtually no bias between the differentially barcoded miRNA and DNA samples, both for the PALM and the TruSeq sample preparation methods. We also multiplexed miRNA reference samples using a pre-PCR barcode ligation. This barcoding strategy results in significant bias.	[Van Nieuwerburgh, Filip; Soetaert, Sandra; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Podshivalova, Katie; Wang, Eileen Ay-Lin; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Ghent University; Scripps Research Institute	Van Nieuwerburgh, F (corresponding author), Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium.	philo@scripps.edu	Van Nieuwerburgh, Filip/H-9697-2015; Podshivalova, Katie/K-7401-2019; Salomon, Daniel/E-9380-2012; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X	Fund for Scientific Research-Flanders, Belgium [F.W.O.-301]; National Institutes of Health [TL1 RR025772-03, U19 302 A1063603-06]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081757] Funding Source: NIH RePORTER	Fund for Scientific Research-Flanders, Belgium(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Fund for Scientific Research-Flanders, Belgium (F.W.O.-301 Vlaanderen) to FVN; and the National Institutes of Health [TL1 RR025772-03] to KP, [U19 302 A1063603-06] to DRS, SRH, GTH and LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buermans HPJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-716; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lopez-Barragan MJ, 2011, MOL BIOCHEM PARASIT, V176, P64, DOI 10.1016/j.molbiopara.2010.11.013; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Nelson PT, 2008, BBA-GENE REGUL MECH, V1779, P758, DOI 10.1016/j.bbagrm.2008.03.012; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Vigneault F, 2008, NAT METHODS, V5, P777, DOI 10.1038/NMETH.1244	13	41	49	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26969	10.1371/journal.pone.0026969	http://dx.doi.org/10.1371/journal.pone.0026969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046424	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800053
J	Zhang, XY; Yang, HD; Zhang, Q; Wang, ZX; Wang, DH				Zhang, Xue-Ying; Yang, Hui-Di; Zhang, Qiang; Wang, Zuoxin; Wang, De-Hua			Increased Feeding and Food Hoarding following Food Deprivation Are Associated with Activation of Dopamine and Orexin Neurons in Male Brandt's Voles	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; LASIOPODOMYS-BRANDTII; CALORIC RESTRICTION; NUCLEUS-ACCUMBENS; LEPTIN RECEPTOR; ENERGY-BALANCE; BODY-WEIGHT; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC NEURONS; LOCOMOTOR-ACTIVITY	Small mammals usually face energetic challenges, such as food shortage, in the field. They have thus evolved species-specific adaptive strategies for survival and reproductive success. In the present study, we examined male Brandt's voles (Lasiopodomys brandtii) for their physiological, behavioral, and neuronal responses to food deprivation (FD) and subsequent re-feeding. Although 48 hr FD induced a decrease in body weight and the resting metabolic rate (RMR), such decreases did not reach statistical significance when compared to the control males that did not experience FD. During the first 2 hr of re-feeding following 48 hr FD, voles showed higher levels of feeding than controls. However, when permitted to hoard food, FD voles showed an increase in food hoarding, rather than feeding, compared to the controls. Further, both feeding and food hoarding induced an increase in neuronal activation, measured by Fos-ir, in a large number of brain areas examined. Interestingly, feeding and food hoarding also induced an increase in the percentage of tyrosine hydroxylase immunoreactive (TH-ir) cells that co-expressed Fos-ir in the ventral tegmental area (VTA), whereas both FD and feeding induced an increase in the percentage of orexin-ir cells that co-expressed Fos-ir in the lateral hypothalamus (LH). Food hoarding also increased orexin-ir/Fos-ir labeling in the LH. Together, our data indicate that food-deprived male Brandt's voles display enhanced feeding or food hoarding dependent upon an environmental setting. In addition, changes in central dopamine and orexin activities in selected brain areas are associated with feeding and hoarding behaviors following FD and subsequent re-feeding.	[Zhang, Xue-Ying; Yang, Hui-Di; Zhang, Qiang; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Wang, Zuoxin] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Wang, Zuoxin] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	wangdh@ioz.ac.cn			National Natural Science Foundation of China [30900175, 31071930]; Chinese Academy of Sciences [KSCX2-EW-N-005]; Key Project of the National Eleventh Five-Year Research Program of China [2009BAI83B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Project of the National Eleventh Five-Year Research Program of China	This study was supported by grants from the National Natural Science Foundation of China (30900175) to XYZ and (31071930) to DHW, from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-N-005) to DHW, and from the Key Project of the National Eleventh Five-Year Research Program of China (2009BAI83B01) to XYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Aston-Jones G, 2009, NEUROPHARMACOLOGY, V56, P112, DOI 10.1016/j.neuropharm.2008.06.060; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; BARTNESS TJ, 1994, AM J PHYSIOL, V266, pR1111, DOI 10.1152/ajpregu.1994.266.4.R1111; Blum K, 2011, CURR PHARM DESIGN, V17, P1158, DOI 10.2174/138161211795656819; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; Bubser M, 2005, EUR J NEUROSCI, V21, P2993, DOI 10.1111/j.1460-9568.2005.04121.x; Buckley CA, 2003, AM J PHYSIOL-REG I, V285, pR1021, DOI 10.1152/ajpregu.00488.2002; Cai XJ, 2001, DIABETES, V50, P105, DOI 10.2337/diabetes.50.1.105; Choi DL, 2010, NEUROSCIENCE, V167, P11, DOI 10.1016/j.neuroscience.2010.02.002; Dailey MJ, 2010, BRAIN RES, V1323, P94, DOI 10.1016/j.brainres.2010.01.078; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Davis JF, 2011, BIOL PSYCHIAT, V69, P668, DOI 10.1016/j.biopsych.2010.08.028; Day DE, 2003, PHYSIOL BEHAV, V78, P655, DOI 10.1016/S0031-9384(03)00052-0; Deacon RMJ, 2006, NAT PROTOC, V1, P2828, DOI 10.1038/nprot.2006.171; Demas GE, 1999, PHYSIOL BEHAV, V67, P243, DOI 10.1016/S0031-9384(99)00066-9; Evans SA, 2005, AM J PHYSIOL-REG I, V288, pR1468, DOI 10.1152/ajpregu.00602.2004; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Gutman R, 2007, PHYSIOL BEHAV, V90, P95, DOI 10.1016/j.physbeh.2006.08.033; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hambly C, 2005, OBES RES, V13, P1548, DOI 10.1038/oby.2005.190; Henny P, 2006, J COMP NEUROL, V499, P645, DOI 10.1002/cne.21131; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Ishibashi M, 2005, PEPTIDES, V26, P471, DOI 10.1016/j.peptides.2004.10.014; Jahng JW, 2007, BRAIN RES, V1150, P100, DOI 10.1016/j.brainres.2007.02.080; Karteris E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1089, DOI 10.1152/ajpendo.00351.2004; Keen-Rhinehart E, 2010, PHILOS T R SOC B, V365, P961, DOI 10.1098/rstb.2009.0225; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; Li YG, 2010, COMP BIOCHEM PHYS A, V157, P204, DOI 10.1016/j.cbpa.2010.06.183; Li YH, 2011, PHYSIOL BEHAV, V102, P42, DOI 10.1016/j.physbeh.2010.10.006; Liu QS, 2007, J COMP PHYSIOL B, V177, P423, DOI 10.1007/s00360-006-0141-4; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Millan EZ, 2010, J NEUROSCI, V30, P4626, DOI 10.1523/JNEUROSCI.4933-09.2010; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mukai K, 2009, PEPTIDES, V30, P1487, DOI 10.1016/j.peptides.2009.04.018; NAGASHIMA Y, 1995, JPN J PHYSIOL, V45, P645, DOI 10.2170/jjphysiol.45.645; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinos H, 2011, PHYSIOL BEHAV, V102, P17, DOI 10.1016/j.physbeh.2010.09.023; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Sanchez E, 2008, ENDOCRINOLOGY, V149, P4329, DOI 10.1210/en.2008-0411; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Shalev U, 2001, J NEUROSCI, V21; STAM CJ, 1989, BEHAV NEUROSCI, V103, P24, DOI 10.1037/0735-7044.103.1.24; Stamp JA, 2008, BRAIN RES, V1204, P94, DOI 10.1016/j.brainres.2008.02.019; Szekely M, 2002, REGUL PEPTIDES, V104, P47, DOI 10.1016/S0167-0115(01)00348-2; Thorpe AJ, 2005, BRAIN RES, V1050, P156, DOI 10.1016/j.brainres.2005.05.045; Timofeeva E, 2002, EUR J NEUROSCI, V15, P1013, DOI 10.1046/j.1460-9568.2002.01942.x; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; van Weenen JED, 2011, J NEUROENDOCRINOL, V23, P158, DOI 10.1111/j.1365-2826.2010.02092.x; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wang B, 2009, BIOL PSYCHIAT, V65, P857, DOI 10.1016/j.biopsych.2009.01.018; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yang HD, 2011, PHYSIOL BEHAV, V104, P429, DOI 10.1016/j.physbeh.2011.04.062; Zhan XM, 2009, J THERM BIOL, V34, P237, DOI 10.1016/j.jtherbio.2009.02.006; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	71	2	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26408	10.1371/journal.pone.0026408	http://dx.doi.org/10.1371/journal.pone.0026408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046281	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400019
J	Comin, A; Klinkenberg, D; Marangon, S; Toffan, A; Stegeman, A				Comin, Arianna; Klinkenberg, Don; Marangon, Stefano; Toffan, Anna; Stegeman, Arjan			Transmission Dynamics of Low Pathogenicity Avian Influenza Infections in Turkey Flocks	PLOS ONE			English	Article							VIRUS; EPIDEMIC; CHICKENS	Low pathogenicity avian influenza (LPAI) viruses of H5 and H7 subtypes have the potential to mutate into highly pathogenic strains (HPAI), which can threaten human health and cause huge economic losses. The current knowledge on the mechanisms of mutation from LPAI to HPAI is insufficient for predicting which H5 or H7 strains will mutate into an HPAI strain, and since the molecular changes necessary for the change in virulence seemingly occur at random, the probability of mutation depends on the number of virus replicates, which is associated with the number of birds that acquire infection. We estimated the transmission dynamics of LPAI viruses in turkeys using serosurveillance data from past epidemics in Italy. We fitted the proportions of birds infected in 36 flocks into a hierarchical model to estimate the basic reproduction number (R-0) and possible variations in R0 among flocks caused by differences among farms. We also estimated the distributions of the latent and infectious periods, using experimental infection data with outbreak strains. These were then combined with the R0 to simulate LPAI outbreaks and characterise the resulting dynamics. The estimated mean within-flock R0 in the population of infected flocks was 5.5, indicating that an infectious bird would infect an average of more than five susceptible birds. The results also indicate that the presence of seropositive birds does not necessarily mean that the virus has already been cleared and the flock is no longer infective, so that seropositive flocks may still constitute a risk of infection for other flocks. In light of these results, the enforcement of appropriate restrictions, the culling of seropositive flocks, or pre-emptive slaughtering may be useful. The model and parameter estimates presented in this paper provide the first complete picture of LPAI dynamics in turkey flocks and could be used for designing a suitable surveillance program.	[Comin, Arianna; Marangon, Stefano; Toffan, Anna] Ist Zooprofilatt Sperimentale Venezie, Legnaro, PD, Italy; [Klinkenberg, Don; Stegeman, Arjan] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	IZS delle Venezie; Utrecht University	Comin, A (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Legnaro, PD, Italy.	acomin@izsvenezie.it	TOFFAN, ANNA/AAW-8725-2020	TOFFAN, ANNA/0000-0003-4389-3489; Klinkenberg, Don/0000-0002-9449-6873; Comin, Arianna/0000-0002-1765-1825; Marangon, Stefano/0000-0002-3158-4243	EU [SSPE-CT-2007-044429]; Italian Ministry of Health	EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This study has been performed with the support from the EU Commission (grant SSPE-CT-2007-044429: Improved diagnosis and early warning systems for avian influenza outbreak management - FLUTEST) and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2003, AVIAN DIS, V47, P976, DOI 10.1637/0005-2086-47.s3.976; Alexander DJ, 2008, AVIAN INFLUENZA; ANDERSON R M, 1991; Bos MEH, 2010, PREV VET MED, V95, P297, DOI 10.1016/j.prevetmed.2010.04.006; Bos MEH, 2009, PREV VET MED, V88, P278, DOI 10.1016/j.prevetmed.2008.12.003; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Capua I, 2004, AVIAN PATHOL, V33, P158, DOI 10.1080/03079450310001652077; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; Comin A., 2010, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings, Nantes, France, 24-26 March, 2010, P145; Comin A, 2010, ZOONOSES PUBLIC HLTH; Dundon WG, 2007, AVIAN DIS, V51, P209, DOI 10.1637/7556-033106R.1; Gonzales JL, 2011, VET MICROBIOL, DOI DOI 10.1016/J.VETMIV.2011.04.22; Lupiani B, 2009, COMP IMMUNOL MICROB, V32, P311, DOI 10.1016/j.cimid.2008.01.004; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; R Core Team, 2018, R LANG ENV STAT COMP; Spiegelhalter D., 2007, WINBUGS USER MANUAL; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; WHO, 2009, H5N1 AV INFL TIM MAJ; World Organizazion for Animal Health-OIE, 2009, WAHD INT SUMM IMM NO	21	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26935	10.1371/journal.pone.0026935	http://dx.doi.org/10.1371/journal.pone.0026935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046417	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600081
J	Checkley, AM; Wyllie, DH; Scriba, TJ; Golubchik, T; Hill, AVS; Hanekom, WA; McShane, H				Checkley, Anna M.; Wyllie, David H.; Scriba, Thomas J.; Golubchik, Tanya; Hill, Adrian V. S.; Hanekom, Willem A.; McShane, Helen			Identification of Antigens Specific to Non-Tuberculous Mycobacteria: The Mce Family of Proteins as a Target of T Cell Immune Responses	PLOS ONE			English	Article							PREDICTED SECRETED ANTIGENS; BOVIS BCG VACCINATION; ENVIRONMENTAL MYCOBACTERIA; COMPARATIVE GENOMICS; DIAGNOSTIC REAGENTS; INTERFERON-GAMMA; CALMETTE-GUERIN; TUBERCULOSIS; EFFICACY; AVIUM	The lack of an effective TB vaccine hinders current efforts in combating the TB pandemic. One theory as to why BCG is less protective in tropical countries is that exposure to non-tuberculous mycobacteria (NTM) reduces BCG efficacy. There are currently several new TB vaccines in clinical trials, and NTM exposure may also be relevant in this context. NTM exposure cannot be accurately evaluated in the absence of specific antigens; those which are known to be present in NTM and absent from M. tuberculosis and BCG. We therefore used a bioinformatic pipeline to define proteins which are present in common NTM and absent from the M. tuberculosis complex, using protein BLAST, TBLASTN and a short sequence protein BLAST to ensure the specificity of this process. We then assessed immune responses to these proteins, in healthy South Africans and in patients from the United Kingdom and United States with documented exposure to NTM. Low level responses were detected to a cluster of proteins from the mammalian cell entry family, and to a cluster of hypothetical proteins, using ex vivo ELISpot and a 6 day proliferation assay. These early findings may provide a basis for characterising exposure to NTM at a population level, which has applications in the field of TB vaccine design as well as in the development of diagnostic tests.	[Checkley, Anna M.; Wyllie, David H.; Hill, Adrian V. S.; McShane, Helen] Univ Oxford, Jenner Inst, Nuffield Dept Med, ORCRB, Oxford, England; [Scriba, Thomas J.; Hanekom, Willem A.] Univ Cape Town, S African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Scriba, Thomas J.; Hanekom, Willem A.] Univ Cape Town, Sch Child & Adolescent Hlth, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Golubchik, Tanya] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Jenner Institute; University of Cape Town; University of Cape Town; University of Oxford	Checkley, AM (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, ORCRB, Oxford, England.	anna.checkley@ndm.ox.ac.uk	Scriba, Thomas/AAH-9413-2020; Golubchik, Tanya/B-4226-2018; Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/H-3633-2013	Golubchik, Tanya/0000-0003-2765-9828; Scriba, Thomas/0000-0002-0641-1359; Hanekom, Willem/0000-0003-3070-6154; McShane, Helen/0000-0002-2126-5142	Medical Research Council; Wellcome Trust; Medical Research Council [G0701309] Funding Source: researchfish; National Institute for Health Research [CL-2011-20-001] Funding Source: researchfish; MRC [G0701309] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AC was supported by a Medical Research Council Clinical Research Fellowship, and HM by a Wellcome Trust Senior Reasearch Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, SCAND J IMMUNOL, V60, P382, DOI 10.1111/j.0300-9475.2004.01490.x; [Anonymous], 2009, GLOB TUB CONTR; Araoz R, 2006, INFECT IMMUN, V74, P175, DOI 10.1128/IAI.74.1.175-182.2006; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Buddle BM, 2011, VET MICROBIOL; Cho D, 2006, CLIN VACCINE IMMUNOL, V13, P1155, DOI 10.1128/CVI.00058-06; Cockle PJ, 2002, INFECT IMMUN, V70, P6996, DOI 10.1128/IAI.70.12.6996-7003.2002; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Conese Massimo, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P8; Corbett EL, 1999, INT J TUBERC LUNG D, V3, P501; de Lisle GW, 2005, TUBERCULOSIS, V85, P73, DOI 10.1016/j.tube.2004.09.007; Donoghue HD, 1997, J APPL MICROBIOL, V82, P57, DOI 10.1111/j.1365-2672.1997.tb03297.x; EDWARDS ML, 1982, J INFECT DIS, V145, P733, DOI 10.1093/infdis/145.2.733; Flaherty DK, 2006, J LEUKOCYTE BIOL, V80, P1262, DOI 10.1189/jlb.0606407; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Geluk A, 2009, CLIN VACCINE IMMUNOL, V16, P352, DOI 10.1128/CVI.00414-08; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Hanekom WA, 2010, TROP MED INT HEALTH, V15, P981, DOI 10.1111/j.1365-3156.2010.02568.x; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; HASLOV K, 1995, INFECT IMMUN, V63, P804; Hatherill M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000021; HernandezPando R, 1997, INFECT IMMUN, V65, P3317, DOI 10.1128/IAI.65.8.3317-3327.1997; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1344, DOI 10.1128/CVI.00261-10; Jones GJ, 2010, INFECT IMMUN, V78, P1326, DOI 10.1128/IAI.01246-09; Jungblut PR, 2001, INFECT IMMUN, V69, P5905, DOI 10.1128/IAI.69.9.5905-5907.2001; Kearns AM, 1999, INT J TUBERC LUNG D, V3, P635; Kvarnstrom A, 2004, CRYOBIOLOGY, V49, P157, DOI 10.1016/j.cryobiol.2004.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lastovicka J, 2009, CELL IMMUNOL, V256, P79, DOI 10.1016/j.cellimm.2009.01.007; MADDEN T, 2002, NCBI HDB BETHSEDA; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; *NCBI, NCBI BLASTCLUST; *NCBI, 2010, NCBI REF SEQ; ORME IM, 1986, TUBERCLE, V67, P41, DOI 10.1016/0041-3879(86)90030-9; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Pidot SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000872; PONNIGHAUS JM, 1992, LANCET, V339, P636, DOI 10.1016/0140-6736(92)90794-4; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; September SM, 2004, APPL ENVIRON MICROB, V70, P7571, DOI 10.1128/AEM.70.12.7571-7573.2004; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Tseng CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-55; Weir RE, 2003, CLIN EXP IMMUNOL, V134, P285, DOI 10.1046/j.1365-2249.2003.02272; WILSON ME, 1995, CLIN INFECT DIS, V20, P982, DOI 10.1093/clinids/20.4.982; Xu GX, 2007, MOL CELL BIOCHEM, V302, P1, DOI 10.1007/s11010-006-9395-0; YATES MD, 1993, THORAX, V48, P990, DOI 10.1136/thx.48.10.990; Young SL, 2007, INFECT IMMUN, V75, P2833, DOI 10.1128/IAI.01826-06; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang F, 2011, MOL CELL BIOCHEM, V352, P1, DOI 10.1007/s11010-011-0733-5; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173	53	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26434	10.1371/journal.pone.0026434	http://dx.doi.org/10.1371/journal.pone.0026434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046285	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000017
J	Schroeder, C; Tank, J; Heusser, K; Diedrich, A; Luft, FC; Jordan, J				Schroeder, Christoph; Tank, Jens; Heusser, Karsten; Diedrich, Andre; Luft, Friedrich C.; Jordan, Jens			Physiological Phenomenology of Neurally-Mediated Syncope with Management Implications	PLOS ONE			English	Article							HEAD-UP TILT; VAGUS NERVE-STIMULATION; VASOVAGAL SYNCOPE; RATE-VARIABILITY; TIME-DOMAIN; AGE; REPRODUCIBILITY; PREVENTION; PACEMAKER; RESPONSES	Background: Due to lack of efficacy in recent trials, current guidelines for the treatment of neurally-mediated (vasovagal) syncope do not promote cardiac pacemaker implantation. However, the finding of asystole during head-up tilt -induced (pre) syncope may lead to excessive cardioinhibitory syncope diagnosis and treatment with cardiac pacemakers as blood pressure is often discontinuously measured. Furthermore, physicians may be more inclined to implant cardiac pacemakers in older patients. We hypothesized that true cardioinhibitory syncope in which the decrease in heart rate precedes the fall in blood pressure is a very rare finding which might explain the lack of efficacy of pacemakers in neurally-mediated syncope. Methods: We studied 173 consecutive patients referred for unexplained syncope (114 women, 59 men, 4261 years, 1762 syncopal episodes). All had experienced (pre) syncope during head-up tilt testing followed by additional lower body negative suction. We classified hemodynamic responses according to the modified Vasovagal Syncope International Study (VASIS) classification as mixed response (VASIS I), cardioinhibitory without (VASIS IIa) or with asystole (VASIS IIb), and vasodepressor (VASIS III). Then, we defined the exact temporal relationship between hypotension and bradycardia to identify patients with true cardioinhibitory syncope. Results: Of the (pre) syncopal events during tilt testing, 63% were classified as VASIS I, 6% as VASIS IIb, 2% as VASIS IIa, and 29% as VASIS III. Cardioinhibitory responses (VASIS class II) progressively decreased from the youngest to the oldest age quartile. With more detailed temporal analysis, blood pressure reduction preceded the heart-rate decrease in all but six individuals (97%) overall and in 10 out of 11 patients with asystole (VASIS IIb). Conclusions: Hypotension precedes bradycardia onset during head-up tilt-induced (pre) syncope in the vast majority of patients, even in those classified as cardioinhibitory syncope according to the modified VASIS classification. Furthermore, cardioinhibitory syncope becomes less frequent with increasing age.	[Schroeder, Christoph; Tank, Jens; Heusser, Karsten; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; [Schroeder, Christoph; Luft, Friedrich C.] Charite, Expt Clin Res Ctr, D-13353 Berlin, Germany; [Schroeder, Christoph; Luft, Friedrich C.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Diedrich, Andre] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Auton Dysfunct Ctr, Nashville, TN USA	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vanderbilt University	Schroeder, C (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	jordan.jens@mh-hannover.de		Luft, Friedrich/0000-0002-8635-1199; Heusser, Karsten/0000-0002-2571-5585; Tank, Jens/0000-0002-5672-1187	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded from institutional funds. Publication costs are funded by the support program 'open access publication' of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alehan D, 2003, INT J CARDIOL, V88, P19, DOI 10.1016/S0167-5273(02)00379-0; Ali II, 2004, EPILEPSY BEHAV, V5, P768, DOI 10.1016/j.yebeh.2004.05.008; Ammirati F, 2001, CIRCULATION, V104, P52, DOI 10.1161/hc2601.091708; Baron-Esquivias G, 2002, EUR HEART J, V23, P483, DOI 10.1053/euhj.2001.2900; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Bloomfield D, 1999, AM J CARDIOL, V83, P1055, DOI 10.1016/S0002-9149(99)00014-4; Brignole M, 2007, EUROPACE, V9, P25, DOI 10.1093/europace/eul135; Brignole M, 2000, EUROPACE, V2, P66, DOI 10.1053/eupc.1999.0064; Brignole M, 2006, EUR HEART J, V27, P2232, DOI 10.1093/eurheartj/ehl164; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen-Scarabelli C, 2004, BMJ-BRIT MED J, V329, P336, DOI 10.1136/bmj.329.7461.336; Connolly SJ, 2003, JAMA-J AM MED ASSOC, V289, P2224, DOI 10.1001/jama.289.17.2224; Connolly SJ, 1999, J AM COLL CARDIOL, V33, P16, DOI 10.1016/S0735-1097(98)00549-X; el-Bedawi K M, 1994, Clin Auton Res, V4, P41; Foglia-Manzillo G, 2002, EUROPACE, V4, P365, DOI 10.1053/eupc.2002.0260; Foglia-Manzillo G, 1999, AM J CARDIOL, V84, P284, DOI 10.1016/S0002-9149(99)00277-5; Hainsworth R, 2003, HEART, V89, P123, DOI 10.1136/heart.89.2.123; Kazemi B, 2006, PACE, V29, P846, DOI 10.1111/j.1540-8159.2006.00450.x; Kim PH, 2004, AM J CARDIOL, V94, P1491, DOI 10.1016/j.amjcard.2004.08.025; Krediet CTP, 2002, CIRCULATION, V106, P1684, DOI 10.1161/01.CIR.0000030939.12646.8F; Kurbaan AS, 2003, J AM COLL CARDIOL, V41, P1004, DOI 10.1016/S0735-1097(02)02967-4; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; LeLorier Paul, 2003, J Cardiovasc Electrophysiol, V14, P920, DOI 10.1046/j.1540-8167.2003.03065.x; Lewis T, 1932, BRIT MED J, V1932, P873, DOI 10.1136/bmj.1.3723.873; McGavigan AD, 2001, AGE AGEING, V30, P295, DOI 10.1093/ageing/30.4.295; Mehlsen J, 2008, EUROPACE, V10, P91, DOI 10.1093/europace/eum237; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Omar AR, 2004, INTERN MED J, V34, P504, DOI 10.1111/j.1444-0903.2004.00626.x; PARRY SW, 2010, BMJ, V340; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Pietrucha AZ, 2009, PACE, V32, pS158, DOI 10.1111/j.1540-8159.2008.02275.x; Raviele A, 2004, EUR HEART J, V25, P1741, DOI 10.1016/j.ehj.2004.06.031; Romme JJCM, 2008, CLIN AUTON RES, V18, P127, DOI 10.1007/s10286-008-0465-0; Rose MS, 2009, EUROPACE, V11, P1369, DOI 10.1093/europace/eup106; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Sutton R, 2000, CIRCULATION, V102, P294; Sutton R, 1992, EUR J CARDIAC PACING, V2, P180; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Vaddadi G, 2010, EUR HEART J, V31, P2027, DOI 10.1093/eurheartj/ehq071; van Dijk N, 2006, J AM COLL CARDIOL, V48, P1652, DOI 10.1016/j.jacc.2006.06.059; Verheyden B, 2007, CLIN SCI, V113, P329, DOI 10.1042/CS20070042; Verheyden B, 2008, HEART RHYTHM, V5, P1695, DOI 10.1016/j.hrthm.2008.09.003; Wieling W, 2009, BRAIN, V132, P2630, DOI 10.1093/brain/awp179; Zulfiqar U, 2010, AM J CARDIOL, V105, P1181, DOI 10.1016/j.amjcard.2009.12.022	45	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26489	10.1371/journal.pone.0026489	http://dx.doi.org/10.1371/journal.pone.0026489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046292	gold, Green Published, Green Accepted			2022-12-27	WOS:000296517000020
J	Revez, J; Rossi, M; Ellstrom, P; de Haan, C; Rautelin, H; Hanninen, ML				Revez, Joana; Rossi, Mirko; Ellstrom, Patrik; de Haan, Caroline; Rautelin, Hilpi; Hanninen, Marja-Liisa			Finnish Campylobacter jejuni Strains of Multilocus Sequence Type ST-22 Complex Have Two Lineages with Different Characteristics	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; LIPO-OLIGOSACCHARIDE; REACTIVE ARTHRITIS; BIOFILM FORMATION; BIOSYNTHESIS; CELLS; COLI; GENES; CORE; CHICKENS	Background: Campylobacter jejuni is the major cause of human bacterial gastroenteritis worldwide, and in a minority of cases, post-infectious complications may occur. ST-22 complex (usually Penner serotype 19) strains have been overrepresented among patients with postinfectious complications of campylobacteriosis. We here present a characterization of a collection of 27 Finnish C. jejuni strains of ST-22 complex, from humans (22 strains) and animal sources (five strains), with the aim of contributing to our knowledge of the pathogenesis of C. jejuni infections. Methodology/Principal Findings: All strains were analyzed by pulsed-field gel electrophoresis (PFGE) genotyping, lipooligosaccharide (LOS) locus class, Y-glutamyl transpeptidase (GGT) activity, in vitro biofilm formation ability, invasion and adhesion in HeLa cells and induction of IL-8 production. ST-22 complex contained five STs (ST-22; ST-1947; ST-1966; ST-3892; ST-3996) which were homogeneous in having sialylated LOS class A(1) but on the other hand were distinguished into two major lineages according to the major STs (ST-22 and ST-1947) by different PFGE genotypes and certain other characteristics. All ST-22 strains had similar SmaI PFGE profiles, were GGT positive, and formed biofilms, except one strain, while ST-1947 strains were all GGT negative, did not form biofilm, had significantly higher motility than ST-22 (p<0.05) and had their SmaI PFGE profile. Invasion and adhesion as well as induction of IL-8 production on HeLa cells were strain-dependent characteristics. Conclusions/Significance: ST-22 complex strains, reveal potential for molecular mimicry in host interactions upon infection as they all express sialylated LOS class A1. The two major STs, ST-22 and ST-1947 formed two homogeneous lineages, which differed from each other both phenotypically and genetically, suggesting that the strains may have evolved separately, perhaps by interacting with different spectra of hosts. Further studies are needed in order to understand if these two lineages are associated with different disease outcomes.	[Revez, Joana; Rossi, Mirko; de Haan, Caroline; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland; [Ellstrom, Patrik; Rautelin, Hilpi] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Rautelin, Hilpi] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Rautelin, Hilpi] Helsinki Univ Cent Hosp Lab, HUSLAB, Helsinki, Finland	University of Helsinki; Uppsala University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Revez, J (corresponding author), Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland.	joana.revez@helsinki.fi	Rossi, Mirko/D-1509-2012; de Haan, Astrid/G-2723-2013	Rossi, Mirko/0000-0002-1585-6384; 	Academy of Finland [118602, 118042]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland grant on behalf of CoE-MiFoSa (no 118602) and ELVIRA grant no 118042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P6942, DOI 10.1128/AEM.01605-10; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Gonzalez M, 2009, APPL ENVIRON MICROB, V75, P1208, DOI 10.1128/AEM.01879-08; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hanninen ML, 2001, APPL ENVIRON MICROB, V67, P1581, DOI 10.1128/AEM.67.4.1581-1586.2001; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Hannu T, 2004, J RHEUMATOL, V31, P528; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Hotter GS, 2010, EPIDEMIOL INFECT, V138, P992, DOI 10.1017/S0950268809991075; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P1683, DOI 10.1128/AEM.02338-06; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Nielsen LN, 2010, J APPL MICROBIOL, V108, P591, DOI 10.1111/j.1365-2672.2009.04444.x; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Perera VN, 2007, FEMS IMMUNOL MED MIC, V50, P27, DOI 10.1111/j.1574-695X.2007.00225.x; Rautelin H, 1999, J MED MICROBIOL, V48, P617, DOI 10.1099/00222615-48-7-617; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Schonberg-Norio D, 2010, EPIDEMIOL INFECT, V138, P1004, DOI 10.1017/S0950268809991099; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359; Taboada EN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-229; Teh KH, 2010, INT J FOOD MICROBIOL, V143, P118, DOI 10.1016/j.ijfoodmicro.2010.07.037; Verhoeff-Bakkenes L, 2008, EPIDEMIOL INFECT, V136, P1401, DOI 10.1017/S0950268807000040; Yabe S, 2010, MICROBIOL IMMUNOL, V54, P362, DOI 10.1111/j.1348-0421.2010.00222.x; Zautner AE, 2011, APPL ENVIRON MICROB, V77, P2359, DOI 10.1128/AEM.02403-10; Zheng J, 2006, J FOOD PROTECT, V69, P768, DOI 10.4315/0362-028X-69.4.768	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26880	10.1371/journal.pone.0026880	http://dx.doi.org/10.1371/journal.pone.0026880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039552	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200051
J	Russo, TA; Shon, AS; Beanan, JM; Olson, R; MacDonald, U; Pomakov, AO; Visitacion, MP				Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Pomakov, Alexander O.; Visitacion, Mark P.			Hypervirulent K. Pneumoniae Secretes More and More Active Iron-Acquisition Molecules than "Classical" K. Pneumoniae Thereby Enhancing its Virulence	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; SEROTYPE K1; SEPTIC ENDOPHTHALMITIS; EMERGING DISEASE; INFECTION; ASSOCIATION; BACTEREMIA; STRAINS	Background: A new hypervirulent (hypermucoviscous) clinical variant of Klebsiella pneumoniae (hvKP) has emerged over the last decade. Our goal is to identify new mechanisms, which increase the virulence hvKP compared to "classic" K. pneumoniae (cKP). Methodology/Principal Findings: Various growth assays were performed in human ascites, human serum, and laboratory medium with the hvKP strain hvKP1 (wt), randomly chosen blood isolates of cKP strains (cKP1-4), and mutant constructs deficient in the secretion of selected compounds. An in vivo mouse model that mimics infection due to hvKP and a quantitative siderophore assay were also used. It was established that a molecule(s)/factor(s) was secreted by hvKP1 significantly enhanced its growth and/or survival in human ascites. This molecule(s)/factor(s) also increased the growth and/or survival of hvKP1 in serum ex vivo and in an in vivo mouse model that measures metastatic spread after subcutaneous challenge, thereby further establishing biologic significance. Although features such as a size of <3kD, heat stability, and growth characteristics in ascites suggested this molecule(s) was a quorum-sensing compound, data presented demonstrates that this molecule(s)/factor(s) is involved in iron uptake and is likely a siderophore(s) or another iron-acquisition molecule. Although it is known that iron acquisition is critical for virulence, a novel aspect of this observation is that hvKP1 produces quantitatively more siderophores that appear to be biologically more active (increased affinity for iron or more resistant to host factors) than those produced by cKP strains. Conclusions/Significance: The data presented delineates a new mechanism by which hvKP increases its pathogenic potential compared to cKP strains. This paradigm may be broadly applicable to other extraintestinal gram-negative bacilli.	[Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Visitacion, Mark P.] SUNY Buffalo, Vet Adm Western New York Healthcare Syst, Buffalo, NY 14260 USA; [Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Pomakov, Alexander O.; Visitacion, Mark P.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Russo, Thomas A.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Russo, Thomas A.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Russo, TA (corresponding author), SUNY Buffalo, Vet Adm Western New York Healthcare Syst, Buffalo, NY 14260 USA.	trusso@acsu.buffalo.edu	Russo, Thomas/ABE-9633-2020		National Institutes of Health [1R21AI088318 - 01A1]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant 1R21AI088318 - 01A1 (Dr. Russo) and by a VA Merit Review from the Department of Veterans Affairs (Dr. Russo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chang Feng-Yee, 1995, Journal of the Formosan Medical Association, V94, P232; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dylewski JS, 1998, CLIN INFECT DIS, V27, P1561, DOI 10.1086/517760; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2000, QJM-MON J ASSOC PHYS, V93, P45, DOI 10.1093/qjmed/93.1.45; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; HAN SHB, 1995, WESTERN J MED, V162, P220; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Jang Tsrang-Neng, 1993, Journal of the Formosan Medical Association, V92, P540; Jones MB, 2003, INFECT IMMUN, V71, P3914, DOI 10.1128/IAI.71.7.3914-3919.2003; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kendall MM, 2007, CURR OPIN GASTROEN, V23, P10, DOI 10.1097/MOG.0b013e3280118289; Keynan Y, 2007, SCAND J INFECT DIS, V39, P828, DOI 10.1080/00365540701266763; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Ku YH, 2008, J MICROBIOL IMMUNOL, V41, P311; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lee HC, 2006, J INTERN MED, V259, P606, DOI 10.1111/j.1365-2796.2006.01641.x; Lee WS, 2011, YONSEI MED J, V52, P288, DOI 10.3349/ymj.2011.52.2.288; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Lu C H, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V60, P296; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; McCabe R, 2010, EMERG INFECT DIS, V16, P1490, DOI 10.3201/eid1609.100386; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nagano N, 2008, J MED MICROBIOL, V57, P121, DOI 10.1099/jmm.0.47380-0; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; POMAKOVA DK, 2011, EUR J CLIN MICROBIOL; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Russo TA, 1999, INFECT IMMUN, V67, P5306, DOI 10.1128/IAI.67.10.5306-5314.1999; Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; SIMOONSSMIT AM, 1984, J MED MICROBIOL, V17, P67, DOI 10.1099/00222615-17-1-67; SIMOONSSMIT AM, 1986, J MED MICROBIOL, V21, P133, DOI 10.1099/00222615-21-2-133; Su SC, 2008, ANTIMICROB AGENTS CH, V52, P804, DOI 10.1128/AAC.01269-07; Tang LM, 1997, EPIDEMIOL INFECT, V119, P135, DOI 10.1017/S0950268897007930; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Turovskiy Y, 2007, ADV APPL MICROBIOL, V62, P191, DOI 10.1016/S0065-2164(07)62007-3; Turovskiy Y, 2006, J MICROBIOL METH, V66, P497, DOI 10.1016/j.mimet.2006.02.001; Turton JF, 2007, J MED MICROBIOL, V56, P593, DOI 10.1099/jmm.0.46964-0; Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yeh KM, 2006, J MED MICROBIOL, V55, P803, DOI 10.1099/jmm.0.46368-0; Yu WL, 2008, DIAGN MICR INFEC DIS, V62, P1, DOI 10.1016/j.diagmicrobio.2008.04.007; Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420	61	74	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26734	10.1371/journal.pone.0026734	http://dx.doi.org/10.1371/journal.pone.0026734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039542	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200047
J	Kofstad, T; Jonassen, CM				Kofstad, Tone; Jonassen, Christine M.			Screening of Feral and Wood Pigeons for Viruses Harbouring a Conserved Mobile Viral Element: Characterization of Novel Astroviruses and Picornaviruses	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; RNA RECOMBINATION; DIVERGENT PICORNAVIRUS; DIVERSE ASTROVIRUSES; ENTRY SITES; ANSER-ANSER; SEQUENCE; TURKEY; ENTEROVIRUS; IDENTIFICATION	A highly conserved RNA-motif of yet unknown function, called stem-loop-2-like motif (s2m), has been identified in the 39 end of the genomes of viruses belonging to different RNA virus families which infect a broad range of mammal and bird species, including Astroviridae, Picornaviridae, Coronaviridae and Caliciviridae. Since s2m is such an extremely conserved motif, it is an ideal target for screening for viruses harbouring it. In this study, we have detected and characterized novel viruses harbouring this motif in pigeons by using a s2m-specific amplification. 84% and 67% of the samples from feral pigeons and wood pigeons, respectively, were found to contain a virus harbouring s2m. Four novel viruses were identified and characterized. Two of the new viruses belong to the genus Avastrovirus in the Astroviridae family. We propose two novel species to be included in this genus, Feral pigeon astrovirus and Wood pigeon astrovirus. Two other novel viruses, Pigeon picornavirus A and Pigeon picornavirus B, belong to the Picornaviridae family, presumably to the genus Sapelovirus. Both of the novel picornaviruses harboured two adjacent s2m, called (s2m) 2, suggesting a possible increased functional effect of s2m when present in two copies.	[Kofstad, Tone; Jonassen, Christine M.] Natl Vet Inst, Dept Lab Serv, Oslo, Norway; [Jonassen, Christine M.] Akershus Univ Hosp, Div Diagnost & Technol, Lorenskog, Norway	Norwegian Veterinary Institute; University of Oslo	Kofstad, T (corresponding author), Natl Vet Inst, Dept Lab Serv, Oslo, Norway.	cjon@ahus.no						Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Chard LS, 2006, J VIROL, V80, P1271, DOI 10.1128/JVI.80.3.1271-1279.2006; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2010, J GEN VIROL, V91, P2457, DOI 10.1099/vir.0.022764-0; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Fernandez-Miragall O, 2009, VIRUS RES, V139, P172, DOI 10.1016/j.virusres.2008.07.009; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Gallei A, 2004, J VIROL, V78, P6271, DOI 10.1128/JVI.78.12.6271-6281.2004; Gmyl AP, 2003, RNA, V9, P1221, DOI 10.1261/rna.5111803; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; Jonassen Christine Monceyron, 2008, V454, P27, DOI 10.1007/978-1-59745-181-9_3; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Jonassen CM, 2003, VIRUS RES, V91, P195, DOI 10.1016/S0168-1702(02)00269-1; Jonassen CM, 2001, J GEN VIROL, V82, P1061, DOI 10.1099/0022-1317-82-5-1061; Kaku Y, 2001, J GEN VIROL, V82, P417, DOI 10.1099/0022-1317-82-2-417; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Koci MD, 2000, J VIROL, V74, P6173, DOI 10.1128/JVI.74.13.6173-6177.2000; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lillehaug A, 2005, ACTA VET SCAND, V46, P193, DOI 10.1186/1751-0147-46-4-193; Mandoki M, 2006, AVIAN PATHOL, V35, P224, DOI 10.1080/03079450600711037; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Mittelholzer C, 2003, J GEN VIROL, V84, P3087, DOI 10.1099/vir.0.19267-0; Monceyron C, 1997, ARCH VIROL, V142, P699, DOI 10.1007/s007050050112; MONCEYRON JC, 2006, DEV BIOL BASEL, V126, P161; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Oberste MS, 2003, VIROLOGY, V314, P283, DOI 10.1016/S0042-6822(03)00420-3; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pantin-Jackwood MJ, 2006, AVIAN DIS, V50, P397, DOI 10.1637/7512-020606R.1; Pantin-Jackwood MJ, 2006, VIRUS GENES, V32, P187, DOI 10.1007/s11262-005-6875-3; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Rivera R, 2010, J GEN VIROL, V91, P166, DOI 10.1099/vir.0.015222-0; Robertson MP, 2005, PLOS BIOL, V3, P86, DOI 10.1371/journal.pbio.0030005; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Strain E, 2008, J VIROL, V82, P5099, DOI 10.1128/JVI.01993-07; Tang Y, 2005, AVIAN DIS, V49, P182, DOI 10.1637/7255-080504R; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Thiel HJ, 1999, VET MICROBIOL, V69, P55, DOI 10.1016/S0378-1135(99)00088-7; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031; Tseng CH, 2007, VIRUS RES, V129, P104, DOI 10.1016/j.virusres.2007.06.023; Walter JE, 2001, ARCH VIROL, V146, P2357, DOI 10.1007/s007050170008; Wang QH, 2001, J MED VIROL, V64, P245, DOI 10.1002/jmv.1043; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Wutz G, 1996, J GEN VIROL, V77, P1719, DOI 10.1099/0022-1317-77-8-1719; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25964	10.1371/journal.pone.0025964	http://dx.doi.org/10.1371/journal.pone.0025964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043297	gold, Green Submitted, Green Published			2022-12-27	WOS:000295984400025
J	Kojima, D; Mori, S; Torii, M; Wada, A; Morishita, R; Fukada, Y				Kojima, Daisuke; Mori, Suguru; Torii, Masaki; Wada, Akimori; Morishita, Rika; Fukada, Yoshitaka			UV-Sensitive Photoreceptor Protein OPN5 in Humans and Mice	PLOS ONE			English	Article							MAMMALIAN NEURAL TISSUE; GTP-BINDING PROTEIN; MOLECULAR-PROPERTIES; ULTRAVIOLET VISION; VISUAL PIGMENTS; CIRCADIAN CLOCK; GAMMA-SUBUNIT; BLUE-LIGHT; ROD; MELANOPSIN	A variety of animal species utilize the ultraviolet (UV) component of sunlight as their environmental cues, whereas physiological roles of UV photoreception in mammals, especially in human beings, remain open questions. Here we report that mouse neuropsin (OPN5) encoded by the Opn5 gene exhibited an absorption maximum (lambda max) at 380 nm when reconstituted with 11-cis-retinal. Upon UV-light illumination, OPN5 was converted to a blue-absorbing photoproduct (lambda max 470 nm), which was stable in the dark and reverted to the UV-absorbing state by the subsequent orange light illumination, indicating its bistable nature. Human OPN5 also had an absorption maximum at 380 nm with spectral properties similar to mouse OPN5, revealing that OPN5 is the first and hitherto unknown human opsin with peak sensitivity in the UV region. OPN5 was capable of activating heterotrimeric G protein Gi in a UV-dependent manner. Immuno-blotting analyses of mouse tissue extracts identified the retina, the brain and, unexpectedly, the outer ears as the major sites of OPN5 expression. In the tissue sections of mice, OPN5 immuno-reactivities were detected in a subset of non-rod/non-cone retinal neurons as well as in the epidermal and muscle cells of the outer ears. Most of these OPN5-immuno-reactivities in mice were co-localized with positive signals for the alpha-subunit of Gi. These results demonstrate the first example of UV photoreceptor in human beings and strongly suggest that OPN5 triggers a UV-sensitive Gi-mediated signaling pathway in the mammalian tissues.	[Kojima, Daisuke; Mori, Suguru; Torii, Masaki; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Kojima, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Wada, Akimori] Kobe Pharmaceut Univ, Dept Organ Chem Life Sci, Kobe, Hyogo 658, Japan; [Morishita, Rika] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kobe Pharmaceutical University	Kojima, D (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	sdkojima@mail.ecc.u-tokyo.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014; Kojima, Daisuke/G-4958-2014	Kojima, Daisuke/0000-0003-2658-780X	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Kurata Memorial Hitachi Science and Technology Foundation; Research Foundation for Opto-Science and Technology; Grants-in-Aid for Scientific Research [21570073] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Memorial Hitachi Science and Technology Foundation; Research Foundation for Opto-Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Precursory Research for Embryonic Science and Technology program from Japan Science and Technology Agency (to D. K.), by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan (to D. K. and Y.F.), by Kurata Grants from the Kurata Memorial Hitachi Science and Technology Foundation (to D. K.), by Research Foundation for Opto-Science and Technology (to D. K.), and by the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO T, 1993, J BIOL CHEM, V268, P20512; ASANO T, 1989, BIOCHEMISTRY-US, V28, P4749, DOI 10.1021/bi00437a035; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; Denda M, 2008, J INVEST DERMATOL, V128, P1335, DOI 10.1038/sj.jid.5701168; EISNER T, 1969, Science (Washington D C), V166, P1172, DOI 10.1126/science.166.3909.1172; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HENSCHKE U., 1939, STRAHLENTHERAPIE, V64, P14; Hiramoto K, 2009, ARCH DERMATOL RES, V301, P239, DOI 10.1007/s00403-008-0926-2; Imai H, 2007, J BIOL CHEM, V282, P6677, DOI 10.1074/jbc.M610086200; IRWIN C, 1993, PHOTOCHEM PHOTOBIOL, V57, P504, DOI 10.1111/j.1751-1097.1993.tb02326.x; JACOBS GH, 1992, AM ZOOL, V32, P544; Jourdie V, 2004, NATURE, V431, P262, DOI 10.1038/431262a; Kojima D, 1996, BIOCHEMISTRY-US, V35, P2625, DOI 10.1021/bi9511548; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Lei B, 2006, EXP EYE RES, V83, P610, DOI 10.1016/j.exer.2006.02.013; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; STARK WS, 1982, PHOTOCHEM PHOTOBIOL, V36, P371, DOI 10.1111/j.1751-1097.1982.tb04389.x; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P837, DOI 10.1067/mjd.2001.114594; Williams GA, 2005, VISUAL NEUROSCI, V22, P807, DOI 10.1017/S095252380522610X; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yao G, 2006, CURR EYE RES, V31, P925, DOI 10.1080/02713680600932308; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	46	113	123	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26388	10.1371/journal.pone.0026388	http://dx.doi.org/10.1371/journal.pone.0026388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043319	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400054
J	Njimona, I; Lamparter, T				Njimona, Ibrahim; Lamparter, Tilman			Temperature Effects on Agrobacterium Phytochrome Agp1	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; CHROMOPHORE-BINDING DOMAIN; HISTIDINE KINASE; PSEUDOMONAS-AERUGINOSA; LIGHT; PROTEIN; CYANOBACTERIAL; TUMEFACIENS; BACTERIOPHYTOCHROME; REVEALS	Phytochromes are widely distributed biliprotein photoreceptors with a conserved N-terminal chromophore-binding domain. Most phytochromes bear a light-regulated C-terminal His kinase or His kinase-like region. We investigated the effects of light and temperature on the His kinase activity of the phytochrome Agp1 from Agrobacterium tumefaciens. As in earlier studies, the phosphorylation activity of the holoprotein after far-red irradiation (where the red-light absorbing Pr form dominates) was stronger than that of the holoprotein after red irradiation (where the far red-absorbing Pfr form dominates). Phosphorylation activities of the apoprotein, far red-irradiated holoprotein, and red-irradiated holoprotein decreased when the temperature increased from 25 degrees C to 35 degrees C; at 40 degrees C, almost no kinase activity was detected. The activity of a holoprotein sample incubated at 40 degrees C was nearly completely restored when the temperature returned to 25 degrees C. UV/visible spectroscopy indicated that the protein was not denatured up to 45 degrees C. At 50 degrees C, however, Pfr denatured faster than the dark-adapted sample containing the Pr form of Agp1. The Pr visible spectrum was unaffected by temperatures of 20-45 degrees C, whereas irradiated samples exhibited a clear temperature effect in the 30-40 degrees C range in which prolonged irradiation resulted in the photoconversion of Pfr into a new spectral species termed Prx. Pfr to Prx photoconversion was dependent on the His-kinase module of Agp1; normal photoconversion occurred at 40 degrees C in the mutant Agp1-M15, which lacks the C-terminal His-kinase module, and in a domain-swap mutant in which the His-kinase module of Agp1 is replaced by the Hiskinase/response regulator module of the other A. tumefaciens phytochrome, Agp2. The temperature-dependent kinase activity and spectral properties in the physiological temperature range suggest that Agp1 serves as an integrated light and temperature sensor in A. tumefaciens.	[Njimona, Ibrahim; Lamparter, Tilman] KIT, Inst Bot, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Njimona, I (corresponding author), KIT, Inst Bot, Campus South, Karlsruhe, Germany.	tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [La 799/10-1]; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	This work was supported be the Deutsche Forschungsgemeinschaft, La 799/10-1. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Brandt S, 2008, J BIOL CHEM, V283, P34605, DOI 10.1074/jbc.M805506200; Braun Y, 2008, MICROBIOL-SGM, V154, P2700, DOI 10.1099/mic.0.2008/018820-0; Elich TD, 1997, CELL, V91, P713, DOI 10.1016/S0092-8674(00)80458-4; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; FIELDING A, 1992, PHOTOCHEM PHOTOBIOL, V56, P623, DOI 10.1111/j.1751-1097.1992.tb02212.x; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Heath J.D., 1995, 2 COMPONENT SIGNAL T, P367; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; Hubschmann T, 2001, EUR J BIOCHEM, V268, P3383, DOI 10.1046/j.1432-1327.2001.02229.x; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; JIN SG, 1993, J BACTERIOL, V175, P6830, DOI 10.1128/jb.175.21.6830-6835.1993; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kyndt JA, 2010, BIOCHEMISTRY-US, V49, P1744, DOI 10.1021/bi901591m; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2005, BIOCHEMISTRY-US, V44, P8461, DOI 10.1021/bi047510g; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Mancinelli Alberto L., 1994, P211; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Noack S, 2007, METHOD ENZYMOL, V423, P203, DOI 10.1016/S0076-6879(07)23009-5; PAYNE PI, 1972, NATURE-NEW BIOL, V235, P145, DOI 10.1038/newbio235145a0; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Rottwinkel GStudienzuVerbreitung, THESIS KIT KARLSRUHE; Sambrook J, 2001, MOL CLONING LAB MAN; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHEIBE J, 1969, PHOTOCHEM PHOTOBIOL, V9, P143, DOI 10.1111/j.1751-1097.1969.tb05918.x; SCHNEIDERPOETSCH HAW, 1992, PHOTOCHEM PHOTOBIOL, V56, P839, DOI 10.1111/j.1751-1097.1992.tb02241.x; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	48	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25977	10.1371/journal.pone.0025977	http://dx.doi.org/10.1371/journal.pone.0025977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043299	Green Published, gold			2022-12-27	WOS:000295984400027
J	Dunn, MR; Forman, JS				Dunn, Matthew R.; Forman, Jeffrey S.			Hypotheses of Spatial Stock Structure in Orange Roughy Hoplostethus atlanticus Inferred from Diet, Feeding, Condition, and Reproductive Activity	PLOS ONE			English	Article							NEW-ZEALAND; FISH; TRACHICHTHYIDAE; ECOLOGY; TEMPERATURE; FISHERIES; SELECTION; PISCES; WATERS; SIZE	We evaluate hypotheses for meso-scale spatial structure in an orange roughy (Hoplostethus atlanticus) stock using samples collected during research trawl surveys off the east coast of New Zealand. Distance-based linear models and generalised additive models were used to identify the most significant biological, environmental, and temporal predictors of variability in diet, proportion of stomachs containing prey, standardised weight of prey, fish somatic weight, fish total weight, and reproductive activity. The diet was similar to that observed elsewhere, and varied with ontogeny, depth, and surface water temperature. Smaller sized and female orange roughy in warmer bottom water were most likely to contain food. Fish condition and reproductive activity were highest at distances more than 20 km from the summit of the hills. Trawl survey catches indicated greater orange roughy densities in hill strata, suggesting hill habitat was favoured. However, analyses of feeding, condition, and reproductive activity indicated hill fish were not superior, despite fish densities on hills being reduced by fishing which, in principle, should have reduced intra-specific competition for food and other resources. Hypotheses for this result include: (1) fish in relatively poor condition visit hills to feed and regain condition and then leave, or (2) commercial fishing has disturbed feeding aggregations and/or caused habitat damage, making fished hills less productive. Mature orange roughy were observed on both flat and hill habitat during periods outside of spawning, and if this spatial structure was persistent then a proportion of the total spawning stock biomass would remain unavailable to fisheries targeting hills. Orange roughy stock assessments informed only by data from hills may well be misleading.	[Dunn, Matthew R.; Forman, Jeffrey S.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Dunn, MR (corresponding author), Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand.	m.dunn@niwa.co.nz			New Zealand Ministry of Fisheries; National Institute of Water and Atmospheric Research [CF113511]	New Zealand Ministry of Fisheries; National Institute of Water and Atmospheric Research	The research trawl surveys were funded by the New Zealand Ministry of Fisheries. The analyses and preparation of the manuscript were funded by National Institute of Water and Atmospheric Research project CF113511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MK, 2002, ENVIRON BIOL FISH, V63, P193; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson OF, 1998, 42 NIWA MIN FISH; Anderson OF, 2008, 200858 NZ FISH ASS M; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Branch TA, 2001, S AFR J MARINE SCI, V23, P181; BULMAN CM, 1992, MAR ECOL PROG SER, V82, P115, DOI 10.3354/meps082115; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Connell AM, 2010, NEW ZEAL J MAR FRESH, V44, P289, DOI 10.1080/00288330.2010.515232; Coombs RF, 2007, ICES J MAR SCI, V64, P1220, DOI 10.1093/icesjms/fsm084; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Doonan IJ, 2009, 200607 NZ FISH ASS M; Doonan IJ, 2009, 200947 NZ FISH ASS M; Doonan IJ, 2011, 201120 NZ FISH ASS M; Dunn MR, 2009, ICES J MAR SCI, V66, P871, DOI 10.1093/icesjms/fsp093; Dunn MR, 2009, NEW ZEAL J MAR FRESH, V43, P1103, DOI 10.1080/00288330.2009.9626533; Dunn MR, 2008, 200823 NZ FISH ASS M; Dunn MR, 2011, WORKSH HELD 31 AUG 3; Dunn MR, 2009, 200939 NZ FISH ASS M; Dunn MR, 2008, 200865 NZ FISH ASS M; Dunn MR, 2010, 201017 NZ FISH ASS M; Dunn MR, 2005, 200518 NZ FISH ASS M; Francis RICC, 2006, 200643 NZ FISH ASS M; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths D, 2007, CAN J FISH AQUAT SCI, V64, P249, DOI 10.1139/F07-002; Hallett CS, 2011, ICES J MAR SCI, V68, P157, DOI 10.1093/icesjms/fsq143; Henderson BA, 2002, J FISH BIOL, V61, P999, DOI 10.1111/j.1095-8649.2002.tb01858.x; Hirch S, 2010, MAR ECOL-EVOL PERSP, V31, P107, DOI 10.1111/j.1439-0485.2010.00366.x; KOSLOW JA, 1995, DEEP-SEA RES PT I, V42, P233, DOI 10.1016/0967-0637(95)93714-P; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Mauchline J., 1980, ADV MAR BIOL, P3; McClatchie S, 2003, DEEP-SEA RES PT I, V50, P1263, DOI 10.1016/S0967-0637(03)00128-6; Ministry of Fisheries, 2011, REP FISH ASS PLEN MA; Morato Telmo, 2007, Fish and Aquatic Resources Series, V12, P170; Morgan MJ, 2004, ICES J MAR SCI, V61, P64, DOI 10.1016/j.icesjms.2003.09.001; Mormede S, 2009, 200915 NZ FISH ASS M; PANKHURST NW, 1987, J FISH BIOL, V30, P193, DOI 10.1111/j.1095-8649.1987.tb05745.x; Pardoe H, 2008, MAR ECOL PROG SER, V362, P261, DOI 10.3354/meps07409; Pinkas L, 1971, FISH B CALIF DEP FIS; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Porteiro Filipe M., 2007, Fish and Aquatic Resources Series, V12, P101; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; ROBERTSON DA, 1978, NEW ZEAL J MAR FRESH, V12, P295, DOI 10.1080/00288330.1978.9515757; ROSECCHI E, 1988, MAR BIOL, V99, P293, DOI 10.1007/BF00391992; Rowden AA, 2008, 27 NZ AQ ENV BIOD MI; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Shephard S, 2006, FISH RES, V77, P17, DOI 10.1016/j.fishres.2005.10.004; Sissenwine M.P., 2007, FAO Fisheries Reports, V838, P61; Stevens DW, 2011, MAR BIOL, V158, P59, DOI 10.1007/s00227-010-1542-1; Tirasin EM, 1999, MAR ECOL PROG SER, V182, P243; Tracey DM, 1999, NEW ZEAL J MAR FRESH, V33, P67, DOI 10.1080/00288330.1999.9516858; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X	60	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26704	10.1371/journal.pone.0026704	http://dx.doi.org/10.1371/journal.pone.0026704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069464	Green Submitted, gold, Green Published			2022-12-27	WOS:000297150900026
J	Luck, K; Fournane, S; Kieffer, B; Masson, M; Nomine, Y; Trave, G				Luck, Katja; Fournane, Sadek; Kieffer, Bruno; Masson, Murielle; Nomine, Yves; Trave, Gilles			Putting into Practice Domain-Linear Motif Interaction Predictions for Exploration of Protein Networks	PLOS ONE			English	Article							PDZ-DOMAIN; BINDING SELECTIVITY; GUANYLATE KINASE; SCAFFOLD PROTEIN; MOLECULAR-BASIS; CELL POLARITY; LIGAND; RECOGNITION; SCRIBBLE; SPECIFICITY	PDZ domains recognise short sequence motifs at the extreme C-termini of proteins. A model based on microarray data has been recently published for predicting the binding preferences of PDZ domains to five residue long C-terminal sequences. Here we investigated the potential of this predictor for discovering novel protein interactions that involve PDZ domains. When tested on real negative data assembled from published literature, the predictor displayed a high false positive rate (FPR). We predicted and experimentally validated interactions between four PDZ domains derived from the human proteins MAGI1 and SCRIB and 19 peptides derived from human and viral C-termini of proteins. Measured binding intensities did not correlate with prediction scores, and the high FPR of the predictor was confirmed. Results indicate that limitations of the predictor may arise from an incomplete model definition and improper training of the model. Taking into account these limitations, we identified several novel putative interactions between PDZ domains of MAGI1 and SCRIB and the C-termini of the proteins FZD4, ARHGAP6, NET1, TANC1, GLUT7, MARCH3, MAS, ABC1, DLL1, TMEM215 and CYSLTR2. These proteins are localised to the membrane or suggested to act close to it and are often involved in G protein signalling. Furthermore, we showed that, while extension of minimal interacting domains or peptides toward tandem constructs or longer peptides never suppressed their ability to interact, the measured affinities and inferred specificity patterns often changed significantly. This suggests that if protein fragments interact, the full length proteins are also likely to interact, albeit possibly with altered affinities and specificities. Therefore, predictors dealing with protein fragments are promising tools for discovering protein interaction networks but their application to predict binding preferences within networks may be limited.	[Luck, Katja; Fournane, Sadek; Masson, Murielle; Nomine, Yves; Trave, Gilles] Ecole Biotechnol Strasbourg 1, Grp Oncoprot, Inst Rech, Illkirch Graffenstaden, France; [Kieffer, Bruno] Inst Genet & Biol Mol & Cellulaire, Biomol NMR Grp, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Luck, K (corresponding author), Ecole Biotechnol Strasbourg 1, Grp Oncoprot, Inst Rech, BP 10413, Illkirch Graffenstaden, France.	gilles.trave@unistra.fr	TRAVE, Gilles/P-8577-2016; Kieffer, Bruno/AAE-8999-2019; Nominé, Yves/P-8670-2016	Nomine, Yves/0000-0002-2912-116X; Kieffer, Bruno/0000-0002-2033-4679	CNRS; Ligue Nationale Contre le Cancer; Association de Recherche contre le Cancer (ARC) [3171]; Agence Nationale de la Recherche (ANR) [ANR-06-BLAN-0404, ANR-MIME-2007, EPI-HPV-3D]; National Institutes of Health (NIH) [R01CA134737]; Region Alsace; College Doctoral Europeen de Strasbourg; University of Strasbourg; NATIONAL CANCER INSTITUTE [R01CA134737] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Alsace(Region Grand-Est); College Doctoral Europeen de Strasbourg; University of Strasbourg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CNRS, University of Strasbourg, Ligue Nationale Contre le Cancer, Association de Recherche contre le Cancer (ARC) grant 3171, Agence Nationale de la Recherche (ANR) programs ANR-06-BLAN-0404 and ANR-MIME-2007 (project EPI-HPV-3D), and National Institutes of Health (NIH) grant R01CA134737. KL was supported by a grant of the "Region Alsace''. SF was supported by grants from the Ligue Nationale contre le Cancer. KL and SF were supported by the College Doctoral Europeen de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Brannetti B, 2001, COMPAR FUNCT GENOM, V2, P314, DOI 10.1002/cfg.104; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Charbonnier S, 2011, J MOL BIOL, V406, P745, DOI 10.1016/j.jmb.2011.01.015; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dev KK, 2004, J BIOL CHEM, V279, P41393, DOI 10.1074/jbc.M404499200; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Encinar JA, 2009, BIOINFORMATICS, V25, P2418, DOI 10.1093/bioinformatics/btp424; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fournane S, 2010, J MOL RECOGNIT; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Gerek ZN, 2010, PROTEIN SCI, V19, P914, DOI 10.1002/pro.366; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Kachel N, 2003, J MOL BIOL, V334, P143, DOI 10.1016/j.jmb.2003.09.026; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Luck K, 2011, BIOINFORMATICS, V27, P899, DOI 10.1093/bioinformatics/btr060; Mino A, 2000, GENES CELLS, V5, P1009, DOI 10.1046/j.1365-2443.2000.00385.x; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Moreau MM, 2010, J NEUROSCI, V30, P9738, DOI 10.1523/JNEUROSCI.6007-09.2010; Myszka DG, 1999, J MOL BIOL, V12, p[279, 779]; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Okuhira K, 2010, J BIOL CHEM, V285, P16369, DOI 10.1074/jbc.M109.061424; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Schillinger C, 2009, BIOINFORMATICS, V25, P1632, DOI 10.1093/bioinformatics/btp264; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shao XJ, 2011, BIOINFORMATICS, V27, P383, DOI 10.1093/bioinformatics/btq657; Simonson SJS, 2005, CANCER RES, V65, P8266, DOI 10.1158/0008-5472.CAN-05-1651; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Thomas M, 2001, ONCOGENE, V20, P5431, DOI 10.1038/sj.onc.1204719; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsukamoto K, 2001, BIOCHEM BIOPH RES CO, V287, P757, DOI 10.1006/bbrc.2001.5575; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wegmann F, 2004, EXP CELL RES, V300, P121, DOI 10.1016/j.yexcr.2004.07.010; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Woszczek G, 2007, J IMMUNOL, V178, P5262, DOI 10.4049/jimmunol.178.8.5262; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yoshihara K, 2011, EXP CELL RES, V317, P413, DOI 10.1016/j.yexcr.2010.12.004; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	78	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e25376	10.1371/journal.pone.0025376	http://dx.doi.org/10.1371/journal.pone.0025376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069443	Green Published, gold			2022-12-27	WOS:000297150900003
J	Seng, TY; Saad, SHM; Chin, CW; Ting, NC; Singh, RSH; Zaman, FQ; Tan, SG; Alwee, SSRS				Seng, Tzer-Ying; Saad, Siti Hawa Mohamed; Chin, Cheuk-Weng; Ting, Ngoot-Chin; Singh, Rajinder Harminder Singh; Zaman, Faridah Qamaruz; Tan, Soon-Guan; Alwee, Sharifah Shahrul Rabiah Syed			Genetic Linkage Map of a High Yielding FELDA Deli x Yangambi Oil Palm Cross	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; EST DATABASE; RFLP MARKERS; AFLP; MICROSATELLITE; CONSTRUCTION; MAIZE	Enroute to mapping QTLs for yield components in oil palm, we constructed the linkage map of a FELDA high yielding oil palm (Elaeis guineensis), hybrid cross. The parents of the mapping population are a Deli dura and a pisifera of Yangambi origin. The cross out-yielded the average by 8-21% in four trials all of which yielded comparably to the best current commercial planting materials. The higher yield derived from a higher fruit oil content. SSR markers in the public domain from CIRAD and MPOB, as well as some developed in FELDA - were used for the mapping, augmented by locally-designed AFLP markers. The female parent linkage map comprised 317 marker loci and the male parent map 331 loci, both in 16 linkage groups each. The number of markers per group ranged from 8-47 in the former and 12-40 in the latter. The integrated map was 2,247.5 cM long and included 479 markers and 168 anchor points. The number of markers per linkage group was 15-57, the average being 29, and the average map density 4.7 cM. The linkage groups ranged in length from 77.5 cM to 223.7 cM, with an average of 137 cM. The map is currently being validated against a closely related population and also being expanded to include yield related QTLs.	[Seng, Tzer-Ying; Saad, Siti Hawa Mohamed; Chin, Cheuk-Weng; Alwee, Sharifah Shahrul Rabiah Syed] Fed Land Dev Author Malaysia Agr Serv Sdn Bhd, Fed Land Dev Author Malaysia Biotechnol Ctr, Kuala Lumpur, Malaysia; [Ting, Ngoot-Chin; Singh, Rajinder Harminder Singh] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Malaysia; [Seng, Tzer-Ying; Zaman, Faridah Qamaruz] Univ Putra Malaysia, Inst Biosci, Serdang, Malaysia; [Tan, Soon-Guan] Univ Putra Malaysia, Dept Cell & Mol Biol, Serdang, Malaysia	Malaysian Palm Oil Board; Universiti Putra Malaysia; Universiti Putra Malaysia	Seng, TY (corresponding author), Fed Land Dev Author Malaysia Agr Serv Sdn Bhd, Fed Land Dev Author Malaysia Biotechnol Ctr, Kuala Lumpur, Malaysia.	ty.seng@felda.net.my	Tan, S G/B-2448-2010; Tan, Soon Guan/V-1782-2019; Singh, Rajinder/P-9179-2015	Tan, S G/0000-0001-9960-4493; Tan, Soon Guan/0000-0001-9960-4493; Singh, Rajinder/0000-0001-9933-4884; Ting, Ngoot Chin/0000-0002-4910-6020	Federal Land Development Authority Malaysia; Malaysian Palm Oil Board	Federal Land Development Authority Malaysia; Malaysian Palm Oil Board	Funding by Federal Land Development Authority Malaysia and Malaysian Palm Oil Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan P., 1998, Theoretical and Applied Genetics, V96, P219, DOI 10.1007/s001220050730; AJMONEMARSAN P, 1995, THEOR APPL GENET, V90, P415, DOI 10.1007/BF00221984; BECKER J, 1995, MOL GEN GENET, V249, P65, DOI 10.1007/BF00290237; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Cho YG, 1998, THEOR APPL GENET, V97, P370, DOI 10.1007/s001220050907; CHUA BH, 2004, MAL SOC MOL BIOL BIO, P127; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayati A, 2004, THEOR APPL GENET, V108, P1274, DOI 10.1007/s00122-003-1545-0; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lespinasse D, 2000, THEOR APPL GENET, V100, P127, DOI 10.1007/s001220050018; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Maizura I, 2006, GENET RESOUR CROP EV, V53, P187, DOI 10.1007/s10722-004-4004-0; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; Moretzsohn MC, 2000, THEOR APPL GENET, V100, P63, DOI 10.1007/s001220050009; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Rance KA, 2001, THEOR APPL GENET, V103, P1302, DOI 10.1007/s122-001-8204-z; Rhode W, 2003, SCI REPORT 2003; Ritter E, 2008, THEOR APPL GENET, V116, P1003, DOI 10.1007/s00122-008-0731-5; Ritter E, 1996, GENET RES, V67, P55, DOI 10.1017/S0016672300033474; RITTER E, 1990, GENETICS, V125, P645; Roy R, 1996, J FORENSIC SCI, V41, P418; Rozen S, 2000, Methods Mol Biol, V132, P365; Seng TzerYing, 2006, Journal of Oil Palm Research, V18, P219; Singh R, 2008, PCR BASED MARKER DIS; Singh R, 2006, MARKERS PREDICT SKIN; SINGH R, 2007, PERTANIKA J TROP AGR, V30, P31; Singh R. N., 2005, THESIS; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; STEFFENS DL, 1993, BIOTECHNIQUES, V15, P580; Ting NC, 2006, PERTANIKA J TROP AGR, V29, P35; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; vanderVoort JNAMR, 1997, MOL GEN GENET, V255, P438, DOI 10.1007/s004380050516; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	38	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26593	10.1371/journal.pone.0026593	http://dx.doi.org/10.1371/journal.pone.0026593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069457	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900019
J	Sun, SH; Guo, Y; Zhao, GY; Zhou, XJ; Li, JF; Hu, JY; Yu, H; Chen, Y; Song, HB; Qiao, F; Xu, GL; Yang, F; Wu, YZ; Tomlinson, S; Duan, ZP; Zhou, YS				Sun, Shihui; Guo, Yan; Zhao, Guangyu; Zhou, Xiaojun; Li, Junfeng; Hu, Jingya; Yu, Hong; Chen, Yu; Song, Hongbin; Qiao, Fei; Xu, Guilian; Yang, Fei; Wu, Yuzhang; Tomlinson, Stephen; Duan, Zhongping; Zhou, Yusen			Complement and the Alternative Pathway Play an Important Role in LPS/D-GalN-Induced Fulminant Hepatic Failure	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANAPHYLATOXIN C5A RECEPTORS; ACUTE LIVER-FAILURE; C3A RECEPTOR; RAT-LIVER; D-GALACTOSAMINE; MICE; INJURY; EXPRESSION; CELLS	Fulminant hepatic failure (FHF) is a clinically severe type of liver injury with an extremely high mortality rate. Although the pathological mechanisms of FHF are not well understood, evidence suggests that the complement system is involved in the pathogenesis of a variety of liver disorders. In the present study, to investigate the role of complement in FHF, we examined groups of mice following intraperitoneal injection of LPS/D-GalN: wild-type C57BL/6 mice, wild-type mice treated with a C3aR antagonist, C5aR monoclonal antibody (C5aRmAb) or CR2-Factor H (CR2-fH, an inhibitor of the alternative pathway), and C3 deficient mice (C3(-/-) mice). The animals were euthanized and samples analyzed at specific times after LPS/D-GalN injection. The results show that intraperitoneal administration of LPS/D-GalN activated the complement pathway, as evidenced by the hepatic deposition of C3 and C5b-9 and elevated serum levels of the complement activation product C3a, the level of which was associated with the severity of the liver damage. C3a receptor (C3aR) and C5a receptor (C5aR) expression was also upregulated. Compared with wild-type mice, C3(-/-) mice survived significantly longer and displayed reduced liver inflammation and attenuated pathological damage following LPS/D-GalN injection. Similar levels of protection were seen in mice treated with C3aR antagonist, C5aRmAb or CR2-fH. These data indicate an important role for the C3a and C5a generated by the alternative pathway in LPS/D-GalN-induced FHF. The data further suggest that complement inhibition may be an effective strategy for the adjunctive treatment of fulminant hepatic failure.	[Sun, Shihui; Guo, Yan; Zhao, Guangyu; Zhou, Xiaojun; Li, Junfeng; Hu, Jingya; Yu, Hong; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Yu; Duan, Zhongping] Capital Univ Med Sci, Artificial Liver Ctr, Beijing You An Hosp, Beijing, Peoples R China; [Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Qiao, Fei; Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Xu, Guilian; Yang, Fei; Wu, Yuzhang] Third Mil Med Univ, Inst Immunol, Coll Basic Med Sci, Chongqing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Capital Medical University; Academy of Military Medical Sciences - China; Medical University of South Carolina; Army Medical University	Sun, SH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	duan2517@163.com; yszhou@nic.bmi.ac.cn	Song, Hongbin/C-1963-2013		11th Five-Year Plan of China [2008ZX10002-005-3, 2009ZX10004-401]; National Natural Science Foundation of China (NSFC) [30972616, 30930086]	11th Five-Year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported in part by the 11th Five-Year Plan of China (2008ZX10002-005-3, 2009ZX10004-401) and the The National Natural Science Foundation of China (NSFC), grant numbers 30972616 and 30930086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe Masayoshi, 2006, Rinsho Byori, V54, P744; Arumugam TV, 2004, J HEPATOL, V40, P934, DOI 10.1016/j.jhep.2004.02.017; Bao LH, 2005, J IMMUNOL, V175, P1947, DOI 10.4049/jimmunol.175.3.1947; Bautsch W, 2000, J IMMUNOL, V165, P5401, DOI 10.4049/jimmunol.165.10.5401; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bhaduri BR, 1996, SEMIN LIVER DIS, V16, P349, DOI 10.1055/s-2007-1007248; Bykov I, 2006, ANN MED, V38, P280, DOI 10.1080/07853890600664608; Cai CC, 2010, AM J PHYSIOL-REG I, V299, pR1175, DOI 10.1152/ajpregu.00282.2010; CAVAILLON JM, 1990, EUR J IMMUNOL, V20, P253, DOI 10.1002/eji.1830200204; Croner RS, 2004, MICROVASC RES, V67, P182, DOI 10.1016/j.mvr.2003.09.009; De Steenwinkel JEM, 2009, INT J IMMUNOPATH PH, V22, P723, DOI 10.1177/039463200902200318; Dejager L, 2008, CYTOKINE, V42, P55, DOI 10.1016/j.cyto.2008.01.014; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; ELSNER J, 1994, EUR J IMMUNOL, V24, P518, DOI 10.1002/eji.1830240304; ELSNER J, 1994, BLOOD, V83, P3324; Fischer WH, 1999, J IMMUNOL, V162, P453; Fukuda T, 2006, LIFE SCI, V79, P822, DOI 10.1016/j.lfs.2006.03.025; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Garrett MC, 2009, BRAIN RES, V1298, P171, DOI 10.1016/j.brainres.2009.04.047; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; He SQ, 2009, J IMMUNOL, V183, P4764, DOI 10.4049/jimmunol.0900550; He SQ, 2009, J CLIN INVEST, V119, P2304, DOI 10.1172/JCI38289; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Ikeda T, 2008, ARCH HISTOL CYTOL, V71, P163, DOI 10.1679/aohc.71.163; Tunon MJ, 2009, WORLD J GASTROENTERO, V15, P3086, DOI 10.3748/wjg.15.3086; Koleva M, 2002, GASTROENTEROLOGY, V122, P697, DOI 10.1053/gast.2002.31883; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Kuhla A, 2009, AM J PHYSIOL-GASTR L, V296, pG1069, DOI 10.1152/ajpgi.90689.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; MURAKAMI Y, 1993, IMMUNOLOGY, V79, P633; OGRADY JG, 1993, LANCET, V342, P273; PHAM BN, 1995, GASTROENTEROLOGY, V108, P495, DOI 10.1016/0016-5085(95)90079-9; Proctor LM, 2006, INT IMMUNOPHARMACOL, V6, P1224, DOI 10.1016/j.intimp.2006.03.002; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Rynkowski MA, 2009, J CEREBR BLOOD F MET, V29, P98, DOI 10.1038/jcbfm.2008.95; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Schieferdecker HL, 1997, FEBS LETT, V406, P305, DOI 10.1016/S0014-5793(97)00292-5; Schieferdecker HL, 2001, INT IMMUNOPHARMACOL, V1, P469, DOI 10.1016/S1567-5769(00)00038-2; Schlaf G, 2003, HISTOL HISTOPATHOL, V18, P299, DOI 10.14670/HH-18.299; Schmid RA, 1998, J THORAC CARDIOV SUR, V116, P90, DOI 10.1016/S0022-5223(98)70246-6; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Sun SH, 2011, AM J RESP CELL MOL, V45, P834, DOI 10.1165/rcmb.2010-0444OC; TIEGS G, 1989, BIOCHEM PHARMACOL, V38, P627, DOI 10.1016/0006-2952(89)90208-6; Tu ZD, 2011, IMMUNOBIOLOGY, V216, P528, DOI 10.1016/j.imbio.2010.08.004; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Zhao LJ, 2002, BLOOD, V100, P3233, DOI 10.1182/blood-2002-01-0252	52	23	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26838	10.1371/journal.pone.0026838	http://dx.doi.org/10.1371/journal.pone.0026838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069473	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900035
J	Jia, Y; Jing, J; Bai, Y; Li, Z; Liu, LD; Luo, J; Liu, MY; Chen, HQ				Jia, Yan; Jing, Ji; Bai, Yang; Li, Zhen; Liu, Lande; Luo, Jian; Liu, Mingyao; Chen, Huaqing			Amelioration of Experimental Autoimmune Encephalomyelitis by Plumbagin through Down-Regulation of JAK-STAT and NF-kappa B Signaling Pathways	PLOS ONE			English	Article							HELPER T-CELLS; MULTIPLE-SCLEROSIS; LINEAGE COMMITMENT; CYTOKINE; INFLAMMATION; DIFFERENTIATION; LYMPHOCYTES; ACTIVATION; APOPTOSIS; ZEYLANICA	Plumbagin(PL), a herbal compound derived from roots of the medicinal plant Plumbago zeylanica, has been shown to have immunosuppressive properties. Present report describes that PL is a potent novel agent in control of encephalitogenic T cell responses and amelioration of mouse experimental autoimmune encephalomyelitis (EAE), through down-regulation of JAK-STAT pathway. PL was found to selectively inhibit IFN-gamma and IL-17 production by CD4(+) T cells, which was mediated through abrogated phosphorylation of JAK1 and JAK2. Consistent with IFN-gamma and IL-17 reduction was suppressed STAT1/STAT4/T-bet pathway which is critical for Th1 differentiation, as well as STAT3/ROR pathway which is essential for Th17 differentiation. In addition, PL suppressed pro-inflammatory molecules such as iNOS, IFN-gamma and IL-6, accompanied by inhibition of I kappa B degradation as well as NF-kappa B phosphorylation. These data give new insight into the novel immune regulatory mechanism of PL and highlight the great value of this kind of herb compounds in probing the complex cytokine signaling network and novel therapeutic targets for autoimmune diseases.	[Jia, Yan; Jing, Ji; Bai, Yang; Li, Zhen; Liu, Lande; Luo, Jian; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Jia, Yan; Jing, Ji; Bai, Yang; Li, Zhen; Liu, Lande; Luo, Jian; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Dept Mol & Cellular Med, Inst Biosci & Technol, Houston, TX USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jia, Y (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China.	huaqingc@yahoo.com.cn	Luo, Jian/H-3362-2016	Luo, Jian/0000-0003-3583-0154; Liu, Mingyao/0000-0001-7339-5048	Science and Technology Commission of Shanghai Municipality [09PJ1403900]; 973 Program [2010CB529704]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); 973 Program(National Basic Research Program of China)	This work was supported by the Pujiang Program (09PJ1403900) from the Science and Technology Commission of Shanghai Municipality (http://www.stcsm.gov.cn) and 973 Program (2010CB529704) (http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Demma J, 2009, TOXICOL IN VITRO, V23, P266, DOI 10.1016/j.tiv.2008.12.007; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dzoyem JP, 2007, PHYTOTHER RES, V21, P671, DOI 10.1002/ptr.2140; Farooqi N, 2010, J NEUROCHEM, V115, P829, DOI 10.1111/j.1471-4159.2010.06982.x; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Glimcher LH, 2000, GENE DEV, V14, P1693; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Jackson JK, 2008, INFLAMM RES, V57, P126, DOI 10.1007/s00011-007-7163-6; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McKallip RJ, 2010, TOXICOL APPL PHARM, V247, P41, DOI 10.1016/j.taap.2010.05.013; Mossa JS, 2004, PHYTOTHER RES, V18, P934, DOI 10.1002/ptr.1420; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tilak JC, 2004, REDOX REP, V9, P219, DOI 10.1179/135100004225005976; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	39	42	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27006	10.1371/journal.pone.0027006	http://dx.doi.org/10.1371/journal.pone.0027006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066025	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000044
J	Kicinski, M; Vangronsveld, J; Nawrot, TS				Kicinski, Michal; Vangronsveld, Jaco; Nawrot, Tim S.			An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis	PLOS ONE			English	Article							5 GENETIC-VARIANTS; RISK-FACTORS; BREAST-CANCER; HISTORY; RELATIVES; MEN; CARCINOMA; COHORT; ASSOCIATION; EXPOSURE	Studies on familial aggregation of cancer may suggest an overall contribution of inherited genes or a shared environment in the development of malignant disease. We performed a meta-analysis on familial clustering of prostate cancer. Out of 74 studies reporting data on familial aggregation of prostate cancer in unselected populations retrieved by a Pubmed search and browsing references, 33 independent studies meeting the inclusion criteria were used in the analysis performed with the random effects model. The pooled rate ratio (RR) for first-degree family history, i.e. affected father or brother, is 2.48 (95% confidence interval: 2.25-2.74). The incidence rate for men who have a brother who got prostate cancer increases 3.14 times (CI: 2.37-4.15), and for those with affected father 2.35 times (CI: 2.02-2.72). The pooled estimate of RR for two or more affected first-degree family members relative to no history in father and in brother is 4.39 (CI: 2.61-7.39). First-degree family history appears to increase the incidence rate of prostate cancer more in men under 65 (RR: 2.87, CI: 2.21-3.74), than in men aged 65 and older (RR: 1.92, CI: 1.49-2.47), p for interaction = 0.002. The attributable fraction among those having an affected first-degree relative equals to 59.7% (CI: 55.6-63.5%) for men at all ages, 65.2% (CI: 57.7-71.4%) for men younger than 65 and 47.9% (CI: 37.1-56.8%) for men aged 65 or older. For those with a family history in 2 or more first-degree family members 77.2% (CI: 65.4-85.0%) of prostate cancer incidence can be attributed to the familial clustering. Our combined estimates show strong familial clustering and a significant effect-modification by age meaning that familial aggregation was associated with earlier disease onset (before age 65).	[Kicinski, Michal] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Vangronsveld, Jaco; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Nawrot, Tim S.] Leuven Univ KULeuven, Dept Publ Hlth, Louvain, Belgium	Hasselt University; Hasselt University; KU Leuven	Kicinski, M (corresponding author), Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium.	michal.kicinski@uhasselt.be	Vangronsveld, Jaco/ABE-5907-2020; Nawrot, Tim/AAA-4531-2019	Vangronsveld, Jaco/0000-0003-4423-8363; Nawrot, Tim/0000-0002-3583-3593	FWO [1.5.158.09.N.00]; Research Foundation - Flanders (FWO)	FWO(FWO); Research Foundation - Flanders (FWO)(FWO)	The study was supported by Scientific Fund FWO (URL: www.fwo.be, krediet aan navorsors; 1.5.158.09.N.00), and Michal Kicinski has a Ph.D. fellowship of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, INT J CANCER, V123, P1154, DOI 10.1002/ijc.23591; Andersson SO, 1996, CANCER EPIDEM BIOMAR, V5, P509; APRIKIAN AG, 1995, J UROLOGY, V154, P404, DOI 10.1016/S0022-5347(01)67063-0; Bai Y, 2005, PROSTATE CANCER P D, V8, P60, DOI 10.1038/sj.pcan.4500775; Beebe-Dimmer JL, 2006, UROLOGY, V68, P1072, DOI 10.1016/j.urology.2006.06.028; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Benichou J, 2007, CR BIOL, V330, P281, DOI 10.1016/j.crvi.2007.02.015; Brandt A, 2010, EUR UROL, V58, P275, DOI 10.1016/j.eururo.2010.02.002; Bratt O, 1997, EUR J CANCER, V33, P2237, DOI 10.1016/S0959-8049(97)00320-1; Bratt O, 1999, EUR J CANCER, V35, P272, DOI 10.1016/S0959-8049(98)00358-X; Bruner DW, 2003, INT J CANCER, V107, P797, DOI 10.1002/ijc.11466; Cannon L., 1982, CANCER SURV, V1, P47; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; Chen YC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-429; Cunningham GR, 2003, PROSTATE, V56, P256, DOI 10.1002/pros.10252; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Damber L, 1998, INT J CANCER, V78, P293, DOI 10.1002/(SICI)1097-0215(19981029)78:3<293::AID-IJC5>3.0.CO;2-Q; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eldon BJ, 2003, BJU INT, V92, P915, DOI 10.1111/j.1464-410X.2003.04536.x; FINCHAM SM, 1990, PROSTATE, V17, P189, DOI 10.1002/pros.2990170303; Gallus S, 2007, UROLOGY, V70, P1121, DOI 10.1016/j.urology.2007.07.020; GHADIRIAN P, 1991, PROSTATE, V19, P43, DOI 10.1002/pros.2990190105; Ghadirian P, 1997, INT J CANCER, V70, P679, DOI 10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.3.CO;2-3; Giovannucci E, 2007, INT J CANCER, V121, P1571, DOI 10.1002/ijc.22788; Glover FE, 1998, UROLOGY, V52, P441, DOI 10.1016/S0090-4295(98)00200-3; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Greenland S, 2001, BIOMETRICS, V57, P182, DOI 10.1111/j.0006-341X.2001.00182.x; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Gronberg H, 1999, CANCER, V86, P477; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hemminki K, 2008, ANN ONCOL, V19, P163, DOI 10.1093/annonc/mdm414; Hemminki K, 2002, CANCER EPIDEM BIOMAR, V11, P1638; Hemminki K, 2000, EUR J CANCER, V36, P229, DOI 10.1016/S0959-8049(99)00263-4; Hemminki K, 2001, ACTA ONCOL, V40, P772; Hemminki K, 2002, CANCER, V15, P346; Hemminki K, 2003, INT J CANCER, V108, P109; Hernandez DJ, 2009, BJU INT, V103, P609, DOI 10.1111/j.1464-410X.2008.08127.x; HONDA GD, 1988, BRIT J CANCER, V57, P326, DOI 10.1038/bjc.1988.74; Isaacs SD, 2005, JNCI-J NATL CANCER I, V87, P991; Ji JG, 2008, J CANCER RES CLIN, V134, P617, DOI 10.1007/s00432-007-0327-5; Johns LE, 2003, BJU INT, V91, P789, DOI 10.1046/j.1464-410X.2003.04232.x; Justine L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-75; Kalish LA, 2000, UROLOGY, V56, P803, DOI 10.1016/S0090-4295(00)00780-9; KEETCH DW, 1995, J UROLOGY, V154, P2100, DOI 10.1016/S0022-5347(01)66705-3; Kerber RA, 2005, CANCER-AM CANCER SOC, V103, P1906, DOI 10.1002/cncr.20989; King G, 2002, STAT MED, V21, P1409, DOI 10.1002/sim.1032; KOLONEL LN, 1988, AM J EPIDEMIOL, V127, P999, DOI 10.1093/oxfordjournals.aje.a114903; KRAIN LS, 1974, PREV MED, V3, P154, DOI 10.1016/0091-7435(74)90070-X; KRAIN LS, 1973, GERIATRICS, V28, P93; Lesko SM, 1996, AM J EPIDEMIOL, V144, P1041, DOI 10.1093/oxfordjournals.aje.a008876; Lightfoot N, 2004, ANN EPIDEMIOL, V14, P655, DOI 10.1016/j.annepidem.2003.11.006; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Makinen T, 2002, J CLIN ONCOL, V20, P2658, DOI 10.1200/JCO.2002.05.006; Matikainen MP, 2001, CANCER CAUSE CONTROL, V12, P223, DOI 10.1023/A:1011283123610; McCahy PJ, 1996, BRIT J UROL, V78, P552, DOI 10.1046/j.1464-410X.1996.17111.x; Mettlin C, 1995, Urol Oncol, V1, P240, DOI 10.1016/1078-1439(96)00013-0; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Nam RK, 2007, J CLIN ONCOL, V25, P3582, DOI 10.1200/JCO.2007.10.6450; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Negri E, 2005, INT J CANCER, V114, P648, DOI 10.1002/ijc.20755; Noe M, 2008, CANCER CAUSE CONTROL, V19, P1, DOI 10.1007/s10552-007-9064-y; Park SY, 2009, CANCER CAUSE CONTROL, V20, P211, DOI 10.1007/s10552-008-9236-4; Randi G, 2007, INT J CANCER, V121, P2748, DOI 10.1002/ijc.23037; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Roemeling S, 2006, J UROLOGY, V175, P1332, DOI 10.1016/S0022-5347(05)00698-1; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rovito PM, 2005, PROSTATE CANCER P D, V8, P69, DOI 10.1038/sj.pcan.4500780; Rybicki BA, 2006, CANCER DETECT PREV, V30, P412, DOI 10.1016/j.cdp.2006.09.004; Salinas CA, 2009, PROSTATE, V69, P363, DOI 10.1002/pros.20887; SCHUMAN LM, 1977, CANCER TREAT REP, V61, P181; Schuurman AG, 1999, EPIDEMIOLOGY, V10, P192, DOI 10.1097/00001648-199903000-00020; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; Staples MP, 2003, CANCER CAUSE CONTROL, V14, P161, DOI 10.1023/A:1023073203467; STEELE R, 1971, J CHRON DIS, V24, P29, DOI 10.1016/0021-9681(71)90056-7; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Stone SN, 2003, ETHNIC DIS, V13, P233; Strom SS, 2008, PROSTATE, V68, P563, DOI 10.1002/pros.20713; Sun JL, 2008, PROSTATE, V68, P1257, DOI 10.1002/pros.20793; Suzuki T, 2007, CANCER, V109, P2116, DOI 10.1002/cncr.22685; Verhage BAJ, 2004, INT J CANCER, V109, P611, DOI 10.1002/ijc.20015; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Zeegers MPA, 2003, CANCER-AM CANCER SOC, V97, P1894, DOI 10.1002/cncr.11262; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2009, CLIN CANCER RES, V15, P1105, DOI 10.1158/1078-0432.CCR-08-1743; Zhu KM, 1996, AM J EPIDEMIOL, V144, P717, DOI 10.1093/oxfordjournals.aje.a008994	90	103	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27130	10.1371/journal.pone.0027130	http://dx.doi.org/10.1371/journal.pone.0027130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073129	gold, Green Submitted, Green Published			2022-12-27	WOS:000296916000056
J	Giardino, WJ; Cocking, DL; Kaur, S; Cunningham, CL; Ryabinin, AE				Giardino, William J.; Cocking, Davelle L.; Kaur, Simranjit; Cunningham, Christopher L.; Ryabinin, Andrey E.			Urocortin-1 within the Centrally-Projecting Edinger-Westphal Nucleus Is Critical for Ethanol Preference	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AMPHETAMINE-REGULATED TRANSCRIPT; CENTRAL-NERVOUS-SYSTEM; ANXIETY-LIKE BEHAVIOR; C-FOS EXPRESSION; RECEPTOR ANTAGONIST ANTALARMIN; DEPENDENCE-INDUCED INCREASES; ALCOHOL-PREFERRING RATS; C57BL/6J MICE; LATERAL SEPTUM	Converging lines of evidence point to the involvement of neurons of the centrally projecting Edinger-Westphal nucleus (EWcp) containing the neuropeptide Urocortin-1 (Ucn1) in excessive ethanol (EtOH) intake and EtOH sensitivity. Here, we expanded these previous findings by using a continuous-access, two-bottle choice drinking paradigm (3%, 6%, and 10% EtOH vs. tap water) to compare EtOH intake and EtOH preference in Ucn1 genetic knockout (KO) and wild-type (WT) mice. Based on previous studies demonstrating that electrolytic lesion of the EWcp attenuated EtOH intake and preference in high-drinking C57BL/6J mice, we also set out to determine whether EWcp lesion would differentially alter EtOH consumption in Ucn1 KO and WT mice. Finally, we implemented well-established place conditioning procedures in KO and WT mice to determine whether Ucn1 and the corticotropin-releasing factor type-2 receptor (CRF-R2) were involved in the rewarding and aversive effects of EtOH (2 g/kg, i.p.). Results from these studies revealed that (1) genetic deletion of Ucn1 dampened EtOH preference only in mice with an intact EWcp, but not in mice that received lesion of the EWcp, (2) lesion of the EWcp dampened EtOH intake in Ucn1 KO and WT mice, but dampened EtOH preference only in WT mice expressing Ucn1, and (3) genetic deletion of Ucn1 or CRF-R2 abolished the conditioned rewarding effects of EtOH, but deletion of Ucn1 had no effect on the conditioned aversive effects of EtOH. The current findings provide strong support for the hypothesis that EWcp-Ucn1 neurons play an important role in EtOH intake, preference, and reward.	[Giardino, William J.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Portland Alcohol Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Giardino, WJ (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	ryabinin@ohsu.edu	Giardino, William/AAD-3030-2019	Giardino, William/0000-0001-7474-7914; Ryabinin, Andrey/0000-0003-4662-3775	NIH [AA013738, AA016647, AA010760, T32 DA7262- 20, AA007702]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007702, P60AA010760, P50AA010760, R37AA007702, R01AA013738, U01AA016647, F31AA021023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by NIH grants to AER (AA013738, AA016647, AA010760) and WJG (T32 DA7262- 20) and CLC (AA007702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker AMJ, 2011, ADDICT BIOL, V16, P92, DOI 10.1111/j.1369-1600.2010.00234.x; Bachtell RK, 1999, BRAIN RES, V847, P157, DOI 10.1016/S0006-8993(99)02019-3; Bachtell RK, 2004, EUR J NEUROSCI, V20, P1613, DOI 10.1111/j.1460-9568.2004.03594.x; Bachtell RK, 2003, J NEUROSCI, V23, P2477; Bachtell RK, 2002, NEUROSCIENCE, V113, P421, DOI 10.1016/S0306-4522(02)00174-4; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bittencourt JC, 1999, J COMP NEUROL, V415, P285; Blednov YA, 2004, ALCOHOL CLIN EXP RES, V28, P1683, DOI 10.1097/01.ALC.0000145790.60216.C8; Cavani JA, 2003, BRAZ J MED BIOL RES, V36, P1695, DOI 10.1590/S0100-879X2003001200011; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHANG SL, 1995, BRAIN RES, V679, P89, DOI 10.1016/0006-8993(95)00210-H; Chu K, 2007, PHARMACOL BIOCHEM BE, V86, P813, DOI 10.1016/j.pbb.2007.03.009; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Cservenka A, 2010, BRAIN RES, V1319, P33, DOI 10.1016/j.brainres.2010.01.003; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; CUNNINGHAM CL, 1992, PSYCHOPHARMACOLOGY, V107, P385, DOI 10.1007/BF02245166; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Cunningham CL, 2000, BEHAV PHARMACOL, V11, P591, DOI 10.1097/00008877-200011000-00006; Dandekar MP, 2008, NEUROPSYCHOPHARMACOL, V33, P1127, DOI 10.1038/sj.npp.1301516; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; Dun SL, 2005, BRAIN RES, V1045, P157, DOI 10.1016/j.brainres.2005.03.024; Fonareva I, 2009, ALCOHOL CLIN EXP RES, V33, P1956, DOI 10.1111/j.1530-0277.2009.01033.x; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Funk CK, 2007, BRAIN RES, V1155, P172, DOI 10.1016/j.brainres.2007.04.009; Funk CK, 2007, BIOL PSYCHIAT, V61, P78, DOI 10.1016/j.biopsych.2006.03.063; Gaszner B, 2007, J COMP NEUROL, V500, P708, DOI 10.1002/cne.21177; Gehlert DR, 2007, J NEUROSCI, V27, P2718, DOI 10.1523/JNEUROSCI.4985-06.2007; Giardino WJ, 2011, GENES BRAIN BEHAV, V10, P78, DOI 10.1111/j.1601-183X.2010.00641.x; Giardino WJ, PSYCHOPHARM IN PRESS; Gilpin NW, 2008, ALCOHOL CLIN EXP RES, V32, P1535, DOI 10.1111/j.1530-0277.2008.00745.x; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Kaur S, ALCOHOL CLI IN PRESS; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kiianmaa K, 2003, ALCOHOL CLIN EXP RES, V27, P209, DOI 10.1097/01.ALC.0000051020.55829.41; King BJ, 2010, BEHAV NEUROSCI, V124, P423, DOI 10.1037/a0019540; Knapp DJ, 2001, ALCOHOL CLIN EXP RES, V25, P1662, DOI 10.1111/j.1530-0277.2001.tb02173.x; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kozicz T, 2003, NEUROSCIENCE, V116, P315, DOI 10.1016/S0306-4522(02)00772-8; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; Kozicz T, 2011, J COMP NEUROL, V519, P1413, DOI 10.1002/cne.22580; Le AD, 2002, J NEUROSCI, V22, P7844; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Lodge DJ, 2003, NEUROSCIENCE, V117, P243, DOI 10.1016/S0306-4522(02)00793-5; Lowery EG, 2010, NEUROPSYCHOPHARMACOL, V35, P1241, DOI 10.1038/npp.2009.209; MACIEWICZ R, 1984, BRAIN RES, V299, P139, DOI 10.1016/0006-8993(84)90796-0; Murphy NP, 2006, BRAIN RES, V1094, P107, DOI 10.1016/j.brainres.2006.03.109; Neufeld-Cohen A, 2010, MOL PSYCHIATR, V15, P426, DOI 10.1038/mp.2009.115; Neufeld-Cohen A, 2010, P NATL ACAD SCI USA, V107, P19020, DOI 10.1073/pnas.1013761107; Pastor R, 2011, PSYCHOPHARMACOLOGY B; Pastor R, 2008, P NATL ACAD SCI USA, V105, P9070, DOI 10.1073/pnas.0710181105; PICH EM, 1995, J NEUROSCI, V15, P5439; Richardson HN, 2008, PHARMACOL BIOCHEM BE, V88, P497, DOI 10.1016/j.pbb.2007.10.008; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Ryabinin AE, 2003, PSYCHOPHARMACOLOGY, V165, P296, DOI 10.1007/s00213-002-1284-y; Ryabinin AE, 2001, BRAIN RES, V890, P192, DOI 10.1016/S0006-8993(00)03251-0; Ryabinin AE, 1997, MOL PSYCHIATR, V2, P32, DOI 10.1038/sj.mp.4000206; Ryabinin AE, 2005, NEUROSCIENCE, V134, P1317, DOI 10.1016/j.neuroscience.2005.05.042; Ryabinin AE, 2006, BRAIN RES REV, V52, P368, DOI 10.1016/j.brainresrev.2006.04.007; Sabino V, 2006, PSYCHOPHARMACOLOGY, V189, P175, DOI 10.1007/s00213-006-0546-5; Sharpe AL, 2005, ALCOHOL CLIN EXP RES, V29, P1419, DOI 10.1097/01.alc.0000174746.64499.83; Sharpe AL, 2009, BEHAV PHARMACOL, V20, P346, DOI 10.1097/FBP.0b013e32832f01ba; Sommer WH, 2008, BIOL PSYCHIAT, V63, P139, DOI 10.1016/j.biopsych.2007.01.010; Spangler E, 2009, NEUROSCIENCE, V160, P115, DOI 10.1016/j.neuroscience.2009.02.030; Sparta DR, 2008, ALCOHOL CLIN EXP RES, V32, P259, DOI 10.1111/j.1530-0277.2007.00575.x; Sparta DR, 2009, ALCOHOL CLIN EXP RES, V33, P31, DOI 10.1111/j.1530-0277.2008.00808.x; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Topple AN, 1998, NEUROSCI LETT, V252, P99, DOI 10.1016/S0304-3940(98)00574-6; Turek VF, 2005, PSYCHOPHARMACOLOGY, V181, P511, DOI 10.1007/s00213-005-0011-x; Turek VF, 2008, GENES BRAIN BEHAV, V7, P113, DOI 10.1111/j.1601-183X.2007.00336.x; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vasconcelos LAP, 2003, J COMP NEUROL, V463, P157, DOI 10.1002/cne.10742; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Vetter DE, 2002, NAT GENET, V31, P363, DOI 10.1038/ng914; Weitemier AZ, 2005, BEHAV NEUROSCI, V119, P1235, DOI 10.1037/0735-7044.119.5.1235; Weitemier AZ, 2005, NEUROSCIENCE, V132, P729, DOI 10.1016/j.neuroscience.2004.12.047; Weitemier AZ, 2001, ALCOHOL CLIN EXP RES, V25, P704, DOI 10.1097/00000374-200105000-00011; Xu L, 2009, NEUROSCIENCE, V162, P1141, DOI 10.1016/j.neuroscience.2009.05.003; Xu L, 2011, ENDOCRINOLOGY, V152, P979, DOI 10.1210/en.2010-1143; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Zhao Y, 2007, J PHARMACOL EXP THER, V323, P846, DOI 10.1124/jpet.107.123208; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773	89	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26997	10.1371/journal.pone.0026997	http://dx.doi.org/10.1371/journal.pone.0026997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046429	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800056
J	Chen, HM; Futcher, B; Leatherwood, J				Chen, Huei-Mei; Futcher, Bruce; Leatherwood, Janet			The Fission Yeast RNA Binding Protein Mmi1 Regulates Meiotic Genes by Controlling Intron Specific Splicing and Polyadenylation Coupled RNA Turnover	PLOS ONE			English	Article							NUCLEAR POLY(A)-BINDING PROTEIN; SMALL NUCLEOLAR RNAS; POLY(A) TAIL LENGTH; MESSENGER-RNA; HAMMERHEAD RIBOZYME; SACCHAROMYCES-CEREVISIAE; SELECTIVE ELIMINATION; RIBOSOMAL-RNA; S. POMBE; EXPRESSION	The polyA tails of mRNAs are monitored by the exosome as a quality control mechanism. We find that fission yeast, Schizosaccharomyces pombe, adopts this RNA quality control mechanism to regulate a group of 30 or more meiotic genes at the level of both splicing and RNA turnover. In vegetative cells the RNA binding protein Mmi1 binds to the primary transcripts of these genes. We find the novel motif U(U/C/G)AAAC highly over-represented in targets of Mmi1. Mmi1 can specifically regulate the splicing of particular introns in a transcript: it inhibits the splicing of introns that are in the vicinity of putative Mmi1 binding sites, while allowing the splicing of other introns that are far from such sites. In addition, binding of Mmi1, particularly near the 3' end, alters 3' processing to promote extremely long polyA tails of up to a kilobase. The hyperadenylated transcripts are then targeted for degradation by the nuclear exonuclease Rrp6. The nuclear polyA binding protein Pab2 assists this hyperadenylation-mediated RNA decay. Rrp6 also targets other hyperadenylated transcripts, which become hyperadenylated in an unknown, but Mmi1-independent way. Thus, hyperadenylation may be a general signal for RNA degradation. In addition, binding of Mmi1 can affect the efficiency of 3' cleavage. Inactivation of Mmi1 in meiosis allows meiotic expression, through splicing and RNA stabilization, of at least 29 target genes, which are apparently constitutively transcribed.	[Chen, Huei-Mei; Futcher, Bruce; Leatherwood, Janet] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, HM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	janet.leatherwood@sunysb.edu			National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants awarded to J. L. from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Cooke C, 1999, MOL CELL BIOL, V19, P4971; Cremona N, 2011, MOL BIOL CELL, V22, P66, DOI 10.1091/mbc.E10-05-0448; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Dower K, 2004, RNA, V10, P1888, DOI 10.1261/rna.7166704; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Duvel K, 2003, CURR GENET, V43, P255, DOI 10.1007/s00294-003-0401-8; Duvel K, 2002, RNA, V8, P336, DOI 10.1071/S1355838202021039; EGLI CM, 1994, J BIOL CHEM, V269, P27378; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gross S, 2001, MOL CELL BIOL, V21, P8045, DOI 10.1128/MCB.21.23.8045-8055.2001; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Lee YJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000107; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Millevoi S, 2002, EMBO REP, V3, P869, DOI 10.1093/embo-reports/kvf173; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; RUPRECHT RM, 1973, BIOCHIM BIOPHYS ACTA, V294, P192, DOI 10.1016/0005-2787(73)90292-X; Samarsky DA, 1999, P NATL ACAD SCI USA, V96, P6609, DOI 10.1073/pnas.96.12.6609; Sambrook J., 2001, MOL CLONING LAB MANU; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Steege DA, 2000, RNA, V6, P1079, DOI 10.1017/S1355838200001023; Sugiyama T, 2011, EMBO J; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang SW, 2005, MOL CELL BIOL, V25, P2288, DOI 10.1128/MCB.25.6.2288-2296.2005; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711	62	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26804	10.1371/journal.pone.0026804	http://dx.doi.org/10.1371/journal.pone.0026804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046364	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400035
J	Ahmed, B; Fatmi, Z; Siddiqui, AR				Ahmed, Bilal; Fatmi, Zafar; Siddiqui, Amna R.			Population Attributable Risk of Unintentional Childhood Poisoning in Karachi Pakistan	PLOS ONE			English	Article							CHILDREN; INJURIES	Background: The percentage of unintentional childhood poisoning cases in a given population attributable to specific risk factors (i.e., the population attributable risk) which can be calculated; determination of such risk factors associated with potentially modifiable risk factors, are necessary to focus on the prevention strategies. Methods: We calculated PARs, using 120 cases with unintentional poisoning and 360 controls in a hospital based matched case-control study. The risk factors were accessibility to hazardous chemicals and medicines due to unsafe storage, child behavior reported as hyperactive, storage of kerosene and petroleum in soft drink bottles, low socioeconomic class, less education of the mother and the history of previous poisoning. Results: The following attributed risks were observed: 12% (95% confidence interval [CI] = 8%-16%) for both chemicals and medicines stored unsafe, 19% (15%-23%) for child reported as hyperactive, 40% (38%-42%) for storage of kerosene and petroleum in soft drink bottles, 48% (42%-54%) for low socioeconomic status, 38% (32%-42%) for no formal mothers education and 5.8% (2%-10%) for history of previous poisoning. 48% of cases for overall study population which could be attributed to at least one of the six risk factors. Among girls, this proportion was 23% and 43% among boys. About half of the unintentional childhood poisoning cases in this Pakistani population could be avoided. Conclusion: Exposure to potentially modifiable risk indicators explained about half of the cases of unintentional poisoning among children under five years of age in this Pakistani population, indicating the theoretical scope for prevention of the disease.	[Ahmed, Bilal] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Fatmi, Zafar; Siddiqui, Amna R.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Siddiqui, Amna R.] King Saud Univ, Coll Med Kingdom Saudi Arabia, Riyadh, Saudi Arabia	Aga Khan University; Aga Khan University; King Saud University	Ahmed, B (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	bilal.ahmed@aku.edu		Fatmi, Zafar/0000-0001-7212-6858				AHMED B, 2010, INJURY PREVENTION; AZIZI BHO, 1993, ANN TROP PAEDIATR, V13, P183, DOI 10.1080/02724936.1993.11747643; BASAVARAJ DS, 1982, J EPIDEMIOL COMMUN H, V36, P31, DOI 10.1136/jech.36.1.31; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Benichou J, 1998, AM J EPIDEMIOL, V148, P424; Branche C., 2008, WORLD REPORT CHILD I; Bronstein AC, 2008, CLIN TOXICOL, V46, P927, DOI 10.1080/15563650802559632; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chatsantiprapa K, 2001, Inj Prev, V7, P214, DOI 10.1136/ip.7.3.214; D'Souza AJ, 2008, J EPIDEMIOL COMMUN H, V62, P899, DOI 10.1136/jech.2007.068072; Fatmi Z, 2009, PAEDIATR PERINAT EP, V23, P229, DOI 10.1111/j.1365-3016.2009.01024.x; Franklin RL, 2008, PEDIATRICS, V122, P1244, DOI 10.1542/peds.2007-3551; Gupta SK, 2003, J OCCUP HEALTH, V45, P191, DOI 10.1539/joh.45.191; Hamid Muhammad Haroon, 2005, J Coll Physicians Surg Pak, V15, P805; Hon KLE, 2005, ANN ACAD MED SINGAP, V34, P356; Hyder AA, 2008, ACTA PAEDIATR, V97, P267, DOI 10.1111/j.1651-2227.2008.00670.x; Janjua NZ, 2008, ENVIRON RES, V108, P69, DOI 10.1016/j.envres.2008.06.004; Ramos CLJ, 2010, J PEDIAT-BRAZIL, V86, P435, DOI 10.2223/JPED.2033; Kendrick D, 2008, ARCH DIS CHILD, V93, P599, DOI 10.1136/adc.2007.133686; Khandwala EH, 1997, PAK PEDIAT J, V21, P159; LITOVITZ TL, 1989, MED TOXICOL ADV DRUG, V4, P381, DOI 10.1007/BF03259919; OBRIEN CW, 2008, PEDIAT POISONING FAT; Odendaal W, 2009, ACCIDENT ANAL PREV, V41, P183, DOI 10.1016/j.aap.2008.10.009; OKASHA A, 1976, BRIT J PSYCHIAT, V129, P539, DOI 10.1192/bjp.129.6.539; PARITSIS N, 1994, PAEDIATR PERINAT EP, V8, P79, DOI 10.1111/j.1365-3016.1994.tb00437.x; Peden MMK, 2002, GRAPHICAL OVERVIEW I; Petridou E, 1996, RISK FACTORS CHILDHO, P208; Rashid AKMM, 2007, PAK J MED SCI, V23, P443; Reimers A, 2005, ACTA PAEDIATR, V94, P1488, DOI 10.1080/08035250510038929; Siddiqui Emad Uddin, 2008, J Pak Med Assoc, V58, P608; SOBEL R, 1970, PEDIATR CLIN N AM, V17, P653; Soori H, 2001, SAUDI MED J, V22, P227; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Tshiamo W, 2009, INT J NURS PRACT, V15, P140, DOI 10.1111/j.1440-172X.2009.01748.x	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26881	10.1371/journal.pone.0026881	http://dx.doi.org/10.1371/journal.pone.0026881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046391	Green Published, gold			2022-12-27	WOS:000296519600072
J	Mariappan, V; Vellasamy, KM; Hashim, OH; Vadivelu, J				Mariappan, Vanitha; Vellasamy, Kumutha Malar; Hashim, Onn Haji; Vadivelu, Jamuna			Profiling of Burkholderia cepacia Secretome at Mid-Logarithmic and Early-Stationary Phases of Growth	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; VIRULENCE FACTORS; PROTEOME ANALYSIS; EPITHELIAL-CELLS; IN-VITRO; INVASION; PROTEINS; CENOCEPACIA; IDENTIFICATION; MULTIVORANS	Background: Burkholderia cepacia is a Gram-negative pathogen that causes serious respiratory infections in immunocompromised patients and individuals with cystic fibrosis. This bacterium is known to release extracellular proteins that may be involved in virulence. Methodology/Principal Findings: In the present study, B. cepacia grown to mid-logarithmic and early-stationary phases were investigated on their ability to invade and survive intracellularly in A549 lung epithelial cells in order to discern the fate of these bacteria in the pathogenesis of B. cepacia lung infections in in vitro condition. The early-stationary phase B. cepacia was demonstrated to be more invasive than mid-logarithmic phase. In addition, culture supernatants of B. cepacia obtained from these phases of growth were also demonstrated to cause different cytotoxic potency on the A549 human lung epithelial cells. Profiling of the supernatants using the gel-based proteomics approach identified 43 proteins that were commonly released in both the growth phases and 40 proteins newly-released at the early-stationary phase. The latter proteins may account for the higher cytotoxic activity of the early-stationary culture supernatant compared to that obtained at the mid-logarithmic phase. Among the newly-released proteins in the early-stationary phase supernatant were flagellar hook-associated domain protein (FliD), flagellar hook-associated protein (FlgK), TonB-dependent siderophore (Fiu), Elongation factor G (FusA), phosphoglycerate kinase (Pgk) and sulfatase (AslA) which are known for their virulence. Conclusion/Significance: Differences in the ability of B. cepacia to invade and survive intracellularly inside the epithelial cells at different phases of growth may improve our understanding of the varied disease progressions associated with B. cepacia infections. In addition, the identified culture supernatant proteins may be used as targets for the development of new strategies to control B. cepacia infection using agents that can block their release.	[Mariappan, Vanitha; Vellasamy, Kumutha Malar; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Univ Malaya Ctr Prote Res UMCPR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Mariappan, V (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Vellasamy, Kumutha Malar/CAF-0007-2022; Mariappan, Vanitha/ABD-4066-2020; VADIVELU, JAMUNARANI S/B-8696-2010; Vellasamy, Kumutha Malar/A-6592-2017; Mariappan, Vanitha/I-4769-2013; Hashim, Onn H/B-9459-2010	Vellasamy, Kumutha Malar/0000-0001-7661-3928; Mariappan, Vanitha/0000-0002-2351-1597; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Mariappan, Vanitha/0000-0002-2351-1597; Hashim, Onn H/0000-0002-0196-6793	Ministry of Science, Innovation and Technology (MOSTI), Malaysia [55-02-03-1002]; Ministry of Higher Education (MOHE), Malaysia [E000013-20001]; MOSTI	Ministry of Science, Innovation and Technology (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education (MOHE), Malaysia; MOSTI(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported by Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund (55-02-03-1002) and Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project (E000013-20001). Ms. M. Vanitha was supported by the Malaysian National Science Fellowship (NSF) from MOSTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Begg K, 1998, J BACTERIOL, V180, P881, DOI 10.1128/JB.180.4.881-884.1998; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Chakravarti DN, 2000, VACCINE, V19, P601, DOI 10.1016/S0264-410X(00)00256-5; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Coombes BK, 2004, CURR BIOL, V14, pR856, DOI 10.1016/j.cub.2004.09.043; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Carvalho APD, 2007, APMIS, V115, P311, DOI 10.1111/j.1600-0463.2007.apm_603.x; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Govan JRW, 1996, J MED MICROBIOL, V45, P395, DOI 10.1099/00222615-45-6-395; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; Kohler S, 1996, MOL MICROBIOL, V20, P701, DOI 10.1111/j.1365-2958.1996.tb02510.x; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Liao XA, 2003, ELECTROPHORESIS, V24, P2864, DOI 10.1002/elps.200305519; LORY S, 1992, J BACTERIOL, V174, P3423; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mariappan V, 2010, VACCINE, V28, P1318, DOI 10.1016/j.vaccine.2009.11.027; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; MCKEVITT AI, 1989, INFECT IMMUN, V57, P771, DOI 10.1128/IAI.57.3.771-778.1989; Melnikov A, 2000, MOL MICROBIOL, V36, P1481, DOI 10.1046/j.1365-2958.2000.01976.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mohr CD, 2001, MICROBES INFECT, V3, P425, DOI 10.1016/S1286-4579(01)01389-2; Mott T, 2010, J CLIN MICROBIOL, V48, P4186, DOI 10.1128/JCM.00577-10; Mullen T, 2007, EUR J CLIN MICROBIOL, V26, P869, DOI 10.1007/s10096-007-0385-2; NELSON JW, 1994, FEMS IMMUNOL MED MIC, V8, P89, DOI 10.1111/j.1574-695X.1994.tb00430.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Riedel K, 2006, PROTEOMICS, V6, P207, DOI 10.1002/pmic.200500097; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Vanghele Monica, 2010, Romanian Journal of Biochemistry, V47, P87; Vellasamy KM, 2011, ELECTROPHORESIS, V32, P310, DOI 10.1002/elps.201000355; Wehmhoner D, 2003, J BACTERIOL, V185, P5807, DOI 10.1128/JB.185.19.5807-5814.2003; Wongtrakoongate P, 2007, MOL CELL PROBE, V21, P81, DOI 10.1016/j.mcp.2006.08.006	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26518	10.1371/journal.pone.0026518	http://dx.doi.org/10.1371/journal.pone.0026518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046299	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600026
J	Trilling, AK; de Ronde, H; Noteboom, L; van Houwelingen, A; Roelse, M; Srivastava, SK; Haasnoot, W; Jongsma, MA; Kolk, A; Zuilhof, H; Beekwilder, J				Trilling, Anke K.; de Ronde, Hans; Noteboom, Linda; van Houwelingen, Adele; Roelse, Margriet; Srivastava, Saurabh K.; Haasnoot, Willem; Jongsma, Maarten A.; Kolk, Arend; Zuilhof, Han; Beekwilder, Jules			A Broad Set of Different Llama Antibodies Specific for a 16 kDa Heat Shock Protein of Mycobacterium tuberculosis	PLOS ONE			English	Article							B-CELL; RAPID DETECTION; IN-VITRO; ANTIGEN; SINGLE; FRAGMENTS; RESISTANCE; EPITOPES; COMPLEX	Background: Recombinant antibodies are powerful tools in engineering of novel diagnostics. Due to the small size and stable nature of llama antibody domains selected antibodies can serve as a detection reagent in multiplexed and sensitive assays for M. tuberculosis. Methodology/Principal Findings: Antibodies for Mycobacterium tuberculosis (M. tb) recognition were raised in Alpaca, and, by phage display, recombinant variable domains of heavy-chain antibodies (VHH) binding to M. tuberculosis antigens were isolated. Two phage display selection strategies were followed: one direct selection using semi-purified protein antigen, and a depletion strategy with lysates, aiming to avoid cross-reaction to other mycobacteria. Both panning methods selected a set of binders with widely differing complementarity determining regions. Selected recombinant VHHs were produced in E. coli and shown to bind immobilized lysate in direct Enzymelinked Immunosorbent Assay (ELISA) tests and soluble antigen by surface plasmon resonance (SPR) analysis. All tested VHHs were specific for tuberculosis-causing mycobacteria (M. tuberculosis, M. bovis) and exclusively recognized an immunodominant 16 kDa heat shock protein (hsp). The highest affinity VHH had a dissociation constant (KD) of 4 x 10(-10) M. Conclusions/Significance: A broad set of different llama antibodies specific for 16 kDa heat shock protein of M. tuberculosis is available. This protein is highly stable and abundant in M. tuberculosis. The VHH that detect this protein are applied in a robust SPR sensor for identification of tuberculosis-causing mycobacteria.	[Trilling, Anke K.; Noteboom, Linda; van Houwelingen, Adele; Roelse, Margriet; Srivastava, Saurabh K.; Jongsma, Maarten A.; Beekwilder, Jules] Plant Res Int, Wageningen, Netherlands; [Trilling, Anke K.; Zuilhof, Han] Wageningen Univ, Organ Chem Lab, Wageningen, Netherlands; [de Ronde, Hans] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Kolk, Arend] Univ Amsterdam, Van t Hoff Inst Mol Sci, Amsterdam, Netherlands; [Haasnoot, Willem] RIKILT Inst Food Safety, Wageningen, Netherlands	Wageningen University & Research; University of Amsterdam; Wageningen University & Research	Trilling, AK (corresponding author), Plant Res Int, Wageningen, Netherlands.	Jules.Beekwilder@wur.nl	Zuilhof, Han/C-3892-2012; Schütz-Trilling, Anke/GWV-0828-2022; Jongsma, Maarten A/A-2118-2010; Beekwilder, Jules/A-6802-2011	Zuilhof, Han/0000-0001-5773-8506; Jongsma, Maarten A/0000-0001-5799-2301; Beekwilder, Jules/0000-0003-3238-4427; Srivastava, Saurabh Kumar/0000-0003-2305-5525	European Union through Marie Curie Integrated Training Network [PITN-2007-215851]; MicroNed Cluster SMACT (Smart Microchannel technology) Work Package II-C; IPOP (Instellings Plan/Ontwikkelings Plan); Wageningen UR strategic research program	European Union through Marie Curie Integrated Training Network; MicroNed Cluster SMACT (Smart Microchannel technology) Work Package II-C; IPOP (Instellings Plan/Ontwikkelings Plan); Wageningen UR strategic research program	This work was funded by the European Union through the Marie Curie Integrated Training Network project Hierarchy (contract: PITN-2007-215851), the MicroNed Cluster SMACT (Smart Microchannel technology) Work Package II-C, and the IPOP (Instellings Plan/Ontwikkelings Plan)-Bionanotechnology program, a Wageningen UR strategic research program running from 2008-2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZEID C, 1988, J GEN MICROBIOL, V134, P531; ANDERSEN AB, 1991, SCAND J IMMUNOL, V34, P365, DOI 10.1111/j.1365-3083.1991.tb01558.x; [Anonymous], 1986, INFECT IMMUN, V51, P718; Beekwilder J, 2008, EUR J PLANT PATHOL, V121, P477, DOI 10.1007/s10658-007-9265-y; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos MAC, 2010, CHEM COMMUN, V46, P5512, DOI 10.1039/c0cc01264e; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; COATES ARM, 1981, LANCET, V2, P167; Cox RA, 2003, MICROBIOL-SGM, V149, P729, DOI 10.1099/mic.0.25645-0; Cummings PJ, 1998, HYBRIDOMA, V17, P151, DOI 10.1089/hyb.1998.17.151; Demkow U, 2005, J Physiol Pharmacol, V56 Suppl 4, P79; Devi KRU, 2002, PROTEIN EXPRES PURIF, V24, P188, DOI 10.1006/prep.2001.1569; Duman M, 2010, BIOSENS BIOELECTRON, V26, P908, DOI 10.1016/j.bios.2010.06.071; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Edwardraja S, 2011, MOL BIOSYST, V7, P258, DOI 10.1039/c0mb00154f; Ferrara G, 2009, ARCH IMMUNOL THER EX, V57, P425, DOI 10.1007/s00005-009-0050-9; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Guo Y, 2009, INT J TUBERC LUNG D, V13, P914; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2007, VET MICROBIOL, V120, P193, DOI 10.1016/j.vetmic.2006.10.029; He FJ, 2002, ANAL SCI, V18, P397, DOI 10.2116/analsci.18.397; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; Kobayashi N, 2010, ANAL CHEM, V82, P1027, DOI 10.1021/ac902283n; KOLK AHJ, 1984, CLIN EXP IMMUNOL, V58, P511; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Mabry R, 2010, IDRUGS, V13, P543; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, J Biotechnol, V74, P277; Palomino JC, 2009, FEMS IMMUNOL MED MIC, V56, P103, DOI 10.1111/j.1574-695X.2009.00555.x; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Qin DL, 2008, BIOSENS BIOELECTRON, V24, P626, DOI 10.1016/j.bios.2008.06.023; Raja A, 2002, CLIN DIAGN LAB IMMUN, V9, P308, DOI 10.1128/CDLI.9.2.308-312.2002; Senol G, 2009, PEDIATR PULM, V44, P839, DOI 10.1002/ppul.20901; Sixholo J, 2011, BIOLOGICALS, V39, P110, DOI 10.1016/j.biologicals.2011.01.007; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Swain MD, 2010, ANAL BIOANAL CHEM, V398, P339, DOI 10.1007/s00216-010-3905-3; VERBON A, 1992, CLIN EXP IMMUNOL, V89, P395; VERBON A, 1990, J GEN MICROBIOL, V136, P955, DOI 10.1099/00221287-136-5-955; VERBON A, 1992, J BACTERIOL, V174, P1352, DOI 10.1128/jb.174.4.1352-1359.1992; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Wingren Christer, 2009, V509, P57, DOI 10.1007/978-1-59745-372-1_5; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	52	16	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26754	10.1371/journal.pone.0026754	http://dx.doi.org/10.1371/journal.pone.0026754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046343	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600052
J	Abramov, AY; Gegg, M; Grunewald, A; Wood, NW; Klein, C; Schapira, AHV				Abramov, Andrey Yurevich; Gegg, Matthew; Grunewald, Anne; Wood, Nicholas William; Klein, Christine; Schapira, Anthony Henry Vernon			Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PINK1/PARKIN PATHWAY; OXIDATIVE STRESS; NEURODEGENERATION; MITOPHAGY; MORPHOLOGY; MITOFUSIN; DEFECTS; CALCIUM; DNA	Background: Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to determine whether cells derived from PD patients with a range of PINK1 mutations demonstrate similar defects of mitochondrial function, whether the nature and severity of the abnormalities vary between mutations and correlate with clinical features. Methodology: We investigated mitochondrial bioenergetics in live fibroblasts from PINK1 mutation patients using single cell techniques. We found that fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening. There was an increase in the basal rate of free radical production in the mutant cells. The pattern and severity of abnormality varied between different mutations, and the less severe defects in these cells were associated with later age of onset of PD. Conclusions: The results provide insight into the molecular pathology of PINK1 mutations in PD and also confirm the critical role of substrate availability in determining the biochemical phenotype - thereby offering the potential for novel therapeutic strategies to circumvent these abnormalities.	[Abramov, Andrey Yurevich; Wood, Nicholas William] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Gegg, Matthew; Schapira, Anthony Henry Vernon] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Grunewald, Anne; Klein, Christine] Univ Lubeck, Dept Neurol, Lubeck, Germany	University of London; University College London; University of London; University College London; University of Lubeck	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London, England.	a.abramov@ucl.ac.uk; a.schapira@ucl.ac.uk	Schapira, Anthony H V/A-1245-2010; Abramov, Andrey Y/H-9053-2012; Gegg, Matthew E/B-4826-2011; Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Wood, Nicholas W/C-2505-2009; Abramov, Andrey/AAC-6712-2019	Schapira, Anthony H V/0000-0002-3018-3966; Abramov, Andrey Y/0000-0002-7646-7235; Gegg, Matthew E/0000-0001-8093-0723; Grünewald, Anne/0000-0002-4179-2994; Wood, Nicholas W/0000-0002-9500-3348; Abramov, Andrey/0000-0002-7646-7235; Klein, Christine/0000-0003-2102-3431	Wellcome Trust/MRC [WT089698]; Kattan Trust; Medical Research Council [MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [F-0806, K-0803, G-0612] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Kattan Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC), and by Kattan Trust. Dr. Abramov is a Parkinson's UK Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Tan EK, 2006, MOVEMENT DISORD, V21, P789, DOI 10.1002/mds.20810; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	29	74	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25622	10.1371/journal.pone.0025622	http://dx.doi.org/10.1371/journal.pone.0025622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043288	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400015
J	Viljoen, H; Bennett, NC; Ueckermann, EA; Lutermann, H				Viljoen, Hermien; Bennett, Nigel C.; Ueckermann, Edward A.; Lutermann, Heike			The Role of Host Traits, Season and Group Size on Parasite Burdens in a Cooperative Mammal	PLOS ONE			English	Article							HOTTENTOTUS-PRETORIAE RODENTIA; HIGHVELD MOLE-RAT; HELIOPHOBIUS-ARGENTEOCINEREUS; SUBTERRANEAN RODENT; HELMINTH INFECTIONS; DISEASE RESISTANCE; SEX-DIFFERENCES; HOUSE-DUST; SOCIALITY; PATTERNS	The distribution of parasites among hosts is often characterised by a high degree of heterogeneity with a small number of hosts harbouring the majority of parasites. Such patterns of aggregation have been linked to variation in host exposure and susceptibility as well as parasite traits and environmental factors. Host exposure and susceptibility may differ with sexes, reproductive effort and group size. Furthermore, environmental factors may affect both the host and parasite directly and contribute to temporal heterogeneities in parasite loads. We investigated the contributions of host and parasite traits as well as season on parasite loads in highveld mole-rats (Cryptomys hottentotus pretoriae). This cooperative breeder exhibits a reproductive division of labour and animals live in colonies of varying sizes that procreate seasonally. Mole-rats were parasitised by lice, mites, cestodes and nematodes with mites (Androlaelaps sp.) and cestodes (Mathevotaenia sp.) being the dominant ecto-and endoparasites, respectively. Sex and reproductive status contributed little to the observed parasite prevalence and abundances possibly as a result of the shared burrow system. Clear seasonal patterns of parasite prevalence and abundance emerged with peaks in summer for mites and in winter for cestodes. Group size correlated negatively with mite abundance while it had no effect on cestode burdens and group membership affected infestation with both parasites. We propose that the mode of transmission as well as social factors constrain parasite propagation generating parasite patterns deviating from those commonly predicted.	[Viljoen, Hermien; Bennett, Nigel C.; Lutermann, Heike] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Ueckermann, Edward A.] ARC Plant Protect Res Inst, Pretoria, South Africa; [Ueckermann, Edward A.] Potchefstroom Univ, Sch Environm Sci & Dev, Potchefstroom, South Africa	University of Pretoria; North West University - South Africa	Viljoen, H (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	hlutermann@zoology.up.ac.za	Lutermann, Heike/A-4692-2008; Bennett, Nigel/E-4238-2010	Lutermann, Heike/0000-0002-7521-2302; Bennett, Nigel/0000-0001-9748-2947	DST-NRF (Department of Science and Technology -National Research Foundation) South African Research Chair for Behavioural Ecology and Physiology	DST-NRF (Department of Science and Technology -National Research Foundation) South African Research Chair for Behavioural Ecology and Physiology	This project was funded by the DST-NRF (Department of Science and Technology -National Research Foundation) South African Research Chair for Behavioural Ecology and Physiology to NC Bennett. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bishop JM, 2004, MOL ECOL, V13, P1217, DOI 10.1111/j.1365-294X.2004.02131.x; Bordes F, 2007, BIOL LETTERS, V3, P692, DOI 10.1098/rsbl.2007.0393; Burland TM, 2002, P ROY SOC B-BIOL SCI, V269, P1025, DOI 10.1098/rspb.2002.1978; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Christe P, 2000, ECOL LETT, V3, P207; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Cornell SJ, 2008, P ROY SOC B-BIOL SCI, V275, P511, DOI 10.1098/rspb.2007.1415; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Ebensperger LA, 2008, BEHAV PROCESS, V79, P85, DOI 10.1016/j.beproc.2008.05.006; Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Hanley JA, 2003, BIOMETRICS, V52, p[364, 354]; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HENRY LG, 1971, J MED ENTOMOL, V8, P504, DOI 10.1093/jmedent/8.5.504; Hillegass MA, 2008, BEHAV ECOL, V19, P1006, DOI 10.1093/beheco/arn070; Hillegass MA, 2010, BEHAV ECOL, V21, P696, DOI 10.1093/beheco/arq041; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; Krasnov BR, 2005, OECOLOGIA, V146, P219; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Lourenco S, 2008, PARASITOL RES, V104, P127, DOI 10.1007/s00436-008-1170-6; Moolman M, 1998, J ZOOL, V246, P193, DOI 10.1017/S0952836998010085; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mumcuoglu KY, 1999, MED VET ENTOMOL, V13, P252, DOI 10.1046/j.1365-2915.1999.00149.x; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Neuhaus P, 2003, P ROY SOC B-BIOL SCI, V270, pS213, DOI 10.1098/rsbl.2003.0073; Pelletier F, 2005, OIKOS, V110, P473, DOI 10.1111/j.0030-1299.2005.14120.x; Podder S, 2009, AEROBIOLOGIA, V25, P39, DOI 10.1007/s10453-008-9107-1; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R., 2007, EVOL ECOL, V2; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rossin A, 2002, J PARASITOL, V88, P1268, DOI 10.1645/0022-3395(2002)088[1268:RBHPAD]2.0.CO;2; Rossin MA, 2010, PARASITOLOGY, V137, P1569, DOI 10.1017/S0031182010000351; Scantlebury M, 2006, NATURE, V440, P795, DOI 10.1038/nature04578; Scharff A, 1997, J ZOOL, V241, P571, DOI 10.1111/j.1469-7998.1997.tb04848.x; Schwanz LE, 2008, BEHAV ECOL SOCIOBIOL, V62, P1351, DOI 10.1007/s00265-008-0563-y; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Snaith TV, 2008, AM J PRIMATOL, V70, P1072, DOI 10.1002/ajp.20601; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; Stearns S.C., 1992, pi; Tenora F, 2003, HELMINTHOLOGIA, V40, P153; Thomas F, 2002, TRENDS PARASITOL, V18, P387, DOI 10.1016/S1471-4922(02)02339-5; van Rensburg LJ, 2003, J ZOOL, V260, P73, DOI 10.1017/S0952836903003443; van Rensburg LJ, 2002, CAN J ZOOL, V80, P810, DOI 10.1139/Z02-051; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; Whiteman NK, 2004, J PARASITOL, V90, P939, DOI 10.1645/GE-310R; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wilson K., 2001, ECOLOGY WILDLIFE DIS, P6; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zelova J, 2011, COMP BIOCHEM PHYS A, V158, P17, DOI 10.1016/j.cbpa.2010.07.026; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	64	38	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27003	10.1371/journal.pone.0027003	http://dx.doi.org/10.1371/journal.pone.0027003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069481	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900001
J	Dietrich, P; Yue, JM; Shuyu, E; Dragatsis, I				Dietrich, Paula; Yue, Junming; Shuyu, E.; Dragatsis, Ioannis			Deletion of Exon 20 of the Familial Dysautonomia Gene Ikbkap in Mice Causes Developmental Delay, Cardiovascular Defects, and Early Embryonic Lethality	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; NEURAL CREST CELLS; B KINASE COMPLEX; ELONGATOR COMPLEX; HEART DEVELOPMENT; MOUSE EMBRYO; SMAD4; EXPRESSION; PROTEIN; IKAP	Familial Dysautonomia (FD) is an autosomal recessive disorder that affects 1/3,600 live births in the Ashkenazi Jewish population, and leads to death before the age of 40. The disease is characterized by abnormal development and progressive degeneration of the sensory and autonomic nervous system. A single base pair substitution in intron 20 of the Ikbkap gene accounts for 98% of FD cases, and results in the expression of low levels of the full-length mRNA with simultaneous expression of an aberrantly spliced mRNA in which exon 20 is missing. To date, there is no animal model for the disease, and the essential cellular functions of IKAP - the protein encoded by Ikbkap - remain unknown. To better understand the normal function of IKAP and in an effort to generate a mouse model for FD, we have targeted the mouse Ikbkap gene by homologous recombination. We created two distinct alleles that result in either loss of Ikbkap expression, or expression of an mRNA lacking only exon 20. Homozygosity for either mutation leads to developmental delay, cardiovascular and brain malformations, accompanied with early embryonic lethality. Our analyses indicate that IKAP is essential for expression of specific genes involved in cardiac morphogenesis, and that cardiac failure is the likely cause of abnormal vascular development and embryonic lethality. Our results also indicate that deletion of exon 20 abolishes gene function. This implies that the truncated IKAP protein expressed in FD patients does not retain any significant biological function.	[Dietrich, Paula; Yue, Junming; Shuyu, E.; Dragatsis, Ioannis] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Dietrich, P (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Physiol, Memphis, TN 38163 USA.	idragatsis@uthsc.edu	e, s/GWU-7511-2022		NIH [RO3-NS050376, RO1-NS061842]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061842, R03NS050376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants RO3-NS050376 and RO1-NS061842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Axelrod F B, 1974, Adv Pediatr, V21, P75; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; Axelrod FB, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-39; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; Buchmann-Moller S, 2009, DEV BIOL, V330, P329, DOI 10.1016/j.ydbio.2009.04.001; Chen Y, 2009, MED RES REV, V29, P29, DOI 10.1002/med.20137; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Coli R, 2001, GENE, V279, P81, DOI 10.1016/S0378-1119(01)00737-5; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dragatsis I, 2004, HUM MOL GENET, V13, P3115, DOI 10.1093/hmg/ddh328; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Gadoth N, 1997, DEV MED CHILD NEUROL, V39, P393; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hilz MJ, 1998, J NEUROL NEUROSUR PS, V65, P338, DOI 10.1136/jnnp.65.3.338; Hogan B, 1994, MANIPULATING MOUSE E; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ji RP, 2003, CIRC RES, V92, P133, DOI 10.1161/01.RES.0000056532.18710.C0; Jiao K, 2006, DEVELOPMENT, V133, P4585, DOI 10.1242/dev.02597; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kaufman M.H., 1992, ATLAS MOUSE DEV; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mallo M, 2006, FRONT BIOSCI-LANDMRK, V11, P313, DOI 10.2741/1799; Mass E, 1996, DEV MED CHILD NEUROL, V38, P133; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; Meagher MJ, 2001, MOL CELL BIOL, V21, P2880, DOI 10.1128/MCB.21.8.2880-2890.2001; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Nie XG, 2008, DEV BIOL, V316, P417, DOI 10.1016/j.ydbio.2008.02.006; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Peterkin T, 2007, DEV BIOL, V311, P623, DOI 10.1016/j.ydbio.2007.08.018; Pietri T, 2003, DEV DYNAM, V227, P309, DOI 10.1002/dvdy.10299; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; RILEY CM, 1949, PEDIATRICS, V3, P468; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Singh MK, 2010, J BIOL CHEM, V285, P1765, DOI 10.1074/jbc.M109.038539; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yamada S, 1995, CELL ADHES COMMUN, V3, P311, DOI 10.3109/15419069509081016; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	64	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27015	10.1371/journal.pone.0027015	http://dx.doi.org/10.1371/journal.pone.0027015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046433	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800058
J	Peng, LX; Fang, BW; Wang, Y; Gao, SN				Peng Longxi; Fang Buwu; Wang Yuan; Gao Sinan			Expression of p53 in the Effects of Artesunate on Induction of Apoptosis and Inhibition of Proliferation in Rat Primary Hepatic Stellate Cells	PLOS ONE			English	Article							FIBROSIS	Background: Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen. p53, the "guardian of the genome", is a transcription factor that can bind to promoter regions of hundreds of genes where it either activates or suppresses gene expression. Thereby, p53 serves as a tumor suppressor by inducing cell cycle arrest, apoptosis, senescence and DNA repair. Artesunate is a derivative of Artemisinin, Scholars had found it had more extensive pharmacological effects past 10 years. However, little is known about the expression of p53 in the effects of Artesunate on induction of apoptosis and inhibition of proliferation in rat HSCs. Methodology/Principal Findings: Isolated and cultured rat primary HSCs in the flask for 10 days to make cells activated. HSCs were divided into two groups: experimental groups and control groups, experimental groups included with various concentrations of Artesunate (125, 150, 175, 200, 225 mu mol/L) for 24, 48 and 72 hours. Analysis of MTT revealed that activated HSCs treated with various concentrations of Artesunate (150-225 mu mol/L) were inhibited on dose and time-effect relationships; Concentration of hydroxyproline in supernatant was detected by digestive method; Analysis of flow cytometry demonstrated that Artesunate could arrest cell cycle in G1 and induce apoptosis; The nuclear morphological changes in apoptotic cells were evaluated with DNA staining by Hoechst 33258 dye; The expression of p53 were up-regulated showed by western blotting and RT-PCR. Conclusion: Artesunate could inhibit HSCs proliferation in dose-dependent and time-dependent manners in vitro through increase the expression of p53.	[Peng Longxi; Fang Buwu; Wang Yuan; Gao Sinan] Tianjin Med Univ, Dept Pharmacol, Tianjin, Peoples R China	Tianjin Medical University	Peng, LX (corresponding author), Tianjin Med Univ, Dept Pharmacol, Tianjin, Peoples R China.	fangdch1962@163.com			National Natural Science Foundation of China [30772856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30772856). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprigliano I, 2008, LIVER INT, V28, P546, DOI 10.1111/j.1478-3231.2008.01682.x; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546; [方步武 Fang Buwu], 2005, [中国药理学通报, Chinese Pharmacological Bulletin], V21, P762; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Jerry DJ, 2002, J DAIRY SCI, V85, P1103, DOI 10.3168/jds.S0022-0302(02)74171-4; Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58; [来丽娜 Lai Lina], 2006, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V22, P25; [来丽娜 Lai Lina], 2006, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V22, P35; Michaelis M, 2010, BIOCHEM PHARMACOL, V79, P130, DOI 10.1016/j.bcp.2009.08.013; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nakahara T, 2003, AM J PHYSIOL-ENDOC M, V285, pE1273, DOI 10.1152/ajpendo.00019.2003; Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; Sun X, 2009, BIOL PHARM BULL, V32, P1533, DOI 10.1248/bpb.32.1533	21	7	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26500	10.1371/journal.pone.0026500	http://dx.doi.org/10.1371/journal.pone.0026500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053192	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800018
J	Veeranki, S; Duan, X; Panchanathan, R; Liu, HZ; Choubey, D				Veeranki, Sudhakar; Duan, Xin; Panchanathan, Ravichandran; Liu, Hongzhu; Choubey, Divaker			IFI16 Protein Mediates the Anti-inflammatory Actions of the Type-I Interferons through Suppression of Activation of Caspase-1 by Inflammasomes	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELLULAR SENESCENCE; CYTOPLASMIC DNA; CYTOSOLIC DNA; HUMAN FIBROBLASTS; HIN-200 FAMILY; AIM2; EXPRESSION; SENSOR; GENE	Background: Type-I interferons (IFNs) are used to treat certain inflammatory diseases. Moreover, activation of type-I IFNsignaling in immune cells inhibits the production of proinflammatory cytokines and activation of inflammasomes. However, the molecular mechanisms remain largely unknown. Upon sensing cytosolic double-stranded DNA, the AIM2 protein forms the AIM2-ASC inflammasome, resulting in activation of caspase-1. Given that the IFI16 and AIM2 proteins are IFN-inducible and can heterodimerize with each other, we investigated the regulation of IFI16, AIM2, and inflammasome proteins by type-I and type-II IFNs and explored whether the IFI16 protein could negatively regulate the activation of the AIM2 (or other) inflammasome. Methodology/Principal Findings: We found that basal levels of the IFI16 and AIM2 proteins were relatively low in peripheral blood monocytes (CD14(+)) and in the THP-1 monocytic cell line. However, treatment of THP-1 cells with type-I (IFN-alpha or beta) or type-II (IFN-gamma) IFN induced the expression levels of IFI16, AIM2, ASC and CASP1 proteins. The induced levels of IFI16 and AIM2 proteins were detected primarily in the cytoplasm. Accordingly, relatively more IFI16 protein bound with the AIM2 protein in the cytoplasmic fraction. Notably, increased expression of IFI16 protein in transfected HEK-293 cells inhibited activation of caspase-1 by the AIM2-ASC inflammasome. Moreover, the constitutive knockdown of the IFI16 expression in THP-1 cells increased the basal and induced [induced by poly(dA:dT) or alum] activation of the caspase-1 by the AIM2 and NLRP3 inflammasomes. Conclusions/Significance: Our observations revealed that the type-I and type-II IFNs induce the expression of IFI16, AIM2, and inflammasome proteins to various extents in THP-1 cells and the expression of IFI16 protein in THP-1 cells suppresses the activation of caspase-1 by the AIM2 and NLRP3 inflammasomes. Thus, our observations identify the IFI16 protein as a mediator of the anti-inflammatory actions of the type-I IFNs.	[Veeranki, Sudhakar; Duan, Xin; Panchanathan, Ravichandran; Liu, Hongzhu; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Panchanathan, Ravichandran; Choubey, Divaker] Cincinnati VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Veeranki, S (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Panchanathan, Ravichandran/E-1801-2015; Choubey, Divaker/A-4771-2008		National Institutes of Health [AI066261, AG025036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a VA Merit Award and grants (AI066261 and AG025036) from the National Institutes of Health to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Alimirah F, 2006, FEBS LETT, V580, P1659, DOI 10.1016/j.febslet.2006.02.015; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Dawson MJ, 1998, J LEUKOCYTE BIOL, V64, P546, DOI 10.1002/jlb.64.4.546; Duan X, 2011, MOL CANCER RES, V9, P589, DOI 10.1158/1541-7786.MCR-10-0565; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gariglio M, 2011, J INTERF CYTOK RES, V31, P159, DOI 10.1089/jir.2010.0106; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kotter I, 2004, SEMIN ARTHRITIS RHEU, V33, P320, DOI 10.1053/S0049-0172(03)00167-7; Krieg AM, 2010, NAT IMMUNOL, V11, P367, DOI 10.1038/ni0510-367; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Mandel M, 2006, LUPUS, V15, P451, DOI 10.1191/0961203306lu2332oa; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; SEN GC, 1992, J BIOL CHEM, V267, P5017; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tweezer-Zaks N, 2008, J RHEUMATOL, V35, P1362; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876	48	90	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27040	10.1371/journal.pone.0027040	http://dx.doi.org/10.1371/journal.pone.0027040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046441	gold, Green Submitted, Green Published			2022-12-27	WOS:000299081800063
J	Yan, C; Sun, GL; Sun, DF				Yan, Chi; Sun, Genlou; Sun, Dongfa			Distinct Origin of the Y and St Genome in Elymus Species: Evidence from the Analysis of a Large Sample of St Genome Species Using Two Nuclear Genes	PLOS ONE			English	Article							INTRASPECIFIC VARIATION; PHYLOGENETIC ANALYSIS; RPB2 GENE; H-GENOME; TRITICEAE; ACCURACY; POACEAE; DNA; ALLOPOLYPLOIDY; LIKELIHOOD	Background: Previous cytological and single copy nuclear genes data suggested the St and Y genome in the StY-genomic Elymus species originated from different donors: the St from a diploid species in Pseudoroegneria and the Y from an unknown diploid species, which are now extinct or undiscovered. However, ITS data suggested that the Y and St genome shared the same progenitor although rather few St genome species were studied. In a recent analysis of many samples of St genome species Pseudoroegneria spicata (Pursh) A. Love suggested that one accession of P. spicata species was the most likely donor of the Y genome. The present study tested whether intraspecific variation during sampling could affect the outcome of analyses to determining the origin of Y genome in allotetraploid StY species. We also explored the evolutionary dynamics of these species. Methodology/Principal Findings: Two single copy nuclear genes, the second largest subunit of RNA polymerase II (RPB2) and the translation elongation factor G (EF-G) sequences from 58 accessions of Pseudoroegneria and Elymus species, together with those from Hordeum (H), Agropyron (P), Australopyrum (W), Lophopyrum (E-e), Thinopyrum (E-a), Thinopyrum (E-b), and Dasypyrum (V) were analyzed using maximum parsimony, maximum likelihood and Bayesian methods. Sequence comparisons among all these genomes revealed that the St and Y genomes are relatively dissimilar. Extensive sequence variations have been detected not only between the sequences from St and Y genome, but also among the sequences from diploid St genome species. Phylogenetic analyses separated the Y sequences from the St sequences. Conclusions/Significance: Our results confirmed that St and Y genome in Elymus species have originated from different donors, and demonstrated that intraspecific variation does not affect the identification of genome origin in polyploids. Moreover, sequence data showed evidence to support the suggestion of the genome convergent evolution in allopolyploid StY genome species.	[Yan, Chi; Sun, Genlou; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Yan, Chi; Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Saint Marys University - Canada	Yan, C (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	genlou.sun@smu.ca; sundongfa1@mail.hzau.edu.cn	Yan, Chi/J-2013-2019	Yan, Chi/0000-0002-8658-7302	Natural Sciences and Engineering Research Council of Canada [238425]; Canadian Foundation for Innovation; Saint Mary's University; earmarked fund for China Agriculture Research System	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Saint Mary's University; earmarked fund for China Agriculture Research System	This research was supported by a discovery grant (238425) from Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation, and a Senate Research Grant at Saint Mary's University to GS, and the earmarked fund for China Agriculture Research System to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyayev A, 2000, GENOME, V43, P1021, DOI 10.1139/gen-43-6-1021; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; DEWEY D R, 1984, P209; DEWEY DR, 1971, AM J BOT, V58, P902, DOI 10.2307/2441256; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han FP, 2003, GENOME, V46, P716, DOI [10.1139/g03-049, 10.1139/G03-049]; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Harmon LJ, 2005, EVOLUTION, V59, P2705; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; JENSEN KB, 1990, GENOME, V33, P563, DOI 10.1139/g90-083; JENSEN KB, 1995, INT J PLANT SCI, V156, P731, DOI 10.1086/297295; Jukes T, 1969, MAMMALIAN PROTEIN ME, VIII, P21; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komatsuda T, 1999, GENOME, V42, P973, DOI 10.1139/gen-42-5-973; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Larson SR, 2004, AM J BOT, V91, P1789, DOI 10.3732/ajb.91.11.1789; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Lu BR, 2005, PLANT BREEDING, V41, P58; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Mason-Gamer R. J., 2005, Czech Journal of Genetics and Plant Breeding, V41, P21; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; McCormack JE, 2009, SYST BIOL, V58, P501, DOI 10.1093/sysbio/syp045; Okito P, 2009, GENOME, V52, P391, DOI [10.1139/G09-015, 10.1139/g09-015]; Ozkan H, 2002, ISRAEL J PLANT SCI, V50, pS65, DOI 10.1560/E282-PV55-G4XT-DRWJ; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Salina EA, 2004, GENOME, V47, P860, DOI 10.1139/G04-044; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; von Bothmer R., 1994, P 2 INT TRIT S UT ST, P1; Wiens JJ, 1997, SYST BIOL, V46, P332, DOI 10.2307/2413627; Wiens JJ, 1998, SYST BIOL, V47, P228, DOI 10.1080/106351598260897	55	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26853	10.1371/journal.pone.0026853	http://dx.doi.org/10.1371/journal.pone.0026853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046383	gold, Green Published			2022-12-27	WOS:000296521400037
J	Wei, HY; Wang, Y; Chowdhury, SI				Wei, Huiyong; Wang, Ying; Chowdhury, Shafiqul I.			Bovine Herpesvirus Type 1 (BHV-1) U(L)49.5 Luminal Domain Residues 30 to 32 Are Critical for MHC-I Down-Regulation in Virus-Infected Cells	PLOS ONE			English	Article							DISULFIDE-LINKED COMPLEX; GLYCOPROTEIN-M; ANTIGEN PRESENTATION; RESPIRATORY-DISEASE; IMMUNE EVASION; PROTEIN; VACCINES; RECOMBINANT; TRANSPORTER; PEPTIDE	Bovine herpesvirus type 1 (BHV-1) U(L)49.5 inhibits transporter associated with antigen processing (TAP) and down-regulates cell-surface expression of major histocompatibility complex (MHC) class I molecules to promote immune evasion. We have constructed a BHV-1 U(L)49.5 cytoplasmic tail (CT) null and several U(L)49.5 luminal domain mutants in the backbone of wildtype BHV-1 or BHV-1 U(L)49.5 CT-null viruses and determined their relative TAP mediated peptide transport inhibition and MHC-1 down-regulation properties compared with BHV-1 wt. Based on our results, the U(L)49.5 luminal domain residues 30-32 and U(L)49.5 CT residues, together, promote efficient TAP inhibition and MHC-I down-regulation functions. In vitro, BHV-1 U(L)49.5 Delta 30-32 CT-null virus growth property was similar to that of BHV-1 wt and like the wt U(L)49.5, the mutant U(L)49.5 was incorporated in the virion envelope and it formed a complex with gM in the infected cells.	[Wei, Huiyong; Wang, Ying; Chowdhury, Shafiqul I.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Wei, HY (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	chowdh@lsu.edu			United States Department of Agriculture (USDA) [2007-35204-17358]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture (USDA) grant 2007-35204-17358 to SIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak A, 2004, J VIROL, V78, P4806, DOI 10.1128/JVI.78.9.4806-4816.2004; Chowdhury SI, 2006, J VIROL, V80, P4396, DOI 10.1128/JVI.80.9.4396-4405.2006; Chowdhury SI, 1996, VET MICROBIOL, V52, P13, DOI 10.1016/0378-1135(96)00043-0; Chowdhury SI, 1999, AM J VET RES, V60, P227; Chowdhury SI, 2000, J VIROL, V74, P2094, DOI 10.1128/JVI.74.5.2094-2106.2000; Ellis John A., 2009, Animal Health Research Reviews, V10, P149, DOI 10.1017/S146625230999020X; Gopinath RS, 2002, VIRAL IMMUNOL, V15, P595, DOI 10.1089/088282402320914539; HARLAND RJ, 1992, CAN VET J, V33, P734; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hinkley S, 1998, VIRUS RES, V53, P91, DOI 10.1016/S0168-1702(97)00128-7; Jones Clinton, 2007, Animal Health Research Reviews, V8, P187, DOI 10.1017/S146625230700134X; Jons A, 1998, J VIROL, V72, P550; Kaashoek MJ, 1996, VET REC, V139, P416, DOI 10.1136/vr.139.17.416; Knittler MR, 1999, CURR BIOL, V9, P999, DOI 10.1016/S0960-9822(99)80448-5; Konig P, 2002, VET MICROBIOL, V86, P37, DOI 10.1016/S0378-1135(01)00489-8; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2001, J GEN VIROL, V82, P2071, DOI 10.1099/0022-1317-82-9-2071; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Liang XP, 1996, J VIROL, V70, P1448, DOI 10.1128/JVI.70.3.1448-1454.1996; Lipinska AD, 2006, J VIROL, V80, P5822, DOI 10.1128/JVI.02707-05; LITTELVANDENHURK SV, 1993, IMMUNOL CELL BIOL, V71, P405, DOI 10.1038/icb.1993.47; LittelvandenHurk SV, 1997, VACCINE, V15, P36, DOI 10.1016/S0264-410X(96)00113-2; Liu ZF, 2008, J VIROL, V82, P7432, DOI 10.1128/JVI.00379-08; Loch S, 2008, J BIOL CHEM, V283, P13428, DOI 10.1074/jbc.M800226200; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Rudolph J, 2002, J VIROL, V76, P2952, DOI 10.1128/JVI.76.6.2952-2963.2002; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; TIKOO SK, 1995, ADV VIRUS RES, V45, P191, DOI 10.1016/S0065-3527(08)60061-5; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; vanOirschot JT, 1996, VET MICROBIOL, V53, P43, DOI 10.1016/S0378-1135(96)01233-3; Verweij MC, 2008, J IMMUNOL, V181, P4894, DOI 10.4049/jimmunol.181.7.4894; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Wu SX, 1998, J VIROL, V72, P3029, DOI 10.1128/JVI.72.4.3029-3036.1998; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	35	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e25742	10.1371/journal.pone.0025742	http://dx.doi.org/10.1371/journal.pone.0025742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046246	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600006
J	Latimer, CS; Searcy, JL; Bridges, MT; Brewer, LD; Popovic, J; Blalock, EM; Landfield, PW; Thibault, O; Porter, NM				Latimer, Caitlin S.; Searcy, James L.; Bridges, Michael T.; Brewer, Lawrence D.; Popovic, Jelena; Blalock, Eric M.; Landfield, Philip W.; Thibault, Olivier; Porter, Nada M.			Reversal of Glial and Neurovascular Markers of Unhealthy Brain Aging by Exercise in Middle-Aged Female Mice	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; COGNITIVE IMPAIRMENT; PHYSICAL-ACTIVITY; ANIMAL-MODELS; MOUSE-BRAIN; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; WHITE-MATTER; HIPPOCAMPUS	Healthy brain aging and cognitive function are promoted by exercise. The benefits of exercise are attributed to several mechanisms, many which highlight its neuroprotective role via actions that enhance neurogenesis, neuronal morphology and/or neurotrophin release. However, the brain is also composed of glial and vascular elements, and comparatively less is known regarding the effects of exercise on these components in the aging brain. Here, we show that aerobic exercise at mid-age decreased markers of unhealthy brain aging including astrocyte hypertrophy, a hallmark of brain aging. Middle-aged female mice were assigned to a sedentary group or provided a running wheel for six weeks. Exercise decreased hippocampal astrocyte and myelin markers of aging but increased VEGF, a marker of angiogenesis. Brain vascular casts revealed exercise-induced structural modifications associated with improved endothelial function in the periphery. Our results suggest that age-related astrocyte hypertrophy/reactivity and myelin dysregulation are aggravated by a sedentary lifestyle and accompanying reductions in vascular function. However, these effects appear reversible with exercise initiated at mid-age. As this period of the lifespan coincides with the appearance of multiple markers of brain aging, including initial signs of cognitive decline, it may represent a window of opportunity for intervention as the brain appears to still possess significant vascular plasticity. These results may also have particular implications for aging females who are more susceptible than males to certain risk factors which contribute to vascular aging.	[Latimer, Caitlin S.; Searcy, James L.; Bridges, Michael T.; Brewer, Lawrence D.; Popovic, Jelena; Blalock, Eric M.; Landfield, Philip W.; Thibault, Olivier; Porter, Nada M.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA	University of Kentucky	Latimer, CS (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA.	nadap@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466	National Institutes of Health (NIH) [P01 AG01836, R01 AG034605, R01 AG020251, T32 AG000242, P20RR021954]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000242, R01AG034605, R01AG037868, R01AG020251] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants P01 AG01836 (PWL, NMP, OT, EMB), R01 AG034605 (PWL), R01 AG020251 (NMP); T32 AG000242 (CSL) to Dr. Greg Gerhardt, and P20RR021954 to Dr. Lisa Cassis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Arribas SM, 1997, HYPERTENSION, V30, P1455, DOI 10.1161/01.HYP.30.6.1455; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; BJORKLUND H, 1985, EXP BRAIN RES, V58, P163; Blalock EM, 2003, J NEUROSCI, V23, P3807; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; *CDCAA, 2007, HLTH BRAIN IN NAT PU; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; GEINISMAN Y, 1978, AM J ANAT, V153, P537, DOI 10.1002/aja.1001530405; Gorelick PB, 2011, STROKE; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; HANSEN LA, 1987, NEUROBIOL AGING, V8, P1, DOI 10.1016/0197-4580(87)90051-0; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263; Lachman ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013297; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LANDFIELD PW, 1977, J GERONTOL, V32, P3, DOI 10.1093/geronj/32.1.3; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lemke R, 1999, NEUROSCI LETT, V267, P53, DOI 10.1016/S0304-3940(99)00332-8; Lerman LO, 2005, J LAB CLIN MED, V146, P160, DOI 10.1016/j.lab.2005.05.005; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Lynch G, 2006, AGEING RES REV, V5, P255, DOI 10.1016/j.arr.2006.03.008; Macklin WB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3140pe32; Marma AK, 2009, CIRCULATION, V120, P384, DOI 10.1161/CIRCULATIONAHA.108.835470; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Moore CS, 2011, J NEUROSCI RES, V89, P13, DOI 10.1002/jnr.22482; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Nalivaiko E, 2011, CLIN EXP PHARMACOL P, V38, P115, DOI 10.1111/j.1440-1681.2010.05465.x; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Peters A., 2007, BRAIN AGING MODELS M, DOI 10.1201/9781420005523-5; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sandell JH, 2002, J COMP NEUROL, V445, P13, DOI 10.1002/cne.10162; Satomi J, 2003, STROKE, V34, P783, DOI 10.1161/01.STR.0000056170.47815.37; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; SIMPKINS JW, 1994, NEUROBIOL AGING, V15, pS195; Singh-Manoux A, 2005, J CLIN EPIDEMIOL, V58, P1308, DOI 10.1016/j.jclinepi.2005.03.016; Singh-Manoux A, 2005, AM J PUBLIC HEALTH, V95, P2252, DOI 10.2105/AJPH.2004.055574; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sohrabji F, 2007, GENE EXPRESSION, V13, P311; Sonntag WE, 2007, BRAIN AGING MODELS M; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tsivgoulis G, 2009, NEUROLOGY, V73, P589, DOI 10.1212/WNL.0b013e3181b38969; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verkhratsky A, 2006, J CELL MOL MED, V10, P826, DOI 10.1111/j.1582-4934.2006.tb00527.x; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Yates MA, 2007, BRAIN RES, V1142, P13, DOI 10.1016/j.brainres.2007.01.043; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370	77	52	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26812	10.1371/journal.pone.0026812	http://dx.doi.org/10.1371/journal.pone.0026812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046366	gold, Green Published, Green Submitted			2022-12-27	WOS:000296517000036
J	Brulc, JM; Yeoman, CJ; Wilson, MK; Miller, MEB; Jeraldo, P; Jindou, S; Goldenfeld, N; Flint, HJ; Lamed, R; Borovok, I; Vodovnik, M; Nelson, KE; Bayer, EA; White, BA				Brulc, Jennifer M.; Yeoman, Carl J.; Wilson, Melissa K.; Miller, Margret E. Berg; Jeraldo, Patricio; Jindou, Sadanari; Goldenfeld, Nigel; Flint, Harry J.; Lamed, Raphael; Borovok, Ilya; Vodovnik, Masa; Nelson, Karen E.; Bayer, Edward A.; White, Bryan A.			Cellulosomics, a Gene-Centric Approach to Investigating the Intraspecific Diversity and Adaptation of Ruminococcus flavefaciens within the Rumen	PLOS ONE			English	Article							COENZYME-M REDUCTASE; 16S RIBOSOMAL-RNA; BOVINE RUMEN; MICROBIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; BACTERIA; CONSERVATION; DEGRADATION; POPULATIONS; SEQUENCES	Background: The bovine rumen maintains a diverse microbial community that serves to break down indigestible plant substrates. However, those bacteria specifically adapted to degrade cellulose, the major structural component of plant biomass, represent a fraction of the rumen microbiome. Previously, we proposed scaC as a candidate for phylotyping Ruminococcus flavefaciens, one of three major cellulolytic bacterial species isolated from the rumen. In the present report we examine the dynamics and diversity of scaC-types both within and between cattle temporally, following a dietary switch from corn-silage to grass-legume hay. These results were placed in the context of the overall bacterial population dynamics measured using the 16S rRNA. Principal Findings: As many as 117 scaC-types were estimated, although just nineteen were detected in each of three rumens tested, and these collectively accounted for the majority of all types present. Variation in scaC populations was observed between cattle, between planktonic and fiber-associated fractions and temporally over the six-week survey, and appeared related to scaC phylogeny. However, by the sixth week no significant separation of scaC populations was seen between animals, suggesting enrichment of a constrained set of scaC-types. Comparing the amino-acid translation of each scaC-type revealed sequence variation within part of the predicted dockerin module but strong conservation in the N-terminus, where the cohesin module is located. Conclusions: The R. flavefaciens species comprises a multiplicity of scaC-types in-vivo. Enrichment of particular scaC-types temporally, following a dietary switch, and between fractions along with the phylogenetic congruence suggests that functional differences exist between types. Observed differences in dockerin modules suggest at least part of the functional heterogeneity may be conferred by scaC. The polymorphic nature of scaC enables the relative distribution of R. flavefaciens strains to be examined and represents a gene-centric approach to investigating the intraspecific adaptation of an important specialist population.	[Brulc, Jennifer M.; Wilson, Melissa K.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Brulc, Jennifer M.; Yeoman, Carl J.; Miller, Margret E. Berg; Jeraldo, Patricio; Goldenfeld, Nigel; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Jeraldo, Patricio; Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Jindou, Sadanari] Meijo Univ, Dept Culture Educ, Fac Sci, Aichi, Japan; [Flint, Harry J.; Vodovnik, Masa] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Lamed, Raphael; Borovok, Ilya] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Vodovnik, Masa] Univ Ljubljana, Chair Microbiol & Microbial Biotechnol, Biotech Fac, Ljubljana, Slovenia; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Meijo University; University of Aberdeen; Tel Aviv University; University of Ljubljana; J. Craig Venter Institute; Weizmann Institute of Science	Brulc, JM (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Vodovnik, Masa/U-4580-2019; BOROVOK, ILYA/ABB-7370-2022; Yeoman, Carl/ABA-1906-2021; Jeraldo, Patricio/H-8178-2019	Yeoman, Carl/0000-0002-8775-7879; Jeraldo, Patricio/0000-0003-0282-4217; Vodovnik, Masa/0000-0002-1189-2417; BOROVOK, ILYA/0000-0003-1602-4499; Berg, Margret/0000-0002-0411-1619	National Research Initiative from the USDA Cooperative State Research, Education, and Extension Service [2006-35206-16652]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF; Israel Science Foundation [966/09, 159/07, 291/08]; Scottish Government Rural and Environmental Science and Analysis Service; BSF	National Research Initiative from the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Scottish Government Rural and Environmental Science and Analysis Service; BSF(US-Israel Binational Science Foundation)	This project was supported by National Research Initiative Competitive Grant no. 2006-35206-16652 from the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/), and in part by grants from the United States-Israel Binational Science Foundation (BSF; http://www.bsf.org.il), Jerusalem, Israel - BSF Energy Research grant to E. A. B. and B. A. W and Regular BSF Research grants to E. A. B. and B. A. W. and to R. L. and B. A. W. and by the Israel Science Foundation (grant nos 966/09, 159/07 and 291/08; http://www.isf.org.il). H.J.F. was supported by the Scottish Government Rural and Environmental Science and Analysis Service. E. A. B. holds The Maynard I. and Elaine Wishner Chair of Bio-organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook KL, 2008, ANAEROBE, V14, P172, DOI 10.1016/j.anaerobe.2008.03.003; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hespell Robert B., 1997, P59; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; KARKHOFFSCHWEIZER RR, 1995, APPL ENVIRON MICROB, V61, P290, DOI 10.1128/AEM.61.1.290-296.1995; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Krause DO, 1999, J APPL MICROBIOL, V86, P487, DOI 10.1046/j.1365-2672.1999.00688.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lamed R, 1983, BIOTECHNOL BIOENG S, V13, P163; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Legendre P., 1998, NUMERICAL ECOLOGY; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Matsui H, 2010, CURR MICROBIOL, V60, P112, DOI 10.1007/s00284-009-9513-9; National Research Council, 2001, NUTR REQ DAIR CATTL, DOI DOI 10.17226/9825; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Robert C, 2003, FEMS MICROBIOL ECOL, V46, P81, DOI 10.1016/S0168-6496(03)00207-1; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tatsuoka N, 2004, LETT APPL MICROBIOL, V39, P257, DOI 10.1111/j.1472-765X.2004.01566.x; Warwick R. M., 2001, PRIMER E; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Yeoman CJ, 2011, ENTROPY-SWITZ, V13, P570, DOI 10.3390/e13030570; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	41	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25329	10.1371/journal.pone.0025329	http://dx.doi.org/10.1371/journal.pone.0025329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043282	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400009
J	Guarnieri, MT; Nag, A; Smolinski, SL; Darzins, A; Seibert, M; Pienkos, PT				Guarnieri, Michael T.; Nag, Ambarish; Smolinski, Sharon L.; Darzins, Al; Seibert, Michael; Pienkos, Philip T.			Examination of Triacylglycerol Biosynthetic Pathways via De Novo Transcriptomic and Proteomic Analyses in an Unsequenced Microalga	PLOS ONE			English	Article							CHLOROPLAST GENE-EXPRESSION; CHLAMYDOMONAS-REINHARDTII; CHLORELLA-VULGARIS; DIRECT TRANSESTERIFICATION; TRANSLATIONAL REGULATION; BIOFUEL PRODUCTION; CELL-WALL; STRESS; RNA; CHLOROPHYCEAE	Biofuels derived from algal lipids represent an opportunity to dramatically impact the global energy demand for transportation fuels. Systems biology analyses of oleaginous algae could greatly accelerate the commercialization of algal-derived biofuels by elucidating the key components involved in lipid productivity and leading to the initiation of hypothesis-driven strain-improvement strategies. However, higher-level systems biology analyses, such as transcriptomics and proteomics, are highly dependent upon available genomic sequence data, and the lack of these data has hindered the pursuit of such analyses for many oleaginous microalgae. In order to examine the triacylglycerol biosynthetic pathway in the unsequenced oleaginous microalga, Chlorella vulgaris, we have established a strategy with which to bypass the necessity for genomic sequence information by using the transcriptome as a guide. Our results indicate an upregulation of both fatty acid and triacylglycerol biosynthetic machinery under oil-accumulating conditions, and demonstrate the utility of a de novo assembled transcriptome as a search model for proteomic analysis of an unsequenced microalga.	[Guarnieri, Michael T.; Darzins, Al; Pienkos, Philip T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA; [Nag, Ambarish] Natl Renewable Energy Lab, Computat Sci Ctr, Golden, CO USA; [Smolinski, Sharon L.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Seibert, Michael] Natl Renewable Energy Lab, Energy Sci Directorate, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Guarnieri, MT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA.	michael.guarnieri@nrel.gov		Guarnieri, Michael/0000-0003-1403-9689; Nag, Ambarish/0000-0001-5174-4673	Air Force Office of Scientific Research [WFC31000]; National Renewable Energy Laboratory (NREL) [06510901]; Alliance for Sustainable Energy, LLC [DE-AC36-08GO28308]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Renewable Energy Laboratory (NREL); Alliance for Sustainable Energy, LLC	This work was supported by Air Force Office of Scientific Research funding, grant WFC31000, for A. D., M. S., P. T. P., and M. T. G., and by the Laboratory Directed Research and Development (LDRD) Program at the National Renewable Energy Laboratory (NREL), LDRD # 06510901 for P. T. P, S. S., M. T. G., and A. N.. NREL is a national laboratory of the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy operated by the Alliance for Sustainable Energy, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by the Alliance for Sustainable Energy, LLC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; Employees of the Alliance for Sustainable Energy, LLC, under Contract No. DE-AC36-08GO28308 with the U.S. Dept. of Energy have authored this work. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for United States Government purposes.	Aizzat O, 2010, ADV MED SCI-POLAND, V55, P281, DOI 10.2478/v10039-010-0046-z; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Chow KC, 1999, PLANT CELL REP, V18, P778, DOI 10.1007/s002990050660; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dickey LA, 2002, N AM J AQUACULT, V64, P158, DOI 10.1577/1548-8454(2002)064&lt;0158:COADTM&gt;2.0.CO;2; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Feng YJ, 2011, BIORESOURCE TECHNOL, V102, P101, DOI 10.1016/j.biortech.2010.06.016; Ferreira VD, 2007, GENE, V389, P136, DOI 10.1016/j.gene.2006.10.023; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GILLHAM NW, 1994, ANNU REV GENET, V28, P71, DOI 10.1146/annurev.ge.28.120194.000443; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; GRUISSEM W, 1993, CRIT REV PLANT SCI, V12, P19, DOI 10.1080/07352689309382355; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Jamers A, 2009, AQUAT TOXICOL, V92, P114, DOI 10.1016/j.aquatox.2009.02.012; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062; Kim YK, 2005, ECOTOXICOLOGY, V14, P589, DOI 10.1007/s10646-005-0009-5; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; LEPAGE G, 1986, J LIPID RES, V27, P114; MAYFIELD SP, 1995, ANNU REV PLANT PHYS, V46, P147, DOI 10.1146/annurev.pp.46.060195.001051; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Ramos AL, 2010, NUTR CANCER, V62, P1170, DOI 10.1080/01635581.2010.513801; Ratledge C, 1988, OVERVIEW MICROBIAL L; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Rochaix JD, 1996, PLANT MOL BIOL, V32, P327, DOI 10.1007/BF00039389; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; ROESSLER PG, 1994, ANN NY ACAD SCI, V721, P250, DOI 10.1111/j.1749-6632.1994.tb47398.x; SCHULZ M, 2010, OASES DE NOVO TRANSC; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Sheehan J, 1998, DOE AQUATIC SPECIES; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; TAKEDA H, 1991, J PHYCOL, V27, P224, DOI 10.1111/j.0022-3646.1991.00224.x; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Wang SB, 2004, PROTEOMICS, V4, P692, DOI 10.1002/pmic.200300634; Ward AJ, 2010, BIORESOURCE TECHNOL, V101, P2210, DOI 10.1016/j.biortech.2009.11.053; Wienkoop S, 2010, MOL BIOSYST, V6, P1018, DOI 10.1039/b920913a; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	53	166	175	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25851	10.1371/journal.pone.0025851	http://dx.doi.org/10.1371/journal.pone.0025851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043295	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400023
J	Case, LB; Waterman, CM				Case, Lindsay B.; Waterman, Clare M.			Adhesive F-actin Waves: A Novel Integrin-Mediated Adhesion Complex Coupled to Ventral Actin Polymerization	PLOS ONE			English	Article							ARP2/3 COMPLEX; CELL LOCOMOTION; MATRIX ADHESION; OSCILLATIONS; INVADOPODIA; ACTIVATION; MATURATION; PODOSOMES; DYNAMICS	At the leading lamellipodium of migrating cells, protrusion of an Arp2/3-nucleated actin network is coupled to formation of integrin-based adhesions, suggesting that Arp2/3-mediated actin polymerization and integrin-dependent adhesion may be mechanistically linked. Arp2/3 also mediates actin polymerization in structures distinct from the lamellipodium, in "ventral F-actin waves'' that propagate as spots and wavefronts along the ventral plasma membrane. Here we show that integrins engage the extracellular matrix downstream of ventral F-actin waves in several mammalian cell lines as well as in primary mouse embryonic fibroblasts. These "adhesive F-actin waves'' require a cycle of integrin engagement and disengagement to the extracellular matrix for their formation and propagation, and exhibit morphometry and a hierarchical assembly and disassembly mechanism distinct from other integrin-containing structures. After Arp2/3-mediated actin polymerization, zyxin and VASP are co-recruited to adhesive F-actin waves, followed by paxillin and vinculin, and finally talin and integrin. Adhesive F-actin waves thus represent a previously uncharacterized integrin-based adhesion complex associated with Arp2/3-mediated actin polymerization.	[Case, Lindsay B.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Case, Lindsay B.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Case, LB (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	watermancm@nhlbi.nih.gov		Waterman, Clare/0000-0001-6142-6775; Case, Lindsay/0000-0003-3166-1138	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005105] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by the Intramural program of the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asano Y, 2008, CELL MOTIL CYTOSKEL, V65, P923, DOI 10.1002/cm.20314; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2009, CELL ADHES MIGR, V3, P373, DOI 10.4161/cam.3.4.9708; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; IZZARD CS, 1976, J CELL SCI, V21, P129; KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shin W., 2010, LIVE CELL IMAGING LA, P119; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	29	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26631	10.1371/journal.pone.0026631	http://dx.doi.org/10.1371/journal.pone.0026631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069459	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900021
J	Jimenez-Morales, D; Liang, J				Jimenez-Morales, David; Liang, Jie			Pattern of Amino Acid Substitutions in Transmembrane Domains of beta-Barrel Membrane Proteins for Detecting Remote Homologs in Bacteria and Mitochondria	PLOS ONE			English	Article							EVOLUTIONARY CONSERVATION; STRUCTURE PREDICTION; BIOGENESIS; PORINS; ARCHITECTURE; TEMPLATES; SEQUENCES; INSIGHTS; DATABASE; GENOMES	beta-barrel membrane proteins play an important role in controlling the exchange and transport of ions and organic molecules across bacterial and mitochondrial outer membranes. They are also major regulators of apoptosis and are important determinants of bacterial virulence. In contrast to alpha-helical membrane proteins, their evolutionary pattern of residue substitutions has not been quantified, and there are no scoring matrices appropriate for their detection through sequence alignment. Using a Bayesian Monte Carlo estimator, we have calculated the instantaneous substitution rates of transmembrane domains of bacterial beta-barrel membrane proteins. The scoring matrices constructed from the estimated rates, called bbTM for beta-barrel Transmembrane Matrices, improve significantly the sensitivity in detecting homologs of bbarrel membrane proteins, while avoiding erroneous selection of both soluble proteins and other membrane proteins of similar composition. The estimated evolutionary patterns are general and can detect beta-barrel membrane proteins very remote from those used for substitution rate estimation. Furthermore, despite the separation of 2-3 billion years since the proto-mitochondrion entered the proto-eukaryotic cell, mitochondria outer membrane proteins in eukaryotes can also be detected accurately using these scoring matrices derived from bacteria. This is consistent with the suggestion that there is no eukaryote-specific signals for translocation. With these matrices, remote homologs of beta-barrel membrane proteins with known structures can be reliably detected at genome scale, allowing construction of high quality structural models of their transmembrane domains, at the rate of 131 structures per template protein. The scoring matrices will be useful for identification, classification, and functional inference of membrane proteins from genome and metagenome sequencing projects. The estimated substitution pattern will also help to identify key elements important for the structural and functional integrity of beta-barrel membrane proteins, and will aid in the design of mutagenesis studies.	[Jimenez-Morales, David; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jimenez-Morales, D (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	jliang@uic.edu	Jimenez-Morales, David/D-9037-2014; Jimenez-Morales, David/AAE-9289-2019	Jimenez-Morales, David/0000-0003-4356-6461; Jimenez-Morales, David/0000-0003-4356-6461	NIH [GM079804, GM081682, GM086145]; NSF [DMS-0800257]; ONR [N00014-09-1-0028]; Andalusian Ministry of Innovation, Science and Enterprise, Junta de Andalucia, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079804, R01GM081682, P50GM086145] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); Andalusian Ministry of Innovation, Science and Enterprise, Junta de Andalucia, Spain(Junta de Andalucia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM079804, GM081682, GM086145, NSF grant DMS-0800257, ONR grant N00014-09-1-0028. DJM is very thankful for the support of Becas Talentia Excellence Grant (Andalusian Ministry of Innovation, Science and Enterprise, Junta de Andalucia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Adiga SP, 2009, WIRES NANOMED NANOBI, V1, P568, DOI 10.1002/wnan.50; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagos PG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-7; Barker WC, 1998, NUCLEIC ACIDS RES, V26, P27, DOI 10.1093/nar/26.1.27; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Bigelow Henry, 2009, V528, P3, DOI 10.1007/978-1-60327-310-7_1; Bigelow HR, 2004, NUCLEIC ACIDS RES, V32, P2566, DOI 10.1093/nar/gkh580; Bishop CR, 2001, J MOL BIOL, V309, P975, DOI 10.1006/jmbi.2001.4715; Bishop RE, 2008, BBA-BIOMEMBRANES, V1778, P1881, DOI 10.1016/j.bbamem.2007.07.021; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delcour AH, 1997, FEMS MICROBIOL LETT, V151, P115, DOI 10.1016/S0378-1097(97)00166-3; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FISCHER K, 1994, J BIOL CHEM, V269, P25754; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Jackups R, 2005, J MOL BIOL, V354, P979, DOI 10.1016/j.jmb.2005.09.094; Jackups R, 2006, J MOL BIOL, V363, P611, DOI 10.1016/j.jmb.2006.07.095; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Larbig M, 2001, VACCINE, V19, P2291, DOI 10.1016/S0264-410X(00)00550-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lio P, 1998, GENOME RES, V8, P1233, DOI 10.1101/gr.8.12.1233; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Muller T, 2001, Bioinformatics, V17 Suppl 1, pS182; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; OVERINGTON J, 1990, P ROY SOC B-BIOL SCI, V241, P132, DOI 10.1098/rspb.1990.0077; OVERINGTON J, 1992, PROTEIN SCI, V1, P216; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; Simamura E, 2008, J BIOENERG BIOMEMBR, V40, P213, DOI 10.1007/s10863-008-9158-6; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Touw DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015016; Tseng YY, 2006, MOL BIOL EVOL, V23, P421, DOI 10.1093/molbev/msj048; Tsirigos KD, 2011, NUCLEIC ACIDS RES, V39, pD324, DOI 10.1093/nar/gkq863; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Yu YK, 2003, P NATL ACAD SCI USA, V100, P15688, DOI 10.1073/pnas.2533904100; Zeth K, 2010, BIOCH BIOPHYSICA ACT; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101	61	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26400	10.1371/journal.pone.0026400	http://dx.doi.org/10.1371/journal.pone.0026400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069449	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900010
J	Bialecki, E; Fernandez, EM; Ivanov, S; Paget, C; Fontaine, J; Rodriguez, F; Lebeau, L; Ehret, C; Frisch, B; Trottein, F; Faveeuw, C				Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Lebeau, Luc; Ehret, Christophe; Frisch, Benoit; Trottein, Francois; Faveeuw, Christelle			Spleen-Resident CD4(+) and CD4(-) CD8 alpha(-) Dendritic Cell Subsets Differ in Their Ability to Prime Invariant Natural Killer T Lymphocytes	PLOS ONE			English	Article							ACTIVATED NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; INNATE IMMUNITY; MARGINAL ZONE; IFN-GAMMA; EXPRESSION; ANTIGENS; IL-12; MICE	One important function of conventional dendritic cells (cDC) is their high capacity to capture, process and present Ag to T lymphocytes. Mouse splenic cDC subtypes, including CD8 alpha(+) and CD8 alpha(-) cDC, are not identical in their Ag presenting and T cell priming functions. Surprisingly, few studies have reported functional differences between CD4(-) and CD4(+) CD8 alpha(-) cDC subsets. We show that, when loaded in vitro with OVA peptide or whole protein, and in steady-state conditions, splenic CD4(-) and CD4(+) cDC are equivalent in their capacity to prime and direct CD4(+) and CD8(+) T cell differentiation. In contrast, in response to alpha-galactosylceramide (alpha-GalCer), CD4(-) and CD4(+) cDC differentially activate invariant Natural Killer T (iNKT) cells, a population of lipid-reactive non-conventional T lymphocytes. Both cDC subsets equally take up alpha-GalCer in vitro and in vivo to stimulate the iNKT hybridoma DN32.D3, the activation of which depends solely on TCR triggering. On the other hand, and relative to their CD4(+) counterparts, CD4(-) cDC more efficiently stimulate primary iNKT cells, a phenomenon likely due to differential production of co-factors (including IL-12) by cDC. Our data reveal a novel functional difference between splenic CD4(+) and CD4(-) cDC subsets that may be important in immune responses.	[Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Trottein, Francois; Faveeuw, Christelle] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Trottein, Francois; Faveeuw, Christelle] Univ Lille Nord France, Lille, France; [Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Trottein, Francois; Faveeuw, Christelle] Ctr Natl Rech Sci CNRS, UMR 8204, Lille, France; [Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Trottein, Francois; Faveeuw, Christelle] Inst Natl Sante & Rech Med Inserm, U1019, Lille, France; [Bialecki, Emilie; Fernandez, Elodie Macho; Ivanov, Stoyan; Paget, Christophe; Fontaine, Josette; Rodriguez, Fabien; Trottein, Francois; Faveeuw, Christelle] Inst Federatif Rech 142, Lille, France; [Lebeau, Luc; Ehret, Christophe; Frisch, Benoit] Univ Strasbourg, Lab Concept & Applicat Mol Bioact, Fac Pharm, CNRS,UMR 7199, Illkirch Graffenstaden, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bialecki, E (corresponding author), Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France.	christelle.faveeuw@pasteur-lille.fr	Lebeau, Luc/M-9964-2019; Faveeuw, Christelle/N-6303-2017; TROTTEIN, Francois/C-2405-2018; Paget, Christophe/P-5165-2014	Faveeuw, Christelle/0000-0002-8373-3992; TROTTEIN, Francois/0000-0003-3373-1814; Paget, Christophe/0000-0002-5374-5407; Ivanov, Stoyan/0000-0002-0527-2297; Lebeau, Luc/0000-0002-3276-6727	Institut National de la Sante et de la Recherche Medicale (Inserm); CNRS; University of Lille Nord de France; Pasteur Institute of Lille; Institut National du Cancer (INCa) [R08046EE/RPT08003EEA]	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille Nord de France; Pasteur Institute of Lille; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the CNRS, the University of Lille Nord de France, the Pasteur Institute of Lille, and the Institut National du Cancer (INCa, projets libres) under reference R08046EE/RPT08003EEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baev DV, 2008, J IMMUNOL, V181, P869, DOI 10.4049/jimmunol.181.2.869; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Bialecki E, 2009, J IMMUNOL, V182, P6105, DOI 10.4049/jimmunol.0802273; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Henri S, 2002, INFECT IMMUN, V70, P3874, DOI 10.1128/IAI.70.7.3874-3880.2002; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Kamijuku H, 2008, MUCOSAL IMMUNOL, V1, P208, DOI 10.1038/mi.2008.2; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Leite-De-Moraes MC, 2001, J IMMUNOL, V166, P945, DOI 10.4049/jimmunol.166.2.945; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Manickasingham SR, 2003, EUR J IMMUNOL, V33, P101, DOI 10.1002/immu.200390001; Maroof A, 2008, INFECT IMMUN, V76, P239, DOI 10.1128/IAI.00643-07; Matsumoto G, 2004, J IMMUNOL, V173, P4976, DOI 10.4049/jimmunol.173.8.4976; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; SIMKINS HM, 2010, J LEUKOC BIOL; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tatsumi T, 2007, HEPATOLOGY, V45, P22, DOI 10.1002/hep.21447; Toura I, 1999, J IMMUNOL, V163, P2387; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Uchida T, 2007, EUR J IMMUNOL, V37, P966, DOI 10.1002/eji.200636465; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978	49	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26919	10.1371/journal.pone.0026919	http://dx.doi.org/10.1371/journal.pone.0026919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066016	Green Submitted, gold, Green Published			2022-12-27	WOS:000296916000032
J	Proulx, MJ				Proulx, Michael J.			Individual Differences and Metacognitive Knowledge of Visual Search Strategy	PLOS ONE			English	Article							DRIVEN ATTENTIONAL CAPTURE; BOTTOM-UP GUIDANCE; WORKING-MEMORY; TOP-DOWN; GUIDED SEARCH; MODEL; MECHANISMS; DEPLOYMENT; EXPERTISE; BEHAVIOR	A crucial ability for an organism is to orient toward important objects and to ignore temporarily irrelevant objects. Attention provides the perceptual selectivity necessary to filter an overwhelming input of sensory information to allow for efficient object detection. Although much research has examined visual search and the 'template' of attentional set that allows for target detection, the behavior of individual subjects often reveals the limits of experimental control of attention. Few studies have examined important aspects such as individual differences and metacognitive strategies. The present study analyzes the data from two visual search experiments for a conjunctively defined target (Proulx, 2007). The data revealed attentional capture blindness, individual differences in search strategies, and a significant rate of metacognitive errors for the assessment of the strategies employed. These results highlight a challenge for visual attention studies to account for individual differences in search behavior and distractibility, and participants that do not (or are unable to) follow instructions.	Queen Mary Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Proulx, MJ (corresponding author), Queen Mary Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England.	m.proulx@qmul.ac.uk	Proulx, Michael J/A-1045-2008	Proulx, Michael/0000-0003-4066-3645				Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Bacon WF, 1997, J EXP PSYCHOL HUMAN, V23, P948, DOI 10.1037/0096-1523.23.4.948; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Bartolomeo P, 2007, CONSCIOUS COGN, V16, P144, DOI 10.1016/j.concog.2005.09.002; Bellenkes AH, 1997, AVIAT SPACE ENVIR MD, V68, P569; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Boot WR, 2009, J VISION, V9, DOI 10.1167/9.3.7; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; EGETH HE, 1984, J EXP PSYCHOL HUMAN, V10, P32, DOI 10.1037/0096-1523.10.1.32; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kawahara J, 2010, ACTA PSYCHOL, V135, P38, DOI 10.1016/j.actpsy.2010.05.002; Kramer AF, 2000, PSYCHOL SCI, V11, P210, DOI 10.1111/1467-9280.00243; Kristjansson A, 2001, PERCEPTION, V30, P1375, DOI 10.1068/p3251; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; McCarley JS, 2004, PSYCHOL SCI, V15, P302, DOI 10.1111/j.0956-7976.2004.00673.x; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; Proulx MJ, 2007, J EXP PSYCHOL HUMAN, V33, P48, DOI 10.1037/0096-1523.33.1.48; Proulx MJ, 2006, PSYCHON B REV, V13, P524, DOI 10.3758/BF03193880; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sala J, 2003, NEUROPSYCHOLOGIA, V41, P341, DOI 10.1016/S0028-3932(02)00166-5; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Sobel KV, 2007, PSYCHON B REV, V14, P840, DOI 10.3758/BF03194109; Sobel KV, 2002, J EXP PSYCHOL HUMAN, V28, P1055, DOI 10.1037//0096-1523.28.5.1055; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2008, CURR DIR PSYCHOL SCI, V17, P171, DOI 10.1111/j.1467-8721.2008.00569.x; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wang D, 2005, PERCEPT PSYCHOPHYS, V67, P239, DOI 10.3758/BF03206488; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; WOLFE JM, 1995, ACAD RADIOL, V2, P74, DOI 10.1016/S1076-6332(05)80252-1; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676	41	12	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27043	10.1371/journal.pone.0027043	http://dx.doi.org/10.1371/journal.pone.0027043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	846PP	22066030	gold, Green Published			2022-12-27	WOS:000296916000049
J	Ren, HJ; Cui, J; Wang, ZQ; Liu, RD				Ren, Hui Jun; Cui, Jing; Wang, Zhong Quan; Liu, Ruo Dan			Normal Mouse Intestinal Epithelial Cells as a Model for the in vitro Invasion of Trichinella spiralis Infective Larvae	PLOS ONE			English	Article							DISSOCIATING ENZYME THERMOLYSIN; ORGAN-CULTURE; PROTEIN; ECDYSIS	It has been known for many years that Trichinella spiralis initiates infection by penetrating the columnar epithelium of the small intestine; however, the mechanisms used by the parasite in the establishment of its intramulticellular niche in the intestine are unknown. Although the previous observations indicated that invasion also occurs in vitro when the infective larvae are inoculated onto cultures of intestinal epithelial cells (e.g., human colonic carcinoma cell line Caco-2, HCT-8), a normal readily manipulated in vitro model has not been established because of difficulties in the culture of primary intestinal epithelial cells (IECs). In this study, we described a normal intestinal epithelial model in which T. spiralis infective larvae were shown to invade the monolayers of normal mouse IECs in vitro. The IECs derived from intestinal crypts of fetal mouse small intestine had the ability to proliferate continuously and express specific cytokeratins as well as intestinal functional cell markers. Furthermore, they were susceptible to invasion by T. spiralis. When inoculated onto the IEC monolayer, infective larvae penetrated cells and migrated through them, leaving trails of damaged cells heavily loaded with T. spiralis larval excretory-secretory (ES) antigens which were recognized by rabbit immune sera on immunofluorescence test. The normal intestinal epithelial model of invasion mimicking the natural environment in vivo will help us to further investigate the process as well as the mechanisms by which T. spiralis establishes its intestinal niche.	[Ren, Hui Jun; Cui, Jing; Wang, Zhong Quan; Liu, Ruo Dan] Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou, Peoples R China	Zhengzhou University	Ren, HJ (corresponding author), Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou, Peoples R China.	cuij@zzu.edu.cn			National Basic Research Program of China [2010CB530000]; National Natural Science Foundation of China [30972492, 30972579]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 2010CB530000), and the National Natural Science Foundation of China (No. 30972492, 30972579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abud HE, 2005, EXP CELL RES, V303, P252, DOI 10.1016/j.yexcr.2004.10.006; BRUCE RG, 1970, J PARASITOL, V56, P540, DOI 10.2307/3277622; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; CARMICHAEL J, 1987, CANCER RES, V47, P936; CRUM ED, 1977, IMMUNOLOGY, V33, P787; Despommier D. D., 1983, TRICHINELLA TRICHINO; DRAKE L, 1994, P ROY SOC B-BIOL SCI, V257, P255, DOI 10.1098/rspb.1994.0123; Fernandes MIM, 1997, BRAZ J MED BIOL RES, V30, P849, DOI 10.1590/S0100-879X1997000700005; Gagliardo LF, 2002, INFECT IMMUN, V70, P1853, DOI 10.1128/IAI.70.4.1853-1859.2002; HAUFT SM, 1989, J BIOL CHEM, V264, P8419; HOTEZ P, 1994, J INFECT DIS, V170, P918, DOI 10.1093/infdis/170.4.918; KHAN ZA, 1966, J PARASITOL, V52, P248, DOI 10.2307/3276480; KOZEK WJ, 1971, J PARASITOL, V57, P1015, DOI 10.2307/3277858; Liu Z, 2010, BRAZ J MED BIOL RES, V43, P451, DOI 10.1590/S0100-879X2010007500036; ManWarren T, 1997, INFECT IMMUN, V65, P4806, DOI 10.1128/IAI.65.11.4806-4812.1997; Martinez J, 2005, PARASITOL RES, V97, P213, DOI 10.1007/s00436-005-1420-9; McVay C, 2000, INFECT IMMUN, V68, P1912, DOI 10.1128/IAI.68.4.1912-1918.2000; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Shimizu M, 2001, EXP CELL RES, V266, P311, DOI 10.1006/excr.2001.5221; Tao R, 2010, CYTOTECHNOLOGY, V62, P489, DOI 10.1007/s10616-010-9303-z; Theodoropoulos G, 2010, EXP PARASITOL, V126, P441, DOI 10.1016/j.exppara.2010.05.013; Wang SW, 2011, PARASITOL RES, V108, P593, DOI 10.1007/s00436-010-2102-9; WRIGHT KA, 1987, J PARASITOL, V73, P935, DOI 10.2307/3282514; WRIGHT KA, 1979, J PARASITOL, V65, P441, DOI 10.2307/3280292; Yamada K, 2009, BIOSCI BIOTECH BIOCH, V73, P1849, DOI 10.1271/bbb.90246	26	53	60	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27010	10.1371/journal.pone.0027010	http://dx.doi.org/10.1371/journal.pone.0027010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066026	Green Submitted, gold, Green Published			2022-12-27	WOS:000296916000045
J	Nishitani, WS; Saif, TA; Wang, YX				Nishitani, Wagner Shin; Saif, Taher A.; Wang, Yingxiao			Calcium Signaling in Live Cells on Elastic Gels under Mechanical Vibration at Subcellular Levels	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; FLUORESCENT INDICATORS; PHOSPHOLIPASE-C; SHEAR-STRESS; CA2+ ENTRY; STRETCH; CHANNEL; PROTEIN; MECHANOTRANSDUCTION; STREPTOMYCIN	A new device was designed to generate a localized mechanical vibration of flexible gels where human umbilical vein endothelial cells (HUVECs) were cultured to mechanically stimulate these cells at subcellular locations. A Fluorescence Resonance Energy Transfer (FRET)-based calcium biosensor (an improved Cameleon) was used to monitor the spatiotemporal distribution of intracellular calcium concentrations in the cells upon this mechanical stimulation. A clear increase in intracellular calcium concentrations over the whole cell body (global) can be observed in the majority of cells under mechanical stimulation. The chelation of extracellular calcium with EGTA or the blockage of stretch-activated calcium channels on the plasma membrane with streptomycin or gadolinium chloride significantly inhibited the calcium responses upon mechanical stimulation. Thapsigargin, an endoplasmic reticulum (ER) calcium pump inhibitor, or U73122, a phospholipase C (PLC) inhibitor, resulted in mainly local calcium responses occurring at regions close to the stimulation site. The disruption of actin filaments with cytochalasin D or inhibition of actomyosin contractility with ML-7 also inhibited the global calcium responses. Therefore, the global calcium response in HUVEC depends on the influx of calcium through membrane stretch-activated channels, followed by the release of inositol trisphosphate (IP3) via PLC activation to trigger the ER calcium release. Our newly developed mechanical stimulation device can also provide a powerful tool for the study of molecular mechanism by which cells perceive the mechanical cues at subcellular levels.	[Nishitani, Wagner Shin; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Nishitani, Wagner Shin; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Saif, Taher A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Inst Genom Biol, Urbana, IL 61801 USA; [Nishitani, Wagner Shin] Minist Educ Brazil, Capes Fdn, Brasilia, DF, Brazil	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Nishitani, WS (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	saif@illinois.edu; yingxiao@uiuc.edu	Nishitani, Wagner/C-9229-2012	Nishitani, Wagner/0000-0003-1643-7357	National Institutes of Health (NIH) [HL098472, CA139272, NS063405]; National Science Foundation (NSF) [CBET0846429, CMMI0800870]; Wallace H. Coulter Foundation; Beckman Laser Institute, Inc.; CAPES/Fulbright [2340/05-4]; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Wallace H. Coulter Foundation; Beckman Laser Institute, Inc.; CAPES/Fulbright(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from National Institutes of Health (NIH) HL098472, CA139272, NS063405, National Science Foundation (NSF) CBET0846429 (Y.W.), the Wallace H. Coulter Foundation and Beckman Laser Institute, Inc. (Y.W.), NSF CMMI0800870 (T.A.S.), and a fellowship from CAPES/Fulbright 2340/05-4 (W.S.N.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feneberg W, 2004, BIOPHYS J, V87, P1338, DOI 10.1529/biophysj.103.037044; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GANNIER F, 1994, CARDIOVASC RES, V28, P1193, DOI 10.1093/cvr/28.8.1193; GARCIA JGN, 1992, BLOOD, V79, P2056; Guo YJ, 2010, J BIOL CHEM, V285, P24999, DOI 10.1074/jbc.M110.132654; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; Hong D, 2006, AM J PHYSIOL-HEART C, V290, pH2498, DOI 10.1152/ajpheart.00828.2005; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; JAFFE EA, 1987, J BIOL CHEM, V262, P8557; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lamberts RR, 2002, AM J PHYSIOL-HEART C, V283, pH1515, DOI 10.1152/ajpheart.00113.2002; Lin YF, 2006, MOL ENDOCRINOL, V20, P2514, DOI 10.1210/me.2005-0347; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mergler S, 2000, J LEUKOCYTE BIOL, V68, P881; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Sawyer SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1038, DOI 10.1152/ajpcell.2001.281.3.C1038; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shen MR, 2003, FEBS LETT, V554, P494, DOI 10.1016/S0014-5793(03)01231-6; Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006; Tang X, 2010, BIOPHYS J, V99, P2460, DOI 10.1016/j.bpj.2010.08.034; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; White CR, 2005, AM J PHYSIOL-HEART C, V289, pH2350, DOI 10.1152/ajpheart.01229.2004; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zhao ZQ, 2008, J CELL PHYSIOL, V214, P595, DOI 10.1002/jcp.21248	41	29	32	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26181	10.1371/journal.pone.0026181	http://dx.doi.org/10.1371/journal.pone.0026181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053183	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800009
J	Wang, DC; Jin, Q; Xiang, H; Wang, W; Guo, N; Zhang, KY; Tang, XD; Meng, RZ; Feng, HH; Liu, LH; Wang, XH; Liang, JC; Shen, FG; Xing, MX; Deng, XM; Yu, L				Wang, Dacheng; Jin, Qi; Xiang, Hua; Wang, Wei; Guo, Na; Zhang, Kaiyu; Tang, Xudong; Meng, Rizeng; Feng, Haihua; Liu, Lihui; Wang, Xiaohong; Liang, Junchao; Shen, Fengge; Xing, Mingxun; Deng, Xuming; Yu, Lu			Transcriptional and Functional Analysis of the Effects of Magnolol: Inhibition of Autolysis and Biofilms in Staphylococcus aureus	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CELL-WALL; GENE-EXPRESSION; EXTRACELLULAR DNA; MAJOR AUTOLYSIN; MICROBIAL LIFE; RESISTANCE; IDENTIFICATION; VANCOMYCIN; TOLERANCE	Background: The targeting of Staphylococcus aureus biofilm structures are now gaining interest as an alternative strategy for developing new types of antimicrobial agents. Magnolol (MOL) shows inhibitory activity against S. aureus biofilms and Triton X-100-induced autolysis in vitro, although there are no data regarding the molecular mechanisms of MOL action in bacteria. Methodology/Principal Findings: The molecular basis of the markedly reduced autolytic phenotype and biofilm inhibition triggered by MOL were explored using transcriptomic analysis, and the transcription of important genes were verified by real-time RT-PCR. The inhibition of autolysis by MOL was evaluated using quantitative bacteriolytic assays and zymographic analysis, and antibiofilm activity assays and confocal laser scanning microscopy were used to elucidate the inhibition of biofilm formation caused by MOL in 20 clinical isolates or standard strains. The reduction in cidA, atl, sle1, and lytN transcript levels following MOL treatment was consistent with the induced expression of their autolytic repressors lrgA, lrgB, arlR, and sarA. MOL generally inhibited or reversed the expression of most of the genes involved in biofilm production. The growth of S. aureus strain ATCC 25923 in the presence of MOL dose-dependently led to decreases in Triton X-100-induced autolysis, extracellular murein hydrolase activity, and the amount of extracellular DNA (eDNA). MOL may impede biofilm formation by reducing the expression of cidA, a murein hydrolase regulator, to inhibit autolysis and eDNA release, or MOL may directly repress biofilm formation. Conclusions/Significance: MOL shows in vitro antimicrobial activity against clinical and standard S. aureus strains grown in planktonic and biofilm cultures, suggesting that the structure of MOL may potentially be used as a basis for the development of drugs targeting biofilms.	[Wang, Dacheng; Xiang, Hua; Wang, Wei; Feng, Haihua; Liu, Lihui; Liang, Junchao; Shen, Fengge; Xing, Mingxun; Deng, Xuming; Yu, Lu] Jilin Univ, Key Lab Zoonosis, Minist Educ, Inst Zoonosis,Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China; [Jin, Qi; Yu, Lu] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Guo, Na] Jilin Univ, Lab Nutr & Funct Food, Changchun 130023, Peoples R China; [Tang, Xudong] Tsinghua Univ, Res Inst, Key Lab New Drug Res TCM, Shenzhen 518057, Peoples R China; [Meng, Rizeng] Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China; [Zhang, Kaiyu] Jilin Univ, Dept Infect Dis, Hosp 1, Changchun 130023, Peoples R China; [Wang, Xiaohong] NW A&F Univ, Coll Vet Med, Yangling, Shanxi, Peoples R China	Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Jilin University; Tsinghua University; Jilin University; Jilin University; Northwest A&F University - China	Wang, DC (corresponding author), Jilin Univ, Key Lab Zoonosis, Minist Educ, Inst Zoonosis,Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China.	dengxm@jlu.edu.cn; yulu225@yahoo.com.cn			National Nature Science Foundation of China [30871889]; State Key Laboratory for Molecular Virology and Genetic Engineering [2011KF05]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [200801831051]; Fund for Science and Technology Development of the Jilin Province, China [200705233]; Fundamental Research Funds for the Central Universities	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Molecular Virology and Genetic Engineering; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fund for Science and Technology Development of the Jilin Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by grants from the National Nature Science Foundation of China (No. 30871889), the State Key Laboratory for Molecular Virology and Genetic Engineering (Grant No. 2011KF05), the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (No. 200801831051), the Fund for Science and Technology Development of the Jilin Province, China (No. 200705233), and the Fundamental Research Funds for the Central Universities. These funding organizations had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Adams D, 2005, J HOSP INFECT, V61, P287, DOI 10.1016/j.jhin.2005.05.015; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; CLARK AM, 1981, J PHARM SCI, V70, P951, DOI 10.1002/jps.2600700833; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Feng Jin, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P456; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Hendry ER, 2009, J ANTIMICROB CHEMOTH, V64, P1219, DOI 10.1093/jac/dkp362; Huang KC, 1993, PHARM CHINESE HERBS; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Kostenko V, 2007, FEMS IMMUNOL MED MIC, V51, P277, DOI 10.1111/j.1574-695X.2007.00300.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledala N, 2006, INT J ANTIMICROB AG, V27, P518, DOI 10.1016/j.ijantimicag.2006.03.008; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Ma Rui, 2010, Shanghai Kou Qiang Yi Xue, V19, P415; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Park J, 2004, EUR J PHARMACOL, V496, P189, DOI 10.1016/j.ejphar.2004.05.047; Parsek MR, 2004, J BACTERIOL, V186, P4427, DOI 10.1128/JB.186.14.4427-4440.2004; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; REINICKE B, 1983, ARCH MICROBIOL, V135, P120, DOI 10.1007/BF00408020; Renzoni A, 2006, ANTIMICROB AGENTS CH, V50, P3048, DOI 10.1128/AAC.00113-06; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Rice KC, 2004, J BACTERIOL, V186, P3029, DOI 10.1128/JB.186.10.3029-3037.2004; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; SHEA SM, 1971, J CELL BIOL, V51, P611, DOI 10.1083/jcb.51.3.611; Sieradzki K, 2006, ANTIMICROB AGENTS CH, V50, P527, DOI 10.1128/AAC.50.2.527-533.2006; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Sugai M, 1998, GENE, V224, P67, DOI 10.1016/S0378-1119(98)00508-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x; Wang DC, 2008, FEMS MICROBIOL LETT, V279, P217, DOI 10.1111/j.1574-6968.2007.01031.x; Wang IN, 2003, J BACTERIOL, V185, P779, DOI 10.1128/JB.185.3.779-787.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wootton M, 2005, J ANTIMICROB CHEMOTH, V56, P944, DOI 10.1093/jac/dki289; Yamada S, 2001, J ELECTRON MICROSC, V50, P359, DOI 10.1093/jmicro/50.4.359; Yoshida R, 2003, J ANTIMICROB CHEMOTH, V51, P247, DOI 10.1093/jac/dkg036	58	29	29	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26833	10.1371/journal.pone.0026833	http://dx.doi.org/10.1371/journal.pone.0026833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046374	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800047
J	Dey, P; Ponnusamy, MP; Deb, S; Batra, SK				Dey, Parama; Ponnusamy, Moorthy P.; Deb, Shonali; Batra, Surinder K.			Human RNA Polymerase II-Association Factor 1 (hPaf1/PD2) Regulates Histone Methylation and Chromatin Remodeling in Pancreatic Cancer	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PAF1 COMPLEX; TRANSCRIPTIONAL ELONGATION; DNA-BINDING; CHD1; PROTEIN; H3; COMPASS; DOMAIN; CHROMODOMAINS	Change in gene expression associated with pancreatic cancer could be attributed to the variation in histone posttranslational modifications leading to subsequent remodeling of the chromatin template during transcription. However, the interconnected network of molecules involved in regulating such processes remains elusive. hPaf1/PD2, a subunit of the human PAF-complex, involved in the regulation of transcriptional elongation has oncogenic potential. Our study explores the possibility that regulation of histone methylation by hPaf1 can contribute towards alteration in gene expression by nucleosomal rearrangement. Here, we show that knockdown of hPaf1/PD2 leads to decreased di- and trimethylation at histone H3 lysine 4 residues in pancreatic cancer cells. Interestingly, hPaf1/PD2 colocalizes with MLL1 (Mixed Lineage Leukemia 1), a histone methyltransferase that methylates H3K4 residues. Also, a reduction in hPaf1 level resulted in reduced MLL1 expression and a corresponding decrease in the level of CHD1 (Chromohelicase DNA-binding protein 1), an ATPase dependent chromatin remodeling enzyme that specifically binds to H3K4 di and trimethyl marks. hPaf1/PD2 was also found to interact and colocalize with CHD1 in both cytoplasmic and nuclear extracts of pancreatic cancer cells. Further, reduced level of CHD1 localization in the nucleus in hPaf1/PD2 Knockdown cells could be rescued by ectopic expression of hPaf1/PD2. Micrococcal nuclease digestion showed an altered chromatin structure in hPaf1/PD2-KD cells. Overall, our results suggest that hPaf1/PD2 in association with MLL1 regulates methylation of H3K4 residues, as well as interacts and regulates nuclear shuttling of chromatin remodeling protein CHD1, facilitating its function in pancreatic cancer cells.	[Dey, Parama; Ponnusamy, Moorthy P.; Deb, Shonali; Batra, Surinder K.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Batra, Surinder K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Dey, P (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu		Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X	National Institutes of Health [CA78590, CA111294, CA127297, CA133774, CA131944]; Department of Defense [BC073541]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA133774, R01CA078590, R01CA131944, P50CA127297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors on this work are supported by grants from the National Institutes of Health (CA78590, CA111294, CA127297, CA133774 and CA131944) and the Department of Defense (BC073541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Moniaux N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007077; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Omura N, 2009, INT J CLIN EXP PATHO, V2, P310; Ponnusamy MP, 2009, STEM CELLS, V27, P3001, DOI 10.1002/stem.237; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	37	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26926	10.1371/journal.pone.0026926	http://dx.doi.org/10.1371/journal.pone.0026926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046413	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400048
J	Hercend, C; Bauvais, C; Bollot, G; Delacotte, N; Chappuis, P; Woimant, F; Launay, JM; Manivet, P				Hercend, Claude; Bauvais, Cyril; Bollot, Guillaume; Delacotte, Nicolas; Chappuis, Philippe; Woimant, France; Launay, Jean-Marie; Manivet, Philippe			Elucidation of the ATP7B N-Domain Mg2+-ATP Coordination Site and Its Allosteric Regulation	PLOS ONE			English	Article							COPPER-TRANSPORTING ATPASE; NUCLEOTIDE-BINDING DOMAIN; WILSONS-DISEASE PROTEIN; AMBER FORCE-FIELD; P-TYPE ATPASES; CRYSTAL-STRUCTURE; SARCOPLASMIC-RETICULUM; FUNCTIONAL-PROPERTIES; MOLECULAR-DYNAMICS; SEQUENCE VARIATION	The diagnostic of orphan genetic disease is often a puzzling task as less attention is paid to the elucidation of the pathophysiology of these rare disorders at the molecular level. We present here a multidisciplinary approach using molecular modeling tools and surface plasmonic resonance to study the function of the ATP7B protein, which is impaired in the Wilson disease. Experimentally validated in silico models allow the elucidation in the Nucleotide binding domain (N-domain) of the Mg2+-ATP coordination site and answer to the controversial role of the Mg2+ ion in the nucleotide binding process. The analysis of protein motions revealed a substantial effect on a long flexible loop branched to the N-domain protein core. We demonstrated the capacity of the loop to disrupt the interaction between Mg2+-ATP complex and the N-domain and propose a role for this loop in the allosteric regulation of the nucleotide binding process.	[Hercend, Claude; Chappuis, Philippe; Launay, Jean-Marie; Manivet, Philippe] Hop Lariboisiere, APHP, Serv Biochim & Biol Mol, F-75475 Paris, France; [Hercend, Claude; Launay, Jean-Marie] Hop Lariboisiere, INSERM, Biomarqueurs & Insuffisance Cardiaque U942, F-75475 Paris, France; [Bauvais, Cyril; Bollot, Guillaume; Delacotte, Nicolas] Bioquanta, Div Struct Biol, Paris, France; [Woimant, France] Hop Lariboisiere, APHP, Serv Neurol, F-75475 Paris, France; [Manivet, Philippe] INSERM, U829, SABNP Lab, Evry, France; [Manivet, Philippe] Univ Evry Val dEssonne, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Hercend, C (corresponding author), Hop Lariboisiere, APHP, Serv Biochim & Biol Mol, F-75475 Paris, France.	philippe.manivet@lrb.aphp.fr	Manivet, Philippe/AAA-1884-2021					Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2010, J BIOL CHEM, V285, P2537, DOI 10.1074/jbc.M109.054262; Banci L, 2009, BIOCHEMISTRY-US, V48, P7849, DOI 10.1021/bi901003k; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bramkamp M, 2007, MOL MEMBR BIOL, V24, P375, DOI 10.1080/09687680701418931; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caca K, 2001, J HEPATOL, V35, P575, DOI 10.1016/S0168-8278(01)00219-7; Case D.A., 2022, AMBER 2020; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Efremov RG, 2004, BIOCHEM J, V382, P293, DOI 10.1042/BJ20040326; Frausto da Silva JJR, 1991, BIOL CHEM ELEMENTS, P250; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Horslen S, 2010, J CLIN GASTROENTEROL, V44, P387, DOI 10.1097/MCG.0b013e3181d96ac4; Hsi G, 2008, HUM MUTAT, V29, P491, DOI 10.1002/humu.20674; Hua SM, 2002, BIOCHEMISTRY-US, V41, P11405, DOI 10.1021/bi026181u; Kenney SM, 2007, HUM MUTAT, V28, P1171, DOI 10.1002/humu.20586; Kim EK, 1998, HUM MUTAT, V11, P275, DOI 10.1002/(SICI)1098-1004(1998)11:4<275::AID-HUMU4>3.3.CO;2-C; Kubala M, 2006, PROTEINS, V64, P1, DOI 10.1002/prot.20969; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Okkeri J, 2004, BIOCHEM J, V377, P95, DOI 10.1042/BJ20030740; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Patchornik G, 2000, P NATL ACAD SCI USA, V97, P11954, DOI 10.1073/pnas.220332897; Rodriguez-Granillo A, 2008, J MOL BIOL, V383, P1097, DOI 10.1016/j.jmb.2008.07.065; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Nguyen TT, 2011, J CHEM INF MODEL, V51, P2266, DOI 10.1021/ci2000743; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	54	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26245	10.1371/journal.pone.0026245	http://dx.doi.org/10.1371/journal.pone.0026245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046264	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400014
J	Savic, D; Distler, MG; Sokoloff, G; Shanahan, NA; Dulawa, SC; Palmer, AA; Nobrega, MA				Savic, Daniel; Distler, Margaret G.; Sokoloff, Greta; Shanahan, Nancy A.; Dulawa, Stephanie C.; Palmer, Abraham A.; Nobrega, Marcelo A.			Modulation of Tcf7l2 Expression Alters Behavior in Mice	PLOS ONE			English	Article							NAIVE SCHIZOPHRENIA-PATIENTS; IMPAIRED GLUCOSE-TOLERANCE; DIABETES-MELLITUS; COMORBID DEPRESSION; INSULIN-RESISTANCE; DEMENTIA-PRAECOX; PREVALENCE; DISORDERS; ANXIETY; RISK	The comorbidity of type 2 diabetes (T2D) with several psychiatric diseases is well established. While environmental factors may partially account for these co-occurrences, common genetic susceptibilities could also be implicated in the confluence of these diseases. In support of shared genetic burdens, TCF7L2, the strongest genetic determinant for T2D risk in the human population, has been recently implicated in schizophrenia (SCZ) risk, suggesting that this may be one of many loci that pleiotropically influence both diseases. To investigate whether Tcf7l2 is involved in behavioral phenotypes in addition to its roles in glucose metabolism, we conducted several behavioral tests in mice with null alleles of Tcf7l2 or overexpressing Tcf7l2. We identified a role for Tcf7l2 in anxiety-like behavior and a dose-dependent effect of Tcf7l2 alleles on fear learning. None of the mutant mice showed differences in prepulse inhibition (PPI), which is a well-established endophenotype for SCZ. These results show that Tcf7l2 alters behavior in mice. Importantly, these differences are observed prior to the onset of detectable glucose metabolism abnormalities. Whether these differences are related to human anxiety-disorders or schizophrenia remains to be determined. These animal models have the potential to elucidate the molecular basis of psychiatric comorbidities in diabetes and should therefore be studied further.	[Savic, Daniel; Sokoloff, Greta; Palmer, Abraham A.; Nobrega, Marcelo A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Distler, Margaret G.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA; [Shanahan, Nancy A.; Dulawa, Stephanie C.; Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Savic, D (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	nobrega@uchicago.edu	Palmer, Abraham/L-2158-2014; Savic, Daniel/N-5525-2018; Dulawa, Stephanie/M-8070-2016	Palmer, Abraham/0000-0003-3634-0747; Savic, Daniel/0000-0002-6693-0265; Dulawa, Stephanie/0000-0003-1281-782X; Woehrle, Nancy/0000-0002-0516-9310; Sokoloff, Greta/0000-0003-3651-1980	National Institutes of Health [DK-078871, HG004428, DA021336, GM097737, MH079103, MH079424, T32GM007197, T32GM07281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097737, T32GM007197, T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079424, R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding came from the National Institutes of Health: DK-078871, HG004428, DA021336, GM097737, MH079103, MH079424, T32GM007197, T32GM07281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; BALU DT, 2010, HIPPOCAMPUS; Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971; BRACELAND FJ, 1945, AM J PSYCHIAT, V102, P108, DOI 10.1176/ajp.102.1.108; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohn TA, 2006, CAN J PSYCHIAT, V51, P382, DOI 10.1177/070674370605100608; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Dasgupta A, 2010, PROG NEURO-PSYCHOPH, V34, P1202, DOI 10.1016/j.pnpbp.2010.06.011; Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504; Dulawa S C, 1996, Chin J Physiol, V39, P139; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Femandez-Egea E, 2008, SCHIZOPHR RES, V98, P302, DOI 10.1016/j.schres.2007.10.002; FREEMAN H, 1946, ARCH NEURO PSYCHIATR, V56, P74, DOI 10.1001/archneurpsyc.1946.02300180084007; Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Guest PC, 2010, MOL PSYCHIATR, V15, P118, DOI 10.1038/mp.2009.81; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Hemsey DR, 2005, NEUROSCI BIOBEHAV R, V29, P977, DOI 10.1016/j.neubiorev.2004.12.008; Holt RIG, 2004, DIABETIC MED, V21, P515, DOI 10.1111/j.1464-5491.2004.01199.x; Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008; Kasanin J, 1926, ARCH NEURO PSYCHIATR, V16, P414, DOI 10.1001/archneurpsyc.1926.02200280022002; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Kooy FH, 1919, BRAIN, V42, P214, DOI 10.1093/brain/42.3.214; Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022; Lorenz WF, 1922, ARCH NEURO PSYCHIATR, V8, P184, DOI 10.1001/archneurpsyc.1922.02190140075007; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; Medved V, 2009, PSYCHIAT DANUB, V21, P585; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MUKHERJEE S, 1989, LANCET, V1, P495; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Pohlack ST, 2011, MOL PSYCHIAT; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Regenold WT, 2002, J AFFECT DISORDERS, V70, P19, DOI 10.1016/S0165-0327(01)00456-6; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Savic D, 2011, GENOME RES; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Subramaniam M, 2003, CAN J PSYCHIAT, V48, P345, DOI 10.1177/070674370304800512	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26897	10.1371/journal.pone.0026897	http://dx.doi.org/10.1371/journal.pone.0026897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046400	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400043
J	Skorupski, P; Chittka, L				Skorupski, Peter; Chittka, Lars			Photoreceptor Processing Speed and Input Resistance Changes during Light Adaptation Correlate with Spectral Class in the Bumblebee, Bombus impatiens	PLOS ONE			English	Article							DROSOPHILA PHOTORECEPTORS; COLORED STIMULI; VISION; RETINA; MOTION; BEES; PHOTOTRANSDUCTION; DISCRIMINATION; EVOLUTION; HONEYBEES	Colour vision depends on comparison of signals from photoreceptors with different spectral sensitivities. However, response properties of photoreceptor cells may differ in ways other than spectral tuning. In insects, for example, broadband photoreceptors, with a major sensitivity peak in the green region of the spectrum (>500 nm), drive fast visual processes, which are largely blind to chromatic signals from more narrowly-tuned photoreceptors with peak sensitivities in the blue and UV regions of the spectrum. In addition, electrophysiological properties of the photoreceptor membrane may result in differences in response dynamics of photoreceptors of similar spectral class between species, and different spectral classes within a species. We used intracellular electrophysiological techniques to investigate response dynamics of the three spectral classes of photoreceptor underlying trichromatic colour vision in the bumblebee, Bombus impatiens, and we compare these with previously published data from a related species, Bombus terrestris. In both species, we found significantly faster responses in green, compared with blueor UV-sensitive photoreceptors, although all 3 photoreceptor types are slower in B. impatiens than in B. terrestris. Integration times for light-adapted B. impatiens photoreceptors (estimated from impulse response half-width) were 11.3 +/- 1.6 ms for green photoreceptors compared with 18.6 +/- 4.4 ms and 15.6 +/- 4.4 for blue and UV, respectively. We also measured photoreceptor input resistance in dark- and light-adapted conditions. All photoreceptors showed a decrease in input resistance during light adaptation, but this decrease was considerably larger (declining to about 22% of the dark value) in green photoreceptors, compared to blue and UV (41% and 49%, respectively). Our results suggest that the conductances associated with light adaptation are largest in green photoreceptors, contributing to their greater temporal processing speed. We suggest that the faster temporal processing of green photoreceptors is related to their role in driving fast achromatic visual processes.	[Skorupski, Peter; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Skorupski, P (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	p.skorupski@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				Anderson J, 1996, J COMP PHYSIOL A, V178, P513, DOI 10.1007/BF00190181; Anderson JC, 2000, VISION RES, V40, P13, DOI 10.1016/S0042-6989(99)00171-6; [Anonymous], 2006, INT J COMP PSYCHOL; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; COLES JA, 1989, J COMP PHYSIOL A, V165, P109, DOI 10.1007/BF00613804; DESOUZA JM, 1989, J COMP PHYSIOL A, V165, P237, DOI 10.1007/BF00619198; DODGE FA, 1968, SCIENCE, V160, P88, DOI 10.1126/science.160.3823.88; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Frederiksen R, 2008, CURR BIOL, V18, P349, DOI 10.1016/j.cub.2008.01.057; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; HOWARD J, 1984, J COMP PHYSIOL, V154, P707, DOI 10.1007/BF01350224; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; JUUSOLA M, 1993, NEUROSCI LETT, V154, P84, DOI 10.1016/0304-3940(93)90177-M; Kelber A, 2006, INVERTEBRATE VISION, P250; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; LEHRER M, 1988, NATURE, V332, P356, DOI 10.1038/332356a0; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J NEUROSCI, V29, P9987, DOI 10.1523/JNEUROSCI.1325-09.2009; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pirhofer-Walzl K, 2007, J COMP PHYSIOL A, V193, P1081, DOI 10.1007/s00359-007-0263-5; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Skorupski P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012049; Skorupski P, 2011, OPT LASER TECHNOL, V43, P251, DOI 10.1016/j.optlastec.2008.12.015; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; SRINIVASAN M, 1985, J COMP PHYSIOL A, V157, P579, DOI 10.1007/BF01351352; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; Tatler B, 2000, J COMP PHYSIOL A, V186, P399, DOI 10.1007/s003590050439; Vahasoyrinki M, 2006, J NEUROSCI, V26, P2652, DOI 10.1523/JNEUROSCI.3316-05.2006; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WECKSTROM M, 1992, P ROY SOC B-BIOL SCI, V250, P83, DOI 10.1098/rspb.1992.0134; Wertlen AM, 2008, J EXP BIOL, V211, P2101, DOI 10.1242/jeb.014571	42	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e25989	10.1371/journal.pone.0025989	http://dx.doi.org/10.1371/journal.pone.0025989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046251	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400007
J	Jimenez, RC; Salazar, GA; Gel, B; Dopazo, J; Mulder, N; Corpas, M				Jimenez, Rafael C.; Salazar, Gustavo A.; Gel, Bernat; Dopazo, Joaquin; Mulder, Nicola; Corpas, Manuel			myKaryoView: A Light-Weight Client for Visualization of Genomic Data	PLOS ONE			English	Article							COPY NUMBER; ANGELMAN; ASSOCIATION; VARIANT; GENES	The Distributed Annotation System (DAS) is a protocol for easy sharing and integration of biological annotations. In order to visualize feature annotations in a genomic context a client is required. Here we present myKaryoView, a simple light-weight DAS tool for visualization of genomic annotation. myKaryoView has been specifically configured to help analyse data derived from personal genomics, although it can also be used as a generic genome browser visualization. Several well-known data sources are provided to facilitate comparison of known genes and normal variation regions. The navigation experience is enhanced by simultaneous rendering of different levels of detail across chromosomes. A simple interface is provided to allow searches for any SNP, gene or chromosomal region. User-defined DAS data sources may also be added when querying the system. We demonstrate myKaryoView capabilities for adding user-defined sources with a set of genetic profiles of family-related individuals downloaded directly from 23andMe. myKaryoView is a web tool for visualization of genomic data specifically designed for direct-to-consumer genomic data that uses publicly available data distributed throughout the Internet. It does not require data to be held locally and it is capable of rendering any feature as long as it conforms to DAS specifications. Configuration and addition of sources to myKaryoView can be done through the interface. Here we show a proof of principle of myKaryoView's ability to display personal genomics data with 23andMe genome data sources. The tool is available at: http://mykaryoview.com.	[Jimenez, Rafael C.] Wellcome Trust Genome Campus, European Bioinformat Inst, Cambridge, England; [Salazar, Gustavo A.; Mulder, Nicola] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, IIDMM, ZA-7925 Cape Town, South Africa; [Gel, Bernat] Univ Politecn Cataluna, Barcelona, Spain; [Dopazo, Joaquin] Ctr Invest Principe Felipe, Valencia, Spain; [Dopazo, Joaquin] CIPF, Funct Genom Node INB, Valencia, Spain; [Corpas, Manuel] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Cape Town; Universitat Politecnica de Catalunya; Prince Felipe Research Center; Prince Felipe Research Center; Wellcome Trust Sanger Institute	Jimenez, RC (corresponding author), Wellcome Trust Genome Campus, European Bioinformat Inst, Cambridge, England.	mc10@sanger.ac.uk	Gel Moreno, Bernat/B-8806-2016; Dopazo, Joaquin/A-9270-2014; Corpas, Manuel/AAE-7869-2020	Gel Moreno, Bernat/0000-0001-8878-349X; Dopazo, Joaquin/0000-0003-3318-120X; Corpas, Manuel/0000-0002-4417-1018; Mulder, Nicola J/0000-0003-4905-0941; Salazar, Gustavo A/0000-0001-9208-4966; Jimenez, Rafael C/0000-0001-5404-7670	ENFIN [LSHG-CT-2005518254]; Spanish Ministry of Science and Innovation [HS2008-0010]	ENFIN(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by ENFIN (contract number LSHG-CT-2005518254) and the Spanish Ministry of Science and Innovation (Subprograma de Acciones Integradas, HS2008-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chang BL, 2009, HUM MOL GENET, V18, P1368, DOI 10.1093/hmg/ddp035; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Down TA, 2011, BIOINFORMATICS, V27, P889, DOI 10.1093/bioinformatics/btr020; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Flicek P, 2010, NUCL ACIDS RES; Forbes S, 2009, NUCL ACIDS RES; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Moreno BG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-23; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sanborn J, 2010, NUCL ACIDS RES; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	17	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26345	10.1371/journal.pone.0026345	http://dx.doi.org/10.1371/journal.pone.0026345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046276	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600015
J	Sato, S; Beakes, G; Idei, M; Nagumo, T; Mann, DG				Sato, Shinya; Beakes, Gordon; Idei, Masahiko; Nagumo, Tamotsu; Mann, David G.			Novel Sex Cells and Evidence for Sex Pheromones in Diatoms	PLOS ONE			English	Article							AUXOSPORE FORMATION; BACILLARIOPHYCEAE; ALGAE; REPRODUCTION; ULTRASTRUCTURE; SYSTEMATICS; PHAEOPHYTA	Background: Diatoms belong to the stramenopiles, one of the largest groups of eukaryotes, which are primarily characterized by a presence of an anterior flagellum with tubular mastigonemes and usually a second, smooth flagellum. Based on cell wall morphology, diatoms have historically been divided into centrics and pennates, of which only the former have flagella and only on the sperm. Molecular phylogenies show the pennates to have evolved from among the centrics. However, the timing of flagellum loss - whether before the evolution of the pennate lineage or after - is unknown, because sexual reproduction has been so little studied in the 'araphid' basal pennate lineages, to which Pseudostaurosira belongs. Methods/Principal Finding: Sexual reproduction of an araphid pennate, Pseudostaurosira trainorii, was studied with light microscopy (including time lapse observations and immunofluorescence staining observed under confocal scanning laser microscopy) and SEM. We show that the species produces motile male gametes. Motility is mostly associated with the extrusion and retrieval of microtubule-based 'threads', which are structures hitherto unknown in stramenopiles, their number varying from one to three per cell. We also report experimental evidence for sex pheromones that reciprocally stimulate sexualization of compatible clones and orientate motility of the male gametes after an initial 'random walk'. Conclusions/Significance: The threads superficially resemble flagella, in that both are produced by male gametes and contain microtubules. However, one striking difference is that threads cannot beat or undulate and have no motility of their own, and they do not bear mastigonemes. Threads are sticky and catch and draw objects, including eggs. The motility conferred by the threads is probably crucial for sexual reproduction of P. trainorii, because this diatom is non-motile in its vegetative stage but obligately outbreeding. Our pheromone experiments are the first studies in which gametogenesis has been induced in diatoms by cell-free exudates, opening new possibilities for molecular 'dissection' of sexualization.	[Sato, Shinya; Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Sato, Shinya] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Beakes, Gordon] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Idei, Masahiko] Bunkyo Univ, Dept Biol, Koshigaya, Saitama, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Dept Biol, Chiyoda Ku, Tokyo, Japan	University of Edinburgh; Newcastle University - UK; Nippon Dental University	Sato, S (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	s.sato@rbge.ac.uk	Mann, David G/I-9018-2014	Mann, David G/0000-0003-0522-6802	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS), awarded to Shinya Sato (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Boland W, 1995, ANGEW CHEM, V107, P1017; BRAWLEY SH, 1991, DEV BIOL, V144, P94, DOI 10.1016/0012-1606(91)90482-I; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Cahill DM, 1996, PROTOPLASMA, V194, P18, DOI 10.1007/BF01273164; Cavalier-Smith T., 1986, Progress phycol. Res., V4, P309; Chepurnov VA, 2004, PHYCOL RES, V52, P1; Chepurnov VA, 2002, J PHYCOL, V38, P1004, DOI 10.1046/j.1529-8817.2002.t01-1-01233.x; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; DERENBACH JB, 1986, MAR CHEM, V19, P337, DOI 10.1016/0304-4203(86)90054-X; Drebes G., 1977, BIOL DIATOMS, P250; GEITLER L, 1973, OSTERR BOT Z, V122, P299, DOI 10.1007/BF01376232; GEITLER LOTHAR, 1932, ARCH PROTISTENK, V78, P1; GELLER A, 1981, J EXP BIOL, V92, P53; Goldstein SF, 1992, CELL MOTILITY, P99; GRAHAM L. E., 2009, ALGAE; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hausmann K., 2003, PROTISTOLOGY; HIBBERD DJ, 1980, PHYTOFLAGELLATES, P273; IDEI M, 1992, BOT MAG TOKYO, V105, P649, DOI 10.1007/BF02489438; INOUYE I, 1994, HAPTOPHYTE ALGAE, P73; Jensen KG, 2003, PHYCOLOGIA, V42, P98, DOI 10.2216/i0031-8884-42-1-98.1; JUTTNER F, 1979, NATURWISSENSCHAFTEN, V66, P363, DOI 10.1007/BF00368476; KAWACHI M, 1991, PHYCOLOGIA, V30, P563, DOI 10.2216/i0031-8884-30-6-563.1; LEIPE DD, 1994, PHYCOLOGIA, V33, P369, DOI 10.2216/i0031-8884-33-5-369.1; Magne-Simon M.-F., 1962, CAH BIOL MAR, V3, P79; MAIER I, 1986, BIOL BULL, V170, P145, DOI 10.2307/1541801; MAIER I, 1992, J EXP BOT, V43, P1651, DOI 10.1093/jxb/43.12.1651; Maier I, 1995, PROGR PHYCOL RES, V11, P51; Mann D., 2007, UNRAVELLING ALGAE PR, P231; Mann DG, 2011, CELL ORIG LIFE EXTRE, V19, P145, DOI 10.1007/978-94-007-1327-7_6; MANN DG, 1989, BRIT PHYCOL J, V24, P167, DOI 10.1080/00071618900650161; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mann DG, 2004, NOVA HEDWIGIA, V79, P237, DOI 10.1127/0029-5035/2004/0079-0237; Morales EA, 2001, P ACAD NAT SCI PHILA, V151, P105, DOI 10.1635/0097-3157(2001)151[0105:MSISFD]2.0.CO;2; Morales EA, 2010, PHYCOL RES, V58, P97, DOI 10.1111/j.1440-1835.2010.00567.x; MULLINS JT, 1994, MYCOTA, V1, P413; PATTERSON DJ, 1989, SYST ASSOC SPEC VOL, V38, P357; Raper JR, 1939, AM J BOT, V26, P639, DOI 10.2307/2436804; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; ROSHCHIN A.M., 1994, ZHIZNENNYE TSIKLY DI; Round F. E., 1990, DIATOMS BIOL MORPHOL; Rozueck, 1968, BEITR BIOL PFLANZ, V44, P365; SANDGREN CD, 1981, J PHYCOL, V17, P199, DOI 10.1111/j.1529-8817.1981.tb00840.x; Sato S, 2006, DIATOM RES, V21, P473; Sekimoto H, 2000, J PLANT RES, V113, P343, DOI 10.1007/PL00013941; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; VONSTOSCH HA, 1958, BER DEUT BOT GES, V71, P241; Webster J., 2007, INTRO FUNGI, V3rd	51	38	39	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26923	10.1371/journal.pone.0026923	http://dx.doi.org/10.1371/journal.pone.0026923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046412	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600080
J	Ma, XH; Gao, F; Rusie, A; Hemingway, J; Ostmann, AB; Sroga, JM; Jegga, AG; Das, SK				Ma, Xinghong; Gao, Fei; Rusie, Allison; Hemingway, Jennifer; Ostmann, Alicia B.; Sroga, Julie M.; Jegga, Anil G.; Das, Sanjoy K.			Decidual Cell Polyploidization Necessitates Mitochondrial Activity	PLOS ONE			English	Article							PERIIMPLANTATION MOUSE UTERUS; ALBUMIN DENSITY GRADIENT; GENE-EXPRESSION; EARLY-PREGNANCY; CYCLIN D3; UTERINE DECIDUALIZATION; EMBRYO IMPLANTATION; HOXA-10 DEFICIENCY; GIANT-CELLS; DIFFERENTIATION	Cellular polyploidy has been widely reported in nature, yet its developmental mechanism and function remain poorly understood. In the present study, to better define the aspects of decidual cell polyploidy, we isolated pure polyploid and non-polyploid decidual cell populations from the in vivo decidual bed. Three independent RNA pools prepared for each population were then subjected to the Affymetrix gene chip analysis for the whole mouse genome transcripts. Our data revealed up-regulation of 1015 genes and down-regulation of 1207 genes in the polyploid populations, as compared to the non-polyploid group. Comparative RT-PCR and in situ hybridization results indeed confirmed differential expressional regulation of several genes between the two populations. Based on functional enrichment analyses, up-regulated polyploidy genes appeared to implicate several functions, which primarily include cell/nuclear division, ATP binding, metabolic process, and mitochondrial activity, whereas that of down-regulated genes primarily included apoptosis and immune processes. Further analyses of genes that are related to mitochondria and bi-nucleation showed differential and regional expression within the decidual bed, consistent with the pattern of polyploidy. Consistently, studies revealed a marked induction of mitochondrial mass and ATP production in polyploid cells. The inhibition of mitochondrial activity by various pharmacological inhibitors, as well as by gene-specific targeting using siRNA-mediated technology showed a dramatic attenuation of polyploidy and bi-nucleation development during in vitro stromal cell decidualization, suggesting mitochondria play a major role in positive regulation of decidual cell polyploidization. Collectively, analyses of unique polyploidy markers and molecular signaling networks may be useful to further characterize functional aspects of decidual cell polyploidy at the site of implantation.	[Ma, Xinghong; Gao, Fei; Rusie, Allison; Hemingway, Jennifer; Ostmann, Alicia B.; Sroga, Julie M.; Das, Sanjoy K.] Univ Cincinnati, Coll Med, Dept Pediat, Div Reprod Sci,Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Ma, Xinghong; Gao, Fei; Rusie, Allison; Hemingway, Jennifer; Ostmann, Alicia B.; Sroga, Julie M.; Das, Sanjoy K.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH USA; [Jegga, Anil G.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Ma, XH (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Reprod Sci,Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	sanjoy.das@cchmc.org	Jegga, Anil/H-6140-2011	Jegga, Anil/0000-0002-4881-7752; Hemingway, Jennifer/0000-0003-2924-8301	National Institutes of Health (NIH) [HD056044, ES007814]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007814] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in parts by National Institutes of Health (NIH) grants HD056044 and ES007814. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 2004, ANAL BIOCHEM, V332, P226, DOI 10.1016/j.ab.2004.05.035; Amaral Sandra, 2009, Curr Aging Sci, V2, P165; ANSELL JD, 1974, J EMBRYOL EXP MORPH, V31, P223; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bramsiepe J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000996; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Chan Gordon K, 2003, Prog Cell Cycle Res, V5, P431; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cross JC, 2000, SEMIN CELL DEV BIOL, V11, P105, DOI 10.1006/scdb.2000.0156; Cvetic CA, 2006, MOL CELL, V21, P143, DOI 10.1016/j.molcel.2006.01.003; Das SK, 2010, MOL REPROD DEV, V77, P387, DOI 10.1002/mrd.21133; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; DAS SK, 1994, DEVELOPMENT, V120, P1071; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; GALASSI L, 1968, DEV BIOL, V17, P75, DOI 10.1016/0012-1606(68)90090-0; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; GRAFI G, 1995, SCIENCE, V269, P1262, DOI 10.1126/science.269.5228.1262; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; LAKE SP, 1987, TRANSPLANTATION, V43, P805, DOI 10.1097/00007890-198743060-00006; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Li FX, 2008, BIOL REPROD, V78, P127, DOI 10.1095/biolreprod.107.063313; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Lu P, 2007, MAMM GENOME, V18, P617, DOI 10.1007/s00335-007-9048-y; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; McCrann DJ, 2009, CELL CYCLE, V8, P902, DOI 10.4161/cc.8.6.7900; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Miller CL, 2004, NEUROBIOL DIS, V15, P618, DOI 10.1016/j.nbd.2003.12.015; Mori M, 2011, J CLIN INVEST, V121, P318, DOI 10.1172/JCI44723; MOULTON BC, 1979, BIOL REPROD, V21, P667, DOI 10.1095/biolreprod21.3.667; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nguyen HG, 2010, ADV EXP MED BIOL, V676, P105; Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Psychoyos A, 1973, Vitam Horm, V31, P201; Rahman MA, 2006, DEV BIOL, V290, P105, DOI 10.1016/j.ydbio.2005.11.016; Rajender S, 2010, MITOCHONDRION, V10, P419, DOI 10.1016/j.mito.2010.05.015; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; SACHS L, 1955, J ENDOCRINOL, V12, P146, DOI 10.1677/joe.0.0120146; Shirakawa H, 2009, J CELL BIOCHEM, V106, P651, DOI 10.1002/jcb.22046; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Ting CM, 2010, BIOCHEM PHARMACOL, V79, P825, DOI 10.1016/j.bcp.2009.10.018; Ullah Z, 2008, GENE DEV, V22, P3024, DOI 10.1101/gad.1718108; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WARBURG O, 1956, SCIENCE, V124, P269; Yoshie M, 2006, MOL REPROD DEV, V73, P164, DOI 10.1002/mrd.20408; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605	64	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26774	10.1371/journal.pone.0026774	http://dx.doi.org/10.1371/journal.pone.0026774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046353	Green Submitted, gold, Green Published			2022-12-27	WOS:000296517000031
J	Vincent, IE; Zannetti, C; Lucifora, J; Norder, H; Protzer, U; Hainaut, P; Zoulim, F; Tommasino, M; Trepo, C; Hasan, U; Chemin, I				Vincent, Isabelle E.; Zannetti, Claudia; Lucifora, Julie; Norder, Helene; Protzer, Ulrike; Hainaut, Pierre; Zoulim, Fabien; Tommasino, Massimo; Trepo, Christian; Hasan, Uzma; Chemin, Isabelle			Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							INHIBITS TLR9-MEDIATED ACTIVATION; BLOOD MONONUCLEAR-CELLS; IMMUNE ACTIVATION; INNATE IMMUNITY; HBV INFECTION; INVOLVEMENT; INDUCTION; WORLDWIDE; PROTEIN; MOTIFS	Plasmacytoid dendritic cells (pDCs) play a key role in detecting pathogens by producing large amounts of type I interferon (IFN) by sensing the presence of viral infections through the Toll-Like Receptor (TLR) pathway. TLR9 is a sensor of viral and bacterial DNA motifs and activates the IRF7 transcription factor which leads to type I IFN secretion by pDCs. However, during chronic hepatitis B virus (HBV) infection, pDCs display an impaired ability to secrete IFN-alpha following ex vivo stimulation with TLR9 ligands. Here we highlight several strategies used by HBV to block IFN-alpha production through a specific impairment of the TLR9 signaling. Our results show that HBV particle internalisation could inhibit TLR9- but not TLR7-mediated secretion of IFN-alpha by pDCs. We observed that HBV down-regulated TLR9 transcriptional activity in pDCs and B cells in which TLR9 mRNA and protein levels were reduced. HBV can interfere with TLR9 activity by blocking the MyD88-IRAK4 axis and Sendai virus targeting IRF7 to block IFN-alpha production. Neutralising CpG motif sequences were identified within HBV DNA genome of genotypes A to H which displayed a suppressive effect on TLR9-immune activation. Moreover, TLR9 mRNA and protein were downregulated in PBMCs from patients with HBV-associated chronic hepatitis and hepatocellular carcinoma. Thus HBV has developed several escape mechanisms to avoid TLR9 activation in both pDCs and B lymphocytes, which may in turn contribute to the establishment and/or persistence of chronic infection.	[Vincent, Isabelle E.; Zoulim, Fabien; Trepo, Christian; Chemin, Isabelle] INSERM, U871, F-69008 Lyon, France; [Vincent, Isabelle E.; Zannetti, Claudia; Zoulim, Fabien; Trepo, Christian; Hasan, Uzma; Chemin, Isabelle] Univ Lyon 1, F-69365 Lyon, France; [Zannetti, Claudia; Hasan, Uzma] Fac Med Lyon Sud, U851, INSERM, Pierre Benite, France; [Zannetti, Claudia; Zoulim, Fabien; Trepo, Christian; Hasan, Uzma] Hosp Civils Lyon, Lyon, France; [Lucifora, Julie; Protzer, Ulrike] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, Munich, Germany; [Norder, Helene] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Hainaut, Pierre; Tommasino, Massimo] Int Agcy Res Canc, F-69372 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Swedish Institute for Infectious Disease Control; World Health Organization; International Agency for Research on Cancer (IARC)	Vincent, IE (corresponding author), INSERM, U871, F-69008 Lyon, France.	isabelle.vincent@inserm.fr	Protzer, Ulrike/D-5915-2015; Hainaut, Pierre/B-6018-2012; Zoulim, Fabien/ABD-5594-2021; Chemin, Isabelle/I-3032-2016; hasan, uzma A/G-3247-2013; Norder, Helene/GSD-5853-2022; LUCIFORA, Julie/L-7449-2017	Protzer, Ulrike/0000-0002-9421-1911; Hainaut, Pierre/0000-0002-1303-1610; Zoulim, Fabien/0000-0002-2245-0083; Chemin, Isabelle/0000-0002-7188-5489; LUCIFORA, Julie/0000-0003-0482-7809; Norder, Helene/0000-0002-7528-3872; Hasan, Uzma/0000-0002-1770-5539; Tommasino, Massimo/0000-0002-0890-8596	"Institut National de la Sante et de la Recherche Medicale" (INSERM); French National Agency for Research on AIDS and viral hepatitis (ANRS); DEMINAP LyonBiopole	"Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Agency for Research on AIDS and viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); DEMINAP LyonBiopole(Region Auvergne-Rhone-Alpes)	This work was funded by the "Institut National de la Sante et de la Recherche Medicale" (INSERM). I. E. V. and J.L. are supported by French National Agency for Research on AIDS and viral hepatitis (ANRS) grants. CZ is supported by INSERM and DEMINAP LyonBiopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Beckebaum S, 2002, CLIN IMMUNOL, V104, P138, DOI 10.1006/clim.2002.5245; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; FATHALLAH I, 2010, J IMMUNOL; Gherardi Arnaud, 2005, Medical Molecular Morphology, V38, P251, DOI 10.1007/s00795-005-0303-6; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Klinman DM, 2003, ANN NY ACAD SCI, V1002, P112, DOI 10.1196/annals.1281.023; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li N, 2005, APMIS, V113, P647, DOI 10.1111/j.1600-0463.2005.apm_218.x; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mrani S, 2007, J MED VIROL, V79, P1075, DOI 10.1002/jmv.20943; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Ottone S, 2007, PROTEIN EXPRES PURIF, V56, P177, DOI 10.1016/j.pep.2007.07.008; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schmitt S, 1999, J BIOL CHEM, V274, P11945, DOI 10.1074/jbc.274.17.11945; Seeds RE, 2006, IMMUNOBIOLOGY, V211, P525, DOI 10.1016/j.imbio.2006.05.024; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SHIINA M, 2007, HEPATOLOGY; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Ulsenheimer A, 2005, HEPATOLOGY, V41, P643, DOI 10.1002/hep.20592; Untergasser A, 2006, HEPATOLOGY, V43, P539, DOI 10.1002/hep.21048; van der Molen RG, 2006, HEPATOLOGY, V44, P907, DOI 10.1002/hep.21340; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Vincent IE, 2007, IMMUNOLOGY, V120, P47, DOI 10.1111/j.1365-2567.2006.02476.x; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wang K, 2007, J VIRAL HEPATITIS, V14, P276, DOI 10.1111/j.1365-2893.2006.00819.x; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xie Q, 2009, MICROBES INFECT, V11, P515, DOI 10.1016/j.micinf.2009.02.008; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zhou J, 2009, J HUAZHONG U SCI-MED, V29, P313, DOI 10.1007/s11596-009-0310-2	45	117	126	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26315	10.1371/journal.pone.0026315	http://dx.doi.org/10.1371/journal.pone.0026315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046272	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000015
J	Ferreira, JP; Leitao, I; Santos-Reis, M; Revilla, E				Ferreira, Joaquim P.; Leitao, Ines; Santos-Reis, Margarida; Revilla, Eloy			Human-Related Factors Regulate the Spatial Ecology of Domestic Cats in Sensitive Areas for Conservation	PLOS ONE			English	Article							WILDCATS FELIS-SILVESTRIS; DOGS CANIS-FAMILIARIS; FERAL CATS; HABITAT USE; HYBRIDIZATION; DIET; INTROGRESSION; POPULATIONS; CARNIVORES; THREATS	Background: Domestic cats ranging freely in natural areas are a conservation concern due to competition, predation, disease transmission or hybridization with wildcats. In order to improve our ability to design effective control policies, we investigate the factors affecting their numbers and space use in natural areas of continental Europe. Methodology/Principal Findings: We describe the patterns of cat presence, abundance and space use and analyse the associated environmental and human constraints in a well-preserved Mediterranean natural area with small scattered local farms. We failed in detecting cats in areas away from human settlements (trapping effort above 4000 trap-nights), while we captured 30 individuals near inhabited farms. We identified 130 cats, all of them in farms still in use by people (30% of 128 farms). All cats were free-ranging and very wary of people. The main factor explaining the presence of cats was the presence of people, while the number of cats per farm was mostly affected by the occasional food provisioning with human refuse and the presence of people. The home ranges of eight radio tagged cats were centred at inhabited farms. Males went furthest away from the farms during the mating season (3.8 km on average, maximum 6.3 km), using inhabited farms as stepping-stones in their mating displacements (2.2 km of maximum inter-farm distance moved). In their daily movements, cats notably avoided entering in areas with high fox density. Conclusions: The presence, abundance and space use of cats were heavily dependent on human settlements. Any strategy aiming at reducing their impact in areas of conservation concern should aim at the presence of settlements and their spatial spread and avoid any access to human refuse. The movements of domestic cats would be limited in areas with large patches of natural vegetation providing good conditions for other carnivore mammals such as red foxes.	[Ferreira, Joaquim P.; Leitao, Ines; Santos-Reis, Margarida] Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias Lisboa, Dept Biol Anim, P-1699 Lisbon, Portugal; [Ferreira, Joaquim P.; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Ferreira, Joaquim P.] Univ Aveiro Campus Univ Santiago, Ctr Environm & Marine Studies CESAM, Aveiro, Portugal; [Ferreira, Joaquim P.] Univ Aveiro Campus Univ Santiago, Dept Biol, Aveiro, Portugal	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade de Aveiro	Ferreira, JP (corresponding author), Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias Lisboa, Dept Biol Anim, P-1699 Lisbon, Portugal.	joaquimpedro.ferreira@gmail.com	Revilla, Eloy/B-5100-2008; Santos-Reis, Margarida/H-4064-2011	Revilla, Eloy/0000-0001-5534-5581; Santos-Reis, Margarida/0000-0002-0337-963X; Ferreira, Joaquim/0000-0002-0469-1529	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/10600/2004, SFRH/BPD/72193/2010]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07301]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	JPF was supported by grants SFRH/BD/10600/2004 and SFRH/BPD/72193/2010 from the Fundacao para a Ciencia e Tecnologia (FCT). ER was supported by project CGL2009-07301 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; ARTOIS M, 1994, VET REC, V134, P651, DOI 10.1136/vr.134.25.651; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Bates D, 2006, LME4 LINEAR MIXED EF; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Biro Z, 2004, MAMM BIOL, V69, P302, DOI 10.1078/1616-5047-00149; Bradshaw JWS, 1999, APPL ANIM BEHAV SCI, V65, P273, DOI 10.1016/S0168-1591(99)00086-6; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butler JRA, 2002, ANIM CONSERV, V5, P29, DOI 10.1017/S136794300200104X; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Daniels MJ, 1999, J WILDLIFE DIS, V35, P121, DOI 10.7589/0090-3558-35.1.121; Daniels MJ, 2001, J APPL ECOL, V38, P146, DOI 10.1046/j.1365-2664.2001.00580.x; Faulquier L, 2009, WATERBIRDS, V32, P330, DOI 10.1675/063.032.0213; Fuchs F, 1972, ORISCHES MUSEUM STAD, V74, P119; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Grimm D, 2009, SCIENCE, V325, P1490, DOI 10.1126/science.325_1490; Hertwig ST, 2009, J ZOOL SYST EVOL RES, V47, P283, DOI 10.1111/j.1439-0469.2009.00536.x; HUBBARD AL, 1992, BIOL CONSERV, V61, P203, DOI 10.1016/0006-3207(92)91117-B; Kerby G., 1988, P67; KIRKPATRICK RD, 1986, BIOTROPICA, V18, P72, DOI 10.2307/2388365; LIBERG O, 1984, J MAMMAL, V65, P424, DOI 10.2307/1381089; Liberg O., 2000, DOMESTIC CAT BIOL IT, P83; Martin GR, 1996, WILDLIFE RES, V23, P475, DOI 10.1071/WR9960475; Matias R, 2008, POLAR BIOL, V31, P609, DOI 10.1007/s00300-007-0396-6; Mechl D, 1983, HDB ANIMAL RADIO TRA; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; Millan J, 2009, VET J, V182, P114, DOI 10.1016/j.tvjl.2008.04.005; Ministerio do Ambiente Ordenamento e do Territorio (MAOT), 2008, DIAR REP, V87, P2017; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; Molsher RL, 1999, THESIS U SYDNEY SYDN; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; O'Brien J, 2009, BIODIVERS CONSERV, V18, P2351, DOI 10.1007/s10531-009-9592-8; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Phillips RB, 2007, J MAMMAL, V88, P173, DOI 10.1644/06-MAMM-A-015R2.1; Pierpaoli M, 2003, MOL ECOL, V12, P2585, DOI 10.1046/j.1365-294X.2003.01939.x; Pires AE, 2003, CONSERV GENET, V4, P525, DOI 10.1023/A:1024762013876; RANDI E, 1991, J MAMMAL, V72, P79, DOI 10.2307/1381981; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Risbey DA, 1999, WILDLIFE RES, V26, P621; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roland K, 2004, ANIMAL CONSERVATION, V7, P1; Say L, 2004, ANIM BEHAV, V68, P175, DOI 10.1016/j.anbehav.2003.11.008; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; VANRENSBURG PJJ, 1988, S AFR J ZOOL, V23, P301; Yamane A, 1996, J ETHOL, V14, P35, DOI 10.1007/BF02350090	54	48	50	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25970	10.1371/journal.pone.0025970	http://dx.doi.org/10.1371/journal.pone.0025970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043298	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400026
J	Reynier, F; Petit, F; Paye, M; Turrel-Davin, F; Imbert, PE; Hot, A; Mougin, B; Miossec, P				Reynier, Frederic; Petit, Fabien; Paye, Malick; Turrel-Davin, Fanny; Imbert, Pierre-Emmanuel; Hot, Arnaud; Mougin, Bruno; Miossec, Pierre			Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD CELLS; TRANSCRIPTIONAL ACTIVITY; REVISED CRITERIA; MESSENGER-RNA; MICROARRAY; ALPHA; DERMATOMYOSITIS; CLASSIFICATION; NORMALIZATION	Background: The analysis of gene expression data shows that many genes display similarity in their expression profiles suggesting some co-regulation. Here, we investigated the co-expression patterns in gene expression data and proposed a correlation-based research method to stratify individuals. Methodology/Principal Findings: Using blood from rheumatoid arthritis (RA) patients, we investigated the gene expression profiles from whole blood using Affymetrix microarray technology. Co-expressed genes were analyzed by a biclustering method, followed by gene ontology analysis of the relevant biclusters. Taking the type I interferon (IFN) pathway as an example, a classification algorithm was developed from the 102 RA patients and extended to 10 systemic lupus erythematosus (SLE) patients and 100 healthy volunteers to further characterize individuals. We developed a correlation-based algorithm referred to as Classification Algorithm Based on a Biological Signature (CABS), an alternative to other approaches focused specifically on the expression levels. This algorithm applied to the expression of 35 IFN-related genes showed that the IFN signature presented a heterogeneous expression between RA, SLE and healthy controls which could reflect the level of global IFN signature activation. Moreover, the monitoring of the IFN-related genes during the anti-TNF treatment identified changes in type I IFN gene activity induced in RA patients. Conclusions: In conclusion, we have proposed an original method to analyze genes sharing an expression pattern and a biological function showing that the activation levels of a biological signature could be characterized by its overall state of correlation.	[Reynier, Frederic; Petit, Fabien; Paye, Malick; Turrel-Davin, Fanny; Imbert, Pierre-Emmanuel; Hot, Arnaud; Mougin, Bruno; Miossec, Pierre] Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France; [Miossec, Pierre] Univ Lyon, Hop Edouard Herriot, Dept Clin Immunol & Rheumatol, Lyon, France; [Miossec, Pierre] Univ Lyon, Hop Edouard Herriot, Immunogenom & Inflammat Res Unit EA 4130, Lyon, France	bioMerieux; CHU Lyon; CHU Lyon; CHU Lyon	Reynier, F (corresponding author), Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France.	pierre.miossec@univ-lyon1.fr			bioMerieux; Hospices Civils de Lyon	bioMerieux; Hospices Civils de Lyon	There are no current external funding sources for this study. This work was supported by both bioMerieux and Hospices Civils de Lyon, with a 50/50 shared contribution. This support goes to a mixed research unit of which Professor Miossec is the director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Chou JW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-427; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerr MK, 2003, BIOMETRICS, V59, P822; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Malarstig A, 2008, ARTERIOSCL THROM VAS, V28, P975, DOI 10.1161/ATVBAHA.108.163733; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pisetsky DS, 2000, ARTHRITIS RHEUM, V43, P2381, DOI 10.1002/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Rainen L, 2002, CLIN CHEM, V48, P1883; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van der Pouw Kraan TCTM, 2003, GENES IMMUN, V4, P187, DOI 10.1038/sj.gene.6363975; Wheelan SJ, 2008, MOL BIOSYST, V4, P726, DOI 10.1039/b706237k	37	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24828	10.1371/journal.pone.0024828	http://dx.doi.org/10.1371/journal.pone.0024828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043277	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400004
J	Prakash, A; Yogeeshwari, S; Sircar, S; Agrawal, S				Prakash, Ananth; Yogeeshwari, S.; Sircar, Sanchari; Agrawal, Shipra			Protein Domain of Unknown Function 3233 is a Translocation Domain of Autotransporter Secretory Mechanism in Gamma proteobacteria	PLOS ONE			English	Article							WEB-BASED PROGRAM; OUTER-MEMBRANE; TRIMERIC AUTOTRANSPORTERS; 2-PARTNER SECRETION; VIBRIO-CHOLERAE; SIGNAL PEPTIDES; I-TASSER; PREDICTION; SEQUENCE; DATABASE	Vibrio cholerae, the enteropathogenic gram negative bacteria is one of the main causative agents of waterborne diseases like cholera. About 1/3(rd) of the organism's genome is uncharacterised with many protein coding genes lacking structure and functional information. These proteins form significant fraction of the genome and are crucial in understanding the organism's complete functional makeup. In this study we report the general structure and function of a family of hypothetical proteins, Domain of Unknown Function 3233 (DUF3233), which are conserved across gram negative gammaproteobacteria (especially in Vibrio sp. and similar bacteria). Profile and HMM based sequence search methods were used to screen homologues of DUF3233. The I-TASSER fold recognition method was used to build a three dimensional structural model of the domain. The structure resembles the transmembrane beta-barrel with an axial N-terminal helix and twelve antiparallel beta-strands. Using a combination of amphipathy and discrimination analysis we analysed the potential transmembrane beta-barrel forming properties of DUF3233. Sequence, structure and phylogenetic analysis of DUF3233 indicates that this gram negative bacterial hypothetical protein resembles the beta-barrel translocation unit of autotransporter Va secretory mechanism with a gene organisation that differs from the conventional Va system.	[Prakash, Ananth; Yogeeshwari, S.; Sircar, Sanchari; Agrawal, Shipra] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India; [Agrawal, Shipra] BioCOS Life Sci Private Ltd, Bangalore, Karnataka, India		Prakash, A (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	shipra@biocosls.in		Prakash, Ananth/0000-0001-5799-9618	Department of Information Technology (DIT), Government of India, New Delhi, India; BioCOS Life Sciences Private Limited, Bangalore, India	Department of Information Technology (DIT), Government of India, New Delhi, India(Ministry of Electronics and Information Technology (MEITY), Government of India); BioCOS Life Sciences Private Limited, Bangalore, India	We thank the Department of Information Technology (DIT), Government of India, New Delhi, India for supporting stipends to AP, YS and SS. We also thank BioCOS Life Sciences Private Limited, Bangalore, India (www.biocosls.com) for financial support and technical assistance to Dr. Agrawal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrixson DR, 1997, MOL MICROBIOL, V26, P505, DOI 10.1046/j.1365-2958.1997.5921965.x; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kim DSH, 2006, J BACTERIOL, V188, P5655, DOI 10.1128/JB.01596-05; Konninger UW, 1999, MOL MICROBIOL, V32, P1212, DOI 10.1046/j.1365-2958.1999.01433.x; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Surana NK, 2006, J BIOL CHEM, V281, P18051, DOI 10.1074/jbc.M600036200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e25570	10.1371/journal.pone.0025570	http://dx.doi.org/10.1371/journal.pone.0025570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22073138	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900004
J	Taman, A; Ribeiro, P				Taman, Amira; Ribeiro, Paula			Characterization of a Truncated Metabotropic Glutamate Receptor in a Primitive Metazoan, the Parasitic Flatworm Schistosoma mansoni	PLOS ONE			English	Article							LIGAND-BINDING; NERVOUS-SYSTEM; VENUS FLYTRAP; EXPRESSION; DOMAIN; IMMUNOREACTIVITY; SUBTYPE; MUSCLE; ACTIVATION; EVOLUTION	A novel glutamate-binding protein was identified in Schistosoma mansoni. The protein (SmGBP) is related to metabotropic glutamate receptors from other species and has a predicted glutamate binding site located within a Venus Flytrap module but it lacks the heptahelical transmembrane segment that normally characterizes these receptors. The SmGBP cDNA was cloned, verified by 5' and 3' Rapid Amplification of cDNA Ends (RACE) and shown to be polyadenylated at the 3' end, suggesting the transcript is full-length. The cloned cDNA was subsequently expressed in bacteria and shown to encode a functional glutamate-binding protein. Other studies, using a specific peptide antibody, determined that SmGBP exists in two forms, a monomer of the expected size and a stable but non-covalent dimer. The monomer and dimer are both present in the membrane fraction of S. mansoni and are resistant to extraction with high-salt, alkaline pH and urea, suggesting SmGBP is either an integral membrane protein or a peripheral protein that is tightly associated with the membrane. Surface biotinylation experiments combined with western blot analyses and confocal immunolocalization revealed that SmGBP localized to the surface membranes of adult male schistosomes, especially the dorsal tubercles. In contrast, we detected little or no expression of SmGBP either in the females or larval stages. A comparative quantitative PCR analysis confirmed that the level of SmGBP expression is several-fold higher in male worms than cercariae, and it is barely detectable in adult females. Together, the results identify SmGBP as a new type of schistosome glutamate receptor that is both gender-and stage-specific. The high-level expression of this protein in the male tubercles suggests a possible role in host-parasite interaction.	[Taman, Amira; Ribeiro, Paula] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada	McGill University	Taman, A (corresponding author), McGill Univ, Inst Parasitol, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	paula.ribeiro@mcgill.ca	Taman, Amira/B-3950-2019	Taman, Amira/0000-0002-4965-449X	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/169998, RGPAS/349890]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN/169998 and RGPAS/349890) to PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley GN, 2004, GENE, V329, P27, DOI 10.1016/j.gene.2003.12.009; Beqollari D, 2010, J NEUROPHYSIOL, V104, P439, DOI 10.1152/jn.00799.2009; Bernstein A. M., 2001, Proceedings from the Institute of Nuclear Theory. Chiral Dynamics Theory and Experiment III, P18; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Brownlee DJA, 1996, PARASITOL RES, V82, P423, DOI 10.1007/s004360050139; Cao JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-67; Cebria F, 2002, MECH DEVELOP, V116, P199, DOI 10.1016/S0925-4773(02)00134-X; Dillon J, 2006, BIOCHEM SOC T, V34, P942, DOI 10.1042/BST0340942; El-Shehabi F, 2009, EXP PARASITOL, V122, P17, DOI 10.1016/j.exppara.2009.01.001; Felder CB, 1999, AAPS PHARMSCI, V1; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543; Forrester SG, 2004, MOL BIOCHEM PARASIT, V136, P149, DOI 10.1016/j.molbiopara.2004.03.007; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; GUSTAFSSON MKS, 1987, PARASITOL RES, V74, P168, DOI 10.1007/BF00536029; Halton DW, 2004, CAN J ZOOL, V82, P316, DOI [10.1139/z03-221, 10.1139/Z03-221]; Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001; Hampson David R., 2008, P363, DOI 10.1007/978-1-59745-055-3_9; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Kammermeier PJ, 2005, J PHARMACOL EXP THER, V312, P502, DOI 10.1124/jpet.104.073155; KEENAN L, 1982, J NEUROBIOL, V13, P9, DOI 10.1002/neu.480130103; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kohn AB, 2001, PARASITOLOGY, V122, P87, DOI 10.1017/S0031182000007022; Lewis F, 2001, CURR PROTOC IMMUNOL, P1911; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; Mendonca-Silva DL, 2002, BIOCHEM PHARMACOL, V64, P1337, DOI 10.1016/S0006-2952(02)01358-8; Miller CL, 1996, EXP PARASITOL, V84, P410, DOI 10.1006/expr.1996.0129; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nabhan JF, 2006, J BIOL CHEM, V281, P16099, DOI 10.1074/jbc.M512086200; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Okamoto T, 2001, CURR PROTOC CELL BIO, P541; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Pin JP, 2002, CNS NEUROL DISORD-DR, V1, P297, DOI 10.2174/1568007023339328; Ribeiro P, 2005, PARASITOLOGY, V131, pS19; Ribeiro P, 2010, CAN J ZOOL, V88, P1, DOI 10.1139/Z09-126; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Sartorius LJ, 2006, J NEUROCHEM, V96, P1139, DOI 10.1111/j.1471-4159.2005.03609.x; SOLISSOTO JM, 1994, PARASITOLOGY, V108, P301, DOI 10.1017/S0031182000076149; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Taman A, 2011, MOL BIOCHEM PARASIT, V176, P42, DOI 10.1016/j.molbiopara.2010.12.001; Taman A, 2009, MOL BIOCHEM PARASIT, V168, P24, DOI 10.1016/j.molbiopara.2009.06.003; THOMPSON CS, 1989, CAN J ZOOL, V67, P1257, DOI 10.1139/z89-179; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Waisberg M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-181; WEBB RA, 1989, PARASITOL RES, V75, P545, DOI 10.1007/BF00931163; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	57	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27119	10.1371/journal.pone.0027119	http://dx.doi.org/10.1371/journal.pone.0027119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069494	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900054
J	Burrell, JR; Yiannikas, C; Rowe, D; Kiernan, MC				Burrell, James R.; Yiannikas, Con; Rowe, Dominic; Kiernan, Matthew C.			Predicting a Positive Response to Intravenous Immunoglobulin in Isolated Lower Motor Neuron Syndromes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL-NERVE-SOCIETY; CONDUCTION BLOCK; NEUROLOGICAL-SOCIETIES; EUROPEAN-FEDERATION; NEUROPATHY; HYPEREXCITABILITY; POLYNEUROPATHY; ANTIBODIES; MANAGEMENT	Objective: To determine clinically related characteristics in patients with pure lower motor neuron (LMN) syndromes, not fulfilling accepted diagnostic criteria, who were likely to respond to intravenous immunoglobulin (IVIg) treatment. Methods: Demographic, clinical, laboratory and neurophysiological characteristics were prospectively collected from patients with undifferentiated isolated LMN syndromes who were then treated with IVIg. Patients were classified as either responders or non-responders to therapy with IVIg based on clinical data and the two groups were compared. Results: From a total cohort of 42 patients (30 males, 12 females, aged 18-83 years), 31 patients responded to IVIg and 11 did not. Compared to patients that developed progressive neurological decline, responders were typically younger (45.8 compared to 56.0 years, P<0.05) and had upper limb (83.9% compared to 63.6%, NS), unilateral (80.6% compared to 45.5%, P<0.05), and isolated distal (54.1% compared to 9.1%, P<0.05) weakness. Patients with predominantly upper limb, asymmetrical, and distal weakness were more likely to respond to IVIg therapy. Of the patients who responded to treatment, only 12.9% had detectable GM(1) antibodies and conduction block (not fulfilling diagnostic criteria) was only identified in 22.6%. Conclusions: More than 70% of patients with pure LMN syndromes from the present series responded to treatment with IVIg therapy, despite a low prevalence of detectable GM(1) antibodies and conduction block. Patients with isolated LMN presentations, not fulfilling accepted diagnostic criteria, may respond to IVIg therapy, irrespective of the presence of conduction block or GM(1) antibodies, and should be given an empirical trial of IVIg to determine treatment responsiveness.	[Burrell, James R.; Kiernan, Matthew C.] Neurosci Res Australia, Sydney, NSW, Australia; [Burrell, James R.; Kiernan, Matthew C.] Univ New S Wales, Sydney, NSW, Australia; [Burrell, James R.; Yiannikas, Con] Concord Repatriat Gen Hosp, Sydney, NSW, Australia; [Rowe, Dominic] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Concord Repatriation General Hospital; Macquarie University	Burrell, JR (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.kiernan@unsw.edu.au	Rowe, Dominic B/B-6661-2011; Kiernan, Matthew C/E-4460-2011	Rowe, Dominic B/0000-0003-0912-2146; Burrell, James/0000-0001-9638-2768; Kiernan, Matthew/0000-0001-9054-026X	National Health and Medical Research Council of Australia; Motor Neurone Disease Research Institute of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia	The authors gratefully acknowledge the support of the National Health and Medical Research Council of Australia and the Motor Neurone Disease Research Institute of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS D, 1991, J NEUROIMMUNOL, V32, P223, DOI 10.1016/0165-5728(91)90192-A; BOUCHE P, 1995, J NEUROL NEUROSUR PS, V59, P38, DOI 10.1136/jnnp.59.1.38; BURKE D, 1974, J NEUROL NEUROSUR PS, V37, P647, DOI 10.1136/jnnp.37.6.647; Burrell JR, 2011, AMYOTROPH LATERAL SC, V12, P283, DOI 10.3109/17482968.2011.551940; Cats EA, 2010, NEUROLOGY, V75, P1961, DOI 10.1212/WNL.0b013e3181ff94c2; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; DAUBE JR, 1991, MUSCLE NERVE, V14, P685; Delmont E, 2006, NEUROLOGY, V67, P592, DOI 10.1212/01.wnl.0000234063.51897.20; Deroide N, 2007, MUSCLE NERVE, V35, P632, DOI 10.1002/mus.20742; Ghosh A, 2005, J NEUROL NEUROSUR PS, V76, P1264, DOI 10.1136/jnnp.2004.047688; Hamrock DJ, 2006, INT IMMUNOPHARMACOL, V6, P535, DOI 10.1016/j.intimp.2005.11.015; Jakhere S, 2011, J POSTGRAD MED, V57, P48, DOI 10.4103/0022-3859.74289; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kiernan MC, 2002, BRAIN, V125, P664, DOI 10.1093/brain/awf041; Levy JB, 2000, QJM-MON J ASSOC PHYS, V93, P751, DOI 10.1093/qjmed/93.11.751; Lin CSY, 2011, ARCH NEUROL-CHICAGO, V68, P862, DOI 10.1001/archneurol.2011.137; Olney RK, 2003, MUSCLE NERVE, V27, P117, DOI 10.1002/mus.10317; *SAUND LTD, 2000, AIDS EX PER NERV SYS; Slee M, 2007, NEUROLOGY, V69, P1680, DOI 10.1212/01.wnl.0000277697.55288.d0; Strigl-Pill N, 2006, EUR J NEUROL, V13, P135, DOI 10.1111/j.1468-1331.2006.01142.x; Taylor BV, 2000, MUSCLE NERVE, V23, P900, DOI 10.1002/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y; Van den Berg-Vos RM, 2000, ANN NEUROL, V48, P919, DOI 10.1002/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J; Van den Berg-Vos RM, 2003, J NEUROL, V250, P1279, DOI 10.1007/s00415-003-0235-9; Van den Bergh PYK, 2010, J PERIPHER NERV SYST, V15, P1, DOI 10.1111/j.1529-8027.2010.00245.x; van Schaik IN, 2006, EUR J NEUROL, V13, P802, DOI 10.1111/j.1468-1331.2006.01466.x; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2007, CLIN NEUROPHYSIOL, V118, P124, DOI 10.1016/j.clinph.2006.09.020; Vucic S, 2010, BRAIN, V133, P2727, DOI 10.1093/brain/awq188	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27041	10.1371/journal.pone.0027041	http://dx.doi.org/10.1371/journal.pone.0027041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066029	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000048
J	Oberpichler, I; Pierik, AJ; Wesslowski, J; Pokorny, R; Rosen, R; Vugman, M; Zhang, F; Neubauer, O; Ron, EZ; Batschauer, A; Lamparter, T				Oberpichler, Inga; Pierik, Antonio J.; Wesslowski, Janine; Pokorny, Richard; Rosen, Ran; Vugman, Michal; Zhang, Fan; Neubauer, Olivia; Ron, Eliora Z.; Batschauer, Alfred; Lamparter, Tilman			A Photolyase-Like Protein from Agrobacterium tumefaciens with an Iron-Sulfur Cluster	PLOS ONE			English	Article							INTRAPROTEIN ELECTRON-TRANSFER; SPORE PHOTOPRODUCT LYASE; COLI DNA PHOTOLYASE; C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 2ND CHROMOPHORE; REPAIR; IDENTIFICATION; CRYPTOCHROMES	Photolyases and cryptochromes are evolutionarily related flavoproteins with distinct functions. While photolyases can repair UV-induced DNA lesions in a light-dependent manner, cryptochromes regulate growth, development and the circadian clock in plants and animals. Here we report about two photolyase-related proteins, named PhrA and PhrB, found in the phytopathogen Agrobacterium tumefaciens. PhrA belongs to the class III cyclobutane pyrimidine dimer (CPD) photolyases, the sister class of plant cryptochromes, while PhrB belongs to a new class represented in at least 350 bacterial organisms. Both proteins contain flavin adenine dinucleotide (FAD) as a primary catalytic cofactor, which is photoreduceable by blue light. Spectral analysis of PhrA confirmed the presence of 5,10-methenyltetrahydrofolate (MTHF) as antenna cofactor. PhrB comprises also an additional chromophore, absorbing in the short wavelength region but its spectrum is distinct from known antenna cofactors in other photolyases. Homology modeling suggests that PhrB contains an Fe-S cluster as cofactor which was confirmed by elemental analysis and EPR spectroscopy. According to protein sequence alignments the classical tryptophan photoreduction pathway is present in PhrA but absent in PhrB. Although PhrB is clearly distinguished from other photolyases including PhrA it is, like PhrA, required for in vivo photoreactivation. Moreover, PhrA can repair UV-induced DNA lesions in vitro. Thus, A. tumefaciens contains two photolyase homologs of which PhrB represents the first member of the cryptochrome/photolyase family (CPF) that contains an iron-sulfur cluster.	[Oberpichler, Inga; Wesslowski, Janine; Zhang, Fan; Lamparter, Tilman] KIT, Karlsruhe, Germany; [Pierik, Antonio J.] Univ Marburg, Inst Cytobiol & Pathol, Core facil Prot Spect, Marburg, Germany; [Rosen, Ran] Agentek 1987 Ltd Atidim Sci Pk, Tel Aviv, Israel; [Vugman, Michal; Ron, Eliora Z.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Neubauer, Olivia] Humboldt Univ, Inst Microbiol, Berlin, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Philipps University Marburg; Tel Aviv University; Humboldt University of Berlin	Oberpichler, I (corresponding author), KIT, Karlsruhe, Germany.	inga.oberpichler@kit.edu	Pierik, Antonio J/G-1108-2010; Lamparter, Tilman/E-4421-2013	Pierik, Antonio J/0000-0002-1509-6370; Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [La 799/7-1, BA 985/10-3]; Karlsruhe Institute of Technology; FEMS (Federation of European Microbiological Societies)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association); FEMS (Federation of European Microbiological Societies)	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. This work was supported by the DFG (Deutsche Forschungsgemeinschaft; La 799/7-1 to TL, BA 985/10-3 to AB) and a FEMS (Federation of European Microbiological Societies) short term fellowship to IO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; BLAIS J, 1994, PHOTOCHEM PHOTOBIOL, V59, P402, DOI 10.1111/j.1751-1097.1994.tb05055.x; Boal AK, 2009, P NATL ACAD SCI USA, V106, P15237, DOI 10.1073/pnas.0908059106; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Buis JM, 2006, J BIOL CHEM, V281, P25994, DOI 10.1074/jbc.M603931200; Byrdin M, 2004, BBA-BIOENERGETICS, V1655, P64, DOI 10.1016/j.bbabio.2003.07.001; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Deakin WJ, 1999, MICROBIOL-UK, V145, P1397, DOI 10.1099/13500872-145-6-1397; DONNELLAN JE, 1965, SCIENCE, V149, P308, DOI 10.1126/science.149.3681.308; EKER APM, 1994, PHOTOCHEM PHOTOBIOL, V60, P125, DOI 10.1111/j.1751-1097.1994.tb05078.x; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Hendrischk AK, 2009, MOL MICROBIOL, V74, P990, DOI 10.1111/j.1365-2958.2009.06912.x; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kao YT, 2005, P NATL ACAD SCI USA, V102, P16128, DOI 10.1073/pnas.0506586102; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Kiontke S, 2011, EMBO J; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; MUNAKATA N, 1972, J BACTERIOL, V11, P192, DOI 10.1128/JB.111.1.192-198.1972; MUNAKATA N, 1974, MOL GEN GENET, V130, P239, DOI 10.1007/BF00268802; Oberpichler I, 2008, ENVIRON MICROBIOL, V10, P2020, DOI 10.1111/j.1462-2920.2008.01618.x; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pieck JC, 2006, J BIOL CHEM, V281, P36317, DOI 10.1074/jbc.M607053200; Pokorny R, 2005, ACTA CRYSTALLOGR F, V61, P935, DOI 10.1107/S1744309105028897; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; SANCAR A, 1984, J MOL BIOL, V172, P223, DOI 10.1016/S0022-2836(84)80040-6; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; SANCAR GB, 1987, J BIOL CHEM, V262, P15457; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todo T, 1997, NUCLEIC ACIDS RES, V25, P764, DOI 10.1093/nar/25.4.764; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; VARGHESE AJ, 1970, BIOCHEM BIOPH RES CO, V38, P484, DOI 10.1016/0006-291X(70)90739-4; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	65	43	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26775	10.1371/journal.pone.0026775	http://dx.doi.org/10.1371/journal.pone.0026775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066008	Green Published, gold			2022-12-27	WOS:000296916000024
J	Wang, J; Kou, HJ; Fu, Q; Han, Y; Qiu, ZF; Zuo, LY; Li, YL; Zhu, Z; Ye, M; Ma, Q; Li, TS				Wang, Jia; Kou, Huijuan; Fu, Qiang; Han, Yang; Qiu, Zhifeng; Zuo, Lingyan; Li, Yanling; Zhu, Zhu; Ye, Min; Ma, Qing; Li, Taisheng			Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; LIVER TOXICITY; EFAVIRENZ; DRUGS; PHARMACOKINETICS; LAMIVUDINE; EXPOSURE	Background: Limited information is available on the relationship between nevirapine plasma concentrations and virologic response or liver toxicity in Chinese patients with HIV infection. The objective of this prospective study was to test this relationship and to determine the minimal therapeutic trough concentration of nevirapine for Chinese patients. Methods: A total of 227 HIV-infected, treatment naive patients were enrolled into this study. Blood samples were taken at C-trough (12 hr postdose) and C-2 (2 hr postdose) for measurement of nevirapine concentrations 6 months after treatment initiation. Therapeutic outcomes, viral load and CD4 cell count, were assessed at 3 and 6 months after starting therapy, while the evaluation of hepatotoxicity was undertaken 12 months after nevirapine treatment. Results: A significant correlation between nevirapine trough concentrations and viral load was noticed after 6 months of treatment, particularly in patients with partial response and viral failure (p < 0.01). The therapeutic C-trough of nevirapine for Chinese patients was determined to be 3.9 mu g/ml using the receiver operating characteristic curve. Virologic failure was observed in 21% (6/29) of patients with low nevirapine concentrations (< 3.9 mu g/ml) versus 5% (4/87) in patients with concentrations higher than 3.9 mu g/ml (p = 0.015). Hepatotoxicity was significantly associated with the median nevirapine trough concentrations among male patients (8.20 vs. 5.48 mu g/ml, p = 0.015) and hepatitis C virus co-infection (p = 0.039). Conclusions: Among Chinese patients with HIV infection, the therapeutic C-trough of nevirapine was 3.9 mg/ml, higher than the recommended 3.0 mg/ml. The correlation between nevirapine concentrations, efficacy and hepatotoxicity suggests the benefit of dosage adjustment based on therapeutic drug monitoring among Chinese HIV-infected patients to optimize nevirapine containing antiretroviral therapy.	[Wang, Jia; Kou, Huijuan; Han, Yang; Qiu, Zhifeng; Zuo, Lingyan; Li, Yanling; Li, Taisheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Wang, Jia] Beijing Jishuitan Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Fu, Qiang; Zhu, Zhu; Ye, Min] Chinese Acad Med Sci, Dept Pharm & Pharmacol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Ma, Qing] SUNY Buffalo, Dept Pharm Practice, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA; [Ma, Qing] Univ Rochester, Ctr Human Expt Therapeut, Rochester, NY USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester	Wang, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	qingma@buffalo.edu; litsh@263.net	Ma, Qing/A-8012-2008; han, yang/GRS-2388-2022; li, yan/GTI-4638-2022	Ma, Qing/0000-0003-0123-9913; 	National Key Technologies Research and Development Program [2008ZX10001-006]; Ministry of Health; Beijing Science and Technology Program Fund [D0906003040491]	National Key Technologies Research and Development Program(National Key Technology R&D Program); Ministry of Health; Beijing Science and Technology Program Fund	This study was supported in part by National Key Technologies Research and Development Program for the 11th Five-Year Plan (2008ZX10001-006), a Ministry of Health Clinical HIV/AIDS Research Grant (2007-2009) and the Beijing Science and Technology Program Fund (D0906003040491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylor MS, 2004, JAIDS-J ACQ IMM DEF, V35, P538, DOI 10.1097/00126334-200404150-00014; Dailly E, 2004, EUR J CLIN PHARMACOL, V60, P343, DOI 10.1007/s00228-004-0769-5; de Requena DG, 2005, ANTIMICROB AGENTS CH, V49, P3966, DOI 10.1128/AAC.49.9.3966-3969.2005; De Requena DG, 2005, AIDS RES HUM RETROV, V21, P555, DOI 10.1089/aid.2005.21.555; de Requena DG, 2002, AIDS, V16, P290, DOI 10.1097/00002030-200201250-00020; de Vries-Sluijs TEMS, 2003, CLIN PHARMACOKINET, V42, P599, DOI 10.2165/00003088-200342060-00009; Donnerer J, 2008, PHARMACOLOGY, V82, P287, DOI 10.1159/000164222; Duong M, 2005, ANN PHARMACOTHER, V39, P603, DOI 10.1345/aph.1E563; Guo FP, 2010, JAIDS-J ACQ IMM DEF, V54, P137, DOI 10.1097/QAI.0b013e3181cc5964; Haas DW, 2005, J INFECT DIS, V191, P1397, DOI 10.1086/429303; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Kappelhoff BS, 2005, ANTIVIR THER, V10, P145; Labarga P, 2007, J INFECT DIS, V196, P670, DOI 10.1086/520092; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Ma Qing, 2005, Expert Opin Drug Metab Toxicol, V1, P473, DOI 10.1517/17425255.1.3.473; Molto J, 2007, BRIT J CLIN PHARMACO, V63, P715, DOI 10.1111/j.1365-2125.2006.02834.x; Nunez M, 2003, AIDS RES HUM RETROV, V19, P187, DOI 10.1089/088922203763315687; Stohr W, 2008, ANTIVIR THER, V13, P675; Stone SF, 2002, J INFECT DIS, V186, P1498, DOI 10.1086/344892; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Tao-ming Huang, 2005, Zhongguo Xinyao yu Linchuang Zazhi, V24, P505; van Heeswijk RPG, 2000, AIDS, V14, pF77, DOI 10.1097/00002030-200005260-00001; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003	24	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26739	10.1371/journal.pone.0026739	http://dx.doi.org/10.1371/journal.pone.0026739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066007	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000023
J	Lee, HC; Yen, YT; Chen, WY; Wu-Hsieh, BA; Wu, SC				Lee, Hsiang-Chi; Yen, Yu-Ting; Chen, Wen-Yu; Wu-Hsieh, Betty A.; Wu, Suh-Chin			Dengue Type 4 Live-Attenuated Vaccine Viruses Passaged in Vero Cells Affect Genetic Stability and Dengue-Induced Hemorrhaging in Mice	PLOS ONE			English	Article							NONHUMAN-PRIMATES; TETRAVALENT VACCINE; NS2B-NS3 PROTEASE; ADULT VOLUNTEERS; FEVER; IMMUNOGENICITY; CANDIDATE; SAFETY; CONSTRUCTION; REPLICATION	Most live-attenuated tetravalent dengue virus vaccines in current clinical trials are produced from Vero cells. In a previous study we demonstrated that an infectious cDNA clone-derived dengue type 4 (DEN-4) virus retains higher genetic stability in MRC-5 cells than in Vero cells. For this study we investigated two DEN-4 viruses: the infectious cDNA clone-derived DEN-4 2A and its derived 39 NCR 30-nucleotide deletion mutant DEN-4 2A Delta 30, a vaccine candidate. Mutations in the C-prM-E, NS2B-NS3, and NS4B-NS5 regions of the DEN genome were sequenced and compared following cell passages in Vero and MRC-5 cells. Our results indicate stronger genetic stability in both viruses following MRC-5 cell passages, leading to significantly lower RNA polymerase error rates when the DEN-4 virus is used for genome replication. Although no significant increases in virus titers were observed following cell passages, DEN-4 2A and DEN-4 2A Delta 30 virus titers following Vero cell passages were 17-fold to 25-fold higher than titers following MRC-5 cell passages. Neurovirulence for DEN-4 2A and DEN-4 2A Delta 30 viruses increased significantly following passages in Vero cells compared to passages in MRC-5 cells. In addition, more severe DEN-induced hemorrhaging in mice was noted following DEN-4 2A and DEN-4 2A Delta 30 passages in Vero cells compared to passages in MRC-5 cells. Target mutagenesis performed on the DEN-4 2A infectious clone indicated that single point mutation of E-Q(438)H, E-V(463)L, NS2B-Q(78)H, and NS2B-A(113)T imperatively increased mouse hemorrhaging severity. The relationship between amino acid mutations acquired during Vero cell passage and enhanced DEN-induced hemorrhages in mice may be important for understanding DHF pathogenesis, as well as for the development of live-attenuated dengue vaccines. Taken together, the genetic stability, virus yield, and DEN-induced hemorrhaging all require further investigation in the context of live-attenuated DEN vaccine development.	[Lee, Hsiang-Chi; Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan; [Wu, Suh-Chin] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Yen, Yu-Ting; Chen, Wen-Yu; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan; National Taiwan University	Lee, HC (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021	WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055	National Science Council of Taiwan [98-2313-B-007-004, NRPGM 98-3112-B-002-042]; Veterans General Hospitals-University System Taiwan [VGHUST100-G6-1-1]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals-University System Taiwan	This work was supported by the National Science Council of Taiwan (98-2313-B-007-004 and NRPGM 98-3112-B-002-042) and the Veterans General Hospitals-University System Taiwan (VGHUST100-G6-1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001; Aunins JG, 2000, ENCY CELL TECHNOLOGY, V2, P1182; Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167; Chambers TJ, 2005, J GEN VIROL, V86, P1403, DOI 10.1099/vir.0.80427-0; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999; Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Droll DA, 2000, VIROLOGY, V275, P335, DOI 10.1006/viro.2000.0488; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069; Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003; Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000; Kanesa-Thasan N, 2003, AM J TROP MED HYG, V69, P17, DOI 10.4269/ajtmh.2003.69.17; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lai CJ, 1998, CLIN DIAGN VIROL, V10, P173, DOI 10.1016/S0928-0197(98)00035-X; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Liu CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001810; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27; Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264; Stinchcomb DT, 2007, 3 AS REG DENG RES NE; Sun W, 2003, AM J TROP MED HYG, V69, P24; Trent D, 2010, VACCINE         0511, DOI [10.1016/j.vaccine.2010.10.043, DOI 10.1016/J.VACCINE.2010.10.043]; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wu-Hsieh BA, 2009, ANN NY ACAD SCI, V1171, pE42, DOI 10.1111/j.1749-6632.2009.05053.x; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	48	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e25800	10.1371/journal.pone.0025800	http://dx.doi.org/10.1371/journal.pone.0025800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053180	gold, Green Submitted, Green Published			2022-12-27	WOS:000299081800006
J	Li, CX; Zhou, C; Wang, SG; Feng, Y; Lin, W; Lin, SS; Wang, Y; Huang, HQ; Liu, PQ; Mu, YG; Shen, XY				Li, Cuixian; Zhou, Chun; Wang, Shaogui; Feng, Ying; Lin, Wei; Lin, Sisi; Wang, Ying; Huang, Heqing; Liu, Peiqing; Mu, Yong-Gao; Shen, Xiaoyan			Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3 beta/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; HIGH-DOSE TAMOXIFEN; PROTEIN-KINASE-C; MALIGNANT GLIOMA; BETA-CATENIN; PHASE-II; IN-VIVO; MCL-1; DIFFERENTIATION; GLIOBLASTOMA	Malignant gliomas represent one of the most aggressive types of cancers and their recurrence is closely linked to acquired therapeutic resistance. A combination of chemotherapy is considered a promising therapeutic model in overcoming therapeutic resistance and enhancing treatment efficacy. Herein, we show by colony formation, Hochest 33342 and TUNEL staining, as well as by flow cytometric analysis, that LY294002, a specific phosphatidylinositide-3-kinase (PI3K) inhibitor, enhanced significantly the sensitization of a traditional cytotoxic chemotherapeutic agent, tamoxifen-induced apoptosis in C6 glioma cells. Activation of PI3K signaling pathway by IGF-1 protected U251 cells from apoptosis induced by combination treatment of LY294002 and tamoxifen. Interference of PI3K signaling pathway by PI3K subunit P85 siRNA enhanced the sensitization of U251 glioma cells to tamoxifen -induced apoptosis. By Western blotting, we found that combination treatment showed lower levels of phosphorylated Akt(Ser473) and GSK-3 beta(Ser9) than a single treatment of LY294002. Further, we showed a significant decrease of nuclear beta-catenin by combination treatment. In response to the inhibition of beta-catenin signaling, mRNA and protein levels of Survivin and the other three antiapoptotic genes Bcl-2, Bcl-xL, and Mcl-1 were significantly decreased by combination treatment. Our results indicated that the synergistic cytotoxic effect of LY294002 and tamoxifen is achieved by the inhibition of GSK-3 beta/beta-catenin signaling pathway.	[Li, Cuixian; Zhou, Chun; Wang, Shaogui; Lin, Wei; Lin, Sisi; Wang, Ying; Huang, Heqing; Liu, Peiqing; Shen, Xiaoyan] Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Feng, Ying] Sun Yat Sen Univ, Dept Histol & Embryol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Mu, Yong-Gao] Sun Yat Sen Univ, Dept Neurosurg Neurooncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, CX (corresponding author), Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	mouyg@mail.sysu.edu.cn; shxiaoy@mail.sysu.edu.cn	Zhou, Chun/AGK-7203-2022; Wang, Ying/T-9438-2018	Wang, Ying/0000-0002-1407-2668; Zhou, Chun/0000-0001-7395-5842	National Natural Science Foundation of China [31070924]; Projects of International Cooperation and Exchanges; Science and Technology Planning Project of Guangdong Province, China [1011420600004]; Research Fund for the Doctoral Program of Higher Education of China [20100171110052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation and Exchanges; Science and Technology Planning Project of Guangdong Province, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation of China (No. 31070924), Projects of International Cooperation and Exchanges, Science and Technology Planning Project of Guangdong Province, China (No. 1011420600004), and Research Fund for the Doctoral Program of Higher Education of China (No. 20100171110052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brandes AA, 1999, J CLIN ONCOL, V17, P645, DOI 10.1200/JCO.1999.17.2.645; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chen RH, 2001, CANCER RES, V61, P4445; Cloughesy TF, 1997, J NEURO-ONCOL, V35, P39, DOI 10.1023/A:1005895616377; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dai Y, 2007, CANCER RES, V67, P2908, DOI 10.1158/0008-5472.CAN-07-0082; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gonzalez J, 2008, EXPERT REV ANTICANC, V8, P1767, DOI 10.1586/14737140.8.11.1767; Gundimeda U, 1996, J BIOL CHEM, V271, P13504, DOI 10.1074/jbc.271.23.13504; HORGAN K, 1986, BIOCHEM PHARMACOL, V35, P4463, DOI 10.1016/0006-2952(86)90764-1; Jones A, 2009, CIRCULATION, V119, P3125, DOI 10.1161/CIRCULATIONAHA.109.852467; Kang Y, 1996, J NATL CANCER I, V88, P279, DOI 10.1093/jnci/88.5.279; Kanwar RK, 2010, CURR MED CHEM, V17, P1509, DOI 10.2174/092986710790979935; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li Y, 2010, INT J CANCER, V127, P1271, DOI 10.1002/ijc.25020; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Moodbidri MS, 2005, J NEUROCHEM, V92, P1, DOI 10.1111/j.1471-4159.2004.02855.x; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Parney IF, 2003, CANCER J, V9, P149, DOI 10.1097/00130404-200305000-00003; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Spence AM, 2004, J NEURO-ONCOL, V70, P91, DOI 10.1023/B:NEON.0000040837.68411.97; Thaker NG, 2009, EXPERT REV NEUROTHER, V9, P1815, DOI 10.1586/ERN.09.116; Warr MR, 2008, CURR MOL MED, V8, P138; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang M, 2006, J EXP CLIN CANC RES, V25, P391	41	28	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e27053	10.1371/journal.pone.0027053	http://dx.doi.org/10.1371/journal.pone.0027053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046442	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400057
J	Ma, LN; Huang, YY; Zhu, WY; Zhou, SQ; Zhou, JH; Zeng, F; Liu, XG; Zhang, YK; Yu, J				Ma, Lina; Huang, Yanyan; Zhu, Wangyu; Zhou, Shiquan; Zhou, Jihang; Zeng, Fang; Liu, Xiaoguang; Zhang, Yongkui; Yu, Jun			An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers	PLOS ONE			English	Article							DNA METHYLATION; HISTONE ACETYLATION; MICRORNA; GENES; PROFILES; MODULATION; PREDICTION; PATTERNS; MIR-96	Using DNA microarrays, we generated both mRNA and miRNA expression data from 6 non-small cell lung cancer (NSCLC) tissues and their matching normal control from adjacent tissues to identify potential miRNA markers for diagnostics. We demonstrated that hsa-miR-96 is significantly and consistently up-regulated in all 6 NSCLCs. We validated this result in an independent set of 35 paired tumors and their adjacent normal tissues, as well as their sera that are collected before surgical resection or chemotherapy, and the results suggested that hsa-miR-96 may play an important role in NSCLC development and has great potential to be used as a noninvasive marker for diagnosing NSCLC. We predicted potential miRNA target mRNAs based on different methods (TargetScan and miRanda). Further classification of miRNA regulated genes based on their relationship with miRNAs revealed that hsa-miR-96 and certain other miRNAs tend to down-regulate their target mRNAs in NSCLC development, which have expression levels permissive to direct interaction between miRNAs and their target mRNAs. In addition, we identified a significant correlation of miRNA regulation with genes coincide with high density of CpG islands, which suggests that miRNA may represent a primary regulatory mechanism governing basic cellular functions and cell differentiations, and such mechanism may be complementary to DNA methylation in repressing or activating gene expression.	[Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS		lxg2004@gmail.com; yongkuizhang53@163.com; junyu@big.ac.cn	Ma, Lina/AAD-2435-2019; 郑, 征/C-8514-2011	Ma, Lina/0000-0001-6390-6289	Natural Science Foundation of Zhejiang Province [Y2110960]; Bureau of Science and Technology of Zhoushan [20081059]; Zhoushan Hospital; National Basic Research Program (973 Program) [2011CB944100, 2011CB944101]; National Natural Science Foundation of China [90919024]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Bureau of Science and Technology of Zhoushan; Zhoushan Hospital; National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of Zhejiang Province (Y2110960) and Bureau of Science and Technology of Zhoushan awarded to Professor Yongkui Zhang (20081059), and the Research Fund of Zhoushan Hospital awarded to Dr. Lina Ma, and the National Basic Research Program (973 Program; 2011CB944100 and 2011CB944101) and National Natural Science Foundation of China (90919024) awarded to Professor Jun Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chang JW, 2008, LUNG CANCER, V60, P264, DOI 10.1016/j.lungcan.2007.09.026; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Clop Alex, 2009, Hum Mutat, V30, pv, DOI 10.1002/humu.21087; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duncan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-100, 10.1186/1471-2105-11-S4-P10]; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; FLEHINGER BJ, 1992, CHEST, V101, P1013, DOI 10.1378/chest.101.4.1013; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Huang BC, 2011, J IMMUNOTHER, V34, P289, DOI 10.1097/CJI.0b013e31820e1b0d; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Jeong HC, 2011, MOL MED REP, V4, P383, DOI 10.3892/mmr.2011.430; Jin MJ, 2009, CANCER SCI, V100, P2325, DOI 10.1111/j.1349-7006.2009.01321.x; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kondo Y, 2009, YONSEI MED J, V50, P455, DOI 10.3349/ymj.2009.50.4.455; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin H, 2011, PLOS ONE, V5; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nambu Yoshihiro, 2003, Methods Mol Med, V74, P259; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roccaro AM, 2010, BLOOD, V116, P1506, DOI 10.1182/blood-2010-01-265686; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ruvkun G, 2006, SCIENCE, V311, P36; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sharif J, 2010, DEV GROWTH DIFFER, V52, P545, DOI 10.1111/j.1440-169X.2010.01193.x; Shimada K, 1984, Rinsho Kyobu Geka, V4, P53; Tani M, 2004, GENE CHROMOSOME CANC, V40, P146, DOI 10.1002/gcc.20027; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Van Den Broeck A, 2010, CELL ADHES MIGR, V4, P107, DOI 10.4161/cam.4.1.10885; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Wang XC, 2011, LUNG CANCER, V72, P92, DOI 10.1016/j.lungcan.2010.07.014; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; *WHO, 2009, CANC; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zheng YL, 2010, INT J CANCER, V126, P2199, DOI 10.1002/ijc.24771	67	56	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26502	10.1371/journal.pone.0026502	http://dx.doi.org/10.1371/journal.pone.0026502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046296	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400022
J	Mpimbaza, A; Filler, S; Katureebe, A; Kinara, SO; Nzabandora, E; Quick, L; Ratcliffe, A; Wabwire-Mangen, F; Chandramohan, D; Staedke, SG				Mpimbaza, Arthur; Filler, Scott; Katureebe, Agaba; Kinara, Steven O.; Nzabandora, Emmanuel; Quick, Linda; Ratcliffe, Amy; Wabwire-Mangen, Fred; Chandramohan, Daniel; Staedke, Sarah G.			Validity of Verbal Autopsy Procedures for Determining Malaria Deaths in Different Epidemiological Settings in Uganda	PLOS ONE			English	Article							MORTALITY FRACTIONS; VALIDATION; CHILDREN; AFRICA; MISCLASSIFICATION; ALGORITHMS; BURDEN; AREA	Background: Verbal autopsy (VA) procedures can be used to estimate cause of death in settings with inadequate vital registries. However, the sensitivity of VA for determining malaria-specific mortality may be low, and may vary with transmission intensity. We assessed the diagnostic accuracy of VA procedures as compared to hospital medical records for determining cause of death in children under five in three different malaria transmission settings in Uganda, including Tororo (high), Kampala (medium), and Kisoro (low). Methods and Findings: Caretakers of children who died in participating hospitals were interviewed using a standardized World Health Organization questionnaire. Medical records from the child's hospitalization were also reviewed. Causes of death based on the VA questionnaires and the medical records were assigned independently by physician reviewers and then compared. A total of 719 cases were included in the final analysis, 67 in Tororo, 600 in Kampala, and 52 in Kisoro. Malaria was classified as the underlying or contributory cause of death by review of medical records in 33 deaths in Tororo, 60 in Kampala, and 0 in Kisoro. The sensitivity of VA procedures for determining malaria deaths in Tororo was 61% (95% CI 44-78%) and 50% in Kampala (95% CI 37-63%). Specificity for determining malaria deaths in Tororo and Kampala was high (>88%), but positive predictive value varied widely, from 83% in Tororo to 34% in Kampala (difference 49%, 95% CI 31-67, p < 0.001). The difference between the cause-specific mortality fraction for malaria as determined by VA procedures and medical records was -11% in Tororo, +5% in Kampala, and +14% in Kisoro. Conclusions: Our results suggest that these VA methods have an acceptable level of diagnostic accuracy for determining malaria deaths at the population level in high and medium transmission areas, but not in low transmission areas.	[Mpimbaza, Arthur; Katureebe, Agaba; Kinara, Steven O.; Nzabandora, Emmanuel] Uganda Malaria Surveillance Project Kampala, Kampala, Uganda; [Mpimbaza, Arthur; Quick, Linda; Ratcliffe, Amy] Makerere Univ, Sch Med, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Filler, Scott] Ctr Dis Control & Prevent, Atlanta, GA USA; [Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Epidemiol & Biostat, Kampala, Uganda; [Chandramohan, Daniel; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England	Makerere University; Centers for Disease Control & Prevention - USA; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Mpimbaza, A (corresponding author), Uganda Malaria Surveillance Project Kampala, Kampala, Uganda.	arthurwakg@yahoo.com			President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development	President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development(United States Agency for International Development (USAID)President's Malaria Initiative (PMI))	This research was made possible through support provided by the President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed herein are those of the author(s) and do not necessarily reflect the views of the Centers for Disease Control and Prevention or the U.S. Agency for International Development.	Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Butler D, 2010, NATURE, V467, P1015, DOI 10.1038/4671015a; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Chandramohan D, 2001, INT J EPIDEMIOL, V30, P509, DOI 10.1093/ije/30.3.509; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Hay SI, 2010, LANCET, V376, P1716, DOI 10.1016/S0140-6736(10)61084-7; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Nykanen M, 1995, E AFR MED J, V72, P731; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; Rowe AK, 2005, INT J EPIDEMIOL, V34, P712, DOI 10.1093/ije/dyi087; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; Valecha N, 2011, LANCET IN PRESS; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; WHO, 1999, WHOCDSCSRISR994; World Health Organization, 2005, WHO TECHN CONS VERB; World Health Organization Verbal autopsy standards, 2007, ASC ATTR CAUS DEATH	31	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26892	10.1371/journal.pone.0026892	http://dx.doi.org/10.1371/journal.pone.0026892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046397	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000296521400042
J	Jungtrakoon, P; Plengvidhya, N; Tangjittipokin, W; Chimnaronk, S; Salaemae, W; Chongjaroen, N; Chanprasert, K; Sujjitjoon, J; Srisawat, C; Yenchitsomanus, PT				Jungtrakoon, Prapaporn; Plengvidhya, Nattachet; Tangjittipokin, Watip; Chimnaronk, Sarin; Salaemae, Wanisa; Chongjaroen, Nalinee; Chanprasert, Kanjana; Sujjitjoon, Jatuporn; Srisawat, Chatchawan; Yenchitsomanus, Pa-thai			Novel Adiponectin Variants Identified in Type 2 Diabetic Patients Reveal Multimerization and Secretion Defects	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SUSCEPTIBILITY GENES; INSULIN-RESISTANCE; INHIBITION; TRAFFICKING; DEGRADATION; SEARCH; RISK; FORM	ADIPOQ, encoding adiponectin, is a candidate gene for type 2 diabetes (T2D) identified by genome-wide linkage analyses with supporting evidence showing the protein function in sensitizing insulin actions. In an endeavor to characterize candidate genes causing T2D in Thai patients, we identified 10 novel ADIPOQ variations, several of which were non-synonymous variations observed only in the patients. To examine the impact of these non-synonymous variations on adiponectin structure and biochemical characteristics, we conducted a structural analysis of the wild-type and variant proteins by in silico modeling and further characterized biochemical properties of the variants with predicted structural abnormalities from the modeling by molecular and biochemical studies. The recombinant plasmids containing wild-type and variant ADIPOQ cDNAs derived from the variations identified by our study (R55H, R112H, and R131H) and previous work (G90S and R112C) were constructed and transiently expressed and co-expressed in cultured HEK293T cells to investigate their oligomerization, interaction, and secretion. We found that the novel R55H variant impaired protein multimerization but it did not exert the effect over the co-expressed wild-type protein while novel R131H variant impaired protein secretion and also affected the co-expressed wild-type protein in a dominant negative fashion. The R131H variant could traffic from the endoplasmic reticulum to the Golgi, trans-Golgi network, and early endosome but could not be secreted. The R131H variant was likely to be degraded through the lysosomal system and inhibition of its degradation rescued the variant protein from secretion defect. We have shown the possibility of using in silico modeling for predicting the effect of amino acid substitution on adiponectin oligomerization. This is also the first report that demonstrates a dominant negative effect of the R131H variant on protein secretion and the possibility of using protein degradation inhibitors as therapeutic agents in the patients carrying adiponectin variants with secretion defect.	[Jungtrakoon, Prapaporn; Tangjittipokin, Watip; Salaemae, Wanisa; Chongjaroen, Nalinee; Chanprasert, Kanjana; Sujjitjoon, Jatuporn] Mahidol Univ, Dept Immunol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Plengvidhya, Nattachet] Mahidol Univ, Dept Med, Fac Med Siriraj Hosp, Div Endocrinol & Metab, Bangkok 10700, Thailand; [Chimnaronk, Sarin] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand; [Srisawat, Chatchawan] Mahidol Univ, Dept Biochem, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Yenchitsomanus, Pa-thai] Mahidol Univ, Div Med Mol Biol, Fac Med Siriraj Hosp, Dept Res & Dev, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Jungtrakoon, P (corresponding author), Mahidol Univ, Dept Immunol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand.	grpye@mahidol.ac.th	Tangjittipokin, Watip/ABE-5922-2020; Salaemae, Wanisa/AAX-1724-2020; Sujjitjoon, Jatuporn/ADE-1978-2022; Sujjitjoon, Jatuporn/AAY-6846-2021	Sujjitjoon, Jatuporn/0000-0002-5459-8031; Sujjitjoon, Jatuporn/0000-0002-5459-8031; Jungtrakoon Thamtarana, Prapaporn/0000-0002-2637-6618; Srisawat, Chatchawan/0000-0001-6593-2499	Mahidol University; Faculty of Medicine Siriraj Hospital; Thailand Research Fund (TRF) [PHD/0245/2547, TRG5280002, RTA5080009]	Mahidol University; Faculty of Medicine Siriraj Hospital; Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This work was supported by Mahidol University research grant (to NP). PJ was formerly supported by Faculty of Medicine Siriraj Hospital Graduated Scholarship and later by the Thailand Research Fund (TRF)-Royal Golden Jubilee PhD Scholarship (PHD/0245/2547). WT was supported by a New Researcher Grant (TRG5280002) from the TRF. PY is a TRF-Senior Research Scholar (RTA5080009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Blumer RME, 2008, METABOLISM, V57, P1655, DOI 10.1016/j.metabol.2008.07.020; Bush KT, 1997, J BIOL CHEM, V272, P9086; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Vanoni O, 2008, MOL BIOL CELL, V19, P4086, DOI 10.1091/mbc.E08-05-0459; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Vogt G, 2007, CURR OPIN GENET DEV, V17, P245, DOI 10.1016/j.gde.2007.04.008; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003; Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	35	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26792	10.1371/journal.pone.0026792	http://dx.doi.org/10.1371/journal.pone.0026792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046359	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600059
J	Raz, L; Zhang, QG; Han, D; Dong, Y; De Sevilla, L; Brann, DW				Raz, Limor; Zhang, Quan-guang; Han, Dong; Dong, Yan; De Sevilla, Liesl; Brann, Darrell W.			Acetylation of the Pro-Apoptotic Factor, p53 in the Hippocampus following Cerebral Ischemia and Modulation by Estrogen	PLOS ONE			English	Article							NEURONAL CELL-DEATH; BRAIN-INJURY; CORTICAL-NEURONS; OXIDATIVE STRESS; ACTIVATION; INHIBITOR; STROKE; PUMA; TRANSCRIPTION; DEACETYLASE	Background: Recent studies demonstrate that acetylation of the transcription factor, p53 on lysine(373) leads to its enhanced stabilization/activity and increased susceptibility of cells to stress. However, it is not known whether acetylation of p53 is altered in the hippocampus following global cerebral ischemia (GCI) or is regulated by the hormone, 17 beta-estradiol (17 beta-E-2), and thus, this study examined these issues. Methodology/Principal Findings: The study revealed that Acetyl p53-Lysine(373) levels were markedly increased in the hippocampal CA1 region after GCI at 3 h, 6 h and 24 h after reperfusion, an effect strongly attenuated by 17 beta-E-2. 17 beta-E-2 also enhanced interaction of p53 with the ubiquitin ligase, Mdm2, increased ubiquitination of p53, and induced its down-regulation, as well as attenuated elevation of the p53 transcriptional target, Puma. We also observed enhanced acetylation of p53 at a different lysine (Lys(382)) at 3 h after reperfusion, and 17 beta-E-2 also markedly attenuated this effect. Furthermore, administration of an inhibitor of CBP/p300 acetyltransferase, which acetylates p53, was strongly neuroprotective of the CA1 region following GCI. In long-term estrogen deprived (LTED) animals, the ability of 17 beta-E-2 to attenuate p53 acetylation was lost, and intriguingly, Acetyl p53-Lysine(373) levels were markedly elevated in sham (non-ischemic) LTED animals. Finally, intracerebroventricular injections of Gp91ds-Tat, a specific NADPH oxidase (NOX2) inhibitor, but not the scrambled tat peptide control (Sc-Tat), attenuated acetylation of p53 and reduced levels of Puma following GCI. Conclusions/Significance: The studies demonstrate that p53 undergoes enhanced acetylation in the hippocampal CA1 region following global cerebral ischemia, and that the neuroprotective agent, 17 beta-E-2, markedly attenuates the ischemia-induced p53 acetylation. Furthermore, following LTED, the suppressive effect of 17 beta-E-2 on p53 acetylation is lost, and p53 acetylation increases in the hippocampus, which may explain previous reports of increased sensitivity of the hippocampus to ischemic stress following LTED.	[Raz, Limor; Zhang, Quan-guang; Han, Dong; Dong, Yan; De Sevilla, Liesl; Brann, Darrell W.] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA	University System of Georgia; Augusta University	Raz, L (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA.	dbrann@georgiahealth.edu			National Institute of Neurological Disorders and Stroke, National Institutes of Health [NS050730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050730] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by a research grant (NS050730) to DWB from the National Institute of Neurological Disorders and Stroke, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Allende-Vega N, 2010, SEMIN CANCER BIOL, V20, P29, DOI 10.1016/j.semcancer.2009.10.004; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P469; Bacigaluppi Marco, 2010, Open Neurol J, V4, P34, DOI 10.2174/1874205X01004020034; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; BURT RL, 1976, OBSTET GYNECOL, V47, pS52; Chan HM, 2001, J CELL SCI, V114, P2363; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; George Mary G., 2009, Morbidity and Mortality Weekly Report, V58, P1; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gupta S, 2007, Indian J Physiol Pharmacol, V51, P62; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Howard VJ, 2011, ANN NEUROL, V69, P619, DOI 10.1002/ana.22385; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Niizuma K, 2009, STROKE, V40, P618, DOI 10.1161/STROKEAHA.108.524447; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Saito A, 2005, J CEREBR BLOOD F MET, V25, P267, DOI 10.1038/sj.jcbfm.9600028; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Smith Wade S, 2004, J Vasc Interv Radiol, V15, pS3; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Terui T, 2003, CANCER RES, V63, P8948; Uo T, 2007, J NEUROSCI, V27, P12198, DOI 10.1523/JNEUROSCI.3222-05.2007; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yonekura I, 2006, J CEREBR BLOOD F MET, V26, P1332, DOI 10.1038/sj.jcbfm.9600293; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang S, 2004, BRIT J CANCER, V91, P178, DOI 10.1038/sj.bjc.6601902; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	56	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e27039	10.1371/journal.pone.0027039	http://dx.doi.org/10.1371/journal.pone.0027039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046440	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600086
J	Yang, L; Li, YY; Ling, XX; Liu, L; Liu, B; Xu, K; Bin, XN; Ji, WD; Lu, JC				Yang, Lei; Li, Yinyan; Ling, Xiaoxuan; Liu, Lin; Liu, Bin; Xu, Kevin; Bin, Xiaonong; Ji, Weidong; Lu, Jiachun			A Common Genetic Variant (97906C > A) of DAB2IP/AIP1 Is Associated with an Increased Risk and Early Onset of Lung Cancer in Chinese Males	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; PROSTATE-CANCER; EXPRESSION; ASK1; INHIBITOR; ANDROGENS; MECHANISM; PATHWAYS; OBESITY	DOC-2/DAB2 interactive protein (DAB2IP) is a novel identified tumor suppressor gene that inhibits cell growth and facilitates cell apoptosis. One genetic variant in DAB2IP gene was reported to be associated with an increased risk of aggressive prostate cancer recently. Since DAB2IP involves in the development of lung cancer and low expression of DAB2IP are observed in lung cancer, we hypothesized that the variations in DAB2IP gene can increase the genetic susceptibility to lung cancer. In a case-control study of 1056 lung cancer cases and 1056 sex and age frequency-matched cancer-free controls, we investigated the association between two common polymorphisms in DAB2IP gene (-1420T>G, rs7042542; 97906C>A, rs1571801) and the risk of lung cancer. We found that compared with the 97906CC genotypes, carriers of variant genotypes (97906AC+AA) had a significant increased risk of lung cancer (adjusted odds ratio [OR]=1.33, 95% CI=1.04-1.70, P=0.023) and the number of variant (risk) allele worked in a dose-response manner (P-trend=0.0158). Further stratification analysis showed that the risk association was more pronounced in subjects aged less than 60 years old, males, non-smokers, nondrinkers, overweight groups and in those with family cancer history in first or second-degree relatives, and the 97906A interacted with overweight on lung cancer risk. We further found the number of risk alleles (97906A allele) were negatively correlated with early diagnosis age of lung cancer in male patients (P=0.003). However, no significant association was observed on the -1420T>G polymorphism. Our data suggested that the 97906A variant genotypes are associated with the increased risk and early onset of lung cancer, particularly in males.	[Yang, Lei; Li, Yinyan; Ling, Xiaoxuan; Liu, Lin; Liu, Bin; Bin, Xiaonong; Ji, Weidong; Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Xu, Kevin; Ji, Weidong] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Yale University	Yang, L (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China.	wdji2008@126.com; jcLu@gzhmc.edu.cn	ling, xiao xuan/GLU-8345-2022		National Natural Scientific Foundation of China [30872178, 81072366, 30872142]; Guangdong Provincial Scientific Research Grants [8251018201000005]; Guangdong Provincial High Level Experts Grants [2010-79]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Scientific Research Grants; Guangdong Provincial High Level Experts Grants	This study was partly supported by the National Natural Scientific Foundation of China grants 30872178, 81072366 (Dr. J. Lu) and 30872142 (Dr. W. Ji), the Guangdong Provincial Scientific Research Grants 8251018201000005 and Guangdong Provincial High Level Experts Grants 2010-79 (Dr. J. Lu). In addition, no additional external funding received for this study. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS CI, 1992, CANCER EPIDEM BIOMAR, V1, P505; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Calvisi DF, 2010, J HEPATOL; Chen H, 2003, J BIOL CHEM, V278, P3121, DOI 10.1074/jbc.M208230200; Chen Wan-qing, 2009, Zhonghua Zhong Liu Za Zhi, V31, P664; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Dote H, 2005, BRIT J CANCER, V92, P1117, DOI 10.1038/sj.bjc.6602458; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JENKINS DJA, 1987, AM J CLIN NUTR, V46, P66, DOI 10.1093/ajcn/46.1.66; Kong ZL, 2010, CANCER RES, V70, P2829, DOI 10.1158/0008-5472.CAN-09-2919; Liao XY, 2008, INT J CANCER, V123, P296, DOI 10.1002/ijc.23494; Lissowska J, 2010, CANCER CAUSE CONTROL, V21, P1091, DOI 10.1007/s10552-010-9537-2; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Nyholt DR, 2006, BIOINFORMATICS, V22, P2960, DOI 10.1093/bioinformatics/btl518; Pan SY, 2004, AM J EPIDEMIOL, V159, P259, DOI 10.1093/aje/kwh041; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; von Bergh ARM, 2004, GENE CHROMOSOME CANC, V39, P324, DOI 10.1002/gcc.20004; Wacholder S, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn380; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790	30	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26944	10.1371/journal.pone.0026944	http://dx.doi.org/10.1371/journal.pone.0026944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046421	Green Submitted, gold, Green Published			2022-12-27	WOS:000296519600082
J	Ayer, JG; Belousova, EG; Harmer, JA; Toelle, B; Celermajer, DS; Marks, GB				Ayer, Julian G.; Belousova, Elena G.; Harmer, Jason A.; Toelle, Brett; Celermajer, David S.; Marks, Guy B.			Lung Function Is Associated with Arterial Stiffness in Children	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; COTININE LEVELS; EXPOSURE; AUGMENTATION; PRESSURE; HEIGHT	Background: In older adults, an independent association exists between impaired lung function and cardiovascular disease. This interaction might be related to the effects of aging and/or smoking. In order to explore possible childhood antecedents to this association, we hypothesized that decreased lung function and vascular stiffness might be related, in early life. Objective: To determine the relationship between lung function and carotid augmentation index (AIx), a measure of vascular stiffness, in 8-year old children. Methods: Data on brachial blood pressure, lung function (FEV(1), FVC, FEV(1)/FVC, obtained by spirometry) and carotid AIx75 (AIx standardised to an arbitrary heart rate of 75 beats per minute, obtained by applanation tonometry) was available in 249 community-based 8-year old children. These healthy children had been subjects in a randomised controlled trial of two interventions (omega-3 fatty acid supplementation and house-dust mite avoidance) to prevent asthma. Smoking in pregnancy and childhood environmental tobacco smoke (ETS) exposure was prospectively collected by questionnaire. The association between lung function and carotid AIx75 was assessed in multivariate models that included sex, height, smoking status during pregnancy, ETS exposure and randomisation groups (house dust mite avoidance and dietary intervention) as covariates. Results: In the fully adjusted models, Carotid AIx75 was independently associated with FEV1 (standardised beta = -0.17, beta = 26.72, partial R(2) = .02, p = 0.03), FVC (standardised beta = -0.29, beta = -9.31, partial R(2) = 0.04, p < 0.001) and FEV1/FVC (standardised beta = .13, beta = 18.4, partial R(2) = 0.02, p = 0.04). Conclusion: Lower lung volumes are associated with increased vascular stiffness at an early age. The interaction between lung function and vascular stiffness may thus represent more than just age-related alterations in both the pulmonary and vascular systems.	[Ayer, Julian G.; Harmer, Jason A.; Celermajer, David S.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Belousova, Elena G.; Toelle, Brett; Marks, Guy B.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Celermajer, David S.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Ayer, Julian G.; Celermajer, David S.] Heart Res Inst, Sydney, NSW, Australia; [Ayer, Julian G.] Childrens Hosp Westmead, Heart Ctr Children, Sydney, NSW, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Heart Research Institute; University of Sydney	Ayer, JG (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.	juliana@chw.edu.au	Marks, Guy B./F-5058-2013; Toelle, Brett G/B-1531-2008	Marks, Guy B./0000-0002-8976-8053; Toelle, Brett G/0000-0002-7375-0019; Celermajer, David/0000-0001-7640-0439	Australian Government National Health and Medical Research Council [222722]; National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma, New South Wales; Department of Health; Children's Hospital at Westmead	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma, New South Wales(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Department of Health; Children's Hospital at Westmead	This work is supported by an Australian Government National Health and Medical Research Council Project Grant (Number 222722 to DC). Grant funding for the original randomized control trial was obtained from the National Health and Medical Research Council of Australia, Cooperative Research Centre for Asthma, New South Wales, Department of Health and Children's Hospital at Westmead. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer JG, 2010, J HYPERTENS, V28, P306, DOI 10.1097/HJH.0b013e3283332286; BOLTON CE, 2009, INT J EPIDEMIOLOGY; COULTAS DB, 1987, AM REV RESPIR DIS, V136, P305, DOI 10.1164/ajrccm/136.2.305; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Groner JA, 2005, ARCH PEDIAT ADOL MED, V159, P450, DOI 10.1001/archpedi.159.5.450; LONDON GM, 1995, HYPERTENSION, V26, P514, DOI 10.1161/01.HYP.26.3.514; Mannino DM, 2001, CHEST, V120, P718, DOI 10.1378/chest.120.3.718; Marks GB, 2006, J ALLERGY CLIN IMMUN, V118, P53, DOI 10.1016/j.jaci.2006.04.004; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; ORourke MF, 1996, J HYPERTENS, V14, pS147; PATTISHALL EN, 1985, AM J DIS CHILD, V139, P1101, DOI 10.1001/archpedi.1985.02140130039026; Seifert JA, 2002, ANN EPIDEMIOL, V12, P273, DOI 10.1016/S1047-2797(01)00264-2; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Wong GC, 2002, ARCH ENVIRON HEALTH, V57, P584, DOI 10.1080/00039890209602092; Zureik M, 2001, AM J RESP CRIT CARE, V164, P2181, DOI 10.1164/ajrccm.164.12.2107137	15	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26303	10.1371/journal.pone.0026303	http://dx.doi.org/10.1371/journal.pone.0026303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046271	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000014
J	Jia, YL; Li, P; Dziennis, S; Wang, RKK				Jia, Yali; Li, Peng; Dziennis, Suzan; Wang, Ruikang K.			Responses of Peripheral Blood Flow to Acute Hypoxia and Hyperoxia as Measured by Optical Microangiography	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VIVO; PHYSIOLOGICAL SIGNIFICANCE; COHERENCE TOMOGRAPHY; SYSTEMIC HYPOXIA; HUMAN SKIN; VELOCITY; OXYGEN; RAT; AUTOREGULATION	Oxygen availability is regarded as a critical factor to metabolically regulate systemic blood flow. There is a debate as to how peripheral blood flow (PBF) is affected and modulated during hypoxia and hyperoxia; however in vivo evaluating of functional PBF under oxygen-related physiological perturbation remains challenging. Microscopic observation, the current frequently used imaging modality for PBF characterization often involves the use of exogenous contrast agents, which would inevitably perturb the intrinsic physiologic responses of microcirculation being investigated. In this paper, optical micro-angiography (OMAG) was employed that uses intrinsic optical scattering signals backscattered from blood flows for imaging PBF in skeletal muscle challenged by the alteration of oxygen concentration. By utilizing optical reflectance signals, we demonstrated that OMAG is able to show the response of hemodynamic activities upon acute hypoxia and hyperoxia, including the modulation of macrovascular caliber, microvascular density, and flux regulation within different sized vessels within skeletal muscle in mice in vivo. Our results suggest that OMAG is a promising tool for in vivo monitoring of functional macro-or micro-vascular responses within peripheral vascular beds.	[Jia, Yali; Li, Peng; Dziennis, Suzan; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Jia, YL (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019; Li, Peng/H-7290-2017; Li, Peng/B-9865-2013	Wang, Ruikang/0000-0001-5169-8822; Li, Peng/0000-0002-9652-2369; Li, Peng/0000-0001-8646-4145; Jia, Yali/0000-0002-2784-1905	National Institute of Biomedical Imaging and Bioengineering [R01 EB009682]; National Heart, Lung, and Blood Institute [R01 HL093140]; American Heart Association [0855733G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009682] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the National Institute of Biomedical Imaging and Bioengineering (R01 EB009682), the National Heart, Lung, and Blood Institute (R01 HL093140), and the American Heart Association (0855733G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DI, 1943, ARCH INTERN MED, V71, P583, DOI 10.1001/archinte.1943.00210050003001; An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; BRITTON SL, 1985, J PHYSIOL-LONDON, V368, P409, DOI 10.1113/jphysiol.1985.sp015865; CHALMERS JP, 1966, J PHYSIOL-LONDON, V184, P698, DOI 10.1113/jphysiol.1966.sp007942; Coney AM, 2003, J PHYSIOL-LONDON, V549, P613, DOI 10.1113/jphysiol.2003.042267; DULING BR, 1972, CIRC RES, V31, P481, DOI 10.1161/01.RES.31.4.481; Freeman NE, 1936, J CLIN INVEST, V15, P651, DOI 10.1172/JCI100817; Gellhorn E, 1938, AM J PHYSIOL, V124, P735, DOI 10.1152/ajplegacy.1938.124.3.735; GRANGER DN, 1998, DIALOGUES CARDIORASC, V3, P123; Green HD, 1944, AM J PHYSIOL, V140, P0726; Hamper UM, 1997, RADIOGRAPHICS, V17, P499, DOI 10.1148/radiographics.17.2.9084086; Hudetz AG, 1997, MICROVASC RES, V54, P35, DOI 10.1006/mvre.1997.2023; Hudson S, 2002, J PHYSIOL-LONDON, V544, p28P; IVANOV KP, 1985, MICROVASC RES, V30, P10, DOI 10.1016/0026-2862(85)90033-0; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; JIA Y, 2011, J BIOMED OP IN PRESS; Jia YL, 2011, MICROVASC RES, V81, P73, DOI 10.1016/j.mvr.2010.11.003; Jia YL, 2010, J NEUROSCI METH, V194, P108, DOI 10.1016/j.jneumeth.2010.09.021; JOHNSON PC, 1978, PERIPHERAL CIRCULATI, P111; JONES RD, 1964, CIRC RES, V15, P30; JONES RD, 1964, CIRC RES, V14, P126, DOI 10.1161/01.RES.14.2.126; LINDBOM L, 1980, MICROVASC RES, V19, P197, DOI 10.1016/0026-2862(80)90040-0; Ray CJ, 2002, J PHYSIOL-LONDON, V544, P195, DOI 10.1113/jphysiol.2002.023440; SPARKS HV, 1978, PERIPHERAL CIRCULATI, P193; STAINSBY WN, 1962, AM J PHYSIOL, V202, P273, DOI 10.1152/ajplegacy.1962.202.2.273; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Wang Y, 2011, OPT LETT, V36, P2143, DOI 10.1364/OL.36.002143; Zhao YH, 2000, OPT LETT, V25, P114, DOI 10.1364/OL.25.000114	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26802	10.1371/journal.pone.0026802	http://dx.doi.org/10.1371/journal.pone.0026802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046363	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000034
J	Liu, Z; Li, SD; Wang, W; Xu, DM; Murphy, RW; Shi, P				Liu, Zhen; Li, Shude; Wang, Wei; Xu, Dongming; Murphy, Robert W.; Shi, Peng			Parallel Evolution of KCNQ4 in Echolocating Bats	PLOS ONE			English	Article							OUTER HAIR-CELLS; SEQUENCE; CONVERGENT; SELECTION; POSITION; MICE	High-frequency hearing is required for echolocating bats to locate, range and identify objects, yet little is known about its molecular basis. The discovery of a high-frequency hearing-related gene, KCNQ4, provides an opportunity to address this question. Here, we obtain the coding regions of KCNQ4 from 15 species of bats, including echolocating bats that have higher frequency hearing and non-echolocating bats that have the same ability as most other species of mammals. The strongly supported protein-tree resolves a monophyletic group containing all bats with higher frequency hearing and this arrangement conflicts with the phylogeny of bats in which these species are paraphyletic. We identify five parallel evolved sites in echolocating bats belonging to both suborders. The evolutionary trajectories of the parallel sites suggest the independent gain of higher frequency hearing ability in echolocating bats. This study highlights the usefulness of convergent or parallel evolutionary studies for finding phenotype-related genes and contributing to the resolution of evolutionary problems.	[Liu, Zhen; Wang, Wei; Xu, Dongming; Murphy, Robert W.; Shi, Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Liu, Zhen; Wang, Wei; Xu, Dongming] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Li, Shude] Kunming Med Univ, Dept Biochem, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University; Royal Ontario Museum	Liu, Z (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	ship@mail.kiz.ac.cn	Liu, Zhen/E-7627-2012; Shi, Peng/B-3372-2008	Shi, Peng/0000-0002-4075-4902; xu, dongming/0000-0003-0630-346X; Murphy, Robert/0000-0001-8555-2338	Chinese Academy of Sciences; National Natural Science Foundation of China [30930015]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a start-up fund of "Hundreds-Talent Program" from the Chinese Academy of Sciences and by grants from the Key Project from National Natural Science Foundation of China (30930015) to P.S. and by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences to R.W.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Fay R. R., 1988, HEARING VERTEBRATES; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li G, 2007, J MAMMAL, V88, P736, DOI 10.1644/06-MAMM-A-273R.1; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Maddison W., 2018, MESQUITE MODULAR SYS; Massey SE, 2008, GENE, V418, P22, DOI 10.1016/j.gene.2008.03.017; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1111/j.1096-0031.1999.tb00391.x; SWOFFORD DL, 1996, MOL SYSTEMATICS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	35	34	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26618	10.1371/journal.pone.0026618	http://dx.doi.org/10.1371/journal.pone.0026618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22046315	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200032
J	Kasper, J; Heesen, C; Kopke, S; Fulcher, G; Geiger, F				Kasper, Juergen; Heesen, Christoph; Koepke, Sascha; Fulcher, Gary; Geiger, Friedemann			Patients' and Observers' Perceptions of Involvement Differ. Validation Study on Inter-Relating Measures for Shared Decision Making	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; PRIMARY-CARE; MEDICAL ENCOUNTER; OPTION SCALE; INFORMATION; PARTICIPATION; PREFERENCES; UNCERTAINTY; CONFLICT; DOCTORS	Objective: Patient involvement into medical decisions as conceived in the shared decision making method (SDM) is essential in evidence based medicine. However, it is not conclusively evident how best to define, realize and evaluate involvement to enable patients making informed choices. We aimed at investigating the ability of four measures to indicate patient involvement. While use and reporting of these instruments might imply wide overlap regarding the addressed constructs this assumption seems questionable with respect to the diversity of the perspectives from which the assessments are administered. Methods: The study investigated a nested cohort (N = 79) of a randomized trial evaluating a patient decision aid on immunotherapy for multiple sclerosis. Convergent validities were calculated between observer ratings of videotaped physician-patient consultations (OPTION) and patients' perceptions of the communication (Shared Decision Making Questionnaire, Control Preference Scale & Decisional Conflict Scale). Results: OPTION reliability was high to excellent. Communication performance was low according to OPTION and high according to the three patient administered measures. No correlations were found between observer and patient judges, neither for means nor for single items. Patient report measures showed some moderate correlations. Conclusion: Existing SDM measures do not refer to a single construct. A gold standard is missing to decide whether any of these measures has the potential to indicate patient involvement. Practice Implications: Pronounced heterogeneity of the underpinning constructs implies difficulties regarding the interpretation of existing evidence on the efficacy of SDM. Consideration of communication theory and basic definitions of SDM would recommend an inter-subjective focus of measurement.	[Kasper, Juergen; Heesen, Christoph] Univ Med Ctr Hamburg, Inst Neuroimmunol & Clin MS Res INiMS, Hamburg, Germany; [Kasper, Juergen] Univ Hamburg, Unit Hlth Sci & Educ, MIN Fac, Hamburg, Germany; [Koepke, Sascha] Univ Hamburg, Inst Hlth Sci & Educ, MIN Fac, Hamburg, Germany; [Fulcher, Gary] MS Australia NSW, Lidcombe, Australia; [Geiger, Friedemann] Univ Med Ctr Schleswig Holstein, Tumor Ctr, Kiel, Germany; [Geiger, Friedemann] Univ Med Ctr Schleswig Holstein, Dept Pediat, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kasper, J (corresponding author), Univ Med Ctr Hamburg, Inst Neuroimmunol & Clin MS Res INiMS, Hamburg, Germany.	k@sper.info			German Ministry of Health [GMQQ01019401]; Biogen-Idec; Bayer-Health Care; Merck-Serono; Teva-Aventes	German Ministry of Health; Biogen-Idec(Biogen); Bayer-Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Merck-Serono(Merck & Company); Teva-Aventes	This work was undertaken as part of the project "Informed shared decision making in multiple sclerosis" which is funded by the German Ministry of Health (grant No GMQQ01019401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Competing Interests: CH has received financial support from Biogen-Idec, Bayer-Health Care, Merck-Serono and Teva-Aventes as an invited speaker for scientific meetings. This support was not connected to the project reported on in this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. SK, JK and FG have nothing to declare. The authors have declared that no competing interests exist.	Bekker HL, 2010, PATIENT EDUC COUNS, V78, P357, DOI 10.1016/j.pec.2010.01.002; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; CANDIB LM, 1995, MED FAMILY; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Degner L F, 1997, Can J Nurs Res, V29, P21; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Elwyn G, 2001, PATIENT EDUC COUNS, V43, P5, DOI 10.1016/S0738-3991(00)00149-X; Elwyn G, 2005, SHARED DECISION MAKI; Entwistle VA, 2004, PATIENT EDUC COUNS, V55, P105, DOI 10.1016/j.pec.2003.08.005; Entwistle VA, 2001, SOC SCI MED, V53, P721, DOI 10.1016/S0277-9536(00)00382-8; Entwistle V, 2008, SOC SCI MED, V66, P362, DOI 10.1016/j.socscimed.2007.09.001; Entwistle VA, 2006, PATIENT EDUC COUNS, V63, P268, DOI 10.1016/j.pec.2006.05.002; Epstein RM, 2006, PATIENT EDUC COUNS, V60, P272, DOI 10.1016/j.pec.2005.11.003; Ford S, 2006, HEALTH EXPECT, V9, P130, DOI 10.1111/j.1369-7625.2006.00382.x; Freedman MS, 2008, EUR NEUROL, V60, P1, DOI 10.1159/000127972; FREIDIN RB, 1980, ANN INTERN MED, V93, P490, DOI 10.7326/0003-4819-93-3-490; *GEN MED COUNC UK, 1998, PROT PAT GUID DOCT S; Giersdorf N, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P969; Goossensen A, 2007, PATIENT EDUC COUNS, V67, P50, DOI 10.1016/j.pec.2007.01.017; Goss C, 2007, EPIDEMIOL PSICHIAT S, V16, P339, DOI 10.1017/S1121189X00002529; Hamann J, 2007, HEALTH EXPECT, V10, P358, DOI 10.1111/j.1369-7625.2007.00458.x; HAYES BR, 2002, BMJ-BRIT MED J, V324, P1350; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2003, ACTA NEUROL SCAND, V107, P363, DOI 10.1034/j.1600-0404.2003.00086.x; JOHNSON CG, 1988, J GEN INTERN MED, V3, P144, DOI 10.1007/BF02596120; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x; Kasper J, 2011, HLTH EXPECT, DOI 10.111/j.1369-7625.2011.00657.x; Kasper J, 2006, PATIENT EDUC COUNS, V62, P56, DOI 10.1016/j.pec.2005.06.002; Kenny D. A., 2006, DYADIC DATA ANAL; Kiesler DJ, 2003, SOC SCI MED, V57, P1707, DOI 10.1016/S0277-9536(02)00558-0; Krones T, 2008, ANN FAM MED, V6, P218, DOI 10.1370/afm.854; LeBlanc A, 2009, MED DECIS MAKING, V29, P61, DOI 10.1177/0272989X08327067; LEGARE F, 2007, BMC MED INFORM DECIS, V15, P7; Loh A, 2006, PATIENT EDUC COUNS, V63, P314, DOI 10.1016/j.pec.2006.04.006; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Martin LR, 2003, BEHAV MED, V28, P159, DOI 10.1080/08964280309596054; Melbourne E, 2010, PATIENT EDUC COUNS, V78, P177, DOI 10.1016/j.pec.2009.07.009; Moumjid N, 2007, MED DECIS MAKING, V27, P539, DOI 10.1177/0272989x07306779; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Ogden J, 2002, PATIENT EDUC COUNS, V48, P171, DOI 10.1016/S0738-3991(02)00020-4; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Scholl I, 2011, Z EVIDENZ FORTBILD Q, V105, P313, DOI 10.1016/j.zefq.2011.04.012; Shields CG, 2005, ANN FAM MED, V3, P436, DOI 10.1370/afm.305; SIMINOFF L, 2005, HEALTH PSYCHOL, V24, P99; Simon D, 2006, PATIENT EDUC COUNS, V63, P319, DOI 10.1016/j.pec.2006.04.012; Simon Daniela, 2007, Z Arztl Fortbild Qualitatssich, V101, P259, DOI 10.1016/j.zgesun.2007.02.029; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127	51	90	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26255	10.1371/journal.pone.0026255	http://dx.doi.org/10.1371/journal.pone.0026255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834SM	22043310	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400038
J	Teng, Y; Xie, XY; Walker, S; Saxena, M; Kozlowski, DJ; Mumm, JS; Cowell, JK				Teng, Yong; Xie, Xiayang; Walker, Steven; Saxena, Meera; Kozlowski, David J.; Mumm, Jeff S.; Cowell, John K.			Loss of Zebrafish lgi1b Leads to Hydrocephalus and Sensitization to Pentylenetetrazol Induced Seizure-Like Behavior	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; C-FOS EXPRESSION; AUTOSOMAL-DOMINANT; GLIOMA-CELLS; SYNAPTIC-TRANSMISSION; GENE; BRAIN; MUTATIONS; MICE; METASTASIS	Mutations in the LGI1 gene predispose to a hereditary epilepsy syndrome and is the first gene associated with this disease which does not encode an ion channel protein. In zebrafish, there are two paralogs of the LGI1 gene, lgi1a and lgi1b. Knockdown of lgi1a results in a seizure-like hyperactivity phenotype with associated developmental abnormalities characterized by cellular loss in the eyes and brain. We have now generated knockdown morphants for the lgi1b gene which also show developmental abnormalities but do not show a seizure-like behavior. Instead, the most striking phenotype involves significant enlargement of the ventricles (hydrocephalus). As shown for the lgi1a morphants, however, lgi1b morphants are also sensitized to PTZ-induced hyperactivity. The different phenotypes between the two lgi1 morphants support a subfunctionalization model for the two paralogs.	[Teng, Yong; Cowell, John K.] Georgia Hlth Sci Univ, Sch Med, GHSU Canc Ctr, Augusta, GA 30912 USA; [Xie, Xiayang; Walker, Steven; Kozlowski, David J.; Mumm, Jeff S.] Georgia Hlth Sci Univ, Sch Med, Dept Cellular Biol & Anat, Augusta, GA USA; [Xie, Xiayang; Walker, Steven; Mumm, Jeff S.] Georgia Hlth Sci Univ, Sch Med, Vis Discovery Inst, Augusta, GA USA; [Kozlowski, David J.] Georgia Hlth Sci Univ, Sch Med, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA USA; [Saxena, Meera] Luminomics Inc, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Teng, Y (corresponding author), Georgia Hlth Sci Univ, Sch Med, GHSU Canc Ctr, Augusta, GA 30912 USA.	jcowell@georgiahealth.edu	Teng, Yong/AAK-4160-2020; Mumm, Jeff S/F-3125-2013	Teng, Yong/0000-0002-1856-7289; Cowell, John/0000-0002-2079-5950; Mumm, Jeff/0000-0002-2575-287X	NICHD NIH HHS [R44 HD047089] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R44HD047089] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Chabrol E, 2010, BRAIN, V133, P2749, DOI 10.1093/brain/awq171; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; DAVAL JL, 1989, J NEUROCHEM, V52, P1954, DOI 10.1111/j.1471-4159.1989.tb07285.x; DRAGUNOW M, 1988, TRENDS PHARMACOL SCI, V9, P5, DOI 10.1016/0165-6147(88)90229-5; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gu WL, 2005, MOL BIOL EVOL, V22, P2209, DOI 10.1093/molbev/msi214; Head K, 2007, MAMM GENOME, V18, P328, DOI 10.1007/s00335-007-9024-6; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobayashi E, 2003, ARCH NEUROL-CHICAGO, V60, P1546, DOI 10.1001/archneur.60.11.1546; Kunapuli P, 2004, J BIOL CHEM, V279, P23151, DOI 10.1074/jbc.M314192200; Kunapuli P, 2003, ONCOGENE, V22, P3985, DOI 10.1038/sj.onc.1206584; Kunapuli P, 2010, GENOMICS, V95, P93, DOI 10.1016/j.ygeno.2009.10.001; Kunapuli P, 2009, J MOL NEUROSCI, V39, P137, DOI 10.1007/s12031-009-9202-y; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Robinson-Rechavi M, 2001, MOL BIOL EVOL, V18, P681, DOI 10.1093/oxfordjournals.molbev.a003849; Sagane K, 2008, INT J BIOL SCI, V4, P387; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Silva J, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-43; Sirerol-Piquer MS, 2006, HUM MOL GENET, V15, P3436, DOI 10.1093/hmg/ddl421; Teng Y, 2010, HUM MOL GENET, V19, P4409, DOI 10.1093/hmg/ddq364; Tessa C, 2007, NEUROLOGY, V69, P1298, DOI 10.1212/01.wnl.0000277045.16688.b6; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Yu YE, 2010, HUM MOL GENET, V19, P1702, DOI 10.1093/hmg/ddq047; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	34	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24596	10.1371/journal.pone.0024596	http://dx.doi.org/10.1371/journal.pone.0024596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	22053218	Green Submitted, Green Published, gold			2022-12-27	WOS:000295173800030
J	Patouillard, E; Conteh, L; Webster, J; Kweku, M; Chandramohan, D; Greenwood, B				Patouillard, Edith; Conteh, Lesong; Webster, Jayne; Kweku, Margaret; Chandramohan, Daniel; Greenwood, Brian			Coverage, Adherence and Costs of Intermittent Preventive Treatment of Malaria in Children Employing Different Delivery Strategies in Jasikan, Ghana	PLOS ONE			English	Article							COMBINATION THERAPY; IMPLEMENTATION; MANAGEMENT; SEEKING; FEVER; CARE	Background: Intermittent preventive treatment of malaria in children (IPTc) involves the administration of a course of antimalarial drugs at specified time intervals to children at risk of malaria regardless of whether or not they are known to be infected. IPTc provides a high level of protection against uncomplicated and severe malaria, with monthly sulphadoxine-pyrimethamine plus amodiaquine (SP&AQ) and sulphadoxine-pyrimethamine plus piperaquine being the most efficacious regimens. A key challenge is the identification of a cost-effective delivery strategy. Methods: A community randomized trial was undertaken in Jasikan district, Ghana to assess IPTc effectiveness and costs using SP&AQ delivered in three different ways. Twelve villages were randomly selected to receive IPTc from village health workers (VHWs) or facility-based nurses working at health centres' outpatient departments (OPD) or EPI outreach clinics. Children aged 3 to 59 months-old received one IPT course (three doses) in May, June, September and October. Effectiveness was measured in terms of children covered and adherent to a course and delivery costs were calculated in financial and economic terms using an ingredient approach from the provider perspective. Results: The economic cost per child receiving at least the first dose of all 4 courses was US$4.58 when IPTc was delivered by VHWs, US$4.93 by OPD nurses and US$5.65 by EPI nurses. The unit economic cost of receiving all 3 doses of all 4 courses was US$7.56 and US$8.51 when IPTc was delivered by VHWs or facility-based nurses respectively. The main cost driver for the VHW delivery was supervision, reflecting resources used for travelling to more remote communities rather than more intense supervision, and for OPD and EPI delivery, it was the opportunity cost of the time spent by nurses in dispensing IPTc. Conclusions: VHWs achieve higher IPTc coverage and adherence at lower costs than facility-based nurses in Jasikan district, Ghana.	[Patouillard, Edith; Webster, Jayne; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England; [Kweku, Margaret] Univ Ghana, Ghana Hlth Serv, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Ghana Health Service; University of Ghana	Patouillard, E (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Edith.Patouillard@lshtm.ac.uk	Conteh, Lesong/ABE-9550-2020	Conteh, Lesong/0000-0002-0719-3672; Patouillard, Edith/0000-0001-7347-2824; Webster, Jayne/0000-0002-0498-8883	Bill and Melinda Gates Foundation; Gates Malaria Partnership	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gates Malaria Partnership	This work was funded by the Gates Malaria Partnership, which received support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adome RO., 1996, POPULAR PILLS COMMUN; AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Ahorlu CK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-292; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2007, TECHN EXP GROUP M IN; [Anonymous], 2009, INT DRUG PRIC IND GU; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; Conteh L, 2010, PLOS ONE; Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-573; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kweku M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007256; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Njau JD, 2006, TROP MED INT HEALTH, V11, P299, DOI 10.1111/j.1365-3156.2006.01569.x; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Onwujekwe O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-5; Philipps M, 1993, GUIDELINES COST EFFE; Tagbor H, 2011, TROP MED INT HEALTH, V16, P280, DOI 10.1111/j.1365-3156.2010.02699.x; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; World Health Organization (WHO), 2010, WHO POL REC INT PREV	24	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e24871	10.1371/journal.pone.0024871	http://dx.doi.org/10.1371/journal.pone.0024871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073137	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000297197000005
J	Audsley, J; Seaberg, EC; Sasadeusz, J; Matthews, GV; Avihingsanon, A; Ruxrungtham, K; Fairley, K; Finlayson, R; Hwang, HS; Littlejohn, M; Locarnini, S; Dore, GJ; Thio, CL; Lewin, SR				Audsley, Jennifer; Seaberg, Eric C.; Sasadeusz, Joe; Matthews, Gail V.; Avihingsanon, Anchalee; Ruxrungtham, Kiat; Fairley, Kit; Finlayson, Robert; Hwang, Hyon S.; Littlejohn, Margaret; Locarnini, Stephen; Dore, Gregory J.; Thio, Chloe L.; Lewin, Sharon R.			Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; ALANINE AMINOTRANSFERASE LEVELS; LIVER-ENZYME ELEVATION; HIV-POSITIVE PATIENTS; RISK-FACTORS; SEVERE HEPATOTOXICITY; MICROBIAL TRANSLOCATION; COINFECTION	Background: Previous studies have demonstrated that hepatitis B virus (HBV) infection increases the risk for ALT elevations in HIV-HBV co-infected patients during the first year of HAART; however, there is limited data on the prevalence of ALT elevations with prolonged HAART in this patient group. Methods/Principal findings: To identify factors associated with ALT elevations in an HIV-HBV co-infected cohort receiving prolonged HAART, data from 143 co-infected patients on HAART enrolled in an international HIV-HBV co-infected cohort where ALT measurements were obtained every 6 months was analysed. A person-visit analysis was used to determine frequency of ALT elevation (>= 2.5 x ULN) at each visit. Factors associated with ALT elevation were determined using multivariate logistic regression with generalized estimating equations to account for correlated data. The median time on HAART at the end of follow-up was 5.6 years (range 0.4-13.3) years. During follow-up, median ALT was 36 U/L with 10.6% of person-visits classified as having ALT elevation. Most ALT elevations were grade 2 (86.5%), with only 13.5% of all ALT elevations grade 3 or higher. Univariate associations with ALT elevation(p<0.05) included history of AIDS, HBV DNA >= 2,000 IU/ml, HBeAg positive, study visit CD4 <200cells/ml and nadir CD4 <200 cells/ml. In the multivariate analysis, only study visit CD4 <200 cells/ml (OR 2.07, 95% CI 1.04-4.11, p = 0.04) and HBeAg positive status (OR 2.22, 95% CI 1.03-4.79, p = 0.04) were independently associated with ALT elevation. Conclusions: In this HIV-HBV co-infected cohort, elevated ALT after >1 year of HAART was uncommon, and severe ALT elevations were rare. HIV-HBV co-infected patients on long-term HAART who are either HBeAg positive or have a CD4 count of <200 cells/ml are at increased risk for ALT elevations.	[Audsley, Jennifer; Lewin, Sharon R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Audsley, Jennifer; Sasadeusz, Joe; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Seaberg, Eric C.; Hwang, Hyon S.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Matthews, Gail V.; Dore, Gregory J.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Avihingsanon, Anchalee; Ruxrungtham, Kiat] HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Avihingsanon, Anchalee; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Fairley, Kit] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Finlayson, Robert] Taylors Sq Private Clin, Sydney, NSW, Australia; [Littlejohn, Margaret; Locarnini, Stephen] Victorian Infect Dis Reference Lab, Melbourne, Australia; [Thio, Chloe L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA; [Lewin, Sharon R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New South Wales Sydney; Kirby Institute; Chulalongkorn University; Victorian Infectious Diseases Reference Laboratory; Johns Hopkins University; Burnet Institute	Audsley, J (corresponding author), Monash Univ, Dept Med, Melbourne, Vic 3004, Australia.	jennifer.audsley@monash.edu	matthews, gail/AAG-8626-2022; Lewin, Sharon/Z-3297-2019; Dore, Gregory John/ABD-5665-2021; matthews, gail/AFL-8501-2022; Audsley, Jennifer/H-4581-2014	Dore, Gregory John/0000-0002-4741-2622; Audsley, Jennifer/0000-0001-6322-3197; Matthews, Gail/0000-0002-1048-6396; Christopher, Fairley/0000-0001-9081-1664; Littlejohn, Margaret/0000-0002-8206-2664; Ruxrungtham, Kiat/0000-0001-7348-2352; Hwang, Hyon Sung/0000-0001-8117-0199; Lewin, Sharon Ruth/0000-0002-0330-8241	National Institutes of Health [RO1 A1060449]; National Institute of Allergy and Infectious Diseases; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, U01AI035040, U01AI035043, U01AI035042, U01AI035039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge funding from the National Institutes of Health RO1 A1060449. Some of the data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) with centres (Principal Investigators) at The Johns Hopkins Bloomberg School of Public Health (Joseph B. Margolick, Lisa P. Jacobson), Howard Brown Health Center, Feinberg School of Medicine, Northwestern University, and Cook County Bureau of Health Services (John P. Phair, Steven M. Wolinsky), University of California, Los Angeles (Roger Detels), and University of Pittsburgh (Charles R. Rinaldo). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute, grants UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, and UO1-AI-35041. JA is a Nation Health and Medical Research Council (NHMRC) Clinical Research Training Fellow and SRL is an NHMRC Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bellini C, 2009, HIV MED, V10, P12, DOI 10.1111/j.1468-1293.2008.00646.x; Bonfanti P, 2001, J ACQ IMMUN DEF SYND, V27, P316; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chang JJ, 2007, IMMUNOL CELL BIOL, V85, P16, DOI 10.1038/sj.icb.7100009; Chang JJ, 2009, J VIROL, V83, P7649, DOI 10.1128/JVI.00183-09; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Cicconi P, 2007, AIDS, V21, P599, DOI 10.1097/QAD.0b013e328013db9c; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; CRANE M, 2011, 18 C RETR OPP INF CR; Crane M, 2009, J INFECT DIS, V199, P974, DOI 10.1086/597276; Degertekin B, 2009, HEPATOLOGY, V49, pS129, DOI 10.1002/hep.22931; Dieterich DT, 2004, CLIN INFECT DIS, V38, pS80, DOI 10.1086/381450; DIETRICH DT, 2002, 14 INT AIDS C 2002 J; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Gao SC, 2010, HEPATOL RES, V40, P287, DOI 10.1111/j.1872-034X.2009.00608.x; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Iser D. M., 2009, HIV Therapy, V3, P405, DOI 10.2217/HIV.09.19; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; LIAW YF, 2009, HEPATOLOGY INT; Lincoln D, 2003, HIV Med, V4, P241, DOI 10.1046/j.1468-1293.2003.00152.x; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Manegold C, 2001, CLIN INFECT DIS, V32, P144, DOI 10.1086/317535; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Matthews GV, 2009, AIDS, V23, P1707, DOI 10.1097/QAD.0b013e32832b43f2; Monforte AD, 2001, J ACQ IMMUN DEF SYND, V28, P114, DOI 10.1097/00042560-200110010-00002; Nunez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; RAJASURIAR R, 2010, J INFECT DI IN PRESS; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Sellier P, 2010, J CLIN VIROL, V47, P13, DOI 10.1016/j.jcv.2009.10.010; Sterling RK, 2008, DIGEST DIS SCI, V53, P1375, DOI 10.1007/s10620-007-9999-6; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; *UN AIDS, 2008, 2008 REP GLOB AIDS E; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Wit FWNM, 2002, J INFECT DIS, V186, P23, DOI 10.1086/341084; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26482	10.1371/journal.pone.0026482	http://dx.doi.org/10.1371/journal.pone.0026482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069454	gold, Green Published			2022-12-27	WOS:000297150900016
J	Georgiadou, D; Chroni, A; Vezeridis, A; Zannis, VI; Stratikos, E				Georgiadou, Dimitra; Chroni, Angeliki; Vezeridis, Alexander; Zannis, Vassilis I.; Stratikos, Efstratios			Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia	PLOS ONE			English	Article							CYSTEINE-ARGININE INTERCHANGE; SULFATE PROTEOGLYCAN-BINDING; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; LDL RECEPTOR-BINDING; E-DEFICIENT MICE; E ISOFORMS; ALZHEIMERS-DISEASE; AQUEOUS-SOLUTION; STRUCTURAL BASIS	Background: Apolipoprotein E (apoE) is a major protein of the lipoprotein transport system that plays important roles in lipid homeostasis and protection from atherosclerosis. ApoE is characterized by structural plasticity and thermodynamic instability and can undergo significant structural rearrangements as part of its biological function. Mutations in the 136-150 region of the N-terminal domain of apoE, reduce its low density lipoprotein (LDL) receptor binding capacity and have been linked with lipoprotein disorders, such as type III hyperlipoproteinemia (HLP) in humans. However, the LDL-receptor binding defects for these apoE variants do not correlate well with the severity of dyslipidemia, indicating that these variants may carry additional properties that contribute to their pathogenic potential. Methodology/Principal Findings: In this study we examined whether three type III HLP predisposing apoE3 variants, namely R136S, R145C and K146E affect the biophysical properties of the protein. Circular dichroism (CD) spectroscopy revealed that these mutations do not significantly alter the secondary structure of the protein. Thermal and chemical unfolding analysis revealed small thermodynamic alterations in each variant compared to wild-type apoE3, as well as effects in the reversibility of the unfolding transition. All variants were able to remodel multillamelar 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) vesicles, but R136S and R145C had reduced kinetics. Dynamic light scattering analysis indicated that the variant R136S exists in a higher-order oligomerization state in solution. Finally, 1-anilinonaphthalene-8-sulfonic acid (ANS) binding suggested that the variant R145C exposes a larger amount of hydrophobic surface to the solvent. Conclusions/Significance: Overall, our findings suggest that single amino acid changes in the functionally important region 136-150 of apoE3 can affect the molecule's stability and conformation in solution and may underlie functional consequences. However, the magnitude and the non-concerted nature of these changes, make it unlikely that they constitute a distinct unifying mechanism leading to type III HLP pathogenesis.	[Georgiadou, Dimitra; Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Prot Chem Lab, Athens, Greece; [Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece; [Vezeridis, Alexander; Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Vezeridis, Alexander; Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; Boston University; Boston University	Georgiadou, D (corresponding author), Natl Ctr Sci Res Demokritos, Prot Chem Lab, Athens, Greece.	stratos@rrp.demokritos.gr	Stratikos, Efstratios/N-2969-2014	Stratikos, Efstratios/0000-0002-3566-2309; Chroni, Angeliki/0000-0003-3107-1189; Zannis, Vassilis/0000-0002-1295-7155	Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; European Union [LSHM-CT-2006 037631]; National Institutes of Health [HL68216]; National Centre for Scientific Research "Demokritos"; NIH [HL007969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068216, T32HL007969] Funding Source: NIH RePORTER	Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centre for Scientific Research "Demokritos"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided from the Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease (to E.S. and A.C.) the 6th Framework Programme of the European Union (LSHM-CT-2006 037631 to A.C. and V. I. Z.), and the National Institutes of Health (HL68216 to V.I.Z.). D.G. received financial support from the graduate student fellowship program of National Centre for Scientific Research "Demokritos". A.V. was supported by the NIH Predoctoral Training Grant HL007969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2002, BBA-MOL CELL BIOL L, V1584, P9, DOI 10.1016/S1388-1981(02)00263-9; AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BRESLOW JL, 1982, J LIPID RES, V23, P1224; CHAPPELL DA, 1989, J CLIN INVEST, V84, P1906, DOI 10.1172/JCI114378; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Chou CY, 2005, BIOPHYS J, V88, P455, DOI 10.1529/biophysj.104.046813; Chroni A, 2005, BIOCHEMISTRY-US, V44, P13132, DOI 10.1021/bi051029o; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Clement-Collin V, 2006, BIOPHYS CHEM, V119, P170, DOI 10.1016/j.bpc.2005.07.009; Cooper AD, 1997, J LIPID RES, V38, P2173; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; deVilliers WJS, 1997, ARTERIOSCL THROM VAS, V17, P865, DOI 10.1161/01.ATV.17.5.865; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Gau B, 2011, BIOCHEMISTRY-US, V50, P8117, DOI 10.1021/bi200911c; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gunzburg MJ, 2007, J BIOL CHEM, V282, P35831, DOI 10.1074/jbc.M706425200; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUANG RY, 2011, BIOCHEMISTRY; Huang YD, 2010, CURR OPIN LIPIDOL, V21, P337, DOI 10.1097/MOL.0b013e32833af368; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; JI ZS, 1994, J BIOL CHEM, V269, P13421; Kypreos KE, 2006, J LIPID RES, V47, P521, DOI 10.1194/jlr.M500322-JLR200; Kypreos KE, 2001, FASEB J, V15, P1598, DOI 10.1096/fj.00-0882fje; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Mahley R., 2001, TYPE 3 HYPERLIPOPROT, P2835; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 1999, J LIPID RES, V40, P1933; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 1999, J LIPID RES, V40, P1; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; MANN WA, 1995, J CLIN INVEST, V96, P1100, DOI 10.1172/JCI118096; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MORIYAMA K, 1992, BIOCHIM BIOPHYS ACTA, V1128, P58, DOI 10.1016/0005-2760(92)90257-V; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2002, EUR J BIOCHEM, V269, P5939, DOI 10.1046/j.1432-1033.2002.03319.x; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pocovi M, 1996, ATHEROSCLEROSIS, V122, P33, DOI 10.1016/0021-9150(95)06745-0; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; SEGREST JP, 1992, J LIPID RES, V33, P141; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; WARDELL MR, 1987, J CLIN INVEST, V80, P483, DOI 10.1172/JCI113096; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P7089, DOI 10.1021/bi00528a006; ZANNIS VI, 1982, J LIPID RES, V23, P911; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; ZANNIS VI, 2004, LIPOPROTEINS ATHEROG	75	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27037	10.1371/journal.pone.0027037	http://dx.doi.org/10.1371/journal.pone.0027037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069485	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900046
J	Dyke, GJ; Wang, X; Habib, MB				Dyke, Gareth J.; Wang, Xia; Habib, Michael B.			Fossil Plotopterid Seabirds from the Eo-Oligocene of the Olympic Peninsula (Washington State, USA): Descriptions and Functional Morphology	PLOS ONE			English	Article							NORTH PACIFIC; BODY SHAPE; BIRDS; BONE; EVOLUTION; PENGUINS; EOCENE; KINEMATICS; REANALYSIS; LOCOMOTION	The plotopterids (Aves, Plotopteridae) were a group of extinct wing-propelled marine birds that are known from Paleogene-aged sediments (Eocene to Miocene), mostly around the Pacific Rim (especially Japan and the northwest coast of North America). While these birds exhibit a strikingly similar wing morphology to penguins (Spheniscidae), they also share derived characters with pelecaniform birds that are absent in penguins and exhibit apparently superficial similarities with auks (Alcidae: Charadriiformes). Despite quite an abundant fossil record, these birds have been little studied, and in particular their functional morphology remains little understood. Here we present osteological overviews of specimens from the northwest coast of Washington state (USA). We give an amended diagnosis for the well-represented North American genus, Tonsala Olson, 1980, describe a new large species, and examine the functional morphology of plotopterids showing that the ratio of humeral strength to femoral strength is quite low in one well-represented species Tonsala buchanani sp. nov., relative to both extant penguins and alcids. While the femoral strength of Tonsala buchanani is 'penguin-grade', its humeral strength is more 'alcid-grade'. These results have implications for understanding the mode-of-locomotion of these extinct marine birds. Although not related to Spheniscidae, our descriptions and functional results suggest that Tonsala buchanani sustained similar loads in walking, but slightly lower humeral loads during swimming, than a modern penguin. This suggests a swimming mode that is more similar to living alcids, than to the highly-specialised locomotor strategy of living and fossil penguins.	[Dyke, Gareth J.; Wang, Xia] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Habib, Michael B.] Chatham Univ, Dept Sci, Pittsburgh, PA USA	University College Dublin	Dyke, GJ (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England.	gareth.dyke@ucd.ie	Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817	Chinese Government	Chinese Government	Xia Wang is supported by a Chinese Government Scholarship to UCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEJANDRO M, 2006, OIKOS, V113, P385; Barnes L.G., 1996, WASHINGTON GEOLOGY, V24, P17; Barnes Lawrence G., 2001, Bulletin of Ashoro Museum of Paleontology, V2, P7; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bertelli S, 2010, PALAEONTOLOGY, V53, P507, DOI 10.1111/j.1475-4983.2010.00950.x; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Blob RW, 1999, J EXP BIOL, V202, P1023; CARTER DR, 1978, CLIN ORTHOP RELAT R, P192; CHU PC, 1995, CONDOR, V97, P174, DOI 10.2307/1368995; CLARK BD, 1979, J ZOOL, V188, P411; Dyke Gareth J., 2005, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V4, P233; Dyke GJ, 2006, CRETACEOUS RES, V27, P947, DOI 10.1016/j.cretres.2006.05.001; Dyke GJ, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)360<0001:TFGBPF>2.0.CO;2; Fordyce R.E., 1990, P419; FORDYCE RE, 1986, GEOLOGICAL SOC NZ NE, V74, P56; GADOW H, 1893, BRONNS KLASSEN ORDNU; Gere J.M., 2004, MECH MATER, V6; GOEDERT J L, 1988, Proceedings of the California Academy of Sciences, V45, P97; Goedert James L., 2002, P63; GOEDERT JL, 1995, PALAEOGEOGR PALAEOCL, V118, P151, DOI 10.1016/0031-0182(94)00139-Y; Habib M, 2010, BIOL J LINN SOC, V99, P687, DOI 10.1111/j.1095-8312.2010.01372.x; Habib MB, 2008, ZOOL J LINN SOC-LOND, V153, P601, DOI 10.1111/j.1096-3642.2008.00402.x; Hasegawa Y, 1979, KITAKYUSHU MUSEUM NA, V1, P41; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; HOWARD H, 1969, CONDOR, V71, P68, DOI 10.2307/1366050; HOWARD HILDEGARDE, 1966, LOS ANGELES COUNTY MUS CONTRIB SCI, V101, P1; Johansson LC, 2002, J EXP BIOL, V205, P371; Kiel S, 2006, PALAIOS, V21, P548, DOI 10.2110/palo.2005.p05-086r; Ksepka DT, 2008, J ANAT, V213, P131, DOI 10.1111/j.1469-7580.2008.00927.x; Linnaeus C, 1758, SYSTEMA NATURAE; LIVEZEY BC, 1988, AUK, V105, P681, DOI 10.1093/auk/105.4.681; Lovvorn JR, 2002, FUNCT ECOL, V16, P106, DOI 10.1046/j.0269-8463.2001.00604.x; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G, 2005, J ZOOL SYST EVOL RES, V43, P61, DOI 10.1111/j.1439-0469.2004.00291.x; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Miller Loye, 1946, CONDOR, V48, P32, DOI 10.2307/1364152; MILLER LOYE, 1949, CARNEGIE INST WASHINGTON PUBL, V584, P201; Olson S.L., 1985, Avian Biology, V8, P79; Olson S. L., 1980, NATURAL HIST MUSEUM, V330, P51; Olson SL, 1996, J VERTEBR PALEONTOL, V16, P742, DOI 10.1080/02724634.1996.10011362; Olson SL, 2001, SM C PALEOB, V90, P233; OLSON SL, 1979, SCIENCE, V206, P688, DOI 10.1126/science.206.4419.688; OLSON SL, 1985, NATL SCI MUSEUM TO C, V11, P137; Palmer C, 2010, J EXP BIOL, V213, P2174, DOI 10.1242/jeb.044537; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; Rees J, 2005, PALAEONTOLOGY, V48, P1321, DOI 10.1111/j.1475-4983.2005.00507.x; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; Sakurai Kazuhiko, 2008, Oryctos, V7, P83; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Smith ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013354; STRAUCH J G JR, 1978, Transactions of the Zoological Society of London, V34, P263; STRAUCH JG, 1985, AUK, V102, P520, DOI 10.1093/auk/102.3.520; SWARTZ SM, 1992, NATURE, V359, P726, DOI 10.1038/359726a0; Warheit Kenneth I., 2002, P17; WARHEIT KI, 1992, PALEOBIOLOGY, V18, P401, DOI 10.1017/S0094837300010976; [No title captured]	58	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25672	10.1371/journal.pone.0025672	http://dx.doi.org/10.1371/journal.pone.0025672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065992	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000296916000008
J	Maniglia, M; Pavan, A; Cuturi, LF; Campana, G; Sato, G; Casco, C				Maniglia, Marcello; Pavan, Andrea; Cuturi, Luigi F.; Campana, Gianluca; Sato, Giovanni; Casco, Clara			Reducing Crowding by Weakening Inhibitory Lateral Interactions in the Periphery with Perceptual Learning	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; SPATIAL INTERACTIONS; NEURONAL RESPONSES; STRIATE CORTEX; FACILITATION; SUPPRESSION; ACUITY; PSYCHOPHYSICS; INTERFERENCE	We investigated whether lateral masking in the near-periphery, due to inhibitory lateral interactions at an early level of central visual processing, could be weakened by perceptual learning and whether learning transferred to an untrained, higher-level lateral masking known as crowding. The trained task was contrast detection of a Gabor target presented in the near periphery (4 degrees) in the presence of co-oriented and co-aligned high contrast Gabor flankers, which featured different target-to-flankers separations along the vertical axis that varied from 2 lambda to 8 lambda. We found both suppressive and facilitatory lateral interactions at target-to-flankers distances (2 lambda-4 lambda and 8 lambda, respectively) that were larger than those found in the fovea. Training reduces suppression but does not increase facilitation. Most importantly, we found that learning reduces crowding and improves contrast sensitivity, but has no effect on visual acuity (VA). These results suggest a different pattern of connectivity in the periphery with respect to the fovea as well as a different modulation of this connectivity via perceptual learning that not only reduces low-level lateral masking but also reduces crowding. These results have important implications for the rehabilitation of low-vision patients who must use peripheral vision to perform tasks, such as reading and refined figure-ground segmentation, which normal sighted subjects perform in the fovea.	[Maniglia, Marcello; Campana, Gianluca; Casco, Clara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Pavan, Andrea] SISSA, Cognit Neurosci Sect, I-34014 Trieste, Italy; [Cuturi, Luigi F.] Univ Hosp Munich Grosshadern, Integrated Ctr Res & Treatment Vertigo Balance &, Munich, Germany; [Sato, Giovanni] Ist L Configliachi, Ctr Riabilitaz Visiva Ipovedenti, Padua, Italy	University of Padua; International School for Advanced Studies (SISSA); University of Munich	Maniglia, M (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	marcello.maniglia@studenti.unipd.it	; Cuturi, Luigi/N-1581-2016; Campana, Gianluca/F-8981-2010; Pavan, Andrea/Y-5507-2018	Pavan, Andrea/0000-0002-7697-6320; Cuturi, Luigi/0000-0001-8144-3740; Campana, Gianluca/0000-0003-4019-085X; Pavan, Andrea/0000-0002-8257-8206; Maniglia, Marcello/0000-0002-2053-0071	Italian Ministry of University, Research; Centro polifunzionale regionale per la promozione della salute e della vita sociale dei ciechi e degli ipovedenti	Italian Ministry of University, Research(Ministry of Education, Universities and Research (MIUR)); Centro polifunzionale regionale per la promozione della salute e della vita sociale dei ciechi e degli ipovedenti	This work was supported by the Italian Ministry of University, Research (PRIN 2007) and Centro polifunzionale regionale per la promozione della salute e della vita sociale dei ciechi e degli ipovedenti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 2001, J OPT SOC AM A, V18, P2228, DOI 10.1364/JOSAA.18.002228; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUTLER TW, 1978, VISION RES, V18, P1387, DOI 10.1016/0042-6989(78)90231-6; Campbell FW, 2008, J PHYSIOL-LONDON, V197, P551; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; De Valois RL, SPATIAL VISION; FLOM MC, 1963, J OPT SOC AM, V53, P1026, DOI 10.1364/JOSA.53.001026; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; Levi DM, 2002, VISION RES, V42, P1379, DOI 10.1016/S0042-6989(02)00061-5; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li RW, 2007, INVEST OPHTH VIS SCI, V48, P5046, DOI 10.1167/iovs.07-0324; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; Li W, 2001, EXP BRAIN RES, V139, P359, DOI 10.1007/s002210100757; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Mizobe K, 2001, VISUAL NEUROSCI, V18, P377, DOI 10.1017/S0952523801183045; Motter B. C., 2002, J VISION, V2, P274, DOI DOI 10.1167/2.7.274; NAKAMURA H, 1993, J NEUROSCI, V13, P3681; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2004, J VISION, V4, P904, DOI 10.1167/4.10.6; Petrov Y, 2007, J VISION, V7, DOI 10.1167/7.2.12; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Polat U, 1996, VISION RES, V36, P2099, DOI 10.1016/0042-6989(95)00281-2; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polat U, 2009, VISION RES, V49, P2566, DOI 10.1016/j.visres.2009.06.005; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Shani R, 2005, VISION RES, V45, P2009, DOI 10.1016/j.visres.2005.01.024; Tailby Chris, 2001, Clin Exp Optom, V84, P354; Tan DTH, 2008, J CATARACT REFR SURG, V34, P570, DOI 10.1016/j.jcrs.2007.11.052; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; TSO DY, 1986, J NEUROSCI, V6, P1160; Wenger MJ, 2008, PERCEPT PSYCHOPHYS, V70, P1248, DOI 10.3758/PP.70.7.1248; WESTHEIMER G, 1975, VISION RES, V15, P1137, DOI 10.1016/0042-6989(75)90012-7; WESTHEIMER G, 1976, J OPT SOC AM, V66, P332, DOI 10.1364/JOSA.66.000332; Williams CB, 1998, J OPT SOC AM A, V15, P2046, DOI 10.1364/JOSAA.15.002046; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Zenger B, 1996, VISION RES, V36, P2497, DOI 10.1016/0042-6989(95)00303-7; Zenger-Landolt B, 2001, VISION RES, V41, P3663, DOI 10.1016/S0042-6989(01)00175-4; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010	55	40	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25568	10.1371/journal.pone.0025568	http://dx.doi.org/10.1371/journal.pone.0025568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065990	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000007
J	Lye, JC; Hwang, JEC; Paterson, D; de Jonge, MD; Howard, DL; Burke, R				Lye, Jessica C.; Hwang, Joab E. C.; Paterson, David; de Jonge, Martin D.; Howard, Daryl L.; Burke, Richard			Detection of Genetically Altered Copper Levels in Drosophila Tissues by Synchrotron X-Ray Fluorescence Microscopy	PLOS ONE			English	Article							TRANSPORTER; HOMEOSTASIS; PIGMENTATION; LOCALIZATION; TOPOGRAPHY; EXPRESSION; MECHANISM; SENSOR	Tissue-specific manipulation of known copper transport genes in Drosophila tissues results in phenotypes that are presumably due to an alteration in copper levels in the targeted cells. However direct confirmation of this has to date been technically challenging. Measures of cellular copper content such as expression levels of copper-responsive genes or cuproenzyme activity levels, while useful, are indirect. First-generation copper-sensitive fluorophores show promise but currently lack the sensitivity required to detect subtle changes in copper levels. Moreover such techniques do not provide information regarding other relevant biometals such as zinc or iron. Traditional techniques for measuring elemental composition such as inductively coupled plasma mass spectroscopy are not sensitive enough for use with the small tissue amounts available in Drosophila research. Here we present synchrotron x-ray fluorescence microscopy analysis of two different Drosophila tissues, the larval wing imaginal disc, and sectioned adult fly heads and show that this technique can be used to detect changes in tissue copper levels caused by targeted manipulation of known copper homeostasis genes.	[Lye, Jessica C.; Hwang, Joab E. C.; Burke, Richard] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Paterson, David; de Jonge, Martin D.; Howard, Daryl L.] Australian Synchrotron, Xray Fluorescence Microscopy, Melbourne, Vic 3004, Australia	Monash University	Lye, JC (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	richard.burke@monash.edu	de Jonge, Martin D/C-3400-2011; Howard, Daryl/E-9107-2013	de Jonge, Martin D/0000-0001-7731-6175; Howard, Daryl/0000-0001-6071-2382; Burke, Richard/0000-0003-0086-0767	National Health and Medical Research Council, Australia [436806, 606609]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council, Australia, Project Grant # 436806 and 606609 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Binks T, 2010, J BIOL INORG CHEM, V15, P621, DOI 10.1007/s00775-010-0629-y; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burke R, 2008, INT J BIOCHEM CELL B, V40, P1850, DOI 10.1016/j.biocel.2008.01.021; DANKS DM, 1988, ANNU REV NUTR, V8, P235, DOI 10.1146/annurev.nu.08.070188.001315; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x; Hua HQ, 2010, J BIOL INORG CHEM, V15, P107, DOI 10.1007/s00775-009-0599-0; James SA, 2011, ANAL BIOANAL CHEM; Kirkham R, 2010, AIP CONF PROC, V1234, P240, DOI 10.1063/1.3463181; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; McRae R, 2010, J BIOL INORG CHEM, V15, P99, DOI 10.1007/s00775-009-0598-1; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Norgate M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014303; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Paterson DJ, 2007, AIP CONF PROC, V879, P864; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Ryan CG, 2010, NUCL INSTRUM METH A, V619, P37, DOI 10.1016/j.nima.2009.11.035; Ryan CG, 2005, NUCL INSTRUM METH B, V231, P183, DOI 10.1016/j.nimb.2005.01.054; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; RYAN CG, 1993, NUCL INSTRUM METH B, V77, P203, DOI 10.1016/0168-583X(93)95545-G; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Southon A, 2010, BIOMETALS; Tumer Z, 1996, ANN MED, V28, P121; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Veldhuis N, 2009, BIOMETALS, V22, P177, DOI 10.1007/s10534-008-9183-2; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	40	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26867	10.1371/journal.pone.0026867	http://dx.doi.org/10.1371/journal.pone.0026867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053217	gold, Green Submitted, Green Published			2022-12-27	WOS:000299081800051
J	Pope, WH; Ferreira, CM; Jacobs-Sera, D; Benjamin, RC; Davis, AJ; DeJong, RJ; Elgin, SCR; Guilfoile, FR; Forsyth, MH; Harris, AD; Harvey, SE; Hughes, LE; Hynes, PM; Jackson, AS; Jalal, MD; MacMurray, EA; Manley, CM; McDonough, MJ; Mosier, JL; Osterbann, LJ; Rabinowitz, HS; Rhyan, CN; Russell, DA; Saha, MS; Shaffer, CD; Simon, SE; Sims, EF; Tovar, IG; Weisser, EG; Wertz, JT; Weston-Hafer, KA; Williamson, KE; Zhang, B; Cresawn, SG; Jain, P; Piuri, M; Jacobs, WR; Hendrix, RW; Hatfull, GF				Pope, Welkin H.; Ferreira, Christina M.; Jacobs-Sera, Deborah; Benjamin, Robert C.; Davis, Ariangela J.; DeJong, Randall J.; Elgin, Sarah C. R.; Guilfoile, Forrest R.; Forsyth, Mark H.; Harris, Alexander D.; Harvey, Samuel E.; Hughes, Lee E.; Hynes, Peter M.; Jackson, Arrykka S.; Jalal, Marilyn D.; MacMurray, Elizabeth A.; Manley, Coreen M.; McDonough, Molly J.; Mosier, Jordan L.; Osterbann, Larissa J.; Rabinowitz, Hannah S.; Rhyan, Corwin N.; Russell, Daniel A.; Saha, Margaret S.; Shaffer, Christopher D.; Simon, Stephanie E.; Sims, Erika F.; Tovar, Isabel G.; Weisser, Emilie G.; Wertz, John T.; Weston-Hafer, Kathleen A.; Williamson, Kurt E.; Zhang, Bo; Cresawn, Steven G.; Jain, Paras; Piuri, Mariana; Jacobs, William R., Jr.; Hendrix, Roger W.; Hatfull, Graham F.			Cluster K Mycobacteriophages: Insights into the Evolutionary Origins of Mycobacteriophage TM4	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; SITE-SPECIFIC INTEGRATION; TRANSFER-RNA GENES; DRUG-SUSCEPTIBILITY; SENSITIVE TOOL; TMRNA GENES; BACTERIOPHAGE; TUBERCULOSIS; PHAGE; DNA	Five newly isolated mycobacteriophages -Angelica, CrimD, Adephagia, Anaya, and Pixie - have similar genomic architectures to mycobacteriophage TM4, a previously characterized phage that is widely used in mycobacterial genetics. The nucleotide sequence similarities warrant grouping these into Cluster K, with subdivision into three subclusters: K1, K2, and K3. Although the overall genome architectures of these phages are similar, TM4 appears to have lost at least two segments of its genome, a central region containing the integration apparatus, and a segment at the right end. This suggests that TM4 is a recent derivative of a temperate parent, resolving a long-standing conundrum about its biology, in that it was reportedly recovered from a lysogenic strain of Mycobacterium avium, but it is not capable of forming lysogens in any mycobacterial host. Like TM4, all of the Cluster K phages infect both fast-and slow-growing mycobacteria, and all of them - with the exception of TM4 - form stable lysogens in both Mycobacterium smegmatis and Mycobacterium tuberculosis; immunity assays show that all five of these phages share the same immune specificity. TM4 infects these lysogens suggesting that it was either derived from a heteroimmune temperate parent or that it has acquired a virulent phenotype. We have also characterized a widely-used conditionally replicating derivative of TM4 and identified mutations conferring the temperature-sensitive phenotype. All of the Cluster K phages contain a series of well conserved 13 bp repeats associated with the translation initiation sites of a subset of the genes; approximately one half of these contain an additional sequence feature composed of imperfectly conserved 17 bp inverted repeats separated by a variable spacer. The K1 phages integrate into the host tmRNA and the Cluster K phages represent potential new tools for the genetics of M. tuberculosis and related species.	[Pope, Welkin H.; Ferreira, Christina M.; Jacobs-Sera, Deborah; Guilfoile, Forrest R.; Russell, Daniel A.; Piuri, Mariana; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; [Pope, Welkin H.; Ferreira, Christina M.; Jacobs-Sera, Deborah; Guilfoile, Forrest R.; Russell, Daniel A.; Piuri, Mariana; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Benjamin, Robert C.; Hughes, Lee E.; Jalal, Marilyn D.; Manley, Coreen M.; Mosier, Jordan L.; Simon, Stephanie E.; Tovar, Isabel G.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Davis, Ariangela J.; DeJong, Randall J.; Harris, Alexander D.; Osterbann, Larissa J.; Wertz, John T.] Calvin Coll, Dept Biol Sci, Grand Rapids, MI 49506 USA; [Elgin, Sarah C. R.; Hynes, Peter M.; Rabinowitz, Hannah S.; Rhyan, Corwin N.; Shaffer, Christopher D.; Sims, Erika F.; Weisser, Emilie G.; Weston-Hafer, Kathleen A.; Zhang, Bo] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Forsyth, Mark H.; Harvey, Samuel E.; Jackson, Arrykka S.; MacMurray, Elizabeth A.; McDonough, Molly J.; Saha, Margaret S.; Williamson, Kurt E.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Cresawn, Steven G.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Jain, Paras; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Texas System; University of North Texas Denton; Calvin University; Washington University (WUSTL); William & Mary; James Madison University; Yeshiva University	Pope, WH (corresponding author), Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Osterbaan, Larissa/AAA-5686-2020; Kozik, Ariangela/AAV-2395-2021	Osterbaan, Larissa/0000-0003-2315-2050; Kozik, Ariangela/0000-0003-2322-4085; Saha, Margaret/0000-0003-0096-2667; Jacobs, William/0000-0003-3321-3080; Elgin, Sarah C. R./0000-0002-5176-2510; Jain, Paras/0000-0002-2288-6776; Forsyth, Mark/0000-0001-8653-6508; Piuri, Mariana/0000-0001-9058-8247	Howard Hughes Medical Institute; National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R03TW008926] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Howard Hughes Medical Institute and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Howard Hughes Medical Institute funders did provide assistance in providing annotation tools to some of the authors.	Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Albert H, 2002, INT J TUBERC LUNG D, V6, P1130; Bardarov S, 2003, DIAGN MICR INFEC DIS, V45, P53, DOI 10.1016/S0732-8893(02)00478-9; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Carriere C, 1997, J CLIN MICROBIOL, V35, P3232; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Cresawn S, 2011, BMC BIOINFO IN PRESS; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; Eltringham IJ, 1999, J CLIN MICROBIOL, V37, P3528, DOI 10.1128/JCM.37.11.3528-3532.1999; Fadeev EA, 2009, J MOL BIOL, V388, P682, DOI 10.1016/j.jmb.2009.03.041; FOLEYTHOMAS EM, 1995, MICROBIOL-SGM, V141, P1173, DOI 10.1099/13500872-141-5-1173; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Freitas-Vieira A, 1998, MICROBIOL-SGM, V144, P3397, DOI 10.1099/00221287-144-12-3397; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Harris NB, 1999, FEMS MICROBIOL LETT, V175, P21, DOI 10.1111/j.1574-6968.1999.tb13597.x; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Henry M, 2010, FEMS MICROBIOL LETT, V311, P126, DOI 10.1111/j.1574-6968.2010.02080.x; Huff J, 2010, GENE, V468, P8, DOI 10.1016/j.gene.2010.07.012; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; JONES WD, 1982, AM REV RESPIR DIS, V125, P640; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim AI, 2003, MOL MICROBIOL, V50, P463, DOI 10.1046/j.1365-2958.2003.03723.x; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Mehta PK, 2006, MICROB PATHOGENESIS, V40, P139, DOI 10.1016/j.micpath.2005.12.002; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pena CEA, 1997, J MOL BIOL, V266, P76, DOI 10.1006/jmbi.1996.0774; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Piuri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004870; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Rybniker J, 2003, J BACTERIOL, V185, P1745, DOI 10.1128/JB.185.5.1745-1748.2003; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; SNIDER DE, 1984, AM REV RESPIR DIS, V130, P1095; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; TIMME TL, 1984, J GEN MICROBIOL, V130, P2059; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vilcheze C, 2006, NAT MED; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wilson SM, 1997, NAT MED, V3, P465, DOI 10.1038/nm0497-465; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	75	47	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26750	10.1371/journal.pone.0026750	http://dx.doi.org/10.1371/journal.pone.0026750			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053209	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000299081800035
J	Totsika, M; Beatson, SA; Sarkar, S; Phan, MD; Petty, NK; Bachmann, N; Szubert, M; Sidjabat, HE; Paterson, DL; Upton, M; Schembri, MA				Totsika, Makrina; Beatson, Scott A.; Sarkar, Sohinee; Minh-Duy Phan; Petty, Nicola K.; Bachmann, Nathan; Szubert, Marek; Sidjabat, Hanna E.; Paterson, David L.; Upton, Mathew; Schembri, Mark A.			Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; BETA-LACTAMASE; TYPE-1 FIMBRIATION; CLONAL GROUPS; SEQUENCE; CTX-M-15; STRAIN; FIMB; EMERGENCE; EPIDEMIC	Escherichia coli strains causing urinary tract infection (UTI) are increasingly recognized as belonging to specific clones. E. coli clone O25b:H4-ST131 has recently emerged globally as a leading multi-drug resistant pathogen causing urinary tract and bloodstream infections in hospitals and the community. While most molecular studies to date examine the mechanisms conferring multi-drug resistance in E. coli ST131, relatively little is known about their virulence potential. Here we examined E. coli ST131 clinical isolates from two geographically diverse collections, one representing the major pathogenic lineages causing UTI across the United Kingdom and a second representing UTI isolates from patients presenting at two large hospitals in Australia. We determined a draft genome sequence for one representative isolate, E. coli EC958, which produced CTX-M-15 extended-spectrum beta-lactamase, CMY-23 type AmpC cephalosporinase and was resistant to ciprofloxacin. Comparative genome analysis indicated that EC958 encodes virulence genes commonly associated with uropathogenic E. coli (UPEC). The genome sequence of EC958 revealed a transposon insertion in the fimB gene encoding the activator of type 1 fimbriae, an important UPEC bladder colonization factor. We identified the same fimB transposon insertion in 59% of the ST131 UK isolates, as well as 71% of ST131 isolates from Australia, suggesting this mutation is common among E. coli ST131 strains. Insertional inactivation of fimB resulted in a phenotype resembling a slower off-to-on switching for type 1 fimbriae. Type 1 fimbriae expression could still be induced in fimB-null isolates; this correlated strongly with adherence to and invasion of human bladder cells and bladder colonisation in a mouse UTI model. We conclude that E. coli ST131 is a geographically widespread, antibiotic resistant clone that has the capacity to produce numerous virulence factors associated with UTI.	[Totsika, Makrina; Beatson, Scott A.; Sarkar, Sohinee; Minh-Duy Phan; Petty, Nicola K.; Bachmann, Nathan; Szubert, Marek; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Sidjabat, Hanna E.; Paterson, David L.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Upton, Mathew] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Manchester	Totsika, M (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	m.upton@manchester.ac.uk; m.schembri@uq.edu.au	Paterson, David L/A-9258-2010; Sidjabat, Hanna Evelina/G-2675-2010; Phan, Minh-Duy/I-9147-2012; Upton, Mathew/J-7514-2019; Schembri, Mark A/C-7262-2009; Petty, Nicola/A-3122-2012; Totsika, Makrina/A-8993-2011; Beatson, Scott/B-6985-2013	Sidjabat, Hanna Evelina/0000-0001-5625-1317; Phan, Minh-Duy/0000-0002-3426-1044; Upton, Mathew/0000-0003-4287-6396; Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Beatson, Scott/0000-0002-1806-3283; Petty, Nicola/0000-0001-6528-9886; Sarkar, Sohinee/0000-0001-9364-1920; Paterson, David/0000-0003-2079-4437	Australian National Health and Medical Research Council [APP1012076, 631654]; Australian Research Council (ARC) [DP0881247, FT100100662]; Science Foundation of Ireland [05/FE1/B882]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Science Foundation of Ireland(Science Foundation Ireland)	This work was supported by grants from the Australian National Health and Medical Research Council [APP1012076 and 631654]. SAB is supported by an Australian Research Council (ARC) Australian Research Fellowship [DP0881247] and MAS by an ARC Future Fellowship [FT100100662]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Tarek Gibreel, Barbara Arnts, Chelsea Stewart and Michael Moore for technical assistance and clinical microbiology laboratory staff in Northwest England and Queensland, Australia, for assistance with strain collection. We would also like to thank Nabil-Fareed Alikhan and Kirstin Hanks-Thomson for their assistance with the analysis of the EC958 genome sequence. Work included in and leading to this study made use of the MLST database maintained at the University of Cork. These data are publicly available at http://mlst.ucc.ie, which is currently supported by a grant from the Science Foundation of Ireland (05/FE1/B882).	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Allsopp LP, 2010, INFECT IMMUN; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Cagnacci S, 2008, J CLIN MICROBIOL, V46, P2605, DOI 10.1128/JCM.00640-08; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ender PT, 2009, J CLIN MICROBIOL, V47, P3780, DOI 10.1128/JCM.01361-09; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hannan TJ, 2008, MOL MICROBIOL, V67, P116, DOI 10.1111/j.1365-2958.2007.06025.x; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Johnson JR, 2009, PEDIAT INFECT DIS J; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Peirano G, 2011, ANTIMICROB AGENTS CH; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Platell JL, 2010, J ANTIMICROB CHEMOTH, V65, P1936, DOI 10.1093/jac/dkq236; Sidjabat HE, 2010, J ANTIMICROB CHEMOTH, V65, P1301, DOI 10.1093/jac/dkq098; Stamm WE, 2001, NEW ENGL J MED, V345, P1055, DOI 10.1056/NEJM200110043451409; Stentebjerg-Olesen B, 1999, J BACTERIOL, V181, P7470, DOI 10.1128/JB.181.24.7470-7478.1999; Stentebjerg-Olesen B, 2000, FEMS MICROBIOL LETT, V182, P319, DOI 10.1016/S0378-1097(99)00608-4; Sullivan MJ, 2011, BIOINFORMATICS; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Xie Y, 2006, INFECT IMMUN, V74, P4039, DOI 10.1128/IAI.02058-05	42	147	149	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26578	10.1371/journal.pone.0026578	http://dx.doi.org/10.1371/journal.pone.0026578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053197	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800023
J	Marti, S; Chabane, YN; Alexandre, S; Coquet, L; Vila, J; Jouenne, T; De, E				Marti, Sara; Chabane, Yassine Nait; Alexandre, Stephane; Coquet, Laurent; Vila, Jordi; Jouenne, Thierry; De, Emmanuelle			Growth of Acinetobacter baumannii in Pellicle Enhanced the Expression of Potential Virulence Factors	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; PSEUDOMONAS-AERUGINOSA BIOFILM; TRANSMEMBRANE PASSAGE; MULTIDRUG-RESISTANCE; PROTEOMIC ANALYSIS; ABIOTIC SURFACES; EPITHELIAL-CELLS; IRON; PILI; ADHERENCE	Background: Interestingly, Acinetobacter baumannii presents an enhanced capacity to form biofilms (also named pellicles) at the air-liquid interface as compared to the other Acinetobacter species. This characteristic questions the contribution of this phenotype to an increased risk of clinical infections by this pathogen. Methodology/Principal Findings: By a proteomic approach using 2-D gel electrophoresis-LC-MS/MS mass spectrometry, we compared the membrane protein patterns of A. baumannii 77, a pellicle-forming clinical isolate, grown in planktonic and in sessile modes. We identified 52 proteins with a differential expression, including 32 up-regulated and 20 down-regulated in the pellicle state. Several proteins, differentially expressed during pellicle development, were of particular interest. We determined the over-expression of four siderophore iron uptake systems including the acinetobactin and enterobactin receptors and confirmed that the development of this type of biofilm is promoted by ferric ions. Two over-expressed proteins, CarO and an OprD-homologue, putative carbapenem-resistance associated porins, would be involved in the transport of specific compounds, like ornithine, a biosynthesis precursor of a siderophore from the hydroxamate family. We evidenced the overexpression of a lipase and a transporter of LCFA that may be involved in the recycling of lipids inside the pellicle matrix. Finally, we demonstrated both by proteomic and by AFM studies that this particular type of biofilm required multiple pili systems to maintain this cohesive structure at the air-liquid interface; two of these systems have never been described in A. baumannii. Conclusions/Significance: Our study demonstrated that several proteins, overexpressed at a late state of pellicle development, could be potentially involved in virulence processes. Therefore, regarding the number of potential virulence factors that are over-expressed in this growth mode, the pellicle-forming clinical isolates should be kept under survey.	[Marti, Sara; Chabane, Yassine Nait; Alexandre, Stephane; Coquet, Laurent; Jouenne, Thierry; De, Emmanuelle] Univ Rouen, CNRS, FR 3038, Lab Polymeres Biopolymeres Surfaces, Mont St Aignan, France; [Vila, Jordi] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain; [Marti, Sara; Chabane, Yassine Nait; Alexandre, Stephane; Coquet, Laurent; Jouenne, Thierry; De, Emmanuelle] Univ Rouen, Lab Polymeres Biopolymeres Surfaces, UMR 6270, CNRS, Mont St Aignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; University of Barcelona; Hospital Clinic de Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie	Marti, S (corresponding author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, UMR 6270, CNRS, Mont St Aignan, France.	emmanuelle.de@univ-rouen.fr	Marti, Sara/D-4823-2014; Vila, Jordi/P-3613-2016; Nait chabane, Yassine/GNN-0300-2022	Marti, Sara/0000-0002-0405-2305; Vila, Jordi/0000-0002-8025-3926; jouenne, thierry/0000-0003-0994-9944; NAIT CHABANE, Yassine/0000-0002-9528-2105; ALEXANDRE, Stephane/0000-0003-0717-8592; De, Emmanuelle/0000-0002-9564-1649; COQUET, Laurent/0000-0001-7778-7321	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region(Region Normandie)	SM has a post-doctoral fellowship from the Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) and YNC a doctoral fellowship from the Haute-Normandie region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewoye LO, 1999, CAN J MICROBIOL, V45, P1033, DOI 10.1139/cjm-45-12-1033; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arhin A, 2010, MICROBIOL-SGM, V156, P1415, DOI 10.1099/mic.0.033472-0; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BLACK PN, 1987, J BIOL CHEM, V262, P1412; Blonder J, 2004, EXPERT REV PROTEOMIC, V1, P153, DOI 10.1586/14789450.1.2.153; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cai Y, 2009, J PHARM PHARMACOL, V61, P1257, DOI 10.1211/jpp/61.09.0017; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; Coquet L, 2005, J PROTEOME RES, V4, P1988, DOI 10.1021/pr050165c; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; DEBEER D, 1994, APPL ENVIRON MICROB, V60, P4339, DOI 10.1128/AEM.60.12.4339-4344.1994; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; GOLDSTEIN R, 1995, J BACTERIOL, V177, P1039, DOI 10.1128/jb.177.4.1039-1052.1995; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; LEISMAN GB, 1995, APPL ENVIRON MICROB, V61, P200, DOI 10.1128/AEM.61.1.200-204.1995; Leopold K, 1997, MICROBIOL-SGM, V143, P1019, DOI 10.1099/00221287-143-3-1019; Lower BH, 2005, J BACTERIOL, V187, P2127, DOI 10.1128/JB.187.6.2127-2137.2005; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Marti S, 2006, PROTEOMICS, V6, pS82, DOI 10.1002/pmic.200500323; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Mussi MA, 2007, FEBS LETT, V581, P5573, DOI 10.1016/j.febslet.2007.10.063; Nucleo E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-270; Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Otto J, 2001, J BACTERIOL, V183, P2445, DOI 10.1128/JB.183.8.2445-2453.2001; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pimenta AD, 2003, MICROBES INFECT, V5, P1177, DOI 10.1016/j.micinf.2003.09.002; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; RABILLOUD T, 1994, CELL MOL BIOL, V40, P57; Raymond KN, 2004, IRON TRANSPORT IN BACTERIA, P3; Rebiere-Huet J, 2002, FEMS MICROBIOL LETT, V215, P121, DOI 10.1016/S0378-1097(02)00920-5; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Scher K, 2007, BIOFOULING, V23, P385, DOI 10.1080/08927010701648265; Seyer D., 2005, BIOFILMS, V2, P27, DOI [10.1017/S1479050505001638, DOI 10.1017/S1479050505001638]; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Siroy A, 2006, J PROTEOME RES, V5, P3385, DOI 10.1021/pr060372s; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Tamber S, 2007, J BACTERIOL, V189, P929, DOI 10.1128/JB.01296-06; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P746, DOI 10.1007/0-387-30746-x_25; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Walsh TR, 2005, CLIN MICROBIOL INFEC, V11, P2, DOI 10.1111/j.1469-0691.2005.01264.x; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; YAMANO Y, 1993, MOL MICROBIOL, V8, P993, DOI 10.1111/j.1365-2958.1993.tb01643.x; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	84	61	64	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26030	10.1371/journal.pone.0026030	http://dx.doi.org/10.1371/journal.pone.0026030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046254	gold, Green Published			2022-12-27	WOS:000296521400008
J	Zhang, Y; Wheatley, R; Fulkerson, E; Tapp, A; Estes, PA				Zhang, Yi; Wheatley, Randi; Fulkerson, Eric; Tapp, Amanda; Estes, Patricia A.			Mastermind Mutations Generate a Unique Constellation of Midline Cells within the Drosophila CNS	PLOS ONE			English	Article							SINGLE-MINDED GENE; CENTRAL-NERVOUS-SYSTEM; NEUROGENIC LOCUS MASTERMIND; TRANSCRIPTIONAL ACTIVATION; NOTCH COACTIVATOR; AXON GUIDANCE; MELANOGASTER; EXPRESSION; COMPLEX; FATE	Background: The Notch pathway functions repeatedly during the development of the central nervous system in metazoan organisms to control cell fate and regulate cell proliferation and asymmetric cell divisions. Within the Drosophila midline cell lineage, which bisects the two symmetrical halves of the central nervous system, Notch is required for initial cell specification and subsequent differentiation of many midline lineages. Methodology/Principal Findings: Here, we provide the first description of the role of the Notch co-factor, mastermind, in the central nervous system midline of Drosophila. Overall, zygotic mastermind mutations cause an increase in midline cell number and decrease in midline cell diversity. Compared to mutations in other components of the Notch signaling pathway, such as Notch itself and Delta, zygotic mutations in mastermind cause the production of a unique constellation of midline cell types. The major difference is that midline glia form normally in zygotic mastermind mutants, but not in Notch and Delta mutants. Moreover, during late embryogenesis, extra anterior midline glia survive in zygotic mastermind mutants compared to wild type embryos. Conclusions/Significance: This is an example of a mutation in a signaling pathway cofactor producing a distinct central nervous system phenotype compared to mutations in major components of the pathway.	[Zhang, Yi; Wheatley, Randi; Fulkerson, Eric; Tapp, Amanda; Estes, Patricia A.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Zhang, Y (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	pat_estes@ncsu.edu		Zhang, Yi/0000-0002-2789-0811	National Science Foundation [0416812, 0750620]; National Institutes of Health; American Foundation for Aging Research	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Aging Research	This work was funded by National Science Foundation grants 0416812 and 0750620. Yi Zhang was supported by an National Institutes of Health Training Grant in the Genetic Architecture of Quantitative Traits and an American Foundation for Aging Research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Araujo SJ, 2003, NAT REV NEUROSCI, V4, P910, DOI 10.1038/nrn1243; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bossing T, 2006, DEVELOPMENT, V133, P1001, DOI 10.1242/dev.02288; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CHOU TB, 1993, DEVELOPMENT, V119, P1359; CREWS S, 1992, J EXP ZOOL, V261, P234, DOI 10.1002/jez.1402610303; Crews S, 1988, CELL, V15, P143; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Dong R, 1997, DEV BIOL, V190, P165, DOI 10.1006/dbio.1997.8688; Estes P, 2008, GENETICS, V178, P787, DOI 10.1534/genetics.107.080440; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Giraldez AJ, 2002, MECH DEVELOP, V115, P101, DOI 10.1016/S0925-4773(02)00124-7; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; JIMENEZ F, 1982, ROUX ARCH DEV BIOL, V191, P191; Kasai Y, 1998, GENE EXPRESSION, V7, P171; KASAI Y, 1992, P NATL ACAD SCI USA, V89, P3414, DOI 10.1073/pnas.89.8.3414; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LINDSLEY DLZ, GENOME DROSOPHILA ME; MARTINBERMUDO MD, 1995, DEVELOPMENT, V121, P219; MENNE TV, 1994, DEVELOPMENT, V120, P123; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Morel V, 2000, GENE DEV, V14, P377; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Price JV, 1997, GENETICS, V147, P1139; Radtke F, 2005, EMBO REP, V6, P1120, DOI 10.1038/sj.embor.7400585; Schuldt AJ, 1999, DEV BIOL, V205, P287, DOI 10.1006/dbio.1998.9014; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; SHEPARD SB, 1989, GENETICS, V122, P429; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Stagg SB, 2011, DEVELOPMENT, V138, P2171, DOI 10.1242/dev.056507; Stemerdink C, 1997, DEVELOPMENT, V124, P3787; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Thor S, 2002, CURR OPIN GENET DEV, V12, P558, DOI 10.1016/S0959-437X(02)00340-4; Vied C, 2009, DEVELOPMENT, V136, P2177, DOI 10.1242/dev.035329; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Ward MP, 1998, DEVELOPMENT, V125, P1599; Watson JD, 2011, DEVELOPMENT, V138, P1285, DOI 10.1242/dev.056895; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; Yedvobnick B, 2004, GENETICS, V166, P1281, DOI 10.1534/genetics.166.3.1281; YEDVOBNICK B, 1988, GENETICS, V118, P483; Yedvobnick B, 2010, DIS MODEL MECH, V3, P540, DOI 10.1242/dmm.005520; 1998, MECH DEV, V79, P39	71	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26197	10.1371/journal.pone.0026197	http://dx.doi.org/10.1371/journal.pone.0026197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046261	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400011
J	Das, M; Das, M; Ithychanda, SS; Qin, J; Plow, EF				Das, Mitali; Das, Mitali; Ithychanda, Sujay Subbayya; Qin, Jun; Plow, Edward F.			Migfilin and Filamin as Regulators of Integrin Activation in Endothelial Cells and Neutrophils	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; LIM PROTEIN; TERMINAL DIFFERENTIATION; SIGNALING FUNCTIONS; STRUCTURAL BASIS; LIGAND-BINDING; LOCALIZATION; EXPRESSION; KINDLIN-2; ADHESION	Cell adhesion and migration depend on engagement of extracellular matrix ligands by integrins. Integrin activation is dynamically regulated by interactions of various cytoplasmic proteins, such as filamin and integrin activators, talin and kindlin, with the cytoplasmic tail of the integrin beta subunit. Although filamin has been suggested to be an inhibitor of integrin activation, direct functional evidence for the inhibitory role of filamin is limited. Migfilin, a filamin-binding protein enriched at cell-cell and cell-extracellular matrix contact sites, can displace filamin from beta 1 and beta 3 integrins and promote integrin activation. However, its role in activation and functions of different beta integrins in human vascular cells is unknown. In this study, using flow cytometry, we demonstrate that filamin inhibits beta 1 and alpha IIb beta 3 integrin activation, and migfilin can overcome its inhibitory effect. Migfilin protein is widely expressed in different adherent and circulating blood cells and can regulate integrin activation in naturally-occurring vascular cells, endothelial cells and neutrophils. Migfilin can activate beta 1, beta 2 and beta 3 integrins and promote integrin mediated responses while migfilin depletion impairs the spreading and migration of endothelial cells. Thus, filamin can act broadly as an inhibitor and migfilin is a promoter of integrin activation.	[Das, Mitali; Das, Mitali; Ithychanda, Sujay Subbayya; Qin, Jun; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Das, M (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	plowe@ccf.org	Ithychanda, Sujay Subbayya/C-7792-2011	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health (NIH) [HL 073311]; American Heart Associate (AHA) [9POST2150124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Associate (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant awarded to EFP from the National Institutes of Health (NIH)(HL 073311), and a grant awarded to MD from the American Heart Associate (AHA) (#9POST2150124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; ARNAOUT MA, 1983, J CLIN INVEST, V72, P171, DOI 10.1172/JCI110955; Bandyopadhyay S, 2007, MOL CELL BIOL, V27, P4207, DOI 10.1128/MCB.00052-07; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; BORREGAARD N, 1994, J LEUKOCYTE BIOL, V56, P80, DOI 10.1002/jlb.56.1.80; BRACKMAN D, 1995, LEUKEMIA RES, V19, P57, DOI 10.1016/0145-2126(94)00061-E; Bunch TA, 2010, J BIOL CHEM, V285, P1841, DOI 10.1074/jbc.M109.057349; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Carrigan SO, 2007, J LEUKOCYTE BIOL, V82, P1575, DOI 10.1189/jlb.0806528; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; David T, 2006, J THROMB HAEMOST, V4, P2645, DOI 10.1111/j.1538-7836.2006.02198.x; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Eades-Perner AM, 1998, BLOOD, V91, P663, DOI 10.1182/blood.V91.2.663.663_663_672; Feng YF, 2005, MOL CELL BIOL, V25, P4010, DOI 10.1128/MCB.25.10.4010-4022.2005; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; HICKSTEIN DD, 1987, J IMMUNOL, V138, P513; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P1293, DOI 10.1073/pnas.76.3.1293; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pluskota E, 2008, J IMMUNOL, V181, P3609, DOI 10.4049/jimmunol.181.5.3609; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Scarpati EM, 1996, J BIOL CHEM, V271, P3025, DOI 10.1074/jbc.271.6.3025; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WOODS VL, 1984, BLOOD, V63, P368; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhao JP, 2009, J BIOL CHEM, V284, P34308, DOI 10.1074/jbc.M109.045021	55	55	58	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26355	10.1371/journal.pone.0026355	http://dx.doi.org/10.1371/journal.pone.0026355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043318	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400050
J	Schmitt, KC; Reith, MEA				Schmitt, Kyle C.; Reith, Maarten E. A.			The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors	PLOS ONE			English	Article							BACTERIAL HOMOLOG; IN-VIVO; NOREPINEPHRINE TRANSPORTER; DISCRIMINATIVE STIMULUS; MONOAMINE TRANSPORTERS; CONFORMATIONAL-CHANGES; REINFORCING STRENGTH; SODIUM SYMPORTER; BINDING-SITES; NEUROTRANSMITTER	Modafinil is a mild psychostimulant with pro-cognitive and antidepressant effects. Unlike many conventional stimulants, modafinil has little appreciable potential for abuse, making it a promising therapeutic agent for cocaine addiction. The chief molecular target of modafinil is the dopamine transporter (DAT); however, the mechanistic details underlying modafinil's unique effects remain unknown. Recent studies suggest that the conformational effects of a given DAT ligand influence the magnitude of the ligand's reinforcing properties. For example, the atypical DAT inhibitors benztropine and GBR12909 do not share cocaine's notorious addictive liability, despite having greater binding affinity. Here, we show that the binding mechanism of modafinil is different than cocaine and similar to other atypical inhibitors. We previously established two mutations (W84L and D313N) that increase the likelihood that the DAT will adopt an outward-facing conformational state-these mutations increase the affinity of cocaine-like inhibitors considerably, but have little or opposite effect on atypical inhibitor binding. Thus, a compound's WT/mutant affinity ratio can indicate whether the compound preferentially interacts with a more outward-or inward-facing conformational state. Modafinil displayed affinity ratios similar to those of benztropine, GBR12909 and bupropion (which lack cocaine-like effects in humans), but far different than those of cocaine, beta-CFT or methylphenidate. Whereas treatment with zinc (known to stabilize an outward-facing transporter state) increased the affinity of cocaine and methylphenidate two-fold, it had little or no effect on the binding of modafinil, benztropine, bupropion or GBR12909. Additionally, computational modeling of inhibitor binding indicated that while b-CFT and methylphenidate stabilize an "open-to-out'' conformation, binding of either modafinil or bupropion gives rise to a more closed conformation. Our findings highlight a mechanistic difference between modafinil and cocaine-like stimulants and further demonstrate that the conformational effects of a given DAT inhibitor influence its phenomenological effects.	[Schmitt, Kyle C.; Reith, Maarten E. A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Sch Med, Dept Psychiat, New York, NY USA	New York University; New York University	Schmitt, KC (corresponding author), NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA.	maarten.reith@nyumc.org	Reith, Maarten E./AAD-2303-2019	Reith, Maarten E./0000-0002-1900-842X; Schmitt, Kyle/0000-0002-8456-422X	United States National Institutes of Health (NIH) [DA013261, DA019676]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019676, R01DA013261] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Project supported by United States National Institutes of Health (NIH) Grants DA013261 and DA019676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballon JS, 2006, J CLIN PSYCHIAT, V67, P554, DOI 10.4088/JCP.v67n0406; Batman AM, 2010, EUR J PHARMACOL, V648, P127, DOI 10.1016/j.ejphar.2010.08.051; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Campbell VC, 2005, J PHARMACOL EXP THER, V315, P631, DOI 10.1124/jpet.105.090829; Cao JJ, 2011, ACS MED CHEM LETT, V2, P48, DOI 10.1021/ml1002025; Chen NH, 2004, J NEUROCHEM, V89, P853, DOI 10.1111/j.1471-4159.2004.02386.x; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen NH, 2003, J NEUROCHEM, V86, P678, DOI 10.1046/j.1471-4159.2003.01889.x; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Czoty PW, 2010, PHARMACOL BIOCHEM BE, V96, P274, DOI 10.1016/j.pbb.2010.05.017; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; Damaj MI, 2004, MOL PHARMACOL, V66, P675, DOI 10.1124/mol.104.001313; Deroche-Gamonet V, 2002, PSYCHOPHARMACOLOGY, V161, P387, DOI 10.1007/s00213-002-1080-8; Desai RI, 2005, J PHARMACOL EXP THER, V315, P397, DOI 10.1124/jpet.105.091231; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; Donovan JL, 2003, THER DRUG MONIT, V25, P197, DOI 10.1097/00007691-200304000-00009; ECKERMAN DA, 1991, PHARMACOL BIOCHEM BE, V40, P875, DOI 10.1016/0091-3057(91)90100-G; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gedeon PC, 2010, PROTEINS, V78, P797, DOI 10.1002/prot.22601; GLENNON RA, 1995, PHARMACOL BIOCHEM BE, V50, P601, DOI 10.1016/0091-3057(94)00348-3; Gold LH, 1996, PSYCHOPHARMACOLOGY, V126, P286, DOI 10.1007/BF02247379; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Herin DV, 2010, ANN NY ACAD SCI, V1187, P76, DOI 10.1111/j.1749-6632.2009.05145.x; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Hiranita T, 2009, J PHARMACOL EXP THER, V329, P677, DOI 10.1124/jpet.108.145813; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Jasinski DR, 2000, J PSYCHOPHARMACOL, V14, P53, DOI 10.1177/026988110001400107; Kimmel HL, 2008, PHARMACOL BIOCHEM BE, V90, P453, DOI 10.1016/j.pbb.2008.03.032; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kopajtic TA, 2010, J PHARMACOL EXP THER, V335, P703, DOI 10.1124/jpet.110.171629; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lam JY, 2007, ANN PHARMACOTHER, V41, P1005, DOI 10.1345/aph.1H526; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SM, 2005, J PHARMACOL EXP THER, V313, P1223, DOI 10.1124/jpet.105.084541; Li SM, 2011, J PHARMACOL EXP THER, V336, P575, DOI 10.1124/jpet.110.173260; Liang YJ, 2009, J NEUROCHEM, V109, P981, DOI 10.1111/j.1471-4159.2009.06034.x; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Marchant NL, 2009, PSYCHOPHARMACOLOGY, V202, P487, DOI 10.1007/s00213-008-1395-1; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Newman JL, 2010, EXP CLIN PSYCHOPHARM, V18, P395, DOI 10.1037/a0021042; Ninan PT, 2004, J CLIN PSYCHIAT, V65, P414; Paterson NE, 2010, PHARMACOL BIOCHEM BE, V95, P449, DOI 10.1016/j.pbb.2010.03.006; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rasetti R, 2010, NEUROPSYCHOPHARMACOL, V35, P2101, DOI 10.1038/npp.2010.83; Regenthal R, 2009, PSYCHOPHARMACOLOGY, V204, P627, DOI 10.1007/s00213-009-1493-8; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; Ridenour TA, 2005, DRUG ALCOHOL DEPEN, V80, P1, DOI 10.1016/j.drugalcdep.2005.02.005; Rothman RB, 2003, J PHARMACOL EXP THER, V307, P138, DOI 10.1124/jpet.103.053975; Rothman RB, 2008, BIOCHEM PHARMACOL, V75, P2, DOI 10.1016/j.bcp.2007.08.007; Schmitt KC, 2008, J NEUROCHEM, V107, P928, DOI 10.1111/j.1471-4159.2008.05667.x; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SOGAARD U, 1990, INT CLIN PSYCHOPHARM, V5, P237, DOI 10.1097/00004850-199010000-00001; Tahsili-Fahadan P, 2010, NEUROPSYCHOPHARMACOL, V35, P2203, DOI 10.1038/npp.2010.94; Tanda G, 2009, J PHARMACOL EXP THER, V330, P802, DOI 10.1124/jpet.109.154302; Tella SR, 1997, J PHARMACOL EXP THER, V281, P508; Tsanov M, 2010, NEUROPHARMACOLOGY, V59, P9, DOI 10.1016/j.neuropharm.2010.03.010; Tsuang MT, 1999, BEHAV GENET, V29, P473, DOI 10.1023/A:1021635223370; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Velazquez-Sanchez C, 2009, NEUROPSYCHOPHARMACOL, V34, P2497, DOI 10.1038/npp.2009.78; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Volz TJ, 2004, SYNAPSE, V52, P272, DOI 10.1002/syn.20021; Vosburg SK, 2010, DRUG ALCOHOL DEPEN, V106, P233, DOI 10.1016/j.drugalcdep.2009.09.002; Wee S, 2006, NEUROPSYCHOPHARMACOL, V31, P351, DOI 10.1038/sj.npp.1300795; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003; Williard RL, 2007, BEHAV PHARMACOL, V18, P39, DOI 10.1097/FBP.0b013e3280143226; Woolverton WL, 2004, EUR J PHARMACOL, V486, P251, DOI 10.1016/j.ejphar.2004.01.003; Wuo-Silva R, 2011, ADDICT BIOL, V16, P565, DOI 10.1111/j.1369-1600.2011.00341.x; Xu TX, 2010, J NEUROCHEM, V115, P1643, DOI 10.1111/j.1471-4159.2010.07073.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zeeuws I, 2010, HUM PSYCHOPHARM CLIN, V25, P326, DOI 10.1002/hup.1120; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	91	88	89	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25790	10.1371/journal.pone.0025790	http://dx.doi.org/10.1371/journal.pone.0025790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043293	gold, Green Submitted, Green Published			2022-12-27	WOS:000295984400021
J	Falik, O; Mordoch, Y; Quansah, L; Fait, A; Novoplansky, A				Falik, Omer; Mordoch, Yonat; Quansah, Lydia; Fait, Aaron; Novoplansky, Ariel			Rumor Has It ... : Relay Communication of Stress Cues in Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; ABSCISIC-ACID; INDUCED RESISTANCE; INDUCED VOLATILES; WATER-STRESS; HERBIVORY; DEFENSE; RECOGNITION; BEHAVIOR; ECOLOGY	Recent evidence demonstrates that plants are able not only to perceive and adaptively respond to external information but also to anticipate forthcoming hazards and stresses. Here, we tested the hypothesis that unstressed plants are able to respond to stress cues emitted from their abiotically-stressed neighbors and in turn induce stress responses in additional unstressed plants located further away from the stressed plants. Pisum sativum plants were subjected to drought while neighboring rows of five unstressed plants on both sides, with which they could exchange different cue combinations. On one side, the stressed plant and its unstressed neighbors did not share their rooting volumes (UNSHARED) and thus were limited to shoot communication. On its other side, the stressed plant shared one of its rooting volumes with its nearest unstressed neighbor and all plants shared their rooting volumes with their immediate neighbors (SHARED), allowing both root and shoot communication. Fifteen minutes following drought induction, significant stomatal closure was observed in both the stressed plants and their nearest unstressed SHARED neighbors, and within one hour, all SHARED neighbors closed their stomata. Stomatal closure was not observed in the UNSHARED neighbors. The results demonstrate that unstressed plants are able to perceive and respond to stress cues emitted by the roots of their drought-stressed neighbors and, via 'relay cuing', elicit stress responses in further unstressed plants. Further work is underway to study the underlying mechanisms of this new mode of plant communication and its possible adaptive implications for the anticipation of forthcoming abiotic stresses by plants.	[Falik, Omer; Mordoch, Yonat; Novoplansky, Ariel] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Quansah, Lydia; Fait, Aaron] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Dryland, Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel	Ben Gurion University; Ben Gurion University	Falik, O (corresponding author), Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel.	anovopla@bgu.ac.il	Fait, Aaron/M-2869-2015; Quansah, Lydia/GPK-6126-2022	Fait, Aaron/0000-0002-9073-8441; Novoplansky, Ariel/0000-0003-0988-786X	Israel Science foundation [341/04]	Israel Science foundation(Israel Science Foundation)	The study was partially funded by grant no. 341/04 from the Israel Science foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	APHALO PJ, 1995, FUNCT ECOL, V9, P5, DOI 10.2307/2390084; Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bruin J, 2001, BIOCHEM SYST ECOL, V29, P1103, DOI 10.1016/S0305-1978(01)00053-9; Callaway RM, 2007, NATURE, V448, P145, DOI 10.1038/448145a; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; CHEPLICK GP, 1993, ECOLOGY, V74, P2161, DOI 10.2307/1940860; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Conrath U, 2009, ADV BOT RES, V51, P361, DOI 10.1016/S0065-2296(09)51009-9; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P1075, DOI 10.1016/S0305-1978(01)00051-5; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gomez S, 2006, OECOLOGIA, V147, P461, DOI 10.1007/s00442-005-0293-z; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Griffin AS, 2005, ANIM BEHAV, V70, P507, DOI 10.1016/j.anbehav.2004.11.023; Haisel D, 2006, PHOTOSYNTHETICA, V44, P606, DOI 10.1007/s11099-006-0079-5; Hartung W, 2005, AUST J AGR RES, V56, P1253, DOI 10.1071/AR05065; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Herben T, 2008, EVOL ECOL, V22, P337, DOI 10.1007/s10682-007-9214-4; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kegge W, 2010, TRENDS PLANT SCI, V15, P126, DOI 10.1016/j.tplants.2009.11.007; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; SACHS T, 1993, ANN BOT-LONDON, V71, P237, DOI 10.1006/anbo.1993.1030; *SPSS INC, 2000, SYSTAT WIND VERS 10; Trewavas A, 2009, PLANT CELL ENVIRON, V32, P606, DOI 10.1111/j.1365-3040.2009.01929.x; Trouverie J, 2003, J EXP BOT, V54, P2177, DOI 10.1093/jxb/erg234; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Wu JS, 2008, PLANTA, V227, P1161, DOI 10.1007/s00425-008-0690-8	52	46	47	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e23625	10.1371/journal.pone.0023625	http://dx.doi.org/10.1371/journal.pone.0023625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073135	Green Published, gold			2022-12-27	WOS:000297154900013
J	Chen, J; Zhang, RF; Wang, JR; Liu, L; Zheng, YF; Shen, YZ; Qi, TK; Lu, HZ				Chen, Jun; Zhang, Renfang; Wang, Jiangrong; Liu, Li; Zheng, Yufang; Shen, Yinzhong; Qi, Tangkai; Lu, Hongzhou			Interferon-Gamma Release Assays for the Diagnosis of Active Tuberculosis in HIV-Infected Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GOLD IN-TUBE; PULMONARY TUBERCULOSIS; RECOMMENDATIONS; SENSITIVITY; PERFORMANCE; MANAGEMENT; ADULTS	Background: Interferon-gamma release assays (IGRAs) have provided a new method for the diagnosis of Mycobacterium tuberculosis infection. However, the role of IGRAs for the diagnosis of active tuberculosis (TB), especially in HIV-infected patients remains unclear. Methods: We searched PubMed, EMBASE and Cochrane databases to identify studies published in January 2001-July 2011 that evaluated the evidence of using QuantiFERON-TB Gold in-tube (QFT-GIT) and T-SPOT. TB (T-SPOT) on blood for the diagnosis of active TB in HIV-infected patients. Results: The search identified 16 eligible studies that included 2801 HIV-infected individuals (637 culture confirmed TB cases). The pooled sensitivity for the diagnosis of active TB was 76.7% (95% CI, 71.6-80.5%) and 77.4% (95% CI, 71.4-82.6%) for QFT-GIT and T-SPOT, respectively, while the specificity was 76.1% (95% CI, 74.0-78.0%) and 63.1% (95% CI, 57.6-68.3%) after excluding the indeterminate results. Studies conducted in low/middle income countries showed slightly lower sensitivity and specificity when compared to that in high-income countries. The proportion of indeterminate results was as high as 10% (95% CI, 8.8-11.3%) and 13.2% (95% CI, 10.6-16.0%) for QFT-GIT and T-SPOT, respectively. Conclusion: IGRAs in their current formulations have limited accuracy in diagnosing active TB in HIV-infected patients, and should not be used alone to rule out or rule in active TB cases in HIV-infected patients. Further modification is needed to improve their accuracy.	[Chen, Jun; Zhang, Renfang; Wang, Jiangrong; Liu, Li; Zheng, Yufang; Shen, Yinzhong; Qi, Tangkai; Lu, Hongzhou] Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Infect Dis, HuaShan Hosp, Shanghai 200433, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, J (corresponding author), Fudan Univ, Dept Infect Dis, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn	Chen, Zhiwei/B-7793-2019; Chen, Jun/K-2085-2012	Chen, Zhiwei/0000-0002-4511-2888; Chen, Jun/0000-0002-3850-4875	Ministry of Science and Technology, the People's Republic of China [2008ZX10001-008]; National Natural Science Foundation of China [81071353]	Ministry of Science and Technology, the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Eleven Fifth Key Research grants from the Ministry of Science and Technology, the People's Republic of China (2008ZX10001-008) and National Natural Science Foundation of China (81071353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Burman William J, 2003, Semin Respir Infect, V18, P263; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Cattamanchi A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-75; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Garcia GF, 2007, REV SOC BRAS MED TRO, V40, P622, DOI 10.1590/S0037-86822007000600004; Garcia-Gasalla M, 2010, ENFERM INFEC MICR CL, V28, P685, DOI 10.1016/j.eimc.2010.01.008; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Legesse M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-354; Ling DI, 2011, EUR RESP J; Markova R, 2009, BIOTECHNOL BIOTEC EQ, V23, P1103, DOI 10.1080/13102818.2009.10817622; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Oni T, 2010, EUR RESPIR J, V36, P594, DOI 10.1183/09031936.00171509; Pozniak AL, 2010, BRIT HIV ASS GUID TR; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rangaka MX, 2011, EUR RESP J; Sauzullo I, 2010, INT J TUBERC LUNG D, V14, P834; Schutz C, 2010, EUR RESPIR J, V36, P1460, DOI 10.1183/09031936.00110210; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester M, 2010, EUR RESPIR J, V36, P1242, DOI 10.1183/09031936.00040910; Tan CK, 2010, JAIDS-J ACQ IMM DEF, V53, P546, DOI 10.1097/QAI.0b013e3181bc467f; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Veldsman C, 2009, FEMS IMMUNOL MED MIC, V57, P269, DOI 10.1111/j.1574-695X.2009.00610.x; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; WHO, 2010, GLOB TUB CONTR 2010; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	35	52	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26827	10.1371/journal.pone.0026827	http://dx.doi.org/10.1371/journal.pone.0026827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069472	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900034
J	Day-Williams, AG; Mclay, K; Drury, E; Edkins, S; Coffey, AJ; Palotie, A; Zeggini, E				Day-Williams, Aaron G.; McLay, Kirsten; Drury, Eleanor; Edkins, Sarah; Coffey, Alison J.; Palotie, Aarno; Zeggini, Eleftheria			An Evaluation of Different Target Enrichment Methods in Pooled Sequencing Designs for Complex Disease Association Studies	PLOS ONE			English	Article							HIGH-THROUGHPUT; RARE VARIANTS; MISSING HERITABILITY; SELECTION; GENOME; STRATEGIES	Pooled sequencing can be a cost-effective approach to disease variant discovery, but its applicability in association studies remains unclear. We compare sequence enrichment methods coupled to next-generation sequencing in non-indexed pools of 1, 2, 10, 20 and 50 individuals and assess their ability to discover variants and to estimate their allele frequencies. We find that pooled resequencing is most usefully applied as a variant discovery tool due to limitations in estimating allele frequency with high enough accuracy for association studies, and that in-solution hybrid-capture performs best among the enrichment methods examined regardless of pool size.	[Day-Williams, Aaron G.; McLay, Kirsten; Drury, Eleanor; Edkins, Sarah; Coffey, Alison J.; Palotie, Aarno; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [McLay, Kirsten] Genome Anal Ctr, Norwich, Norfolk, England; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA USA; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland	Wellcome Trust Sanger Institute; The Genome Analysis Centre (TGAC); University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Day-Williams, AG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	Eleftheria@sanger.ac.uk		Zeggini, Eleftheria/0000-0003-4238-659X; Palotie, Aarno/0000-0002-2527-5874; Edkins, Sarah/0000-0003-0717-1972	Wellcome Trust [WT088885/Z/09/Z]; Library Construction team; Illumina Sequencing team; New Technology Pipeline	Wellcome Trust(Wellcome TrustEuropean Commission); Library Construction team; Illumina Sequencing team; New Technology Pipeline	This work is supported by the Wellcome Trust (WT088885/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Manuel Rivas and Mark Daly for making their variant calling Syzygy software available to us, and to Karen McLaren (project management), Cordelia Langford (genotyping), Sarah Hunt (informatics), Carol Scott (informatics), Sanjeev Bhaskar (informatics), Mike Quail and the Library Construction team, John Burton and the Illumina Sequencing team and David Jackson and the New Technology Pipeline, for their support in the project.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2010, R LANG ENV STAT COMP; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lawrence R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-527; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Smit A, 1996, REPEATMASKER OPEN 30; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; [No title captured]	25	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26279	10.1371/journal.pone.0026279	http://dx.doi.org/10.1371/journal.pone.0026279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069447	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900008
J	Lin, J; Yao, DM; Qian, J; Chen, Q; Qian, W; Li, Y; Yang, J; Wang, CZ; Chai, HY; Qian, Z; Xiao, GF; Xu, WR				Lin, Jiang; Yao, Dong-ming; Qian, Jun; Chen, Qin; Qian, Wei; Li, Yun; Yang, Jing; Wang, Cui-zhu; Chai, Hai-yan; Qian, Zhen; Xiao, Gao-fei; Xu, Wen-rong			Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome	PLOS ONE			English	Article							DNA METHYLTRANSFERASES; MYELOPROLIFERATIVE NEOPLASMS; CLASSIFICATION; METHYLATION; EXPRESSION; 3A	Somatic mutations of DNMT3A gene have recently been reported in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We examined the entire coding sequences of DNMT3A gene by high-resolution melting analysis and sequencing in Chinese patients with myeloid malignancies. R882 mutations were found in 12/182 AML and in 4/51 MDS, but not in either 79 chronic myeloid leukemia (CML), or 57 myeloproliferative neoplasms (MPNs), or 4 chronic monomyelocytic leukemia. No other DNMT3A mutations were detected in all patients. R882 mutations were associated with old age and more frequently present in monoblastic leukemia (M4 and M5, 7/52) compared to other subtypes (5/130). Furthermore, 14/16 (86.6%) R882 mutations were observed in patients with normal karyotypes. The overall survival of mutated MDS patients was shorter than those without mutation (median 9 and 25 months, respectively). We conclude that DNMT3A R882 mutations are recurrent molecular aberrations in AML and MDS, and may be an adverse prognostic event in MDS.	[Lin, Jiang; Yao, Dong-ming; Qian, Jun; Chen, Qin; Li, Yun; Yang, Jing; Wang, Cui-zhu; Chai, Hai-yan; Qian, Zhen] Jiangsu Univ, Dept Haematol, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Lin, Jiang; Qian, Wei; Xiao, Gao-fei] Jiangsu Univ, Lab Ctr, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wen-rong] Jiangsu Univ, Key Inst Clin Lab Sci, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wen-rong] Jiangsu Univ, Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University	Lin, J (corresponding author), Jiangsu Univ, Dept Haematol, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China.	qianjun0007@hotmail.com; dwqian@yahoo.com			Jiangsu Province's Key Medical Talent Program [RC2007035]	Jiangsu Province's Key Medical Talent Program	This study was supported by Jiangsu Province's Key Medical Talent Program (RC2007035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Ho PA, 2011, PEDIATR BLOOD CANCER, V57, P204, DOI 10.1002/pbc.23179; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Qian J, 2010, CLIN CHIM ACTA, V411, P2097, DOI 10.1016/j.cca.2010.08.020; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhao ZJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737535	19	107	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26906	10.1371/journal.pone.0026906	http://dx.doi.org/10.1371/journal.pone.0026906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066015	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000031
J	Swisher, KD; Parker, R				Swisher, Kylie D.; Parker, Roy			Interactions between Upf1 and the Decapping Factors Edc3 and Pat1 in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; CRYSTAL-STRUCTURE; PROTEIN COMPLEXES; STRUCTURAL BASIS; YEAST; IDENTIFICATION; PATHWAY; DCP2; RECOGNITION	In Saccharomyces cerevisiae, mRNA transcripts with premature termination codons are targeted for deadenylation independent decapping and 5' to 3' decay in a quality control pathway termed nonsense-mediated decay (NMD). Critical factors in NMD include Upf1, Upf2, and Upf3, as well as the decapping enzyme, Dcp2/Dcp1. Loss of Upf2 or Upf3 leads to the accumulation of not only Upf1 and Dcp2 in P-bodies, but also of the decapping-activators Pat1, Dhh1, and Lsm1. An interaction between Upf1 and Dcp2 has been identified, which might recruit Dcp2 to the NMD decapping complex. To determine the nature and significance of the Dcp2-Upf1 interaction, we utilized the yeast two-hybrid assay to assess Upf1 interactions with various mRNA decapping factors. We find that although Dcp2 can interact with Upf1, this interaction is indirect and is largely dependent on the Edc3 protein, which interacts with the N-terminal domain of Upf1 at an overlapping, but not identical, site as Upf2. We also found that Pat1 has an independent two-hybrid interaction with the N-terminus of Upf1. Assessment of both reporter and endogenous NMD transcripts suggest that the decapping stimulators, including Edc3 and Pat1, as well as Edc1 and Edc2, are not essential for NMD under normal conditions. This work defines a larger decapping complex involved in NMD, but indicates that components of that complex are not required for general NMD and might either regulate a subset of NMD transcripts or be essential for proper NMD under different environmental conditions.	[Swisher, Kylie D.; Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Parker, Roy] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Swisher, KD (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			Howard Hughes Medical Institute; National Institutes of Health [GM008659, GM045443]; Parker laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659, R37GM045443, R01GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (http://www.hhmi.org/), the National Institutes of Health Training Grant (GM008659), and a National Institutes of Health Grant (GM045443). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank John Gross for kindly providing us with the structure predictions and SASA values for S. cerevisiae Dcp2 and Upf1. We thank the entire Parker laboratory for their discussion and support of this research.	Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Cao D, 2003, CELL, V113, P533, DOI 10.1016/S0092-8674(03)00353-2; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Dunckley T, 2001, GENETICS, V157, P27; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Harigaya Y, 2010, MOL CELL BIOL, V30, P1446, DOI 10.1128/MCB.01305-09; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He F, 1996, RNA, V2, P153; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hu WQ, 2010, NAT STRUCT MOL BIOL, V17, P244, DOI 10.1038/nsmb.1734; James P, 1996, GENETICS, V144, P1425; Kadlec J, 2004, NAT STRUCT MOL BIOL, V11, P330, DOI 10.1038/nsmb741; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Ling SHM, 2008, MOL CELL BIOL, V28, P5965, DOI 10.1128/MCB.00761-08; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Maquat LE, 2009, BIOCHEM SOC T, V37, P1287, DOI 10.1042/BST0371287; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Schwartz D, 2003, RNA, V9, P239, DOI 10.1261/rna.2171203; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahashi S, 2008, RNA, V14, P1950, DOI 10.1261/rna.536308; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Wang WR, 2006, MOL CELL BIOL, V26, P3390, DOI 10.1128/MCB.26.9.3390-3400.2006	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26547	10.1371/journal.pone.0026547	http://dx.doi.org/10.1371/journal.pone.0026547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065998	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000014
J	Talmage, SC; Gobler, CJ				Talmage, Stephanie C.; Gobler, Christopher J.			Effects of Elevated Temperature and Carbon Dioxide on the Growth and Survival of Larvae and Juveniles of Three Species of Northwest Atlantic Bivalves	PLOS ONE			English	Article							SCALLOPS ARGOPECTEN-IRRADIANS; OCEAN ACIDIFICATION; CLIMATE-CHANGE; MERCENARIA-MERCENARIA; BAY SCALLOPS; HARD CLAM; COASTAL; WATER; PCO(2); CO2	Rising CO2 concentrations and water temperatures this century are likely to have transformative effects on many coastal marine organisms. Here, we compared the responses of two life history stages (larval, juvenile) of three species of calcifying bivalves (Mercenaria mercenaria, Crassostrea virginica, and Argopecten irradians) to temperatures (24 and 28 degrees C) and CO2 concentrations (similar to 250, 390, and 750 ppm) representative of past, present, and future summer conditions in temperate estuaries. Results demonstrated that increases in temperature and CO2 each significantly depressed survival, development, growth, and lipid synthesis of M. mercenaria and A. irradians larvae and that the effects were additive. Juvenile M. mercenaria and A. irradians were negatively impacted by higher temperatures while C. virginica juveniles were not. C. virginica and A. irradians juveniles were negatively affected by higher CO2 concentrations, while M. mercenaria was not. Larvae were substantially more vulnerable to elevated CO2 than juvenile stages. These findings suggest that current and future increases in temperature and CO2 are likely to have negative consequences for coastal bivalve populations.	[Talmage, Stephanie C.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Talmage, SC (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA.	christopher.gobler@sunysb.edu			New Tamarind Foundation	New Tamarind Foundation	This research was supported by the New Tamarind Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE C, 1991, MAR ECOL PROG SER, V71, P227, DOI 10.3354/meps071227; ANSELL AD, 1968, J CONSEIL, V31, P364; Arnold WS, 2008, REV FISH SCI, V16, P65, DOI 10.1080/10641260701678140; Barber BJ., 2006, SCALLOPS BIOL ECOLOG, P357; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Brand AR., 2006, DEV AQUAC FISH SCI, V35, P651, DOI [DOI 10.1016/S0167-9309(06)80039-6, 10.1016/S0167-9309(06)80039-6]; Brun NT, 2008, J EXP MAR BIOL ECOL, V358, P151, DOI 10.1016/j.jembe.2008.02.006; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Cao L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028605; CARLTON JT, 1996, E OYSTER CRASSOSTREA; Carmichael RH, 2004, J EXP MAR BIOL ECOL, V313, P75, DOI 10.1016/j.jembe.2004.08.006; Carriker MR, 2001, DEV AQUAC FISH SCI, V31, P283; CASTAGNA M, 1975, MAR FISH REV, V37, P19; CASTELL LL, 1994, AQUACULTURE, V119, P89, DOI 10.1016/0044-8486(94)90445-6; Cherkasov AS, 2010, AQUAT TOXICOL, V97, P68, DOI 10.1016/j.aquatox.2009.12.004; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; CRAGG SM, 2006, SCALLOPS BIOL ECOLOG, P45; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Dickson A.G., PICES SPECIAL PUBLIC, V3; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Eversole AG, 2001, DEV AQUAC FISH SCI, V31, P221; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; Fritz LW, 2001, DEV AQUAC FISH SCI, V31, P53; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gobler CJ, 2005, ESTUARIES, V28, P726, DOI 10.1007/BF02732911; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; GRIZZLE RE, 2001, BIOL HARD CLAM; Harte ME, 2001, DEV AQUAC FISH SCI, V31, P3; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Houghton J. T., 2001, CLIMATE CHANGE 2001; IPCC, 2007, INT PAN CLIM CHANG S; Koch F, 2009, ESTUAR COAST, V32, P261, DOI 10.1007/s12237-008-9123-y; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; LOOSANOFF VL, 1965, US DEP INTERIOR CIRC, V205, P1; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MCGLADDERY SE, 2006, SCALLOPS BIOL ECOLOG, P595; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Orensanz J.M., 2006, SCALLOPS BIOL ECOLOG, P765; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Phillips NE, 2002, ECOLOGY, V83, P2562, DOI 10.2307/3071815; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; PRATT DM, 1956, LIMNOL OCEANOGR, V1, P2, DOI 10.4319/lo.1956.1.1.0002; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; SCDHS, 1976, SUFF COUNT DEP HLTH; Schneider DW, 2003, ECOL LETT, V6, P352, DOI 10.1046/j.1461-0248.2003.00443.x; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Shumway S.E., 1996, E OYSTER CRASSOSTREA; TALMAGE SC, 2010, P NATL ACAD SCI US; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tettelbach ST, 1999, J SHELLFISH RES, V18, P47; Thomas H, 2004, SCIENCE, V304, P1005, DOI 10.1126/science.1095491; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Wacker A, 2002, P ROY SOC B-BIOL SCI, V269, P2113, DOI 10.1098/rspb.2002.2139; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss MB, 2007, J EXP MAR BIOL ECOL, V345, P12, DOI 10.1016/j.jembe.2006.12.025; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WIKFORS GH, 1992, AQUACULTURE, V108, P135, DOI 10.1016/0044-8486(92)90324-E; Zippay ML, 2010, J SHELLFISH RES, V29, P429, DOI 10.2983/035.029.0220	81	182	186	1	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26941	10.1371/journal.pone.0026941	http://dx.doi.org/10.1371/journal.pone.0026941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066018	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000034
J	Tulone, C; Sponaas, AM; Raiber, EA; Tabor, AB; Langhorne, J; Chain, BM				Tulone, Calogero; Sponaas, Anne-Marit; Raiber, Eun-Ang; Tabor, Alethea B.; Langhorne, Jean; Chain, Benny M.			Differential Requirement for Cathepsin D for Processing of the Full Length and C-Terminal Fragment of the Malaria Antigen MSP1	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; LYSOSOMAL STORAGE; DENDRITIC CELLS; ANTIBODY; IMMUNITY; MACROPHAGES; MECHANISM; RESPONSES; PARASITE; CHABAUDI	Merozoite Surface Protein 1 is expressed on the surface of malaria merozoites and is important for invasion of the malaria parasite into erythrocytes. MSP1-specific CD4 T cell responses and antibody can confer protective immunity in experimental models of malaria. In this study we explore the contributions of cathepsins D and E, two aspartic proteinases previously implicated in antigen processing, to generating MSP1 CD4 T-cell epitopes for presentation. The absence of cathepsin D, a late endosome/lysosomal enzyme, is associated with a reduced presentation of MSP1 both following in vitro processing of the epitope MSP1 from infected erythrocytes by bone marrow-derived dendritic cells, and following in vivo processing by splenic CD11c+ dendritic cells. By contrast, processing and presentation of the soluble recombinant protein fragment of MSP1 is unaffected by the absence of cathepsin D, but is inhibited when both cathepsin D and E are absent. The role of different proteinases in generating the CD4 T cell repertoire, therefore, depends on the context in which an antigen is introduced to the immune system.	[Tulone, Calogero; Chain, Benny M.] UCL, Div Infect & Immun, London, England; [Sponaas, Anne-Marit; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Raiber, Eun-Ang; Tabor, Alethea B.] UCL, Dept Chem, London, England	University of London; University College London; MRC National Institute for Medical Research; University of London; University College London	Tulone, C (corresponding author), UCL, Div Infect & Immun, London, England.	b.chain@ucl.ac.uk		Chain, Benny/0000-0002-7417-3970; Langhorne, Jean/0000-0002-2257-9733	Biotechnology and Biological Sciences Research Council under the Selective Chemical Intervention in Biological Systems initiative [BB/D005469/1]; Medical Research Council, United Kingdom [U117584248]; Biotechnology and Biological Sciences Research Council [BB/D005469/1] Funding Source: researchfish; Medical Research Council [G9721629B, MC_U117584248, G9721629, G0900950B, G0900950] Funding Source: researchfish; BBSRC [BB/D005469/1] Funding Source: UKRI; MRC [MC_U117584248, G9721629, G0900950] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council under the Selective Chemical Intervention in Biological Systems initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Biotechnology and Biological Sciences Research Council (BB/D005469/1) under the Selective Chemical Intervention in Biological Systems initiative and by the Medical Research Council, United Kingdom, ref. U117584248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Chain BM, 2005, J IMMUNOL, V174, P1791, DOI 10.4049/jimmunol.174.4.1791; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Free P, 2006, ORG BIOMOL CHEM, V4, P1817, DOI 10.1039/b600060f; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; MOORE MJ, 1991, IMMUNOLOGY, V74, P31; Nishioku T, 2002, J BIOL CHEM, V277, P4816, DOI 10.1074/jbc.M108382200; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Quin SJ, 2001, EUR J IMMUNOL, V31, P72, DOI 10.1002/1521-4141(200101)31:1&lt;72::AID-IMMU72&gt;3.0.CO;2-Z; Raiber EA, 2010, ACS CHEM BIOL, V5, P461, DOI 10.1021/cb100008p; Rasband WS, 2007, IMAGE J; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Tulone C, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-22; Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e24886	10.1371/journal.pone.0024886	http://dx.doi.org/10.1371/journal.pone.0024886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053177	gold, Green Published, Green Submitted			2022-12-27	WOS:000299081800003
J	Chawla, B; Jhingran, A; Panigrahi, A; Stuart, KD; Madhubala, R				Chawla, Bhavna; Jhingran, Anupam; Panigrahi, Aswini; Stuart, Kenneth D.; Madhubala, Rentala			Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin -Susceptible -Resistant Leishmania donovani	PLOS ONE			English	Article							PROTOZOAN PARASITE LEISHMANIA; WORLD CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; RIBOSOMAL-RNA; TRANSCRIPTION FACTOR-3; INJECTABLE PAROMOMYCIN; TRYPANOSOMA-BRUCEI; NUCLEOLAR PROTEIN; ESCHERICHIA-COLI; CELL-LINE	Leishmania donovani is a protozoan parasite that causes visceral leishmaniasis (VL) and is responsible for significant mortality and morbidity. Increasing resistance towards antimonial drugs poses a great challenge in chemotherapy of VL. Paromomycin is an aminoglycosidic antibiotic and is one of the drugs currently being used in the chemotherapy of cutaneous and visceral leishmaniasis. To understand the mode of action of this antibiotic at the molecular level, we have investigated the global proteome differences between the wild type AG83 strain and a paromomycin resistant (PRr) strain of L. donovani. Stable isotope labeling of amino acids in cell culture (SILAC) followed by quantitative mass spectrometry of the wild type AG83 strain and the paromomycin resistant (PRr) strain identified a total of 226 proteins at >= 95% confidence. Data analysis revealed upregulation of 29 proteins and down-regulation of 21 proteins in the PRr strain. Comparative proteomic analysis of the wild type and the paromomycin resistant strains showed upregulation of the ribosomal proteins in the resistant strain indicating role in translation. Elevated levels of glycolytic enzymes and stress proteins were also observed in the PRr strain. Most importantly, we observed upregulation of proteins that may have a role in intracellular survival and vesicular trafficking in the PRr strain. Furthermore, ultra-structural analysis by electron microscopy demonstrated increased number of vesicular vacuoles in PRr strain when compared to the wild-type strain. Drug affinity pull-down assay followed by mass spectrometery identified proteins in L. donovani wild type strain that were specifically and covalently bound to paromomycin. These results provide the first comprehensive insight into the mode of action and underlying mechanism of resistance to paromomycin in Leishmania donovani.	[Chawla, Bhavna; Jhingran, Anupam; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Panigrahi, Aswini; Stuart, Kenneth D.] Seattle Biomed, Seattle, WA USA	Jawaharlal Nehru University, New Delhi; Center for Infectious Disease Research	Chawla, B (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	madhubala@mail.jnu.ac.in	madhubala, Rentala/C-3445-2015	madhubala, rentala/0000-0002-0034-399X	Department of Biotechnology, Government of India; Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR), India; Fogarty International Center [D43TW000924]; FOGARTY INTERNATIONAL CENTER [D43TW000924] Funding Source: NIH RePORTER	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a grant from the Department of Biotechnology, Government of India to RM. RM is a JC Bose National Fellow supported by the Department of Science and Technology (DST), India. BC and AJ are supported by Council of Scientific and Industrial Research (CSIR), India. BC is a trainee of the Global Infectious Diseases program supported by the Fogarty International Center. The project described was also supported by Grant Number D43TW000924 from the Fogarty International Center to KS. The equipment and facility for this study was purchased from Applied Bio-systems, whose team members, Dr. Indrajeet Kaur and Dr. Annu Uppal, provided technical help; this assistance is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; Armijos RX, 2004, ACTA TROP, V91, P153, DOI 10.1016/j.actatropica.2004.03.009; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brochu C, 2004, CELL STRESS CHAPERON, V9, P294, DOI 10.1379/CSC-15R1.1; Brockstedt E, 1999, J PROTEIN CHEM, V18, P225, DOI 10.1023/A:1020636308270; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dea-Ayuela MA, 2006, PROTEOMICS, V6, P4187, DOI 10.1002/pmic.200600101; Descoteaux A, 2002, EMBO J, V21, P4458, DOI 10.1093/emboj/cdf447; DESOUZA W, 1980, J PARASITOL, V66, P229, DOI 10.2307/3280809; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; ELON J, 1992, J AM ACAD DERMATOL, V27, P227, DOI 10.1016/0190-9622(92)70175-F; Fernandez MM, 2011, ANTIMICROB AGENTS CH, V55, P86, DOI 10.1128/AAC.00506-10; Flanigan TP, 1996, AM J MED, V100, P370, DOI 10.1016/S0002-9343(97)89499-5; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; GILLIN FD, 1981, J ANTIMICROB CHEMOTH, V8, P305, DOI 10.1093/jac/8.4.305; GLASER TA, 1988, P NATL ACAD SCI USA, V85, P7602, DOI 10.1073/pnas.85.20.7602; Guha-Niyogi A, 2001, GLYCOBIOLOGY, V11, p45R, DOI 10.1093/glycob/11.4.45R; Hirokawa G, 2007, ANTIMICROB AGENTS CH, V51, P175, DOI 10.1128/AAC.01096-06; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Jain R, 2010, CELL MICROBIOL, V12, P432, DOI 10.1111/j.1462-5822.2009.01406.x; JANSEN RP, 1991, J CELL BIOL, V113, P715, DOI 10.1083/jcb.113.4.715; Jhingran A, 2009, MOL BIOCHEM PARASIT, V164, P111, DOI 10.1016/j.molbiopara.2008.12.007; Khalil EAG, 1998, ANN TROP MED PARASIT, V92, P151, DOI 10.1080/00034989859988; Kramer DL, 1998, CANCER RES, V58, P3883; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Li Rong, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P323; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; MAAROUF M, 1995, PARASITOL RES, V81, P421, DOI 10.1007/BF00931504; Maarouf M, 1997, EXP CELL RES, V232, P339, DOI 10.1006/excr.1997.3500; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; SCOTT JAG, 1992, T ROY SOC TROP MED H, V86, P617, DOI 10.1016/0035-9203(92)90151-2; Shapiro AB, 1998, INT J CANCER, V76, P857, DOI 10.1002/(SICI)1097-0215(19980610)76:6<857::AID-IJC15>3.0.CO;2-#; SOGNIER MA, 1994, BIOCHEM PHARMACOL, V48, P391, DOI 10.1016/0006-2952(94)90112-0; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P432, DOI 10.1016/S0035-9203(00)90131-7; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Vergnes B, 2007, MOL CELL PROTEOMICS, V6, P88, DOI 10.1074/mcp.M600319-MCP200; Vieira M, 2005, BIOCHEM J, V392, P467, DOI 10.1042/BJ20051319; Vila-Sanjurjo A, 1999, J MOL BIOL, V293, P1, DOI 10.1006/jmbi.1999.3160; Walker J, 2006, MOL BIOCHEM PARASIT, V145, P254, DOI 10.1016/j.molbiopara.2005.10.008; Welburn SC, 1998, CELL DEATH DIFFER, V5, P615, DOI 10.1038/sj.cdd.4400393; WU MA, 1994, GENE, V150, P401, DOI 10.1016/0378-1119(94)90461-8; Zheng ZF, 2005, EUKARYOT CELL, V4, P556, DOI 10.1128/EC.4.3.556-566.2005	50	61	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26660	10.1371/journal.pone.0026660	http://dx.doi.org/10.1371/journal.pone.0026660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046323	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400029
J	Mohanty, SK				Mohanty, Sanjay K.			Multidimensional Poverty and Child Survival in India	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; UNDERLYING CAUSE; MORTALITY; UNDERNUTRITION; DETERMINANTS; TRENDS	Background: Though the concept of multidimensional poverty has been acknowledged cutting across the disciplines (among economists, public health professionals, development thinkers, social scientists, policy makers and international organizations) and included in the development agenda, its measurement and application are still limited. Objectives and Methodology: Using unit data from the National Family and Health Survey 3, India, this paper measures poverty in multidimensional space and examine the linkages of multidimensional poverty with child survival. The multidimensional poverty is measured in the dimension of knowledge, health and wealth and the child survival is measured with respect to infant mortality and under-five mortality. Descriptive statistics, principal component analyses and the life table methods are used in the analyses. Results: The estimates of multidimensional poverty are robust and the inter-state differentials are large. While infant mortality rate and under-five mortality rate are disproportionately higher among the abject poor compared to the non-poor, there are no significant differences in child survival among educationally, economically and health poor at the national level. State pattern in child survival among the education, economical and health poor are mixed. Conclusion: Use of multidimensional poverty measures help to identify abject poor who are unlikely to come out of poverty trap. The child survival is significantly lower among abject poor compared to moderate poor and non-poor. We urge to popularize the concept of multiple deprivations in research and program so as to reduce poverty and inequality in the population.	Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India	International Institute for Population Sciences	Mohanty, SK (corresponding author), Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India.	sanjayiips@yahoo.co.in	Mohanty, Sanjay K/AAR-7658-2020	Mohanty, Sanjay K/0000-0001-9041-5952				Akire S, 2010, 38 OPHI U OXF OXF DE; Alkire S, 75 OPHI U OXF OXF DE; Alkire S, 2008, 15 OPHI U OXF OXF DE; Alkire S, 2007, OXF DEV STUD, V35, P347, DOI 10.1080/13600810701701863; Alkire Sabina, 2011, 43 OPHI U OXF OXF DE; [Anonymous], 1999, DEV FREEDOM; Barbin BJ, 2001, J NUTR, V131, p636S; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhat BNM, 1999, ECON POLIT WEEKLY, V34, P3008; Bhat PNM, 1999, ECON POLIT WEEKLY, V34, P3019; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Booysen F, 2008, WORLD DEV, V36, P1113, DOI 10.1016/j.worlddev.2007.10.008; Bourguignon F., 2003, J ECON INEQUAL, V1, P25, DOI DOI 10.1023/A:1023913831342; Calvo C, 2008, WORLD DEV, V36, P1011, DOI 10.1016/j.worlddev.2007.10.001; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Deutsch J, 2005, REV INCOME WEALTH, P145; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Government of India Planning Commission, 2009, REP EXP GROUP REV ME; Government of India Planning Commission, 2007, POV EST 2004 05; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Johnson K, 2004, DHS COMP REPORTS; Kanjilal B, 2010, INT J EQUITY HEALTH, P9; Klasen S, 2000, REV INCOME WEALTH, P33; Kumar A, 2011, J URBAN HEALTH, V88, P311, DOI 10.1007/s11524-010-9532-7; Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X; Mohanty Sanjay K., 2009, Genus, V65, P113; Office of the Registrar General of India (RGI) and Centre for Global Health Research (CGHR), 2009, REP CAUS DEATH IND 2; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Planning Commission Government of India, 2002, NAT HUM DEV REP; Ram, 2009, EC POLITICAL WEEKLY, VXLIV; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Sahn DE, 2000, WORLD DEV, V28, P2123, DOI 10.1016/S0305-750X(00)00075-9; Sen A, 1992, INEQUALITY RE EXAMIN; Seth S, 2008, INDIAN J HUMAN DEV, V2, P407; Srinivasan K., 2008, Economic and Political Weekly, V43, P67; Sundaram K., 2003, ECON POLIT WEEKLY, V38, P896; Townsend, 2003, DISTRIBUTION CHILD P; UNDP, 1990, HUM DEV REP; UNDP, 2010, HUM DEV REP 2010; United Nations Development Program (UNDP), 1997, HUM DEV REP; Wagle UR, 2008, SOC SCI RES, V37, P559, DOI 10.1016/j.ssresearch.2007.06.013; Wang LM, 2003, HEALTH POLICY, V65, P277, DOI 10.1016/S0168-8510(03)00039-3; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	48	33	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26857	10.1371/journal.pone.0026857	http://dx.doi.org/10.1371/journal.pone.0026857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046384	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400038
J	Smith, JS; Xu, ZL; Tian, J; Palmer, DJ; Ng, P; Byrnes, AP				Smith, Jeffrey S.; Xu, Zhili; Tian, Jie; Palmer, Donna J.; Ng, Philip; Byrnes, Andrew P.			The Role of Endosomal Escape and Mitogen-Activated Protein Kinases in Adenoviral Activation of the Innate Immune Response	PLOS ONE			English	Article							IN-VIVO; GENE-THERAPY; MOUSE-LIVER; VECTORS; EXPRESSION; P38; VIRUS; TRIGGERS; PATHWAYS; CELLS	Adenoviral vectors (AdV) activate multiple signaling pathways associated with innate immune responses, including mitogen-activated protein kinases (MAPKs). In this study, we investigated how systemically-injected AdVs activate two MAPK pathways (p38 and ERK) and the contribution of these kinases to AdV-induced cytokine and chemokine responses in mice. Mice were injected intravenously either with a helper-dependent Ad2 vector that does not express viral genes or transgenes, or with the Ad2 mutant ts1, which is defective in endosomal escape. We found that AdV induced rapid phosphorylation of p38 and ERK as well as a significant cytokine response, but ts1 failed to activate p38 or ERK and induced only a limited cytokine response. These results demonstrate that endosomal escape of virions is a critical step in the induction of these innate pathways and responses. We then examined the roles of p38 and ERK pathways in the innate cytokine response by administering specific kinase inhibitors to mice prior to AdV. The cytokine and chemokine response to AdV was only modestly suppressed by a p38 inhibitor, while an ERK inhibitor has mixed effects, lowering some cytokines and elevating others. Thus, even though p38 and ERK are rapidly activated after i.v. injection of AdV, cytokine and chemokine responses are mostly independent of these kinases.	[Smith, Jeffrey S.; Xu, Zhili; Tian, Jie; Byrnes, Andrew P.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Palmer, Donna J.; Ng, Philip] Baylor Coll Med, Houston, TX 77030 USA	US Food & Drug Administration (FDA); Baylor College of Medicine	Smith, JS (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	andrew.byrnes@fda.hhs.gov	Byrnes, Andrew/D-2808-2013	Byrnes, Andrew/0000-0003-1135-2629	Federal Drug Administration (FDA)	Federal Drug Administration (FDA)	This research was supported by the Federal Drug Administration (FDA), including the FDA's Critical Path program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Bruder JT, 1997, J VIROL, V71, P398, DOI 10.1128/JVI.71.1.398-404.1997; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Cotter MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1098, DOI 10.2741/1603; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Huang XP, 2009, HUM GENE THER, V20, P293, DOI 10.1089/hum.2008.141; Ivanenkov YA, 2008, DRUGS R&D, V9, P397, DOI 10.2165/0126839-200809060-00005; Lee Y, 2010, EXP DERMATOL, V19, pE44, DOI 10.1111/j.1600-0625.2009.00963.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ng Philip, 2002, Methods Mol Med, V69, P371; Oguro T, 2002, FEBS LETT, V516, P63, DOI 10.1016/S0014-5793(02)02502-4; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Shayakhmetov DM, 2010, MOL THER, V18, P1422, DOI 10.1038/mt.2010.124; Smith JS, 2008, HUM GENE THER, V19, P547, DOI 10.1089/hum.2008.004; Smith JS, 2004, GENE THER, V11, P431, DOI 10.1038/sj.gt.3302149; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; SUZUKI M, 2011, HUM GENE THER; Tamanini A, 2006, J VIROL, V80, P11241, DOI 10.1128/JVI.00721-06; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Toietta G, 2002, MOL THER, V5, P204, DOI 10.1006/mthe.2002.0532; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Vellekamp G, 2001, HUM GENE THER, V12, P1923, DOI 10.1089/104303401753153974; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; YEI SP, 1994, HUM GENE THER, V5, P731, DOI 10.1089/hum.1994.5.6-731; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26755	10.1371/journal.pone.0026755	http://dx.doi.org/10.1371/journal.pone.0026755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046344	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400032
J	Aguero-Chapin, G; Sanchez-Rodriguez, A; Hidalgo-Yanes, PI; Perez-Castillo, Y; Molina-Ruiz, R; Marchal, K; Vasconcelos, V; Antunes, A				Agueero-Chapin, Guillermin; Sanchez-Rodriguez, Aminael; Hidalgo-Yanes, Pedro I.; Perez-Castillo, Yunierkis; Molina-Ruiz, Reinaldo; Marchal, Kathleen; Vasconcelos, Vitor; Antunes, Agostinho			An Alignment-Free Approach for Eukaryotic ITS2 Annotation and Phylogenetic Inference	PLOS ONE			English	Article							GENETIC NEURAL-NETWORKS; EDGE-ADJACENCY MATRIX; TOPOLOGICAL INDEXES; SECONDARY STRUCTURE; SPECTRAL MOMENTS; MOLECULAR GRAPHS; PREDICTION; SEQUENCE; QSAR; COMMON	The ITS2 gene class shows a high sequence divergence among its members that have complicated its annotation and its use for reconstructing phylogenies at a higher taxonomical level (beyond species and genus). Several alignment strategies have been implemented to improve the ITS2 annotation quality and its use for phylogenetic inferences. Although, alignment based methods have been exploited to the top of its complexity to tackle both issues, no alignment-free approaches have been able to successfully address both topics. By contrast, the use of simple alignment-free classifiers, like the topological indices (TIs) containing information about the sequence and structure of ITS2, may reveal to be a useful approach for the gene prediction and for assessing the phylogenetic relationships of the ITS2 class in eukaryotes. Thus, we used the TI2BioP (Topological Indices to BioPolymers) methodology [1,2], freely available at http://ti2biop.sourceforge.net/ to calculate two different TIs. One class was derived from the ITS2 artificial 2D structures generated from DNA strings and the other from the secondary structure inferred from RNA folding algorithms. Two alignment-free models based on Artificial Neural Networks were developed for the ITS2 class prediction using the two classes of TIs referred above. Both models showed similar performances on the training and the test sets reaching values above 95% in the overall classification. Due to the importance of the ITS2 region for fungi identification, a novel ITS2 genomic sequence was isolated from Petrakia sp. This sequence and the test set were used to comparatively evaluate the conventional classification models based on multiple sequence alignments like Hidden Markov based approaches, revealing the success of our models to identify novel ITS2 members. The isolated sequence was assessed using traditional and alignment-free based techniques applied to phylogenetic inference to complement the taxonomy of the Petrakia sp. fungal isolate.	[Agueero-Chapin, Guillermin; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Agueero-Chapin, Guillermin; Hidalgo-Yanes, Pedro I.; Perez-Castillo, Yunierkis; Molina-Ruiz, Reinaldo] Univ Cent Marta Abreu Las Villas UCLV, Mol Simulat & Drug Design CBQ, Santa Clara, Cuba; [Agueero-Chapin, Guillermin; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Sanchez-Rodriguez, Aminael; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, CMPG, Louvain, Belgium; [Hidalgo-Yanes, Pedro I.] Univ Leon, Area Microbiol, E-24071 Leon, Spain	Universidade do Porto; Universidad Central "Marta Abreu" de Las Villas; Universidade do Porto; KU Leuven; Universidad de Leon	Aguero-Chapin, G (corresponding author), Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Perez-Castillo, Yunierkis/AAY-1756-2020; Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; Vasconcelos, Vitor/A-8933-2008; Agüero-Chapin, Guillermin/C-8067-2019	Perez-Castillo, Yunierkis/0000-0002-3710-0035; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Vasconcelos, Vitor/0000-0003-3585-2417; Agüero-Chapin, Guillermin/0000-0002-9908-2418; Antunes, Agostinho/0000-0002-1328-1732; Molina-Ruiz, Reinaldo/0000-0001-5098-5432; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/47256/2008];  [PTDC/BIA-BDE/69144/2006];  [PTDC/AA-AMB/104983/2008]	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); ; 	The authors acknowledge the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) for financial support to GACH (SFRH/BD/47256/2008), and the project PTDC/BIA-BDE/69144/2006 and PTDC/AA-AMB/104983/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Chapin G, 2008, J CHEM INF MODEL, V48, P434, DOI 10.1021/ci7003225; Agueero-Chapin G, 2011, J THEOR BIOL, V273, P167, DOI 10.1016/j.jtbi.2010.12.019; Aguero-Chapin G, 2011, AMINO ACIDS, V40, P431, DOI 10.1007/s00726-010-0653-9; Aguero-Chapin G, 2009, J PROTEOME RES, V8, P2122, DOI 10.1021/pr800867y; Aguero-Chapin GA, 2006, FEBS LETT, V580, P723, DOI 10.1016/j.febslet.2005.12.072; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BISBY FA, 2000, SPECIES 2000 ITIS CA; Caballero J, 2008, CURR TOP MED CHEM, V8, P1580, DOI 10.2174/156802608786786570; CHOU KC, 2009, AUTOMATION PROTEOMIC, P97; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; Estrada E, 2000, SAR QSAR ENVIRON RES, V11, P55, DOI 10.1080/10629360008033229; Estrada E, 1997, J CHEM INF COMP SCI, V37, P320, DOI 10.1021/ci960113v; Estrada E, 1996, J CHEM INF COMP SCI, V36, P844, DOI 10.1021/ci950187r; Fernandez M, 2010, MOL DIVERS; Fernandez M, 2007, J MOL GRAPH MODEL, V26, P748, DOI 10.1016/j.jmgm.2007.04.011; Finn R. D., 2009, NUCL ACIDS RES; Gonzalez-Diaz H, 2005, BIOORG MED CHEM LETT, V15, P2932, DOI 10.1016/j.bmcl.2005.03.017; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, J COMPUT CHEM, V28, P1049, DOI 10.1002/jcc.20576; GONZALEZDIAZ H, 2007, MARCH INSIDE V3 0 MA; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gutierrez Y, 2002, MODESLAB 1 0  MOL DE; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kirk PM., 2008, DICT FUNGI, V10th ed; KOETSCHAN C, 2009, NUCL ACIDS RES; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; KUTNER MH, 2005, STANDARDIZED MULTIPL, P271; Marrero-Ponce Y, 2005, BIOORGAN MED CHEM, V13, P1005, DOI 10.1016/j.bmc.2004.11.040; Mathews David H, 2006, Curr Protoc Bioinformatics, VChapter 12, DOI [10.1002/0471250953.bi1206s46, 10.1002/0471250953.bi1206s13]; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Meneses-Marcel A, 2005, BIOORG MED CHEM LETT, V15, P3838, DOI 10.1016/j.bmcl.2005.05.124; Molina R, TI2BIOP TOPOLOGICAL; Nagano Y, 2009, MED MYCOL       0811, V1-12; Nandy A, 1996, COMPUT APPL BIOSCI, V12, P55; Nandy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006829; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Perez-Bello A, 2009, J THEOR BIOL, V256, P458, DOI 10.1016/j.jtbi.2008.09.035; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Ponce YM, 2004, BIOORGAN MED CHEM, V12, P5331, DOI 10.1016/j.bmc.2004.07.051; Qi FH, 2009, LETT APPL MICROBIOL, V49, P98, DOI 10.1111/j.1472-765X.2009.02626.x; Rivals I, 1999, NEURAL COMPUT, V11, P863, DOI 10.1162/089976699300016476; Rumelhart D., 1986, PARALLEL DISTRIBUTED; SACKS W, 1995, MOL GEN GENET, V246, P45, DOI 10.1007/BF00290132; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2006, NUCL ACIDS RES, V34; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Sieber TN, FUNGAL BIOL REV, V75-89; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sokolova M., ACCURACY F SCORE ROC, P1015; Statsoft, 2007, STAT 7 0 DAT AN SOFT; Strope PK, 2007, GENOMICS, V89, P602, DOI 10.1016/j.ygeno.2007.01.008; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; von Arx J.A., 1975, STUD MYCOL, V9, P1, DOI DOI 10.2307/3758851; von Arx JA, 1981, GENERA FUNGI SPORULA; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Winters-Hilt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S14; Wong TKF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012848; Zupan J, 1999, NEURAL NETWORKS CHEM	64	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26638	10.1371/journal.pone.0026638	http://dx.doi.org/10.1371/journal.pone.0026638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046320	gold, Green Published			2022-12-27	WOS:000296519600039
J	Jahn, H; Wittke, S; Zurbig, P; Raedler, TJ; Arlt, S; Kellmann, M; Mullen, W; Eichenlaub, M; Mischak, H; Wiedemann, K				Jahn, Holger; Wittke, Stefan; Zuerbig, Petra; Raedler, Thomas J.; Arlt, Soenke; Kellmann, Markus; Mullen, William; Eichenlaub, Martin; Mischak, Harald; Wiedemann, Klaus			Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; URINARY PROTEOME ANALYSIS; CHRONIC KIDNEY-DISEASE; CHROMOGRANIN-A; MASS-SPECTROMETRY; SURROGATE MARKER; TAU INCLUSIONS; TASK-FORCE; DEMENTIA; DISCOVERY	Background: Today, dementias are diagnosed late in the course of disease. Future treatments have to start earlier in the disease process to avoid disability requiring new diagnostic tools. The objective of this study is to develop a new method for the differential diagnosis and identification of new biomarkers of Alzheimer's disease (AD) using capillary-electrophoresis coupled to mass-spectrometry (CE-MS) and to assess the potential of early diagnosis of AD. Methods and Findings: Cerebrospinal fluid (CSF) of 159 out-patients of a memory-clinic at a University Hospital suffering from neurodegenerative disorders and 17 cognitively-healthy controls was used to create differential peptide pattern for dementias and prospective blinded-comparison of sensitivity and specificity for AD diagnosis against the Criterion standard in a naturalistic prospective sample of patients. Sensitivity and specificity of the new method compared to standard diagnostic procedures and identification of new putative biomarkers for AD was the main outcome measure. CE-MS was used to reliably detect 1104 low-molecular-weight peptides in CSF. Training-sets of patients with clinically secured sporadic Alzheimer's disease, frontotemporal dementia, and cognitively healthy controls allowed establishing discriminative biomarker pattern for diagnosis of AD. This pattern was already detectable in patients with mild cognitive impairment (MCI). The AD-pattern was tested in a prospective sample of patients (n = 100) and AD was diagnosed with a sensitivity of 87% and a specificity of 83%. Using CSF measurements of beta-amyloid1-42, total-tau, and phospho(181)-tau, AD-diagnosis had a sensitivity of 88% and a specificity of 67% in the same sample. Sequence analysis of the discriminating biomarkers identified fragments of synaptic proteins like proSAAS, apolipoprotein J, neurosecretory protein VGF, phospholemman, and chromogranin A. Conclusions: The method may allow early differential diagnosis of various dementias using specific peptide fingerprints and identification of incipient AD in patients suffering from MCI. Identified biomarkers facilitate face validity for the use in AD diagnosis.	[Jahn, Holger; Raedler, Thomas J.; Arlt, Soenke; Eichenlaub, Martin; Wiedemann, Klaus] Univ Hosp Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany; [Wittke, Stefan; Zuerbig, Petra; Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Wittke, Stefan] Univ Appl Sci, Bremerhaven, Germany; [Raedler, Thomas J.] Univ Calgary, Foothills Hosp, Dept Psychiat, Calgary, AB, Canada; [Kellmann, Markus] Thermo Fisher Sci GmbH, Bremen, Germany; [Mullen, William; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	University of Hamburg; University Medical Center Hamburg-Eppendorf; Modular Open Systems Approach (MOSA) Solutions; University of Calgary; Thermo Fisher Scientific; University of Glasgow	Jahn, H (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany.	jahn@uke.uni-hamburg.de	Jahn, Holger/A-9255-2008; Mullen, William/GWC-8078-2022	Jahn, Holger/0000-0003-3607-7651; Mullen, William/0000-0002-5685-1563; Mischak, Harald/0000-0003-0323-0306; Wittke, Stefan/0000-0002-2133-3360; Zurbig, Petra/0000-0003-3465-2173	BioProfile Initiative [0313347]; German Federal Ministry of Education and Research [01EW0909]	BioProfile Initiative; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant No. 0313347 from the BioProfile Initiative and grant No. 01EW0909 to HJ by the German Federal Ministry of Education and Research in the frame of the ERA-NET NEURO project "ADtest: Role of proteases and their inhibitors in pathophysiology and diagnosis of Alzheimer Disease''. The Memory Clinic of the Department of Psychiatry and Psychotherapy at the University Hospital Hamburg-Eppendorf is a member of the German National Dementia Competence Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HJ had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Bergquist J, 2002, MASS SPECTROM REV, V21, P2, DOI 10.1002/mas.10016; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; Borroni B, 2006, EUR J PHARMACOL, V545, P73, DOI 10.1016/j.ejphar.2006.06.023; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Bullock R, 2002, BRIT J PSYCHIAT, V180, P135, DOI 10.1192/bjp.180.2.135; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Chalmers MJ, 2005, ANAL CHEM, V77, P7163, DOI 10.1021/ac050983o; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; Choudhary J, 2004, NAT NEUROSCI, V7, P440, DOI 10.1038/nn1240; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harting C., 2000, DTSCH ADAPTATION REV; Haubitz M, 2005, KIDNEY INT, V67, P2313, DOI 10.1111/j.1523-1755.2005.00335.x; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Hook VYH, 2006, BIODRUGS, V20, P105, DOI 10.2165/00063030-200620020-00005; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jelic V, 2006, J NEUROL NEUROSUR PS, V77, P429, DOI 10.1136/jnnp.2005.072926; Kikuchi K, 2003, BIOCHEM BIOPH RES CO, V308, P646, DOI 10.1016/S0006-291X(03)01391-3; Knibb JA, 2006, ANN NEUROL, V59, P156, DOI 10.1002/ana.20700; Kuki K, 1996, DEMENTIA, V7, P233, DOI 10.1159/000106885; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Lewczuk P, 2006, J NEURAL TRANSM, V113, P1075, DOI 10.1007/s00702-006-0511-9; Mayeux R, 1998, NEUROBIOL AGING, V19, P139, DOI 10.1016/S0197-4580(98)00014-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; METZGER J, 2011, PROTEOMICS IN PRESS; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2007, PROTEOM CLIN APPL, V1, P148, DOI 10.1002/prca.200600771; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mulder C, 2000, ANN CLIN BIOCHEM, V37, P593, DOI 10.1258/0004563001899898; MUNOZ DG, 1991, LAB INVEST, V64, P826; Mzhavia N, 2002, BIOCHEM J, V361, P67, DOI 10.1042/0264-6021:3610067; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Okochi M, 2010, NEURODEGENER DIS, V7, P42, DOI 10.1159/000283481; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; RAY S, 2007, NAT MED; Reitan R.M., 1979, TRAIL MAKING TEST TM; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Schiffer E, 2009, CLIN CANCER RES, V15, P4935, DOI 10.1158/1078-0432.CCR-09-0226; Shulman K. I., 1986, INT J GERIATR PSYCH, V1, P135, DOI [10.1002/gps.930010209, DOI 10.1002/GPS.930010209]; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Thalmann B., 1998, CERAD NEUROPSYCHOLOG; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2008, PROTEOM CLIN APPL, V2, P556, DOI 10.1002/prca.200780082; Twig G, 2005, AM J PHYSIOL-CELL PH, V288, pC169, DOI 10.1152/ajpcell.00308.2004; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wada M, 2004, NEUROSCI LETT, V356, P49, DOI 10.1016/j.neulet.2003.11.028; Weissinger EM, 2004, KIDNEY INT, V65, P2426, DOI 10.1111/j.1523-1755.2004.00659.x; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786; Wimo A, 2006, DEMENT GERIATR COGN, V21, P175, DOI 10.1159/000090733; World Health Organization, 2004, INT STAT CLASS DIS H; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	75	93	95	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26540	10.1371/journal.pone.0026540	http://dx.doi.org/10.1371/journal.pone.0026540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046305	Green Published, Green Accepted, gold			2022-12-27	WOS:000296519600030
J	Reitz, C; Lee, JH; Rogers, RS; Mayeux, R				Reitz, Christiane; Lee, Joseph H.; Rogers, Robert S.; Mayeux, Richard			Impact of Genetic Variation in SORCS1 on Memory Retention	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RECEPTOR FAMILY; NEUROPSYCHOLOGICAL BATTERY; ASSOCIATION; PROTEIN; MEMBER; IDENTIFICATION; BRAIN	Objective: We previously reported that genetic variants in SORCS1 increase the risk of AD, that over-expression of SorCS1 reduces c-secretase activity and A beta levels, and that SorCS1 suppression increases c-secretase processing of APP and A beta levels. We now explored the effect of variation in SORCS1 on memory. Methods: We explored associations between SORCS1-SNPs and memory retention in the NIA-LOAD case control dataset (162 cases, 670 controls) and a cohort of Caribbean Hispanics (549 cases, 544 controls) using single marker and haplotype analyses. Results: Three SNPs in intron 1, were associated with memory retention in the NIA-LOAD dataset or the Caribbean Hispanic dataset (rs10884402(A allele: beta = -0.15, p = 0.008), rs7078098(C allele: beta = 0.18, p = 0.007) and rs950809(C allele: beta = 0.17, p = 0.008)) and all three SNPs were significant in a meta-analysis of both datasets (0.002<p<0.03). The corresponding A-T-T haplotype for these SNPs was associated with lower scores in both datasets (p = 0.02, p = 0.0009), and the complementary G-C-C haplotype was associated with higher scores in NIA-LOAD (p = 0.02). These associations were restricted to cases. Conclusions: Variation in intron 1 in SORCS1 is associated with memory changes in AD.	[Reitz, Christiane; Lee, Joseph H.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Reitz, Christiane; Lee, Joseph H.; Rogers, Robert S.; Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Lee, Joseph H.] Columbia Univ, Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Reitz, C (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	rpm2@columbia.edu	Mayeux, Richard/E-9788-2013; Reitz, Christiane/GNP-0257-2022; Lee, Joseph H/D-2441-2012	Mayeux, Richard/0000-0001-6519-9696; Lee, Joseph H/0000-0002-2000-4821	National Institutes of Health; National Institute on Aging [R37-AG15473, P01-AG07232, U24AG026390]; Blanchett Hooker Rockefeller Foundation; Banbury Fund; Merrill Lynch Foundation; Canadian Institutes of Health Research; Alzheimer Society of Canada; Alzheimer Society of Ontario; Howard Hughes Medical Institute; Wellcome Trust; Paul B. Beeson Career Development Award [K23AG034550]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034550, R01AG037212, U24AG021886, R01AG041797, R37AG015473, R01AG026390, P01AG007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Blanchett Hooker Rockefeller Foundation; Banbury Fund; Merrill Lynch Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Alzheimer Society of Ontario; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission); Paul B. Beeson Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health and the National Institute on Aging: R37-AG15473, P01-AG07232, The Blanchett Hooker Rockefeller Foundation, The Charles S. Robertson Gift from the Banbury Fund, and The Merrill Lynch Foundation. This work was also supported by Canadian Institutes of Health Research (ER, PH), the Alzheimer Society of Canada, the Alzheimer Society of Ontario, Howard Hughes Medical Institute, and The Wellcome Trust (PH). Dr. Reitz was further supported by a Paul B. Beeson Career Development Award (K23AG034550). Data and samples from the National Institute on Aging - Late Onset Alzheimer's Disease Family Study, which receives government support under a cooperative agreement grant (U24AG026390), were also used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENTON A, 1955, BENTON VISAL RETENTI; Benton A, 1967, FAS TEST; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Harter C, 2000, Subcell Biochem, V34, P1; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 2001, NEUROSCI LETT, V313, P83, DOI 10.1016/S0304-3940(01)02252-2; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; LEE JH, 2010, ARCH NEUROL IN PRESS; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Reitz C, 2009, J NEUROL NEUROSUR PS, V80, P715, DOI 10.1136/jnnp.2008.154146; REITZ C, 2010, ANN NEUROL IN PRESS; Rezgaoui M, 2001, MECH DEVELOP, V100, P335, DOI 10.1016/S0925-4773(00)00523-2; ROSEN W, 1981, ROSEN DRAWING TEST V; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Stricks L, 1998, J INT NEUROPSYCH SOC, V4, P311, DOI 10.1017/S1355617798003117; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P19, DOI 10.1159/000085309; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179	34	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e24588	10.1371/journal.pone.0024588	http://dx.doi.org/10.1371/journal.pone.0024588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046233	Green Submitted, gold, Green Published			2022-12-27	WOS:000296519600003
J	Eren, AM; Zozaya, M; Taylor, CM; Dowd, SE; Martin, DH; Ferris, MJ				Eren, A. Murat; Zozaya, Marcela; Taylor, Christopher M.; Dowd, Scot E.; Martin, David H.; Ferris, Michael J.			Exploring the Diversity of Gardnerella vaginalis in the Genitourinary Tract Microbiota of Monogamous Couples Through Subtle Nucleotide Variation	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; GENE; COMMUNITIES; PROKARYOTES; PHYLOGENY; INFERENCE; BIOTYPES; MRBAYES; WOMEN; TREES	Background: Bacterial vaginosis (BV) is an enigmatic disease of unknown origin that affects a large percentage of women. The vaginal microbiota of women with BV is associated with serious sequelae, including abnormal pregnancies. The etiology of BV is not fully understood, however, it has been suggested that it is transmissible, and that G. vaginalis may be an etiological agent. Studies using enzymatic assays to define G. vaginalis biotypes, as well as more recent genomic comparisons of G. vaginalis isolates from symptomatic and asymptomatic women, suggest that particular G. vaginalis strains may play a key role in the pathogenesis of BV. Methodology/Principal Findings: To explore G. vaginalis diversity, distribution and sexual transmission, we developed a Shannon entropy-based method to analyze low-level sequence variation in 65,710 G. vaginalis 16S rRNA gene segments that were PCR-amplified from vaginal samples of 53 monogamous women and from urethral and penile skin samples of their male partners. We observed a high degree of low-level diversity among G. vaginalis sequences with a total of 46 unique sequence variants (oligotypes), and also found strong correlations of these oligotypes between sexual partners. Even though Gram stain-defined normal and some Gram stain-defined intermediate oligotype profiles clustered together in UniFrac analysis, no single G. vaginalis oligotype was found to be specific to BV or normal vaginal samples. Conclusions: This study describes a novel method for investigating G. vaginalis diversity at a low level of taxonomic discrimination. The findings support cultivation-based studies that indicate sexual partners harbor the same strains of G. vaginalis. This study also highlights the fact that a few, reproducible nucleotide variations within the 16S rRNA gene can reveal clinical or epidemiological associations that would be missed by genus-level or species-level categorization of 16S rRNA data.	[Eren, A. Murat; Taylor, Christopher M.] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Eren, A. Murat] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Zozaya, Marcela; Taylor, Christopher M.; Ferris, Michael J.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Dowd, Scot E.] Res & Testing Lab, Lubbock, TX USA; [Martin, David H.] Louisiana State Univ Hlth Sci Ctr, Infect Dis Sect, New Orleans, LA USA; [Ferris, Michael J.] Louisiana State Univ Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Ferris, Michael J.] Louisiana State Univ Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	University of Louisiana System; University of New Orleans; Marine Biological Laboratory - Woods Hole; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Eren, AM (corresponding author), Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA.	meren@mbl.edu	Dowd, Scot E/M-5386-2017; Taylor, Christopher M./AAF-5480-2020; Eren, A. Murat/Q-5497-2019; Eren, A. Murat/J-3408-2014	Dowd, Scot E/0000-0002-6296-1427; Taylor, Christopher M./0000-0002-7983-5275; Eren, A. Murat/0000-0001-9013-4827; Eren, A. Murat/0000-0001-9013-4827	Research Institute for Children in New Orleans; NIH [5RO1AI79071-2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079071, R56AI079071] Funding Source: NIH RePORTER	Research Institute for Children in New Orleans; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by funding from the Research Institute for Children in New Orleans and NIH grant 5RO1AI79071-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; BRISELDEN AM, 1990, J CLIN MICROBIOL, V28, P2761, DOI 10.1128/JCM.28.12.2761-2764.1990; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1995, J MOL EVOL, V41, P1105; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Larsson PG, 2005, APMIS, V113, P233, DOI 10.1111/j.1600-0463.2005.apm_01.x; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LLOYD AT, 1993, J MOL EVOL, V37, P399; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Mashayekhi F, 2007, ANAL BIOCHEM, V363, P275, DOI 10.1016/j.ab.2007.02.002; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Numanovic F, 2008, BOSNIAN J BASIC MED, V8, P270, DOI 10.17305/bjbms.2008.2932; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sekirov I, 2006, NAT MED, V12, P736, DOI 10.1038/nm0706-736; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Ward DM, 1998, CURR OPIN MICROBIOL, V1, P271, DOI 10.1016/S1369-5274(98)80029-5; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	45	147	147	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26732	10.1371/journal.pone.0026732	http://dx.doi.org/10.1371/journal.pone.0026732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046340	gold, Green Published			2022-12-27	WOS:000296517000028
J	James, LR; Andrews, S; Walker, S; de Sousa, PRS; Ray, A; Russell, NA; Bellamy, TC				James, Laura R.; Andrews, Simon; Walker, Simon; de Sousa, Paula R. S.; Ray, Aaron; Russell, Noah A.; Bellamy, Tomas C.			High-Throughput Analysis of Calcium Signalling Kinetics in Astrocytes Stimulated with Different Neurotransmitters	PLOS ONE			English	Article							GLIAL CALCIUM; CELLS; COMMUNICATION; VARIABILITY; CHANNELS	Astrocytes express a wide range of receptors for neurotransmitters and hormones that are coupled to increases in intracellular Ca(2+) concentration, enabling them to detect activity in both neuronal and vascular networks. There is increasing evidence that astrocytes are able to discriminate between different Ca(2+)-linked stimuli, as the efficiency of some Ca(2+) dependent processes - notably release of gliotransmitters - depends on the stimulus that initiates the Ca(2+) signal. The spatiotemporal complexity of Ca(2+) signals is substantial, and we here tested the hypothesis that variation in the kinetics of Ca(2+) responses could offer a means of selectively engaging downstream targets, if agonists exhibited a "signature shape'' in evoked Ca(2+) response. To test this, astrocytes were exposed to three different receptor agonists (ATP, glutamate and histamine) and the resultant Ca(2+) signals were analysed for systematic differences in kinetics that depended on the initiating stimulus. We found substantial heterogeneity between cells in the time course of Ca(2+) responses, but the variation did not correlate with the type or concentration of the stimulus. Using a simple metric to quantify the extent of difference between populations, it was found that the variation between agonists was insufficient to allow signal discrimination. We conclude that the time course of global intracellular Ca(2+) signals does not offer the cells a means for distinguishing between different neurotransmitters.	[James, Laura R.; Walker, Simon; Bellamy, Tomas C.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [de Sousa, Paula R. S.; Ray, Aaron; Bellamy, Tomas C.] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham, England; [Russell, Noah A.] Univ Nottingham, Sch Biol, Inst Biophys Imaging & Opt Sci, Nottingham NG7 2RD, England; [Russell, Noah A.] Univ Nottingham, Sch Elect & Elect Engn, Inst Biophys Imaging & Opt Sci, Nottingham NG7 2RD, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Nottingham; University of Nottingham; University of Nottingham	James, LR (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge, England.	tomas.bellamy@nottingham.ac.uk		Walker, Simon/0000-0001-9185-4922; Bellamy, Tomas/0000-0003-0204-7366; Russell, N/0000-0002-0998-6094	Biotechnology and Biological Sciences Research Council, UK [BB/B5009581]; Cairn Research Ltd (Faversham, UK); BBSRC; Cairn Research Limited; Biotechnology and Biological Sciences Research Council [BB/B500958/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cairn Research Ltd (Faversham, UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cairn Research Limited; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, UK (grant number: BB/B5009581) and by Cairn Research Ltd (Faversham, UK). LRJ was supported by a BBSRC CASE studentship in association with Cairn Research Limited. TCB held a BBSRC David Phillips Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; BOWMAN CL, 1984, NATURE, V311, P656, DOI 10.1038/311656a0; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Gatenby RA, 2007, B MATH BIOL, V69, P635, DOI 10.1007/s11538-006-9141-5; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; KETTENMANN H, 1984, NEUROSCI LETT, V52, P25, DOI 10.1016/0304-3940(84)90345-8; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nakamura N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.6; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Venance L, 1998, J PHYSIOL-LONDON, V510, P429, DOI 10.1111/j.1469-7793.1998.429bk.x; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26889	10.1371/journal.pone.0026889	http://dx.doi.org/10.1371/journal.pone.0026889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046396	Green Submitted, Green Published, gold			2022-12-27	WOS:000296517000039
J	Martin-Lopez, E; Blanchart, A; De Carlos, JA; Lopez-Mascaraque, L				Martin-Lopez, Eduardo; Blanchart, Albert; De Carlos, Juan A.; Lopez-Mascaraque, Laura			Dab1 (Disable Homolog-1) Reelin Adaptor Protein Is Overexpressed in the Olfactory Bulb at Early Postnatal Stages	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MITRAL CELL-DEVELOPMENT; APOE RECEPTOR 2; NEURONAL MIGRATION; BRAIN-DEVELOPMENT; VLDL RECEPTOR; TYROSINE PHOSPHORYLATION; LAMINAR ORGANIZATION; SIGNALING PATHWAY; RADIAL GLIA	Dab1 mediates reelin signalling and plays critical roles in early brain development such as the stereotypical positioning of neurons in the brain. The olfactory bulb undergoes a prominent layering reorganization, but shows not apparent differences between wild type and reeler in the layer organization. Therefore, an accurate regional and cellular simultaneous analysis of these molecules becomes essential to clarify the role played by Dab1 upon Reelin effect. The present study reveals a strong and consistent Dab1 mRNA and protein expressions, throughout the olfactory bulb layers in both wild type and reeler mice. In addition, noteworthy is the pattern of Dab1 location within cell nuclei in both strains. Furthermore, a temporal increment of Dab1 expression levels is detected from P0 to P15 in both strains, being the protein quantity higher in reeler than in wild type mice. Altogether, our results revealed that Reln acts directly from projection neurons via the production of different Reln fragments. Changes in the pattern of Dab1 expression could reflect an alternative Reln function in postnatal and adult stages, besides a possible regulation of Dab1 by other molecules distinct to Reln.	[Martin-Lopez, Eduardo; Blanchart, Albert; De Carlos, Juan A.; Lopez-Mascaraque, Laura] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Martin-Lopez, E (corresponding author), CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain.	mascaraque@cajal.csic.es	Martin-Lopez, Eduardo/K-8765-2019; Lopez-Mascaraque, Laura/M-2448-2014; Blanchart, Albert/C-8457-2014; De Carlos, Juan A./Q-8999-2018	Lopez-Mascaraque, Laura/0000-0002-7154-5687; De Carlos, Juan A./0000-0001-9096-5372; Martin-Lopez, Eduardo/0000-0002-7654-638X	Spanish Ministerio de Ciencia e Innovacion [BFU2010-15564]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was sponsored by Research grant BFU2010-15564 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; Bock HH, 2004, J BIOL CHEM, V279, P33471, DOI 10.1074/jbc.M401770200; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Gao ZH, 2011, CELL SIGNAL, V23, P555, DOI 10.1016/j.cellsig.2010.11.007; Gao ZH, 2010, MOL CELL BIOL, V30, P4339, DOI 10.1128/MCB.00545-10; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HINDS JW, 1973, J COMP NEUROL, V151, P281, DOI 10.1002/cne.901510305; Honda T, 2006, J BIOL CHEM, V281, P38951, DOI 10.1074/jbc.M609061200; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Jossin Y, 2003, CEREB CORTEX, V13, P627, DOI 10.1093/cercor/13.6.627; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; TERASHIMA T, 1985, DEV BRAIN RES, V18, P103, DOI 10.1016/0165-3806(85)90254-8; Tinnes S, 2011, FASEB J, V25, P1002, DOI 10.1096/fj.10-168294; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhao ST, 2004, DEVELOPMENT, V131, P5117, DOI 10.1242/dev.01387	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26673	10.1371/journal.pone.0026673	http://dx.doi.org/10.1371/journal.pone.0026673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046330	gold, Green Published			2022-12-27	WOS:000296517000026
J	Waki, ML; Onoue, K; Takahashi, T; Goto, K; Saito, Y; Inami, K; Makita, I; Angata, Y; Suzuki, T; Yamashita, M; Sato, N; Nakamura, S; Yuki, D; Sugiura, Y; Zaima, N; Goto-Inoue, N; Hayasaka, T; Shimomura, Y; Setou, M				Waki, Michihiko Luca; Onoue, Kenji; Takahashi, Tsukasa; Goto, Kensuke; Saito, Yusuke; Inami, Katsuaki; Makita, Ippei; Angata, Yurika; Suzuki, Tomomi; Yamashita, Mihi; Sato, Narumi; Nakamura, Saki; Yuki, Dai; Sugiura, Yuki; Zaima, Nobuhiro; Goto-Inoue, Naoko; Hayasaka, Takahiro; Shimomura, Yutaka; Setou, Mitsutoshi			Investigation by Imaging Mass Spectrometry of Biomarker Candidates for Aging in the Hair Cortex	PLOS ONE			English	Article							FOLLICLE; SECTIONS; AGE	Background: Human hair is one of the essential components that define appearance and is a useful source of samples for non-invasive biomonitoring. We describe a novel application of imaging mass spectrometry (IMS) of hair biomolecules for advanced molecular characterization and a better understanding of hair aging. As a cosmetic and biomedical application, molecules whose levels in hair altered with aging were comprehensively investigated. Methods: Human hair was collected from 15 young (20 +/- 65 years old) and 15 older (50 +/- 65 years old) volunteers. Matrix-free laser desorption/ionization IMS was used to visualize molecular distribution in the hair sections. Hair-specific ions displaying a significant difference in the intensities between the 2 age groups were extracted as candidate markers for aging. Tissue localization of the molecules and alterations in their levels in the cortex and medulla in the young and old groups were determined. Results: Among the 31 molecules detected specifically in hair sections, 2-one at m/z 153.00, tentatively assigned to be dihydrouracil, and the other at m/z 207.04, identified to be 3,4-dihydroxymandelic acid (DHMA)-exhibited a higher signal intensity in the young group than in the old, and 1 molecule at m/z 164.00, presumed to be O-phosphoethanolamine, displayed a higher intensity in the old group. Among the 3, putative O-phosphoethanolamine showed a cortex-specific distribution. The 3 molecules in cortex presented the same pattern of alteration in signal intensity with aging, whereas those in medulla did not exhibit significant alteration. Conclusion: Three molecules whose levels in hair altered with age were extracted. While they are all possible markers for aging, putative dihydrouracil and DHMA, are also suspected to play a role in maintaining hair properties and could be targets for cosmetic supplementation. Mapping of ion localization in hair by IMS is a powerful method to extract biomolecules in specified regions and determine their tissue distribution.	[Waki, Michihiko Luca; Onoue, Kenji; Takahashi, Tsukasa; Goto, Kensuke; Saito, Yusuke; Inami, Katsuaki; Makita, Ippei; Angata, Yurika; Suzuki, Tomomi; Yamashita, Mihi; Sato, Narumi; Nakamura, Saki; Yuki, Dai; Sugiura, Yuki; Zaima, Nobuhiro; Goto-Inoue, Naoko; Hayasaka, Takahiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan; [Shimomura, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Lab Genet Skin Dis, Niigata, Japan	Hamamatsu University School of Medicine; Niigata University	Waki, ML (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan.	setou@hama-med.ac.jp	MAKITA, Ippei/HIR-2425-2022; Onoue, Kenji/GRJ-6704-2022	Sugiura, Yuki/0000-0002-6983-8958; Waki, Michihiko/0000-0002-3754-9780	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This research was supported by grants-in-aid for the scientific research project "Machinery of bioactive lipids in homeostatis and diseases" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and for the project "Development of Systems and Technology for Advanced Measurement and Analysis" by Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Balikova Marie, 2005, Biomedical Papers (Olomouc), V149, P199; BARTONE NA, 1991, J PROTEIN CHEM, V10, P603, DOI 10.1007/BF01025712; Bryson WG, 2009, J STRUCT BIOL, V166, P46, DOI 10.1016/j.jsb.2008.12.006; Chen N, 2005, J MICROSC-OXFORD, V220, P96, DOI 10.1111/j.1365-2818.2005.01517.x; Deedrick D. W., 2000, FORENSIC SCI COMMUN, V2; DEEMING SB, 1978, AM J CLIN NUTR, V31, P1175, DOI 10.1093/ajcn/31.7.1175; Gamez-Garcia M, 2009, J COSMET SCI, V60, P85; GERACE E, 2011, FORENSIC SCI INT; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Goto-Inoue N, 2010, METHOD ENZYMOL, V478, P287, DOI 10.1016/S0076-6879(10)78014-9; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Haake HM, 2009, J COSMET SCI, V60, P143; Hagan NA, 2008, INT J MASS SPECTROM, V278, P158, DOI 10.1016/j.ijms.2008.04.009; Hallegot P, 2004, J INVEST DERMATOL, V122, P381, DOI 10.1046/j.0022-202X.2004.22217.x; HALLEGOT P, 1993, J MICROSC-OXFORD, V172, P131, DOI 10.1111/j.1365-2818.1993.tb03404.x; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; Hayasaka T, 2010, J AM SOC MASS SPECTR, V21, P1446, DOI 10.1016/j.jasms.2010.04.005; Jiang H, 2004, BRIT J PHARMACOL, V141, P616, DOI 10.1038/sj.bjp.0705651; Keis K, 2007, J COSMET SCI, V58, P135; Kempson IM, 2005, SCI TOTAL ENVIRON, V338, P213, DOI 10.1016/j.scitotenv.2004.07.017; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lee Won-Soo, 2009, Int J Trichology, V1, P94, DOI 10.4103/0974-7753.58551; LV J, 2011, BIOL TRACE ELEM RES; Mathur BN, 2009, CEREB CORTEX, V19, P2372, DOI 10.1093/cercor/bhn253; McMullen R, 2003, J COSMET SCI, V54, P335; Nagase S, 2009, J COSMET SCI, V60, P637; Petzke KJ, 2010, CURR OPIN CLIN NUTR, V13, P532, DOI 10.1097/MCO.0b013e32833c3c84; POLITI L, 2010, J PHARM BIOMED ANAL, V54, P1192; Porta T, 2011, ANAL CHEM, V83, P4266, DOI 10.1021/ac200610c; ROGERS GE, 1959, ANN NY ACAD SCI, V83, P378; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Setou M, 2011, J ELECTRON MICROSC, V60, P47, DOI 10.1093/jmicro/dfq079; Setou M, 2010, MED MOL MORPHOL, V43, P1, DOI 10.1007/s00795-009-0489-0; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Shrivas K, 2010, ANAL CHEM; STEPIEN KB, 1982, BIOCHEM PHARMACOL, V31, P3359, DOI 10.1016/0006-2952(82)90612-8; Sugiura Y, 2009, RAPID COMMUN MASS SP, V23, P3269, DOI 10.1002/rcm.4242; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; TODD MK, 1994, J APPL PHYSIOL, V76, P1548, DOI 10.1152/jappl.1994.76.4.1548; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Washam C, 2006, ENVIRON HEALTH PERSP, V114, pA636, DOI 10.1289/ehp.114-a636; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001; SPECIALCHEM4COSMETIC	50	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26721	10.1371/journal.pone.0026721	http://dx.doi.org/10.1371/journal.pone.0026721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039541	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200046
J	Duc, C; Nentwig, W; Lindfeld, A				Duc, Caroline; Nentwig, Wolfgang; Lindfeld, Andreas			No Adverse Effect of Genetically Modified Antifungal Wheat on Decomposition Dynamics and the Soil Fauna Community - A Field Study	PLOS ONE			English	Article							MILDEW RESISTANCE GENES; TRANSGENIC BT MAIZE; CROPPING SYSTEMS; ORIBATID MITE; SILVER BIRCH; LITTER; MICROARTHROPODS; POPULATIONS; PATTERNS; FOREST	The cultivation of genetically modified (GM) plants has raised several environmental concerns. One of these concerns regards non-target soil fauna organisms, which play an important role in the decomposition of organic matter and hence are largely exposed to GM plant residues. Soil fauna may be directly affected by transgene products or indirectly by pleiotropic effects such as a modified plant metabolism. Thus, ecosystem services and functioning might be affected negatively. In a litterbag experiment in the field we analysed the decomposition process and the soil fauna community involved. Therefore, we used four experimental GM wheat varieties, two with a race-specific antifungal resistance against powdery mildew (Pm3b) and two with an unspecific antifungal resistance based on the expression of chitinase and glucanase. We compared them with two non-GM isolines and six conventional cereal varieties. To elucidate the mechanisms that cause differences in plant decomposition, structural plant components (i.e. C:N ratio, lignin, cellulose, hemicellulose) were examined and soil properties, temperature and precipitation were monitored. The most frequent taxa extracted from decaying plant material were mites (Cryptostigmata, Gamasina and Uropodina), springtails (Isotomidae), annelids (Enchytraeidae) and Diptera (Cecidomyiidae larvae). Despite a single significant transgenic/month interaction for Cecidomyiidae larvae, which is probably random, we detected no impact of the GM wheat on the soil fauna community. However, soil fauna differences among conventional cereal varieties were more pronounced than between GM and non-GM wheat. While leaf residue decomposition in GM and non-GM wheat was similar, differences among conventional cereals were evident. Furthermore, sampling date and location were found to greatly influence soil fauna community and decomposition processes. The results give no indication of ecologically relevant adverse effects of antifungal GM wheat on the composition and the activity of the soil fauna community.	[Duc, Caroline; Nentwig, Wolfgang; Lindfeld, Andreas] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Bern	Duc, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	andreas.lindfeld@iee.unibe.ch	Nentwig, Wolfgang/A-6624-2011		Swiss National Science Foundation [405940-115604]; wheat consortium, a subunit of the National Research Programme [NRP 59]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); wheat consortium, a subunit of the National Research Programme	This project was funded by the Swiss National Science Foundation (http://www.snf.ch; SNF Grant 405940-115604) and is part of the wheat consortium, a subunit of the National Research Programme NRP 59 "Benefits and risks of the deliberate release of genetically modified plants'' (www.NRP59.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Bigler I, 2012, J APPL ENTOMOL, V136, P51, DOI 10.1111/j.1439-0418.2011.01622.x; Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170; Chen YH, 2009, MOL BREEDING, V24, P141, DOI 10.1007/s11032-009-9279-6; Cortet J, 2007, PEDOBIOLOGIA, V51, P207, DOI 10.1016/j.pedobi.2007.04.001; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Doane JF, 2008, CROP PROT, V27, P951, DOI 10.1016/j.cropro.2007.11.016; Donegan KK, 1997, J APPL ECOL, V34, P767, DOI 10.2307/2404921; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Griffiths BS, 2007, PEDOBIOLOGIA, V51, P195, DOI 10.1016/j.pedobi.2007.04.002; Grime JP, 1996, OIKOS, V77, P489, DOI 10.2307/3545938; Hedlund K, 2000, OIKOS, V88, P585, DOI 10.1034/j.1600-0706.2000.880315.x; Honemann L, 2008, APPL SOIL ECOL, V40, P203, DOI 10.1016/j.apsoil.2008.04.006; Honemann L, 2009, EUR J SOIL BIOL, V45, P351, DOI 10.1016/j.ejsobi.2009.03.001; Huhta V, 1998, APPL SOIL ECOL, V9, P53, DOI 10.1016/S0929-1393(98)00053-5; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Illig J, 2005, J TROP ECOL, V21, P589, DOI 10.1017/S0266467405002646; Ioset JR, 2007, PLANT MOL BIOL, V65, P645, DOI 10.1007/s11103-007-9229-9; Jacobs W, 1988, BIOL OKOLOGIE INSEKT; Kotilainen T, 2004, EUR J SOIL BIOL, V40, P155, DOI 10.1016/j.ejsobi.2005.03.001; LAGERLOF J, 1989, J APPL ECOL, V26, P183, DOI 10.2307/2403660; Lindfeld A, 2011, APPL SOIL ECOL, V47, P51, DOI 10.1016/j.apsoil.2010.10.012; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Manu Minodora, 2010, Acta Entomologica Serbica, V15, P129; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; O'Callaghan M, 2001, N Z PLANT PROTECT-SE, V54, P105, DOI 10.30843/nzpp.2001.54.3725; Peschel K, 2006, SOIL BIOL BIOCHEM, V38, P2985, DOI 10.1016/j.soilbio.2006.04.035; Peter M, 2010, PEDOBIOLOGIA, V53, P271, DOI 10.1016/j.pedobi.2009.12.006; Poerschmann J, 2005, J ENVIRON QUAL, V34, P1508, DOI 10.2134/jeq2005.0070; Prasifka JR, 2007, J APPL ENTOMOL, V131, P115, DOI 10.1111/j.1439-0418.2006.01141.x; R Core Team, 2020, R LANG ENV STAT COMP; Romeis J, 2003, PEDOBIOLOGIA, V47, P141, DOI 10.1078/0031-4056-00177; Rottmann N, 2010, EUR J SOIL BIOL, V46, P27, DOI 10.1016/j.ejsobi.2009.09.004; SANTOS PF, 1981, ECOLOGY, V62, P654, DOI 10.2307/1937733; Sanvido O, 2007, J VERBRAUCH LEBENSM, V2, P37, DOI 10.1007/s00003-007-0292-6; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P133, DOI 10.1016/S0038-0717(01)00161-4; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; SIEPEL H, 1994, BIOL FERT SOILS, V18, P263, DOI 10.1007/BF00570628; Srichumpa P, 2005, PLANT PHYSIOL, V139, P885, DOI 10.1104/pp.105.062406; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wu WX, 2009, J SOIL SEDIMENT, V9, P457, DOI 10.1007/s11368-009-0106-9; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Zeilinger AR, 2010, SOIL BIOL BIOCHEM, V42, P1284, DOI 10.1016/j.soilbio.2010.04.004; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; Zheng DW, 1997, AM NAT, V149, P125, DOI 10.1086/285982; Zurbrugg C, 2010, TRANSGENIC RES, V19, P257, DOI 10.1007/s11248-009-9304-x; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	54	12	12	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25014	10.1371/journal.pone.0025014	http://dx.doi.org/10.1371/journal.pone.0025014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043279	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400006
J	Baillet, A; Le Bouffant, R; Volff, JN; Luangpraseuth, A; Poumerol, E; Thepot, D; Pailhoux, E; Livera, G; Cotinot, C; Mandon-Pepin, B				Baillet, Adrienne; Le Bouffant, Ronan; Volff, Jean Nicolas; Luangpraseuth, Alix; Poumerol, Elodie; Thepot, Dominique; Pailhoux, Eric; Livera, Gabriel; Cotinot, Corinne; Mandon-Pepin, Beatrice			TOPAZ1, a Novel Germ Cell-Specific Expressed Gene Conserved during Evolution across Vertebrates	PLOS ONE			English	Article							RETINOIC ACID; SMALL RNAS; MEIOTIC INITIATION; CHROMOSOME SYNAPSIS; SUPPRESSES MEIOSIS; SEQUENCE ALIGNMENT; SEX DETERMINATION; DNA METHYLATION; MOUSE OVARIES; PAZ DOMAIN	Background: We had previously reported that the Suppression Subtractive Hybridization (SSH) approach was relevant for the isolation of new mammalian genes involved in oogenesis and early follicle development. Some of these transcripts might be potential new oocyte and granulosa cell markers. We have now characterized one of them, named TOPAZ1 for the Testis and Ovary-specific PAZ domain gene. Principal Findings: Sheep and mouse TOPAZ1 mRNA have 4,803 bp and 4,962 bp open reading frames (20 exons), respectively, and encode putative TOPAZ1 proteins containing 1,600 and 1653 amino acids. They possess PAZ and CCCH domains. In sheep, TOPAZ1 mRNA is preferentially expressed in females during fetal life with a peak during prophase I of meiosis, and in males during adulthood. In the mouse, Topaz1 is a germ cell-specific gene. TOPAZ1 protein is highly conserved in vertebrates and specifically expressed in mouse and sheep gonads. It is localized in the cytoplasm of germ cells from the sheep fetal ovary and mouse adult testis. Conclusions: We have identified a novel PAZ-domain protein that is abundantly expressed in the gonads during germ cell meiosis. The expression pattern of TOPAZ1, and its high degree of conservation, suggests that it may play an important role in germ cell development. Further characterization of TOPAZ1 may elucidate the mechanisms involved in gametogenesis, and particularly in the RNA silencing process in the germ line.	[Baillet, Adrienne; Luangpraseuth, Alix; Poumerol, Elodie; Thepot, Dominique; Pailhoux, Eric; Cotinot, Corinne; Mandon-Pepin, Beatrice] INRA, UMR 1198 Biol Dev & Reprod, Jouy En Josas, France; [Baillet, Adrienne; Luangpraseuth, Alix; Poumerol, Elodie; Thepot, Dominique; Pailhoux, Eric; Cotinot, Corinne; Mandon-Pepin, Beatrice] ENVA, Maisons Alfort, France; [Le Bouffant, Ronan; Livera, Gabriel] CEA, DSV DRR SEGG LDRG, Lab Differentiat & Radiobiol Gonads, Unit Gametogenesis & Genotox, Fontenay Aux Roses, France; [Volff, Jean Nicolas] Univ Lyon, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,CNRS, Lyon, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); CEA; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Baillet, A (corresponding author), INRA, UMR 1198 Biol Dev & Reprod, Jouy En Josas, France.	beatrice.pepin@jouy.inra.fr	LIVERA, Gabriel/F-5740-2019	LIVERA, Gabriel/0000-0001-8436-4730; Le Bouffant, Ronan/0000-0002-0995-7373; Mandon-Pepin, Beatrice/0000-0002-5424-0822	PHASE Division, INRA; Ministere delegue a l'Enseignement superieur et a la Recherche, France	PHASE Division, INRA; Ministere delegue a l'Enseignement superieur et a la Recherche, France	This work was supported in part by PHASE Division, INRA. AB was supported by a doctoral fellowship from the Ministere delegue a l'Enseignement superieur et a la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Baillet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-436; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bernex F, 1996, DEVELOPMENT, V122, P3023; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Capel B, 2009, ANN REV CELL DEV BIO; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Choi Y, 2006, J BIOL CHEM, V281, P35747, DOI 10.1074/jbc.M604008200; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GONDOS B, 1971, AM J OBSTET GYNECOL, V110, P644, DOI 10.1016/0002-9378(71)90245-6; GONDOS B, 1969, FERTIL STERIL, V20, P176; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Herrera L, 2005, DEV BIOL, V279, P271, DOI 10.1016/j.ydbio.2004.11.029; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; KONISHI I, 1986, J ANAT, V148, P121; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krotz SP, 2009, FERTIL STERIL, V91, P2020, DOI 10.1016/j.fertnstert.2008.05.042; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Nicholas CR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-2; Ohta K, 2010, BIOL REPROD, V83, P1056, DOI 10.1095/biolreprod.110.085787; Olesen C, 2007, CELL TISSUE RES, V328, P207, DOI 10.1007/s00441-006-0205-5; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Petre-Lazar B, 2007, J CELL PHYSIOL, V210, P87, DOI 10.1002/jcp.20829; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Roy A, 2006, REPRODUCTION, V131, P207, DOI 10.1530/rep.1.00530; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wartenberg H, 1998, MICROSC RES TECHNIQ, V40, P377, DOI 10.1002/(SICI)1097-0029(19980301)40:5<377::AID-JEMT5>3.3.CO;2-S; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zamudio N, 2010, HEREDITY, V105, P92, DOI 10.1038/hdy.2010.53; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	90	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26950	10.1371/journal.pone.0026950	http://dx.doi.org/10.1371/journal.pone.0026950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069478	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900040
J	Kuang, ZZ; Hao, YH; Walling, BE; Jeffries, JL; Ohman, DE; Lau, GW				Kuang, Zhizhou; Hao, Yonghua; Walling, Brent E.; Jeffries, Jayme L.; Ohman, Dennis E.; Lau, Gee W.			Pseudomonas aeruginosa Elastase Provides an Escape from Phagocytosis by Degrading the Pulmonary Surfactant Protein-A	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE PHAGOCYTOSIS; PROTEOLYTIC INACTIVATION; SECRETION SYSTEM; LUNG COLLECTINS; HOST-DEFENSE; EXPRESSION; INFECTION; CLEAVAGE; ASSOCIATION; SUPPRESS	Pseudomonas aeruginosa is an opportunistic pathogen that causes both acute pneumonitis in immunocompromised patients and chronic lung infections in individuals with cystic fibrosis and other bronchiectasis. Over 75% of clinical isolates of P. aeruginosa secrete elastase B (LasB), an elastolytic metalloproteinase that is encoded by the lasB gene. Previously, in vitro studies have demonstrated that LasB degrades a number of components in both the innate and adaptive immune systems. These include surfactant proteins, antibacterial peptides, cytokines, chemokines and immunoglobulins. However, the contribution of LasB to lung infection by P. aeruginosa and to inactivation of pulmonary innate immunity in vivo needs more clarification. In this study, we examined the mechanisms underlying enhanced clearance of the Delta lasB mutant in mouse lungs. The DlasB mutant was attenuated in virulence when compared to the wild-type strain PAO1 during lung infection in SP-A(+/+) mice. However, the DlasB mutant was as virulent as PAO1 in the lungs of SP-A(-/-) mice. Detailed analysis showed that the Delta lasB mutant was more susceptible to SP-A-mediated opsonization but not membrane permeabilization. In vitro and in vivo phagocytosis experiments revealed that SP-A augmented the phagocytosis of Delta lasB mutant bacteria more efficiently than the isogenic wild-type PAO1. The Delta lasB mutant was found to have a severely reduced ability to degrade SP-A, consequently making it unable to evade opsonization by the collectin during phagocytosis. These results suggest that P. aeruginosa LasB protects against SP-A-mediated opsonization by degrading the collectin.	[Kuang, Zhizhou; Hao, Yonghua; Walling, Brent E.; Jeffries, Jayme L.; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	University of Illinois System; University of Illinois Urbana-Champaign; Virginia Commonwealth University	Kuang, ZZ (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL USA.	geelau@uiuc.edu	Kuang, Zhizhou/B-8368-2012; Lau, Gee W/H-4073-2018		National Institutes of Health [HL090699]; American Lung Association [DS-192835-N]; National Center for Research Resources, National Institutes of Health [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health grant HL090699 and the American Lung Association DeSouza Research Award DS-192835-N to GWL. This investigation was conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Azghani AO, 1996, AM J RESP CELL MOL, V15, P132, DOI 10.1165/ajrcmb.15.1.8679217; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; Beatty AL, 2005, AM J RESP CELL MOL, V32, P128, DOI 10.1165/rcmb.2004-0276OC; Canadas O, 2008, BIOPHYS J, V95, P3287, DOI 10.1529/biophysj.108.137323; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; Diebel LN, 2009, J TRAUMA, V66, P1336, DOI 10.1097/TA.0b013e31819dc577; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; Frick R, 1989, CHEST S, V95, p206s; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gil M, 2009, J BIOL CHEM, V284, P7495, DOI 10.1074/jbc.M808643200; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; HORVAT RT, 1989, INFECT IMMUN, V57, P1668, DOI 10.1128/IAI.57.6.1668-1674.1989; JACQUOT J, 1985, INFECT IMMUN, V47, P555, DOI 10.1128/IAI.47.2.555-560.1985; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; KRATOCHVIL B, 1965, ANAL CHEM, V37, P111, DOI 10.1021/ac60220a028; Kuang ZZ, 2011, MOL MICROBIOL, V79, P1220, DOI 10.1111/j.1365-2958.2010.07516.x; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Kuzmenko AI, 2005, J BIOL CHEM, V280, P25913, DOI 10.1074/jbc.M411344200; Laboratories B.R., 1986, FOCUS, V8, P9; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 1996, CRIT CARE MED, V24, P1062, DOI 10.1097/00003246-199606000-00029; Liau DF, 1996, BBA-LIPID LIPID MET, V1302, P117, DOI 10.1016/0005-2760(96)00042-2; Mariencheck WI, 2003, AM J RESP CELL MOL, V28, P528, DOI 10.1165/rcmb.2002-0141OC; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; McIver KS, 2004, MICROBIOL-SGM, V150, P3969, DOI 10.1099/mic.0.27340-0; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MORIHARA K, 1964, J BACTERIOL, V88, P745, DOI 10.1128/JB.88.3.745-757.1964; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Noah TL, 2003, AM J RESP CRIT CARE, V168, P685, DOI 10.1164/rccm.200301-005OC; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; PISON U, 1989, BIOCHIM BIOPHYS ACTA, V992, P251, DOI 10.1016/0304-4165(89)90082-2; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; SCHAD PA, 1987, J BACTERIOL, V169, P2691, DOI 10.1128/jb.169.6.2691-2696.1987; Schaeffer LM, 2004, J IMMUNOL, V173, P1959, DOI 10.4049/jimmunol.173.3.1959; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SCHULTZ DR, 1974, INFECT IMMUN, V10, P128, DOI 10.1128/IAI.10.1.128-135.1974; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Shepherd VL, 2002, AM J RESP CELL MOL, V26, P257, DOI 10.1165/ajrcmb.26.3.f227; Suwabe A, 1996, ARCH BIOCHEM BIOPHYS, V327, P285, DOI 10.1006/abbi.1996.0123; THEANDER TG, 1988, INFECT IMMUN, V56, P1673, DOI 10.1128/IAI.56.7.1673-1677.1988; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564; Zhang SP, 2005, PLOS PATHOG, V1, P259, DOI 10.1371/journal.ppat.0010031; Zoumot Z, 2010, CURR OPIN INFECT DIS, V23, P165, DOI 10.1097/QCO.0b013e328335af91	70	93	96	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27091	10.1371/journal.pone.0027091	http://dx.doi.org/10.1371/journal.pone.0027091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069491	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900051
J	Kono, M; Hotomi, M; Hollingshead, SK; Briles, DE; Yamanaka, N				Kono, Masamitsu; Hotomi, Muneki; Hollingshead, Susan K.; Briles, David E.; Yamanaka, Noboru			Maternal Immunization with Pneumococcal Surface Protein A Protects against Pneumococcal Infections among Derived Offspring	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NONTYPABLE HAEMOPHILUS-INFLUENZAE; NEONATAL FC-RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; INTRANASAL IMMUNIZATION; NASOPHARYNGEAL CARRIAGE; POLYSACCHARIDE VACCINE; PSPA FRAGMENTS; CAPSULAR POLYSACCHARIDES	Pathogen-specific antibody plays an important role in protection against pneumococcal carriage and infections. However, neonates and infants exhibit impaired innate and adaptive immune responses, which result in their high susceptibility to pneumococci. To protect neonates and infants against pneumococcal infection it is important to elicit specific protective immune responses at very young ages. In this study, we investigated the protective immunity against pneumococcal carriage, pneumonia, and sepsis induced by maternal immunization with pneumococcal surface protein A (PspA). Mother mice were intranasally immunized with recombinant PspA (rPspA) and cholera toxin B subunit (CTB) prior to being mated. Anti-PspA specific IgG, predominantly IgG1, was present at a high level in the serum and milk of immunized mothers and in the sera of their pups. The pneumococcal densities in washed nasal tissues and in lung homogenate were significantly reduced in pups delivered from and/or breast-fed by PspA-immunized mothers. Survival after fatal systemic infections with various types of pneumococci was significantly extended in the pups, which had received anti-PspA antibody via the placenta or through their milk. The current findings strongly suggest that maternal immunization with PspA is an attractive strategy against pneumococcal infections during early childhood. (191 words)	[Kono, Masamitsu; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Hollingshead, Susan K.; Briles, David E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Wakayama Medical University; University of Alabama System; University of Alabama Birmingham	Kono, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21592164]; NIH [AI021458]; National Research Council of Korea; Grants-in-Aid for Scientific Research [21592164] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Council of Korea; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by national grants No. 21592164 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MH & NY), NIH grant AI021458 (DEB & SKH) and the National Research Council of Korea Grant WCU (DEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Arvola M, 2000, BIOL REPROD, V63, P1817, DOI 10.1095/biolreprod63.6.1817; Baril L, 2004, CLIN EXP IMMUNOL, V135, P474, DOI 10.1111/j.1365-2249.2003.02357.x; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; Briles DE, 2000, VACCINE, V18, P1707, DOI 10.1016/S0264-410X(99)00511-3; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 1998, CLIN MICROBIOL REV, V11, P645, DOI 10.1128/CMR.11.4.645; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Daly KA, 2003, VACCINE, V21, P3473, DOI 10.1016/S0264-410X(03)00354-2; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; Ferreira DM, 2008, CLIN VACCINE IMMUNOL, V15, P499, DOI 10.1128/CVI.00400-07; Ferreira DM, 2010, MICROB PATHOGENESIS, V48, P205, DOI 10.1016/j.micpath.2010.02.009; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Gall SA, 2005, EXPERT REV VACCINES, V4, P813, DOI 10.1586/14760584.4.6.813; GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Giebink GS, 2001, NEW ENGL J MED, V345, P1177, DOI 10.1056/NEJMra010462; Glezen WP, 1999, CLIN INFECT DIS, V28, P219, DOI 10.1086/515122; Hanage WP, 2007, J INFECT DIS, V196, P1282, DOI 10.1086/521630; Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hotomi M, 1999, ACTA OTO-LARYNGOL, V119, P703, DOI 10.1080/00016489950180667; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; ISRAEL EJ, 1995, J IMMUNOL, V154, P6246; Katsurahara Toshiki, 2008, Journal of Infection and Chemotherapy, V14, P393, DOI 10.1007/s10156-008-0647-7; KIYONO H, 1992, Regional Immunology, V4, P54; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P365, DOI 10.1023/B:EJEP.0000024752.48929.bd; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Mera R, 2008, MICROB DRUG RESIST, V14, P101, DOI 10.1089/mdr.2008.0782; Miyaji EN, 2002, INFECT IMMUN, V70, P5086, DOI 10.1128/IAI.70.9.5086-5090.2002; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Munoz FM, 2001, VACCINE, V20, P826, DOI 10.1016/S0264-410X(01)00397-8; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Nair N, 2007, J INFECT DIS, V196, P1339, DOI 10.1086/522519; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ochs MM, 2008, MICROB PATHOGENESIS, V44, P204, DOI 10.1016/j.micpath.2007.09.007; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Paradiso PR, 2011, CLIN INFECT DIS, V52, P1241, DOI 10.1093/cid/cir142; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Quiambao BP, 2003, VACCINE, V21, P3451, DOI 10.1016/S0264-410X(03)00349-9; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; Rubin JL, 2010, VACCINE, V28, P7634, DOI 10.1016/j.vaccine.2010.09.049; Samukawa T, 2000, J INFECT DIS, V181, P1842, DOI 10.1086/315427; Simell B, 2007, J INFECT DIS, V196, P1528, DOI 10.1086/522607; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Tart RC, 1996, J INFECT DIS, V173, P380, DOI 10.1093/infdis/173.2.380; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Virolainen A, 2000, PEDIATR INFECT DIS J, V19, P134, DOI 10.1097/00006454-200002000-00011; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980; YAMANAKA N, 1993, J PEDIATR-US, V122, P212, DOI 10.1016/S0022-3476(06)80115-0; Yamauchi K, 2006, VACCINE, V24, P5294, DOI 10.1016/j.vaccine.2006.03.056; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	75	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27102	10.1371/journal.pone.0027102	http://dx.doi.org/10.1371/journal.pone.0027102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073127	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000054
J	Zhao, HY; Zhang, YJ; Dai, H; Zhang, Y; Shen, YF				Zhao, Hai-yong; Zhang, Yan-jun; Dai, Hui; Zhang, Ye; Shen, Yu-fei			CARM1 Mediates Modulation of Sox2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ARGININE METHYLATION; CARCINOMA-CELLS; DNA-BINDING; DIFFERENTIATION; OCT4; GENE; PLURIPOTENCY; ENHANCER; COMPLEX	Sox2 is a key component of the transcription factor network that maintains the pluripotent state of embryonic stem cells (ESCs). Sox2 is regulated by multiple post-translational modifications, including ubiquitination, sumoylation, acetylation and phosphorylation. Here we report that Sox2 is in association with and methylated by coactivator-associated arginine methyltransferase 1 (CARM1), a protein arginine methyltransferase that plays a pivotal role in ESCs. We found that CARM1 facilitates Sox2-mediated transactivation and directly methylates Sox2 at arginine 113. This methylation event enhances Sox2 self-association. Furthermore, the physiological retention of Sox2 on chromatin restricts the Sox2 methylation level. Our study reveals the direct regulation of Sox2 by CARM1 that sheds lights on how arginine methylation signals are integrated into the pluripotent transcription factor network.	[Zhao, Hai-yong] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, HY (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	yezhang@pumc.edu.cn; yfshen@pumc.edu.cn	Zhang, Ye/D-5015-2011	Zhang, Ye/0000-0002-3494-7206	National Key Scientific Program of China [2011CB964902]; NSFC [90919048]; 973 Program of China [2005CB522405]; State Key Laboratories [2060204]	National Key Scientific Program of China; NSFC(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); State Key Laboratories	This work was supported by the National Key Scientific Program of China (2011CB964902), the NSFC 90919048, the 973 Program of China 2005CB522405, and Special Funds from the State Key Laboratories (2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boer B, 2006, J CELL PHYSIOL, V208, P97, DOI 10.1002/jcp.20635; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Gao X, 2010, J CELL BIOCHEM, V110, P162, DOI 10.1002/jcb.22522; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Ito T, 2009, ASIAN ECON POLICY R, V4, P1, DOI 10.1111/j.1748-3131.2009.01102.x; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim D, J BIOL CHEM, V285, P1147; Kuhn P, 2010, NUCL ACIDS RES; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100	31	35	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27026	10.1371/journal.pone.0027026	http://dx.doi.org/10.1371/journal.pone.0027026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046437	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800060
J	Veerman, JL; Barendregt, JJ; Forster, M; Vos, T				Veerman, J. Lennert; Barendregt, Jan J.; Forster, Megan; Vos, Theo			Cost-Effectiveness of Pharmacotherapy to Reduce Obesity	PLOS ONE			English	Article							LONG-TERM PHARMACOTHERAPY; BODY-MASS INDEX; WEIGHT-LOSS; FUTURE COSTS; METAANALYSIS; OVERWEIGHT; ORLISTAT; HEALTH; SIBUTRAMINE; AUSTRALIA	Aims: Obesity causes a high disease burden in Australia and across the world. We aimed to analyse the cost-effectiveness of weight reduction with pharmacotherapy in Australia, and to assess its potential to reduce the disease burden due to excess body weight. Methods: We constructed a multi-state life-table based Markov model in Excel in which body weight influences the incidence of stroke, ischemic heart disease, hypertensive heart disease, diabetes mellitus, osteoarthritis, post-menopausal breast cancer, colon cancer, endometrial cancer and kidney cancer. We use data on effectiveness identified from PubMed searches, on mortality from Australian Bureau of Statistics, on disease costs from the Australian Institute of Health and Welfare, and on drug costs from the Department of Health and Ageing. We evaluate 1-year pharmacological interventions with sibutramine and orlistat targeting obese Australian adults free of obesity-related disease. We use a lifetime horizon for costs and health outcomes and a health sector perspective for costs. Incremental Cost-Effectiveness Ratios (ICERs) below A$50 000 per Disability Adjusted Life Year (DALY) averted are considered good value for money. Results: The ICERs are A$130 000/DALY (95% uncertainty interval [UI] 93 000-180 000) for sibutramine and A$ 230 000/DALY (170 000-340 000) for orlistat. The interventions reduce the body weight-related disease burden at the population level by 0.2% and 0.1%, respectively. Modest weight loss during the interventions, rapid post-intervention weight regain and low adherence limit the health benefits. Conclusions: Treatment with sibutramine or orlistat is not cost-effective from an Australian health sector perspective and has a negligible impact on the total body weight-related disease burden.	[Veerman, J. Lennert; Barendregt, Jan J.; Forster, Megan; Vos, Theo] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Queensland	Veerman, JL (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	l.veerman@uq.edu.au	Barendregt, Jan J/F-6895-2010; Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232	Australian National Health and Medical Research Council (NHMRC) Health Services Research [351558]; NHMRC [456002]	Australian National Health and Medical Research Council (NHMRC) Health Services Research(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by an Australian National Health and Medical Research Council (NHMRC) Health Services Research grant (no. 351558) and an NHMRC Capacity Building Grant (no. 456002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2003, ABS CONS PRIC IND; ABS, 2003, LAB FORC AUSTR 2003; ABS, 2003, AV WEEKL EARN; AIHW, 2008, HLTH EXP AUSTR; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Bamford EJ, 1999, MED J AUSTRALIA, V171, P614, DOI 10.5694/j.1326-5377.1999.tb123821.x; Barendregt J J, 1998, Math Popul Stud, V7, P29; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 2009, J EPIDEMIOL COMMUNIT; Begg S., 2007, BURDEN DIS INJURY AU; Beilby J, 2005, GEN PRACTITIONER SER; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Carter R, 2006, EC ASSESSMENT UNPUB; Carter Rob, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P593, DOI 10.1586/14737167.8.6.593; Cobiac LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014148; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Curfman GD, 2010, NEW ENGL J MED, V363, P972, DOI 10.1056/NEJMe1007993; Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007; Department of Health and Ageing, 2009, PHARM BEN SCHEM DHA; Ezzati M, 2003, COMP QUANTIFICATION; Flegal K, 2005, JAMA-J AM MED ASSOC, V293, P1864; Forster M, 2011, INT J OBES IN PRESS; Forster M, 2011, INT J OBES LOND; Foxcroft DR, 2005, OBES REV, V6, P323, DOI 10.1111/j.1467-789X.2005.00211.x; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Garber AM, 2008, J HEALTH ECON, V27, P819, DOI 10.1016/j.jhealeco.2008.05.002; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Gronniger JT, 2006, AM J PUBLIC HEALTH, V96, P173, DOI 10.2105/AJPH.2004.045823; Haby MM, 2011, HLTH PROMOT INT; Hakim Z, 2002, PHARMACOECONOMICS, V20, P393, DOI 10.2165/00019053-200220060-00004; Hampp C, 2008, VALUE HEALTH, V11, P389, DOI 10.1111/j.1524-4733.2007.00281.x; Hertzman P, 2005, PHARMACOECONOMICS, V23, P1007, DOI 10.2165/00019053-200523100-00004; Jacobs P, 1998, INT J TECHNOL ASSESS, V14, P799, DOI 10.1017/S0266462300012095; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; James WPT, 2004, COMP QUANTIFICATION, P497; Lacey LA, 2005, INT J OBESITY, V29, P975, DOI 10.1038/sj.ijo.0802947; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; LIPSCOMB J, 1989, MED CARE, V27, pS233, DOI 10.1097/00005650-198903001-00019; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Meltzer D, 2008, J HEALTH ECON, V27, P822, DOI 10.1016/j.jhealeco.2008.05.001; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P127; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Neovius M, 2008, INT J OBESITY, V32, P1752, DOI 10.1038/ijo.2008.189; Organisation for Economic Cooperation and Development, 2006, PURCH POW PAR PPPS O; Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pharmaceutical Benefits Advisory Committee, 2008, PUBL SUMM DOC SIB HY; Rankin S L, 2002, Rural Remote Health, V2, P119; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Ruof J, 2005, INT J OBESITY, V29, P517, DOI 10.1038/sj.ijo.0802925; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; Therapeutic Goods Administration DoHaA Government of Australia, 2010, SIB RED WITHDR AUSTR; van Baal PHM, 2008, VALUE HEALTH, V11, P1033, DOI 10.1111/j.1524-4733.2008.00328.x; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010	59	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26051	10.1371/journal.pone.0026051	http://dx.doi.org/10.1371/journal.pone.0026051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046255	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400009
J	Li, M; Liu, J; Zhang, CY				Li, Meng; Liu, Jun; Zhang, Chiyu			Evolutionary History of the Vertebrate Mitogen Activated Protein Kinases Family	PLOS ONE			English	Article							MAPK FAMILY; DOCKING INTERACTIONS; MAXIMUM-LIKELIHOOD; CELL-GROWTH; ERK3; MODELS; PATHWAYS; SPECIFICITY; INFERENCE; ZEBRAFISH	Background: The mitogen activated protein kinases (MAPK) family pathway is implicated in diverse cellular processes and pathways essential to most organisms. Its evolution is conserved throughout the eukaryotic kingdoms. However, the detailed evolutionary history of the vertebrate MAPK family is largely unclear. Methodology/Principal Findings: The MAPK family members were collected from literatures or by searching the genomes of several vertebrates and invertebrates with the known MAPK sequences as queries. We found that vertebrates had significantly more MAPK family members than invertebrates, and the vertebrate MAPK family originated from 3 progenitors, suggesting that a burst of gene duplication events had occurred after the divergence of vertebrates from invertebrates. Conservation of evolutionary synteny was observed in the vertebrate MAPK subfamilies 4, 6, 7, and 11 to 14. Based on synteny and phylogenetic relationships, MAPK12 appeared to have arisen from a tandem duplication of MAPK11 and the MAPK13-MAPK14 gene unit was from a segmental duplication of the MAPK11-MAPK12 gene unit. Adaptive evolution analyses reveal that purifying selection drove the evolution of MAPK family, implying strong functional constraints of MAPK genes. Intriguingly, however, intron losses were specifically observed in the MAPK4 and MAPK7 genes, but not in their flanking genes, during the evolution from teleosts to amphibians and mammals. The specific occurrence of intron losses in the MAPK4 and MAPK7 subfamilies might be associated with adaptive evolution of the vertebrates by enhancing the gene expression level of both MAPK genes. Conclusions/Significance: These results provide valuable insight into the evolutionary history of the vertebrate MAPK family.	[Li, Meng; Liu, Jun; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Li, M (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857	Jiangsu University	Jiangsu University	This study was supported by the "Top-notch personnel'' Project of Jiangsu University (to C Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Almog T, 2010, MOL CELL ENDOCRINOL, V314, P239, DOI 10.1016/j.mce.2009.05.009; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haagenson KK, 2010, CANCER METAST REV, V29, P143, DOI 10.1007/s10555-010-9208-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kawaguchi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-260; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Kultz D, 1998, J MOL EVOL, V46, P571, DOI 10.1007/PL00006338; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Turgeon B, 2002, GENOMICS, V80, P673, DOI 10.1006/geno.2002.7013; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zheng QL, 2004, J BIOL CHEM, V279, P8787, DOI 10.1074/jbc.M310212200	58	36	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26999	10.1371/journal.pone.0026999	http://dx.doi.org/10.1371/journal.pone.0026999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046431	Green Published, Green Submitted, gold			2022-12-27	WOS:000296519600085
J	Morales, R; Sriratana, P; Zhang, J; Cann, IKO				Morales, Raymond; Sriratana, Palita; Zhang, Jing; Cann, Isaac K. O.			Methanosarcina acetivorans C2A Topoisomerase III alpha, an Archaeal Enzyme with Promiscuity in Divalent Cation Dependence	PLOS ONE			English	Article							ESCHERICHIA-COLI DNA; I TOPOISOMERASE; REVERSE GYRASE; CRYSTAL-STRUCTURE; PURIFICATION; MECHANISMS; SULFOLOBUS; PROTEINS; CLEAVAGE; CLONING	Topoisomerases play a fundamental role in genome stability, DNA replication and repair. As a result, topoisomerases have served as therapeutic targets of interest in Eukarya and Bacteria, two of the three domains of life. Since members of Archaea, the third domain of life, have not been implicated in any diseased state to-date, there is a paucity of data on archaeal topoisomerases. Here we report Methanosarcina acetivorans TopoIII alpha (MacTopoIII alpha) as the first biochemically characterized mesophilic archaeal topoisomerase. Maximal activity for MacTopoIIIa was elicited at 30-35 degrees C and 100 mM NaCl. As little as 10 fmol of the enzyme initiated DNA relaxation, and NaCl concentrations above 250 mM inhibited this activity. The present study also provides the first evidence that a type IA Topoisomerase has activity in the presence of all divalent cations tested (Mg(2+), Ca(2+), Sr(2+), Ba(2+), Mn(2+), Fe(2+), Co(2+), Ni(2+), Cu(2+), Zn(2+) and Cd(2+)). Activity profiles were, however, specific to each metal. Known type I (ssDNA and camptothecin) and type II (etoposide, novobiocin and nalidixic acid) inhibitors with different mechanisms of action were used to demonstrate that MacTopoIII alpha is a type IA topoisomerase. Alignment of MacTopoIII alpha with characterized topoisomerases identified Y317 as the putative catalytic residue, and a Y317F mutation ablated DNA relaxation activity, demonstrating that Y317 is essential for catalysis. As the role of Domain V (C-terminal domain) is unclear, MacTopoIII alpha was aligned with the canonical E. coli TopoI 67 kDa fragment in order to construct an N-terminal (1-586) and a C-terminal (587-752) fragment for analysis. Activity could neither be elicited from the fragments individually nor reconstituted from a mixture of the fragments, suggesting that native folding is impaired when the two fragments are expressed separately. Evidence that each of the split domains plays a role in Zn(2+) binding of the enzyme is also provided.	[Morales, Raymond] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Sriratana, Palita; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Zhang, Jing; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Morales, R (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	icann@illinois.edu			National Science Foundation Central Europe Summer Research Institute; National Institutes of Health from the National Institute of General Medical Sciences [5 T32 GM070421]; National Science Foundation [MCB-0238451]; Agricultural Experimental Station University of Illinois [1-600111-538026-538364]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	National Science Foundation Central Europe Summer Research Institute; National Institutes of Health from the National Institute of General Medical Sciences; National Science Foundation(National Science Foundation (NSF)); Agricultural Experimental Station University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RM's work was supported by grants from the National Science Foundation Central Europe Summer Research Institute and by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 5 T32 GM070421 from the National Institute of General Medical Sciences. This research was supported by National Science Foundation Grant MCB-0238451 (to IKOC) and in part by the Agricultural Experimental Station University of Illinois grant (1-600111-538026-538364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkorta I, 1999, ARCH BIOCHEM BIOPHYS, V362, P123, DOI 10.1006/abbi.1998.1023; Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Bhaduri T, 1998, J BIOL CHEM, V273, P13925, DOI 10.1074/jbc.273.22.13925; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; CRAWFORD LV, 1967, J MOL BIOL, V25, P23, DOI 10.1016/0022-2836(67)90276-8; Dai PG, 2003, J BACTERIOL, V185, P5500, DOI 10.1128/JB.185.18.5500-5507.2003; DARPA P, 1990, CANCER RES, V50, P6919; DELATOUR CB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P213, DOI 10.1016/0167-4781(93)90147-6; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Gabay C, 1998, FEMS MICROBIOL LETT, V159, P343, DOI 10.1016/S0378-1097(97)00584-3; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Goodwin A, 1999, NUCLEIC ACIDS RES, V27, P4050, DOI 10.1093/nar/27.20.4050; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hansen G, 2006, J MOL BIOL, V358, P1328, DOI 10.1016/j.jmb.2006.03.012; HEATHPAGLIUSO S, 1990, PLANT PHYSIOL, V94, P599, DOI 10.1104/pp.94.2.599; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kwack MS, 2005, ARCH BIOCHEM BIOPHYS, V437, P168, DOI 10.1016/j.abb.2005.03.014; Kwan KY, 2007, P NATL ACAD SCI USA, V104, P9242, DOI 10.1073/pnas.0703587104; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; LIANG C, 2006, MOL MICROBIOL, V60, P783; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x; PARK JE, ARCH BIOCH BIOPHYS, V508, P78; PEDRINI AM, 1983, P NATL ACAD SCI-BIOL, V80, P1787, DOI 10.1073/pnas.80.7.1787; POMMIER Y, CHEM BIOL, V17, P421; Robbins JB, 2004, J BIOL CHEM, V279, P6315, DOI 10.1074/jbc.M304491200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; ROSE D, 1990, CELL, V60, P1009, DOI 10.1016/0092-8674(90)90349-J; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; SCHMIDT BH, NATURE, V465, P641; SCHOFIELD MA, 1992, J BACTERIOL, V174, P5168, DOI 10.1128/JB.174.15.5168-5170.1992; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; SLESAREV AI, 1991, J BIOL CHEM, V266, P12321; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; SRIVENUGOPAL KS, 1984, BIOCHEMISTRY-US, V23, P1899, DOI 10.1021/bi00304a002; SRIVENUGOPAL KS, 1985, BIOCHEMISTRY-US, V24, P4766, DOI 10.1021/bi00339a009; TSEDINH YC, 1991, J BIOL CHEM, V266, P14317; Vianna ME, 2009, ORAL MICROBIOL IMMUN, V24, P417, DOI 10.1111/j.1399-302X.2009.00539.x; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Yang FD, 1996, GENE, V178, P63, DOI 10.1016/0378-1119(96)00335-6; Zhu CX, 1997, J BIOL CHEM, V272, P16206, DOI 10.1074/jbc.272.26.16206; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26903	10.1371/journal.pone.0026903	http://dx.doi.org/10.1371/journal.pone.0026903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046402	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600076
J	Yebra, G; de Mulder, M; Perez-Elias, MJ; Perez-Molina, JA; Galan, JC; Llenas-Garcia, J; Moreno, S; Holguin, A				Yebra, Gonzalo; de Mulder, Miguel; Jesus Perez-Elias, Maria; Antonio Perez-Molina, Jose; Carlos Galan, Juan; Llenas-Garcia, Jara; Moreno, Santiago; Holguin, Africa			Increase of Transmitted Drug Resistance among HIV-Infected Sub-Saharan Africans Residing in Spain in Contrast to the Native Population	PLOS ONE			English	Article							NON-B SUBTYPES; ANTIRETROVIRAL THERAPY; TYPE-1; PREVALENCE; RECOMMENDATIONS; INDIVIDUALS; IMMIGRANTS; MUTATIONS; VIRUS	Background: The prevalence of transmitted HIV drug resistance (TDR) is stabilizing or decreasing in developed countries. However, this trend is not specifically evaluated among immigrants from regions without well-implemented antiretroviral strategies. Methods: TDR trends during 1996-2010 were analyzed among naive HIV-infected patients in Spain, considering their origin and other factors. TDR mutations were defined according to the World Health Organization list. Results: Pol sequence was available for 732 HIV-infected patients: 292 native Spanish, 226 sub-Saharan Africans (SSA), 114 Central-South Americans (CSA) and 100 from other regions. Global TDR prevalence was 9.7% (10.6% for Spanish, 8.4% for SSA and 7.9% for CSA). The highest prevalences were found for protease inhibitors (PI) in Spanish (3.1%), for non-nucleoside reverse transcriptase inhibitors (NNRTI) in SSA (6.5%) and for nucleoside reverse transcriptase inhibitors (NRTI) in both Spanish and SSA (6.5%). The global TDR rate decreased from 11.3% in 2004-2006 to 8.4% in 2007-2010. Characteristics related to a decreasing TDR trend in 2007-10 were Spanish and CSA origin, NRTI-and NNRTI-resistance, HIV-1 subtype B, male sex and infection through injection drug use. TDR remained stable for PI-resistance, in patients infected through sexual intercourse and in those carrying non-B variants. However, TDR increased among SSA and females. K103N was the predominant mutation in all groups and periods. Conclusion: TDR prevalence tended to decrease among HIV-infected native Spanish and Central-South Americans, but it increased up to 13% in sub-Saharan immigrants in 2007-2010. These results highlight the importance of a specific TDR surveillance among immigrants to prevent future therapeutic failures, especially when administering NNRTIs.	[Yebra, Gonzalo; de Mulder, Miguel; Holguin, Africa] IRYCIS Hosp Ramon y Cajal, Dept Microbiol, HIV Mol Epidemiol Lab 1, Madrid, Spain; [Yebra, Gonzalo; de Mulder, Miguel; Holguin, Africa] CIBER ESP, Madrid, Spain; [Jesus Perez-Elias, Maria; Antonio Perez-Molina, Jose; Moreno, Santiago] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain; [Carlos Galan, Juan] Hosp Ramon & Cajal, Dept Microbiol, E-28034 Madrid, Spain; [Llenas-Garcia, Jara] Hosp Doce Octubre, HIV Unit, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Hospital Universitario 12 de Octubre	Yebra, G (corresponding author), IRYCIS Hosp Ramon y Cajal, Dept Microbiol, HIV Mol Epidemiol Lab 1, Madrid, Spain.	aholguin.hciii@salud.madrid.org	Elias, Maria Jesus Perez/AAD-8652-2020; Holguín, Africa/AAF-9001-2021; de Mulder Rougvie, Miguel/AAG-6224-2020	Holguín, Africa/0000-0002-1330-8050; de Mulder Rougvie, Miguel/0000-0002-8026-7076; Perez-Molina, Jose Antonio/0000-0001-8735-4124; Yebra, Gonzalo/0000-0002-3472-3667; Perez Elias/0000-0001-5700-5257; Llenas-Garcia, Jara/0000-0001-9125-7706	Fondo de Investigaciones Sanitarias (FIS) [09/00284]; Agencia Lain Entralgo; Consejeria de Educacion de la Comunidad de Madrid; Fondo Social Europeo (FSE)	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Agencia Lain Entralgo; Consejeria de Educacion de la Comunidad de Madrid; Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission)	This work was supported by grants from Fondo de Investigaciones Sanitarias (FIS 09/00284). AH is supported by Agencia Lain Entralgo. GY is supported by Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwale SM, 2006, AIDS RES HUM RETROV, V22, P22, DOI 10.1089/aid.2006.22.22; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Chan Philip A., 2009, HIV Therapy, V3, P447, DOI [10.2217/hiv.09.30, 10.2217/HIV.09.30]; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; *GRUP EST SID SEIM, 2011, DOC CONS GES PLAN NA; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harrison L, 2010, AIDS, V24, P1917, DOI 10.1097/QAD.0b013e32833c1d93; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Caro-Murillo AM, 2009, ENFERM INFEC MICR CL, V27, P380, DOI 10.1016/j.eimc.2008.10.007; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61; *MIN CIENC INN, 2010, VIG EP VIH ESP NUEV; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Perez-Molina JA, 2010, CURR HIV RES, V8, P521, DOI 10.2174/157016210793499178; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Vandamme AM, 2011, AIDS REV, V13, P77; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	38	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26757	10.1371/journal.pone.0026757	http://dx.doi.org/10.1371/journal.pone.0026757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046345	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000029
J	Liang, BH; Luo, M; Scott-Herridge, J; Semeniuk, C; Mendoza, M; Capina, R; Sheardown, B; Ji, HZ; Kimani, J; Ball, BT; Van Domselaar, G; Graham, M; Tyler, S; Jones, SJM; Plummer, FA				Liang, Binhua; Luo, Ma; Scott-Herridge, Joel; Semeniuk, Christina; Mendoza, Mark; Capina, Rupert; Sheardown, Brent; Ji, Hezhao; Kimani, Joshua; Ball, Blake T.; Van Domselaar, Gary; Graham, Morag; Tyler, Shane; Jones, Steven J. M.; Plummer, Francis A.			A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT-EXPERIENCED PATIENTS; DRUG-RESISTANCE MUTATIONS; CYTOTOXIC T-LYMPHOCYTES; AMINO-ACID SITES; RELATIVE DOMINANCE; ADAPTIVE EVOLUTION; CORECEPTOR USAGE; VIRAL VARIANTS; IMMUNE ESCAPE	Background: Pyrosequencing technology has the potential to rapidly sequence HIV-1 viral quasispecies without requiring the traditional approach of cloning. In this study, we investigated the utility of ultra-deep pyrosequencing to characterize genetic diversity of the HIV-1 gag quasispecies and assessed the possible contribution of pyrosequencing technology in studying HIV-1 biology and evolution. Methodology/Principal Findings: HIV-1 gag gene was amplified from 96 patients using nested PCR. The PCR products were cloned and sequenced using capillary based Sanger fluorescent dideoxy termination sequencing. The same PCR products were also directly sequenced using the 454 pyrosequencing technology. The two sequencing methods were evaluated for their ability to characterize quasispecies variation, and to reveal sites under host immune pressure for their putative functional significance. A total of 14,034 variations were identified by 454 pyrosequencing versus 3,632 variations by Sanger clone-based (SCB) sequencing. 11,050 of these variations were detected only by pyrosequencing. These undetected variations were located in the HIV-1 Gag region which is known to contain putative cytotoxic T lymphocyte (CTL) and neutralizing antibody epitopes, and sites related to virus assembly and packaging. Analysis of the positively selected sites derived by the two sequencing methods identified several differences. All of them were located within the CTL epitope regions. Conclusions/Significance: Ultra-deep pyrosequencing has proven to be a powerful tool for characterization of HIV-1 genetic diversity with enhanced sensitivity, efficiency, and accuracy. It also improved reliability of downstream evolutionary and functional analysis of HIV-1 quasispecies.	[Liang, Binhua; Luo, Ma; Scott-Herridge, Joel; Semeniuk, Christina; Mendoza, Mark; Capina, Rupert; Sheardown, Brent; Ji, Hezhao; Ball, Blake T.; Van Domselaar, Gary; Graham, Morag; Tyler, Shane; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Luo, Ma; Kimani, Joshua; Ball, Blake T.; Van Domselaar, Gary; Graham, Morag; Jones, Steven J. M.; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kimani, Joshua] Univ Nairobi, Ctr STD HIV Res & Training, Nairobi, Kenya; [Jones, Steven J. M.] British Columbia Canc Res Ctr, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada	Public Health Agency of Canada; University of Manitoba; University of Nairobi; British Columbia Cancer Agency	Liang, BH (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	ben.liang@phac-aspc.gc.ca	Jones, Steven J/C-3621-2009; Pillay, Nischalan/F-9536-2012; Liang, Binhua/ABN-9806-2022	Jones, Steven J/0000-0003-3394-2208; Ji, Hezhao/0000-0002-5451-6294; liang, binhua/0000-0002-1108-6407	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from Canadian Institute of Health Research (CIHR), http://www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Abbate I, 2011, AIDS, V25, P611, DOI 10.1097/QAD.0b013e328343489e; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archer J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001022; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; Borrego P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-78; Bush RM, 2001, NAT REV GENET, V2, P387, DOI 10.1038/35072023; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; CASEMENT KS, 1995, VIROLOGY, V211, P261, DOI 10.1006/viro.1995.1399; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Delaunay C, 2005, J VIROL, V79, P9572, DOI 10.1128/JVI.79.15.9572-9578.2005; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Joos B, 2007, J INFECT DIS, V196, P313, DOI 10.1086/518935; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KORBER BTM, 1994, J VIROL, V68, P6730, DOI 10.1128/JVI.68.10.6730-6744.1994; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Liang BH, 2008, CURR HIV RES, V6, P370, DOI 10.2174/157016208785132554; Long EM, 2000, NAT MED, V6, P71; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; MCKNIGHT A, 1995, TRENDS MICROBIOL, V3, P356, DOI 10.1016/S0966-842X(00)88975-1; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Peters HO, 2008, J VIROL, V82, P1980, DOI 10.1128/JVI.02742-06; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Shao W, 2009, CHARACTERIZATION HIV; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Wagner R, 1999, J IMMUNOL, V162, P3727; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Yang W, 2003, J MOL EVOL, V57, P212, DOI 10.1007/s00239-003-2467-9; Yang Z, 2001, Pac Symp Biocomput, P226; Yang ZH, 2000, GENETICS, V155, P431; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	68	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26745	10.1371/journal.pone.0026745	http://dx.doi.org/10.1371/journal.pone.0026745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039546	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200050
J	Garie, KT; Yassin, MA; Cuevas, LE				Garie, Kefyalew T.; Yassin, Mohammed A.; Cuevas, Luis E.			Lack of Adherence to Isoniazid Chemoprophylaxis in Children in Contact with Adults with Tuberculosis in Southern Ethiopia	PLOS ONE			English	Article							PREVENTIVE THERAPY; INFECTION	Setting: Hawassa, Southern Region of Ethiopia. Objectives: To determine compliance to isoniazid (INH) preventive therapy (IPT) and its effectiveness in preventing (TB) disease in children in contact with adults with pulmonary TB (PTB). Design: This was a prospective cohort study of children <15 years old in contact with adults with smear-positive PTB. Asymptomatic children <= 5 years were provided IPT independently of their Tuberculin Skin Test (TST) status and children >5 years old were given advice but did not receive IPT, as recommended by the National TB control programme. Compliance to IPT and incidence of clinical TB were determined monthly for six months and then quarterly for up to 30 months. Results: One hundred and eighty four children in contact with 83 smear-positive PTB cases were identified. Eighty two were <= 5 and 102>5 years old. Only 27 (33%) of 82 children given IPT took it for >4 months and 10 (12%) completed the 6-month course. The main reason for non-compliance was the perception that drugs were not necessary when the child was healthy. Eleven children (all except one >5 years old) developed symptoms of TB disease and initiated treatment, resulting in an incidence of 28.6 cases for all and 53.5 for children >5 years old per 1000 children-year. Conclusion: Compliance to IPT in children is poor in Southern Region of Ethiopia and this was associated with the parents' perception of the low importance of chemoprophylaxis in asymptomatic children. Poor compliance might be an important barrier for the wider implementation of IPT.	[Garie, Kefyalew T.] Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Yassin, Mohammed A.; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Yassin, Mohammed A.] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Hawassa University; Liverpool School of Tropical Medicine; University of Liverpool	Garie, KT (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia.	mohammed.yassin@theglobalfund.org	Cuevas, Luis E/I-3697-2015; garie, kefyalew/AAU-9087-2020	Cuevas, Luis E/0000-0002-6581-0587; Yassin, Mohammed Ahmed/0000-0002-9766-2072	Thrasher Foundation, USA	Thrasher Foundation, USA	The study was supported by the Thrasher Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibi H, 2002, ISR MED ASSOC J, V4, P13; FMOHE, 2008, TUB LEPR TB HIV PREV; Maher D, 2006, INT J TUBERC LUNG D, V10, P1331; Marais BJ, 2006, ARCH DIS CHILD, V91, P762, DOI 10.1136/adc.2006.097220; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mtombeni S, 2002, Cent Afr J Med, V48, P28; Munoz-Sellart M, 2009, SCAND J INFECT DIS, V41, P450, DOI 10.1080/00365540902865736; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Reichler MR, 2002, SOUTH MED J, V95, P414, DOI 10.1097/00007611-200295040-00009; STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3; van Zyl S, 2006, INT J TUBERC LUNG D, V10, P13; WHO, 2010, GLOB TUB CONTR REP; World Health Organization, 1998, WHOTB98255; Yassin MA, 2011, PLOS ONE; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	17	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26452	10.1371/journal.pone.0026452	http://dx.doi.org/10.1371/journal.pone.0026452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069451	Green Published, Green Submitted, gold			2022-12-27	WOS:000297150900013
J	Pedersen, GK; Ebensen, T; Gjeraker, IH; Svindland, S; Bredholt, G; Guzman, CA; Cox, RJ				Pedersen, Gabriel Kristian; Ebensen, Thomas; Gjeraker, Ingrid Hjetland; Svindland, Signe; Bredholt, Geir; Guzman, Carlos Alberto; Cox, Rebecca Jane			Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP	PLOS ONE			English	Article							ADJUVANT CHOLERA-TOXIN; T-CELL RESPONSES; MEMORY B-CELLS; PANDEMIC INFLUENZA; MUCOSAL ADJUVANT; CROSS-PROTECTION; VIRUS-INFECTION; INACTIVATED VACCINES; SYSTEMIC ANTIBODY; AVIAN INFLUENZA	Avian influenza A H5N1 is a virus with pandemic potential. Mucosal vaccines are attractive as they have the potential to block viruses at the site of entry, thereby preventing both disease and further transmission. The intranasal route is safe for the administration of seasonal live-attenuated influenza vaccines, but may be less suitable for administration of pandemic vaccines. Research into novel mucosal routes is therefore needed. In this study, a murine model was used to compare sublingual administration with intranasal and intramuscular administration of influenza H5N1 virosomes (2 mu g haemagglutinin; HA) in combination with the mucosal adjuvant (3',5')-cyclic dimeric guanylic acid (c-di-GMP). We found that sublingual immunisation effectively induced local and systemic H5N1-specific humoral and cellular immune responses but that the magnitude of response was lower than after intranasal administration. However, both the mucosal routes were superior to intramuscular immunisation for induction of local humoral and systemic cellular immune responses including high frequencies of splenic H5N1-specific multifunctional (IL-2(+)TNF-alpha(+)) CD4(+) T cells. The c-di-GMP adjuvanted vaccine elicited systemic haemagglutination inhibition (HI) antibody responses (geometric mean titres >= 40) both when administered sublingually, intranasally and inramuscularly. In addition, salivary HI antibodies were elicited by mucosal, but not intramuscular vaccination. We conclude that the sublingual route is an attractive alternative for administration of pandemic influenza vaccines.	[Pedersen, Gabriel Kristian; Gjeraker, Ingrid Hjetland; Svindland, Signe; Bredholt, Geir; Cox, Rebecca Jane] Univ Bergen, Gade Inst, N-5020 Bergen, Norway; [Ebensen, Thomas; Guzman, Carlos Alberto] HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Cox, Rebecca Jane] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway	University of Bergen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bergen; Haukeland University Hospital	Pedersen, GK (corresponding author), Univ Bergen, Gade Inst, N-5020 Bergen, Norway.	gabriel.pedersen@gades.uib.no		Bredholt, Geir/0000-0002-8953-8821; Pedersen, Gabriel/0000-0001-6872-3975	Norwegian Research Counsil Globvac [185441]; EU [202083, 044115]; Influenza Centre, University of Bergen	Norwegian Research Counsil Globvac; EU(European Commission); Influenza Centre, University of Bergen	This study was supported by the Norwegian Research Counsil Globvac (185441, http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1224697869238&p=1224697869238&pagename=globvac%2FHovedsidemal) the EU FP6 and FP7 funded projects NASPANVAC (202083, http://www.naspanvac.com/introduction.asp) and PANFLUVAC (044115, http://www.panfluvac.org/)) and intramurally by the Influenza Centre, University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alecsandru D, 2011, CLIN EXP IMMUNOL, V164, P100, DOI 10.1111/j.1365-2249.2011.04320.x; Appledorn DM, 2011, CLIN VACCINE IMMUNOL, V18, P150, DOI 10.1128/CVI.00341-10; Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brokstad KA, 2002, J INFECT DIS, V185, P878, DOI 10.1086/339710; BROKSTAD KA, 1995, J INFECT DIS, V171, P1072, DOI 10.1093/infdis/171.4.1072-a; Burdette DL, 2011, NATURE; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; CHMP, 1997, NOT GUID HARM REQ IN; Cox RJ, 2002, SCAND J IMMUNOL, V55, P14, DOI 10.1046/j.1365-3083.2002.01015.x; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Ebensen T, 2007, CLIN VACCINE IMMUNOL, V14, P952, DOI 10.1128/CVI.00119-07; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Frati F, 2010, DRUG DES DEV THER, V4, P99; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; Grunewald SM, 2002, J INVEST DERMATOL, V118, P645, DOI 10.1046/j.1523-1747.2002.01732.x; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Huang CF, 2008, J PEDIATR GASTR NUTR, V46, P262, DOI 10.1097/MPG.0b013e318156050d; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044; MANTLE JA, 1976, AM J CARDIOL, V37, P263, DOI 10.1016/0002-9149(76)90322-2; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Pedersen G, 2011, INFLUENZA OTHER RESP; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; ROSS P, 1990, J BIOL CHEM, V265, P18933; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sjolander S, 2001, VACCINE, V19, P4072, DOI 10.1016/S0264-410X(01)00110-4; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; TAMURA SI, 1992, J IMMUNOL, V149, P981; TAYLOR HP, 1985, J EXP MED, V161, P198, DOI 10.1084/jem.161.1.198; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; WALDMAN RH, 1970, J IMMUNOL, V105, P1477; Wang X, 2011, CELL MOL IMMUNOL; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; World Health Organization (WHO), 2011, TABL CLIN TRIALS PAN; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Zeng F, 1997, CHEMINFORM, V28; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	65	43	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26973	10.1371/journal.pone.0026973	http://dx.doi.org/10.1371/journal.pone.0026973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069479	gold, Green Published			2022-12-27	WOS:000297150900041
J	Cooper, TF; Berkelmans, R; Ulstrup, KE; Weeks, S; Radford, B; Jones, AM; Doyle, J; Canto, M; O'Leary, RA; van Oppen, MJH				Cooper, Timothy F.; Berkelmans, Ray; Ulstrup, Karin E.; Weeks, Scarla; Radford, Ben; Jones, Alison M.; Doyle, Jason; Canto, Marites; O'Leary, Rebecca A.; van Oppen, Madeleine J. H.			Environmental Factors Controlling the Distribution of Symbiodinium Harboured by the Coral Acropora millepora on the Great Barrier Reef	PLOS ONE			English	Article							SCLERACTINIAN CORALS; SYMBIONT SPECIFICITY; ALGAL ENDOSYMBIONTS; REDUNDANCY ANALYSIS; BLEACHING EVENT; CLIMATE-CHANGE; ZOOXANTHELLAE; PATTERNS; DIVERSITY; ECOLOGY	Background: The Symbiodinium community associated with scleractinian corals is widely considered to be shaped by seawater temperature, as the coral's upper temperature tolerance is largely contingent on the Symbiodinium types harboured. Few studies have challenged this paradigm as knowledge of other environmental drivers on the distribution of Symbiodinium is limited. Here, we examine the influence of a range of environmental variables on the distribution of Symbiodinium associated with Acropora millepora collected from 47 coral reefs spanning 1,400 km on the Great Barrier Reef (GBR), Australia. Methodology/Principal Findings: The environmental data included Moderate Resolution Imaging Spectroradiometer (MODIS) satellite data at 1 km spatial resolution from which a number of sea surface temperature (SST) and water quality metrics were derived. In addition, the carbonate and mud composition of sediments were incorporated into the analysis along with in situ water quality samples for a subset of locations. Analyses were conducted at three spatio-temporal scales [GBR (regional-scale), Whitsunday Islands (local-scale) and Keppel Islands/Trunk Reef (temporal)] to examine the effects of scale on the distribution patterns. While SST metrics were important drivers of the distribution of Symbiodinium types at regional and temporal scales, our results demonstrate that spatial variability in water quality correlates significantly with Symbiodinium distribution at local scales. Background levels of Symbiodinium types were greatest at turbid inshore locations of the Whitsunday Islands where SST predictors were not as important. This was not the case at regional scales where combinations of mud and carbonate sediment content coupled with SST anomalies and mean summer SST explained 51.3% of the variation in dominant Symbiodinium communities. Conclusions/Significance: Reef corals may respond to global-scale stressors such as climate change through changes in their resident symbiont communities, however, management of local-scale stressors such as altered water quality is also necessary for maintenance of coral-Symbiodinium associations.	[Cooper, Timothy F.; Radford, Ben; O'Leary, Rebecca A.] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, Australia; [Berkelmans, Ray; Doyle, Jason; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Ulstrup, Karin E.] DHI Water & Environm, Perth, Australia; [Weeks, Scarla; Canto, Marites] Univ Queensland, Ctr Spatial Environm Res, St Lucia, Qld, Australia; [Weeks, Scarla; Canto, Marites] Univ Queensland, Coral Reef Ecosyst Lab, St Lucia, Qld, Australia; [Jones, Alison M.] Cent Queensland Univ, Ctr Environm Management, Rockhampton, Qld 4702, Australia	Australian Institute of Marine Science; University of Western Australia; Australian Institute of Marine Science; University of Queensland; University of Queensland; Central Queensland University	Cooper, TF (corresponding author), Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, Australia.	kau@dhigroup.com	Weeks, Scarla J/E-8632-2013; Jones, Alison/AAF-5530-2020; van Oppen, Madeleine JH/C-3261-2008	Weeks, Scarla J/0000-0002-0579-7069; van Oppen, Madeleine/0000-0003-4607-0744	Australian Institute of Marine Science; University of Queensland; DHI Group; Reef and Rainforest Research Centre	Australian Institute of Marine Science; University of Queensland(University of Queensland); DHI Group; Reef and Rainforest Research Centre	This study was supported by the Australian Institute of Marine Science, University of Queensland, DHI Group and the Marine Tropical Science Research Facility through the Reef and Rainforest Research Centre. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DHI Group supported the time of KU to develop and produce the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BARNES DJ, 1990, CORAL REEFS, P109; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Cooper TF, 2009, ESTUAR COAST SHELF S, V83, P186, DOI 10.1016/j.ecss.2009.03.015; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FABRICIUS KE, MARINE POLLUTION B; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; HOEGHGULDBERG O, 1989, MAR ECOL PROG SER, V57, P173, DOI 10.3354/meps057173; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lee Z, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003802; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Maxwell W., 1968, ATLAS GREAT BARRIER; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MOREL A, 1988, J GEOPHYS RES-OCEANS, V93, P10749, DOI 10.1029/JC093iC09p10749; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; O'Reilly J. E, 2000, SEAWIFS POSTLAUNCH 3, V11; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez-Lanetty M, 2001, MAR BIOL, V138, P1175; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Schaffelke B., 2009, REEF RESCUE MARINE M; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P2617, DOI 10.1098/rspb.2001.2007; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; WEEKS SJ, 2011, P 34 INT S REM SENS; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0	60	55	56	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e25536	10.1371/journal.pone.0025536	http://dx.doi.org/10.1371/journal.pone.0025536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065989	gold, Green Published			2022-12-27	WOS:000296916000006
J	Javanbakht, M; Baradaran, HR; Mashayekhi, A; Haghdoost, AA; Khamseh, ME; Kharazmi, E; Sadeghi, A				Javanbakht, Mehdi; Baradaran, Hamid R.; Mashayekhi, Atefeh; Haghdoost, Ali Akbar; Khamseh, Mohammad E.; Kharazmi, Erfan; Sadeghi, Aboozar			Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE COSTS; ECONOMIC COSTS; RISK-FACTORS; COMPLICATIONS; PREVALENCE; POPULATION; GLUCOSE	Introduction: Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year. Methods: This is a prevalence-based cost-of-illness study focusing on quantifying direct health care costs by bottom-up approach. Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, laboratory test, education and non-medical cost were collected from two national registries. The human capital approach was used to calculate indirect costs separately in male and female and also among different age groups. Results: The total national cost of diagnosed T2DM in 2009 is estimated at 3.78 billion USA dollars (USD) including 2.04 +/- 0.28 billion direct (medical and non-medical) costs and indirect costs of 1.73 million. Average direct and indirect cost per capita was 842.6 +/- 102 and 864.8 USD respectively. Complications (48.9%) and drugs (23.8%) were main components of direct cost. The largest components of medical expenditures attributed to diabetes's complications are cardiovascular disease (42.3% of total Complications cost), nephropathy (23%) and ophthalmic complications (14%). Indirect costs include temporarily disability (335.7 million), permanent disability (452.4 million) and reduced productivity due to premature mortality (950.3 million). Conclusions: T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority.	[Javanbakht, Mehdi; Mashayekhi, Atefeh] Univ Tehran Med Sci, Hlth Econ Dept, Sch Hlth Care Management, Tehran, Iran; [Baradaran, Hamid R.] Minist Hlth Iran, Ctr Noncommunicable Dis Control, Tehran, Iran; [Baradaran, Hamid R.; Khamseh, Mohammad E.] Univ Tehran Med Sci, Endocrine Res Ctr Firoozgar, Tehran, Iran; [Javanbakht, Mehdi; Kharazmi, Erfan; Sadeghi, Aboozar] Shiraz Univ Med Sci, Sch Management Informat Sci, Shiraz, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Res Ctr Modeling Hlth, Kerman, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shiraz University of Medical Science; Kerman University of Medical Sciences	Javanbakht, M (corresponding author), Univ Tehran Med Sci, Hlth Econ Dept, Sch Hlth Care Management, Tehran, Iran.	javanbakhtm@gmail.com	ad, m/K-3654-2012; Kharazmi, Erfan/AAB-7022-2020; Baradaran, Hamid R/N-2577-2019; Baradaran, Hamid Reza/C-1556-2017; Haghdoost, Ali Akbar/C-2823-2009; Khamseh, Mohammad Ebrahim/L-9391-2018	ad, m/0000-0001-5932-9917; Baradaran, Hamid R/0000-0002-5070-5864; Baradaran, Hamid Reza/0000-0002-5070-5864; Haghdoost, Ali Akbar/0000-0003-4628-4849; Kharazmi, Erfan/0000-0002-2138-896X; Javanbakht, Mehdi/0000-0002-8661-8439	Endocrine Research Center (Firoozgar) [358]; Tehran University of Medical Sciences	Endocrine Research Center (Firoozgar); Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was supported by a grant (number 358) from the Endocrine Research Center (Firoozgar) affiliated with Tehran University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfkhamiArdekani M, 2009, IRAN J DIABETES OBES, V1, P36; Al-Maskari F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-679; Alavi A, 2007, WOUND REG, V15, P47; *AM DIAB ASS, 2008, DIABETES CARE, V31, P1, DOI DOI 10.2337/DC07-2052; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Gonzalez JC, 2009, REV PANAM SALUD PUBL, V26, P55, DOI 10.1590/S1020-49892009000700009; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Central Bank of Iran, EXCH RAT; Clarke P, 2003, DIABETIC MED, V20, P442, DOI 10.1046/j.1464-5491.2003.00972.x; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Esteghamati A, 2008, DIABETES CARE, V31, P96, DOI 10.2337/dc07-0959; Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128; Gary WT, 2010, DIABETES CARE, V33, P1200; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176; Janghorbani M, 2006, ACTA CARDIOL, V61, P13, DOI 10.2143/AC.61.1.2005135; Javadi MA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-12; Kapur A, 2007, INDIAN J MED RES, V125, P473; Khazai MH, 2006, ARYA ATHEROSCLER, V2, P79; Khowaja LA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-189; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Moradi S, 2006, DIABETIC MED, V23, P181; Narayan KMV, 2006, CAN MED ASSOC J, V175, P733, DOI 10.1503/cmaj.060367; Oliva J, 2004, DIABETES CARE, V27, P2616, DOI 10.2337/diacare.27.11.2616; Posnett J, 1996, HEALTH ECON, V5, P13, DOI 10.1002/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J; Sobel BE, 2005, CURR OPIN PHARMACOL, V5, P143, DOI 10.1016/j.coph.2005.01.002; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Wang WB, 2009, AM J MANAG CARE, V15, P593; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhang P, 2010, EC IMPACT DIABETES; Zhang YD, 2009, POPUL HEALTH MANAG, V12, P95, DOI 10.1089/pop.2009.12202	33	87	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26864	10.1371/journal.pone.0026864	http://dx.doi.org/10.1371/journal.pone.0026864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066013	gold, Green Submitted, Green Published			2022-12-27	WOS:000296916000029
J	Marom, L; Ulitsky, I; Cabilly, Y; Shamir, R; Elroy-Stein, O				Marom, Liraz; Ulitsky, Igor; Cabilly, Yuval; Shamir, Ron; Elroy-Stein, Orna			A Point Mutation in Translation Initiation Factor eIF2B Leads to Function- and Time-Specific Changes in Brain Gene Expression	PLOS ONE			English	Article							VANISHING WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; UNFOLDED PROTEIN RESPONSE; CHILDHOOD ATAXIA; BASIC-PROTEIN; RAT-BRAIN; STRESS; LEUKOENCEPHALOPATHY; DISEASE; MUTANT	Background: Mutations in eukaryotic translation initiation factor 2B (eIF2B) cause Childhood Ataxia with CNS Hypomyelination (CACH), also known as Vanishing White Matter disease (VWM), which is associated with a clinical pathology of brain myelin loss upon physiological stress. eIF2B is the guanine nucleotide exchange factor (GEF) of eIF2, which delivers the initiator tRNA Met to the ribosome. We recently reported that a R132H mutation in the catalytic subunit of this GEF, causing a 20% reduction in its activity, leads under normal conditions to delayed brain development in a mouse model for CACH/VWM. To further explore the effect of the mutation on global gene expression in the brain, we conducted a wide-scale transcriptome analysis of the first three critical postnatal weeks. Methodology/Principal Findings: Genome-wide mRNA expression of wild-type and mutant mice was profiled at postnatal (P) days 1, 18 and 21 to reflect the early proliferative stage prior to white matter establishment (P1) and the peak of oligodendrocye differentiation and myelin synthesis (P18 and P21). At each developmental stage, between 441 and 818 genes were differentially expressed in the mutant brain with minimal overlap, generating unique time point-specific gene expression signatures. Conclusions: The current study demonstrates that a point mutation in eIF2B, a key translation initiation factor, has a massive effect on global gene expression in the brain. The overall changes in expression patterns reflect multiple layers of indirect effects that accumulate as the brain develops and matures. The differentially expressed genes seem to reflect delayed waves of gene expression as well as an adaptation process to cope with hypersensitivity to cellular stress.	[Marom, Liraz; Cabilly, Yuval; Elroy-Stein, Orna] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Elroy-Stein, Orna] Tel Aviv Univ, Interdisciplinary Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Marom, L (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il	Shamir, Ron/E-6514-2011; Ulitsky, Igor/HCH-7453-2022	Shamir, Ron/0000-0003-1889-9870; Ulitsky, Igor/0000-0003-0555-6561; Elroy-Stein, Orna/0000-0002-3716-1540	European Leukodystrophy Association (ELA) Foundation [2008-21]; Israel Science Foundation [1911/08]; Tel Aviv University; Legacy Heritage Fund	European Leukodystrophy Association (ELA) Foundation; Israel Science Foundation(Israel Science Foundation); Tel Aviv University; Legacy Heritage Fund	This study was supported by grants from the European Leukodystrophy Association (ELA) Foundation (grant no. 2008-21) and from The Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant no. 1911/08) to OES. IU was supported in part by fellowships from the Edmond J. Safra Bioinformatics program at Tel Aviv University and the Legacy Heritage Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CASS WA, 1993, J NEUROCHEM, V61, P2269, DOI 10.1111/j.1471-4159.1993.tb07469.x; CONNER DA, 2000, CURRENT PROTOCOLS MO; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; DELASSALLE A, 1981, J NEUROSCI RES, V6, P303, DOI 10.1002/jnr.490060305; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Han ZH, 2003, P NATL ACAD SCI USA, V100, P1256, DOI 10.1073/pnas.252764399; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaczorowska M, 2006, EUR J PAEDIATR NEURO, V10, P192, DOI 10.1016/j.ejpn.2006.05.008; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; KARHUNEN T, 1995, NEUROSCI LETT, V187, P57, DOI 10.1016/0304-3940(95)11337-V; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Matoba R, 2000, PHYSIOL GENOMICS, V4, P155, DOI 10.1152/physiolgenomics.2000.4.2.155; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; MOR E, NUCL ACIDS RES; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pongrac JL, 2004, BIOL PSYCHIAT, V56, P943, DOI 10.1016/j.biopsych.2004.09.005; Pramparo T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001331; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Saito S, 2002, PHYSIOL GENOMICS, V8, P131, DOI 10.1152/physiolgenomics.00077.2001; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schiffmann R, 2006, MOL GENET METAB, V88, P7, DOI 10.1016/j.ymgme.2005.10.019; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; SORG BA, 1987, J NEUROCHEM, V49, P1146, DOI 10.1111/j.1471-4159.1987.tb10005.x; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Van Den Hove DLA, 2006, NEUROSCIENCE, V137, P145, DOI 10.1016/j.neuroscience.2005.08.060; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26992	10.1371/journal.pone.0026992	http://dx.doi.org/10.1371/journal.pone.0026992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073122	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000043
J	Edwards, LA; Bajaj-Elliott, M; Klein, NJ; Murch, SH; Phillips, AD				Edwards, Lindsey A.; Bajaj-Elliott, Mona; Klein, Nigel J.; Murch, Simon H.; Phillips, Alan D.			Bacterial- Epithelial Contact Is a Key Determinant of Host Innate Immune Responses to Enteropathogenic and Enteroaggregative Escherichia coli	PLOS ONE			English	Article							III SECRETION SYSTEM; PROINFLAMMATORY GENE-EXPRESSION; INTESTINAL INFLAMMATION; AGGREGATIVE ADHERENCE; PROTEIN TRANSLOCATION; CUTTING EDGE; HEP-2 CELLS; IN-VITRO; ACTIVATION; FLAGELLIN	Background: Enteropathogenic (EPEC) and Enteroaggregative (EAEC) E. coli have similar, but distinct clinical symptoms and modes of pathogenesis. Nevertheless when they infect the gastrointestinal tract, it is thought that their flagellin causes IL-8 release leading to neutrophil recruitment and gastroenteritis. However, this may not be the whole story as the effect of bacterial adherence to IEC innate response(s) remains unclear. Therefore, we have characterized which bacterial motifs contribute to the innate epithelial response to EPEC and EAEC, using a range of EPEC and EAEC isogenic mutant strains. Methodology: Caco-2 and HEp-2 cell lines were exposed to prototypical EPEC strain E2348/69 or EAEC strain O42, in addition to a range of isogenic mutant strains. E69 [LPS, non-motile, non-adherent, type three secretion system (TTSS) negative, signalling negative] or O42 [non-motile, non-adherent]. IL-8 and CCL20 protein secretion was measured. Bacterial surface structures were assessed by negative staining Transmission Electron Microscopy. The Fluorescent-actin staining test was carried out to determine bacterial adherence. Results: Previous studies have reported a balance between the host pro-inflammatory response and microbial suppression of this response. In our system an overall balance towards the host pro-inflammatory response is seen with the E69 WT and to a greater extent O42 WT, which is in fit with clinical symptoms. On removal of the external EPEC structures flagella, LPS, BFP, EspA and EspC; and EAEC flagella and AAF, the host inflammatory response is reduced. However, removal of E69 lymphostatin increases the host inflammatory response suggesting involvement in the bacterial mediated anti-inflammatory response. Conclusion: Epithelial responses were due to combinations of bacterial agonists, with host-bacterial contact a key determinant of these innate responses. Host epithelial recognition was offset by the microbe's ability to down-regulate the inflammatory response. Understanding the complexity of this host-microbial balance will contribute to improved vaccine design for infectious gastroenteritis.	[Edwards, Lindsey A.; Phillips, Alan D.] Royal Free Hosp, Ctr Paediat Gastroenterol, London NW3 2QG, England; [Edwards, Lindsey A.; Bajaj-Elliott, Mona; Klein, Nigel J.] Inst Child Hlth, London, England; [Murch, Simon H.] Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of Warwick	Edwards, LA (corresponding author), Royal Free Hosp, Ctr Paediat Gastroenterol, Pond St, London NW3 2QG, England.	l.edwards@ich.ucl.ac.uk	Edwards, Lindsey Ann/AAC-1156-2020; Edwards, Lindsey/L-8536-2015	Edwards, Lindsey Ann/0000-0002-8222-4555; Edwards, Lindsey/0000-0002-8222-4555; Bajaj-Elliott, Mona/0000-0002-5234-576X; Klein, Nigel/0000-0003-3925-9258	Crohn's in childhood Research Appeal (CICRA) charity	Crohn's in childhood Research Appeal (CICRA) charity	LA Edwards was supported by the Crohn's in childhood Research Appeal (CICRA) charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Afset JE, 2006, J CLIN MICROBIOL, V44, P3703, DOI 10.1128/JCM.00429-06; Bajaj-Elliott M, 2002, GUT, V51, P356, DOI 10.1136/gut.51.3.356; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bielaszewska M, 2011, LANCET INFECT DIS; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; CRAVIOTO A, 1991, J INFECT DIS, V163, P1247, DOI 10.1093/infdis/163.6.1247; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Edwards LA, 2011, INFLAMM BOWEL DIS, V17, P1201, DOI 10.1002/ibd.21501; Edwards LA, 2011, INFLAMM BOWEL DIS; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Frank C, 2011, N ENGL J MED; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Hedlund M, 2001, J INFECT DIS, V183, pS47, DOI 10.1086/318851; Huang DB, 2004, CLIN DIAGN LAB IMMUN, V11, P548, DOI 10.1128/CDLI.11.3.548-551.2004; Ismaili A, 1999, AM J PHYSIOL-GASTR L, V277, pG201, DOI 10.1152/ajpgi.1999.277.1.G201; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kaur P, 2010, INTERDISCIP PERSPECT, V2010; Khan MAS, 2004, IMMUNOLOGY, V112, P651, DOI 10.1111/j.1365-2567.2004.01923.x; Khan MA, 2008, INFECT IMMUN, V76, P1410, DOI 10.1128/IAI.01141-07; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; KNUTTON S, 1987, INFECT IMMUN, V55, P78, DOI 10.1128/IAI.55.1.78-85.1987; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Martinez-Argudo I, 2007, CELL MICROBIOL, V9, P1538, DOI 10.1111/j.1462-5822.2007.00891.x; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; NATARO JP, 1987, INFECT IMMUN, V55, P2370, DOI 10.1128/IAI.55.10.2370-2377.1987; Nguyen HTT, 2009, GASTROENTEROLOGY, V137, P1435, DOI 10.1053/j.gastro.2009.06.043; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; RILEY LW, 1987, INFECT IMMUN, V55, P2052, DOI 10.1128/IAI.55.9.2052-2056.1987; Ruchaud-Sparagano MH, 2007, CELL MICROBIOL; Salazar-Gonzalez H, 2011, SCAND J IMMUNOL; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Savkovic SD, 1996, INFECT IMMUN, V64, P4480, DOI 10.1128/IAI.64.11.4480-4487.1996; Savkovic SD, 1997, AM J PHYSIOL-CELL PH, V273, pC1160, DOI 10.1152/ajpcell.1997.273.4.C1160; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; Schuller S, 2009, CELL MICROBIOL, V11, P521, DOI 10.1111/j.1462-5822.2008.01275.x; Sharma R, 2006, AM J PHYSIOL-GASTR L, V290, pG685, DOI 10.1152/ajpgi.00404.2005; Shaw RK, 2001, CELL MICROBIOL, V3, P213, DOI 10.1046/j.1462-5822.2001.00105.x; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Targosz M, 2006, NANOMED-NANOTECHNOL, V2, P82, DOI 10.1016/j.nano.2006.04.006; Triantafilou M, 2010, SUBCELL BIOCHEM, V53, P173, DOI 10.1007/978-90-481-9078-2_8; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; Vidal JE, 2008, CELL MICROBIOL, V10, P1975, DOI 10.1111/j.1462-5822.2008.01181.x; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003	65	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27030	10.1371/journal.pone.0027030	http://dx.doi.org/10.1371/journal.pone.0027030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046438	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800061
J	Measey, GJ; Tolley, KA				Measey, G. John; Tolley, Krystal A.			Sequential Fragmentation of Pleistocene Forests in an East Africa Biodiversity Hotspot: Chameleons as a Model to Track Forest History	PLOS ONE			English	Article							ARC MOUNTAINS; TAITA HILLS; MOLECULAR PHYLOGENETICS; POPULATION-GROWTH; DWARF CHAMELEONS; CLIMATE-CHANGE; SOUTH-AFRICA; BRADYPODION; SPECIATION; DIVERSIFICATION	Background: The Eastern Arc Mountains (EAM) is an example of naturally fragmented tropical forests, which contain one of the highest known concentrations of endemic plants and vertebrates. Numerous paleo-climatic studies have not provided direct evidence for ancient presence of Pleistocene forests, particularly in the regions in which savannah presently occurs. Knowledge of the last period when forests connected EAM would provide a sound basis for hypothesis testing of vicariance and dispersal models of speciation. Dated phylogenies have revealed complex patterns throughout EAM, so we investigated divergence times of forest fauna on four montane isolates in close proximity to determine whether forest break-up was most likely to have been simultaneous or sequential, using population genetics of a forest restricted arboreal chameleon, Kinyongia boehmei. Methodology/Principal Findings: We used mitochondrial and nuclear genetic sequence data and mutation rates from a fossil-calibrated phylogeny to estimate divergence times between montane isolates using a coalescent approach. We found that chameleons on all mountains are most likely to have diverged sequentially within the Pleistocene from 0.93-0.59 Ma (95% HPD 0.22-1.84 Ma). In addition, post-hoc tests on chameleons on the largest montane isolate suggest a population expansion similar to 182 Ka. Conclusions/Significance: Sequential divergence is most likely to have occurred after the last of three wet periods within the arid Plio-Pleistocene era, but was not correlated with inter-montane distance. We speculate that forest connection persisted due to riparian corridors regardless of proximity, highlighting their importance in the region's historic dispersal events. The population expansion coincides with nearby volcanic activity, which may also explain the relative paucity of the Taita's endemic fauna. Our study shows that forest chameleons are an apposite group to track forest fragmentation, with the inference that forest extended between some EAM during the Pleistocene 1.1-0.9 Ma.	[Measey, G. John; Tolley, Krystal A.] S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa; [Measey, G. John] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Tolley, Krystal A.] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa	South African National Biodiversity Institute; University of the Western Cape; Stellenbosch University	Measey, GJ (corresponding author), S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa.	john@measey.com	Tolley, Krystal A/D-9738-2011; Measey, John/F-2028-2010	Measey, John/0000-0001-9939-7615; Tolley, Krystal/0000-0002-7778-1963	Critical Ecosystem Partnerships Fund; Percy Sladen Memorial Trust; South African National Biodiversity Institute	Critical Ecosystem Partnerships Fund; Percy Sladen Memorial Trust; South African National Biodiversity Institute	Field work was funded by a Critical Ecosystem Partnerships Fund (www.cepf.net) and a grant for exploration from the Percy Sladen Memorial Trust (www.linnean.org). Laboratory work was funded by the South African National Biodiversity Institute (www.sanbi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2011, PLANT ECOL, V212, P639, DOI 10.1007/s11258-010-9853-3; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blackburn DC, 2009, MOL ECOL, V18, P1904, DOI 10.1111/j.1365-294X.2009.04156.x; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bowie RCK, 2004, AUK, V121, P660, DOI 10.1642/0004-8038(2004)121[0660:SABODS]2.0.CO;2; Bruford Michael W., 1992, P225; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; Drummond A. J., 2007, GENEIOUS V4 8; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finch J., 2010, VEG HIST ARCHAEOBOT, V20, P109; Finch J, 2009, QUATERNARY RES, V72, P111, DOI 10.1016/j.yqres.2009.02.005; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P315, DOI 10.1023/A:1018304522320; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Foster A, 1997, J GEOL SOC LONDON, V154, P689, DOI 10.1144/gsjgs.154.4.0689; Fu YX, 1997, GENETICS, V147, P915; Fuchs J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-117; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hopkins KP, 2011, BIOL J LINN SOC, V102, P878, DOI 10.1111/j.1095-8312.2011.01618.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2011, GENOME BIOL EVOL, V3, P23, DOI 10.1093/gbe/evq077; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackman TR, 2008, MOL PHYLOGENET EVOL, V46, P74, DOI 10.1016/j.ympev.2007.10.018; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; Le Gall B, 2008, TECTONOPHYSICS, V448, P1, DOI 10.1016/j.tecto.2007.11.005; Loader SP, 2011, HERPETOL J, V21, P5; Loader SP, 2004, AFR ZOOL, V39, P71; Lovett JC, 2005, CONSERV BIOL SER, V8, P198; Lovett JC, BIOGEOGRAPHY ECOLOGY; Macey JR, 1997, J MOL EVOL, V44, P660, DOI 10.1007/PL00006190; Malonza Patrick K., 2010, Journal of East African Natural History, V99, P47, DOI 10.2982/028.099.0103; Mariaux J, 2008, ZOOL J LINN SOC-LOND, V152, P367, DOI 10.1111/j.1096-3642.2007.00332.x; Mark BG, 2008, J QUATERNARY SCI, V23, P589, DOI 10.1002/jqs.1222; Matthee CA, 2004, P ROY SOC B-BIOL SCI, V271, P1967, DOI 10.1098/rspb.2004.2806; Measey GJ, 2007, CONSERV GENET, V8, P1177, DOI 10.1007/s10592-006-9272-0; Measey GJ, 2011, CONSERV GENET, V12, P61, DOI 10.1007/s10592-009-9989-7; Measey GJ, 2009, AMPHIBIANS TAITA HIL; Menegon M, 2004, TROP ZOOL, V17, P97, DOI 10.1080/03946975.2004.10531201; Menegon M, 2009, AFR J HERPETOL, V58, P59, DOI 10.1080/21564574.2009.9650026; Moernaut J, 2010, EARTH PLANET SC LETT, V290, P214, DOI 10.1016/j.epsl.2009.12.023; Muller H, 2005, ZOOTAXA, P37; Mulwa RK, 2007, BIRD CONSERV INT, V17, P141, DOI 10.1017/S0959270907000664; Mumbi CT, 2008, QUATERNARY RES, V69, P326, DOI 10.1016/j.yqres.2007.10.012; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nonnotte P, 2008, J VOLCANOL GEOTH RES, V173, P99, DOI 10.1016/j.jvolgeores.2007.12.042; Palumbi Stephen R., 1996, P205; Rambaut A, 2007, TRACER 1 4; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rucina SM, 2009, PALAEOGEOGR PALAEOCL, V283, P1, DOI 10.1016/j.palaeo.2009.08.008; Schneider S, 1999, GENETICS, V152, P1079; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Stanley WT, 2005, J ZOOL, V266, P341, DOI 10.1017/S0952836905007016; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Tilbury C.R., 2010, CHAMELEONS AFRICA AT; Tilbury Colin R., 2006, Zootaxa, V1363, P23; Tilbury CR, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2226.1.4; Tilbury CR, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2079.1.2; Tolley KA, 2006, MOL ECOL, V15, P781, DOI 10.1111/j.1365-294X.2006.02836.x; Tolley KA, 2004, MOL PHYLOGENET EVOL, V30, P354, DOI 10.1016/S1055-7903(03)00211-2; Tolley KA, 2008, J BIOGEOGR, V35, P1402, DOI 10.1111/j.1365-2699.2008.01889.x; Tolley KA, 2007, AFR J HERPETOL, V56, P85, DOI 10.1080/21564574.2007.9635554; Tolley KA, 2011, J BIOGEOGR, V38, P1748, DOI 10.1111/j.1365-2699.2011.02529.x; Tolley KA, 2009, MOL PHYLOGENET EVOL, V51, P120, DOI 10.1016/j.ympev.2008.11.017; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; Voje KL, 2009, MOL ECOL, V18, P93, DOI 10.1111/j.1365-294X.2008.04002.x; Wilder C., 1998, J EAST AFR NAT HIST, V87, P181, DOI [10.2982/0012-8317(1998)87[181:VSACOT]2.0.CO;2, DOI 10.2982/0012-8317(1998)87[181:VSACOT]2.0.CO;2]; Zwickl D. J, 2006, GENETIC ALGORITHM AP	82	27	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26606	10.1371/journal.pone.0026606	http://dx.doi.org/10.1371/journal.pone.0026606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053198	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800024
J	Bernard, X; Robinson, P; Nomine, Y; Masson, M; Charbonnier, S; Ramirez-Ramos, JR; Deryckere, F; Trave, G; Orfanoudakis, G				Bernard, Xavier; Robinson, Philip; Nomine, Yves; Masson, Murielle; Charbonnier, Sebastian; Ramirez-Ramos, Juan Ramon; Deryckere, Francois; Trave, Gilles; Orfanoudakis, Georges			Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain	PLOS ONE			English	Article							MDM2 BINDING-SITE; DNA-BINDING; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL ACTIVATION; SEQUENCE ELEMENT; HPV-16 E6; IN-VIVO; PROTEIN; UBIQUITINATION	The E6 oncoprotein produced by high-risk mucosal HPV stimulates ubiquitinylation and proteasome-dependent degradation of the tumour suppressor p53 via formation of a trimeric complex comprising E6, p53, and E6-AP. p53 is also degraded by its main cellular regulator MDM2. The main binding site of p53 to MDM2 is situated in the natively unfolded N-terminal region of p53. By contrast, the regions of p53 implicated in the degradation by viral E6 are not fully identified to date. Here we generated a series of mutations (Y103G, Y107G, T155A, T155V, T155D, L264A, L265A) targeting the central folded core domain of p53 within a region opposite to its DNA-binding site. We analysed by in vitro and in vivo assays the impact of these mutations on p53 degradation mediated by viral E6 oncoprotein. Whereas all mutants remained susceptible to MDM2-mediated degradation, several of them (Y103G, Y107G, T155D, L265A) became resistant to E6-mediated degradation, confirming previous works that pointed to the core domain as an essential region for the degradation of p53. In parallel, we systematically checked the impact of the mutations on the transactivation activity of p53 as well as on the conformation of p53, analysed by Nuclear Magnetic Resonance (NMR), circular dichroism (CD), and antibody probing. These measurements suggested that the conformational integrity of the core domain is an essential parameter for the degradation of p53 by E6, while it is not essential for the degradation of p53 by MDM2. Thus, the intracellular stability of a protein may or may not rely on its biophysical stability depending on the degradation pathway taken into consideration.	[Bernard, Xavier; Nomine, Yves; Masson, Murielle; Charbonnier, Sebastian; Ramirez-Ramos, Juan Ramon; Deryckere, Francois; Trave, Gilles; Orfanoudakis, Georges] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, CNRS, UMR 7242, Illkirch Graffenstaden, France; [Robinson, Philip] Univ Bordeaux, INSERM CIC 0005, CHU Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bernard, X (corresponding author), Univ Strasbourg, Ecole Super Biotechnol Strasbourg, CNRS, UMR 7242, Illkirch Graffenstaden, France.	gilles.trave@unistra.fr; georges.orfanoudakis@unistra.fr	Nominé, Yves/P-8670-2016; TRAVE, Gilles/P-8577-2016	Nomine, Yves/0000-0002-2912-116X; Orfanoudakis, Georges/0000-0002-0064-1305	CNRS; Universite de Strasbourg; Ligue Contre le Cancer [CCIR-GE 2009]; ARC [n3171]; CNRS BDI; Arbor Vita Corp.; European College of the University of Strasbourg; ANR;  [ANR-06-BLAN-0404]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Ligue Contre le Cancer(Ligue nationale contre le cancer); ARC(Australian Research Council); CNRS BDI(Centre National de la Recherche Scientifique (CNRS)); Arbor Vita Corp.; European College of the University of Strasbourg; ANR(French National Research Agency (ANR)); 	This work was supported by the CNRS, Universite de Strasbourg, Ligue Contre le Cancer CCIR-GE 2009, ARC n3171 and ANR-06-BLAN-0404. X. B. was funded through CNRS BDI, Arbor Vita Corp and ARC fellowships. P. R. was funded through ARC and European College of the University of Strasbourg fellowships. S. C. was funded by Ligue Contre le Cancer. J.R. R.-R. was funded by ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARBOSA MS, 1989, ONCOGENE, V4, P1529; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2004, CELL CYCLE, V3, P895; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Giovane C, 1999, J MOL RECOGNIT, V12, P141, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<141::AID-JMR453>3.3.CO;2-F; Grand RJA, 1999, ONCOGENE, V18, P955, DOI 10.1038/sj.onc.1202358; GROSSMAN SR, 1989, J VIROL, V63, P366, DOI 10.1128/JVI.63.1.366-374.1989; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Gu JJ, 2001, ONCOGENE, V20, P3519, DOI 10.1038/sj.onc.1204454; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LEACH FS, 1993, CANCER RES, V53, P2231; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Li XQ, 1996, J BIOL CHEM, V271, P4447; Liu Y, 2004, J BIOL CHEM, V279, P21766, DOI 10.1074/jbc.M314321200; Maki CG, 1996, CANCER RES, V56, P2649; MANSUR CP, 1995, ONCOGENE, V10, P457; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; PICKSLEY SM, 1994, ONCOGENE, V9, P2523; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Stewart D, 2004, J GEN VIROL, V85, P1419, DOI 10.1099/vir.0.19679-0; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; THOMAS M, 1995, ONCOGENE, V10, P261; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang PL, 2001, ONCOGENE, V20, P2318, DOI 10.1038/sj.onc.1204316; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	55	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e25981	10.1371/journal.pone.0025981	http://dx.doi.org/10.1371/journal.pone.0025981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046250	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400006
J	Chaisson, LH; Kass, NE; Chengeta, B; Mathebula, U; Samandari, T				Chaisson, Lelia H.; Kass, Nancy E.; Chengeta, Bafanana; Mathebula, Unami; Samandari, Taraz			Repeated Assessments of Informed Consent Comprehension among HIV-Infected Participants of a Three-Year Clinical Trial in Botswana	PLOS ONE			English	Article							INTERNATIONAL HEALTH RESEARCH; INJECTION-DRUG USERS; VACCINE TRIALS; SOUTH-AFRICA; PHASE-I; QUALITY; PERCEPTIONS; READABILITY; UNDERSTAND; FORMS	Background: Informed consent (IC) has been an international standard for decades for the ethical conduct of clinical trials. Yet frequently study participants have incomplete understanding of key issues, a problem exacerbated by language barriers or lack of familiarity with research concepts. Few investigators measure participant comprehension of IC, while even fewer conduct interim assessments once a trial is underway. Methods and Findings: We assessed comprehension of IC using a 20-question true/false quiz administered in 6-month intervals in the context of a placebo-controlled, randomized trial for the prevention of tuberculosis among HIV-infected adults in Botswana (2004-2009). Quizzes were offered in both Setswana and English. To enroll in the TB trial, participants were required to have >= 16/20 correct responses. We examined concepts understood and the degree to which understanding changed over three-years. We analyzed 5,555 quizzes from 1,835 participants. The participants' highest education levels were: 28% primary, 59% secondary, 9% tertiary and 7% no formal education. Eighty percent of participants passed the enrollment quiz (Quiz1) on their first attempt and the remainder passed on their second attempt. Those having higher than primary education and those who took the quiz in English were more likely to receive a passing score on their first attempt (adjusted odds ratios and 95% confidence intervals, 3.1 (2.4-4.0) and 1.5 (1.2, 1.9), respectively). The trial's purpose or procedures were understood by 90-100% of participants, while 44-77% understood randomization, placebos, or risks. Participants who failed Quiz1 on their initial attempt were more likely to fail quizzes later in the trial. Pass rates improved with quiz re-administration in subsequent years. Conclusions: Administration of a comprehension quiz at enrollment and during follow-up was feasible in a large, international collaboration and efficiently determined IC comprehension by trial participants. Strategies to improve understanding of concepts like placebos and randomization are needed. Comprehension assessments throughout a study may reinforce key concepts.	[Chaisson, Lelia H.; Kass, Nancy E.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA; [Kass, Nancy E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Chengeta, Bafanana; Samandari, Taraz] Botswana USA Partnership, Gaborone, Botswana; [Chengeta, Bafanana; Samandari, Taraz] Botswana USA Partnership, Francistown, Botswana; [Mathebula, Unami; Samandari, Taraz] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Chaisson, LH (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.	nkass@jhu.edu			Centers for Disease Control and Prevention (CDC) Division of TB Elimination; Johns Hopkins University	Centers for Disease Control and Prevention (CDC) Division of TB Elimination(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Johns Hopkins University(Johns Hopkins University)	This analysis of comprehension quizzes was funded by the Centers for Disease Control and Prevention (CDC) Division of TB Elimination as well as by a student grant from the Merck Summer Scholars program at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1996, J CLIN ONCOL, V14, P984, DOI 10.1200/JCO.1996.14.3.984; Achrekar A, 1998, NEW ENGL J MED, V339, P1331, DOI 10.1056/NEJM199810293391815; Agard A, 2005, NAT CLIN PRACT CARD, V2, P270, DOI 10.1038/ncpcardio0220; [Anonymous], 1989, CONTROL CLIN TRIALS, V10, P83; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Berger O, 2008, ANN ONCOL; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Buchanan L, 1995, ANN ONCOL, V6, P867, DOI 10.1093/oxfordjournals.annonc.a059352; CASSILETH BR, 1980, NEW ENGL J MED, V302, P896, DOI 10.1056/NEJM198004173021605; Cheng JD, 2000, J CLIN ONCOL, V18, P421, DOI 10.1200/JCO.2000.18.2.421; Christopher PP, 2007, PSYCHIAT SERV, V58, P227, DOI 10.1176/appi.ps.58.2.227; *CIOMS, 2002, INT ETH GUID BIOM RE; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Dawson L, 2005, SOC SCI MED, V61, P1211, DOI 10.1016/j.socscimed.2005.02.004; Dormandy E, 2007, PATIENT EDUC COUNS, V66, P278, DOI 10.1016/j.pec.2007.01.001; Dunn LB, 2006, SCHIZOPHRENIA BULL, V32, P137; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; Faden R., 1986, HIST THEORY INFORM C; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Fortun P, 2008, QJM-INT J MED, V101, P625, DOI 10.1093/qjmed/hcn067; HARRISON K, 1995, J ACQ IMMUN DEF SYND, V10, P386; HARTH SC, 1995, SOC SCI MED, V40, P1573, DOI 10.1016/0277-9536(94)00412-M; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Jegede AS, 2009, DEV WORLD BIOETH, V9, P81, DOI 10.1111/j.1471-8847.2008.00238.x; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kass Nancy E., 2001, COMMISSIONED PAPERS, VII, pB1; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; Kripalani Sunil, 2008, IRB, V30, P13; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Kucia AM, 2000, AM HEART J, V140, P94, DOI 10.1067/mhj.2000.106625; Lansimies-Antikainen H, 2009, SCAND J CARING SCI; Leroy T, 2011, INVEST NEW DRUG, V29, P700, DOI 10.1007/s10637-009-9315-8; Lindegger G, 2006, JAIDS-J ACQ IMM DEF, V43, P560; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; MacQueen KM, 1999, J ACQ IMMUN DEF SYND, V21, P243, DOI 10.1097/00126334-199907010-00010; Marshall P. A., 2001, ETHICAL POLICY ISSUE, VII, pC1; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; McCabe M, 2005, ETHNIC DIS, V15, P300; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V26, P176, DOI 10.1097/00126334-200102010-00012; Minnies Deon, 2008, BMC Med Ethics, V9, P15, DOI 10.1186/1472-6939-9-15; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Moodley K, 2005, J MED ETHICS, V31, P727, DOI 10.1136/jme.2004.009910; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Ndebele P, 2009, E COMMUNICATION; Onvomaha Tindana Paulina, 2006, IRB, V28, P1; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; PENMAN DT, 1984, J CLIN ONCOL, V2, P849, DOI 10.1200/JCO.1984.2.7.849; Prentice Kristen J, 2007, IRB, V29, P1; Ridpath JR, 2009, AM J HEALTH PROMOT, V23, P371, DOI 10.4278/ajhp.080613-CIT-94; RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344; Robinson EJ, 2005, HEALTH TECHNOL ASSES, V9, pIII; Rounsaville DB, 2008, J AM ACAD PSYCHIATRY, V36, P354; Steinke Elaine E, 2004, Clin Nurse Spec, V18, P88, DOI 10.1097/00002800-200403000-00014; Taiwo OO, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-11; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; Tomamichel M, 2000, ANN ONCOL, V11, P289, DOI 10.1023/A:1008393031299; Wendler D, 2004, ARCH INTERN MED, V164, P2201, DOI 10.1001/archinte.164.20.2201	65	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e22696	10.1371/journal.pone.0022696	http://dx.doi.org/10.1371/journal.pone.0022696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841OJ	22046230	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400001
J	Hamtiaux, L; Hansoulle, L; Dauguet, N; Muccioli, GG; Gallez, B; Lambert, DM				Hamtiaux, Laurie; Hansoulle, Laurie; Dauguet, Nicolas; Muccioli, Giulio G.; Gallez, Bernard; Lambert, Didier M.			Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism	PLOS ONE			English	Article							COLORECTAL-CARCINOMA CELLS; ACID AMIDE HYDROLASE; COLON-CANCER CELLS; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; CHOLANGIOCARCINOMA GROWTH; TUMOR-GROWTH; VANILLOID RECEPTORS; OPPOSING ACTIONS; LIPID RAFTS	The antitumoral properties of endocannabinoids received a particular attention these last few years. Indeed, these endogenous molecules have been reported to exert cytostatic, apoptotic and antiangiogenic effects in different tumor cell lines and tumor xenografts. Therefore, we investigated the cytotoxicity of three N-acylethanolamines - N-arachidonoylethanolamine (anandamide, AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) - which were all able to time-and dose-dependently reduce the viability of murine N1E-115 neuroblastoma cells. Moreover, several inhibitors of FAAH and NAAA, whose presence was confirmed by RT-PCR in the cell line, induced cell cytotoxicity and favored the decrease in cell viability caused by N-acylethanolamines. The most cytotoxic treatment was achieved by the co-incubation of AEA with the selective FAAH inhibitor URB597, which drastically reduced cell viability partly by inhibiting AEA hydrolysis and consequently increasing AEA levels. This combination of molecules synergistically decreased cell proliferation without inducing cell apoptosis or necrosis. We found that these effects are independent of cannabinoid, TRPV1, PPAR alpha, PPAR gamma or GPR55 receptors activation but seem to occur through a lipid raft-dependent mechanism. These findings further highlight the interest of targeting the endocannabinoid system to treat cancer. More particularly, this emphasizes the great potential benefit of designing novel anti-cancerous therapies based on the association of endocannabinoids and inhibitors of their hydrolysis.	[Hamtiaux, Laurie; Hansoulle, Laurie; Lambert, Didier M.] Catholic Univ Louvain, Med Chem Cannabinoid & Endocannabinoid Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Dauguet, Nicolas] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Hamtiaux, L (corresponding author), Catholic Univ Louvain, Med Chem Cannabinoid & Endocannabinoid Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium.	Didier.lambert@uclouvain.be		Muccioli, Giulio/0000-0002-1600-9259	Fonds National de la Recherche Scientifique [FRFC 2.4555.08]; Universite catholique de Louvain	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain	This work was supported by the "Fonds National de la Recherche Scientifique" (FRFC 2.4555.08) and by a FSR grant from Universite catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V364, P131, DOI 10.1016/j.bbrc.2007.09.107; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bifulco M, 2004, FASEB J, V18, P1606, DOI 10.1096/fj.04-1754fje; Bifulco M, 2001, FASEB J, V15, P2745, DOI 10.1096/fj.01-0320fje; Bosier B, 2007, J NEUROCHEM, V102, P1996, DOI 10.1111/j.1471-4159.2007.04679.x; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Catanzaro G, 2009, BIOCHEM BIOPH RES CO, V388, P439, DOI 10.1016/j.bbrc.2009.08.037; Contassot E, 2004, J NEUROPATH EXP NEUR, V63, P956, DOI 10.1093/jnen/63.9.956; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2002, FUND CLIN PHARMACOL, V16, P297, DOI 10.1046/j.1472-8206.2002.00094.x; De Petrocellis L, 1998, P NATL ACAD SCI USA, V95, P8375, DOI 10.1073/pnas.95.14.8375; DeMorrow S, 2007, J BIOL CHEM, V282, P13098, DOI 10.1074/jbc.M608238200; DeMorrow S, 2008, AM J PHYSIOL-GASTR L, V295, pG1150, DOI 10.1152/ajpgi.90455.2008; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; Di Marzo V, 2001, BIOCHEM J, V358, P249, DOI 10.1042/0264-6021:3580249; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; Favier J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-139; Fowler CJ, 2003, BIOCHEM PHARMACOL, V66, P757, DOI 10.1016/S0006-2952(03)00392-7; Frampton G, 2010, EXP CELL RES, V316, P1465, DOI 10.1016/j.yexcr.2010.03.017; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Grimbly C, 2009, J MOL NEUROSCI, V39, P117, DOI 10.1007/s12031-009-9194-7; Gustafsson SB, 2009, CANCER CHEMOTH PHARM, V63, P691, DOI 10.1007/s00280-008-0788-5; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Herrera B, 2006, EXP CELL RES, V312, P2121, DOI 10.1016/j.yexcr.2006.03.009; Hsu SS, 2007, TOXICOLOGY, V231, P21, DOI 10.1016/j.tox.2006.11.005; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; Linsalata M, 2010, ANTICANCER RES, V30, P2583; Ma DWL, 2007, APPL PHYSIOL NUTR ME, V32, P341, DOI 10.1139/H07-036; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Miyato H, 2009, J SURG RES, V155, P40, DOI 10.1016/j.jss.2008.06.045; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Patsos HA, 2005, GUT, V54, P1741, DOI 10.1136/gut.2005.073403; Patsos HA, 2010, INT J ONCOL, V37, P187, DOI 10.3892/ijo_00000666; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Sarker KP, 2003, J NEUROCHEM, V85, P50, DOI 10.1046/j.1471-4159.2003.01663.x; Siegmund SV, 2006, J BIOL CHEM, V281, P10431, DOI 10.1074/jbc.M509706200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sun YX, 2005, BIOCHIM BIOPHYS ACTA, P211; Szoke E, 2002, NEUROSCIENCE, V115, P805, DOI 10.1016/S0306-4522(02)00420-7; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Wasilewski M, 2004, BBA-BIOENERGETICS, V1657, P151, DOI 10.1016/j.bbabio.2004.05.004; Wu Wen-Jie, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P204, DOI 10.3760/cma.j.issn.1007-3418.2010.03.013; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	57	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26823	10.1371/journal.pone.0026823	http://dx.doi.org/10.1371/journal.pone.0026823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046372	gold, Green Published, Green Submitted			2022-12-27	WOS:000296521400036
J	Mayfield, AB; Wang, LH; Tang, PC; Fan, TY; Hsiao, YY; Tsai, CL; Chen, CS				Mayfield, Anderson B.; Wang, Li-Hsueh; Tang, Pei-Ciao; Fan, Tung-Yung; Hsiao, Yi-Yuong; Tsai, Ching-Lin; Chen, Chii-Shiarng			Assessing the Impacts of Experimentally Elevated Temperature on the Biological Composition and Molecular Chaperone Gene Expression of a Reef Coral	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SERIATOPORA-HYSTRIX; BUILDING CORALS; POCILLOPORA-DAMICORNIS; MONTASTRAEA-FAVEOLATA; HSP70 EXPRESSION; THERMAL-STRESS; CLIMATE-CHANGE; SYMBIOSIS; ACCLIMATIZATION	Due to the potential for increasing ocean temperatures to detrimentally impact reef-building corals, there is an urgent need to better understand not only the coral thermal stress response, but also natural variation in their sub-cellular composition. To address this issue, while simultaneously developing a molecular platform for studying one of the most common Taiwanese reef corals, Seriatopora hystrix, 1,092 cDNA clones were sequenced and characterized. Subsequently, RNA, DNA and protein were extracted sequentially from colonies exposed to elevated (30 degrees C) temperature for 48 hours. From the RNA phase, a heat shock protein-70 (hsp70)-like gene, deemed hsp/c, was identified in the coral host, and expression of this gene was measured with real-time quantitative PCR (qPCR) in both the host anthozoan and endosymbiotic dinoflagellates (genus Symbiodinium). While mRNA levels were not affected by temperature in either member, hsp/c expression was temporally variable in both and co-varied within biopsies. From the DNA phase, host and Symbiodinium hsp/c genome copy proportions (GCPs) were calculated to track changes in the biological composition of the holobiont during the experiment. While there was no temperature effect on either host or Symbiodinium GCP, both demonstrated significant temporal variation. Finally, total soluble protein was responsive to neither temperature nor exposure time, though the protein/DNA ratio varied significantly over time. Collectively, it appears that time, and not temperature, is a more important driver of the variation in these parameters, highlighting the need to consider natural variation in both gene expression and the molecular make-up of coral holobionts when conducting manipulative studies. This represents the first study to survey multiple macromolecules from both compartments of an endosymbiotic organism with methodologies that reflect their dual-compartmental nature, ideally generating a framework for assessing molecular-level changes within corals and other endosymbioses exposed to changes in their environment.	[Mayfield, Anderson B.; Wang, Li-Hsueh; Fan, Tung-Yung; Hsiao, Yi-Yuong; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Wang, Li-Hsueh; Hsiao, Yi-Yuong; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Checheng, Pingtung, Taiwan; [Tang, Pei-Ciao] Univ Louisiana, Dept Biol, Lafayette, LA USA; [Fan, Tung-Yung] Natl Dong Hwa Univ, Grad Inst Biodivers & Evolut, Checheng, Pingtung, Taiwan; [Tsai, Ching-Lin; Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Resources, Kaohsiung 80424, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; University of Louisiana Lafayette; National Dong Hwa University; National Sun Yat Sen University	Mayfield, AB (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	mayfield@lifesci.ucsb.edu		Mayfield, Anderson/0000-0003-0138-7844	NSF [OCE 04-17412]; Journal of Experimental Biology; NSF East Asia; Pacific Summer Institutes; International Research fellowships [OISE-0852960]; NMMBA	NSF(National Science Foundation (NSF)); Journal of Experimental Biology; NSF East Asia; Pacific Summer Institutes; International Research fellowships; NMMBA	The Mo'orea Coral Reef Long Term Ecological Research program (NSF OCE 04-17412, http://mcr.lternet.edu/) provided funding to Dr. Peter Edmunds for a collaborative visit, including ABM, to Taiwan's National Museum of Marine Biology and Aquarium (NMMBA) in 2008, during which the project was conceived. The Journal of Experimental Biology generously funded this work through a travel fellowship (http://jeb.biologists.org/site/misc/fellowships.xhtml) to ABM. ABM was also funded by both NSF East Asia and Pacific Summer Institutes (www.nsf.gov/eapsi) and International Research (OISE-0852960, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5179) fellowships. A PADI Project Aware (www.projectaware.org) grant to ABM was used to purchase gene expression reagents, and intramural funds from NMMBA supported the remainder of the laboratory analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Bower NI, 2007, BIOTECHNIQUES, V42, P197, DOI 10.2144/000112314; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Buckley BA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P570, DOI 10.1086/420944; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; CRAIG EA, 1983, DEV BIOL, V99, P418, DOI 10.1016/0012-1606(83)90291-9; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Gates RD, 1999, AM ZOOL, V39, P30; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hung Tsu-Chang, 1998, Chemistry and Ecology, V15, P129, DOI 10.1080/02757549808037625; Jan S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004887; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HJ, 1999, ESTUAR COAST SHELF S, V49, P775, DOI 10.1006/ecss.1999.0524; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Starcevic A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013975; Theodorakis NG, 1999, J BIOL CHEM, V274, P12081, DOI 10.1074/jbc.274.17.12081; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Traylor-Knowles N, BMC GENOMIC IN PRESS; Tsai CL, 2007, MAR BIOTECHNOL, V9, P243, DOI 10.1007/s10126-006-6089-2; Tung YH, 2006, P 10 INT COR REEF S, P737; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; Venn AA, 2009, AQUAT TOXICOL, V93, P188, DOI 10.1016/j.aquatox.2009.05.003; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009	48	42	42	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26529	10.1371/journal.pone.0026529	http://dx.doi.org/10.1371/journal.pone.0026529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046302	Green Submitted, gold, Green Published			2022-12-27	WOS:000296521400025
J	Morera, D; Roher, N; Ribas, L; Balasch, JC; Donate, C; Callol, A; Boltana, S; Roberts, S; Goetz, G; Goetz, FW; MacKenzie, SA				Morera, Davinia; Roher, Nerea; Ribas, Laia; Carles Balasch, Joan; Donate, Carmen; Callol, Agnes; Boltana, Sebastian; Roberts, Steven; Goetz, Giles; Goetz, Frederick W.; MacKenzie, Simon A.			RNA-Seq Reveals an Integrated Immune Response in Nucleated Erythrocytes	PLOS ONE			English	Article							DEFINITIVE HEMATOPOIESIS; BLOOD-CELLS; EXPRESSION; ALPHA; ERYTHROPOIESIS	Background: Throughout the primary literature and within textbooks, the erythrocyte has been tacitly accepted to have maintained a unique physiological role; namely gas transport and exchange. In non-mammalian vertebrates, nucleated erythrocytes are present in circulation throughout the life cycle and a fragmented series of observations in mammals support a potential role in non-respiratory biological processes. We hypothesised that nucleated erythrocytes could actively participate via ligand-induced transcriptional re-programming in the immune response. Methodology/Principal Findings: Nucleated erythrocytes from both fish and birds express and regulate specific pattern recognition receptor (PRR) mRNAs and, thus, are capable of specific pathogen associated molecular pattern (PAMP) detection that is central to the innate immune response. In vitro challenge with diverse PAMPs led to de novo specific mRNA synthesis of both receptors and response factors including interferon-alpha (IFN alpha) that exhibit a stimulus-specific polysomal shift supporting active translation. RNA-Seq analysis of the PAMP (Poly (I:C), polyinosinic: polycytidylic acid)-erythrocyte response uncovered diverse cohorts of differentially expressed mRNA transcripts related to multiple physiological systems including the endocrine, reproductive and immune. Moreover, erythrocyte-derived conditioned mediums induced a type-1 interferon response in macrophages thus supporting an integrative role for the erythrocytes in the immune response. Conclusions/Significance: We demonstrate that nucleated erythrocytes in non-mammalian vertebrates spanning significant phylogenetic distance participate in the immune response. RNA-Seq studies highlight a mRNA repertoire that suggests a previously unrecognized integrative role for the erythrocytes in other physiological systems.	[Morera, Davinia; Roher, Nerea; Callol, Agnes; Boltana, Sebastian; MacKenzie, Simon A.] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain; [Ribas, Laia; Carles Balasch, Joan; Donate, Carmen] Univ Autonoma Barcelona, Unitat Fisiol Anim, Dept Biol Cellular Fisiol & Immunol, Fac Ciencies, Bellaterra, Barcelona, Spain; [Roberts, Steven] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Goetz, Giles; Goetz, Frederick W.] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee	Morera, D (corresponding author), Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain.	Simon.Mackenzie@uab.es	Boltana, Sebastian/AAC-8944-2019; Balasch, Joan Carles/R-9874-2019; Balasch, Joan Carles/J-8651-2017; Ribas, Laia/E-1466-2013; Roher, Nerea/F-3216-2016; MacKenzie, Simon/Q-2362-2019; Matz, Mikhail/K-4392-2017	Boltana, Sebastian/0000-0002-5195-0490; Balasch, Joan Carles/0000-0002-0771-3746; Balasch, Joan Carles/0000-0002-0771-3746; Ribas, Laia/0000-0001-5538-6236; Roher, Nerea/0000-0002-6659-4038; MacKenzie, Simon/0000-0003-1845-6826; Matz, Mikhail/0000-0001-5453-9819; Roberts, Steven/0000-0001-8302-1138	Spanish Ministry of Science and Innovation [CSD2007-0002]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation; Consolider-Ingenio Programme 2010, project CSD2007-0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; CHATTORAJ D K, 1971, Proceedings of the Indian National Science Academy Part B Biological Sciences, V37, P140; Claver JA, 2009, J EXOT PET MED, V18, P87, DOI 10.1053/j.jepm.2009.04.006; Damson AB, 1933, BIOL BULL-US, V64, P33, DOI 10.2307/1537497; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hess C, 2003, NEWS PHYSIOL SCI, V18, P104, DOI 10.1152/nips.01425.2002; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; MacKenzie S, 2003, DEV COMP IMMUNOL, V27, P393, DOI 10.1016/S0145-305X(02)00135-0; MacKenzie S, 2002, J LEUKOCYTE BIOL, V71, P1026; Mazzarello P, 1998, NATURE, V392, P543, DOI 10.1038/33266; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai H, 2008, DEV DYNAM, V237, P3332, DOI 10.1002/dvdy.21746; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pottinger TG, 1997, J EXP BIOL, V200, P2035; Sennikov SV, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-39; Workenhe ST, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-36	26	90	93	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26998	10.1371/journal.pone.0026998	http://dx.doi.org/10.1371/journal.pone.0026998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046430	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400054
J	Alves, H; Dechering, K; Van Blitterswijk, C; De Boer, J				Alves, Hugo; Dechering, Koen; Van Blitterswijk, Clemens; De Boer, Jan			High-Throughput Assay for the Identification of Compounds Regulating Osteogenic Differentiation of Human Mesenchymal Stromal Cells	PLOS ONE			English	Article							TETRAZOLIUM FORMAZAN ASSAY; STEM-CELLS; COLORIMETRIC ASSAY; ENDOTHELIAL-CELLS; BONE-FORMATION; PROLIFERATION; INHIBITION; GROWTH; VIABILITY; CULTURE	Human mesenchymal stromal cells are regarded as the golden standard for cell-based therapies. They present multilineage differentiation potential and trophic and immunosuppressive abilities, making them the best candidate for clinical applications. Several molecules have been described to increase bone formation and were mainly discovered by candidate approaches towards known signaling pathways controlling osteogenesis. However, their bone forming potential is still limited, making the search for novel molecules a necessity. High-throughput screening (HTS) not only allows the screening of a large number of diverse chemical compounds, but also allows the discovery of unexpected signaling pathways and molecular mechanisms for a certain application, even without the prior knowledge of the full molecular pathway. Typically HTS is performed in cell lines, however, in this manuscript we have performed a phenotypical screen on more clinically relevant human mesenchymal stromal cells, as a proof of principle that HTS can be performed in those cells and can be used to find small molecules that impact stem cell fate. From a library of pharmacologically active small molecules, we were able to identify novel compounds with increased osteogenic activity. These compounds allowed achieving levels of bone-specific alkaline phosphatase higher than any other combination previously known. By combining biochemical techniques, we were able to demonstrate that a medium to high-throughput phenotypic assay can be performed in academic research laboratories allowing the discovery of novel molecules able to enhance stem cell differentiation.	[Alves, Hugo; Van Blitterswijk, Clemens; De Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Dechering, Koen] Merck Res Labs, Dept Mol Pharmacol, Oss, Netherlands	University of Twente; Merck & Company	Alves, H (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.	hugoandrealves@gmail.com		van Blitterswijk, Clemens/0000-0003-2371-4615; de Boer, Jan/0000-0001-9188-9324	Netherlands Technology Foundation (STW) [TGT.6745]	Netherlands Technology Foundation (STW)(Technologiestichting STW)	This work was supported by a grant from The Netherlands Technology Foundation (STW grant TGT.6745; www.stw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x; An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; BECKER B, 1994, ANAL BIOCHEM, V221, P78, DOI 10.1006/abio.1994.1382; BLAHETA RA, 1991, J IMMUNOL METHODS, V142, P199, DOI 10.1016/0022-1759(91)90107-Q; Brey DM, 2011, BIOTECHNOL BIOENG, V108, P163, DOI 10.1002/bit.22925; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; De Boer J, 2006, TISSUE ENG, V12, P2927; Fabbri E, 1991, J Enzyme Inhib, V5, P87, DOI 10.3109/14756369109069062; Fickert S, 2011, J BONE MINER METAB, V29, P224, DOI 10.1007/s00774-010-0215-y; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JAUREGUI HO, 1981, IN VITRO CELL DEV B, V17, P1100; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lea MA, 2007, ANTICANCER RES, V27, P741; Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; MCBURNEY A, 1988, EUR J CLIN PHARMACOL, V35, P93, DOI 10.1007/BF00555515; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; OLANDER JV, 1982, IN VITRO CELL DEV B, V18, P99, DOI 10.1007/BF02796401; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAGO R, 1990, ANAL BIOCHEM, V191, P31; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Wu ZJ, 2008, J BIOMOL SCREEN, V13, P159, DOI 10.1177/1087057107312628; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	41	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26678	10.1371/journal.pone.0026678	http://dx.doi.org/10.1371/journal.pone.0026678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046332	Green Published, gold			2022-12-27	WOS:000296519600043
J	Doud, AJ; Lucas, JP; Pisansky, MT; He, B				Doud, Alexander J.; Lucas, John P.; Pisansky, Marc T.; He, Bin			Continuous Three-Dimensional Control of a Virtual Helicopter Using a Motor Imagery Based Brain-Computer Interface	PLOS ONE			English	Article							CORTICAL CONTROL; COMMUNICATION; CLASSIFICATION; DEVICES; SYSTEM; TASKS; ARM	Brain-computer interfaces (BCIs) allow a user to interact with a computer system using thought. However, only recently have devices capable of providing sophisticated multi-dimensional control been achieved non-invasively. A major goal for non-invasive BCI systems has been to provide continuous, intuitive, and accurate control, while retaining a high level of user autonomy. By employing electroencephalography (EEG) to record and decode sensorimotor rhythms (SMRs) induced from motor imaginations, a consistent, user-specific control signal may be characterized. Utilizing a novel method of interactive and continuous control, we trained three normal subjects to modulate their SMRs to achieve three-dimensional movement of a virtual helicopter that is fast, accurate, and continuous. In this system, the virtual helicopter's forward-backward translation and elevation controls were actuated through the modulation of sensorimotor rhythms that were converted to forces applied to the virtual helicopter at every simulation time step, and the helicopter's angle of left or right rotation was linearly mapped, with higher resolution, from sensorimotor rhythms associated with other motor imaginations. These different resolutions of control allow for interplay between general intent actuation and fine control as is seen in the gross and fine movements of the arm and hand. Subjects controlled the helicopter with the goal of flying through rings (targets) randomly positioned and oriented in a three-dimensional space. The subjects flew through rings continuously, acquiring as many as 11 consecutive rings within a five-minute period. In total, the study group successfully acquired over 85% of presented targets. These results affirm the effective, three-dimensional control of our motor imagery based BCI system, and suggest its potential applications in biological navigation, neuroprosthetics, and other applications.	[Doud, Alexander J.; Lucas, John P.; Pisansky, Marc T.; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Doud, AJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	binhe@umn.edu			Natinal Science Foundation [CBET-0933067]; National Institutes of Health [RO1EB006433, RO1EB007920]; Directorate For Engineering [0933067] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006433, R01EB007920] Funding Source: NIH RePORTER	Natinal Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by Natinal Science Foundation CBET-0933067, National Institutes of Health RO1EB006433, and RO1EB007920. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2010, CLIN NEUROPHYSIOL, V121, P1293, DOI 10.1016/j.clinph.2010.02.157; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hashimoto Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-117; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kamousi B, 2005, IEEE T NEUR SYS REH, V13, P166, DOI 10.1109/TNSRE.2005.847386; Kamousi B, 2007, J NEURAL ENG, V4, P17, DOI 10.1088/1741-2560/4/2/002; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Qin L, 2005, J NEURAL ENG, V2, P65, DOI 10.1088/1741-2560/2/4/001; Royer AS, 2010, IEEE T NEUR SYS REH, V18, P581, DOI 10.1109/TNSRE.2010.2077654; Royer AS, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016005; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Vallabhaneni A, 2005, BRAIN COMPUTER INTER; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang T, 2004, CLIN NEUROPHYSIOL, V115, P2744, DOI 10.1016/j.clinph.2004.06.022; Wang T, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/001; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yuan H, 2008, IEEE T NEUR SYS REH, V16, P425, DOI 10.1109/TNSRE.2008.2003384; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	28	161	172	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26322	10.1371/journal.pone.0026322	http://dx.doi.org/10.1371/journal.pone.0026322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046274	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600014
J	Hansen, J; Palmfeldt, J; Vang, S; Corydon, TJ; Gregersen, N; Bross, P				Hansen, Jakob; Palmfeldt, Johan; Vang, Soren; Corydon, Thomas J.; Gregersen, Niels; Bross, Peter			Quantitative Proteomics Reveals Cellular Targets of Celastrol	PLOS ONE			English	Article							NF-KAPPA-B; HEAT-SHOCK PROTEINS; THUNDER GOD VINE; WILFORDII HOOK-F; INDUCED APOPTOSIS; OXIDATIVE STRESS; AMINO-ACIDS; CELLS; ACTIVATION; DEATH	Celastrol, a natural substance isolated from plant extracts used in traditional Chinese medicine, has been extensively investigated as a possible drug for treatment of cancer, autoimmune diseases, and protein misfolding disorders. Although studies focusing on celastrol's effects in specific cellular pathways have revealed a considerable number of targets in a diverse array of in vitro models there is an essential need for investigations that can provide a global view of its effects. To assess cellular effects of celastrol and to identify target proteins as biomarkers for monitoring treatment regimes, we performed large-scale quantitative proteomics in cultured human lymphoblastoid cells, a cell type that can be readily prepared from human blood samples. Celastrol substantially modified the proteome composition and 158 of the close to 1800 proteins with robust quantitation showed at least a 1.5 fold change in protein levels. Up-regulated proteins play key roles in cytoprotection with a prominent group involved in quality control and processing of proteins traversing the endoplasmic reticulum. Increased levels of proteins essential for the cellular protection against oxidative stress including heme oxygenase 1, several peroxiredoxins and thioredoxins as well as proteins involved in the control of iron homeostasis were also observed. Specific analysis of the mitochondrial proteome strongly indicated that the mitochondrial association of certain antioxidant defense and apoptosis-regulating proteins increased in cells exposed to celastrol. Analysis of selected mRNA transcripts showed that celastrol activated several different stress response pathways and dose response studies furthermore showed that continuous exposure to sub-micromolar concentrations of celastrol is associated with reduced cellular viability and proliferation. The extensive catalog of regulated proteins presented here identifies numerous cellular effects of celastrol and constitutes a valuable biomarker tool for the development and monitoration of disease treatment strategies.	[Hansen, Jakob] Aarhus Univ, Dept Forens Med, Aarhus, Denmark; [Hansen, Jakob; Palmfeldt, Johan; Vang, Soren; Gregersen, Niels; Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark; [Vang, Soren] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Corydon, Thomas J.] Aarhus Univ, Dept Human Genet, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Hansen, J (corresponding author), Aarhus Univ, Dept Forens Med, Aarhus, Denmark.	Jakob.Hansen@ki.au.dk	Hansen, Jakob/W-1318-2017; Hansen, Jakob/F-7034-2013; Bross, Peter/B-7219-2013	Hansen, Jakob/0000-0002-4115-2858; Bross, Peter/0000-0001-9526-8525; Palmfeldt, Johan/0000-0001-5585-639X; Vang, Soren/0000-0002-1899-4205	Lundbeck Foundation; John and Birthe Meyer Foundation; Ludvig og Sara Elsass Fond	Lundbeck Foundation(Lundbeckfonden); John and Birthe Meyer Foundation; Ludvig og Sara Elsass Fond	This work was supported by the Lundbeck Foundation, The John and Birthe Meyer Foundation, and the Ludvig og Sara Elsass Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Chow AM, 2007, CELL STRESS CHAPERON, V12, P237, DOI 10.1379/CSC-269.1; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; Hansen J, 2010, METHODS MOL BIOL, V648, P303, DOI 10.1007/978-1-60761-756-3_21; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu Z, 2011, MOLECULES, V16, P5283, DOI 10.3390/molecules16065283; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmfeldt J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-20; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tao XL, 2002, ARTHRITIS RHEUM, V46, P1735, DOI 10.1002/art.10411; Tao XL, 2000, RHEUM DIS CLIN N AM, V26, P29, DOI 10.1016/S0889-857X(05)70118-6; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu XA, 2010, AM J HYPERTENS, V23, P895, DOI 10.1038/ajh.2010.75; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030; Zhu H, 2010, CANCER INVEST, V28, P23, DOI 10.3109/07357900903095664; 2010, NUCL ACIDS RES, V38, pD142	54	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26634	10.1371/journal.pone.0026634	http://dx.doi.org/10.1371/journal.pone.0026634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046318	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600037
J	McFarland, R; Majolo, B				McFarland, Richard; Majolo, Bonaventura			Grooming Coercion and the Post-Conflict Trading of Social Services in Wild Barbary Macaques	PLOS ONE			English	Article							JAPANESE MACAQUES; FEMALE BABOONS; MACACA-FUSCATA; RELATIONSHIP QUALITY; ANIMAL SOCIETIES; PARTNER CHOICE; MARKET FORCES; PRIMATES; AGGRESSION; ANXIETY	In animal and human societies, social services such as protection from predators are often exchanged between group members. The tactics that individuals display to obtain a service depend on its value and on differences between individuals in their capacity to aggressively obtain it. Here we analysed the exchange of valuable social services (i.e. grooming and relationship repair) in the aftermath of a conflict, in wild Barbary macaques (Macaca sylvanus). The relationship repair function of post-conflict affiliation (i.e. reconciliation) was apparent in the victim but not in the aggressor. Conversely, we found evidence for grooming coercion by the aggressor; when the victim failed to give grooming soon after a conflict they received renewed aggression from the aggressor. We argue that post-conflict affiliation between former opponents can be better described as a trading of social services rather than coercion alone, as both animals obtain some benefits (i.e. grooming for the aggressor and relationship repair for the victim). Our study is the first to test the importance of social coercion in the aftermath of a conflict. Differences in competitive abilities can affect the exchange of services and the occurrence of social coercion in animal societies. This may also help explain the variance between populations and species in their social behaviour and conflict management strategies.	[McFarland, Richard; Majolo, Bonaventura] Lincoln Univ, Sch Psychol, Brayford Pool, Lincoln, England	University of Lincoln	McFarland, R (corresponding author), Lincoln Univ, Sch Psychol, Brayford Pool, Lincoln, England.	rmcfarland@lincoln.ac.uk		McFarland, Richard/0000-0001-8245-9269; Majolo, Bonaventura/0000-0002-0235-3040	University of Lincoln, UK	University of Lincoln, UK	This research project received financial support from the University of Lincoln, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F., 2000, NATURAL CONFLICT RES; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colmenares F, 2002, BEHAVIOUR, V139, P1525, DOI 10.1163/15685390260514753; DEWAAL FBM, 1996, MINDS GREAT APES, P80; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Hesler N, 2008, GESTURAL COMMUNICATI, P159; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Koski SE, 2007, AM J PRIMATOL, V69, P158, DOI 10.1002/ajp.20338; KOYAMA NF, 2000, NATURAL CONFLICT RES, P130; MAESTRIPIERI D, 1993, AM NAT, V141, P744, DOI 10.1086/285503; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Majolo B, 2009, ETHOLOGY, V115, P986, DOI 10.1111/j.1439-0310.2009.01685.x; Majolo B, 2009, ETHOLOGY, V115, P152, DOI 10.1111/j.1439-0310.2008.01591.x; McFarland R, 2011, ETHOLOGY, V117, P928, DOI 10.1111/j.1439-0310.2011.01948.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Parr LA, 1997, ANIM BEHAV, V54, P361, DOI 10.1006/anbe.1996.0419; Patzelt A, 2009, ETHOLOGY, V115, P658, DOI 10.1111/j.1439-0310.2009.01649.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2007, ETHOLOGY, V113, P1081, DOI 10.1111/j.1439-0310.2007.01407.x; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Silk JB, 1996, ANIM BEHAV, V52, P259, DOI 10.1006/anbe.1996.0171; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Thierry B., 2004, MACAQUE SOC MODEL ST; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682	37	21	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26893	10.1371/journal.pone.0026893	http://dx.doi.org/10.1371/journal.pone.0026893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046398	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000296519600075
J	Moorefield, EC; McKee, EE; Solchaga, L; Orlando, G; Yoo, JJ; Walker, S; Furth, ME; Bishop, CE				Moorefield, Emily C.; McKee, Elizabeth E.; Solchaga, Luis; Orlando, Guisseppe; Yoo, James J.; Walker, Steve; Furth, Mark E.; Bishop, Colin E.			Cloned, CD117 Selected Human Amniotic Fluid Stem Cells Are Capable of Modulating the Immune Response	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HUMAN MARROW; PROGENITOR CELLS; T-CELLS; BONE; INHIBIT; TRANSPLANTATION; ACTIVATION; THERAPY; DIFFERENTIATION	Amniotic fluid stem (AFS) cells are broadly multipotent, can be expanded extensively in culture, are not tumorigenic and can be readily cryopreserved for cell banking. Mesenchymal stem cells (MSC) show immunomodulatory activity and secrete a wide spectrum of cytokines and chemokines that suppress inflammatory responses, block mixed lymphocyte reactions (MLR) and other immune reactions, and have proven therapeutic against conditions such as graft-versus-host disease. AFS cells resemble MSCs in many respects including surface marker expression and differentiation potential. We therefore hypothesized that AFS cells may exhibit similar immunomodulatory capabilities. We present data to demonstrate that direct contact with AFS cells inhibits lymphocyte activation. In addition, we show that cell-free supernatants derived from AFS cells primed with total blood monocytes or IL-1 beta, a cytokine released by monocytes and essential in mediation of the inflammatory response, also inhibited lymphocyte activation. Further investigation of AFS cell-free supernatants by protein array revealed secretion of multiple factors in common with MSCs that are known to be involved in immune regulation including growth related oncogene (GRO) and monocyte chemotactic protein (MCP) family members as well as interleukin-6 (IL-6). AFS cells activated by PBMCs released several additional cytokines as compared to BM-MSCs, including macrophage inflammatory protein-3 alpha (MIP-3 alpha), MIP-1 alpha and Activin. AFS cells also released higher levels of MCP-1 and lower levels of MCP-2 compared to BM-MSCs in response to IL-1 beta activation. This suggests that there may be some AFS-specific mechanisms of inhibition of lymphocyte activation. Our results indicate that AFS cells are able to suppress inflammatory responses in vitro and that soluble factors are an essential component in the communication between lymphocytes and AFS cells. Their extensive self-renewal capacity, possibility for banking and absence of tumorigenicity may make AFS cells a superior source of stable, well characterized "off the shelf" immunomodulatory cells for a variety of immunotherapies.	[Moorefield, Emily C.; McKee, Elizabeth E.; Orlando, Guisseppe; Yoo, James J.; Walker, Steve; Furth, Mark E.; Bishop, Colin E.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Solchaga, Luis] Case Western Reserve Univ, Ctr Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Orlando, Guisseppe] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford, England	Wake Forest University; Case Western Reserve University; University of Oxford	Moorefield, EC (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	emooref@wfubmc.edu	Yoo, James J./L-4850-2017		National Instititues of Health [5R01HD060097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060097] Funding Source: NIH RePORTER	National Instititues of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Instititues of Health grant no. 5R01HD060097 ("Pluripotency of Amniotic Fluid-Derived Stem Cells") to CEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Betz AG, 2010, SCIENCE, V330, P1635, DOI 10.1126/science.1200406; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Chen SF, 2004, CHINESE MED J-PEKING, V117, P1443; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krishnaswamy G, 1999, J INTERF CYTOK RES, V19, P91, DOI 10.1089/107999099314234; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Liu Li-Hui, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P417; Ma Teng, 2010, World J Stem Cells, V2, P13, DOI 10.4252/wjsc.v2.i2.13; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; Mushtaq M, 2011, CIRC RES, V108, P398, DOI 10.1161/CIRCRESAHA.111.240218; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Sensebe L, 2009, TRANSPLANTATION, V87, pS49, DOI 10.1097/TP.0b013e3181a28635; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9	39	78	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26535	10.1371/journal.pone.0026535	http://dx.doi.org/10.1371/journal.pone.0026535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046303	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600028
J	Vitali, S; Glattfelder, JB; Battiston, S				Vitali, Stefania; Glattfelder, James B.; Battiston, Stefano			The Network of Global Corporate Control	PLOS ONE			English	Article							OWNERSHIP	The structure of the control network of transnational corporations affects global market competition and financial stability. So far, only small national samples were studied and there was no appropriate methodology to assess control globally. We present the first investigation of the architecture of the international ownership network, along with the computation of the control held by each global player. We find that transnational corporations form a giant bow-tie structure and that a large portion of control flows to a small tightly-knit core of financial institutions. This core can be seen as an economic "superentity" that raises new important issues both for researchers and policy makers.	[Vitali, Stefania; Glattfelder, James B.; Battiston, Stefano] ETH, Chair Syst Design, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vitali, S (corresponding author), ETH, Chair Syst Design, Zurich, Switzerland.	sbattiston@ethz.ch	Battiston, Stefano/I-2624-2012; Glattfelder, James B/B-4772-2012; /M-1612-2017	Battiston, Stefano/0000-0002-0051-973X; Glattfelder, James B/0000-0001-7767-3500; /0000-0002-0051-973X	ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH [CH1-01-08-2]; European Commission [255987]	ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge financial support from the ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH Research Grant CH1-01-08-2; the European Commission FP7 FET Open Project "FOC" No. 255987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesandri P, 2009, BANKING STATE SPEECH; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Atkinson Anthony, 2000, HDB INCOME DISTRIBUT; Baldone S., 1998, 4 JAFEE INT C INV DE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Battiston S, 2004, EUR PHYS J B, V38, P345, DOI 10.1140/epjb/e2004-00127-8; Battiston S., 2009, 15611 NBER; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; BRIOSCHI F, 1989, J BANK FINANC, V13, P747, DOI 10.1016/0378-4266(89)90040-X; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Dietzenbacher E, 2008, J ECON, V95, P189, DOI 10.1007/s00712-008-0018-y; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Garlaschelli D, 2007, NAT PHYS, V3, P813, DOI 10.1038/nphys729; Gilo D, 2006, RAND J ECON, V37, P81, DOI 10.1111/j.1756-2171.2006.tb00005.x; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Granovetter M, IND CORP CHANGE; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Kogut B, 2001, AM SOCIOL REV, V66, P317, DOI 10.2307/3088882; La Porta R, 1999, J FINANC, V54, P471, DOI 10.1111/0022-1082.00115; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; O'Brien DP, 2000, ANTITRUST LAW J, V67, P559; Santos JAC, 2006, J FINANC ECON, V80, P419, DOI 10.1016/j.jfineco.2005.03.011; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Stiglitz JE, 2010, 15718 NBER; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Williamson O.E., 1975, MARKETS HIERARCHIES	29	343	355	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e25995	10.1371/journal.pone.0025995	http://dx.doi.org/10.1371/journal.pone.0025995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046252	gold, Green Published, Green Submitted			2022-12-27	WOS:000296519600008
J	Maruvka, YE; Kessler, DA; Shnerb, NM				Maruvka, Yosef E.; Kessler, David A.; Shnerb, Nadav M.			The Birth-Death-Mutation Process: A New Paradigm for Fat Tailed Distributions	PLOS ONE			English	Article							POWER LAWS; NEUTRAL THEORY; EVOLUTION; POPULATION; EMERGENCE; ECOLOGY; RATES	Fat tailed statistics and power-laws are ubiquitous in many complex systems. Usually the appearance of of a few anomalously successful individuals (bio-species, investors, websites) is interpreted as reflecting some inherent "quality'' (fitness, talent, giftedness) as in Darwin's theory of natural selection. Here we adopt the opposite, "neutral'', outlook, suggesting that the main factor explaining success is merely luck. The statistics emerging from the neutral birth-death-mutation (BDM) process is shown to fit marvelously many empirical distributions. While previous neutral theories have focused on the power-law tail, our theory economically and accurately explains the entire distribution. We thus suggest the BDM distribution as a standard neutral model: effects of fitness and selection are to be identified by substantial deviations from it.	[Maruvka, Yosef E.; Kessler, David A.; Shnerb, Nadav M.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel	Bar Ilan University	Maruvka, YE (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	nadav.shnerb@gmail.com	Maruvka, Yosef/G-6261-2010; Kessler, David/B-1391-2008	Kessler, David/0000-0002-5279-1655; Maruvka, Yosef/0000-0002-8918-9887	EU; Israeli Ministry of science; Israeli Science Foundation [1026/11]	EU(European Commission); Israeli Ministry of science(Ministry of Science, Technology and Space (MOST), Israel); Israeli Science Foundation(Israel Science Foundation)	The authors were funded by an EU grant: the complexity pathfinder of NEST, by the Israeli Ministry of science TASHTIOT program, and by the Israeli Science Foundation BIKURA grant no. 1026/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HANBOOK MATH FUNCTIO, V55; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bisby F. A., 2009, SPECIES 2000 ITIS CA; Blank A, 2000, PHYSICA A, V287, P279, DOI 10.1016/S0378-4371(00)00464-7; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Darwin C, 1859, ORIGIN SPECIES MEANS; Frigyesi A, 2003, CANCER RES, V63, P7094; Gibrat R., 1931, INEGALITES EC; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell Stephen P., 2001, V32, pi; Kessler DA, 2007, J STAT PHYS, V127, P861, DOI 10.1007/s10955-007-9312-2; Kimura M, 1985, NEUTRAL THEORY MOL E; Manrubia SC, 2002, J THEOR BIOL, V216, P461, DOI 10.1006/jtbi.2002.3002; Maruvka YE, 2010, J THEOR BIOL, V262, P245, DOI 10.1016/j.jtbi.2009.09.022; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Raup D.M., 1992, EXTINCTION BAD GENES; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; Sean N, 2005, FUNCTIONAL ECOLOGY, V19, P173; SIMON HA, 1958, AM ECON REV, V48, P607; SIMON HA, 1955, BIOMETRIKA, V42, P425; Solomon S, 2002, EUR PHYS J B, V27, P257, DOI 10.1140/epjb/e20020152; Taleb N. N., 2010, BLACK SWAN, DOI DOI 10.1176/PS.2009.60.11.1564; Taleb NN, 2005, FOOLED RANDOMNESS HI; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P1224, DOI 10.1371/journal.pcbi.0030139; 2010, MITELMAN DATABASE CH	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26480	10.1371/journal.pone.0026480	http://dx.doi.org/10.1371/journal.pone.0026480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069453	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900015
J	Terahara, T; Chow, S; Kurogi, H; Lee, SH; Tsukamoto, K; Mochioka, N; Tanaka, H; Takeyama, H				Terahara, Takeshi; Chow, Seinen; Kurogi, Hiroaki; Lee, Sun-Hee; Tsukamoto, Katsumi; Mochioka, Noritaka; Tanaka, Hideki; Takeyama, Haruko			Efficiency of Peptide Nucleic Acid-Directed PCR Clamping and Its Application in the Investigation of Natural Diets of the Japanese Eel Leptocephali	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL DNA; ANGUILLA-JAPONICA; GUT CONTENTS; LARVAE; PNA; SEQUENCES; LENGTH; FEED	Polymerase chain reaction (PCR)-clamping using blocking primer and DNA-analogs, such as peptide nucleotide acid (PNA), may be used to selectively amplify target DNA for molecular diet analysis. We investigated PCR-clamping efficiency by studying PNA position and mismatch with complementary DNA by designing PNAs at five different positions on the nuclear rDNA internal transcribed spacer 1 of the Japanese eel Anguilla japonica in association with intra-specific nucleotide substitutions. All five PNAs were observed to efficiently inhibit amplification of a fully complementary DNA template. One mismatch between PNA and template DNA inhibited amplification of the template DNA, while two or more mismatches did not. DNA samples extracted from dorsal muscle and intestine of eight wild-caught leptochephalus larvae were subjected to this analysis, followed by cloning, nucleotide sequence analysis, and database homology search. Among 12 sequence types obtained from the intestine sample, six were identified as fungi. No sequence similarities were found in the database for the remaining six types, which were not related to one another. These results, in conjunction with our laboratory observations on larval feeding, suggest that eel leptocephali may not be dependent upon living plankton for their food source.	[Terahara, Takeshi; Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Chow, Seinen; Kurogi, Hiroaki] Natl Res Inst Aquaculture, Yokosuka, Kanagawa, Japan; [Lee, Sun-Hee] Dong A Univ, Pusan, South Korea; [Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Mochioka, Noritaka] Kyushu Univ, Fukuoka 812, Japan; [Tanaka, Hideki] Natl Res Inst Aquaculture, Tsu, Mie, Japan	Waseda University; Dong A University; University of Tokyo; Kyushu University; Japan Fisheries Research & Education Agency (FRA)	Terahara, T (corresponding author), Tokyo Univ Marine Sci & Technol, Minato Ku, Tokyo, Japan.	haruko-takeyama@waseda.jp		Chow, Seinen/0000-0001-9552-2669	Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Science, Sports and Culture [15380137]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Agriculture, Forestry and Fisheries of Japan and a Grant-in-Aid for Scientific Research on Priority Area (B), No. 15380137, from the Ministry of Education, Science, Sports and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Chow S, 2009, MAR BIOTECHNOL, V11, P301, DOI 10.1007/s10126-008-9153-2; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; FEIBELMAN T, 1994, MYCOL RES, V98, P614, DOI 10.1016/S0953-7562(09)80407-3; Govoni JJ, 2010, SCI MAR, V74, P339, DOI 10.3989/scimar.2010.74n2339; Igloi GL, 1998, P NATL ACAD SCI USA, V95, P8562, DOI 10.1073/pnas.95.15.8562; Inamadar A C, 2003, Indian J Dermatol Venereol Leprol, V69, P265; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; MOCHIOKA N, 1993, ENVIRON BIOL FISH, V36, P381, DOI 10.1007/BF00012416; Mochioka N, 1996, MAR BIOL, V125, P447; OTAKE T, 1993, MAR ECOL PROG SER, V92, P27, DOI 10.3354/meps092027; PFEILER E, 1986, ENVIRON BIOL FISH, V15, P3, DOI 10.1007/BF00005385; Ratilainen T, 2000, BIOCHEMISTRY-US, V39, P7781, DOI 10.1021/bi000039g; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Schulenburg JHGV, 2001, MOL BIOL EVOL, V18, P648, DOI 10.1093/oxfordjournals.molbev.a003845; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x	31	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e25715	10.1371/journal.pone.0025715	http://dx.doi.org/10.1371/journal.pone.0025715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069444	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900005
J	Grigoriadis, G; Vasanthakumar, A; Banerjee, A; Grumont, R; Overall, S; Gleeson, P; Shannon, F; Gerondakis, S				Grigoriadis, George; Vasanthakumar, Ajithkumar; Banerjee, Ashish; Grumont, Raelene; Overall, Sarah; Gleeson, Paul; Shannon, Frances; Gerondakis, Steve			c-Rel Controls Multiple Discrete Steps in the Thymic Development of Foxp3(+) CD4 Regulatory T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; LINEAGE COMMITMENT; CD28 COSTIMULATION; LYMPHOID-CELLS; TGF-BETA; EXPRESSION; INDUCTION; THYMOCYTES; SELECTION; RECEPTOR	The development of natural Foxp3(+) CD4 regulatory T cells (nTregs) proceeds via two steps that involve the initial antigen dependent generation of CD25(+)GITR(hi)Foxp3(+)CD4(+) nTreg precursors followed by the cytokine induction of Foxp3. Using mutant mouse models that lack c-Rel, the critical NF-kappa B transcription factor required for nTreg differentiation, we establish that c-Rel regulates both of these developmental steps. c-Rel controls the generation of nTreg precursors via a haplo-insufficient mechanism, indicating that this step is highly sensitive to c-Rel levels. However, maintenance of c-Rel in an inactive state in nTreg precursors demonstrates that it is not required for a constitutive function in these cells. While the subsequent IL-2 induction of Foxp3 in nTreg precursors requires c-Rel, this developmental transition does not coincide with the nuclear expression of c-Rel. Collectively, our results support a model of nTreg differentiation in which c-Rel generates a permissive state for foxp3 transcription during the development of nTreg precursors that influences the subsequent IL-2 dependent induction of Foxp3 without a need for c-Rel reactivation.	[Grigoriadis, George; Vasanthakumar, Ajithkumar; Banerjee, Ashish; Grumont, Raelene; Gerondakis, Steve] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Grigoriadis, George; Gerondakis, Steve] Monash Univ, Australian Ctr Blood Dis, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Grigoriadis, George; Gerondakis, Steve] Monash Univ, Dept Clin Hematol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Overall, Sarah; Gleeson, Paul] Univ Melbourne, Bio21, Parkville, Vic 3052, Australia; [Shannon, Frances] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Gerondakis, Steve] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia	Burnet Institute; Monash University; Monash University; University of Melbourne; Australian National University; John Curtin School of Medical Research; Monash University	Grigoriadis, G (corresponding author), Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia.	gerondakis@burnet.edu.au		VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781; Overall, Sarah/0000-0002-9906-2791	National Health and Medical Research Council, Australia [257502, 543141]; Leukemia and Lymphoma society [SCOR 7015]; Alfred Foundation; Hematology Society of Australia and New Zealand	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma society(Leukemia and Lymphoma Society); Alfred Foundation; Hematology Society of Australia and New Zealand	This work was supported by funding from National Health and Medical Research Council (Program 257502 and Project 543141, Australia, and the Leukemia and Lymphoma society (SCOR 7015). George Grigoriadis is supported by a scholarship from the Hematology Society of Australia and New Zealand and The Alfred Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Hsieh CS, 2009, IMMUNITY, V31, P852, DOI 10.1016/j.immuni.2009.11.006; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KahnPerles B, 1997, J BIOL CHEM, V272, P21774, DOI 10.1074/jbc.272.35.21774; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; MOORE NC, 1995, J IMMUNOL, V155, P4653; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2006, CURR TOP MICROBIOL, V305, P51, DOI 10.1007/3-540-29714-6_3; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2008, J CLIN IMMUNOL, V28, P640, DOI 10.1007/s10875-008-9240-1; Stankovic S, 2011, IMMUNOL CELL BIOL, V89, P294, DOI 10.1038/icb.2010.93; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	48	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26851	10.1371/journal.pone.0026851	http://dx.doi.org/10.1371/journal.pone.0026851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066012	gold, Green Published, Green Submitted			2022-12-27	WOS:000296916000028
J	Martinez-Abadias, N; Heuze, Y; Wang, YL; Jabs, EW; Aldridge, K; Richtsmeier, JT				Martinez-Abadias, Neus; Heuze, Yann; Wang, Yingli; Jabs, Ethylin Wang; Aldridge, Kristina; Richtsmeier, Joan T.			FGF/FGFR Signaling Coordinates Skull Development by Modulating Magnitude of Morphological Integration: Evidence from Apert Syndrome Mouse Models	PLOS ONE			English	Article							FGFR2; SHAPE; MODULARITY; ABNORMALITIES; CANALIZATION; ACTIVATION; MUTATIONS; SUTURE	The fibroblast growth factor and receptor system (FGF/FGFR) mediates cell communication and pattern formation in many tissue types (e. g., osseous, nervous, vascular). In those craniosynostosis syndromes caused by FGFR1-3 mutations, alteration of signaling in the FGF/FGFR system leads to dysmorphology of the skull, brain and limbs, among other organs. Since this molecular pathway is widely expressed throughout head development, we explore whether and how two specific mutations on Fgfr2 causing Apert syndrome in humans affect the pattern and level of integration between the facial skeleton and the neurocranium using inbred Apert syndrome mouse models Fgfr2(+/S252W) and Fgfr2(+/P253R) and their non-mutant littermates at P0. Skull morphological integration (MI), which can reflect developmental interactions among traits by measuring the intensity of statistical associations among them, was assessed using data from microCT images of the skull of Apert syndrome mouse models and 3D geometric morphometric methods. Our results show that mutant Apert syndrome mice share the general pattern of MI with their non-mutant littermates, but the magnitude of integration between and within the facial skeleton and the neurocranium is increased, especially in Fgfr2(+/S252W) mice. This indicates that although Fgfr2 mutations do not disrupt skull MI, FGF/FGFR signaling is a covariance-generating process in skull development that acts as a global factor modulating the intensity of MI. As this pathway evolved early in vertebrate evolution, it may have played a significant role in establishing the patterns of skull MI and coordinating proper skull development.	[Martinez-Abadias, Neus; Heuze, Yann; Richtsmeier, Joan T.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Wang, Yingli; Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Aldridge, Kristina] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Icahn School of Medicine at Mount Sinai; University of Missouri System; University of Missouri Columbia	Martinez-Abadias, N (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	jtr505@gmail.com	HEUZE, Yann/A-9371-2011; Martinez-Abadias, Neus/H-2029-2015	Martinez-Abadias, Neus/0000-0003-3061-2123; Heuze, Yann/0000-0002-0660-9613; Jabs, Ethylin/0000-0001-8983-5466; Aldridge, Kristina/0000-0003-3924-761X	National Institutes of Craniofacial and Dental Research (NIDCR), National Institutes of Health (NIH) [R01DE018500, 3R01DE018500-02S1]; Comissionat per a Universitats i Recerca (CUR), Generalitat de Catalunya, Spain [2008 BP A 00170]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018500, R01DE022988] Funding Source: NIH RePORTER	National Institutes of Craniofacial and Dental Research (NIDCR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Comissionat per a Universitats i Recerca (CUR), Generalitat de Catalunya, Spain(Generalitat de Catalunya); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institutes of Craniofacial and Dental Research (NIDCR), National Institutes of Health (NIH): R01DE018500 and 3R01DE018500-02S1. Comissionat per a Universitats i Recerca (CUR), Generalitat de Catalunya, Spain: 2008 BP A 00170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2010, DEV DYNAM, V239, P987, DOI 10.1002/dvdy.22218; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Hajihosseini Mohammad K., 2008, V12, P160, DOI 10.1159/000115037; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2006, EVOL DEV, V8, P61, DOI 10.1111/j.1525-142X.2006.05075.x; Hallgrimsson B, 2007, NOVART FDN SYMP, V284, P185; Hallgrimsson B, 2008, INTEGR COMP BIOL, V48, P373, DOI 10.1093/icb/icn076; Hallgrimsson Benedikt, 2007, Novartis Found Symp, V284, P164; Ibrahimi OA, 2005, PLAST RECONSTR SURG, V115, P264, DOI 10.1097/01.PRS.0000146703.08958.95; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jamniczky HA, 2009, EVOLUTION, V63, P1540, DOI 10.1111/j.1558-5646.2009.00651.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Lele SR, 2002, J AM STAT ASSOC, V97, P796, DOI 10.1198/016214502388618609; Martinez-Abadias N, 2010, DEV DYNAM, V239, P3058, DOI 10.1002/dvdy.22414; Martinez-Abadias N, 2009, EVOL BIOL, V36, P37, DOI 10.1007/s11692-008-9045-4; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Ornitz DM, 2001, GENOME BIOL, V2; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Richtsmeier JT, 2009, ORTHOD CRANIOFAC RES, V12, P149, DOI 10.1111/j.1601-6343.2009.01448.x; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Sperber GH, 2011, AM J MED GENET A, V155A, P280; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; Wang YL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-22; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Wilke TA, 1997, DEV DYNAM, V210, P41, DOI 10.1002/(SICI)1097-0177(199709)210:1<41::AID-AJA5>3.0.CO;2-1; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	37	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26425	10.1371/journal.pone.0026425	http://dx.doi.org/10.1371/journal.pone.0026425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053191	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800017
J	Wang, XF; Chen, Z; Wang, C; Yan, RX; Zhang, ZD; Song, JN				Wang, Xiao-Feng; Chen, Zhen; Wang, Chuan; Yan, Ren-Xiang; Zhang, Ziding; Song, Jiangning			Predicting Residue-Residue Contacts and Helix-Helix Interactions in Transmembrane Proteins Using an Integrative Feature-Based Random Forest Approach	PLOS ONE			English	Article							CORRELATED MUTATIONS; MEMBRANE-PROTEINS; SEARCH; CONSTRAINTS; INFORMATION; NETWORKS; SERVER; MAPS	Integral membrane proteins constitute 25-30% of genomes and play crucial roles in many biological processes. However, less than 1% of membrane protein structures are in the Protein Data Bank. In this context, it is important to develop reliable computational methods for predicting the structures of membrane proteins. Here, we present the first application of random forest (RF) for residue-residue contact prediction in transmembrane proteins, which we term as TMhhcp. Rigorous cross-validation tests indicate that the built RF models provide a more favorable prediction performance compared with two state-of-the-art methods, i.e., TMHcon and MEMPACK. Using a strict leave-one-protein-out jackknifing procedure, they were capable of reaching the top L/5 prediction accuracies of 49.5% and 48.8% for two different residue contact definitions, respectively. The predicted residue contacts were further employed to predict interacting helical pairs and achieved the Matthew's correlation coefficients of 0.430 and 0.424, according to two different residue contact definitions, respectively. To facilitate the academic community, the TMhhcp server has been made freely accessible at http://protein.cau.edu.cn/tmhhcp.	[Wang, Xiao-Feng; Chen, Zhen; Wang, Chuan; Yan, Ren-Xiang; Zhang, Ziding] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Song, Jiangning] Chinese Acad Sci, State Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Fac Med, Melbourne, Vic 3004, Australia	China Agricultural University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University	Wang, XF (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zidingzhang@cau.edu.cn; jiangning.song@monash.edu	Song, Jiangning/F-9787-2010; , zidingzhang/E-9320-2011; Wang, Chuan/B-7071-2012	Song, Jiangning/0000-0001-8031-9086; , zidingzhang/0000-0002-9296-571X; Wang, Chuan/0000-0001-5143-1714; Chen, Zhen/0000-0002-9412-9774	National Key Basic Research Project of China [2009CB918802]; State High Technology Development Program [2008AA02Z307]; Chinese Academy of Sciences (CAS); Tianjin Municipal Science & Technology Commission [10ZCKFSY05600]; National Health and Medical Research Council of Australia (NHMRC); CAS	National Key Basic Research Project of China(National Basic Research Program of China); State High Technology Development Program; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Tianjin Municipal Science & Technology Commission; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); CAS(Chinese Academy of Sciences)	This work was supported by grants from the National Key Basic Research Project of China (2009CB918802), the State High Technology Development Program (2008AA02Z307), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), Tianjin Municipal Science & Technology Commission (No. 10ZCKFSY05600) and the National Health and Medical Research Council of Australia (NHMRC). JS is an NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of the CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen P, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P703, DOI 10.1109/ICMLA.2008.74; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; DECHTER R, 1985, J ACM, V32, P505, DOI 10.1145/3828.3830; Doerr A, 2009, NAT METHODS, V6, P35, DOI 10.1038/NMETH.F.240; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fuchs A, 2009, PROTEINS, V74, P857, DOI 10.1002/prot.22194; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160; Han PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-8; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Lippi M, 2009, BIOINFORMATICS, V25, P2326, DOI 10.1093/bioinformatics/btp421; Liu Y, 2002, GENOME BIOL, V3; Lo A, 2009, BIOINFORMATICS, V25, P996, DOI 10.1093/bioinformatics/btp114; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Nugent T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000714; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Shao Y, 2003, PROTEINS, V53, P497, DOI 10.1002/prot.10539; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stevens TJ, 2001, PROTEIN SCI, V10, P2507, DOI 10.1110/ps.ps.10501; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Vullo A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-180; Wallin E, 1997, PROTEIN SCI, V6, P808; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Xue B, 2009, PROTEINS, V76, P176, DOI 10.1002/prot.22329; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26767	10.1371/journal.pone.0026767	http://dx.doi.org/10.1371/journal.pone.0026767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046350	gold, Green Published			2022-12-27	WOS:000299081800039
J	Cipriani, S; Mencarelli, A; Chini, MG; Distrutti, E; Renga, B; Bifulco, G; Baldelli, F; Donini, A; Fiorucci, S				Cipriani, Sabrina; Mencarelli, Andrea; Chini, Maria Giovanna; Distrutti, Eleonora; Renga, Barbara; Bifulco, Giuseppe; Baldelli, Franco; Donini, Annibale; Fiorucci, Stefano			The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis	PLOS ONE			English	Article							ENTEROENDOCRINE CELL-LINE; ACTIVATION; PERMEABILITY; DERIVATIVES; EXPRESSION; THERAPY; DISEASE; MICE	Background: GP-BAR1, a member G protein coupled receptor superfamily, is a cell surface bile acid-activated receptor highly expressed in the ileum and colon. In monocytes, ligation of GP-BAR1 by secondary bile acids results in a cAMP-dependent attenuation of cytokine generation. Aims: To investigate the role GP-BAR1 in regulating intestinal homeostasis and inflammation-driven immune dysfunction in rodent models of colitis. Methods: Colitis was induced in wild type and GP-BAR1(-/-) mice by DSS and TNBS administration. Potential GP-BAR1 agonists were identified by in silico screening and computational docking studies. Results: GP-BAR1(-/-) mice develop an abnormal morphology of colonic mucous cells and an altered molecular architecture of epithelial tight junctions with increased expression and abnormal subcellular distribution of zonulin 1 resulting in increased intestinal permeability and susceptibility to develop severe colitis in response to DSS at early stage of life. By in silico screening and docking studies we identified ciprofloxacin as a GP-BAR1 ligand. In monocytes, ciprofloxacin increases cAMP concentrations and attenuates TNF alpha release induced by TLR4 ligation in a GP-BAR1 dependent manner. Treating mice rendered colitic by TNBS with ciprofloxacin and oleanolic acid, a well characterized GP-BAR1 ligand, abrogates signs and symptoms of colitis. Colonic expression of GP-BAR1 mRNA increases in rodent models of colitis and tissues from Crohn's disease patients. Flow cytometry analysis demonstrates that approximate to 90% of CD14+ cells isolated from the lamina propria of TNBS-treated mice stained positively for GP-BAR1. Conclusions: GP-BAR1 regulates intestinal barrier structure. Its expression increases in rodent models of colitis and Crohn's disease. Ciprofloxacin is a GP-BAR1 ligand.	[Cipriani, Sabrina; Mencarelli, Andrea; Renga, Barbara; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Chini, Maria Giovanna; Bifulco, Giuseppe] Univ Salerno, Dipartimento Sci Farmaceut, I-84100 Salerno, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy; [Baldelli, Franco] Univ Perugia, Dipartimento Med & Sci Biochim, I-06100 Perugia, Italy; [Donini, Annibale] Univ Perugia, Dipartimento Sci Chirurg Radiol & Odontostomatol, Perugia, Italy	University of Perugia; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia; University of Perugia	Cipriani, S (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012; Chini, Maria Giovanna/C-8066-2014; Bifulco, Giuseppe/A-5413-2011; Donini, Annibale/G-2522-2011	Bifulco, Giuseppe/0000-0002-1788-5170; Chini, Maria Giovanna/0000-0002-3943-5883; Donini, Annibale/0000-0002-8846-7208				DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; HOV JR, 2010, PLOS ONE, P1; Hughes R, 2008, NUTR CANCER, V60, P259, DOI 10.1080/01635580701649644; Juillerat P, 2007, DIGESTION, V76, P161, DOI 10.1159/000111031; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Pellicciari R, 2007, J MED CHEM, V50, P4265, DOI 10.1021/jm070633p; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santucci L, 2005, GASTROENTEROLOGY, V128, P1243, DOI 10.1053/j.gastro.2005.01.051; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330	29	226	237	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e25637	10.1371/journal.pone.0025637	http://dx.doi.org/10.1371/journal.pone.0025637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046243	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400005
J	Hill, M; Deghmane, AE; Segovia, M; Zarantonelli, ML; Tilly, G; Blancou, P; Beriou, G; Josien, R; Anegon, I; Hong, E; Ruckly, C; Antignac, A; El Ghachi, M; Boneca, IG; Taha, MK; Cuturi, MC				Hill, Marcelo; Deghmane, Ala-Eddine; Segovia, Mercedes; Zarantonelli, Maria Leticia; Tilly, Gaelle; Blancou, Philippe; Beriou, Gaelle; Josien, Regis; Anegon, Ignacio; Hong, Eva; Ruckly, Corinne; Antignac, Aude; El Ghachi, Meriem; Boneca, Ivo Gomperts; Taha, Muhamed-Kheir; Cuturi, Maria Cristina			Penicillin Binding Proteins as Danger Signals: Meningococcal Penicillin Binding Protein 2 Activates Dendritic Cells through Toll-Like Receptor 4	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; IMMUNE-RESPONSE; CONJUGATE VACCINE; PEPTIDOGLYCAN; RECOGNITION; ANTIBODIES; TLR4; POLYSACCHARIDES; IMMUNOGENICITY; SUPPRESSION	Neisseria meningitidis is a human pathogen responsible for life-threatening inflammatory diseases. Meningococcal penicillin-binding proteins (PBPs) and particularly PBP2 are involved in bacterial resistance to beta-lactams. Here we describe a novel function for PBP2 that activates human and mouse dendritic cells (DC) in a time and dose-dependent manner. PBP2 induces MHC II (LOGEC50=4.7 mu g/ml +/- 0.1), CD80 (LOGEC50=4.88 mu g/ml +/- 0.15) and CD86 (LOGEC50=5.36 mu g/ml +/- 0.1). This effect was abolished when DCs were co-treated with anti-PBP2 antibodies. PBP2-treated DCs displayed enhanced immunogenic properties in vitro and in vivo. Furthermore, proteins co-purified with PBP2 showed no effect on DC maturation. We show through different in vivo and in vitro approaches that this effect is not due to endotoxin contamination. At the mechanistic level, PBP2 induces nuclear localization of p65 NF-kB of 70.7 +/- 5.1% cells versus 12 +/- 2.6% in untreated DCs and needs TLR4 expression to mature DCs. Immunoprecipitation and blocking experiments showed that PBP2 binds TLR4. In conclusion, we describe a novel function of meningococcal PBP2 as a pathogen associated molecular pattern (PAMP) at the host-pathogen interface that could be recognized by the immune system as a danger signal, promoting the development of immune responses.	[Hill, Marcelo; Segovia, Mercedes; Tilly, Gaelle; Beriou, Gaelle; Josien, Regis; Anegon, Ignacio; Cuturi, Maria Cristina] Univ Nantes, INSERM, U643, CHU Nantes,IUN,UMR 643, Nantes, France; [Hill, Marcelo] Univ Republica, Fac Med, Dept Inmunobiol, Montevideo, Uruguay; [Deghmane, Ala-Eddine; Zarantonelli, Maria Leticia; Hong, Eva; Ruckly, Corinne; Antignac, Aude; Taha, Muhamed-Kheir] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France; [Blancou, Philippe] Univ Nantes, Ecole Natl Vet, Inst Natl Rech Agron, Nantes, France; [El Ghachi, Meriem; Boneca, Ivo Gomperts] Inst Pasteur, Biol & Genet Bacterial Cell Wall Grp, Paris, France; [El Ghachi, Meriem; Boneca, Ivo Gomperts] INSERM, Biol & Genet Bacterial Cell Wall Grp Avenir, Paris, France; [Josien, Regis] CHU Nantes, Immunol Lab, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Hill, M (corresponding author), Univ Nantes, INSERM, U643, CHU Nantes,IUN,UMR 643, Nantes, France.	mhill@nantes.inserm.fr; mktaha@pasteur.fr	Josien, Regis/L-7468-2015; Anegon, Ignacio/I-7498-2018; Josien, Regis/U-4405-2019; Deghmane, Ala-Eddine/CAF-2140-2022; Anegon, Ignacio/I-7760-2018; Boneca, Ivo G/H-1677-2014; Blancou, Philippe/M-4149-2018	Josien, Regis/0000-0001-7900-7413; Boneca, Ivo G/0000-0001-8122-509X; Blancou, Philippe/0000-0003-0305-8622; Hill, Marcelo/0000-0002-1589-0320; Zarantonelli, Leticia/0000-0002-7170-6102	Institut Pasteur; Fondation Progreffe; IMBIO; ERC [202283]	Institut Pasteur(European Commission); Fondation Progreffe; IMBIO; ERC(European Research Council (ERC)European Commission)	This work is supported by the Institut Pasteur, Fondation Progreffe and IMBIO. Meriem El Ghachi was supported by a post-doctoral Roux Fellowship (Institut Pasteur). Work in the group of Ivo G. Boneca is supported by an ERC starting Grant (PGNfromSHAPEtoVIR n<SUP>o</SUP> 202283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignac A, 2003, J BIOL CHEM, V278, P31529, DOI 10.1074/jbc.M304607200; Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; AUSTRUP F, 1991, IMMUNOLOGY, V73, P508; BEUVERY EC, 1982, INFECT IMMUN, V37, P15, DOI 10.1128/IAI.37.1.15-22.1982; Dagan R, 1998, INFECT IMMUN, V66, P2093, DOI 10.1128/IAI.66.5.2093-2098.1998; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Fattom A, 1999, VACCINE, V17, P126, DOI 10.1016/S0264-410X(98)00162-5; Favali C, 2007, J LEUKOCYTE BIOL, V82, P1401, DOI 10.1189/jlb.0307187; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kolb-Maurer A, 2003, INT J MED MICROBIOL, V293, P241, DOI 10.1078/1438-4221-00266; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; NATO F, 1991, J CLIN MICROBIOL, V29, P1447, DOI 10.1128/JCM.29.7.1447-1452.1991; Neumann M, 2000, BLOOD, V95, P277; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Richmond P, 1999, VACCINE, V18, P641, DOI 10.1016/S0264-410X(99)00276-5; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; Richmond P, 2000, J INFECT DIS, V181, P761, DOI 10.1086/315284; Rico AI, 1998, INFECT IMMUN, V66, P347, DOI 10.1128/IAI.66.1.347-352.1998; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHUTZE MP, 1985, J IMMUNOL, V135, P2319; Senna JPM, 2003, VACCINE, V21, P2661, DOI 10.1016/S0264-410X(02)00738-7; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; Sundquist M, 2003, APMIS, V111, P715, DOI 10.1034/j.1600-0463.2003.11107804.x; TAHA MK, 1993, INFECT IMMUN, V61, P4662, DOI 10.1128/IAI.61.11.4662-4668.1993; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tsan MF, 2011, J LEUKOC BIOL; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zarantonelli ML, 2006, J ANTIMICROB CHEMOTH, V57, P924, DOI 10.1093/jac/dkl066; Zhu LX, 2004, WORLD J GASTROENTERO, V10, P2488, DOI 10.3748/wjg.v10.i17.2488	47	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e23995	10.1371/journal.pone.0023995	http://dx.doi.org/10.1371/journal.pone.0023995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046231	Green Published, gold			2022-12-27	WOS:000296521400002
J	Rodriguez, EE; Hernandez-Lemus, E; Itza-Ortiz, BA; Jimenez, I; Rudomin, P				Rodriguez, Erika E.; Hernandez-Lemus, Enrique; Itza-Ortiz, Benjamin A.; Jimenez, Ismael; Rudomin, Pablo			Multichannel Detrended Fluctuation Analysis Reveals Synchronized Patterns of Spontaneous Spinal Activity in Anesthetized Cats	PLOS ONE			English	Article							DORSAL-HORN NEURONS; BAND EEG ACTIVITY; GAMMA-BAND; INTERSEGMENTAL SYNCHRONIZATION; TIME-SERIES; CORD; OSCILLATIONS; AFFERENTS; NETWORKS	The analysis of the interaction and synchronization of relatively large ensembles of neurons is fundamental for the understanding of complex functions of the nervous system. It is known that the temporal synchronization of neural ensembles is involved in the generation of specific motor, sensory or cognitive processes. Also, the intersegmental coherence of spinal spontaneous activity may indicate the existence of synaptic neural pathways between different pairs of lumbar segments. In this study we present a multichannel version of the detrended fluctuation analysis method (mDFA) to analyze the correlation dynamics of spontaneous spinal activity (SSA) from time series analysis. This method together with the classical detrended fluctuation analysis (DFA) were used to find out whether the SSA recorded in one or several segments in the spinal cord of the anesthetized cat occurs either in a random or in an organized manner. Our results are consistent with a non-random organization of the sets of neurons involved in the generation of spontaneous cord dorsum potentials (CDPs) recorded either from one lumbar segment (DFA-alpha mean = 1.04 +/- 0.09) or simultaneously from several lumbar segments (mDFA-alpha mean = 1.01 +/- 0.06), where alpha=0.5 indicates randomness while alpha>0.5 indicates long-term correlations. To test the sensitivity of the mDFA method we also examined the effects of small spinal lesions aimed to partially interrupt connectivity between neighboring lumbosacral segments. We found that the synchronization and correlation between the CDPs recorded from the L5 and L6 segments in both sides of the spinal cord were reduced when a lesion comprising the left dorsal quadrant was performed between the segments L5 and L6 (mDFA-alpha=0.992 as compared to initial conditions mDFA-alpha=1.186). The synchronization and correlation were reduced even further after a similar additional right spinal lesion (mDFA-alpha=0.924). In contrast to the classical methods, such as correlation and coherence quantification that define a relation between two sets of data, the mDFA method properly reveals the synchronization of multiple groups of neurons in several segments of the spinal cord. This method is envisaged as a useful tool to characterize the structure of higher order ensembles of cord dorsum spontaneous potentials after spinal cord or peripheral nerve lesions.	[Rodriguez, Erika E.; Jimenez, Ismael; Rudomin, Pablo] Ctr Res & Adv Studies CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico; [Rodriguez, Erika E.; Itza-Ortiz, Benjamin A.] Autonomous Univ Hidalgo UAEH, Ctr Res Math, Pachuca, Mexico; [Hernandez-Lemus, Enrique] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma del Estado de Hidalgo; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Rodriguez, EE (corresponding author), Ctr Res & Adv Studies CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx; rudomin@fisio.cinvestav.mx	Torres, Erika Elizabeth Rodríguez/A-3843-2019	Torres, Erika Elizabeth Rodríguez/0000-0002-7738-1863; Hernandez-Lemus, Enrique/0000-0002-1872-1397; Itza-Ortiz, Benjamin A./0000-0002-6189-3266	NIH [NS09196]; CONACYT [50900]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by NIH (www.nih.gov) under grant NS09196 and by CONACYT (www.conacyt.mx) under grant 50900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi C, 2000, NEUROREPORT, V11, P689, DOI 10.1097/00001756-200003200-00007; BREMER F., 1941, ARCH INTERNAT PHYSIOL, V51, P51, DOI 10.3109/13813454109145564; Chavez D, 2011, J PHYSL UNPUB; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERTEKIN C, 1983, ELECTROEN CLIN NEURO, V55, P13, DOI 10.1016/0013-4694(83)90142-6; Feder J, 1988, FRACTALS; Garcia CA, 2004, NEUROSCI LETT, V361, P102, DOI 10.1016/j.neulet.2003.12.068; Gerasimenko YP, 2001, B ESP BIOL MED, V11, P575; Gifani P, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6225; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Holste D, 2005, PHYS REV E, V71; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; KASPRZAK H, 1970, BRAIN RES, V22, P207, DOI 10.1016/0006-8993(70)90005-3; KERKUT GA, 1995, PROG NEUROBIOL, V46, P1, DOI 10.1016/0301-0082(94)00055-M; Lidierth M, 1996, NEUROSCI LETT, V220, P25, DOI 10.1016/S0304-3940(96)13231-6; Manjarrez E, 2003, EXP BRAIN RES, V148, P401, DOI 10.1007/s00221-002-1303-6; Manjarrez E, 2000, J PHYSIOL-LONDON, V529, P445, DOI 10.1111/j.1469-7793.2000.00445.x; MARK VH, 1953, ELECTROEN CLIN NEURO, V5, P251, DOI 10.1016/0013-4694(53)90012-1; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Muller MM, 1999, CLIN NEUROPHYSIOL, V110, P1913, DOI 10.1016/S1388-2457(99)00151-0; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PULVERMULLER F, 1995, NEUROREPORT, V6, P2059, DOI 10.1097/00001756-199510010-00025; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rosas A, 2002, PHYS REV E, V66, P1; Rudomin P, 2007, EXP BRAIN RES, V176, P98, DOI 10.1007/s00221-006-0600-x; Telesca L, 2007, PHYSICA A, V377, P279, DOI 10.1016/j.physa.2006.10.092; TENCATE J, 1950, ELECTROEN CLIN NEURO, V2, P445, DOI 10.1016/0013-4694(50)90080-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748	33	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26449	10.1371/journal.pone.0026449	http://dx.doi.org/10.1371/journal.pone.0026449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046288	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400021
J	Yu, L; Jin, W; Zhang, X; Wang, D; Zheng, JS; Yang, G; Xu, SX; Cho, S; Zhang, YP				Yu, Li; Jin, Wei; Zhang, Xin; Wang, Ding; Zheng, Jin-song; Yang, Guang; Xu, Shi-xia; Cho, Soochin; Zhang, Ya-ping			Evidence for Positive Selection on the Leptin Gene in Cetacea and Pinnipedia	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; EPISODIC EVOLUTION; POTENTIAL ROLE; MESSENGER-RNA; BONE-MARROW; BODY-WEIGHT; OBESE GENE; SEAL PUPS; RECEPTOR; EXPRESSION	The leptin gene has received intensive attention and scientific investigation for its importance in energy homeostasis and reproductive regulation in mammals. Furthermore, study of the leptin gene is of crucial importance for public health, particularly for its role in obesity, as well as for other numerous physiological roles that it plays in mammals. In the present work, we report the identification of novel leptin genes in 4 species of Cetacea, and a comparison with 55 publicly available leptin sequences from mammalian genome assemblies and previous studies. Our study provides evidence for positive selection in the suborder Odontoceti (toothed whales) of the Cetacea and the family Phocidae (earless seals) of the Pinnipedia. We also detected positive selection in several leptin gene residues in these two lineages. To test whether leptin and its receptor evolved in a coordinated manner, we analyzed 24 leptin receptor gene (LPR) sequences from available mammalian genome assemblies and other published data. Unlike the case of leptin, our analyses did not find evidence of positive selection for LPR across the Cetacea and Pinnipedia lineages. In line with this, positively selected sites identified in the leptin genes of these two lineages were located outside of leptin receptor binding sites, which at least partially explains why co-evolution of leptin and its receptor was not observed in the present study. Our study provides interesting insights into current understanding of the evolution of mammalian leptin genes in response to selective pressures from life in an aquatic environment, and leads to a hypothesis that new tissue specificity or novel physiologic functions of leptin genes may have arisen in both odontocetes and phocids. Additional data from other species encompassing varying life histories and functional tests of the adaptive role of the amino acid changes identified in this study will help determine the factors that promote the adaptive evolution of the leptin genes in marine mammals.	[Yu, Li; Jin, Wei; Zhang, Xin; Zhang, Ya-ping] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China; [Yu, Li; Jin, Wei; Zhang, Xin; Zhang, Ya-ping] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming 650091, Peoples R China; [Wang, Ding; Zheng, Jin-song] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Yang, Guang; Xu, Shi-xia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Peoples R China; [Yang, Guang; Xu, Shi-xia] Nanjing Normal Univ, Coll Life Sci, Inst Genet Resources, Nanjing, Peoples R China; [Cho, Soochin] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Zhang, Ya-ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Yunnan University; Yunnan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Nanjing Normal University; Nanjing Normal University; Creighton University; Chinese Academy of Sciences; Kunming Institute of Zoology	Yu, L (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China.	yuli1220@yahoo.com.cn; zhangyp@mail.kiz.ac.cn			State Key Basic Research and Development Plan [2007CB411600]; National Natural Science Foundation of China [U0836603]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the State Key Basic Research and Development Plan (2007CB411600) and National Natural Science Foundation of China (U0836603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnould JPY, 2002, J COMP PHYSIOL B, V172, P27; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Beck RMD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-93; Benner SA, 2000, RES MICROBIOL, V151, P97, DOI 10.1016/S0923-2508(00)00123-6; Benner SA, 1998, ADV ENZYME REGUL, V38, P155, DOI 10.1016/S0065-2571(97)00019-8; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; Benner SA, 2001, TRENDS GENET, V17, P414, DOI 10.1016/S0168-9525(01)02320-4; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; BERTA A, 2006, MARINE MAMMALS EVOLU; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Cioffi JA, 1996, NAT MED, V2, P585, DOI 10.1038/nm0596-585; Considine RV, 1997, INT J BIOCHEM CELL B, V29, P1255, DOI 10.1016/S1357-2725(97)00050-2; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; FRIEDMAN JM, 1991, ANN NY ACAD SCI, V630, P100, DOI 10.1111/j.1749-6632.1991.tb19579.x; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gatesy John, 2009, P511; Gaucher EA, 2003, GENETICS, V163, P1549; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Guilherme C, 2004, GEN COMP ENDOCR, V139, P137, DOI 10.1016/j.ygcen.2004.09.003; Gurun G, 2001, FASEB J, V15, pA414; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hammond JA, 2005, AM J PHYSIOL-REG I, V289, pR545, DOI 10.1152/ajpregu.00203.2004; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; HeideJorgensen MP, 1995, CAN J ZOOL, V73, P2120, DOI 10.1139/z95-249; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Hoelzel R A, 2002, MARINE MAMMAL BIOL E; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Kapitonov VV, 1999, J MOL EVOL, V48, P248, DOI 10.1007/PL00013153; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Laharrague P, 1998, FASEB J, V12, P747, DOI 10.1096/fasebj.12.9.747; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li Y, 2005, J MOL ENDOCRINOL, V35, P411, DOI 10.1677/jme.1.01798; Liberles D.A., 2001, GENOME BIOL, V2; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Liu JC, 2001, MOL BIOL EVOL, V18, P945, DOI 10.1093/oxfordjournals.molbev.a003895; Martin AR, 1999, CAN J ZOOL, V77, P1783, DOI 10.1139/cjz-77-11-1783; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nielsen R, 1998, GENETICS, V148, P929; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; Ortiz RM, 2003, GEN COMP ENDOCR, V130, P78, DOI 10.1016/S0016-6480(02)00572-5; Ortiz RM, 2001, AM J PHYSIOL-REG I, V280, pR790, DOI 10.1152/ajpregu.2001.280.3.R790; Ortiz RM, 2001, AM J PHYSIOL-ENDOC M, V281, pE1347, DOI 10.1152/ajpendo.2001.281.6.E1347; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perrin WF, 2002, ENCY MARINE MAMMALS; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rea LD, 2000, P COMP NUTR SOC, V3, P171; Sambrook J., 2001, MOL CLONING LAB MANU; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Senaris R, 1997, ENDOCRINOLOGY, V138, P4501, DOI 10.1210/en.138.10.4501; Siltberg J, 2002, J EVOLUTION BIOL, V15, P588, DOI 10.1046/j.1420-9101.2002.00416.x; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Vogel P, 2005, PLACENTA, V26, P591, DOI 10.1016/j.placenta.2004.11.005; Wang MY, 1996, FEBS LETT, V392, P87, DOI 10.1016/0014-5793(96)00790-9; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; WHITTOW GC, 1987, MAR MAMMAL SCI, V3, P220, DOI 10.1111/j.1748-7692.1987.tb00165.x; WORTHY GAJ, 1983, CAN J ZOOL, V61, P447, DOI 10.1139/z83-059; Yang J, 2006, BIOCHEM BIOPH RES CO, V345, P1405, DOI 10.1016/j.bbrc.2006.05.052; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOUNG RA, 1976, AM ZOOL, V16, P699; Yu L, 2010, MOL BIOL EVOL, V27, P1467, DOI 10.1093/molbev/msq027; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	93	13	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26579	10.1371/journal.pone.0026579	http://dx.doi.org/10.1371/journal.pone.0026579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046310	gold, Green Submitted, Green Published			2022-12-27	WOS:000296521400027
J	Dacquin, R; Domenget, C; Kumanogoh, A; Kikutani, H; Jurdic, P; Machuca-Gayet, I				Dacquin, Romain; Domenget, Chantal; Kumanogoh, Atsushi; Kikutani, Hitoshi; Jurdic, Pierre; Machuca-Gayet, Irma			Control of Bone Resorption by Semaphorin 4D Is Dependent on Ovarian Function	PLOS ONE			English	Article							OSTEOCLAST FUNCTION; MINERAL DENSITY; FRACTURE RISK; MOUSE OVARY; MICE; ACTIVATION; SEMA4D; MASS; POLYMORPHISMS; ANGIOGENESIS	Osteoporosis is one of the most common bone pathologies, which are characterized by a decrease in bone mass. It is well established that bone mass, which results from a balanced bone formation and bone resorption, is regulated by many hormonal, environmental and genetic factors. Here we report that the immune semaphorin 4D (Sema4D) is a novel factor controlling bone resorption. Sema4D-deficient primary osteoclasts showed impaired spreading, adhesion, migration and resorption due to altered beta 3 integrin sub-unit downstream signaling. In apparent accordance with these in vitro results, Sema4D deletion in sexually mature female mice led to a high bone mass phenotype due to defective bone resorption by osteoclasts. Mutant males, however, displayed normal bone mass and the female osteopetrotic phenotype was only detected at the onset of sexual maturity, indicating that, in vivo, this intrinsic osteoclast defect might be overcome in these mice. Using bone marrow cross transplantation, we confirmed that Sema4D controls bone resorption through an indirect mechanism. In addition, we show that Sema4D -/- mice were less fertile than their WT littermates. A decrease in Gnrh1 hypothalamic expression and a reduced number of ovarian follicles can explain this attenuated fertility. Interestingly, ovariectomy abrogated the bone resorption phenotype in Sema4D -/- mice, providing the evidence that the observed high bone mass phenotype is strictly dependent on ovarian function. Altogether, this study reveals that, in vivo, Sema4D is an indirect regulator of bone resorption, which acts via its effect on reproductive function.	[Dacquin, Romain; Domenget, Chantal; Jurdic, Pierre; Machuca-Gayet, Irma] Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Lyon, France; [Kumanogoh, Atsushi; Kikutani, Hitoshi] Osaka Univ, Dept Immunopathol, Microbial Dis Res Inst, Osaka, Japan	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Osaka University	Dacquin, R (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Lyon, France.	imachuca@ens-lyon.fr		Machuca- Gayet, irma/0000-0002-3010-9774	ARC (Association pour la Recherche contre le Cancer)	ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by a grant and a fellowship from ARC (Association pour la Recherche contre le Cancer). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allan CM, 2006, J ENDOCRINOL, V188, P549, DOI 10.1677/joe.1.06614; ALLAN CM, P NATL ACAD SCI US, V107, P22629; Anginot A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000585; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Delorme G, 2005, BIOL CELL, V97, P589; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Gaddy Dana, 2008, Curr Osteoporos Rep, V6, P51, DOI 10.1007/s11914-008-0009-5; Giacobini P, 2008, J CELL BIOL, V183, P555, DOI 10.1083/jcb.200806160; Hwang JY, 2006, OSTEOPOROSIS INT, V17, P1592, DOI 10.1007/s00198-006-0126-x; Katsoff B, 2008, CLIN EXP OBSTET GYN, V35, P147; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; Koh JM, 2006, J HUM GENET, V51, P112, DOI 10.1007/s10038-005-0331-z; LI JY, P NATL ACAD SCI US, V108, P768; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3; Nicks KM, 2010, ANN NY ACAD SCI, V1192, P153, DOI 10.1111/j.1749-6632.2009.05349.x; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Regev A, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-12; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Touraine P, 2010, ANN ENDOCRINOL-PARIS, V71, P203, DOI 10.1016/j.ando.2010.02.023; Wannemacher KM, 2010, BLOOD, V116, P5707, DOI 10.1182/blood-2010-04-279943; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104	35	57	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26627	10.1371/journal.pone.0026627	http://dx.doi.org/10.1371/journal.pone.0026627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046317	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600036
J	Dahe, GJ; Kadam, SS; Sabale, SS; Kadam, DP; Sarkate, LB; Bellare, JR				Dahe, Ganpat J.; Kadam, Sachin S.; Sabale, Siddharth S.; Kadam, Dattatray P.; Sarkate, Laxman B.; Bellare, Jayesh R.			In Vivo Evaluation of the Biocompatibility of Surface Modified Hemodialysis Polysulfone Hollow Fibers in Rat	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; DIALYSIS MEMBRANE; HEMOCOMPATIBILITY; SUCCINATE; MARKER	Polysulfone (Psf) hollow fiber membranes (HFMs) have been widely used in blood purification but their biocompatibility remains a concern. To enhance their biocompatibility, Psf/TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) composite HFMs and 2-methacryloyloxyethyl phosphorylcholine (MPC) coated Psf HFMs have been prepared. They have been evaluated for in vivo biocompatibility and graft acceptance and compared with sham and commercial membranes by intra-peritoneal implantation in rats at day 7 and 21. Normal body weights, tissue formation and angiogenesis indicate acceptance of implants by the animals. Hematological observations show presence of post-surgical stress which subsides over time. Serum biochemistry results reveal normal organ function and elevated liver ALP levels at day 21. Histological studies exhibit fibroblast recruitment cells, angiogenesis and collagen deposition at the implant surface indicating new tissue formation. Immuno-histochemistry studies show non-activation of MHC molecules signifying biocompatibilty. Additionally, Psf/TPGS exhibit most favorable tissue response as compared with other HFMs making them the material of choice for HFM preparation for hemodialysis applications.	[Dahe, Ganpat J.; Kadam, Sachin S.; Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India; [Sabale, Siddharth S.; Kadam, Dattatray P.] Bombay Vet Coll, Dept Vet Pathol, Bombay, Maharashtra, India; [Sarkate, Laxman B.] Bombay Vet Coll, Dept Surg & Radiol, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Maharashtra Animal & Fishery Sciences University; Maharashtra Animal & Fishery Sciences University	Dahe, GJ (corresponding author), Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India.	jb@iitb.ac.in	Dahe, Ganpat/N-3585-2013; Bellare, Jayesh/AAO-8713-2020; Kadam, Sachin/E-5050-2010	Bellare, Jayesh/0000-0002-6792-8327; Kadam, Sachin/0000-0002-9937-4736	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research was supported by the Department of Science and Technology, Government of India (www.dst.gov.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaslan G, 1997, J ORAL MAXIL SURG, V55, P56, DOI 10.1016/S0278-2391(97)90447-X; ANDORSON JM, 2004, BIOMATERIALS SCI INT, P296; Bolliger AP., 2010, SCHALMS VET HEMATOLO, P852; CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150; Clark WR, 2002, CONTRIB NEPHROL, V137, P70; Dahe GJ, 2011, BIOMATERIALS, V32, P352, DOI 10.1016/j.biomaterials.2010.09.005; HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272; ISHIHARA K, 1994, ARTIF ORGANS, V18, P559, DOI 10.1111/j.1525-1594.1994.tb03379.x; Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3; Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057; KELLER JC, 1984, J BIOMED MATER RES, V18, P829, DOI 10.1002/jbm.820180713; Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027; Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003; LUNA GL, 1968, MANUAL HISTOLOGIC ST, P82; Oczenski W, 2003, INTENS CARE MED, V29, P1253, DOI 10.1007/s00134-003-1826-8; Pastan S, 1998, NEW ENGL J MED, V338, P1428, DOI 10.1056/NEJM199805143382006; SCHIFFL H, 1994, LANCET, V344, P570, DOI 10.1016/S0140-6736(94)91964-X; Sheehan D., 1980, THEORY PRACTICE HIST, P189; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sirolli V, 2002, INT J ARTIF ORGANS, V25, P529, DOI 10.1177/039139880202500607; SORG DA, 1964, P SOC EXP BIOL MED, V115, P1131, DOI 10.3181/00379727-115-29134; Subramanian S, 2002, KIDNEY INT, V62, P1819, DOI 10.1046/j.1523-1755.2002.00608.x; TRABER MG, 1988, AM J CLIN NUTR, V48, P605, DOI 10.1093/ajcn/48.3.605; Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5; Williams D. F, 1986, P CONS C EUR SOC BIO; Yan A, 2007, CARBON, V45, P2463, DOI 10.1016/j.carbon.2007.08.035; 1999, 1099351999 ISO, P1; 2003, 1099312003 ISO, P1	28	24	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25236	10.1371/journal.pone.0025236	http://dx.doi.org/10.1371/journal.pone.0025236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046236	Green Published, gold, Green Submitted			2022-12-27	WOS:000296517000003
J	Haring, M; Kaiser, N; Monory, K; Lutz, B				Haering, Martin; Kaiser, Nadine; Monory, Krisztina; Lutz, Beat			Circuit Specific Functions of Cannabinoid CB1 Receptor in the Balance of Investigatory Drive and Exploration	PLOS ONE			English	Article							SOCIAL PLAY-BEHAVIOR; ENDOCANNABINOID SYSTEM; RECOGNITION MEMORY; ADOLESCENT; ANXIETY; ENHANCEMENT; DYSFUNCTION; MODULATION; EXPRESSION; PREFERENCE	Well balanced novelty seeking and exploration are fundamental behaviours for survival and are found to be dysfunctional in several psychiatric disorders. Recent studies suggest that the endocannabinoid (eCB) system is an important control system for investigatory drive. Pharmacological treatment of rodents with cannabinergic drugs results in altered social and object investigation. Interestingly, contradictory results have been obtained, depending on the treatment, drug concentration and experimental conditions. The cannabinoid type 1 (CB1) receptor, a central component of the eCB system, is predominantly found at the synapses of two opposing neuronal populations, i.e. on inhibitory GABAergic and excitatory glutamatergic neurons. In the present study, using different transgenic mouse lines, we aimed at investigating the impact of CB1 receptor inactivation in glutamatergic or GABAergic neurons on investigatory behaviour. We evaluated animate (interaction partner) and inanimate (object) exploratory behaviour in three different paradigms. We show that exploration was increased when CB1 receptor was deleted from cortical and striatal GABAergic neurons. No effect was observed when CB1 receptor was deleted specifically from dopamine receptor D1-expressing striatal GABAergic medium spiny neurons. In contrast, deletion of CB1 receptor from cortical glutamatergic neurons resulted in a decreased exploration. Thus, our results indicate that exploratory behaviour is accurately balanced in both, the social and non-social context, by the eCB system via CB1 receptor activation on cortical glutamatergic and GABAergic neurons. In addition, the results could explain the contradictory findings of previous pharmacological studies and could further suggest a possibility to readjust an imbalance in exploratory behaviour observed in psychiatric disorders.	[Haering, Martin; Kaiser, Nadine; Monory, Krisztina; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany	Johannes Gutenberg University of Mainz	Haring, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany.	blutz@uni-mainz.de	Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022		Deutsche Forschungsgemeinschaft DFG [FOR926, SPP1226]; University Medical Center of the Johannes Gutenberg University Mainz	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University Medical Center of the Johannes Gutenberg University Mainz	This work was supported by research grants from the Deutsche Forschungsgemeinschaft DFG (to B. L., FOR926, SPP1226), and by the University Medical Center of the Johannes Gutenberg University Mainz. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai N, 2011, NEUROPHARMACOLOGY, V69, P875; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Del Arco A, 2011, PSYCHOPHARMACOLOGY, V214, P525, DOI 10.1007/s00213-010-2055-9; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GOYENS J, 1975, DEV PSYCHOBIOL, V8, P79, DOI 10.1002/dev.420080111; Guidali C, 2011, INT J NEUROPSYCHOPH, V14, P17, DOI 10.1017/S1461145710000209; Haller J, 2004, EUR J NEUROSCI, V19, P1906, DOI 10.1111/j.1460-9568.2004.03293.x; Hill MN, 2005, EUR NEUROPSYCHOPHARM, V15, P593, DOI 10.1016/j.euroneuro.2005.03.003; Jacob W, 2009, GENES BRAIN BEHAV, V8, P685, DOI 10.1111/j.1601-183X.2009.00512.x; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawa R, 2010, ACTA NEUROBIOL EXP, V70, P131; Lafenetre P, 2009, NEUROPHARMACOLOGY, V57, P715, DOI 10.1016/j.neuropharm.2009.07.014; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2009, CURR TOP BEHAV NEURO, V1, P201, DOI 10.1007/978-3-540-88955-7_8; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Newcorn J H, 2001, Curr Psychiatry Rep, V3, P87, DOI 10.1007/s11920-001-0004-3; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Sala M, 2011, BIOL PSYCHIAT, V69, P875, DOI 10.1016/j.biopsych.2010.12.022; Schneider M, 2008, ADDICT BIOL, V13, P345, DOI 10.1111/j.1369-1600.2008.00117.x; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P54, DOI 10.1016/j.psyneuen.2007.09.008; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; THOR DH, 1976, BEHAV BIOL, V17, P237, DOI 10.1016/S0091-6773(76)90546-0; Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x; Trezza V, 2008, EUR NEUROPSYCHOPHARM, V18, P519, DOI 10.1016/j.euroneuro.2008.03.001; Trezza V, 2008, PSYCHOPHARMACOLOGY, V197, P217, DOI 10.1007/s00213-007-1025-3; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Viveros MP, 2005, PHARMACOL BIOCHEM BE, V81, P331, DOI 10.1016/j.pbb.2005.01.029	40	53	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26617	10.1371/journal.pone.0026617	http://dx.doi.org/10.1371/journal.pone.0026617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069458	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900020
J	Kato, I; Niwa, A; Heike, T; Fujino, H; Saito, MK; Umeda, K; Hiramatsu, H; Ito, M; Morita, M; Nishinaka, Y; Adachi, S; Ishikawa, F; Nakahata, T				Kato, Itaru; Niwa, Akira; Heike, Toshio; Fujino, Hisanori; Saito, Megumu K.; Umeda, Katsutsugu; Hiramatsu, Hidefumi; Ito, Mamoru; Morita, Makiko; Nishinaka, Yoko; Adachi, Souichi; Ishikawa, Fumihiko; Nakahata, Tatsutoshi			Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MOUSE MODEL; STROMAL CELLS; CHEMOTHERAPY; EXPRESSION; SURVIVAL; MICE; AML; ADHESION	In acute lymphoblastic leukemia (ALL) patients, the bone marrow niche is widely known to be an important element of treatment response and relapse. Furthermore, a characteristic liver pathology observed in ALL patients implies that the hepatic microenvironment provides an extramedullary niche for leukemic cells. However, it remains unclear whether the liver actually provides a specific niche. The mechanism underlying this pathology is also poorly understood. Here, to answer these questions, we reconstituted the histopathology of leukemic liver by using patients-derived primary ALL cells into NOD/SCID/Yc(null) mice. The liver pathology in this model was similar to that observed in the patients. By using this model, we clearly demonstrated that bile duct epithelial cells form a hepatic niche that supports infiltration and proliferation of ALL cells in the liver. Furthermore, we showed that functions of the niche are maintained by the SDF-1/CXCR4 axis, proposing a novel therapeutic approach targeting the extramedullary niche by inhibition of the SDF-1/CXCR4 axis. In conclusion, we demonstrated that the liver dissemination of leukemia is not due to nonselective infiltration, but rather systematic invasion and proliferation of leukemic cells in hepatic niche. Although the contribution of SDF-1/CXCR4 axis is reported in some cancer cells or leukemic niches such as bone marrow, we demonstrated that this axis works even in the extramedullary niche of leukemic cells. Our findings form the basis for therapeutic approaches that target the extramedullary niche by inhibiting the SDF-1/CXCR4 axis.	[Kato, Itaru; Niwa, Akira; Saito, Megumu K.; Nakahata, Tatsutoshi] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Kato, Itaru; Niwa, Akira; Heike, Toshio; Fujino, Hisanori; Saito, Megumu K.; Hiramatsu, Hidefumi; Nakahata, Tatsutoshi] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto 606, Japan; [Umeda, Katsutsugu] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell Res, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX USA	Kyoto University; Kyoto University; University of Texas System; University of Texas Health Science Center Houston	Kato, I (corresponding author), Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	tnakaha@kuhp.kyoto-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [19109006]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [11J03388] Funding Source: KAKEN	Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) (19109006) from the Ministry of Education, Science, Technology, Sports and Culture of Japan, and Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALASTAIR D, 2007, MACSWEENS PATHOLOGY; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Chang H, 2004, LEUKEMIA RES, V28, P1007, DOI 10.1016/j.leukres.2004.01.006; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Fujino H, 2007, FASEB J, V21, P3499, DOI 10.1096/fj.06-6109com; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Juarez J, 2007, LEUKEMIA, V21, P1249, DOI 10.1038/sj.leu.2404684; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kawaguchi A, 2009, BLOOD, V114, P2961, DOI 10.1182/blood-2008-11-189308; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kong Y, 2008, LEUKEMIA, V22, P1207, DOI 10.1038/leu.2008.83; Kucia M, 2004, J MOL HISTOL, V35, P233; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Lee Y, 2002, BLOOD, V99, P4307, DOI 10.1182/blood.V99.12.4307; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; MANABE A, 1994, BLOOD, V83, P758; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; WINICK NJ, 1993, J CLIN ONCOL, V11, P271, DOI 10.1200/JCO.1993.11.2.271; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	40	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27042	10.1371/journal.pone.0027042	http://dx.doi.org/10.1371/journal.pone.0027042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069486	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900047
J	Qin, YY; Li, H; Guo, XJ; Ye, XF; Wei, X; Zhou, YH; Zhang, XJ; Wang, C; Qian, W; Lu, J; He, J				Qin, Ying-Yi; Li, Hui; Guo, Xiao-Jing; Ye, Xiao-Fei; Wei, Xin; Zhou, Yu-Hao; Zhang, Xin-Ji; Wang, Chao; Qian, Wei; Lu, Jian; He, Jia			Adjuvant Chemotherapy, with or without Taxanes, in Early or Operable Breast Cancer: A Meta-Analysis of 19 Randomized Trials with 30698 Patients	PLOS ONE			English	Article							DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; PHASE-III TRIAL; HIGH-RISK; COMPARING DOXORUBICIN; DOCETAXEL; PACLITAXEL; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; VINORELBINE	Background: Taxanes have been extensively used as adjuvant chemotherapy for the treatment of early or operable breast cancer, particularly in high risk, node-negative breast cancer. Previous studies, however, have reported inconsistent findings regarding their clinical efficacy and safety. We investigated disease-free survival (DFS), overall survival (OS), and drug-related toxicities of taxanes by a systematic review and meta-analysis. Methodology and Principal Findings: We systematically searched PubMed, EMBASE, the Cochrane Center Register of Controlled Trials, proceedings of major meetings, and reference lists of articles for studies conducted between January 1980 and April 2011. Randomized controlled trials (RCTs) comparing chemotherapy with and without taxanes in the treatment of patients with early-stage or operable breast cancer were eligible for inclusion in our analysis. The primary endpoint was DFS. Nineteen RCTs including 30698 patients were identified, including 8426 recurrence events and 3803 deaths. Taxanes administration yielded a 17% reduction of hazard ratio (HR) for DFS (HR = 0.83, 95% CI 0.79-0.88, p<0.001) and a 17% reduction of HR for OS (HR = 0.83, 95% CI 0.77-0.90, p<0.001). For high risk, node-negative breast cancer, the pooled HR also favoured the taxane-based treatment arm over the taxane-free treatment arm (HR = 0.82, 95% CI 0.77-0.87, p = 0.022). A significantly increased rate of neutropenia, febrile neutropenia, fatigue, diarrhea, stomatitis, and oedema was observed in the taxane-based treatment arm. Conclusions/Significance: Adjuvant chemotherapy with taxanes could reduce the risk of cancer recurrence and death in patients with early or operable breast cancer, although the drug-related toxicities should be balanced. Furthermore, we also demonstrated that patients with high risk, node-negative breast cancer also benefited from taxanes therapy, a result that was not observed in previous studies.	[Qin, Ying-Yi; Li, Hui; Guo, Xiao-Jing; Ye, Xiao-Fei; Zhou, Yu-Hao; Zhang, Xin-Ji; Wang, Chao; Qian, Wei; Lu, Jian; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Wei, Xin] Shanghai Jiao Tong Univ, Coll Basic Med, Sch Med, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Qin, YY (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com	guo, xiaojing/GYJ-0885-2022	He, Jia/0000-0002-2338-9501; Wei, Qian/0000-0001-5753-7579	National Nature Science Foundation of China [30872186, 81072388]; leading talents of science in Shanghai [022]; Shanghai Subject Chief Scientist [09XD1405500]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); leading talents of science in Shanghai; Shanghai Subject Chief Scientist	National Nature Science Foundation of China (30872186, 81072388), a grant from the leading talents of science in Shanghai 2010 (022) and a grant sponsored by Program of Shanghai Subject Chief Scientist (09XD1405500). The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit for publication.	Abe O, 2005, LANCET, V366, P2087; Abe O, 1998, LANCET, V352, P930; Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Andre F, 2008, J CLIN ONCOL, V26, P2636, DOI 10.1200/JCO.2007.14.9146; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bianco AR, 2008, BREAST CANC S S; Boccardo F, 2010, ONCOLOGY-BASEL, V78, P274, DOI 10.1159/000315735; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Buzdar AU, 2002, CLIN CANCER RES, V8, P1073; Cognetti F, 2008, ANN ONCOL, V19, P77; Crown JP, 2006, J CLIN ONCOL ASC S18; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; Ferguson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004421.pub2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher B, 2004, JNCI-J NATL CANCER I, V96, P1823, DOI 10.1093/jnci/djh338; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Gianni L, 2005, CLIN CANCER RES, V11, P8715, DOI 10.1158/1078-0432.CCR-05-0539; Gianni L, 2005, J CLIN ONCOL ASC S16; Goldstein L, 2005, J CLIN ONCOL ASC S16; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4092, DOI 10.1200/JCO.2008.16.7841; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Lee KS, 2008, BREAST CANCER RES TR, V109, P481, DOI 10.1007/s10549-007-9672-y; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; Mansi JL, 2010, BREAST CANCER RES TR, V122, P787, DOI 10.1007/s10549-010-0989-6; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2007, BREAST, V16, pS127, DOI 10.1016/j.breast.2007.09.001; Martin M, 2008, JNCI-J NATL CANCER I, V100, P805, DOI 10.1093/jnci/djn151; Martin M, 2010, NEW ENGL J MED, V363, P2200, DOI 10.1056/NEJMoa0910320; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moore HCF, 2007, J CLIN ONCOL, V25, P1677, DOI 10.1200/JCO.2006.08.9383; Polyzos A, 2010, BREAST CANCER RES TR, V119, P95, DOI 10.1007/s10549-009-0468-0; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Verma S, 2010, CURR ONCOL, V17, P154	46	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26946	10.1371/journal.pone.0026946	http://dx.doi.org/10.1371/journal.pone.0026946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069477	Green Published, gold			2022-12-27	WOS:000297150900039
J	Adone, R; Muscillo, M; La Rosa, G; Francia, M; Tarantino, M				Adone, Rosanna; Muscillo, Michele; La Rosa, Giuseppina; Francia, Massimiliano; Tarantino, Michela			Antigenic, Immunologic and Genetic Characterization of Rough Strains B.abortus RB51, B.melitensis B115 and B.melitensis B18	PLOS ONE			English	Article							COMPLEMENT-FIXATION TEST; BRUCELLA-ABORTUS RB51; LINKED-IMMUNOSORBENT-ASSAY; O-SIDE-CHAIN; MONOCLONAL-ANTIBODIES; MELITENSIS STRAIN-B115; PHENOTYPE VACCINE; WBOA GENE; LIPOPOLYSACCHARIDE; POLYSACCHARIDE	The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes have been identified involved in the synthesis of the three LPS components: lipid A, core and O-PS. Usually, Brucella strains devoid of O-PS (rough mutants) are less virulent than the wild type and do not induce undesirable interfering antibodies. Such of them proved to be protective against brucellosis in mice. Because of these favorable features, rough strains have been considered potential brucellosis vaccines. In this study, we evaluated the antigenic, immunologic and genetic characteristics of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18. RB51 derived from B. abortus 2308 virulent strain and B115 is a natural rough strain in which the O-PS is present in the cytoplasm. B18 is a rough rifampin-resistan mutant isolated in our laboratory. The surface antigenicity of RB51, B115 and B18 was evaluated by testing their ability to bind antibodies induced by rough or smooth Brucella strains. The antibody response induced by each strain was evaluated in rabbits. Twenty-one genes, involved in the LPS-synthesis, were sequenced and compared with the B. melitensis 16M strain. The results indicated that RB51, B115 and B18 have differences in antigenicity, immunologic and genetic properties. Particularly, in B115 a nonsense mutation was detected in wzm gene, which could explain the intracellular localization of O-PS in this strain. Complementation studies to evaluate the precise role of each mutation in affecting Brucella morphology and its virulence, could provide useful information for the assessment of new, attenuated vaccines for brucellosis.	[Adone, Rosanna; Francia, Massimiliano; Tarantino, Michela] Ist Super Sanita, Dipartimento Sanita Pubbl Vet & Sicurezza Aliment, I-00161 Rome, Italy; [Muscillo, Michele; La Rosa, Giuseppina] Ist Super Sanita, Dipartimento Ambiente & Connessa Prevenz Primaria, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Adone, R (corresponding author), Ist Super Sanita, Dipartimento Sanita Pubbl Vet & Sicurezza Aliment, Viale Regina Elena 299, I-00161 Rome, Italy.	adone@iss.it	FRANCIA, MASSIMILIANO/C-7035-2015; La Rosa, Giuseppina/I-8532-2016; Tarantino, Michela/C-7039-2015	FRANCIA, MASSIMILIANO/0000-0002-0672-8639; La Rosa, Giuseppina/0000-0002-2657-100X; Tarantino, Michela/0000-0001-5241-8044	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This study is supported by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adone R, 2008, VACCINE, V26, P4913, DOI 10.1016/j.vaccine.2008.07.030; Adone R, 2008, J APPL MICROBIOL, V105, P567, DOI 10.1111/j.1365-2672.2008.03787.x; Adone R, 2005, INFECT IMMUN, V73, P4198, DOI 10.1128/IAI.73.7.4198-4204.2005; Adone R, 2001, CLIN DIAGN LAB IMMUN, V8, P385, DOI 10.1128/CDLI.8.2.385-387.2001; Adone R, 1999, CLIN DIAGN LAB IMMUN, V6, P787, DOI 10.1128/CDLI.6.6.787-790.1999; Adone R, 2011, VACCINE, V29, P2523, DOI 10.1016/j.vaccine.2011.01.072; Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998; BRAUN W, 1947, BACTERIOL REV, V11, P75, DOI 10.1128/MMBR.11.2.75-114.1947; Cardoso PCG, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-13; Cloeckaert A, 1998, CLIN DIAGN LAB IMMUN, V5, P862, DOI 10.1128/CDLI.5.6.862-870.1998; CLOECKAERT A, 1990, INFECT IMMUN, V58, P3980, DOI 10.1128/IAI.58.12.3980-3987.1990; CLOECKAERT A, 1992, J GEN MICROBIOL, V138, P1211, DOI 10.1099/00221287-138-6-1211; CLOECKAERT A, 1993, J GEN MICROBIOL, V139, P1551, DOI 10.1099/00221287-139-7-1551; Cloeckaert A, 2002, VACCINE, V20, P1820, DOI 10.1016/S0264-410X(02)00035-X; Cloeckaert A, 2000, RES MICROBIOL, V151, P209, DOI 10.1016/S0923-2508(00)00141-8; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DIAZ R, 1968, J BACTERIOL, V96, P893, DOI 10.1128/JB.96.4.893-901.1968; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Godfroid F, 2000, RES MICROBIOL, V151, P655, DOI 10.1016/S0923-2508(00)90130-X; Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; HALLING SM, 1991, INFECT IMMUN, V59, P3863, DOI 10.1128/IAI.59.11.3863-3868.1991; Henry BS, 1933, J INFECT DIS, V52, P374, DOI 10.1093/infdis/52.3.374; JONES LM, 1973, BRIT J EXP PATHOL, V54, P492; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Olsen SC, 1999, RES VET SCI, V66, P101, DOI 10.1053/rvsc.1998.0251; PERRY MB, 1990, ADVANCES IN BRUCELLOSIS RESEARCH, P76; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003; Vemulapalli R, 1999, CLIN DIAGN LAB IMMUN, V6, P760, DOI 10.1128/CDLI.6.5.760-764.1999; Vemulapalli R, 2000, INFECT IMMUN, V68, P3927, DOI 10.1128/IAI.68.7.3927-3932.2000; Vemulapalli R, 2000, INFECT IMMUN, V68, P3286, DOI 10.1128/IAI.68.6.3286-3289.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Vizcaino N, 2004, MICROBES INFECT, V6, P821, DOI 10.1016/j.micinf.2004.04.009; Winter AJ, 1996, AM J VET RES, V57, P677; Zygmunt MS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-92	43	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e24073	10.1371/journal.pone.0024073	http://dx.doi.org/10.1371/journal.pone.0024073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22065984	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000001
J	Bitume, EV; Bonte, D; Magalhaes, S; Martin, GS; Van Dongen, S; Bach, F; Anderson, JM; Olivieri, I; Nieberding, CM				Bitume, Ellyn Valery; Bonte, Dries; Magalhaes, Sara; Martin, Gilles San; Van Dongen, Stefan; Bach, Fabien; Anderson, Justin Michael; Olivieri, Isabelle; Nieberding, Caroline Marie			Heritability and Artificial Selection on Ambulatory Dispersal Distance in Tetranychus urticae: Effects of Density and Maternal Effects	PLOS ONE			English	Article							QUANTITATIVE GENETIC-ANALYSIS; 2-SPOTTED SPIDER-MITE; EPIPHYAS-POSTVITTANA; EVOLUTION; BEHAVIOR; ACARI; POPULATION; RESISTANCE; TRAITS; METAPOPULATION	Dispersal distance is understudied although the evolution of dispersal distance affects the distribution of genetic diversity through space. Using the two-spotted spider mite, Tetranychus urticae, we tested the conditions under which dispersal distance could evolve. To this aim, we performed artificial selection based on dispersal distance by choosing 40 individuals (out of 150) that settled furthest from the home patch (high dispersal, HDIS) and 40 individuals that remained close to the home patch (low dispersal, LDIS) with three replicates per treatment. We did not observe a response to selection nor a difference between treatments in life-history traits (fecundity, survival, longevity, and sex-ratio) after ten generations of selection. However, we show that heritability for dispersal distance depends on density. Heritability for dispersal distance was low and non-significant when using the same density as the artificial selection experiments while heritability becomes significant at a lower density. Furthermore, we show that maternal effects may have influenced the dispersal behaviour of the mites. Our results suggest primarily that selection did not work because high density and maternal effects induced phenotypic plasticity for dispersal distance. Density and maternal effects may affect the evolution of dispersal distance and should be incorporated into future theoretical and empirical studies.	[Bitume, Ellyn Valery; Bach, Fabien; Anderson, Justin Michael; Olivieri, Isabelle] Univ Montpellier 2, Montpellier, France; [Bitume, Ellyn Valery; Martin, Gilles San; Nieberding, Caroline Marie] Acad Louvain, Evolutionary Ecol & Genet Biodivers Res Ctr, Earth & Life Inst, Louvain, Belgium; [Bonte, Dries] Univ Ghent, Terr Ecol Unit, B-9000 Ghent, Belgium; [Magalhaes, Sara] Univ Lisbon, Ctr Environm Biol, P-1699 Lisbon, Portugal; [Van Dongen, Stefan] Univ Antwerp, StatUA Stat Ctr, B-2020 Antwerp, Belgium	Universite de Montpellier; Ghent University; Universidade de Lisboa; University of Antwerp	Bitume, EV (corresponding author), Univ Montpellier 2, Montpellier, France.	ellyn.bitume@uclouvain.be	S., Magalhaes/B-9673-2012; Olivieri, Isabelle/E-5872-2016; San Martin, Gilles/B-7827-2015; Bonte, Dries/AAH-3913-2021	S., Magalhaes/0000-0002-8609-7768; San Martin, Gilles/0000-0002-0434-9416; Bonte, Dries/0000-0002-3320-7505	Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) [1.EO25.09]; Universite catholique de Louvain-la-Neuve [ARC 10/15-031, 605031]; University Montpellier; PESSOA; CNRS [PICS 2010-2012]; Research Network EVENET; FWO [G.0057.09, G.0610.11]	Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain-la-Neuve; University Montpellier; PESSOA; CNRS(Centre National de la Recherche Scientifique (CNRS)); Research Network EVENET; FWO(FWO)	Dr. Bitume is funded by: Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A. grant 1.EO25.09), from the Universite catholique de Louvain-la-Neuve (grant n<SUP>o</SUP> ARC 10/15-031 and FSR grant n<SUP>o</SUP> 605031) to Dr. Nieberding, a University Montpellier 2 contract to Dr. Bach, a PESSOA travel grant to Dr. Olivieri and Dr. Magalhaes, and a Programme International de Cooperation Scientifique (PICS 2010-2012) from CNRS to Dr. Olivieri and Dr. Magalhaes. Dr. Bonte was funded by the Research Network EVENET and FWO projects G.0057.09 and G.0610.11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Bolland HR., 1998, WORLD CATALOGUE SPID; Bonte D, 2007, EVOL ECOL RES, V9, P817; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clotuche G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018854; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; De Meester N, 2010, BEHAV ECOL, V21, P992, DOI 10.1093/beheco/arq088; FAIRBAIRN DJ, 1990, EVOLUTION, V44, P1787, DOI [10.2307/2409507, 10.1111/j.1558-5646.1990.tb05249.x]; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Gandon S, 1999, J THEOR BIOL, V199, P275, DOI 10.1006/jtbi.1999.0960; GU HN, 1992, HEREDITY, V68, P53, DOI 10.1038/hdy.1992.7; GU HN, 1992, HEREDITY, V68, P61, DOI 10.1038/hdy.1992.8; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2000, ECOLOGY, V81, P239, DOI 10.1890/0012-9658(2000)081[0239:ETPOSA]2.0.CO;2; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; HUSSEY N. W., 1963, ENTOMOL EXP APPL, V6, P207, DOI 10.1007/BF00300527; Kennedy G.G., 1985, P233; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Konarzewski M, 2005, INTEGR COMP BIOL, V45, P416, DOI 10.1093/icb/45.3.416; KOT M, 1996, ECOLOGY, V77, P2027, DOI DOI 10.2307/2265698; Le Goff G, 2009, CR BIOL, V332, P927, DOI 10.1016/j.crvi.2009.06.002; Le Goff GJ, 2010, BEHAVIOUR, V147, P1169, DOI 10.1163/000579510X510980; LI J, 1993, HEREDITY, V70, P544, DOI 10.1038/hdy.1993.78; LI JB, 1994, HEREDITY, V72, P10, DOI 10.1038/hdy.1994.2; LI JB, 1993, ENTOMOL EXP APPL, V68, P79, DOI 10.1007/BF02380584; Lynch M., 1998, GENETICS ANAL QUANTI; MARGOLIES DC, 1985, ENTOMOL EXP APPL, V37, P55, DOI 10.1007/BF00366808; Massot M, 2002, J ANIM ECOL, V71, P253, DOI 10.1046/j.1365-2656.2002.00592.x; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Navajas M, 2002, INSECT MOL BIOL, V11, P157, DOI 10.1046/j.1365-2583.2002.00320.x; Oku K, 2003, APPL ENTOMOL ZOOL, V38, P267, DOI 10.1303/aez.2003.267; Oku K, 2002, APPL ENTOMOL ZOOL, V37, P425, DOI 10.1303/aez.2002.425; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poethke HJ, 2011, J THEOR BIOL, V282, P93, DOI 10.1016/j.jtbi.2011.05.012; PORTNOY S, 1993, EVOL ECOL, V7, P25, DOI 10.1007/BF01237733; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ronce O, 2000, THEOR POPUL BIOL, V58, P143, DOI 10.1006/tpbi.2000.1476; Ronce Ophelie, 2001, P341; Rousset F, 2002, J EVOLUTION BIOL, V15, P515, DOI 10.1046/j.1420-9101.2002.00430.x; Sabelis M.W., 1986, Lecture Notes in Biomathematics, V68, P298; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; SCHMITT J, 1985, AM NAT, V126, P570, DOI 10.1086/284439; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sinervo B, 2006, AM NAT, V168, P88, DOI 10.1086/505765; SMITLEY DR, 1985, ANN ENTOMOL SOC AM, V78, P609, DOI 10.1093/aesa/78.5.609; Starrfelt J, 2010, AM NAT, V175, P38, DOI 10.1086/648605; Tien NSH, 2011, EXP APPL ACAROL, V53, P349, DOI 10.1007/s10493-010-9411-7; Travis JMJ, 2010, J EVOLUTION BIOL, V23, P2656, DOI 10.1111/j.1420-9101.2010.02123.x; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Uesugi R, 2009, EXP APPL ACAROL, V47, P99, DOI 10.1007/s10493-008-9201-7; Van Leeuwen T, 2004, EXP APPL ACAROL, V32, P249, DOI 10.1023/B:APPA.0000023240.01937.6d; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2006, INSECT BIOCHEM MOLEC, V36, P869, DOI 10.1016/j.ibmb.2006.08.005; Van Valen Leigh, 1971, Evolution, V25, P591, DOI [10.1111/j.1558-5646.1971.tb01919.x, 10.2307/2406942]; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Yano S, 2002, EXP APPL ACAROL, V27, P1, DOI 10.1023/A:1021518221031; [No title captured]; [No title captured]; [No title captured]	76	22	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26927	10.1371/journal.pone.0026927	http://dx.doi.org/10.1371/journal.pone.0026927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066017	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000033
J	Nickerson, PEB; Ronellenfitch, K; McEwan, J; Kim, H; McInnes, RR; Chow, RL				Nickerson, Philip E. B.; Ronellenfitch, Kara; McEwan, Jason; Kim, Howard; McInnes, Roderick R.; Chow, Robert L.			A Transgenic Mouse Line Expressing Cre Recombinase in Undifferentiated Postmitotic Mouse Retinal Bipolar Cell Precursors	PLOS ONE			English	Article							HOMEOBOX GENE CHX10; PROGENITOR CELLS; DENTATE GYRUS; PAIRED-TYPE; DIFFERENTIATION; PROLIFERATION; HOMEODOMAIN; VSX-2; UPSTREAM; ELEGANS	Approaches for manipulating cell type-specific gene expression during development depend on the identification of novel genetic tools. Here, we report the generation of a transgenic mouse line that utilizes Vsx2 upstream sequences to direct Cre recombinase to developing retinal bipolar cells. In contrast to the endogenous Vsx2 expression pattern, transgene expression was not detected in proliferating retinal progenitor cells and was restricted to post-mitotic bipolar cells. Cre immunolabeling was detected in rod bipolar cells and a subset of ON and OFF cone bipolar cells. Expression was first observed at postnatal day 3 and was detectable between 24 hours and 36 hours after the last S-phase of the cell cycle. The appearance of Cre-immunolabeled cells preceded the expression of bipolar cell type-specific markers such as PKC alpha and Cabp5 suggesting that transgene expression is initiated prior to terminal differentiation. In the presence of a constitutive conditional reporter transgene, reporter fluorescence was detected in Cre-expressing bipolar cells in the mature retina as expected, but was also observed in Cre-negative Type 2 bipolar cells and occasionally in Cre-negative photoreceptor cells. Together these findings reveal a new transgenic tool for directing gene expression to post-mitotic retinal precursors that are mostly committed to a bipolar cell fate.	[Nickerson, Philip E. B.; Ronellenfitch, Kara; McEwan, Jason; Chow, Robert L.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Kim, Howard] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [McInnes, Roderick R.] McGill Univ, Dept Biochem, Lady Davis Res Inst, Montreal, PQ, Canada	University of Victoria; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University	Nickerson, PEB (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	bobchow@uvic.ca			Canadian Institutes for Health Research; Canada Research Chairs program	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by an operating grant to RLC from the Canadian Institutes for Health Research and was undertaken, in part, thanks to funding to RLC from the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chen CMA, 2000, MECH DEVELOP, V90, P293; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Erclik T, 2008, CURR BIOL, V18, P1278, DOI 10.1016/j.cub.2008.07.076; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HAWKINS NC, 1990, NUCLEIC ACIDS RES, V18, P6101, DOI 10.1093/nar/18.20.6101; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Levine EM, 1997, J COMP NEUROL, V387, P439; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Passini MA, 1997, J COMP NEUROL, V388, P495, DOI 10.1002/(SICI)1096-9861(19971124)388:3<495::AID-CNE11>3.0.CO;2-L; Passini MA, 1998, DEV BRAIN RES, V109, P129, DOI 10.1016/S0165-3806(98)00069-8; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Rowan S, 2005, DEV BIOL, V281, P240, DOI 10.1016/j.ydbio.2005.02.023; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; SHI Z, 2011, J COMP NEUR IN PRESS; SHI ZTS, 2011, J NEUROSCI IN PRESS; Ueda Y, 1997, J NEUROSCI, V17, P3014; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27145	10.1371/journal.pone.0027145	http://dx.doi.org/10.1371/journal.pone.0027145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22073130	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000058
J	de Figueiredo-Pontes, LL; Assis, PA; Santana-Lemos, BAA; Jacomo, RH; Lima, ASG; Garcia, AB; Thome, CH; Araujo, AG; Panepucci, RA; Zago, MA; Nagler, A; Falcao, RP; Rego, EM				de Figueiredo-Pontes, Lorena L.; Assis, Patricia A.; Santana-Lemos, Barbara A. A.; Jacomo, Rafael H.; Lima, Ana Silvia G.; Garcia, Aglair B.; Thome, Carolina H.; Araujo, Amelia G.; Panepucci, Rodrigo A.; Zago, Marco A.; Nagler, Arnon; Falcao, Roberto P.; Rego, Eduardo M.			Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway	PLOS ONE			English	Article							TGF-BETA; HEPATOCELLULAR-CARCINOMA; CELL-DIFFERENTIATION; PML/RAR-ALPHA; C-MYC; INHIBITION; FIBROSIS; MICE; ANGIOGENESIS; SUPPRESSION	Promyelocytic leukemia-retinoic acid receptor alpha (PML-RAR alpha) expression in acute promyelocytic leukemia (APL) impairs transforming growth factor beta (TGF beta) signaling, leading to cell growth advantage. Halofuginone (HF), a low-molecular-weight alkaloid that modulates TGFb signaling, was used to treat APL cell lines and non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice subjected to transplantation with leukemic cells from human chorionic gonadotrophin-PML-RAR alpha transgenic mice (TG). Cell cycle analysis using incorporated bromodeoxyuridine and 7-amino-actinomycin D showed that, in NB4 and NB4-R2 APL cell lines, HF inhibited cellular proliferation (P<0.001) and induced apoptosis (P = 0.002) after a 24-hour incubation. Addition of TGFb revealed that NB4 cells were resistant to its growth-suppressive effects and that HF induced these effects in the presence or absence of the cytokine. Cell growth inhibition was associated with up-regulation of TGFb target genes involved in cell cycle regulation (TGFB, TGFBRI, SMAD3, p15, and p21) and downregulation of MYC. Additionally, TGFb protein levels were decreased in leukemic TG animals and HF in vivo could restore TGFb values to normal. To test the in vivo anti-leukemic activity of HF, we transplanted NOD/SCID mice with TG leukemic cells and treated them with HF for 21 days. HF induced partial hematological remission in the peripheral blood, bone marrow, and spleen. Together, these results suggest that HF has anti-proliferative and anti-leukemic effects by reversing the TGFb blockade in APL. Since loss of the TGFb response in leukemic cells may be an important second oncogenic hit, modulation of TGFb signaling may be of therapeutic interest.	[de Figueiredo-Pontes, Lorena L.; Assis, Patricia A.; Santana-Lemos, Barbara A. A.; Lima, Ana Silvia G.; Garcia, Aglair B.; Thome, Carolina H.; Araujo, Amelia G.; Panepucci, Rodrigo A.; Zago, Marco A.; Falcao, Roberto P.; Rego, Eduardo M.] Univ Sao Paulo, Med Sch Ribeirao Preto, Div Hematol, Dept Internal Med, Sao Paulo, Brazil; [Jacomo, Rafael H.] Univ Brasilia, Div Hematol, Dept Internal Med, Sch Med, Brasilia, DF, Brazil; [Nagler, Arnon] Tel Aviv Univ, Div Hematol, Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Nagler, Arnon] Tel Aviv Univ, Cord Blood Bank, Chaim Sheba Med Ctr, Tel Hashomer, Israel	Universidade de Sao Paulo; Universidade de Brasilia; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	de Figueiredo-Pontes, LL (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Div Hematol, Dept Internal Med, Sao Paulo, Brazil.	emrego@hcrp.fmrp.usp.br	SANTANA, BARBARA A/T-3867-2017; Panepucci, Rodrigo A/C-2365-2012; Falcao, Roberto P/L-7370-2017; Figueiredo-Pontes, Lorena L/K-6520-2013; de Figueiredo Pontes, Lorena Lobo/GPC-6003-2022; ZAGO, MARCO A/E-9442-2017; Assis, Patricia/AAW-8642-2021; Rego, Eduardo M/A-1058-2012; Rego, Eduardo/AFS-7973-2022; Rego, Eduardo M./Y-5572-2019; Terapia celular, Cepid/I-4398-2013	SANTANA, BARBARA A/0000-0001-7361-0764; Panepucci, Rodrigo A/0000-0002-1119-4352; Falcao, Roberto P/0000-0002-2633-3909; Figueiredo-Pontes, Lorena L/0000-0002-2139-5756; de Figueiredo Pontes, Lorena Lobo/0000-0002-2139-5756; Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [98/14247-6, 02/11086-9, 08/52634-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant No. 98/14247-6). LLFP and PAA were recipients of FAPESP fellowships (Grant No. 02/11086-9 and 08/52634-5, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 2004, NEOPLASIA, V6, P480, DOI 10.1593/neo.03520; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casini T, 1999, ONCOGENE, V18, P3235, DOI 10.1038/sj.onc.1202630; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Duprez E, 2000, LEUKEMIA, V14, P255, DOI 10.1038/sj.leu.2401683; Elkin M, 2000, FASEB J, V14, P2477, DOI 10.1096/fj.00-0292com; Fortunel NO, 2000, BLOOD, V96, P2022; Gavish Z, 2002, PROSTATE, V51, P73, DOI 10.1002/pros.10059; Gnainsky Y, 2007, CELL TISSUE RES, V328, P153, DOI 10.1007/s00441-006-0330-1; Gross DJ, 2003, CLIN CANCER RES, V9, P3788; Guteerrez NC, 2005, LEUKEMIA, V19, P402, DOI 10.1038/sj.leu.2403625; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Jakubowiak A, 2000, J BIOL CHEM, V275, P40282, DOI 10.1074/jbc.C000485200; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; LANOTTE M, 1991, BLOOD, V77, P1080; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; Nagler A, 2004, EUR J CANCER, V40, P1397, DOI 10.1016/j.ejca.2003.11.036; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; RAZA A, 1992, BLOOD, V79, P1037; Rego EM, 2006, ONCOGENE, V25, P1974, DOI 10.1038/sj.onc.1209216; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; SCHREIBER G, 1973, SUB-CELL BIOCHEM, V2, P307; Sheffer Y, 2007, MOL CANCER THER, V6, P570, DOI 10.1158/1535-7163.MCT-06-0468; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Stecklair KP, 2001, CANCER CHEMOTH PHARM, V48, P375, DOI 10.1007/s002800100367; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Taras D, 2006, NEOPLASIA, V8, P312, DOI 10.1593/neo.05796; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Zion O, 2009, PANCREAS, V38, P427, DOI 10.1097/MPA.0b013e3181967670	42	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26713	10.1371/journal.pone.0026713	http://dx.doi.org/10.1371/journal.pone.0026713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053203	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800029
J	Guiard, Y; Olafsdottir, HB				Guiard, Yves; Olafsdottir, Halla B.			On the Measurement of Movement Difficulty in the Standard Approach to Fitts' Law	PLOS ONE			English	Article							INFORMATION CAPACITY; MOTOR-PERFORMANCE; ACCURACY; DISCRETE; TIME; SPEED; HAND; DYNAMICS; TASK	Fitts' law is an empirical rule of thumb which predicts the time it takes people, under time pressure, to reach with some pointer a target of width W located at a distance D. It has been traditionally assumed that the predictor of movement time must be some mathematical transform of the quotient of D/W, called the index of difficulty ( ID) of the movement task. We ask about the scale of measurement involved in this independent variable. We show that because there is no such thing as a zero-difficulty movement, the IDs of the literature run on non-ratio scales of measurement. One notable consequence is that, contrary to a widespread belief, the value of the y-intercept of Fitts' law is uninterpretable. To improve the traditional Fitts paradigm, we suggest grounding difficulty on relative target tolerance W/D, which has a physical zero, unlike relative target distance D/W. If no one can explain what is meant by a zero-difficulty movement task, everyone can understand what is meant by a target layout whose relative tolerance W/D is zero, and hence whose relative intolerance 1-W/D is 1 or 100%. We use the data of Fitts' famous tapping experiment to illustrate these points. Beyond the scale of measurement issue, there is reason to doubt that task difficulty is the right object to try to measure in basic research on Fitts' law, target layout manipulations having never provided users of the traditional Fitts paradigm with satisfactory control over the variations of the speed and accuracy of movements. We advocate the trade-off paradigm, a recently proposed alternative, which is immune to this criticism.	[Guiard, Yves; Olafsdottir, Halla B.] Telecom ParisTech, CNRS, Lab Traitement & Commun Informat, Paris, France	Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris	Guiard, Y (corresponding author), Telecom ParisTech, CNRS, Lab Traitement & Commun Informat, Paris, France.	yves.guiard@telecom-paristech.fr			Institut TELECOM	Institut TELECOM	This research was supported by Institut TELECOM with a Carnot post-doctoral fellowship granted to HBO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES RO, 1989, HUM FACTORS, V31, P703, DOI 10.1177/001872088903100606; Bacon F., 1960, NEW ORGANON; Billon M, 2000, NEUROSCI LETT, V286, P49, DOI 10.1016/S0304-3940(00)01089-2; Bootsma RJ, 1998, CR ACAD SCI III-VIE, V321, P377, DOI 10.1016/S0764-4469(98)80301-6; CARD SK, 1978, ERGONOMICS, V21, P601, DOI 10.1080/00140137808931762; Crossman E.R., 1956, MEASUREMENT PERCEPTU; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Davis NJ, 2008, EXP BRAIN RES, V188, P141, DOI 10.1007/s00221-008-1379-8; DRURY CG, 1975, HUM FACTORS, V17, P368, DOI 10.1177/001872087501700408; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Epps B. W., 1986, Proceedings of the Human Factors Society 30th Annual Meeting, P327; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1966, J EXP PSYCHOL, V71, P475, DOI 10.1037/h0022970; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GLENCROSS D, 1983, J MOTOR BEHAV, V15, P191; Guiard Y, 1997, HUM MOVEMENT SCI, V16, P97, DOI 10.1016/S0167-9457(96)00045-0; GUIARD Y, 2009, P CHI 2009 ACM C HUM, P1908; GUIARD Y, 2004, SPECIAL ISSUE INT J, V61; GUIARD Y, 1998, EFFETS GAMME OPTIMUM, V34, P19; Guiard Y, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1619; Hancock P.A., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [10.1007/978-3-642-69749-4_5, DOI 10.1007/978-3-642-69749-4_5]; HOFFMANN ER, 1991, J MOTOR BEHAV, V23, P259, DOI 10.1080/00222895.1991.9942037; JAGACINSKI RJ, 1985, J MOTOR BEHAV, V17, P77; KANTOWITZ BH, 1988, J MOTOR BEHAV, V20, P53; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KELSO JAS, 1992, J EXP PSYCHOL GEN, V121, P260, DOI 10.1037/0096-3445.121.3.260; KERR BA, 1977, Q J EXP PSYCHOL, V29, P475, DOI 10.1080/14640747708400623; KERR R, 1978, J MOTOR BEHAV, V10, P255; KERR R, 1973, J MOTOR BEHAV, V5, P175, DOI 10.1080/00222895.1973.10734962; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; LANGOLF GD, 1976, J MOTOR BEHAV, V8, P113, DOI 10.1080/00222895.1976.10735061; Lazzari S, 2009, J MOTOR BEHAV, V41, P294, DOI 10.3200/JMBR.41.4.294-304; Luce R.D., 2002, STEVENS HDB EXPT PSY, DOI [10.1002/0471214426.pas0401, DOI 10.1002/0471214426.PAS0401, DOI 10.1002/0471214426.pas0401]; Luce RD, 2003, REV GEN PSYCHOL, V7, P183, DOI 10.1037/1089-2680.7.2.183; MACKENZIE CL, 1987, Q J EXP PSYCHOL-A, V39, P629, DOI 10.1080/14640748708401806; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; MacKenzie I.S., 1991, THESIS U TORONTO; MacKenzie IS, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1633; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; Meehl P.E., 1997, MULTIVAR APPL SER, P393; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mohagheghi AA, 2001, HUM MOVEMENT SCI, V20, P603, DOI 10.1016/S0167-9457(01)00070-7; NORMAN DA, 1976, PSYCHOL REV, V83, P508, DOI 10.1037/0033-295X.83.6.508; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; POPPER K, 1983, POSTSCRIPT LOGIC SCI; Popper K.R., 1959, LOGIC SCI DISCOVERY; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schmidt RA, 2005, MOTOR CONTROL LEARNI; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Soukoreff RW, 2009, IEEE SYS MAN CYBERN, P2890, DOI 10.1109/ICSMC.2009.5346580; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; TOATES FM, 1975, CONTROL THEORY BIOL; WELFORD AT, 1960, ERGONOMICS, V3, P189, DOI 10.1080/00140136008930484; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; ZHAI S, 2002, P CHI 2002 ACM C HUM, P17; [No title captured]	62	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e24389	10.1371/journal.pone.0024389	http://dx.doi.org/10.1371/journal.pone.0024389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876BL	22053175	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800001
J	Sundqvist, MK; Giesler, R; Wardle, DA				Sundqvist, Maja K.; Giesler, Reiner; Wardle, David A.			Within- and Across-Species Responses of Plant Traits and Litter Decomposition to Elevation across Contrasting Vegetation Types in Subarctic Tundra	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; LAND-USE CHANGE; NUTRIENT LIMITATION; RESORPTION PROFICIENCY; ENVIRONMENTAL-CHANGE; LEAF TRAITS; QUALITY; COMMUNITIES; DYNAMICS; NITROGEN	Elevational gradients are increasingly recognized as a valuable tool for understanding how community and ecosystem properties respond to climatic factors, but little is known about how plant traits and their effects on ecosystem processes respond to elevation. We studied the response of plant leaf and litter traits, and litter decomposability across a gradient of elevation, and thus temperature, in subarctic tundra in northern Sweden for each of two contrasting vegetation types, heath and meadow, dominated by dwarf shrubs and herbaceous plants respectively. This was done at each of three levels; across species, within individual species, and the plant community using a community weighted average approach. Several leaf and litter traits shifted with increasing elevation in a manner consistent with greater conservation of nutrients at all three levels, and the most consistent response was an increase in tissue N to P ratio. However, litter decomposition was less directly responsive to elevation because the leaf and litter traits which were most responsive to elevation were not necessarily those responsible for driving decomposition. At the community level, the response to elevation of foliar and litter traits, and decomposability, varied greatly among the two vegetation types, highlighting the importance of vegetation type in determining ecological responses to climatic factors such as temperature. Finally our results highlight how understanding the responses of leaf and litter characteristics of functionally distinct vegetation types, and the processes that they drive, to temperature helps provide insights about how future climate change could affect tundra ecosystems.	[Sundqvist, Maja K.; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Giesler, Reiner] Umea Univ, Climate Impacts Res Ctr, Dept Ecol & Environm Sci, Abisko, Sweden	Swedish University of Agricultural Sciences; Umea University	Sundqvist, MK (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden.	maja.sundqvist@slu.se	Wardle, David A./F-6031-2011; Sundqvist, Maja/C-6100-2015	Wardle, David A./0000-0002-0476-7335; Sundqvist, Maja/0000-0001-5947-839X	Centre For Environmental Research in Umea (CMF) [0632292]	Centre For Environmental Research in Umea (CMF)	This project was funded by the Centre For Environmental Research in Umea (CMF) (grant number 0632292; http://www8.umu.se/cmf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Bjork RG, 2007, PLANT SOIL, V294, P247, DOI 10.1007/s11104-007-9250-4; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Classen AT, 2007, J ECOL, V95, P1181, DOI 10.1111/j.1365-2745.2007.01297.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cortez J, 2007, PLANT SOIL, V296, P19, DOI 10.1007/s11104-007-9285-6; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Grime J. P., 2001, PLANT STRATEGIES VEG; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Hertel D, 2008, PLANT ECOL DIVERS, V1, P21, DOI 10.1080/17550870802257026; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Huber E, 2007, PLANT SOIL, V301, P65, DOI 10.1007/s11104-007-9422-2; Kazakou E, 2006, FUNCT ECOL, V20, P21, DOI 10.1111/j.1365-2435.2006.01080.x; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Molau U, 1998, AMBIO, V27, P322; Nilsson O., 1991, NORDISK FJALLFLORA, V3rd; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Sjogersten S, 2002, SOIL BIOL BIOCHEM, V34, P1633, DOI 10.1016/S0038-0717(02)00147-5; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Sundqvist MK, 2011, OIKOS, V120, P128, DOI 10.1111/j.1600-0706.2010.18811.x; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van de Weg MJ, 2009, PLANT ECOL DIVERS, V2, P243, DOI 10.1080/17550870903518045; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Wardle DA, 2009, FUNCT ECOL, V23, P442, DOI 10.1111/j.1365-2435.2008.01513.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	42	64	66	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e27056	10.1371/journal.pone.0027056	http://dx.doi.org/10.1371/journal.pone.0027056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046443	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800064
J	Willing, BP; Vacharaksa, A; Croxen, M; Thanachayanont, T; Finlay, BB				Willing, Benjamin P.; Vacharaksa, Anjalee; Croxen, Matthew; Thanachayanont, Teerawat; Finlay, B. Brett			Altering Host Resistance to Infections through Microbial Transplantation	PLOS ONE			English	Article							CITROBACTER-RODENTIUM INFECTION; BACTERIAL COMPOSITION; GUT MICROBIOTA; SUSCEPTIBILITY; DEFENSE; MICE; COLITIS; CELLS; INTERLEUKIN-22; COLONIZATION	Host resistance to bacterial infections is thought to be dictated by host genetic factors. Infections by the natural murine enteric pathogen Citrobacter rodentium (used as a model of human enteropathogenic and enterohaemorrhagic E. coli infections) vary between mice strains, from mild self-resolving colonization in NIH Swiss mice to lethality in C3H/HeJ mice. However, no clear genetic component had been shown to be responsible for the differences observed with C. rodentium infections. Because the intestinal microbiota is important in regulating resistance to infection, and microbial composition is dependent on host genotype, it was tested whether variations in microbial composition between mouse strains contributed to differences in "host'' susceptibility by transferring the microbiota of resistant mice to lethally susceptible mice prior to infection. Successful transfer of the microbiota from resistant to susceptible mice resulted in delayed pathogen colonization and mortality. Delayed mortality was associated with increased IL-22 mediated innate defense including antimicrobial peptides Reg3 gamma and Reg3 beta, and immunono-neutralization of IL-22 abrogated the beneficial effect of microbiota transfer. Conversely, depletion of the native microbiota in resistant mice by antibiotics and transfer of the susceptible mouse microbiota resulted in reduced innate defenses and greater pathology upon infection. This work demonstrates the importance of the microbiota and how it regulates mucosal immunity, providing an important factor in susceptibility to enteric infection. Transfer of resistance through microbial transplantation (bacteriotherapy) provides additional mechanisms to alter "host'' resistance, and a novel means to alter enteric infection and to study host-pathogen interactions.	[Willing, Benjamin P.; Vacharaksa, Anjalee; Croxen, Matthew; Thanachayanont, Teerawat; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Willing, BP (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca	Willing, Benjamin/AAA-9650-2019	Croxen, Matthew/0000-0002-9564-7952	Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada	This work was supported by grants from the Canadian Institutes of Health Research, The Canadian Association of Gastroenterology and the Crohn's and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Borenshtein D, 2007, INFECT IMMUN, V75, P3271, DOI 10.1128/IAI.01810-06; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Diez E, 2011, GENES IMMUN, V12, P280, DOI 10.1038/gene.2010.76; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; ITOH K, 1988, INFECT IMMUN, V56, P930, DOI 10.1128/IAI.56.4.930-935.1988; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kalman D, 2007, J IMMUNOL, V179, P566; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marquis JF, 2008, CURR TOP MICROBIOL, V321, P27; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	36	114	116	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26988	10.1371/journal.pone.0026988	http://dx.doi.org/10.1371/journal.pone.0026988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046427	Green Published, Green Submitted, gold			2022-12-27	WOS:000299081800054
J	Zou, HB; Chen, Y; Duan, ZP; Zhang, H				Zou, Huaibin; Chen, Yu; Duan, Zhongping; Zhang, Hua			Protective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PERINATAL TRANSMISSION; ACTIVE IMMUNIZATION; NEWBORN-INFANTS; IMMUNE GLOBULIN; CARRIER STATE; DOUBLE-BLIND; VIRUS; IMMUNOGENICITY; PREVENTION	Background: Despite the use of hepatitis B (HB) vaccine and hepatitis B immunoglobulin (HBIG), a portion of infants are still non-or low-responders, or even immunoprophylaxis failure. We aimed to determine the immune response in the infants from the mothers being positive for hepatitis B surface antigen (HBsAg), by which the infants received three doses of HB vaccine in combination with two-dose 200 IU HBIG injections. Methods: In this retrospective study, 621 infants from HBsAg-positive mothers in Beijing YouAn Hospital between January 2008 and December 2009 were included. All the infants were given three doses of 10 mu g HB vaccine (at 0, 1 and 6 months of age) and two-dose of 200 IU HBIG (at birth and in 2 weeks of age). Serum HBsAg and antibody to HBsAg (anti-HBs) in all the infants were determined at 7 months of age. Results: Of the 621 infants, 2.9% were immunoprophylaxis failure (positive for HBsAg), 1.4% were non-responders (anti-HBs undetectable), 95.7% were responders. The 594 responders could be categorized into three subsets, 22 were 10 to 99 IU/L for anti-HBs levels, 191 were 100 to 999 IU/L, and 381 were >= 1000 IU/L. The immunoprophylaxis failure rate was at 0% and 5.2% for the infants of HBeAg-negative and HBeAg-positive mothers(P<0.001). Infants from mothers with detectable HBV DNA had higher incidence of immunoprophylaxis failure than those of mothers without detectable HBV DNA (P = 0.002). The factors including gender, birth weight, gestation weeks, the rates of maternal HBeAg-positive, and detectable HBV DNA did not contribute to the no response to HB vaccination. Conclusions: Through vaccination by three doses of HB and two-dose of HBIG, majority of the infants (95.7%) achieved a protective level of anti-HBs at 7 months of age. Maternal HBeAg-positive and HBV DNA detectable were associated with the immunoprophylaxis failure, but not contribute to the non-or low-response to HB vaccination.	[Zou, Huaibin; Chen, Yu; Duan, Zhongping] Capital Med Univ, Artificial Liver Ctr, Beijing YouAn Hosp, Beijing, Peoples R China; [Zhang, Hua] Capital Med Univ, Dept Obstet & Gynecol, Beijing YouAn Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zou, HB (corresponding author), Capital Med Univ, Artificial Liver Ctr, Beijing YouAn Hosp, Beijing, Peoples R China.	chybeyond@163.com; duan2517@163.com			National Eleventh Five-Year Key Projects in infectious diseases of China [2008ZX10002-001, 2009ZX10004-903]; National Natural Science Foundation of China [30800517]; 973 program [2007CB512801]	National Eleventh Five-Year Key Projects in infectious diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This work was supported by the National Eleventh Five-Year Key Projects in infectious diseases of China (no. 2008ZX10002-001 and no. 2009ZX10004-903), the National Natural Science Foundation of China (no. 30800517), and the "973 program'' (no. 2007CB512801). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agladioglu S, 2010, INFECTION, V38, P269, DOI 10.1007/s15010-010-0031-2; ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; BEASLEY RP, 1983, HEPATOLOGY, V3, P135; BEASLEY RP, 1983, LANCET, V2, P1099; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, ZHONGHUA GANZANGBING, V1, P11; Chinese Society of Hepatology and Chinese Society of Infectious Diseases CMA, 2005, ZHONGHUA GANZANGBING, V2005, P881; CRAVEN DE, 1986, ANN INTERN MED, V105, P356, DOI 10.7326/0003-4819-105-3-356; D'Angio Carl T, 2007, Paediatr Drugs, V9, P17, DOI 10.2165/00148581-200709010-00003; delCanho R, 1997, VACCINE, V15, P1624, DOI 10.1016/S0264-410X(97)00080-7; GROSHEIDE PM, 1994, VACCINE, V12, P1059, DOI 10.1016/0264-410X(94)90173-2; Hollinger FB, 1989, AM J MED A, V3, pS36S; HSU HY, 1993, VACCINE, V11, P1437, DOI 10.1016/0264-410X(93)90173-U; Jan CF, 2010, HEPATOLOGY, V51, P1547, DOI 10.1002/hep.23543; Kojouharova M, 2001, INFECTION, V29, P342, DOI 10.1007/s15010-001-1150-6; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lee C, 2006, COCHRANE DB SYST REV, V2; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lewis E, 2001, PEDIATR INFECT DIS J, V20, P1049, DOI 10.1097/00006454-200111000-00009; Liu PB, 2000, CHINESE MED J-PEKING, V113, P547; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Junqueira ALN, 2010, INT J NURS STUD, V47, P1074, DOI 10.1016/j.ijnurstu.2010.01.009; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Niu MT, 1996, PEDIATR INFECT DIS J, V15, P771, DOI 10.1097/00006454-199609000-00007; Roberton D M, 2004, Expert Rev Vaccines, V3, P343, DOI 10.1586/14760584.3.4.343; Roque D. M., 2011, Morbidity and Mortality Weekly Report, V60, P410; Roukens AH, 2010, VACCINE, V28, P4288, DOI 10.1016/j.vaccine.2010.04.029; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Song YM, 2007, EUR J PEDIATR, V166, P813, DOI 10.1007/s00431-006-0327-5; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; WHO Publication, 2010, Vaccine, V28, P589, DOI 10.1016/j.vaccine.2009.10.110; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; WONG VCW, 1984, LANCET, V1, P921; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; Yen YH, 2005, LIVER INT, V25, P1162, DOI 10.1111/j.1478-3231.2005.01157.x; Zhu QR, 2003, CHINESE MED J-PEKING, V116, P685	40	21	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26748	10.1371/journal.pone.0026748	http://dx.doi.org/10.1371/journal.pone.0026748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053208	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800034
J	Kupfer, SS; Anderson, JR; Ludvik, AE; Hooker, S; Skol, A; Kittles, RA; Keku, TO; Sandler, RS; Ruiz-Ponte, C; Castellvi-Bel, S; Castells, A; Carracedo, A; Ellis, NA				Kupfer, Sonia S.; Anderson, Jeffrey R.; Ludvik, Anton E.; Hooker, Stanley; Skol, Andrew; Kittles, Rick A.; Keku, Temitope O.; Sandler, Robert S.; Ruiz-Ponte, Clara; Castellvi-Bel, Sergi; Castells, Antoni; Carracedo, Angel; Ellis, Nathan A.			Genetic Associations in the Vitamin D Receptor and Colorectal Cancer in African Americans and Caucasians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLON-CANCER; UNITED-STATES; DIETARY CALCIUM; RECTAL-CANCER; VDR GENE; SERUM 25-HYDROXYVITAMIN-D; EUROPEAN AMERICANS; D METABOLITES; GENOTYPE DATA	Low vitamin D levels are associated with an increased incidence of colorectal cancer (CRC) and higher mortality from the disease. In the US, African Americans (AAs) have the highest CRC incidence and mortality and the lowest levels of vitamin D. Single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene have been previously associated with CRC, but few studies have included AAs. We studied 795 AA CRC cases and 985 AA controls from Chicago and North Carolina as well as 1324 Caucasian cases and 990 Caucasian controls from Chicago and Spain. We genotyped 54 tagSNPs in VDR (46586959 to 46521297 Mb) and tested for association adjusting for West African ancestry, age, gender, and multiple testing. Untyped markers were imputed using MACH1.0. We analyzed associations by gender and anatomic location in the whole study group as well as by vitamin D intake in the North Carolina AA group. In the joint analysis, none of the SNPs tested was significantly associated with CRC. For four previously tested restriction fragment length polymorphisms, only one (referred to as ApaI), tagged by the SNP rs79628898, had a nominally significant p-value in AAs; none of these polymorphisms were associated with CRC in Caucasians. In the North Carolina AAs, for whom we had vitamin D intake data, we found a significant association between an intronic SNP rs11574041 and vitamin D intake, which is evidence for a VDR gene-environment interaction in AAs. In summary, using a systematic tagSNP approach, we have not found evidence for significant associations between VDR and CRC in AAs or Caucasians.	[Kupfer, Sonia S.; Anderson, Jeffrey R.; Ludvik, Anton E.] Univ Chicago, Med Ctr, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA; [Hooker, Stanley; Skol, Andrew] Univ Chicago, Med Ctr, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Inst Human Genet, Chicago, IL USA; [Keku, Temitope O.; Sandler, Robert S.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Ruiz-Ponte, Clara; Carracedo, Angel] Univ Santiago de Compostela, Galician Publ Fdn Genom Med FPGMX, CIBERER, Genom Med Grp,Hosp Clin, Santiago De Compostela, Galicia, Spain; [Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin, CIBERehd,IDIBAPS, Barcelona, Catalonia, Spain; [Ellis, Nathan A.] Univ Illinois, Dept Pediat, Inst Human Genet, Chicago, IL USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kupfer, SS (corresponding author), Univ Chicago, Med Ctr, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA.	naellis@uic.edu	Carracedo, Angel/D-4257-2012; Ruiz-Ponte, Clara/I-3849-2015; Castells, Antoni/ABC-1002-2021; Kupfer, Sonia S/ABD-9416-2021	Carracedo, Angel/0000-0003-1085-8986; Ruiz-Ponte, Clara/0000-0002-2200-0162; Castells, Antoni/0000-0001-8431-2033; Castellvi-Bel, Sergi/0000-0003-1217-5097	National Institutes of Health [K08 CA142892, R01 CA 66635, U01 CA153060]; American Institute for Cancer Research [09-A116]; American Cancer Society Illinois Division [PSB 09-02]; Digestive Disease Research Core Center at UC [P30 DK42086]; Digestive Disease Research Core Center at UNC [P30 DK34987]; American Cancer Society Institutional Research; Clinical Translational Science Award; Department of Medicine at the University of Chicago; Xunta de Galicia [PGIDIT 08CSA005208PR]; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion [08/0024, 08/1276, PS09/02368]; Instituto de Salud Carlos III (Accion Transversal de Cancer); Ministerio de Ciencia e Innovacion [SAF2010-19273]; Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); Fundacio Olga Torres; FP7 CHIBCHA Consortium; Fondo de Investigacion Sanitaria [CP 03-0070]; Instituto de Salud Carlos III; NATIONAL CANCER INSTITUTE [K08CA142892, U01CA153060, R01CA066635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; American Cancer Society Illinois Division(American Cancer Society); Digestive Disease Research Core Center at UC; Digestive Disease Research Core Center at UNC; American Cancer Society Institutional Research(American Cancer Society); Clinical Translational Science Award; Department of Medicine at the University of Chicago; Xunta de Galicia(Xunta de GaliciaEuropean Commission); ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Instituto de Salud Carlos III (Accion Transversal de Cancer)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona); Fundacio Olga Torres; FP7 CHIBCHA Consortium; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants from the National Institutes of Health (K08 CA142892 to S. S. K.; R01 CA 66635 to R. S. S.; and U01 CA153060 to N.A.E.), American Institute for Cancer Research (09-A116 to N.A.E.), and American Cancer Society Illinois Division (PSB 09-02 to N.A.E.). Institutional support was provided by the Digestive Disease Research Core Centers at UC and UNC (P30 DK42086 and P30 DK34987, respectively), The Cancer Research Foundation, the University of Chicago Comprehensive Cancer Research Center, development grants from the American Cancer Society Institutional Research Grant program and the Clinical Translational Science Award, and support from the Department of Medicine at the University of Chicago. The authors' Spanish partners were supported by Xunta de Galicia (PGIDIT 08CSA005208PR to A. Carracedo), ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion/FEDER (08/0024, 08/1276, PS09/02368 to A. Carracedo), Instituto de Salud Carlos III (Accion Transversal de Cancer), Ministerio de Ciencia e Innovacion (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona), Fundacio Olga Torres (to S.C.-B. and C. R.-P.), and FP7 CHIBCHA Consortium (A. Carracedo and S. C. B.). S.C.-B. is supported by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070). CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Egan JB, 2010, CANCER RES, V70, P1496, DOI 10.1158/0008-5472.CAN-09-3264; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Rozadilla C, 2010, CANCER EPIDEM BIOMAR, V19, P619, DOI 10.1158/1055-9965.EPI-09-1175; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Fiscella K, 2011, CANCER-AM CANCER SOC, V117, P1061, DOI 10.1002/cncr.25647; Flugge J, 2009, INT J COLORECTAL DIS, V24, P171, DOI 10.1007/s00384-008-0617-7; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gong YL, 2005, WORLD J GASTROENTERO, V11, P4794, DOI 10.3748/wjg.v11.i31.4794; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Holick MF, 2000, CLIN LAB MED, V20, P569; Hughes David J, 2011, J Gastrointest Cancer, V42, P149, DOI 10.1007/s12029-010-9168-6; Ingles SA, 2001, CANCER CAUSE CONTROL, V12, P607, DOI 10.1023/A:1011292002475; Jenab M, 2009, CANCER EPIDEM BIOMAR, V18, P2485, DOI 10.1158/1055-9965.EPI-09-0319; Kim HS, 2001, CANCER EPIDEM BIOMAR, V10, P869; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Levine AJ, 2001, NUTR CANCER, V39, P35, DOI 10.1207/S15327914nc391_5; Li C, 2009, DIGEST DIS SCI, V54, P634, DOI 10.1007/s10620-008-0375-y; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mahmoudi T, 2010, DIGEST DIS SCI, V55, P2008, DOI 10.1007/s10620-009-0989-8; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; MATSUOKA LY, 1991, ARCH DERMATOL, V127, P536, DOI 10.1001/archderm.127.4.536; Murtaugh MA, 2006, NUTR CANCER, V55, P35, DOI 10.1207/s15327914nc5501_5; Ochs-Balcom HM, 2008, CARCINOGENESIS, V29, P1788, DOI 10.1093/carcin/bgn166; Parisi E, 2008, J STEROID BIOCHEM, V111, P87, DOI 10.1016/j.jsbmb.2008.05.001; Park K, 2006, CANCER LETT, V237, P199, DOI 10.1016/j.canlet.2005.05.048; Peters U, 2004, CANCER EPIDEM BIOMAR, V13, P546; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Platz EA, 2000, CANCER EPIDEM BIOMAR, V9, P1059; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Sansbury LB, 2006, CANCER CAUSE CONTROL, V17, P257, DOI 10.1007/s10552-005-0417-0; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P2752, DOI 10.1158/1055-9965.EPI-07-2611; Slattery ML, 2010, NUTR CANCER, V62, P436, DOI 10.1080/01635580903441204; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Slattery ML, 2004, CANCER CAUSE CONTROL, V15, P863, DOI 10.1007/s10552-004-1048-6; Slattery ML, 2004, INT J CANCER, V111, P750, DOI 10.1002/ijc.20330; Slattery ML, 2001, CANCER CAUSE CONTROL, V12, P359, DOI 10.1023/A:1011280518278; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Sweeney C, 2006, CANCER EPIDEM BIOMAR, V15, P744, DOI 10.1158/1055-9965.EPI-05-0814; Tangrea J, 1997, CANCER CAUSE CONTROL, V8, P615, DOI 10.1023/A:1018450531136; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Wei MY, 2008, CANCER EPIDEM BIOMAR, V17, P2958, DOI 10.1158/1055-9965.EPI-08-0402; WEINBERG CR, 1991, AM J EPIDEMIOL, V134, P421, DOI 10.1093/oxfordjournals.aje.a116104; Wong HL, 2003, CARCINOGENESIS, V24, P1091, DOI 10.1093/carcin/bgg059; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Yaylim-Eraltan I, 2007, CELL BIOCHEM FUNCT, V25, P731, DOI 10.1002/cbf.1386; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	59	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26123	10.1371/journal.pone.0026123	http://dx.doi.org/10.1371/journal.pone.0026123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046258	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400010
J	Lou, PH; Gustavsson, N; Wang, Y; Radda, GK; Han, WP				Lou, Phing-How; Gustavsson, Natalia; Wang, Yue; Radda, George K.; Han, Weiping			Increased Lipolysis and Energy Expenditure in a Mouse Model with Severely Impaired Glucagon Secretion	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; UNCOUPLING PROTEIN-3; ADIPOSE-TISSUE; RECEPTOR ANTAGONIST; DIABETIC RATS; IN-VIVO; MICE; GLUCOSE	Background: Secretion of insulin and glucagon is triggered by elevated intracellular calcium levels. Although the precise mechanism by which the calcium signal is coupled to insulin and glucagon granule exocytosis is unclear, synaptotagmin-7 has been shown to be a positive regulator of calcium-dependent insulin and glucagon secretion, and may function as a calcium sensor for insulin and glucagon granule exocytosis. Deletion of synaptotagmin-7 leads to impaired glucose-stimulated insulin secretion and nearly abolished Ca2+-dependent glucagon secretion in mice. Under non-stressed resting state, however, synaptotagmin-7 KO mice exhibit normal insulin level but severely reduced glucagon level. Methodology/Principal Findings: We studied energy expenditure and metabolism in synaptotagmin-7 KO and control mice using indirect calorimetry and biochemical techniques. Synaptotagmin-7 KO mice had lower body weight and body fat content, and exhibited higher oxygen consumption and basal metabolic rate. Respiratory exchange ratio (RER) was lower in synaptotagmin-7 KO mice, suggesting an increased use of lipid in their energy production. Consistent with lower RER, gene expression profiles suggest enhanced lipolysis and increased capacity for fatty acid transport and oxidation in synaptotagmin-7 KO mice. Furthermore, expression of uncoupling protein 3 (UCP3) in skeletal muscle was approximately doubled in the KO mice compared with control mice. Conclusions: These results show that the lean phenotype in synaptotagmin-7 KO mice was mostly attributed to increased lipolysis and energy expenditure, and suggest that reduced glucagon level may have broad influence on the overall metabolism in the mouse model.	[Lou, Phing-How; Gustavsson, Natalia; Wang, Yue; Radda, George K.; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Gustavsson, Natalia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Wang, Yue; Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore	Lou, PH (corresponding author), ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	weiping_han@sbic.a-star.edu.sg	Petersen, Natalia/J-8800-2015	Petersen, Natalia/0000-0001-9344-6041	A*STAR Biomedical Research Council	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by A*STAR Biomedical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Barger JL, 2006, J APPL PHYSIOL, V101, P339, DOI 10.1152/japplphysiol.01260.2005; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boss O, 1998, FASEB J, V12, P335, DOI 10.1096/fasebj.12.3.335; Brand CL, 1996, DIABETES, V45, P1076, DOI 10.2337/diabetes.45.8.1076; BRAND CL, 1995, AM J PHYSIOL-ENDOC M, V269, pE469, DOI 10.1152/ajpendo.1995.269.3.E469; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Cortright RN, 1999, AM J PHYSIOL-ENDOC M, V276, pE217, DOI 10.1152/ajpendo.1999.276.1.E217; Dallas-Yang Q, 2004, EUR J PHARMACOL, V501, P225, DOI 10.1016/j.ejphar.2004.08.023; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gong DW, 1999, BIOCHEM BIOPH RES CO, V256, P27, DOI 10.1006/bbrc.1999.0239; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gustavsson N, 2011, DIABETOLOGIA, V54, P415, DOI 10.1007/s00125-010-1950-2; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Jocken JWE, 2008, PHYSIOL BEHAV, V94, P219, DOI 10.1016/j.physbeh.2008.01.002; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Lou PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011669; Mang Y, 2004, DIABETES, V53, P410; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; UNGER RH, 1975, LANCET, V1, P14; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005	45	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26671	10.1371/journal.pone.0026671	http://dx.doi.org/10.1371/journal.pone.0026671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046328	gold, Green Submitted, Green Published			2022-12-27	WOS:000296521400030
J	Gayet-Ageron, A; Agoritsas, T; Schiesari, L; Kolly, V; Perneger, TV				Gayet-Ageron, Angele; Agoritsas, Thomas; Schiesari, Laura; Kolly, Veronique; Perneger, Thomas V.			Barriers to Participation in a Patient Satisfaction Survey: Who Are We Missing?	PLOS ONE			English	Article							DECISIONAL CAPACITY; ALCOHOL-CONSUMPTION; LANGUAGE BARRIERS; NONRESPONSE BIAS; RESPONSE RATES; HEALTH-CARE; DISEASE; WILLINGNESS; INDIVIDUALS; PERCEPTIONS	Background: A common weakness of patient satisfaction surveys is a suboptimal participation rate. Some patients may be unable to participate, because of language barriers, physical limitations, or mental problems. As the role of these barriers is poorly understood, we aimed to identify patient characteristics that are associated with non-participation in a patient satisfaction survey. Methodology: At the University Hospitals of Geneva, Switzerland, a patient satisfaction survey is regularly conducted among all adult patients hospitalized for >24 hours on a one-month period in the departments of internal medicine, geriatrics, surgery, neurosciences, psychiatry, and gynaecology-obstetrics. In order to assess the factors associated with non-participation to the patient satisfaction survey, a case-control study was conducted among patients selected for the 2005 survey. Cases (non respondents, n = 195) and controls (respondents, n = 205) were randomly selected from the satisfaction survey, and information about potential barriers to participation was abstracted in a blinded fashion from the patients' medical and nursing charts. Principal Findings: Non-participation in the satisfaction survey was independently associated with the presence of a language barrier (odds ratio [OR] 4.53, 95% confidence interval [CI95%]: 2.14-9.59), substance abuse (OR 3.75, CI95%: 1.97-7.14), cognitive limitations (OR 3.72, CI95%: 1.64-8.42), a psychiatric diagnosis (OR 1.99, CI95%: 1.23-3.23) and a sight deficiency (OR 2.07, CI95%: 0.98-4.36). The odds ratio for non-participation increased gradually with the number of predictors. Conclusions: Five barriers to non-participation in a mail survey were identified. Gathering patient feedback through mailed surveys may lead to an under-representation of some patient subgroups.	[Gayet-Ageron, Angele; Agoritsas, Thomas; Perneger, Thomas V.] Univ Geneva, Div Clin Epidemiol, Dept Community Hlth & Med, Univ Hosp Geneva, Geneva, Switzerland; [Schiesari, Laura] Univ Geneva, Qual Care Serv, Univ Hosp Geneva, Geneva, Switzerland; [Schiesari, Laura] Hosp Sirio Libanes, Qual Care Unit, Sao Paulo, Brazil; [Kolly, Veronique] Univ Hosp Geneva, Off Mediat, Geneva, Switzerland	University of Geneva; University of Geneva; Hospital Sirio Libanes; University of Geneva	Gayet-Ageron, A (corresponding author), Univ Geneva, Div Clin Epidemiol, Dept Community Hlth & Med, Univ Hosp Geneva, Geneva, Switzerland.	angele.gayet-ageron@hcuge.ch	Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969; Gayet-Ageron, Angele/0000-0002-6164-9693				ASCH DA, 1994, EPIDEMIOLOGY, V5, P364, DOI 10.1097/00001648-199405000-00020; Bischoff A, 1999, SOZ PRAVENTIV MED, V44, P248, DOI 10.1007/BF01358973; Boshuizen HC, 2006, PUBLIC HEALTH, V120, P297, DOI 10.1016/j.puhe.2005.09.008; Candilis PJ, 2006, SCHIZOPHRENIA BULL, V32, P159; Conner KR, 2009, J SUBST ABUSE TREAT, V37, P127, DOI 10.1016/j.jsat.2008.11.007; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Duncan PW, 2002, STROKE, V33, P2593, DOI 10.1161/01.STR.0000034395.06874.3E; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Etter JF, 1997, J CLIN EPIDEMIOL, V50, P1123, DOI 10.1016/S0895-4356(97)00166-2; Frei D, 2006, STAT MEMENTO CANTON; Gmel G, 2003, ALCOHOL RES HEALTH, V27, P52; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Groves R, 2004, SURV METHODOL, P169; Groves R, 2004, SURV METHODOL, P201; Harmsen JAM, 2008, PATIENT EDUC COUNS, V72, P155, DOI 10.1016/j.pec.2008.03.018; Hartge P, 1999, EPIDEMIOLOGY, V10, P105; Hebert R, 1996, J CLIN EPIDEMIOL, V49, P373, DOI 10.1016/0895-4356(95)00527-7; Holt VL, 1997, J CLIN EPIDEMIOL, V50, P1117, DOI 10.1016/S0895-4356(97)00096-6; Hudelson P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-187; Jacomb PA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-4; Jefferson AL, 2008, J AM GERIATR SOC, V56, P1236, DOI 10.1111/j.1532-5415.2008.01752.x; Jeste DV, 2006, SCHIZOPHRENIA BULL, V32, P121; Kjoller M, 2005, EUR J PUBLIC HEALTH, V15, P528, DOI 10.1093/eurpub/cki023; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; Nakash Rachel A, 2006, BMC Med Res Methodol, V6, P5, DOI 10.1186/1471-2288-6-5; Nelson KM, 2004, ETHNIC DIS, V14, P580; Okonkwo OC, 2008, NEUROLOGY, V71, P1474, DOI 10.1212/01.wnl.0000334301.32358.48; Palmer BW, 2007, J CLIN PSYCHIAT, V68, P689, DOI 10.4088/JCP.v68n0505; Penckofer S, 2011, NURS SCI QUART, V24, P146, DOI 10.1177/0894318411399454; Perneger TV, 2005, MED CARE, V43, P374, DOI 10.1097/01.mlr.0000156856.36901.40; Peytremann-Bridevaux I, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-108; Pignone M, 2005, J GEN INTERN MED, V20, P185, DOI 10.1111/j.1525-1497.2005.40208.x; Rehm J, 2007, INT J PUBLIC HEALTH, V52, P383, DOI 10.1007/s00038-007-7010-0; Rendell JM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000021.pub3; Rosenthal GE, 1997, MED CARE, V35, pNS58, DOI 10.1097/00005650-199711001-00007; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Schouten BC, 2007, PATIENT EDUC COUNS, V67, P214, DOI 10.1016/j.pec.2007.03.018; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tolonen H, 2010, EUR J EPIDEMIOL, V25, P69, DOI 10.1007/s10654-009-9389-9; Wall M, 2004, SCAND J PRIM HEALTH, V22, P248, DOI 10.1080/02813430410006611; Wild TC, 2001, J STUD ALCOHOL, V62, P257, DOI 10.15288/jsa.2001.62.257; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Young GJ, 2000, MED CARE, V38, P325, DOI 10.1097/00005650-200003000-00009	43	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26852	10.1371/journal.pone.0026852	http://dx.doi.org/10.1371/journal.pone.0026852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046382	Green Published, gold			2022-12-27	WOS:000296519600068
J	Javadi, M; Ebrahimpour, R; Sajedin, A; Faridi, S; Zakernejad, S				Javadi, Mehrdad; Ebrahimpour, Reza; Sajedin, Atena; Faridi, Soheil; Zakernejad, Shokoufeh			Improving ECG Classification Accuracy Using an Ensemble of Neural Network Modules	PLOS ONE			English	Article							COMBINING MULTIPLE CLASSIFIERS; PATTERN-RECOGNITION; WAVELET; MIXTURE; EXPERTS; TRANSFORMS	This paper illustrates the use of a combined neural network model based on Stacked Generalization method for classification of electrocardiogram (ECG) beats. In conventional Stacked Generalization method, the combiner learns to map the base classifiers' outputs to the target data. We claim adding the input pattern to the base classifiers' outputs helps the combiner to obtain knowledge about the input space and as the result, performs better on the same task. Experimental results support our claim that the additional knowledge according to the input space, improves the performance of the proposed method which is called Modified Stacked Generalization. In particular, for classification of 14966 ECG beats that were not previously seen during training phase, the Modified Stacked Generalization method reduced the error rate for 12.41% in comparison with the best of ten popular classifier fusion methods including Max, Min, Average, Product, Majority Voting, Borda Count, Decision Templates, Weighted Averaging based on Particle Swarm Optimization and Stacked Generalization.	[Javadi, Mehrdad; Sajedin, Atena; Faridi, Soheil] Islamic Azad Univ, S Tehran Branch, Tehran, Iran; [Ebrahimpour, Reza; Zakernejad, Shokoufeh] Shahid Rajaee Teacher Training Univ, Brain & Intelligent Syst Res Lab, Dept Elect & Comp Engn, Tehran, Iran; [Ebrahimpour, Reza; Sajedin, Atena; Faridi, Soheil] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran	Islamic Azad University; Shahid Rajaee Teacher Training University (SRTTU)	Javadi, M (corresponding author), Islamic Azad Univ, S Tehran Branch, Tehran, Iran.	MJavadi@azad.ac.ir	Ebrahimpour, Reza/AAH-8531-2019; Javadi, Mehrdad/AAK-6699-2021; Ebrahimpour, Reza/A-9721-2009	Ebrahimpour, Reza/0000-0002-7013-8078; Javadi, Mehrdad/0000-0001-6328-1063; 	Islamic Azad University, South Tehran Branch	Islamic Azad University, South Tehran Branch(Islamic Azad University)	This work was supported by a grant from Islamic Azad University, South Tehran Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2003, PATTERN RECOGN, V36, P61, DOI 10.1016/S0031-3203(02)00063-8; Addison PS, 2000, IEEE ENG MED BIOL, V19, P104, DOI 10.1109/51.870237; Akay M, 1997, IEEE SPECTRUM, V34, P50, DOI 10.1109/6.590747; Al-Fahoum AS, 1999, MED BIOL ENG COMPUT, V37, P566, DOI 10.1007/BF02513350; ALALAOUI MA, 1986, IEEE T INSTRUM MEAS, V35, P304, DOI 10.1109/TIM.1986.6499214; Alpaydin E, 1996, IEEE T NEURAL NETWOR, V7, P788, DOI 10.1109/72.501737; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CHALLIS RE, 1990, MED BIOL ENG COMPUT, V28, P509, DOI 10.1007/BF02442601; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; de Chazal P, 2003, INT CONF ACOUST SPEE, P269; Dokur Z, 2001, COMPUT METH PROG BIO, V66, P167, DOI 10.1016/S0169-2607(00)00133-4; Dokur Z, 1999, ELECTRON LETT, V35, P1502, DOI 10.1049/el:19991095; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Ebrahimpour R, 2008, INTELL AUTOM SOFT CO, V14, P151, DOI 10.1080/10798587.2008.10642988; Ebrahimpour R, 2011, MACH VISION APPL, V22, P421, DOI 10.1007/s00138-009-0232-9; Ebrahimzadeh A, 2010, MEASUREMENT, V43, P103, DOI 10.1016/j.measurement.2009.07.002; Ebrahimzadeh A, 2009, ADV ELECTR COMPUT EN, V9, P89, DOI 10.4316/AECE.2009.03016; Foo SY, 2002, ENG APPL ARTIF INTEL, V15, P253, DOI 10.1016/S0952-1976(02)00041-6; GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960; Guler I, 2005, COMPUT BIOL MED, V35, P565, DOI 10.1016/j.compbiomed.2004.04.001; Guler I, 2005, PATTERN RECOGN, V38, P199, DOI 10.1016/j.patcog.2004.06.009; Haykin S, 1999, P842; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hu YH, 1997, IEEE T BIO-MED ENG, V44, P891, DOI 10.1109/10.623058; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kuncheva L I, 2004, COMBINING PATTERN CL; Kuncheva LI, 2001, PATTERN RECOGN, V34, P299, DOI 10.1016/S0031-3203(99)00223-X; Kundu M, 2000, PATTERN RECOGN, V33, P351, DOI 10.1016/S0031-3203(99)00065-5; Maglaveras N, 1998, INT J MED INFORM, V52, P191, DOI 10.1016/S1386-5056(98)00138-5; Minami K, 1999, IEEE T BIO-MED ENG, V46, P179, DOI 10.1109/10.740880; Moody G. B., 1990, COMPUT CARDIOL, P185, DOI DOI 10.1109/CIC.1990.144205; Moraes JCTB, 2002, COMPUT CARDIOL, V29, P201, DOI 10.1109/CIC.2002.1166742; Nabavi-Kerizi SH, 2010, COMPUT ELECTR ENG, V36, P886, DOI 10.1016/j.compeleceng.2008.04.006; NG KC, 1992, IEEE T SYST MAN CYB, V22, P916, DOI 10.1109/21.179832; Nugent CD, 1999, ARTIF INTELL MED, V16, P205, DOI 10.1016/S0933-3657(99)00006-8; Osowski S, 2008, MEASUREMENT, V41, P610, DOI 10.1016/j.measurement.2007.07.006; Osowski S, 2001, IEEE T BIO-MED ENG, V48, P1265, DOI 10.1109/10.959322; Ozbay Y, 2006, COMPUT BIOL MED, V36, P376, DOI 10.1016/j.compbiomed.2005.01.006; Ozbay Y, 2001, P ANN INT IEEE EMBS, V23, P1680; Pektatli R, 2003, P INT 12 TAINN 03 CA, V1, P105; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Rafiee J, 2011, EXPERT SYST APPL, V38, P6190, DOI 10.1016/j.eswa.2010.11.050; Rastrigin L. A., 1981, METHOD COLLECTIVE RE; Rosenblatt F., 1957, 854601 CORN AER LAB; Saxena SC, 2002, INT J SYST SCI, V33, P1073, DOI 10.1080/00207720210167159; Simon BP, 1997, COMPUT BIOMED RES, V30, P257, DOI 10.1006/cbmr.1997.1446; Singh BN, 2006, DIGIT SIGNAL PROCESS, V16, P275, DOI 10.1016/j.dsp.2005.12.003; Sternickel K, 2002, COMPUT METH PROG BIO, V68, P109, DOI 10.1016/S0169-2607(01)00168-7; Tax DMJ, 2000, PATTERN RECOGN, V33, P1475, DOI 10.1016/S0031-3203(99)00138-7; Ubeyli ED, 2007, DIGIT SIGNAL PROCESS, V17, P675, DOI 10.1016/j.dsp.2006.11.009; Ubeyli ED, 2009, DIGIT SIGNAL PROCESS, V19, P320, DOI 10.1016/j.dsp.2008.09.002; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; Wang ZS, 1997, P ANN INT IEEE EMBS, V19, P1351, DOI 10.1109/IEMBS.1997.756627; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Woods K, 1997, IEEE T PATTERN ANAL, V19, P405, DOI 10.1109/34.588027; XU L, 1992, IEEE T SYST MAN CYB, V22, P418, DOI 10.1109/21.155943	57	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e24386	10.1371/journal.pone.0024386	http://dx.doi.org/10.1371/journal.pone.0024386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046232	Green Published, gold			2022-12-27	WOS:000296519600002
J	MacPherson, JI; Sidders, B; Wieland, S; Zhong, J; Targett-Adams, P; Lohmann, V; Backes, P; Delpuech-Adams, O; Chisari, F; Lewis, M; Parkinson, T; Robertson, DL				MacPherson, Jamie I.; Sidders, Ben; Wieland, Stefan; Zhong, Jin; Targett-Adams, Paul; Lohmann, Volker; Backes, Perdita; Delpuech-Adams, Oona; Chisari, Francis; Lewis, Marilyn; Parkinson, Tanya; Robertson, David L.			An Integrated Transcriptomic and Meta-Analysis of Hepatoma Cells Reveals Factors That Influence Susceptibility to HCV Infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INNATE IMMUNE-RESPONSE; CORE PROTEIN; RNA REPLICATION; GENE-EXPRESSION; CELLULAR COFACTORS; UBIQUITIN LIGASE; F PROTEIN; APOPTOSIS; IDENTIFICATION	Hepatitis C virus (HCV) is a global problem. To better understand HCV infection researchers employ in vitro HCV cell-culture (HCVcc) systems that use Huh-7 derived hepatoma cells that are particularly permissive to HCV infection. A variety of hyper-permissive cells have been subcloned for this purpose. In addition, subclones of Huh-7 which have evolved resistance to HCV are available. However, the mechanisms of susceptibility or resistance to infection among these cells have not been fully determined. In order to elucidate mechanisms by which hepatoma cells are susceptible or resistant to HCV infection we performed genome-wide expression analyses of six Huh-7 derived cell cultures that have different levels of permissiveness to infection. A great number of genes, representing a wide spectrum of functions are differentially expressed between cells. To focus our investigation, we identify host proteins from HCV replicase complexes, perform gene expression analysis of three HCV infected cells and conduct a detailed analysis of differentially expressed host factors by integrating a variety of data sources. Our results demonstrate that changes relating to susceptibility to HCV infection in hepatoma cells are linked to the innate immune response, secreted signal peptides and host factors that have a role in virus entry and replication. This work identifies both known and novel host factors that may influence HCV infection. Our findings build upon current knowledge of the complex interplay between HCV and the host cell, which could aid development of new antiviral strategies.	[MacPherson, Jamie I.; Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Sidders, Ben; Targett-Adams, Paul; Delpuech-Adams, Oona; Lewis, Marilyn; Parkinson, Tanya] Pfizer Global Res & Dev, Sandwich, Kent, England; [Wieland, Stefan; Zhong, Jin; Chisari, Francis] Scripps Res Inst, La Jolla, CA 92037 USA; [Lohmann, Volker; Backes, Perdita] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany	University of Manchester; Pfizer; Scripps Research Institute; Ruprecht Karls University Heidelberg	MacPherson, JI (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.robertson@manchester.ac.uk	Zhong, Jin/J-4613-2019; Chisari, Francis V/A-3086-2008; Lohmann, Volker/H-4211-2019; Zhong, Jin/M-6859-2018	Lohmann, Volker/0000-0001-8719-7608; Sidders, Ben/0000-0003-2733-3078; Targett-Adams, Paul/0000-0003-4967-1668; Chisari, Francis/0000-0002-4832-1044; Zhong, Jin/0000-0002-3554-1275	BBSRC; Pfizer; National Institutes of Health [R01-AI079043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079043] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JIM was funded by a BBSRC CASE studentship with industry partner Pfizer Global Research and Development. Pfizer funded the experiments. The Pfizer authors had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. This work was also supported by National Institutes of Health Grant R01-AI079043 (FC).	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; [Anonymous], R PROJECT STAT COMPU; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Drouet C, 1999, FEBS LETT, V458, P415, DOI 10.1016/S0014-5793(99)01194-1; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YP, 2005, WORLD J GASTROENTERO, V11, P5659, DOI 10.3748/wjg.v11.i36.5659; Inoue Y, 2007, JPN J INFECT DIS, V60, P173; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lu XS, 2006, BIOESSAYS, V28, P739, DOI 10.1002/bies.20433; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ng TI, 2007, HEPATOLOGY, V45, P1413, DOI 10.1002/hep.21608; Nguyen H, 2006, VIROLOGY, V354, P58, DOI 10.1016/j.virol.2006.04.028; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Park KJ, 2002, J BIOL CHEM, V277, P13122, DOI 10.1074/jbc.M111599200; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Richer MJ, 2004, J BIOL CHEM, V279, P10222, DOI 10.1074/jbc.M313852200; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao SW, 2009, HEPATOL RES, V39, P282, DOI 10.1111/j.1872-034X.2008.00452.x; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zhu HZ, 2004, BIOCHEM BIOPH RES CO, V324, P518, DOI 10.1016/j.bbrc.2004.09.081; QC REPORT GENERATION; VARIOUS R PROGRAMMIN; COLLECTION PCA METHO	96	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25584	10.1371/journal.pone.0025584	http://dx.doi.org/10.1371/journal.pone.0025584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046242	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000296517000008
J	Uchiyama, J; Takemura, I; Satoh, M; Kato, SI; Ujihara, T; Akechi, K; Matsuzaki, S; Daibata, M				Uchiyama, Jumpei; Takemura, Iyo; Satoh, Miho; Kato, Shin-ichiro; Ujihara, Takako; Akechi, Kazue; Matsuzaki, Shigenobu; Daibata, Masanori			Improved Adsorption of an Enterococcus faecalis Bacteriophage Phi EF24C with a Spontaneous Point Mutation	PLOS ONE			English	Article							CHRONIC BACTERIAL PROSTATITIS; PHAGE THERAPY; HOST-RANGE; T2 PHAGE; TAIL; EVOLUTION; GENOME; MICROBIOLOGY; COEVOLUTION; INFECTIONS	Some bacterial strains of the multidrug-resistant Gram-positive bacteria Enterococcus faecalis can significantly reduce the efficacy of conventional antimicrobial chemotherapy. Thus, the introduction of bacteriophage (phage) therapy is expected, where a phage is used as a bioagent to destroy bacteria. E. faecalis phage Phi EF24C is known to be a good candidate for a therapeutic phage against E. faecalis. However, this therapeutic phage still produces nonuniform antimicrobial effects with different bacterial strains of the same species and this might prove detrimental to its therapeutic effects. One solution to this problem is the preparation of mutant phages with higher activity, based on a scientific rationale. This study isolated and analyzed a spontaneous mutant phage, Phi EF24C-P2, which exhibited higher infectivity against various bacterial strains when compared with phage Phi EF24C. First, the improved bactericidal effects of phage Phi EF24C-P2 were attributable to its increased adsorption rate. Moreover, genomic sequence scanning revealed that phage Phi EF24C-P2 had a point mutation in orf31. Proteomic analysis showed that ORF31 (mw, 203 kDa) was present in structural components, and immunological analysis using rabbit-derived antibodies showed that it was a component of a long, flexible fine tail fiber extending from the tail end. Finally, phage Phi EF24C-P2 also showed higher bactericidal activity in human blood compared with phage Phi EF24C using the in vitro assay system. In conclusion, the therapeutic effects of phage Phi EF24C-P2 were improved by a point mutation in gene orf31, which encoded a tail fiber component.	[Uchiyama, Jumpei; Takemura, Iyo; Akechi, Kazue; Matsuzaki, Shigenobu; Daibata, Masanori] Kochi Univ, Dept Microbiol & Infect, Fac Med, Kochi 780, Japan; [Satoh, Miho; Kato, Shin-ichiro; Ujihara, Takako] Kochi Univ, Ctr Sci Res, Kochi 780, Japan	Kochi University; Kochi University	Uchiyama, J (corresponding author), Kochi Univ, Dept Microbiol & Infect, Fac Med, Kochi 780, Japan.	matuzaki@kochi-u.ac.jp	Uchiyama, Jumpei/GWC-4189-2022; Uchiyama, Jumpei/GNP-6661-2022	Uchiyama, Jumpei/0000-0003-0846-0100	Center of Biomembrane Functions Controlling Biological Systems, Kochi University; Kochi System Glycobiology Center, Kochi University;  [22890129]; Grants-in-Aid for Scientific Research [22890129, 23591391] Funding Source: KAKEN	Center of Biomembrane Functions Controlling Biological Systems, Kochi University; Kochi System Glycobiology Center, Kochi University; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This article was supported by a Grant-in-Aid for Research Activity Startup No. 22890129 (http://kaken.nii.ac.jp/ja/r/20574619); the Center of Biomembrane Functions Controlling Biological Systems, Kochi University (http://www.kochi-ms.ac.jp/similar to cbm/index.htm); the Kochi System Glycobiology Center, Kochi University (http://www.kochi-ms.ac.jp/similar to ksglycoc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Alemayehu D, 2009, GENE, V448, P29, DOI 10.1016/j.gene.2009.08.008; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carlson K, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P437; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P7069, DOI 10.1128/JB.186.21.7069-7083.2004; Deshpande LM, 2007, DIAGN MICR INFEC DIS, V58, P163, DOI 10.1016/j.diagmicrobio.2006.12.022; Desplats C, 2003, RES MICROBIOL, V154, P259, DOI 10.1016/S0923-2508(03)00069-X; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Fujita Naohisa, 2005, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V16, P1; GORSKI A, 2009, FOLIA MICROBIOL PRAH, V54, P5; Hatfull GF, 2002, SCIENCE, V295, P2031, DOI 10.1126/science.1070586; Hsieh SE, 2011, APPL ENVIRON MICROB, V77, P756, DOI 10.1128/AEM.01848-10; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Inal JM, 2003, ARCH IMMUNOL THER EX, V51, P237; JONCZYK E, 2010, FEMS IMMUNOL MED MIC, V60, P99; Kashiwagi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002188; Kasparek P, 2007, FOLIA MICROBIOL, V52, P331, DOI 10.1007/BF02932087; Kayser FH, 2003, INT J FOOD MICROBIOL, V88, P255, DOI 10.1016/S0168-1605(03)00188-0; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Klumpp J, 2010, ARCH VIROL, V155, P1547, DOI 10.1007/s00705-010-0783-0; Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Letkiewicz S, 2009, FOLIA MICROBIOL, V54, P457, DOI 10.1007/s12223-009-0064-z; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Mazzoli S, 2010, FEMS IMMUNOL MED MIC, V59, P337, DOI 10.1111/j.1574-695X.2010.00659.x; Mesyanzhinov VV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1190, DOI 10.1007/s10541-005-0064-9; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Powers JH, 2004, CLIN MICROBIOL INFEC, V10, P23, DOI 10.1111/j.1465-0691.2004.1007.x; SANDMEIER H, 1992, J BACTERIOL, V174, P3936, DOI 10.1128/jb.174.12.3936-3944.1992; SELICK HE, 1988, J BIOL CHEM, V263, P11336; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Sood S, 2008, INDIAN J MED RES, V128, P111; Stewart CR, 2009, J MOL BIOL, V388, P48, DOI 10.1016/j.jmb.2009.03.009; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Switala-Jelen K, 2002, ACTA VIROL, V46, P57; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tamames J, 2001, GENOME BIOL, V2; Uchiyama J, 2008, APPL ENVIRON MICROB, V74, P4149, DOI 10.1128/AEM.02371-07; Uchiyama J, 2008, FEMS MICROBIOL LETT, V278, P200, DOI 10.1111/j.1574-6968.2007.00996.x; Uchiyama J, 2009, MICROBIOL IMMUNOL, V53, P301, DOI 10.1111/j.1348-0421.2009.00125.x; Yoichi M, 2005, J BIOTECHNOL, V115, P101, DOI 10.1016/j.jbiotec.2004.08.003	53	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26648	10.1371/journal.pone.0026648	http://dx.doi.org/10.1371/journal.pone.0026648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046321	Green Published, gold			2022-12-27	WOS:000296517000023
J	Persons, WS; Currie, PJ				Persons, W. Scott; Currie, Philip J.			Dinosaur Speed Demon: The Caudal Musculature of Carnotaurus sastrei and Implications for the Evolution of South American Abelisaurids	PLOS ONE			English	Article							CARNIVOROUS DINOSAUR; ROTATIONAL INERTIA; ALLIGATOR; THEROPODA; TAIL	In the South American abelisaurids Carnotaurus sastrei, Aucasaurus garridoi, and, to a lesser extent Skorpiovenator bustingorryi, the anterior caudal ribs project at a high dorsolateral inclination and have interlocking lateral tips. This unique morphology facilitated the expansion of the caudal hypaxial musculature at the expense of the epaxial musculature. Distinct ridges on the ventrolateral surfaces of the caudal ribs of Aucasaurus garridoi are interpreted as attachment scars from the intra caudofemoralis/ilio-ischiocaudalis septa, and confirm that the M. caudofemoralis of advanced South American abelisaurids originated from a portion of the caudal ribs. Digital muscle models indicate that, relative to its overall body size, Carnotaurus sastrei had a substantially larger M. caudofemoralis than any other theropod yet studied. In most non-avian theropods, as in many extant sauropsids, the M. caudofemoralis served as the primary femoral retractor muscle during the locomotive power stroke. This large investment in the M. caudofemoralis suggests that Carnotaurus sastrei had the potential for great cursorial abilities, particularly short-burst sprinting. However, the tightly interlocking morphology of the anterior caudal vertebrae implies a reduced ability to make tight turns. Examination of these vertebral traits in evolutionary context reveals a progressive sequence of increasing caudofemoral mass and tail rigidity among the Abelisauridae of South America.	[Persons, W. Scott; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Persons, WS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	persons@ualberta.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Dinosaur Research Institute	Dinosaur Research Institute	This work was made possible by the financial support of the Dinosaur Research Institute (http://www.dinosaurresearch.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Bates KT, 2010, J VERTEBR PALEONTOL, V30, P458, DOI 10.1080/02724630903409329; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Calvo JO, 2004, AMEGHINIANA, V41, P555; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Carrier DR, 2001, J EXP BIOL, V204, P3917; Cong L., 1998, GROSS ANATOMY ALLIGA; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria Rodolfo A., 2000, Gaia (Lisboa), V15, P89; Coria Rodolfo A., 2007, P229; Ernelinnov SW., 1937, ZOOLOGISCHE JB AOT, V62, P173; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Higgins GM, 1923, AM J ANAT, V31, P373, DOI 10.1002/aja.1000310405; Juarez Valieri RD, 2010, PALEONTOLOGIA DINOSA, P161; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Manning P., 2008, GRAVE SECRETS DINOSA; Mazzatta Gerardo V., 2000, Gaia (Lisboa), V15, P185; McNeel Robert & Associates, 2007, RHIN NURBS MOD WIND; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P67; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Paul GS, 2010, DINOSAUR MASS ESTIMA; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; Romer A, 1956, OSTEOLOGY REPTILES; ROMER ALFRED S., 1927, ACTA ZOOL [STOCKHOLM], V8, P225; Romer AS, 1923, B AM MUS NAT HIST, V48, P605; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; SNYDER RC, 1962, AM ZOOL, V2, P191; Wilhite R., 2003, THESIS LOUISIANA STA; Wilson Jeffrey A., 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P1	39	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25763	10.1371/journal.pone.0025763	http://dx.doi.org/10.1371/journal.pone.0025763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043292	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400020
J	Backman, LJ; Fong, G; Andersson, G; Scott, A; Danielson, P				Backman, Ludvig J.; Fong, Gloria; Andersson, Gustav; Scott, Alexander; Danielson, Patrik			Substance P Is a Mechanoresponsive, Autocrine Regulator of Human Tenocyte Proliferation	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; LOCAL CATECHOLAMINE PRODUCTION; IN-SITU HYBRIDIZATION; NEUROKININ-1 RECEPTOR; GROWTH-FACTOR; FIBROBLAST PROLIFERATION; PATELLAR TENDINOSIS; HUMAN COLONOCYTES; PAINFUL ACHILLES; DOWN-REGULATION	It has been hypothesised that substance P (SP) may be produced by primary fibroblastic tendon cells (tenocytes), and that this production, together with the widespread distribution of the neurokinin-1 receptor (NK-1 R) in tendon tissue, could play an important role in the development of tendinopathy, a condition of chronic tendon pain and thickening. The aim of this study was to examine the possibility of endogenous SP production and the expression of NK-1 R by human tenocytes. Because tendinopathy is related to overload, and because the predominant tissue pathology (tendinosis) underlying early tendinopathy is characterized by tenocyte hypercellularity, the production of SP in response to loading/strain and the effects of exogenously administered SP on tenocyte proliferation were also studied. A cell culture model of primary human tendon cells was used. The vast majority of tendon cells were immunopositive for the tenocyte/fibroblast markers tenomodulin and vimentin, and immunocytochemical counterstaining revealed that positive immunoreactions for SP and NK-1 R were seen in a majority of these cells. Gene expression analyses showed that mechanical loading (strain) of tendon cell cultures using the FlexCell (R) technique significantly increased the mRNA levels of SP, whereas the expression of NK-1 R mRNA decreased in loaded as compared to unloaded tendon cells. Reduced NK-1 R protein was also observed, using Western blot, after exogenously administered SP at a concentration of 10(-7) M. SP exposure furthermore resulted in increased cell metabolism, increased cell viability, and increased cell proliferation, all of which were found to be specifically mediated via the NK-1 R; this in turn involving a common mitogenic cell signalling pathway, namely phosphorylation of ERK1/2. This study indicates that SP, produced by tenocytes in response to mechanical loading, may regulate proliferation through an autocrine loop involving the NK-1 R.	[Backman, Ludvig J.; Fong, Gloria; Andersson, Gustav; Danielson, Patrik] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Backman, Ludvig J.] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Backman, Ludvig J.; Fong, Gloria; Scott, Alexander] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Fong, Gloria; Scott, Alexander] Vancouver Coastal Hlth & Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada	Umea University; Umea University; University of British Columbia; Vancouver Coastal Health Research Institute	Backman, LJ (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	patrik.danielson@anatomy.umu.se		Scott, Alex/0000-0003-0366-8404	National Swedish Research Council [521-2009-2921]; Swedish National Centre for Research in Sports [54/10, P2011-0170]; Sven and Dagmar Salen Foundation; Magn. Bergvall Foundation; Tore Nilsson Foundation for Medical Research; Sigurd and Elsa Golje Memorial Foundation; Swedish Society of Medicine; Fund-raising Foundation of the Faculty of Medicine at Umel University; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Umea University; Swedish Fund for Research Without Animal Experiments; Foundation Muskelfond Norr; Knut and Alice Wallenberg Foundation, Umea University; J.C. Kempe Memorial Foundation Academic Funds at Umea University; University of British Columbia	National Swedish Research Council(Swedish Research Council); Swedish National Centre for Research in Sports; Sven and Dagmar Salen Foundation; Magn. Bergvall Foundation; Tore Nilsson Foundation for Medical Research; Sigurd and Elsa Golje Memorial Foundation; Swedish Society of Medicine; Fund-raising Foundation of the Faculty of Medicine at Umel University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Umea University; Swedish Fund for Research Without Animal Experiments; Foundation Muskelfond Norr; Knut and Alice Wallenberg Foundation, Umea University(Knut & Alice Wallenberg Foundation); J.C. Kempe Memorial Foundation Academic Funds at Umea University; University of British Columbia	Financially, this work was primarily supported by the National Swedish Research Council (P.D., A.S.; 521-2009-2921). Financial support was furthermore obtained by the Swedish National Centre for Research in Sports (P.D.; 54/10 and P2011-0170), the Sven and Dagmar Salen Foundation (P.D.), the Magn. Bergvall Foundation (P.D.), the Tore Nilsson Foundation for Medical Research (P.D.), the Sigurd and Elsa Golje Memorial Foundation (P.D.), the Swedish Society of Medicine (P.D.), the Fund-raising Foundation of the Faculty of Medicine at Umel University (P.D.), the Canadian Institutes of Health Research (A.S.), the Michael Smith Foundation for Health Research (A.S.), and the Umea University Young Researcher Award (P.D.). The Swedish Fund for Research Without Animal Experiments (P.D.), the Foundation Muskelfond Norr (P.D.), the Knut and Alice Wallenberg Foundation (Vice-chancelor's fund at Umea University; L.J.B.), and the J.C. Kempe Memorial Foundation Academic Funds at Umea University (L.J.B.) generously provided travelling grants which made the co-operation between Umea University and the University of British Columbia possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750; Andersson G, 2011, BRIT J SPORT MED, V45, P399, DOI 10.1136/bjsm.2009.068122; BACKMAN C, 1990, J ORTHOPAED RES, V8, P541, DOI 10.1002/jor.1100080410; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Bennett VJ, 2002, J PHARMACOL EXP THER, V303, P1155, DOI 10.1124/jpet.102.040378; Bjur D, 2008, CELL TISSUE RES, V331, P385, DOI 10.1007/s00441-007-0524-1; Bjur D, 2008, HISTOL HISTOPATHOL, V23, P197, DOI 10.14670/HH-23.197; Burssens P, 2005, FOOT ANKLE INT, V26, P832, DOI 10.1177/107110070502601008; Carlsson O, 2011, SCAND J MED SCI SPOR, V21, P562, DOI 10.1111/j.1600-0838.2009.01080.x; Corps AN, 2008, MATRIX BIOL, V27, P393, DOI 10.1016/j.matbio.2008.02.002; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; Courneya JP, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-9; Danielson P, 2009, BRIT J SPORT MED, V43, P265, DOI 10.1136/bjsm.2008.054593; Danielson P, 2007, LIFE SCI, V80, P2235, DOI 10.1016/j.lfs.2007.01.005; Danielson P, 2007, MICROSC RES TECHNIQ, V70, P908, DOI 10.1002/jemt.20495; Danielson P, 2007, MICROSC RES TECHNIQ, V70, P310, DOI 10.1002/jemt.20413; Danielson P, 2006, MICROSC RES TECHNIQ, V69, P808, DOI 10.1002/jemt.20351; de Mos M, 2009, AM J SPORT MED, V37, P1214, DOI 10.1177/0363546508331137; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; FAN TPD, 1993, BRIT J PHARMACOL, V110, P43, DOI 10.1111/j.1476-5381.1993.tb13769.x; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; Forsgren S, 2005, REGUL PEPTIDES, V126, P173, DOI 10.1016/j.regpep.2004.09.008; Goodman SA, 2004, BIORHEOLOGY, V41, P613; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Jozsa L.G., 1997, HUMAN TENDONS ANATOM; KAHLER CM, 1993, J CELL PHYSIOL, V156, P579, DOI 10.1002/jcp.1041560318; Kahler CM, 1996, J CELL PHYSIOL, V166, P601; Khan KM, 2000, BRIT J SPORT MED, V34, P81, DOI 10.1136/bjsm.34.2.81; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; KVIST M, 1987, PATHOLOGY, V19, P1; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lind H, 1996, CLIN PHYSIOL, V16, P73, DOI 10.1111/j.1475-097X.1996.tb00557.x; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Messner K, 1999, CELLS TISSUES ORGANS, V165, P30, DOI 10.1159/000016671; Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; RUFAI A, 1992, ANAT EMBRYOL, V186, P611; Santoni G, 2002, NEUROIMMUNOMODULAT, V10, P232, DOI 10.1159/000068327; Schubert TEO, 2005, ANN RHEUM DIS, V64, P1083, DOI 10.1136/ard.2004.029876; Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124; Scott A, 2008, J ORTHOP RES, V26, P685, DOI 10.1002/jor.20536; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Steyaert A, 2010, ACTA ORTHOP BELG, V76, P387; Tansky MF, 2007, P NATL ACAD SCI USA, V104, P10691, DOI 10.1073/pnas.0703394104; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10	49	62	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27209	10.1371/journal.pone.0027209	http://dx.doi.org/10.1371/journal.pone.0027209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069500	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900060
J	Brogren, H; Wallmark, K; Deinum, J; Karlsson, L; Jern, S				Brogren, Helen; Wallmark, Karin; Deinum, Johanna; Karlsson, Lena; Jern, Sverker			Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ANTIGEN ASSAYS; PAI-1; TYPE-1; THROMBI; PROTEINS; PLASMA; IDENTIFICATION; THROMBOLYSIS; VITRONECTIN	The vascular fibrinolytic system is crucial for spontaneous lysis of blood clots. Plasminogen activator inhibitor 1 (PAI-1), the principal inhibitor of the key fibrinolytic enzyme tissue-type plasminogen activator (tPA), is present in platelets at high concentrations. However, the majority of PAI-1 stored in platelets has been considered to be inactive. Our recent finding (Brogren H, et al. Blood 2004) that PAI-1 de novo synthesized in platelets remained active for over 24 h, suggested that PAI-1 stored in the a-granules might be active to a larger extent than previously reported. To re-evaluate this issue, we performed experiments where the fraction of active PAI-1 was estimated by analyzing the tPA-PAI-1 complex formation. In these experiments platelets were lysed with Triton X-100 in the presence of serial dilutions of tPA and subsequently the tPA-PAI-1 complex was evaluated by Western blot. Also, using a non-immunologic assay, tPA was labeled with I-125, and I-125-tPA and I-125-tPA-PAI-1 was quantified by scintigraphy. Interestingly, both methods demonstrated that the majority (>50%) of platelet PAI-1 is active. Further analyses suggested that pre-analytical procedures used in previous studies (sonication or freezing/thawing) may have substantially reduced the activity of platelet PAI-1, which has lead to an underestimation of the proportion of active PAI-1. Our in vitro results are more compatible with the role of PAI-1 in clot stabilization as demonstrated in physiological and pathophysiological studies.	[Brogren, Helen; Wallmark, Karin; Karlsson, Lena; Jern, Sverker] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Inst Med, Gothenburg, Sweden; [Deinum, Johanna] AstraZeneca R&D, Molndal, Sweden	University of Gothenburg; AstraZeneca	Brogren, H (corresponding author), Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Inst Med, Gothenburg, Sweden.	helen.brogren@gu.se			Swedish Research Council [9046, 20325]; Heart Lung Foundation; Swedish federal government under the LUA/ALF; Faculty of Medicine, University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish federal government under the LUA/ALF; Faculty of Medicine, University of Gothenburg	This work was financially supported by the Swedish Research Council (No. 9046, 20325), the Heart Lung Foundation, the Swedish federal government under the LUA/ALF agreement, and the Faculty of Medicine, University of Gothenburg. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 1999, THROMB HAEMOSTASIS, V81, P407; [Anonymous], 2000, EJIFCC, V12; Bjorquist P, 1997, BBA-PROTEIN STRUCT M, V1341, P87, DOI 10.1016/S0167-4838(97)00065-4; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; BOOTH NA, 1990, FIBRINOLYSIS, V4, P138, DOI 10.1016/0268-9499(90)90391-V; BOOTH NA, 1992, ANN NY ACAD SCI, V667, P70, DOI 10.1111/j.1749-6632.1992.tb51599.x; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; DECLERCK PJ, 1990, THROMB RES, P3; DECLERCK PJ, 1988, BLOOD, V71, P220; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; Fay WP, 1996, ARTERIOSCL THROM VAS, V16, P1277, DOI 10.1161/01.ATV.16.10.1277; FAY WP, 1994, BLOOD, V83, P351; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GAUSSEM P, 1993, J BIOL CHEM, V268, P12150; GAUSSEM P, 1991, BIOCHIM BIOPHYS ACTA, V1079, P321, DOI 10.1016/0167-4838(91)90076-C; Gils A, 1998, THROMB HAEMOSTASIS, V80, P286, DOI 10.1055/s-0037-1615189; GRAM J, 1993, THROMB HAEMOSTASIS, V70, P852; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; KLUFT C, 1990, FIBRINOLYSIS, V4, P136, DOI 10.1016/0268-9499(90)90390-6; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; KOOISTRA T, 1986, BIOCHEM J, V239, P497, DOI 10.1042/bj2390497; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERS JWJ, 1987, J BIOL CHEM, V262, P17492; LANG IM, 1992, BLOOD, V80, P2269; Lang IM, 1996, J BIOL CHEM, V271, P2754, DOI 10.1074/jbc.271.5.2754; LEVIN EG, 1987, BLOOD, V70, P1090; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; MEIJER P, 1994, CLIN CHEM, V40, P110; Nordenhem A, 1997, SCAND J CLIN LAB INV, V57, P453, DOI 10.3109/00365519709084594; Robbie LA, 1996, THROMB HAEMOSTASIS, V75, P127; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; STRINGER HAR, 1994, ARTERIOSCLER THROMB, V14, P1452, DOI 10.1161/01.ATV.14.9.1452; STROMQVIST M, 1994, PROTEIN EXPRES PURIF, V5, P309, DOI 10.1006/prep.1994.1046; TORRBROWN SR, 1993, THROMB RES, V72, P413, DOI 10.1016/0049-3848(93)90241-F; URDEN G, 1987, THROMB HAEMOSTASIS, V57, P29; VANLOON BJP, 1992, THROMB HAEMOSTASIS, V67, P101; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2	38	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26762	10.1371/journal.pone.0026762	http://dx.doi.org/10.1371/journal.pone.0026762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069469	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900031
J	Siehr, MS; Koo, PK; Sherlekar, AL; Bian, XL; Bunkers, MR; Miller, RM; Portman, DS; Lints, R				Siehr, Meagan S.; Koo, Pamela K.; Sherlekar, Amrita L.; Bian, Xuelin; Bunkers, Meredith R.; Miller, Renee M.; Portman, Douglas S.; Lints, Robyn			Multiple doublesex-Related Genes Specify Critical Cell Fates in a C. elegans Male Neural Circuit	PLOS ONE			English	Article							MALE MATING-BEHAVIOR; RAY SENSORY NEURONS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR; PATTERN-FORMATION; GENITAL DISC; DNA-BINDING; NEMATODE	Background: In most animal species, males and females exhibit differences in behavior and morphology that relate to their respective roles in reproduction. DM (Doublesex/MAB-3) domain transcription factors are phylogenetically conserved regulators of sexual development. They are thought to establish sexual traits by sex-specifically modifying the activity of general developmental programs. However, there are few examples where the details of these interactions are known, particularly in the nervous system. Methodology/Principal Findings: In this study, we show that two C. elegans DM domain genes, dmd-3 and mab-23, regulate sensory and muscle cell development in a male neural circuit required for mating. Using genetic approaches, we show that in the circuit sensory neurons, dmd-3 and mab-23 establish the correct pattern of dopaminergic (DA) and cholinergic (ACh) fate. We find that the ETS-domain transcription factor gene ast-1, a non-sex-specific, phylogenetically conserved activator of dopamine biosynthesis gene transcription, is broadly expressed in the circuit sensory neuron population. However, dmd-3 and mab-23 repress its activity in most cells, promoting ACh fate instead. A subset of neurons, preferentially exposed to a TGF-beta ligand, escape this repression because signal transduction pathway activity in these cells blocks dmd-3/mab-23 function, allowing DA fate to be established. Through optogenetic and pharmacological approaches, we show that the sensory and muscle cell characteristics controlled by dmd-3 and mab-23 are crucial for circuit function. Conclusions/Significance: In the C. elegans male, DM domain genes dmd-3 and mab-23 regulate expression of cell sub-type characteristics that are critical for mating success. In particular, these factors limit the number of DA neurons in the male nervous system by sex-specifically regulating a phylogenetically conserved dopamine biosynthesis gene transcription factor. Homologous interactions between vertebrate counterparts could regulate sex differences in neuron sub-type populations in the brain.	[Siehr, Meagan S.; Koo, Pamela K.; Sherlekar, Amrita L.; Bian, Xuelin; Bunkers, Meredith R.; Lints, Robyn] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Miller, Renee M.; Portman, Douglas S.] Univ Rochester, Dept Biomed Genet, Ctr Neural Dev & Dis, Rochester, NY USA	Texas A&M University System; Texas A&M University College Station; University of Rochester	Siehr, MS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rlints@bio.tamu.edu		Lints, Robyn/0000-0002-1403-2121; Portman, Douglas/0000-0003-2686-8839; Miller, Renee/0000-0001-6124-6563	NSF [EF-0436308, 0818595]; NIH [R01 NS050268]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050268] Funding Source: NIH RePORTER; Direct For Biological Sciences [0818595] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	M.S.S. and M.R.B. are supported by an NSF-funded Undergraduate Biology-Mathematics Program grant (Award No: EF-0436308). The research was supported by an NSF grant (Award No.: 0818595) awarded to R.L. and by an NIH grant (R01 NS050268) awarded to D.S.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Arnold AP, 2004, TRENDS ENDOCRIN MET, V15, P6, DOI 10.1016/j.tem.2003.11.001; BAIRD SE, 1991, DEVELOPMENT, V113, P515; Balciuniene J, 2006, MOL CELL BIOL, V26, P8984, DOI 10.1128/MCB.00959-06; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Bocklandt S, 2007, ADV GENET, P245; BRENNER S, 1974, GENETICS, V77, P71; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Estrada B, 2001, DEVELOPMENT, V128, P331; FERGUSON EL, 1985, GENETICS, V110, P17; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Gennet N, 2011, P NATL ACAD SCI USA, V108, P9131, DOI 10.1073/pnas.1016679108; GRANATO M, 1994, DEVELOPMENT, V120, P3005; Guo YQ, 2004, BIOCHEM BIOPH RES CO, V324, P569, DOI 10.1016/j.bbrc.2004.09.085; HALL DH, 1991, J NEUROSCI, V11, P1; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; HODGKIN J, 1979, GENETICS, V91, P67; Huang X, 2005, P NATL ACAD SCI USA, V102, P11349, DOI 10.1073/pnas.0505106102; Hurd DD, 2010, GENETICS, V185, P883, DOI 10.1534/genetics.110.116996; Hutter H, 2005, DEV BIOL, V284, P260, DOI 10.1016/j.ydbio.2005.05.025; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Krishna S, 1999, DEVELOPMENT, V126, P251; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; Lee YS, 2000, J NEUROCHEM, V75, P1800, DOI 10.1046/j.1471-4159.2000.0751800.x; Lints R, 1999, DEVELOPMENT, V126, P5819; Lints R, 2004, DEV BIOL, V269, P137, DOI 10.1016/j.ydbio.2004.01.021; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Mason DA, 2008, DEVELOPMENT, V135, P2373, DOI 10.1242/dev.017046; Morita K, 1999, DEVELOPMENT, V126, P1337; Murphy MW, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-58; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nass R, 2005, J NEUROCHEM, V94, P774, DOI 10.1111/j.1471-4159.2005.03205.x; Portman DS, 2004, DEV BIOL, V270, P499, DOI 10.1016/j.ydbio.2004.02.020; Portman DS, 2007, ADV GENET, P1; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ross JM, 2005, DEV CELL, V8, P881, DOI 10.1016/j.devcel.2005.03.017; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Schmid C, 2006, DEV BIOL, V293, P403, DOI 10.1016/j.ydbio.2006.02.042; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Wang D, 2004, COLD SPRING HARB SYM, V69, P429, DOI 10.1101/sqb.2004.69.429; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yang Y, 2007, P NATL ACAD SCI USA, V104, P852, DOI 10.1073/pnas.0610261104; Yi W, 2000, DEVELOPMENT, V127, P4469; Yi WS, 1999, DEVELOPMENT, V126, P873; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	79	23	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26811	10.1371/journal.pone.0026811	http://dx.doi.org/10.1371/journal.pone.0026811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069471	gold, Green Published, Green Submitted			2022-12-27	WOS:000297150900033
J	Cutrullis, RA; Moscatelli, GF; Moroni, S; Volta, BJ; Cardoni, RL; Altcheh, JM; Corral, RS; Freilij, HL; Petray, PB				Cutrullis, Romina A.; Moscatelli, Guillermo F.; Moroni, Samanta; Volta, Bibiana J.; Cardoni, Rita L.; Altcheh, Jaime M.; Corral, Ricardo S.; Freilij, Hector L.; Petray, Patricia B.			Benznidazole Therapy Modulates Interferon-gamma and M2 Muscarinic Receptor Autoantibody Responses in Trypanosoma cruzi-Infected Children	PLOS ONE			English	Article							HUMAN CHAGAS-DISEASE; DYSFUNCTION; CYTOKINES; CARDIOMYOPATHY; ANTIBODIES	Objective: The presence of autoantibodies with adrenergic and cholinergic activity, capable of triggering neurotransmitter receptor-mediated effects, has been associated with pathogenesis in T. cruzi-infected hosts. The goal of this study was to investigate the production of anti-M2 muscarinic receptor autoantibodies (Anti-M2R AAbs) as well as the IFN-gamma profile in children at the early stage of Chagas disease, and to examine whether trypanocidal chemotherapy with benznidazole (BZ) could modify both response patterns. Methods: This study comprised 30 T. cruzi-infected children (mean age: 13.8 years) and 19 uninfected controls (mean age: 12.7 years). Infected patients were treated with BZ and followed-up. Blood samples collected at diagnosis-T0, end of treatment-T1, and six months later-T2 were analysed by ELISA for detection of Anti-M2R AAbs and circulating levels of IFN-gamma. Results: At T0, anti-M2R AAbs were demonstrated in 56.7% of T. cruzi-infected patients, whereas uninfected controls were 100% negative. The average age of Anti-M2R AAbs(+) patients was higher than that from negative population. Infected children also displayed significantly stronger serum IFN-gamma responses than controls. Upon BZ treatment, a significant linear decreasing trend in Anti-M2R AAb reactivity was recorded throughout the follow-up, with 29.7-88.1% decrease at T2. IFN-gamma circulating levels also declined by T2. Conclusion: Anti-M2R AAbs and IFN-gamma raise early during chagasic infection in children and are downmodulated by BZ therapy. These findings reinforce the usefulness of early BZ treatment not only to eliminate the parasite but also to reduce potentially pathogenic immune responses.	[Cutrullis, Romina A.; Moscatelli, Guillermo F.; Moroni, Samanta; Altcheh, Jaime M.; Corral, Ricardo S.; Freilij, Hector L.; Petray, Patricia B.] Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol & Enfermedad Chagas, Buenos Aires, DF, Argentina; [Volta, Bibiana J.; Cardoni, Rita L.] Inst Nacl Parasitol Dr M Fatala Chaben, Adm Nacl Labs, Buenos Aires, DF, Argentina; [Volta, Bibiana J.; Cardoni, Rita L.] Inst Salud Dr CG Malbran, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Cutrullis, RA (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol & Enfermedad Chagas, Buenos Aires, DF, Argentina.	ppetray@conicet.gov.ar		Volta, Bibiana Julieta/0000-0003-3246-8161; Altcheh, jaime/0000-0002-5865-7991	Bunge & Born Foundation (Argentina); National Research Council (CONICET, Argentina)	Bunge & Born Foundation (Argentina); National Research Council (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The study was funded by Bunge & Born Foundation (Argentina) and National Research Council (CONICET, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altcheh J, 2005, REV SOC BRAS MED TRO, V38, P41; Bahia-Oliveira LMG, 1998, BRAZ J MED BIOL RES, V31, P127, DOI 10.1590/S0100-879X1998000100017; Benchimol-Barbosa PR, 2011, INT J CARDIOL, V146, P88, DOI 10.1016/j.ijcard.2009.09.560; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; BORDA E, 1991, J NEUROIMMUNOL, V32, P53, DOI 10.1016/0165-5728(91)90071-E; Borda ES, 1996, INT J CARDIOL, V54, P149, DOI 10.1016/0167-5273(96)02592-2; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; Cutrullis R., 2007, Revista de Patologia Tropical, V36, P141; De Andrade ALSS, 1998, AM J TROP MED HYG, V59, P530, DOI 10.4269/ajtmh.1998.59.530; FERRARI I, 1995, J EXP MED, V182, P59, DOI 10.1084/jem.182.1.59; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gimenez L, 2003, REV ARGENT CARDIOL, V71, P109; GOIN JC, 1994, J AUTONOM NERV SYST, V47, P45, DOI 10.1016/0165-1838(94)90064-7; Goin JC, 1999, HEART, V82, P273, DOI 10.1136/hrt.82.3.273; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Labovsky V, 2007, CLIN EXP IMMUNOL, V148, P440, DOI 10.1111/j.1365-2249.2007.03381.x; Laucella SA, 2009, CLIN INFECT DIS, V49, P1675, DOI 10.1086/648072; Leiros CP, 1997, NEUROIMMUNOMODULAT, V4, P91, DOI 10.1159/000097326; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Manzullo EC, 1999, MEM I OSWALDO CRUZ, V94, P317, DOI 10.1590/S0074-02761999000700060; Marin-Neto JA, CIRCULATION, V115, P1109; Milei J, 1994, ENFERMEDAD CHAGAS, P103; Moretti E, 2002, CLIN DIAGN LAB IMMUN, V9, P1324, DOI 10.1128/CDLI.9.6.1324-1327.2002; Nussinovitch U, 2011, CLIN REV ALLERG 0105; Olivieri BP, 2002, ANTIMICROB AGENTS CH, V46, P3790, DOI 10.1128/AAC.46.12.3790-3796.2002; OROURKE RA, 1995, CURR PROB CARDIOLOGY, V20, P829, DOI 10.1016/S0146-2806(06)80001-0; Peraza-Cruces K, 2008, BRAZ J MED BIOL RES, V41, P796, DOI 10.1590/S0100-879X2008000900009; Piaggio E, 2001, PARASITOL RES, V87, P539, DOI 10.1007/s004360000357; Ribeiro ALP, 2007, INT J CARDIOL, V117, P59, DOI 10.1016/j.ijcard.2006.04.053; Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Samudio M, 1998, AM J TROP MED HYG, V58, P119, DOI 10.4269/ajtmh.1998.58.119; Talvani A, 2006, MICROBES INFECT, V8, P2459, DOI 10.1016/j.micinf.2006.06.006; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; VILLINGER F, 1993, CYTOKINE, V5, P469, DOI 10.1016/1043-4666(93)90038-7; WHO, 2007, REP GRUP TRAB CIENT	38	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e27133	10.1371/journal.pone.0027133	http://dx.doi.org/10.1371/journal.pone.0027133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066031	Green Published, gold, Green Submitted			2022-12-27	WOS:000296916000057
J	Nasrollahzadeh, D; Aghcheli, K; Sotoudeh, M; Shakeri, R; Persson, EC; Islami, F; Kamangar, F; Abnet, CC; Boffetta, P; Engstrand, L; Dawsey, SM; Malekzadeh, R; Ye, WM				Nasrollahzadeh, Dariush; Aghcheli, Karim; Sotoudeh, Masoud; Shakeri, Ramin; Persson, E. Christina; Islami, Farhad; Kamangar, Farin; Abnet, Christian C.; Boffetta, Paolo; Engstrand, Lars; Dawsey, Sanford M.; Malekzadeh, Reza; Ye, Weimin			Accuracy and Cut-Off Values of Pepsinogens I, II and Gastrin 17 for Diagnosis of Gastric Fundic Atrophy: Influence of Gastritis	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SERUM PEPSINOGEN; GENERAL-POPULATION; ESOPHAGEAL CANCER; ACID-SECRETION; RISK; MARKERS; IRAN; ERADICATION; SEVERITY	Background: To establish optimal cutoff values for serologic diagnosis of fundic atrophy in a high-risk area for oesophageal squamous cell carcinoma and gastric cancer with high prevalence of Helicobacter pylori (H. pylori) in Northern Iran, we performed an endoscopy-room-based validation study. Methods: We measured serum pepsinogens I (PGI) and II (PGII), gastrin 17 (G-17), and antibodies against whole H. pylori, or cytotoxin-associated gene A (CagA) antigen among 309 consecutive patients in two major endoscopy clinics in northeastern Iran. Updated Sydney System was used as histology gold standard. Areas under curves (AUCs), optimal cutoff and predictive values were calculated for serum biomarkers against the histology. Results: 309 persons were recruited (mean age: 63.5 years old, 59.5% female). 84.5% were H. pylori positive and 77.5% were CagA positive. 21 fundic atrophy and 101 nonatrophic pangastritis were diagnosed. The best cutoff values in fundic atrophy assessment were calculated at PGI<56 mu g/l (sensitivity: 61.9%, specificity: 94.8%) and PGI/PGII ratio<5 (sensitivity: 75.0%, specificity: 91.0%). A serum G-17<2.6 pmol/l or G-17>40 pmol/l was 81% sensitive and 73.3% specific for diagnosing fundic atrophy. At cutoff concentration of 11.8 mu g/l, PGII showed 84.2% sensitivity and 45.4% specificity to distinguish nonatrophic pangastritis. Exclusion of nonatrophic pangastritis enhanced diagnostic ability of PGI/PGII ratio (from AUC = 0.66 to 0.90) but did not affect AUC of PGI. After restricting study samples to those with PGII<11.8, the sensitivity of using PGI<56 to define fundic atrophy increased to 83.3% (95%CI 51.6-97.9) and its specificity decreased to 88.8% (95%CI 80.8-94.3). Conclusions: Among endoscopy clinic patients, PGII is a sensitive marker for extension of nonatrophic gastritis toward the corpus. PGI is a stable biomarker in assessment of fundic atrophy and has similar accuracy to PGI/PGII ratio among populations with prevalent nonatrophic pangastritis.	[Nasrollahzadeh, Dariush; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nasrollahzadeh, Dariush; Aghcheli, Karim; Sotoudeh, Masoud; Shakeri, Ramin; Islami, Farhad; Kamangar, Farin; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Persson, E. Christina; Kamangar, Farin; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Islami, Farhad] Int Agcy Res Canc, F-69372 Lyon, France; [Kamangar, Farin] Morgan State Univ, Dept Publ Hlth Anal, Sch Community Hlth & Policy, Baltimore, MD 21239 USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst & Inst Translat Epidemiol, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Engstrand, Lars] Swedish Inst Infect Dis Control, Stockholm, Sweden	Karolinska Institutet; Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Morgan State University; Icahn School of Medicine at Mount Sinai; Swedish Institute for Infectious Disease Control	Nasrollahzadeh, D (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	malek@ams.ac.ir; weimin.ye@ki.se	Boffetta, Paolo/AAI-7767-2021; Abnet, Christian C/C-4111-2015; Malekzadeh, Reza/U-1382-2017	Boffetta, Paolo/0000-0002-3811-2791; Abnet, Christian C/0000-0002-3008-7843; Malekzadeh, Reza/0000-0002-9820-6335; , Ramin/0000-0003-0487-3629; ye, weimin/0000-0002-6859-4648; Islami, Farhad/0000-0002-7357-5994; Malekzadeh, Reza/0000-0003-1043-3814	Swedish Research Council; Digestive Disease Research Centre, Tehran University of Medical Sciences; Karolinska Institute; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Digestive Disease Research Centre, Tehran University of Medical Sciences(Tehran University of Medical Sciences); Karolinska Institute(Karolinska Institutet); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the research grants from Swedish Research Council and Digestive Disease Research Centre, Tehran University of Medical Sciences. DN was partly supported by a scholarship from Karolinska Institute (KID-December 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNET CC, 2011, BR J CANC; Adamu MA, 2011, INT J CANCER, V128, P1652, DOI 10.1002/ijc.25476; Bodger K, 2001, HELICOBACTER, V6, P216, DOI 10.1046/j.1523-5378.2001.00031.x; Brenner H, 2007, INT J CANCER, V121, P2782, DOI 10.1002/ijc.22992; Broutet N, 2003, BRIT J CANCER, V88, P1239, DOI 10.1038/sj.bjc.6600877; Chang YW, 2008, SCAND J GASTROENTERO, V43, P1184, DOI 10.1080/00365520802130209; CORREA P, 1992, CANCER RES, V52, P6735; Di Mario F, 2004, DIGESTION, V70, P167, DOI 10.1159/000081517; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gao L, 2009, EUR J CANCER, V45, P2860, DOI 10.1016/j.ejca.2009.04.015; Gatta L, 2011, CLIN GASTROENTEROL H, V9, P440, DOI 10.1016/j.cgh.2010.12.009; Graham DY, 2006, CLIN GASTROENTEROL H, V4, P306, DOI 10.1016/j.cgh.2005.11.003; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; Haj-Sheykholeslami A, 2008, CLIN GASTROENTEROL H, V6, P174, DOI 10.1016/j.cgh.2007.11.016; He CY, 2011, J GASTROEN HEPATOL, V26, P1039, DOI 10.1111/j.1440-1746.2011.06692.x; Iijima K, 2009, J GASTROENTEROL, V44, P819, DOI 10.1007/s00535-009-0066-2; Imagawa S, 2008, DIGEST DIS SCI, V53, P1818, DOI 10.1007/s10620-007-0077-x; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Kang JM, 2008, HELICOBACTER, V13, P146, DOI 10.1111/j.1523-5378.2008.00592.x; Kikuchi Shogo, 2002, J Epidemiol, V12, P351; Knight T, 1996, BRIT J CANCER, V73, P819, DOI 10.1038/bjc.1996.144; MAHBOUBI E, 1973, BRIT J CANCER, V28, P192, DOI 10.1038/bjc.1973.138; Malekzadeh R, 2004, J CLIN PATHOL, V57, P37, DOI 10.1136/jcp.57.1.37; Mardh E, 2002, CLIN CHIM ACTA, V320, P17; McColl K E, 1997, Semin Gastrointest Dis, V8, P142; MIKI K, 1987, Gastroenterologia Japonica, V22, P133; Nardone G, 2005, ALIMENT PHARM THER, V22, P1139, DOI 10.1111/j.1365-2036.2005.02734.x; Pakseresht M, 2011, CANCER CAUSE CONTROL, V22, P725, DOI 10.1007/s10552-011-9744-5; PARENTE F, 1985, GUT, V26, P1327, DOI 10.1136/gut.26.12.1327; Pepe MS, 2009, STATA J, V9, P1; Ren JS, 2009, GUT, V58, P636, DOI 10.1136/gut.2008.168641; Ricci C, 2004, AM J GASTROENTEROL, V99, P1910, DOI 10.1111/j.1572-0241.2004.40614.x; Saidi F, 2000, BRIT J CANCER, V83, P1249, DOI 10.1054/bjoc.2000.1414; Semnani S, 2006, CANCER DETECT PREV, V30, P14, DOI 10.1016/j.cdp.2005.11.002; Shimatani T, 2005, HELICOBACTER, V10, P256, DOI 10.1111/j.1523-5378.2005.00318.x; Shiotani A, 2005, INT J CANCER, V115, P463, DOI 10.1002/ijc.20852; Sipponen P, 2000, GASTROENTEROL CLIN N, V29, P579, DOI 10.1016/S0889-8553(05)70131-X; Sipponen P, 2002, SCAND J GASTROENTERO, V37, P785, DOI 10.1080/713786525; Song HJ, 2010, GUT LIVER, V4, P475, DOI 10.5009/gnl.2010.4.4.475; Storskrubb T, 2008, SCAND J GASTROENTERO, V43, P1448, DOI 10.1080/00365520802273025; Tatemichi M, 2001, JPN J CANCER RES, V92, P243, DOI 10.1111/j.1349-7006.2001.tb01088.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaananen H, 2003, EUR J GASTROEN HEPAT, V15, P885, DOI 10.1097/01.meg.0000059169.46867.01; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Weck MN, 2009, EPIDEMIOLOGY, V20, P569, DOI 10.1097/EDE.0b013e3181a3d5f4; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057	46	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26957	10.1371/journal.pone.0026957	http://dx.doi.org/10.1371/journal.pone.0026957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066020	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000036
J	Zuo, XN; Xing, XX				Zuo, Xi-Nian; Xing, Xiu-Xia			Effects of Non-Local Diffusion on Structural MRI Preprocessing and Default Network Mapping: Statistical Comparisons with Isotropic/Anisotropic Diffusion	PLOS ONE			English	Article							ANISOTROPIC DIFFUSION; BRAIN EXTRACTION; IMAGES; SEGMENTATION; NOISE; FILTER	Neuroimaging community usually employs spatial smoothing to denoise magnetic resonance imaging (MRI) data, e. g., Gaussian smoothing kernels. Such an isotropic diffusion (ISD) based smoothing is widely adopted for denoising purpose due to its easy implementation and efficient computation. Beyond these advantages, Gaussian smoothing kernels tend to blur the edges, curvature and texture of images. Researchers have proposed anisotropic diffusion (ASD) and non-local diffusion (NLD) kernels. We recently demonstrated the effect of these new filtering paradigms on preprocessing real degraded MRI images from three individual subjects. Here, to further systematically investigate the effects at a group level, we collected both structural and functional MRI data from 23 participants. We first evaluated the three smoothing strategies' impact on brain extraction, segmentation and registration. Finally, we investigated how they affect subsequent mapping of default network based on resting-state functional MRI (R-fMRI) data. Our findings suggest that NLD-based spatial smoothing maybe more effective and reliable at improving the quality of both MRI data preprocessing and default network mapping. We thus recommend NLD may become a promising method of smoothing structural MRI images of R-fMRI pipeline.	[Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Ctr, Beijing 100101, Peoples R China; [Xing, Xiu-Xia] Beijing Univ Technol, Coll Appl Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing University of Technology	Zuo, XN (corresponding author), Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zuoxn@psych.ac.cn; xingxx@bjut.edu.cn	Zuo, Xi-Nian/A-7273-2009; Xing, Xiu-Xia/ABG-3628-2021	Zuo, Xi-Nian/0000-0001-9110-585X; Xing, Xiu-Xia/0000-0002-4883-3971	Startup Foundation for Distinguished Research Professor of Institute for Psychology [Y0CX492S03]; National Nature Science Foundation of China [10006012200802]; Youth Foundation of Beijing University of Technology [X1006012201001]; Natural Science Foundation for Basic Research of Beijing University of Technology [JX006012201002]; Scientific Research Foundation for the Youth Specialized in Differential Equations of Beijing University of Technology [X3006012200801]	Startup Foundation for Distinguished Research Professor of Institute for Psychology; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Beijing University of Technology; Natural Science Foundation for Basic Research of Beijing University of Technology; Scientific Research Foundation for the Youth Specialized in Differential Equations of Beijing University of Technology	The current study was partially supported by the Startup Foundation for Distinguished Research Professor of Institute for Psychology (Y0CX492S03), the National Nature Science Foundation of China (10006012200802), Youth Foundation of Beijing University of Technology (X1006012201001), Natural Science Foundation for Basic Research of Beijing University of Technology (JX006012201002), and the Scientific Research Foundation for the Youth Specialized in Differential Equations of Beijing University of Technology (X3006012200801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ L, 1993, ARCH RATION MECH AN, V123, P199, DOI 10.1007/BF00375127; Andersson JLR, 2007, TR07JA2 NONLINEAR RE; Andrade A, 2001, HUM BRAIN MAPP, V12, P79, DOI 10.1002/1097-0193(200102)12:2<79::AID-HBM1005>3.0.CO;2-I; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aubert G., 2006, MATH PROBLEMS IMAGE, DOI 10.1007/978-0-387-44588-5; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Buades A, 2010, SIAM REV, V52, P113, DOI 10.1137/090773908; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cachia A, 2003, IEEE T MED IMAGING, V22, P754, DOI 10.1109/TMI.2003.814781; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Dong B, 2008, MULTISCALE MODEL SIM, V7, P589, DOI 10.1137/070705556; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Gaser C, 2010, ORG HUM BRAIN MAPP 2; GERIG G, 1992, IEEE T MED IMAGING, V11, P221, DOI 10.1109/42.141646; Gilboa G, 2008, MULTISCALE MODEL SIM, V7, P1005, DOI 10.1137/070698592; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Joshi AA, 2009, IEEE T IMAGE PROCESS, V18, P1358, DOI 10.1109/TIP.2009.2016163; Kim HY, 2005, COMPUT VIS IMAGE UND, V99, P435, DOI 10.1016/j.cviu.2005.04.004; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu H, 2010, MAGN RESON IMAGING, V28, P1485, DOI 10.1016/j.mri.2010.06.023; Manjon JV, 2008, MED IMAGE ANAL, V12, P514, DOI 10.1016/j.media.2008.02.004; Manjon JV, 2010, NEUROIMAGE, V53, P480, DOI 10.1016/j.neuroimage.2010.06.046; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Weickert J., 1998, ANISOTROPIC DIFFUSIO; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037; Zuo XN, 2011, CEREB CORTE IN PRESS	41	39	40	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26703	10.1371/journal.pone.0026703	http://dx.doi.org/10.1371/journal.pone.0026703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066005	Green Published, Green Submitted, gold			2022-12-27	WOS:000296916000021
J	Golozar, A; Khademi, H; Kamangar, F; Poutschi, H; Islami, F; Abnet, CC; Freedman, ND; Taylor, PR; Pharoah, P; Boffetta, P; Brennan, PJ; Dawsey, SM; Malekzadeh, R; Etemadi, A				Golozar, Asieh; Khademi, Hooman; Kamangar, Farin; Poutschi, Hossein; Islami, Farhad; Abnet, Christian C.; Freedman, Neal D.; Taylor, Philip R.; Pharoah, Paul; Boffetta, Paolo; Brennan, Paul J.; Dawsey, Sanford M.; Malekzadeh, Reza; Etemadi, Arash			Diabetes Mellitus and Its Correlates in an Iranian Adult Population	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC-STATUS; ESOPHAGEAL CANCER; BIRTH-WEIGHT; GREEN TEA; NONCOMMUNICABLE DISEASES; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLUCOSE-TOLERANCE	The rising epidemic of diabetes imposes a substantial economic burden on the Middle East. Using baseline data from a population based cohort study, we aimed to identify the correlates of diabetes mellitus (DM) in a mainly rural population from Iran. Between 2004 and 2007, 50044 adults between 30 and 87 years old from Golestan Province located in Northeast Iran were enrolled in the Golestan Cohort Study. Demographic and health-related information was collected using questionnaires. Individuals' body sizes at ages 15 and 30 were assessed by validated pictograms ranging from 1 (very lean) to 7 in men and 9 in women. DM diagnosis was based on the self-report of a physician's diagnosis. The accuracy of self-reported DM was evaluated in a subcohort of 3811 individuals using fasting plasma glucose level and medical records. Poisson regression with robust variance estimator was used to estimate prevalence ratios (PR's). The prevalence of self-reported DM standardized to the national and world population was 5.7% and 6.2%, respectively. Self-reported DM had 61.5% sensitivity and 97.6% specificity. Socioeconomic status was inversely associated with DM prevalence. Green tea and opium consumption increased the prevalence of DM. Obesity at all ages and extreme leanness in childhood increased diabetes prevalence. Being obese throughout life doubled DM prevalence in women (PR: 2.1; 95% CI: 1.8, 2.4). These findings emphasize the importance of improving DM awareness, improving general living conditions, and early lifestyle modifications in diabetes prevention.	[Golozar, Asieh; Khademi, Hooman; Kamangar, Farin; Poutschi, Hossein; Islami, Farhad; Malekzadeh, Reza; Etemadi, Arash] Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Tehran, Iran; [Golozar, Asieh; Kamangar, Farin; Abnet, Christian C.; Freedman, Neal D.; Taylor, Philip R.; Dawsey, Sanford M.; Etemadi, Arash] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Kamangar, Farin] Morgan State Univ, Dept Publ Hlth Anal, Sch Community Hlth & Policy, Baltimore, MD 21239 USA; [Islami, Farhad; Brennan, Paul J.] Int Agcy Res Canc, F-69372 Lyon, France; [Pharoah, Paul] Univ Cambridge, Canc Res UK, Dept Oncol, Cambridge, England; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Inst Translat Epidemiol, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Morgan State University; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Icahn School of Medicine at Mount Sinai	Golozar, A (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Tehran, Iran.	etemadia@mail.nih.gov	Freedman, Neal David/B-9741-2015; Khademi, Hooman/AAZ-8798-2020; Boffetta, Paolo/AAI-7767-2021; Malekzadeh, Reza/U-1382-2017; Pharoah, Paul/V-6658-2019; Etemadi, Arash/Y-7082-2018; Etemadi, Arash/C-1386-2016; Abnet, Christian C/C-4111-2015	Freedman, Neal David/0000-0003-0074-1098; Boffetta, Paolo/0000-0002-3811-2791; Malekzadeh, Reza/0000-0002-9820-6335; Pharoah, Paul/0000-0001-8494-732X; Etemadi, Arash/0000-0002-3458-1072; Etemadi, Arash/0000-0002-3458-1072; Abnet, Christian C/0000-0002-3008-7843; Islami, Farhad/0000-0002-7357-5994; Malekzadeh, Reza/0000-0003-1043-3814	Division of Cancer Epidemiology and Genetics; National Cancer Institute at the National Institutes of Health; Digestive Disease Research Center of Tehran University of Medical Sciences [82-603]; International Agency for Research on Cancer	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Digestive Disease Research Center of Tehran University of Medical Sciences(Tehran University of Medical Sciences); International Agency for Research on Cancer	This study was supported in part by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, by the Digestive Disease Research Center of Tehran University of Medical Sciences (grant No 82-603), and by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amini Masoud, 2007, Rev Diabet Stud, V4, P169, DOI 10.1900/RDS.2007.4.169; [Anonymous], 2009, GLOBAL BURDEN   0808; [Anonymous], 2005, PREV CHRON DIS VIT I; AXELSON O, 1994, OCCUP ENVIRON MED, V51, P574, DOI 10.1136/oem.51.8.574; Azimi-Nezhad M, 2008, SINGAP MED J, V49, P571; Bahrami H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-158; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Blaha MJ, 2008, OBESITY, V16, P869, DOI 10.1038/oby.2008.12; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Chaturvedi N, 2004, INT J EPIDEMIOL, V33, P871, DOI 10.1093/ije/dyh187; Chiarelli F, 1999, ACTA PAEDIATR, V88, P62, DOI 10.1111/j.1651-2227.1999.tb14353.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Lauzon-Guillain B, 2010, DIABETES CARE, V33, P298, DOI 10.2337/dc09-1304; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Esteghamati A, 2008, DIABETES CARE, V31, P96, DOI 10.2337/dc07-0959; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadaegh F, 2007, DIABETES RES CLIN PR, V76, P449, DOI 10.1016/j.diabres.2006.09.030; Harati H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-186; Hosseinpanah F, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-328; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Keshtkar AA, 2010, J CLIN EPIDEMIOL, V63, P655, DOI 10.1016/j.jclinepi.2009.08.014; Kuh D, 2002, INT J OBESITY, V26, P40, DOI 10.1038/sj.ijo.0801861; Leger J, 1997, BRIT MED J, V315, P341; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; Mirmiran P, 2004, EUR J CLIN NUTR, V58, P1110, DOI 10.1038/sj.ejcn.1601936; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Robinson R, 2001, BRIT MED J, V322, P375, DOI 10.1136/bmj.322.7283.375; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109; Sadeghi M, 2007, ANN ACAD MED SINGAP, V36, P175; Sajjadi F., 2008, Eastern Mediterranean Health Journal, V14, P1080; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512; World Health Organization, 1995, PHYS STAT US INT ANT; Yeung EH, 2010, DIABETES CARE, V33, P1364, DOI 10.2337/dc10-0100	54	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26725	10.1371/journal.pone.0026725	http://dx.doi.org/10.1371/journal.pone.0026725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053206	Green Submitted, gold, Green Published			2022-12-27	WOS:000299081800032
J	Borghi, M; Rus, A; Salt, DE				Borghi, Monica; Rus, Ana; Salt, David E.			Loss-of-Function of Constitutive Expresser of Pathogenesis Related Genes5 Affects Potassium Homeostasis in Arabidopsis thaliana	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; DEFENSE RESPONSES; LEAF SENESCENCE; SALICYLIC-ACID; ION-CHANNEL; GENE-EXPRESSION; PROTEIN-KINASE; JASMONIC ACID; CELL-DEATH; K+ UPTAKE	Here, we demonstrate that the reduction in leaf K(+) observed in a mutant previously identified in an ionomic screen of fast neutron mutagenized Arabidopsis thaliana is caused by a loss-of-function allele of CPR5, which we name cpr5-3. This observation establishes low leaf K(+) as a new phenotype for loss-of-function alleles of CPR5. We investigate the factors affecting this low leaf K(+) in cpr5 using double mutants defective in salicylic acid (SA) and jasmonic acid (JA) signalling, and by gene expression analysis of various channels and transporters. Reciprocal grafting between cpr5 and Col-0 was used to determine the relative importance of the shoot and root in causing the low leaf K(+) phenotype of cpr5. Our data show that loss-of-function of CPR5 in shoots primarily determines the low leaf K(+) phenotype of cpr5, though the roots also contribute to a lesser degree. The low leaf K(+) phenotype of cpr5 is independent of the elevated SA and JA known to occur in cpr5. In cpr5 expression of genes encoding various Cyclic Nucleotide Gated Channels (CNGCs) are uniquely elevated in leaves. Further, expression of HAK5, encoding the high affinity K(+) uptake transporter, is reduced in roots of cpr5 grown with high or low K(+) supply. We suggest a model in which low leaf K(+) in cpr5 is driven primarily by enhanced shoot-to-root K(+) export caused by a constitutive activation of the expression of various CNGCs. This activation may enhance K(+) efflux, either indirectly via enhanced cytosolic Ca(2+) and/or directly by increased K(+) transport activity. Enhanced shoot-to-root K(+) export may also cause the reduced expression of HAK5 observed in roots of cpr5, leading to a reduction in uptake of K(+). All ionomic data presented is publically available at www.ionomicshub.org.	[Borghi, Monica; Rus, Ana; Salt, David E.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Borghi, M (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.	david.salt@abdn.ac.uk		Borghi, Monica/0000-0003-1359-7611	US National Science Foundation; Plant Genome Research programs [IOS 0419695, DBI 0701119]	US National Science Foundation(National Science Foundation (NSF)); Plant Genome Research programs	This work was supported by grants to D. E. S. from the US National Science Foundation Arabidopsis 2010 and Plant Genome Research programs (IOS 0419695 and DBI 0701119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2006, J EXP BOT, V57, P125, DOI 10.1093/jxb/erj012; Amtmann A, 2008, PHYSIOL PLANTARUM, V133, P682, DOI 10.1111/j.1399-3054.2008.01075.x; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Freeman JL, 2005, PLANT PHYSIOL, V137, P1082, DOI 10.1104/pp.104.055293; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Gao GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019406; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; Guo KM, 2008, PHYSIOL PLANTARUM, V134, P499, DOI 10.1111/j.1399-3054.2008.01157.x; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jain A, 2009, PLANT PHYSIOL, V150, P1033, DOI 10.1104/pp.109.136184; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Jing HC, 2008, PLANT BIOLOGY, V10, P85, DOI 10.1111/j.1438-8677.2008.00087.x; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jing HC, 2002, PLANT J, V32, P51, DOI 10.1046/j.1365-313X.2002.01400.x; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Li XL, 2005, FUNCT PLANT BIOL, V32, P643, DOI 10.1071/FP04233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Marschner H, 2002, MINERAL NUTR HIGHER, P299; Moeder W, 2011, MOL PLANT, V4, P442, DOI 10.1093/mp/ssr018; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Perazza D, 2011, PLANT PHYSIOL, DOI [10.1104/111.179804, DOI 10.1104/111.179804]; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Rubio F, 2008, PHYSIOL PLANTARUM, V134, P598, DOI 10.1111/j.1399-3054.2008.01168.x; Rubio F, 2010, PHYSIOL PLANTARUM, V139, P220, DOI 10.1111/j.1399-3054.2010.01354.x; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shabala S, 2007, PLANT SOLUTE TRANSPO, P214; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; White PJ, 1997, J EXP BOT, V48, P2063, DOI 10.1093/jxb/48.12.2063; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yoshida S, 2002, PLANT J, V29, P427, DOI 10.1046/j.0960-7412.2001.01228.x; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Yoshioka K, 2001, PLANT J, V26, P447, DOI 10.1046/j.1365-313X.2001.2641039.x; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	56	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26360	10.1371/journal.pone.0026360	http://dx.doi.org/10.1371/journal.pone.0026360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046278	Green Published, Green Submitted, gold			2022-12-27	WOS:000296521400017
J	Haviland, R; Eschrich, S; Bloom, G; Ma, YH; Minton, S; Jove, R; Cress, WD				Haviland, Rachel; Eschrich, Steven; Bloom, Gregory; Ma, Yihong; Minton, Susan; Jove, Richard; Cress, W. Douglas			Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; SIGNAL TRANSDUCERS; MOLECULAR TARGETS; NUCLEAR-PROTEIN; CELL-GROWTH; V-SRC; TRANSCRIPTIONAL CONTROL; CONFERS RESISTANCE; SUPPRESSES GROWTH; EXPRESSION	Cytokine and growth factor signaling pathways involving STAT3 are frequently constitutively activated in many human primary tumors, and are known for the transcriptional role they play in controlling cell growth and cell cycle progression. However, the extent of STAT3's reach on transcriptional control of the genome as a whole remains an important question. We predicted that this persistent STAT3 signaling affects a wide variety of cellular functions, many of which still remain to be characterized. We took a broad approach to identify novel STAT3 regulated genes by examining changes in the genome-wide gene expression profile by microarray, using cells expressing constitutively-activated STAT3. Using computational analysis, we were able to define the gene expression profiles of cells containing activated STAT3 and identify candidate target genes with a wide range of biological functions. Among these genes we identified Necdin, a negative growth regulator, as a novel STAT3 target gene, whose expression is down-regulated at the mRNA and protein levels when STAT3 is constitutively active. This repression is STAT3 dependent, since inhibition of STAT3 using siRNA restores Necdin expression. A STAT3 DNA-binding site was identified in the Necdin promoter and both EMSA and chromatin immunoprecipitation confirm binding of STAT3 to this region. Necdin expression has previously been shown to be down-regulated in a melanoma and a drug-resistant ovarian cancer cell line. Further analysis of Necdin expression demonstrated repression in a STAT3-dependent manner in human melanoma, prostate and breast cancer cell lines. These results suggest that STAT3 coordinates expression of genes involved in multiple metabolic and biosynthetic pathways, integrating signals that lead to global transcriptional changes and oncogenesis. STAT3 may exert its oncogenic effect by up-regulating transcription of genes involved in promoting growth and proliferation, but also by down-regulating expression of negative regulators of the same cellular processes, such as Necdin.	[Haviland, Rachel; Minton, Susan] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Breast Canc Program, Tampa, FL 33612 USA; [Jove, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; City of Hope; Beckman Research Institute of City of Hope	Haviland, R (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Breast Canc Program, Tampa, FL 33612 USA.	RJove@coh.org; Douglas.Cress@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788	Angela Musette Russo Foundation; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI) [R01-CA115674]; NATIONAL CANCER INSTITUTE [R01CA115674, P30CA076292] Funding Source: NIH RePORTER	Angela Musette Russo Foundation; H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Angela Musette Russo Foundation (http://www.russofoundation.com/), H. Lee Moffitt Cancer Center and Research Institute (http://www.moffitt.org) and National Cancer Institute (NCI) Grant R01-CA115674 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Buettner R, 2002, CLIN CANCER RES, V8, P945; Buettner R, 2007, MOL CANCER RES, V5, P823, DOI 10.1158/1541-7786.MCR-06-0352; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chapman EJ, 2009, MOL CARCINOGEN, V48, P975, DOI 10.1002/mc.20567; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gao S Paul, 2006, Sci STKE, V2006, ppe30, DOI 10.1126/stke.3432006pe30; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; Kreis S, 2007, MOL CANCER RES, V5, P1331, DOI 10.1158/1541-7786.MCR-07-0317; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Mora LB, 2002, CANCER RES, V62, P6659; Ni Z, 2000, CANCER RES, V60, P1225; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niu GL, 1999, CANCER RES, V59, P5059; Odajima J, 2000, J BIOL CHEM, V275, P24096, DOI 10.1074/jbc.M001606200; Okamoto M, 1997, CANCER RES, V57, P141; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Turkson J, 2004, MOL CANCER THER, V3, P1533; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Varma RR, 2005, ONCOL REP, V14, P925; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; Zhang YW, 2002, ONCOGENE, V21, P217, DOI 10.1038/sj/onc/1205004; Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4	66	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e24923	10.1371/journal.pone.0024923	http://dx.doi.org/10.1371/journal.pone.0024923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046235	Green Submitted, Green Published, gold			2022-12-27	WOS:000296521400003
J	Astarita, G; Jung, KM; Vasilevko, V; DiPatrizio, NV; Martin, SK; Cribbs, DH; Head, E; Cotman, CW; Piomelli, D				Astarita, Giuseppe; Jung, Kwang-Mook; Vasilevko, Vitaly; DiPatrizio, Nicholas V.; Martin, Sarah K.; Cribbs, David H.; Head, Elizabeth; Cotman, Carl W.; Piomelli, Daniele			Elevated Stearoyl-CoA Desaturase in Brains of Patients with Alzheimer's Disease	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; INSULIN SENSITIVITY; DOCOSAHEXAENOIC ACID; ORBITOFRONTAL CORTEX; METABOLIC SYNDROME; MASS-SPECTROMETRY; MOUSE MODEL; CHOLESTEROL; GENE; ASSOCIATION	The molecular bases of Alzheimer's disease (AD) remain unclear. We used a lipidomic approach to identify lipid abnormalities in the brains of subjects with AD (N = 37) compared to age-matched controls (N = 17). The analyses revealed statistically detectable elevations in levels of non-esterified monounsaturated fatty acids (MUFAs) and mead acid (20:3n-9) in mid-frontal cortex, temporal cortex and hippocampus of AD patients. Further studies showed that brain mRNAs encoding for isoforms of the rate-limiting enzyme in MUFAs biosynthesis, stearoyl-CoA desaturase (SCD-1, SCD-5a and SCD-5b), were elevated in subjects with AD. The monounsaturated/saturated fatty acid ratio ('desaturation index') - displayed a strong negative correlation with measures of cognition: the Mini Mental State Examination test (r = -0.80; P = 0.0001) and the Boston Naming test (r = -0.57; P = 0.0071). Our results reveal a previously unrecognized role for the lipogenic enzyme SCD in AD.	[Astarita, Giuseppe; Jung, Kwang-Mook; DiPatrizio, Nicholas V.; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Astarita, Giuseppe; Piomelli, Daniele] Italian Inst Technol, Unit Drug Discovery & Dev, Genoa, Italy; [Vasilevko, Vitaly; Cribbs, David H.; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Martin, Sarah K.; Head, Elizabeth] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of Kentucky; University of California System; University of California Irvine	Astarita, G (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	DiPatrizio, NIcholas/AAV-1865-2021; Jung, Kwang-Mook/F-1035-2018; Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014	DiPatrizio, NIcholas/0000-0001-8423-0695; Jung, Kwang-Mook/0000-0003-4096-6953; Astarita, Giuseppe/0000-0001-6700-301X	National Institutes on Drug Abuse [RC2 DA028902]; Alzheimer's Association [IIRG-08-92000]; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028902] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by the National Institutes on Drug Abuse (RC2 DA028902 to D. P.) and the Alzheimer's Association (IIRG-08-92000 to K-M.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita G, 2009, METHODS MOL BIOL, V579, P201, DOI 10.1007/978-1-60761-322-0_10; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Corpeleijn E, 2006, DIABETOLOGIA, V49, P2392, DOI 10.1007/s00125-006-0383-4; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Finch CE, 2005, NEUROBIOL AGING, V26, P281, DOI 10.1016/j.neurobiolaging.2004.03.015; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Huttunen HJ, 2008, NEURODEGENER DIS, V5, P212, DOI 10.1159/000113705; Issandou M, 2009, EUR J PHARMACOL, V618, P28, DOI 10.1016/j.ejphar.2009.07.004; Kalra SP, 2008, PEPTIDES, V29, P127, DOI 10.1016/j.peptides.2007.10.017; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Lengi AJ, 2008, COMP BIOCHEM PHYS B, V150, P440, DOI 10.1016/j.cbpb.2008.05.001; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lukiw WL, 2005, CELL MOL NEUROBIOL, V25, P475, DOI 10.1007/s10571-005-4010-6; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; McNamara RK, 2008, PSYCHIAT RES, V160, P285, DOI 10.1016/j.psychres.2007.08.021; McNamara RK, 2008, PROSTAG LEUKOTR ESS, V78, P293, DOI 10.1016/j.plefa.2008.04.001; Ntambi JM, 1999, J LIPID RES, V40, P1549; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Prince M, 2009, WORLD ALZHEIMER REPO; Puglielli L, 2004, J MOL NEUROSCI, V24, P93, DOI 10.1385/JMN:24:1:093; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Sampath H, 2008, FUTURE LIPIDOL, V3, P163, DOI 10.2217/17460875.3.2.163; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Uto Y, 2010, EUR J MED CHEM, V45, P4788, DOI 10.1016/j.ejmech.2010.07.044; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Windig W, 1996, ANAL CHEM, V68, P3602, DOI 10.1021/ac960435y; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255	36	82	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e24777	10.1371/journal.pone.0024777	http://dx.doi.org/10.1371/journal.pone.0024777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046234	Green Published, gold			2022-12-27	WOS:000296519600004
J	Moura, GR; Pinheiro, M; Freitas, A; Oliveira, JL; Frommlet, JC; Carreto, L; Soares, AR; Bezerra, AR; Santos, MAS				Moura, Gabriela R.; Pinheiro, Miguel; Freitas, Adelaide; Oliveira, Jose L.; Frommlet, Joerg C.; Carreto, Laura; Soares, Ana R.; Bezerra, Ana R.; Santos, Manuel A. S.			Species-Specific Codon Context Rules Unveil Non-Neutrality Effects of Synonymous Mutations	PLOS ONE			English	Article							DNA METHYLATION; RNA; SELECTION; PAIR; GENOMES; SCALE; METHODOLOGIES; ERRORS; USAGE; COLI	Background: Codon pair usage (codon context) is a species specific gene primary structure feature whose evolutionary and functional roles are poorly understood. The data available show that codon-context has direct impact on both translation accuracy and efficiency, but one does not yet understand how it affects these two translation variables or whether context biases shape gene evolution. Methodologies/Principal Findings: Here we study codon-context biases using a set of 72 orthologous highly conserved genes from bacteria, archaea, fungi and high eukaryotes to identify 7 distinct groups of codon context rules. We show that synonymous mutations, i.e., neutral mutations that occur in synonymous codons of codon-pairs, are selected to maintain context biases and that non-synonymous mutations, i.e., non-neutral mutations that alter protein amino acid sequences, are also under selective pressure to preserve codon-context biases. Conclusions: Since in vivo studies provide evidence for a role of codon context on decoding fidelity in E. coli and for decoding efficiency in mammalian cells, our data support the hypothesis that, like codon usage, codon context modulates the evolution of gene primary structure and fine tunes the structure of open reading frames for high genome translational fidelity and efficiency in the 3 domains of life.	[Moura, Gabriela R.; Frommlet, Joerg C.; Carreto, Laura; Soares, Ana R.; Bezerra, Ana R.; Santos, Manuel A. S.] Univ Aveiro, RNA Biol Lab, Dept Biol, P-3800 Aveiro, Portugal; [Moura, Gabriela R.; Frommlet, Joerg C.; Carreto, Laura; Soares, Ana R.; Bezerra, Ana R.; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Pinheiro, Miguel; Oliveira, Jose L.] Univ Aveiro, Inst Elect & Telemat Engn IEETA, P-3800 Aveiro, Portugal; [Freitas, Adelaide] Univ Aveiro, Dept Math, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Moura, GR (corresponding author), Univ Aveiro, RNA Biol Lab, Dept Biol, P-3800 Aveiro, Portugal.	gmoura@ua.pt	/AAD-1722-2020; Bezerra, Ana/G-7380-2014; Freitas, Adelaide/H-8880-2012; Soares, Ana RSCM/G-7331-2014; Moura, Gabriela/GPF-9079-2022; Menezes Oliveira, Joselina Luzia/D-1416-2012; Moura, Gabriela R/E-6717-2010; UA, DMat/B-5289-2012; Pinheiro, Miguel/K-6572-2017; Santos, Manuel/E-6704-2010; Oliveira, José Luis/A-2223-2012	/0000-0001-7399-3021; Freitas, Adelaide/0000-0002-4685-1615; Soares, Ana RSCM/0000-0003-4000-7461; Moura, Gabriela/0000-0003-2243-6123; Menezes Oliveira, Joselina Luzia/0000-0002-3701-1323; Moura, Gabriela R/0000-0003-2243-6123; Pinheiro, Miguel/0000-0002-6601-7513; Santos, Manuel/0000-0002-0437-1146; Oliveira, José Luis/0000-0002-6672-6176; Bezerra, Ana/0000-0003-4613-1711	EU; Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BCM/72251/2006, PTDC/BIA-BCM/64745/2006, PTDC/BIA-GEN/110383/2009]; The Institute of Electronics and Telematics Enginnering of Aveiro (IEETA); Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/72251/2006, PTDC/BIA-GEN/110383/2009] Funding Source: FCT	EU(European Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); The Institute of Electronics and Telematics Enginnering of Aveiro (IEETA); Fundação para a Ciência e a Tecnologia	This study was founded by the EU-FP7 MEPHITIS project and by the Portuguese Foundation for Science and Technology (FCT) projects PTDC/BIA-BCM/72251/2006, PTDC/BIA-BCM/64745/2006 and PTDC/BIA-GEN/110383/2009. The Institute of Electronics and Telematics Enginnering of Aveiro (IEETA) supported the development of the Anaconda software package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; BOSSI L, 1980, NATURE, V286, P123, DOI 10.1038/286123a0; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P683, DOI 10.1093/nar/23.4.683; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P4104, DOI 10.1093/nar/23.20.4104; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Forman MD, 1998, PROTEIN SCI, V7, P500; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hildebrand F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001107; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; KOPELOWITZ J, 1992, J MOL BIOL, V225, P261, DOI 10.1016/0022-2836(92)90920-F; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; Moura Gabriela, 2007, V395, P449; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; MURGOLA EJ, 1984, J MOL BIOL, V175, P19, DOI 10.1016/0022-2836(84)90442-X; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Plant EP, 2004, NUCLEIC ACIDS RES, V32, P784, DOI 10.1093/nar/gkh256; PRECUP J, 1987, J BIOL CHEM, V262, P11351; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rocha EPC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001104; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Tats A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-463; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207	39	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26817	10.1371/journal.pone.0026817	http://dx.doi.org/10.1371/journal.pone.0026817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046369	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600061
J	Park, SC; Lee, JK; Kim, SW; Park, Y				Park, Seong-Cheol; Lee, Jong-Kook; Kim, Si Wouk; Park, Yoonkyung			Selective Algicidal Action of Peptides against Harmful Algal Bloom Species	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO; FATTY-ACIDS; CHATTONELLA-ANTIQUA; RED; PHYTOPLANKTON; COMBINATION; MECHANISM; MARINA; SEA	Recently, harmful algal bloom (HAB), also termed "red tide", has been recognized as a serious problem in marine environments according to climate changes worldwide. Many novel materials or methods to prevent HAB have not yet been employed except for clay dispersion, in which can the resulting sedimentation on the seafloor can also cause alteration in marine ecology or secondary environmental pollution. In the current study, we investigated that antimicrobial peptide have a potential in controlling HAB without cytotoxicity to harmless marine organisms. Here, antimicrobial peptides are proposed as new algicidal compounds in combating HAB cells. HPA3 and HPA3NT3 peptides which exert potent antimicrobial activity via pore forming action in plasma membrane showed that HPA3NT3 reduced the motility of algal cells, disrupted their plasma membrane, and induced the efflux of intracellular components. Against raphidoflagellate such as Heterosigma akashiwo, Chattonella sp., and C. marina, it displayed a rapid lysing action in cell membranes at 1 similar to 4 mu M within 2 min. Comparatively, its lysing effects occurred at 8 mM within 1 h in dinoflagellate such as Cochlodium polykrikoides, Prorocentrum micans, and P. minimum. Moreover, its lysing action induced the lysis of chloroplasts and loss of chlorophyll a. In the contrary, this peptide was not effective against Skeletonema costatum, harmless algal cell, even at 256 mM, moreover, it killed only H. akashiwo or C. marina in co-cultivation with S. costatum, indicating to its selective algicidal activity between harmful and harmless algal cells. The peptide was non-hemolytic against red blood cells of Sebastes schlegeli, the black rockfish, at 120 mu M. HAB cells were quickly and selectively lysed following treatment of antimicrobial peptides without cytotoxicity to harmless marine organisms. Thus, the antibiotic peptides examined in our study appear to have much potential in effectively controlling HAB with minimal impact on marine ecology.	[Park, Seong-Cheol; Lee, Jong-Kook; Park, Yoonkyung] Chosun Univ, RCPM, Kwangju, South Korea; [Kim, Si Wouk] Chosun Univ, Dept Environm Engn, Kwangju, South Korea; [Park, Yoonkyung] Chosun Univ, Dept Biotechnol, Kwangju, South Korea	Chosun University; Chosun University; Chosun University	Park, SC (corresponding author), Chosun Univ, RCPM, Kwangju, South Korea.	y_k_park@chosun.ac.kr		Park, Seong-Cheol/0000-0001-9051-0183; Kim, Si Wouk/0000-0001-8539-6777	Pioneer Research Center Program through the National Research Program of Korea; Ministry of Education, Science and Technology [2008-2000122]	Pioneer Research Center Program through the National Research Program of Korea; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Pioneer Research Center Program through the National Research Program of Korea (http://www.nrf.re.kr/html/kr) funded by the Ministry of Education, Science and Technology (Grant No. 2008-2000122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamsjah MA, 2005, BIOSCI BIOTECH BIOCH, V69, P2186, DOI 10.1271/bbb.69.2186; Alamsjah MA, 2007, BIOSCI BIOTECH BIOCH, V71, P265, DOI 10.1271/bbb.60475; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; BRICELJ VM, 1984, MAR BIOL, V84, P155, DOI 10.1007/BF00393000; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Dominguez HJ, 2010, TOXICON, V56, P191, DOI 10.1016/j.toxicon.2009.11.005; Edvardsen B, 2006, ECOL STU AN, V189, P67, DOI 10.1007/978-3-540-32210-8_6; Fleming LE, 2007, CHEST, V131, P187, DOI 10.1378/chest.06-1830; Gao KS, 2007, J PHOTOCH PHOTOBIO B, V86, P140, DOI 10.1016/j.jphotobiol.2006.05.007; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; Haque SM, 2002, ENVIRON TOXICOL, V17, P113, DOI 10.1002/tox.10039; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ishida K, 2000, J ORG CHEM, V65, P5898, DOI 10.1021/jo991918f; Iwataki M, 2010, J EUKARYOT MICROBIOL, V57, P308, DOI 10.1111/j.1550-7408.2010.00491.x; Jacobs MA, 1999, PLANT MOL BIOL, V41, P645, DOI 10.1023/A:1006394925182; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jeong HJ, 2003, J EUKARYOT MICROBIOL, V50, P274, DOI 10.1111/j.1550-7408.2003.tb00134.x; Kim DK, 2001, MAR BIOL, V139, P625; Kim D, 2008, J MICROBIOL BIOTECHN, V18, P1621; Marshall JA, 2002, J APPL PHYCOL, V14, P255, DOI 10.1023/A:1021101203543; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mizumoto H, 2008, APPL ENVIRON MICROB, V74, P3105, DOI 10.1128/AEM.02190-07; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; Nishibori N, 2009, FEMS MICROBIOL LETT, V298, P74, DOI 10.1111/j.1574-6968.2009.01701.x; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; Park Young-Tae, 1998, Journal of the Korean Fisheries Society, V31, P920; PARRISH CC, 1988, MAR CHEM, V23, P17, DOI 10.1016/0304-4203(88)90020-5; Pearson LA, 2008, CRIT REV TOXICOL, V38, P847, DOI [10.1080/10408440802291513, 10.1080/10408440802291513 ]; Sakai H, 2007, WATER RES, V41, P3458, DOI 10.1016/j.watres.2007.04.031; Sato N, 2000, BIOCHEM SOC T, V28, P912, DOI 10.1042/0300-5127:0280912; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Sokolov Y, 1999, BBA-BIOMEMBRANES, V1420, P23, DOI 10.1016/S0005-2736(99)00086-3; Sun XX, 2004, MAR POLLUT BULL, V48, P863, DOI 10.1016/j.marpolbul.2003.11.002; Tang DL, 2006, HYDROBIOLOGIA, V568, P245, DOI 10.1007/s10750-006-0108-1; Volcani B., 1981, SILICON SILICEOUS ST, P157; Wada H, 2007, PHOTOSYNTH RES, V92, P205, DOI 10.1007/s11120-007-9203-z; WADA M, 1987, PROTOPLASMA, V137, P134, DOI 10.1007/BF01281148; Watkins SM, 2008, MAR DRUGS, V6, P431, DOI 10.3390/md20080021; Wu JT, 2006, AQUAT TOXICOL, V80, P338, DOI 10.1016/j.aquatox.2006.09.011; Yoo YD, 2009, J EUKARYOT MICROBIOL, V56, P413, DOI 10.1111/j.1550-7408.2009.00421.x; Yoo YD, 2010, J EUKARYOT MICROBIOL, V57, P145, DOI 10.1111/j.1550-7408.2009.00448.x	47	40	45	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26733	10.1371/journal.pone.0026733	http://dx.doi.org/10.1371/journal.pone.0026733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046341	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600050
J	Tan, XL; Wang, QY; Tian, BX; Zhang, HA; Lu, DL; Zhou, J				Tan, Xiaoli; Wang, Qiuye; Tian, Baoxia; Zhang, Henan; Lu, Daoli; Zhou, Jia			A Brassica napus Lipase Locates at the Membrane Contact Sites Involved in Chloroplast Development	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; LIPID TRAFFICKING; TRIACYLGLYCEROL LIPASE; PLASMA-MEMBRANE; ARABIDOPSIS; TRANSFORMATION; BIOSYNTHESIS; BIOGENESIS; PLASTIDS; MUTATION	Background: Fatty acids synthesized in chloroplast are transported to endoplasmic reticulum (ER) for triacylglycerols (TAGs) resembling. The development of chloroplast also requires lipids trafficking from ER to chloroplast. The membrane contact sites (MCSs) between ER and chloroplast has been demonstrated to be involved for the trafficking of lipids and proteins. Lipids trafficking between ER and chloroplast is often accompanied by lipids interconversion. However, it is rarely known how lipids interconversion happens during their trafficking. Methodology/Principal Findings: We cloned a lipase gene from Brassica napus L., designated as BnCLIP1. Green fluorescence protein (GFP)-tagged BnCLIP1 was shown to locate at the MCSs between ER and chloroplasts in tobacco leaves. Heterogeneous expression of BnCLIP1 in Saccharomyces cerevisiae (pep4) reduced the total amount of fatty acid. Gas chromatography-mass spectrometry (GC-MS) analysis revealed that the truncated BnCLIP1 had a substrate preference for C16:0 lipids in Saccharomyces cerevisiae (pep4). To probe the physiological function of BnCLIP1, two Brassica napus lines with different oil-content were introduced to investigate the transcript patterns of BnCLIP1 during seed development. Intriguingly, the transcript level of BnCLIP1 was found to be immediately up-regulated during the natural seed senescence of both lines; the transcription response of BnCLIP1 in the high oil-content seeds was faster than the lower ones, suggesting a potential role of BnCLIP1 in affecting seed oil synthesis via regulating chloroplast integrity. Further researches showed that chemical disruption of leaf chloroplast also activated the transcription of BnCLIP1. Conclusions/Significance: The findings of this study show that BnCLIP1 encodes a lipase, localizes at the MCSs and involves in chloroplast development.	[Tan, Xiaoli; Wang, Qiuye; Tian, Baoxia; Zhang, Henan; Lu, Daoli; Zhou, Jia] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Tan, XL (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	joe50@live.cn			The National Basic Research Program [2006CB101600]; National High-Tech RD Program [2008AA10Z152]; Jiangsu University [05JDG003]	The National Basic Research Program(National Basic Research Program of China); National High-Tech RD Program(National High Technology Research and Development Program of China); Jiangsu University	This work was supported by The National Basic Research Program (2006CB101600)(http://www.973.gov.cn/AreaItem.aspx?fid = 01), National High-Tech R&D Program (2008AA10Z152) (http://www.863.gov.cn/) and Talent Fund of Jiangsu University (05JDG003) (to Xiaoli Tan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2007, PLANT SIGNAL BEHAV, V2, P185, DOI 10.4161/psb.2.3.3973; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Eastmond PJ, 2004, J BIOL CHEM, V279, P45540, DOI 10.1074/jbc.M408686200; EVANS CT, 1985, J MICROBIOL METH, V4, P203, DOI 10.1016/0167-7012(85)90038-7; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; Hong JK, 2008, PLANTA, V227, P539, DOI 10.1007/s00425-007-0637-5; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Hyun Y, 2008, DEV CELL, V14, P183, DOI 10.1016/j.devcel.2007.11.010; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jo Y, 2011, PROTOPLASMA, V248, P191, DOI 10.1007/s00709-010-0251-4; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Kaneko Y, 1996, PROTOPLASMA, V195, P59, DOI 10.1007/BF01279186; Karim EK, 2005, FEBS LETT, V579, P6067, DOI 10.1016/j.febslet.2005.09.072; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kaup MT, 2002, PLANT PHYSIOL, V129, P1616, DOI 10.1104/pp.003087; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; Kong FM, 2009, AFR J BIOTECHNOL, V8, P2497; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lin WL, 2008, PLANT SCI, V175, P233, DOI 10.1016/j.plantsci.2008.04.003; MacKinney G, 1941, J BIOL CHEM, V140, P315; Metcalfe C. R., 1950, Anatomy of the Dicotyledons: leaves, stem, and wood, in relation to taxonomy, with notes on economic uses.; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; MUKHERJEE KD, 1994, PROG LIPID RES, V33, P165, DOI 10.1016/0163-7827(94)90019-1; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Redon M, 2009, EUR FOOD RES TECHNOL, V228, P833, DOI 10.1007/s00217-008-0996-6; SMITHJOHANNSEN H, 1980, J CELL SCI, V43, P119; SOROKIN HP, 1955, AM J BOT, V42, P225, DOI 10.2307/2438558; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Vyssotski M, 2009, LIPIDS, V44, P381, DOI 10.1007/s11745-008-3272-4; Wang G, 2007, PHYTOCHEMISTRY, V68, P2112, DOI 10.1016/j.phytochem.2007.04.040; WHATLEY JM, 1991, NEW PHYTOL, V117, P209, DOI 10.1111/j.1469-8137.1991.tb04901.x; Williams JP, 2000, BIOCHEM J, V349, P127, DOI 10.1042/0264-6021:3490127; WOODING FBP, 1965, AM J BOT, V52, P526, DOI 10.2307/2440270; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Xu CC, 2008, PLANT J, V54, P163, DOI 10.1111/j.1365-313X.2008.03417.x; Xu CC, 2010, PLANT CELL PHYSIOL, V51, P1019, DOI 10.1093/pcp/pcq053; Xue LG, 1997, PLANT PHYSIOL, V113, P549, DOI 10.1104/pp.113.2.549	56	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26831	10.1371/journal.pone.0026831	http://dx.doi.org/10.1371/journal.pone.0026831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046373	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600062
J	Howard, TD; Ho, SM; Zhang, L; Chen, J; Cui, W; Slager, R; Gray, S; Hawkins, GA; Medvedovic, M; Wagner, JD				Howard, Timothy D.; Ho, Shuk-Mei; Zhang, Li; Chen, Jing; Cui, Wei; Slager, Rebecca; Gray, Stanton; Hawkins, Gregory A.; Medvedovic, Mario; Wagner, Janice D.			Epigenetic Changes with Dietary Soy in Cynomolgus Monkeys	PLOS ONE			English	Article							INCREASES SUSCEPTIBILITY; PROSTATE CARCINOGENESIS; DEVELOPMENTAL EXPOSURE; PERINATAL EXPOSURE; ISOFLAVONES; PROTEIN; ALTERS; ESTRADIOL; WEIGHT; MODELS	Nutritional interventions are important alternatives for reducing the prevalence of many chronic diseases. Soy is a good source of protein that contains isoflavones, including genistein and daidzein, and may alter the risk of obesity, Type 2 diabetes, osteoporosis, cardiovascular disease, and reproductive cancers. We have shown previously in nonhuman primates that soy protein containing isoflavones leads to improved body weight, insulin sensitivity, lipid profiles, and atherosclerosis compared to protein without soy isoflavones (casein), and does not increase the risk of cancer. Since genistein has been shown to alter DNA methylation, we compared the methylation profiles of cynomolgus monkeys, from multiple tissues, eating two high-fat, typical American diets (TAD) with similar macronutrient contents, with or without soy protein. DNA methylation status was successfully determined for 80.6% of the probes in at least one tissue using Illumina's HumanMethylation27 BeadChip. Overall methylation increased in liver and muscle tissue when monkeys switched from the TAD-soy to the TAD-casein diets. Genes involved in epigenetic processes, specifically homeobox genes (HOXA5, HOXA11, and HOXB1), and ABCG5 were among those that changed between diets. These data support the use of the HumanMethylation27 BeadChip in cynomolgus monkeys and identify epigenetic changes associated with dietary interventions with soy protein that may potentially affect the etiology of complex diseases.	[Howard, Timothy D.; Cui, Wei; Slager, Rebecca; Hawkins, Gregory A.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Zhang, Li; Gray, Stanton; Wagner, Janice D.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Ho, Shuk-Mei; Chen, Jing; Medvedovic, Mario] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Ho, Shuk-Mei; Chen, Jing; Medvedovic, Mario] Univ Cincinnati, Ctr Environm Genet, Cincinnati, OH USA; [Ho, Shuk-Mei] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	Wake Forest University; Wake Forest University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Howard, TD (corresponding author), Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA.	tdhoward@wfubmc.edu	Chen, Jing/A-7928-2013	Gray, Stanton/0000-0002-8816-0898; Chen, Jing/0000-0002-6227-7393	National Institutes of Health from the National Center for Research Resources [P40RR021380, ES015584, ES018758, ES018789, ES006096, ES019480]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR021380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018789, P30ES006096, U01ES019480, R01ES015584, RC2ES018758] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in part, by the National Institutes of Health awards P40RR021380 from the National Center for Research Resources (JDW), ES015584 (MM, SMH), ES018758 (MM, SMH), ES018789 (MM, SMH), ES006096 (MM, SMH), ES019480 (SMH), and an award from the Department of Veterans Affairs (SMH). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 2005, J NUTR, V135, P2852, DOI 10.1093/jn/135.12.2852; Badger TM, 2002, J NUTR, V132, p559S, DOI 10.1093/jn/132.3.559S; BARKER DJP, 1989, LANCET, V2, P577; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Cline JM, 2009, AM J PRIMATOL, V71, P722, DOI 10.1002/ajp.20680; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Droke Elizabeth A, 2007, J Inflamm (Lond), V4, P17, DOI 10.1186/1476-9255-4-17; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Jefferson WN, 2009, BIOL REPROD, V80, P425, DOI 10.1095/biolreprod.108.073171; Jensen MN, 2007, LAB ANIM-UK, V41, P1, DOI 10.1258/002367707779399428; Klein SL, 2002, MOL MED, V8, P742, DOI 10.1007/BF03402038; Lamartiniere CA, 2002, J NUTR, V132, p552S, DOI 10.1093/jn/132.3.552S; Morito K, 2002, BIOL PHARM BULL, V25, P48, DOI 10.1248/bpb.25.48; Newbold RR, 2005, BIRTH DEFECTS RES A, V73, P478, DOI 10.1002/bdra.20147; Prins GS, 2008, BASIC CLIN PHARMACOL, V102, P134, DOI 10.1111/j.1742-7843.2007.00166.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins Gail S, 2008, Fertil Steril, V89, pe41, DOI 10.1016/j.fertnstert.2007.12.023; Souzeau E, 2005, AM J PHYSIOL-HEART C, V289, pH715, DOI 10.1152/ajpheart.00061.2005; Stroud FC, 2006, J AM ASSOC LAB ANIM, V45, P20; Thigpen JE, 1999, LAB ANIM SCI, V49, P530; Wagner JD, 2008, METABOLISM, V57, pS24, DOI 10.1016/j.metabol.2008.04.001; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Wagner JD, 2009, AM J PRIMATOL, V71, P802, DOI 10.1002/ajp.20716; Wagner JD, 2003, ARTERIOSCL THROM VAS, V23, P2241, DOI 10.1161/01.ATV.0000102925.49136.52; Wisniewski AB, 2005, PHYSIOL BEHAV, V84, P327, DOI 10.1016/j.physbeh.2004.12.008; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	32	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26791	10.1371/journal.pone.0026791	http://dx.doi.org/10.1371/journal.pone.0026791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046358	Green Submitted, gold, Green Published			2022-12-27	WOS:000296517000032
J	Leroy, Q; Armougom, F; Barbry, P; Raoult, D				Leroy, Quentin; Armougom, Fabrice; Barbry, Pascal; Raoult, Didier			Genomotyping of Coxiella burnetii Using Microarrays Reveals a Conserved Genomotype for Hard Tick Isolates	PLOS ONE			English	Article							Q-FEVER; SEQUENCE-ANALYSIS; DIVERSITY; DIFFERENTIATION; NETHERLANDS; INFECTION; DESIGN; MODEL; COM1; GENE	C. burnetii is a Gram-negative intracellular Y-proteobacteria that causes the zoonotic disease Q fever. Q fever can manifest as an acute or chronic illness. Different typing methods have been previously developed to classify C. burnetii isolates to explore its pathogenicity. Here, we report a comprehensive genomotyping method based on the presence or absence of genes using microarrays. The genomotyping method was then tested in 52 isolates obtained from different geographic areas, different hosts and patients with different clinical manifestations. The analysis revealed the presence of 10 genomotypes organized into 3 groups, with a topology congruent with that obtained through multi-spacer typing. We also found that only 4 genomotypes were specifically associated with acute Q fever, whereas all of the genomotypes could be associated to chronic human infection. Serendipitously, the genomotyping results revealed that all hard tick isolates, including the Nine Mile strain, belong to the same genomotype.	[Leroy, Quentin; Armougom, Fabrice; Raoult, Didier] Univ Mediterranee, Fac Med, UMR 6236, URMITE,CNRS IRD, Marseille, France; [Barbry, Pascal] CNRS UNSA, UMR 6079, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur	Leroy, Q (corresponding author), Univ Mediterranee, Fac Med, UMR 6236, URMITE,CNRS IRD, Marseille, France.	didier.raoult@gmail.com	Barbry, Pascal/O-5021-2016; RAOULT, Didier/A-8434-2008	Barbry, Pascal/0000-0001-9632-6483; RAOULT, Didier/0000-0002-0633-5974				Andoh M, 2004, MICROBIOL IMMUNOL, V48, P971, DOI 10.1111/j.1348-0421.2004.tb03627.x; Balashov Y.S., 1973, BLOOD FEEDING ARTROP; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Carter B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-53; Enserink M, 2010, SCIENCE, V327, P266, DOI [10.1126/science.327.5963.266-a, 10.1126/science.327.5963.266-b]; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; HEINZEN R, 1990, ANN NY ACAD SCI, V590, P504, DOI 10.1111/j.1749-6632.1990.tb42260.x; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; Hoover TA, 2002, INFECT IMMUN, V70, P6726, DOI 10.1128/IAI.70.12.6726-2733.2002; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; PHILIP CB, 1948, J PARASITOL, V34, P457, DOI 10.2307/3273312; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2009, CLIN INFECT DIS, V48, P558, DOI 10.1086/596706; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; Russell-Lodrigue KE, 2006, INFECT IMMUN, V74, P6085, DOI 10.1128/IAI.00763-06; Russell-Lodrigue KE, 2009, INFECT IMMUN, V77, P5640, DOI 10.1128/IAI.00851-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sekeyova Z, 1999, FEMS MICROBIOL LETT, V180, P61, DOI 10.1016/S0378-1097(99)00462-0; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; SMITH D. J. W., 1939, Medical Journal of Australia, V1, P13; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; STEIN A, 1993, MICROB PATHOGENESIS, V15, P177, DOI 10.1006/mpat.1993.1068; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Van Nguyen S, 1999, FEMS MICROBIOL LETT, V180, P249, DOI 10.1111/j.1574-6968.1999.tb08803.x; WEYER F, 1953, Z Tropenmed Parasitol, V4, P344; Zhang GQ, 1997, MICROBIOL IMMUNOL, V41, P871, DOI 10.1111/j.1348-0421.1997.tb01943.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25781	10.1371/journal.pone.0025781	http://dx.doi.org/10.1371/journal.pone.0025781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046248	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000011
J	Rao, SQ; Yuan, MQ; Zuo, XY; Su, WY; Zhang, F; Huang, K; Lin, MH; Ding, YL				Rao, Shaoqi; Yuan, Manqiong; Zuo, Xiaoyu; Su, Weiyang; Zhang, Fan; Huang, Ke; Lin, Meihua; Ding, Yuanlin			A Novel Evolution-Based Method for Detecting Gene-Gene Interactions	PLOS ONE			English	Article							GENOME-WIDE; MULTIPLE LOCI; CLASSIFICATION; EPISTASIS; BIOLOGY	Background: The rapid advance in large-scale SNP-chip technologies offers us great opportunities in elucidating the genetic basis of complex diseases. Methods for large-scale interactions analysis have been under development from several sources. Due to several difficult issues (e. g., sparseness of data in high dimensions and low replication or validation rate), development of fast, powerful and robust methods for detecting various forms of gene-gene interactions continues to be a challenging task. Methodology/Principal Findings: In this article, we have developed an evolution-based method to search for genome-wide epistasis in a case-control design. From an evolutionary perspective, we view that human diseases originate from ancient mutations and consider that the underlying genetic variants play a role in differentiating human population into the healthy and the diseased. Based on this concept, traditional evolutionary measure, fixation index (Fst) for two unlinked loci, which measures the genetic distance between populations, should be able to reveal the responsible genetic interplays for disease traits. To validate our proposal, we first investigated the theoretical distribution of Fst by using extensive simulations. Then, we explored its power for detecting gene-gene interactions via SNP markers, and compared it with the conventional Pearson Chi-square test, mutual information based test and linkage disequilibrium based test under several disease models. The proposed evolution-based method outperformed these compared methods in dominant and additive models, no matter what the disease allele frequencies were. However, its performance was relatively poor in a recessive model. Finally, we applied the proposed evolution-based method to analysis of a published dataset. Our results showed that the P value of the Fst -based statistic is smaller than those obtained by the LD-based statistic or Poisson regression models. Conclusions/Significance: With rapidly growing large-scale genetic association studies, the proposed evolution-based method can be a promising tool in the identification of epistatic effects.	[Rao, Shaoqi; Lin, Meihua; Ding, Yuanlin] Guangdong Med Coll, Dept Med Stat & Epidemiol, Sch Publ Hlth, Dongguan, Guangdong, Peoples R China; [Rao, Shaoqi; Yuan, Manqiong] Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Shaoqi; Zuo, Xiaoyu; Su, Weiyang; Zhang, Fan] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ke] Guangzhou Blood Ctr, Inst Blood Transfus, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Guangzhou Blood Center	Rao, SQ (corresponding author), Guangdong Med Coll, Dept Med Stat & Epidemiol, Sch Publ Hlth, Dongguan, Guangdong, Peoples R China.	paulsrrao@yahoo.com.cn		Rao, Shaoqi/0000-0001-7809-3700	National Natural Science Foundation of China [30830104, 31071166]; Natural Science Foundation of Guangdong Province, China [8251008901000007]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China; State Key Laboratory of Oncology in South China; SYSU Labs; Guangdong Medical College [XG1001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); State Key Laboratory of Oncology in South China; SYSU Labs; Guangdong Medical College	This work was supported in part by the National Natural Science Foundation of China (grant nos. 30830104 and 31071166), Natural Science Foundation of Guangdong Province, China (grant no. 8251008901000007), Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China (to S.-Q.R.), State Key Laboratory of Oncology in South China (to S.-Q.R.), SYSU Labs Open-Ended Fund (to S.-Q.R.) and the Guangdong Medical College Start-up Fund (grant no. XG1001, to S.-Q.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; BRILLINGER DR, 2005, BRAZ J PROBAB STAT, V18, P163; Camp NJ, 2002, CANCER CAUSE CONTROL, V13, P813, DOI 10.1023/A:1020611416907; Chang HW, 2008, OMICS, V12, P71, DOI 10.1089/omi.2007.0036; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; EWALD PW, 1980, J THEOR BIOL, V86, P169, DOI 10.1016/0022-5193(80)90073-9; Gayan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-360; Hallgrimsdottir IB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-17; Han B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S5; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Johnson RA., 2007, APPL MULTIVARIATE ST, Vxviii; Li CX, 2008, GENE, V408, P104, DOI 10.1016/j.gene.2007.10.028; Lozano GA, 2010, MED HYPOTHESES, V74, P746, DOI 10.1016/j.mehy.2009.11.003; Malecot G., 1969, MATH HEREDITY; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Nesse RM, 2008, LANCET, pS21; Nesse RM, 1998, SCI AM, V279, P86, DOI 10.1038/scientificamerican1198-86; Nesse RM, 1999, NEUROSCI BIOBEHAV R, V23, P895, DOI 10.1016/S0149-7634(99)00023-8; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Wick G, 2003, EXP GERONTOL, V38, P13, DOI 10.1016/S0531-5565(02)00161-4; WILLIAMS C, 2002, AM STAT, V56, P248; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; YANG RC, 1993, THEOR APPL GENET, V87, P568, DOI 10.1007/BF00221880; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; Zhao JY, 2005, AM J HUM GENET, V77, P27, DOI 10.1086/431243	34	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26435	10.1371/journal.pone.0026435	http://dx.doi.org/10.1371/journal.pone.0026435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046286	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000018
J	Laxman, S; Tu, BP				Laxman, Sunil; Tu, Benjamin P.			Multiple TORC1-Associated Proteins Regulate Nitrogen Starvation-Dependent Cellular Differentiation in Saccharomyces cerevisiae	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; HAPLOID INVASIVE GROWTH; PSEUDOHYPHAL DIFFERENTIATION; FILAMENTOUS GROWTH; KINASE-A; TOR KINASES; MAP KINASE; GENE; EXPRESSION; DISTINCT	Background: The budding yeast Saccharomyces cerevisiae undergoes differentiation into filamentous-like forms and invades the growth medium as a foraging response to nutrient and environmental stresses. These developmental responses are under the downstream control of effectors regulated by the cAMP/PKA and MAPK pathways. However, the upstream sensors and signals that induce filamentous growth through these signaling pathways are not fully understood. Herein, through a biochemical purification of the yeast TORC1 (Target of Rapamycin Complex 1), we identify several proteins implicated in yeast filamentous growth that directly associate with the TORC1 and investigate their roles in nitrogen starvation-dependent or independent differentiation in yeast. Methodology: We isolated the endogenous TORC1 by purifying tagged, endogenous Kog1p, and identified associated proteins by mass spectrometry. We established invasive and pseudohyphal growth conditions in two S. cerevisiae genetic backgrounds (Sigma 1278b and CEN.PK). Using wild type and mutant strains from these genetic backgrounds, we investigated the roles of TORC1 and associated proteins in nitrogen starvation-dependent diploid pseudohyphal growth as well as nitrogen starvation-independent haploid invasive growth. Conclusions: We show that several proteins identified as associated with the TORC1 are important for nitrogen starvation-dependent diploid pseudohyphal growth. In contrast, invasive growth due to other nutritional stresses was generally not affected in mutant strains of these TORC1-associated proteins. Our studies suggest a role for TORC1 in yeast differentiation upon nitrogen starvation. Our studies also suggest the CEN. PK strain background of S. cerevisiae may be particularly useful for investigations of nitrogen starvation-induced diploid pseudohyphal growth.	[Laxman, Sunil; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Laxman, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	sunil.laxman@utsouthwestern.edu; benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080	University of Texas; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Welch Foundation [I-1697]; American Cancer Society/Simmons Cancer Center [ACS-IRG-02-196]; National Institute of General Medical Sciences [R01GM094314]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	University of Texas; Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Welch Foundation(The Welch Foundation); American Cancer Society/Simmons Cancer Center(American Cancer Society); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Texas Southwestern Endowed Scholars Program, a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Welch Foundation Research Grant I-1697, an American Cancer Society/Simmons Cancer Center Institutional Research Grant (ACS-IRG-02-196), and award R01GM094314 from the National Institute of General Medical Sciences (B. P. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Dumortier F, 2000, INT J FOOD MICROBIOL, V55, P103, DOI 10.1016/S0168-1605(00)00184-7; Duvel K, 2003, CURR TOP MICROBIOL, V279, P19; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Edskes HK, 1999, GENETICS, V153, P585; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz MC, 2000, GENETICS, V154, P609; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Orlova M, 2010, EUKARYOT CELL, V9, P208, DOI 10.1128/EC.00216-09; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Strudwick N, 2010, MOL CELL BIOL, V30, P5514, DOI 10.1128/MCB.00390-10; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Tu BP, 2010, METHOD ENZYMOL, V470, P857, DOI 10.1016/S0076-6879(10)70035-5; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Van de Velde S, 2008, EUKARYOT CELL, V7, P286, DOI 10.1128/EC.00276-07; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	57	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26081	10.1371/journal.pone.0026081	http://dx.doi.org/10.1371/journal.pone.0026081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043304	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400032
J	Malessy, MJA; Pondaag, W; Yang, LJS; Hofstede-Buitenhuis, SM; le Cessie, S; van Dijk, JG				Malessy, Martijn J. A.; Pondaag, Willem; Yang, Lynda J. -S.; Hofstede-Buitenhuis, Sonja M.; le Cessie, Saskia; van Dijk, J. Gert			Severe Obstetric Brachial Plexus Palsies Can Be Identified at One Month of Age	PLOS ONE			English	Article							BIRTH PALSY; NATURAL-HISTORY; SURGICAL-TREATMENT; LESIONS; RECONSTRUCTION; MANAGEMENT; PROGNOSIS; INJURIES	Objective: To establish whether severe obstetric brachial plexus palsy (OBPP) can be identified reliably at or before three months of age. Methods: Severe OBPP was defined as neurotmesis or avulsion of spinal nerves C5 and C6 irrespective of additional C7-T1 lesions, assessed during surgery and confirmed by histopathological examination. We first prospectively studied a derivation group of 48 infants with OBPP with a minimal follow-up of two years. Ten dichotomous items concerning active clinical joint movement and needle electromyography of the deltoid, biceps and triceps muscles were gathered at one week, one month and three months of age. Predictors for a severe lesion were identified using a two-step forward logistic regression analysis. The results were validated in two independent cohorts of OBPP infants of 60 and 13 infants. Results: Prediction of severe OBPP at one month of age was better than at one week and at three months. The presence of elbow extension, elbow flexion and of motor unit potentials in the biceps muscle correctly predicted whether lesions were mild or severe in 93.6% of infants in the derivation group (sensitivity 1.0, specificity 0.88), in 88.3% in the first validation group (sensitivity 0.97, specificity 0.76) and in 84.6% in the second group (sensitivity of 1.0, specificity 0.66). Interpretation: Infants with OBPP with severe lesions can be identified at one month of age by testing elbow extension, elbow flexion and recording motor unit potentials (MUPs) in the biceps muscle. The decision rule implies that children without active elbow extension at one month should be referred to a specialized center, while children with active elbow extension as well as active flexion should not. When there is active elbow extension, but no active elbow flexion an EMG is needed; absence of MUPs in the biceps muscle is an indication for referral.	[Malessy, Martijn J. A.; Pondaag, Willem; Hofstede-Buitenhuis, Sonja M.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Yang, Lynda J. -S.] Univ Michigan Hosp, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Hofstede-Buitenhuis, Sonja M.] Leiden Univ, Med Ctr, Dept Neurosurg Phys Therapy, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Neurosurg Med Stat, Leiden, Netherlands; [van Dijk, J. Gert] Leiden Univ, Med Ctr, Dept Neurosurg Neurol & Clin Neurophysiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Malessy, MJA (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	malessy@lumc.nl	Malessy, Martijn/AAZ-9996-2021; le+Cessie, Saskia/HGC-8966-2022	Malessy, Martijn/0000-0003-1936-3664; le Cessie, Saskia/0000-0003-2154-4923	ZON-MW, the Netherlands Organization for Health Research and Development	ZON-MW, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	Martijn J. A. Malessy was supported by ZON-MW (http://www.zonmw.nl), the Netherlands Organization for Health Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager B, 1997, ACTA PAEDIATR, V86, P1214, DOI 10.1111/j.1651-2227.1997.tb14849.x; Bellew M, 2003, J HAND SURG-BRIT EUR, V28B, P339, DOI 10.1016/S0266-7681(03)00081-0; Bisinella GL, 2003, J HAND SURG-BRIT EUR, V28B, P148, DOI 10.1016/S0266-7681(02)00281-4; BORRERO JL, 2005, OBSTET BRACHIAL PLEX; Clark LP, 1905, AM J MED SCI, V130, P670, DOI 10.1097/00000441-190510000-00013; Dawodu A, 1997, ANN TROP PAEDIATR, V17, P195, DOI 10.1080/02724936.1997.11747886; Evans-Jones G, 2003, ARCH DIS CHILD-FETAL, V88, P185, DOI 10.1136/fn.88.3.F185; GILBERT A, 1991, CLIN ORTHOP RELAT R, P39; KAWABATA H, 1987, CLIN ORTHOP RELAT R, P233; Kay SPJ, 1998, BRIT J PLAST SURG, V51, P43, DOI 10.1054/bjps.1997.0166; Malessy MJA, 2009, NEUROSURGERY, V65, pA153, DOI 10.1227/01.NEU.0000338429.66249.7D; Malessy MJA, 2009, NEUROSURG CLIN N AM, V20, P1, DOI 10.1016/j.nec.2008.07.024; Marcus JR, 2003, CLIN PLAST SURG, V30, P289, DOI 10.1016/S0094-1298(02)00100-1; METAIZEAU JP, 1979, CHIR PEDIATR, V20, P159; MICHELOW BJ, 1994, PLAST RECONSTR SURG, V93, P675, DOI 10.1097/00006534-199404000-00001; Pondaag W, 2005, NEUROSURGERY, V57, P530, DOI 10.1227/01.NEU.0000170557.13788.D2; Pondaag W, 2004, DEV MED CHILD NEUROL, V46, P138; Smith NC, 2004, J BONE JOINT SURG AM, V86A, P2163, DOI 10.2106/00004623-200410000-00006; Steens SCA, 2011, RADIOLOGY, V259, P508, DOI 10.1148/radiol.10101417; Sunderland S, 1991, NERVE INJURIES THEIR; Tassin J. L., 1983, THESIS U PARIS; van Dijk JG, 2001, MUSCLE NERVE, V24, P1451, DOI 10.1002/mus.1168; Waters PM, 2005, J PEDIATR ORTHOP B, V14, P233, DOI 10.1097/01202412-200507000-00001; Waters PM, 1999, J BONE JOINT SURG AM, V81A, P649, DOI 10.2106/00004623-199905000-00006	24	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26193	10.1371/journal.pone.0026193	http://dx.doi.org/10.1371/journal.pone.0026193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043309	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400037
J	Wu, Q; Gou, YW; Wang, QM; Jin, HF; Cui, LN; Zhang, YG; He, LJ; Wang, JB; Nie, YZ; Shi, YQ; Fan, DM				Wu, Qiong; Gou, Yawen; Wang, Qiaomin; Jin, Haifeng; Cui, Lina; Zhang, Yongguo; He, Lijie; Wang, Jingbo; Nie, Yongzhan; Shi, Yongquan; Fan, Daiming			Downregulation of RPL6 by siRNA Inhibits Proliferation and Cell Cycle Progression of Human Gastric Cancer Cell Lines	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN; OVER-EXPRESSION; PROSTATE-CANCER; TUMOR-ANTIGEN; GENE; OSTEOPONTIN; RESISTANCE; CARCINOMA; APOPTOSIS; INVASION	Our previous study revealed that human ribosomal protein L6 (RPL6) was up-regulated in multidrug-resistant gastric cancer cells and over-expression of RPL6 could protect gastric cancer from drug-induced apoptosis. It was further demonstrated that up-regulation of RPL6 accelerated growth and enhanced in vitro colony forming ability of GES cells while down-regulation of RPL6 exhibited the opposite results. The present study was designed to investigate the potential role of RPL6 in therapy of gastric cancer for clinic. The expression of RPL6 and cyclin E in gastric cancer tissues and normal gastric mucosa was evaluated by immunohistochemisty. It was found that RPL6 and cyclin E were expressed at a higher level in gastric cancer tissues than that in normal gastric mucosa and the two were correlative in gastric cancer. Survival time of postoperative patients was analyzed by Kaplan-Meier analysis and it was found that patients with RPL6 positive expression showed shorter survival time than patients that with RPL6 negative expression. RPL6 was then genetically down-regulated in gastric cancer SGC7901 and AGS cell lines by siRNA. It was demonstrated that down-regulation of RPL6 reduced colony forming ability of gastric cancer cells in vitro and reduced cell growth in vivo. Moreover, down-regulation of RPL6 could suppress G1 to S phase transition in these cells. Further, we evidenced that RPL6 siRNA down-regulated cyclin E expression in SGC7901 and AGS cells. Taken together, these data suggested that RPL6 was over-expressed in human gastric tissues and caused poor prognosis. Down-regulation of RPL6 could suppress cell growth and cell cycle progression at least through down-regulating cyclin E and which might be used as a novel approach to gastric cancer therapy.	[Wu, Qiong; Gou, Yawen; Jin, Haifeng; Cui, Lina; Zhang, Yongguo; He, Lijie; Wang, Jingbo; Nie, Yongzhan; Shi, Yongquan; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Gou, Yawen; Wang, Qiaomin] Anhui Med Univ, Affiliated Prov Hosp, Dept Digest Dis, Hefei, Anhui, Peoples R China	Air Force Military Medical University; Anhui Medical University	Wu, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	shiyquan@fmmu.edu.cn; daimingfan@fmmu.edu.cn	wang, jing/GRS-7509-2022; Shi, Yongquan/AAE-3954-2020		National Basic Research Program of China [2010CB732400, 2010CB529300]; National Natural Science Foundation of China [30801349]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the National Basic Research Program of China (No. 2010CB732400, No. 2010CB529300), and the National Natural Science Foundation of China (No. 30801349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Cheng Q, 2002, BRIT J CANCER, V86, P274, DOI 10.1038/sj.bjc.6600038; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Du JP, 2005, CANCER BIOL THER, V4, P242; Forootan SS, 2010, INT J ONCOL, V36, P69, DOI 10.3892/ijo_00000476; Gong MC, 2008, CANCER LETT, V272, P148, DOI 10.1016/j.canlet.2008.07.004; Gou YW, 2010, BIOCHEM BIOPH RES CO, V393, P788, DOI 10.1016/j.bbrc.2010.02.083; GUO X, 2009, J CELL MOL MED; He LJ, 2009, CANCER LETT, V276, P88, DOI 10.1016/j.canlet.2008.10.044; He S, 2009, MOL BIOL REP, V36, P2153, DOI 10.1007/s11033-008-9429-7; HENRY JL, 1993, CANCER RES, V53, P1403; Hu YP, 2003, CLIN CANCER RES, V9, P2826; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597; KONDOH N, 1992, CANCER RES, V52, P791; Lai MD, 2007, CURR GENOMICS, V8, P43; Liu N, 2004, CLIN CANCER RES, V10, P6239, DOI 10.1158/1078-0432.CCR-04-0242; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Wang X, 2002, WORLD J GASTROENTERO, V8, P54, DOI 10.3748/wjg.v8.i1.54; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Yang XF, 2001, P NATL ACAD SCI USA, V98, P7492, DOI 10.1073/pnas.131590998; Zajac-Kaye M, 2001, LUNG CANCER-J IASLC, V34, pS43, DOI 10.1016/S0169-5002(01)00343-9; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	32	45	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26401	10.1371/journal.pone.0026401	http://dx.doi.org/10.1371/journal.pone.0026401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043320	gold, Green Published, Green Submitted			2022-12-27	WOS:000295984400055
J	Zhang, ZF; Zhang, J; Hui, YN; Zheng, MH; Liu, XP; Kador, PF; Wang, YS; Yao, LB; Zhou, J				Zhang, Zi-Feng; Zhang, Jian; Hui, Yan-Nian; Zheng, Min-Hua; Liu, Xin-Ping; Kador, Peter F.; Wang, Yu-Sheng; Yao, Li-Bo; Zhou, Jian			Up-Regulation of NDRG2 in Senescent Lens Epithelial Cells Contributes to Age-Related Cataract in Human	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; HUMAN-DIPLOID FIBROBLASTS; N-MYC; CELLULAR SENESCENCE; NEURITE OUTGROWTH; BREAST-CANCER; GENE FAMILY; DNA-DAMAGE; PC12 CELLS; EXPRESSION	Background: Human N-Myc downstream regulated gene2 (NDRG2), a novel gene has been cloned and shown to be related to a number of cellular processes, including proliferation, differentiation, stress, and apoptosis. NDRG2 has also been linked to age-related Alzheimer's disease. Since the role of this gene in senescence is limited, we have investigated the potential role of NDRG2 in human lens epithelial cells (HLECs), a paradigm implicated in age-related cataract. Methodology/Principal Findings: Cultured HLECs (SRA01/04) were subjected to prolonged exposure to low dose of H2O2 to simulate senescence. After being exposed to 50 mu M H2O2 for 2 weeks, HLECs senescent-morphological changes appeared, cell viability decreased dramatically, cell proliferation reduced from 37.4% to 16.1%, and senescence-associated beta-galactosidase activity increased from 0 to 90.3%. Ndrg2 protein expression was also significantly increased in these senescent cells. To induce overexpression of NDRG2, SRA01/04 cells were infected with the adenoviral vector of NDRG2. In these cells, overexpression of NDRG2 resulted in a fibroblast-like appearance and the cell viability decreased about 20%. In addition, the NDRG2-overexpression cells demonstrated 20% lower viability when exposed to 50-200 mu M H2O2 for acute oxidative stress. Furthermore, the expression of NDRG2 from age-related cataracts was up-regulated 2-fold at both mRNA and protein levels compared with the clear lenses. Conclusions/Significance: NDRG2 is up regulated not only in the ageing process of HLECs in vitro but also in the cells from human age-related cortical cataract in vivo. Up-regulation of NDRG2 induces cell morphological changes, reduces cell viability, and especially lowers cellular resistance to oxidative stress. NDRG2-mediated affects in HLECs may associate with age-related cataract formation.	[Zhang, Zi-Feng; Hui, Yan-Nian; Wang, Yu-Sheng; Zhou, Jian] Fourth Mil Med Univ, Xi Jing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China; [Zhang, Jian; Liu, Xin-Ping; Yao, Li-Bo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zheng, Min-Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Kador, Peter F.] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Coll Pharm, Omaha, NE USA; [Kador, Peter F.] Univ Nebraska, Sch Med, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhang, ZF (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China.	bioyao@fmmu.edu.cn; zhoujian@fmmu.edu.cn			National Natural Science Foundation of China (NSFC) [30000185, 30672292, 30801275]; Program for New Century Excellent Talents in University (NCET) [NCET-06-0932]; University funds for PhD thesis [2004012]; Alexander von Humboldt Foundation in Germany [V-8151/02085]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); University funds for PhD thesis; Alexander von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This study was supported by the grants from National Natural Science Foundation of China (NSFC) to J. Zhou (No. 30000185 and No. 30672292) and Z.-F. Zhang (No. 30801275), Program for New Century Excellent Talents in University (NCET) to J. Zhou (No. NCET-06-0932), and the University funds for PhD thesis to Z.-F. Zhang (No. 2004012). The study was also sponsored partly by the equipment donation from the Alexander von Humboldt Foundation in Germany to Y.-S. Wang (V-8151/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179; Choi SC, 2003, FEBS LETT, V553, P413, DOI 10.1016/S0014-5793(03)01030-5; Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Furuta H, 2010, BIOCHEM BIOPH RES CO, V391, P1785, DOI 10.1016/j.bbrc.2009.12.156; Hou WG, 2009, CELL TISSUE RES, V337, P257, DOI 10.1007/s00441-009-0814-x; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kurdistani SK, 1998, CANCER RES, V58, P4439; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Liu XP, 2009, APPL BIOCHEM BIOTECH, V152, P306, DOI 10.1007/s12010-008-8267-3; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lorentzen A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-14; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 1999, BIOCHEM BIOPH RES CO, V266, P208, DOI 10.1006/bbrc.1999.1780; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wu Guo-Qiang, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P357; Yang JD, 2010, WOUND REPAIR REGEN, V18, P524, DOI 10.1111/j.1524-475X.2010.00614.x; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zhao W, 2001, BBA-GENE STRUCT EXPR, V1519, P134, DOI 10.1016/S0167-4781(01)00210-X; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	46	16	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26102	10.1371/journal.pone.0026102	http://dx.doi.org/10.1371/journal.pone.0026102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043305	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400033
J	Purcell, EK; Liu, LQ; Thomas, PV; Duncan, RK				Purcell, Erin K.; Liu, Liqian; Thomas, Paul V.; Duncan, R. Keith			Cholesterol Influences Voltage-Gated Calcium Channels and BK-Type Potassium Channels in Auditory Hair Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRESYNAPTIC ACTIVE ZONES; MEMBRANE CHOLESTEROL; CA(V)1.3 CHANNELS; LARGE-CONDUCTANCE; BASILAR PAPILLA; PLASMA-MEMBRANE; RIBBON SYNAPSE; DIVALENT IONS; LIPID RAFTS	The influence of membrane cholesterol content on a variety of ion channel conductances in numerous cell models has been shown, but studies exploring its role in auditory hair cell physiology are scarce. Recent evidence shows that cholesterol depletion affects outer hair cell electromotility and the voltage-gated potassium currents underlying tall hair cell development, but the effects of cholesterol on the major ionic currents governing auditory hair cell excitabilityare unknown. We investigated the effects of a cholesterol-depleting agent (methyl beta cyclodextrin, M beta CD) on ion channels necessary for the early stages of sound processing. Large-conductance BK-type potassium channels underlie temporal processing and open in a voltage-and calcium-dependent manner. Voltage-gated calcium channels (VGCCs) are responsible for calcium-dependent exocytosis and synaptic transmission to the auditory nerve. Our results demonstrate that cholesterol depletion reduced peak steady-state calcium-sensitive (BK-type) potassiumcurrent by 50% in chick cochlear hair cells. In contrast, M beta CD treatment increased peak inward calcium current (similar to 30%), ruling out loss of calcium channel expression or function as a cause of reduced calcium-sensitive outward current. Changes in maximal conductance indicated a direct impact of cholesterol on channel number or unitary conductance. Immunoblotting following sucrose-gradient ultracentrifugation revealed BK expression in cholesterol-enriched microdomains. Both direct impacts of cholesterol on channel biophysics, as well as channel localization in the membrane, may contribute to the influence of cholesterol on hair cell physiology. Our results reveal a new role for cholesterol in the regulation of auditory calcium and calcium-activated potassium channels and add to the growing evidence that cholesterol is a key determinant in auditory physiology.	[Purcell, Erin K.; Liu, Liqian; Thomas, Paul V.; Duncan, R. Keith] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Purcell, EK (corresponding author), Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA.	rkduncan@umich.edu	Tuluc, Petronel/C-2527-2011	Duncan, Robert/0000-0002-8949-8727	National Institutes of Health [NIDCD R01 DC007432, ARRA R01 supplement DC007432-04S1, T32 DC00011, P30 DC005188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011, R01DC007432, P30DC005188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (NIDCD R01 DC007432, ARRA R01 supplement DC007432-04S1, T32 DC00011 and P30 DC005188)(www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Campbell K.C.M., 1996, AM J AUDIOL, V5, P11, DOI [10.1044/1059-0889.0503.11, DOI 10.1044/1059-0889.0503.11]; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Duncan RK, 2003, J PHYSIOL-LONDON, V547, P357, DOI 10.1113/jphysiol.2002.029785; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1992, PROG NEUROBIOL, V39, P493, DOI 10.1016/0301-0082(92)90003-W; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; FUCHS PA, 1988, J NEUROSCI, V8, P2460; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JOHNSON SL, 2011, NAT NEUROSCI; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Levic S, 2011, J BIOL CHEM, V286, P5768, DOI 10.1074/jbc.M110.186486; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; MCLAUGHLIN SG, 1971, J GEN PHYSIOL, V58, P667, DOI 10.1085/jgp.58.6.667; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Pantelias AA, 2001, HEARING RES, V156, P81, DOI 10.1016/S0378-5955(01)00269-6; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Singh DK, 2011, BBA-BIOMEMBRANES, V1808, P2527, DOI 10.1016/j.bbamem.2011.07.006; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Tsujikawa H, 2008, AM J PHYSIOL-HEART C, V294, pH285, DOI 10.1152/ajpheart.00824.2007; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	47	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26289	10.1371/journal.pone.0026289	http://dx.doi.org/10.1371/journal.pone.0026289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22046269	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600047
J	Berger, I; Guttman, C; Amar, D; Zarivach, R; Aharoni, A				Berger, Ilana; Guttman, Chen; Amar, Dotan; Zarivach, Raz; Aharoni, Amir			The Molecular Basis for the Broad Substrate Specificity of Human Sulfotransferase 1A1	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DIRECTED EVOLUTION; INHIBITION; ENZYME; SULT1A1; STABILITY; LIBRARIES; MODEL	Cytosolic sulfotransferases (SULTs) are mammalian enzymes that detoxify a wide variety of chemicals through the addition of a sulfate group. Despite extensive research, the molecular basis for the broad specificity of SULTs is still not understood. Here, structural, protein engineering and kinetic approaches were employed to obtain deep understanding of the molecular basis for the broad specificity, catalytic activity and substrate inhibition of SULT1A1. We have determined five new structures of SULT1A1 in complex with different acceptors, and utilized a directed evolution approach to generate SULT1A1 mutants with enhanced thermostability and increased catalytic activity. We found that active site plasticity enables binding of different acceptors and identified dramatic structural changes in the SULT1A1 active site leading to the binding of a second acceptor molecule in a conserved yet non-productive manner. Our combined approach highlights the dominant role of SULT1A1 structural flexibility in controlling the specificity and activity of this enzyme.	[Berger, Ilana; Guttman, Chen; Amar, Dotan; Zarivach, Raz; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zarivach, Raz; Aharoni, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Berger, I (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	zarivach@bgu.ac.il; aaharoni@bgu.ac.il	ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Aharoni, Amir/0000-0003-2701-6996; Berger, Ilana/0000-0002-9268-5435	European Research Council (ERC); Israel Science Foundation (ISF); Deutsch-Israelische Projektkooperation (DIP)	European Research Council (ERC)(European Research Council (ERC)); Israel Science Foundation (ISF)(Israel Science Foundation); Deutsch-Israelische Projektkooperation (DIP)	This work was funded by a grant from the European Research Council (ERC) 'Ideas Program', the Israel Science Foundation (ISF), and the Deutsch-Israelische Projektkooperation (DIP) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, CURR OPIN CHEM BIOL, V9, P210, DOI 10.1016/j.cbpa.2005.02.002; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bidwell LM, 1999, J MOL BIOL, V293, P521, DOI 10.1006/jmbi.1999.3153; Blanchard RL, 2004, PHARMACOGENETICS, V14, P199, DOI 10.1097/00008571-200403000-00009; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hempel N, 2007, INT J BIOCHEM CELL B, V39, P685, DOI 10.1016/j.biocel.2006.10.002; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8; Wolfenden R, 1985, J CHEM SCI, V94, P121; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	35	43	45	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26794	10.1371/journal.pone.0026794	http://dx.doi.org/10.1371/journal.pone.0026794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069470	Green Submitted, gold, Green Published			2022-12-27	WOS:000297150900032
J	Liao, YH; Tang, JS; Deng, QJ; Deng, YW; Luo, T; Wang, XY; Chen, HX; Liu, TQ; Chen, XG; Brody, AL; Hao, W				Liao, Yanhui; Tang, Jinsong; Deng, Qijian; Deng, Yongwen; Luo, Tao; Wang, Xuyi; Chen, Hongxian; Liu, Tieqiao; Chen, Xiaogang; Brody, Arthur L.; Hao, Wei			Bilateral Fronto-Parietal Integrity in Young Chronic Cigarette Smokers: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; ANISOTROPIC WATER DIFFUSION; MICROSTRUCTURAL INTEGRITY; TOBACCO CONTROL; NICOTINE; SMOKING; DEPENDENCE; APOPTOSIS; DISORDER; EXPOSURE	Background: Cigarette smoking continues to be the leading cause of preventable morbidity and mortality in China and other countries. Previous studies have demonstrated gray matter loss in chronic smokers. However, only a few studies assessed the changes of white matter integrity in this group. Based on those previous reports of alterations in white matter integrity in smokers, the aim of this study was to examine the alteration of white matter integrity in a large, well-matched sample of chronic smokers and non-smokers. Methodology/Principal Findings: Using in vivo diffusion tensor imaging (DTI) to measure the differences of whole-brain white matter integrity between 44 chronic smoking subjects (mean age, 28.0 +/- 5.6 years) and 44 healthy age- and sex-matched comparison non-smoking volunteers (mean age, 26.3 +/- 5.8 years). DTI was performed on a 3-Tesla Siemens scanner (Allegra; Siemens Medical System). The data revealed that smokers had higher fractional anisotropy (FA) than healthy non-smokers in almost symmetrically bilateral fronto-parietal tracts consisting of a major white matter pathway, the superior longitudinal fasciculus (SLF). Conclusion/Significance: We found the almost symmetrically bilateral fronto-parietal whiter matter changes in a relatively large sample of chronic smokers. These findings support the hypothesis that chronic cigarette smoking involves alterations of bilateral fronto-parietal connectivity.	[Liao, Yanhui; Tang, Jinsong; Deng, Qijian; Luo, Tao; Wang, Xuyi; Chen, Hongxian; Liu, Tieqiao; Chen, Xiaogang; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Deng, Yongwen] Peoples Hosp Hunan Prov, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Brody, Arthur L.] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Brody, Arthur L.] Greater Los Angeles VA Healthcare Syst, Dept Psychiat, Los Angeles, CA USA; [Brody, Arthur L.] Greater Los Angeles VA Healthcare Syst, Dept Res, Los Angeles, CA USA	Central South University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Liao, YH (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China.	abrody@ucla.edu; weihaochangsha@gmail.com	Liao, Yanhui/L-1590-2016; liu, tieqiao/GSE-2327-2022	Liao, Yanhui/0000-0003-4735-3252; 	Central Colleges basic scientific research operating expenses; National Key Technology R&D Program in the 11th Five-Year Plan of China [2011QNZT170, 2007BAI07B01]; Natural Science Foundation of China [81100996, 30971050, 30900486, 81130020]; National Key Basic Research and Development Program(NKBRDP) (973) [2009CB522000]; Hunan Provincial Natural Science Foundation of China [10JJ5038]; Tobacco-Related Disease Research Program [19XT-0135]; National Institute on Drug Abuse [R01 DA20872]; China Scholarship Council; University of Cambridge; Behavioural and Clinical Neuroscience Institute; Veterans Affairs Type I Merit Review Award; Richard Metzner Chair in Clinical Neuropharmacology	Central Colleges basic scientific research operating expenses; National Key Technology R&D Program in the 11th Five-Year Plan of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(NKBRDP) (973)(National Basic Research Program of China); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Tobacco-Related Disease Research Program(University of California System); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); China Scholarship Council(China Scholarship Council); University of Cambridge(University of Cambridge); Behavioural and Clinical Neuroscience Institute; Veterans Affairs Type I Merit Review Award; Richard Metzner Chair in Clinical Neuropharmacology	This work was supported by grants from the Central Colleges basic scientific research operating expenses. 2011QNZT170, National Key Technology R&D Program in the 11th Five-Year Plan of China (2007BAI07B01), Natural Science Foundation of China (81100996, 30971050, 30900486, 81130020), National Key Basic Research and Development Program(NKBRDP) (973, 2009CB522000) and from Hunan Provincial Natural Science Foundation of China (10JJ5038). Tobacco-Related Disease Research Program (19XT-0135), the National Institute on Drug Abuse (R01 DA20872), a Veterans Affairs Type I Merit Review Award, and an endowment from the Richard Metzner Chair in Clinical Neuropharmacology. Yanhui Liao is supported by a fellowship from the China Scholarship Council to study at University of Cambridge, Behavioural and Clinical Neuroscience Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2008, DRUG TODAY, V44, P895, DOI 10.1358/dot.2008.44.12.1308898; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alicata D, 2009, PSYCHIAT RES-NEUROIM, V174, P1, DOI 10.1016/j.pscychresns.2009.03.011; Azizian Allen, 2009, Handb Exp Pharmacol, P113, DOI 10.1007/978-3-540-69248-5_5; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Brody AL, 2006, J PSYCHIATR RES, V40, P404, DOI 10.1016/j.jpsychires.2005.04.012; Chung A, 2007, INT J NEUROPSYCHOPH, V10, P765, DOI 10.1017/Sl461145706007395; Cohen A, 2009, PSYCHOPHARMACOLOGY, V204, P541, DOI 10.1007/s00213-009-1486-7; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Gao J, 2011, J ALZHEIMERS DI 0510; Garrido R, 2003, NEUROSCI RES, V47, P349, DOI 10.1016/S0168-0102(03)00222-0; Garrido R, 2001, J NEUROCHEM, V76, P1395, DOI 10.1046/j.1471-4159.2001.00135.x; Garrido R, 2000, BRAIN RES, V861, P59, DOI 10.1016/S0006-8993(00)01977-6; Gaworski CL, 2011, INHAL TOXICOL   0322; Gazdzinski S, 2005, ALCOHOL CLIN EXP RES, V29, P1484, DOI 10.1097/01.alc.0000175018.72488.61; Gazdzinski S, 2010, BRAIN, V133, P1043, DOI 10.1093/brain/awp343; Gons RAR, 2011, BRAIN, V134, P2116, DOI 10.1093/brain/awr145; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Hattori T, 2011, HUM BRAIN MAPP  0414; Heishman S J, 1999, Nicotine Tob Res, V1 Suppl 2, pS143; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Holzapfel M, 2006, J NEUROSCI, V26, P7007, DOI 10.1523/JNEUROSCI.1764-06.2006; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Jacobsen LK, 2007, BIOL PSYCHIAT, V61, P31, DOI 10.1016/j.biopsych.2006.02.014; Kemp Florence Berteletti, 2009, Pneumologia, V58, P155; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Kyriakopoulos M, 2008, EUR PSYCHIAT, V23, P255, DOI 10.1016/j.eurpsy.2007.12.004; Kyriakopoulos M, 2009, CURR OPIN PSYCHIATR, V22, P168, DOI 10.1097/YCO.0b013e328325aa23; Liao Y, 2010, ADDICT BIOL     0823; Liao YH, 2010, BRAIN, V133, P2115, DOI 10.1093/brain/awq131; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lindquist S, 2007, MULT SCLER J, V13, P471, DOI 10.1177/1352458506071329; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu JX, 2010, J AFFECT DISORDERS, V127, P309, DOI 10.1016/j.jad.2010.05.026; Liu JJ, 2005, EUR J NEUROSCI, V22, P2462, DOI 10.1111/j.1460-9568.2005.04423.x; Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S., 2005, MRI ATLAS HUMAN WHIT; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Ray R, 2008, BEHAV BRAIN RES, V193, P159, DOI 10.1016/j.bbr.2008.05.021; Romero MJ, 2010, PSYCHIAT RES-NEUROIM, V181, P57, DOI 10.1016/j.pscychresns.2009.07.004; Rosenbloom M, 2003, ALCOHOL RES HEALTH, V27, P146; Sharma Anil, 2009, Handb Exp Pharmacol, P145, DOI 10.1007/978-3-540-69248-5_6; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Siahpush M, 2006, TOB CONTROL, V15, P65, DOI 10.1136/tc.2005.013276; Silk TJ, 2009, HUM BRAIN MAPP, V30, P2757, DOI 10.1002/hbm.20703; Slama K, 2008, INT J TUBERC LUNG D, V12, P3; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thompson R, 2009, NEUROIMAGE, V48, P436, DOI 10.1016/j.neuroimage.2009.06.066; Van Haren NE, 2010, EUR NEUROPSYCHO 0313; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Warner K E, 2006, Glob Public Health, V1, P65, DOI 10.1080/17441690500430771; Weaver KE, 2009, EXP NEUROL, V216, P525, DOI 10.1016/j.expneurol.2008.12.026; Wessa M, 2009, BIPOLAR DISORD, V11, P504, DOI 10.1111/j.1399-5618.2009.00718.x; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Zhang L, 2011, J AFFECT DISORD 0414; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008	61	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26460	10.1371/journal.pone.0026460	http://dx.doi.org/10.1371/journal.pone.0026460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069452	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900014
J	Lua, SX; Qin, HN; Lim, LZ; Shi, JH; Gupta, G; Song, JX				Lua, Shixiong; Qin, Haina; Lim, Liangzhong; Shi, Jiahai; Gupta, Garvita; Song, Jianxing			Structural, Stability, Dynamic and Binding Properties of the ALS-Causing T46I Mutant of the hVAPB MSP Domain as Revealed by NMR and MD Simulations	PLOS ONE			English	Article							PROTEIN-ASSOCIATED PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM; FFAT MOTIF; VAPB; MUTATION; ER; TRANSPORT; SPECTROSCOPY; AGGREGATION	T46I is the second mutation on the hVAPB MSP domain which was recently identified from non-Brazilian kindred to cause a familial amyotrophic lateral sclerosis (ALS). Here using CD, NMR and molecular dynamics (MD) simulations, we characterized the structure, stability, dynamics and binding capacity of the T46I-MSP domain. The results reveal: 1) unlike P56S which we previously showed to completely eliminate the native MSP structure, T46I leads to no significant disruption of the native secondary and tertiary structures, as evidenced from its far-UV CD spectrum, as well as C alpha and C beta NMR chemical shifts. 2) Nevertheless, T46I does result in a reduced thermodynamic stability and loss of the cooperative urea-unfolding transition. As such, the T46I-MSP domain is more prone to aggregation than WT at high protein concentrations and temperatures in vitro, which may become more severe in the crowded cellular environments. 3) T46I only causes a 3-fold affinity reduction to the Nir2 peptide, but a significant elimination of its binding to EphA4. 4) EphA4 and Nir2 peptide appear to have overlapped binding interfaces on the MSP domain, which strongly implies that two signaling networks may have a functional interplay in vivo. 5) As explored by both H/D exchange and MD simulations, the MSP domain is very dynamic, with most loop residues and many residues on secondary structures highly fluctuated or/and exposed to bulk solvent. Although T46I does not alter overall dynamics, it does trigger increased dynamics of several local regions of the MSP domain which are implicated in binding to EphA4 and Nir2 peptide. Our study provides the structural and dynamic understanding of the T46I-causing ALS; and strongly highlights the possibility that the interplay of two signaling networks mediated by the FFAT-containing proteins and Eph receptors may play a key role in ALS pathogenesis.	[Lua, Shixiong; Qin, Haina; Lim, Liangzhong; Shi, Jiahai; Gupta, Garvita; Song, Jianxing] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore; [Song, Jianxing] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore, Singapore	National University of Singapore; National University of Singapore	Lua, SX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore.	bchsj@nus.edu.sg	shi, jiahai/D-7650-2013; Song, Jianxing/H-8026-2012; Shi, Jiahai/AAH-1103-2019; Qin, Haina/AAB-7486-2020	shi, jiahai/0000-0002-6467-8289; Shi, Jiahai/0000-0002-6467-8289; Song, Jianxing/0000-0003-0224-6322; Haina, Qin/0000-0002-9175-8014	National Medical Research Council (NMRC) [R154-000-454-213]; Ministry of Education (MOE) of Singapore [R154-000-388-112]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Ministry of Education (MOE) of Singapore(Ministry of Education, Singapore)	This study is supported by National Medical Research Council (NMRC) grant R154-000-454-213, and Ministry of Education (MOE) of Singapore Tier 2 Grant R154-000-388-112 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 2008, CELL, V133, P949, DOI 10.1016/j.cell.2008.05.028; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirano M, 2008, NEUROLOGY, V70, P1161, DOI 10.1212/01.wnl.0000307756.15383.fc; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kanekura K, 2009, MOL NEUROBIOL, V39, P81, DOI 10.1007/s12035-009-8054-3; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Laue T, 2011, NAT CHEM BIOL, V7, P331, DOI 10.1038/nchembio.575; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007805; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Mitne-Neto M, 2007, PROTEIN EXPRES PURIF, V55, P139, DOI 10.1016/j.pep.2007.04.007; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Qin H, 1998, BIOCHEMISTRY-US, V47, P13647; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Schlesinger AP, 2011, J AM CHEM SOC, V133, P8082, DOI 10.1021/ja201206t; Schlick T, 2002, MOL MODELING SIMULAT, DOI DOI 10.1007/978-0-387-22464-0; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wei Z, 2005, J MOL BIOL, V348, P205, DOI 10.1016/j.jmb.2005.02.028; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200	61	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e27072	10.1371/journal.pone.0027072	http://dx.doi.org/10.1371/journal.pone.0027072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22069488	Green Published, gold, Green Submitted			2022-12-27	WOS:000297150900048
J	Rainone, V; Dubois, G; Temchura, V; Uberla, K; Clivio, A; Nebuloni, M; Lauri, E; Trabattoni, D; Veas, F; Clerici, M				Rainone, Veronica; Dubois, Gregor; Temchura, Vladimir; Ueberla, Klaus; Clivio, Alberto; Nebuloni, Manuela; Lauri, Eleonora; Trabattoni, Daria; Veas, Francisco; Clerici, Mario			CCL28 Induces Mucosal Homing of HIV-1-Specific IgA-Secreting Plasma Cells in Mice Immunized with HIV-1 Virus-Like Particles	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; CHEMOKINE RECEPTORS; CUTTING EDGE; AIDS VACCINE; DNA VACCINES; T-CELLS; CCR10; INDIVIDUALS; EXPRESSION; INFECTION	Mucosae-associated epithelial chemokine (MEC or CCL28) binds to CCR3 and CCR10 and recruits IgA-secreting plasma cells (IgA-ASCs) in the mucosal lamina propria. The ability of this chemokine to enhance migration of IgA-ASCs to mucosal sites was assessed in a mouse immunization model using HIV-1(IIIB) Virus-like particles (VLPs). Mice receiving either HIV-1(IIIB) VLPs alone, CCL28 alone, or the irrelevant CCL19 chemokine were used as controls. Results showed a significantly increased CCR3 and CCR10 expression on CD19(+) splenocytes of HIV-1(IIIB) VPL-CCL28-treated mice. HIV-1 Env-specific IFN-gamma, IL-4 and IL-5 production, total IgA, anti-Env IgA as well as gastro-intestinal mucosal IgA-secreting plasma cells were also significantly augmented in these mice. Notably, sera and vaginal secretions from HIV-1(IIIB) VLP-CCL28-treated mice exhibited an enhanced neutralizing activity against both a HIV-1/B-subtype laboratory strain and a heterologous HIV-1/C-subtype primary isolate. These data suggest that CCL28 could be useful in enhancing the IgA immune response that will likely play a pivotal role in prophylactic HIV vaccines.	[Rainone, Veronica; Clivio, Alberto] Univ Milan, Dept Clin Sci, FoldLESs SrI, Milan, Italy; [Dubois, Gregor; Veas, Francisco] Univ Montpellier, Comparat Mol Immunophysiopathol Lab, Fac Pharm, UMR MD3, F-34059 Montpellier, France; [Temchura, Vladimir; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, Milan, Italy; [Clerici, Mario] Fdn Don C Gnocchi, IRCCS, Milan, Italy	University of Milan; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Ruhr University Bochum; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Rainone, V (corresponding author), Univ Milan, Dept Clin Sci, FoldLESs SrI, Milan, Italy.	veronica.rainone@unimi.it	Trabattoni, Daria/G-7424-2012; CLIVIO, ALBERTO/S-9320-2017; NEBULONI, MANUELA/L-3969-2017	Trabattoni, Daria/0000-0001-9535-3359; Clerici, Mario/0000-0001-5920-6191; CLIVIO, ALBERTO/0000-0002-1423-046X; NEBULONI, MANUELA/0000-0002-2773-734X	SIDACTION-France; European Union [Health-F3-2008-201433]; European community [LSHP-CT-2005-018685, LSHP-CT-2006-037611]	SIDACTION-France; European Union(European Commission); European community(European Commission)	This research was supported by SIDACTION-France and the European Union program NGIN, "Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies" (Health-F3-2008-201433). The work of KU was supported by the European community FP6 DEC-VAC (LSHP-CT-2005-018685) and EUROPRISE (LSHP-CT-2006-037611) projects. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bomsel M, 2007, AIDS, V21, P13, DOI 10.1097/QAD.0b013e328011049b; Boyer JD, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00235-2; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Castelletti E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000969; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Chang SY, 2008, J IMMUNOL, V180, P1609, DOI 10.4049/jimmunol.180.3.1609; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; D'Cruz OJ, 2004, CURR PHARM DESIGN, V10, P315, DOI 10.2174/1381612043386374; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Desimmie BA, 2010, IDRUGS, V13, P622; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x; Gao JL, 1996, BIOCHEM BIOPH RES CO, V223, P679, DOI 10.1006/bbrc.1996.0955; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Iijima H, 2001, REV MED VIROL, V11, P117, DOI 10.1002/rmv.307; Kang SM, 2009, CURR TOP MICROBIOL, V333, P269, DOI 10.1007/978-3-540-92165-3_14; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kim JJ, 2000, J INTERF CYTOK RES, V20, P487, DOI 10.1089/10799900050023906; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kutzler MA, 2010, GENE THER, V17, P72, DOI 10.1038/gt.2009.112; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Kweon MN, 2002, GUT, V50, P299, DOI 10.1136/gut.50.3.299; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lehner T, 2005, VACCINE, V23, P5551, DOI 10.1016/j.vaccine.2005.07.009; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; McGowan I, 2006, BIOLOGICALS, V34, P241, DOI 10.1016/j.biologicals.2006.08.002; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Plotkin SA, 2010, HUM VACCINES, V6, P159; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; POST TW, 1995, J IMMUNOL, V155, P5299; Qin LZ, 2004, J VIROL, V78, P7016, DOI 10.1128/JVI.78.13.7016-7022.2004; ROVINSKI B, 1992, J VIROL, V66, P4003, DOI 10.1128/JVI.66.7.4003-4012.1992; Roy P, 2009, ADV EXP MED BIOL, V655, P145, DOI 10.1007/978-1-4419-1132-2_11; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Soderlund J, 2004, SCAND J INFECT DIS, V36, P663, DOI 10.1080/00365540410020857; Tan JQ, 2003, J IMMUNOL, V171, P1722, DOI 10.4049/jimmunol.171.4.1722; Vaccari M, 2010, EXPERT REV VACCINES, V9, P997, DOI [10.1586/erv.10.104, 10.1586/ERV.10.104]; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Watkins David I, 2010, Top HIV Med, V18, P35; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Wu XL, 2003, AIDS RES HUM RETROV, V19, P275, DOI 10.1089/088922203764969474; Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024	55	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26979	10.1371/journal.pone.0026979	http://dx.doi.org/10.1371/journal.pone.0026979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066023	gold, Green Published			2022-12-27	WOS:000296916000041
J	Crawfurd, KJ; Raven, JA; Wheeler, GL; Baxter, EJ; Joint, I				Crawfurd, Katharine J.; Raven, John A.; Wheeler, Glen L.; Baxter, Emily J.; Joint, Ian			The Response of Thalassiosira pseudonana to Long-Term Exposure to Increased CO2 and Decreased pH	PLOS ONE			English	Article							EMILIANIA-HUXLEYI; CONCENTRATING MECHANISMS; CARBONIC-ANHYDRASES; OCEAN ACIDIFICATION; MARINE DIATOMS; GROWTH; PHYTOPLANKTON; CHEMISTRY; COCCOLITHOPHORE; PHOTOSYNTHESIS	The effect of ocean acidification conditions has been investigated in cultures of the diatom Thalassiosira pseudonana CCMP1335. Expected end-of-the-century pCO(2) (aq) concentrations of 760 mu atm (equivalent to pH 7.8) were compared with present-day condition (380 matm CO2, pH 8.1). Batch culture pH changed rapidly because of CO2 (aq) assimilation and pH targets of 7.8 and 8.1 could not be sustained. Long-term (similar to 100 generation) pH-auxostat, continuous cultures could be maintained at target pH when cell density was kept low (<2X10(5) cells mL(-1)). After 3 months continuous culture, the C:N ratio was slightly decreased under high CO2 conditions and red fluorescence per cell was slightly increased. However, no change was detected in photosynthetic efficiency (F-v/F-m) or functional cross section of PS II (sigma(PSII)). Elevated pCO(2) has been predicted to be beneficial to diatoms due to reduced cost of carbon concentration mechanisms. There was reduced transcription of one putative delta-carbonic anhydrase (CA-4) after 3 months growth at increased CO2 but 3 other delta-CAs and the small subunit of RUBISCO showed no change. There was no evidence of adaptation or clade selection of T. pseudonana after similar to 100 generations at elevated CO2. On the basis of this long-term culture, pH change of this magnitude in the future ocean may have little effect on T. pseudonana in the absence of genetic adaption.	[Crawfurd, Katharine J.; Wheeler, Glen L.; Baxter, Emily J.; Joint, Ian] Plymouth Marine Lab, Plymouth, Devon, England; [Raven, John A.] Univ Dundee, Div Plant Sci, James Hutton Inst, Dundee, Scotland	Plymouth Marine Laboratory; James Hutton Institute; University of Dundee	Crawfurd, KJ (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Den Burg, Netherlands.	glw@pml.ac.uk			Natural Environmental Research Council; NERC; Plymouth Marine Laboratory [1091222]; University of Dundee [SC015096]	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Dundee	The research was funded by the Natural Environmental Research Council (www.nerc.ac.uk), through the Oceans 2025 programme. Dr. Crawfurd acknowledges a NERC PhD studentship. The Plymouth Marine Laboratory is a registered Charity, No 1091222, the University of Dundee is a registered Scottish Charity, No. SC015096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Author's committee on the development of an integrated science strategy for ocean science monitoring research and impacts assessment: National Research Council (2010), 2010, OC AC NAT STRAT MEET, P175; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Collins S, 2010, BIOGEOSCIENCES, V7, P2199, DOI 10.5194/bg-7-2199-2010; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Engel A, 2004, AQUAT MICROB ECOL, V34, P93, DOI 10.3354/ame034093; Findlay HS, 2011, LIMNOL OCEANOGR, V56, P1168, DOI 10.4319/lo.2011.56.3.1168; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Granum E, 2009, J PHYCOL, V45, P1083, DOI 10.1111/j.1529-8817.2009.00728.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Harris R, 2010, J PLANKTON RES, V32, P577, DOI 10.1093/plankt/fbq021; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Husic MD, 1987, PROGR PHOTOSYNTHESIS, P317; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; MARTIN GA, 1976, ARCH MICROBIOL, V107, P41, DOI 10.1007/BF00427865; McGinn PJ, 2008, PHYSIOL PLANTARUM, V133, P78, DOI 10.1111/j.1399-3054.2007.01039.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PRUDER GD, 1979, AQUACULTURE, V17, P1, DOI 10.1016/0044-8486(79)90133-9; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P779, DOI 10.1111/j.1365-3040.1991.tb01442.x; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P385; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Tortell PD, 1997, NATURE, V390, P243, DOI 10.1038/36765; Tortell PD, 2008, LIMNOL OCEANOGR, V53, P1266, DOI 10.4319/lo.2008.53.4.1266; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE	43	89	89	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26695	10.1371/journal.pone.0026695	http://dx.doi.org/10.1371/journal.pone.0026695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053201	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800027
J	Lai, YZ; Asthana, A; Cheng, K; Kisaalita, WS				Lai, Yinzhi; Asthana, Amish; Cheng, Ke; Kisaalita, William S.			Neural Cell 3D Microtissue Formation Is Marked by Cytokines' Up-Regulation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; 3-DIMENSIONAL CULTURE; IN-VIVO; NEURONAL DIFFERENTIATION; REACTIVE ASTROCYTES; GLIOMA ANGIOGENESIS; CCN FAMILY; TISSUE; VEGF	Cells cultured in three dimensional (3D) scaffolds as opposed to traditional two-dimensional (2D) substrates have been considered more physiologically relevant based on their superior ability to emulate the in vivo environment. Combined with stem cell technology, 3D cell cultures can provide a promising alternative for use in cell-based assays or biosensors in non-clinical drug discovery studies. To advance 3D culture technology, a case has been made for identifying and validating three-dimensionality biomarkers. With this goal in mind, we conducted a transcriptomic expression comparison among neural progenitor cells cultured on 2D substrates, 3D porous polystyrene scaffolds, and as 3D neurospheres (in vivo surrogate). Up-regulation of cytokines as a group in 3D and neurospheres was observed. A group of 13 cytokines were commonly up-regulated in cells cultured in polystyrene scaffolds and neurospheres, suggesting potential for any or a combination from this list to serve as three-dimensionality biomarkers. These results are supportive of further cytokine identification and validation studies with cells from non-neural tissue.	[Lai, Yinzhi; Asthana, Amish; Cheng, Ke; Kisaalita, William S.] Univ Georgia, Cellular Bioengn Lab, Dept Biol & Agr Engn, Fac Engn,Driftmier Engn Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Lai, YZ (corresponding author), Univ Georgia, Cellular Bioengn Lab, Dept Biol & Agr Engn, Fac Engn,Driftmier Engn Ctr, Athens, GA 30602 USA.	williamk@engr.uga.edu	Lai, Yinzhi/G-8892-2012; ASTHANA, AMISH/GZH-0907-2022	Lai, Yinzhi/0000-0003-0131-2172; ASTHANA, AMISH/0000-0002-4597-5982	National Science Foundation (NSF) [0304340]; UGA Engineering Grant	National Science Foundation (NSF)(National Science Foundation (NSF)); UGA Engineering Grant	This work was supported by a National Science Foundation (NSF) grant (0304340) and a UGA Engineering Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerstorfer S, 2008, ONCOGENE, V27, P4180, DOI 10.1038/onc.2008.61; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Calzolari F, 2008, NEOPLASIA, V10, P1373, DOI 10.1593/neo.08814; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Chevalier G, 1998, AM J PATHOL, V152, P1563; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Good P, 2005, PERMUTATION PARAMETR; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Ito Y, 2000, NEUROCHEM RES, V25, P1113, DOI 10.1023/A:1007674113440; Junier MP, 2000, PROG NEUROBIOL, V62, P443, DOI 10.1016/S0301-0082(00)00017-4; Kato-Negishi M, 2010, BIOMATERIALS, V31, P8939, DOI 10.1016/j.biomaterials.2010.08.008; Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853; Kisaalita WS, 2010, 3D CELL BASED BIOSEN, P77; Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025; Koide Yoshio, 2006, Rinsho Byori, V54, P213; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lai YZ, 2011, DRUG DISCOV TODAY, V16, P293, DOI 10.1016/j.drudis.2011.01.009; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; LINDHOLM D, 1994, EUR J NEUROSCI, V6, P244, DOI 10.1111/j.1460-9568.1994.tb00267.x; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nagashima G, 2002, CLIN NEUROL NEUROSUR, V104, P125, DOI 10.1016/S0303-8467(01)00197-4; NAKAO N, 1994, EXP BRAIN RES, V101, P291, DOI 10.1007/BF00228749; Oppenheim JJ, 2001, INT J HEMATOL, V74, P3, DOI 10.1007/BF02982543; Peek R, 2002, J BIOL CHEM, V277, P686, DOI 10.1074/jbc.M105746200; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Pries AR, 2001, AM J PHYSIOL-HEART C, V281, pH1015, DOI 10.1152/ajpheart.2001.281.3.H1015; Reuss B, 2000, GLIA, V30, P231, DOI 10.1002/(SICI)1098-1136(200005)30:3<231::AID-GLIA3>3.3.CO;2-T; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Serlachius M, 2004, PEPTIDES, V25, P1657, DOI 10.1016/j.peptides.2004.03.031; Sharief MK, 1998, MULT SCLER, V4, P169, DOI 10.1191/135245898678909484; Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761; Sjoborg M, 1998, EXP BRAIN RES, V119, P245, DOI 10.1007/s002210050338; Volante M, 2009, J PATHOL, V218, P458, DOI 10.1002/path.2551; Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Wu ZZ, 2010, BIOTECHNOL BIOENG, V106, P649, DOI 10.1002/bit.22715; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yanagisawa M, 2000, J NEUROCHEM, V74, P1498, DOI 10.1046/j.1471-4159.2000.0741498.x; Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088; Yang YY, 2008, BIOMATERIALS, V29, P1901, DOI 10.1016/j.biomaterials.2007.12.042; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje; Zhang KZ, 2000, P NATL ACAD SCI USA, V97, P3637, DOI 10.1073/pnas.070045897	61	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26821	10.1371/journal.pone.0026821	http://dx.doi.org/10.1371/journal.pone.0026821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22046371	Green Published, gold, Green Submitted			2022-12-27	WOS:000299081800046
J	Landgraf, S; Steingen, J; Eppert, Y; Niedermeyer, U; van der Meer, E; Krueger, F				Landgraf, Steffen; Steingen, Joerg; Eppert, Yvonne; Niedermeyer, Ulrich; van der Meer, Elke; Krueger, Frank			Temporal Information Processing in Short- and Long-Term Memory of Patients with Schizophrenia	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FRONTAL-LOBE; PHYSIOLOGICAL DYSFUNCTION; HIPPOCAMPAL VOLUME; BRAIN ACTIVATION; EPISODIC MEMORY; ATTENTION; DEFICITS; ABNORMALITIES; STRATEGY	Cognitive deficits of patients with schizophrenia have been largely recognized as core symptoms of the disorder. One neglected factor that contributes to these deficits is the comprehension of time. In the present study, we assessed temporal information processing and manipulation from short-and long-term memory in 34 patients with chronic schizophrenia and 34 matched healthy controls. On the short-term memory temporal-order reconstruction task, an incidental or intentional learning strategy was deployed. Patients showed worse overall performance than healthy controls. The intentional learning strategy led to dissociable performance improvement in both groups. Whereas healthy controls improved on a performance measure (serial organization), patients improved on an error measure (inappropriate semantic clustering) when using the intentional instead of the incidental learning strategy. On the long-term memory script-generation task, routine and non-routine events of everyday activities (e. g., buying groceries) had to be generated in either chronological or inverted temporal order. Patients were slower than controls at generating events in the chronological routine condition only. They also committed more sequencing and boundary errors in the inverted conditions. The number of irrelevant events was higher in patients in the chronological, non-routine condition. These results suggest that patients with schizophrenia imprecisely access temporal information from short-and long-term memory. In short-term memory, processing of temporal information led to a reduction in errors rather than, as was the case in healthy controls, to an improvement in temporal-order recall. When accessing temporal information from long-term memory, patients were slower and committed more sequencing, boundary, and intrusion errors. Together, these results suggest that time information can be accessed and processed only imprecisely by patients who provide evidence for impaired time comprehension. This could contribute to symptomatic cognitive deficits and strategic inefficiency in schizophrenia.	[Landgraf, Steffen; Steingen, Joerg; Eppert, Yvonne; van der Meer, Elke] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Landgraf, Steffen] Serv Hosp Univ, Hop St Anne, Inserm Lab Psychopathol & Mental Dis, Ctr Psychiat & Neurosci,U984, Paris, France; [Niedermeyer, Ulrich] Dept Psychiat & Psychotherapy, Frankfurt, Germany; [Krueger, Frank] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Humboldt University of Berlin; Assistance Publique Hopitaux Paris (APHP); GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; George Mason University; George Mason University	Landgraf, S (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	FKruegerF@gmu.edu		Landgraf, Steffen/0000-0002-3423-8880				ANDREASEN N, 1986, ARCH GEN PSYCHIAT, V43, P136; Andreasen NC, 2007, SCHIZOPHRENIA BULL, V33, P108, DOI 10.1093/schbul/sbl054; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943; Andreasen NC, 2006, INTRO TXB PSYCHIAT; Aukes MF, 2008, BIOL PSYCHIAT, V64, P128, DOI 10.1016/j.biopsych.2007.12.013; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; BERTHOZ A., 2006, PHENOMENOLOGIE PHYSI; BERTHOZ A, 1996, SENSE MOUVEMENT; Bidwell LC, 2006, PSYCHIAT RES, V145, P1, DOI 10.1016/j.psychres.2005.05.019; Birkett P, 2008, AM J MED GENET B, V147B, P285, DOI 10.1002/ajmg.b.30594; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Bleuler E., 1911, HDB PSYCHIAT; Bleuler E., 1908, ALLG Z PSYCHIAT, V65, P436; Bokat CE, 2003, SCHIZOPHR RES, V64, P73, DOI 10.1016/S0920-9964(02)00282-7; Bonner-Jackson A, 2005, BIOL PSYCHIAT, V58, P47, DOI 10.1016/j.biopsych.2005.05.011; Bonner-Jackson A, 2008, PSYCHIAT RES-NEUROIM, V164, P1, DOI 10.1016/j.pscychresns.2007.12.012; Calkins ME, 2000, AM J MED GENET, V97, P72, DOI 10.1002/(SICI)1096-8628(200021)97:1<72::AID-AJMG10>3.0.CO;2-L; Celex, 2000, CEL LEX DAT; Chen Y, 2006, CURR PSYCHIATRY REV, V2, P431, DOI 10.2174/157340006778699729; Cohen R, 1987, SEARCH CAUSES SCHIZO; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; Danckert J, 2004, SCHIZOPHR RES, V70, P241, DOI 10.1016/j.schres.2003.12.007; Daniel M-P, 2007, SPAT COGN COMPUT, V7, P287, DOI DOI 10.1080/13875860701608368; Delevoye-Turrell Y, 2003, AM J PSYCHIAT, V160, P134, DOI 10.1176/appi.ajp.160.1.134; Delevoye-Turrell Y, 2007, J ABNORM PSYCHOL, V116, P56, DOI 10.1037/0021-843X.116.1.56; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Elvevag B, 2000, SCHIZOPHR RES, V46, P187, DOI 10.1016/S0920-9964(00)00014-1; Fourneret Pierre, 2002, Cogn Neuropsychiatry, V7, P139, DOI 10.1080/13546800143000212; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Godbout L, 1995, NEUROPSYCHOLOGIA, V33, P1671, DOI 10.1016/0028-3932(95)00047-X; Gold JM, 2007, SCHIZOPHR RES, V94, P148, DOI 10.1016/j.schres.2007.04.023; Gold JM, 2010, ARCH GEN PSYCHIAT, V67, P570, DOI 10.1001/archgenpsychiatry.2010.65; GOLDEN CJ, 1981, ARCH GEN PSYCHIAT, V38, P1014; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Gouzoulis-Mayfrank E, 2007, SCHIZOPHR RES, V97, P35, DOI 10.1016/j.schres.2007.06.028; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P37, DOI 10.1016/j.ijpsycho.2003.12.004; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Iddon JL, 1998, PSYCHOL MED, V28, P1049, DOI 10.1017/S0033291798006758; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klix F., 1992, NATUR VERSTANDES; Knutson KM, 2004, NEUROIMAGE, V23, P1299, DOI 10.1016/j.neuroimage.2004.08.012; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; Kruger F, 2001, Z PSYCHOL, V209, P402, DOI 10.1026//0044-3409.209.4.402; Kuchinke L, 2009, BRAIN COGNITION, V69, P245, DOI 10.1016/j.bandc.2008.07.014; Landgraf S, 2008, PSYCHOL MED, V38, P861, DOI 10.1017/S0033291707001912; Landgraf S, 2011, SCHIZOPHR RES, V127, P163, DOI 10.1016/j.schres.2010.11.027; Landgraf S, 2011, WORLD J BIOL PSYCHIA; Landgraf S, 2010, NEUROPSYCHOLOGIA, V48, P2922, DOI 10.1016/j.neuropsychologia.2010.05.034; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Langdon R, 2009, SCHIZOPHRENIA BULL, V35, P1003, DOI 10.1093/schbul/sbn039; Laws K R, 1999, Cogn Neuropsychiatry, V4, P1, DOI 10.1080/135468099396025; Laws KR, 1999, COGN NEUROPSYCHIATRY, V4, P31, DOI DOI 10.1080/135468099396025; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; Merz J, 1975, Psychiatr Neurol Med Psychol (Leipz), V27, P423; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Nuthmann A, 2005, PSYCHOPHYSIOLOGY, V42, P306, DOI 10.1111/j.1469-8986.2005.00291.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Partiot A, 1996, NEUROREPORT, V7, P761, DOI 10.1097/00001756-199602290-00020; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; POSNER MI, 1988, ARCH GEN PSYCHIAT, V45, P814; RAINE A, 1992, PSYCHIAT RES-NEUROIM, V45, P123, DOI 10.1016/0925-4927(92)90006-P; Rosen VM, 2003, BEHAV RES METH INS C, V35, P32, DOI 10.3758/BF03195495; ROSSE RB, 1991, BIOL PSYCHIAT, V30, P63, DOI 10.1016/0006-3223(91)90071-S; Schank RC., 1977, SCRIPTS PLANS GOALS; SEEMAN MV, 1976, PSYCHIATRY, V39, P189, DOI 10.1080/00332747.1976.11023888; Sirigu A, 1998, CORTEX, V34, P771, DOI 10.1016/S0010-9452(08)70780-9; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; van der Meer E, 1999, Z PSYCHOL, V207, P363; Velakoulis D, 1999, ARCH GEN PSYCHIAT, V56, P133, DOI 10.1001/archpsyc.56.2.133; Velakoulis D, 2001, BIOL PSYCHIAT, V50, P531, DOI 10.1016/S0006-3223(01)01121-0; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1991, ARCH GEN PSYCHIAT, V48, P85; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Weiss AP, 2003, BIOL PSYCHIAT, V53, P48, DOI 10.1016/S0006-3223(02)01541-X; Wood JN, 2005, CEREB CORTEX, V15, P1155, DOI 10.1093/cercor/bhh215; Wood SJ, 2001, SCHIZOPHR RES, V52, P37, DOI 10.1016/S0920-9964(01)00175-X; World Health Organization, 2007, ICD 10 INT CLASS DIS; YurgelunTodd DA, 1996, AM J PSYCHIAT, V153, P200; Zalla T, 2006, BRAIN RES BULL, V68, P195, DOI 10.1016/j.brainresbull.2005.04.020; Zalla T, 2004, PSYCHIAT RES, V128, P39, DOI 10.1016/j.psychres.2003.12.026; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8; Zalla T, 2002, CORTEX, V38, P215, DOI 10.1016/S0010-9452(08)70651-8; Zalla T, 2000, CORTEX, V36, P163, DOI 10.1016/S0010-9452(08)70522-7; Zalla T., 2001, COGN NEUROPSYCHIATRY, V6, P271, DOI [DOI 10.1080/13546800143000087, 10.1080/13546800143000087]; Zalla T, 2006, J AUTISM DEV DISORD, V36, P527, DOI 10.1007/s10803-006-0092-3; Zanini S, 2002, NEUROCASE, V8, P88, DOI 10.1076/neur.8.1.88.16233	99	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26140	10.1371/journal.pone.0026140	http://dx.doi.org/10.1371/journal.pone.0026140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	876BL	22053182	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800008
J	Seuront, L				Seuront, Laurent			Hydrocarbon Contamination Decreases Mating Success in a Marine Planktonic Copepod	PLOS ONE			English	Article							BRACHIONUS-CALYCIFLORUS ROTIFER; CLADOCERAN DAPHNIA-MAGNA; WATER-SOLUBLE FRACTIONS; SWIMMING BEHAVIOR; OIL-SPILL; BALANUS-AMPHITRITE; TEMORA-LONGICORNIS; PHEROMONE TRAIL; SOUTHERN BIGHT; MATE-TRACKING	The mating behavior and the mating success of copepods rely on chemoreception to locate and track a sexual partner. However, the potential impact of the water-soluble fraction of hydrocarbons on these aspects of copepod reproduction has never been tested despite the widely acknowledged acute chemosensory abilities of copepods. I examined whether three concentrations of the water-soluble fraction of diesel oil (0.01%, 0.1% and 1%) impacts (i) the swimming behavior of both adult males and females of the widespread calanoid copepod Temora longcornis, and (ii) the ability of males to locate, track and mate with females. The three concentrations of the water-soluble fraction of diesel oil (WSF) significantly and non-significantly affect female and male swimming velocities, respectively. In contrast, both the complexity of male and female swimming paths significantly decreased with increasing WSF concentrations, hence suggesting a sex-specific sensitivity to WSF contaminated seawater. In addition, the three WSF concentrations impacted both T. longicornis mating behavior and mating success. Specifically, the ability of males to detect female pheromone trails, to accurately follow trails and to successfully track a female significantly decreased with increasing WSF concentrations. This led to a significant decrease in contact and capture rates from control to WSF contaminated seawater. These results indicate that hydrocarbon contamination of seawater decreases the ability of male copepods to detect and track a female, hence suggest an overall impact on population fitness and dynamics.	[Seuront, Laurent] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seuront, Laurent] Aquat Sci, S Australian Res & Dev Inst, W Beach, Australia; [Seuront, Laurent] CNRS, UMR LOG 8187, Wimereux, France; [Seuront, Laurent] Boston Univ, Dept Phys, Ctr Polymer Studies, Boston, MA 02215 USA	Flinders University South Australia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Boston University	Seuront, L (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	laurent.seuront@flinders.edu.au		Seuront, Laurent/0000-0002-0051-5202	Australian Research Council [DP0988554]; Australian Professorial Fellowship [DP0988554]	Australian Research Council(Australian Research Council); Australian Professorial Fellowship(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP0988554; www.arc.gov.au). Professor Seuront is the recipient of an Australian Professorial Fellowship (project number DP0988554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados CL, 2000, ETHOLOGY, V106, P105, DOI 10.1046/j.1439-0310.2000.00497.x; Alados CL, 1990, ENVIRON TOXICOL CHEM, V18, P2392; Albaiges J, 2003, HUELLA FUEL ENSAYOS; Amsler MO, 2006, MAR FRESHW BEHAV PHY, V39, P259, DOI 10.1080/10236240600980640; Bagoien E, 2005, MAR ECOL PROG SER, V300, P105, DOI 10.3354/meps300105; Baillieul M, 1999, AQUAT TOXICOL, V44, P245, DOI 10.1016/S0166-445X(98)00080-0; Barata C, 2002, MAR ECOL PROG SER, V230, P183, DOI 10.3354/meps230183; BERDUGO V, 1977, Marine Pollution Bulletin, V8, P138, DOI 10.1016/0025-326X(77)90154-0; Boxshall GA, 1998, PHILOS T ROY SOC B, V353, P669, DOI 10.1098/rstb.1998.0232; BUNDY MH, 1993, B MAR SCI, V53, P15; Cailleaud K, 2011, AQUAT TOXICOL, V102, P228, DOI 10.1016/j.aquatox.2010.12.017; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; CARLS MG, 1990, FISH B-NOAA, V88, P29; Charoy C, 1999, CHEMOSPHERE, V38, P3247, DOI 10.1016/S0045-6535(98)00557-8; CHAROY CP, 1995, AQUAT TOXICOL, V32, P271, DOI 10.1016/0166-445X(94)00098-B; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P121, DOI 10.1017/S0025315400020488; COUGHLIN DJ, 1992, ANIM BEHAV, V44, P427, DOI 10.1016/0003-3472(92)90053-C; COWLES TJ, 1983, MAR BIOL, V78, P45, DOI 10.1007/BF00392970; DAAN R, 1989, NETH J SEA RES, V23, P305, DOI 10.1016/0077-7579(89)90051-3; DAM HG, 1993, J MAR RES, V51, P561, DOI 10.1357/0022240933223972; DEFLORA S, 1991, MUTAT RES, V258, P285, DOI 10.1016/0165-1110(91)90013-L; DELPROO SAG, 1986, J PLANKTON RES, V8, P557; Doall MH, 1998, PHILOS T ROY SOC B, V353, P681, DOI 10.1098/rstb.1998.0234; Doval MD, 2006, ESTUAR COAST SHELF S, V67, P205, DOI 10.1016/j.ecss.2005.11.013; Dowling NA, 2000, J FISH BIOL, V57, P337, DOI 10.1111/j.1095-8649.2000.tb02176.x; Duquesne S, 2010, ECOTOX ENVIRON SAFE, V73, P353, DOI 10.1016/j.ecoenv.2009.11.008; Elordui-Zapatarietxe S, 2008, CHEMOSPHERE, V73, P1811, DOI 10.1016/j.chemosphere.2008.08.018; Escos JM, 1995, OIKOS, V74, P310, DOI 10.2307/3545661; Faimali M, 2006, MAR BIOL, V149, P87, DOI 10.1007/s00227-005-0209-9; Faimali M, 2002, PERIOD BIOL, V104, P225; Gajbhiye SN, 1995, INDIAN J MAR SCI, V24, P196; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Gerhardt A, 2005, ENVIRON SCI TECHNOL, V39, P4150, DOI 10.1021/es048589f; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Goetze E, 2008, MAR ECOL PROG SER, V370, P185, DOI 10.3354/meps07616; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goto T, 2003, MAR POLLUT BULL, V47, P139, DOI 10.1016/S0025-326X(03)00052-3; HARRIS RP, 1977, MAR BIOL, V42, P187, DOI 10.1007/BF00397743; Hashim AA, 2010, TURK J FISH AQUAT SC, V10, P499, DOI 10.4194/trjfas.2010.0409; JANSSEN CR, 1994, ECOTOX ENVIRON SAFE, V28, P244, DOI 10.1006/eesa.1994.1050; JOHANSSON S, 1980, MAR POLLUT BULL, V11, P284, DOI 10.1016/0025-326X(80)90166-6; Kiorboe T, 2008, OECOLOGIA, V155, P179, DOI 10.1007/s00442-007-0893-x; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Maria GA, 2004, APPL ANIM BEHAV SCI, V86, P93, DOI 10.1016/j.applanim.2003.11.012; MOTOHASHI Y, 1993, NEUROTOXICOL TERATOL, V15, P3, DOI 10.1016/0892-0362(93)90039-Q; Ohwada K, 2003, MAR POLLUT BULL, V47, P78, DOI 10.1016/S0025-326X(03)00112-7; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Razouls C., 2005, DIVERSITE REPARTITIO; Ringuette M, 2002, CAN J FISH AQUAT SCI, V59, P646, DOI 10.1139/F02-039; Rodrigues RV, 2010, SCI TOTAL ENVIRON, V408, P2054, DOI 10.1016/j.scitotenv.2010.01.063; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rutherford KMD, 2004, ANIM WELFARE, V13, pS99; Rutherford KMD, 2003, APPL ANIM BEHAV SCI, V83, P125, DOI 10.1016/S0168-1591(03)00115-1; Saeed T, 1999, ENVIRON INT, V25, P117, DOI 10.1016/S0160-4120(98)00093-2; Seuront L, 2005, J PLANKTON RES, V27, P1301, DOI 10.1093/plankt/fbi088; Seuront L, 2004, MAR ECOL PROG SER, V283, P199, DOI 10.3354/meps283199; Seuront L, 2004, ZOOL STUD, V43, P376; Seuront L, 2010, MAR FRESHWATER RES, V61, P263, DOI 10.1071/MF09055; Seuront L., 2010, FRACTALS MULTIFRACTA, P344; Seuront L, 2008, MAR ECOL PROG SER, V363, P131, DOI 10.3354/meps07373; Seuront L, 2006, J PLANKTON RES, V28, P805, DOI 10.1093/plankt/fbl012; Seuront L, 2011, PHYSICA A, V390, P2333, DOI 10.1016/j.physa.2011.02.015; Seuront L, 2011, PHYSICA A, V390, P250, DOI 10.1016/j.physa.2010.09.025; Seuront Laurent, 2007, Open Oceanography Journal, V1, P1; Shimizu N, 2002, ENVIRON TOXICOL, V17, P441, DOI 10.1002/tox.10077; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SULLIVAN BK, 1983, MAR BIOL, V77, P299, DOI 10.1007/BF00395819; Untersteiner H, 2005, ZOOL STUD, V44, P71; Untersteiner H, 2003, AQUAT TOXICOL, V65, P435, DOI 10.1016/S0166-445X(03)00157-7; Uttieri M, 2005, ECOL MODEL, V185, P51, DOI 10.1016/j.ecolmodel.2004.11.015; Uttieri M, 2008, MAR BIOL, V153, P925, DOI 10.1007/s00227-007-0864-0; Uttieri M, 2007, J THEOR BIOL, V247, P480, DOI 10.1016/j.jtbi.2007.03.026; Uttieri M, 2007, J PLANKTON RES, V29, pI17, DOI 10.1093/plankt/fbl062; Varela M, 2006, MAR POLLUT BULL, V53, P272, DOI 10.1016/j.marpolbul.2005.10.005; Rao JV, 2007, ARCH ENVIRON CON TOX, V53, P227, DOI 10.1007/s00244-006-0226-9; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Weissburg MJ, 1998, PHILOS T R SOC B, V353, P701, DOI 10.1098/rstb.1998.0236; West BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051917; Woodson CB, 2007, MAR ECOL PROG SER, V330, P163, DOI 10.3354/meps330163; Woodson CB, 2007, INTEGR COMP BIOL, V47, P831, DOI 10.1093/icb/icm091; Woodson CB, 2005, LIMNOL OCEANOGR, V50, P1552, DOI 10.4319/lo.2005.50.5.1552; Yen J, 1998, PHILOS T R SOC B, V353, P787, DOI 10.1098/rstb.1998.0243; Yen Jeannette, 2004, P149; Yen J, 2011, J PLANKTON RES, V33, P907, DOI 10.1093/plankt/fbq164; Zar J.H., 2009, BIOSTATISTICAL ANAL; [No title captured]	86	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2011	6	10							e26283	10.1371/journal.pone.0026283	http://dx.doi.org/10.1371/journal.pone.0026283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876BL	22053187	Green Submitted, Green Published, gold			2022-12-27	WOS:000299081800013
J	Espinoza-Fonseca, LM; Thomas, DD				Espinoza-Fonseca, L. Michel; Thomas, David D.			Atomic-Level Characterization of the Activation Mechanism of SERCA by Calcium	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; CONFORMATIONAL FLUCTUATIONS; STRUCTURAL DYNAMICS; CRYSTAL-STRUCTURE; ENZYME CATALYSIS; PROTEINS; MYOSIN; ATPASE	We have performed molecular dynamics (MD) simulations to elucidate, in atomic detail, the mechanism by which the sarcoplasmic reticulum Ca2+-ATPase (SERCA) is activated by Ca2+. Crystal structures suggest that activation of SERCA occurs when the cytoplasmic head-piece, in an open (E1) conformation stabilized by Ca2+, undergoes a large-scale open-to-closed (E1 to E2) transition that is induced by ATP binding. However, spectroscopic measurements in solution suggest that these structural states (E1 and E2) are not tightly coupled to biochemical states (defined by bound ligands); the closed E2 state predominates even in the absence of ATP, in both the presence and absence of Ca2+. How is this loose coupling consistent with the high efficiency of energy transduction in the Ca2+-ATPase? To provide insight into this question, we performed long (500 ns) all-atom MD simulations starting from the open crystal structure, including a lipid bilayer and water. In both the presence and absence of Ca2+, we observed a large-scale open-to-closed conformational transition within 400 ns, supporting the weak coupling between structural and biochemical states. However, upon closer inspection, it is clear that Ca2+ is necessary and sufficient for SERCA to reach the precise geometrical arrangement necessary for activation of ATP hydrolysis. Contrary to suggestions from crystal structures, but in agreement with solution spectroscopy, the presence of ATP is not required for this activating transition. Principal component analysis showed that Ca2+ reshapes the free energy landscape of SERCA to create a path between the open conformation and the activated closed conformation. Thus the malleability of the free energy landscape is essential for SERCA efficiency, ensuring that ATP hydrolysis is tightly coupled to Ca2+ transport. These results demonstrate the importance of real-time dynamics in the formation of catalytically competent conformations of SERCA, with broad implications for understanding enzymatic catalysis in atomic detail.	[Espinoza-Fonseca, L. Michel; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Espinoza-Fonseca, LM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ddt@umn.edu	Thomas, David D/B-4257-2012	Espinoza-Fonseca, L. Michel/0000-0002-7356-5681; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [GM27906]; American Heart Association; Minnesota Supercomputing Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Minnesota Supercomputing Institute	National Institutes of Health, grant number GM27906; American Heart Association; Minnesota Supercomputing Institute The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov RV, 2008, P NATL ACAD SCI USA, V105, P13397, DOI 10.1073/pnas.0801342105; Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frauenfelder H, 1998, P NATL ACAD SCI USA, V95, P4795, DOI 10.1073/pnas.95.9.4795; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gustavsson M, 2011, J MOL BIOL, V408, P755, DOI 10.1016/j.jmb.2011.03.015; Hauser K, 2007, BIOPHYS J, V93, P3259, DOI 10.1529/biophysj.107.109363; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kast D, 2010, P NATL ACAD SCI USA, V107, P8207, DOI 10.1073/pnas.1001941107; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Nesmelov Yuri E, 2010, Biophys Rev, V2, P91, DOI 10.1007/s12551-010-0032-5; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330	40	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26936	10.1371/journal.pone.0026936	http://dx.doi.org/10.1371/journal.pone.0026936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046418	Green Published, gold			2022-12-27	WOS:000296521400052
J	Lin, JA; Liao, CC; Chang, CC; Chang, H; Chen, TL				Lin, Jui-An; Liao, Chien-Chang; Chang, Chuen-Chau; Chang, Hang; Chen, Ta-Liang			Postoperative Adverse Outcomes in Intellectually Disabled Surgical Patients: A Nationwide Population-Based Study	PLOS ONE			English	Article							GASTRO-ESOPHAGEAL REFLUX; MENTAL-RETARDATION; RESPIRATORY COMPLICATIONS; HANDICAPPED PEOPLE; LIFE EXPECTANCY; RENAL-FUNCTION; DISABILITIES; SURGERY; DEFICIENCY; MANAGEMENT	Background: Intellectually disabled patients have various comorbidities, but their risks of adverse surgical outcomes have not been examined. This study assesses pre-existing comorbidities, adjusted risks of postoperative major morbidities and mortality in intellectually disabled surgical patients. Methods: A nationwide population-based study was conducted in patients who underwent inpatient major surgery in Taiwan between 2004 and 2007. Four controls for each patient were randomly selected from the National Health Insurance Research Database. Preoperative major comorbidities, postoperative major complications and 30-day in-hospital mortality were compared between patients with and without intellectual disability. Use of medical services also was analyzed. Adjusted odds ratios using multivariate logistic regression analyses with 95% confidence intervals were applied to verify intellectual disability's impact. Results: Controls were compared with 3983 surgical patients with intellectual disability. Risks for postoperative major complications were increased in patients with intellectual disability, including acute renal failure (odds ratio 3.81, 95% confidence interval 2.28 to 6.37), pneumonia (odds ratio 2.01, 1.61 to 2.49), postoperative bleeding (odds ratio 1.35, 1.09 to 1.68) and septicemia (odds ratio 2.43, 1.85 to 3.21) without significant differences in overall mortality. Disability severity was positively correlated with postoperative septicemia risk. Medical service use was also significantly higher in surgical patients with intellectual disability. Conclusion: Intellectual disability significantly increases the risk of overall major complications after major surgery. Our findings show a need for integrated and revised protocols for postoperative management to improve care for intellectually disabled surgical patients.	[Lin, Jui-An; Liao, Chien-Chang; Chang, Chuen-Chau; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Jui-An; Liao, Chien-Chang; Chang, Chuen-Chau; Chen, Ta-Liang] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Lin, Jui-An] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chang, Hang] Shin Kong Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Chang, Hang] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chang, Hang] Taiwan Joint Commiss Hosp Accreditat, New Taipei City, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University	Chen, TL (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	tlc@tmu.edu.tw		Lin, Jui-An/0000-0003-0855-4828				Ali A, 2008, BMJ-BRIT MED J, V336, P570, DOI 10.1136/bmj.39490.543137.80; ANDERSON PR, 1985, ACTA ANAESTH SCAND, V29, P186, DOI 10.1111/j.1399-6576.1985.tb02183.x; BIESECKER LG, 1987, AM J MED GENET, V28, P131, DOI 10.1002/ajmg.1320280119; Bittles AH, 2002, J GERONTOL A-BIOL, V57, pM470, DOI 10.1093/gerona/57.7.M470; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; Cooper SA, 2004, BMJ-BRIT MED J, V329, P414, DOI 10.1136/bmj.329.7463.414; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; EKEDAHL C, 1974, ACTA OTO-LARYNGOL, V78, P141, DOI 10.3109/00016487409126339; EYMAN RK, 1990, NEW ENGL J MED, V323, P584, DOI 10.1056/NEJM199008303230906; FREDERICK FJ, 1982, J OTOLARYNGOL, V11, P289; FUTTERWEIT W, 1986, JAMA-J AM MED ASSOC, V255, P3280, DOI 10.1001/jama.255.23.3280; Garrison MM, 2005, J PEDIATR-US, V147, P748, DOI 10.1016/j.jpeds.2005.06.032; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Girolami A, 2008, HAEMOPHILIA, V14, P323, DOI 10.1111/j.1365-2516.2007.01612.x; Girolami A, 2007, ACTA HAEMATOL-BASEL, V117, P51, DOI 10.1159/000096789; Grange CS, 1998, CAN J ANAESTH, V45, P332, DOI 10.1007/BF03012024; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Khalid K, 2006, ANZ J SURG, V76, P145, DOI 10.1111/j.1445-2197.2006.03621.x; Kose G, 2009, J CHILD NEUROL, V24, P1493, DOI 10.1177/0883073808331084; Lantman-de Valk HMJV, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2507; Lin JD, 2003, J INTELL DISABIL RES, V47, P169, DOI 10.1046/j.1365-2788.2003.00454.x; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; MCNEELEY SG, 1989, OBSTET GYNECOL, V74, P155; Messini M, 1999, J CLIN PERIODONTOL, V26, P469, DOI 10.1034/j.1600-051X.1999.260709.x; Michalek P, 2009, J ANESTH, V23, P456, DOI 10.1007/s00540-009-0779-7; Ozawa H, 2003, EUR J PEDIATR, V162, P51, DOI 10.1007/s00431-002-1082-x; Parmet Sharon, 2002, JAMA, V288, P1548; Salvador-Carulla L, 2009, LANCET, V374, P1798, DOI 10.1016/S0140-6736(09)62034-1; Seeman T, 2009, PEDIATR NEPHROL, V24, P1409, DOI 10.1007/s00467-008-1049-x; SEMENZA GL, 1988, MEDICINE, V67, P209, DOI 10.1097/00005792-198807000-00002; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Singer G, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.07.048; SMITH DC, 1969, AM J PUBLIC HEALTH N, V59, P1376, DOI 10.2105/AJPH.59.8.1376; SPITZ L, 1982, J ROY SOC MED, V75, P525; SPITZ L, 1985, ARCH DIS CHILD, V60, P743, DOI 10.1136/adc.60.8.743; Strauser LM, 1999, J CLIN ANESTH, V11, P431, DOI 10.1016/S0952-8180(99)00073-2; TSUDA H, 1990, ACTA HAEMATOL-BASEL, V83, P49; YAMASHITA M, 1985, ANESTHESIOLOGY, V63, P201, DOI 10.1097/00000542-198508000-00017; ZINKHAM WH, 1993, NEW ENGL J MED, V328, P1126, DOI 10.1056/NEJM199304153281513; Zlotnik A, 2010, J ANESTH, V24, P778, DOI 10.1007/s00540-010-0985-3	42	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26977	10.1371/journal.pone.0026977	http://dx.doi.org/10.1371/journal.pone.0026977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046425	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400053
J	Otero, L; Krapp, F; Tomatis, C; Zamudio, C; Matthys, F; Gotuzzo, E; Van der Stuyft, P; Seas, C				Otero, Larissa; Krapp, Fiorella; Tomatis, Cristina; Zamudio, Carlos; Matthys, Francine; Gotuzzo, Eduardo; Van der Stuyft, Patrick; Seas, Carlos			High Prevalence of Primary Multidrug Resistant Tuberculosis in Persons with No Known Risk Factors	PLOS ONE			English	Article								Introduction: In high multidrug resistant (MDR) tuberculosis (TB) prevalence areas, drug susceptibility testing (DST) at diagnosis is recommended for patients with risk factors for MDR. However, this approach might miss a substantial proportion of MDR-TB in the general population. We studied primary MDR in patients considered to be at low risk of MDR-TB in Lima, Peru. Methods: We enrolled new sputum smear-positive TB patients who did not report any MDR-TB risk factor: known exposure to a TB patient whose treatment failed or who died or who was known to have MDR-TB; immunosuppressive co-morbidities, ex prison inmates; prison and health care workers; and alcohol or drug abuse. A structured questionnaire was applied to all enrolled participants to confirm the absence of these factors and thus minimize underreporting. Sputum from all participants was cultured on Lowenstein-Jensen media and DST for first line drugs was performed using the 7H10 agar method. Results: Of 875 participants with complete data, 23.2% (203) had risk factors for MDR-TB elicited after enrolment. Among the group with no reported risk factors who had a positive culture, we found a 6.3% (95% CI 4.4-8.3) (37/584) rate of MDR-TB. In this group no epidemiological characteristics were associated with MDR-TB. Thus, in this group, multidrug resistance occurred in patients with no identifiable risk factors. Conclusions: We found a high rate of primary MDR-TB in a general population with no identifiable risk factors for MDR-TB. This suggests that in a high endemic area targeting patients for MDR-TB based on the presence of risk factors is an insufficient intervention.	[Otero, Larissa; Krapp, Fiorella; Tomatis, Cristina; Zamudio, Carlos; Gotuzzo, Eduardo; Seas, Carlos] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Matthys, Francine; Van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Sect, Dept Publ Hlth, B-2000 Antwerp, Belgium	Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM)	Otero, L (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	larissaotero@gmail.com	Krapp, Fiorella/ABG-7436-2021	Krapp, Fiorella/0000-0002-8404-2827; Zamudio, Carlos/0000-0001-7479-127X; Seas, Carlos/0000-0001-7067-9141; Otero, Larissa/0000-0002-8348-4340	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium; Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium; Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	This study was funded by the Belgian Cooperation through a project of Institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 4 WHO; Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Barroso EC, 2003, J PNEUMOLOGIA, V29; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Caminero JA, 2008, INT J TUBERC LUNG D, V12, P869; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Ministerio de Salud, 2010, ESTR SAN NAC PREV CO; Ministerio de Salud, 2005, DIR SAL 4 LIM EST AN; Ministerio de Salud, 2010, DIR SAL 4 LIM EST PL; Ministerio de Salud, 2006, ESTR SAN NAC PREV CO; Ministerio de Salud, 2010, EST POBL; Ridderhof JC, 2007, B WORLD HEALTH ORGAN, V85, P354, DOI 10.2471/BLT.06.039081; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Toman K., 2004, TOMAN, P44; Velasquez GE, 2011, EMERG INFECT DIS, V17, P432, DOI 10.3201/eid1703.101553; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization (WHO), 2010, WHO GLOB REP 2009	20	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2011	6	10							e26276	10.1371/journal.pone.0026276	http://dx.doi.org/10.1371/journal.pone.0026276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841OJ	22046266	Green Published, gold, Green Submitted			2022-12-27	WOS:000296521400015
J	Ball, DA; Marchand, J; Poulet, M; Baumann, WT; Chen, KC; Tyson, JJ; Peccoud, J				Ball, David A.; Marchand, Julie; Poulet, Magaly; Baumann, William T.; Chen, Katherine C.; Tyson, John J.; Peccoud, Jean			Oscillatory Dynamics of Cell Cycle Proteins in Single Yeast Cells Analyzed by Imaging Cytometry	PLOS ONE			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; GENE-EXPRESSION; MITOTIC EXIT; S-PHASE; SPINDLE CHECKPOINT; GLOBAL ANALYSIS; G1 CYCLINS; ANAPHASE	Progression through the cell division cycle is orchestrated by a complex network of interacting genes and proteins. Some of these proteins are known to fluctuate periodically during the cell cycle, but a systematic study of the fluctuations of a broad sample of cell-cycle proteins has not been made until now. Using time-lapse fluorescence microscopy, we profiled 16 strains of budding yeast, each containing GFP fused to a single gene involved in cell cycle regulation. The dynamics of protein abundance and localization were characterized by extracting the amplitude, period, and other indicators from a series of images. Oscillations of protein abundance could clearly be identified for Cdc15, Clb2, Cln1, Cln2, Mcm1, Net1, Sic1, and Whi5. The period of oscillation of the fluorescently tagged proteins is generally in good agreement with the inter-bud time. The very strong oscillations of Net1 and Mcm1 expression are remarkable since little is known about the temporal expression of these genes. By collecting data from large samples of single cells, we quantified some aspects of cell-to-cell variability due presumably to intrinsic and extrinsic noise affecting the cell cycle.	[Ball, David A.; Marchand, Julie; Poulet, Magaly; Peccoud, Jean] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Baumann, William T.] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Chen, Katherine C.; Tyson, John J.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Peccoud, Jean] Virginia Tech, Ctr Syst Biol Engn Tissues, Inst Crit Technol & Appl Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Ball, DA (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	peccoud@vt.edu	Ball, David/A-3814-2010; Tyson, John J/A-2942-2014; Peccoud, Jean/A-2374-2008	Tyson, John J/0000-0001-7560-6013; Peccoud, Jean/0000-0001-7649-6127	National Institutes of Health [R01-GM078989]; National Science Foundation [DBI-0963988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01-GM078989 from the National Institutes of Health and National Science Foundation Award DBI-0963988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Ball DA, 2011, CELL CYCLE, V10, P999, DOI 10.4161/cc.10.6.14966; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; BOLL SF, 1979, IEEE T ACOUST SPEECH, V27, P113, DOI 10.1109/TASSP.1979.1163209; BREWER BJ, 1984, MOL CELL BIOL, V4, P2529, DOI 10.1128/MCB.4.11.2529; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cooper S, 2004, TRENDS BIOTECHNOL, V22, P266, DOI 10.1016/j.tibtech.2004.04.009; Cooper S, 2004, TRENDS BIOTECHNOL, V22, P274, DOI 10.1016/S0167-7799(04)00116-7; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikui AE, 2009, GENETICS, V183, P51, DOI 10.1534/genetics.109.105148; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; KAR S, 2009, P NATL ACAD SCI US; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 2004, TRENDS BIOTECHNOL, V22, P277, DOI 10.1016/j.tibtech.2004.04.012; Spellman PT, 2004, TRENDS BIOTECHNOL, V22, P270, DOI 10.1016/j.tibtech.2004.04.010; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tully GH, 2009, MOL BIOL CELL, V20, P1201, DOI 10.1091/mbc.E08-08-0822; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	49	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26272	10.1371/journal.pone.0026272	http://dx.doi.org/10.1371/journal.pone.0026272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046265	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600012
J	Golubitzky, A; Dan, P; Weissman, S; Link, G; Wikstrom, JD; Saada, A				Golubitzky, Anna; Dan, Phyllis; Weissman, Sarah; Link, Gabriela; Wikstrom, Jakob D.; Saada, Ann			Screening for Active Small Molecules in Mitochondrial Complex I Deficient Patient's Fibroblasts, Reveals AICAR as the Most Beneficial Compound	PLOS ONE			English	Article							SODIUM PHENYLBUTYRATE; ARACHIDONIC-ACID; DYSFUNCTION; RESVERATROL; ACTIVATION; INHIBITION; APOPTOSIS; METABOLISM; GENERATION; DISORDERS	Congenital deficiency of the mitochondrial respiratory chain complex I (CI) is a common defect of oxidative phosphorylation (OXPHOS). Despite major advances in the biochemical and molecular diagnostics and the deciphering of CI structure, function assembly and pathomechanism, there is currently no satisfactory cure for patients with mitochondrial complex I defects. Small molecules provide one feasible therapeutic option, however their use has not been systematically evaluated using a standardized experimental system. In order to evaluate potentially therapeutic compounds, we set up a relatively simple system measuring different parameters using only a small amount of patient's fibroblasts, in glucose free medium, where growth is highly OXPOS dependent. Ten different compounds were screened using fibroblasts derived from seven CI patients, harboring different mutations. 5-Aminoimidazole-4-carboxamide ribotide (AICAR) was found to be the most beneficial compound improving growth and ATP content while decreasing ROS production. AICAR also increased mitochondrial biogenesis without altering mitochondrial membrane potential (Delta psi). Fluorescence microscopy data supported increased mitochondrial biogenesis and activation of the AMP activated protein kinase (AMPK). Other compounds such as; bezafibrate and oltipraz were rated as favorable while polyphenolic phytochemicals (resverastrol, grape seed extract, genistein and epigallocatechin gallate) were found not significant or detrimental. Although the results have to be verified by more thorough investigation of additional OXPHOS parameters, preliminary rapid screening of potential therapeutic compounds in individual patient's fibroblasts could direct and advance personalized medical treatment.	[Golubitzky, Anna; Dan, Phyllis; Weissman, Sarah; Link, Gabriela; Saada, Ann] Hebrew Univ Jerusalem, Monique & Jacques Roboh Dept Genet Res, Dept Genet & Metab Dis, Jerusalem, Israel; [Wikstrom, Jakob D.] Hebrew Univ Jerusalem, Dept Endocrinol & Metab, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Golubitzky, A (corresponding author), Hebrew Univ Jerusalem, Monique & Jacques Roboh Dept Genet Res, Dept Genet & Metab Dis, Jerusalem, Israel.	annsr@hadassah.org.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656; Wikstrom, Jakob/0000-0002-4287-1774	Israeli Academy of Sciences, ISF [1462/09]	Israeli Academy of Sciences, ISF(Israel Science Foundation)	This work was funded by the Israeli Academy of Sciences, ISF grant, # 1462/09 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bar-Meir M, 2001, J PEDIATR-US, V139, P868, DOI 10.1067/mpd.2001.118885; Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013; Bosselaar M, 2010, J CLIN PHAR IN PRESS; Briere JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002; Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312; Burlina AB, 2001, MOL GENET METAB, V72, P351, DOI 10.1006/mgme.2001.3156; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; DiMauro S, 2010, Acta Myol, V29, P333; DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4; Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414; Gogada R, 2011, J BIOL CHEM IN PRESS; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Jones CN, 2009, MITOCHONDRION, V9, P429, DOI 10.1016/j.mito.2009.08.001; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kloska A, 2011, METAB BRAIN DIS, V26, P1, DOI 10.1007/s11011-011-9233-2; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kwon YN, 2009, DRUG METAB DISPOS, V37, P1187, DOI 10.1124/dmd.108.025908; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Pajuelo D, 2011, J AGR FOOD CHEM, V59, P4279, DOI 10.1021/jf200322x; Panickars KS, 2009, NUTR NEUROSCI, V12, P105, DOI 10.1179/147683009X423300; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845; Plin C, 2005, EUR J PHARMACOL, V528, P162, DOI 10.1016/j.ejphar.2005.10.044; Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2012, J INHERIT METAB DIS, V35, P125, DOI 10.1007/s10545-011-9348-y; Saada A, 2011, MOL GENET METAB, V104, P39, DOI 10.1016/j.ymgme.2011.07.016; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Shin SM, 2009, MOL PHARMACOL, V75, P242, DOI 10.1124/mol.108.051128; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Szkudelska K, 2011, METABOLISM, V60, P720, DOI 10.1016/j.metabol.2010.07.006; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Wenz T, 2010, J CELL MOL IN PRESS; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	52	79	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26883	10.1371/journal.pone.0026883	http://dx.doi.org/10.1371/journal.pone.0026883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046392	Green Submitted, Green Published, gold			2022-12-27	WOS:000296519600073
J	Gregoric, M; Agnarsson, I; Blackledge, TA; Kuntner, M				Gregoric, Matjaz; Agnarsson, Ingi; Blackledge, Todd A.; Kuntner, Matjaz			How Did the Spider Cross the River? Behavioral Adaptations for River-Bridging Webs in Caerostris darwini (Araneae: Araneidae)	PLOS ONE			English	Article							ORB-WEB; PHYLOGENY; EVOLUTION; CONSTRUCTION; DIVERSIFICATION; COEVOLUTION; ULOBORIDAE; GIGANTISM; SIZE	Background: Interspecific coevolution is well described, but we know significantly less about how multiple traits coevolve within a species, particularly between behavioral traits and biomechanical properties of animals' "extended phenotypes''. In orb weaving spiders, coevolution of spider behavior with ecological and physical traits of their webs is expected. Darwin's bark spider (Caerostris darwini) bridges large water bodies, building the largest known orb webs utilizing the toughest known silk. Here, we examine C. darwini web building behaviors to establish how bridge lines are formed over water. We also test the prediction that this spider's unique web ecology and architecture coevolved with new web building behaviors. Methodology: We observed C. darwini in its natural habitat and filmed web building. We observed 90 web building events, and compared web building behaviors to other species of orb web spiders. Conclusions: Caerostris darwini uses a unique set of behaviors, some unknown in other spiders, to construct its enormous webs. First, the spiders release unusually large amounts of bridging silk into the air, which is then carried downwind, across the water body, establishing bridge lines. Second, the spiders perform almost no web site exploration. Third, they construct the orb capture area below the initial bridge line. In contrast to all known orb-weavers, the web hub is therefore not part of the initial bridge line but is instead built de novo. Fourth, the orb contains two types of radial threads, with those in the upper half of the web doubled. These unique behaviors result in a giant, yet rather simplified web. Our results continue to build evidence for the coevolution of behavioral (web building), ecological (web microhabitat) and biomaterial (silk biomechanics) traits that combined allow C. darwini to occupy a unique niche among spiders.	[Gregoric, Matjaz; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia; [Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Blackledge, Todd A.] Univ Akron, Dept Biol, Integrated Biosci Program, Akron, OH 44325 USA; [Agnarsson, Ingi; Kuntner, Matjaz] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kuntner, Matjaz] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University System of Ohio; University of Akron; Smithsonian Institution; Smithsonian National Museum of Natural History; Hubei University	Gregoric, M (corresponding author), Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.	matjaz.gregoric@gmail.com	Kuntner, Matjaz/AAE-2195-2020; Gregorič, Matjaž/AAG-5913-2021	Gregoric, Matjaz/0000-0002-4882-4282	National Geographic [8655-09]; Slovenian Research Agency [P1-0236, J1-2063]; National Science Foundation [IOS-0745379]	National Geographic(National Geographic Society); Slovenian Research Agency(Slovenian Research Agency - Slovenia); National Science Foundation(National Science Foundation (NSF))	This is the second contribution resulting from the 2010 Madagascar expedition, funded by National Geographic (grant 8655-09 to Dr. Agnarsson, Dr. Kuntner and Dr. Blackledge). Additional funding came from the Slovenian Research Agency (grants P1-0236, J1-2063 to Dr. Kuntner) and National Science Foundation (IOS-0745379 to Dr. Blackledge). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2004, ZOOL J LINN SOC-LOND, V141, P447, DOI 10.1111/j.1096-3642.2004.00120.x; Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Black ledge T.A, 2011, ADV INSECT IN PRESS; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Coddington J., 1986, P319; CODDINGTON J A, 1986, Cladistics, V2, P53, DOI 10.1111/j.1096-0031.1986.tb00442.x; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Corcobado G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-236; CRAIG CL, 1987, AM NAT, V129, P47, DOI 10.1086/284622; Eberhard W.G., 1981, Bulletin of the British Arachnological Society, V5, P189; EBERHARD W G, 1986, P70; EBERHARD WG, 1990, J ARACHNOL, V18, P205; EBERHARD WG, 1987, J ARACHNOL, V15, P1; EBERHARD WG, 1982, EVOLUTION, V36, P1067, DOI 10.1111/j.1558-5646.1982.tb05475.x; EBERHARD WG, 1973, J ZOOL, V171, P367; EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013; EBERHARD WG, 1972, J ZOOL, V66, P417; Eberhard WG, 2008, SYST BIODIVERS, V6, P415, DOI 10.1017/S1477200008002855; Foelix R, 2010, BIOL SPIDERS; Foelix R.F., 1996, BIOL SPIDERS, P336; Foelix RF, 1996, BIOL SPIDERS; Futuyma D. J., 1997, EVOLUTIONARY BIOL, P763; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gregoric M, 2011, J ARACHNOLO IN PRESS; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; HORMIGA G, 1995, AUST J ZOOL, V43, P313, DOI 10.1071/ZO9950313; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1; Kuntner M, 2010, BIOL J LINN SOC, V99, P849, DOI 10.1111/j.1095-8312.2010.01414.x; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peters H. M., 1990, ACTA ZOOL FENN, V190, P309; Peters HM, 1939, Z MORPHOL OKOL TIERE, V36, P180; Ridley M, 1993, EVOLUTION, P670; Rodriguez-Girones MA, 2010, J THEOR BIOL, V266, P430, DOI 10.1016/j.jtbi.2010.06.031; Savory TH, 1952, SPIDERS WEB; Scharff N, 1997, ZOOL J LINN SOC-LOND, V120, P355, DOI 10.1111/j.1096-3642.1997.tb01281.x; Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x; Shear W. A., 1986, SPIDERS WEBS BEHAV E; Weyman GS, 2002, ETHOL ECOL EVOL, V14, P307; WIEHLE HERMAN, 1927, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V8, P468, DOI 10.1007/BF00407450; WIRTH E, 1992, J COMP PHYSIOL A, V171, P359, DOI 10.1007/BF00223966; Witt P.N., 1968, SPIDERS WEB PROBLEMS; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584; Zschokke S, 1999, J ARACHNOL, V27, P542; Zschokke S, 2000, J COMP PHYSIOL A, V186, P999, DOI 10.1007/s003590000155; Zschokke S, 2002, EUROPEAN ARACHNOLOGY 2000, P99; Zschokke S, 2002, J ARACHNOL, V30, P246, DOI 10.1636/0161-8202(2002)030[0246:UROSAW]2.0.CO;2; Zschokke S, 2000, EKOL BRATISLAVA, V19, P307; Zschokke Samuel, 1996, Revue Suisse de Zoologie Volume Hors Serie, V2, P709	52	18	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26847	10.1371/journal.pone.0026847	http://dx.doi.org/10.1371/journal.pone.0026847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046378	Green Submitted, gold, Green Published			2022-12-27	WOS:000296519600065
J	Hurst, JM; Allen, RB; Coomes, DA; Duncan, RP				Hurst, Jennifer M.; Allen, Robert B.; Coomes, David A.; Duncan, Richard P.			Size-Specific Tree Mortality Varies with Neighbourhood Crowding and Disturbance in a Montane Nothofagus Forest	PLOS ONE			English	Article							POSITIVE INTERACTIONS; NATURAL FORESTS; LOGISTIC MODEL; WHITE SPRUCE; GROWTH; COMPETITION; DROUGHT; DISTRIBUTIONS; PRODUCTIVITY; WINDTHROW	Tree mortality is a fundamental process governing forest dynamics, but understanding tree mortality patterns is challenging because large, long-term datasets are required. Describing size-specific mortality patterns can be especially difficult, due to few trees in larger size classes. We used permanent plot data from Nothofagus solandri var. cliffortioides (mountain beech) forest on the eastern slopes of the Southern Alps, New Zealand, where the fates of trees on 250 plots of 0.04 ha were followed, to examine: (1) patterns of size-specific mortality over three consecutive periods spanning 30 years, each characterised by different disturbance, and (2) the strength and direction of neighbourhood crowding effects on size-specific mortality rates. We found that the size-specific mortality function was U-shaped over the 30-year period as well as within two shorter periods characterised by small-scale pinhole beetle and windthrow disturbance. During a third period, characterised by earthquake disturbance, tree mortality was less size dependent. Small trees (< 20 cm in diameter) were more likely to die, in all three periods, if surrounded by a high basal area of larger neighbours, suggesting that size-asymmetric competition for light was a major cause of mortality. In contrast, large trees (>= 20 cm in diameter) were more likely to die in the first period if they had few neighbours, indicating that positive crowding effects were sometimes important for survival of large trees. Overall our results suggest that temporal variability in size-specific mortality patterns, and positive interactions between large trees, may sometimes need to be incorporated into models of forest dynamics.	[Hurst, Jennifer M.; Allen, Robert B.; Coomes, David A.; Duncan, Richard P.] Landcare Res, Lincoln, New Zealand; [Hurst, Jennifer M.; Duncan, Richard P.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Coomes, David A.] Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge, England	Landcare Research - New Zealand; Lincoln University - New Zealand; University of Cambridge	Hurst, JM (corresponding author), Landcare Res, Lincoln, New Zealand.	hurstj@landcareresearch.co.nz	Duncan, Richard/ABD-4099-2020; Coomes, David/H-5630-2011; Duncan, Richard P/E-7899-2013	Duncan, Richard/0000-0003-2295-449X; Duncan, Richard P/0000-0003-2295-449X; Coomes, David/0000-0002-8261-2582	New Zealand Foundation for Research, Science and Technology Ecosystem Resilience Outcome-Based Investment [C09X0502]	New Zealand Foundation for Research, Science and Technology Ecosystem Resilience Outcome-Based Investment(New Zealand Foundation for Research, Science and Technology)	This research was funded by the New Zealand Foundation for Research, Science and Technology Ecosystem Resilience Outcome-Based Investment (Contract ID C09X0502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen RB, 1999, ECOLOGY, V80, P708, DOI 10.1890/0012-9658(1999)080[0708:IDBAET]2.0.CO;2; Bellingham PJ, 1999, J VEG SCI, V10, P825, DOI 10.2307/3237307; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bigler C, 2003, CAN J FOREST RES, V33, P210, DOI [10.1139/x02-180, 10.1139/X02-180]; BINKLEY D, 1995, CAN J FOREST RES, V25, P621, DOI 10.1139/x95-069; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Canham CD, 2001, CAN J FOREST RES, V31, P1, DOI 10.1139/cjfr-31-1-1; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Das AJ, 2007, CAN J FOREST RES, V37, P580, DOI 10.1139/X06-262; Davis MR, 2004, CAN J FOREST RES, V34, P2037, DOI [10.1139/x04-067, 10.1139/X04-067]; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A., 2007, DATA ANAL USING REGR; Gillman LN, 2003, PLANT ECOL, V169, P53, DOI 10.1023/A:1026288306932; GOFF FG, 1975, FOREST SCI, V21, P98; GRIFFITHS GA, 1983, NEW ZEAL J SCI, V26, P197; HAMILTON DA, 1986, FOREST SCI, V32, P989; Harcombe P. A., 1998, Journal of Sustainable Forestry, V6, P313; HARCOMBE PA, 1987, BIOSCIENCE, V37, P557, DOI 10.2307/1310666; Harper J. L, 1977, POPULATION BIOL PLAN; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hurst JM., 2007, PERMANENT PLOT METHO; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; LEE YJ, 1971, FOREST CHRON, V47, P29; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Magnani F, 2000, PLANT CELL ENVIRON, V23, P251, DOI 10.1046/j.1365-3040.2000.00537.x; Manion P. D., 1981, TREE DIS CONCEPTS; McCracken IJ, 1980, 70 FOR RES I, P41; MONSERUD RA, 1976, FOREST SCI, V22, P438; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Mosley MP, 1979, 68 FOR RES I; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; NELSON THOMAS C, 1959, JOUR FOREST, V57, P39; Oliver C.D., 1990, FOREST STAND DYNAMIC; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pedersen BS, 1998, ECOLOGY, V79, P79, DOI 10.1890/0012-9658(1998)079[0079:TROSIT]2.0.CO;2; PEET RK, 1987, BIOSCIENCE, V37, P586, DOI 10.2307/1310669; Peterson CJ, 2004, CAN J FOREST RES, V34, P365, DOI 10.1139/X03-257; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; R Core Team, 2018, R LANG ENV STAT COMP; Rousset O, 2000, J ECOL, V88, P401, DOI 10.1046/j.1365-2745.2000.00457.x; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; SING T, 2004, ROCR R PACKAGE VISUA; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tewksbury JJ, 2001, OECOLOGIA, V127, P425, DOI 10.1007/s004420000614; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Van Nieuwstadt MGL, 2005, J ECOL, V93, P191, DOI 10.1111/j.1365-2745.2004.00954.x; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392; Vieilledent G, 2009, CAN J FOREST RES, V39, P1430, DOI 10.1139/X09-047; Wardle DA, 2001, ECOL MONOGR, V71, P587, DOI 10.1890/0012-9615(2001)071[0587:IBMINZ]2.0.CO;2; Wardle J., 1984, NZ BEECHES ECOLOGY U; WARDLE JA, 1983, PAC SCI, V37, P397; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITEHOUSE IE, 1983, NEW ZEAL J GEOL GEOP, V26, P271, DOI 10.1080/00288306.1983.10422240; Wiser SK, 1998, ECOLOGY, V79, P2071, DOI 10.1890/0012-9658(1998)079[2071:CSAFIB]2.0.CO;2; Woods KD, 2004, J ECOL, V92, P464, DOI 10.1111/j.0022-0477.2004.00881.x; Wunder J, 2007, J VEG SCI, V18, P525, DOI 10.1111/j.1654-1103.2007.tb02567.x; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Wyckoff PH, 1990, FOREST SCI, V36, P1044; Yang YQ, 2003, ECOL MODEL, V163, P209, DOI 10.1016/S0304-3800(03)00008-5; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	74	53	53	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26670	10.1371/journal.pone.0026670	http://dx.doi.org/10.1371/journal.pone.0026670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046327	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600041
J	Regular, PM; Hedd, A; Montevecchi, WA				Regular, Paul M.; Hedd, April; Montevecchi, William A.			Fishing in the Dark: A Pursuit-Diving Seabird Modifies Foraging Behaviour in Response to Nocturnal Light Levels	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; COMMON MURRES; PREY; PENGUINS; DEPTH; LUNAR; DIVE; EYE; CORMORANTS; VISION	Visual predators tend not to hunt during periods when efficiency is compromised by low light levels. Yet common murres, a species considered a diurnal visual predator, frequently dive at night. To study foraging of murres under different light conditions, we used a combination of archival tagging methods and astronomical models to assess relationships between diving behaviour and light availability. During diurnal and crepuscular periods, murres used a wide range of the water column (2-177 m), foraging across light intensities that spanned several orders of magnitude (10(3)-10(-10) Wm(-2)). Through these periods, they readily dived under conditions equivalent to ambient moonlight (similar to 10(-4) Wm(-2)) but rarely under conditions equivalent to starlight (similar to 10(-8) Wm(-2)). At night, murres readily foraged during both moonlit and starlit periods, and diving depth and efficiency increased with nocturnal light intensity, suggesting that night diving is at least partially visually guided. Whether visually guided foraging is possible during starlit periods is less clear. Given the dense prey landscape available, random-walk simulations suggest that murres could benefit from random prey encounters. We hypothesise that murres foraging through starlit periods rely either on close-range visual or possibly nonvisual cues to acquire randomly encountered prey. This research highlights the flexibility of breeding common murres and raises questions about the strategies and mechanisms birds use to find prey under very low light conditions.	[Regular, Paul M.; Hedd, April; Montevecchi, William A.] Mem Univ Newfoundland, Cognit & Behav Ecol Program, Dept Psychol, St John, NF, Canada	Memorial University Newfoundland	Regular, PM (corresponding author), Mem Univ Newfoundland, Cognit & Behav Ecol Program, Dept Psychol, St John, NF, Canada.	paul.regular@mun.ca	Regular, Paul/AAY-5741-2021	Regular, Paul/0000-0003-0318-2615; Hedd, April/0000-0003-2222-2627	Natural Sciences and Engineering Research Council of Canada (NSERC); George Weston Graduate Scholarship; Leslie Tuck Avian Ecology Award; Maritime Awards Society of Canada (MASC); Newfoundland and Labrador Murre Conservation Fund; Government of Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); George Weston Graduate Scholarship; Leslie Tuck Avian Ecology Award; Maritime Awards Society of Canada (MASC); Newfoundland and Labrador Murre Conservation Fund; Government of Canada(CGIAR)	PMR benefited from the following: Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship, George Weston Graduate Scholarship, Leslie Tuck Avian Ecology Award, and Maritime Awards Society of Canada (MASC) Maritime Studies Scholarship. This research was supported by the following grants (to WAM): NSERC Discovery Grant, Newfoundland and Labrador Murre Conservation Fund, and the Government of Canada's Program for International Polar Year Program. All procedures were in full compliance with guidelines of the President's Committee on Animal Care at Memorial University of Newfoundland. Research on the Witless Bay and Funk Island Seabird Ecological Reserves was permitted by the Canadian Wildlife Service and Newfoundland and Labrador Parks Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 1990, P51; [Anonymous], 2010, R LANG ENV STAT COMP; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Fraser NHC, 1997, FUNCT ECOL, V11, P385, DOI 10.1046/j.1365-2435.1997.00098.x; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Halsey LG, 2007, POLAR BIOL, V30, P991, DOI 10.1007/s00300-007-0257-3; Hedd A, 2009, MAR BIOL, V156, P741, DOI 10.1007/s00227-008-1125-6; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Iqbal M, 1984, INTRO SOLAR RAD; Janssen J, 1996, ENVIRON BIOL FISH, V47, P51, DOI 10.1007/BF00002379; Jetz W, 2003, OIKOS, V103, P627, DOI 10.1034/j.1600-0706.2003.12856.x; Land MF, 2002, ANIMAL EYES; Levenson DH, 1999, MAR MAMMAL SCI, V15, P1303, DOI 10.1111/j.1748-7692.1999.tb00892.x; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; MARTIN GR, 1984, PROC R SOC SER B-BIO, V223, P197, DOI 10.1098/rspb.1984.0090; Martin GR, 1999, IBIS, V141, P444, DOI 10.1111/j.1474-919X.1999.tb04413.x; Martin GR, 2007, IBIS, V149, P750, DOI 10.1111/j.1474-919X.2007.00706.x; MCMAHON TE, 1995, J FISH BIOL, V46, P759, DOI 10.1111/j.1095-8649.1995.tb01599.x; MOURITSEN KN, 1994, J AVIAN BIOL, V25, P55, DOI 10.2307/3677294; O'Driscoll RL, 2002, ICES J MAR SCI, V59, P1062, DOI 10.1006/jmsc.2002.1262; PAPAIOANNOU G, 1993, THEOR APPL CLIMATOL, V48, P23, DOI 10.1007/BF00864910; Piatt J. F., 1987, THESIS MEMORIAL U NE; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; SANFORD RC, 1967, CONDOR, V69, P298, DOI 10.2307/1366319; TUCK L.M, 1960, MURRES THEIR DISTRIB; White CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000639; Wilhelm SI, 2003, WATERBIRDS, V26, P376, DOI 10.1675/1524-4695(2003)026[0376:SCOBCM]2.0.CO;2; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; YDENBERG RC, 1989, J THEOR BIOL, V139, P437, DOI 10.1016/S0022-5193(89)80064-5; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804; Zimmer I, 2008, AQUAT BIOL, V3, P217, DOI 10.3354/ab00082; [No title captured]	36	67	69	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26763	10.1371/journal.pone.0026763	http://dx.doi.org/10.1371/journal.pone.0026763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046348	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000296519600054
J	Tanaka, Y; Nakamura, A; Morioka, MS; Inoue, S; Tamamori-Adachi, M; Yamada, K; Taketani, K; Kawauchi, J; Tanaka-Okamoto, M; Miyoshi, J; Tanaka, H; Kitajima, S				Tanaka, Yujiro; Nakamura, Aya; Morioka, Masaki Suimye; Inoue, Shoko; Tamamori-Adachi, Mimi; Yamada, Kazuhiko; Taketani, Kenji; Kawauchi, Junya; Tanaka-Okamoto, Miki; Miyoshi, Jun; Tanaka, Hiroshi; Kitajima, Shigetaka			Systems Analysis of ATF3 in Stress Response and Cancer Reveals Opposing Effects on Pro-Apoptotic Genes in p53 Pathway	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; ENDOTHELIAL-CELLS; GENOTOXIC STRESS; INDUCIBLE GENE; HUMAN GENOME; C-JUN; EXPRESSION; PROMOTER	Stress-inducible transcription factors play a pivotal role in cellular adaptation to environment to maintain homeostasis and integrity of the genome. Activating transcription factor 3 (ATF3) is induced by a variety of stress and inflammatory conditions and is over-expressed in many kinds of cancer cells. However, molecular mechanisms underlying pleiotropic functions of ATF3 have remained elusive. Here we employed systems analysis to identify genome-wide targets of ATF3 that is either induced by an alkylating agent methyl methanesulfonate (MMS) or over-expressed in a prostate tumour cell line LNCaP. We show that stress-induced and cancer-associated ATF3 is recruited to 5,984 and 1,423 targets, respectively, in the human genome, 89% of which are common. Notably, ATF3 targets are highly enriched for not only ATF/CRE motifs but also binding sites of several other stress-inducible transcription factors indicating an extensive network of stress response factors in transcriptional regulation of target genes. Further analysis of effects of ATF3 knockdown on these targets revealed that stress-induced ATF3 regulates genes in metabolic pathways, cell cycle, apoptosis, cell adhesion, and signalling including insulin, p53, Wnt, and VEGF pathways. Cancer-associated ATF3 is involved in regulation of distinct sets of genes in processes such as calcium signalling, Wnt, p53 and diabetes pathways. Notably, stress-induced ATF3 binds to 40% of p53 targets and activates pro-apoptotic genes such as TNFRSF10B/DR5 and BBC3/PUMA. Cancer-associated ATF3, by contrast, represses these pro-apoptotic genes in addition to CDKN1A/p21. Taken together, our data reveal an extensive network of stress-inducible transcription factors and demonstrate that ATF3 has opposing, cell context-dependent effects on p53 target genes in DNA damage response and cancer development.	[Tanaka, Yujiro; Nakamura, Aya; Inoue, Shoko; Tamamori-Adachi, Mimi; Yamada, Kazuhiko; Taketani, Kenji; Kawauchi, Junya; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Lab Genome Struct & Regulat, Sch Biomed Sci, Tokyo, Japan; [Tanaka, Yujiro; Nakamura, Aya; Inoue, Shoko; Tamamori-Adachi, Mimi; Yamada, Kazuhiko; Taketani, Kenji; Kawauchi, Junya; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Tokyo, Japan; [Morioka, Masaki Suimye; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Computat Biol, Sch Med Sci, Tokyo, Japan; [Morioka, Masaki Suimye; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Tokyo, Japan; [Tanaka-Okamoto, Miki; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka Medical Center for Cancer & Cardiovascular Diseases	Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Lab Genome Struct & Regulat, Sch Biomed Sci, Tokyo, Japan.	ytanaka.bgen@mri.tmd.ac.jp; kita.bgen@mri.tmd.ac.jp		Tanaka-Okamoto, Miki/0000-0002-6429-7662	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18012015, 18055008, 21590302, 20510183]; Grants-in-Aid for Scientific Research [22700878] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants to S.K. (18012015, 18055008, and 21590302) and a grant to Y.T. (20510183) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bottone FG, 2005, J PHARMACOL EXP THER, V315, P668, DOI 10.1124/jpet.105.089607; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Daino K, 2006, BBA-GENE STRUCT EXPR, V1759, P458, DOI 10.1016/j.bbaexp.2006.09.005; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gilbert LA, 2011, CANC RES; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 1999, GENE EXPRESSION, V7, P321; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taketani K, 2011, ONCOGENE; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016515; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhao RB, 2000, GENE DEV, V14, P981	56	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2011	6	10							e26848	10.1371/journal.pone.0026848	http://dx.doi.org/10.1371/journal.pone.0026848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841NR	22046379	Green Published, gold, Green Submitted			2022-12-27	WOS:000296519600066
J	Yaddanapudi, K; De Miranda, J; Hornig, M; Lipkin, WI				Yaddanapudi, Kavitha; De Miranda, Joari; Hornig, Mady; Lipkin, W. Ian			Toll-like Receptor 3 Regulates Neural Stem Cell Proliferation by Modulating the Sonic Hedgehog Pathway	PLOS ONE			English	Article							FAS-MEDIATED APOPTOSIS; NERVE GROWTH-FACTOR; DOUBLE-STRANDED-RNA; NF-KAPPA-B; NEURONAL DIFFERENTIATION; SUSTAINED ACTIVATION; NEGATIVE REGULATOR; CYCLE PROGRESSION; RADIAL GLIA; EXPRESSION	Toll-like receptor 3 (TLR3) signaling has been implicated in neural stem/precursor cell (NPC) proliferation. However, the molecular mechanisms involved, and their relationship to classical TLR-mediated innate immune pathways, remain unknown. Here, we report investigation of the mechanics of TLR3 signaling in neurospheres comprised of epidermal growth factor (EGF)-responsive NPC isolated from murine embryonic cerebral cortex of C57BL/6 (WT) or TLR3 deficient (TLR3(-/-)) mice. Our data indicate that the TLR3 ligand polyinosinic-polycytidylic acid (PIC) negatively regulates NPC proliferation by inhibiting Sonic Hedgehog (Shh) signaling, that PIC induces apoptosis in association with inhibition of Ras-ERK signaling and elevated expression of Fas, and that these effects are TLR3-dependent, suggesting convergent signaling between the Shh and TLR3 pathways.	[Yaddanapudi, Kavitha; De Miranda, Joari; Hornig, Mady; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA	Columbia University	Yaddanapudi, K (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	wil2001@columbia.edu	Hornig, Mady/AAE-8431-2020; Lipkin, W. Ian/ABE-6216-2020	Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386	National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID) [5 U01, AI070411]; Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070411] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID), 5 U01 and AI070411 to WIL, and the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10; De Miranda J, 2009, FASEB J, V23, P1064, DOI 10.1096/fj.08-121434; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1995, INT J DEV BIOL, V39, P809; Eriksson C, 2003, EXP NEUROL, V184, P615, DOI 10.1016/S0014-4886(03)00271-1; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fenton RG, 1998, CANCER RES, V58, P3391; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kazama H, 2000, J CELL BIOL, V148, P557, DOI 10.1083/jcb.148.3.557; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Lee J, 1997, DEVELOPMENT, V124, P2537; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li CX, 2004, ONCOGENE, V23, P1608, DOI 10.1038/sj.onc.1207273; Ma BF, 2006, NEUROREPORT, V17, P377, DOI 10.1097/01.wnr.0000204981.36995.db; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mo R, 1997, DEVELOPMENT, V124, P113; Nery S, 2001, DEVELOPMENT, V128, P527; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Park HL, 2000, DEVELOPMENT, V127, P1593; Parmar M, 2003, MOL CELL NEUROSCI, V23, P531, DOI 10.1016/S1044-7431(03)00097-6; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RUIZ IAA, 1999, NAT CELL BIOL, V1, pE147; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Theil T, 1999, DEVELOPMENT, V126, P3561; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 1998, J NEUROCHEM, V70, P1327; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	72	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26766	10.1371/journal.pone.0026766	http://dx.doi.org/10.1371/journal.pone.0026766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22046349	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000030
J	Margalida, A; Oro, D; Cortes-Avizanda, A; Heredia, R; Donazar, JA				Margalida, Antoni; Oro, Daniel; Cortes-Avizanda, Ainara; Heredia, Rafael; Donazar, Jose A.			Misleading Population Estimates: Biases and Consistency of Visual Surveys and Matrix Modelling in the Endangered Bearded Vulture	PLOS ONE			English	Article							GYPAETUS-BARBATUS; CONSERVATION; BIRD; AGE; DYNAMICS; LIMITATION; MORTALITY; VIABILITY; RECOVERY; SURVIVAL	Conservation strategies for long-lived vertebrates require accurate estimates of parameters relative to the populations' size, numbers of non-breeding individuals (the "cryptic" fraction of the population) and the age structure. Frequently, visual survey techniques are used to make these estimates but the accuracy of these approaches is questionable, mainly because of the existence of numerous potential biases. Here we compare data on population trends and age structure in a bearded vulture (Gypaetus barbatus) population from visual surveys performed at supplementary feeding stations with data derived from population matrix-modelling approximations. Our results suggest that visual surveys overestimate the number of immature (<2 years old) birds, whereas subadults (3-5 y.o.) and adults (>6 y.o.) were underestimated in comparison with the predictions of a population model using a stable-age distribution. In addition, we found that visual surveys did not provide conclusive information on true variations in the size of the focal population. Our results suggest that although long-term studies (i.e. population matrix modelling based on capture-recapture procedures) are a more time-consuming method, they provide more reliable and robust estimates of population parameters needed in designing and applying conservation strategies. The findings shown here are likely transferable to the management and conservation of other long-lived vertebrate populations that share similar life-history traits and ecological requirements.	[Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Oro, Daniel] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain; [Cortes-Avizanda, Ainara; Donazar, Jose A.] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Helmholtz Ctr Environm Res UFZ, Leipzig, Germany; [Cortes-Avizanda, Ainara] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain	Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Margalida, A (corresponding author), Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain.	antoni.margalida@iee.unibe.ch	Margalida, Antoni/AAG-5337-2020; Cortés-Avizanda, Ainara/C-6634-2013; Oro, Daniel/H-4208-2012; Margalida, Antoni/A-2723-2011; CORTES-AVIZANDA, AINARA/O-3248-2019; Margalida, Antoni/A-2723-2011	Cortés-Avizanda, Ainara/0000-0002-9674-6434; Oro, Daniel/0000-0003-4782-3007; Margalida, Antoni/0000-0002-0576-3993; CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212; Donazar, Jose Antonio/0000-0002-9433-9755	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente	AM was supported by the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 2003, MAR MAMMAL SCI, V19, P764, DOI 10.1111/j.1748-7692.2003.tb01129.x; Antor RJ, 2007, ACTA ORNITHOL, V42, P114, DOI 10.3161/068.042.0106; Bibby C., 1993, BIRD CENSUS TECHNIQU; Blanco G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014163; Brown CJ, 1997, AFR J ECOL, V35, P53, DOI 10.1111/j.1365-2028.1997.048-89048.x; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Caswell, 2000, MATRIX POPULATION MO; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Chaudhary A, BIRD CONSER IN PRESS; CLARKE R, 1990, BIRD STUDY, V37, P84, DOI 10.1080/00063659009477044; Cortes-Avizanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021016; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Donazar J.A., 2009, MUNIBE S, V29; Donazar JA., 1996, BIOLOG A CONSERVACI, P189; FRANKLIN AB, 1992, WILDLIFE 2001 : POPULATIONS, P815; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; Green RE, 2008, P ROY SOC B-BIOL SCI, V275, P2381, DOI 10.1098/rspb.2008.0473; Heredia Rafael, 1991, P101; Hernandez M, 2009, ENVIRON RES, V109, P837, DOI 10.1016/j.envres.2009.05.001; Holt KR, 2008, CAN J FISH AQUAT SCI, V65, P212, DOI 10.1139/F07-160; Huot M, 2006, ANN ZOOL FENN, V43, P131; Kasprzykowski Z, 2011, ORNIS FENNICA, V88, P98; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; KLOMP NI, 1992, J APPL ECOL, V29, P341, DOI 10.2307/2404503; Lebreton J.-D., 1991, BIRD POPULATION STUD, P105; Margalida A, 2003, J RAPTOR RES, V37, P157; Margalida A, 2003, IBIS, V145, P244, DOI 10.1046/j.1474-919X.2003.00148.x; Margalida A, 2000, IBIS, V142, P225, DOI 10.1111/j.1474-919X.2000.tb04862.x; Margalida A, 2005, BIOL CONSERVACION QU; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Margalida A, 2009, IBIS, V151, P235; McCullagh P., 2000, GEN LINEAR MIXED MOD; McGowan CP, 2009, J FIELD ORNITHOL, V80, P79, DOI 10.1111/j.1557-9263.2009.00207.x; MMA, 2001, ESTR CONS QUEBR GYP; Mundy P., 1992, VULTURES AFRICA; NEWTON I, 1992, BIOL REV, V67, P129, DOI 10.1111/j.1469-185X.1992.tb01017.x; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Penteriani V, 2005, P ROY SOC LOND B BIO, V18, P58; PIENKOWSKI MW, 1991, IBIS, V133, P62, DOI 10.1111/j.1474-919X.1991.tb07670.x; Rohner C, 1996, J ANIM ECOL, V65, P359, DOI 10.2307/5882; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Sarasola JH, 2008, DIVERS DISTRIB, V14, P686, DOI 10.1111/j.1472-4642.2008.00475.x; SAS Institute Inc, 2009, SAS STAT 9 2 LANG RE; Schaub M, 2011, J OMITH, V152, pS227; Schaub M, 2009, J APPL ECOL, V46, P92, DOI 10.1111/j.1365-2664.2008.01585.x; Sergio F, 2011, BASIC APPL ECOL, V12, P107, DOI 10.1016/j.baae.2010.11.004; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Sese JA, 2005, BIOL CONSERVACION QU, P279; Sternberg H, 2002, ARDEA, V90, P461; Taylor SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003047; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Van Beest F, 2008, BIRD CONSERV INT, V18, P102, DOI 10.1017/S0959270908000129; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; Williams AK, 2004, J WILDLIFE MANAGE, V68, P418, DOI 10.2193/0022-541X(2004)068[0418:RFAISD]2.0.CO;2; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273	62	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26784	10.1371/journal.pone.0026784	http://dx.doi.org/10.1371/journal.pone.0026784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039550	gold, Green Published			2022-12-27	WOS:000296513200053
J	Truttmann, MC; Guye, P; Dehio, C				Truttmann, Matthias C.; Guye, Patrick; Dehio, Christoph			BID-F1 and BID-F2 Domains of Bartonella henselae Effector Protein BepF Trigger Together with BepC the Formation of Invasome Structures	PLOS ONE			English	Article							RHO-PROTEINS; BACTERIAL; FAMILY; BINDING; GTPASES; GLUCOSYLATION; LAMELLIPODIA; CYTOSKELETON; PREDICTION; SEQUENCE	The gram-negative, zoonotic pathogen Bartonella henselae (Bhe) translocates seven distinct Bartonella effector proteins (Beps) via the VirB/VirD4 type IV secretion system (T4SS) into human cells, thereby interfering with host cell signaling [1,2]. In particular, the effector protein BepG alone or the combination of effector proteins BepC and BepF trigger massive F-actin rearrangements that lead to the establishment of invasome structures eventually resulting in the internalization of entire Bhe aggregates [2,3]. In this report, we investigate the molecular function of the effector protein BepF in the eukaryotic host cell. We show that the N-terminal [E/T]PLYAT tyrosine phosphorylation motifs of BepF get phosphorylated upon translocation but do not contribute to invasome-mediated Bhe uptake. In contrast, we found that two of the three BID domains of BepF are capable to trigger invasome formation together with BepC, while a mutation of the WxxxE motif of the BID-F1 domain inhibited its ability to contribute to the formation of invasome structures. Next, we show that BepF function during invasome formation can be replaced by the over-expression of constitutive-active Rho GTPases Rac1 or Cdc42. Finally we demonstrate that BID-F1 and BID-F2 domains promote the formation of filopodia-like extensions in NIH 3T3 and HeLa cells as well as membrane protrusions in HeLa cells, suggesting a role for BepF in Rac1 and Cdc42 activation during the process of invasome formation.	[Truttmann, Matthias C.; Guye, Patrick; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Guye, Patrick] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Basel; Massachusetts Institute of Technology (MIT)	Truttmann, MC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	Christoph.dehio@unibas.ch	Dehio, Christoph/R-8277-2016; truttmann, matthias/ABC-2727-2021; Dehio, Christoph/AAD-5572-2019	Dehio, Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923; Dehio, Christoph/0000-0001-7288-1052	Swiss National Science Foundation [31003A-132979]; Howard Hughes Medical Institute; SystemsX.ch [51RT-0_126008]; Swiss Initiative for Systems Biology;  [5500550]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SystemsX.ch; Swiss Initiative for Systems Biology; 	This work was supported by grant 31003A-132979 from the Swiss National Science Foundation, grant 5500550 and from the Howard Hughes Medical Institute and grant 51RT-0_126008 (InfectX) from SystemsX.ch, the Swiss Initiative for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700; Dehio C, 1997, J CELL SCI, V110, P2141; Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x; Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532; Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897; Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Litvak Y, 2003, TRENDS BIOCHEM SCI, V28, P628, DOI 10.1016/j.tibs.2003.10.001; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmid MC, 2006, TRANSLOCATED BACTERI; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	33	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25106	10.1371/journal.pone.0025106	http://dx.doi.org/10.1371/journal.pone.0025106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043280	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400007
J	Prasanthi, RPJ; Larson, T; Schommer, J; Ghribi, O				Prasanthi, Jaya R. P.; Larson, Tyler; Schommer, Jared; Ghribi, Othman			Silencing GADD153/CHOP Gene Expression Protects against Alzheimer's Disease-Like Pathology Induced by 27-Hydroxycholesterol in Rabbit Hippocampus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; AMYLOID PRECURSOR PROTEIN; IRON REGULATORY PROTEIN-2; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELL-DEATH; OXIDATIVE STRESS; TRANSFERRIN RECEPTOR; A-BETA; PARKINSONS-DISEASE; MOLECULAR CONTROL	Endoplasmic reticulum (ER) stress is suggested to play a key role in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD). Sustained ER stress leads to activation of the growth arrest and leucine zipper transcription factor, DNA damage inducible gene 153 (gadd153; also called CHOP). Activated gadd153 can generate oxidative damage and reactive oxygen species (ROS), increase beta-amyloid (A beta) levels, disturb iron homeostasis and induce inflammation as well as cell death, which are all pathological hallmarks of AD. Epidemiological and laboratory studies suggest that cholesterol dyshomeostasis contributes to the pathogenesis of AD. We have previously shown that the cholesterol oxidized metabolite 27-hydroxycholesterol (27-OHC) triggers AD-like pathology in organotypic slices. However, the extent to which gadd153 mediates 27-OHC effects has not been determined. We silenced gadd153 gene with siRNA and determined the effects of 27-OHC on AD hallmarks in organotypic slices from adult rabbit hippocampus. siRNA to gadd153 reduced 27-OHC-induced A beta production by mechanisms involving reduction in levels of beta-amyloid precursor protein (APP) and beta-secretase (BACE1), the enzyme that initiates cleavage of APP to yield A beta peptides. Additionally, 27-OHC-induced tau phosphorylation, ROS generation, TNF-alpha activation, and iron and apoptosis-regulatory protein levels alteration were also markedly reduced by siRNA to gadd153. These data suggest that ER stress-mediated gadd153 activation plays a central role in the triggering of AD pathological hallmarks that result from incubation of hippocampal slices with 27-OHC. Our results add important insights into cellular mechanisms that underlie the potential contribution of cholesterol metabolism in AD pathology, and suggest that preventing gadd153 activation protects against AD related to cholesterol oxidized products.	[Prasanthi, Jaya R. P.; Larson, Tyler; Schommer, Jared; Ghribi, Othman] Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Prasanthi, RPJ (corresponding author), Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	othman.ghribi@med.und.edu			National Institutes of Health (NIH) [RO1ES014826]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014826] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Institutes of Health (NIH) (RO1ES014826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bouton C., 2003, SCI STKE, V2003, pe17; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Cudna RE, 2003, BIOTECHNOL BIOENG, V81, P56, DOI 10.1002/bit.10445; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FLEMING J, 1987, P NATL ACAD SCI USA, V84, P7866, DOI 10.1073/pnas.84.22.7866; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Ghribi O, 2006, J NEUROCHEM, V99, P438, DOI 10.1111/j.1471-4159.2006.04079.x; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hascalovici JR, 2009, J NEUROCHEM, V110, P1241, DOI 10.1111/j.1471-4159.2009.06213.x; Henderson RJ, 2003, NEURONAL AND VASCULAR PLASTICITY: ELUCIDATING BASIC CELLULAR MECHANISMS FOR FUTURE THERAPEUTIC DISCOVERY, P165; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Imaizumi K, 2001, BBA-MOL BASIS DIS, V1536, P85, DOI 10.1016/S0925-4439(01)00049-7; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299; KALARIA RN, 1992, BRAIN RES, V585, P87, DOI 10.1016/0006-8993(92)91193-I; Kaur D, 2002, AGING CELL, V1, P17, DOI 10.1046/j.1474-9728.2002.00001.x; KIM E, 1995, TOXICOL APPL PHARM, V130, P57, DOI 10.1006/taap.1995.1008; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Milhavet O, 2002, J NEUROCHEM, V83, P673, DOI 10.1046/j.1471-4159.2002.01165.x; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paradis E, 1996, J NEUROSCI, V16, P7533; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Petrat F, 2000, ARCH BIOCHEM BIOPHYS, V376, P74, DOI 10.1006/abbi.2000.1711; Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rogers JT, 2004, CURR DRUG TARGETS, V5, P535, DOI 10.2174/1389450043345272; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; SEISER C, 1995, J BIOL CHEM, V270, P29400, DOI 10.1074/jbc.270.49.29400; Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002; Smith MA, 1998, BRAIN RES, V788, P232, DOI 10.1016/S0006-8993(98)00002-X; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tamagno E, 2003, NEUROBIOL DIS, V14, P291, DOI 10.1016/S0969-9961(03)00131-1; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; TESTA U, 1989, J BIOL CHEM, V264, P13181; THEIL EC, 1990, J BIOL CHEM, V265, P4771; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; THOMPSON CM, 1988, NEUROTOXICOLOGY, V9, P1; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todorich BM, 2004, ANN NY ACAD SCI, V1012, P171, DOI 10.1196/annals.1306.014; TORTI SV, 1988, J BIOL CHEM, V263, P12638; TSUJI Y, 1991, J BIOL CHEM, V266, P7257; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Whitnall Megan, 2006, Semin Pediatr Neurol, V13, P186, DOI 10.1016/j.spen.2006.08.008; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Woltjer RL, 2005, J NEUROCHEM, V93, P1047, DOI 10.1111/j.1471-4159.2005.03109.x; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109	79	59	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26420	10.1371/journal.pone.0026420	http://dx.doi.org/10.1371/journal.pone.0026420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22046282	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600058
J	Zhu, X; Wang, F; Lin, MCM; Tian, LW; Fan, WG; Ng, SS; Liu, MJ; Huang, JQ; Xu, ZH; Li, DP; Kung, HF				Zhu, Xiao; Wang, Fang; Lin, Marie C. M.; Tian, Linwei; Fan, Wenguo; Ng, Samuel S.; Liu, Minjuan; Huang, Jianqing; Xu, Zhenhua; Li, Dongpei; Kung, Hsiangfu			The 3 ' UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular Carcinoma	PLOS ONE			English	Article							PROGNOSIS; RISK; GENE; SUSCEPTIBILITY; POLYMORPHISM	Background: Elevated glucose-regulated protein 78 (GRP78) levels in tissues have been known to be related with poor prognosis in hepatocellular carcinoma (HCC) patients. Though the variants in the 39 untranslated region (UTR) of GRP78 gene were not associated with HCC risk, we wonder whether these polymorphisms affect survival of HCC patients. Methodology/Principal Findings: Blood samples of HCC patients were maintained in our specimen bank between 1996 to 2003. DNA from 576 unrelated and resectable patients with HCC was typed for rs16927997 (T>C), rs1140763 (T>C) and rs12009 (T. C) by TaqMan assays. The Kaplan-Meier method and log-rank test were used to estimate overall survival. Linkage disequilibrium (LD) analysis identified a total of 3 haplotypes and 6 diplotypes in this region. The distribution of haplotype was not related to the clinical characteristics. Univariate analysis showed that the allele, genotype, haplotype and diplotype did not effect the survival. None of the clinical features show a significant association (P-correced > 0.05) with overall patient outcome in multiple comparisons. Conclusions/Significance: There is no noteworthy influence of 39 UTR variants in the GRP78 on prognosis of resectable HCC in the Chinese population.	[Zhu, Xiao; Wang, Fang; Kung, Hsiangfu] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xiao; Liu, Minjuan; Huang, Jianqing] Affiliated Tumor Hosp, Guangzhou Med Coll, Guangzhou, Guangdong, Peoples R China; [Lin, Marie C. M.; Xu, Zhenhua] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Dept Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Fan, Wenguo; Li, Dongpei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Ng, Samuel S.] Univ Hong Kong, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Xiao; Kung, Hsiangfu] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sun Yat Sen University; University of Hong Kong; Chinese University of Hong Kong	Zhu, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	bioxzhu@yahoo.com; lidp@mail.sysu.edu.cn	Tian, Linwei/A-9736-2009; wang, fang/GYD-4295-2022; Xu, Zhenhua/J-9200-2015	Tian, Linwei/0000-0002-4739-1534; Xu, Zhenhua/0000-0001-9481-5611; Tian, Linwei/0000-0003-2240-8886; Li, Dongpei/0000-0002-4734-6776	National Nature Science Foundation of China [81071697]; Research Project of Health Bureau of Guangzhou City [201102A213005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Health Bureau of Guangzhou City	This work was supported by the National Nature Science Foundation of China ( Grant No. 81071697) and the Research Project of Health Bureau of Guangzhou City (Grant No. 201102A213005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellavance EC, 2008, J GASTROINTEST SURG, V12, P1699, DOI 10.1007/s11605-008-0652-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Kim KA, 2003, CLIN IMAG, V27, P340, DOI 10.1016/S0899-7071(02)00574-0; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nogueira JA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-204; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Vormfelde SV, 2007, NAT REV GENET, V8, DOI 10.1038/nrg1916-c2; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Woodcock J, 2009, NEW ENGL J MED, V360, P811, DOI 10.1056/NEJMe0810630; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yano M, 2007, EUR J CANCER, V43, P1092, DOI 10.1016/j.ejca.2007.01.032; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; ZHU X, HEPATOGASTR IN PRESS; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	24	151	158	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17783	10.1371/journal.pone.0017783	http://dx.doi.org/10.1371/journal.pone.0017783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21445355	Green Published, Green Submitted, gold			2022-12-27	WOS:000288809100008
J	Mohan, RR; Tovey, JCK; Sharma, A; Schultz, GS; Cowden, JW; Tandon, A				Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Schultz, Gregory S.; Cowden, John W.; Tandon, Ashish			Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo	PLOS ONE			English	Article							SUBCONJUNCTIVAL INJECTION; COLLAGEN FIBRILLOGENESIS; ENDOTHELIAL-CELLS; ANGIOGENESIS; EXPRESSION; AAV; INJURY; VECTORS; BEVACIZUMAB; INHIBITION	Decorin, small leucine-rich proteoglycan, has been shown to modulate angiogenesis in nonocular tissues. This study tested a hypothesis that tissue-selective targeted decorin gene therapy delivered to the rabbit stroma with adeno-associated virus serotype 5 (AAV5) impedes corneal neovascularization (CNV) in vivo without significant side effects. An established rabbit CNV model was used. Targeted decorin gene therapy in the rabbit stroma was delivered with a single topical AAV5 titer (100 mu l; 5 x 10(12) vg/ml) application onto the stroma for two minutes after removing corneal epithelium. The levels of CNV were examined with stereomicroscopy, H&E staining, lectin, collagen type IV, CD31 immunocytochemistry and CD31 immunoblotting. Real-time PCR quantified mRNA expression of pro-and anti-angiogenic genes. Corneal health in live animals was monitored with clinical, slit-lamp and optical coherence tomography biomicroscopic examinations. Selective decorin delivery into stroma showed significant 52% (p<0.05), 66% (p<0.001), and 63% (p<0.01) reduction at early (day 5), mid (day 10), and late (day 14) stages of CNV in decorin-delivered rabbit corneas compared to control (no decorin delivered) corneas in morphometric analysis. The H&E staining, lectin, collagen type IV, CD31 immunostaining (57-65, p<0.5), and CD31 immunoblotting (62-67%, p<0.05) supported morphometric findings. Quantitative PCR studies demonstrated decorin gene therapy down-regulated expression of VEGF, MCP1 and angiopoietin (pro-angiogenic) and up-regulated PEDF (anti-angiogenic) genes. The clinical, biomicroscopy and transmission electron microscopy studies revealed that AAV5-mediated decorin gene therapy is safe for the cornea. Tissue-targeted AAV5-mediated decorin gene therapy decreases CNV with no major side effects, and could potentially be used for treating patients.	[Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Tandon, Ashish] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Cowden, John W.; Tandon, Ashish] Univ Missouri, Mason Eye Inst, Columbia, MO USA; [Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Schultz, Gregory S.] Univ Florida, Dept Ophthalmol & Obstet & Gynecol, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; State University System of Florida; University of Florida	Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	mohanr@health.missouri.edu	Wong, Pak Kin/A-7974-2012; Bercovici, Moran/F-6076-2013	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463; Bercovici, Moran/0000-0002-7803-4791	National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States [RO1EY17294, RO1EY17294S2]; Veteran Health Affairs, Washington, DC, United States [1I01BX000357-01]; Research to Prevent Blindness, New York, New York, United States	National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Eye Institute (NEI)); Veteran Health Affairs, Washington, DC, United States; Research to Prevent Blindness, New York, New York, United States(Research to Prevent Blindness (RPB))	The work was supported by the RO1EY17294 (RRM) and RO1EY17294S2 (RRM) grants from the National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States; 1I01BX000357-01 (RRM) grant from the Veteran Health Affairs, Washington, DC, United States and an unrestricted grant from the Research to Prevent Blindness, New York, New York, United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin E, 2008, CORNEA, V27, P446, DOI 10.1097/ICO.0b013e3181605ff9; Buss DG, 2010, VET OPHTHALMOL, V13, P301, DOI 10.1111/j.1463-5224.2010.00813.x; Chen WL, 2009, INVEST OPHTH VIS SCI, V50, P1659, DOI 10.1167/iovs.08-1997; Cheng HC, 2007, MOL VIS, V13, P2344; Chung ES, 2009, INVEST OPHTH VIS SCI, V50, P1613, DOI 10.1167/iovs.08-2212; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dastjerdi MH, 2009, ARCH OPHTHALMOL-CHIC, V127, P381, DOI 10.1001/archophthalmol.2009.18; Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Jani PD, 2007, INVEST OPHTH VIS SCI, V48, P2030, DOI 10.1167/iovs.06-0853; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Kuo CN, 2009, EXP EYE RES, V89, P678, DOI 10.1016/j.exer.2009.06.021; Lai LJ, 2007, J BIOMED SCI, V14, P313, DOI 10.1007/s11373-007-9153-7; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Liu J, 2008, MOL VIS, V14, P2087; Mimura T, 2009, J VASC RES, V46, P541, DOI 10.1159/000226222; Mohan RR, 2011, CURR MOL MED, V11, P110; Mohan RR, 2010, MOL VIS, V16, P2494; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Qazi Y, 2009, J GENET, V88, P495, DOI 10.1007/s12041-009-0068-0; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; SHARMA A, 2010, ENCY EYE, P185; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Sharma A, 2010, MOL VIS, V16, P720; Sharma A, 2010, BRAIN RES BULL, V81, P273, DOI 10.1016/j.brainresbull.2009.07.005; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; Wilson SE, 2004, INVEST OPHTH VIS SCI, V45, P2201, DOI 10.1167/iovs.03-1162; Wilson SE, 2002, ADV EXP MED BIOL, V506, P821; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	39	111	118	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26432	10.1371/journal.pone.0026432	http://dx.doi.org/10.1371/journal.pone.0026432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22066011	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500068
J	Clark, JM; Aleksiyadis, K; Martin, A; McNamee, K; Tharmalingam, T; Williams, RO; Memet, S; Cope, AP				Clark, Joanna M.; Aleksiyadis, Karolina; Martin, Alex; McNamee, Kay; Tharmalingam, Tharsana; Williams, Richard O.; Memet, Sylvie; Cope, Andrew P.			Inhibitor of Kappa B Epsilon (I kappa B epsilon) Is a Non-Redundant Regulator of c-Rel-Dependent Gene Expression in Murine T and B Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; IMMUNE-SYSTEM; NEGATIVE FEEDBACK; IL-2 PROMOTER; ACTIVATION; BETA; PROLIFERATION	Inhibitors of kappa B (I kappa Bs) -alpha, -beta and -epsilon effect selective regulation of specific nuclear factor of kappa B (NF-kappa B) dimers according to cell lineage, differentiation state or stimulus, in a manner that is not yet precisely defined. Lymphocyte antigen receptor ligation leads to degradation of all three I kappa Bs but activation only of subsets of NF-kappa B-dependent genes, including those regulated by c-Rel, such as anti-apoptotic CD40 and BAFF-R on B cells, and interleukin-2 (IL-2) in T cells. We report that pre-culture of a mouse T cell line with tumour necrosis factor-alpha (TNF) inhibits IL-2 gene expression at the level of transcription through suppressive effects on NF-kappa B, AP-1 and NFAT transcription factor expression and function. Selective upregulation of I kappa B epsilon and suppressed nuclear translocation of c-Rel were very marked in TNF-treated, compared to control cells, whether activated via T cell receptor (TCR) pathway or TNF receptor. I kappa B epsilon associated with newly synthesised c-Rel in activated cells and, in contrast to I kappa B alpha and -beta, showed enhanced association with p65/c-Rel in TNF-treated cells relative to controls. Studies in I kappa B epsilon-deficient mice revealed that basal nuclear expression and nuclear translocation of c-Rel at early time-points of receptor ligation were higher in I kappa B epsilon-/- T and B cells, compared to wild-type. I kappa B epsilon-/- mice exhibited increased lymph node cellularity and enhanced basal thymidine incorporation by lymphoid cells ex vivo. I kappa B epsilon-/- T cell blasts were primed for IL-2 expression, relative to wild-type. I kappa B epsilon-/- splenic B cells showed enhanced survival ex vivo, compared to wild-type, and survival correlated with basal expression of CD40 and induced expression of CD40 and BAFF-R. Enhanced basal nuclear translocation of c-Rel, and upregulation of BAFF-R and CD40 occurred despite increased I kappa B alpha expression in I kappa B epsilon-/- B cells. The data imply that regulation of these c-Rel-dependent lymphoid responses is a non-redundant function of I kappa B epsilon.	[Clark, Joanna M.; Tharmalingam, Tharsana; Cope, Andrew P.] Kings Coll London, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Sch Med,Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Aleksiyadis, Karolina; Martin, Alex; McNamee, Kay; Williams, Richard O.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London, England; [Memet, Sylvie] Inst Pasteur, Unite Mycol Mol, Paris, France; [Memet, Sylvie] CNRS, Unite Rech Associee 3012, Paris, France	University of London; King's College London; Imperial College London; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Clark, JM (corresponding author), Kings Coll London, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Sch Med,Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	andrew.cope@kcl.ac.uk	Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Amin, Janaki/0000-0003-2161-9366; Memet, Sylvie/0000-0001-6571-4192; Cope, Andrew/0000-0001-6735-5496; Boyd, Mark/0000-0002-6848-3307; Medland, Nicholas Andrew/0000-0003-0403-8930; Martin, Allison/0000-0001-6065-1188	Wellcome Trust; Arthritis Research UK; European Community [HEALTH-F2-2008-223404]	Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); European Community(European Commission)	This work was funded by (1) The Wellcome Trust: http://www.wellcome.ac.uk/ (2) Arthritis Research UK: http://www.arthritisresearchuk.org/ (3) The European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (http://www.Masterswitchproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JRF, 2009, J IMMUNOL, V183, P621, DOI 10.4049/jimmunol.0803278; Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Castro I, 2009, J IMMUNOL, V182, P7729, DOI 10.4049/jimmunol.0803281; Clark JM, 2004, P NATL ACAD SCI USA, V101, P1696, DOI 10.1073/pnas.0308231100; Cope AP, 2002, ARTHRITIS RES THER, V4; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#; Criswell LA, 2010, IMMUNOL REV, V233, P55, DOI 10.1111/j.0105-2896.2009.00862.x; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Doerre S, 1999, J IMMUNOL, V163, P269; Doerre S, 2005, J IMMUNOL, V174, P983, DOI 10.4049/jimmunol.174.2.983; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fu LC, 2009, BLOOD, V113, P4627, DOI 10.1182/blood-2008-10-183467; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Goudeau B, 2003, P NATL ACAD SCI USA, V100, P15800, DOI 10.1073/pnas.2535880100; GREGERSEN PK, 2009, NAT GENET; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim D, 2009, FASEB J, V23, P2796, DOI 10.1096/fj.09-130369; Laskov R, 2005, EUR CYTOKINE NETW, V16, P267; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; McGuire KL, 1997, J IMMUNOL, V159, P1319; Memet S, 1999, J IMMUNOL, V163, P5994; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Simeonidis S, 1997, P NATL ACAD SCI USA, V94, P14372, DOI 10.1073/pnas.94.26.14372; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VISA N, COLD SPRING HARB PER, V2; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	59	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24504	10.1371/journal.pone.0024504	http://dx.doi.org/10.1371/journal.pone.0024504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915344	Green Submitted, Green Published, gold			2022-12-27	WOS:000294689200051
J	Park, BS; Jin, SH; Park, JJ; Park, JW; Namgoong, IS; Kim, YI; Lee, BJ; Kim, JG				Park, Byong Seo; Jin, Sung Ho; Park, Joong Jean; Park, Jeong Woo; Namgoong, Il Seong; Kim, Young Il; Lee, Byung Ju; Kim, Jae Geun			Visfatin Induces Sickness Responses in the Brain	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; INSULIN-RESISTANCE; INFLAMMATION; ANOREXIA; BEHAVIOR; OBESITY; ADIPOCYTOKINE; HYPOTHALAMUS; MECHANISMS; APPETITE	Background/Objective: Visfatin, also known as nicotiamide phosphoribosyltransferase or pre-B cell colony enhancing factor, is a pro-inflammatory cytokine whose serum level is increased in sepsis and cancer as well as in obesity. Here we report a pro-inflammatory role of visfatin in the brain, to mediate sickness responses including anorexia, hyperthermia and hypoactivity. Methodology: Rats were intracerebroventricularly (ICV) injected with visfatin, and changes in food intake, body weight, body temperature and locomotor activity were monitored. Real-time PCR was applied to determine the expressions of proinflammatory cytokines, proopiomelanocortin (POMC) and prostaglandin-synthesizing enzymes in their brain. To determine the roles of cyclooxygenase (COX) and melanocortin in the visfatin action, rats were ICV-injected with visfatin with or without SHU9119, a melanocortin receptor antagonist, or indomethacin, a COX inhibitor, and their sickness behaviors were evaluated. Principal Findings: Administration of visfatin decreased food intake, body weight and locomotor activity and increased body temperature. Visfatin evoked significant increases in the levels of pro-inflammatory cytokines, prostaglandin-synthesizing enzymes and POMC, an anorexigenic neuropeptide. Indomethacin attenuated the effects of visfatin on hyperthermia and hypoactivity, but not anorexia. Further, SHU9119 blocked visfatin-induced anorexia but did not affect hyperthermia or hypoactivity. Conclusions: Visfatin induced sickness responses via regulation of COX and the melanocortin pathway in the brain.	[Park, Byong Seo; Jin, Sung Ho; Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Biomed Res Ctr, Coll Med, Ulsan 680749, South Korea; [Park, Joong Jean] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Namgoong, Il Seong; Kim, Young Il] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Ulsan University Hospital	Park, BS (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr; jg-kim@mail.ulsan.ac.kr		NAM-GOONG, IL SEONG/0000-0002-0492-0467; Park, Byong Seo/0000-0001-6463-9645; Park, Joong-Jean/0000-0002-4534-3002	National Research Foundation (NRF) of Korea [BRL 2009-0087350]; Brain Research Center [2009K001268]; Ministry of Education, Science and Technology (MEST) [2009-0076067]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	B.J.L. was supported by the National Research Foundation (NRF) of Korea Grant (BRL 2009-0087350) and by Research Grant (2009K001268) from the Brain Research Center of the 21st Century Frontier Research Program. J.G.K. was supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology (MEST; 2009-0076067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2007, BRAIN BEHAV IMMUN, V21, P147, DOI 10.1016/j.bbi.2006.08.002; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Carrero JJ, 2010, NEPHROL DIAL TRANSPL, V25, P901, DOI 10.1093/ndt/gfp587; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Johnson PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE650, DOI 10.1152/ajpendo.00388.2001; Kim JG, 2006, BIOCHEM BIOPH RES CO, V349, P969, DOI 10.1016/j.bbrc.2006.08.147; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laviano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1000, DOI 10.1152/ajpendo.90252.2008; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Mercader J, 2008, HORM METAB RES, V40, P467, DOI 10.1055/s-2008-1065324; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Oki K, 2007, CLIN ENDOCRINOL, V67, P796, DOI 10.1111/j.1365-2265.2007.02966.x; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Pecchi E, 2009, PHYSIOL BEHAV, V97, P279, DOI 10.1016/j.physbeh.2009.02.040; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rorato R, 2009, EXP PHYSIOL, V94, P371, DOI 10.1113/expphysiol.2008.045435; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Skinner GW, 2009, PHYSIOL BEHAV, V96, P421, DOI 10.1016/j.physbeh.2008.11.004; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002	29	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15981	10.1371/journal.pone.0015981	http://dx.doi.org/10.1371/journal.pone.0015981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283791	Green Submitted, Green Published, gold			2022-12-27	WOS:000286522200020
J	Mohan, R; Mach, KE; Bercovici, M; Pan, Y; Dhulipala, L; Wong, PK; Liao, JC				Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Dhulipala, Lakshmi; Wong, Pak Kin; Liao, Joseph C.			Clinical Validation of Integrated Nucleic Acid and Protein Detection on an Electrochemical Biosensor Array for Urinary Tract Infection Diagnosis	PLOS ONE			English	Article							UROPATHOGENS; LACTOFERRIN; SAMPLES	Background: Urinary tract infection (UTI) is a common infection that poses a substantial healthcare burden, yet its definitive diagnosis can be challenging. There is a need for a rapid, sensitive and reliable analytical method that could allow early detection of UTI and reduce unnecessary antibiotics. Pathogen identification along with quantitative detection of lactoferrin, a measure of pyuria, may provide useful information towards the overall diagnosis of UTI. Here, we report an integrated biosensor platform capable of simultaneous pathogen identification and detection of urinary biomarker that could aid the effectiveness of the treatment and clinical management. Methodology/Principal Findings: The integrated pathogen 16S rRNA and host lactoferrin detection using the biosensor array was performed on 113 clinical urine samples collected from patients at risk for complicated UTI. For pathogen detection, the biosensor used sandwich hybridization of capture and detector oligonucleotides to the target analyte, bacterial 16S rRNA. For detection of the protein biomarker, the biosensor used an analogous electrochemical sandwich assay based on capture and detector antibodies. For this assay, a set of oligonucleotide probes optimized for hybridization at 37 degrees C to facilitate integration with the immunoassay was developed. This probe set targeted common uropathogens including E. coli, P. mirabilis, P. aeruginosa and Enterococcus spp. as well as less common uropathogens including Serratia, Providencia, Morganella and Staphylococcus spp. The biosensor assay for pathogen detection had a specificity of 97% and a sensitivity of 89%. A significant correlation was found between LTF concentration measured by the biosensor and WBC and leukocyte esterase (p<0.001 for both). Conclusion/Significance: We successfully demonstrate simultaneous detection of nucleic acid and host immune marker on a single biosensor array in clinical samples. This platform can be used for multiplexed detection of nucleic acid and protein as the next generation of urinary tract infection diagnostics.	[Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Liao, Joseph C.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Liao, Joseph C.] Stanford Univ, Biox Program, Sch Med, Stanford, CA 94305 USA; [Mohan, Ruchika; Mach, Kathleen E.; Pan, Ying; Dhulipala, Lakshmi; Liao, Joseph C.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Arizona	Mohan, R (corresponding author), Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA.	jliao@stanford.edu	Wong, Pak Kin/A-7974-2012; Bercovici, Moran/F-6076-2013	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463; Bercovici, Moran/0000-0002-7803-4791	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01 AI082457]; National Science Foundation [ECCS-0901292]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases U01 AI082457 (http://grants.nih.gov/grants/) and National Science Foundation ECCS-0901292 (http://www.nsf.gov/) to Joseph C. Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arao S, 1999, J CLIN MICROBIOL, V37, P553, DOI 10.1128/JCM.37.3.553-557.1999; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Ruz AE, 2000, J UROLOGY, V164, P1285, DOI 10.1016/S0022-5347(05)67157-1; DRUMMOND AJ, 2009, GENEIOUS V4 7; Gao J, 2011, LAB CHIP, V11, P1770, DOI [10.1039/c1lc20054b, 10.1039/c11c20054b]; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Jolkkonen S, 2010, J CLIN MICROBIOL, V48, P3117, DOI 10.1128/JCM.00617-10; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; Liao JC, 2006, J CLIN MICROBIOL, V44, P561, DOI 10.1128/JCM.44.2.561-570.2006; Liao JC, 2007, J MOL DIAGN, V9, P158, DOI 10.2353/jmoldx.2007.060052; Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001; Mach KE, 2011, J UROLOGY, V185, P148, DOI 10.1016/j.juro.2010.09.022; Mach KE, 2009, J UROLOGY, V182, P2735, DOI 10.1016/j.juro.2009.08.028; Manoni F, 2009, DIAGN MICR INFEC DIS, V65, P103, DOI 10.1016/j.diagmicrobio.2009.06.003; Mariella R, 2008, BIOMED MICRODEVICES, V10, P777, DOI 10.1007/s10544-008-9190-7; Mastali M, 2008, J CLIN MICROBIOL, V46, P2707, DOI 10.1128/JCM.00423-08; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Nayak M, 2009, BIOSENS BIOELECTRON, V25, P661, DOI 10.1016/j.bios.2009.08.037; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Pan Y, 2010, BIOSENS BIOELECTRON, V26, P649, DOI 10.1016/j.bios.2010.07.002; Pieretti B, 2010, J CLIN MICROBIOL, V48, P3990, DOI 10.1128/JCM.00975-10; Sin MLY, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-6; Summanen PH, 2005, J CLIN MICROBIOL, V43, P4455, DOI 10.1128/JCM.43.9.4455-4459.2005	27	111	118	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26846	10.1371/journal.pone.0026846	http://dx.doi.org/10.1371/journal.pone.0026846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066011	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000027
J	Huang, QD; Zhong, GX; Zhang, Y; Ren, J; Fu, Y; Zhang, J; Zhu, W; Yu, XQ				Huang, Qing-Dong; Zhong, Guo-Xing; Zhang, Yang; Ren, Jiang; Fu, Yun; Zhang, Ji; Zhu, Wen; Yu, Xiao-Qi			Cyclen-Based Cationic Lipids for Highly Efficient Gene Delivery towards Tumor Cells	PLOS ONE			English	Article							DNA COMPLEXES; TRANSFECTION; VECTORS; THERAPY; LINKER; GROWTH	Background: Gene therapy has tremendous potential for both inherited and acquired diseases. However, delivery problems limited their clinical application, and new gene delivery vehicles with low cytotoxicity and high transfection efficiency are greatly required. Methods: In this report, we designed and synthesized three amphiphilic molecules (L1-L3) with the structures involving 1, 4, 7, 10-tetraazacyclododecane (cyclen), imidazolium and a hydrophobic dodecyl chain. Their interactions with plasmid DNA were studied via electrophoretic gel retardation assays, fluorescent quenching experiments, dynamic light scattering and transmission electron microscopy. The in vitro gene transfection assay and cytotoxicity assay were conducted in four cell lines. Results: Results indicated that L1 and L3-formed liposomes could effectively bind to DNA to form well-shaped nanoparticles. Combining with neutral lipid DOPE, L3 was found with high efficiency in gene transfer in three tumor cell lines including A549, HepG2 and H460. The optimized gene transfection efficacy of L3 was nearly 5.5 times more efficient than that of the popular commercially available gene delivery agent Lipofectamine 2000 (TM) in human lung carcinoma cells A549. In addition, since L1 and L3 had nearly no gene transfection performance in normal cells HEK293, these cationic lipids showed tumor cell-targeting property to a certain extent. No significant cytotoxicity was found for the lipoplexes formed by L1-L3, and their cytotoxicities were similar to or slightly lower than the lipoplexes prepared from Lipofectamine 2000 (TM). Conclusion: Novel cyclen-based cationic lipids for effective in vitro gene transfection were founded, and these studies here may extend the application areas of macrocyclic polyamines, especially for cyclen.	[Huang, Qing-Dong] Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China; Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Huang, QD (corresponding author), Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China.	jzhang@scu.edu.cn; zhuwen@scu.edu.cn; xqyu@scu.edu.cn	Yu, Xiao-Qi/AAF-2741-2020	YU, WEI/0000-0002-1777-5254	National Science Foundation of China [20972104, 20725206, 20732004, 20902062]; Program for Changjiang Scholars and Innovative Research Team in University; Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	This work was financially supported by the National Science Foundation of China (Nos. 20972104, 20725206, 20732004 and 20902062), the Program for Changjiang Scholars and Innovative Research Team in University, the Key Project of Chinese Ministry of Education in China and the Scientific Fund of Sichuan Province for Outstanding Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J GENE MED, V7, P739, DOI 10.1002/jgm.717; Aissaoui A, 2004, J MED CHEM, V47, P5210, DOI 10.1021/jm0408159; Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Boktov J, 2007, J GENE MED, V9, P884, DOI 10.1002/jgm.1079; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cheung JL, 1997, J ORG CHEM, V62, P62, DOI 10.1021/jo961254z; Dobbs W, 2009, J AM CHEM SOC, V131, P13338, DOI 10.1021/ja903028f; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; Ewert KK, 2006, J AM CHEM SOC, V128, P3998, DOI 10.1021/ja055907h; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2000, BBA-BIOMEMBRANES, V1468, P396, DOI 10.1016/S0005-2736(00)00278-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Huang QD, 2008, CHEM BIOL DRUG DES, V71, P224, DOI 10.1111/j.1747-0285.2008.00631.x; Kimura E, 1999, CHEM-EUR J, V5, P3113, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3113::AID-CHEM3113>3.0.CO;2-L; Lam AMI, 2000, BBA-BIOMEMBRANES, V1463, P279, DOI 10.1016/S0005-2736(99)00219-9; Li QL, 2006, BIOORGAN MED CHEM, V14, P4151, DOI 10.1016/j.bmc.2006.01.069; Liberska A, 2009, ORG BIOMOL CHEM, V7, P61, DOI 10.1039/b815733b; Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Petukhov IA, 2010, RUSS CHEM B+, V59, P260, DOI 10.1007/s11172-010-0071-x; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Xia CQ, 2006, BIOORGAN MED CHEM, V14, P5756, DOI 10.1016/j.bmc.2006.04.048; Xiang YZ, 2010, ORG BIOMOL CHEM, V8, P640, DOI 10.1039/b914877a; Yang XB, 2008, BIOORGAN MED CHEM, V16, P3871, DOI 10.1016/j.bmc.2008.01.037; Yi WJ, 2011, ORG BIOMOL CHEM, V9, P2413, DOI 10.1039/c0ob00879f; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016; Zhou LH, 2009, CHEM BIOL DRUG DES, V73, P216, DOI 10.1111/j.1747-0285.2008.00765.x	35	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23134					11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21887233				2022-12-27	WOS:000295454200045
J	Holodniy, M; Brown, ST; Cameron, DW; Kyriakides, TC; Angus, B; Babiker, A; Singer, J; Owens, DK; Anis, A; Goodall, R; Hudson, F; Piaseczny, M; Russo, J; Schechter, M; Deyton, L; Darbyshire, J				Holodniy, Mark; Brown, Sheldon T.; Cameron, D. William; Kyriakides, Tassos C.; Angus, Brian; Babiker, Abdel; Singer, Joel; Owens, Douglas K.; Anis, Aslam; Goodall, Ruth; Hudson, Fleur; Piaseczny, Mirek; Russo, John; Schechter, Martin; Deyton, Lawrence; Darbyshire, Janet		OPTIMA Team	Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial	PLOS ONE			English	Article							STRUCTURED TREATMENT INTERRUPTION; QUALITY-OF-LIFE; CROSS-RESISTANCE; CLINICAL PROGRESSION; VIROLOGICAL FAILURE; MEGA-HAART; COHORT; THERAPY; INHIBITORS; VIRUS	Background: Guidance is needed on best medical management for advanced HIV disease with multidrug resistance (MDR) and limited retreatment options. We assessed two novel antiretroviral (ARV) treatment approaches in this setting. Methods and Findings: We conducted a 262 factorial randomized open label controlled trial in patients with a CD4 count <= 300 cells/mu l who had ARV treatment (ART) failure requiring retreatment, to two options (a) re-treatment with either standard (<= 4 ARVs) or intensive (>= 5 ARVs) ART and b) either treatment starting immediately or after a 12-week monitored ART interruption. Primary outcome was time to developing a first AIDS-defining event (ADE) or death from any cause. Analysis was by intention to treat. From 2001 to 2006, 368 patients were randomized. At baseline, mean age was 48 years, 2% were women, median CD4 count was 106/mu l, mean viral load was 4.74 log(10) copies/ml, and 59% had a prior AIDS diagnosis. Median follow-up was 4.0 years in 1249 person-years of observation. There were no statistically significant differences in the primary composite outcome of ADE or death between re-treatment options of standard versus intensive ART (hazard ratio 1.17; CI 0.86-1.59), or between immediate retreatment initiation versus interruption before re-treatment (hazard ratio 0.93; CI 0.68-1.30), or in the rate of non-HIV associated serious adverse events between re-treatment options. Conclusions: We did not observe clinical benefit or harm assessed by the primary outcome in this largest and longest trial exploring both ART interruption and intensification in advanced MDR HIV infection with poor retreatment options.	[Holodniy, Mark; Owens, Douglas K.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Holodniy, Mark; Owens, Douglas K.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Cameron, D. William] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Cameron, D. William; Singer, Joel; Anis, Aslam; Piaseczny, Mirek; Schechter, Martin] St Pauls Hosp, Canadian HIV Trials Network, Vancouver, BC V6Z 1Y6, Canada; [Kyriakides, Tassos C.; Russo, John] VA Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Angus, Brian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Babiker, Abdel; Goodall, Ruth; Hudson, Fleur; Darbyshire, Janet] MRC Clin Trials Unit, London, England; [Deyton, Lawrence] Off Publ Hlth & Environm Hazards, Dept Vet Affairs, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of Ottawa; Ottawa Hospital Research Institute; St. Paul's Hospital; University of Saskatchewan; University of Oxford; Medical Research Council Clinical Trials Unit	Holodniy, M (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	bcameron@ohri.ca	Kyriakides, Tassos/E-4980-2013; Angus, Brian/L-9246-2019; Cameron, Bill/E-9180-2010; Giongo, Adriana/P-8718-2015; Wasserfall, Clive/J-9078-2012	Kyriakides, Tassos/0000-0001-8913-108X; Angus, Brian/0000-0003-3598-7784; Cameron, Bill/0000-0002-0090-3539; Hyoty, Heikki/0000-0003-0370-4145; Kozal, Michael/0000-0002-3100-8254; Holodniy, Mark/0000-0002-6655-7982; Ilonen, Jorma/0000-0002-9973-2062; Knip, Mikael/0000-0003-0474-0033; Giongo, Adriana/0000-0002-1412-7040; Wasserfall, Clive/0000-0002-3522-8932; , Michael/0000-0002-7719-7396; Drew, Jennifer/0000-0002-4037-108X; Brown, Chris/0000-0002-7758-6447; Schechter, Martin/0000-0001-6063-2155; Goodall, Ruth/0000-0003-0622-5035	Ontario Ministry of Health/Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network, Canada; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish	Ontario Ministry of Health/Ontario HIV Treatment Network(Ministry of Health and Long-Term Care, Ontario); CIHR Canadian HIV Trials Network, Canada(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DWC is supported with a Career Scientist Award of the Ontario Ministry of Health/Ontario HIV Treatment Network. The study was supported in part in Canada through the CIHR Canadian HIV Trials Network. The study funders (MRC-UK, VACSP, CIHR) reviewed and approved the design and conduct of the trial, with external expert reviewers who were represented on the Trial Steering Committee. The OPTIMA Writing Committee and the OPTIMA team had full access to the statistical report and to the study data by request and the Writing Committee had final responsibility for the submitted manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 2002, AIDS RES HUM RETROV, V18, P835, DOI 10.1089/08892220260190308; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; DARMINIO MA, 2005, ARCH INTERN MED, V0165; *DEP HLTH HUM SERV, PAN ANT GUID AD GUID; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Katlama C, 2004, AIDS, V18, P217, DOI 10.1097/00002030-200401230-00011; KAUF TL, 2008, PREDICTIVE MODEL HLT; Kyriakides TC, 2003, CONTROL CLIN TRIALS, V24, P481, DOI 10.1016/S0197-2456(03)00029-1; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; LAWRENCE JKH, 2006, ANTIRETROVIRAL PHENO; Lawrence J, 2006, JAIDS-J ACQ IMM DEF, V43, P169, DOI 10.1097/01.qai.0000242450.74779.ee; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lo Re V, 2008, CLIN LIVER DIS, V12, P587, DOI 10.1016/j.cld.2008.03.009; Miller V, 2000, ANTIVIR THER, V5, P49; Miller V, 2001, ANTIVIR THER, V6, P25; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; Pai N. P., 2006, COCHRANE DB SYST REV, V3; Perno CF, 2008, J MED VIROL, V80, P565, DOI 10.1002/jmv.21034; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Rottmann C, 1999, ANTIVIR THER, V4, P93; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad	30	445	452	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14764	10.1371/journal.pone.0014764	http://dx.doi.org/10.1371/journal.pone.0014764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483491	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200001
J	Weller, K; Ziege, C; Staubach, P; Brockow, K; Siebenhaar, F; Krause, K; Altrichter, S; Church, MK; Maurer, M				Weller, Karsten; Ziege, Claudia; Staubach, Petra; Brockow, Knut; Siebenhaar, Frank; Krause, Karoline; Altrichter, Sabine; Church, Martin K.; Maurer, Marcus			H-1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects - A Retrospective Survey Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; H-1-RECEPTOR ANTAGONISTS; ANTIHISTAMINES; CETIRIZINE; LEVOCETIRIZINE; DESLORATADINE; RUPATADINE; IMPACT; SAFETY; NEEDS	Background: The guidelines recommend that first line treatment of chronic spontaneous urticaria should be second generation non-sedating H-1-antihistamines with a positive recommendation against the use of old sedating first generation antihistamines. If standard dosing is not effective, increasing the dosage up to four-fold is recommended. The objective of this study was to obtain the chronic spontaneous urticaria-patient perspective on the effectiveness and unwanted effects of H1-antihistamines in standard and higher doses. Methodology/Principal Findings: This was a questionnaire based survey, initially completed by 368 individuals. 319 (248 female, 71 male, median age 42 years) had a physician-confirmed diagnosis of chronic spontaneous urticaria and were included in the results. Participants believed standard doses (manufacturers recommended dose) of second generation antihistamines to be significantly (P<0.005) more effective than first generation drugs. Furthermore, they believed that second generation drugs caused significantly (P<0.001) fewer unwanted effects and caused significantly (P<0.001) less sedation than first generation antihistamines. Three-quarters of the patients stated that they had up-dosed with antihistamines with 40%, 42% and 54% reporting significant added benefit from taking 2, 3 or 4 tablets daily respectively. The number of reports of unwanted effects and sedation following up-dosing were not significantly different from those reported for standard doses. Conclusions: This survey supports the urticaria guidelines recommendations that the first line treatment for chronic spontaneous urticaria should be second generation rather than first generation H1-antihistamines and that, if standard dosing is not effective, the dosage should be increased up to four-fold.	[Weller, Karsten; Ziege, Claudia; Siebenhaar, Frank; Krause, Karoline; Altrichter, Sabine; Church, Martin K.; Maurer, Marcus] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, D-13353 Berlin, Germany; [Staubach, Petra] Univ Med Mainz, Dept Dermatol, Mainz, Germany; [Brockow, Knut] Tech Univ, Dept Dermatol & Allergy Biederstein, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Technical University of Munich	Weller, K (corresponding author), Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Krause, Karoline/G-5218-2018; Maurer, Marcus/ABG-2174-2020	Krause, Karoline/0000-0001-9711-9654; Maurer, Marcus/0000-0002-4121-481X; Siebenhaar, Frank/0000-0003-4532-1644; Altrichter, Sabine/0000-0001-9955-385X; Weller, Karsten/0000-0003-4437-0313; Palmer, Kirsten/0000-0001-7421-6291; Tong, Stephen/0000-0002-2319-0586	Essex Pharma (now MSD); Urtikaria Network e.V. (UNEV); Regeneron Pharmaceuticals	Essex Pharma (now MSD); Urtikaria Network e.V. (UNEV); Regeneron Pharmaceuticals(Regeneron)	This work was supported by Essex Pharma (now MSD) and the Urtikaria Network e.V. (UNEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. This work was supported by Essex Pharma (now MSD). KW: The author declares that he is or recently was involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures by Essex Pharma (now MSD), Novartis, Shire and UCB. PS: The author declares that he is or recently was involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures by Essex Pharma (now MSD), Novartis and Shire. FS: The author declares that he was previously involved in clinical trials supported by Essex Pharma (now MSD) and was compensated for educational lectures. KK: The author declares that she was compensated for educational lectures by Novartis, Dr. Pfleger, Shire and received a travel grant from Regeneron Pharmaceuticals. MKC: The author declares that he has received honoraria for lectures or consulting from UCB Pharma, Glaxo Smith Kline, Aventis, FAES Pharma and Schering Plough. MM: The author declares that he is or recently was a speaker and/or advisor for Almirall Hermal, Bayer Schering Pharma, Biofrontera, Essex Pharma, Genentech, JADO Technologies, Jerini, Merckle Recordati, Novartis, Sanofi Aventis, Schering-Plough, Leo, MSD, Merck, Shire, Symbiopharm, UCB, and Uriach. None of the authors has patents or commercial interests in products in development or marketed products to declare. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Asero R, 2007, CLIN EXP DERMATOL, V32, P34, DOI 10.1111/j.1365-2230.2006.02278.x; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Devillier P, 2008, CLIN PHARMACOKINET, V47, P217, DOI 10.2165/00003088-200847040-00001; ESTELLE F, 1994, DRUG SAFETY, V10, P350, DOI 10.2165/00002018-199410050-00002; Gimenez-Arnau A, 2009, J EUR ACAD DERMATOL, V23, P1088, DOI 10.1111/j.1468-3083.2009.03289.x; Godse Kiran V, 2010, Indian Dermatol Online J, V1, P45, DOI 10.4103/2229-5178.73262; Grob JJ, 2005, BRIT J DERMATOL, V152, P289, DOI 10.1111/j.1365-2133.2005.06385.x; Kameyoshi Y, 2007, BRIT J DERMATOL, V157, P803, DOI 10.1111/j.1365-2133.2007.08060.x; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Maurer M, 2009, BRIT J DERMATOL, V160, P633, DOI 10.1111/j.1365-2133.2008.08920.x; Metz M, 2010, ANN ALLERG ASTHMA IM, V104, P86, DOI 10.1016/j.anai.2009.11.013; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Poon E, 1999, BRIT J DERMATOL, V140, P667; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Siebenhaar F, 2009, J ALLERGY CLIN IMMUN, V123, P672, DOI 10.1016/j.jaci.2008.12.008; Simons FER, 1999, ANN ALLERG ASTHMA IM, V83, P481, DOI 10.1016/S1081-1206(10)62855-4; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Simons FER, 2002, J ALLERGY CLIN IMMUN, V110, P777, DOI 10.1067/mai.2002.129123; Staevska M, 2010, J ALLERGY CLIN IMMUN, V125, P676, DOI 10.1016/j.jaci.2009.11.047; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Van der Valk PGM, 2002, BRIT J DERMATOL, V146, P110, DOI 10.1046/j.1365-2133.2002.04582.x; Verster JC, 2004, ANN ALLERG ASTHMA IM, V92, P294, DOI 10.1016/S1081-1206(10)61566-9; Zuberbier T, 1996, DERMATOLOGY, V193, P324, DOI 10.1159/000246281; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	25	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2011	6	9							e23931	10.1371/journal.pone.0023931	http://dx.doi.org/10.1371/journal.pone.0023931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817OO	22046419	Green Published, gold, Green Submitted			2022-12-27	WOS:000294683900014
J	Taylor, AM; Reby, D; McComb, K				Taylor, Anna M.; Reby, David; McComb, Karen			Cross Modal Perception of Body Size in Domestic Dogs (Canis familiaris)	PLOS ONE			English	Article							VOCAL-TRACT RESONANCES; RED DEER; INDIVIDUAL RECOGNITION; PHONETIC INFORMATION; RHESUS MACAQUES; MONKEYS; VOICE; CHIMPANZEE; MACACA; DISCRIMINATION	While the perception of size-related acoustic variation in animal vocalisations is well documented, little attention has been given to how this information might be integrated with corresponding visual information. Using a cross-modal design, we tested the ability of domestic dogs to match growls resynthesised to be typical of either a large or a small dog to size-matched models. Subjects looked at the size-matched model significantly more often and for a significantly longer duration than at the incorrect model, showing that they have the ability to relate information about body size from the acoustic domain to the appropriate visual category. Our study suggests that the perceptual and cognitive mechanisms at the basis of size assessment in mammals have a multisensory nature, and calls for further investigations of the multimodal processing of size information across animal species.	[Taylor, Anna M.; Reby, David; McComb, Karen] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	Taylor, AM (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	anna.magdalena.taylor@gmail.com	reby, david/A-4227-2013	Goldingay, Ross/0000-0002-6684-9299; Reby, David/0000-0001-9261-1711; Walker, Faith/0000-0001-8435-4452	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was entirely funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to author AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adachi I, 2007, BEHAV PROCESS, V74, P27, DOI 10.1016/j.beproc.2006.09.004; [Anonymous], SPORTST VERS 5 4 48; BAUER HR, 1983, PSYCHOL REC, V33, P161, DOI 10.1007/BF03394834; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Johnston RE, 2008, J COMP PSYCHOL, V122, P121, DOI 10.1037/0735-7036.122.2.121; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; Miller E.H., 1991, P128; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Riede T, 1999, J EXP BIOL, V202, P2859; SCHMIDTNIELSEN K, 1975, J EXP ZOOL, V194, P287, DOI 10.1002/jez.1401940120; SINNOTT JM, 1991, J ACOUST SOC AM, V89, P2421, DOI 10.1121/1.400974; SINNOTT JM, 1989, J ACOUST SOC AM, V86, P557, DOI 10.1121/1.398235; SOMMERS MS, 1992, J ACOUST SOC AM, V91, P3499, DOI 10.1121/1.402839; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; WILSON EO, 1972, SCI AM, V227, P52, DOI 10.1038/scientificamerican0972-52	36	54	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17069	10.1371/journal.pone.0017069	http://dx.doi.org/10.1371/journal.pone.0017069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22053200	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000287392700043
